PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Saito, N; Ohira, H				Saito, Natsuki; Ohira, Hideki			Effects of perspective-taking on the pain empathy in alexithymia	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Meeting Abstract	17th World Congress of Psychophysiology of the International-Organization-of-Psychophysiology (IOP)	SEP 23-27, 2014	Hiroshima, JAPAN	Int Org Psychophysiol					[Saito, Natsuki; Ohira, Hideki] Nagoya Univ, Dept Psychol, Nagoya, Aichi 4648601, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	NOV	2014	94	2					247	248		10.1016/j.ijpsycho.2014.08.946		2	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	AR2AJ	WOS:000343385400363		
J	Watanabe, Y; Aikawa, N; Iwaki, T				Watanabe, Yuki; Aikawa, Naoyuki; Iwaki, Tatsuya			Analytical performance of a Fujimori method-based system for EEG analysis	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Meeting Abstract	17th World Congress of Psychophysiology of the International-Organization-of-Psychophysiology (IOP)	SEP 23-27, 2014	Hiroshima, JAPAN	Int Org Psychophysiol					[Watanabe, Yuki; Aikawa, Naoyuki] Tokyo Univ Sci, Tokyo 162, Japan; [Iwaki, Tatsuya] Hiroshima Int Univ, Hiroshima, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	NOV	2014	94	2					248	248		10.1016/j.ijpsycho.2014.08.947		1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	AR2AJ	WOS:000343385400364		
J	Fuseda, K; Nagano, Y; Kobayashi, T				Fuseda, Kohei; Nagano, Yuichiro; Kobayashi, Takefumi			An evaluation of the differences in subjective responses to the attractiveness of pictures of the opposite sex after a visual presentation	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Meeting Abstract	17th World Congress of Psychophysiology of the International-Organization-of-Psychophysiology (IOP)	SEP 23-27, 2014	Hiroshima, JAPAN	Int Org Psychophysiol					[Fuseda, Kohei; Nagano, Yuichiro; Kobayashi, Takefumi] Bunkyo Gakuin Univ, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	NOV	2014	94	2					249	249		10.1016/j.ijpsycho.2014.08.951		1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	AR2AJ	WOS:000343385400368		
J	Mori, K; Wada, Y; Iwanaga, M				Mori, Kazuma; Wada, Yuji; Iwanaga, Makoto			Empathic trait predicts the psychophysiological response of emotional tears	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Meeting Abstract	17th World Congress of Psychophysiology of the International-Organization-of-Psychophysiology (IOP)	SEP 23-27, 2014	Hiroshima, JAPAN	Int Org Psychophysiol					[Mori, Kazuma; Wada, Yuji] Natl Food Res Inst, Tsukuba, Ibaraki, Japan; [Iwanaga, Makoto] Hiroshima Univ, Hiroshima 730, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	NOV	2014	94	2					249	250		10.1016/j.ijpsycho.2014.08.952		2	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	AR2AJ	WOS:000343385400369		
J	Kawamoto, T; Nittono, H; Ura, M				Kawamoto, Taishi; Nittono, Hiroshi; Ura, Mitsuhiro			Event-related potentials indicate low self-esteem individuals give enhanced attention to disgusted faces after being ostracized	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Meeting Abstract	17th World Congress of Psychophysiology of the International-Organization-of-Psychophysiology (IOP)	SEP 23-27, 2014	Hiroshima, JAPAN	Int Org Psychophysiol					[Kawamoto, Taishi; Nittono, Hiroshi] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Hiroshima 730, Japan; [Ura, Mitsuhiro] Otemon Gakuin Univ, Dept Psychol, Ibaraki, Osaka, Japan			Nittono, Hiroshi/C-4043-2009; 	Nittono, Hiroshi/0000-0001-5671-609X; Kawamoto, Taishi/0000-0001-5069-597X				0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	NOV	2014	94	2					251	252		10.1016/j.ijpsycho.2014.08.958		2	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	AR2AJ	WOS:000343385400375		
J	Tamamiya, Y; Kazuo, H				Tamamiya, Yoshiyuki; Kazuo, Hiraki			Video game exposure and recognition of facial expressions: Event-related potential data	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Meeting Abstract	17th World Congress of Psychophysiology of the International-Organization-of-Psychophysiology (IOP)	SEP 23-27, 2014	Hiroshima, JAPAN	Int Org Psychophysiol					[Tamamiya, Yoshiyuki; Kazuo, Hiraki] Univ Tokyo, Grad Sch Arts & Sci, Tokyo 1138654, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	NOV	2014	94	2					251	251		10.1016/j.ijpsycho.2014.08.957		1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	AR2AJ	WOS:000343385400374		
J	Abe, N; Fujii, T; Ito, A; Ueno, A; Koseki, Y; Hashimoto, R; Hayashi, A; Mugikura, S; Takahashi, S; Mori, E				Abe, Nobuhito; Fujii, Toshikatsu; Ito, Ayahito; Ueno, Aya; Koseki, Yuta; Hashimoto, Ryusaku; Hayashi, Akiko; Mugikura, Shunji; Takahashi, Shoki; Mori, Etsuro			Neural basis of dishonest choices for harmful and helpful stories	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Meeting Abstract	17th World Congress of Psychophysiology of the International-Organization-of-Psychophysiology (IOP)	SEP 23-27, 2014	Hiroshima, JAPAN	Int Org Psychophysiol					[Abe, Nobuhito] Kyoto Univ, Kokoro Res Ctr, Kyoto 6068501, Japan; [Fujii, Toshikatsu; Ito, Ayahito; Ueno, Aya; Koseki, Yuta; Hayashi, Akiko; Mori, Etsuro] Tohoku Univ, Grad Sch Med, Dept Behav Neurol & Cognit Neurosci, Sendai, Miyagi 980, Japan; [Hashimoto, Ryusaku; Mugikura, Shunji; Takahashi, Shoki] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Sendai, Miyagi 980, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	NOV	2014	94	2					252	252		10.1016/j.ijpsycho.2014.08.959		1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	AR2AJ	WOS:000343385400376		
J	Himichi, T; Kaneko, M; Nomura, J; Okuma, Y; Nomura, Y; Nomura, M				Himichi, Toshiyuki; Kaneko, Masayuki; Nomura, Jun; Okuma, Yasunobu; Nomura, Yasuyuki; Nomura, Michio			Effect of 5HT2A receptor gene polymorphism on lateral prefrontal cortex activation during empathy	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Meeting Abstract	17th World Congress of Psychophysiology of the International-Organization-of-Psychophysiology (IOP)	SEP 23-27, 2014	Hiroshima, JAPAN	Int Org Psychophysiol					[Himichi, Toshiyuki; Nomura, Michio] Kyoto Univ, Kyoto 6068501, Japan; [Kaneko, Masayuki] Gifu Pharmaceut Univ, Gifu, Japan; [Nomura, Jun] Hiroshima Univ, Hiroshima 730, Japan; [Okuma, Yasunobu] Chiba Inst Sci, Choshi, Chiba, Japan; [Nomura, Yasuyuki] Yokohama Coll Pharm, Yokohama, Kanagawa, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	NOV	2014	94	2					253	253		10.1016/j.ijpsycho.2014.08.961		1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	AR2AJ	WOS:000343385400378		
J	Nakao, T; Bai, Y; Nashiwa, H; Northoff, G				Nakao, Takashi; Bai, Yu; Nashiwa, Hitomi; Northoff, Georg			Resting-state EEG power predicts conflict-related brain activity in internally guided but not in externally guided decision-making	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Meeting Abstract	17th World Congress of Psychophysiology of the International-Organization-of-Psychophysiology (IOP)	SEP 23-27, 2014	Hiroshima, JAPAN	Int Org Psychophysiol					[Nakao, Takashi; Nashiwa, Hitomi] Hiroshima Univ, Hiroshima 730, Japan; [Bai, Yu] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Northoff, Georg] Univ Ottawa, Ottawa, ON K1N 6N5, Canada								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	NOV	2014	94	2					253	253		10.1016/j.ijpsycho.2014.08.963		1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	AR2AJ	WOS:000343385400380		
J	Akiyama, M; Hasegawa, C				Akiyama, Manabu; Hasegawa, Chihiro			Anticipatory SCRs associated with decision making under ambiguity and risk in Iowa gambling task	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Meeting Abstract	17th World Congress of Psychophysiology of the International-Organization-of-Psychophysiology (IOP)	SEP 23-27, 2014	Hiroshima, JAPAN	Int Org Psychophysiol					[Akiyama, Manabu; Hasegawa, Chihiro] Kobe Gakuin Univ, Dept Psychol, Kobe, Hyogo, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	NOV	2014	94	2					254	254		10.1016/j.ijpsycho.2014.08.964		1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	AR2AJ	WOS:000343385400381		
J	Katayama, M; Fujita, T				Katayama, Masazumi; Fujita, Takahiro			Grasp points in different tasks are switched by each task demand: An investigation by a task-change paradigm	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Meeting Abstract	17th World Congress of Psychophysiology of the International-Organization-of-Psychophysiology (IOP)	SEP 23-27, 2014	Hiroshima, JAPAN	Int Org Psychophysiol					[Katayama, Masazumi] Univ Fukui, Grad Sch Engn, Fukui, Japan; [Fujita, Takahiro] Fukui Natl Coll Technol, Sabae, Fukui, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	NOV	2014	94	2					254	255		10.1016/j.ijpsycho.2014.08.966		2	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	AR2AJ	WOS:000343385400383		
J	Yamanaka, K				Yamanaka, Kentaro			Performance and cortical EEG dynamics during bimanual go/stop tasks in right- and left-handed individuals	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Meeting Abstract	17th World Congress of Psychophysiology of the International-Organization-of-Psychophysiology (IOP)	SEP 23-27, 2014	Hiroshima, JAPAN	Int Org Psychophysiol					[Yamanaka, Kentaro] Showa Womens Univ, Grad Sch Human Life Sci, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	NOV	2014	94	2					254	254		10.1016/j.ijpsycho.2014.08.965		1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	AR2AJ	WOS:000343385400382		
J	Ida, H; Mohapatra, S; Aruin, AS				Ida, Hirofumi; Mohapatra, Sambit; Aruin, Alexander S.			How does foot elevation height during upright standing affect the activity of leg muscles on the supporting and lifting side?	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Meeting Abstract	17th World Congress of Psychophysiology of the International-Organization-of-Psychophysiology (IOP)	SEP 23-27, 2014	Hiroshima, JAPAN	Int Org Psychophysiol					[Ida, Hirofumi] Jobu Univ, Dept Sports & Hlth Management, Gunma, Japan; [Mohapatra, Sambit] MedStar Natl Rehabil Network, Washington, DC 20010 USA; [Aruin, Alexander S.] Univ Illinois, Dept Phys Therapy, Chicago, IL USA								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	NOV	2014	94	2					255	255		10.1016/j.ijpsycho.2014.08.967		1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	AR2AJ	WOS:000343385400384		
J	Matsuo, E; Matsubara, S; Shiota, M; Shiga, S; Yamanaka, K				Matsuo, Eriko; Matsubara, Shigeru; Shiota, Masatoshi; Shiga, Seigo; Yamanaka, Kentaro			Effects of subjective and physiological responses during steady-state exercise on post-exercise self-efficacy	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Meeting Abstract	17th World Congress of Psychophysiology of the International-Organization-of-Psychophysiology (IOP)	SEP 23-27, 2014	Hiroshima, JAPAN	Int Org Psychophysiol					[Matsuo, Eriko; Matsubara, Shigeru] Nihon Univ, Sch Pharm, Tokyo 102, Japan; [Shiota, Masatoshi] Yamaguchi Univ, Fac Educ, Yamaguchi, Japan; [Matsuo, Eriko; Shiga, Seigo; Yamanaka, Kentaro] Showa Womens Univ, Grad Sch Human Life Sci, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	NOV	2014	94	2					255	256		10.1016/j.ijpsycho.2014.08.969		2	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	AR2AJ	WOS:000343385400386		
J	Li, JH; Semenyuk, R; Ratmanova, P; Napalkov, D; Cichocki, A				Li, Junhua; Semenyuk, Roxana; Ratmanova, Patricia; Napalkov, Dmitry; Cichocki, Andrzej			Source localization and synchronization analysis on EEG recorded from professional shooters and novices: A comparison study	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Meeting Abstract	17th World Congress of Psychophysiology of the International-Organization-of-Psychophysiology (IOP)	SEP 23-27, 2014	Hiroshima, JAPAN	Int Org Psychophysiol					[Li, Junhua; Cichocki, Andrzej] RIKEN, Brain Sci Inst, Lab Adv Brain Signal Proc, Wako, Saitama, Japan; [Semenyuk, Roxana; Ratmanova, Patricia; Napalkov, Dmitry] Moscow MV Lomonosov State Univ, Fac Biol, Dept Higher Nervous Act, Moscow 117234, Russia			Cichocki, Andrzej/A-1545-2015					0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	NOV	2014	94	2					256	257		10.1016/j.ijpsycho.2014.08.971		2	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	AR2AJ	WOS:000343385400388		
J	Wasaka, T				Wasaka, Toshiaki			Unpredictable visual feedback modulates activation in somatosensory areas during movement execution	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Meeting Abstract	17th World Congress of Psychophysiology of the International-Organization-of-Psychophysiology (IOP)	SEP 23-27, 2014	Hiroshima, JAPAN	Int Org Psychophysiol					[Wasaka, Toshiaki] Nagoya Inst Technol, Nagoya, Aichi, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	NOV	2014	94	2					256	256		10.1016/j.ijpsycho.2014.08.970		1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	AR2AJ	WOS:000343385400387		
J	Sato, M; Miyazawa, S; Iwasaki, S; Suzuki, D; Sora, I				Sato, Megumi; Miyazawa, Shiho; Iwasaki, Shoichi; Suzuki, Daisuke; Sora, Ichiro			The validity of detection of guilty knowledge using fNIRS in a practical situation	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Meeting Abstract	17th World Congress of Psychophysiology of the International-Organization-of-Psychophysiology (IOP)	SEP 23-27, 2014	Hiroshima, JAPAN	Int Org Psychophysiol					[Sato, Megumi; Iwasaki, Shoichi] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan; [Miyazawa, Shiho; Suzuki, Daisuke; Sora, Ichiro] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	NOV	2014	94	2					259	259		10.1016/j.ijpsycho.2014.08.978		1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	AR2AJ	WOS:000343385400395		
J	Ganmaru, S; Akikawa, M; Chung, I				Ganmaru, Shinichi; Akikawa, Motoyoshi; Chung, Inho			The developmental changes of eye movements during sign language reading of a hearing child: From 2 years-old zero month to 2 years-old six months	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Meeting Abstract	17th World Congress of Psychophysiology of the International-Organization-of-Psychophysiology (IOP)	SEP 23-27, 2014	Hiroshima, JAPAN	Int Org Psychophysiol					[Ganmaru, Shinichi] Univ Tsukuba, Special Needs Educ Deaf, Tsukuba, Ibaraki 305, Japan; [Akikawa, Motoyoshi; Chung, Inho] Univ Tsukuba, Tsukuba, Ibaraki 305, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	NOV	2014	94	2					260	261		10.1016/j.ijpsycho.2014.08.982		2	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	AR2AJ	WOS:000343385400399		
J	Izawa, S; Miki, K; Tsuchiya, M; Yamada, H; Nagayama, M				Izawa, Shuhei; Miki, Keiichi; Tsuchiya, Masao; Yamada, Haruyo; Nagayama, Masatoshi			Hair and fingernail cortisol and acute coronary syndrome in middle-aged and elderly men	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Meeting Abstract	17th World Congress of Psychophysiology of the International-Organization-of-Psychophysiology (IOP)	SEP 23-27, 2014	Hiroshima, JAPAN	Int Org Psychophysiol					[Yamada, Haruyo] Chiba Hokusou Hosp, Nippon Med Sch, Chiba, Japan; [Nagayama, Masatoshi] Sakakibara Heart Inst, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	NOV	2014	94	2					261	261		10.1016/j.ijpsycho.2014.08.984		1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	AR2AJ	WOS:000343385400401		
J	Kadooka, S; Matsutake, T; Sugo, T; Araki, M				Kadooka, Susumu; Matsutake, Takahiro; Sugo, Takayuki; Araki, Masanobu			Effects of depression on cortisol awakening responses in college athletes	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Meeting Abstract	17th World Congress of Psychophysiology of the International-Organization-of-Psychophysiology (IOP)	SEP 23-27, 2014	Hiroshima, JAPAN	Int Org Psychophysiol					[Kadooka, Susumu] Osaka Univ Hlth & Sport Sci, Grad Sch, Kumatori, Osaka, Japan; [Matsutake, Takahiro] Osaka Univ Hlth & Sport Sci, Training Sci Ctr, Kumatori, Osaka, Japan; [Sugo, Takayuki; Araki, Masanobu] Osaka Univ Hlth & Sport Sci, Kumatori, Osaka, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	NOV	2014	94	2					261	261		10.1016/j.ijpsycho.2014.08.983		1	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	AR2AJ	WOS:000343385400400		
J	Nowotny, J; Atanacio, AJ; Bak, T; Belova, IV; Fiechter, S; Ikuma, Y; Ionescu, M; Kennedy, BJ; Majewski, P; Murch, GE; Wachsman, ED				Nowotny, J.; Atanacio, A. J.; Bak, T.; Belova, I. V.; Fiechter, S.; Ikuma, Y.; Ionescu, M.; Kennedy, B. J.; Majewski, P.; Murch, G. E.; Wachsman, E. D.			Photosensitive oxide semiconductors for solar hydrogen fuel and water disinfection	INTERNATIONAL MATERIALS REVIEWS			English	Review						Titanium dioxide; Photocatalysis; Photoelectrochemistry; Solar energy conversion; Water splitting; Defect disorder	VISIBLE-LIGHT IRRADIATION; PAST 2 CENTURIES; CR-DOPED COO; TITANIUM-DIOXIDE; ION-IMPLANTATION; GRAIN-BOUNDARIES; TIO2 RUTILE; PHOTOCATALYTIC ACTIVITY; GOLD NANOPARTICLES; MOLECULAR-DYNAMICS	Hydrogen is expected to become a commonly used energy carrier on the global scale in the near future. However, hydrogen as a fuel is environmentally friendly only when generated from water using renewable energy, such as solar energy. Therefore, intensive research aims to develop a new generation of solar materials, which may be used for the production of hydrogen fuel from water using solar energy. The highly promising candidates for solar energy conversion are photosensitive oxide semiconductors (POSs), particularly the TiO2-based semiconductors, which may be used for converting solar energy into the chemical energy required for hydrogen generation from water, as well as water purification (removal of microbial agents and toxic contaminants from water). The present work considers an R&D strategy for developing TiO2-based systems capable of converting solar energy into the chemical energy via water oxidation. The effect of surface versus bulk semiconducting properties on the performance of POSs is considered in terms of partial and total water oxidation. The progress requires modification of the key performance-related properties (KPPs) in order to enhance the light-induced reactivity of the POSs with water. The most recent approach in the development of POSs with enhanced performance is deposition of metallic islets of different size and shape in order to induce a plasmonic effect. The development of high-performance POSs can be achieved through a multidisciplinary approach. It is shown that defect disorder has a critical effect on the light-induced reactivity of POSs and the solar energy conversion. Therefore, defect engineering may be applied in the development of high-performance POSs. This work considers the hurdles in the development of high-performance POSs for specific applications and formulates the key questions that must be addressed to overcome these hurdles. The concepts developed for TiO2 may be expanded for other metal oxides.	[Nowotny, J.; Bak, T.] Univ Western Sydney, Penrith, NSW 2751, Australia; [Atanacio, A. J.; Ionescu, M.] Australian Nucl Sci & Technol Org, Inst Environm Res, Kirrawee Dc, NSW 2232, Australia; [Belova, I. V.; Murch, G. E.] Univ Newcastle, Sch Engn, Callaghan, NSW 2308, Australia; [Fiechter, S.] Helmholtz Zentrum Berlin Mat & Energie, Inst Solar Fuels, D-14109 Berlin, Germany; [Ikuma, Y.] Kanagawa Inst Technol, Atsugi, Kanagawa 24302, Japan; [Kennedy, B. J.] Univ Sydney, Dept Chem, Sydney, NSW 2006, Australia; [Majewski, P.] Univ S Australia, Sch Engn, Adelaide, SA 5095, Australia; [Wachsman, E. D.] Univ Maryland, Energy Res Ctr, College Pk, MD 20742 USA	Nowotny, J (reprint author), Univ Western Sydney, Penrith, NSW 2751, Australia.	J.Nowotny@uws.edu.au					Abdi FF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3195; Alves E, 2012, NUCL INSTRUM METH B, V272, P61, DOI 10.1016/j.nimb.2011.01.033; Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374; Abdi FF, 2013, CHEMCATCHEM, V5, P490, DOI 10.1002/cctc.201200472; Hossain FM, 2012, ADV APPL CERAM, V111, P72, DOI 10.1179/1743676111Y.0000000063; MORISAKI H, 1976, APPL PHYS LETT, V29, P338, DOI 10.1063/1.89088; MURCH GE, 1987, PHIL MAG LETT, V56, P187, DOI 10.1080/09500838708214706; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Nowotny J, 2008, J AM CHEM SOC, V130, P9984, DOI 10.1021/ja7108695; Li SQ, 2009, J PHYS CHEM C, V113, P12759, DOI 10.1021/jp903037f; Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0; ISMAIL A, 1985, SURF SCI, V164, P43, DOI 10.1016/0039-6028(85)90699-5; Jia CL, 2013, NUCL INSTRUM METH B, V313, P50, DOI 10.1016/j.nimb.2013.08.026; HENRICH VE, 1978, J VAC SCI TECHNOL, V15, P534, DOI 10.1116/1.569464; Ni M, 2007, RENEW SUST ENERG REV, V11, P401, DOI 10.1016/j.rser.2005.01.009; Uedono A, 2009, J CRYST GROWTH, V311, P3075, DOI 10.1016/j.jcrysgro.2009.01.051; Paracchino A, 2011, NAT MATER, V10, P456, DOI [10.1038/nmat3017, 10.1038/NMAT3017]; Miller EL, 2005, ELECTROCHEM SOLID ST, V8, pA247, DOI 10.1149/1.1887196; Veziroglu TN, 2000, INT J HYDROGEN ENERG, V25, P1143; Kronik L, 1999, SURF SCI REP, V37, P1, DOI 10.1016/S0167-5729(99)00002-3; Bak T, 2011, J PHYS CHEM C, V115, P15711, DOI 10.1021/jp2027862; Nowotny J, 2008, ENERG ENVIRON SCI, V1, P565, DOI 10.1039/b809111k; Armstrong EN, 2013, PHYS CHEM CHEM PHYS, V15, P2298, DOI 10.1039/c2cp42919e; Paulose M, 2007, J PHYS CHEM C, V111, P14992, DOI 10.1021/jp075258r; KERKER M, 1985, J COLLOID INTERF SCI, V105, P297, DOI 10.1016/0021-9797(85)90304-2; IKEDA JAS, 1993, J AM CERAM SOC, V76, P2447, DOI 10.1111/j.1151-2916.1993.tb03965.x; Yamashita H, 2001, J SYNCHROTRON RADIAT, V8, P569, DOI 10.1107/S090904950001712X; Anpo M, 2003, J CATAL, V216, P505, DOI 10.1016/S0021-9517(02)00104-5; Licht S, 2000, J PHYS CHEM B, V104, P8920, DOI 10.1021/jp002083b; Nowotny J, 2011, INT J HYDROGEN ENERG, V36, P13218, DOI 10.1016/j.ijhydene.2011.07.071; Jin S, 2004, CHEM ENG J, V97, P203, DOI 10.1016/j.cej.2003.04.001; Takeuchi M, 2012, RES CHEM INTERMEDIAT, V38, P1261, DOI 10.1007/s11164-011-0465-x; Galstyan V, 2011, RSC ADV, V1, P1038, DOI 10.1039/c1ra00077b; El-Brolossy TA, 2008, EUR PHYS J-SPEC TOP, V153, P361, DOI 10.1140/epjst/e2008-00462-0; Zhang G, 2007, ELECTROCHEM COMMUN, V9, P2854, DOI 10.1016/j.elecom.2007.10.014; LIU CL, 1995, PHYS REV B, V51, P4523, DOI 10.1103/PhysRevB.51.4523; Abidin Z, 2007, J COMPUT-AIDED MATER, V14, P5, DOI 10.1007/s10820-006-9022-0; Peharz G, 2007, INT J HYDROGEN ENERG, V32, P3248, DOI 10.1016/j.ijhydene.2007.04.036; Menetrey M, 2003, SURF SCI, V524, P49, DOI 10.1016/S0039-6028(02)02464-0; Nowotny J, 2006, J PHYS CHEM B, V110, P18492, DOI 10.1021/jp063699p; Sivula K, 2011, CHEMSUSCHEM, V4, P432, DOI 10.1002/cssc.201000416; Awazu K, 2008, J AM CHEM SOC, V130, P1676, DOI 10.1021/ja076503n; Bak T, 2014, CATAL TODAY, V224, P200, DOI 10.1016/j.cattod.2013.11.039; Sucher NJ, 2012, ADV APPL CERAM, V111, P16, DOI 10.1179/1743676111Y.0000000039; Prasad M, 2005, J COMPUT-AIDED MATER, V12, P17, DOI 10.1007/s10820-005-0697-4; DO YR, 1994, J SOLID STATE CHEM, V108, P198, DOI 10.1006/jssc.1994.1031; Stepanov AL, 2012, REV ADV MATER SCI, V30, P150; Tao JG, 2011, NAT CHEM, V3, P296, DOI [10.1038/nchem.1006, 10.1038/NCHEM.1006]; Haring A, 2012, MATERIALS, V5, P1890, DOI 10.3390/ma5101890; Armstrong EN, 2011, J ELECTROCHEM SOC, V158, pB283, DOI 10.1149/1.3528270; Arnason B, 2000, INT J HYDROGEN ENERG, V25, P389, DOI 10.1016/S0360-3199(99)00077-4; Atanacio AJ, 2012, ACS APPL MATER INTER, V4, P6626, DOI 10.1021/am301729z; Azimi S, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/11/113001; Bak T., 2010, RES REP; Bak T, 2006, J PHYS CHEM B, V110, P21560, DOI 10.1021/jp063700k; BECKER JH, 1962, J APPL PHYS, V33, P447, DOI 10.1063/1.1777139; BOURASSE.S, 1974, J CHIM PHYS PCB, V71, P1017; Breese MBH, 2007, NUCL INSTRUM METH B, V260, P288, DOI 10.1016/j.nimb.2007.02.110; Chen Y., 2012, PHOTON SENSORS, V2, P37, DOI DOI 10.1007/S13320-011-0051-2; Dearnaley G., 1973, ION IMPLANTATION; Fledman L. C., 1985, MAT ANAL; Friedli H., 1986, NATURE, V324, P237, DOI DOI 10.1038/324237A0; Fujishima A., 1999, TIO2 PHOTOCATALYSIS; Gopal K., 2006, SOL ENERG MAT SOL C, V90, P2011; Gopal P., 2006, SOL ENERG MAT SOL C, V90, P2011; HABER J, 1984, APPL SURF SCI, V17, P324, DOI 10.1016/0378-5963(84)90020-5; Henrich V, 1994, SURFACE SCI METAL OX; Herrmann-Geppert I, 2013, PHYS CHEM CHEM PHYS, V15, P1389, DOI 10.1039/c2cp42651j; Ikuma Y, 2013, J CERAM SOC JPN, V121, P254, DOI 10.2109/jcersj2.121.254; Kaiser B., 2011, BUNSEN MAGAZIN, V13, P104; Kan CC, 2009, J ELECTROCHEM SOC, V156, pB695, DOI 10.1149/1.3110983; Kashelev O., 1998, SCIENCE, V280, P425; Keeling CD., 1989, GEOPHYS MONOGR SER, V55, P165, DOI DOI 10.1029/GM055P0165; Kofstad P., 1972, ELECT CONDUCTIVITY D; Kroger F.A., 1974, CHEM IMPERFECT CRYST; Kumari P, 2012, J NANOSCI NANOTECHNO, V12, P8001, DOI 10.1166/jnn.2012.6655; Liu B, 2004, COMPUT METHOD APPL M, V193, P1849, DOI 10.1016/j.cma.2003.12.037; Markwitz A, 2012, NUCL INSTRUM METH B, V273, P199, DOI 10.1016/j.nimb.2011.07.075; Martin C, 1997, CATAL LETT, V49, P235, DOI 10.1023/A:1019025926206; Mock JJ, 2002, J CHEM PHYS, V116, P6755, DOI 10.1063/1.1462610; NAKAMURA S, 1988, NUCL INSTRUM METH B, V33, P729; NEFTEL A, 1985, NATURE, V315, P45, DOI 10.1038/315045a0; Norby T, 2009, MRS BULL, V34, P923, DOI 10.1557/mrs2009.214; Nowotny J, 2005, ADV APPL CERAM, V104, P214, DOI 10.1179/174367605X46849; Nowotny J, 2014, INT J HYDROGEN ENERG, V39, P4151, DOI 10.1016/j.ijhydene.2013.12.114; NOWOTNY J, 1982, J AM CERAM SOC, V65, P192, DOI 10.1111/j.1151-2916.1982.tb10402.x; Nowotny J, 1991, SCI CERAMIC INTERFAC, P79; Nowotny J, 2012, GREEN CHEM CHEM ENG, P1; NOWOTNY J, 1984, SOLID STATE IONICS, V12, P253, DOI 10.1016/0167-2738(84)90154-1; Nozik A., 1976, J APPL PHYS, V29, P150; Service RF, 2002, SCIENCE, V297, P2189; Tesmer J. R., 1995, HDB MODERN ION BEAM, P83; Thomas CE, 1998, INT J HYDROGEN ENERG, V23, P949, DOI 10.1016/S0360-3199(97)00150-X; Wang ML, 2012, ELECTROCHIM ACTA, V62, P424, DOI 10.1016/j.electacta.2011.12.054; Yamaki T, 2003, NUCL INSTRUM METH B, V206, P254, DOI 10.1016/S0168-583X(03)00735-3; YONEYAMA H, 1975, ELECTROCHIM ACTA, V20, P341, DOI 10.1016/0013-4686(75)90016-X; Ziegler J. F., 2004, NUCL INSTRUM METH B, V1027, P219	97	3	3	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0950-6608	1743-2804		INT MATER REV	Int. Mater. Rev.	NOV	2014	59	8					449	478		10.1179/1743280414Y.0000000039		30	Materials Science, Multidisciplinary	Materials Science	AR6KB	WOS:000343691400003		
J	Furuta, A; Suzuki, Y; Naruoka, T; Asano, K; Egawa, S; Yoshimura, N				Furuta, Akira; Suzuki, Yasuyuki; Naruoka, Takehito; Asano, Kouji; Egawa, Shin; Yoshimura, Naoki			Cross-sensitization mechanisms between colon and bladder via transient receptor potential A1 stimulation in rats	INTERNATIONAL UROGYNECOLOGY JOURNAL			English	Article						Transient receptor potential A1; Colon; Bladder; Cross-sensitization; Interstitial cystitis/bladder pain syndrome	IRRITABLE-BOWEL-SYNDROME; MOUSE URINARY-BLADDER; INTERSTITIAL CYSTITIS; CHANNEL; PAIN; EXPRESSION; FIBERS; NERVE; TRPA1; INFLAMMATION	Introduction and hypothesis The aim of this study was to analyze the mechanism underlying cross-sensitization between the colon and the bladder via activation of transient receptor potential A1 (TRPA1) channels. Methods Using female Sprague-Dawley rats, polyethylene catheters were inserted into the colon between two ligations at the levels of 40 and 60 mm rostral to the anus and into the bladder. (1) We examined changes in colon and bladder activity after the application of allyl isothiocyanate (AI, 50 mM, 300 mu l), a TRPA1 activator, into the colon or the bladder in an awake condition. Inhibitory effects of the pretreatment with HC-030031 (HC, 3 mg/kg), a TRPA1 inhibitor, on colon-to-bladder cross-sensitization induced by AI instilled in the colon were also investigated. (2) We examined Evans blue (EB) dye extravasation after TRPA1 stimulation in the colon or the bladder to evaluate vascular permeability due to tissue inflammation. Results (1) Intercontraction intervals during continuous saline infusion into the bladder (0.04 ml/min) were significantly decreased after the intracolonic AI application, which significantly increased mean intracolonic pressure, indicative of colon-to-bladder cross-sensitization. The AI-induced colon-to-bladder cross-sensitization was completely prevented by the pretreatment with intravenous application of HC. On the other hand, mean intracolonic pressure was significantly decreased after the intravesical AI application, which significantly increased mean intravesical pressure. (2) EB dye extravasation was significantly increased in the AI-treated inflamed organs and also in the bladder following intracolonic AI treatment. Conclusions Colon-to-bladder cross-sensitization is mediated via TRPA1 stimulation in the colon, although TRPA1 expressed in the bladder does not seem to participate in bladder-to-colon cross-sensitization.	[Furuta, Akira; Naruoka, Takehito; Asano, Kouji; Egawa, Shin] Jikei Univ, Sch Med, Dept Urol, Tokyo, Japan; [Suzuki, Yasuyuki] Tokyo Rehabil Hosp, Dept Urol, Tokyo, Japan; [Yoshimura, Naoki] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA USA	Furuta, A (reprint author), 3-25-8 Nishi Shinbashi Minato Ku, Tokyo 1058461, Japan.	a-furuta@rf7.so-net.ne.jp			Department of Defense [W81XWH-12-1-0565]	This study was supported by Department of Defense grant W81XWH-12-1-0565.	Liu L, 2007, NEUROUROL URODYNAM, V26, P433, DOI 10.1002/nau.20326; Yamada T, 2009, J HISTOCHEM CYTOCHEM, V57, P277, DOI 10.1369/jhc.2008.951962; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Tsukimi Y, 2005, UROLOGY, V65, P406, DOI 10.1016/j.urology.2004.10.006; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; La JH, 2011, NEUROSCIENCE, V186, P179, DOI 10.1016/j.neuroscience.2011.04.049; Suzuki M, 2003, NEUROSCI LETT, V353, P189, DOI 10.1016/j.neulet.2003.09.041; Malykhina AP, 2007, NEUROSCIENCE, V149, P660, DOI 10.1016/j.neuroscience.2007.07.053; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; de Groat WC, 2006, BRIT J PHARMACOL, V147, pS25, DOI 10.1038/sj.bjp.0706604; Andrade EL, 2006, BIOCHEM PHARMACOL, V72, P104, DOI 10.1016/j.bcp.2006.04.003; Christianson JA, 2007, PAIN, V128, P235, DOI 10.1016/j.pain.2006.09.023; Peng HY, 2009, PAIN, V142, P75, DOI 10.1016/j.pain.2008.11.017; Brierley SM, 2009, GASTROENTEROLOGY, V137, P2084, DOI 10.1053/j.gastro.2009.07.048; Alagiri M, 1997, UROLOGY, V49, P52, DOI 10.1016/S0090-4295(99)80332-X; Andersson KE, 2010, BJU INT, V106, P1114, DOI 10.1111/j.1464-410X.2010.09650.x; Du SQ, 2008, UROLOGY, V72, P450, DOI 10.1016/j.urology.2007.11.127; Blanchard EB, 2004, J PSYCHOSOM RES, V56, P431, DOI 10.1016/S0022-3999(03)00627-5; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Akbar A, 2008, GUT, V57, P923, DOI 10.1136/gut.2007.138982; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Asfaw TS, 2011, AM J PHYSIOL-REG I, V300, pR1392, DOI 10.1152/ajpregu.00804.2010; Berkley KJ, 2005, PHYSIOL BEHAV, V86, P272, DOI 10.1016/j.physbeh.2005.08.013; Furuta A, 2012, INT J UROL, V19, P429, DOI 10.1111/j.1442-2042.2012.02966.x; Malykhina AP, 2006, NEUROGASTROENT MOTIL, V18, P936, DOI 10.1111/j.1365-2982.2006.00807.x; Novi JM, 2005, J UROLOGY, V174, P937, DOI 10.1097/01.ju.0000169258.31345.5d; Rouzade-Dominguez ML, 2003, EUR J NEUROSCI, V18, P3311, DOI 10.1046/j.1460-9568.2003.03071.x; Satoh JI, 2009, J ANESTH, V23, P620, DOI 10.1007/s00540-009-0786-8; Winnard KP, 2006, AM J PHYSIOL-REG I, V291, pR1592, DOI 10.1152/ajpregu.00455.2006	29	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-3462	1433-3023		INT UROGYNECOL J	Int. Urogynecol. J.	NOV	2014	25	11					1575	1581		10.1007/s00192-014-2405-y		7	Obstetrics & Gynecology; Urology & Nephrology	Obstetrics & Gynecology; Urology & Nephrology	AR5XQ	WOS:000343655000018		
J	Fujiwara, KP; Zaman, H; Surinkum, A; Chaiwong, N; Fujihara, M; Ahn, HS; Otofuji, Y				Fujiwara, Katsuya P.; Zaman, Haider; Surinkum, Adichat; Chaiwong, Nikhom; Fujihara, Makoto; Ahn, Hyeon-Seon; Otofuji, Yo-ichiro			New insights into regional tectonics of the Indochina Peninsula inferred from Lower-Middle Jurassic paleomagnetic data of the Sibumasu Terrane	JOURNAL OF ASIAN EARTH SCIENCES			English	Article						Sibumasu Terrane; Paleomagnetism; Jurassic; Tectonics; SE Asia	STRIKE-SLIP FAULTS; NORTHERN THAILAND; SOUTHEAST-ASIA; SEDIMENTARY-ROCKS; WESTERN THAILAND; SHAN-THAI; FOLD TEST; SE ASIA; MAE SOT; DEFORMATION	The post-Jurassic occurrence of differential tectonic rotation between the Indochina and South Sundaland blocks remains an issue to be properly investigated. New paleomagnetic study is used here to find the role of Sibumasu Terrane in this rotation, which is located between a clockwise rotated Indochina Block and a counter-clockwise rotated South Sundaland Block. For this purpose, lower to middle Jurassic red sandstones of the Umphang Group in the Sibumasu Terrane were sampled at 21 sites in the Ratchaburi area (13.6 degrees E, 99.6 degrees E), Thailand. Stepwise thermal demagnetization by 680 degrees C unblocked a pre-folding characteristic remanent magnetization. A mean direction of this component at 100% unfolding is Ds = 348.5 degrees, Is = 24.7 degrees, alpha(95) = 10.5 degrees, k = 10.7, N = 20, corresponding to an Early-Middle Jurassic pole of lambda = 78.6 degrees N, phi = 10.6 degrees E (A(95) = 9.3). Comparison of this direction with those reported from other localities of the Umphang Group (Kalaw, Mae Sot and North Trang Syncline localities) reveal variable declinations (between 348.5 degrees and 44.7 degrees) for the Sibumasu Terrane. We ascribe this variation to differential tectonic deformation in the Sibumasu Terrane, as reflected from sinusoidal shaped structural features in the study area. The presence of such features in the granitic rocks indicates the occurrences of deformational activities after their intrusion, which took place in the period between 130 Ma and 51 Ma. The Sibumasu Terrane behaved as an independent fragment at a time when Indochina was undergoing a clockwise rotation and southward displacement, as a result of extrusion tectonics after the gigantic India-Asia collision. Taking into consideration a westerly deflected declination (D = 342.8 degrees) from the West Trang area in Peninsular Thailand, a counterclockwise rotation of 15 degrees is estimated for the Sibumasu Terrane, as a result of continuous northward indentation of the Australian Plate into South Sundaland Block. (C) 2014 Elsevier Ltd. All rights reserved.	[Fujiwara, Katsuya P.; Ahn, Hyeon-Seon; Otofuji, Yo-ichiro] Kobe Univ, Fac Sci, Dept Earth & Planetary Sci, Kobe, Hyogo 657, Japan; [Zaman, Haider] Taibah Univ, Fac Sci, Dept Geol, Madinah 41477, Saudi Arabia; [Surinkum, Adichat; Chaiwong, Nikhom] Dept Mineral Resources, Econ Geol Div, Bangkok, Thailand; [Fujihara, Makoto] Horizon Inst Geol & Chronol Co Ltd, Okayama 7038252, Japan	Otofuji, Y (reprint author), Kobe Univ, Fac Sci, Dept Earth & Planetary Sci, Kobe, Hyogo 657, Japan.	otofuji@kobe-u.ac.jp			Toyota Foundation, Japan; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [18403012, 22403012]; Global Center of Excellence (GCOE); International Center of Planetary Sciences (also under the MEXT)	Koji Uno, Masako Miki and Masatoshi Sone are warmly thanked for their valuable comments. We are grateful to Mineral Resources Department of Bangkok for logistical support in the field. We thank M. Tanaka for his help during the sampling trip. We also thank A.J. Barber, R. Hall and four anonymous reviewers for their constructive comments that greatly improved the quality of the paper. This research work is partly supported by Toyota Foundation, Japan. In addition, Grant-in aid (Nos. 18403012, 22403012) from Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) has been used to accomplish this project. Finally, we would also like to thank the Global Center of Excellence (GCOE), a Program and Foundation from International Center of Planetary Sciences (also under the MEXT) for their support in accomplishing this project.	ACHACHE J, 1984, J GEOPHYS RES, V89, P311, DOI 10.1029/JB089iB12p10311; Otofuji YI, 2007, EARTH PLANET SC LETT, V262, P581, DOI 10.1016/j.epsl.2007.08.013; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Enkin RJ, 2003, EARTH PLANET SC LETT, V212, P151, DOI 10.1016/S0012-821X(03)00238-3; Charusiri P, 2006, GONDWANA RES, V9, P310, DOI 10.1016/j.gr.2005.11.006; Lee TY, 1995, TECTONOPHYSICS, V251, P85, DOI 10.1016/0040-1951(95)00023-2; Yang ZY, 1995, EARTH PLANET SC LETT, V136, P325, DOI 10.1016/0012-821X(95)00192-F; Takemoto K, 2009, GEOPHYS J INT, V179, P97, DOI [10.1111/j.1365-246X.2009.04274.X, 10.1111/j.1365-246X.2009.04274.x]; MCFADDEN PL, 1990, GEOPHYS J INT, V103, P163, DOI 10.1111/j.1365-246X.1990.tb01761.x; Otofuji Y, 2012, GONDWANA RES, V22, P615, DOI 10.1016/j.gr.2011.09.015; Metcalfe I, 2013, J ASIAN EARTH SCI, V66, P1, DOI 10.1016/j.jseaes.2012.12.020; HOUSEMAN G, 1993, J GEOPHYS RES-SOL EA, V98, P12233, DOI 10.1029/93JB00443; FISHER R, 1953, PROC R SOC LON SER-A, V217, P295, DOI 10.1098/rspa.1953.0064; Morley CK, 2007, J STRUCT GEOL, V29, P36, DOI 10.1016/j.jsg.2006.07.003; PULLAIAH G, 1975, EARTH PLANET SC LETT, V28, P133, DOI 10.1016/0012-821X(75)90221-6; Plattner C, 2010, GEOPHYS J INT, V183, P1089, DOI 10.1111/j.1365-246X.2010.04803.x; Hall R, 2012, TECTONOPHYSICS, V570, P1, DOI 10.1016/j.tecto.2012.04.021; Aihara K, 2007, J ASIAN EARTH SCI, V30, P530, DOI 10.1016/j.jseaes.2007.01.002; Smyth HR, 2007, EARTH PLANET SC LETT, V258, P269, DOI 10.1016/j.epsl.2007.03.044; Mitchell AHG, 2007, J ASIAN EARTH SCI, V29, P891, DOI 10.1016/j.jseaes.2006.05.009; Cogne JP, 2013, GEOPHYS J INT, V192, P1000, DOI 10.1093/gji/ggs104; Ferrari OM, 2008, TECTONOPHYSICS, V451, P346, DOI 10.1016/j.tecto.2007.11.065; Fenton CH, 2003, ANN GEOPHYS-ITALY, V46, P957; Searle MP, 2011, GEOLOGY OF THAILAND, P539; YANG ZY, 1993, EARTH PLANET SC LETT, V117, P525, DOI 10.1016/0012-821X(93)90101-E; Otofuji Y, 2010, J ASIAN EARTH SCI, V37, P438, DOI 10.1016/j.jseaes.2009.11.003; LOWRIE W, 1990, GEOPHYS RES LETT, V17, P159, DOI 10.1029/GL017i002p00159; Allmendinger RW, 2007, TECTONICS, V26, DOI 10.1029/2006TC002030; MCELHINNY MW, 1964, GEOPHYS J ROY ASTR S, V8, P338; KIRSCHVINK JL, 1980, GEOPHYS J ROY ASTR S, V62, P699, DOI 10.1111/j.1365-246X.1980.tb02601.x; Coster P, 2010, GEOL SOC AM BULL, V122, P1180, DOI 10.1130/B26568.1; SCHWARTZ SY, 1983, GEOPHYS RES LETT, V10, P505, DOI 10.1029/GL010i007p00505; Cogne JP, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000227; Fuller M, 1999, J ASIAN EARTH SCI, V17, P3, DOI 10.1016/S0743-9547(98)00057-9; Gan WJ, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB004120; Barr S.M., 1991, J THAI GEOSCIENCE, V1, P11; Benammi M, 2001, GEOL SOC AM BULL, V113, P265, DOI 10.1130/0016-7606(2001)113<0265:EKBSTP>2.0.CO;2; Besse J., 2002, J GEOPHYS RES, V107; Bhongsuwan T., 2002, SCI ASIA, V28, P277, DOI 10.2306/scienceasia1513-1874.2002.28.277; Bunapas S, 1981, THESIS VICTORIA U WE; COBBING EJ, 1986, J GEOL SOC LONDON, V143, P537, DOI 10.1144/gsjgs.143.3.0537; Cogne JP, 2013, CR GEOSCI, V345, P419, DOI 10.1016/j.crte.2013.10.001; Cook K., 2008, J GEOPHYS RES, V113, DOI http://dx.doi.org/10.1029/2007JB005457; HAILE NS, 1978, TECTONOPHYSICS, V46, P77, DOI 10.1016/0040-1951(78)90106-3; Hirsch F, 2006, GEOSCI J, V10, P195, DOI 10.1007/BF02910364; Hisada K, 2004, ISL ARC, V13, P119, DOI 10.1111/j.1440-1738.2003.00412.x; HOUSEMAN G, 1986, J GEOPHYS RES-SOLID, V91, P3651, DOI 10.1029/JB091iB03p03651; Kornfeld D., 2014, GEOPHYS J INT, V19, P149; Kozai T, 2006, GEOSCI J, V10, P205, DOI 10.1007/BF02910365; Kozai T, 2011, GONDWANA RES, V19, P37, DOI 10.1016/j.gr.2010.04.003; Meesook A, 1996, J SOUTHE ASIAN EARTH, V14, P377, DOI 10.1016/S0743-9547(96)00073-6; Meesook A, 2011, GEOLOGY OF THAILAND, P151; Morley CK, 2012, EARTH-SCI REV, V115, P37, DOI 10.1016/j.earscirev.2012.08.002; PELTZER G, 1988, J GEOPHYS RES-SOLID, V93, P15085, DOI 10.1029/JB093iB12p15085; Pubellier M, 2003, TECTONOPHYSICS, V363, P181, DOI 10.1016/S0040-1951(02)00671-6; Putthapiban P., 2002, P S GEOL THAIL AUG 2, P156; Rhodes B.P., 2005, INT C GEOL GEOT MIN, P498; Richter B., 1996, GEOLOGICAL SOC SPECI, V106, P203, DOI 10.1144/GSL.SP.1996.106.01.13; Richter B., 1999, J ASIAN EARTH SCI, V17, P419; Ridd M.F., 2014, J ASIAN EAR IN PRESS; Ridd MF, 2012, J ASIAN EARTH SCI, V51, P63, DOI 10.1016/j.jseaes.2012.01.018; SASAJIMA S, 1980, TECTONOPHYSICS, V64, P163, DOI 10.1016/0040-1951(80)90267-X; SCHMIDTKE EA, 1990, TECTONICS, V9, P123, DOI 10.1029/TC009i001p00123; SHIBUYA H, 1991, P OCEAN DRILLING PRO, V0124; Sone M, 2008, CR GEOSCI, V340, P166, DOI 10.1016/j.crte.2007.09.008; Sunata W., 1991, STUDIES E ASIAN TECT; TAPPONNIER P, 1982, GEOLOGY, V10, P611, DOI 10.1130/0091-7613(1982)10<611:PETIAN>2.0.CO;2; Ueno K., 2001, GONDWANA RES, V4, P804, DOI 10.1016/S1342-937X(05)70590-6; Watkinson I, 2008, J STRUCT GEOL, V30, P1554, DOI 10.1016/j.jsg.2008.09.001; Yamashita I, 2011, J ASIAN EARTH SCI, V40, P784, DOI 10.1016/j.jseaes.2010.11.001; Zijderveld J.D.A., 1967, METHODS PALEOMAGNETI, P254	71	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1367-9120	1878-5786		J ASIAN EARTH SCI	J. Asian Earth Sci.	NOV	2014	94				SI		126	138		10.1016/j.jseaes.2014.08.020		13	Geosciences, Multidisciplinary	Geology	AR1ND	WOS:000343351000011		
J	Ohnishi, M; Sasaki, N; Kishimoto, T; Watanabe, H; Takagi, M; Mizutani, S; Kishii, N; Yasuda, A				Ohnishi, Michihiro; Sasaki, Naoyuki; Kishimoto, Takuya; Watanabe, Hidetoshi; Takagi, Masatoshi; Mizutani, Shuki; Kishii, Noriyuki; Yasuda, Akio			A new microcolumn-type microchip for examining the expression of chimeric fusion genes using a nucleic acid sandwich hybridization technique	JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES			English	Article						Chimeric fusion gene; Gene expression; Nucleic acid sandwich hybridization; Microcolumn chromatography; Semi-transparent microbead; Fluorescent detection		We report a new type of microcolumn installed in a microchip. The architecture allows use of a nucleic acid sandwich hybridization technique to detect a messenger RNA (mRNA) chain as a target. Data are presented that demonstrate that the expression of a chimeric fusion gene can be detected. The microcolumn was filled with semi-transparent microbeads made of agarose gel that acted as carriers, allowing increased efficiency of the optical detection of fluorescence from the microcolumn. The hybrid between the target trapped on the microbeads and a probe DNA labeled with a fluorescent dye was detected by measuring the intensity of the fluorescence from the microcolumn directly. These results demonstrate an easy and simple method for determining the expression of chimeric fusion genes with no preamplification. (C) 2014 Elsevier B.V. All rights reserved.	[Ohnishi, Michihiro; Sasaki, Naoyuki; Kishimoto, Takuya; Watanabe, Hidetoshi; Kishii, Noriyuki; Yasuda, Akio] Sony Corp, R&D Div, Med Business Unit, Shinagawa Ku, Tokyo 1410001, Japan; [Takagi, Masatoshi; Mizutani, Shuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138510, Japan	Ohnishi, M (reprint author), Sony Corp, Reliabil & Qual Assurance Div, Med Business Unit, Minato Ku, 1-7-1 Konan, Tokyo 1080075, Japan.	Michihiro.Ohnishi@jp.sony.com					Anderson M.L.M., 1999, NUCL ACID HYBRIDIZAT; Katamori T., 2004, TECHNOLOGY APPL MICR; Makabe K., 1997, BIO EXPT ILLUSTRATED, P4; Mihashi K., 2006, KEIKO BUNKO IMEIJING; Ohnishi M., IUMRS INT C 2008 IUM; Ohnishi M, 2006, J CHROMATOGR A, V1109, P122, DOI 10.1016/j.chroma.2005.11.031; Weinberg R.A., 2007, BIOL CANC GARLAND SC	7	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-0232	1873-376X		J CHROMATOGR B	J. Chromatogr. B	NOV 1	2014	970						60	67		10.1016/j.jchromb.2014.08.036		8	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	AR1KE	WOS:000343343300009		
J	Kobayashi, Y; Yamada, A; Watabe, H; Takahashi, R; Suzuki, H; Hirata, Y; Yamaji, Y; Yoshida, H; Koike, K				Kobayashi, Yuka; Yamada, Atsuo; Watabe, Hirotsugu; Takahashi, Ryota; Suzuki, Hirobumi; Hirata, Yoshihiro; Yamaji, Yutaka; Yoshida, Haruhiko; Koike, Kazuhiko			Sonographic Detection of a Patency Capsule Prior to Capsule Endoscopy: Case Report	JOURNAL OF CLINICAL ULTRASOUND			English	Article						patency capsule; ultrasonography; capsule endoscopy; abdomen; gastrointestinal tract	INTESTINAL STRICTURES; RETENTION; DIAGNOSIS; RISK	To avoid retention of the capsule used in capsule endoscopy (CE), the patency capsule (PC), a self-disintegrating sham capsule, is administered prior to CE in patients suspected of small intestinal stenosis. If the PC is excreted intact within 30 hours of ingestion, the patient can undergo CE without retention. However, if the PC is not excreted within 30 hours, its location must be confirmed as in either the small intestine or the colon because of the potential for small intestinal stenosis in the former case. It is often difficult to confirm the location of the PC by abdominal radiograph. We report the case of one patient who did not excrete the PC within 30 hours and for whom it was difficult to distinguish whether the PC was in the small intestine or the colon on abdominal series. Abdominal sonography revealed the PC in the colon and subsequent CE was performed without complication. (c) 2014 Wiley Periodicals, Inc. J Clin Ultrasound42:554-556, 2014	[Kobayashi, Yuka; Yamada, Atsuo; Watabe, Hirotsugu; Takahashi, Ryota; Suzuki, Hirobumi; Hirata, Yoshihiro; Yamaji, Yutaka; Yoshida, Haruhiko; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan	Yamada, A (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.						Iddan G, 2000, NATURE, V405, P417, DOI 10.1038/35013140; Cheifetz AS, 2006, AM J GASTROENTEROL, V101, P2218, DOI 10.1111/j.1572-0241.2006.00761.x; Cave D, 2005, ENDOSCOPY, V37, P1065, DOI 10.1055/s-870264; Yadav A, 2011, GASTROINTEST ENDOSC, V74, P834, DOI 10.1016/j.gie.2011.05.038; Liao ZA, 2010, GASTROINTEST ENDOSC, V71, P280, DOI 10.1016/j.gie.2009.09.031; Herrerias JM, 2008, GASTROINTEST ENDOSC, V67, P902, DOI 10.1016/j.gie.2007.10.063; Li F, 2008, GASTROINTEST ENDOSC, V68, P174, DOI 10.1016/j.gie.2008.02.037; Ripolles T, 2001, AM J ROENTGENOL, V177, P65; Ido K, 1998, J CLIN ULTRASOUND, V26, P125, DOI 10.1002/(SICI)1097-0096(199803/04)26:3<125::AID-JCU3>3.0.CO;2-O; Parra DA, 2008, PEDIATR RADIOL, V38, P680, DOI 10.1007/s00247-008-0812-2	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0091-2751	1097-0096		J CLIN ULTRASOUND	J. Clin. Ultrasound	NOV-DEC	2014	42	9					554	556		10.1002/jcu.22147		3	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	AR7NM	WOS:000343766500007		
J	Charlier, E; Kamae, T; Puzynina, S; Zamboni, LQ				Charlier, Emilie; Kamae, Teturo; Puzynina, Svetlana; Zamboni, Luca Q.			Infinite self-shuffling words	JOURNAL OF COMBINATORIAL THEORY SERIES A			English	Article						Word shuffling; Sturmian words; Lyndon words; Morphic words; Thue-Morse word	STURMIAN WORDS; SEQUENCES; INVARIANT	In this paper we introduce and study a new property of infinite words: An infinite word x is an element of A(II), with values in a finite set A, is said to be k-self-shuffling (k >= 2) if x admits factorizations: x = Pi(infinity)(i=0) U-i((I)) ... U-i((k)) = Pi(infinity)(i=0) U-i((I))) = ... = Pi(infinity)(i=0) U-i((k)). In other words, there exists a shuffle of k-copies of x which produces x. We are particularly interested in the case k = 2, in which case we say x is self-shuffling. This property of infinite words is shown to be independent of the complexity of the word as measured by the number of distinct factors of each length. Examples exist from bounded to full complexity. It is also an intrinsic property of the word and not of its language (set of factors). For instance, every aperiodic word contains a non-self-shuffling word in its shift orbit closure. While the property of being self-shuffling is a relatively strong condition, many important words arising in the area of symbolic dynamics are verified to be self-shuffling. They include for instance the Thue-Morse word fixed by the morphism 0 bar right arrow 01, 1 bar right arrow 10. As another example we show that all Sturmian words of slope alpha is an element of R \ Q and intercept 0 < p < 1 are self-shuffling (while those of intercept p = 0 are not). Our characterization of self-shuffling Sturmian words can be interpreted arithmetically in terms of a dynamical embedding and defines an arithmetic process we call the stepping stone model. One important feature of self-shuffling words stems from their morphic invariance: The rnorphic image of a self-shuffling word is self-shuffling. This provides a useful tool for showing that one word is not the morphic image of another. In addition to its morphic invariance, this new notion has other unexpected applications particularly in the area of substitutive dynamical systems. For example, as a consequence of our characterization of self-shuffling Sturmian words, we recover a number theoretic result, originally due to Yasutomi, on a classification of pure morphic Sturmian words in the orbit of the characteristic. (C) 2014 Elsevier Inc. All rights reserved.	[Charlier, Emilie] Univ Liege, Dept Math, B-4000 Liege, Belgium; [Kamae, Teturo] Osaka City Univ, Adv Math Inst, Osaka, Japan; [Puzynina, Svetlana; Zamboni, Luca Q.] Univ Turku, Dept Math & Stat, SF-20500 Turku, Finland; [Puzynina, Svetlana] Sobolev Inst Math, Novosibirsk, Russia; [Zamboni, Luca Q.] Univ Lyon 1, CNRS, UMR 5208, Inst Camille Jordan, F-69622 Villeurbanne, France	Charlier, E (reprint author), Univ Liege, Dept Math, B-4000 Liege, Belgium.	echarlier@ulg.ac.be; kamae@apost.plala.or.jp; svepuz@utu.fi; lupastis@gmail.com			Academy of Finland [251371]; Russian Foundation of Basic Research [12-01-00448, 12-01-00089]; FiDiPro grant from the Academy of Finland [137991]; ANR grant SUBTILE	Partially supported by the Academy of Finland under grant 251371, by Russian Foundation of Basic Research (grants 12-01-00448 and 12-01-00089).; Partially supported by a FiDiPro grant (137991) from the Academy of Finland and by ANR grant SUBTILE.	Allouche J.-P., 2003, AUTOMATIC SEQUENCES; Durand F, 1998, DISCRETE MATH, V179, P89, DOI 10.1016/S0012-365X(97)00029-0; Charlier E, 2013, LECT NOTES COMPUT SC, V7966, P113, DOI 10.1007/978-3-642-39212-2_13; deLuca A, 1997, THEOR COMPUT SCI, V183, P45, DOI 10.1016/S0304-3975(96)00310-6; Yasutomi SI, 1999, DEV MATH, V2, P347; Harju T, 2004, INT J FOUND COMPUT S, V15, P349, DOI 10.1142/S0129054104002467; Berstel J., 1994, LECT NOTES COMPUTER, V812, P19; Berthe V, 2007, RAIRO-THEOR INF APPL, V41, P329, DOI 10.1051/ita:2007026; Buss S., ARXIV12117161; Cassaigne J, 1997, EUR J COMBIN, V18, P497, DOI 10.1006/eujc.1996.0110; Fagnot I, 2006, RAIRO-THEOR INF APPL, V40, P511, DOI 10.1051/ita:2006031; Morse M, 1940, AM J MATH, V62, P1, DOI 10.2307/2371431; Henshall Dane, 2012, Bulletin of the European Association for Theoretical Computer Science, V107; Lothaire M., 2002, ENCY MATH APPL, V90; Risley RN, 2000, ACTA ARITH, V95, P167; Rizzi R., 2013, LECT NOTES COMPUT SC, V7913, P235; Shallit J., 1999, SEQUENCES THEIR APPL, P1; SIROMONEY R, 1994, INFORM PROCESS LETT, V50, P101, DOI 10.1016/0020-0190(94)90016-7; Thue A., 1906, NORSKE VID SELSK IMN, V7, P1	19	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0097-3165	1096-0899		J COMB THEORY A	J. Comb. Theory Ser. A	NOV	2014	128						1	40		10.1016/j.jcta.2014.07.008		40	Mathematics	Mathematics	AR3ZZ	WOS:000343529100001		
J	Frankl, P; Lee, SJ; Siggers, M; Tokushige, N				Frankl, Peter; Lee, Sang June; Siggers, Mark; Tokushige, Norihide			An Erdos-Ko-Rado theorem for cross t-intersecting families	JOURNAL OF COMBINATORIAL THEORY SERIES A			English	Article						Cross intersecting families; Erdos Ko-Rado; Shifting; Random walks	INTEGER SEQUENCES; FINITE SETS; SYSTEMS; SPACES	Two families A and B, of k-subsets of an n-set, are cross t-intersecting if for every choice of subsets A is an element of A and B is an element of B we have |A boolean AND B| >= t. We address the following conjectured cross t-intersecting version of the Erdos-Ko-Rado theorem: For all n >= (t + 1)(k - t + 1) the maximum value of |A||B| for two cross t-intersecting families A, B subset of ([n] k) is (n-t k-t)(2). We verify this for all t >= 14 except finitely many n and k for each fixed t. Further, we prove uniqueness and stability results in these cases, showing, for instance, that the families reaching this bound are unique up to isomorphism. We also consider a p-weight version of the problem, which comes from the product measure on the power set of an n-set. (C) 2014 Elsevier Inc. All rights reserved.	[Frankl, Peter] Alfred Renyi Inst Math, H-1364 Budapest, Hungary; [Lee, Sang June] Duksung Womens Univ, Dept Math, Seoul 132714, South Korea; [Siggers, Mark] Kyungpook Natl Univ, Coll Nat Sci, Taegu 702701, South Korea; [Tokushige, Norihide] Univ Ryukyus, Coll Educ, Nishihara, Okinawa 9030213, Japan	Frankl, P (reprint author), Alfred Renyi Inst Math, POB 127, H-1364 Budapest, Hungary.	peter.frankl@gmail.com; sanglee242@duksung.ac.kr; mhsiggers@knu.ac.kr; hide@edu.u-ryukyu.ac.jp			National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2013R1A1A1059913]; Korea Institute for Advanced Study (KIAS) - Korean government (MEST); Korea NRF Basic Science Research Program - Korean government (MEST) [2014-06060000]; JSPS KAKENHI [20340022, 25287031]	Supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2013R1A1A1059913); and also by Korea Institute for Advanced Study (KIAS) grant funded by the Korean government (MEST).; Supported by the Korea NRF Basic Science Research Program (2014-06060000) funded by the Korean government (MEST).; Supported by JSPS KAKENHI (20340022 and 25287031).	Ahlswede R, 1998, ADV APPL MATH, V20, P429, DOI 10.1006/aama.1998.0588; Ahlswede R, 1997, EUR J COMBIN, V18, P125, DOI 10.1006/eujc.1995.0092; Friedgut E, 2008, COMBINATORICA, V28, P503, DOI 10.1007/s00493-008-2318-9; ERDOS P, 1961, Q J MATH, V12, P313, DOI 10.1093/qmath/12.1.313; WILSON RM, 1984, COMBINATORICA, V4, P247, DOI 10.1007/BF02579226; Gromov M, 2010, GEOM FUNCT ANAL, V20, P416, DOI 10.1007/s00039-010-0073-8; Frankl P, 1999, COMBINATORICA, V19, P55, DOI 10.1007/s004930050045; Bey C, 2000, NUMBERS, INFORMATION AND COMPLEXITY, P45; Borg P., 2014, AUSTRALAS J COMBIN, V60, P69; Dinur I, 2005, ANN MATH, V162, P439; FRANKL P, 1991, J COMB THEORY A, V56, P182, DOI 10.1016/0097-3165(91)90031-B; Frankl P., 1978, C MATH SOC J BOLYAI, V18, P365; FRANKL P, 1980, SIAM J ALGEBRA DISCR, V1, P376, DOI 10.1137/0601044; Frankl P, 2003, STUD SCI MATH HUNG, V40, P287, DOI 10.1556/SScMath.40.2003.3.2; Frankl P, 2002, J COMB THEORY A, V100, P94, DOI 10.1006/jcta.2002.3282; Katona G. O. H., 1972, J COMB THEORY B, V13, P183, DOI 10.1016/0095-8956(72)90054-8; Kindler G., PREPRINT; Kleitman D.J., 1966, J COMBINATORIAL THEO, V1, P153, DOI 10.1016/S0021-9800(66)80012-1; Matsumoto M., 1989, J COMB THEORY A, V52, P90; MOON A, 1982, J COMB THEORY A, V32, P386, DOI 10.1016/0097-3165(82)90054-1; PYBER L, 1986, J COMB THEORY A, V43, P85, DOI 10.1016/0097-3165(86)90025-7; Suda S, 2014, B LOND MATH SOC, V46, P342, DOI 10.1112/blms/bdt101; Tokushige N, 2013, J ALGEBR COMB, V38, P653, DOI 10.1007/s10801-012-0419-4; Tokushige N, 2010, J COMB THEORY A, V117, P1167, DOI 10.1016/j.jcta.2010.01.002; Tokushige N., 2005, RYUKYU MATH J, V18, P89; Tokushige N, 2013, COMB PROBAB COMPUT, V22, P622, DOI 10.1017/S0963548313000138; Tokushige N, 2008, BOLYAI SOC MATH STUD, V17, P215; Weichsel P M, 1962, P AM MATH SOC, V13, P47, DOI 10.2307/2033769	28	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0097-3165	1096-0899		J COMB THEORY A	J. Comb. Theory Ser. A	NOV	2014	128						207	249		10.1016/j.jcta.2014.08.006		43	Mathematics	Mathematics	AR3ZZ	WOS:000343529100011		
J	Dainichi, T; Hanakawa, S; Kabashima, K				Dainichi, Teruki; Hanakawa, Sho; Kabashima, Kenji			Classification of inflammatory skin diseases: A proposal based on the disorders of the three-layered defense systems, barrier, innate immunity and acquired immunity	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Review						Dermatitis; Innate immunity; Acquired immunity; Barrier	TOLL-LIKE RECEPTORS; PATTERN-RECOGNITION RECEPTORS; ATOPIC-DERMATITIS; CYSTEINE PROTEASES; BEHCETS-DISEASE; MUTATIONS; PATHOGENESIS; AUTOANTIBODIES; FILAGGRIN; RESPONSES	The host defense system of the skin is composed of (1) a barrier, (2) innate immunity, and (3) acquired immunity. Inflammatory skin diseases can be classified into one of the disorders of these layers of the defense system, unless there is an ordinary response to specific infectious agents or internal/external injury. Any inflammatory skin disease partly simulates the response to real infections or dangers. Disorders of acquired immunity can be classified into (1) immunodeficiency, (2) immunohyperactivity (allergy), and (3) qualitative disorder (autoimmunity). Disorders of innate immunity can be classified into (1) innate immunodeficiency, (2) innate immunohyperactivity (general or local autoinflammation), and (3) qualitative disorder (general or local innate autoimmunity). The barrier of the skin is composed of (1) the physical barrier and (2) the chemical barrier. Several diseases, such as atopic dermatitis, are attributed to the disorder of these components of the barrier. Here, we propose an algorithm to classify the pathology of inflammatory skin diseases by means of what disorder in the specific layer of the host defense system is truly responsible. (C) 2014 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Dainichi, Teruki; Hanakawa, Sho; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068507, Japan	Dainichi, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	dainichi@kuhp.kyoto-u.ac.jp			JSID's Fellowship Shiseido Award; Japan Society for the Promotion of Science (JSPS) KAKENHI [25893108]	This work was supported in part by the JSID's Fellowship Shiseido Award and the Japan Society for the Promotion of Science (JSPS) KAKENHI (25893108).	ALY R, 1978, J INVEST DERMATOL, V71, P378, DOI 10.1111/1523-1747.ep12556778; Bennett CL, 2001, NAT GENET, V27, P20; Tran M, 2008, CANCER RES, V68, P2885, DOI 10.1158/0008-5472.CAN-07-6160; Dainichi T, 2009, P NATL ACAD SCI USA, V106, P2800, DOI 10.1073/pnas.0809230106; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Samuelov L, 2013, NAT GENET, V45, P1244, DOI 10.1038/ng.2739; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Marodi L, 2007, NAT REV IMMUNOL, V7, P851, DOI 10.1038/nr2195; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Pink AE, 2013, J INVEST DERMATOL, V133, P601, DOI 10.1038/jid.2012.372; de Chambrun MP, 2012, AUTOIMMUN REV, V11, P687, DOI 10.1016/j.autrev.2011.11.026; Minegishi Y, 2012, ALLERGOL INT, V61, P191, DOI 10.2332/allergolint.12-RAI-0423; Oji V, 2010, AM J HUM GENET, V87, P274, DOI 10.1016/j.ajhg.2010.07.005; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Kalia S, 2007, DERMATOL THER, V20, P160, DOI 10.1111/j.1529-8019.2007.00131.x; Negishi H, 2012, NAT IMMUNOL, V13, P659, DOI 10.1038/ni.2307; Kabashima K, 2013, J DERMATOL SCI, V70, P3, DOI 10.1016/j.jdermsci.2013.02.001; Schumann H, 2000, AM J PATHOL, V156, P685, DOI 10.1016/S0002-9440(10)64772-4; Qian Y, 2012, J IMMUNOL, V189, P1535, DOI 10.4049/jimmunol.1200842; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Zaiou M, 2003, J INVEST DERMATOL, V120, P810, DOI 10.1046/j.1523-1747.2003.12132.x; Palmer CNA, 2007, J ALLERGY CLIN IMMUN, V120, P64, DOI 10.1016/j.jaci.2007.04.001; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Jeremy AHT, 2003, J INVEST DERMATOL, V121, P20, DOI 10.1046/j.1523-1747.2003.12321.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Assassi S, 2010, ARTHRITIS RHEUM-US, V62, P589, DOI 10.1002/art.27224; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Kim J, 2002, J IMMUNOL, V169, P1535; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; NOVEY HS, 1979, J ALLERGY CLIN IMMUN, V63, P98, DOI 10.1016/0091-6749(79)90198-2; Niyonsaba F, 2005, J DERMATOL SCI, V40, P157, DOI 10.1016/j.jdermsci.2005.07.009; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Brooklyn TN, 2006, GUT, V55, P505, DOI 10.1136/gut.2005.074815; Meyer-Hoffert U, 2009, ARCH IMMUNOL THER EX, V57, P345, DOI 10.1007/s00005-009-0045-6; Fuchs-Telem D, 2012, AM J HUM GENET, V91, P163, DOI 10.1016/j.ajhg.2012.05.010; Kim D, 2008, ARTHRITIS RHEUM, V58, P2163, DOI 10.1002/art.23486; De Benedetto A, 2011, J ALLERGY CLIN IMMUN, V127, P773, DOI 10.1016/j.jaci.2010.10.018; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Nakatsuji T, 2012, J INVEST DERMATOL, V132, P887, DOI 10.1038/jid.2011.387; Bosch X, 2011, NEW ENGL J MED, V365, P758, DOI 10.1056/NEJMcibr1107085; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; de Veer SJ, 2014, TRENDS MOL MED, V20, P166, DOI 10.1016/j.molmed.2013.11.005; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gul Ahmet, 2005, Current Drug Targets - Inflammation and Allergy, V4, P81, DOI 10.2174/1568010053622894; Guy R, 1996, J INVEST DERMATOL, V106, P176, DOI 10.1111/1523-1747.ep12329907; Hadj-Rabia S, 2004, GASTROENTEROLOGY, V127, P1386, DOI 10.1053/j.gast.2004.07.022; Honda T, 2010, CURR DRUG TARGETS, V11, P1605; Kabashima K, 2004, J DERMATOL SCI, V34, P177, DOI 10.1016/j.jdermsci.2003.11.008; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Lazarczyk M, 2009, MICROBIOL MOL BIOL R, V73, P348, DOI 10.1128/MMBR.00033-08; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Nakahigashi K, 2012, J ALLERGY CLIN IMMUN, V129, P536, DOI 10.1016/j.jaci.2011.11.034; Nomura T, 2007, J ALLERGY CLIN IMMUN, V119, P434, DOI 10.1016/j.jaci.2006.12.646; Roh JY, 2000, BRIT J DERMATOL, V143, P104, DOI 10.1046/j.1365-2133.2000.03598.x; SANDERS DA, 1994, BRIT J DERMATOL, V131, P166; Steinhoff M, 2013, J AM ACAD DERMATOL, V69, pS15, DOI 10.1016/j.jaad.2013.04.045; Xiang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084214	73	3	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	NOV	2014	76	2					81	89		10.1016/j.jdermsci.2014.08.010		9	Dermatology	Dermatology	AR7UA	WOS:000343784000001		
J	Shoda, T; Futamura, K; Kobayashi, F; Saito, H; Matsumoto, K; Matsuda, A				Shoda, Tetsuo; Futamura, Kyoko; Kobayashi, Fumio; Saito, Hirohisa; Matsumoto, Kenji; Matsuda, Akio			Expression of thymus and activation-regulated chemokine (TARC) by human dermal cells, but not epidermal keratinocytes	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Article						Atopic dermatitis; TARC; TNF-alpha; IL-4; Dermal cells; Corticosteroid	MACROPHAGE-DERIVED CHEMOKINE; ATOPIC-DERMATITIS; PROACTIVE TREATMENT; DISEASE-ACTIVITY; SERUM THYMUS; RECEPTOR 4; TNF-ALPHA; IN-VITRO; INFLAMMATION; FIBROBLASTS	Background: Serum levels of thymus and activation-regulated chemokine (TARC/CCL17) have served as a reliable biomarker of disease progression of atopic dermatitis (AD). However, it remains to be scientifically explained why serum TARC levels correlate well with the degree of AD progression. Objective: We hypothesized that dermal cells, but not epidermal keratinocytes, are major cellular sources of TARC and thus responsible for subclinical skin inflammation. This study aimed to identify the skin cells that can produce TARC protein. Methods: Primary normal human epidermal keratinocytes (NHEK), dermal microvascular endothelial cells (HMVEC-dBl) and dermal fibroblasts (NHDF) were stimulated with TNE-alpha and IL-4, alone and in combination. TARC mRNA and protein levels were quantified by qPCR and ELISA, respectively. We also investigated the effects of such immunosuppressants as a corticosteroid (dexamethasone) and tacrolimus (FK506) on TARC production, and used various signaling inhibitors to evaluate the signaling pathways involved in TARC expression. Results: Although neither TNE-alpha nor IL-4 alone induced TARC production by any of the tested cell types, together they induced expression of TARC mRNA and appreciable amounts of TARC protein by HMVEC-dBl and NHDF, but not by NHEK. TARC production by those dermal cells was not inhibited by dexamethasone or FK506. TARC production by HMVEC-dBl was completely inhibited by NF-kappa B and p38 MAPK inhibitors, but not by an ERK inhibitor. Conclusion: Dermal cells, but not epidermal keratinocytes, may be important cellular sources of TARC in AD skin. Therefore, even if epidermal eczematous lesions seem to be improved, complete inhibition of inflammation in the dermis is thought to be particularly important for suppressing both the TARC blood level and progression of AD. However, immunosuppressants did not directly inhibit TARC production by the dermal cells. Anti-inflammatory therapy may decrease TARC blood levels in AD patients indirectly, via its inhibitory effects on TNF-alpha- and/or IL-4-producing cells in the dermis. (C) 2014 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Shoda, Tetsuo; Futamura, Kyoko; Saito, Hirohisa; Matsumoto, Kenji; Matsuda, Akio] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Setagaya Ku, Tokyo 1578535, Japan; [Shoda, Tetsuo; Kobayashi, Fumio] Aichi Med Univ, Sch Med, Dept Hlth & Psychosocial Med, Nagakute, Aichi 4801195, Japan	Shoda, T (reprint author), Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	shoda-t@ncchd.go.jp; matsuda-a@ncchd.go.jp			National Institute of Biomedical Innovation [ID10-43]; National Center for Child Health and Development [26-9]; Research of Allergic Diseases and Immunology in Health Labour and Sciences Research Grant; JSPS KAKENHI [23591666]	This work was funded by National Institute of Biomedical Innovation Grant ID10-43 (to MM), The Grant of National Center for Child Health and Development (26-9) (to KM), Research of Allergic Diseases and Immunology in Health Labour and Sciences Research Grant (to HS) and JSPS KAKENHI Grant Number 23591666 (to AM).	Adachi T, 2010, INVEST OPHTH VIS SCI, V51, P3954, DOI 10.1167/iovs.09-4161; Matsuda A, 2008, AM J RESP CELL MOL, V38, P168, DOI 10.1165/rcmb.2007-0162OC; Homey B, 2006, J ALLERGY CLIN IMMUN, V118, P178, DOI 10.1016/j.jaci.2006.03.047; Kakinuma T, 2001, J ALLERGY CLIN IMMUN, V107, P535, DOI 10.1067/mai.2001.113237; Wong CK, 2002, CLIN EXP IMMUNOL, V128, P483, DOI 10.1046/j.1365-2249.2002.01880.x; Imai T, 1998, J BIOL CHEM, V273, P1764, DOI 10.1074/jbc.273.3.1764; Hijnen DJ, 2004, J ALLERGY CLIN IMMUN, V113, P334, DOI 10.1016/j.jaci.2003.12.007; Eichenfield LF, 2014, J AM ACAD DERMATOL, V71, P116, DOI 10.1016/j.jaad.2014.03.023; Suarez-Farinas M, 2011, J ALLERGY CLIN IMMUN, V127, P954, DOI 10.1016/j.jaci.2010.12.1124; Steinhoff M, 2006, J ALLERGY CLIN IMMUN, V118, P190, DOI 10.1016/j.jaci.2006.04.025; Yagami A, 2010, J IMMUNOL, V185, P5743, DOI 10.4049/jimmunol.0903818; Masuoka M, 2012, J CLIN INVEST, V122, P2590, DOI 10.1172/JCI58978; Tsuda T, 2003, J DERMATOL SCI, V31, P37, DOI 10.1016/S0923-1811(02)00138-X; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Fukuda K, 2003, J ALLERGY CLIN IMMUN, V111, P520, DOI 10.1067/mai.2003.59; Huber MA, 2002, J BIOL CHEM, V277, P1268, DOI 10.1074/jbc.M109358200; Wollenberg A, 2008, ALLERGY, V63, P742, DOI 10.1111/j.1398-9995.2008.01683.x; Imai T, 1997, J BIOL CHEM, V272, P15036, DOI 10.1074/jbc.272.23.15036; Fujisawa T, 2002, J ALLERGY CLIN IMMUN, V110, P139, DOI 10.1067/mai.2002.126079; Katayama Ichiro, 2011, Allergology International, V60, P205, DOI [10.2332/allergolint. 11-RAI-0333, 10.2332/allergolint.11-RAI-0333]; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Matsuda A, 2008, ALLERGY, V63, P1610, DOI 10.1111/j.1398-9995.2008.01775.x; Tang TS, 2014, J ALLERGY CLIN IMMUN, V133, P1615, DOI 10.1016/j.jaci.2013.12.1079; Fukuie T, 2010, BRIT J DERMATOL, V163, P1127, DOI 10.1111/j.1365-2133.2010.09904.x; Fujisawa T, 2009, PEDIATR ALLERGY IMMU, V20, P633, DOI 10.1111/j.1399-3038.2009.00851.x; Hashimoto S, 2006, J DERMATOL SCI, V44, P93, DOI 10.1016/j.jdermsci.2006.08.004; Holvoet S, 2003, EXP CELL RES, V290, P108, DOI 10.1016/S0014-4827(03)00293-3; Kataoka Y, 2014, J DERMATOL, V41, P221, DOI 10.1111/1346-8138.12440; Komine M, 2005, J INVEST DERMATOL, V125, P491, DOI 10.1111/j.0022-202X.2005.23840.x; Kou K, 2014, BRIT J DERMATOL, V171, P283, DOI 10.1111/bjd.12943; Mitsuishi K, 2005, CLIN EXP ALLERGY, V35, P1327, DOI 10.1111/j.1365-2222.2005.02353.x; Shoda T, 2013, ALLERGY, V68, P1467, DOI 10.1111/all.12240	32	2	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	NOV	2014	76	2					90	95		10.1016/j.jdermsci.2014.08.009		6	Dermatology	Dermatology	AR7UA	WOS:000343784000002		
J	Yoshimasu, T; Kuramoto, T; Kaminaka, C; Kanazawa, N; Yamamoto, Y; Furukawa, F				Yoshimasu, Takashi; Kuramoto, Takashi; Kaminaka, Chikako; Kanazawa, Nobuo; Yamamoto, Yuki; Furukawa, Fukumi			Efficacy of 0.1% adapalene in a non-inflammatory Kyoto Rhino Rat acne model	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Article						Acne; Comedone; Adapalene; Rhino rat; Krh; Model rat	RETINOIC ACID; HUMAN SKIN; IN-VITRO; EXPRESSION; LESIONS; GAMMA; MOUSE	Background: Acne vulgaris is a disorder of the pilosebaceous unit of the skin, and the underlying mechanism is still obscure. Kyoto rhino (krh/krh) rats were made by ethylnitrosourea (ENU) mutagenesis and harbor S413X nonsense mutation of the rat hairless (Hr) gene. Krh/krh rats develop comedones with hair loss on their back as they grow. Objective: Our purpose is to assess whether or not the krh/krh rat is a suitable model of noninflammatory acne, and to investigate the comedolytic effects of adapalene in krh/krh rats. Methods: Krh/krh rats at 12 weeks of age were topically treated with adapalene or a vehicle 6 times a week, for 12 weeks. Skin lesions were clinically investigated and skin samples were obtained from treated skins from each animal after 6 and 12 weeks of treatments. Results: Comedone was clinically enlarged in the control group compared with the adapalene group. The adapalene group showed significantly increased epidermal thickness as compared to the control group. Furthermore, open comedone areas were also significantly decreased in the adapalene group as compared to the control group. The adapalene group also showed reduced lipid production in open comedones as compared to the control group. Cytokine productions including IL-10 and IL-12a tended to increase in skin treated with adapalene as compared to the control group. Conclusion: Krh/krh rats represented a new model for non-inflammatory acne with abnormalities in both hair follicles and sebaceous glands. It is hypothesized that adapalene is a superior drug to decrease open comedones by modifying lipid metaboism and cytokine production in krh/krh rats. (C) 2014 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Yoshimasu, Takashi; Kanazawa, Nobuo; Yamamoto, Yuki; Furukawa, Fukumi] Wakayama Med Univ, Dept Dermatol, Wakayama, Japan; [Yoshimasu, Takashi] Arida Municipal Hosp, Dept Dermatol, Wakayama, Japan; [Kuramoto, Takashi] Kyoto Univ, Grad Sch Med, Inst Lab Anim, Kyoto 6068501, Japan; [Kaminaka, Chikako; Yamamoto, Yuki] Wakayama Med Univ, Dept Cosmet Dermatol & Photomed, Wakayama, Japan	Yoshimasu, T (reprint author), 811-1 Kimiidera, Wakayama 6410012, Japan.	yosshii8@jg8.so-net.ne.jp			Galderma [E 23360]	Financial support for this study as well as adapalene and its vehicle were provided for our department by Galderma (Grant no. E 23360).	Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Tenaud I, 2007, EXP DERMATOL, V16, P500, DOI 10.1111/j.1600-0625.2007.00552.x; Szabo K, 2011, ARCH DERMATOL RES, V303, P19, DOI 10.1007/s00403-010-1050-7; Czernielewski J, 2001, J EUR ACAD DERMATOL, V15, P5, DOI 10.1046/j.0926-9959.2001.00006.x; Azaka N, 2009, J DERMATOL, V36, P213; BERNARD BA, 1993, SKIN PHARMACOL, V6, P61; GRIFFITHS CEM, 1993, J INVEST DERMATOL, V101, P325, DOI 10.1111/1523-1747.ep12365480; Kuramoto T, 2011, EXP ANIM TOKYO, V60, P57, DOI 10.1538/expanim.60.57; Kwon HH, 2013, BRIT J DERMATOL, V169, P1152, DOI 10.1111/bjd.12486; Michel S, 1998, BRIT J DERMATOL, V139, P3; Miyai Eriko, 2009, Folia Pharmacologica Japonica, V134, P37; Nieves NJ, 2010, J INVEST DERMATOL, V130, P2359, DOI 10.1038/jid.2010.142; Odorisio T, 2012, EUR J DERMATOL, V4, P505; Sakuta T, 2005, EUR J DERMATOL, V15, P459; Sato T, 2013, J DERMATOL SCI, V70, P204, DOI 10.1016/j.jdermsci.2013.02.003; Sugisaki H, 2009, J DERMATOL SCI, V55, P47, DOI 10.1016/j.jdermsci.2009.02.015; Uede M, 2013, OPEN DERMATOL J, V7, P42	17	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	NOV	2014	76	2					143	148		10.1016/j.jdermsci.2014.08.001		6	Dermatology	Dermatology	AR7UA	WOS:000343784000009		
J	Tamari, M; Saeki, H; Hayashi, M; Umezawa, Y; Ito, T; Fukuchi, O; Nobeyama, Y; Yanaba, K; Nakagawa, H; Tsunemi, Y; Kato, T; Shibata, S; Sugaya, M; Sato, S; Tada, Y; Doi, S; Miyatake, A; Ebe, K; Noguchi, E; Fujieda, S; Ebihara, T; Amagai, M; Esaki, H; Takeuchi, S; Furue, M; Hirota, T				Tamari, Mayumi; Saeki, Hidehisa; Hayashi, Mitsuha; Umezawa, Yoshinori; Ito, Toshihiro; Fukuchi, Osamu; Nobeyama, Yoshimasa; Yanaba, Koichi; Nakagawa, Hidemi; Tsunemi, Yuichiro; Kato, Toyoaki; Shibata, Sayaka; Sugaya, Makoto; Sato, Shinichi; Tada, Yayoi; Doi, Satoru; Miyatake, Akihiko; Ebe, Kouji; Noguchi, Emiko; Fujieda, Shigeharu; Ebihara, Tamotsu; Amagai, Masayuki; Esaki, Hitokazu; Takeuchi, Satoshi; Furue, Masutaka; Hirota, Tomomitsu			An association study of 36 psoriasis susceptibility loci for psoriasis vulgaris and atopic dermatitis in a Japanese population	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Letter						Genetic polymorphism; Genome-wide association study; Atopic dermatitis; Psoriasis vulgaris; Japanese population	GENOME-WIDE ASSOCIATION; GENE; POLYMORPHISM		[Tamari, Mayumi; Hirota, Tomomitsu] RIKEN, Lab Resp & Allerg Dis, Ctr Integrat Med Sci, Saitama, Japan; [Saeki, Hidehisa] Nippon Med Sch, Dept Dermatol, Tokyo 1138603, Japan; [Hayashi, Mitsuha; Umezawa, Yoshinori; Ito, Toshihiro; Fukuchi, Osamu; Nobeyama, Yoshimasa; Yanaba, Koichi; Nakagawa, Hidemi] Jikei Univ, Sch Med, Dept Dermatol, Minato, Tokyo, Japan; [Tsunemi, Yuichiro] Tokyo Womens Med Univ, Dept Dermatol, Tokyo, Japan; [Kato, Toyoaki; Shibata, Sayaka; Sugaya, Makoto; Sato, Shinichi] Univ Tokyo, Fac Med, Dept Dermatol, Tokyo 1138654, Japan; [Tada, Yayoi] Teikyo Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Doi, Satoru] Osaka Prefectual Med Ctr Resp & Allerg Dis, Osaka, Japan; [Miyatake, Akihiko] Miyatake Asthma Clin, Kyoto, Japan; [Ebe, Kouji] Takao Hosp, Tokyo, Japan; [Noguchi, Emiko] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 305, Japan; [Fujieda, Shigeharu] Univ Fukui, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Fukui, Japan; [Ebihara, Tamotsu; Amagai, Masayuki] Keio Univ, Sch Med, Dept Dermatol, Tokyo 108, Japan; [Esaki, Hitokazu; Takeuchi, Satoshi; Furue, Masutaka] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka 812, Japan	Saeki, H (reprint author), Nippon Med Sch, Dept Dermatol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	h-saeki@nms.ac.jp	Amagai, Masayuki/K-5325-2013; Tamari, Mayumi/N-5378-2015				Elder JT, 2010, J INVEST DERMATOL, V130, P1213, DOI 10.1038/jid.2009.319; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Li XM, 2006, J BIOL CHEM, V281, P23748, DOI 10.1074/jbc.M508365200; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Weidinger S, 2013, HUM MOL GENET, V22, P4841, DOI 10.1093/hmg/ddt317; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; Hayashi M, 2014, J DERMATOL SCI, V73, P264, DOI 10.1016/j.jdermsci.2013.11.012; Oka A, 1999, HUM MOL GENET, V8, P2165, DOI 10.1093/hmg/8.12.2165; Tsunemi Y, 2002, J DERMATOL SCI, V30, P161, DOI 10.1016/S0923-1811(02)00072-5	10	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	NOV	2014	76	2					156	157		10.1016/j.jdermsci.2014.08.005		2	Dermatology	Dermatology	AR7UA	WOS:000343784000013		
J	Murata, T; Honda, T; Egawa, G; Miyachi, Y; Kabashima, K				Murata, Teruasa; Honda, Tetsuya; Egawa, Gyohei; Miyachi, Yoshiki; Kabashima, Kenji			Epicutaneous detection of transepidermally eliminated collagen by multiphoton microscopy: A possible non-invasive diagnosis method for acquired reactive perforating dermatosis	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Letter						Acquired reactive perforating dermatosis; Multiphoton microscopy; Second harmonic generation; Human skin	2-PHOTON MICROSCOPY		[Murata, Teruasa; Honda, Tetsuya; Egawa, Gyohei; Miyachi, Yoshiki; Kabashima, Kenji] Kyoto Univ, Dept Dermatol, Grad Sch Med, Kyoto 6068507, Japan; [Murata, Teruasa] Japan Soc Promot Sci, Tokyo, Japan	Kabashima, K (reprint author), Kyoto Univ, Dept Dermatol, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawara, Kyoto 6068507, Japan.	kaba@kuhp.kyoto-u.ac.jp					Egawa G, 2013, J DERMATOL SCI, V70, P143, DOI 10.1016/j.jdermsci.2013.01.005; Egawa G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01932; Kabashima K., 2014, J INVEST DERMATOL; Koehler MJ, 2008, EXP DERMATOL, V17, P519, DOI 10.1111/j.1600-0625.2007.00669.x; Murata T, 2013, J DERMATOL SCI, V72, P199, DOI 10.1016/j.jdermsci.2013.06.016; RAPINI RP, 1989, ARCH DERMATOL, V125, P1074, DOI 10.1001/archderm.125.8.1074; Tong PL, 2013, BRIT J DERMATOL, V169, P869, DOI 10.1111/bjd.12430; Tsai TH, 2009, J DERMATOL SCI, V56, P1, DOI 10.1016/j.jdermsci.2009.06.008	8	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	NOV	2014	76	2					158	160		10.1016/j.jdermsci.2014.08.004		3	Dermatology	Dermatology	AR7UA	WOS:000343784000014		
J	Sato, Y; Kamada, T; Yamauchi, A				Sato, Youichi; Kamada, Takanobu; Yamauchi, Aiko			The role of dipeptidyl peptidase 4 (DPP4) in the preservation of renal function: DPP4 involvement in hemoglobin expression	JOURNAL OF ENDOCRINOLOGY			English	Article						DPP4 deficient; streptozotocin; diabetes; renal function; hemoglobin	INCRETIN MIMETICS; IV INHIBITORS; ALPHA-2U-GLOBULIN NEPHROPATHY; DIABETES-MELLITUS; RATS; DYSLIPIDEMIA; PATHOBIOLOGY; SITAGLIPTIN; RECEPTOR; STRESS	In a previous study, we demonstrated that dipeptidyl peptidase 4 (DPP4)-deficient rats were susceptible to reduced glomerular filtration rate as a result of streptozotocin (STZ)-induced diabetes. Therefore, we proposed that DPP4 might be responsible for the preservation of renal function. In this study, to verify the role of DPP4 in the preservation of renal function, we performed a microarray analysis of the kidneys of WT and DPP4-deficient rats after STZ treatment, and gene expression analysis using rat kidneys, human embryonic kidney 293 (HEK293) cells, and human renal cancer cells (CakI-1). The microarray analysis indicated that the expression levels of the transporter activity, heme-binding, and pheromone binding-related genes changed significantly. The results of gene expression analysis indicated that there were no significant differences in the expression levels of hemoglobin mRNA between the DPP4-deficient and WT rats; however, the expression levels of hemoglobin mRNA in the kidneys of DPP4-deficient rats tended to decrease when compared with those of both the non-STZ-treated and STZ-treated WT rats. The expression levels of hemoglobin in HEK293 and Caki-1 cells were significantly decreased when DPP4 was knocked down by siRNA, were significantly increased by the addition of soluble human DPP4, and were also significantly increased by the addition of the DPP4 inhibitor, sitagliptin. The expression level of DPP4 was also significantly increased by the addition of sitagliptin in both cell types. Our findings indicate that DPP4 regulates the expression of the hemoglobin genes, and might play a role in the preservation of renal function; however, the underlying mechanism of this preservation remains to be elucidated.	[Sato, Youichi; Kamada, Takanobu; Yamauchi, Aiko] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Pharmaceut Informat Sci, Tokushima 7708505, Japan	Sato, Y (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Pharmaceut Informat Sci, 1-78-1 Sho Machi, Tokushima 7708505, Japan.	youichi.sato@tokushima-u.ac.jp					Chang GL, 2013, EUR J PHARMACOL, V718, P105, DOI [10.1016/j.ejphar.2013.09.007, 10.1010/j.ejphar.2013.09.007]; Holst JJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE199, DOI 10.1152/ajpendo.00545.2003; Femia AP, 2013, INT J CANCER, V133, P2498, DOI 10.1002/ijc.28260; Holst JJ, 2006, DIABETOLOGIA, V49, P253, DOI 10.1007/s00125-005-0107-1; Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328; Morimoto C, 1998, IMMUNOL REV, V161, P55, DOI 10.1111/j.1600-065X.1998.tb01571.x; Nishi H, 2008, J AM SOC NEPHROL, V19, P1500, DOI 10.1681/ASN.2007101085; De Meester I, 2000, ADV EXP MED BIOL, V477, P67; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Srinivasan BT, 2008, POSTGRAD MED J, V84, P524, DOI 10.1136/pgmj.2008.067918; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; SWENBERG JA, 1989, TOXICOL APPL PHARM, V97, P35, DOI 10.1016/0041-008X(89)90053-7; BORGHOFF SJ, 1990, ANNU REV PHARMACOL, V30, P349, DOI 10.1146/annurev.pa.30.040190.002025; Kirino Y, 2009, J ENDOCRINOL, V200, P53, DOI 10.1677/JOE-08-0424; Cannon CP, 2008, AM J CARDIOL, V102, p5L, DOI 10.1016/j.amjcard.2008.09.067; CROFFORD OB, 1995, ANNU REV MED, V46, P267; Green Brian D, 2006, Diab Vasc Dis Res, V3, P159, DOI 10.3132/dvdr.2006.024; Hinnen D, 2006, J AM BOARD FAM MED, V19, P612; Ihara Yoshito, 2010, Nihon Rinsho, V68 Suppl 9, P49; Ikeda T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066520; Kendall DM, 2006, DIABETES TECHNOL THE, V8, P385, DOI 10.1089/dia.2006.8.385; Kitamura M, 2008, CLIN EXP NEPHROL, V12, P317, DOI 10.1007/s10157-008-0060-7; MURTY CVR, 1986, BIOCHEMISTRY-US, V25, P4376, DOI 10.1021/bi00363a030; Nielsen LL, 2005, DRUG DISCOV TODAY, V10, P703, DOI 10.1016/S1359-6446(05)03460-4; Nussbaum RL, 2007, THOMPSON THOMPSON GE, P181; Schlessinger A, 2010, PROTEIN SCI, V19, P412, DOI 10.1002/pro.320; Sharma V, 2014, MOL CELL BIOCHEM, V388, P95, DOI 10.1007/s11010-013-1902-5; Stephan M., 2013, PHYSL REP, V1, DOI DOI 10.1002/PHY2.95; Tilton RG, 2007, PROTEOMICS, V7, P1729, DOI 10.1002/pmic.200700017; WATANABE Y, 1987, EXPERIENTIA, V43, P400, DOI 10.1007/BF01940426; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	31	0	0	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0022-0795	1479-6805		J ENDOCRINOL	J. Endocrinol.	NOV	2014	223	2					133	142		10.1530/JOE-14-0016		10	Endocrinology & Metabolism	Endocrinology & Metabolism	AR5YT	WOS:000343659000007		
J	Ono, YJ; Terai, Y; Tanabe, A; Hayashi, A; Hayashi, M; Yamashita, Y; Kyo, S; Ohmichi, M				Ono, Yoshihiro Joshua; Terai, Yoshito; Tanabe, Akiko; Hayashi, Atsushi; Hayashi, Masami; Yamashita, Yoshiki; Kyo, Satoru; Ohmichi, Masahide			Decorin induced by progesterone plays a crucial role in suppressing endometriosis	JOURNAL OF ENDOCRINOLOGY			English	Article						decorin; progesterone; dienogest; endometriosis; cell cycle arrest; p21	LEUCINE-RICH PROTEOGLYCANS; STROMAL CELLS; COLLAGEN FIBRILLOGENESIS; TUMOR MICROENVIRONMENT; LAPAROSCOPIC SURGERY; GROWTH-INHIBITION; CELLULAR FUNCTION; EPITHELIAL-CELLS; GENE-EXPRESSION; CANCER CELLS	Dienogest, a synthetic progestin, has been shown to be effective against endometriosis, although it is still unclear as to how it affects the ectopic endometrial cells. Decorin has been shown to be a powerful endogenous tumor repressor acting in a paracrine fashion to limit tumor growth. Our objectives were to examine the direct effects of progesterone and dienogest on the in vitro proliferation of the human ectopic endometrial epithelial and stromal cell lines, and evaluate as to how decorin contributes to this effect. We also examined DCN mRNA expression in 50 endometriosis patients. The growth of both cell lines was inhibited in a dose-dependent manner by both decorin and dienogest. Using a chromatin immunoprecipitation assay, it was noted that progesterone and dienogest directly induced the binding of the decorin promoter in the EMOsis cc/TERT cells (immortalized human ovarian epithelial cells) and CRL-4003 cells (immortalized human endometrial stromal cells). Progesterone and dienogest also led to significant induced cell cycle arrest via decorin by promoting production of p21 in both cell lines in a dosedependent manner. Decorin also suppressed the expression of MET in both cell lines. We confirmed that DCN mRNA expression in patients treated with dienogest was higher than that in the control group. In conclusion, decorin induced by dienogest appears to play a crucial role in suppressing endometriosis by exerting anti-proliferative effects and inducing cell cycle arrest via the production of p21 human ectopic endometrial cells and eutopic endometrial stromal cells.	[Ono, Yoshihiro Joshua; Terai, Yoshito; Tanabe, Akiko; Hayashi, Atsushi; Hayashi, Masami; Yamashita, Yoshiki; Ohmichi, Masahide] Osaka Med Coll, Dept Obstet & Gynecol, Takatsuki, Osaka 5658686, Japan; [Kyo, Satoru] Kanazawa Univ, Grad Sch Med Sci, Dept Obstet & Gynaecol, Kanazawa, Ishikawa, Japan	Terai, Y (reprint author), Osaka Med Coll, Dept Obstet & Gynecol, 2-7 Daigaku Machi, Takatsuki, Osaka 5658686, Japan.	y-terai@poh.osaka-med.ac.jp			Japan Society for the Promotion of Science (JSPS) [25462621]; Takeda Science Foundation	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI grant numbers 25462621 (to Y Terai) and the Takeda Science Foundation (to A Tanabe).	Canis M, 1997, FERTIL STERIL, V67, P817; Guo SW, 2009, HUM REPROD UPDATE, V15, P441, DOI 10.1093/humupd/dmp007; Nap AW, 2004, J CLIN ENDOCR METAB, V89, P1089, DOI 10.1210/jc.2003-031406; Cosson M, 2002, FERTIL STERIL, V77, P684, DOI 10.1016/S0015-0282(01)03270-8; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Strowitzki T, 2010, HUM REPROD, V25, P633, DOI 10.1093/humrep/dep469; LOCKWOOD CJ, 1993, J CLIN ENDOCR METAB, V76, P231, DOI 10.1210/jc.76.1.231; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Nash MA, 1999, CANCER RES, V59, P6192; Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8; Weber IT, 1996, J BIOL CHEM, V271, P31767; Schaefer L, 2007, AM J PATHOL, V170, P301, DOI 10.2353/ajpath.2007.060497; Fu L, 2008, FERTIL STERIL, V89, P1344, DOI 10.1016/j.fertnstert.2007.03.042; Okada H, 2001, MOL HUM REPROD, V7, P341, DOI 10.1093/molehr/7.4.341; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; Foster RH, 1998, DRUGS, V56, P825, DOI 10.2165/00003495-199856050-00007; Horie S, 2005, FERTIL STERIL, V83, P1530, DOI 10.1016/j.fertnstert.2004.11.042; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Sasagawa S, 2008, STEROIDS, V73, P222, DOI 10.1016/j.steroids.2007.10.003; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Shimizu Y, 2009, MOL HUM REPROD, V15, P693, DOI 10.1093/molehr/gap042; Seidler DG, 2008, IUBMB LIFE, V60, P729, DOI 10.1002/iub.115; Fairlie DP, 1998, CURR MED CHEM, V5, P29; Momoeda M, 2009, J OBSTET GYNAECOL RE, V35, P1069, DOI 10.1111/j.1447-0756.2009.01076.x; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jeb.20776; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Bono Y, 2012, BRIT J CANCER, V106, P1205, DOI 10.1038/bjc.2012.26; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Koninger J, 2004, CLIN CANCER RES, V10, P4776, DOI 10.1158/1078-0432.CCR-1190-03; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Kohler G, 2010, INT J GYNECOL OBSTET, V108, P21, DOI 10.1016/j.ijgo.2009.08.020; Strowitzki T, 2010, EUR J OBSTET GYN R B, V151, P193, DOI 10.1016/j.ejogrb.2010.04.002; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Irahara Minoru, 2007, Reproductive Medicine and Biology, V6, P223, DOI 10.1111/j.1447-0578.2007.00189.x; Zhang YW, 2003, P NATL ACAD SCI USA, V100, P12718, DOI 10.1073/pnas.2135113100; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200; Brown J, 2010, COCHRANE DB SYST REV, V12; Cawthorn TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030992; Felice P, 2012, ARCH GYNECOLOGY OBST, V285, P167, DOI [10.1007/s00404-011-1941-7, DOI 10.1007/S00404-011-1941-7]; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Jee BC, 2009, FERTIL STERIL, V91, P40, DOI 10.1016/j.fertnstert.2007.11.027; KRESSE H, 1993, EXPERIENTIA, V49, P403, DOI 10.1007/BF01923585; Neame P.J., 2000, PROTEOGLYCANS STRUCT, P201; Salgado RM, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-22; SANTRA M, 1994, J BIOL CHEM, V269, P579; SANTRA M, 1995, P NATL ACAD SCI USA, V92, P7016, DOI 10.1073/pnas.92.15.7016; Sitruk WR, 2004, DRUGS AGING, V21, P865, DOI [10.2165/00002512-200421130-00004, DOI 10.2165/00002512-200421130-00004]; Sitruk WR, 2004, MATURITAS, V47, P277, DOI [10.1016/j.maturitas.2004.01.001, DOI 10.1016/J.MATURITAS.2004.01.001]; Thomas N, 2012, AM J PATHOL, V181, P380, DOI [10.1016/j.ajpath.2012.04.029, DOI 10.1016/J.AJPATH.2012.04.029]; Vercellini P, 2009, DRUGS, V69, P649, DOI 10.2165/00003495-200969060-00002	53	2	2	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0022-0795	1479-6805		J ENDOCRINOL	J. Endocrinol.	NOV	2014	223	2					203	216		10.1530/JOE-14-0393		14	Endocrinology & Metabolism	Endocrinology & Metabolism	AR5YT	WOS:000343659000013		
J	Kurikami, H; Kitamura, A; Yokuda, ST; Onishi, Y				Kurikami, Hiroshi; Kitamura, Akihiro; Yokuda, Satoru Thomas; Onishi, Yasuo			Sediment and Cs-137 behaviors in the Ogaki Dam Reservoir during a heavy rainfall event	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						Fukushima Daiichi NPP; Ogaki Dam Reservoir; Numerical modeling; Cesium; Sediment; Heavy rainfall events	RADIONUCLIDES; MODELS	We performed a simulation of sediment and Cs-137 behaviors in the Ogaki Dam Reservoir, one of the main irrigation reservoirs in the Fukushima prefecture, japan, during a heavy rainfall event occurred in 2013. The one-dimensional river and reservoir simulation scheme TODAM, Time-dependent One-dimensional Degradation and Migration, was applied for calculating the time dependent migration of sediment and Cs-137 in dissolved and sediment-sorbed forms in the reservoir. Continuous observational data achieved in the upper rivers were used as the input boundary conditions for the simulation. The simulation results were compared with the continuous data achieved in the lower river and we confirmed the predicted values of sediment and Cs-137 in sediment-sorbed form at the exit of reservoir satisfactorily reproduced the observational data. We also performed sediment and Cs-137 behavioral simulation by changing the water level of the reservoir, because such a dam operation could control the quantities of sediment and Cs-137 discharge from and/or deposition in the reservoir. The simulation clarified that the reservoir played an important role to delay and buffer the movement of radioactive cesium in heavy rainfall events and the buffer effect of the reservoir depended on particle sizes of suspended sediment and the water level. It was also understood that silt deposition was the main source of the bed contamination (except for the initial fallout impact), while clay was the main carrier of Cs-137 to the lower river at a later stage of rainfall events. (C) 2014 Elsevier Ltd. All rights reserved.	[Kurikami, Hiroshi; Kitamura, Akihiro] Japan Atom Energy Agcy, Sect Fukushima Res & Dev, Tokai, Ibaraki 3191194, Japan; [Yokuda, Satoru Thomas; Onishi, Yasuo] Pacific NW Natl Lab, Richland, WA 99352 USA	Kurikami, H (reprint author), Japan Atom Energy Agcy, Sect Fukushima Res & Dev, 4-33 Muramatsu, Tokai, Ibaraki 3191194, Japan.	kurikami.hiroshi@jaea.go.jp; kitamura.akihiro@jaea.go.jp; satoru.yokuda@pnnl.gov; yasuo.onishi@pnnl.gov					Nagao S, 2013, BIOGEOSCIENCES, V10, P6215, DOI 10.5194/bg-10-6215-2013; Monte L, 2005, J ENVIRON RADIOACTIV, V79, P273, DOI 10.1016/j.jenvard.2004.08.002; Holly Jr. F.M., 1990, 343 IIHR U IOW IOW I; International Atomic Energy Agency, 2001, SAF REP SER, V19; Japan Atomic Energy Agency, 2013, EST TECHN ID LONG TE; Japan Atomic Energy Agency, 2013, INV STUD SEC DISTR R; Kryshev II, 2009, SCI TOTAL ENVIRON, V407, P2349, DOI 10.1016/j.scitotenv.2008.12.012; Monte L, 2006, J ENVIRON RADIOACTIV, V88, P267, DOI 10.1016/j.jenvrad.2006.02.006; Onishi Y., 1994, THEORY NUMERICAL MET, V1; Onishi Y, 2007, J ENVIRON ENG-ASCE, V133, P1015, DOI 10.1061/(ASCE)0733-9372(2007)133:11(1015); Onishi Y., 1993, COASTAL ESTUARINE ST, V42; Otsubo K., 1983, RES REPORTS NATL I E; Perkins W., 1994, USERS GUIDE, V2; Teeter A.M., 1988, EL8815 US ARM CORPS; Vanoni V.A., 1975, ASCE MANUALS REPORT; Whelan G., 1983, 1983 INT S URB HYDR	16	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	NOV	2014	137						10	17		10.1016/j.jenvrad.2014.06.013		8	Environmental Sciences	Environmental Sciences & Ecology	AR5MG	WOS:000343628100002		
J	Teramage, MT; Onda, Y; Patin, J; Kato, H; Gomi, T; Nam, S				Teramage, Mengistu T.; Onda, Yuichi; Patin, Jeremy; Kato, Hiroaki; Gomi, Takashi; Nam, Sooyoun			Vertical distribution of radiocesium in coniferous forest soil after the Fukushima nuclear power plant accident	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						Deposition; Forest floor; Migration; Radiocesium; Cs-137; Cs-134	CHERNOBYL ACCIDENT; SOUTHERN GERMANY; NORWAY SPRUCE; SCOTS PINE; CS-137; MIGRATION; FALLOUT; ECOSYSTEMS; PROFILES; RADIONUCLIDES	This study deals with the description of the vertical distribution of radiocaesium (Cs-137 and Cs-134) in a representative coniferous forest soil, investigated 10 months after the Fukushima radioactive fallout. During soil sampling, the forest floor components (understory plants, litter (Ol-) and fermented layers (Of)) were collected and treated separately. The results indicate that radiocesium is concentrated in the forest floor, and high radiocesium transfer factor observed in the undergrowth plants (3.3). This made the forest floor an active exchanging interphase for radiocesium. The raw organic layer (Ol + Of) holds 52% (5.3 kBq m(-2)) of the Fukushima-derived and 25% (0.7 kBq m(-2)) of the pre-Fukushima Cs-137 at the time of the soil sampling. Including the pre-Fukushima Cs-137, 99% of the total soil inventory was in the upper 10 cm, in which the organic matter (OM) content was greater than 10%, suggesting the subsequent distribution most likely depends on the OM turnover. However, the small fraction of the Fukushima-derived Cs-137 at a depth of 16 cm is most likely due to the infiltration of radiocesium-circumscribed rainwater during the fallout before that selective adsorption prevails and reduces the migration of soluble Cs-137. The values of the depth distribution parameters revealed that the distribution of the Fukushima-derived Cs-137 was somewhat rapid. (C) 2014 Elsevier Ltd. All rights reserved.	[Teramage, Mengistu T.; Onda, Yuichi; Patin, Jeremy; Kato, Hiroaki] Univ Tsukuba, Ctr Res Isotopes & Environm Dynam, Tsukuba, Ibaraki 3058572, Japan; [Gomi, Takashi; Nam, Sooyoun] Tokyo Univ Agr & Technol, Dept Int Environm & Agr Sci, Fuchu, Tokyo 1838509, Japan	Teramage, MT (reprint author), Univ Tsukuba, Ctr Res Isotopes & Environm Dynam, Tennodai 1-1-1, Tsukuba, Ibaraki 3058572, Japan.	teramaget@yahoo.com	Onda, Yuichi/N-6527-2014; Kato, Hiroaki/E-7695-2015; Gomi, Takashi/E-3504-2010	Onda, Yuichi/0000-0001-8753-0378; Kato, Hiroaki/0000-0003-0194-3775; 	Ministry of Education, Culture, Sports, Science and Technology of japan [24110006]	This study is part of the Core Research for Evolutional Science and Technology (CREST) research project "Development of Innovative Technologies for Increasing in Watershed Runoff and Improving River Environment by the Management Practice of Devastated Forest Plantation". This work was also partially supported by Grant-in-Aid for Scientific Research on Innovative Areas Grant Number 24110006 of the Ministry of Education, Culture, Sports, Science and Technology of japan.	He Q, 1997, APPL RADIAT ISOTOPES, V48, P677, DOI 10.1016/S0969-8043(96)00302-8; Porto P, 2001, J HYDROL, V248, P93, DOI 10.1016/S0022-1694(01)00389-4; Gomi T, 2002, BIOSCIENCE, V52, P905, DOI 10.1641/0006-3568(2002)052[0905:UPADLO]2.0.CO;2; Strebl F, 1996, SCI TOTAL ENVIRON, V181, P237, DOI 10.1016/0048-9697(95)05023-X; Almgren S, 2006, J ENVIRON RADIOACTIV, V91, P90, DOI 10.1016/j.jenvrad.2006.08.008; Kruyts N, 2002, J ENVIRON RADIOACTIV, V58, P175, DOI 10.1016/S0265-931X(01)00065-0; Delvaux B, 2000, ENVIRON SCI TECHNOL, V34, P1489, DOI 10.1021/es990658g; BUNZL K, 1989, SCI TOTAL ENVIRON, V78, P77, DOI 10.1016/0048-9697(89)90023-5; Koarashi J, 2012, SCI TOTAL ENVIRON, V431, P392, DOI 10.1016/j.scitotenv.2012.05.041; VALCKE E, 1994, SCI TOTAL ENVIRON, V157, P275; Onda Y, 2010, HYDROL PROCESS, V24, P527, DOI 10.1002/hyp.7548; Bunzl K., 1998, J ENVIRON RADIOACTIV, V39, P58; Bunzl K, 1995, SCI TOTAL ENVIRON, V175, P49, DOI 10.1016/0048-9697(95)04842-1; Calmon P, 2009, J ENVIRON RADIOACTIV, V100, P757, DOI 10.1016/j.jenvrad.2008.11.005; DEBROUWER S, 1994, SCI TOTAL ENVIRON, V143, P183, DOI 10.1016/0048-9697(94)90456-1; DORR H, 1991, WATER AIR SOIL POLL, V57-8, P809, DOI 10.1007/BF00282944; FAWARIS BH, 1994, SCI TOTAL ENVIRON, V157, P133; Fesenko SV, 2001, RADIAT ENVIRON BIOPH, V40, P105, DOI 10.1007/s004110100090; Fujiyoshi R, 2004, SCI TOTAL ENVIRON, V320, P177, DOI 10.1016/j.scitotenv.2003.08.007; Goor F, 2007, J ENVIRON MANAGE, V85, P129, DOI 10.1016/j.jenvman.2006.08.008; IAEA, 2010, TECH REP SER, V472, P1; ISAKSSON M, 1995, J ENVIRON RADIOACTIV, V27, P141, DOI 10.1016/0265-931X(95)00017-5; IUSS Working Group WRB, 1998, WORLD SOIL RES REP; Karadeniz O., 2008, J RAD PROT DOSIM, P1; Kato H, 2012, J ENVIRON RADIOACTIV, V111, P59, DOI 10.1016/j.jenvrad.2011.10.003; Konopleva I, 2009, J ENVIRON RADIOACTIV, V100, P315, DOI 10.1016/j.jenvrad.2008.12.010; Livens F.R., 1992, J ENVIRON RADIOACTIV, V16, P243; Loughran RJ, 2002, HANDBOOK FOR THE ASSESSMENT OF SOIL EROSION AND SEDIMENTATION USING ENVIRONMENTAL RADIONUCLIDES, P41, DOI 10.1007/0-306-48054-9_3; Maes E, 1998, EUR J SOIL SCI, V49, P133, DOI 10.1046/j.1365-2389.1998.00139.x; MELIN J, 1994, SCI TOTAL ENVIRON, V157, P93; MEXT (Ministry of Education Culture Sports Science and Technology), 2011, CORR READ AIRB MON S; Poreba G., 2003, J METHODS APPL ABSOL, V22, P67; Rafferty B, 2000, J ENVIRON RADIOACTIV, V48, P131, DOI 10.1016/S0265-931X(99)00027-2; RAITIO H, 1994, SCI TOTAL ENVIRON, V157, P171; Rosen K, 1999, J ENVIRON RADIOACTIV, V46, P45, DOI 10.1016/S0265-931X(99)00040-5; Sakaguchi A, 2010, SCI TOTAL ENVIRON, V408, P5392, DOI 10.1016/j.scitotenv.2010.07.073; Schimmack W, 2006, SCI TOTAL ENVIRON, V368, P863, DOI 10.1016/j.scitotenv.2006.03.028; SCHIMMACK W, 1989, GEODERMA, V44, P211, DOI 10.1016/0016-7061(89)90030-X; SCHIMMACK W, 1992, SCI TOTAL ENVIRON, V116, P93, DOI 10.1016/0048-9697(92)90367-2; SOMBRE L, 1994, SCI TOTAL ENVIRON, V157, P59; STRANDBERG M, 1994, SCI TOTAL ENVIRON, V157, P125; Sun X., 2013, ECOYDROLOGY; Teramage T.M., 2014, SCI TOTAL ENV; Teramage T.M., 2013, GEODERMA, V192, P59; THIRY Y, 1993, J ENVIRON RADIOACTIV, V18, P247, DOI 10.1016/0265-931X(93)90030-B; Thiry Y, 2000, J ENVIRON QUAL, V29, P1194; Thorring H, 2012, J ENVIRON RADIOACTIV, V110, P69, DOI 10.1016/j.jenvrad.2012.02.002; TIKHOMIROV FA, 1993, SCI TOTAL ENVIRON, V137, P289, DOI 10.1016/0048-9697(93)90395-M; TOBLER L, 1988, J ENVIRON RADIOACTIV, V6, P225, DOI 10.1016/0265-931X(88)90079-3; Walling DE, 2002, HANDBOOK FOR THE ASSESSMENT OF SOIL EROSION AND SEDIMENTATION USING ENVIRONMENTAL RADIONUCLIDES, P111; WITKAMP M., 1964, RADIAT BOT, V4, P485, DOI 10.1016/S0033-7560(64)80015-6; Zibold G, 2009, J ENVIRON RADIOACTIV, V100, P489, DOI 10.1016/j.jenvrad.2009.03.011	52	4	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	NOV	2014	137						37	45		10.1016/j.jenvrad.2014.06.017		9	Environmental Sciences	Environmental Sciences & Ecology	AR5MG	WOS:000343628100006		
J	Inoue, M; Kofuji, H; Fujimoto, K; Furusawa, Y; Yoshida, K; Nagao, S; Yamamoto, M; Hamajima, Y; Minakawa, M				Inoue, M.; Kofuji, H.; Fujimoto, K.; Furusawa, Y.; Yoshida, K.; Nagao, S.; Yamamoto, M.; Hamajima, Y.; Minakawa, M.			Delivery mechanism of Cs-134 and Cs-137 in seawater off the Sanriku Coast, Japan, following the Fukushima Dai-ichi NPP accident	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						Radiocesium; Ra-228; Off Sanriku Coast; Tsugaru warm current; Radioactive deposition; Fukushima Dai-ichi nuclear power plant accident	POWER-PLANT ACCIDENT; PACIFIC INTERMEDIATE WATER; WESTERN NORTH PACIFIC; NORTHEASTERN JAPAN; SPATIAL VARIATIONS; SEA; DEPOSITION; TRANSPORT; RA-228	To assess the delivery mechanism of radiocesium emitted from the Fukushima Dai-ichi Nuclear Power Plant (FDNPP), we examined vertical profiles of Cs-134, Cs-137, and Ra-228 concentrations and the Ra-228/Ra-226 ratio in the water columns off the Sanriku Coast in the northwestern Pacific Ocean, in July 2012, along with their surface lateral variations in July 2009. Radiocesium concentrations exhibited maximum peaks (3-5 mBq/L for Cs-134) at depths of 100-200 m, accompanied by high Ra-228 concentrations (0.6-0.8 mBq/L) in comparison with shallower depths (similar to 0.4 mBq/L). Taking the circulation patterns of currents in the area into account, it was inferred that radioactive depositions were supplied to the Ra-228-rich Tsugaru Warm Current Water (TWCW) in the offshore area of the Sanriku Coast following the FDNPP accident, and that after the spring of 2011, this water (similar to 26.5 sigma(theta)) was covered by lower density surface water, which helped intrude its way to depths of 100-200 m. (C) 2014 Elsevier Ltd. All rights reserved.	[Inoue, M.; Kofuji, H.; Furusawa, Y.; Yoshida, K.; Nagao, S.; Yamamoto, M.; Hamajima, Y.] Kanazawa Univ, Low Level Radioact Lab, Nomi, Ishikawa 9231224, Japan; [Kofuji, H.] Japan Marine Sci Fdn, Minato Ku, Mutsu, Aomori 0350064, Japan; [Fujimoto, K.; Minakawa, M.] Natl Res Inst Fisheries Sci, Fisheries Res Agcy, Kanazawa, Ishikawa 2368648, Japan	Inoue, M (reprint author), Kanazawa Univ, Low Level Radioact Lab, Nomi, Ishikawa 9231224, Japan.	mutsuo@llrl.ku-unet.ocn.ne.jp	HAMAJIMA, Yasunori/L-3802-2015	HAMAJIMA, Yasunori/0000-0002-8485-4606	Ministry of Education, Culture, Sports, Science, and Technology in Japan [21510011, 24510011]	We would like to thank three anonymous reviewers for constructive comments on this manuscript. We thank the researchers, captain, and crew of the R/V Soyo Maru for their assistance during sampling. This study was supported partly by a Grant-in-Aid for Scientific Research (Nos. 21510011 and 24510011) (M. Inoue) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan.	Kofuji H, 2013, J ENVIRON RADIOACTIV, V124, P239, DOI 10.1016/j.jenvrad.2013.06.003; TALLEY LD, 1993, J PHYS OCEANOGR, V23, P517, DOI 10.1175/1520-0485(1993)023<0517:DAFONP>2.0.CO;2; Tsumune D, 2012, J ENVIRON RADIOACTIV, V111, P100, DOI 10.1016/j.jenvrad.2011.10.007; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108; Inoue M, 2012, GEOCHEM J, V46, P311; TALLEY LD, 1995, J PHYS OCEANOGR, V25, P475, DOI 10.1175/1520-0485(1995)025<0475:NPIWIT>2.0.CO;2; Honda MC, 2012, GEOCHEM J, V46, pE1; Charette MA, 2013, BIOGEOSCIENCES, V10, P2159, DOI 10.5194/bg-10-2159-2013; Oguma S, 2002, J OCEANOGR, V58, P825, DOI 10.1023/A:1022823213855; Kaeriyama H, 2014, ENVIRON SCI TECHNOL, V48, P3120, DOI 10.1021/es403686v; Hirose K, 2012, J ENVIRON RADIOACTIV, V111, P13, DOI 10.1016/j.jenvrad.2011.09.003; Buesseler K.O., 2012, P NATL ACAD SCI US; Conlon D.M., 1982, LA MER, V20, P60; Hamajima Y, 2004, APPL RADIAT ISOTOPES, V61, P179, DOI 10.1016/j.apradiso.2004.03.041; Hanawa K., 1987, J OCEANOGR SOC JAPAN, V42, P435; Inatomi N., 1998, SEA SKY UMITOSORA, V73, P7; Inoue M, 2013, APPL RADIAT ISOTOPES, V81, P340, DOI 10.1016/j.apradiso.2013.03.084; Inoue M, 2012, J ENVIRON RADIOACTIV, V111, P116, DOI 10.1016/j.jenvrad.2011.09.012; Inoue M, 2012, GEOCHEM J, V46, P429; Inoue M, 2013, J ENVIRON RADIOACTIV, V126, P176, DOI 10.1016/j.jenvrad.2013.08.001; Kawakami H, 2008, J ENVIRON RADIOACTIV, V99, P1335, DOI 10.1016/j.jenvrad.2008.04.011; Kofuji H., 2010, LOW LEVEL MEASUREMEN, P98; Kumamoto Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04276; Ministry of Education/Culture/Sports/Science/Technology, 2011, READ RAD LEV FALL PR	24	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	NOV	2014	137						113	118		10.1016/j.jenvrad.2014.07.001		6	Environmental Sciences	Environmental Sciences & Ecology	AR5MG	WOS:000343628100015		
J	Takeda, A; Tsukada, H; Yamaguchi, N; Takeuchi, M; Sato, M; Nakao, A; Hisamatsu, S				Takeda, Akira; Tsukada, Hirofumi; Yamaguchi, Noriko; Takeuchi, Megumi; Sato, Mutsuto; Nakao, Atsushi; Hisamatsu, Shun'ichi			Relationship between the radiocesium interception potential and the transfer of radiocesium from soil to soybean cultivated in 2011 in Fukushima Prefecture, Japan	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						Cs-137; Exchangeable K; RIP; Transfer factor	ORGANIC-MATTER; ROOT UPTAKE; PLANT; CS-137; RETENTION	The concentration of radiocesium (Cs-134 and Cs-137) in agricultural fields around Fukushima Dai-ichi Nuclear Power Plant (FDNPP) was elevated after the accident in March 2011. Evaluation of soil properties that influence phytoavailability of radiocesium is important for optimal soil management to minimize radiocesium transfer to crops. In this study, soybean grain and soil samples (0-15 cm) were collected from 46 locations in Fukushima Prefecture in 2011, and Cs-137 concentrations were measured. 137Cs concentration ranges were 11-329 Bq kg(-1) in soybean grain samples, and 0.29-2.49 kBq kg(-1) -dry in soil samples. The radiocesium interception potential (RIP) values in the soil samples ranged from 0.30 to 8.61 mol kg(-1). RIP negatively correlated with total carbon content and oxalate-extractable Si and Al + 1/2 Fe in the soils, suggesting that soils rich in organic matter and poorly crystalline clays tended to have lower RIP in this region. The soil-to-plant transfer factor for Cs-137, analyzed in relation with various soil characteristics, varied by two orders of magnitude and was significantly negatively correlated with RIP and exchangeable K concentration in soil. The results show that RIP is useful for evaluating the efficiency of radiocesium transfer from soil to plants in this region. (C) 2014 Elsevier Ltd. All rights reserved.	[Takeda, Akira; Tsukada, Hirofumi; Hisamatsu, Shun'ichi] Inst Environm Sci, Rokkasho, Aomori 0393212, Japan; [Yamaguchi, Noriko] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan; [Takeuchi, Megumi; Sato, Mutsuto] Fukushima Agr Technol Ctr, Koriyama, Fukushima 9630531, Japan; [Nakao, Atsushi] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Sakyo Ku, Kyoto 6068522, Japan	Takeda, A (reprint author), Inst Environm Sci, 1-7 Ienomae, Rokkasho, Aomori 0393212, Japan.	takeda@ies.or.jp		Hisamatsu, Shun'ichi/0000-0001-6410-5387	Government of Aomori Prefecture, Japan	We are grateful to Dr. I. Taniyama (National Institute for Agro-Environmental Sciences) and Dr. T. Saito (Fukushima Agricultural Technology Center) for their support to our study. We also thank Mses. J. Ohta, Y. Uetake, and Mr. K. Sato (ZAX Co., Ltd.) for their assistance in sample preparation. This work was carried out under contract with the Government of Aomori Prefecture, Japan.	Absalom JP, 1999, ENVIRON SCI TECHNOL, V33, P1218, DOI 10.1021/es9808853; Ehlken S, 2002, J ENVIRON RADIOACTIV, V58, P97, DOI 10.1016/S0265-931X(01)00060-1; Dumat C, 1997, EUR J SOIL SCI, V48, P675, DOI 10.1046/j.1365-2389.1997.00114.x; Smolders E, 1997, ENVIRON SCI TECHNOL, V31, P3432, DOI 10.1021/es970113r; Morino Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048689; Delvaux B, 2000, ENVIRON SCI TECHNOL, V34, P1489, DOI 10.1021/es990658g; Takeda A, 2013, J ENVIRON RADIOACTIV, V122, P29, DOI 10.1016/j.jenvrad.2013.02.005; CREMERS A, 1988, NATURE, V335, P247, DOI 10.1038/335247a0; Blakemore L.C., 1981, NZ SOIL BUREAU SCI R; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; International Atomic Energy Agency, 2010, TECHN REP SER, V472; IUSS Working Group WRB, 2006, WORLD SOIL RES RESP; Joussein E, 2004, SOIL SCI SOC AM J, V68, P313; Nakamaru Y, 2007, COLLOID SURFACE A, V306, P111, DOI 10.1016/j.colsurfa.2007.01.014; Nakao A, 2014, SCI TOTAL ENVIRON, V468, P523, DOI 10.1016/j.scitotenv.2013.08.062; SAIGUSA M, 1978, GEODERMA, V20, P115, DOI 10.1016/0016-7061(78)90039-3; Saigusa Masahiko, 1998, Tohoku Journal of Agricultural Research, V48, P75; Sano O., 2010, Pedologist, V54, P83; SHAW G, 1993, SCI TOTAL ENVIRON, V137, P119, DOI 10.1016/0048-9697(93)90381-F; Tarsitano D, 2011, J ENVIRON RADIOACTIV, V102, P262, DOI 10.1016/j.jenvrad.2010.11.017; Vandebroek L, 2012, J ENVIRON RADIOACTIV, V104, P87, DOI 10.1016/j.jenvrad.2011.09.002; Waegeneers N, 1999, J ENVIRON QUAL, V28, P1005; Wauters J, 1996, APPL GEOCHEM, V11, P589, DOI 10.1016/0883-2927(96)00027-3	23	4	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	NOV	2014	137						119	124		10.1016/j.jenvrad.2014.06.022		6	Environmental Sciences	Environmental Sciences & Ecology	AR5MG	WOS:000343628100016		
J	Iwaoka, K; Tabe, H; Yonehara, H				Iwaoka, Kazuki; Tabe, Hiroyuki; Yonehara, Hidenori			Activity concentration of natural radioactive nuclides in nonmetallic industrial raw materials in Japan	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						NORM; Nonmetallic material; Activity concentration; Dose estimation	RADIATION; THORIUM; EXPOSURE; ORISSA; COAST; PLANT; INDIA; AREA	Natural materials such as rock, ore, and clay, containing natural radioactive nuclides are widely used as industrial raw materials in Japan. If these are high concentrations, the workers who handle the material can be unknowingly exposed to radiation at a high level. In this study, about 80 nonmetallic natural materials frequently used as industrial raw materials in Japan were comprehensively collected from several industrial companies, and the activity concentrations of U-238 series, Th-232 series and K-40 in the materials was determined by ICP-MS (inductively-coupled plasma mass spectrometer) and gamma ray spectrum analyses. Effective doses to workers handling them were estimated by using methods for dose estimation given in the RP 122. We found the activity concentrations to be lower than the critical values defined by regulatory requirements as described in the IAEA Safety Guide. The maximum estimated effective dose to workers handling these materials was 0.16 mSv y(-1), which was lower than the reference level (1-20 mSv y(-1)) for existing situation given in the ICRP Publ.103. (C) 2014 Elsevier Ltd. All rights reserved.	[Iwaoka, Kazuki; Tabe, Hiroyuki; Yonehara, Hidenori] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Inage Ku, Chiba 2638555, Japan; [Iwaoka, Kazuki] Hirosaki Univ, Inst Radiat Emergency Med, Hirosaki, Aomori 0368564, Japan	Iwaoka, K (reprint author), Natl Inst Radiol Sci, Res Ctr Radiat Protect, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	iwaoka@nirs.go.jp					El Afifi EM, 2006, RADIAT MEAS, V41, P627, DOI 10.1016/j.radmeas.2005.09.014; Iwaoka K, 2009, J ENVIRON RADIOACTIV, V100, P993, DOI 10.1016/j.jenvrad.2009.08.004; BAILEY EH, 1993, J ANAL ATOM SPECTROM, V8, P551, DOI 10.1039/ja9930800551; Ballesteros L, 2008, J ENVIRON RADIOACTIV, V99, P1525, DOI 10.1016/j.jenvrad.2007.12.019; Chu T., 2000, J NUCL RADIOCHEM SCI, V1, P5; EC (European commission), 2002, PRACT US CONC CLEA 2; Haridasan PP, 2008, RADIAT PROT DOSIM, V129, P381, DOI 10.1093/rpd/ncm446; Holmes L, 2000, APPL RADIAT ISOTOPES, V53, P63, DOI 10.1016/S0969-8043(00)00170-6; IAEA (International Atomic Energy Agency), 2004, SAF STAND SER, V1.7, P1; ICRP, 2007, ICRP PUBL, V103; ICRP I, 1991, ICRP PUBL, V60; JOHNSTON G, 1991, HEALTH PHYS, V60, P781, DOI 10.1097/00004032-199106000-00003; Martin M., 1999, J ENVIRON RADIOACTIV, V46, P271; Mohanty AK, 2004, RADIAT MEAS, V38, P153, DOI 10.1016/j.radmeas.2003.08.003; Mohanty AK, 2004, J ENVIRON RADIOACTIV, V75, P15, DOI 10.1016/j.jenvrad.2003.09.004; Panda NK, 2003, J GEOL SOC INDIA, V62, P429	16	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	NOV	2014	137						130	136		10.1016/j.jenvrad.2014.06.020		7	Environmental Sciences	Environmental Sciences & Ecology	AR5MG	WOS:000343628100018		
J	Tomita, J; Zhang, J; Yamamoto, M				Tomita, Jumpei; Zhang, Jing; Yamamoto, Masayoshi			Radium isotopes (Ra-226 and Ra-228) in Na-Cl type groundwaters from Tohoku District (Aomori, Akita and Yamagata Prefectures) in Japan	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						Radium isotopes; Na-CI type groundwater; Alpha-recoil; Adsorption-desorption reaction	UNITED-STATES; AQUIFER; WATERS; BRINES; GEOCHEMISTRY; NUCLIDES; BEHAVIOR; EAST; USA	A total of 28 Na-Cl type groundwater samples were collected from Aomori, Akita and Yamagata Prefectures, in the Tohoku District of Japan, and their radium isotope (Ra-226 and Ra-228) concentrations were measured along with their chemical components and stable isotope ratios (delta H-2 and delta Os-18). The Ra-226 concentrations in groundwater samples varied widely, ranging from 8.8 to 1587 mBq kg(-1). These concentrations showed an increasing tendency with the increase of the total dissolved solid (TDS) contents. The Ra-228/Ra-226 activity ratios were in the range from 0.3 to 4.2, with most data being around 0.5-2. These ratios were within those of Th-232/U-238 found in granitic and related rocks and so on in Japan, indicating that Ra isotopes mainly ejected into the groundwater by the alpha-recoil process. The relationship between Ra-226 and other parameters suggested that Ra isotopes in groundwater samples in this study were mainly constrained by adsorption-desorption reactions depending on salinity with wide variation. Clear correlation between Ra-226-Ca, Ra-226-Sr, Ra-226-Ba and Ra-226-TDS observed in sulfate-free groundwater samples indicated that Ra isotopes of them were constrained by adsorption-desorption reactions depending on salinity under reducing condition. In contrast, relationship of Ra-226-Ca, Ra-226-Sr, Ra-226-Ba and Ra-226-TDS in sulfate-containing groundwater samples varied widely, and then, removal or enhanced mobility of Ra isotopes of them were observed. (C) 2014 Elsevier Ltd. All rights reserved.	[Tomita, Jumpei; Yamamoto, Masayoshi] Kanazawa Univ, Inst Nat & Environm Technol, Low Level Radioact Lab, Nomi, Ishikawa 9231224, Japan; [Zhang, Jing] Toyama Univ, Fac Sci, Dept Environm Biol & Chem, Gofuku, Toyama 9308555, Japan	Tomita, J (reprint author), Japan Atom Energy Agcy, Tokai Res & Dev Ctr, Nucl Sci Res Inst, Dept Radiat Protect, 2-4 Shirakata Shirane, Naka, Ibaraki 3191195, Japan.	tomitajumpei@jaea.go.jp			JSPS Research Fellowships for Young Scientists from Japan Society for the Promotion of Science [20-6070]; Ministry of Education, Culture, Sports, Science and Technology, MEXT, Japan [22510057]	This work was supported by JSPS Research Fellowships for Young Scientists from Japan Society for the Promotion of Science (Tomita 2008-2009, contact No. 20-6070) and supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, MEXT, Japan (Yamamoto 2010-2012, No. 22510057).	Vengosh A, 2009, ENVIRON SCI TECHNOL, V43, P1769, DOI 10.1021/es802969r; EPSTEIN S, 1953, GEOCHIM COSMOCHIM AC, V4, P213, DOI 10.1016/0016-7037(53)90051-9; Yamanaka M, 2006, J HYDROL, V325, P35, DOI 10.1016/j.jhydrol.2005.09.026; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; Szabo Z, 2012, APPL GEOCHEM, V27, P729, DOI 10.1016/j.apgeochem.2011.11.002; MIZOTA C, 1994, GEOCHEM J, V28, P387; Araki N., 1993, J JAPAN ASS PETROL T, V58, P119; HERCZEG AL, 1988, CHEM GEOL, V72, P181; Isshiki K., 2005, CHEM OCEAN LAKE, P14; KANAI Y, 1988, GEOCHEM J, V22, P285; Kato S., 2000, J JPN ASS PETROL TEC, V65, P229; KRAEMER TF, 1984, ISOT GEOSCI, V2, P153; KRISHNASWAMI S, 1991, CHEM GEOL, V87, P125, DOI 10.1016/0168-9622(91)90046-Y; Krishnaswami S., 1982, WATER RESOUR RES, V18, P1633; Matsubaya O., 1973, GEOCHEM J, V7, P123; Matsubaya O., 1975, B GEOL SURV JAPAN, V26, P1; Miyake Y., 1975, P 2 INT S NAT ENV, P535; Moise T, 2000, GEOCHIM COSMOCHIM AC, V64, P2371, DOI 10.1016/S0016-7037(00)00369-0; Nathwani J.S., 1979, CHEMOSPHERE, V5, P293; Ohsumi T., 1986, ANAL SCI, V2, P489, DOI DOI 10.2116/ANALSCI.2.489; Pluta U., 1995, APPL GEOCHEM, V10, P447; Sturchio NC, 2001, APPL GEOCHEM, V16, P109, DOI 10.1016/S0883-2927(00)00014-7; Tomita J., 2014, J HOT SPRIN IN PRESS; Tomita J., 2009, J HOT SPRING SCI, V58, P241; Tomita J, 2010, J ENVIRON RADIOACTIV, V101, P201, DOI 10.1016/j.jenvrad.2009.10.009; Tomiyama S., 2010, J HOT SPRING SCI, V59, P261; Tricca A, 2001, GEOCHIM COSMOCHIM AC, V65, P1187, DOI 10.1016/S0016-7037(00)00617-7; Tsuchiya N., 1995, GEOFIS INT, V34, P293; Vinson S.D., 2012, CHEM GEOL, V334, P280; Vinson S.D., 2013, APPL GEOCHEM, V38, P161; Vinson S.D., 2009, CHEM GEOL, V260, P159; Yokoyama Y., 1955, J CHEM SOC JAPAN, V76, P558	32	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	NOV	2014	137						204	212		10.1016/j.jenvrad.2014.07.021		9	Environmental Sciences	Environmental Sciences & Ecology	AR5MG	WOS:000343628100027		
J	Uskul, AK; Kikutani, M				Uskul, Ayse K.; Kikutani, Mariko			Concerns about losing face moderate the effect of visual perspective on health-related intentions and behaviors	JOURNAL OF EXPERIMENTAL SOCIAL PSYCHOLOGY			English	Article						Face; Visual imagery perspective; Dental health behaviors; Public vs. private actions	AUTOBIOGRAPHICAL MEMORY; IMAGERY PERSPECTIVE; DIGNITY CULTURES; SELF-AWARENESS; MENTAL-IMAGERY; VANTAGE POINT; MOTIVATION; INFORMATION; STUDENTS; EMOTION	Visualizing oneself engaging in future actions has been shown to increase the likelihood of actually engaging in the visualized action. In three studies, we examined the effect of perspective taken to visualize a future action (first-person vs. third-person) as a function of the degree to which individuals worry about others' evaluation of themselves (face) and whether the visualized behavior is public or private. Across all studies, the effect of visual perspective was present only for participants with a high level of face. In this group, the third-person visualization induced stronger intentions to engage in the behavior when the imagined behavior was public (Study 1), whereas the first-person visualization induced stronger intentions and greater likelihood to engage in that behavior when it was private (Study 2). The influence of the first-person perspective on flossing behavior was eliminated when people with high levels of face were encouraged to consider inter-personal consequences of the action (Study 3). Results are discussed in the light of recent theorizing on the cognitive consequences of taking a third-person versus a first-person perspective in visual imagery. (C) 2014 The Authors. Published by Elsevier Inc.	[Uskul, Ayse K.] Univ Kent, Canterbury CT2 7NP, Kent, England; [Kikutani, Mariko] Doshisha Univ, Kyoto, Japan	Uskul, AK (reprint author), Univ Kent, Sch Psychol, Keynes Coll, Canterbury CT2 7NP, Kent, England.	a.k.uskul@kent.ac.uk					ADA, 2012, FLOSS; Sherman DK, 2006, MOTIV EMOTION, V30, P165, DOI 10.1007/s11031-006-9001-5; Zane N, 2002, INT CUL PSY, P123; Libby LK, 2007, PSYCHOL SCI, V18, P199, DOI 10.1111/j.1467-9280.2007.01872.x; Berntsen D, 2006, COGNITION EMOTION, V20, P1193, DOI 10.1080/02699930500371190; Kim YH, 2010, PERS SOC PSYCHOL B, V36, P537, DOI 10.1177/0146167210362398; Kitayama S, 2004, PSYCHOL SCI, V15, P527, DOI 10.1111/j.0956-7976.2004.00714.x; Kim YH, 2010, J PERS SOC PSYCHOL, V98, P904, DOI 10.1037/a0017936; McIsaac HK, 2002, PSYCHON B REV, V9, P146, DOI 10.3758/BF03196271; Libby LK, 2011, ADV EXP SOC PSYCHOL, V44, P185, DOI 10.1016/B978-0-12-385522-0.00004-4; Hamamura T, 2009, PERS SOC PSYCHOL B, V35, P454, DOI 10.1177/0146167208329512; Choi SC, 2002, J CROSS CULT PSYCHOL, V33, P332, DOI 10.1177/0022022102033003008; Conway M, 2004, MEMORY, V12, P525, DOI 10.1080/09658210444000151; Cohen D, 2007, ADV EXP SOC PSYCHOL, V39, P1, DOI 10.1016/S0065-2601(06)39001-6; Gerber AS, 2009, J POLIT, V71, P178, DOI 10.1017/S0022381608090117; Leung AKY, 2011, J PERS SOC PSYCHOL, V100, P507, DOI 10.1037/a0022151; Heine SJ, 2008, PERS SOC PSYCHOL B, V34, P879, DOI 10.1177/0146167208316921; Vasquez NA, 2007, PERS SOC PSYCHOL B, V33, P1392, DOI 10.1177/0146167207304541; Heine SJ, 2005, ONT SYMP P, V10, P95; Goddard RD, 2003, EDUC EVAL POLICY AN, V25, P59, DOI 10.3102/01623737025001059; Hwang A, 2003, J CROSS CULT PSYCHOL, V34, P72, DOI 10.1177/0022022102239156; Libby LK, 2002, J PERS SOC PSYCHOL, V82, P167, DOI 10.1037//0022-3514.82.2.167; Ho DYF, 2004, CULT PSYCHOL, V10, P64, DOI 10.1177/1354067X04044166; Uskul AK, 2009, J EXP SOC PSYCHOL, V45, P535, DOI 10.1016/j.jesp.2008.12.005; Heine SJ, 1999, PSYCHOL REV, V106, P766, DOI 10.1037//0033-295X.106.4.766; Mann T, 2004, HEALTH PSYCHOL, V23, P330, DOI 10.1037/0278-6133.23.3.330; BDA, 2012, ORTH MOUTHW; Carlsson F., 2009, WORKING PAPERS EC, V366; Cohen D, 2002, PSYCHOL SCI, V13, P55, DOI 10.1111/1467-9280.00409; GREGORY WL, 1982, J PERS SOC PSYCHOL, V43, P89, DOI 10.1037//0022-3514.43.1.89; Heine Steven J., 2008, CULTURAL PSYCHOL; Ji L. J., 2000, PERSONALITY SOCIAL P, V26, P586, DOI DOI 10.1177/0146167200267006; Jones EE, 1971, ATTRIBUTION PERCEIV, P79; Klages U, 2004, EUR J ORTHODONT, V26, P507, DOI 10.1093/ejo/26.5.507; Libby LK, 2014, J EXP PSYCHOL GEN, V143, P492, DOI 10.1037/a0033705; Libby LK, 2005, J PERS SOC PSYCHOL, V88, P50, DOI 10.1037/0022-3514.88.1.50; NIGRO G, 1983, COGNITIVE PSYCHOL, V15, P467, DOI 10.1016/0010-0285(83)90016-6; Sherman DK, 2010, J EXP SOC PSYCHOL, V46, P461, DOI 10.1016/j.jesp.2009.12.008; Sutin AR, 2008, CONSCIOUS COGN, V17, P1386, DOI 10.1016/j.concog.2008.09.001	39	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-1031	1096-0465		J EXP SOC PSYCHOL	J. Exp. Soc. Psychol.	NOV	2014	55						201	209		10.1016/j.jesp.2014.07.010		9	Psychology, Social	Psychology	AR5IH	WOS:000343618000025		
J	Hobiger, T; Otsubo, T				Hobiger, Thomas; Otsubo, Toshimichi			Combination of GPS and VLBI on the observation level during CONT11-common parameters, ties and inter-technique biases	JOURNAL OF GEODESY			English	Article						GPS; VLBI; Combination; GGOS	ASTROMETRY; GEODESY	Multi-technique space geodetic analysis software has been developed which allows to combine data on the observation level. In addition to local tie information, site-wise common parameters, i.e., troposphere and clocks, can be estimated with this software. Thus, it will be discussed how common parameters have to be estimated and where biases/offsets need to be taken into account. To test such a novel concept, Global Positioning System (GPS) and Very Long Baseline Interferometry (VLBI) data from the CONT11 campaign are being utilized. Since the VLBI baselines of this campaign extend over several thousands of kilometers, GPS data are processed in precise-point positioning mode and satellite orbits and clocks are kept fixed to the IGS final products. From the obtained results, it can be shown that the combination of space geodetic data on the observation level leads to a consistent improvement of station position repeatability as well as nuisance parameters like troposphere estimates. Furthermore, estimation of common parameters (troposphere or clocks) at co-located sites helps to improve the solution further and derive an utmost physically consistent model of the concerned parameters.	[Hobiger, Thomas] Natl Inst Informat & Commun Technol NICT, Space Time Stand Grp, Koganei, Tokyo 1848795, Japan; [Otsubo, Toshimichi] Hitotsubashi Univ, Geosci Lab, Kunitachi, Tokyo 1868601, Japan	Hobiger, T (reprint author), Chalmers, Dept Earth & Space Sci, Onsala Space Observ, SE-43992 Onsala, Sweden.	thomas@hobiger.org; t.otsubo@r.hit-u.ac.jp	Hobiger, Thomas/O-7369-2014	Hobiger, Thomas/0000-0003-3116-2742			Ray RD, 2003, ANN GEOPHYS-GERMANY, V21, P1897; Teke K, 2011, J GEODESY, V85, P395, DOI 10.1007/s00190-010-0434-y; Chen G, 1997, J GEOPHYS RES-SOL EA, V102, P20489, DOI 10.1029/97JB01739; Dow JM, 2009, J GEODESY, V83, P191, DOI 10.1007/s00190-008-0300-3; Schuh H, 2012, J GEODYN, V61, P68, DOI 10.1016/j.jog.2012.07.007; Ray J, 2005, J GEODESY, V79, P189, DOI 10.1007/s00190-005-0456-z; Altamimi Z, 2011, J GEODESY, V85, P457, DOI 10.1007/s00190-011-0444-4; Lagler K, 2013, GEOPHYS RES LETT, V40, P1069, DOI 10.1002/grl.50288; Rothacher M, 2009, GLOBAL GEODETIC OBSERVING SYSTEM: MEETING THE REQUIREMENTS OF A GLOBAL SOCIETY ON A CHANGING PLANET IN 2020, P237, DOI 10.1007/978-3-642-02687-4_9; Willis P, 2010, ADV SPACE RES, V45, P1408, DOI 10.1016/j.asr.2009.11.018; DAVIS JL, 1993, RADIO SCI, V28, P1003, DOI 10.1029/93RS01917; Coulot D, 2007, J GEOPHYS RES, V112, P2156, DOI 10.1029/2006JB004336; Gurtner W., 1994, GPS WORLD, V5, P48; Hobiger T, 2010, EARTH PLANETS SPACE, V45, P75, DOI DOI 10.5047/EPS.2010.11.008; Hobiger T, 2014, ADV SPACE RES, V53, P119, DOI 10.1016/j.asr.2013.10.004; Kalman R. E., 1960, T ASME D, V82, P35, DOI DOI 10.1115/1.3662552; Kelm R, 2009, IAG SYMP, V134, P39, DOI 10.1007/978-3-642-00860-3_6; Koch K R, 1997, PARAMETER ESTIMATION; Kouba J., 2001, GPS SOLUT, V5, P12, DOI DOI 10.1007/PL00012883; Otsubo T, 2002, IVS 2002 GEN M P, P300; Otten M, 2012, GEOPH RES ABSTR, V14; Panek P, 2013, METROLOGIA, V50, P60, DOI 10.1088/0026-1394/50/1/60; Petit G, 2010, IERS CONV, V36, P179; Petrachenko WT, 2012, IAG SYMP, V136, P999, DOI 10.1007/978-3-642-20338-1_125; Plank L, 2011, 12 IVS AN WORKSH MAR; Rieck C, 2012, 2012 EUROPEAN FREQUENCY AND TIME FORUM (EFTF), P163; Thaller D, 2008, 0815 STR DTSCH GEOFO	27	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0949-7714	1432-1394		J GEODESY	J. Geodesy	NOV	2014	88	11					1017	1028		10.1007/s00190-014-0740-x		12	Geochemistry & Geophysics; Remote Sensing	Geochemistry & Geophysics; Remote Sensing	AR5XT	WOS:000343655500001		
J	Ueno, Y; Hoshinoo, K; Tagawa, Y				Ueno, Yuichi; Hoshinoo, Kaori; Tagawa, Yuichi			Mutations in the major outer membrane protein gene from Histophilus somni by an allelic exchange method	JOURNAL OF MICROBIOLOGICAL METHODS			English	Article						Histophilus somni; Major outer membrane protein; Mutations; Allelic exchange; Serum susceptibility	TEMPERATURE-SENSITIVE PLASMID; PARASUIS SC096 STRAIN; COMPLEMENT FACTOR-H; HAEMOPHILUS-SOMNUS; SERUM-RESISTANCE; MOLECULAR CHARACTERIZATION; PASTEURELLA-MULTOCIDA; NEISSERIA-GONORRHOEAE; BACTERIAL PORINS; BINDING	Functional roles of the major outer membrane protein (MOMP) gene from the bovine pathogen Histophilus somni have remained to be elucidated due to lack of mutagenesis methods easily applicable to this gene. In this study, the direct use of PCR-amplified mutated DNA flanking by an antibiotic selection marker for transformation of H. somni was applied to accomplish the site-directed mutagenesis via homologous recombination in H. somni non-pathogenic strain 129Pt and pathogenic strain 2336. A protocol for unmarking the antibiotic resistance gene from the created MOMP mutant by using a temperature-sensitive plasmid vector was also established. In both strains, no significant phenotypic difference was observed between the wild-type strain and its isogenic mutant expressing the exchanged MOMP in growth in broth medium and antibiotic susceptibility. However, the mutant 129Pt expressing MOMP from strain 2336 was significantly more susceptible to bacterial killing by fresh normal bovine serum than its wild-type parent strain. Serum susceptibility of the mutant 2336 expressing MOMP from strain 129Pt was significantly lower than its wild-type parent strain although the susceptibility difference was considerably less than that found between the 129Pt wild-type and MOMP mutant strains. From further assays using MOMP mutants that express chimeric MOMP consisting of the amino-terminal part that contains loops L1-L3 from one strain and the carboxyl-terminal part that contains loops L4-L8 from another strain, the C-terminal part of MOMP was found to affect serum susceptibility of H. somni. (C) 2014 Elsevier B.V. All rights reserved.	[Ueno, Yuichi; Hoshinoo, Kaori; Tagawa, Yuichi] NARO, Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Tsukuba, Ibaraki 3050856, Japan	Tagawa, Y (reprint author), NARO, Natl Inst Anim Hlth, 3-1-5 Tsukuba, Ibaraki 3050856, Japan.	ytagawa@affrc.go.jp			Ministry of Education, Culture, Sports, Science and Technology, MEXT, Japan [22580359]	This study was supported in part by Grant-in-Aid for Scientific Research, JSPS KAKENHI 22580359 from the Ministry of Education, Culture, Sports, Science and Technology, MEXT, Japan.	Zhang B, 2012, FEMS MICROBIOL LETT, V326, P109, DOI 10.1111/j.1574-6968.2011.02433.x; Tagawa Y, 2000, VET MICROBIOL, V71, P245, DOI 10.1016/S0378-1135(99)00165-0; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; COLE SP, 1993, J GEN MICROBIOL, V139, P2135; Galdiero S, 2012, CURR PROTEIN PEPT SC, V13, P843; Achouak W, 2001, FEMS MICROBIOL LETT, V199, P1; Gill MJ, 1998, ANTIMICROB AGENTS CH, V42, P2799; HARRIS FW, 1989, CAN VET J, V30, P816; Zhang B, 2013, VET MICROBIOL, V162, P713, DOI 10.1016/j.vetmic.2012.09.021; Hoshinoo K, 2009, MICROB PATHOGENESIS, V46, P273, DOI 10.1016/j.micpath.2009.02.003; Ram S, 2001, J EXP MED, V193, P281, DOI 10.1084/jem.193.3.281; HAMILTON CM, 1989, J BACTERIOL, V171, P4617; D'Amours GH, 2011, VET MICROBIOL, V150, P362, DOI 10.1016/j.vetmic.2011.02.051; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Wu YP, 2000, INFECT IMMUN, V68, P310; Briggs RE, 2005, APPL ENVIRON MICROB, V71, P7187, DOI 10.1128/AEM.71.11.7187-7195.2005; Clinical and Laboratory Standards Institute, 2005, METH ANT DIL DISK SU; COPE LD, 1990, INFECT IMMUN, V58, P3312; CORBEIL LB, 1985, J CLIN MICROBIOL, V22, P192; DIXON LG, 1994, PLASMID, V32, P228, DOI 10.1006/plas.1994.1060; GOGOLEWSKI RP, 1987, INFECT IMMUN, V55, P1403; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Humphrey J. D., 1983, Veterinary Bulletin, V53, P987; Inzana TJ, 2012, VET MICROBIOL, V161, P113, DOI 10.1016/j.vetmic.2012.07.008; Ishiguro K, 2005, J VET MED SCI, V67, P817, DOI 10.1292/jvms.67.817; Khan MSR, 2005, VET MICROBIOL, V107, P179, DOI 10.1016/j.vetmic.2005.01.025; Kim JM, 2008, FEMS MICROBIOL LETT, V278, P78, DOI 10.1111/j.1574-6968.2007.00981.x; KWIECIEN JM, 1991, CAN VET J, V32, P595; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Ram S, 1998, J EXP MED, V188, P671, DOI 10.1084/jem.188.4.671; Sanders JD, 1997, FEMS MICROBIOL LETT, V154, P251, DOI 10.1111/j.1574-6968.1997.tb12652.x; SETLOW JK, 1968, J BACTERIOL, V95, P546; Tagawa Y, 2005, MICROB PATHOGENESIS, V39, P159, DOI 10.1016/j.micpath.2005.08.002; Tatum FM, 2005, APPL ENVIRON MICROB, V71, P7196, DOI 10.1128/AEM.71.11.7196-7202.2005; Tracy E, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-101	35	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7012	1872-8359		J MICROBIOL METH	J. Microbiol. Methods	NOV	2014	106						83	92		10.1016/j.mimet.2014.08.008		10	Biochemical Research Methods; Microbiology	Biochemistry & Molecular Biology; Microbiology	AR1PX	WOS:000343358200014		
J	Fujiwara, M; Shiokawa, K; Yotsuya, K; Matsumoto, K				Fujiwara, Masahiro; Shiokawa, Kumi; Yotsuya, Koji; Matsumoto, Kazutsugu			Immobilization of lipase from Burkholderia cepacia into calcium carbonate microcapsule and its use for enzymatic reactions in organic and aqueous media	JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC			English	Article						Calcium carbonate; Enzymatic esterification; Enzymatic hydrolysis; Immobilization of lipase; Vaterite	POROUS CACO3 MICROPARTICLES; ENANTIOSELECTIVE HYDROLYSIS; INTERFACIAL REACTION; RHIZOPUS-ORYZAE; ENCAPSULATION; NANOPARTICLES; COMBINATION; MECHANISM; VATERITE	We disclosed a useful procedure for the immobilization of a lipase from Burkholderia cepacia based on its encapsulation into vaterite calcium carbonate microcapsule. The immobilized enzyme had an adequate activity for the hydrolysis of 4-nitrophenyl acetate, which was preserved over 2 years in storage at 4 degrees C. The enantioselective esterification of (+/-)-1-phenylethanol with vinyl acetate using the immobilized lipase smoothly progressed to afford the corresponding optically active compounds, where the enzyme was easily recovered for reuse. Although the hydrolysis of (+/-)-2-acetoxyhexyl tosylate in aqueous solution was catalyzed by the enzyme, the phase transition of calcium carbonate from vaterite to poorly porous calcite during the reaction prevented the access of the reactant to the active site of the lipase, resulting in the significant decrease of the activity of the recovered enzyme. However, the treatment of the immobilized enzyme with zinc chloride solution inhibited the phase transition under the reaction conditions. The enzyme after the zinc treatment was recyclable for the hydrolysis of the substrate without significant decrease of the reactivity even after the uses in aqueous media. (C) 2014 Elsevier B.V. All rights reserved.	[Fujiwara, Masahiro; Shiokawa, Kumi] Natl Inst Adv Ind Sci & Technol, Kansai Ctr, Ikeda, Osaka 5638577, Japan; [Yotsuya, Koji; Matsumoto, Kazutsugu] Meisei Univ, Dept Chem & Life Sci, Hino, Tokyo 1918506, Japan	Fujiwara, M (reprint author), Natl Inst Adv Ind Sci & Technol, Kansai Ctr, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.	m-fujiwara@aist.go.jp; mkazu@chem.meisei-u.ac.jp					Tran DN, 2011, ACS CATAL, V1, P956, DOI 10.1021/cs200124a; DiCosimo R, 2013, CHEM SOC REV, V42, P6437, DOI 10.1039/c3cs35506c; Volodkin DV, 2004, BIOMACROMOLECULES, V5, P1962, DOI 10.1021/bm049669e; Biradar S, 2011, J NANOSCI NANOTECHNO, V11, P6868, DOI 10.1166/jnn.2011.4251; Demir S, 2012, STARCH-STARKE, V64, P3, DOI 10.1002/star.201100058; Wang YJ, 2009, J MATER CHEM, V19, P6451, DOI 10.1039/b901742a; Shan D, 2007, BIOSENS BIOELECTRON, V22, P1612, DOI 10.1016/j.bios.2006.07.019; Cai WY, 2006, CHEM MATER, V18, P279, DOI 10.1021/cm051442i; Wang CY, 2006, INT J PHARM, V308, P160, DOI 10.1016/j.ijpharm.2005.11.004; Rodrigues RC, 2013, CHEM SOC REV, V42, P6290, DOI 10.1039/c2cs35231a; Fujiwara M, 2010, CRYST GROWTH DES, V10, P4030, DOI 10.1021/cg100631v; Fujiwara M, 2004, CHEM MATER, V16, P5420, DOI 10.1021/cm048804r; Won YH, 2010, J MATER CHEM, V20, P7728, DOI 10.1039/c0jm01231a; OGINO T, 1987, GEOCHIM COSMOCHIM AC, V51, P2757, DOI 10.1016/0016-7037(87)90155-4; Ghamgui H, 2007, BIOCHEM ENG J, V37, P34, DOI 10.1016/j.bej.2007.03.006; Fujiwara M, 2008, CHEM ENG J, V137, P14, DOI 10.1016/j.cej.2007.09.010; Sheldon RA, 2013, CHEM SOC REV, V42, P6223, DOI 10.1039/c3cs60075k; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Bornscheuer U, 1999, HYDROLASES ORGANIC S; Brabcova J, 2013, CURR BIOACT COMPD, V9, P113; Cai WY, 2008, ADV FUNCT MATER, V18, P3127, DOI 10.1002/adfm.200800531; CHEN CS, 1982, J AM CHEM SOC, V104, P7294, DOI 10.1021/ja00389a064; Drauz K., 2012, ENZYME CATALYSIS ORG; Faber K., 2004, BIOTRANSFORMATIONS O; Fan X., 2012, METHOD MOL BIOL, P471; Fujiwara M, 2014, ADV POWDER TECHNOL, V25, P1147, DOI 10.1016/j.apt.2014.02.022; Ghamgui H, 2004, ENZYME MICROB TECH, V35, P355, DOI 10.1016/j.enzmictec.2004.06.002; Lu Z, 2012, MAT SCI ENG C-MATER, V32, P1982, DOI 10.1016/j.msec.2012.05.027; Matsumoto K, 2013, TETRAHEDRON-ASYMMETR, V24, P108, DOI 10.1016/j.tetasy.2012.11.023; Minovska V, 2005, J SERB CHEM SOC, V70, P609, DOI 10.2298/JSC0504609M; NAKAHARA Y, 1979, J COLLOID INTERF SCI, V68, P401, DOI 10.1016/0021-9797(79)90298-4; Nakamae K., 1986, J ADHES SOC JPN, V22, P573; Nwagu TN, 2012, J MOL CATAL B-ENZYM, V78, P1, DOI 10.1016/j.molcatb.2012.01.019; Okudomi M, 2010, TETRAHEDRON, V66, P8060, DOI 10.1016/j.tet.2010.07.076; Palomo JM., 2008, CURR BIOACT COMPD, V4, P126, DOI 10.2174/157340708785294208; Sawangpanya N., 2010, SCI J UBU, V1, P46; Shimada Y, 2008, SYNLETT, P367, DOI 10.1055/s-2008-1032047; Shimada Y, 2008, SYNLETT, P2981, DOI 10.1055/s-0028-1083632; Shimada Y, 2009, TETRAHEDRON-ASYMMETR, V20, P2802, DOI 10.1016/j.tetasy.2009.11.005	39	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-1177	1873-3158		J MOL CATAL B-ENZYM	J. Mol. Catal. B-Enzym.	NOV	2014	109						94	100		10.1016/j.molcatb.2014.08.009		7	Biochemistry & Molecular Biology; Chemistry, Physical	Biochemistry & Molecular Biology; Chemistry	AR8XG	WOS:000343854100013		
J	Natori, N; Nakagawara, K; Shoji, M; Sugai, T; Hanaya, K				Natori, Naoki; Nakagawara, Kaoruko; Shoji, Mitsuru; Sugai, Takeshi; Hanaya, Kengo			Recognition of the remote chiral center in lipase-catalyzed kinetic resolution of [2-methyl-2-(2 '-naphthyl)-1,3-benzodioxol-4-yl]methyl acetate, the precursor of 2-methyl-2-(2 '-naphthyl)-1,3-benzodioxole-4-carboxylic acid (MNB carboxylic acid)	JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC			English	Article						Lipase; Transesterification; Kinetic resolution; Remote chiral center; Molecular dynamics simulation	ENANTIOMERS; OXIDATION; ESTERS	To access the enantiomers of 2-methyl-2-(2'-naphthyl)-1,3-benzodioxole-4-carboxylic acid (MNB carboxylic acid), lipase-catalyzed kinetic resolution of racemic [2-methyl-2-(2'-naphthyl)-1,3-benzodioxol-4-yl]methyl acetate was examined with Burkholderia cepacia lipase (Amano PS-IM) and Candida antarctica lipase B (Novozym 435) under transesterification conditions. Enantioselectivity of B. cepacia lipase (E = 72) was higher than that of C antarctica lipase B (E = 1.7), and these lipases showed a reversal of enantiopreference in the recognition of a remote chiral center. The computational study showed that the tetrahedral intermediate complex of B. cepacia lipase with (R)-4a, the fast isomer, was more stable than that with (S)-4a, the slow isomer. The repetitive use of B. cepacia lipase and further chemical transformation provided both enantiomers [(R)-: 99.4% ee and (S)-: 99.4% eel of MNB carboxylic acid as methyl esters. (C) 2014 Elsevier B.V. All rights reserved.	[Natori, Naoki; Nakagawara, Kaoruko; Shoji, Mitsuru; Sugai, Takeshi; Hanaya, Kengo] Keio Univ, Dept Pharmaceut Sci, Minato Ku, Tokyo 1058512, Japan	Hanaya, K (reprint author), Keio Univ, Dept Pharmaceut Sci, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	hanaya-kn@pha.keio.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [23580152]	We acknowledge the generous gift of lipases: PS-IM from Amano Enzyme Inc. and Novozym 435 from Novozymes Japan. We thank Prof. Tadashi Ema from Okayama University for helpful discussions on computational simulation. We also thank our junior colleagues, Ms. Mel Takahashi, Mr. Masanori Miyazawa, and Mr. Keisuke Yuki, for their efforts in the early stage of this study. This study was supported by a Grant-in-Aid for Scientific Research (No. 23580152) for T.S. and Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and this grant is acknowledged with thanks. The authors would like to thank Enago (www.enago.jp) for the English language review.	Accelrys Software Inc, 2013, DISC STUD MOD ENV RE; Akeboshi T, 2001, ADV SYNTH CATAL, V343, P624, DOI 10.1002/1615-4169(200108)343:6/7<624::AID-ADSC624>3.3.CO;2-H; CYGLER M, 1994, J AM CHEM SOC, V116, P3180, DOI 10.1021/ja00087a002; HUGHES DL, 1990, J ORG CHEM, V55, P6252, DOI 10.1021/jo00313a010; COREY EJ, 1968, J AM CHEM SOC, V90, P5616, DOI 10.1021/ja01022a059; Shibuya M, 2006, J AM CHEM SOC, V128, P8412, DOI 10.1021/ja0620336; Yadav GD, 2005, J MOL CATAL B-ENZYM, V32, P107, DOI 10.1016/j.molcatb.2004.10.003; Ema T, 1998, B CHEM SOC JPN, V71, P443, DOI 10.1246/bcsj.71.443; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Higashi T, 2010, ADV SYNTH CATAL, V352, P2549, DOI 10.1002/adsc.201000446; Ito E., 1995, BUNSEKI KAGAKU, V44, P739; Kawasaki M, 1999, J MOL CATAL B-ENZYM, V6, P447, DOI 10.1016/S1381-1177(99)00002-8; Kobayashi R, 2012, CHEM PHARM BULL, V60, P1220	13	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-1177	1873-3158		J MOL CATAL B-ENZYM	J. Mol. Catal. B-Enzym.	NOV	2014	109						130	135		10.1016/j.molcatb.2014.08.010		6	Biochemistry & Molecular Biology; Chemistry, Physical	Biochemistry & Molecular Biology; Chemistry	AR8XG	WOS:000343854100018		
J	Nojiri, M; Taoka, N; Yasohara, Y				Nojiri, Masutoshi; Taoka, Naoaki; Yasohara, Yoshihiko			Characterization of an enantioselective amidase from Cupriavidus sp. KNK-J915 (FERM BP-10739) useful for enzymatic resolution of racemic 3-piperidinecarboxamide	JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC			English	Article						Amidase; Cupriavidus sp.; Enzymatic resolution; 3-Piperidinecarboxamide	PIPERAZINE-2-TERT-BUTYLCARBOXAMIDE; INHIBITOR; POTENT	A novel amidase (CsAM) acting on (R,S)-N-benzyl-3-piperidinecarboxamide was purified from Cupriavidus sp. KNK-J915 (FERM BP-10739) and characterized. The enzyme acts on (R,S)-N-benzyl-3-piperidinecarboxamide S-selectively to yield (R)-N-benzyl-3-piperidinecarboxamide. Analytical gel filtration column chromatography and SDS-PAGE revealed that the enzyme is a tetramer with a subunit of approximately 47 kDa. It has a broad substrate spectrum against nitrogen-containing heterocyclic amides. Its optimal pH and temperature are 8.0-9.0 and 50 degrees C, respectively. The CsAM gene was cloned and sequenced, and it was found to comprise 1341 bp and encode a polypeptide of 46,388 Da. The deduced amino acid sequence exhibited 78% identity to that of a putative amidase (CnAM) from Cupriavidus necator JMP134. The cultured cells of recombinant Escherichia coli producing CnAM could be used for the S-selective hydrolysis of (R,S)-N-benzyl-3-piperidinecarboxamide but could not be used for the S-selective hydrolysis of (R,S)-3-piperidinecarboxamide because of its very low level of selectivity. In contrast, the cultured cells of recombinant E. coli producing CsAM could hydrolyze both (R,S)-N-benzyl-3-piperidinecarboxamide and (R,S)-3-piperidinecarboxamide with high S-selectivity. (C) 2014 Elsevier B.V. All rights reserved.	[Nojiri, Masutoshi; Taoka, Naoaki; Yasohara, Yoshihiko] Kaneka Corp, Biotechnol Dev Labs, Takasago, Hyogo 6768688, Japan	Nojiri, M (reprint author), Kaneka Corp, Biotechnol Dev Labs, 1-8 Miyamae, Takasago, Hyogo 6768688, Japan.	Masutoshi_Nojiri@kn.kaneka.co.jp					Feng J, 2007, J MED CHEM, V50, P2297, DOI 10.1021/jm0701041; Straathof AJJ, 1997, ENZYME MICROB TECH, V21, P559, DOI 10.1016/S0141-0229(97)00066-5; KOBAYASHI M, 1993, EUR J BIOCHEM, V217, P327, DOI 10.1111/j.1432-1033.1993.tb18250.x; Nojiri M, 2013, J APPL MICROBIOL, V115, P1127, DOI 10.1111/jam.12309; OCHMAN H, 1988, GENETICS, V120, P621; Eckhardt M, 2007, J MED CHEM, V50, P6450, DOI 10.1021/jm701280z; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Inoue A, 2005, ADV SYNTH CATAL, V347, P1132, DOI 10.1002/adsc.200505028; Komeda H, 2004, EUR J BIOCHEM, V271, P1465, DOI 10.1111/j.1432-1033.2004.04056.x; Komeda H, 2004, EUR J BIOCHEM, V271, P1580, DOI 10.1111/j.1432-1033.2004.04069.x; Nanba H, 1999, J BIOSCI BIOENG, V87, P149, DOI 10.1016/S1389-1723(99)89004-5; Peng C., 2012, J ORG CHEM, V77, P4063; Sambrook J, 2001, MOL CLONING LAB MANU; Shioiri T., 1991, COMPREHENSIVE ORGANI, V6, P800; Velankar H, 2010, TRENDS BIOTECHNOL, V28, P561, DOI 10.1016/j.tibtech.2010.08.004	16	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-1177	1873-3158		J MOL CATAL B-ENZYM	J. Mol. Catal. B-Enzym.	NOV	2014	109						136	142		10.1016/j.molcatb.2014.08.016		7	Biochemistry & Molecular Biology; Chemistry, Physical	Biochemistry & Molecular Biology; Chemistry	AR8XG	WOS:000343854100019		
J	Katayama, S; Imori, S				Katayama, Shota; Imori, Shinpei			Lasso penalized model selection criteria for high-dimensional multivariate linear regression analysis	JOURNAL OF MULTIVARIATE ANALYSIS			English	Article						Multivariate linear regression; Model selection; High-dimensional data; Consistency	COVARIANCE ESTIMATION; VARIABLES; MATRIX	This paper proposes two model selection criteria for identifying relevant predictors in the high-dimensional multivariate linear regression analysis. The proposed criteria are based on a Lasso type penalized likelihood function to allow the high-dimensionality. Under the asymptotic framework that the dimension of multiple responses goes to infinity while the maximum size of candidate models has smaller order of the sample size, it is shown that the proposed criteria have the model selection consistency, that is, they can asymptotically pick out the true model. Simulation studies show that the proposed criteria outperform existing criteria when the dimension of multiple responses is large. (C) 2014 Elsevier Inc. All rights reserved.	[Katayama, Shota] Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Meguro Ku, Tokyo 1528550, Japan; [Imori, Shinpei] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan	Katayama, S (reprint author), Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528550, Japan.	katayama.s.ad@m.titech.ac.jp; imori.stat@gmail.com	Katayama, Shota/B-9352-2015	Katayama, Shota/0000-0003-1205-4084	JSPS [23-2789]	We would like to thank the associate editor and the two referees for their careful reading of the original article and for their valuable comments that greatly helped improve the article. This work was supported by the JSPS Grant-in-Aid for JSPS Fellows Number 23-2789.	Akaike H, 1973, 2 INT S INF THEOR, V1, P267; Zhang CH, 2008, ANN STAT, V36, P1567, DOI 10.1214/07-AOS520; NISHII R, 1984, ANN STAT, V12, P758, DOI 10.1214/aos/1176346522; Rothman AJ, 2010, J COMPUT GRAPH STAT, V19, P947, DOI 10.1198/jcgs.2010.09188; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Fan YY, 2013, J R STAT SOC B, V75, P531, DOI 10.1111/rssb.12001; Rothman AJ, 2008, ELECTRON J STAT, V2, P494, DOI 10.1214/08-EJS176; Peng J, 2010, ANN APPL STAT, V4, P53, DOI 10.1214/09-AOAS271; Kim Y, 2012, J MACH LEARN RES, V13, P1037; Xu J, 2008, BIOINFORMATICS, V24, P1056, DOI 10.1093/bioinformatics/btn053; Kubokawa T, 2008, J MULTIVARIATE ANAL, V99, P1906, DOI 10.1016/j.jmva.2008.01.016; Chen JH, 2008, BIOMETRIKA, V95, P759, DOI 10.1093/biomet/asn034; Zhang YY, 2010, J AM STAT ASSOC, V105, P312, DOI 10.1198/jasa.2009.tm08013; Lam C, 2009, ANN STAT, V37, P4254, DOI 10.1214/09-AOS720; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; MALLOWS CL, 1973, TECHNOMETRICS, V15, P661, DOI 10.2307/1267380; Obozinski G, 2011, ANN STAT, V39, P1, DOI 10.1214/09-AOS776; Chen JH, 2012, STAT SINICA, V22, P555, DOI 10.5705/ss.2010.216; Yuan M, 2007, BIOMETRIKA, V94, P19, DOI 10.1093/biomet/asm018; Boyd Stephen, 2010, Foundations and Trends in Machine Learning, V3, DOI 10.1561/2200000016; Foygel R., 2010, ARXIV10116640V1; Fujikoshi Y, 2010, WILEY SER PROBAB ST, P1, DOI 10.1002/9780470539873; Kubokawa T, 2012, COMMUN STAT-THEOR M, V41, P2465, DOI 10.1080/03610926.2011.624242; Scheinberg K., 2010, ARXIV10110097; Schott J.R., 2005, MATRIX ANAL STAT; Srivastava M.S., 2008, J JAPAN STAT SOC, V38, P259; Van der Vaart A., 1996, WEAK CONVERGENCE EMP; Wang H., 2009, J R STAT SOC B, V71, P1418; Yamamura M., 2010, J APPL STAT, V39, P1; Yanagihara H., 2012, 1208 HIR U STAT RES	30	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0047-259X			J MULTIVARIATE ANAL	J. Multivar. Anal.	NOV	2014	132						138	150		10.1016/j.jmva.2014.08.002		13	Statistics & Probability	Mathematics	AR5NY	WOS:000343632300010		
J	Tsukada, S				Tsukada, Shin-ichi			Equivalence testing of mean vector and covariance matrix for multi-populations under a two-step monotone incomplete sample	JOURNAL OF MULTIVARIATE ANALYSIS			English	Article						Mean vector; Covariance matrix; Likelihood ratio criterion; Wald-type criterion; Monotone incomplete data	MULTIVARIATE NORMAL-DISTRIBUTION; MISSING DATA; INFERENCE	This paper investigates the hypothesis testing of a mean vector and covariance matrix for multi-populations in the context of two-step monotone incomplete data drawn from Np+q(mu, Sigma), a multivariate normal population with mean mu and covariance matrix Sigma. Three null hypotheses are considered, and the likelihood ratio criterion and Wald-type criterion are derived. On the basis of numerical simulations, the test that employs the Wald-type criterion is recommended. (C) 2014 Elsevier Inc. All rights reserved.	Meisei Univ, Sch Educ, Hino, Tokyo 1918506, Japan	Tsukada, S (reprint author), Meisei Univ, Sch Educ, 2-1-1 Hodokubo, Hino, Tokyo 1918506, Japan.	tsukada@ed.meisei-u.ac.jp					ANDERSON TW, 1957, J AM STAT ASSOC, V52, P200, DOI 10.2307/2280845; Chang WY, 2010, J MULTIVARIATE ANAL, V101, P603, DOI 10.1016/j.jmva.2009.09.011; Chang WY, 2009, J MULTIVARIATE ANAL, V100, P1883, DOI 10.1016/j.jmva.2009.05.003; ANDERSON TW, 1985, LINEAR ALGEBRA APPL, V70, P147, DOI 10.1016/0024-3795(85)90049-7; Tsukada S, 2014, COMMUN STAT-THEOR M, V43, P1613, DOI 10.1080/03610926.2012.671881; Hao J, 2001, J MULTIVARIATE ANAL, V78, P62, DOI 10.1006/jmva.2000.1939; Kanda T, 1998, AM S MATH M, P161; Little R. J. A., 2002, STAT ANAL MISSING DA; PROVOST SB, 1991, ENVIRONMETRICS, V2, P487, DOI 10.1002/env.3770020407; SRIVASTAVA MS, 1985, COMMUN STAT-THEOR M, V14, P775, DOI 10.1080/03610928508828949; Yamada T., 2012, PREPRINT	11	1	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0047-259X			J MULTIVARIATE ANAL	J. Multivar. Anal.	NOV	2014	132						183	196		10.1016/j.jmva.2014.08.005		14	Statistics & Probability	Mathematics	AR5NY	WOS:000343632300014		
J	Emura, T; Kao, FH; Michimae, H				Emura, Takeshi; Kao, Fan-Hsuan; Michimae, Hirofumi			An improved nonparametric estimator of sub-distribution function for bivariate competing risk models	JOURNAL OF MULTIVARIATE ANALYSIS			English	Article						Bivariate survival function; Right censoring; Survival analysis	KAPLAN-MEIER ESTIMATE; TIME; COEFFICIENT; PLANE	For competing risks data, it is of interest to estimate the sub-distribution function of a particular failure event, which is the failure probability in the presence of competing risks. However, if multiple failure events per subject are available, estimation procedures become challenging even for the bivariate case. In this paper, we consider nonparametric estimation of a bivariate sub-distribution function, which has been discussed in the related literature. Adopting a decision-theoretic approach, we propose a new nonparametric estimator which improves upon an existing estimator. We show theoretically and numerically that the proposed estimator has smaller mean square error than the existing one. The consistency of the proposed estimator is also established. The usefulness of the estimator is illustrated by the salamander data and mouse data. (C) 2014 Elsevier Inc. All rights reserved.	[Emura, Takeshi; Kao, Fan-Hsuan] Natl Cent Univ, Grad Inst Stat, Zhongli, Taiwan; [Michimae, Hirofumi] Kitasato Univ, Sch Pharm, Dept Clin Med Biostat, Tokyo, Japan	Emura, T (reprint author), Natl Cent Univ, Grad Inst Stat, Zhongli, Taiwan.	emura@stat.ncu.edu.tw			 [NSC101-2118-M008-002-MY2]	We would like to thank the anonymous reviewer for his/her helpful comments that greatly Unproved the manuscript. The work is supported by the grant NSC101-2118-M008-002-MY2.	Akritas MG, 2003, J ROY STAT SOC B, V65, P457, DOI 10.1111/1467-9868.00396; Andersen P.K., 1993, STAT MODELS BASED CO; Michimae H, 2012, J EVOLUTION BIOL, V25, P1331, DOI 10.1111/j.1420-9101.2012.02523.x; CLAYTON DG, 1978, BIOMETRIKA, V65, P141, DOI 10.1093/biomet/65.1.141; Andersen PK, 2002, STAT METHODS MED RES, V11, P203, DOI 10.1191/0962280202sm281ra; Bakoyannis G, 2012, STAT METHODS MED RES, V21, P257, DOI 10.1177/0962280210394479; DABROWSKA DM, 1988, ANN STAT, V16, P1475, DOI 10.1214/aos/1176351049; YING Z, 1994, J MULTIVARIATE ANAL, V50, P17, DOI 10.1006/jmva.1994.1031; MANTEL N, 1979, CANCER RES, V39, P4308; Antony A.A., 2005, J STAT THEORY APPL, V4, P401; Chung K. L., 2001, COURSE PROBABILITY T; Crowder M.J., 2001, CLASSICAL COMPETING; DABROWSKA DM, 1989, J MULTIVARIATE ANAL, V29, P308, DOI 10.1016/0047-259X(89)90030-4; Emura T., 2012, PLOS ONE, V7; KHAN RA, 1968, J AM STAT ASSOC, V63, P1039, DOI 10.2307/2283896; Moeschberger M. L., 2003, SURVIVAL ANAL TECHNI; PRENTICE RL, 1992, BIOMETRIKA, V79, P495, DOI 10.1093/biomet/79.3.495; Sankaran P, 2009, STAT PAP, V50, P339, DOI 10.1007/s00362-007-0086-z; Sankaran P.G., 2007, SANKHYA, V69, P425; Sankaran PG, 2006, BIOMETRICAL J, V48, P399, DOI 10.1002/bimj.200510173; Shen PS, 2011, J STAT PLAN INFER, V141, P2614, DOI 10.1016/j.jspi.2011.02.013; Van der Vaart A., 1996, WEAK CONVERGENCE EMP; Wang WJ, 1997, BIOMETRIKA, V84, P863, DOI 10.1093/biomet/84.4.863; Wencheko E, 2005, STAT PAP, V46, P101, DOI 10.1007/BF02762037	24	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0047-259X			J MULTIVARIATE ANAL	J. Multivar. Anal.	NOV	2014	132						229	241		10.1016/j.jmva.2014.08.009		13	Statistics & Probability	Mathematics	AR5NY	WOS:000343632300018		
J	Kawaguchi, T; Kumabe, T; Saito, R; Kanamori, M; Iwasaki, M; Yamashita, Y; Sonoda, Y; Tominaga, T				Kawaguchi, Tomohiro; Kumabe, Toshihiro; Saito, Ryuta; Kanamori, Masayuki; Iwasaki, Masaki; Yamashita, Yon; Sonoda, Yukihiko; Tominaga, Teiji			Practical surgical indicators to identify candidates for radical resection of insulo-opercular gliomas	JOURNAL OF NEUROSURGERY			English	Article						glioma; insulo-operculum; outcome; surgery; surgical indication; oncology	SURVIVAL; MOTOR; PRESERVATION; GLIOBLASTOMA; ASSOCIATION; ASTROCYTOMA; DEFICITS; ARTERY	Object. Maximum resection of gliomas with minimum surgical complications usually leads to optimum outcomes for patients. Radical resection of insulo-opercular gliomas is still challenging, and selection of ideal patients can reduce risk and obtain better outcomes. Methods. This retrospective study included 83 consecutively treated patients with newly diagnosed gliomas located at the insulo-opercular region and extending to the sylvian fissure around the primary motor and somatosensory cortices. The authors selected 4 characteristics as surgical indicators: clear tumor boundaries, negative enhancement, intact lenticulostriate arteries, and intact superior extremity of the central insular sulcus. Results. Univariate analysis showed that tumors with clear boundaries were associated with higher rates of gross-total resection than were tumors with ambiguous boundaries (75.7% vs 19.6%). Tumors with negative enhancement compared with enhanced tumors were associated with lower frequency of tumor progression (32.0% vs 81.8%, respectively) and lower rates of surgical complications (14.0% vs 45.5%, respectively). Tumors with intact lenticulostriate arteries were associated with higher rates of gross-total resection than were tumors with involved lenticulostriate arteries (67.3% vs 11.8%, respectively). Tumors with intact superior extremity of the central insular sulcus were associated with higher rates of gross-total resection (57.4% vs 20.7%, respectively) and lower rates of surgical complications (18.5% vs 41.4%, respectively) than were tumors with involved anatomical structures. Multivariate analysis showed that clear tumor boundaries were independently associated with gross-total resection (p < 0.001). Negative enhancement was found to be independently associated with surgical complications (p = 0.005), overall survival times (p <0.001), and progression-free survival times (p = 0.004). Independent associations were also found between intact lenticulostriate arteries and gross-total resection (p < 0.001), between intact lenticulostriate arteries and progression-free survival times (p = 0.026), and between intact superior extremity of the central insular sulcus and gross-total resection (p = 0.043). Among patients in whom all 4 indicators were present, prognosis was good (5-year survival rate 93.3%), resection rate was maximal (gross-total resection 100%), and surgical complication rate was minimal (6.7%). Also among these patients, overall rates of survival (p = 0.003) and progression-free survival (p = 0.005) were significantly higher than among patients in whom fewer indicators were present. Conclusions. The authors propose 4 simple indicators that can be used to identify ideal candidates for radical resection of insulo-opercular gliomas, improve the outcomes, and promote maximum resection without introducing neurological complications. The indicators are clear tumor boundaries, negative enhancement, intact lenticulostriate arteries, and intact superior extremity of the central insular sulcus.	[Kawaguchi, Tomohiro; Kumabe, Toshihiro; Saito, Ryuta; Kanamori, Masayuki; Iwasaki, Masaki; Yamashita, Yon; Sonoda, Yukihiko; Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 980, Japan	Kumabe, T (reprint author), Kitasato Univ, Dept Neurosurg, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374+, Japan.	kuma@kitasato-u.ac.jp		Iwasaki, Masaki/0000-0002-4204-7144; Sonoda, Yukihiko/0000-0001-7651-1374			Ture U, 2000, J NEUROSURG, V92, P676, DOI 10.3171/jns.2000.92.4.0676; Chang EF, 2011, J NEUROSURG, V114, P566, DOI 10.3171/2010.6.JNS091246; Matar E, 2010, J CLIN NEUROSCI, V17, P993, DOI 10.1016/j.jocn.2009.12.015; Sanai N, 2010, J NEUROSURG, V112, P1, DOI 10.3171/2009.6.JNS0952; Hentschel SJ, 2005, NEUROSURGERY, V57, P176, DOI 10.1227/01.NEU.0000163603.70972.AB; Saito R, 2009, J NEUROSURG, V111, P278, DOI 10.3171/2008.11.JNS08858; Krieg SM, 2012, NEUROSURGERY, V70, P1060, DOI 10.1227/NEU.0b013e31823f5ade; Moshel YA, 2008, J NEUROSURG, V109, P825, DOI 10.3171/JNS/2008/109/11/0825; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; Hentschel SJ, 2003, CANCER J, V9, P113, DOI 10.1097/00130404-200303000-00007; McGirt MJ, 2009, J NEUROSURG, V110, P156, DOI 10.3171/2008.4.17536; McGirt MJ, 2009, NEUROSURGERY, V65, P463, DOI 10.1227/01.NEU.0000349763.42238.E9; EBELING U, 1995, ACTA NEUROCHIR, V132, P66, DOI 10.1007/BF01404850; De Witt Hamer PC, 2012, J CLIN ONCOL, V30, P2559, DOI DOI 10.1200/JC0.2011.38.4818; Iwasaki M, 2014, NEUROL MED-CHIR, V54, P321, DOI 10.2176/nmc.cr2012-0361; Kayama T, 1996, NEUROL RES, V18, P321; Kumabe T, 2007, J NEUROSURG, V106, P263, DOI 10.3171/jns.2007.106.2.263; Louis ND, 2007, WHO CLASSIFICATION T; Sanai N, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.12.FOCUS09266	19	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2014	121	5					1124	1132		10.3171/2014.7.JNS13899		9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AR4AM	WOS:000343530400019		
J	Watanabe, S; Yamamoto, M; Sato, Y; Kawabe, T; Higuchi, Y; Kasuya, H; Yamamoto, T; Matsumura, A; Barfod, BE				Watanabe, Shinya; Yamamoto, Masaaki; Sato, Yasunori; Kawabe, Takuya; Higuchi, Yoshinori; Kasuya, Hidetoshi; Yamamoto, Tetsuya; Matsumura, Akira; Barfod, Bierta E.			Stereotactic radiosurgery for brain metastases: a case-matched study comparing treatment results for patients 80 years of age or older versus patients 65-79 years of age	JOURNAL OF NEUROSURGERY			English	Article						brain metastases; radiation therapy; oncology; stereotactic radiosurgery; Gamma Knife; elderly cases	POSITRON-EMISSION-TOMOGRAPHY; PROGNOSTIC GRADING INDEXES; ELDERLY-PATIENTS; COMPETING RISKS; RADIATION-THERAPY; CLINICAL ARTICLE; CANCER-PATIENTS; SAFE TREATMENT; VALIDITY; BREAST	Object. Recently, an increasing number of patients with brain metastases, even patients over 80 years of age, have been treated with stereotactic radiosurgery (SRS). However, there is little information on SRS treatment results for patients with brain metastases 80 years of age and older. The authors undertook this study to reappraise whether SRS treatment results for patients 80 years of age or older differ from those of patients who are 65-79 years old. Methods. This was an institutional review board approved, retrospective cohort study. Among 2552 consecutive brain metastasis patients who underwent SRS during the 1998-2011 period, we studied 165 who were 80 years of age or older (Group A) and 1181 who were age 65-79 years old (Group B). Because of the remarkable disproportion in patient numbers between the 2 groups and considerable differences in pre-SRS clinical factors, the authors conducted a case-matched study using the propensity score matching method. Ultimately, 330 patients (165 from each group, A and B) were selected. For time-to-event outcomes, the Kaplan-Meier method was used to estimate overall survival and competing risk analysis was used to estimate other study end points, as appropriate. Results. Although the case-matched study showed that post-SRS median survival time (MST, months) was shorter in Group A patients (5.3 months, 95% CI 3.9-7.0 months) than in Group B patients (6.9 months, 95% Cl 5.0-8.1 months), this difference was not statistically significant (HR 1.147, 95% CI 0.921-1.429, p = 0.22). Incidences of neurological death and deterioration were slightly lower in Group A than in Group B patients (6.3% vs 11.8% and 8.5% vs 13.9%), but these differences did not reach statistical significance (p = 0.11 and p = 0.16). Furthermore, competing risk analyses showed that the 2 groups did not differ significantly in cumulative incidence of local recurrence (HR 0.830,95% CI 0.268-2.573, p = 0.75), rates of repeat SRS (HR 0.738,95% Cl 0.438-1.242, p = 0.25), or incidence of SRS-related complications (HR 0.616,95% CI 0.152-2.495, p = 0.49). Among the Group A patients, post-SRS MSTs were 11.6 months (95% CI 7.8-19.6 months), 7.9 months (95% CI 5.2-10.9 months), and 2.8 months (95% CI; 2.4-4.6 months) in patients whose disease status was modified recursive partitioning analysis (RPA) Class(es) I+IIa, IIb, and IIc+III, respectively (p <0.001). Conclusions. Our results suggest that patients 80 years of age or older are not unfavorable candidates for SRS as compared with those 65-79 years old. Particularly, even among patients 80 years and older, those with modified-RPA Class I+IIa or lIb disease are considered to be favorable candidates for more aggressive treatment of brain metastases.	[Watanabe, Shinya; Yamamoto, Masaaki; Kawabe, Takuya; Barfod, Bierta E.] Katsuta Hosp Mito GammaHouse, Hitachi, Ibaraki 3120011, Japan; [Watanabe, Shinya; Yamamoto, Tetsuya; Matsumura, Akira] Univ Tsukuba, Fac Med, Dept Neurosurg, Tsukuba, Ibaraki, Japan; [Yamamoto, Masaaki; Kasuya, Hidetoshi] Tokyo Womens Med Univ, Med Ctr East, Dept Neurosurg, Tokyo, Japan; [Sato, Yasunori] Chiba Univ, Grad Sch Med, Clin Res Ctr, Chiba, Japan; [Higuchi, Yoshinori] Chiba Univ, Grad Sch Med, Dept Neurosurg, Chiba, Japan; [Kawabe, Takuya] Kyoto Prefectural Univ Med, Dept Neurosurg, Grad Sch Med Sci, Kyoto 602, Japan	Barfod, BE (reprint author), Katsuta Hosp Mito GammaHouse, 5125-2 Nakane, Hitachi, Ibaraki 3120011, Japan.	bcd06275@nifty.com					Tsao M, 2012, CANCER-AM CANCER SOC, V118, P2486, DOI 10.1002/cncr.26515; Nariai T, 2005, J NEUROSURG, V103, P498, DOI 10.3171/jns.2005.103.3.0498; Yamamoto M, 2013, J NEURO-ONCOL, V111, P327, DOI 10.1007/s11060-012-1019-9; Lorenzoni J, 2004, INT J RADIAT ONCOL, V60, P218, DOI 10.1016/j.ijrobp.2004.02.017; Gaspar L, 1997, INT J RADIAT ONCOL, V37, P745, DOI 10.1016/S0360-3016(96)00619-0; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Weltman E, 2000, INT J RADIAT ONCOL, V46, P1155, DOI 10.1016/S0360-3016(99)00549-0; Matsuo M, 2009, INT J RADIAT ONCOL, V74, P714, DOI 10.1016/j.ijrobp.2008.08.056; Yamamoto M, 2013, J NEUROSURG, V118, P1258, DOI 10.3171/2013.3.JNS121900; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Bakoyannis G, 2012, STAT METHODS MED RES, V21, P257, DOI 10.1177/0962280210394479; Sperduto PW, 2010, INT J RADIAT ONCOL, V77, P655, DOI 10.1016/j.ijrobp.2009.08.025; Sperduto PW, 2008, INT J RADIAT ONCOL, V70, P510, DOI 10.1016/j.ijrobp.2007.06.074; Yancik R, 2004, SEMIN ONCOL, V31, P128, DOI 10.1053/j.seminoncol.2003.12.024; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Minniti G, 2013, J NEURO-ONCOL, V111, P319, DOI 10.1007/s11060-012-1016-z; Tsuyuguchi N, 2003, J NEUROSURG, V98, P1056, DOI 10.3171/jns.2003.98.5.1056; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Hanssens P, 2011, J NEUROSURG, V115, P499, DOI 10.3171/2011.4.JNS101832; Hayashi M, 2007, Neuroradiol J, V20, P481; Hotta T, 1999, JPN J CANC CLIN, V45, P1143; Kano H, 2010, NEUROSURGERY, V66, P486, DOI 10.1227/01.NEU.0000360391.35749.A5; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karnofsky D, 1949, EVALUATION CHEMOTHER, P191; Kim SH, 2008, CANCER, V113, P834, DOI 10.1002/cncr.23625; Lutterbach J, 2005, CANCER, V103, P1234, DOI 10.1002/cncr.20895; Noel G, 2005, INT J RADIAT ONCOL, V63, P1555, DOI 10.1016/j.ijrobp.2005.04.037; Parsons LS, REDUCING BIAS PROPEN; Rades D, 2008, STRAHLENTHER ONKOL, V184, P565, DOI 10.1007/s00066-008-1908-1; Yamamoto M, 2013, INT J RADIAT ONCOL, V85, P53, DOI 10.1016/j.ijrobp.2012.04.018; Yamamoto M, 2012, INT J RADIAT ONCOL, V84, P1110, DOI 10.1016/j.ijrobp.2012.02.040; Yamamoto M, 2012, INT J RADIAT ONCOL, V83, P1399, DOI 10.1016/j.ijrobp.2011.10.018; Yamamoto M, 2002, INT J RADIAT ONCOL, V53, P1279, DOI 10.1016/S0360-3016(02)02855-9	34	2	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2014	121	5					1148	1157		10.3171/2014.6.JNS132790		10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AR4AM	WOS:000343530400022		
J	Yoshimoto, Y; Nagaki, T; Sato, K; Yoshida, T				Yoshimoto, Yuhei; Nagaki, Tomohito; Sato, Kali; Yoshida, Takaaki			The effect of carotid endarterectomy RESPONSE	JOURNAL OF NEUROSURGERY			English	Letter							STENOSIS		[Yoshimoto, Yuhei; Nagaki, Tomohito; Sato, Kali; Yoshida, Takaaki] Gunma Univ, Grad Sch Med, Maebashi, Gumma 371, Japan	Yoshimoto, Y (reprint author), Gunma Univ, Grad Sch Med, Maebashi, Gumma 371, Japan.						Halliday A, 2004, LANCET, V363, P1491; LaMuraglia GM, 2004, ANN SURG, V240, P535, DOI 10.1097/01.sla.0000137142.26925.3c; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421; Kragsterman B, 2006, STROKE, V37, P2886, DOI 10.1161/01.STR.0000248967.44015.88	4	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2014	121	5					1286	1287				2	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AR4AM	WOS:000343530400040		
J	Ogiwara, H; Morota, N				Ogiwara, Hideki; Morota, Nobuhito			Flexible endoscopy for management of intraventricular brain tumors in patients with small ventricles	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						flexible endoscopy; small ventricles; intraventricular tumor; oncology	PINEAL REGION TUMORS; OCCIPITAL HORN RATIO; COLLOID CYSTS; TECHNICAL NOTE; NEUROENDOSCOPY; 3RD-VENTRICLE; HYDROCEPHALUS; RESECTION; SURGERY; VENTRICULOSTOMY	Object. Endoscopic surgery is generally withheld in patients with small ventricles due to difficulties in ventricular cannulation and intraventricular manipulation. The effectiveness of flexible endoscopy for management of intraventricular brain tumors in patients with small ventricles was evaluated. Methods. Forty-five patients who underwent endoscopic surgery with a flexible endoscope for intraventricular brain tumors were divided into small-ventricle and ventriculomegaly groups according to the frontal and occipital horn ratio (FOR). Retrospective review of these cases was performed and achievement of surgical goals and morbidity were assessed. Results. Among the 45 patients, there were 14 with small ventricles and 31 with ventriculomegaly. In the small-ventricle group, targeted tumors were located in the suprasellar region in 12 patients and in the pineal region in 2. In the ventriculomegaly group, tumors were located in the pineal region in 15 patients, in the suprasellar region in 9, in the lateral ventricle in 4, in the midbrain in 2, and in the fourth ventricle in 1. In the small-ventricle group, ventricular cannulation was successful and the surgical goals were accomplished in all patients. In ventriculomegaly group, sampling of the tumor was not diagnostic due to intraoperative hemorrhage in 1 patient. There were no significant differences in the rate of achieving the surgical goals or the morbidity between the 2 groups. Conclusions. Endoscopic surgery using a flexible endoscope is useful for management of intraventricular brain tumors in patients with small ventricles. A flexible endoscope allows excellent maneuverability in introducing the device into the lateral ventricle and manipulating through small ventricles.	[Ogiwara, Hideki; Morota, Nobuhito] Natl Ctr Child Hlth & Dev, Div Neurosurg, Tokyo, Japan	Ogiwara, H (reprint author), Okura 2-10-1,Setagaya Ku, Tokyo 1578535, Japan.	hideki_o@d5.dion.ne.jp					Abdou MS, 1998, J NEUROSURG, V89, P1062, DOI 10.3171/jns.1998.89.6.1062; ABDULLAH J, 1995, MINIM INVAS NEUROSUR, V38, P79, DOI 10.1055/s-2008-1053462; Hellwig D, 2003, NEUROSURGERY, V52, P525, DOI 10.1227/01.NEU.0000047671.27057.55; O'Hayon BB, 1998, PEDIATR NEUROSURG, V29, P245, DOI 10.1159/000028730; Kulkarni AV, 1999, PEDIATR NEUROSURG, V31, P65, DOI 10.1159/000028836; Gaab MR, 1998, J NEUROSURG, V88, P496, DOI 10.3171/jns.1998.88.3.0496; Huyette DR, 2008, J NEUROSURG, V108, P88, DOI 10.3171/JNS/2008/108/01/0088; COHEN AR, 1993, PEDIATR NEUROSURG, V19, P127, DOI 10.1159/000120717; Ferrer E, 1997, ACTA NEUROCHIR, V139, P12, DOI 10.1007/BF01850862; Fukushima T, 1978, Neurosurgery, V2, P110; Grunert P, 1997, STEREOT FUNCT NEUROS, V68, P80, DOI 10.1159/000099907; Kakarla UK, 2008, NEUROSURGERY S1, V63; King WA, 1999, NEUROSURGERY, V44, P1103, DOI 10.1097/00006123-199905000-00090; KONDZIOLKA D, 1994, ACT NEUR S, V61, P76; LEWIS AI, 1994, J NEUROSURG, V81, P174, DOI 10.3171/jns.1994.81.2.0174; Macarthur DC, 2002, BRIT J NEUROSURG, V16, P465, DOI 10.1080/0268869021000030276; Macarthur DC, 2001, CHILD NERV SYST, V17, P589; Naftel RP, 2010, J NEUROSURG-PEDIATR, V6, P325, DOI 10.3171/2010.7.PEDS10165; Naftel RP, 2011, J NEUROSURG-PEDIATR, V7, P104, DOI 10.3171/2010.10.PEDS10338; Oi S, 2000, J NEUROSURG, V93, P245, DOI 10.3171/jns.2000.93.2.0245; OKA K, 1994, CHILD NERV SYST, V10, P162, DOI 10.1007/BF00301083; Decq P, 1998, NEUROSURGERY, V42, P1288, DOI 10.1097/00006123-199806000-00051; Pople IK, 2001, BRIT J NEUROSURG, V15, P305; Robinson S, 1997, SURG NEUROL, V48, P360, DOI 10.1016/S0090-3019(97)00018-9; Rodziewicz GS, 2000, NEUROSURGERY, V46, P655, DOI 10.1097/00006123-200003000-00025; Schroeder HWS, 2002, NEUROSURGERY, V51, P1441, DOI 10.1227/01NEU.0000036094.01658.60; Schroeder HWS, 2001, J NEUROSURG, V94, P72, DOI 10.3171/jns.2001.94.1.0072; Souweidane MM, 2000, PEDIATR NEUROSURG, V33, P132, DOI 10.1159/000028994; Souweidane MM, 2008, NEUROSURGERY, V62, P1042, DOI [10.1227/01.neu.0000333769.51069.80, 10.1227/01.NEU.0000176641.17216.FB]; Torrens MJ, 1995, NEUROSURG QUART, V5, P18, DOI 10.1097/00013414-199503000-00002; Yamamoto M, 1997, MINIM INVAS NEUROSUR, V40, P139, DOI 10.1055/s-2008-1053435	31	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	NOV	2014	14	5					490	494		10.3171/2014.7.PEDS13648		5	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AR4AS	WOS:000343531000007		
J	Aoyama, T; Yasuda, M; Yamahata, H; Takeuchi, M; Joko, M; Hongo, K; Takayasu, M				Aoyama, Tatsuro; Yasuda, Muneyoshi; Yamahata, Hitoshi; Takeuchi, Mikinobu; Joko, Masahiro; Hongo, Kazuhiro; Takayasu, Masakazu			Radiographic measurements of C-2 in patients with atlas assimilation	JOURNAL OF NEUROSURGERY-SPINE			English	Article						C-1 assimilation; C-1 lateral mass screw; C-2 pedicle screw; C-2 translaminar screw; computed tomography; occipitocervical fixation; cervical spine	C2 PEDICLE SCREWS; ANATOMICAL CONSIDERATIONS; COMPUTED-TOMOGRAPHY; TRANSLAMINAR SCREW; CERVICAL PEDICLE; PLACEMENT; FEASIBILITY; FIXATION; INSTABILITY; POPULATION	Object. The object of this study was to evaluate the radiographic characteristics of C-2 using multiplanar CT measurements for anchor screw placement in patients with C-1 assimilation (CIA). Insertion of a C-2 pedicle screw in the setting of CIA is relatively difficult and technically demanding, and there has been no report about the optimal sizes of the pedicles and laminae of C-2 for screw placement in CIA. Methods. An institutional database was searched for all patients who had undergone cervical CT scanning and cervical spine surgery between April 2006 and December 2012. Two neurosurgeons reviewed the CT scans from 462 patients who met these criteria, looking for CIA and other anomalies of the craniocervical junction such as high-riding vertebral artery (VA), basilar invagination, and VA anomaly. The routine axial images were reloaded on a workstation, and reconstruction CT images were used to measure parameters: the minimum width of bilateral pedicles and laminae and the length of bilateral laminae of the atlas. Results. Seven patients with CIA were identified, and 14 sex-matched patients without CIA were randomly selected from the same database as a control group. The mean minimum pedicle width was 5.21 mm in patients with CIA and 7.17 mm in those without. The mean minimum laminae width was 5.29 mm in patients with CIA and 6.53 mm in controls. The mean minimum pedicle and laminae widths were statistically significantly smaller in the patients with CIA (p < 0.05). Conclusions. In patients with CIA, the C-2 bony structures are significantly smaller than normal, making C-2 pedicle screw or translaminar screw placement more difficult.	[Aoyama, Tatsuro; Yasuda, Muneyoshi; Yamahata, Hitoshi; Takeuchi, Mikinobu; Joko, Masahiro; Takayasu, Masakazu] Aichi Med Univ, Dept Neurosurg, Nagakute, Aichi 4801195, Japan; [Aoyama, Tatsuro; Hongo, Kazuhiro] Shinshu Univ, Sch Med, Dept Neurosurg, Matsumoto, Nagano 390, Japan; [Yamahata, Hitoshi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neurosurg, Kagoshima 890, Japan	Aoyama, T (reprint author), Aichi Med Univ, Dept Neurosurg, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	bluemountain069@gmail.com					Alosh H, 2010, J SPINAL DISORD TECH, V23, P9, DOI 10.1097/BSD.0b013e318194e746; Meyer D, 2012, NEUROSURG REV, V35, P255, DOI 10.1007/s10143-011-0358-x; Wang MY, 2006, NEUROSURGERY, V59, P84, DOI 10.1227/01.NEU.0000219900.24467.32; Dorward IG, 2011, NEUROSURGERY, V68, P1491, DOI 10.1227/NEU.0b013e318212a4d7; Ma XY, 2010, SPINE, V35, P704, DOI 10.1097/BRS.0b013e3181bb8831; Ishikawa Y, 2011, J NEUROSURG-SPINE, V15, P472, DOI 10.3171/2011.6.SPINE10809; Park JS, 2012, J SPINAL DISORD TECH, V25, P254, DOI 10.1097/BSD.0b013e318218a4f7; Sakamoto T, 2004, SPINE, V29, P2510, DOI 10.1097/01.brs.0000144404.68486.85; Jian FZ, 2010, NEUROSURGERY, V66, P678, DOI 10.1227/01.NEU.0000367632.45384.5A; Hong JT, 2008, J NEUROSURG-SPINE, V8, P230, DOI [10.3171/SPI/2008/8/3/230, 10.3171/SPI/2008/3/3/230]; Jian FZ, 2012, CLIN NEUROL NEUROSUR, V114, P590, DOI 10.1016/j.clineuro.2011.12.017; Menezes AH, 2011, CRANIOVERTEBRAL JUNC, P72; Onibokun A, 2009, SPINE J, V9, P729, DOI 10.1016/j.spinee.2009.04.021; Smith ZA, 2010, J SPINAL DISORD TECH, V23, P176, DOI 10.1097/BSD.0b013e3181b40234; Yuan F, 2013, EUR SPINE J, V22, P39, DOI 10.1007/s00586-012-2417-6; Yusof MI, 2006, SPINE, V31, pE221, DOI 10.1097/01.brs.0000210263.87578.65	16	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	NOV	2014	21	5					732	735		10.3171/2014.7.SPINE131087		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AR4AI	WOS:000343530000007		
J	Ito, H; Takai, K; Taniguchi, M				Ito, Hirotaka; Takai, Keisuke; Taniguchi, Makoto			Cervical duraplasty with tenting sutures via laminoplasty for cervical flexion myelopathy in patients with Hirayama disease: successful decompression of a "tight dural canal in flexion" without spinal fusion	JOURNAL OF NEUROSURGERY-SPINE			English	Article						cervical flexion myelopathy; systematic review; forward displacement of the dura mater; spinal fusion; complication; follow-up study	JUVENILE MUSCULAR-ATROPHY; DISTAL UPPER EXTREMITY; SURGICAL-TREATMENT; CORD; SPONDYLOSIS; SAC	Object. Hirayama disease, juvenile muscular atrophy of the distal upper extremity, is a rare type of cervical flexion segmental myelopathy and its etiology is still being debated. Two theories have been proposed: a "contact pressure" theory and "tight dural canal in flexion" theory. Previously reported treatments, including conservative neck collar therapy and surgical spinal fusion, used fixation of the cervical spine with the aim of avoiding contact pressure between the cord and anterior structures. On the other hand, treatment by duraplasty without spinal fusion has also been used, which aims at decompressing a tight dural canal in flexion by preventing abnormal forward displacement of the posterior dura mater without restricting cervical motion in young patients. The authors developed a new surgical approach for treating a tight dural canal in flexion in patients with Hirayama disease: cervical duraplasty with tenting sutures via laminoplasty without spinal fusion. With this treatment they aimed to both decompress the spinal cord and preserve as much cervical motion as possible. The purpose of this study was to assess the clinical outcomes of patients who underwent this new surgical procedure and to investigate the etiology of Hirayama disease. Methods. Six male patients (age range 17-23 years) with Hirayama disease underwent surgery between 2006 and 2012. The pre- and postoperative anteroposterior diameters of the dural canal in the flexed neck position, grip strength of the bilateral upper extremities, cervical alignment (C2-7), and cervical local flexion range of motion were compared. The presence or absence of surgical complications was assessed. To investigate the comparison group of Hirayama disease treated with spinal decompression, the PubMed database was searched for all relevant English-language case reports and series published between 1990 and 2013. Results. The postoperative anteroposterior diameters of the dural canal were significantly expanded in the flexed neck position (7.2 +/- 2.2 mm preoperatively vs 9.8 +/- 1.7 mm postoperatively, p = 0.001). Grip strength of the upper extremities significantly improved bilaterally (20 14 kg preoperatively vs 26 15 kg postoperatively, p = 0.001). No significant difference was observed between pre- and postoperative cervical alignment in the neutral neck position (7.7 degrees +/- 8.1 degrees preoperatively vs 9.0 degrees +/- 7.7 degrees postoperatively, p = 0.74) or the cervical local flexion angle in the flexed neck position at the corresponding level of laminoplasty (16.6 degrees +/- 5.1 degrees preoperatively vs 15.0 degrees +/- 9.4 degrees postoperatively, p = 0.8). No surgical complications were noted, except for transient CSF leakage, which was resolved after lumbar drainage. The systematic review identified 37 cases from 7 reports: 26 with spinal fusion only, 5 with duraplasty without fusion, and 6 with combined duraplasty and fusion. In the largest series, in which 12 cases were treated with anterior fusion, cervical alignment was maintained, but local flexion motion was significantly decreased as a result of fixation. Although significant improvements in or stabilization of grip strength occurred in all 7 reported studies regardless of decompression procedures, one major delayed surgical complication was noted in a patient treated with anterior fusion. The patient developed severe kyphotic changes, which required reconstruction surgeries. Conclusions. Cervical duraplasty with tenting sutures via laminoplasty prevented abnormal forward displacement of the posterior dura mater while preserving normal anterior structures and flexion motion of the cervical spine without major surgical complications. The clinical improvements achieved by the authors' method support evidence that a tight dural canal in flexion largely contributes to segmental myelopathy in patients with Hirayama disease.	[Ito, Hirotaka; Takai, Keisuke; Taniguchi, Makoto] Tokyo Metropolitan Neurol Hosp, Dept Neurosurg, Fuchu, Tokyo 1830042, Japan	Takai, K (reprint author), Tokyo Metropolitan Neurol Hosp, Dept Neurosurg, 2-6-1 Musashidai, Fuchu, Tokyo 1830042, Japan.	takai-nsu@umin.ac.jp					Lin MS, 2010, J NEUROSURG-SPINE, V12, P629, DOI 10.3171/2009.12.SPINE09431; Levine DN, 1997, J NEUROL NEUROSUR PS, V62, P334, DOI 10.1136/jnnp.62.4.334; Arrese I, 2009, NEUROCIRUGIA, V20, P555; Hou C, 2012, NEUROL SCI, V33, P1101, DOI 10.1007/s10072-011-0912-x; Hirayama K, 2000, NEUROLOGY, V54, P1922; BREIG A, 1966, J NEUROSURG, V25, P45, DOI 10.3171/jns.1966.25.1.0045; REID JD, 1960, J NEUROL NEUROSUR PS, V23, P214, DOI 10.1136/jnnp.23.3.214; HIRAYAMA K, 1987, J NEUROL NEUROSUR PS, V50, P285, DOI 10.1136/jnnp.50.3.285; Tashiro K, 2006, AMYOTROPH LATERAL SC, V7, P38, DOI 10.1080/14660820500396877; Fujimoto Y, 2002, EUR SPINE J, V11, P276, DOI 10.1007/s005860100344; IWASAKI Y, 1987, J NEUROSURG, V66, P935, DOI 10.3171/jns.1987.66.6.0935; JEFFREYS RV, 1986, J NEUROL NEUROSUR PS, V49, P353, DOI 10.1136/jnnp.49.4.353; Kato Y, 2008, J NEUROSURG-SPINE, V8, P436, DOI 10.3171/SPI/2008/8/5/436; Kohno M, 1999, J NEUROSURG, V91, P33, DOI 10.3171/spi.1999.91.1.0033; Konno S, 1997, SPINE, V22, P486; Lai V, 2011, EUR J RADIOL, V80, P724, DOI 10.1016/j.ejrad.2010.07.021; Lehman VT, 2013, AM J NEURORADIOL, V34, P451, DOI 10.3174/ajnr.A3277; Patel TR, 2009, NEUROSURGERY, V64, P1196, DOI 10.1227/01.NEU.0000345951.24132.7F; Tokumaru Y, 2001, Rinsho Shinkeigaku, V41, P173; Watanabe K, 2005, J NEUROSURG-SPINE, V3, P86, DOI 10.3171/spi.2005.3.2.0086	20	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	NOV	2014	21	5					743	752		10.3171/2014.7.SPINE13955		10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AR4AI	WOS:000343530000009		
J	Iwasaki, K; Ikedo, T; Hastokata, H; Toda, H				Iwasaki, Koichi; Ikedo, Taichi; Hastokata, Hirokuni; Toda, Hiroki			Autologous clavicle bone graft for anterior cervical discectomy and fusion with titanium interbody cage	JOURNAL OF NEUROSURGERY-SPINE			English	Article						anterior cervical discectomy and fusion; autologous bone graft; clavicle; donor-site complications; iliac crest; titanium cage; technique	DONOR SITE PAIN; ALLOGRAFT; DISC	A variety of donor-site complications have been reported for anterior cervical discectomy and fusion (ACDF) using autologous iliac bone graft. To minimize such morbidities and to obtain optimal bony fusion at the ACDF surgery, a novel technique was used to harvest cancellous bone from the autologous clavicle instead of the popular iliac crest graft. After a routine cervical discectomy of the affected level, a 1.5-cm linear skin incision was made over the clavicle within 2.5 cm of the sternoclavicular joint on the medial one-third portion. This portion is known as an anatomically safe zone, with no subcutaneous distribution of the supraclavicular nerve. Then, cancellous bone was harvested through a small cortical window developed on the clavicle. Care was taken not to injure the subclavian major vessels and the lung below the clavicle. A box-type titanium cage was packed with the harvested cancellous bone and then inserted into the discectomy-treated space for cervical interbody fusion. From 2009 to 2013, 16 patients with cervical radiculopathy and/or myelopathy underwent single-level ACDF with this method. All but 1 patient experienced significant improvement of clinical symptoms after the surgery and showed radiographic evidence of solid bony fusion and spinal stabilization within 6 months. Further, no peri- and postoperative complications at the clavicular donor site were noted. The mean visual analog scale pain score (range 0 [no pain to 10 [maximum pain]) at 1 year after the surgery was 0.1, and 13 of 14 patients with data at 1-year follow-up were highly satisfied with their donor-site cosmetic outcome. The clavicle is a safe, reliable, and technically easy source of autologous bone graft that yields optimal fusion rates and patient satisfaction with ACDF surgery.	[Iwasaki, Koichi; Hastokata, Hirokuni; Toda, Hiroki] Kitano Med Res Inst & Hosp, Dept Neurosurg, Osaka 5308480, Japan; [Ikedo, Taichi] Himeji Med Ctr, Dept Neurosurg, Himeji, Hyogo, Japan	Iwasaki, K (reprint author), Kitano Med Res Inst & Hosp, Dept Neurosurg, Kita Ku, 2-4-20 Ogi Machi, Osaka 5308480, Japan.	todaiji2005@yahoo.co.jp					Heary RF, 2002, NEUROSURGERY, V50, P510, DOI 10.1097/00006123-200203000-00015; Shamsaldin M, 2006, ACTA NEUROCHIR, V148, P1071, DOI 10.1007/s00701-006-0864-8; Jensen WK, 2009, J SPINAL DISORD TECH, V22, P392, DOI 10.1097/BSD.0b013e3181844d8e; Chau AMT, 2009, EUR SPINE J, V18, P449, DOI 10.1007/s00586-008-0878-4; KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009; Hwang SL, 2005, J SPINAL DISORD TECH, V18, P326, DOI 10.1097/01.bsd.0000164198.30725.2d; SMITH GW, 1958, J BONE JOINT SURG AM, V40, P607; Fowler B L, 1995, Am J Orthop (Belle Mead NJ), V24, P895; Jagannathan J, 2008, J NEUROSURG-SPINE, V9, P454, DOI 10.3171/SPI.2008.9.11.454; Lebow R, 2011, YOUMANS NEUROLOGICAL, V3, P2992; Martin GJ, 1999, SPINE, V24, P852, DOI 10.1097/00007632-199905010-00004; Nathe T, 2011, CLIN ORTHOP RELAT R, V469, P890, DOI 10.1007/s11999-010-1608-x; ODOM GL, 1958, JAMA-J AM MED ASSOC, V166, P23; Pollock R, 2008, EUR SPINE J, V17, P845, DOI 10.1007/s00586-008-0648-3; Ryken TC, 2009, J NEUROSURG-SPINE, V11, P203, DOI 10.3171/2009.2.SPINE08723; Sangala JR, 2010, CLIN NEUROL NEUROSUR, V112, P470, DOI 10.1016/j.clineuro.2010.03.011; Seiler J G 3rd, 2000, J South Orthop Assoc, V9, P91; Skeppholm M, 2013, EUR SPINE J, V22, P142, DOI 10.1007/s00586-012-2456-z; Tubbs RS, 2008, CHILD NERV SYST, V24, P337, DOI 10.1007/s00381-007-0433-3	19	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	NOV	2014	21	5					761	768		10.3171/2014.7.SPINE131000		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AR4AI	WOS:000343530000011		
J	Sugita, S; Chikuda, H; Takeshita, K; Seichi, A; Tanaka, S				Sugita, Shurei; Chikuda, Hirotaka; Takeshita, Katsushi; Seichi, Atsushi; Tanaka, Sakae			Progression of ossification of the posterior longitudinal ligament of the thoracic spine following posterior decompression and stabilization	JOURNAL OF NEUROSURGERY-SPINE			English	Article						posterior decompression and fixation; thoracic spine; ossification of the posterior longitudinal ligament; progression	OPEN-DOOR LAMINOPLASTY; CERVICAL-SPINE; MYELOPATHY; SURGERY; FUSION	Object. Despite its potential clinical impact, information regarding progression of thoracic ossification of the posterior longitudinal ligament (OPLL) is scarce. Posterior decompression with stabilization is currently the primary surgical treatment for symptomatic thoracic OPLL; however, it remains unclear whether thoracic OPLL increases in size following spinal stabilization. It is also unknown whether patients' clinical symptoms worsen as OPLL size increases. In this retrospective case series study, the authors examined the postoperative progression of thoracic OPLL. Methods. Nine consecutive patients with thoracic OPLL who underwent posterior decompression and fixation with a minimum follow-up of 3 years were included in this study. Thin-slice CT scans of the thoracic spine obtained at the time of surgery and the most recent follow-up were analyzed. The level of the most obvious protrusion of ossification was determined using the sagittal reconstructions, and the ossified area was measured on the axial reconstructed scan at the level of the most obvious protrusion of ossification using the DICOM (digital imaging and communications in medicine) software program. Myelopathy severity was assessed according to the Japanese Orthopaedic Association (JOA) scale score for lower-limb motor function on admission, at postoperative discharge, and at the last follow-up visit. Results. The OPLL area was increased in all patients. The mean area of ossification increased from 83.6 +/- 25.3 mm(2) at the time of surgery to 114.8 +/- 32.4 mm(2) at the last follow-up visit. No patients exhibited any neurological deterioration due to OPLL progression. Conclusions. The present study demonstrated that the size of the thoracic OPLL increased after spinal stabilization. Despite diminished local spinal motion, OPLL progression did not decrease or stop. Physicians should pay attention to ossification progression in patients with thoracic OPLL.	[Sugita, Shurei; Chikuda, Hirotaka; Takeshita, Katsushi; Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 113, Japan; [Seichi, Atsushi] Jichi Med Univ, Dept Orthoped, Shimotsuke, Tochigi, Japan	Sugita, S (reprint author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.	ssugita-tky@umin.ac.jp			Ministry of Health, Labour, and Welfare of Japan (Research on Intractable Diseases grant) [H23-Nanchi-032]	The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper. This study was funded by a grant from the Ministry of Health, Labour, and Welfare of Japan (Research on Intractable Diseases grant no. H23-Nanchi-032). The funders played no role in the design of the study, data collection and analysis, decision to publish, or preparation of the manuscript.	Yamazaki M, 2006, SPINE, V31, P1452, DOI 10.1097/01.brs.0000220834.22131.fb; Matsunaga S, 2002, J NEUROSURG, V96, P168, DOI 10.3171/spi.2002.96.2.0168; Matsunaga S, 2012, SPINE, V37, pE309, DOI 10.1097/BRS.0b013e318241ad33; Iwasaki M, 2002, J NEUROSURG, V96, P180, DOI 10.3171/spi.2002.96.2.0180; Matsuyama Y, 2009, EUR SPINE J, V18, P943, DOI 10.1007/s00586-009-0956-2; Ogawa Y, 2004, J NEUROSURG-SPINE, V1, P168, DOI 10.3171/spi.2004.1.2.0168; Kawaguchi Y, 2001, J BONE JOINT SURG AM, V83A, P1798; Kawahara N, 2008, SPINE, V33, P39, DOI 10.1097/BRS.0b013e31815e3911; Fujiyoshi T, 2010, J CLIN NEUROSCI, V17, P320, DOI 10.1016/j.jocn.2009.06.023; Min JH, 2008, J SPINAL DISORD TECH, V21, P116, DOI 10.1097/BSD.0b013e318060091a; Matsumoto M, 2011, J NEUROSURG-SPINE, V15, P380, DOI 10.3171/2011.6.SPINE10816; Fargen KM, 2012, J NEUROSURG-SPINE, V17, P512, DOI 10.3171/2012.9.SPINE12548; Fujimura Y, 1998, ARCH ORTHOP TRAUM SU, V117, P471, DOI 10.1007/s004020050296; Inoue H, 1996, J NEUROSURG, V85, P817, DOI 10.3171/jns.1996.85.5.0817; Kato Y, 1998, J NEUROSURG, V89, P217, DOI 10.3171/jns.1998.89.2.0217; Murakami M, 2010, J NEUROSURG-SPINE, V12, P577, DOI [10.3171/2010.1.SPINE09452, 10.3171/2010.11.SPINE09452]; Ohtsuka K, 1983, ORTHOP SURG TRAUMATO, V26, P1083; SEICHI A, 1992, SPINE, V17, pS30; SUZUKI K, 1991, NEURORADIOLOGY, V33, P427; Tsukamoto N, 2006, J NEUROSURG-SPINE, V5, P234, DOI 10.3171/spi.2006.5.3.234	20	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	NOV	2014	21	5					773	777		10.3171/2014.7.SPINE131191		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AR4AI	WOS:000343530000013		
J	Tachibana, T; Moriyama, T; Maruo, K; Inoue, S; Arizumi, F; Yoshiya, S				Tachibana, Toshiya; Moriyama, Tokuhide; Maruo, Keishi; Inoue, Shinichi; Arizumi, Fumihiro; Yoshiya, Shinichi			Subarachnoid-subarachnoid bypass for spinal adhesive arachnoiditis	JOURNAL OF NEUROSURGERY-SPINE			English	Article						adhesive arachnoiditis; arachnoid cyst; syrinx; subarachnoid to subarachnoid bypass	SYRINGOMYELIA	The authors report a case of adhesive arachnoiditis (AA) and arachnoid cyst successfully treated by subarachnoid to subarachnoid bypass (S-S bypass). Arachnoid cysts or syringes sometimes compress the spinal cord and cause compressive myelopathy that requires surgical treatment. However, surgical treatment for AA is challenging. A 57-year-old woman developed leg pain and gait disturbance. A dorsal arachnoid cyst compressed the spinal cord at T7-9, the spinal cord was swollen, and a small syrinx was present at T9-10. An S-S bypass was performed from T6-7 to TI 1-12. The patient's gait disturbance resolved immediately after surgery. Two years later, a small arachnoid cyst developed. However, there was no neurological deterioration. The myelopathy associated with thoracic spinal AA, subarachnoid cyst, and syrinx improved after S-S bypass.	[Tachibana, Toshiya; Moriyama, Tokuhide; Maruo, Keishi; Inoue, Shinichi; Arizumi, Fumihiro; Yoshiya, Shinichi] Hyogo Coll Med, Dept Orthopaed Surg, Nishinomiya, Hyogo 6638501, Japan	Tachibana, T (reprint author), Hyogo Coll Med, Dept Orthopaed Surg, Nishinomiya, Hyogo 6638501, Japan.	tachi@hyo-med.ac.jp					Klekamp J, 1997, J NEUROSURG, V86, P233, DOI 10.3171/jns.1997.86.2.0233; Chang HS, 2004, J NEUROL NEUROSUR PS, V75, P754, DOI 10.1136/jnnp.2003.018671; Hirai T, 2012, SPINE, V37, pE195, DOI 10.1097/BRS.0b013e31822ba817; Inoue Y, 2001, NEURORADIOLOGY, V43, P325; Ishizaka S, 2012, NEUROL MED-CHIR, V52, P686; Morisako Hiroki, 2010, J Craniovertebr Junction Spine, V1, P100, DOI 10.4103/0974-8237.77673; Ohta H, 2009, PAIN CLINIC, V30, P783; SHIKATA J, 1989, SPINE, V14, P870, DOI 10.1097/00007632-198908000-00018	8	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	NOV	2014	21	5					817	820		10.3171/2014.7.SPINE131082		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AR4AI	WOS:000343530000020		
J	Miwa, S; Matsumoto, Y; Hiroshima, Y; Yano, S; Uehara, F; Yamamoto, M; Zhang, Y; Kimura, H; Hayashi, K; Yamamoto, N; Bouvet, M; Sugimoto, N; Tsuchiya, H; Hoffman, RM				Miwa, Shinji; Matsumoto, Yasunori; Hiroshima, Yukihiko; Yano, Shuya; Uehara, Fuminari; Yamamoto, Mako; Zhang, Yong; Kimura, Hiroaki; Hayashi, Katsuhiro; Yamamoto, Norio; Bouvet, Michael; Sugimoto, Naotoshi; Tsuchiya, Hiroyuki; Hoffman, Robert M.			Fluorescence-guided surgery of prostate cancer bone metastasis	JOURNAL OF SURGICAL RESEARCH			English	Article						Prostate cancer; Bone metastasis; GFP; Fluorescence-guided surgery; Bright-light surgery; Nude mice; Zoledronic acid	ORTHOTOPIC MOUSE MODELS; HUMAN COLON-CANCER; PANCREATIC-CANCER; SURGICAL NAVIGATION; COMPLETE RESECTION; IMAGING-SYSTEM; IN-VIVO; TUMOR; ANTIBODY; DISEASE	Background: The aim of this study is to investigate the effectiveness of fluorescence-guided surgery (FGS) of prostate cancer experimental skeletal metastasis. Materials and methods: Green fluorescent protein-expressing PC-3 human prostate cancer cells (PC-3-green fluorescent protein) were injected into the intramedullary cavity of the tibia in 32 nude mice. After 2 wk, 16 of the mice underwent FGS; the other 16 mice underwent bright-light surgery (BLS). Half of BLS and FGS mice (8 mice in each group) received zoledronic acid (ZOL). Weekly fluorescence imaging of the mice was performed. Six weeks after surgery, metastases to lung and inguinal lymph node were evaluated by fluorescence imaging. Results: The percentage of residual tumor after BLS and FGS was 9.9 +/- 2.2% and 0.9 +/- 0.3%, respectively (P < 0.001). FGS reduced recurrent cancer growth compared with BLS (P < 0.005). Although FGS alone had no significant effect on inguinal lymph node metastases, lung metastasis or disease-free survival (DFS), ZOL in combination with FGS significantly increased DFS (P = 0.01) in comparison with the combination of BLS and ZOL. ZOL reduced lymph node metastases (P = 0.033) but not lung metastasis. Conclusions: FGS significantly reduced recurrence of experimental prostate cancer bone metastasis compared with BLS. The combination of FGS and ZOL increased DFS over BLS and ZOL. ZOL inhibited lymph node metastasis but not lung metastasis. (C) 2014 Elsevier Inc. All rights reserved.	[Miwa, Shinji; Hiroshima, Yukihiko; Yano, Shuya; Uehara, Fuminari; Yamamoto, Mako; Zhang, Yong; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Miwa, Shinji; Matsumoto, Yasunori; Hiroshima, Yukihiko; Yano, Shuya; Uehara, Fuminari; Yamamoto, Mako; Bouvet, Michael; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Miwa, Shinji; Kimura, Hiroaki; Hayashi, Katsuhiro; Yamamoto, Norio; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthoped Surg, Kanazawa, Ishikawa, Japan; [Sugimoto, Naotoshi] Kanazawa Univ, Grad Sch Med Sci, Dept Physiol, Kanazawa, Ishikawa, Japan	Bouvet, M (reprint author), Moores UCSD, Ctr Canc, Dept Surg, 3855 Hlth Sci Dr 0987, La Jolla, CA 92093 USA.	mbouvet@ucsd.edu	Sugimoto, Naotoshi/C-4739-2015; hayashi, katsuhiro/C-4685-2015	Sugimoto, Naotoshi/0000-0003-1995-5002; 	National Cancer Institute [CA132971, CA142669]	This study was supported in part by National Cancer Institute grants CA132971 and CA142669.	Metildi CA, 2013, J SURG RES, V179, P87, DOI 10.1016/j.jss.2012.08.052; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Metildi CA, 2012, J AM COLL SURGEONS, V215, P126, DOI 10.1016/j.jamcollsurg.2012.02.021; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Kishimoto H, 2011, CELL CYCLE, V10, P2737, DOI 10.4161/cc.10.16.16756; Metildi CA, 2014, J SURG ONCOL, V109, P451, DOI 10.1002/jso.23507; McElroy M, 2008, WORLD J SURG, V32, P1057, DOI 10.1007/s00268-007-9452-1; Yang M, 1999, CANCER RES, V59, P781; Rassweiler J, 2005, J UROLOGY, V173, P761, DOI 10.1097/01.ju.0000153486.94741.e5; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; Kimura H, 2010, CELL PROLIFERAT, V43, P41, DOI 10.1111/j.1365-2184.2009.00652.x; Kishimoto H, 2009, P NATL ACAD SCI USA, V106, P14514, DOI 10.1073/pnas.0906388106; Hessels D, 2013, ASIAN J ANDROL, V15, P333, DOI 10.1038/aja.2013.6; Yang M, 2000, P NATL ACAD SCI USA, V97, P1206, DOI 10.1073/pnas.97.3.1206; Yang M, 1998, CANCER RES, V58, P4217; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; Yang M, 1999, CLIN CANCER RES, V5, P3549; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Bickels J, 2009, J BONE JOINT SURG AM, V91A, P1503, DOI 10.2106/JBJS.H.00175; Bouvet M, 2012, J AM COLL SURGEONS, V215, P592; Bouvet M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003375; Burton DW, 2005, PROSTATE, V62, P275, DOI 10.1002/pros.20146; Coleman R.E., 2006, CLIN CANCER RES, V12, P6243, DOI DOI 10.1158/1078-0432.CCR-06-0931; Hiroshima Y, 2014, J SURG RES, V187, P510, DOI 10.1016/j.jss.2013.11.1083; Metildi CA, 2012, J AM COLL SURGEONS, V214, P997, DOI 10.1016/j.jamcollsurg.2012.02.009; Metildi CA, 2014, ANN SURG ONCOL, V21, P1405, DOI 10.1245/s10434-014-3495-y; Metildi CA, 2013, GASTROENT RES PRACT, DOI 10.1155/2013/290634; Ongkeko WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085803; Ratasvuori M, 2013, SURG ONCOL, V22, P132, DOI 10.1016/j.suronc.2013.02.008; Stiles BM, 2006, CANCER GENE THER, V13, P53, DOI 10.1038/sj.cgt.7700860; Urano Y, 2011, SCI TRANSL MED, V3, pra119; Yang M, 2006, CLIN CANCER RES, V12, P2602, DOI 10.1158/1078-0432.CCR-05-2050	32	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	NOV	2014	192	1					124	133		10.1016/j.jss.2014.05.049		10	Surgery	Surgery	AR2FY	WOS:000343400300019		
J	Sugihara, T; Yasunaga, H; Horiguchi, H; Matsui, H; Nishimatsu, H; Nakagawa, T; Fushimi, K; Kattan, MW; Homma, Y				Sugihara, Toru; Yasunaga, Hideo; Horiguchi, Hiromasa; Matsui, Hiroki; Nishimatsu, Hiroaki; Nakagawa, Tohru; Fushimi, Kiyohide; Kattan, Michael W.; Homma, Yukio			Comparison of Perioperative Outcomes including Severe Bladder Injury between Monopolar and Bipolar Transurethral Resection of Bladder Tumors: A Population Based Comparison	JOURNAL OF UROLOGY			English	Article						electrocoagulation; outcome assessment; postoperative complications; urinary bladder neoplasms	PROCEDURE COMBINATION DATABASE; RANDOMIZED CONTROLLED-TRIAL; PROPENSITY-SCORE; PROSTATE; PERFORATION; COMPLICATIONS; JAPAN; RISK	Purpose: In this study we used nationwide population based data to compare perioperative outcomes, including severe bladder injury, between monopolar and bipolar transurethral resection of bladder tumors. Materials and Methods: Data of patients with clinical T2 or less bladder cancer who underwent monopolar or bipolar transurethral bladder tumor resection were collected from 788 hospitals in the Japanese Diagnosis Procedure Combination database 2007-2012. One-to-one propensity score matching was performed. End points assessed were severe bladder injury requiring placement of a drainage tube or repair surgery within 3 postoperative days, hemostasis procedures consisting of clot removal or transurethral coagulation within 3 postoperative days, transfusion, other complications, anesthesia duration, postoperative length of stay and total costs. Multivariate analyses compared outcomes of bipolar and monopolar transurethral bladder tumor resection with gender, age, Charlson comorbidity index, clinical stage, hospital volume and hospital academic status as covariates. Results: A total of 8,188 pairs were generated. Compared with monopolar transurethral bladder tumor resection, bipolar resection was associated with a significantly lower incidence of severe bladder injury (0.3% vs 0.6%, OR 0.57), other complications (4.6% vs 5.8%, OR 0.78), slightly shorter postoperative stay (mean 6.4 vs 6.7 days, difference -3.3%) and slightly lower total costs (mean $4,628 vs $4,727; difference -1.1%, all p < 0.05). There were no differences in postoperative hemostasis procedures, transfusion and anesthesia duration. Conclusions: Bipolar transurethral bladder tumor resection was associated with a substantially lower incidence of several perioperative complications including severe bladder injury. The findings support the benefit of bipolar transurethral bladder tumor resection over monopolar resection in real-world clinical practice.	[Sugihara, Toru; Kattan, Michael W.] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; [Sugihara, Toru; Nishimatsu, Hiroaki; Nakagawa, Tohru; Homma, Yukio] Univ Tokyo, Dept Urol, Tokyo, Japan; [Yasunaga, Hideo; Matsui, Hiroki] Univ Tokyo, Dept Clin Epidemiol & Hlth Econ, Sch Publ Hlth, Tokyo, Japan; [Horiguchi, Hiromasa] Natl Hosp Org Headquarters, Dept Clin Data Management & Res, Clin Res Ctr, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Dept Hlth Care Informat, Tokyo, Japan	Sugihara, T (reprint author), Cleveland Clin, Dept Quantitat Hlth Sci, Main Campus,Mail Code JJN3-01,9500 Euclid Ave, Cleveland, OH 44195 USA.	ezy04707@nifty.com		Yasunaga, Hideo/0000-0002-6017-469X	ITO Genboku; SAGARA Chian Memorial Scholarship from Saga Prefecture, Japan; Ministry of Health, Labour and Welfare, Japan [H22-Policy-031]; Ministry of Education, Culture, Sports, Science and Technology [22390131]; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Council for Science and Technology Policy, Japan [0301002001001]	Supported by an ITO Genboku and SAGARA Chian Memorial Scholarship from Saga Prefecture, Japan; a Grant-in-Aid for Research on Policy Planning and Evaluation from the Ministry of Health, Labour and Welfare, Japan (No. H22-Policy-031); a Grant-in-Aid for Scientific Research B (No. 22390131) from the Ministry of Education, Culture, Sports, Science and Technology; and a grant from the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Council for Science and Technology Policy, Japan (No. 0301002001001).	Sugihara T, 2012, INT J UROL, V19, P86, DOI 10.1111/j.1442-2042.2011.02883.x; Pu XY, 2008, J ENDOUROL, V22, P545, DOI 10.1089/end.2007.0467; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Mamoulakis C, 2009, EUR UROL, V56, P798, DOI 10.1016/j.eururo.2009.06.037; Huang X, 2011, UROLOGY, V77, P1183, DOI 10.1016/j.urology.2010.08.013; Sugihara T, 2013, INT J UROL, V20, P1193, DOI 10.1111/iju.12157; Griswold ME, 2010, ANN INTERN MED, V152, P393, DOI 10.7326/0003-4819-152-6-201003160-00010; Panageas KS, 2003, ANN INTERN MED, V139, P658; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Del Rosso A, 2013, INT J UROL, V20, P399, DOI 10.1111/j.1442-2042.2012.03174.x; Huang X, 2007, UROLOGY, V70, P180, DOI 10.1016/j.urology.2007.02.051; Golan S, 2011, BJU INT, V107, P1065, DOI 10.1111/j.1464-410X.2010.09696.x; Masumori N, 2011, INT J UROL, V18, P166, DOI 10.1111/j.1442-2042.2010.02687.x; Mamoulakis C, 2012, BJU INT, V109, P240, DOI 10.1111/j.1464-410X.2011.10222.x; Sugihara T, 2013, INT J UROL, V20, P349, DOI 10.1111/iju.12079; Chakravarti A, 2000, BJU INT, V85, P1150, DOI 10.1046/j.1464-410x.2000.00684.x; Herr HW, 2006, J ENDOUROL, V20, P85, DOI 10.1089/end.2006.20.85; Organisation for Economic Co-operation and Development, 2013, OECD HLTH DAT 2013; Skolarikos A, 2005, J UROLOGY, V173, P1908, DOI 10.1097/01.ju.0000158450.71497.ae; Sobin LH, 2002, TNM CLASSIFICATION M; Sugihara T, 2012, J ENDOUROL, V26, P1053, DOI 10.1089/end.2011.0592; Traxer O, 2004, BJU INT, V94, P492, DOI 10.1111/j.1464-410X.2004.04990.x; Venkatramani V, 2013, J UROLOGY, V191, P1703; Xishuang Song, 2010, J Endourol, V24, P69, DOI 10.1089/end.2009.0171	24	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5347	1527-3792		J UROLOGY	J. Urol.	NOV	2014	192	5					1355	1359		10.1016/j.juro.2014.05.100		5	Urology & Nephrology	Urology & Nephrology	AR8YJ	WOS:000343856900011		
J	Fernandez, IV; Okamoto, N; Ito, A; Fukuda, M; Someya, A; Nishino, Y; Sasaki, N; Maeda, A				Fernandez, Igor Velado; Okamoto, Natsumi; Ito, Aki; Fukuda, Miki; Someya, Azusa; Nishino, Yosii; Sasaki, Nobuya; Maeda, Akihiko			Development of a novel protocol for generating flavivirus reporter particles	JOURNAL OF VIROLOGICAL METHODS			English	Article						West Nile virus; Reporter virus particles; Protocol	WEST-NILE-VIRUS; BORNE ENCEPHALITIS-VIRUS; IN-VITRO; REPLICON RNA; INFECTION; SYSTEM; COMPLEMENTATION; DIAGNOSIS; PROTEINS; TRANS	Infection with West Nile virus (WNV), a mosquito-borne flavivirus, is a growing public and animal health concern worldwide. Prevention, diagnosis and treatment strategies for the infection are urgently required. Recently, viral reverse genetic systems have been developed and applied to clinical WNV virology. We developed a protocol for generating reporter virus particles (RVPs) of WNV with the aim of overcoming two major problems associated with conventional protocols, the difficulty in generating RVPs due to the specific skills required for handling RNAs, and the potential for environmental contamination by antibiotic-resistant genes encoded within the genome RNA of the RVPs. By using the proposed protocol, cells were established in which the RVP genome RNA is replicated constitutively and does not encode any antibiotic-resistant genes, and used as the cell supply for RVP genome RNA. Generation of the WNV RVPs requires only the simple transfection of the expression vectors for the viral structural proteins into the cells. Therefore, no RNA handling is required in this protocol. The WNV RVP yield obtained using this protocol was similar that obtained using the conventional protocol. According to these results, the newly developed protocol appears to be a good alternative for the generation of WNV RVPs, particularly for clinical applications. (C) 2014 Elsevier B.V. All rights reserved.	[Fernandez, Igor Velado; Okamoto, Natsumi; Ito, Aki; Fukuda, Miki; Maeda, Akihiko] Kyoto Sangyo Univ, Fac Life Sci, Dept Anim Med Sci, Lab Environm Hyg,Kita Ku, Kyoto 6038555, Japan; [Fukuda, Miki; Someya, Azusa] Kyoto Sangyo Univ, Fac Life Sci, Dept Anim Med Sci, Bacteriol Lab,Kita Ku, Kyoto 6038555, Japan; [Nishino, Yosii] Kyoto Sangyo Univ, Fac Life Sci, Dept Anim Med Sci, Virol Lab,Kita Ku, Kyoto 6038555, Japan; [Sasaki, Nobuya] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Lab Anim Sci & Med,Kita Ku, Sapporo, Hokkaido 0600818, Japan; [Sasaki, Nobuya] Kitasato Univ, Fac Vet Med, Sch Vet Med & Anim Sci, Lab Expt Anim Sci, Towada, Aomori 0348626, Japan	Maeda, A (reprint author), Kyoto Sangyo Univ, Fac Life Sci, Dept Anim Med Sci, Lab Environm Hyg,Kita Ku, Kyoto 6038555, Japan.	amaeda@cc.kyoto-su.ac.jp			Ministry of Health, Labor and Welfare [H20-Shinkou-ippam-015, H24-Shinkou-ippam-013]; Ministry of Education, Culture, Sports, Science and Technology [20405040, 24658261]; Kyoto Sangyo University [E1217]	This research was partially supported by grants-in-aid from the Ministry of Health, Labor and Welfare (H20-Shinkou-ippam-015 and H24-Shinkou-ippam-013), the Ministry of Education, Culture, Sports, Science and Technology (20405040 and 24658261), and a research grant from Kyoto Sangyo University (E1217).	Gehrke R, 2003, J VIROL, V77, P8924, DOI 10.1128/JVI.77.16.8924-8933.2003; Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019; Scholle F, 2004, J VIROL, V78, P11605, DOI 10.1128/JVI.78.21.11605-11614.2004; Dauphin G, 2007, VACCINE, V25, P5563, DOI 10.1016/j.vaccine.2006.12.005; Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109; Ohtaki N, 2010, VACCINE, V28, P6588, DOI 10.1016/j.vaccine.2010.07.055; Rossi SL, 2007, VIROLOGY, V364, P184, DOI 10.1016/j.virol.2007.02.009; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021; Blitvich BJ, 2003, EMERG INFECT DIS, V9, P853; Fayzulin R, 2006, VIROLOGY, V351, P196, DOI 10.1016/j.virol.2006.2.036; Gubler D., 2007, FIELDS VIROLOGY, V1, P1153; Khromykh AA, 1998, J VIROL, V72, P5967; Komar Nicholas, 2003, Adv Virus Res, V61, P185; Lindenbach BD, 2001, FIELDS VIROLOGY, VII, P991; Mackenzie J.S., 2004, NAT MED S12, V10, P98; Maeda J, 2008, J VIROL METHODS, V148, P244, DOI [10.1016/j.jviromet.2007.12.005, 10.1016/j.jviromet-2007.12.005]; Makino Y, 2014, J VIROL METHODS, V195, P250, DOI 10.1016/j.jviromet.2013.10.002; Moritoh K, 2011, J VET MED SCI, V73, P683, DOI 10.1292/jvms.10-0495; Puig-Basagoiti F, 2007, VIROLOGY, V361, P229, DOI 10.1016/j.virol.2006.11.012; Puig-Basagoiti F., 2005, ANTIMICROB AGENTS CH, V49, P49980; Qing Min, 2009, Virologica Sinica, V24, P136, DOI 10.1007/s12250-009-3023-6; Shang WL, 2012, APPL MICROBIOL BIOT, V94, P39, DOI 10.1007/s00253-012-3958-7; Suzuki R, 2014, J GEN VIROL, V95, P60, DOI 10.1099/vir.0.058008-0; WESTAWAY EG, 1985, INTERVIROLOGY, V24, P183, DOI 10.1159/000149642; Yoshii K, 2008, J GEN VIROL, V89, P200, DOI 10.1099/vir.0.82824-0; Yoshii K, 2005, VACCINE, V23, P3946, DOI 10.1016/j.vaccine.2005.03.004	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-0934	1879-0984		J VIROL METHODS	J. Virol. Methods	NOV	2014	208						96	101		10.1016/j.jviromet.2014.08.002		6	Biochemical Research Methods; Biotechnology & Applied Microbiology; Virology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Virology	AR1KN	WOS:000343344200016		
J	Kohda, C; Chiba, N; Shimokoba, K; Mizuno, K; Negoro, T; Nakano, Y; Tanaka, K				Kohda, Chikara; Chiba, Nao; Shimokoba, Kengo; Mizuno, Katsumi; Negoro, Takaharu; Nakano, Yasuko; Tanaka, Kazuo			A simple smart amplification assay for the rapid detection of human cytomegalovirus in the urine of neonates	JOURNAL OF VIROLOGICAL METHODS			English	Article						Human cytomegalovirus; Smart amplification; Isothermal nucleotide amplification; Real-time PCR	PRETERM INFANTS; BREAST-MILK; INFECTION; SNP; TRANSMISSION; PREGNANCY	Human cytomegalovirus (CMV) is the most common cause of infection-related congenital abnormalities in neonates and the leading cause of non-hereditary sensorineural hearing loss in childhood. In addition, the number of low-birth-weight infants has recently increased, especially in Japan, in association with an increasing frequency of postnatal CMV infections transferred through raw breast milk. The increase in the number of congenital CMV and postnatal CMV infections in low-birth-weight infants requires rapid detection at the bedside in order to ensure a correct diagnosis and provide early anti-viral therapy. In this report, a simplified smart amplification (SMAP) method was developed to detect CMV in the urine of neonates. This method does not require DNA extraction, and the DNA amplification procedure is performed under isothermal conditions. Therefore, it takes only 60 min to detect CMV in a urine sample, and CMV DNA was rapidly detectable in symptomatic infants. In brief, this SMAP-based assay provides a simple, rapid and efficient method for detecting human CMV at the bedside. (C) 2014 Elsevier B.V. All rights reserved.	[Kohda, Chikara; Tanaka, Kazuo] Showa Univ, Sch Med, Dept Microbiol & Immunol, Shinagawa Ku, Tokyo 1428555, Japan; [Chiba, Nao; Shimokoba, Kengo] Shino Test Corp, Dept Res & Dev, Sagamihara, Kanagawa 2290011, Japan; [Mizuno, Katsumi] Showa Univ, Sch Med, Dept Pediat, Shinagawa Ku, Tokyo 1428555, Japan; [Negoro, Takaharu; Nakano, Yasuko] Showa Univ, Sch Pharmaceut Sci, Dept Pharmacogen, Shinagawa Ku, Tokyo 1428555, Japan	Kohda, C (reprint author), Showa Univ, Sch Med, Dept Microbiol & Immunol, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	kohda@med.showa-u.ac.jp					Pignatelli S, 2004, REV MED VIROL, V14, P383, DOI 10.1002/rmv.438; Ornoy A, 2006, REPROD TOXICOL, V21, P446, DOI 10.1016/j.reprotox.2005.12.007; Kurath S, 2010, CLIN MICROBIOL INFEC, V16, P1172, DOI 10.1111/j.1469-0691.2010.03140.x; Yinon Y, 2010, OBSTET GYNECOL SURV, V65, P736, DOI 10.1097/OGX.0b013e31821102b4; Hamprecht K, 2008, J CLIN VIROL, V41, P198, DOI 10.1016/j.jcv.2007.12.005; Schleiss MR, 2006, CURR OPIN PEDIATR, V18, P48; Nagy A, 2004, IN VIVO, V18, P819; Mitani Y, 2007, NAT METHODS, V4, P257, DOI 10.1038/NMETH1007; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; Fukushima E, 2008, J VIROL METHODS, V151, P55, DOI 10.1016/j.jviromet.2008.03.022; Goelz R, 2013, ARCH DIS CHILD-FETAL, V98, pF430, DOI 10.1136/archdischild-2012-303384; Lezhava A, 2009, METHODS MOL BIOL, V578, P437, DOI 10.1007/978-1-60327-411-1_28; Luck S, 2009, ARCH DIS CHILD-FETAL, V94, pF58, DOI 10.1136/adc.2007.131623; Mitani Y, 2009, PHARMACOGENOMICS, V10, P1187, DOI [10.2217/pgs.09.39, 10.2217/PGS.09.39]; Mosca F, 2007, J Chemother, V19 Suppl 2, P46; Wakabayashi H, 2012, AM J PERINAT, V29, P377, DOI 10.1055/s-0031-1300971; Ye Q, 2004, TRANSPLANT P, V36, P3036, DOI 10.1016/j.transproceed.2004.10.050	17	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-0934	1879-0984		J VIROL METHODS	J. Virol. Methods	NOV	2014	208						160	165		10.1016/j.jviromet.2014.07.034		6	Biochemical Research Methods; Biotechnology & Applied Microbiology; Virology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Virology	AR1KN	WOS:000343344200026		
J	Khan, I; Katikaneni, DS; Han, QX; Sanchez-Felipe, L; Hanada, K; Ambrose, RL; Mackenzie, JM; Konan, KV				Khan, Irfan; Katikaneni, Divya S.; Han, Qingxia; Sanchez-Felipe, Lorena; Hanada, Kentaro; Ambrose, Rebecca L.; Mackenzie, Jason M.; Konan, Kouacou V.			Modulation of Hepatitis C Virus Genome Replication by Glycosphingolipids and Four-Phosphate Adaptor Protein 2	JOURNAL OF VIROLOGY			English	Article							MAMMALIAN SERINE PALMITOYLTRANSFERASE; OXYSTEROL-BINDING-PROTEIN; HCV RNA REPLICATION; 4-KINASE III ALPHA; CELL-CULTURE; N-BUTYLDEOXYNOJIRIMYCIN; SPHINGOLIPID METABOLISM; COMPLEX-FORMATION; MEMBRANE; TRAFFICKING	Hepatitis C virus (HCV) assembles its replication complex on cytosolic membrane vesicles often clustered in a membranous web (MW). During infection, HCV NS5A protein activates PI4KIII alpha enzyme, causing massive production and redistribution of phosphatidylinositol 4-phosphate (PI4P) lipid to the replication complex. However, the role of PI4P in the HCV life cycle is not well understood. We postulated that PI4P recruits host effectors to modulate HCV genome replication or virus particle production. To test this hypothesis, we generated cell lines for doxycycline-inducible expression of short hairpin RNAs (shRNAs) targeting the PI4P effector, four-phosphate adaptor protein 2 (FAPP2). FAPP2 depletion attenuated HCV infectivity and impeded HCV RNA synthesis. Indeed, FAPP2 has two functional lipid-binding domains specific for PI4P and glycosphingolipids. While expression of the PI4P-binding mutant protein was expected to inhibit HCV replication, a marked drop in replication efficiency was observed unexpectedly with the glycosphingolipid-binding mutant protein. These data suggest that both domains are crucial for the role of FAPP2 in HCV genome replication. We also found that HCV significantly increases the level of some glycosphingolipids, whereas adding these lipids to FAPP2-depleted cells partially rescued replication, further arguing for the importance of glycosphingolipids in HCV RNA synthesis. Interestingly, FAPP2 is redistributed to the replication complex (RC) characterized by HCV NS5A, NS4B, or double-stranded RNA (dsRNA) foci. Additionally, FAPP2 depletion disrupts the RC and alters the colocalization of HCV replicase proteins. Altogether, our study implies that HCV coopts FAPP2 for virus genome replication via PI4P binding and glycosphingolipid transport to the HCV RC. IMPORTANCE Like most viruses with a positive-sense RNA genome, HCV replicates its RNA on remodeled host membranes composed of lipids hijacked from various internal membrane compartments. During infection, HCV induces massive production and retargeting of the PI4P lipid to its replication complex. However, the role of PI4P in HCV replication is not well understood. In this study, we have shown that FAPP2, a PI4P effector and glycosphingolipid-binding protein, is recruited to the HCV replication complex and is required for HCV genome replication and replication complex formation. More importantly, this study demonstrates, for the first time, the crucial role of glycosphingolipids in the HCV life cycle and suggests a link between PI4P and glycosphingolipids in HCV genome replication.	[Khan, Irfan; Katikaneni, Divya S.; Han, Qingxia; Sanchez-Felipe, Lorena; Konan, Kouacou V.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Ambrose, Rebecca L.; Mackenzie, Jason M.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo, Japan	Konan, KV (reprint author), Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.	KonanK@mail.amc.edu	han, qingxia/G-6260-2015; Khan, Irfan/O-8965-2015; 	Khan, Irfan/0000-0003-3854-5420; Mackenzie, Jason/0000-0001-6613-8350	National Institutes of Health [1R56AI087769, 1R21AI097858-01]; Takeda Science Foundation	This work was supported by 1R56AI087769 (K.V.K.) and 1R21AI097858-01 (K.V.K.), from the National Institutes of Health, and by the Takeda Science Foundation (to K.H.).	Ali N, 2002, J VIROL, V76, P12001, DOI 10.1128/JVI.76.23.12001-12007.2002; Alter MJ, 1997, HEPATOLOGY, V26, pS62, DOI 10.1002/hep.510260711; Hanada K, 2007, BBA-MOL CELL BIOL L, V1771, P644, DOI 10.1016/j.bbalip.2007.01.009; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Elazar M, 2004, J VIROL, V78, P11393, DOI 10.1128/JVI.78.20.11393-11400.2004; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Gottwein JM, 2011, J VIROL, V85, P8913, DOI 10.1128/JVI.00049-11; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Lundin M, 2003, J VIROL, V77, P5428, DOI 10.1128/JVI.77.9.5428-5438.2003; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Su WC, 2011, J VIROL, V85, P10561, DOI 10.1128/JVI.00173-11; Weng LY, 2010, J VIROL, V84, P11761, DOI 10.1128/JVI.00638-10; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Cao XW, 2009, P NATL ACAD SCI USA, V106, P21121, DOI 10.1073/pnas.0911789106; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Berger KL, 2011, J VIROL, V85, P8870, DOI 10.1128/JVI.00059-11; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Targett-Adams P, 2008, J VIROL, V82, P2182, DOI 10.1128/JVI.01565-07; MILLER RH, 1990, P NATL ACAD SCI USA, V87, P2057, DOI 10.1073/pnas.87.6.2057; Yi MK, 2007, J VIROL, V81, P629; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Han QX, 2013, J VIROL, V87, P7409, DOI 10.1128/JVI.03523-12; Paul D, 2013, J VIROL, V87, P10612, DOI 10.1128/JVI.01370-13; Santiago-Tirado FH, 2011, TRENDS CELL BIOL, V21, P515, DOI 10.1016/j.tcb.2011.05.005; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Goueslain L, 2010, J VIROL, V84, P773, DOI 10.1128/JVI.01190-09; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Bishe B, 2012, J BIOL CHEM, V287, P27637, DOI 10.1074/jbc.M112.346569; Kuiken Carla, 2009, V510, P33, DOI 10.1007/978-1-59745-394-3_4; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Wolk B, 2008, J VIROL, V82, P10519, DOI 10.1128/JVI.00640-08; Friebe P, 2001, J VIROL, V75, P12047, DOI 10.1128/JVI.75.24.12047-12057.2001; Aligo J, 2009, VIROLOGY, V393, P68, DOI 10.1016/j.virol.2009.07.033; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Wang HL, 2014, GASTROENTEROLOGY, V146, P1373, DOI 10.1053/j.gastro.2014.02.002; Ye J, 2003, P NATL ACAD SCI USA, V100, P15865, DOI 10.1073/pnas.2237238100; Konan KV, 2003, J VIROL, V77, P7843, DOI 10.1128/JVI.77.14.7843-7855.2003; Han QX, 2011, J VIROL, V85, P6464, DOI 10.1128/JVI.02298-10; Stone M, 2007, J VIROL, V81, P4551, DOI 10.1128/JVI.01366-06; Ishido S, 1998, BIOCHEM BIOPH RES CO, V244, P35, DOI 10.1006/bbrc.1998.8202; Reiss S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003359; Amako Y, 2009, J VIROL, V83, P9237, DOI 10.1128/JVI.00958-09; Platt FM, 1997, J BIOL CHEM, V272, P19365, DOI 10.1074/jbc.272.31.19365; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Bartenschlager R, 2007, VIRUS RES, V127, P195, DOI 10.1016/j.virusres.2007.02.022; Manna D, 2010, VIROLOGY, V398, P21, DOI 10.1016/j.virol.2009.11.034; Bartenschlager R, 2000, J GEN VIROL, V81, P1631; Bieberich E, 1999, J NEUROCHEM, V72, P1040, DOI 10.1046/j.1471-4159.1999.0721040.x; Averhoff FM, 2012, CLIN INFECT DIS, V55, pS10, DOI 10.1093/cid/cis361; Casson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054525; Ciesek S, 2008, J INFECT DIS, V198, P1091, DOI 10.1086/591463; D'Angelo G, 2012, BBA-MOL CELL BIOL L, V1821, P1089, DOI 10.1016/j.bbalip.2012.01.003; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; D'Angelo G, 2013, NATURE, V501, DOI 10.1038/nature12423; El-Hage N, 2003, J GEN VIROL, V84, P2761, DOI 10.1099/vir.0.19305-0; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hanada Kentaro, 2003, Methods Mol Biol, V228, P163, DOI 10.1385/1-59259-400-X:163; Hirata Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002860; Hornemann T, 2007, BIOCHEM J, V405, P157, DOI 10.1042/BJ20070025; Hug P, 2000, J VIROL, V74, P6377, DOI 10.1128/JVI.74.14.6377-6385.2000; Kamlekar RK, 2013, BBA-MOL CELL BIOL L, V1831, P417, DOI 10.1016/j.bbalip.2012.10.010; Komori H, 1999, J BIOL CHEM, V274, P8981, DOI 10.1074/jbc.274.13.8981; Lenoir M, 2010, EMBO REP, V11, P279, DOI 10.1038/embor.2010.28; Platt FM, 1997, SCIENCE, V276, P428, DOI 10.1126/science.276.5311.428; Rawat SS, 2005, BIOSCIENCE REP, V25, P329, DOI 10.1007/s10540-005-2894-5; Tai AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026300; Tuuf J, 2014, CHEM PHYS LIPIDS, V178, P27, DOI 10.1016/j.chemphyslip.2013.10.013; Yamaji T, 2008, IUBMB LIFE, V60, P511, DOI 10.1002/iub.83; Yasuda S, 2003, J BIOL CHEM, V278, P4176, DOI 10.1074/jbc.M209602200; Zhang L. B., 2012, NPG ASIA MATER, V4, P1	80	9	9	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	NOV	2014	88	21					12276	12295		10.1128/JVI.00970-14		20	Virology	Virology	AR1BN	WOS:000343314900011		
J	Matsuzaki, Y; Sugawara, K; Nakauchi, M; Takahashi, Y; Onodera, T; Tsunetsugu-Yokota, Y; Matsumura, T; Ato, M; Kobayashi, K; Shimotai, Y; Mizuta, K; Hongo, S; Tashiro, M; Nobusawa, E				Matsuzaki, Yoko; Sugawara, Kanetsu; Nakauchi, Mina; Takahashi, Yoshimasa; Onodera, Taishi; Tsunetsugu-Yokota, Yasuko; Matsumura, Takayuki; Ato, Manabu; Kobayashi, Kazuo; Shimotai, Yoshitaka; Mizuta, Katsumi; Hongo, Seiji; Tashiro, Masato; Nobusawa, Eri			Epitope Mapping of the Hemagglutinin Molecule of A/(H1N1)pdm09 Influenza Virus by Using Monoclonal Antibody Escape Mutants	JOURNAL OF VIROLOGY			English	Article							A H1N1 VIRUSES; ANTIGENIC STRUCTURE; RECOGNIZES; EVOLUTION; VARIANTS; SUBTYPE; STRAINS; RATES; DRIFT	We determined the antigenic structure of pandemic influenza A(H1N1)pdm09 virus hemagglutinin (HA) using 599 escape mutants that were selected using 16 anti-HA monoclonal antibodies (MAbs) against A/Narita/1/2009. The sequencing of mutant HA genes revealed 43 amino acid substitutions at 24 positions in three antigenic sites, Sa, Sb, and Ca2, which were previously mapped onto A/PuertoRico/8/34 (A/PR/8/34) HA (A. J. Caton, G. G. Brownlee, J. W. Yewdell, and W. Gerhard, Cell 31:417-427, 1982), and an undesignated site, i.e., amino acid residues 141, 142, 143, 171, 172, 174, 177, and 180 in the Sa site, residues 170, 173, 202, 206, 210, 211, and 212 in the Sb site, residues 151, 154, 156, 157, 158, 159, 200, and 238 in the Ca2 site, and residue 147 in the undesignated site (numbering begins at the first methionine). Sixteen MAbs were classified into four groups based on their cross-reactivity with the panel of escape mutants in the hemagglutination inhibition test. Among them, six MAbs targeting the Sa and Sb sites recognized both residues at positions 172 and 173. MAb n2 lost reactivity when mutations were introduced at positions 147, 159 (site Ca2), 170 (site Sb), and 172 (site Sa). We designated the site consisting of these residues as site Pa. From 2009 to 2013, no antigenic drift was detected for the A(H1N1) pdm09 viruses. However, if a novel variant carrying a mutation at a position involved in the epitopes of several MAbs, such as 172, appeared, such a virus would have the advantage of becoming a drift strain. IMPORTANCE The first influenza pandemic of the 21st century occurred in 2009 with the emergence of a novel virus originating with swine influenza, A(H1N1) pdm09. Although HA of A(H1N1) pdm09 has a common origin (1918 H1N1) with seasonal H1N1, the antigenic divergence of HA between the seasonal H1N1 and A(H1N1) pdm09 viruses gave rise to the influenza pandemic in 2009. To take precautions against the antigenic drift of the A(H1N1) pdm09 virus in the near future, it is important to identify its precise antigenic structure. To obtain various mutants that are not neutralized by MAbs, it is important to neutralize several plaque-cloned parent viruses rather than only a single parent virus. We characterized 599 escape mutants that were obtained by neutralizing four parent viruses of A(H1N1) pdm09 in the presence of 16 MAbs. Consequently, we were able to determine the details of the antigenic structure of HA, including a novel epitope.	[Matsuzaki, Yoko; Sugawara, Kanetsu; Shimotai, Yoshitaka; Hongo, Seiji] Yamagata Univ, Fac Med, Dept Infect Dis, Yamagata 990, Japan; [Nakauchi, Mina; Tashiro, Masato; Nobusawa, Eri] Natl Inst Infect Dis, Influenza Virus Res Ctr, Tokyo, Japan; [Takahashi, Yoshimasa; Onodera, Taishi; Tsunetsugu-Yokota, Yasuko; Matsumura, Takayuki; Ato, Manabu; Kobayashi, Kazuo] Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan; [Mizuta, Katsumi] Yamagata Prefectural Inst Publ Hlth, Dept Microbiol, Yamagata 9900031, Japan	Nobusawa, E (reprint author), Natl Inst Infect Dis, Influenza Virus Res Ctr, Tokyo, Japan.	nobusawa@nih.go.jp			Health Labor Sciences Research Grant; Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labor and Welfare of Japan [H22-//Shinko-Ippan-001//]	This study was supported in part by a Health Labor Sciences Research Grant, Research on Emerging and Re-emerging Infectious Diseases (to E.N.; no. H22-//Shinko-Ippan-001//) from the Ministry of Health, Labor and Welfare of Japan.	Chen ZY, 2010, J VIROL, V84, P44, DOI 10.1128/JVI.02106-09; Krause JC, 2011, J VIROL, V85, P10905, DOI 10.1128/JVI.00700-11; Rudneva I, 2012, VIRUS RES, V166, P61, DOI 10.1016/j.virusres.2012.03.003; Nakajima S, 2007, MICROBIOL IMMUNOL, V51, P1179; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Tsuchiya E, 2001, J GEN VIROL, V82, P2475; NAKAJIMA K, 1978, NATURE, V274, P334, DOI 10.1038/274334a0; WEBSTER RG, 1979, VIROLOGY, V96, P258, DOI 10.1016/0042-6822(79)90189-2; Nobusawa E, 2006, J VIROL, V80, P3675, DOI 10.1128/JVI.80.7.3675-3678.2006; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Barr IG, 2010, EUROSURVEILLANCE, V15, P6; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Dapat IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036455; Guarnaccia T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003354; hemisphere Review of the 2013 influenza season in the southern, 2013, WKLY EPIDEMIOL REC, V88, P509; KENDAL AP, 1979, AM J EPIDEMIOL, V110, P449; LUBECK MD, 1981, VIROLOGY, V113, P64, DOI 10.1016/0042-6822(81)90136-7; Nakajima S, 2000, MICROBIOL IMMUNOL, V44, P841; NAKAJIMA S, 1981, VIROLOGY, V113, P656, DOI 10.1016/0042-6822(81)90194-X; NOBUSAWA E, 1987, VIROLOGY, V159, P10, DOI 10.1016/0042-6822(87)90342-4; O'Donnell C. D., 2012, MBIO, V3; RAYMOND FL, 1983, NUCLEIC ACIDS RES, V11, P7191, DOI 10.1093/nar/11.20.7191; Strengell M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025848; World Health Organization, 2011, WKLY EPIDEMIOL REC, V86, P61; World Health Organization, 2013, WKLY EPIDEMIOL REC, V88, P225; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P81; Yang H., 2010, PLOS CURR, V2, DOI DOI 10.1371/CURRENTS.RRN1152	30	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	NOV	2014	88	21					12364	12373		10.1128/JVI.01381-14		10	Virology	Virology	AR1BN	WOS:000343314900017		
J	Sharifi, A; Chiba, Y; Okamoto, K; Yokoyama, S; Murayama, A				Sharifi, Ayyoob; Chiba, Yoshihiro; Okamoto, Kohei; Yokoyama, Satoshi; Murayama, Akito			Can master planning control and regulate urban growth in Vientiane, Laos?	LANDSCAPE AND URBAN PLANNING			English	Article						Vientiane; Laos; Land-use and land-cover change; Urbanization; Master planning; Urban growth	LAND-USE; DYNAMICS; CITIES; SUSTAINABILITY; URBANIZATION; PATTERN; CHINA; AREA	The rate of urbanization in Laos has increased significantly since the country began its transition to a market economy in 1986. Although urbanization in developing countries has been examined extensively in the literature, very few researchers have focused on Laos. Our main aim here was to examine the effectiveness of utilizing the master plan as a management tool to regulate urban growth in Vientiane, the capital city of Laos. We used a mixed-methods approach to address the research objective. First, we examined the population changes since 1985. Next, land-use and land-cover changes were detected by analyzing the satellite images from three different time periods. Then, we analyzed the city's recently approved master plan to determine whether it can regulate urban growth. Finally, to investigate the socioeconomic and institutional issues and better understand the reasons for rapid land-use and land-cover changes, we interviewed several key figures from the departments related to urban management and a number of residents living in the pen-urban area. Between 1995 and 2011, the urban population in the study area increased from 337,000 to 780,000. In the same time period, the built-up area increased from approximately 154 km(2) to more than 206 km(2). The total area of the forests decreased from approximately 2354 km(2) to approximately 1353 km(2). The results indicate that there is an urgent need for improvements in the regulatory and management aspects and that the master plan should be revised to provide a more realistic account of the existing situation. (C) 2014 Elsevier B.V. All rights reserved.	[Sharifi, Ayyoob] Natl Inst Environm Studies, Global Carbon Project, Tsukuba, Ibaraki 3058506, Japan; [Chiba, Yoshihiro] Nagoya Univ, Dept Environm Engn & Architecture, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan; [Okamoto, Kohei; Yokoyama, Satoshi] Nagoya Univ, Dept Social & Human Environm, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan; [Murayama, Akito] Univ Tokyo, Dept Urban Engn, Sch Engn, Tokyo 1138654, Japan	Sharifi, A (reprint author), Natl Inst Environm Studies, Tsukuba Int Off, Global Carbon Project, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	sharifigeomatic@gmail.com; yossy2727@gmail.com; h44540a@cc.nagoya-u.ac.jp; s-yokoyama@nagoya-u.jp; murayama@up.t.u-tokyo.ac.jp	Sharifi, Ayyoob/M-7584-2013	Sharifi, Ayyoob/0000-0002-8983-8613	Nagoya University Global COE (Center of Excellence) Program "From Earth System Science to Basic and Clinical Environmental Studies"(GCOE-BCES) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [K04]	This research was made possible by a grant from the Nagoya University Global COE (Grant No. K04) (Center of Excellence) Program "From Earth System Science to Basic and Clinical Environmental Studies"(GCOE-BCES) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. Many people have contributed either directly or indirectly to this study. In particular, we would like to thank Dr. Isao Hirota and Dr. Tomohiro Oh for assistance in acquiring data and arranging the fieldwork, Dr. Edit Nagy-Tanaka for technical assistance in preparing the manuscript, and our colleague Mr. Phanxay Ingxay for his help in conducting interviews. Thanks are also due to officials in JICA, VUDAA, DPWT, OPWT, and all other interview and survey respondents who generously provided us with information necessary for conducting this study. In addition, we would like to thank the Co-Editor, Prof. W.-N. Xiang, and the four anonymous reviewers for their constructive comments on the earlier versions of this work. Any errors of omission or commission remain the responsibility of the authors.	Huang SL, 2009, LANDSCAPE URBAN PLAN, V90, P20, DOI 10.1016/j.landurbplan.2008.10.010; Todes A, 2012, CITIES, V29, P158, DOI 10.1016/j.cities.2011.08.004; Albrechts L, 2006, ENVIRON PLANN A, V38, P1149, DOI 10.1068/a37304; Wu KY, 2012, APPL GEOGR, V34, P137, DOI 10.1016/j.apgeog.2011.11.006; Sharifi A, 2013, HABITAT INT, V38, P126, DOI 10.1016/j.habitatint.2012.05.007; Conway T, 2007, CAN GEOGR-GEOGR CAN, V51, P43; Dewan AM, 2009, APPL GEOGR, V29, P390, DOI 10.1016/j.apgeog.2008.12.005; Tacoli C, 2010, ENVIRON URBAN, V22, P389, DOI 10.1177/0956247810379935; Meyfroidt P, 2011, ANNU REV ENV RESOUR, V36, P343, DOI 10.1146/annurev-environ-090710-143732; Goldman M, 2011, INT J URBAN REGIONAL, V35, P555, DOI 10.1111/j.1468-2427.2010.01001.x; Vermeiren K, 2012, LANDSCAPE URBAN PLAN, V106, P199, DOI 10.1016/j.landurbplan.2012.03.006; Albrechts L, 2004, ENVIRON PLANN B, V31, P743, DOI 10.1068/b3065; Qian H, 2012, URBAN POLICY RES, V30, P403, DOI 10.1080/08111146.2012.737778; Huang SL, 2010, CURR OPIN SUST, V2, P136, DOI 10.1016/j.cosust.2010.06.004; Martinuzzi S, 2007, LANDSCAPE URBAN PLAN, V79, P288, DOI 10.1016/j.landurbplan.2006.02.014; Roy M, 2009, HABITAT INT, V33, P276, DOI 10.1016/j.habitatint.2008.10.022; Seto KC, 2010, ANNU REV ENV RESOUR, V35, P167, DOI 10.1146/annurev-environ-100809-125336; Kelly PF, 1999, INT J URBAN REGIONAL, V23, P283, DOI 10.1111/1468-2427.00196; Lambin EF, 2003, ANNU REV ENV RESOUR, V28, P205, DOI 10.1146/annurev.energy.28.050302.105459; Wentz EA, 2006, COMPUT ENVIRON URBAN, V30, P320, DOI 10.1016/j.compenvurbsys.2004.07.002; Miller RB, 2003, ENVIRON SCI POLICY, V6, P129, DOI 10.1016/S1462-9011(03)00002-9; Askew M, 2007, ASIAS TRANSFORM, P1; Balbo M, 1993, 3 WORLD PLANNING REV, V15, P23; Bourdic L, 2012, BUILD RES INF, V40, P592, DOI 10.1080/09613218.2012.703488; CIA, 2012, WORLD FACTB 2012; Cohen B., 2006, TECHNOL SOC, V28, P63, DOI DOI 10.1016/J.TECHS0C.2005.10.005; Comte D. L, 2009, WEATHERWISE, V62, P22; de Graaf RS, 2010, HABITAT INT, V34, P471, DOI 10.1016/j.habitatint.2010.02.005; Doygun H, 2009, ENVIRON MONIT ASSESS, V158, P471, DOI 10.1007/s10661-008-0597-7; Firl G. J., 2011, CALCULATING VEGETATI; JICA, 2011, PROJ URB DEV MAST PL; Kironde JML, 2006, LAND USE POLICY, V23, P460, DOI 10.1016/j.landusepol.2005.07.004; Le Quere C, 2012, EARTH SYSTEM SCI DAT, V5, P1107, DOI DOI 10.5194/ESSDD-5-1107-2012; LSB, 2006, RES POP HOUS CENS; Lund C., 2010, URBANIZATION LAND CO; Martin G. S., 2011, Proceedings of the 2011 Argentine School of Micro-Nanoelectronics, Technology and Applications (EAMTA 2011); Mega VP, 2010, SUSTAINABLE CITIES FOR THE THIRD MILLENNIUM: THE ODYSSEY OF URBAN EXCELLENCE, P3, DOI 10.1007/978-1-4419-6037-5; Newman P, 2000, ACHIEVING SUSTAINABL, P109; Nolintha V., 2011, INTRAAND INTERCITY C, P176; Okamoto K, 2014, ADV ASIAN HUM-ENV RE, P29, DOI 10.1007/978-4-431-54956-7_2; Owen D., 2009, GREEN METROPOLIS WHY; Parnwell M., 1996, ENV CHANGE S E ASIA; Rabe P., 2007, URBAN LAND MANAGEMEN; Rafiqui PS, 2009, CITIES, V26, P38, DOI 10.1016/j.cities.2008.10.002; Rigg J., 1996, ENV CHANGE S E ASIA, P139; Sarkheyli E, 2012, CITIES, V29, P223, DOI 10.1016/j.cities.2011.09.004; Sharifi A., 2014, J ENV PLANNING MANAG; Sharifi A, 2014, BUILD ENVIRON, V72, P243, DOI 10.1016/j.buildenv.2013.11.006; Sheng Y. K., 2012, URBANIZATION SE ASIA; Shieh E., 2011, INT J ARCHITECTURE E, V21, P119; United Nations Department of Economic and Social Affairs (UNDESA), 2012, WORLD URB PROSP 2011; Urdal H, 2012, GLOBAL ENVIRON CHANG, V23, P1; Wheeler Stephen M., 2004, SUSTAINABLE URBAN DE; World Bank, 2012, LAO PDR; WWIS, 2012, WEATH INF VIENT	55	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-2046	1872-6062		LANDSCAPE URBAN PLAN	Landsc. Urban Plan.	NOV	2014	131						1	13		10.1016/j.landurbplan.2014.07.014		13	Ecology; Environmental Studies; Geography; Geography, Physical; Urban Studies	Environmental Sciences & Ecology; Geography; Physical Geography; Urban Studies	AR2BQ	WOS:000343388900001		
J	Asgarzadeh, M; Koga, T; Hirate, K; Farvid, M; Lusk, A				Asgarzadeh, Morteza; Koga, Takaaki; Hirate, Kotaroh; Farvid, Maryam; Lusk, Anne			Investigating oppressiveness and spaciousness in relation to building, trees, sky and ground surface: A study in Tokyo	LANDSCAPE AND URBAN PLANNING			English	Article						Oppressiveness; Spaciousness; Built environment; Sky; Buildings; Trees	URBAN; LAND	This article investigates views of buildings, trees, sky, and ground surface in Tokyo and associations with oppressiveness, spaciousness, and other variables. Oppressiveness, a perception that can be experienced when surrounded by high-rise buildings, can cause stress. Earlier research that measured oppressiveness was conducted in an experiment room and this research was conducted in the field with ground surface perception added. For this pilot research, 20 participants assessed 15 urban views on one typical street in Tokyo through a questionnaire. Overall, oppressiveness was perceived less with views of trees (-1.13; p<0.01); sky (-0.43; p<0.01); and ground surface (-0.33; p<0.05). Perceived spaciousness of the environment decreased with dominant views of ground surface (-0.45; p<0.05) but increased with more views of trees (0.43; p<0.01). This study corroborates the findings in the experiment room that views of trees lower perception of oppressiveness and adds the finding that additional ground also lowers perception of oppressiveness. (C) 2014 Elsevier B.V. All rights reserved.	[Asgarzadeh, Morteza; Farvid, Maryam; Lusk, Anne] Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA; [Koga, Takaaki; Hirate, Kotaroh] Univ Tokyo, Grad Sch Engn, Tokyo 1138654, Japan; [Farvid, Maryam] Shahid Beheshti Univ Med Sci, Fac Nutr Sci & Food Technol, Dept Community Nutr, Tehran, Iran	Asgarzadeh, M (reprint author), Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA.	masgarza@hsph.harvard.edu					Torija AJ, 2013, J ACOUST SOC AM, V134, P791, DOI 10.1121/1.4807804; Hofmann M, 2012, URBAN FOR URBAN GREE, V11, P303, DOI 10.1016/j.ufug.2012.04.001; Asgarzadeh M, 2012, LANDSCAPE URBAN PLAN, V107, P1, DOI 10.1016/j.landurbplan.2012.04.001; Hein C, 2010, J URBAN HIST, V36, P447, DOI 10.1177/0096144209347737; Palmer JF, 2001, LANDSCAPE URBAN PLAN, V54, P149, DOI 10.1016/S0169-2046(01)00133-5; Appleton J., 1996, EXPERIENCE LANDSCAPE; Asgarzadeh M., 2009, IEEE INT C SCI TECHN; Asgarzadeh M, 2010, J ASIAN ARCHIT BUILD, V9, P555, DOI 10.3130/jaabe.9.555; Byun K., 2010, J ENV ENG T AIJ, V75, P553; Cain R, 2013, APPL ACOUST, V74, P232, DOI 10.1016/j.apacoust.2011.11.006; Cheng Sheauchi, 2006, Urban Forestry & Urban Greening, V5, P155, DOI 10.1016/j.ufug.2006.07.003; Evans G.W., 1987, HDB ENV PSYCHOL; Hwang T., 2007, T ARCHITECTURAL I JA, V616, P25; Krauss E., 1980, POLITICAL OPPOSITION; Maki K., 2006, J ENV ENG, P79; Oohara M., 1981, T ARCHITECTURAL I JA, V310, P98; Oohara M., 1978, T ARCHITECTURE I JAP, V263, P71; Oohara M., 1977, T ARCHITECUTURE I JA, V261, P105; Sorensen, 2006, CITIES AUTONOMY DECE; Sorensen A., 2010, URBAN STUD, V47, P564; Sorensen A., 2002, MAKING URBAN JAPAN C; Sorensen A, 2011, INT J URBAN REGIONAL, V35, P712, DOI 10.1111/j.1468-2427.2010.00975.x; Stamps A.E., 2002, ENV BEHAV; Waley P., 2006, JAPAN FORUM, V18, P361, DOI 10.1080/09555800600947231	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-2046	1872-6062		LANDSCAPE URBAN PLAN	Landsc. Urban Plan.	NOV	2014	131						36	41		10.1016/j.landurbplan.2014.07.011		6	Ecology; Environmental Studies; Geography; Geography, Physical; Urban Studies	Environmental Sciences & Ecology; Geography; Physical Geography; Urban Studies	AR2BQ	WOS:000343388900004		
J	Kanto-Nishimaki, Y; Saito, H; Watanabe-Aoyagi, M; Toda, R; Iwadate, K				Kanto-Nishimaki, Yuko; Saito, Haruka; Watanabe-Aoyagi, Miwako; Toda, Ritsuko; Iwadate, Kimiharu			Investigation of oxyhemoglobin and carboxyhemoglobin ratios in right and left cardiac blood for diagnosis of fatal hypothermia and death by fire	LEGAL MEDICINE			English	Article						Oxyhemoglobin ratio; Carboxyhemoglobin ratio; Fatal hypothermia; Death by fire	POSTMORTEM OXYMETRY; CARBON-MONOXIDE; METHEMOGLOBIN; THIOCYANATE; STABILITY; ACCURACY; SMOKING	Few large-scale investigations have looked at the oxyhemoglobin ratio (%O-2-Hb) or the carboxyhemoglobin ratio (%CO-Hb) in fatal hypothermia and death by fire as applicable to forensic medicine. We therefore retrospectively examined right and left cardiac blood samples for both %O-2-Hb and %CO-Hb in 690 forensic autopsy cases. We therefore sought to establish reference values for the above forensic diagnoses, to compare %O-2-Hb in fatal hypothermia with or without cardiopulmonary resuscitation (CPR), and to compare the relationship between %CO-Hb and smoking history. All %O-2-Hb and %CO-Hb data were obtained during or immediately after autopsies using a portable CO-oximeter. Death by carbon monoxide (CO) intoxication and death by fire were excluded from the analysis involving smoking history. In fatal hypothermia, %O-2-Hb in the left cardiac blood was significantly higher than that in the right cardiac blood, providing important evidence for fatal hypothermia. Furthermore, %O-2-Hb in the left cardiac blood increases with CPR but that in the right cardiac blood increases in parallel. No correlation was observed between rectal temperature and %O-2-Hb in the right and left cardiac blood, indicating that it is unlikely that postmortem cooling increases %O-2-Hb in cardiac blood. %CO-Hb in smokers was significantly higher than that in non-smokers, although the number of cigarettes smoked did not appear to be significant. When assessing death by fire, we identified that %CO-Hb of >10% was a reliable marker of antemortem CO inhalation, regardless of smoking history. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Kanto-Nishimaki, Yuko; Saito, Haruka; Watanabe-Aoyagi, Miwako; Toda, Ritsuko; Iwadate, Kimiharu] Jikei Univ, Dept Forens Med, Sch Med, Tokyo, Japan	Kanto-Nishimaki, Y (reprint author), 3-25-8 Nishi Shinbashi,Minato ku, Tokyo 1058461, Japan.	kanto@jikei.ac.jp					AKANE A, 1985, Research and Practice in Forensic Medicine, V28, P185; RODKEY FL, 1979, CLIN CHEM, V25, P1388; Turk EE, 2010, FORENSIC SCI MED PAT, V6, P106, DOI 10.1007/s12024-010-9142-4; Maeda H, 1996, FORENSIC SCI INT, V81, P201, DOI 10.1016/S0379-0738(96)01952-4; Maeda H, 1997, FORENSIC SCI INT, V87, P201, DOI 10.1016/S0379-0738(97)00050-9; Bailey SR, 1997, J CLIN MONITOR, V13, P191, DOI 10.1023/A:1007308616686; BROWN LJ, 1980, IEEE T BIO-MED ENG, V27, P132, DOI 10.1109/TBME.1980.326613; Fujihara J, 2013, J FORENSIC SCI, V58, P1047, DOI 10.1111/1556-4029.12144; Higuchi T, 1992, Nihon Hoigaku Zasshi, V46, P416; Iwadate K., 2012, NEW ESSENTIALS FOREN, P189; KATSUMATA Y, 1982, J FORENSIC SCI, V27, P928; MARSHALL MD, 1995, CLIN CHEM, V41, P1434; Ministry of Health Labour and Welfare, 2011, VIT STAT JAP, V3, P296; Nakagawa H, 2013, ACTA CRIM JAPON, V79, P16; Neumann T, 2008, BIOMARK MED, V2, P31, DOI 10.2217/17520363.2.1.31; Okada M, 1985, NIHON HOIGAKU ZASSHI, V39, P318; POJER R, 1984, CLIN CHEM, V30, P1377; SALOOJEE Y, 1982, THORAX, V37, P521, DOI 10.1136/thx.37.7.521; Saukko P, 2004, KNIGHTS FORENSIC PAT; Seto Y, 2001, FORENSIC SCI INT, V121, P144, DOI 10.1016/S0379-0738(01)00465-0; Shimizu K, 1998, Nihon Hoigaku Zasshi, V52, P196; Tanaka N, 2010, RES PRACT FORENS MED, V53, P39; Tanaka N, 2011, RES PRACT FORENSIC M, V54, P205	23	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	NOV	2014	16	6					321	325		10.1016/j.legalmed.2014.06.010		5	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	AR6KS	WOS:000343693100001		
J	Nishio, H; Okudaira, N; Matsushita, K; Yoshimoto, T; Sato, T; Suzuki, K				Nishio, Hajime; Okudaira, Noriyuki; Matsushita, Kazufumi; Yoshimoto, Tomohiro; Sato, Takako; Suzuki, Koichi			Hypertrophy of lymphoid organs is a possible phenotypic characteristic of R420W mutation of the cardiac ryanodine receptor gene: A study using a knock-in mouse model	LEGAL MEDICINE			English	Article						Arrhythmia; Autopsy; Sudden death; Status thymicolymphaticus; Thymus	SUDDEN UNEXPLAINED DEATH; POLYMORPHIC VENTRICULAR-ARRHYTHMIAS; CHANNEL MOLECULAR AUTOPSY; STATUS LYMPHATICUS; IDENTIFICATION; FAMILIES; DISEASE; MICE	Cardiac ryanodine receptor gene (RyR2) mutations sometimes result in sudden cardiac death due to fatal arrhythmias. N-terminal R420W mutation of RyR2 is known to show similar phenotypes to arrhythmogenic right ventricular cardiomyopathy and to cause juvenile sudden death. We previously reported two sudden death cases with the same R420W mutation. Interestingly, the cases showed hypertrophy of lymphoid organs such as the thymus and mesenteric lymph nodes. The present study examined whether R420W mutation of RYR2 causes hypertrophy of lymphoid organs by generating a mouse model carrying the mutation. Homozygous (RyR2(R420W/R420W)) mice showed significant increases in thymus and spleen weights but not in kidney, heart, and brain weights compared with wild-type mice. The mice also showed remarkable hypertrophy of mesenteric lymph nodes. Immunohistochemical study revealed that RyR2 protein was prominently expressed in epithelial cells of the thymic medulla in the thymus. These findings show that mice with R420W mutation of RyR2 exhibit hypertrophy of lymphoid organs. Sudden unexplained death cases with the mutation may display such findings at autopsy. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Nishio, Hajime; Okudaira, Noriyuki] Hyogo Coll Med, Dept Legal Med, Nishinomiya, Hyogo 6638501, Japan; [Matsushita, Kazufumi; Yoshimoto, Tomohiro] Hyogo Coll Med, Inst Adv Med Sci, Lab Allergy Dis, Nishinomiya, Hyogo 6638501, Japan; [Sato, Takako; Suzuki, Koichi] Osaka Med Coll, Dept Legal Med, Takatsuki, Osaka 5698686, Japan	Nishio, H (reprint author), Hyogo Coll Med, Dept Legal Med, 1-1 Mukogawa, Nishinomiya, Hyogo 6638501, Japan.	hnishio@hyo-med.ac.jp; noku@hyo-med.ac.jp; mkazu@hyo-med.ac.jp; tomo@hyo-med.ac.jp; leg017@art.osaka-med.ac.jp; koichisz@art.osaka-med.ac.jp			JSPS KAKENHI [22590643, 24890282]; Cardiovascular Research Fund, Tokyo, Japan; Hyogo College of Medicine	Assessment of histological results was carried out by Biopathology Institute Co., Ltd (Kunisaki, Japan). This research was supported by JSPS KAKENHI Grant Nos. 22590643, 24890282 and Grants-in-Aid of Cardiovascular Research Fund, Tokyo, Japan (to N.O.). This work was also supported by a Grant-in-Aid for Researchers, Hyogo College of Medicine, 2012 (to N.O.). The funders had no role in the study design, data collection or analysis, decision to publish, or in the preparation of the manuscript.	Ackerman MJ, 2009, PACE, V32, pS86, DOI 10.1111/j.1540-8159.2009.02393.x; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; Tester DJ, 2012, MAYO CLIN PROC, V87, P524, DOI 10.1016/j.mayocp.2012.02.017; Skinner JR, 2011, HEART RHYTHM, V8, P412, DOI 10.1016/j.hrthm.2010.11.016; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Gui JG, 2012, AGING DIS, V3, P280; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; Priori SG, 2001, CIRCULATION, V103, P196; WANG SD, 1994, J IMMUNOL, V152, P5014; Kimlicka L, 2013, STRUCTURE, V21, P1440, DOI 10.1016/j.str.2013.06.012; Van Petegem F, 2012, J BIOL CHEM, V287, P31624, DOI 10.1074/jbc.R112.349068; Azaouagh A, 2011, CLIN RES CARDIOL, V100, P383, DOI 10.1007/s00392-011-0295-2; Bauce B, 2002, J AM COLL CARDIOL, V40, P341, DOI 10.1016/S0735-1097(02)01946-0; d'Amati G, 2005, HUM PATHOL, V36, P761, DOI 10.1016/j.humpath.2005.04.019; Herren T, 2009, CLIN RES CARDIOL, V98, P141, DOI 10.1007/s00392-009-0751-4; Komazaki S, 1998, CELL TISSUE RES, V294, P467, DOI 10.1007/s004410051198; Larsen MK, 2013, INT J LEGAL MED, V127, P139, DOI 10.1007/s00414-011-0658-2; Nishio H, 2006, CIRC J, V70, P1402, DOI 10.1253/circj.70.1402; Nishio Hajime, 2008, Legal Medicine, V10, P196, DOI 10.1016/j.legalmed.2007.12.003; Paltauf A., 1889, WIEN KLIN WOCHENSCHR, V2, P877; Steffen J M, 1984, Physiologist, V27, pS39; Symmers D, 1918, AM J MED SCI, V156, P40, DOI 10.1097/00000441-191807000-00006; VANDIJK H, 1978, IMMUNOLOGY, V35, P637; Willson D., 1950, CURR RES ANESTH ANAL, V29, P356; Young M, 1931, J PATHOL BACTERIOL, V34, P213, DOI 10.1002/path.1700340211	26	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	NOV	2014	16	6					326	332		10.1016/j.legalmed.2014.06.008		7	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	AR6KS	WOS:000343693100002		
J	Ishikawa, T; Inamori-Kawamoto, O; Quan, L; Michiue, T; Chen, JH; Wang, Q; Zhu, BL; Maeda, H				Ishikawa, Takaki; Inamori-Kawamoto, Osamu; Quan, Li; Michiue, Tomomi; Chen, Jian-Hua; Wang, Qi; Zhu, Bao-li; Maeda, Hitoshi			Postmortem urinary catecholamine levels with regard to the cause of death	LEGAL MEDICINE			English	Article						Forensic pathophysiology; Postmortem biochemistry; Urine; Catecholamine; Physical stress	PERFORMANCE LIQUID-CHROMATOGRAPHY; C-REACTIVE PROTEIN; MEDICOLEGAL AUTOPSY; FATAL HYPOTHERMIA; PLASMA PHARMACOKINETICS; CEREBROSPINAL-FLUID; PERICARDIAL FLUID; EPIDURAL OPIOIDS; METHAMPHETAMINE; MARKERS	Previous studies suggested that serum catecholamines are useful for investigating stress responses in the death process. The present study analyzed postmortem urinary adrenaline (Ad), noradrenaline (Nad) and dopamine (DA) in serial forensic autopsy cases (n = 199: 154 males and 45 females: age >9 years; survival time <0.5-168 h; within 10 days postmortem) to investigate the differences among the causes of death with special regard to hyperthermia (heatstroke; n = 11) and hypothermia (cold exposure; n = 10); other cases included fatalities from injury (n = 47), mechanical asphyxiation (n = 18), drowning (n = 14), intoxication (n = 31), fire fatality (n = 33) and natural death (n = 35). Each catecholamine level in urine was independent of the age or gender of the subjects, postmortem interval over 10 days or survival time, and did not correlate with the blood level. Urinary Adr and Nad levels were similar to those of clinical serum reference ranges, while DA was higher in all cases. Adr and Nad were higher in blunt head injury, methamphetamine abuse, hypothermia (cold exposure) and hyperthermia (heat stroke), but were low in mechanical asphyxia, drowning, fire fatality, sedative-hypnotic intoxication and acute cardiac death. DA was higher in injury, drowning, fire fatality, methamphetamine abuse and acute cardiac death, but was lower in mechanical asphyxiation and sedative-hypnotic intoxication. These profiles were quite different from those of serum levels, involving a predominant increase of DA, and may be useful for differentiating hyperthermia (heatstroke) and hypothermia (cold exposure) from drowning, sedative-hypnotic intoxication and sudden cardiac death. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Ishikawa, Takaki; Inamori-Kawamoto, Osamu; Quan, Li; Michiue, Tomomi; Chen, Jian-Hua; Wang, Qi; Zhu, Bao-li; Maeda, Hitoshi] Osaka City Univ, Dept Legal Med, Sch Med, Abeno Ku, Osaka 5458585, Japan; [Ishikawa, Takaki; Inamori-Kawamoto, Osamu; Michiue, Tomomi; Chen, Jian-Hua; Wang, Qi; Maeda, Hitoshi] Osaka City Univ, Medicolegal Consultat & Postmortem Invest Support, Dept Legal Med, Forens Autopsy Sect,Med Sch,Abeno Ku, Osaka 5458585, Japan; [Quan, Li] Sun Yat Sen Univ, Dept Forens Pathol, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China; [Zhu, Bao-li] China Med Univ, Dept Forens Pathol, Sch Forens Med, Shenyang 110001, Liaoning Provin, Peoples R China; [Ishikawa, Takaki] Tottori Univ, Div Legal Med, Fac Med, Yonago, Tottori 6838503, Japan	Ishikawa, T (reprint author), Tottori Univ, Div Legal Med, Fac Med, 86 Nishi Cho, Yonago, Tottori 6838503, Japan.	takaki@med.tottori-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [19890189]	The authors are deeply grateful to coworkers at their institute. This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (Grant No. 19890189).	Andersen JP, 2006, J INSECT PHYSIOL, V52, P1163, DOI 10.1016/j.jinsphys.2006.08.004; Madea B, 2007, FORENSIC SCI INT, V165, P165, DOI 10.1016/j.forsciint.2006.05.023; BOULOUX P, 1985, ANN CLIN BIOCHEM, V22, P194; Wong DL, 2008, ANN NY ACAD SCI, V1148, P249, DOI 10.1196/annals.1410.048; Ishikawa T, 2008, FORENSIC SCI INT, V179, P147, DOI 10.1016/j.forsciint.2008.04.023; Zhu Bao-Li, 2007, Legal Medicine, V9, P241, DOI 10.1016/j.legalmed.2007.01.010; Drummer OH, 2004, FORENSIC SCI INT, V142, P101, DOI 10.1016/j.forsciint.2004.02.013; Ishikawa T, 2013, FORENSIC SCI INT, V228, P52, DOI 10.1016/j.forsciint.2013.02.008; HJEMDAHL P, 1984, AM J PHYSIOL, V247, pE13; MELL LD, 1978, CLIN CHEM, V24, P23; Marik PE, 2002, INTENS CARE MED, V28, P877, DOI 10.1007/s00134-002-1346-y; Vexler A, 2008, STAT MED, V27, P280, DOI 10.1002/sim.3035; Maeda H, 1996, FORENSIC SCI INT, V81, P201, DOI 10.1016/S0379-0738(96)01952-4; Zhu BL, 2007, FORENSIC SCI INT, V173, P122, DOI 10.1016/j.forsciint.2007.02.013; Maeda H, 1997, FORENSIC SCI INT, V87, P201, DOI 10.1016/S0379-0738(97)00050-9; Oritani S, 2000, FORENSIC SCI INT, V113, P375, DOI 10.1016/S0379-0738(00)00227-9; Palmiere C, 2013, FORENSIC SCI INT, V226, P54, DOI 10.1016/j.forsciint.2012.12.007; Bernards CM, 2003, ANESTHESIOLOGY, V99, P466, DOI 10.1097/00000542-200308000-00030; BERG S, 1973, Z RECHTSMED, V72, P56, DOI 10.1007/BF02076849; Bernards CM, 2003, ANESTHESIOLOGY, V99, P455, DOI 10.1097/00000542-200308000-00029; DiGregorio Robert V, 2009, J Emerg Nurs, V35, P165, DOI 10.1016/j.jen.2008.07.019; Hickman PE, 2009, PATHOLOGY, V41, P173, DOI 10.1080/00313020802579284; Hirvonen J, 1996, INT J LEGAL MED, V109, P143, DOI 10.1007/BF01369675; Ishikawa T, 2008, FORENSIC SCI INT, V179, P135, DOI 10.1016/j.forsciint.2008.04.021; Ishikawa T, 2007, FORENSIC SCI INT, V171, P136, DOI 10.1016/j.forsciint.2006.10.016; Kernbach-Wighton G, 2007, ROM J LEG MED, V15, P32; Li Dong-Ri, 2006, Legal Medicine, V8, P78, DOI 10.1016/j.legalmed.2005.09.002; Maeda H, 2008, FORENSIC SCI MED PAT, V4, P175, DOI 10.1007/s12024-008-9029-9; Michiue T, 2008, FORENSIC SCI INT, V178, P185, DOI 10.1016/j.forsciint.2008.03.019; Myburgh John A, 2007, Crit Care Resusc, V9, P352; Nakashima K, 2003, BIOMED CHROMATOGR, V17, P471, DOI 10.1002/bmc.278; Pakanen L, 2011, J FORENSIC SCI, V56, P1213, DOI 10.1111/j.1556-4029.2011.01805.x; Quan Li, 2005, Legal Medicine, V7, P157, DOI 10.1016/j.legalmed.2004.11.004; Quan L, 2008, INT J LEGAL MED, V122, P481, DOI 10.1007/s00414-008-0276-9; Sadler DW, 1995, FORENSIC SCI INT, V76, P227, DOI 10.1016/0379-0738(95)01814-X; Saito T, 2000, FORENSIC SCI INT, V112, P65, DOI 10.1016/S0379-0738(00)00165-1; STEWART RV, 1984, AM J CLIN PATHOL, V82, P411; Wingo JE, 2009, J APPL PHYSIOL, V106, P571, DOI 10.1152/japplphysiol.91249.2008; Yui K, 2000, J CLIN PSYCHOPHARM, V20, P165, DOI 10.1097/00004714-200004000-00008; Zhao Dong, 2006, Legal Medicine, V8, P132, DOI 10.1016/j.legalmed.2005.09.001; Zhu Bao-Li, 2006, Legal Medicine, V8, P86, DOI 10.1016/j.legalmed.2005.10.004; Zhu Bao-Li, 2008, Legal Medicine, V10, P11, DOI 10.1016/j.legalmed.2007.06.002	42	2	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	NOV	2014	16	6					344	349		10.1016/j.legalmed.2014.07.006		6	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	AR6KS	WOS:000343693100005		
J	Iino, M; Nakajima, Y; Ueno, M; Mikami, K; Fujita, MQ				Iino, Morio; Nakajima, Yasuhiro; Ueno, Mari; Mikami, Kazue; Fujita, Masaki Q.			A case of an infant suffered from a fatal scald injury - Validity and limitations of postmortem CT imaging	LEGAL MEDICINE			English	Article						Postmortem computed tomography; Autopsy imaging; Scald burn; Infant; Child abuse; Accident prevention	COMPUTED-TOMOGRAPHY; FORENSIC MEDICINE; CHILD-ABUSE; DEATH; AUTOPSY; DOCUMENTATION; SURFACE; TOKYO	A 9 months-old infant has died of scald burn by the hot water from the fallen electric pot at home. Postmortem computed tomography (CT) scanning prior to autopsy contributed to exclude the possibilities of old and new bone fractures or hidden massive hemorrhages. This procedure helped the pathologists to avoid dissecting all the extremities, which is time-consuming, laborious and often hurtful to the innocent parents of the deceased. On the other hand it did not successfully show the distribution of the scald burn injury on the skin, which reminded us of the importance of external examination even when the whole-body CT is performed. The manner of death was considered to be accident since the cause of death was burn shock and there was no significant evidence suggesting child abuse. Scene investigation and reproductive experiment have revealed that there was a structural problem in the lid of the pot, which comes off very easily in a certain condition. In order to prevent a similar accident, report of the case to the manufacturer is essential for the improvement of the apparatus. This case, however, has been remained to be unreported because of the confidentiality of the investigative information in judicial autopsy. Finally, we recommend a partial revision of the reporting system in Japan to prevent the recurrence of such tragic accidents. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Iino, Morio; Nakajima, Yasuhiro; Ueno, Mari; Mikami, Kazue; Fujita, Masaki Q.] Keio Univ, Dept Legal Med Forens Med, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan	Iino, M (reprint author), Keio Univ, Dept Legal Med Forens Med, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	iino@z5.keio.jp; ynakajma@z3.keio.jp; m.ueno@z2.keio.jp; k.mikami@a5.keio.jp; mqfujita@z8.keio.jp			JSPS KAKENHI [22689024]	This work was supported by Grant of JSPS KAKENHI No. 22689024.	Iwase H, 2010, J FORENSIC SCI, V55, P1509, DOI 10.1111/j.1556-4029.2010.01465.x; [Anonymous], 2012, STAT INF DEP; Proisy M, 2013, EUR RADIOL, V23, P1711, DOI 10.1007/s00330-012-2738-1; Thali MJ, 2003, J FORENSIC SCI, V48, P1356; Wilcken B, 2010, J INHERIT METAB DIS, V33, P501, DOI 10.1007/s10545-009-9001-1; Hong TS, 2011, PEDIATR RADIOL, V41, P736, DOI 10.1007/s00247-010-1953-7; Byard Roger W., 2014, FORENSIC SCI MED PAT, V10, P155; Byard RW, 2000, PEDIATR DEVEL PATHOL, V3, P405, DOI 10.1007/s100240010089; Cordner S M, 2001, Leg Med (Tokyo), V3, P95, DOI 10.1016/S1344-6223(01)00016-5; COREY TS, 1992, AM J DIS CHILD, V146, P968; Ebert LC, 2014, FORENSIC SCI MED PAT, V10, P179, DOI 10.1007/s12024-013-9520-9; FUKUNAGA T, 1992, FORENSIC SCI INT, V53, P69, DOI 10.1016/0379-0738(92)90134-I; Kemp AM, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1518; Lonergan GJ, 2003, RADIOGRAPHICS, V23, P811, DOI 10.1148/rg.234035030; Nakayma Nakagawa SM, 2006, J JAP SIDS RES SOC, V6, P73; Onwuachi-Saunders C, 1999, Inj Prev, V5, P276; Rimsza ME, 2002, PEDIATRICS, V110, P110; Saukko P, 2004, KNIGHTS FORENSIC PAT, P461; Scholing M, 2009, EUR RADIOL, V19, P2333, DOI 10.1007/s00330-009-1440-4; Suzuki H, 2014, J EPIDEMIOL, V24, P178, DOI 10.2188/jea.JE20130060; Suzuki H, 2011, LEGAL MED-TOKYO, V13, P273, DOI 10.1016/j.legalmed.2011.09.001; The Advisory Panel to the Ministry of Health Law and Welfare, 2013, 9 ADV PAN MIN HLTH L; Weber Martin A, 2009, Forensic Sci Int, V189, P75, DOI 10.1016/j.forsciint.2009.04.015; Zaloga WF, 2006, J FORENSIC SCI, V51, P396, DOI 10.1111/j.1556-4029.2006.00066.x	24	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	NOV	2014	16	6					367	372		10.1016/j.legalmed.2014.07.001		6	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	AR6KS	WOS:000343693100009		
J	Suzuki, H; Shigeta, A; Fukunaga, T				Suzuki, Hideto; Shigeta, Akio; Fukunaga, Tatsushige			Death resulting from a mesenteric hemorrhage due to acute myeloid leukemia: An autopsy case	LEGAL MEDICINE			English	Article						Mesenteric hemorrhage; Acute leukemia; Leukostasis; Forensic autopsy	ACUTE PROMYELOCYTIC LEUKEMIA; SUDDEN-DEATH; HEMOPERITONEUM	Acute leukemia causes hemorrhage in various sites throughout the body, such as the brain parenchyma, resulting in serious complications. Here, we present an autopsy case where the patient succumbed to a ruptured mesenteric hematoma caused by acute leukemia. A 58-year-old man, without a significant past medical history, was found dead at his workplace. An external examination showed subcutaneous hemorrhage on the left upper extremity. Macroscopic autopsy findings revealed a massive hemoperitoneum (1000 mL) and extensive hematoma in the mesentery. Histopathological findings showed monotonous cell proliferation not only in the mesentery, but in many organs, such as the liver, spleen, and kidney; aggregates of the infiltrating cells were also observed in the microvessels of various organs. Immunohistochemical staining indicated that the infiltrating cells showed variable myeloperoxidase positivity, and the cells were strongly positive for CD68 (PG-M1). From the autopsy findings and the immunohistochemical staining, we concluded that the underlying cause of death was acute myeloid leukemia (M5). This case was not only a rare presentation of acute leukemia, but provides a lesson to forensic pathologists regarding noting underlying hematological disease, particularly when a case of massive hemorrhage of unknown etiology is encountered. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Suzuki, Hideto; Shigeta, Akio; Fukunaga, Tatsushige] Tokyo Metropolitan Govt, Tokyo Med Examiners Off, Tokyo 1120012, Japan	Suzuki, H (reprint author), Tokyo Metropolitan Govt, Tokyo Med Examiners Off, Bunkyo Ku, 4-21-18 Otsuka, Tokyo 1120012, Japan.	hideto-@qk9.so-net.ne.jp					BENNETT JM, 1985, ANN INTERN MED, V103, P620; Porcu P, 2000, LEUKEMIA LYMPHOMA, V39, P1, DOI 10.3109/10428190009053534; Basmaci Mehmet, 2012, Indian J Crit Care Med, V16, P222, DOI 10.4103/0972-5229.106508; CEPICKY P, 1991, ACTA CLIN BELG, V46, P28; Comanescu A, 2008, ROM J MORPHOL EMBRYO, V49, P259; Gucalp R, 2008, HARRISONS PRINCIPLES, P2272; Habek Dubravko, 2004, Archives of Gynecology and Obstetrics, V270, P122, DOI 10.1007/s00404-002-0453-x; Jinnai K, 2011, NEUROPATHOLOGY, V21, P241; Li SX, 2012, AM J FOREN MED PATH, V33, P102, DOI 10.1097/PAF.0b013e3181f474b0; Manaloor EJ, 2000, AM J CLIN PATHOL, V113, P814; Nishimoto F, 2008, GYNECOL OBSTET INVES, V66, P12, DOI 10.1159/000114249; Parker SG, 2012, BMJ CASE REP; Saint-Martin P, 2012, J FORENSIC SCI, V57, P829, DOI 10.1111/j.1556-4029.2012.02053.x; SAKA H, 1992, INTERNAL MED, V31, P457, DOI 10.2169/internalmedicine.31.457; Sakai K, 2007, INT J LEGAL MED, V121, P311, DOI 10.1007/s00414-006-0106-x; Stoecker MM, 2012, AM J FOREN MED PATH, V33, P314, DOI 10.1097/PAF.0b013e31823d7d27	16	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	NOV	2014	16	6					373	375		10.1016/j.legalmed.2014.07.003		3	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	AR6KS	WOS:000343693100010		
J	Thu, TV; Sandhu, A				Tran Viet Thu; Sandhu, Adarsh			Chemical synthesis of Fe3O4-graphene oxide nanohybrids as building blocks for magnetic and conductive membranes	MATERIALS SCIENCE AND ENGINEERING B-ADVANCED FUNCTIONAL SOLID-STATE MATERIALS			English	Article						Graphene oxide; Fe3O4 nanocrystals; Hybrids; Magnetic; Membrane	IN-SITU SYNTHESIS; GRAPHENE OXIDE; FUNCTIONALIZED GRAPHENE; METAL NANOPARTICLES; GRAPHITE OXIDE; COMPOSITE; SHEETS; NANOCOMPOSITES; PERFORMANCE; ABSORPTION	We have developed a facile and scalable method for synthesising superparamagnetic Fe3O4 nanocrystals (NCs) anchored on graphene oxide (GO) sheets by a co-precipitation reaction. As-synthesized Fe3O4-GO nanohybrids (NHs) were characterized using X-ray diffraction, X-ray photoelectron spectroscopy, Raman spectroscopy, atomic force microscopy, field-emission scanning electron microscopy, transmission electron microscopy, and vibrating sample magnetometer. Fe3O4 NCs with a narrow size distribution (4.5 +/- 0.6 nm) were uniformly decorated over GO surface at high density. The GO sheets act as two-dimensional substrates and surfactants for the growth and adhesion of Fe3O4 NCs. Structural changes induced in the GO due to Fe3O4 decoration were clearly observed using Raman spectroscopy. The magnetic properties of Fe3O4-GO NHs could be tuned by varying Fe3O4 content and a saturation magnetization as high as 39.2 emu g(-1) was achieved. Fe3O4-GO NHs in their colloidal suspension were used as building blocks to fabricate magnetic and electrically conductive membranes by a vacuum-assisted assembly process. (C) 2014 Elsevier B.V. All rights reserved.	[Tran Viet Thu; Sandhu, Adarsh] Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst, Tempa Ku, Toyohashi, Aichi 4418580, Japan; [Sandhu, Adarsh] Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Tempa Ku, Toyohashi, Aichi 4418580, Japan	Thu, TV (reprint author), Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst, Tempa Ku, 1-1 Hibarigaoka, Toyohashi, Aichi 4418580, Japan.	tranvietthu@gmail.com	Sandhu, Adarsh/A-1818-2011		Electronics-Inspired Interdisciplinary Research Institute (EIIRIS) at Toyohashi University of Technology, Japan	This work was partly funded by a start-up grant from the Electronics-Inspired Interdisciplinary Research Institute (EIIRIS) at Toyohashi University of Technology, Japan. We thank Ito Kokuen Co., Ltd. for providing graphite flakes. Prof. Atsunori Matsuda, Dr. Ryugo Tero, Dr. Pil Ju Ko, Mr. Hirokazu Muramoto, and Mr. Abderrahmane Abdelkader of Toyohashi University of Technology, Japan for their support in experimental facilities and characterizations of materials. Dr. D. Ortega of IMDEA Nanoscience, Spain is thanked for the fruitful discussion.	Tung VC, 2009, NAT NANOTECHNOL, V4, P25, DOI [10.1038/nnano.2008.329, 10.1038/NNANO.2008.329]; Zhou GM, 2010, CHEM MATER, V22, P5306, DOI 10.1021/cm101532x; Liang JJ, 2010, J PHYS CHEM C, V114, P17465, DOI 10.1021/jp105629r; Chandra V, 2010, ACS NANO, V4, P3979, DOI 10.1021/nn1008897; He HK, 2010, ACS APPL MATER INTER, V2, P3201, DOI 10.1021/am100673g; McAllister MJ, 2007, CHEM MATER, V19, P4396, DOI 10.1021/cm0630800; Huang X, 2012, CHEM SOC REV, V41, P666, DOI 10.1039/c1cs15078b; Shen JF, 2010, J PHYS CHEM C, V114, P1498, DOI 10.1021/jp909756r; Wang TS, 2013, J APPL PHYS, V113, DOI 10.1063/1.4774243; Shen B, 2013, ACS APPL MATER INTER, V5, P11383, DOI 10.1021/am4036527; Fujii T, 1999, PHYS REV B, V59, P3195, DOI 10.1103/PhysRevB.59.3195; He FA, 2010, CARBON, V48, P3139, DOI 10.1016/j.carbon.2010.04.052; Kovtyukhova NI, 1999, CHEM MATER, V11, P771, DOI 10.1021/cm981085u; Su J, 2011, J PHYS CHEM C, V115, P14469, DOI 10.1021/jp201666s; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Cong HP, 2010, SMALL, V6, P169, DOI 10.1002/smll.200901360; Teymourian H, 2013, BIOSENS BIOELECTRON, V49, P1, DOI 10.1016/j.bios.2013.04.034; Grosvenor AP, 2004, SURF INTERFACE ANAL, V36, P1564, DOI 10.1002/sia.1984; Zhou XZ, 2009, J PHYS CHEM C, V113, P10842, DOI 10.1021/jp903821n; Singh AP, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/46/465701; Kassaee MZ, 2011, CHEM ENG J, V172, P540, DOI 10.1016/j.cej.2011.05.093; Yang XY, 2009, J MATER CHEM, V19, P2710, DOI 10.1039/b821416f; Kamat PV, 2010, J PHYS CHEM LETT, V1, P520, DOI 10.1021/jz900265j; Xie GQ, 2012, J MATER CHEM, V22, P1033, DOI 10.1039/c1jm13433g; Liu PB, 2013, ACS APPL MATER INTER, V5, P12355, DOI 10.1021/am404561c; Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g; Liang JJ, 2011, ADV FUNCT MATER, V21, P3778, DOI 10.1002/adfm.201101072; Ma XX, 2012, NANO RES, V5, P199, DOI 10.1007/s12274-012-0200-y; Liu MC, 2011, J PHYS CHEM C, V115, P25234, DOI 10.1021/jp208575m; Narayanan TN, 2012, CARBON, V50, P1338, DOI 10.1016/j.carbon.2011.11.005; Hu CG, 2013, PHYS CHEM CHEM PHYS, V15, P13038, DOI 10.1039/c3cp51253c; Cornell R.M., 2003, IRON OXIDES STRUCTUR, P121; Dikin D.A., 2007, NATURE, V442, P282; Ishikawa R, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.06GC02; Kudin KN, 2008, NANO LETT, V8, P36, DOI 10.1021/nl071822y; Moon IK, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1067; Sharifi T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3319; Thu TV, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1975-9; Thu TV, 2014, AIP CONF PROC, V1585, P136, DOI 10.1063/1.4866631	39	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-5107	1873-4944		MATER SCI ENG B-ADV	Mater. Sci. Eng. B-Adv. Funct. Solid-State Mater.	NOV	2014	189						13	20		10.1016/j.mseb.2014.07.004		8	Materials Science, Multidisciplinary; Physics, Condensed Matter	Materials Science; Physics	AR5RS	WOS:000343641800003		
J	Akazawa, H; Shinojima, H				Akazawa, Housei; Shinojima, Hiroyuki			Relation between process parameters of ZnO host films and optical activation of doped Er3+ ions	MATERIALS SCIENCE AND ENGINEERING B-ADVANCED FUNCTIONAL SOLID-STATE MATERIALS			English	Article						ZnO:Er; Photoluminescence; Concentration quenching; 1.54 mu m; Sputtering	M EMISSION DYNAMICS; SOL-GEL METHOD; THIN-FILMS; UP-CONVERSION; IMPLANTED ZNO; LUMINESCENCE; TEMPERATURE; DEPOSITION	We investigated how the crystallinity of ZnO host films deposited on Si(1 0 0) substrates by electron cyclotron resonance (ECR) plasma sputtering affects the optical activity of Er3+ ions doped in them under resonant excitation with 532-nm laser light. Photoluminescence from ZnO:Er films deposited at room temperature (RT) exhibited a main emission peak at 1538 nm with a sub-peak at 1553 nm. The emission intensity reached a steady state at Er content between 0.6 and 3 at.%, and attenuated above 3 at.%. This concentration quenching correlates with derivation of X-ray diffraction angles from the Vegard's law. Deposition at RT produced non-equilibrium state of ZnO:Er films possibly stabilized with vacancies to maintain charge neutrality. After post annealing of ZnO:Er films with Er content less than 1 at.%, the emission intensities were markedly reduced as the crystalline lattice was rearranged. For films in the concentration quenching range, however, post annealing increased the emission peak width while maintaining emission intensity, indicating that Er3+ ions migrated and populated various emission-active sites. In this case, the main peak wavelength blue shifted to 1536 nm and produced a new sub peak at 1546 nm. When the deposition temperature exceeded 500 degrees C, emissions from Er3+ ions were greatly enhanced. This will result from improvement in crystallinity and fixing Er3+ ions at six-fold coordinated C-4v symmetry sites. (C) 2014 Elsevier B.V. All rights reserved.	[Akazawa, Housei] NTT Microsyst Integrat Labs, Atsugi, Kanagawa 2430198, Japan; [Shinojima, Hiroyuki] Kurume Natl Coll Technol, Kurume, Fukuoka 8308555, Japan	Akazawa, H (reprint author), NTT Microsyst Integrat Labs, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan.	akazawa.housei@lab.ntt.co.jp	Akazawa, Housei/N-1441-2015				Akazawa H, 2013, J APPL PHYS, V114, DOI 10.1063/1.4825121; Wang X, 2007, J PHYS CHEM C, V111, P15119, DOI 10.1021/jp0686689; Jang YR, 2011, APPL SURF SCI, V257, P2822, DOI 10.1016/j.apsusc.2010.10.069; Ishii M, 2001, J APPL PHYS, V89, P3679, DOI 10.1063/1.1355284; Douglas L, 2008, OPT LETT, V33, P815, DOI 10.1364/OL.33.000815; Polman A, 1997, J APPL PHYS, V82, P1, DOI 10.1063/1.366265; Wang J, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2399340; Terai Y, 2009, J VAC SCI TECHNOL B, V27, P2248, DOI 10.1116/1.3204981; Mais N, 1999, APPL PHYS LETT, V75, P2005, DOI 10.1063/1.124897; Komuro S, 2000, J APPL PHYS, V88, P7129, DOI 10.1063/1.1326470; Alves E, 2003, NUCL INSTRUM METH B, V206, P1047, DOI 10.1016/S0168-583X(03)00931-5; Pecora EF, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4766947; Steckl AJ, 1998, APPL PHYS LETT, V73, P1700, DOI 10.1063/1.122250; Zhou Z, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2035867; Pradhan AK, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2560764; Iwan S, 2012, PHYSICA B, V407, P2721, DOI 10.1016/j.physb.2012.03.072; DESURVIRE E, 1990, OPT LETT, V15, P547, DOI 10.1364/OL.15.000547; FLEUSTER M, 1994, J APPL PHYS, V75, P173, DOI 10.1063/1.355879; Fukudome T, 2003, NUCL INSTRUM METH B, V206, P287, DOI 10.1016/S0168-583X(03)00746-8; Ishikawa Y, 2005, J MATER RES, V20, P2578, DOI 10.1557/JMR.2005.0323; Kik PG, 2003, J APPL PHYS, V93, P5008, DOI 10.1063/1.1565697; KOJIMA K, 1995, APPL PHYS LETT, V67, P3423, DOI 10.1063/1.115267; Komuro S, 2000, APPL PHYS LETT, V76, P3935, DOI 10.1063/1.126826; Miao L, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.061101; Pan Z, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/26/266216; Perez-Casero R, 2005, J APPL PHYS, V97, DOI 10.1063/1.1858058; Ran F, 2008, MATER SCI ENG B-ADV, V148, P35, DOI 10.1016/j.mseb.2007.09.029; Yang Y., 2013, APPL PHYS LETT, V102, P18111; Zhang XT, 2002, THIN SOLID FILMS, V413, P257, DOI 10.1016/S0040-6090(02)00356-5; Zhao X, 2000, J LUMIN, V87-9, P1254, DOI 10.1016/S0022-2313(99)00545-1; Zhou Z, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1856692	31	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-5107	1873-4944		MATER SCI ENG B-ADV	Mater. Sci. Eng. B-Adv. Funct. Solid-State Mater.	NOV	2014	189						38	44		10.1016/j.mseb.2014.07.007		7	Materials Science, Multidisciplinary; Physics, Condensed Matter	Materials Science; Physics	AR5RS	WOS:000343641800007		
J	Kim, M; Tanaka, K				Kim, Maengkyu; Tanaka, Kiyoji			Non-High-Density Lipoprotein Cholesterol Changes in Middle-Aged Obese Men With and Without Metabolic Syndrome During Weight Loss	METABOLIC SYNDROME AND RELATED DISORDERS			English	Article							NON-HDL CHOLESTEROL; HOMEOSTASIS MODEL ASSESSMENT; MAXIMAL OXYGEN-UPTAKE; APOLIPOPROTEIN-A-I; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ENERGY-EXPENDITURE; RISK	Non-high-density lipoprotein (non-HDL-C) is the best predictor of coronary artery disease and stroke. Studies have shown that weight loss decreases non-HDL-C levels. However, whether diet-induced weight loss in individuals with and without metabolic syndrome causes a reduction in non-HDL-C levels remains unclear. We investigated the effects of weight loss on non-HDL-C levels in 34 middle-aged obese men with and without metabolic syndrome classified using National Cholesterol Education Panel Adult Treatment Panel III criteria (metabolic syndrome, n=17; non-metabolic syndrome, n=17). We conducted a 12-week dietary intervention using a low-carbohydrate, -fat, and -protein diet to reduce body weight. A significant decrease in body weight and body mass index in both groups was observed. However, the non-HDL-C level after weight loss was significantly decreased in the metabolic syndrome group (151.9 +/- 6.8 to 131.4 +/- 6.2 mg/dL, P<0.01) but not in the non-metabolic syndrome group (152.1 +/- 8.2 to 141.2 +/- 8.1 mg/dL, P>0.05). Levels of apolipoprotein AII and B, but not AI, were similarly decreased in both groups (P>0.05). Pearson correlation analysis showed that the change in non-HDL-C levels in the metabolic syndrome group was strongly associated with levels of total cholesterol, fasting insulin, and alanine and aspartate transaminase, as well as homeostatic model assessment index, diastolic blood pressure, and maximal oxygen uptake (P<0.05). These results demonstrated that diet-induced weight loss without physical activity decreases non-HDL-C levels, an important factor associated with changes in cardiorespiratory fitness and insulin sensitivity, in obese individuals with metabolic syndrome.	[Kim, Maengkyu] Kyungpook Natl Univ, Dept Phys Educ, Sports Med Lab, Taegu 702701, South Korea; [Tanaka, Kiyoji] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 305, Japan	Kim, M (reprint author), Kyungpook Natl Univ, Dept Phys Educ, Sports Med Lab, 80 Daehak Ro, Taegu 702701, South Korea.	kimmk@knu.ac.kr					Walldius G, 2004, J INTERN MED, V255, P188, DOI 10.1046/j.1365-2796.2003.01276.x; Sniderman AD, 2011, CIRC-CARDIOVASC QUAL, V4, P337, DOI 10.1161/CIRCOUTCOMES.110.959247; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Sattar N, 2004, CIRCULATION, V110, P2687, DOI 10.1161/01.CIR.0000145660.60487.94; Kumahara H, 2004, BRIT J NUTR, V91, P235, DOI 10.1079/BJN20031033; Blaha MJ, 2008, J CLIN LIPIDOL, V2, P267, DOI 10.1016/j.jacl.2008.06.013; Contois JH, 2011, J CLIN LIPIDOL, V5, P264, DOI 10.1016/j.jacl.2011.05.004; Sothern MS, 2000, J INVEST MED, V48, P411; Marrugat J, 1996, AM J EPIDEMIOL, V143, P562; Laukkanen JA, 2001, ARCH INTERN MED, V161, P825, DOI 10.1001/archinte.161.6.825; [Anonymous], 2001, JAMA, V285, P2486; Virani SS, 2012, J CLIN LIPIDOL, V6, P545, DOI 10.1016/j.jacl.2012.04.080; Sniderman AD, 2003, AM J CARDIOL, V91, P1173, DOI 10.1016/S0002-9149(03)00262-5; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Cui YD, 2001, ARCH INTERN MED, V161, P1413, DOI 10.1001/archinte.161.11.1413; Ng TWK, 2007, DIABETES CARE, V30, P2945, DOI 10.2337/dc07-0768; Goodpaster BH, 1999, DIABETES, V48, P839, DOI 10.2337/diabetes.48.4.839; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Kim SW, 2013, INT J CARDIOL, V168, P2678, DOI 10.1016/j.ijcard.2013.03.027; Carr MC, 2004, J LIPID RES, V45, P466, DOI 10.1194/jlr.M300295-JLR200; Carroll S, 2001, SCAND J MED SCI SPOR, V11, P38, DOI 10.1034/j.1600-0838.2001.011001038.x; Chapman MJ, 2004, EUR HEART J SUPPL, V6, pA43, DOI 10.1016/j.ehjsup.2004.01.010; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; Frost PH, 1998, AM J CARDIOL, V26, p26B; LEENEN R, 1993, J LIPID RES, V34, P2183; Lu WQ, 2003, DIABETES CARE, V26, P16, DOI 10.2337/diacare.26.1.16; Rafamantanantsoa HH, 2002, J NUTR SCI VITAMINOL, V48, P517; REAVEN GM, 1993, ANNU REV MED, V44, P121, DOI 10.1146/annurev.med.44.1.121; SCHNABEL A, 1982, EUR J APPL PHYSIOL O, V48, P263, DOI 10.1007/BF00422987; Studies to Treat or Prevent Pediatric Type 2 Diabetes Prevention Study Group, 2008, DIABETES CARE, V31, P2020; Turley ML, 1998, EUR J CLIN NUTR, V52, P728, DOI 10.1038/sj.ejcn.1600634; Virani SS, 2011, TEX HEART I J, V38, P160; Zabeen S, 2012, AKMMC J, V3, P15	34	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1540-4196	1557-8518		METAB SYNDR RELAT D	Metab. Syndr. Relat. Disord.	NOV 1	2014	12	9					464	471		10.1089/met.2014.0032		8	Medicine, Research & Experimental	Research & Experimental Medicine	AR5XN	WOS:000343654700004		
J	Imamura, S; Morioka, T; Yamazaki, Y; Numaguchi, R; Urata, H; Motoyama, K; Mori, K; Fukumoto, S; Shoji, T; Emoto, M; Inaba, M				Imamura, Satoshi; Morioka, Tomoaki; Yamazaki, Yuko; Numaguchi, Ryutaro; Urata, Hiromi; Motoyama, Koka; Mori, Katsuhito; Fukumoto, Shinya; Shoji, Tetsuo; Emoto, Masanori; Inaba, Masaaki			Plasma polyunsaturated fatty acid profile and delta-5 desaturase activity are altered in patients with type 2 diabetes	METABOLISM-CLINICAL AND EXPERIMENTAL			English	Article						PUFA; Arachidonic acid; Dihomo-gamma-linolenic acid; Delta-5 desaturase	FADS1-FADS2 GENE-CLUSTER; ERYTHROCYTE-MEMBRANES; EICOSAPENTAENOIC ACID; CARDIOVASCULAR EVENTS; INSULIN-RESISTANCE; METABOLIC SYNDROME; ARACHIDONIC-ACID; HEART-DISEASE; SERUM-LIPIDS; N-3	Objective. The association between imbalance of polyunsaturated fatty acids (PUFAs), especially low plasma n-3 to n-6 PUFA ratio, and risk of cardiovascular diseases is well known. A balance of plasma PUFAs is determined not only by dietary fatty acid intake, but also by the endogenous fatty acid metabolism, which could be dysregulated by diabetes. In this study, we investigated the plasma n-3 and n-6 PUFA profile and fatty acid desaturase activity in patients with type 2 diabetes (T2D). Materials/Methods. The subjects were 396 patients with T2D and 122 healthy controls. Plasma eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), arachidonic acid (AA), and dihomo -gamma-linolenic acid (DGLA) levels were measured by capillary gas chromatography. Results. Plasma DHA, AA, and DGLA levels were significantly higher, and EPA levels tended to be lower in patients with T2D than in the controls. Patients with T2D also exhibited significantly lower EPA/AA, DHA/AA, and (EPA + DHA)/AA ratios, and a higher AA/DGLA ratio than the controls. Multiple regression analyses, including age, sex, body mass index, and metabolic parameters in the total population, revealed that the presence of T2D was independently associated with elevated plasma DHA, AA, and DGLA levels and decreased EPA/AA, DHA/AA, and (EPA + DHA)/AA ratios. Furthermore, T2D was independently and positively related to the AA/DGLA ratio, which serves as an estimate of delta (Delta)-5 desaturase activity. Conclusions. Elevated plasma AA levels and decreased n-3 PUFA/AA ratios in T2D are attributable, at least partly, to Delta 5 desaturase activation. (C) 2014 Elsevier Inc. All rights reserved.	[Imamura, Satoshi; Morioka, Tomoaki; Yamazaki, Yuko; Numaguchi, Ryutaro; Urata, Hiromi; Motoyama, Koka; Mori, Katsuhito; Fukumoto, Shinya; Emoto, Masanori; Inaba, Masaaki] Osaka City Univ Grad Sch Med, Dept Metab Endocrinol & Mol Med, Abeno Ku, Osaka 5458585, Japan; [Shoji, Tetsuo] Osaka City Univ Grad Sch Med, Dept Geriatr & Vasc Med, Abeno Ku, Osaka 5458585, Japan	Morioka, T (reprint author), Osaka City Univ Grad Sch Med, Dept Metab Endocrinol & Mol Med, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	m-tomo@med.osaka-cu.ac.jp			Japan Society for the Promotion of Science [20591068]	This study was supported by a Grant-in-Aid for Scientific Research (No. 20591068) from the Japan Society for the Promotion of Science (to M.E. and K.Mor.).	American Diabetes Association, 2013, DIABETES CARE S1, V36, pS11, DOI DOI 10.2337/DC13-S011; Matsuzaki M, 2009, CIRC J, V73, P1283; Shoji T, 2013, AM J KIDNEY DIS, V62, P568, DOI 10.1053/j.ajkd.2013.02.362; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Yanagisawa N, 2010, J ATHEROSCLER THROMB, V17, P285; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Blok WL, 1996, J NUTR, V126, P1515; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Ninomiya T, 2013, ATHEROSCLEROSIS, V231, P261, DOI 10.1016/j.atherosclerosis.2013.09.023; Melanson EL, 2009, ANN NUTR METAB, V55, P229, DOI 10.1159/000229004; Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Mathias RA, 2010, J LIPID RES, V51, P2766, DOI 10.1194/jlr.M008359; Sergeant S, 2012, BRIT J NUTR, V107, P547, DOI 10.1017/S0007114511003230; Rzehak P, 2009, BRIT J NUTR, V101, P20, DOI 10.1017/S0007114508992564; Kurotani K, 2012, NUTR RES, V32, P669, DOI 10.1016/j.nutres.2012.07.004; Huang T, 2010, MOL NUTR FOOD RES, V54, pS112, DOI 10.1002/mnfr.200900189; Zietemann V, 2010, BRIT J NUTR, V104, P1748, DOI 10.1017/S0007114510002916; Domei T, 2012, CIRC J, V76, P423, DOI 10.1253/circj.CJ-11-0941; Yuan JM, 2001, AM J EPIDEMIOL, V154, P809, DOI 10.1093/aje/154.9.809; Pelikanova T, 2001, METABOLISM, V50, P1472, DOI 10.1053/meta.2001.27195; Rissanen T, 2000, CIRCULATION, V102, P2677; Marquardt A, 2000, GENOMICS, V66, P175, DOI 10.1006/geno.2000.6196; Kroger J, 2012, CURR OPIN LIPIDOL, V23, P4, DOI 10.1097/MOL.0b013e32834d2dc5; Mozaffarian D, 2013, ANN INTERN MED, V158, P515, DOI 10.7326/0003-4819-158-7-201304020-00003; Iso H, 2006, CIRCULATION, V113, P195, DOI 10.1161/CIRCULATIONAHA.105.581355; Aslan M, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-169; Bassi A, 1996, J CLIN ENDOCR METAB, V81, P1650, DOI 10.1210/jc.81.4.1650; Brenner RR, 2003, PROSTAG LEUKOTR ESS, V68, P151, DOI 10.1016/S0952-3278(02)00265-X; Decsi T, 2005, ACTA PAEDIATR, V94, P850, DOI 10.1080/08035250510028254; ELBOUSTANI S, 1989, METABOLISM, V38, P315, DOI 10.1016/0026-0495(89)90117-0; FAAS FH, 1988, METABOLISM, V37, P711, DOI 10.1016/0026-0495(88)90002-9; James MJ, 2000, AM J CLIN NUTR, V71, p343S; Jo S, 2013, ANN NUTR METAB, V63, P283, DOI 10.1159/000357018; PELIKANOVA T, 1991, METABOLISM, V40, P175, DOI 10.1016/0026-0495(91)90170-2; SALOMAA V, 1990, METABOLISM, V39, P1285, DOI 10.1016/0026-0495(90)90185-F; Sartore G, 2008, PROSTAG LEUKOTR ESS, V79, P55, DOI 10.1016/j.plefa.2008.07.001; Van Woudenbergh GJ, 2012, NUTR METAB CARDIOVAS, V22, P133, DOI 10.1016/j.numecd.2010.05.008; Vessby B, 2002, ANN NY ACAD SCI, V967, P183; Warensjo E, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-37	42	3	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0026-0495	1532-8600		METABOLISM	Metab.-Clin. Exp.	NOV	2014	63	11					1432	1438		10.1016/j.metabol.2014.08.003		7	Endocrinology & Metabolism	Endocrinology & Metabolism	AR4AV	WOS:000343531300008		
J	Usami, S; Okazaki, M; Tanaka, K; Homma, T; Yano, T				Usami, Satoshi; Okazaki, Mutsumi; Tanaka, Kentaro; Homma, Tsutomu; Yano, Tomoyuki			LENGTHENING THE PEDICLE OF A SCAPULAR OSSEOUS FREE FLAP BY ANGULAR BRANCH RECONNECTION WITHIN THE SUBSCAPULAR ARTERY SYSTEM	MICROSURGERY			English	Article							LATISSIMUS-DORSI MUSCLE; THORACODORSAL ARTERY; NECK RECONSTRUCTION; HEAD; DEFECTS; ANATOMY; CADAVER; GRAFTS	This report describes a case of a patient who underwent secondary reconstruction of the maxilla using a combined scapular osseous and thoracodorsal artery perforator (TAP) flap, in which the pedicle of the scapular osseous flap was lengthened by reconnecting the angular branch of the thoracodorsal artery to the serratus branch. The patient was a 62-year-old man who had undergone left total maxillectomy for maxillary carcinoma and came for reconstruction of left deformity. A reconstructive procedure involving a vascularized scapular osseous and TAP flap transfer was planned. However, the patient's ipsilateral superficial temporary artery and facial artery was found stenosed due to previous radiotherapy and chemotherapy and were not suitable for use as recipient vessels. Thus, a long flap pedicle was needed for anastomoses to the contralateral recipient vessels. We lengthened the pedicle of the scapular osseous flap by reconnecting the angular branch of the thoracodorsal artery to the serratus branch within the chimeric free flap and then anastomosed it to the contralateral facial vessels. The postoperative course was uneventful, and the left cheek deformity was well corrected. Using the technique of reconnection of branches within the blood supply system, a chimeric flap with a long pedicle may be elevated safely whilst avoiding the need for vein grafts. (c) 2014 Wiley Periodicals, Inc. Microsurgery 34:662-665, 2014.	[Usami, Satoshi; Okazaki, Mutsumi; Tanaka, Kentaro; Homma, Tsutomu; Yano, Tomoyuki] Tokyo Med & Dent Univ, Grad Sch Sci, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138519, Japan	Usami, S (reprint author), Tokyo Med & Dent Univ, Grad Sch Sci, Dept Plast & Reconstruct Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	s-usaplas@mail.goo.ne.jp			Ministry of Health, Labor and Welfare of Japan	Grant sponsor: Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare of Japan.	Muzaffar AR, 1999, PLAST RECONSTR SURG, V104, P2172, DOI 10.1097/00006534-199912000-00035; Seitz A, 1999, CELLS TISSUES ORGANS, V164, P227, DOI 10.1159/000016663; Germann G, 1999, PLAST RECONSTR SURG, V103, P1386, DOI 10.1097/00006534-199904050-00007; Seneviratne S, 1999, PLAST RECONSTR SURG, V104, P85, DOI 10.1097/00006534-199907000-00011; Joseph G, 2011, J CRANIOFAC SURG, V22, P2199, DOI 10.1097/SCS.0b013e3182326f83; BARTLETT SP, 1981, PLAST RECONSTR SURG, V67, P631, DOI 10.1097/00006534-198105000-00010; NASSIF TM, 1982, PLAST RECONSTR SURG, V69, P591, DOI 10.1097/00006534-198204000-00001; Valentini V, 2009, J CRANIOFAC SURG, V20, P1125, DOI 10.1097/SCS.0b013e3181abb482; Cordeiro PG, 1998, PLAST RECONSTR SURG, V102, P1874, DOI 10.1097/00006534-199811000-00011; Okazaki M, 2007, PLAST RECONSTR SURG, V119, P1223, DOI 10.1097/01.prs.0000254400.29522.1c; Cavadas PC, 2008, PLAST RECONSTR SURG, V121, P514, DOI 10.1097/01.prs.0000297634.53915.e5; Chen CC, 2012, MICROSURG, V32, P485, DOI 10.1002/micr.22033; Coleman SC, 2000, LARYNGOSCOPE, V110, P1419, DOI 10.1097/00005537-200009000-00001; HARII K, 1982, PLAST RECONSTR SURG, V70, P620, DOI 10.1097/00006534-198211000-00019; Karacalar A, 2005, J RECONSTR MICROSURG, V21, P173, DOI 10.1055/s-2005-869823; L'Heureux-Lebeau B, 2013, J PLAST RECONSTR AES, V66, P900, DOI 10.1016/j.bjps.2013.02.031; Li L, 2007, J ORAL MAXIL SURG, V65, P281, DOI 10.1016/j.joms.2006.08.009; MILLER MJ, 1993, J RECONSTR MICROSURG, V9, P245, DOI 10.1055/s-2007-1006652; NAAS R, 1977, SCAND J PLAST RECONS, V11, P23; NAHAI F, 1986, PLAST RECONSTR SURG, V77, P312; Peng F, 2013, MICROSURGERY; Roan TL, 2013, MICROSURG, V33, P439, DOI 10.1002/micr.22123; ROWSELL AR, 1984, BRIT J PLAST SURG, V37, P574, DOI 10.1016/0007-1226(84)90152-8; SCHMIDT A, 1991, ANN PLAS SURG, V27, P97, DOI 10.1097/00000637-199108000-00001; Shimizu T, 1997, PLAST RECONSTR SURG, V99, P1947, DOI 10.1097/00006534-199706000-00021; Takayanagi S, 1989, J RECONSTR MICROSURG, V5, P176; Wagner AJ, 2008, ARCH OTOLARYNGOL, V134, P1214, DOI 10.1001/archotol.134.11.1214	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0738-1085	1098-2752		MICROSURG	Microsurgery	NOV	2014	34	8					662	665		10.1002/micr.22246		4	Surgery	Surgery	AR7LR	WOS:000343761700013		
J	Hirajima, T; Mori, M; Ichikawa, O; Sasaki, K; Miki, H; Farahat, M; Sawada, M				Hirajima, Tsuyoshi; Mori, Masanori; Ichikawa, Osamu; Sasaki, Keiko; Miki, Hajime; Farahat, Mohsen; Sawada, Mitsuru			Selective flotation of chalcopyrite and molybdenite with plasma pre-treatment	MINERALS ENGINEERING			English	Article						Selective flotation; Plasma; Oxidation; Chalcopyrite; Molybdenite; AFM	RAY PHOTOELECTRON-SPECTROSCOPY; MOS2; XPS; RECOVERY; OXIDE; IRON	For pretreatment of selective flotation, plasma treatment of chalcopyrite and molybdenite was applied then the minerals were washed by solution at pH 9 with oxygen bubbling. Surface characteristics of these minerals were investigated with AFM, XPS, zeta potential and contact angle measurements. Contact angle of chalcopyrite and molybdenite decreased a lot by plasma treatment. When they were washed with pH 9 solution with oxygen bubbling, contact angle of molybdenite increased whereas chalcopyrite one kept low. Adhesion force measurements indicated similar behavior. Result of flotation experiments indicated low recovery of both chalcopyrite and molybdenite after plasma treatment and only molybdenite recovery became higher after washing. Selective flotation of chalcopyrite and molybdenite could be achieved with this process. However, flotation of mixture of chalcopyrite and molybdenite after these treatments indicated both chalcopyrite and molybdenite were depressed. Addition of emulsified kerosene changed the flotation results where molybdenite was floated and chalcopyrite was depressed. Possible mechanism of selective flotation was proposed from the results of XPS, AFM, etc. (C) 2014 Elsevier Ltd. All rights reserved.	[Hirajima, Tsuyoshi; Mori, Masanori; Ichikawa, Osamu; Sasaki, Keiko; Miki, Hajime; Farahat, Mohsen] Kyushu Univ, Fac Engn, Fukuoka 812, Japan; [Sawada, Mitsuru] Sumitomo Met Min Co Ltd, Niihama, Japan	Hirajima, T (reprint author), Kyushu Univ, Fac Engn, 6-10-1 Hakozaki, Fukuoka 812, Japan.	hirajima@mine.kyushu-u.ac.jp			Sumitomo Metal Mining, Co., Ltd.; Japan Society for the Promotion of Science (JSPS) [24246149]	We appreciate support of this research by Sumitomo Metal Mining, Co., Ltd., and by a Grant-in-Aid for Science Research (No. 24246149) from Japan Society for the Promotion of Science (JSPS).	Yu HL, 2014, J MATER CHEM A, V2, P4551, DOI 10.1039/c3ta14744d; BRION D, 1980, APPL SURF SC, V5, P133, DOI 10.1016/0378-5963(80)90148-8; BUCKLEY AN, 1984, AUST J CHEM, V37, P2403; TAN BJ, 1990, CHEM MATER, V2, P186, DOI 10.1021/cm00008a021; Sasaki K, 2010, HYDROMETALLURGY, V100, P144, DOI 10.1016/j.hydromet.2009.11.007; Cao ZF, 2009, HYDROMETALLURGY, V99, P2, DOI 10.1016/j.hydromet.2009.05.001; Iranmahboob J, 2004, J COLLOID INTERF SCI, V270, P123, DOI 10.1016/j.jcis.2003.11.013; Ansari A, 2007, MINER ENG, V20, P609, DOI 10.1016/j.mineng.2006.12.008; PARKS GA, 1965, CHEM REV, V65, P177, DOI 10.1021/cr60234a002; Klauber C, 2001, INT J MINER PROCESS, V62, P65, DOI 10.1016/S0301-7516(00)00045-4; Song SX, 2012, SEP PURIF TECHNOL, V98, P451, DOI 10.1016/j.seppur.2012.06.016; Baker MA, 1999, APPL SURF SCI, V150, P255, DOI 10.1016/S0169-4332(99)00253-6; SHUXIAN Z, 1986, J CATAL, V100, P167, DOI 10.1016/0021-9517(86)90082-5; Zanin M, 2009, INT J MINER PROCESS, V93, P256, DOI 10.1016/j.minpro.2009.10.001; Arbiter N., 1951, US Patent, Patent No. 2559104; Briggs D., 1990, AUGER XRAY PHOTOELEC, V1; Bulatovic SM, 2010, HANDBOOK OF FLOTATION REAGENTS: CHEMISTRY, THEORY AND PRACTICE: FLOTATION OF GOLD, PGM AND OXIDE MINERALS, VOL 2, P1; Curtis C.H., 1941, US Patent, Patent No. 2238250; Fuerstenau D.W., 1957, ENG MIN J, V158, P93; GAJARDO P, 1979, J PHYS CHEM-US, V83, P1771, DOI 10.1021/j100476a017; Ghahremaninezhad A, 2013, ELECTROCHIM ACTA, V87, P97, DOI 10.1016/j.electacta.2012.07.119; HACKL RP, 1995, HYDROMETALLURGY, V39, P25, DOI 10.1016/0304-386X(95)00023-A; Liu GY, 2012, MINER ENG, V36-38, P37, DOI 10.1016/j.mineng.2012.02.008; May F, 2012, MINER ENG, V35, P67, DOI 10.1016/j.mineng.2012.05.005; Odaka T., 1993, JP Patent, Patent No. [H5-195106, 5195106]; SHIRLEY DA, 1972, PHYS REV B, V5, P4709, DOI 10.1103/PhysRevB.5.4709; SIRIWARDANE RV, 1985, J COLLOID INTERF SCI, V104, P250, DOI 10.1016/0021-9797(85)90029-3; Triffett B, 2008, MINER ENG, V21, P832, DOI 10.1016/j.mineng.2008.03.003; Wada M., 1962, FUSEN, V17, P9	29	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0892-6875			MINER ENG	Miner. Eng.	NOV	2014	66-68				SI		102	111		10.1016/j.mineng.2014.07.011		10	Engineering, Chemical; Mineralogy; Mining & Mineral Processing	Engineering; Mineralogy; Mining & Mineral Processing	AR1MY	WOS:000343350500014		
J	Mikheyev, AS; Tin, MMY				Mikheyev, Alexander S.; Tin, Mandy M. Y.			A first look at the Oxford Nanopore MinION sequencer	MOLECULAR ECOLOGY RESOURCES			English	Editorial Material						bioinformatics; genomics; nanopore sequencing; next-generation sequencing	BASIC LOCAL ALIGNMENT; HUMAN GENOME; PACIFIC BIOSCIENCES; DNA; PLATFORMS; DISCOVERY; FRAMEWORK	Oxford Nanopore's third-generation single-molecule sequencing platform promises to decrease costs for reagents and instrumentation. After a 2-year hiatus following the initial announcement, the first devices have been released as part of an early access program. We explore the performance of this platform by resequencing the lambda phage genome, and amplicons from a snake venom gland transcriptome. Although the handheld MinION sequencer can generate more than 150 megabases of raw data in one run, at most a quarter of the resulting reads map to the reference, with less than average 10% identity. Much of the sequence consists of insertion/deletion errors, or is seemingly without similarity to the template. Using the lambda phage data as an example, although the reads are long, averaging 5kb, at best 890 +/- 1932 bases per mapped read could be matched to the reference without soft clipping. In the course of a 36h run on the MinION, it was possible to resequence the 48kb lambda phage reference at 16x coverage. Currently, substantially larger projects would not be feasible using the MinION. Without increases in accuracy, which would be required for applications such as genome scaffolding and phasing, the current utility of the MinION appears limited. Library preparation requires access to a molecular laboratory, and is of similar complexity and cost to that of other next-generation sequencing platforms. The MinION is an exciting step in a new direction for single-molecule sequencing, though it will require dramatic decreases in error rates before it lives up to its promise.	[Mikheyev, Alexander S.; Tin, Mandy M. Y.] Okinawa Inst Sci & Technol Grad Univ, Ecol & Evolut Unit, Onna Son, Okinawa 9040495, Japan	Mikheyev, AS (reprint author), Okinawa Inst Sci & Technol Grad Univ, Ecol & Evolut Unit, 1919-1 Tancha, Onna Son, Okinawa 9040495, Japan.	sasha@homologo.us	Mikheyev, Alexander/O-7670-2014	Mikheyev, Alexander/0000-0003-4369-1019			Aird SD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-790; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Desai AN, 2012, CLIN GENET, V81, P503, DOI 10.1111/j.1399-0004.2012.01865.x; Korlach J, 2010, METHOD ENZYMOL, V472, P431, DOI 10.1016/S0076-6879(10)72001-2; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Narum SR, 2013, MOL ECOL, V22, P2841, DOI 10.1111/mec.12350; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; SANGER F, 1982, J MOL BIOL, V162, P729, DOI 10.1016/0022-2836(82)90546-0; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Stoddart D, 2009, P NATL ACAD SCI USA, V106, P7702, DOI 10.1073/pnas.0901054106; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Timp W, 2012, BIOPHYS J, V102, pL37, DOI 10.1016/j.bpj.2012.04.009; Andrew RL, 2013, MOL ECOL, V22, P2605, DOI 10.1111/mec.12319; Carneiro MO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-375; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543; Wetterstrand KA, 2014, DNA SEQUENCING COSTS	26	27	28	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-098X	1755-0998		MOL ECOL RESOUR	Mol. Ecol. Resour.	NOV	2014	14	6					1097	1102		10.1111/1755-0998.12324		6	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	AR8DJ	WOS:000343805400001		
J	Nishijo, M; Pham, TT; Nguyen, ATN; Tran, NN; Nakagawa, H; Hoang, LV; Tran, AH; Morikawa, Y; Ho, MD; Kido, T; Nguyen, MN; Nguyen, HM; Nishijo, H				Nishijo, M.; Pham, T. T.; Nguyen, A. T. N.; Tran, N. N.; Nakagawa, H.; Hoang, L. V.; Tran, A. H.; Morikawa, Y.; Ho, M. D.; Kido, T.; Nguyen, M. N.; Nguyen, H. M.; Nishijo, H.			2,3,7,8-Tetrachlorodibenzo-p-dioxin in breast milk increases autistic traits of 3-year-old children in Vietnam	MOLECULAR PSYCHIATRY			English	Article							MATERNAL EXPOSURE; DIOXIN EXPOSURE; POLYCHLORINATED-BIPHENYLS; HEAD CIRCUMFERENCE; DEVELOPING BRAIN; PREVALENCE; SPECTRUM; DISORDERS; DIAGNOSIS; INFANTS	Dioxin levels in the breast milk of mothers residing near a contaminated former airbase in Vietnam remain much higher than in unsprayed areas, suggesting high perinatal dioxin exposure for their infants. The present study investigated the association of perinatal dioxin exposure with autistic traits in 153 3-year-old children living in a contaminated area in Vietnam. The children were followed up from birth using the neurodevelopmental battery Bayley-III. The high-2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposed groups (>= 3.5 pg per g fat) showed significantly higher Autism Spectrum Rating Scale (ASRS) scores for both boys and girls than the mild-TCDD exposed groups, without differences in neurodevelopmental scores. In contrast, the high total dioxin-exposed group, indicated by polychlorinated dibenzo-p-dioxins/furans (PCDDs/Fs)-the toxic equivalents (TEQ) levels >= 17.9 pg-TEQ per g fat, had significantly lower neurodevelopmental scores than the mild-exposed group in boys, but there was no difference in the ASRS scores. The present study demonstrates a specific impact of perinatal TCDD on autistic traits in childhood, which is different from the neurotoxicity of total dioxins (PCDDs/Fs).	[Nishijo, M.; Nguyen, A. T. N.; Tran, N. N.; Nakagawa, H.] Kanazawa Med Univ, Dept Publ Hlth, Uchinada, Ishikawa 9200293, Japan; [Pham, T. T.; Hoang, L. V.; Tran, A. H.; Nguyen, M. N.; Nguyen, H. M.] Vietnam Mil Med Univ, Biomed & Pharmaceut Res Ctr, Hanoi, Vietnam; [Morikawa, Y.] Kanazawa Med Univ, Sch Nursing, Uchinada, Ishikawa 9200293, Japan; [Ho, M. D.; Kido, T.] Kanazawa Univ, Fac Hlth Sci, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9201192, Japan; [Nguyen, M. N.; Nguyen, H. M.; Nishijo, H.] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Syst Emot Sci, Toyama 930, Japan	Nishijo, M (reprint author), Kanazawa Med Univ, Dept Publ Hlth, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	ni-koei@kanazawa-med.ac.jp			JSPS (Japan Society for the Promotion of Science) Asian Core Program and the Japan Society for the Promotion of Science [25305024, 25290005]	We thank the medical staffs in the Health Department of Da Nang city, Thanh Khe and Son Tra district hospitals and 17 commune health centers of Thanh Khe and Son Tra districts for their enthusiastic collaborations. This work was supported by the JSPS (Japan Society for the Promotion of Science) Asian Core Program and the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research (B) (25305024) and (25290005)). None of the founders had role in the study design, sample collection, analysis, interpretation of data, writing the report or decision to submit the manuscript for publication.	Mocarelli P, 2011, ENVIRON HEALTH PERSP, V119, P713, DOI 10.1289/ehp.1002134; Gillberg C, 2002, DEV MED CHILD NEUROL, V44, P296; Grandgeorge M, 2013, ACTA PAEDIATR, V102, P901, DOI 10.1111/apa.12264; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Teitelbaum P, 1998, P NATL ACAD SCI USA, V95, P13982, DOI 10.1073/pnas.95.23.13982; Croen LA, 2002, J AUTISM DEV DISORD, V32, P207, DOI 10.1023/A:1015453830880; Nishijo M, 2007, TOXICOL LETT, V173, P41, DOI 10.1016/j.toxlet.2007.06.007; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Teitelbaum O, 2004, P NATL ACAD SCI USA, V101, P11909, DOI 10.1073/pnas.0403919101; SCHANTZ SL, 1989, NEUROTOXICOL TERATOL, V11, P13, DOI 10.1016/0892-0362(89)90080-9; Hays LE, 2002, ENVIRON HEALTH PERSP, V110, P369; RODIER PM, 1995, ENVIRON HEALTH PERSP, V103, P73, DOI 10.2307/3432351; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Landrigan PJ, 2010, CURR OPIN PEDIATR, V22, P219, DOI 10.1097/MOP.0b013e328336eb9a; Nguyen MN, 2013, TOXICOLOGY, V314, P125, DOI 10.1016/j.tox.2013.09.005; Nakajima S, 2006, ENVIRON HEALTH PERSP, V114, P773, DOI 10.1289/ehp.8614; Mocarelli P, 2000, LANCET, V355, P1858, DOI 10.1016/S0140-6736(00)02290-X; Weiss B, 2000, ENVIRON HEALTH PERSP, V108, P375, DOI 10.2307/3454523; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; KoopmanEsseboom C, 1996, PEDIATRICS, V97, P700; Patandin S, 1999, ENVIRON HEALTH PERSP, V107, P45, DOI 10.2307/3434288; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; Seo BW, 1999, NEUROTOXICOL TERATOL, V21, P231, DOI 10.1016/S0892-0362(98)00049-X; Tsukimori K, 2012, ENVIRON INT, V38, P79, DOI 10.1016/j.envint.2011.08.010; Baccarelli A, 2008, PLOS MED, V5, P1133, DOI 10.1371/journal.pmed.0050161; Baht A.N., 2012, INFANT BEHAV DEV, V35, P838; Bayley N., 2006, EVIDENCE VALIDITY BA, P69; Dwernychuk LW, 2005, CHEMOSPHERE, V60, P998, DOI 10.1016/j.chemosphere.2005.01.052; Hatfield Consultants Office of National Committee 33, 33 HATF CONS OFF NAT; Ilsen A, 1996, CHEMOSPHERE, V33, P1317, DOI 10.1016/0045-6535(96)00269-X; KOPPE JG, 1991, SCI TOTAL ENVIRON, V106, P33, DOI 10.1016/0048-9697(91)90018-A; Marz KD, 2007, J CHILD NEUROL, V22, P700; Minh N. H., 2009, INTERDISCIPLINARY ST, P21; Nguyen Anh T N, 2013, Environ Health Insights, V7, P1, DOI 10.4137/EHI.S10346; Nguyen P.T., 2011, PLOS ONE, V6, DOI DOI 10.1371/JOURNAL.PONE.0018004; Tai PT, 2013, OCCUP ENVIRON MED, V70, P656, DOI 10.1136/oemed-2012-101021; Nishijo M, 2012, ORGANOHALOGEN COMPOU, V74, P1332; Nishijo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040273; Pollack MH, 2008, PROG NEURO-PSYCHOPH, V32, P739, DOI 10.1016/j.pnpbp.2007.11.023; Schellart NAM, 2008, CLIN NEUROPHYSIOL, V119, P1486, DOI 10.1016/j.clinph.2008.03.002; Tai PT, 2011, ENVIRON SCI TECHNOL, V45, P6625, DOI 10.1021/es201666d; Tawara K, 2003, J KANAZAWA MED U, V28, P17, DOI DOI 10.1210/JC.80.3.942; Weiss J, 2003, ACTA PAEDIATR, V92, P467	43	7	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1359-4184	1476-5578		MOL PSYCHIATR	Mol. Psychiatr.	NOV	2014	19	11					1220	1226		10.1038/mp.2014.18		7	Biochemistry & Molecular Biology; Neurosciences; Psychiatry	Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry	AR5ZT	WOS:000343662300011		
J	Ueda, H; Hara, T; Gouda, N; Yano, T				Ueda, H.; Hara, T.; Gouda, N.; Yano, T.			Torus-fitting method for obtaining action variables in two-dimensional Galactic potentials	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						galaxies: kinematics and dynamics	CONSTRUCTION; ORBITS	A phase-space distribution function of the steady state in galaxy models that admits regular orbits overall in the phase space can be represented by a function of three action variables. This type of distribution function in Galactic models is often constructed theoretically for comparison of the Galactic models with observational data as a test of the models. On the other hand, observations give Cartesian phase-space coordinates of stars. Therefore, it is necessary to relate action variables and Cartesian coordinates in investigating whether the distribution function constructed in galaxy models can explain observational data. Generating functions are very useful in practice for this purpose, because calculations of relations between action variables and Cartesian coordinates by generating functions do not require a lot of computational time or computer memory in comparison with direct numerical integration calculations of stellar orbits. Here, we propose a new method called a torus-fitting method, by which a generating function is derived numerically for models of the Galactic potential in which almost all orbits are regular. We confirmed that the torus-fitting method can be applied to major orbit families (box and loop orbits) in some two-dimensional potentials. Furthermore, the torus-fitting method is still applicable to resonant orbit families, besides major orbit families. Hence, the torus-fitting method is useful for analysing real Galactic systems in which a lot of resonant orbit families might exist.	[Ueda, H.] Akita Univ, Fac Educ & Human Studies, Akita 0108502, Japan; [Hara, T.; Gouda, N.; Yano, T.] Natl Astron Observ, Mitaka, Tokyo 1818588, Japan	Ueda, H (reprint author), Akita Univ, Fac Educ & Human Studies, Akita 0108502, Japan.	ueda@ipc.akita-u.ac.jp			JSPS KAKENHI Grant [23244034]	This was supported by the JSPS KAKENHI Grant Number 23244034 (Grant-in Aid for Scientific Research (A)).	KAASALAINEN M, 1994, MON NOT R ASTRON SOC, V268, P1041; MIYAMOTO M, 1975, PUBL ASTRON SOC JPN, V27, P533; BINNEY J, 1993, MON NOT R ASTRON SOC, V261, P584; KAASALAINEN M, 1994, MON NOT R ASTRON SOC, V268, P1033; Sanders JL, 2014, MON NOT R ASTRON SOC, V441, P3284, DOI 10.1093/mnras/stu796; Arnold V I, 1989, MATH METHODS CLASSIC; Binney J., 2002, EAS PUB SER, P245, DOI doi:10.1051/eas:2002023.; MCGILL C, 1990, MON NOT R ASTRON SOC, V244, P634; Binney J., 1987, GALACTIC DYNAMICS; Goldstein H., 2002, CLASSICAL MECHANICS; KAASALAINEN M, 1995, MON NOT R ASTRON SOC, V275, P162	11	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	NOV 1	2014	444	3					2218	2227		10.1093/mnras/stu1490		10	Astronomy & Astrophysics	Astronomy & Astrophysics	AR2FS	WOS:000343399600021		
J	Takeuchi, Y; Zaroubi, S; Sugiyama, N				Takeuchi, Yoshitaka; Zaroubi, Saleem; Sugiyama, Naoshi			Probing large-scale filaments with H I and He-3 II	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						intergalactic medium; large-scale structure of Universe; radio lines: general	GALAXY REDSHIFT SURVEY; SPIN-EXCHANGE RATES; SIMILAR-TO 0.8; 21 CM; COSMIC WEB; INTERGALACTIC MEDIUM; HYDROGEN COLLISIONS; 21-CM LINE; SKY SURVEY; REIONIZATION	We explore the observability of the neutral hydrogen (H I) and the singly ionized isotope helium-3 (He-3 II) in the intergalactic medium (IGM) from the Epoch of Reionization down to the local Universe. The hyperfine transition of He-3 II, which is not as well known as the H I transition, has energy splitting corresponding to 8 cm. It also has a larger spontaneous decay rate than that of neutral hydrogen, whereas its primordial abundance is much smaller. Although both species are mostly ionized in the IGM, the balance between ionization and recombination in moderately high-density regions renders them abundant enough to be observed. We estimate the emission signal of both hyperfine transitions from large-scale filamentary structures and discuss the prospects for observing them with current and future radio telescopes. We conclude that H I in filaments is possibly observable even with current telescopes after 100 h of observation. On the other hand, He-3 II is only detectable with future telescopes, such as Square Kilometre Array, after the same amount of time.	[Takeuchi, Yoshitaka; Sugiyama, Naoshi] Nagoya Univ, Dept Phys, Nagoya, Aichi 4648602, Japan; [Zaroubi, Saleem] Univ Groningen, Kapteyn Astron Inst, NL-9700 AV Groningen, Netherlands; [Sugiyama, Naoshi] Nagoya Univ, Kobayashi Maskawa Inst, Nagoya, Aichi 4648602, Japan; [Sugiyama, Naoshi] Univ Tokyo, Kavli Inst Phys & Math Universe, Kashiwa, Chiba 2778568, Japan	Takeuchi, Y (reprint author), Nagoya Univ, Dept Phys, Nagoya, Aichi 4648602, Japan.	yoshitaka@nagoya-u.jp			Japan Society for Promotion of Science (JSPS) fellowship; JSPS [25287057]; Kobayashi-Maskawa Institute for the Origin of Particles and the Universe; World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan; Netherlands Organization for Scientific Research (NWO) VICI grant; JSPS Strategic Young Researcher Overseas Visits Programme for Accelerating Brain Circulation	We would like to thank A. G. de Bruyn for useful discussions and Elizabeth Fernandez for comments on the manuscript. We acknowledge support from Japan Society for Promotion of Science (JSPS) fellowship (YT); JSPS Grant-in-Aid for Scientific Research under grants no. 25287057 (NS); Kobayashi-Maskawa Institute for the Origin of Particles and the Universe; and the World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan. SZ acknowledges the Netherlands Organization for Scientific Research (NWO) VICI grant for financial support. This work was supported by the JSPS Strategic Young Researcher Overseas Visits Programme for Accelerating Brain Circulation.	Pritchard JR, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/8/086901; Cen RY, 1999, ASTROPHYS J, V514, P1, DOI 10.1086/306949; Tempel E, 2014, MON NOT R ASTRON SOC, V438, P3465, DOI 10.1093/mnras/stt2454; Madau P, 1997, ASTROPHYS J, V475, P429, DOI 10.1086/303549; Furlanetto SR, 2006, PHYS REP, V433, P181, DOI 10.1016/j.physrep.2006.08.002; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Choi E, 2010, MON NOT R ASTRON SOC, V406, P320, DOI 10.1111/j.1365-2966.2010.16707.x; Chang TC, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.091303; KAISER N, 1987, MON NOT R ASTRON SOC, V227, P1; Hirata CM, 2006, MON NOT R ASTRON SOC, V367, P259, DOI 10.1111/j.1365-2966.2005.09949.x; Popping A, 2009, ASTRON ASTROPHYS, V504, P15, DOI 10.1051/0004-6361/200911811; Chapman E, 2013, MON NOT R ASTRON SOC, V429, P165, DOI 10.1093/mnras/sts333; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; Switzer ER, 2013, MON NOT R ASTRON SOC, V434, pL46, DOI 10.1093/mnrasl/slt074; Bernardi G, 2009, ASTRON ASTROPHYS, V500, P965, DOI 10.1051/0004-6361/200911627; Bond JR, 1996, NATURE, V380, P603, DOI 10.1038/380603a0; Shaver PA, 1999, ASTRON ASTROPHYS, V345, P380; Sigurdson K, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.091301; Jelic V, 2010, MON NOT R ASTRON SOC, V409, P1647, DOI 10.1111/j.1365-2966.2010.17407.x; Verner DA, 1996, ASTROPHYS J SUPPL S, V103, P467, DOI 10.1086/192284; NUSSBAUMER H, 1983, ASTRON ASTROPHYS, V126, P75; Jelic V, 2008, MON NOT R ASTRON SOC, V389, P1319, DOI 10.1111/j.1365-2966.2008.13634.x; McQuinn M, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.063010; Furlanetto SR, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.103502; Harker G, 2009, MON NOT R ASTRON SOC, V397, P1138, DOI 10.1111/j.1365-2966.2009.15081.x; Fukugita M, 2004, ASTROPHYS J, V616, P643, DOI 10.1086/425155; Obreschkow D, 2009, ASTROPHYS J, V703, P1890, DOI 10.1088/0004-637X/703/2/1890; Colless M, 2001, MON NOT R ASTRON SOC, V328, P1039, DOI 10.1046/j.1365-8711.2001.04902.x; EWEN HI, 1951, NATURE, V168, P356, DOI 10.1038/168356a0; Bagla J. S., 2009, MNRAS; Bell MB, 2000, ASTROPHYS J, V531, P820, DOI 10.1086/308522; Bernardi G, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/200913420; BLACK JH, 1981, MON NOT R ASTRON SOC, V197, P553; CEN R, 1992, ASTROPHYS J SUPPL S, V78, P341, DOI 10.1086/191630; Chang T.-C., 2010, NATURE; Chapman E, 2012, MON NOT R ASTRON SOC, V423, P2518, DOI 10.1111/j.1365-2966.2012.21065.x; Erdogdu P, 2004, MON NOT R ASTRON SOC, V352, P939, DOI 10.1111/j.1365-2966.2004.07984.x; FIELD GB, 1958, P IRE, V46, P240, DOI 10.1109/JRPROC.1958.286741; FIELD GB, 1959, ASTROPHYS J, V129, P536, DOI 10.1086/146653; Freudling W, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/1/40; FUKUGITA M, 1994, MON NOT R ASTRON SOC, V269, P563; Furlanetto SR, 2007, MON NOT R ASTRON SOC, V374, P547, DOI 10.1111/j.1365-2966.2006.11169.x; Furlanetto SR, 2007, MON NOT R ASTRON SOC, V379, P130, DOI 10.1111/j.1365-2966.2007.11921.x; Furlanetto SR, 2006, MON NOT R ASTRON SOC, V372, P1093, DOI 10.1111/j.1365-2966.2006.10899.x; GOLDWIRE HC, 1967, ASTROPHYS J, V149, P15, DOI 10.1086/149225; GOULD RJ, 1994, ASTROPHYS J, V423, P522, DOI 10.1086/173830; Haardt F, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/125; Komatsu E, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/2/18; Masui KW, 2013, ASTROPHYS J LETT, V763, DOI 10.1088/2041-8205/763/1/L20; MATSUDA T, 1971, PROG THEOR PHYS, V46, P416, DOI 10.1143/PTP.46.416; Menzel DH, 1935, MON NOT R ASTRON SOC, V96, P0077; Mo H., 2010, GALAXY FORMATION EVO; MULLER CA, 1951, NATURE, V168, P357, DOI 10.1038/168357a0; Nan RD, 2011, INT J MOD PHYS D, V20, P989, DOI 10.1142/S0218271811019335; Osterbrock D. E., 1989, ASTROPHYSICS GASEOUS; Pandey B, 2011, MON NOT R ASTRON SOC, V411, P332, DOI 10.1111/j.1365-2966.2010.17686.x; Popping A, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/201014407; Pritchard JR, 2006, MON NOT R ASTRON SOC, V367, P1057, DOI 10.1111/j.1365-2966.2006.10028.x; ROOD RT, 1979, ASTROPHYS J, V227, pL97, DOI 10.1086/182875; Shchekinov YA, 2007, MON NOT R ASTRON SOC, V379, P1003, DOI 10.1111/j.1365-2966.2007.11715.x; Spitzer L, 1978, PHYS PROCESSES INTER; Springel V, 2005, MON NOT R ASTRON SOC, V364, P1105, DOI 10.1111/j.1365-2966.2005.09655.x; Sunyaev R. A., 1966, ASTRON ZH, V43, P1237; Townes C. H., 1957, P IAU S, V4, P92; van de Hulst H., 1945, NED TIJDSCHR NATUURK, V11, P210; van Haarlem MP, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201220873; WOUTHUYSEN SA, 1952, ASTRON J, V57, P31, DOI 10.1086/106661; Zaroubi S., 2013, ASTROPHYSICS SPACE S, V396, P45; Zygelman B, 2005, ASTROPHYS J, V622, P1356, DOI 10.1086/427682	69	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	NOV 1	2014	444	3					2236	2250		10.1093/mnras/stu1550		15	Astronomy & Astrophysics	Astronomy & Astrophysics	AR2FS	WOS:000343399600023		
J	Murata, K; Pearson, CP; Goto, T; Kim, SJ; Matsuhara, H; Wada, T				Murata, K.; Pearson, C. P.; Goto, T.; Kim, S. J.; Matsuhara, H.; Wada, T.			The 2-24 mu m source counts from the AKARI North Ecliptic Pole survey	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						galaxies: evolution; infrared: galaxies	INFRARED LUMINOSITY FUNCTIONS; ACTIVE GALACTIC NUCLEI; EXTRAGALACTIC SOURCE COUNTS; SPITZER-SPACE-TELESCOPE; AREA ISO SURVEY; MIDINFRARED SOURCE CATALOG; STAR-FORMATION; DEEP SURVEY; GALAXY COUNTS; LEGACY SURVEY	We present herein galaxy number counts of the nine bands in the 2-24 mu m range on the basis of the AKARI North Ecliptic Pole (NEP) surveys. The number counts are derived from NEP-deep and NEP-wide surveys, which cover areas of 0.5 and 5.8 deg(2), respectively. To produce reliable number counts, the sources were extracted from recently updated images. Completeness and difference between observed and intrinsic magnitudes were corrected by Monte Carlo simulation. Stellar counts were subtracted by using the stellar fraction estimated from optical data. The resultant source counts are given down to the 80 per cent completeness limit; 0.18, 0.16, 0.10, 0.05, 0.06, 0.10, 0.15, 0.16 and 0.44 mJy in the 2.4, 3.2, 4.1, 7, 9, 11, 15, 18 and 24 mu m bands, respectively. On the bright side of all bands, the count distribution is flat, consistent with the Euclidean universe, while on the faint side, the counts deviate, suggesting that the galaxy population of the distant universe is evolving. These results are generally consistent with previous galaxy counts in similar wavebands. We also compare our counts with evolutionary models and find them in good agreement. By integrating the models down to the 80 per cent completeness limits, we calculate that the AKARI NEP survey revolves 20-50 per cent of the cosmic infrared background, depending on the wavebands.	[Murata, K.; Matsuhara, H.; Wada, T.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; [Murata, K.; Matsuhara, H.] Grad Univ Adv Studies, Dept Space & Astronaut Sci, Hayama, Kanagawa, Japan; [Pearson, C. P.] Open Univ, Dept Phys, Astrophys Grp, Milton Keynes MK7 6AA, Bucks, England; [Pearson, C. P.] Rutherford Appleton Lab, RAL Space, Didcot OX11 0QX, Oxon, England; [Pearson, C. P.] Univ Oxford, Oxford Astrophys, Oxford OX1 3RH, England; [Goto, T.] Natl Tsing Hua Univ, Inst Astron, Hsinchu 30013, Taiwan; [Goto, T.] Natl Tsing Hua Univ, Dept Phys, Hsinchu 30013, Taiwan; [Kim, S. J.] Seoul Natl Univ, Dept Phys & Astron, Seoul 151742, South Korea	Murata, K (reprint author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2298510, Japan.	murata@ir.isas.jaxa.jp			JSPS [23244040]	The AKARI NEP-Deep survey project activities are supported by JSPS grant 23244040. The authors would like to thank Enago (www.enago.jp) for the English language review.	Altieri B, 1999, ASTRON ASTROPHYS, V343, pL65; Fazio GG, 2004, ASTROPHYS J SUPPL S, V154, P39, DOI 10.1086/422585; Scott KS, 2012, MON NOT R ASTRON SOC, V423, P575, DOI 10.1111/j.1365-2966.2012.20905.x; Kochanek CS, 2001, ASTROPHYS J, V560, P566, DOI 10.1086/322488; Rowan-Robinson M, 2004, MON NOT R ASTRON SOC, V351, P1290, DOI 10.1111/j.1365-2966.2004.07868.x; Papovich C, 2004, ASTROPHYS J SUPPL S, V154, P70, DOI 10.1086/422880; Matsuhara H, 2006, PUBL ASTRON SOC JPN, V58, P673; Lasker BM, 2008, ASTRON J, V136, P735, DOI 10.1088/0004-6256/136/2/735; Efstathiou A, 2000, MON NOT R ASTRON SOC, V313, P734, DOI 10.1046/j.1365-8711.2000.03269.x; Saunders W, 2000, MON NOT R ASTRON SOC, V317, P55, DOI 10.1046/j.1365-8711.2000.03528.x; Rowan-Robinson M, 2005, ASTRON J, V129, P1183, DOI 10.1086/428001; Metcalfe L, 2003, ASTRON ASTROPHYS, V407, P791, DOI 10.1051/0004-6361:20030621; SAUNDERS W, 1990, MON NOT R ASTRON SOC, V242, P318; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Lagache G, 2004, ASTROPHYS J SUPPL S, V154, P112, DOI 10.1086/422392; Bethermin M, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201015841; Bielby R, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201118547; Bruzual A. G., 1993, APJ, V405, P538; Cai ZY, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/21; Chary R, 2004, ASTROPHYS J SUPPL S, V154, P80, DOI 10.1086/423307; Efstathiou A, 2000, MON NOT R ASTRON SOC, V319, P1169, DOI 10.1046/j.1365-8711.2000.03914.x; Efstathiou A, 2003, MON NOT R ASTRON SOC, V343, P322, DOI 10.1046/j.1365-8711.2003.06679.x; Elbaz D, 2005, SPACE SCI REV, V119, P93, DOI 10.1007/s11214-005-8060-3; Elbaz D, 1999, ASTRON ASTROPHYS, V351, pL37; Goto T, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913182; Gruppioni C, 2013, MON NOT R ASTRON SOC, V432, P23, DOI 10.1093/mnras/stt308; Hopwood R, 2010, ASTROPHYS J LETT, V716, pL45, DOI 10.1088/2041-8205/716/1/L45; Hwang N, 2007, ASTROPHYS J SUPPL S, V172, P583, DOI 10.1086/519216; Jarrett TH, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/2/112; Kim SJ, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201219105; King AJ, 2003, MON NOT R ASTRON SOC, V339, P260, DOI 10.1046/j.1365-8711.2003.06240.x; Le Floc'h E, 2005, ASTROPHYS J, V632, P169, DOI 10.1086/432789; Lee HM, 2009, PUBL ASTRON SOC JPN, V61, P375; Matute I, 2006, ASTRON ASTROPHYS, V451, P443, DOI 10.1051/0004-6361:20053710; Mobasher B, 2009, ASTROPHYS J, V690, P1074, DOI 10.1088/0004-637X/690/2/1074; Mobasher B, 2000, ASTRON ASTROPHYS, V363, P517; Murakami H., 2007, PASJ, V59, P369; Murata K, 2013, ASTRON ASTROPHYS, V559, DOI 10.1051/0004-6361/201321505; Onaka T., 2007, PASJ, V59, P401; Patel H, 2013, MON NOT R ASTRON SOC, V428, P291, DOI 10.1093/mnras/sts013; Pearson C, 2005, MON NOT R ASTRON SOC, V358, P1417, DOI 10.1111/j.1365-2966.2005.08861.x; Pearson C, 1996, MON NOT R ASTRON SOC, V283, P174; Pearson C, 2009, MON NOT R ASTRON SOC, V399, pL11, DOI 10.1111/j.1745-3933.2009.00706.x; Pearson C. P., 2014, ARXIV14081617; Pearson CP, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913382; Rowan-Robinson M, 2009, MON NOT R ASTRON SOC, V394, P117, DOI 10.1111/j.1365-2966.2008.14339.x; EFSTATHIOU A, 1995, MON NOT R ASTRON SOC, V273, P649; Sato Y, 2003, ASTRON ASTROPHYS, V405, P833, DOI 10.1051/0004-6361:20030661; Serjeant S, 2000, MON NOT R ASTRON SOC, V316, P768, DOI 10.1046/j.1365-8711.2000.03551.x; SMAIL I, 1995, ASTROPHYS J, V449, pL105, DOI 10.1086/309647; Takagi T, 2012, ASTRON ASTROPHYS, V537, DOI 10.1051/0004-6361/201117759; Tanabe T., 2008, PASJ, V60, P375; Teplitz HI, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/1/1; Vaccari M, 2005, MON NOT R ASTRON SOC, V358, P397, DOI 10.1111/j.1365-2966.2005.08773.x; Wada T., 2008, PASJ, V60, P517	55	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	NOV 1	2014	444	3					2346	2354		10.1093/mnras/stu1617		9	Astronomy & Astrophysics	Astronomy & Astrophysics	AR2FS	WOS:000343399600031		
J	Rusu, CE; Oguri, M; Minowa, Y; Iye, M; More, A; Inada, N; Oya, S				Rusu, Cristian E.; Oguri, Masamune; Minowa, Yosuke; Iye, Masanori; More, Anupreeta; Inada, Naohisa; Oya, Shin			Adaptive optics observations of the gravitationally lensed quasar SDSS J1405+0959	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						gravitational lensing strong; instrumentation adaptive optics; quasars: individual: 14: 05: 15. 42+09: 59: 31.3	DIGITAL SKY SURVEY; EARLY-TYPE GALAXIES; LENSING GALAXIES; EXTINCTION CURVES; SUBARU TELESCOPE; MASS; DUST; EVOLUTION; DISCOVERY; SYSTEM	We present the result of Subaru Telescope multiband adaptive optics observations of the complex gravitationally lensed quasar SDSS J1405+0959, which is produced by two lensing galaxies. These observations reveal dramatically enhanced morphological detail, leading to the discovery of an additional object 0.26 arcsec from the secondary lensing galaxy, as well as three collinear clumps located in between the two lensing galaxies. The new object is likely to be the third quasar image, although the possibility that it is a galaxy cannot be entirely excluded. If confirmed via future observations, it would be the first three-image lensed quasar produced by two galaxy lenses. In either case, we show based on gravitational lensing models and photometric redshift that the collinear clumps represent merging images of a portion of the quasar host galaxy, with a magnification factor of similar to 15-20, depending on the model.	[Rusu, Cristian E.; Iye, Masanori] Natl Inst Nat Sci, Natl Astron Observ Japan, Div Opt & Infrared Astron, Mitaka, Tokyo 1818588, Japan; [Oguri, Masamune] Univ Tokyo, Res Ctr Early Univ, Bunkyo Ku, Tokyo 1130033, Japan; [Oguri, Masamune] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Oguri, Masamune; More, Anupreeta] Univ Tokyo, Kavli IPMU, WPI, Kashiwa, Chiba 2778583, Japan; [Minowa, Yosuke; Oya, Shin] Natl Inst Nat Sci, Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; [Minowa, Yosuke; Iye, Masanori] Natl Astron Observ Japan, Dept Astron Sci, Grad Univ Adv Studies SOKENDAI, Mitaka, Tokyo 1818588, Japan; [Iye, Masanori] Univ Tokyo, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Inada, Naohisa] Nara Natl Coll Technol, Dept Phys, Yamato Koriyama, Nara 6391080, Japan	Rusu, CE (reprint author), Natl Inst Nat Sci, Natl Astron Observ Japan, Div Opt & Infrared Astron, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	eduard.rusu@nao.ac.jp	Oguri, Masamune/C-6230-2011		Japan Society for the Promotion of Science (JSPS) KAKENHI [26800093]; World Premier International Research Center Initiative (WPI Initiative), Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; JSPS Research Fellowship	This work was supported in part by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 26800093 and World Premier International Research Center Initiative (WPI Initiative), Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. CER acknowledges the support of the JSPS Research Fellowship.	Keeton CR, 1998, ASTROPHYS J, V509, P561, DOI 10.1086/306502; Bernstein G, 1999, ASTRON J, V118, P14, DOI 10.1086/300949; Bolzonella M, 2000, ASTRON ASTROPHYS, V363, P476; Oguri M, 2006, ASTRON J, V132, P999, DOI 10.1086/506019; FABER SM, 1976, ASTROPHYS J, V204, P668, DOI 10.1086/154215; MOFFAT AFJ, 1969, ASTRON ASTROPHYS, V3, P455; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Suyu SH, 2009, ASTROPHYS J, V691, P277, DOI 10.1088/0004-637X/691/1/277; Peng CY, 2006, ASTROPHYS J, V649, P616, DOI 10.1086/506266; Lawrence A, 2007, MON NOT R ASTRON SOC, V379, P1599, DOI 10.1111/j.1365-2966.2007.12040.x; Trujillo I, 2007, MON NOT R ASTRON SOC, V382, P109, DOI 10.1111/j.1365-2966.2007.12388.x; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; Koopmans LVE, 2009, ASTROPHYS J LETT, V703, pL51, DOI 10.1088/0004-637X/703/1/L51; Winn JN, 2004, NATURE, V427, P613, DOI 10.1038/nature02279; Kobayashi N, 2000, PROC SPIE, V4008, P1056, DOI 10.1117/12.395423; Oguri M, 2014, MON NOT R ASTRON SOC, V439, P2494, DOI 10.1093/mnras/stu106; Lagattuta DJ, 2010, ASTROPHYS J LETT, V716, pL185, DOI 10.1088/2041-8205/716/2/L185; Ostman L, 2008, ASTRON ASTROPHYS, V485, P403, DOI 10.1051/0004-6361:20079187; Peng CY, 2002, ASTRON J, V124, P266, DOI 10.1086/340952; Bruzual A. G., 1993, APJ, V405, P538; Ducati JR, 2001, ASTROPHYS J, V558, P309, DOI 10.1086/322439; Eliasdottir A, 2006, ASTROPHYS J SUPPL S, V166, P443, DOI 10.1086/507131; Falco EE, 1999, ASTROPHYS J, V523, P617, DOI 10.1086/307758; Ferreras I, 2008, MON NOT R ASTRON SOC, V383, P857, DOI 10.1111/j.1365-2966.2007.12606.x; Gavazzi R, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/170; Gelman A., 1995, BAYESIAN DATA ANAL; Hayano Y., 2010, P SOC PHOTO-OPT INS, V7736, P21; Hayano Y., 2008, P SOC PHOTO-OPT INS, V7015, P25; Inada N, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/6/153; Inada N, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/5/119; Jackson N, 2012, MON NOT R ASTRON SOC, V419, P2014, DOI 10.1111/j.1365-2966.2011.19857.x; Koopmans LVE, 2002, MON NOT R ASTRON SOC, V334, P39, DOI 10.1046/j.1365-8711.2002.05438.x; Koptelova E., 2014, ASTRON ASTROPHYS, V566, P36; Kuhlbrodt B, 2005, ASTRON ASTROPHYS, V439, P497, DOI 10.1051/0004-6361:20041305; LAWRENCE CR, 1984, SCIENCE, V223, P46, DOI 10.1126/science.223.4631.46; Lewis GF, 2002, MON NOT R ASTRON SOC, V334, pL7, DOI 10.1046/j.1365-8711.2002.05700.x; Minowa Y, 2005, ASTROPHYS J, V629, P29, DOI 10.1086/431196; Minowa Y., 2012, P SOC PHOTO-OPT INS, V8447, P1; More A, 2009, MON NOT R ASTRON SOC, V394, P174, DOI 10.1111/j.1365-2966.2008.14342.x; Oguri M, 2008, ASTROPHYS J LETT, V676, pL1, DOI 10.1086/586897; Oguri M, 2010, PUBL ASTRON SOC JPN, V62, P1017; Oya S, 2013, PUBL ASTRON SOC JPN, V65; Rusu CE, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/30; Schechter PL, 2002, ASTROPHYS J, V580, P685, DOI 10.1086/343856; Shin EM, 2008, MON NOT R ASTRON SOC, V390, P505, DOI 10.1111/j.1365-2966.2008.13738.x; Sluse D., 2012, ASTRON ASTROPHYS, V544A, P62; Watanabe N., 2004, P SOC PHOTO-OPT INS, V5490, P1096; Yonehara A, 2008, ASTRON ASTROPHYS, V478, P95, DOI 10.1051/0004-6361:20067014; Zacharias N., 2004, BAAS, V36, P1418	49	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	NOV 1	2014	444	3					2561	2570		10.1093/mnras/stu1621		10	Astronomy & Astrophysics	Astronomy & Astrophysics	AR2FS	WOS:000343399600047		
J	Obase, K; Matsuda, Y				Obase, Keisuke; Matsuda, Yosuke			Culturable fungal endophytes in roots of Enkianthus campanulatus (Ericaceae)	MYCORRHIZA			English	Article						Endophyte; Ericaceous plant; Evolution; Molecular identification; Mycorrhiza	ERICOID MYCORRHIZAL FUNGI; AUSTRALIAN SCLEROPHYLL FOREST; EPACRIS-PULCHELLA ERICACEAE; DIRECT DNA EXTRACTION; ECTOMYCORRHIZAL FUNGI; MONOTROPA-UNIFLORA; QUERCUS-ILEX; NO EVIDENCE; HAIR ROOTS; DIVERSITY	Roots of plants in the genus Enkianthus, which belongs to the earliest diverging lineage in the Ericaceae, are commonly colonized by arbuscular mycorrhizal (AM) fungi. We documented the community of fungal root endophytes associated with Enkianthus species using a culture-based method for better understanding the members of root-colonizing fungi, except for AM fungi. Fungal isolates were successfully obtained from 610 out of 3,599 (16.9 %) root segments. Molecular analysis of fungal cultures based on ribosomal internal transcribed spacer (ITS) sequences yielded 63 operational taxonomical units (OTUs: 97 % sequence similarity cutoff) from 315 representative isolates. Further phylogenetic analysis showed that most (296 isolates) belonged to Ascomycota and were either members of Helotiales (Dermataceae, Hyaloscyphaceae, Phialocephala and Rhizoscyphus ericae aggregate), Oidiodendron, or other Pezizomycotina. Twenty-three out of 63 OTUs, which mainly consisted of Leotiomycetes, showed high similarities with reference sequences derived from roots of other ericaceous plants such as Rhododendron. The results indicated that Enkianthus houses variable root mycobionts including putative endophytic and mycorrhizal fungi in addition to AM fungi.	[Obase, Keisuke] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Matsuda, Yosuke] Mie Univ, Grad Sch Bioresources, Lab Forest Pathol & Mycol, Tsu, Mie 5148507, Japan	Obase, K (reprint author), Univ Florida, Dept Plant Pathol, 2523 Fifield Hall, Gainesville, FL 32611 USA.	oba-suke@hotmail.co.jp			Ministry of Education, Science, Sports and Culture of Japan [22688011, 23658124, 25304026]	This study was carried out partly with the financial support of Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan to YM (22688011, 23658124, and 25304026). We are grateful for sampling supports of Kyoto Botanical Gardens (Kyoto City, Kyoto Prefecture), Mie Prefecture Forestry Research Institute (Tsu City, Mie Prefecture), Mr. Keizo Kanazawa (Tsu City, Mie Prefecture), Dr. Hirosuke Oba (Nikko Botanical Gardens, Graduate School of Science, The University of Tokyo), and Ohmi-Fuji Karyoku Park (Yasu City, Shiga Prefecture), and for sequence analyses of Ms. Tomiko Chikada (Life Science Research Center, Center for Molecular Biology and Genetics, Mie University). We specially thank Dr. Shin-ichiro Ito (Graduate School of Bioresources, Mie University) and the members of the Laboratory of Forest Pathology and Mycology, Mie University, for their assistance and Dr. Matthew E Smith for critical comments and editing the manuscript.	Abe JP, 2005, INOCULUM, V56, P6; Young BW, 2002, MYCORRHIZA, V12, P75, DOI 10.1007/s00572-0153-6; Ishida TA, 2010, SOIL BIOL BIOCHEM, V42, P234, DOI 10.1016/j.soilbio.2009.10.021; Villarreal-Ruiz L, 2012, SYMBIOSIS, V56, P67, DOI 10.1007/s13199-012-0161-7; Hynson NA, 2009, P ROY SOC B-BIOL SCI, V276, P4053, DOI 10.1098/rspb.2009.1190; Jumpponen A, 1998, MYCORRHIZA, V7, P261, DOI 10.1007/s005720050190; Obase Keisuke, 2010, Mycobiology, V38, P225, DOI 10.4489/MYCO.2010.38.3.225; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Walker JF, 2011, NEW PHYTOL, V191, P515, DOI 10.1111/j.1469-8137.2011.03703.x; Chambers SM, 2008, FEMS MICROBIOL ECOL, V65, P263, DOI 10.1111/j.1574-6941.2008.00481.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Vohnik M, 2013, FUNGAL ECOL, V6, P281, DOI 10.1016/j.funeco.2013.03.006; Yukawa T, 2009, AM J BOT, V96, P1997, DOI 10.3732/ajb.0900101; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; RAUP DM, 1979, J PALEONTOL, V53, P1213; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; Bougoure DS, 2005, ENVIRON MICROBIOL, V7, P1743, DOI 10.1111/j.1462-2920.2005.00919.x; Schussler A, 2001, MYCOL RES, V105, P5, DOI 10.1017/S0953756200003725; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Allen TR, 2003, NEW PHYTOL, V160, P255, DOI 10.1046/j.1469-8137.2003.00885.x; Bougoure DS, 2007, MOL ECOL, V16, P4624, DOI 10.1111/j.1365-294X.2007.03540.x; Kron KA, 2002, BOT REV, V68, P335, DOI 10.1663/0006-8101(2002)068[0335:PCOEMA]2.0.CO;2; Richard F, 2005, NEW PHYTOL, V166, P1011, DOI 10.1111/j.1469-8137.2005.01382.x; Berch SM, 2002, PLANT SOIL, V244, P55, DOI 10.1023/A:1020291516884; Upson R, 2007, NEW PHYTOL, V176, P460, DOI 10.1111/j.1469-8137.2007.02178.x; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Matsuda Y, 2012, AM J BOT, V99, P1177, DOI 10.3732/ajb.1100546; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Bergero R, 2000, MOL ECOL, V9, P1639, DOI 10.1046/j.1365-294x.2000.01059.x; Bougoure DS, 2005, ENVIRON MICROBIOL, V7, P819, DOI 10.1111/j.1462-2920.2005.00755.x; COUTURE M, 1983, NEW PHYTOL, V95, P375, DOI 10.1111/j.1469-8137.1983.tb03505.x; Curlevski NJA, 2009, FEMS MICROBIOL ECOL, V67, P411, DOI 10.1111/j.1574-6941.2008.00637.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Fukuchi S., 2011, Eurasian Journal of Forest Research, V14-1, P1; Gorman NR, 2003, HORTSCIENCE, V38, P1163; Gorzelak MA, 2012, FUNGAL ECOL, V5, P36; Hammer O, 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025; Katenin AE, 1964, PROBLEMY SEVERA, V8, P148; Kennedy PG, 2012, AM J BOT, V99, P1691, DOI 10.3732/ajb.1200277; Krpata D, 2007, FOREST ECOL MANAG, V250, P167, DOI 10.1016/j.foreco.2007.05.012; Mandyam K, 2005, STUD MYCOL, P173; Matsuda Y, 2011, MYCORRHIZA, V21, P569, DOI 10.1007/s00572-011-0365-3; Moyersoen B, 2006, NEW PHYTOL, V172, P753, DOI 10.1111/j.1469-8137.2006.01860.x; Obase K, 2013, MYCORRHIZA, V23, P199, DOI 10.1007/s00572-012-0462-y; Oberwinkler F, 2013, MYCOL PROG, V12, P1, DOI 10.1007/s11557-012-0880-4; Schulz BJE, 2006, MICROBIAL ROOT ENDOP, V9; Selosse MA, 2007, NEW PHYTOL, V174, P864, DOI 10.1111/j.1469-8137.2007.02064.x; Sharples JM, 2000, NEW PHYTOL, V148, P153, DOI 10.1046/j.1469-8137.2000.00734.x; Shen M, 2012, SYMBIOSIS, V57, P1; Smith FA, 1997, NEW PHYTOL, V137, P373, DOI 10.1046/j.1469-8137.1997.00848.x; Smith ME, 2007, MYCORRHIZA, V18, P15, DOI 10.1007/s00572-007-0148-z; Stevens PF, 2014, ANGIOSPERM PHYLOGENY; Sun LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049867; Tian W, 2011, MYCOLOGIA, V103, P703, DOI 10.3852/10-296; Toftegaard T, 2010, BIODIVERS CONSERV, V19, P3963, DOI 10.1007/s10531-010-9940-8; Usuki Fumiaki, 2003, Mycoscience, V44, P97, DOI 10.1007/s10267-002-0086-8; Vandenkoornhuyse P, 2002, SCIENCE, V295, P2051, DOI 10.1126/science.295.5562.2051; Vohnik M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039524; Vralstad T, 2002, NEW PHYTOL, V155, P131, DOI 10.1046/j.1469-8137.2002.00444.x; White TJ, 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1139/B07-071; Yang S, 2006, MYCOLOGIA, V98, P535, DOI 10.3852/mycologia.98.4.535; Zhang C, 2009, MYCORRHIZA, V19, P417, DOI 10.1007/s00572-009-0246-1; Zhuang X, 1997, CHIN BIODIVERS, V5, P287	64	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6360	1432-1890		MYCORRHIZA	Mycorrhiza	NOV	2014	24	8					635	644		10.1007/s00572-014-0584-5		10	Mycology	Mycology	AR6WI	WOS:000343721000007		
J	Suzuki, T; Tanaka, K; Wakabayashi, C; Saita, E; Yoshida, M				Suzuki, Toshiharu; Tanaka, Kazumi; Wakabayashi, Chiaki; Saita, Ei-ichiro; Yoshida, Masasuke			Chemomechanical coupling of human mitochondrial F-1-ATPase motor	NATURE CHEMICAL BIOLOGY			English	Article							BOVINE HEART-MITOCHONDRIA; ESCHERICHIA-COLI; ATP SYNTHASE; NUCLEOTIDE-BINDING; INHIBITOR PROTEIN; GAMMA-SUBUNIT; F-1 MOTOR; ROTATION; MECHANISM; ACTIVATION	The rotary motor enzyme F-1-ATPase (F-1) is a catalytic subcomplex of F0F1-ATP synthase that produces most of the ATP in respiring cells. Chemomechanical coupling has been studied extensively for bacterial F-1 but very little for mitochondrial F-1. Here we report ATP-driven rotation of human mitochondrial F-1. A rotor-shaft gamma-subunit in the stator alpha(3)beta(3) ring rotates 1200 per ATP with three catalytic steps: ATP binding to one beta-subunit at 0 degrees, inorganic phosphate (P-i) release from another beta-subunit at 65 degrees and ATP hydrolysis on the third beta-subunit at 90 degrees. Rotation is often interrupted at 900 by persistent ADP binding and is stalled at 65 degrees by a specific inhibitor azide. A mitochondrial endogenous inhibitor for F0F1-ATP synthase, IF1, blocks rotation at 90 degrees. These features differ from those of bacterial F-1, in which both ATP hydrolysis and P-i release occur at around 80 degrees, demonstrating that chemomechanical coupling angles of the gamma-subunit are tuned during evolution.	[Suzuki, Toshiharu; Yoshida, Masasuke] Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Tokyo, Japan; [Tanaka, Kazumi; Wakabayashi, Chiaki; Saita, Ei-ichiro; Yoshida, Masasuke] Japan Sci & Technol Corp JST, Int Res Project ICORP, ATP Synth Regulat Project, Miraikan,Koto Ku, Tokyo, Japan; [Suzuki, Toshiharu] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 227, Japan; [Tanaka, Kazumi; Saita, Ei-ichiro; Yoshida, Masasuke] Kyoto Sangyo Univ, Dept Mol Biosci, Kyoto 603, Japan	Suzuki, T (reprint author), Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Tokyo, Japan.	toshisuz@aoni.waseda.jp; masasuke.yoshida@cc.kyoto-su.ac.jp			Japan Society for the Promotion of Science [24570149, 23227006]	We thank our colleagues B. Feniouk, N. Taniguchi and K. Sugawara (Japan Science and Technology Agency), S. Furuike (Osaka Medical college), K. Kinosita Jr., N. Soga and K. Adachi (Waseda University) and T. Hisabori (Tokyo Institute of Technology) for their valuable discussions. S. Furuike helped T.S. in setting up the center-shielded dark-field microscopic system. We thank K. Adachi (Waseda University) for the kind gift of the software program Center-5. The cDNA library from human lung cells was a kind gift from F. Ishikawa of Kyoto University and M. Fujikawa of the Japan Science and Technology Agency. This work was supported in part by grant-in-aid for Scientific Research from the Japan Society for the Promotion of Science (grant numbers 24570149 (T.S.) and 23227006 (M.Y.)).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; HYNDMAN DJ, 1994, J BIOL CHEM, V269, P28871; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Martin JL, 2014, P NATL ACAD SCI USA, V111, P3715, DOI 10.1073/pnas.1317784111; vanRaaij MJ, 1996, P NATL ACAD SCI USA, V93, P6913, DOI 10.1073/pnas.93.14.6913; Spetzler D, 2009, BIOCHEMISTRY-US, V48, P7979, DOI 10.1021/bi9008215; Fujikawa M, 2012, J BIOL CHEM, V287, P18781, DOI 10.1074/jbc.M112.345793; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Sielaff H, 2008, P NATL ACAD SCI USA, V105, P17760, DOI 10.1073/pnas.0807683105; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Braig K, 2000, STRUCT FOLD DES, V8, P567, DOI 10.1016/S0969-2126(00)00145-3; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; Feniouk BA, 2010, BIOPHYS J, V98, P434, DOI 10.1016/j.bpj.2009.10.023; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Abrahams JP, 1996, P NATL ACAD SCI USA, V93, P9420, DOI 10.1073/pnas.93.18.9420; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Okuno D, 2008, P NATL ACAD SCI USA, V105, P20722, DOI 10.1073/pnas.0805828106; Bilyard T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0023; Boyer P.D., 2002, J BIOL CHEM, V277, P39045; Furuike S, 2008, SCIENCE, V319, P955, DOI 10.1126/science.1151343; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Hong S, 2008, MICROBIOL MOL BIOL R, V72, P590, DOI 10.1128/MMBR.00016-08; LUTTER R, 1993, J MOL BIOL, V229, P787, DOI 10.1006/jmbi.1993.1081; MAGARIYAMA Y, 1994, NATURE, V371, P752, DOI 10.1038/371752b0; MUNEYUKI E, 1993, BIOCHIM BIOPHYS ACTA, V1144, P62, DOI 10.1016/0005-2728(93)90031-A; Noji H, 1999, BIOCHEM BIOPH RES CO, V260, P597, DOI 10.1006/bbrc.1999.0885; Okuno D, 2010, EUR BIOPHYS J BIOPHY, V39, P1589, DOI 10.1007/s00249-010-0616-9; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Saita E, 2010, J BIOL CHEM, V285, P11411, DOI 10.1074/jbc.M109.099143; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; VASILYEVA EA, 1982, BIOCHEM J, V202, P15; Watanabe R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4486	41	13	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2014	10	11					930	936		10.1038/NCHEMBIO.1635		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AR5JP	WOS:000343621500015		
J	Bertin, S; Aoki-Nonaka, Y; de Jong, PR; Nohara, LL; Xu, HJ; Stanwood, SR; Srikanth, S; Lee, J; To, K; Abramson, L; Yu, T; Han, T; Touma, R; Li, XL; Gonzalez-Navajas, JM; Herdman, S; Corr, M; Fu, G; Dong, H; Gwack, Y; Franco, A; Jefferies, WA; Raz, E				Bertin, Samuel; Aoki-Nonaka, Yukari; de Jong, Petrus Rudolf; Nohara, Lilian L.; Xu, Hongjian; Stanwood, Shawna R.; Srikanth, Sonal; Lee, Jihyung; To, Keith; Abramson, Lior; Yu, Timothy; Han, Tiffany; Touma, Ranim; Li, Xiangli; Gonzalez-Navajas, Jose M.; Herdman, Scott; Corr, Maripat; Fu, Guo; Dong, Hui; Gwack, Yousang; Franco, Alessandra; Jefferies, Wilfred A.; Raz, Eyal			The ion channel TRPV1 regulates the activation and proinflammatory properties of CD4(+) T cells	NATURE IMMUNOLOGY			English	Article							CAPSAICIN RECEPTOR; VANILLOID RECEPTOR-1; TYROSINE KINASE; GENE-EXPRESSION; CALCIUM; LYMPHOCYTES; MICE; ANTAGONIST; POTENT; MEMBRANE	TRPV1 is a Ca2+-permeable channel studied mostly as a pain receptor in sensory neurons. However, its role in other cell types is poorly understood. Here we found that TRPV1 was functionally expressed in CD4+ T cells, where it acted as a non-store-operated Ca2+ channel and contributed to T cell antigen receptor (TCR)-induced Ca2+ influx, TCR signaling and T cell activation. In models of T cell-mediated colitis, TRPV1 promoted colitogenic T cell responses and intestinal inflammation. Furthermore, genetic and pharmacological inhibition of TRPV1 in human CD4+ T cells recapitulated the phenotype of mouse Trpvl(-/-) CD4+ T cells. Our findings suggest that inhibition of TRPV1 could represent a new therapeutic strategy for restraining proinflammatory T cell responses.	[Bertin, Samuel; Aoki-Nonaka, Yukari; de Jong, Petrus Rudolf; Lee, Jihyung; To, Keith; Abramson, Lior; Yu, Timothy; Han, Tiffany; Li, Xiangli; Gonzalez-Navajas, Jose M.; Herdman, Scott; Corr, Maripat; Dong, Hui; Raz, Eyal] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Aoki-Nonaka, Yukari] Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Sci Hlth Promot, Niigata, Japan; [Nohara, Lilian L.; Xu, Hongjian; Stanwood, Shawna R.; Jefferies, Wilfred A.] Univ British Columbia, Dept Med Genet, Dept Microbiol & Immunol, Michael Smith Labs,Ctr Blood Res,Brain Res Ctr, Vancouver, BC, Canada; [Nohara, Lilian L.; Xu, Hongjian; Stanwood, Shawna R.; Jefferies, Wilfred A.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Srikanth, Sonal; Gwack, Yousang] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Touma, Ranim; Franco, Alessandra] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Fu, Guo] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Fu, Guo] Xiamen Univ, State Key Lab Cellular Stress Biol, Innovat Ctr Cell Biol, Sch Life Sci, Xiamen, Fujian, Peoples R China	Jefferies, WA (reprint author), Univ British Columbia, Dept Med Genet, Dept Microbiol & Immunol, Michael Smith Labs,Ctr Blood Res,Brain Res Ctr, Vancouver, BC, Canada.	wilf@msl.ubc.ca; eraz@ucsd.edu		Gonzalez-Navajas, Jose Manuel/0000-0002-1591-939X	National Institute of Neurological Disorders and Stroke of the US National Institutes of Health [P30 NS047101]; US National Institutes of Health [U01 AI095623, P01 DK35108, AI083432]; Canadian Institutes of Health Research [MOP-102698]; Broad Foundation [IBD-0342R]; Crohn's & Colitis Foundation of America [SRA 3038, RFA 3574, RFA 2927]; European Molecular Biology Organization [ALTF 288-2009]; Fulbright Association; Philippe Foundation; Japan Society for the Promotion of Science	We thank C. Conche and K. Sauer for help with measurements of Ca<SUP>2+</SUP>; A. Patapoutian (The Scripps Research Institute) for Chinese hamster ovary cells transfected to express TRPV1; E. Garcia and T. Snutch for access to electrophysiological equipment; J. Lee and C. Quinley for discussions; M. Scholl for animal breeding; T. Rambaldo for cell sorting; S. Shenouda for tissue processing; N. Varki and L. Eckmann for help with histological evaluations; and J. Santini for technical assistance with confocal imaging at the Neuroscience microscopy shared facility of the University of California San Diego (supported by the National Institute of Neurological Disorders and Stroke of the US National Institutes of Health (P30 NS047101)). Supported by the US National Institutes of Health (U01 AI095623 and P01 DK35108 to E.R., and AI083432 to Y.G.), the Canadian Institutes of Health Research (MOP-102698 to W.A.J.), the Broad Foundation (IBD-0342R to E.R.), the Crohn's & Colitis Foundation of America (SRA 3038 to E.R., RFA 3574 to S.B., and RFA 2927 to P.R.d.J.), the European Molecular Biology Organization (ALTF 288-2009 to S.B.), the Fulbright Association (S.B.), the Philippe Foundation (S.B.) and the Japan Society for the Promotion of Science (Y.A.-N.).	Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Moran MM, 2011, NAT REV DRUG DISCOV, V10, P601, DOI 10.1038/nrd3456; Gad M, 2009, INFLAMM BOWEL DIS, V15, P1174, DOI 10.1002/ibd.20902; Oh-hora M, 2009, IMMUNOL REV, V231, P210, DOI 10.1111/j.1600-065X.2009.00819.x; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Wirtz S, 2007, ADV DRUG DELIVER REV, V59, P1073, DOI 10.1016/j.addr.2007.07.003; Gunthorpe MJ, 2004, NEUROPHARMACOLOGY, V46, P133, DOI 10.1016/S0028-3908(03)00305-8; Armstrong DL, 2010, METHOD CELL BIOL, V99, P183, DOI [10.1016/B978-0-12-374841-6.00007-4, 10.1016/S0091-679X(10)99007-9]; Berg DJ, 2002, GASTROENTEROLOGY, V123, P1527, DOI 10.1053/gast; Wahl P, 2001, MOL PHARMACOL, V59, P9; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Arenkiel BR, 2008, NAT METHODS, V5, P299, DOI [10.1038/nmeth.1190, 10.1038/NMETH.1190]; Touska F, 2011, CURR PHARM BIOTECHNO, V12, P122, DOI 10.2174/138920111793937826; Valenzano KJ, 2003, J PHARMACOL EXP THER, V306, P377, DOI 10.1124/jpet.102.045674; Engler A, 2007, BIOCHEM BIOPH RES CO, V359, P884, DOI 10.1016/j.bbrc.2007.05.178; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Yao XQ, 2005, NEUROSIGNALS, V14, P273, DOI 10.1159/000093042; Schumacher MA, 2000, J BIOL CHEM, V275, P2756, DOI 10.1074/jbc.275.4.2756; Omilusik K, 2011, IMMUNITY, V35, P349, DOI 10.1016/j.immuni.2011.07.011; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Parekh AB, 1997, PHYSIOL REV, V77, P901; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Caterina MJ, 1997, NATURE, V389, P816; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Wenning AS, 2011, BBA-MOL CELL RES, V1813, P412, DOI 10.1016/j.bbamcr.2010.12.022; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Hanke JH, 1996, J BIOL CHEM, V271, P695; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Bachiocco V, 2011, CLIN J PAIN, V27, P631, DOI 10.1097/AJP.0b013e3182119356; Barr VA, 2009, IMMUNOL REV, V231, P148, DOI 10.1111/j.1600-065X.2009.00812.x; Jin XC, 2004, AM J PHYSIOL-CELL PH, V287, pC558, DOI 10.1152/ajpcell.00113.2004; Omilusik KD, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00164; Saunders CIM, 2007, MOL IMMUNOL, V44, P1429, DOI 10.1016/j.molimm.2006.04.027; Schwarz E. C., 2007, V179, P445; Shin JS, 2001, NEUROSCI LETT, V299, P135, DOI 10.1016/S0304-3940(00)01777-8; Spinsanti G, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-51; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Voolstra Olaf, 2014, Cells, V3, P258, DOI 10.3390/cells3020258	40	8	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2014	15	11					1055	1063		10.1038/ni.3009		9	Immunology	Immunology	AR5RH	WOS:000343640700011		
J	Natsuaki, Y; Egawa, G; Nakamizo, S; Ono, S; Hanakawa, S; Okada, T; Kusuba, N; Otsuka, A; Kitoh, A; Honda, T; Nakajima, S; Tsuchiya, S; Sugimoto, Y; Ishii, KJ; Tsutsui, H; Yagita, H; Iwakura, Y; Kubo, M; Ng, LG; Hashimoto, T; Fuentes, J; Guttman-Yassky, E; Miyachi, Y; Kabashima, K				Natsuaki, Yohei; Egawa, Gyohei; Nakamizo, Satoshi; Ono, Sachiko; Hanakawa, Sho; Okada, Takaharu; Kusuba, Nobuhiro; Otsuka, Atsushi; Kitoh, Akihiko; Honda, Tetsuya; Nakajima, Saeko; Tsuchiya, Soken; Sugimoto, Yukihiko; Ishii, Ken J.; Tsutsui, Hiroko; Yagita, Hideo; Iwakura, Yoichiro; Kubo, Masato; Ng, Lai Guan; Hashimoto, Takashi; Fuentes, Judilyn; Guttman-Yassky, Emma; Miyachi, Yoshiki; Kabashima, Kenji			Perivascular leukocyte clusters are essential for efficient activation of effector T cells in the skin	NATURE IMMUNOLOGY			English	Article							CONTACT HYPERSENSITIVITY RESPONSE; RECEPTOR ANTAGONIST; ELICITATION PHASE; LYMPHOID-TISSUE; IMMUNE EVENTS; INTERLEUKIN-1; DERMATITIS; INDUCTION; ALLERGY; NODES	It remains largely unclear how antigen-presenting cells (APCs) encounter effector or memory T cells efficiently in the periphery. Here we used a mouse contact hypersensitivity (CHS) model to show that upon epicutaneous antigen challenge, dendritic cells (DCs) formed clusters with effector T cells in dermal perivascular areas to promote in situ proliferation and activation of skin T cells in a manner dependent on antigen and the integrin LFA-1. We found that DCs accumulated in perivascular areas and that DC clustering was abrogated by depletion of macrophages. Treatment with interleukin 1 alpha (IL-1 alpha) induced production of the chemokine CXCL2 by dermal macrophages, and DC clustering was suppressed by blockade of either the receptor for IL-1 (IL-1R) or the receptor for CXCL2 (CXCR2). Our findings suggest that the dermal leukocyte cluster is an essential structure for elicitating acquired cutaneous immunity.	[Natsuaki, Yohei; Egawa, Gyohei; Nakamizo, Satoshi; Ono, Sachiko; Hanakawa, Sho; Kusuba, Nobuhiro; Otsuka, Atsushi; Kitoh, Akihiko; Honda, Tetsuya; Nakajima, Saeko; Miyachi, Yoshiki; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Natsuaki, Yohei; Hashimoto, Takashi] Kurume Univ, Sch Med, Dept Dermatol, Fukuoka, Japan; [Okada, Takaharu] RIKEN Res Ctr Allergy & Immunol, Res Unit Immunodynam, Yokohama, Kanagawa, Japan; [Tsuchiya, Soken; Sugimoto, Yukihiko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Biochem, Kumamoto, Japan; [Ishii, Ken J.] Natl Inst Biomed Innovat, Lab Adjuvant Innovat, Osaka, Japan; [Ishii, Ken J.] Osaka Univ, Lab Vaccine Sci, WPI Immunol Frontier Res Ctr, Osaka, Japan; [Tsutsui, Hiroko] Hyogo Coll Med, Dept Microbiol, Nishinomiya, Hyogo, Japan; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Chiba, Japan; [Iwakura, Yoichiro] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan; [Kubo, Masato] RIKEN Ctr Integrat Med Sci, Lab Cytokine Regulat, Yokohama, Kanagawa, Japan; [Kubo, Masato] Tokyo Univ Sci, Res Inst Biomed Sci, Div Mol Pathol, Chiba, Japan; [Ng, Lai Guan] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore; [Fuentes, Judilyn; Guttman-Yassky, Emma] Mt Sinai Sch Med Ctr, Icahn Sch Med, Dept Dermatol, New York, NY USA	Kabashima, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan.	kaba@kuhp.kyoto-u.ac.jp	Ng, Lai Guan/E-5673-2011	Ng, Lai Guan/0000-0003-1905-3586	Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank H. Yagita (Juntendo University) for the KBA neutralizing antibody to LFA-1; P. Bergstresser and J. Cyster for critical reading of our manuscript. Supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Sawaguchi M, 2012, J IMMUNOL, V188, P1809, DOI 10.4049/jimmunol.1101746; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; ENK AH, 1992, P NATL ACAD SCI USA, V89, P1398, DOI 10.1073/pnas.89.4.1398; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Murphy JE, 2000, J INVEST DERMATOL, V114, P602, DOI 10.1046/j.1523-1747.2000.00917.x; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Thyssen JP, 2009, BRIT J DERMATOL, V161, P1124, DOI 10.1111/j.1365-2133.2009.09325.x; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Nakae S, 2003, INT IMMUNOL, V15, P251, DOI 10.1093/intimm/dxg028; Clark RA, 2006, J IMMUNOL, V176, P4431; Brandtzaeg P, 2008, MUCOSAL IMMUNOL, V1, P31, DOI 10.1038/mi.2007.9; Cattani F, 2006, EUR CYTOKINE NETW, V17, P42; Egawa G, 2011, J INVEST DERMATOL, V131, P2178, DOI 10.1038/jid.2011.198; Egawa G, 2011, J INVEST DERMATOL, V131, P977, DOI 10.1038/jid.2010.386; Kish DD, 2012, J IMMUNOL, V188, P1761, DOI 10.4049/jimmunol.1100928; KONDO S, 1995, J INVEST DERMATOL, V105, P334, DOI 10.1111/1523-1747.ep12320329; Lee RT, 1997, J IMMUNOL, V159, P5084; Liao LJ, 2006, PEDIATR RES, V60, P299, DOI 10.1203/01.pdr.0000233058.08200.d6; Ng LG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000222; Otsuka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025538; SACKSTEIN R, 1988, J INVEST DERMATOL, V91, P423, DOI 10.1111/1523-1747.ep12476441; Streilein JW, 1983, J INVEST DERMATOL S, V80, P12; Wang LC, 2008, J IMMUNOL, V180, P4722; Weisser Shelley B, 2013, Methods Mol Biol, V946, P225, DOI 10.1007/978-1-62703-128-8_14	28	11	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2014	15	11					1064	1069		10.1038/ni.2992		6	Immunology	Immunology	AR5RH	WOS:000343640700012		
J	Hatano, T; Funayama, M; Kubo, SI; Mata, IF; Oji, Y; Mori, A; Zabetian, CP; Waldherr, SM; Yoshino, H; Oyama, G; Shimo, Y; Fujimoto, KI; Oshima, H; Kunii, Y; Yabe, H; Mizuno, Y; Hattori, N				Hatano, Taku; Funayama, Manabu; Kubo, Shin-ichiro; Mata, Ignacio F.; Oji, Yutaka; Mori, Akio; Zabetian, Cyrus P.; Waldherr, Sarah M.; Yoshino, Hiroyo; Oyama, Genko; Shimo, Yasushi; Fujimoto, Ken-ichi; Oshima, Hirokazu; Kunii, Yasuto; Yabe, Hirooki; Mizuno, Yoshikuni; Hattori, Nobutaka			Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease	NEUROBIOLOGY OF AGING			English	Article						Parkinson's disease; LRRK2; p.R1441G; Asia; Intrafamilial clinical heterogeneity	R1441G MUTATION; HAPLOTYPE ANALYSIS; GENETIC-ANALYSIS; G2019S; NEUROPATHOLOGY; PATHOLOGY; CARRIERS; DARDARIN	Leucine-rich repeat kinase 2 (LRRK2) is a causative gene of autosomal dominant familial Parkinson's disease (PD). We screened for LRRK2 mutations in 3 frequently reported exons (31, 41, and 48) in our cohort of 871 Japanese patients with PD (430 with sporadic PD and 441 probands with familial PD). Direct sequencing analysis of LRRK2 revealed 1 proband (0.11%) with a p.R1441G mutation, identified for the first time in Asian countries, besides frequently reported substitutions including, the p.G2019S mutation (0.11%) and p.G2385R variant (11.37%). Several studies have suggested that the LRRK2 p.R1441G mutation, which is highly prevalent in the Basque country, is extremely rare outside of northern Spain. Further analysis of family members of the proband with the p.R1441G mutation revealed that her mother and first cousin shared the same mutation and parkinsonism. Haplotype analysis revealed a different haplotype from that of the original Spanish families. Our patients demonstrated levodopa-responsive parkinsonism with intrafamilial clinical heterogeneity. This is the first report of familial PD because of the LRRK2 p.R1441G mutation in Asia. (C) 2014 Elsevier Inc. All rights reserved.	[Hatano, Taku; Funayama, Manabu; Kubo, Shin-ichiro; Oji, Yutaka; Mori, Akio; Oyama, Genko; Shimo, Yasushi; Mizuno, Yoshikuni; Hattori, Nobutaka] Juntendo Univ, Dept Neurol, Sch Med, Tokyo 1138421, Japan; [Funayama, Manabu; Yoshino, Hiroyo; Hattori, Nobutaka] Juntendo Univ, Grad Sch Med, Res Inst Dis Old Age, Tokyo 1138421, Japan; [Shimo, Yasushi] Juntendo Univ, Dept Res & Therapeut Movement Disorders, Sch Med, Tokyo 1138421, Japan; [Mata, Ignacio F.; Zabetian, Cyrus P.; Waldherr, Sarah M.] VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA; [Mata, Ignacio F.; Zabetian, Cyrus P.; Waldherr, Sarah M.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Fujimoto, Ken-ichi] Jichi Idai Stn Brain Clin, Fukuoka, Tochigi, Japan; [Oshima, Hirokazu; Kunii, Yasuto; Yabe, Hirooki] Fukushima Med Univ, Dept Neuropsychiat, Fukushima, Japan	Hatano, T (reprint author), Juntendo Univ, Dept Neurol, Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	thatano@juntendo.ac.jp; nhattori@juntendo.ac.jp	Funayama, Manabu/E-6485-2013; 	Zabetian, Cyrus/0000-0002-7739-4306	Strategic Research Foundation; KAKENHI [24390224, 25461290]; Japanese Ministry of Education, Culture, Sports, Science and Technology [23111003, 25129707]; Parkinson's Disease Foundation, United States; National Institutes of Health, United States [R01 NS065070, P50 NS062684]	The authors thank Dr Hideo Mori (Juntendo Koshigaya Hospital) and all the participants in this study. This work was supported by a Strategic Research Foundation Grant-in-Aid Project for Private Universities, Grants-in-Aid for Scientific Research (KAKENHI) (to Nobutaka Hattori, 24390224 and to Taku Hatano, 25461290) and a Grant-in-Aid for Scientific Research on Innovative Areas (to Nobutaka Hattori, 23111003 and to Manabu Funayama, 25129707) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. This work was also supported by grants from the Parkinson's Disease Foundation, United States and the National Institutes of Health, United States (R01 NS065070 and P50 NS062684). Appendix A. Supplementary dataSupplementary Video 1. Supplementary Video 2.	Abe Y, 2003, J NEUROL NEUROSUR PS, V74, P419, DOI 10.1136/jnnp.74.4.419; Paisan-Ruiz C, 2004, NEURON, V44, P595; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005; Ross OA, 2006, ANN NEUROL, V59, P388, DOI 10.1002/ana.20731; Cookson MR, 2008, INT J CLIN EXP PATHO, V1, P217; Haugarvoll K, 2008, NEUROLOGY, V70, P1456, DOI 10.1212/01.wnl.0000304044.22253.03; Deng H, 2006, J NEUROL SCI, V251, P102, DOI 10.1016/j.jns.2006.09.017; Ross OA, 2011, LANCET NEUROL, V10, P898, DOI 10.1016/S1474-4422(11)70175-2; Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540; Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509; Tan EK, 2005, NEUROSCI LETT, V384, P327, DOI 10.1016/j.neulet.2005.04.103; Hasegawa K, 2009, PARKINSONISM RELAT D, V15, P300, DOI 10.1016/j.parkreldis.2008.07.010; Khoo TK, 2013, NEUROLOGY, V80, P276, DOI 10.1212/WNL.0b013e31827deb74; Mata IF, 2009, PARKINSONISM RELAT D, V15, P370, DOI 10.1016/j.parkreldis.2008.09.002; Cornejo-Olivas M.R., 2013, MOVEMENT DISORD, V23, P1154; Funayama M, 2007, NEUROREPORT, V18, P273, DOI 10.1097/WNR.0b013e32801254b6; Gomez-Esteban JC, 2008, NEUROSURGERY, V62, P857, DOI [10.1227/01.neu.0000318171.82719.35, 10.1227/01.NEU.0000313147.96184.F5]; Gonzalez-Fernandez MC, 2007, PARKINSONISM RELAT D, V13, P509, DOI 10.1016/j.parkreldis.2007.04.003; Haugarvoll Kristoffer, 2009, Parkinsonism Relat Disord, V15 Suppl 3, pS205, DOI 10.1016/S1353-8020(09)70815-6; Marti-Masso JF, 2009, MOVEMENT DISORD, V24, P1998, DOI 10.1002/mds.22677; Mata IF, 2009, NEUROGENETICS, V10, P347, DOI 10.1007/s10048-009-0187-z; Mata IF, 2005, NEUROSCI LETT, V382, P309, DOI 10.1016/j.neulet.2005.03.033; Paisan-Ruiz C, 2005, ANN NEUROL, V57, P365, DOI 10.1002/ana.20391; Ross OA, 2009, PARKINSONISM RELAT D, V15, P466, DOI 10.1016/j.parkreldis.2008.09.001; Ruiz-Martinez J, 2011, MOVEMENT DISORD, V26, P2026, DOI 10.1002/mds.23773; Simon-Sanchez J, 2006, MOVEMENT DISORD, V21, P1954, DOI 10.1002/mds.21114; Tijero B, 2013, PARKINSONISM RELAT D, V19, P906, DOI 10.1016/j.parkreldis.2013.05.008; Tomiyama H, 2006, MOVEMENT DISORD, V21, P1102, DOI 10.1002/mds.20886; Ujiie S, 2012, PARKINSONISM RELAT D, V18, P819, DOI 10.1016/j.parkreldis.2012.03.024; Yescas P, 2010, NEUROSCI LETT, V485, P79, DOI 10.1016/j.neulet.2010.08.029; Zabetian CP, 2006, NEUROLOGY, V67, P697, DOI 10.1212/01.wnl.0000227732.37801.d4	31	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	NOV	2014	35	11							2656.e17	10.1016/j.neurobiolaging.2014.05.025		7	Geriatrics & Gerontology; Neurosciences	Geriatrics & Gerontology; Neurosciences & Neurology	AR2LX	WOS:000343419800029		
J	Sakai, A; Suzuki, H				Sakai, Atsushi; Suzuki, Hidenori			Emerging roles of microRNAs in chronic pain	NEUROCHEMISTRY INTERNATIONAL			English	Review						Astrocyte; Cancer pain; Hyperexcitability; Inflammatory pain; Microglia; microRNA; Neuroinflammation; Neuropathic pain; Primary sensory neuron; Spinal cord	SPINAL NERVE LIGATION; CHRONIC CONSTRICTION INJURY; CPG-BINDING PROTEIN-2; DORSAL-ROOT GANGLIA; NEUROPATHIC PAIN; SODIUM-CHANNELS; SENSORY NEURONS; DIFFERENTIAL EXPRESSION; NUCLEUS-ACCUMBENS; CALCIUM-CHANNEL	Chronic pain is a debilitating syndrome caused by a variety of disorders, and represents a major clinical problem because of the lack of adequate medication. In chronic pain, massive changes in gene expression are observed in a variety of cells, including neurons and glia, in the overall somatosensory system from the sensory ganglia to the higher central nervous system. The protein expressions of hundreds of genes are thought to be post-transcriptionally regulated by a single type of microRNA in a sequence-specific manner. Recently, critical roles of microRNAs in the pathophysiology of chronic pain have been emerging. Genome-wide screenings of microRNA expression changes have been reported in a variety of painful conditions, including peripheral nerve injury, inflammatory diseases, cancer and spinal cord injury. The data obtained suggest that a wide range of microRNAs change their expressions in individual pain conditions, although the pathological significance of individual microRNAs as causal mediators in distinct pain conditions remains to be revealed for a limited number of microRNAs. Insights into the roles of microRNAs in chronic pain will enhance our understanding of the pathophysiology of chronic pain and allow prompt therapeutic application of microRNA-related drugs against intractable persistent pain. (C) 2014 Elsevier Ltd. All rights reserved.	[Sakai, Atsushi; Suzuki, Hidenori] Nippon Med Sch, Grad Sch Med, Dept Pharmacol, Bunkyo Ku, Tokyo 1138602, Japan	Suzuki, H (reprint author), Nippon Med Sch, Grad Sch Med, Dept Pharmacol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	sa19@nms.ac.jp; hsuzuki@nms.ac.jp			Japan Society for the Promotion of Science [25462454]; Ministry of Education, Culture, Sports, Science and Technology, Japan [S0801035]	This work was supported by a Grant-in-Aid for Encouragement of Young Scientists (B) (25462454 to A.S.) from the Japan Society for the Promotion of Science and a grant (S0801035 to H.S.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Stemkowski PL, 2012, CAN J NEUROL SCI, V39, P416; Park CK, 2014, NEURON, V82, P47, DOI 10.1016/j.neuron.2014.02.011; WAXMAN SG, 1994, J NEUROPHYSIOL, V72, P466; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Shi GD, 2013, GLIA, V61, P504, DOI 10.1002/glia.22451; Bushnell MC, 2013, NAT REV NEUROSCI, V14, P502, DOI 10.1038/nrn3516; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Obata K, 2004, J NEUROSCI, V24, P10211, DOI 10.1523/JNEUROSCI.3388-04.2004; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Genda Y, 2013, INT J MOL MED, V31, P129, DOI 10.3892/ijmm.2012.1163; Geranton SM, 2007, J NEUROSCI, V27, P6163, DOI 10.1523/JNEUROSCI.1306-07.2007; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Yu C, 2011, J INT MED RES, V39, P1; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Chan EKL, 2013, ANN RHEUM DIS, V72, P90, DOI 10.1136/annrheumdis-2012-202203; Aldrich BT, 2009, NEUROSCIENCE, V164, P711, DOI 10.1016/j.neuroscience.2009.08.033; Nakanishi K, 2010, SPINAL CORD, V48, P192, DOI 10.1038/sc.2009.89; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Lin CR, 2014, EUR J NEUROSCI, V39, P1682, DOI 10.1111/ejn.12522; Fourie NH, 2014, EXP MOL PATHOL, V96, P422, DOI 10.1016/j.yexmp.2014.04.009; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Li X, 2011, GENE, V480, P34, DOI 10.1016/j.gene.2011.03.003; Morel L, 2013, J BIOL CHEM, V288, P7105, DOI 10.1074/jbc.M112.410944; Bali KK, 2013, EMBO MOL MED, V5, P1740, DOI 10.1002/emmm.201302797; Ammari M, 2013, CURR OPIN RHEUMATOL, V25, P225, DOI 10.1097/BOR.0b013e32835d8385; Junn E, 2009, P NATL ACAD SCI USA, V106, P13052, DOI 10.1073/pnas.0906277106; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Beutler AS, 2009, GENE THER, V16, P461, DOI 10.1038/gt.2009.23; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Crown ED, 2012, EXP NEUROL, V234, P330, DOI 10.1016/j.expneurol.2011.10.019; Wu D, 2011, NEUROSCIENCE, V190, P386, DOI 10.1016/j.neuroscience.2011.06.017; Fossat P, 2010, J NEUROSCI, V30, P1073, DOI 10.1523/JNEUROSCI.3145-09.2010; Sorge RE, 2012, NAT MED, V18, P595, DOI 10.1038/nm.2710; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Zhao J, 2010, J NEUROSCI, V30, P10860, DOI 10.1523/JNEUROSCI.1980-10.2010; Favereaux A, 2011, EMBO J, V30, P3830, DOI 10.1038/emboj.2011.249; Saab CY, 2012, TRENDS NEUROSCI, V35, P629, DOI 10.1016/j.tins.2012.06.002; Rebane A, 2013, J ALLERGY CLIN IMMUN, V132, P15, DOI 10.1016/j.jaci.2013.04.011; Devor M, 2006, J PAIN, V7, pS3, DOI 10.1016/j.jpain.2005.09.006; Lopez-Santiago LF, 2006, J NEUROSCI, V26, P7984, DOI 10.1523/JNEUROSCI.2211-06.2006; Bhalala OG, 2012, J NEUROSCI, V32, P17935, DOI 10.1523/JNEUROSCI.3860-12.2012; He Y, 2010, J NEUROSCI, V30, P10251, DOI 10.1523/JNEUROSCI.2419-10.2010; Mullenbrock S, 2011, J BIOL CHEM, V286, P45131, DOI 10.1074/jbc.M111.274076; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Buller B, 2010, FEBS J, V277, P4299, DOI 10.1111/j.1742-4658.2010.07818.x; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Willemen HLDM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-143; Dworkin RH, 2013, PAIN, V154, P2249, DOI 10.1016/j.pain.2013.06.004; Apkarian AV, 2011, PAIN, V152, pS49, DOI 10.1016/j.pain.2010.11.010; Gheinani AH, 2013, CELL MOL LIFE SCI, V70, P3773, DOI 10.1007/s00018-013-1275-7; de Chevigny A, 2012, NAT NEUROSCI, V15, P1120, DOI 10.1038/nn.3142; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Kynast KL, 2013, PAIN, V154, P368, DOI 10.1016/j.pain.2012.11.010; Zhang HY, 2011, BRAIN RES, V1383, P62, DOI 10.1016/j.brainres.2011.01.067; Sengupta JN, 2013, PAIN, V154, P59, DOI 10.1016/j.pain.2012.09.002; Xu YM, 2013, GENE, V527, P584, DOI 10.1016/j.gene.2013.05.085; Waxman SG, 2014, NAT NEUROSCI, V17, P153, DOI 10.1038/nn.3602; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Xu JT, 2007, EXP NEUROL, V206, P269, DOI 10.1016/j.expneurol.2007.05.029; Bhalala OG, 2013, NAT REV NEUROL, V9, P328, DOI 10.1038/nrneurol.2013.67; Strickland ER, 2011, NEUROSCIENCE, V186, P146, DOI 10.1016/j.neuroscience.2011.03.063; Brandenburger T, 2012, NEUROSCI LETT, V506, P281, DOI 10.1016/j.neulet.2011.11.023; Imai S, 2011, J NEUROSCI, V31, P15294, DOI 10.1523/JNEUROSCI.0921-11.2011; Arai M, 2013, PAIN MED, V14, P720, DOI 10.1111/pme.12066; Zhou SL, 2011, NEUROSCI LETT, V494, P89, DOI 10.1016/j.neulet.2011.02.064; Li X, 2013, J BONE MINER RES, V28, P2512, DOI 10.1002/jbmr.2002; Bai G, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-15; Bjersing JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078762; Chakrabarti M, 2014, NEUROSCIENCE, V256, P322, DOI 10.1016/j.neuroscience.2013.10.027; Chen H.P., 2014, NEUROCHEM RES, V39, P76; Geranton SM, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-35; Goss JR, 2014, J PAIN RES, V7, P71, DOI 10.2147/JPR.S36619; Hori Y, 2013, INT J MOL MED, V32, P1287, DOI 10.3892/ijmm.2013.1504; Hu G, 2012, CELL DEATH DIS, V3, P381, DOI DOI 10.1038/CDDIS.2012.114; Huang Y, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0376-8; Im YB, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.168; Ji Ru-Rong, 2004, Sci STKE, V2004, preE14, DOI 10.1126/stke.2522004re14; Kusuda R, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-17; McWilliams LA, 2003, PAIN, V106, P127, DOI 10.1016/S0304-3959(03)00301-4; Montagner S, 2013, IMMUNOL REV, V253, P12, DOI 10.1111/imr.12042; Obara K, 2011, INT J CELL BIOL, V2011, DOI DOI 10.1155/2011/713435; Orlova IA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-195; Poh K-W, 2011, EUR J PAIN, V15; Rao P, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00039; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Sakai A, 2013, BIOCHEM BIOPH RES CO, V435, P176, DOI 10.1016/j.bbrc.2013.04.089; Sakai A, 2013, BRAIN, V136, P2738, DOI 10.1093/brain/awt191; Shi Y, 2012, RADIAT RES, V177, P124, DOI 10.1667/RR2764.1; Smythies John, 2012, Front Integr Neurosci, V6, P126, DOI 10.3389/fnint.2012.00126; Strickland IT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023423; Takasu K, 2011, J PAIN, V12, P1130, DOI 10.1016/j.jpain.2011.04.003; Tam Tam S., 2011, CELL TISSUE RES, V346, P163; Vannucci L, 2013, NEW MICROBIOL, V36, P1; von Schack D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017670; Wang L., 2013, NEUROSCIENCE, V259, P155; Wang ZG, 2013, COMPR PHYSIOL, V3, P599, DOI 10.1002/cphy.c110002; Yu B, 2011, ACTA BIOCH BIOPH SIN, V43, P909, DOI 10.1093/abbs/gmr083; Yu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024612; Yunta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034534; Zhou S., 2012, PLOS ONE, V7	106	6	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	NOV	2014	77				SI		58	67		10.1016/j.neuint.2014.05.010		10	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	AR5MH	WOS:000343628200009		
J	Hashimoto, A; Kaneno, Y; Semboshi, S; Yoshizaki, H; Saitoh, Y; Okamoto, Y; Iwase, A				Hashimoto, A.; Kaneno, Y.; Semboshi, S.; Yoshizaki, H.; Saitoh, Y.; Okamoto, Y.; Iwase, A.			Microstructure evolution and hardness change in ordered Ni3V intermetallic alloy by energetic ion irradiation	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Ni3V; Ion irradiation; Order disorder transformation; Energy deposition; Vickers hardness	ELECTRON-IRRADIATION; AMORPHIZATION; STABILITY; SYSTEM; PHASE	Ni3V bulk intermetallic compounds with ordered D0(22) structure were irradiated with 16 MeV Au ions at room temperature. The irradiation induced phase transformation was examined by means of the transmission electron microscope (TEM), the extended X-ray absorption fine structure measurement (EXAFS) and the X-ray diffraction (XRD). We also measured the Vickers hardness for unirradiated and irradiated specimens. The TEM observation shows that by the Au irradiation, the lamellar microstructures and the super lattice spot in diffraction pattern for the unirradiated specimen disappeared. This TEM result as well as the result of XRD and EXAFS measurements means that the intrinsic D0(22) structure of Ni3V changes into the A1 (fcc) structure which is the lattice structure just below the melting point in the thermal equilibrium phase diagram. The lattice structure change from D0(22) to A1 (fcc) accompanies a remarkable decrease in Vickers microhardness. The change in crystal structure was discussed in terms of the thermal spike and the sequential atomic displacements induced by the energetic heavy ion irradiation. (C) 2014 Elsevier B.V. All rights reserved.	[Hashimoto, A.; Kaneno, Y.; Yoshizaki, H.; Iwase, A.] Osaka Prefecture Univ, Dept Mat Sci, Sakai, Osaka 5998531, Japan; [Semboshi, S.] Tohoku Univ, Kansai Ctr, Inst Mat Res, Sakai, Osaka 5998531, Japan; [Saitoh, Y.] Japan Atom Energy Agcy, Takasaki Adv Radiat Res Inst, Takasaki, Gumma 3701292, Japan; [Okamoto, Y.] Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Tokai, Ibaraki 3191195, Japan	Iwase, A (reprint author), Osaka Prefecture Univ, Dept Mat Sci, Sakai, Osaka 5998531, Japan.	iwase@mtr.osakafu-u.ac.jp	Semboshi, Satoshi/A-8291-2011				ABROMEIT C, 1995, SCRIPTA METALL MATER, V32, P1519, DOI 10.1016/0956-716X(94)00025-D; Kosugi S, 2011, NUCL INSTRUM METH B, V269, P869, DOI 10.1016/j.nimb.2010.12.061; Shibuya S, 2006, ACTA MATER, V54, P861, DOI 10.1016/j.actamat.2005.10.016; SEITZ F, 1956, SOLID STATE PHYS, V2, P305; Moronaga T, 2012, INTERMETALLICS, V21, P80, DOI 10.1016/j.intermet.2011.09.012; Kaneno Y, 2006, MAT SCI ENG A-STRUCT, V431, P328, DOI 10.1016/j.msea.2006.06.054; Nunomura Y, 2004, INTERMETALLICS, V12, P389, DOI 10.1016/j.intermet.2003.12.011; Fujioka K, 2013, MAT SCI ENG A-STRUCT, V588, P239, DOI 10.1016/j.msea.2013.09.037; ARDELL AJ, 1992, MAT SCI ENG A-STRUCT, V152, P212, DOI 10.1016/0921-5093(92)90070-H; Barbu A, 1995, MRS BULL, V20, P29; CARPENTER GJC, 1981, SCRIPTA METALL MATER, V15, P549, DOI 10.1016/0036-9748(81)90201-5; CHANG KM, 1982, ACTA METALL MATER, V30, P961, DOI 10.1016/0001-6160(82)90203-6; DIMITROV O, 1994, INTERMETALLICS, V2, P249, DOI 10.1016/0966-9795(94)90011-6; Harris VG, 1996, PHYS REV B, V54, P6929, DOI 10.1103/PhysRevB.54.6929; Hashimoto A, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FC08; Hashimoto A., 2013, T MAT RES SOC JPN, V38, P329; KOIKE J, 1988, J NON-CRYST SOLIDS, V106, P230, DOI 10.1016/0022-3093(88)90265-7; LIU HC, 1983, ACTA METALL MATER, V31, P863, DOI 10.1016/0001-6160(83)90114-1; Liua Z.-J., 2005, APPL SURF SCI, V246, P102; Motta AT, 1999, J NUCL MATER, V270, P174, DOI 10.1016/S0022-3115(98)00657-6; SAITO K, 1989, MAT SCI ENG A-STRUCT, V115, P355, DOI 10.1016/0921-5093(89)90703-X; Suzuki A, 2004, INTERMETALLICS, V12, P969, DOI 10.1016/j.intermet.2004.02.028; WAS GS, 1991, J MATER RES, V6, P1615, DOI 10.1557/JMR.1991.1615; XU GB, 1993, J ALLOY COMPD, V194, P401, DOI 10.1016/0925-8388(93)90025-I	24	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	NOV 1	2014	338						72	76		10.1016/j.nimb.2014.08.008		5	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	AR2CE	WOS:000343390400011		
J	Do, TN; Nishida, K				Thu Nga Do; Nishida, Kei			A nitrogen cycle model in paddy fields to improve material flow analysis: the Day-Nhue River Basin case study	NUTRIENT CYCLING IN AGROECOSYSTEMS			English	Article						Material flow analysis (MFA); Day-Nhue River; Nitrogen; Paddy; Runoff load; Loss rates	TAIHU LAKE REGION; AMMONIA VOLATILIZATION; RICE FIELDS; NUTRIENT LOADS; FLOODED RICE; RED-RIVER; WATER; UREA; VIETNAM; CHINA	Material flow analysis (MFA) has been applied to assess the environmental impact of human activities on nutrient flows at the river basin scale. This paper reports the enhancement of the MFA model by incorporating a nitrogen cycle model for the paddy process in the Day-Nhue River Basin, Vietnam. Dynamic transport and transformation of nitrogen in the paddy soil were quantified using the results from previous studies. All nitrogen inputs to a paddy were considered. The primary nitrogen inputs were classified as nitrate, ammonium, and organic nitrogen. The modified MFA model was used to quantify nitrogen loads from paddy fields to atmosphere, surface water, and soil/groundwater using the classified nitrogen inputs and corresponding nitrogen loss rates. This restructured paddy process significantly influenced the estimated nitrogen loads to the environment. Nitrogen loads to the air and soil/groundwater increased by 18 and 64 % in spring fields and by 0 and 25 % in summer fields, respectively. Compared with MFA that did not apply the nitrogen cycle, nitrogen load to surface water remarkably increased; it was 39 times higher for spring fields and 29 times higher for summer fields. The estimated runoff loads for the two rice seasons were in the range of measured values reported in previous studies. As a result of these calculations, it was proposed that the application of chemical fertilizer could be reduced by 50 % in both seasons to control environmental impacts without impacting rice production. The inclusion of this detailed paddy nitrogen cycle significantly enhanced the quality of the MFA model.	[Thu Nga Do; Nishida, Kei] Univ Yamanashi, Int Res Ctr River Basin Environm ICRE, Kofu, Yamanashi 4008510, Japan	Nishida, K (reprint author), Univ Yamanashi, Int Res Ctr River Basin Environm ICRE, 4-3-11 Takeda, Kofu, Yamanashi 4008510, Japan.	dothu_nga2005@yahoo.com; nishida@yamanashi.ac.jp			Global COE Program, "Evolution of Research and Education on Integrated River Basin Management in Asian Region'', from the Ministry of Education, Culture, Sport, Science and Technology of Japan	We gratefully acknowledge Dr. Futaba Kazama for providing basic information on nitrogen cycles in field crops. We are grateful to Dr. Yasushi Sakamoto for his assessment of our research methodology. We would like to thank the local authorities in Vu Ban district, Nam Dinh Province. We would also like to thank the authorities in Chuong My district, Hanoi City for their cooperation in collecting data and interviewing local residents. This study was supported by the Global COE Program, "Evolution of Research and Education on Integrated River Basin Management in Asian Region'', from the Ministry of Education, Culture, Sport, Science and Technology of Japan.	ADB, 2007, IMPR WAT QUAL DAY NH; Lin DX, 2007, PEDOSPHERE, V17, P639, DOI 10.1016/S1002-0160(07)60076-9; Tian YH, 2007, PEDOSPHERE, V17, P445, DOI 10.1016/S1002-0160(07)60054-X; Chung SO, 2003, AGR WATER MANAGE, V62, P1, DOI 10.1016/S0378-3774(03)00078-7; Liang XQ, 2007, ENVIRON POLLUT, V150, P313, DOI 10.1016/j.envpol.2007.02.003; Takeda I, 2006, WATER RES, V40, P569, DOI 10.1016/j.watres.2005.08.034; Kim JS, 2006, J HYDROL, V327, P128, DOI 10.1016/j.jhydrol.2005.11.062; Schaffner M, 2009, SCI TOTAL ENVIRON, V407, P4902, DOI 10.1016/j.scitotenv.2009.05.007; [Anonymous], 2010, FAO STAT DIV; Zhang YS, 2011, J ENVIRON MANAGE, V92, P480, DOI 10.1016/j.jenvman.2010.09.018; Chowdary VM, 2004, AGR ECOSYST ENVIRON, V103, P425, DOI 10.1016/j.agee.2003.12.001; RAO PSC, 1984, SOIL SCI, V138, P54, DOI 10.1097/00010694-198407000-00009; Sanchez M, 2005, BIORESOURCE TECHNOL, V96, P1117, DOI 10.1016/j.biortech.2004.10.002; Gross A, 2000, AQUACULT ENG, V24, P1, DOI 10.1016/S0144-8609(00)00062-5; Montangero A, 2007, SCI TOTAL ENVIRON, V384, P55, DOI 10.1016/j.scitotenv.2007.05.032; Le TPQ, 2007, J HYDROL, V334, P199, DOI 10.1016/j.jhydrol.2006.10.020; Hayashi K, 2008, SCI TOTAL ENVIRON, V390, P485, DOI 10.1016/j.scitotenv.2007.10.037; Tian GM, 2001, CHEMOSPHERE, V42, P123, DOI 10.1016/S0045-6535(00)00117-X; Burger M, 2008, SOIL SCI SOC AM J, V72, P1570, DOI 10.2136/sssaj2007.0118; CAI GX, 1986, FERT RES, V10, P203, DOI 10.1007/BF01049350; DARD-Ha Noi, 2009, GUID CHEM FERT UT CH; Datta SD, 1986, FERT RES, V9, P171, DOI 10.1007/BF01048702; Dinh DARD-Nam, 2011, GUID CHEM FERT UT VU; Do TN, 2014, RESOUR CONSERV RECY, DOI [10.1016/j.resconrec.2014.04.006, DOI 10.1016/J.RESCONREC.2014.04.006]; Dobermann A, 2003, NUTR DISORDERS NUTR; Do-Thu N, 2011, RES CONSERV RECYCL, V55, P849; FILLERY IRP, 1986, FERT RES, V8, P193, DOI 10.1007/BF01048620; Fuu MK, 2011, NATURE, V476, P194, DOI [10.1038/nature10259, DOI 10.1038/NATURE10259]; Gao C, 2004, ENVIRON GEOCHEM HLTH, V26, P199, DOI 10.1023/B:EGAH.0000039582.68882.7f; GSO, 2010, STAT YB HA NOI; Ha SR, 2001, WATER SCI TECHNOL, V43, P193; Hama T, 2011, ECOL ENG, V37, P1563, DOI 10.1016/j.ecoleng.2011.03.032; Hanh PTM, 2009, ENVIRON GEOCHEM HLTH, V32, P227; Hayashi K, 2006, SOIL SCI PLANT NUTR, V52, P545, DOI 10.1111/j.1747-0765.2006.00053.x; Hua L, 2008, AGR WATER MANAGE, V95, P887; IFA, 2007, SUST MAN NITR CYCL A; Iqbal M. T., 2011, Malaysian Journal of Soil Science, V15, P101; Ji-yun J, 2002, SPECIAL S, V16; Katayanagi N, 2013, NUTR CYCL AGROECOSYS, V95, P255, DOI 10.1007/s10705-013-9561-1; Kim SM, 2007, J ENVIRON SCI HEAL A, V42, P305, DOI 10.1080/10934520601144543; Kim SM, 2008, ENVIRON MODEL ASSESS, V13, P305, DOI 10.1007/s10666-007-9093-7; Kurosawa K, 2006, COMMUN SOIL SCI PLAN, V37, P403, DOI 10.1080/00103620500447025; Kurosawa K, 2004, COMMUN SOIL SCI PLAN, V35, P1645, DOI 10.1081/CSS-120038560; LOTSE EG, 1992, J CONTAM HYDROL, V10, P183, DOI 10.1016/0169-7722(92)90060-R; MARD, 2008, GUID FERT APPL RIC; MOC, 2009, MON PLANN MAN SOL WA; MONRE, 2006, STAT ENV VIETN 2006; Montangero A, 2008, J ENVIRON MANAGE, V88, P1538, DOI 10.1016/j.jenvman.2007.07.033; Nguyen CT, 2006, OMONRICE, V14, P111; OBCEMEA W N, 1988, Philippine Journal of Crop Science, V13, P145; Parkpian P, 2003, NUTR CYCL AGROECOSYS, V65, P173, DOI 10.1023/A:1022107630352; Pathak BK, 2007, 10 INT RIV S ENV FLO; PENNELL KD, 1990, WATER RESOUR RES, V26, P2679; RAMOS C, 1991, FERT RES, V27, P171, DOI 10.1007/BF01051125; Schaffner M, 2010, ENV DEV SUSTAIN, V13, P403; Shimasaki Y, 2008, P JSPS INT SEM KYUSH; Sinsupan T., 2004, THESIS ASIAN I TECHN; Sugimoto Y., 2008, Journal of Water and Environment Technology, V6, P113; TN Do, 2013, SE ASIAN WATER ENV, V5; Udomsinroj K, 1996, WASTEWATER TREATMENT; Yoshinaga I, 2007, AGR WATER MANAGE, V87, P217, DOI 10.1016/j.agwat.2006.06.020; Zessner M, 2002, WATER SCI TECHNOL, V46, P9	62	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1385-1314	1573-0867		NUTR CYCL AGROECOSYS	Nutr. Cycl. Agroecosyst.	NOV	2014	100	2					215	226		10.1007/s10705-014-9639-4		12	Soil Science	Agriculture	AR6ZJ	WOS:000343729300007		
J	Yanase, A				Yanase, Akihiko			Indeterminacy and Pollution Haven Hypothesis in a Dynamic General Equilibrium Model	OPEN ECONOMIES REVIEW			English	Article						Dynamic general equilibrium model; Indeterminacy; Small open economy; Pollution haven hypothesis	ENVIRONMENTAL PUBLIC-POLICIES; ENDOGENOUS GROWTH; INTERNATIONAL-TRADE; CONSTANT RETURNS; REGULATIONS; IMPATIENCE; IMPACT; EXTERNALITIES; ABATEMENT; PATTERNS	This paper develops a two-sector dynamic general equilibrium model of a small open economy in which production activities are accompanied by pollution emissions that have a negative effect on welfare. It is shown that the dynamic equilibrium may display indeterminacy (i.e., continuum of dynamic equilibrium paths converging to a common steady state), depending on (i) the relationship between capital intensity and pollution intensity, (ii) the property of households' discount rate as a function of total pollution, and (iii) the pollution-consumption relationship in instantaneous utility. In addition, the effect of environmental policy on the economy's comparative advantage and its relation to indeterminacy are examined.	Nagoya Univ, Grad Sch Econ, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Yanase, A (reprint author), Nagoya Univ, Grad Sch Econ, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	yanase@soec.nagoya-u.ac.jp					Akbostanci E, 2007, ENVIRON DEV ECON, V12, P297, DOI 10.1017/S1355770X06003512; Cole MA, 2003, J ENVIRON ECON MANAG, V46, P363, DOI 10.1016/S0095-0696(03)00021-4; vanBeers C, 1997, KYKLOS, V50, P29, DOI 10.1111/1467-6435.00002; PETHIG R, 1976, J ENVIRON ECON MANAG, V2, P160, DOI 10.1016/0095-0696(76)90031-0; Antweiler W, 2001, AM ECON REV, V91, P877, DOI 10.1257/aer.91.4.877; Le Kama AA, 2007, MACROECON DYN, V11, P272, DOI 10.1017/S1365100506060068; Benhabib J, 1998, J ECON THEORY, V81, P58, DOI 10.1006/jeth.1998.2414; EPSTEIN LG, 1987, J ECON THEORY, V41, P68, DOI 10.1016/0022-0531(87)90006-8; Yanase A, 2011, J ECON DYN CONTROL, V35, P1789, DOI 10.1016/j.jedc.2011.06.010; MCGUIRE MC, 1982, J PUBLIC ECON, V17, P335, DOI 10.1016/0047-2727(82)90069-X; Mohtadi H, 1996, J PUBLIC ECON, V63, P119, DOI 10.1016/0047-2727(95)01562-0; Bogmans C, 2010, REV EC, V61, P103; BOLDRIN M, 1994, ECONOMETRICA, V62, P323, DOI 10.2307/2951615; Bond EW, 2006, 06W26 VAND U DEP EC; Cunha-e-Sa MA, 2007, ENVIRON RESOUR ECON, V36, P35, DOI 10.1007/s10640-006-9045-8; Egli H, 2007, ENVIRON RESOUR ECON, V36, P15, DOI 10.1007/s10640-006-9044-9; Heal GM, 1998, VALUING FUTURE EC TH; Itaya JI, 2008, J ECON DYN CONTROL, V32, P1156, DOI 10.1016/j.jedc.2007.05.002; BENHABIB J, 1994, J ECON THEORY, V63, P19, DOI 10.1006/jeth.1994.1031; JONES RW, 1971, J POLIT ECON, V79, P437, DOI 10.1086/259762; Larson BA, 2002, WORLD DEV, V30, P1057, DOI 10.1016/S0305-750X(02)00023-2; Low P., 1992, INT TRADE ENV, P89; Lucas R. E. B., 1992, INT TRADE ENV, P67; MARKUSEN JR, 1993, J ENVIRON ECON MANAG, V24, P69, DOI 10.1006/jeem.1993.1005; Meng QL, 2006, J ECON DYN CONTROL, V30, P2671, DOI 10.1016/j.jedc.2005.07.01; Meng QL, 2004, J INT ECON, V64, P503, DOI 10.1016/j.jinteco.2003.08.001; Michel Ph., 1995, ENVIRON RESOUR ECON, V6, P279; Mino K, 2001, J ECON THEORY, V97, P203, DOI 10.1006/jeth.2000.2693; Nishimura K, 2002, J ECON DYN CONTROL, V27, P271, DOI 10.1016/S0165-1889(01)00036-7; Nishimura K, 2002, J ECON THEORY, V105, P244, DOI 10.1006/jeth.2001.2892; OBSTFELD M, 1990, J MONETARY ECON, V26, P45, DOI 10.1016/0304-3932(90)90031-X; ONIKI H, 1965, REV ECON STUD, V32, P15, DOI 10.2307/2296328; Perez R, 2007, ECON MODEL, V24, P431, DOI 10.1016/j.econmod.2006.10.004; Perez R, 2006, NEW HOR ENV ECO, P147; Pittel K., 2002, SUSTAINABILITY ENDOG; Portney P. R., 1999, DISCOUNTING INTERGEN; ROBISON HD, 1988, CAN J ECON, V21, P187, DOI 10.2307/135219; TOBEY JA, 1990, KYKLOS, V43, P191, DOI 10.1111/j.1467-6435.1990.tb00207.x; Uzawa H., 1968, VALUE CAPITAL GROWTH, P485; WEITZMAN ML, 1994, J ENVIRON ECON MANAG, V26, P200, DOI 10.1006/jeem.1994.1012; Xu XP, 1999, WORLD DEV, V27, P1215, DOI 10.1016/S0305-750X(99)00055-8	41	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0923-7992	1573-708X		OPEN ECON REV	Open Econ. Rev.	NOV	2014	25	5					959	980		10.1007/s11079-014-9316-x		22	Economics	Business & Economics	AR6TG	WOS:000343715400007		
J	Pilarczyk, JE; Dura, T; Horton, BP; Engelhart, SE; Kemp, AC; Sawai, Y				Pilarczyk, Jessica E.; Dura, Tina; Horton, Benjamin P.; Engelhart, Simon E.; Kemp, Andrew C.; Sawai, Yuki			Microfossils from coastal environments as indicators of paleo-earthquakes, tsunamis and storms	PALAEOGEOGRAPHY PALAEOCLIMATOLOGY PALAEOECOLOGY			English	Article						Overwash; Transfer functions; Land-level change; Foraminifera; Diatoms; Pollen	SEA-LEVEL CHANGE; CASCADIA SUBDUCTION ZONE; SOUTH-CAROLINA COAST; INDIAN-OCEAN TSUNAMI; TOHOKU-OKI TSUNAMI; TIDAL MARSH STRATIGRAPHY; LATE HOLOCENE EARTHQUAKE; 1960 CHILE EARTHQUAKE; NEW-GUINEA TSUNAMI; SULTANATE-OF-OMAN	Coastal risk assessment and hazard mitigation require datasets on centennial and millennial temporal scales to capture natural variability and multiple occurrences of the largest, but least frequent, events. Coastal sediments from low-energy depositional environments archive geologic evidence of paleo-earthquakes, tsunamis, and storms. Many of the best reconstructions of these events are derived from changes in microfossil (diatoms, foraminifera, and pollen) assemblages. In this review we explain how microfossils are used to reconstruct records of paleoearthquakes by quantifying the amount of coseismic and interseismic vertical land movements along tectonically active coastlines. Examples from the United States (Alaska and the Pacific Northwest), Japan, and Chile show that microfossil-based transfer functions may provide continuous records of vertical land movement during earthquake deformation cycles. We discuss how microfossil habitat preferences and taphonomic character are used to constrain sediment provenance (e.g., beach, nearshore, or offshore sources) and identify overwash deposits, and how this information can be used to reconstruct the recurrence of tsunamis and storms. Analysis of overwash deposits from Thailand and Malaysia indicates the ability of microfossils to resolve individual waves within tsunami sediments, and an example from the Sendai coastal plain in Japan uses foraminifera to ascribe a beach to nearshore provenance for the 2011 Tohoku tsunami deposit. Finally, we present recent examples from the Gulf of Mexico on the use of foraminifera to estimate the volume and distance of transport of storm overwash from hurricanes. (C) 2014 Elsevier B.V. All rights reserved.	[Pilarczyk, Jessica E.; Horton, Benjamin P.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Pilarczyk, Jessica E.; Horton, Benjamin P.] Nanyang Technol Univ, Earth Observ Singapore, Singapore 639798, Singapore; [Dura, Tina] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Engelhart, Simon E.] Univ Rhode Isl, Dept Geosci, Kingston, RI 02881 USA; [Kemp, Andrew C.] Tufts Univ, Dept Earth & Ocean Sci, Medford, MA 02155 USA; [Sawai, Yuki] Natl Inst Adv Ind Sci & Technol, Geol Survey Japan, Tsukuba, Ibaraki 3058567, Japan	Pilarczyk, JE (reprint author), Rutgers State Univ, Inst Marine & Coastal Sci, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	jpilar@marine.rutgers.edu			National Science Foundation (NSF) [EAR 1357722, 1402017, 1418717]	Funding for this study was provided by the National Science Foundation (NSF) awards EAR 1357722, 1402017, and 1418717. This paper is a contribution to IGCP project 588 'Preparing for coastal change'. The manuscript benefited from the thoughtful and productive comments of Adam Switzer and an anonymous reviewer.	Admirall W, 1984, PROGR PHYCOLOGICAL R, V3, P269; Iinuma T, 2011, EARTH PLANETS SPACE, V63, P643, DOI 10.5047/eps.2011.06.013; Lane P, 2011, MAR GEOL, V287, P14, DOI 10.1016/j.margeo.2011.07.001; Hawkes AD, 2010, QUATERN INT, V221, P116, DOI 10.1016/j.quaint.2009.09.019; Smith DE, 2004, QUATERNARY SCI REV, V23, P2291, DOI 10.1016/j.quascirev.2004.04.001; HALLOCK P, 1984, J FORAMIN RES, V14, P250; Horton BP, 2011, MAR MICROPALEONTOL, V79, P132, DOI 10.1016/j.marmicro.2011.02.001; Salonen JS, 2014, QUATERNARY SCI REV, V88, P69, DOI 10.1016/j.quascirev.2014.01.011; Bourgeois J, 1999, PURE APPL GEOPHYS, V154, P513, DOI 10.1007/s000240050242; LIU KB, 1993, GEOLOGY, V21, P793, DOI 10.1130/0091-7613(1993)021<0793:LSROLH>2.3.CO;2; Gelfenbaum G, 2003, PURE APPL GEOPHYS, V160, P1969, DOI 10.1007/s00024-003-2416-y; Shennan I, 1996, QUATERNARY SCI REV, V15, P1023, DOI 10.1016/S0277-3791(96)00007-8; Woodruff JD, 2009, QUATERNARY SCI REV, V28, P1774, DOI 10.1016/j.quascirev.2009.02.005; Shennan I, 1998, QUATERNARY SCI REV, V17, P365, DOI 10.1016/S0277-3791(97)00055-3; Banerjee P, 2007, B SEISMOL SOC AM, V97, pS86, DOI 10.1785/0120050609; Nelson AR, 1996, GEOL SOC AM BULL, V108, P141, DOI 10.1130/0016-7606(1996)108<0141:AEHDFS>2.3.CO;2; Mann ME, 2009, NATURE, V460, P880, DOI 10.1038/nature08219; Garrett E, 2013, QUATERNARY SCI REV, V75, P11, DOI 10.1016/j.quascirev.2013.04.007; Zong YQ, 1996, J QUATERNARY SCI, V11, P43, DOI 10.1002/(SICI)1099-1417(199601/02)11:1<43::AID-JQS217>3.0.CO;2-T; Pilarczyk JE, 2014, MAR MICROPALEONTOL, V109, P21, DOI 10.1016/j.marmicro.2014.03.004; Parsons ML, 1998, J COASTAL RES, V14, P939; Collins ES, 1999, QUATERN INT, V56, P15, DOI 10.1016/S1040-6182(98)00013-5; Khan NS, 2013, GEOLOGY, V41, P391, DOI 10.1130/G33805.1; Hawkes AD, 2005, GEOL SOC AM BULL, V117, P996, DOI 10.1130/B25455.1; Pilarczyk JE, 2012, MAR GEOL, V295, P128, DOI 10.1016/j.margeo.2011.12.002; Kortekaas S, 2007, SEDIMENT GEOL, V200, P208, DOI 10.1016/j.sedgeo.2007.01.004; Pre CAG, 2012, QUATERNARY SCI REV, V54, P142, DOI 10.1016/j.quascirev.2012.03.011; Nelson AR, 1996, J GEOPHYS RES-SOL EA, V101, P6115, DOI 10.1029/95JB01051; Clague JJ, 1999, J COASTAL RES, V15, P45; Hawkes AD, 2012, GEOMORPHOLOGY, V171, P180, DOI 10.1016/j.geomorph.2012.05.017; Hallegatte S, 2013, NAT CLIM CHANGE, V3, P802, DOI [10.1038/nclimate1979, 10.1038/NCLIMATE1979]; Sawai Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053692; Nanayama F, 2003, NATURE, V424, P660, DOI 10.1038/nature01864; Dura T, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008205; Nanayama F, 2007, SEDIMENT GEOL, V200, P275, DOI 10.1016/j.sedgeo.2007.01.008; SCOTT DB, 1991, J FORAMIN RES, V21, P20; Brush GS, 2009, ESTUAR COAST, V32, P18, DOI 10.1007/s12237-008-9106-z; Monecke K, 2008, NATURE, V455, P1232, DOI 10.1038/nature07374; Freund H, 2004, QUATERN INT, V112, P71, DOI 10.1016/S1040-6182(03)00066-1; Mamo B, 2009, EARTH-SCI REV, V96, P263, DOI 10.1016/j.earscirev.2009.06.007; Chlieh M, 2007, B SEISMOL SOC AM, V97, pS152, DOI 10.1785/0120050631; Pilarczyk JE, 2012, SEDIMENT GEOL, V282, P78, DOI 10.1016/j.sedgeo.2012.08.011; Goff J, 2012, SEDIMENT GEOL, V243, P70, DOI 10.1016/j.sedgeo.2011.11.002; Moss PT, 2005, REV PALAEOBOT PALYNO, V134, P55, DOI 10.1016/j.revpalbo.2004.11.003; Berkeley A, 2007, EARTH-SCI REV, V83, P205, DOI 10.1016/j.earscirev.2007.04.003; Donnelly JP, 2007, NATURE, V447, P465, DOI 10.1038/nature05834; Jankaew K, 2008, NATURE, V455, P1228, DOI 10.1038/nature07373; Cisternas M, 2005, NATURE, V437, P404, DOI 10.1038/nature03943; Hamilton S, 2005, QUATERNARY SCI REV, V24, P1479, DOI 10.1016/j.quascirev.2004.11.003; Hayward BW, 1999, NEW ZEAL J GEOL GEOP, V42, P395; PLAFKER G, 1970, GEOL SOC AM BULL, V81, P1001, DOI 10.1130/0016-7606(1970)81[1001:MOTCEO]2.0.CO;2; ATWATER BF, 1987, SCIENCE, V236, P942, DOI 10.1126/science.236.4804.942; Sawai Y, 2004, SCIENCE, V306, P1918, DOI 10.1126/science.1104895; Horton BP, 2009, QUATERN INT, V195, P15, DOI 10.1016/j.quaint.2008.03.004; BARRIENTOS SE, 1990, GEOPHYS J INT, V103, P589, DOI 10.1111/j.1365-246X.1990.tb05673.x; Takashimizu Y, 2012, SEDIMENT GEOL, V282, P124, DOI 10.1016/j.sedgeo.2012.07.004; Zong Y, 2007, NATURE, V449, P459, DOI 10.1038/nature06135; Sawai Y, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2007JB005503; Simons M, 2011, SCIENCE, V332, P1421, DOI 10.1126/science.1206731; Hippensteel SP, 1999, PALAEOGEOGR PALAEOCL, V149, P115, DOI 10.1016/S0031-0182(98)00196-5; Toomey MR, 2013, QUATERNARY SCI REV, V77, P181, DOI 10.1016/j.quascirev.2013.07.019; Shennan I, 2000, QUATERNARY SCI REV, V19, P1103, DOI 10.1016/S0277-3791(99)00089-X; Satake K, 2007, ANNU REV EARTH PL SC, V35, P349, DOI 10.1146/annurev.earth.35.031306.140302; Szczucinski W, 2012, SEDIMENT GEOL, V282, P40, DOI 10.1016/j.sedgeo.2012.07.019; Ellison JC, 2008, AQUAT BOT, V89, P93, DOI 10.1016/j.aquabot.2008.02.007; Hawkes AD, 2007, MAR GEOL, V242, P169, DOI 10.1016/j.margeo.2007.02.017; Liu KB, 2000, QUATERNARY RES, V54, P238, DOI 10.1006/qres.2000.2166; Scott DB, 2003, GEOL SOC AM BULL, V115, P1027, DOI 10.1130/B25011.1; Dominey-Howes D, 2000, MAR GEOL, V163, P303, DOI 10.1016/S0025-3227(99)00100-0; Switzer AD, 2008, HOLOCENE, V18, P787, DOI 10.1177/0959683608089214; Malik JN, 2011, GEOLOGY, V39, P559, DOI 10.1130/G31707.1; SCOTT DS, 1978, NATURE, V272, P528, DOI 10.1038/272528a0; Shennan I, 2006, QUATERNARY SCI REV, V25, P1, DOI 10.1016/j.quascirev.2005.09.002; Kelsey HM, 2005, GEOL SOC AM BULL, V117, P1009, DOI 10.1130/B25452.1; Zong Y, 2003, HOLOCENE, V13, P7, DOI 10.1191/0959683603hl590rp; Nelson AR, 2009, B SEISMOL SOC AM, V99, P71, DOI 10.1785/0120080103; Szczucinski W, 2012, NAT HAZARDS, V60, P115, DOI 10.1007/s11069-011-9956-8; Charman DJ, 2001, QUATERNARY SCI REV, V20, P1753, DOI 10.1016/S0277-3791(01)00036-1; Sawai Y, 2008, HOLOCENE, V18, P517, DOI 10.1177/0959683608089206; Birks H. J. B., 1995, STAT MODELLING QUATE, V5, P161; Bondevik S, 2003, BOREAS, V32, P476, DOI 10.1080/03009480310003379; Bourgeois J., 1989, AM GEOPHYS UNION T, V70, P1331; Brady H.B., 1884, REPORT FORAMINIFERA; Briggs RW, 2014, GEOPHYS RES LETT, V41, P2289, DOI 10.1002/2014GL059380; Brill D, 2014, Z GEOMORPHOL, V58, P273, DOI 10.1127/0372-8854/2014/0132; Bronnimann P., 1988, P1, DOI 10.1037/10066-001; Chappell J.MA., 1985, COASTS TIDAL WETLAND, P225; Cleve P.T., 1894, K SVENSKA VETENSK AK, V26, P1; Cleve P.T., 1895, K SVENSKA VETENSK AK, V27, P1; Cleve-Euler A., 1922, SVERIGES GEOL UNDE C, VC309, P1; CLIMAP, 1976, SCIENCE, V191, P1131, DOI [http://dx.doi.org/10.1126/science.191.4232.1131, DOI 10.1126/SCIENCE.191.4232.1131]; Cooper S., 2010, The diatoms: applications for the environmental and earth sciences, P324; Dawson S, 2007, SEDIMENT GEOL, V200, P328, DOI 10.1016/j.sedgeo.2007.01.011; Dawson S., 1996, PHYS CHEM EARTH, V21, P87, DOI DOI 10.1016/S0079-1946(97)00015-3; ELLISON JC, 1989, PALAEOGEOGR PALAEOCL, V74, P327, DOI 10.1016/0031-0182(89)90068-0; Ellison JC, 1996, GLOBAL ECOL BIOGEOGR, V5, P315, DOI 10.2307/2997587; Engelhart SE, 2013, GEOLOGY, V41, P1067, DOI 10.1130/G34544.1; van de Plassche O, 2006, GEOLOGY, V34, P829, DOI 10.1130/G22598.1; Fourtanier Elisabeth, 1999, Diatom Research, V14, P1; GODWIN H., 1934, NEW PHYTOLOGIST, V33, P278, DOI 10.1111/j.1469-8137.1934.tb06815.x; Goff J, 2011, EARTH-SCI REV, V107, P91, DOI 10.1016/j.earscirev.2010.11.003; GRINDROD J, 1985, J BIOGEOGR, V12, P323, DOI 10.2307/2844865; GUILBAULT JP, 1995, PALAEOGEOGR PALAEOCL, V118, P49, DOI 10.1016/0031-0182(94)00135-U; Guilbault JP, 1996, QUATERNARY SCI REV, V15, P913, DOI 10.1016/S0277-3791(96)00058-3; Hawkes AD, 2011, QUATERNARY SCI REV, V30, P364, DOI 10.1016/j.quascirev.2010.11.017; HemphillHaley E, 1996, HOLOCENE, V6, P439, DOI 10.1177/095968369600600406; HEMPHILLHALEY E, 1995, GEOL SOC AM BULL, V107, P367, DOI 10.1130/0016-7606(1995)107<0367:DEFEIS>2.3.CO;2; Hippensteel SP, 2005, GEOL SOC AM BULL, V117, P250, DOI 10.1130/B25535.1; Horton BP, 2005, HOLOCENE, V15, P216, DOI 10.1191/0959683605hl787rp; Horton B.P., 2006, CUSHMAN FDN RES SPEC, V40; Horton B.P., 2013, TREATISE GEOMORPHOLO, V14, P292; Hustedt F, 1953, ARCH HYDROBIOL, V47, P625; Hustedt F.R., 1957, ABH NATW VER BREMEN, V34, P181; Imbrie J, 1971, LATE CENOZOIC GLACIA, P71; Javaux E.J., 2003, PALAEONTOL ELECT, V6; JENNINGS AE, 1995, J COASTAL RES, V11, P107; Jones V., 2007, ENCY QUATERNARY SCI, P476; Juggins S., 1992, BIBLIOTHECA DIATOMOL, V25, P216; Kemp AC, 2009, GEOLOGY, V37, P1035, DOI 10.1130/G30352A.1; Khazaradze G, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015986; Lane CS, 2013, PALAEOGEOGR PALAEOCL, V369, P99, DOI 10.1016/j.palaeo.2012.10.007; Leonard LJ, 2010, GEOL SOC AM BULL, V122, P2079, DOI 10.1130/B30108.1; LOEBLICH AR, 1986, T AM MICROSC SOC, V105, P239, DOI 10.2307/3226297; Milker Y, 2012, PALAEONTOL ELECTRON, V15; MINOURA K., 2001, J NATURAL DISASTER S, V23, P83; Montagu G., 1808, TESTACEA BRITANNICA; Murray J., 1991, ECOLOGY PALEOECOLOGY; Murray JW, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1, DOI 10.1017/CBO9780511535529; Murray J.W., 1993, DISTRIBUTION ECOLOGY; NELSON AR, 1993, J COASTAL RES, V9, P673; NELSON AR, 1995, NATURE, V378, P371, DOI 10.1038/378371a0; Nicholls R. J., 2007, CLIMATE CHANGE 2007, P315; Nikitina DL, 2014, GEOMORPHOLOGY, V208, P160, DOI 10.1016/j.geomorph.2013.11.022; Nott JF, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002726; Ozawa S., 2012, J GEOPHYS RES, V117; Palmer AJM, 1986, SEA LEVEL RES MANUAL, P457; PARKER W. K., 1859, ANN MAG NAT HIST SER, V3, P333; Patrick R., 1990, SURFACE WATER HYDROL; Patterson RT, 2005, QUATERNARY SCI REV, V24, P2002, DOI 10.1016/j.quascirev.2004.11.013; Paul J., 2007, GEOPHYS RES LETT, V34; Pilarczyk JE, 2011, MAR MICROPALEONTOL, V80, P62, DOI 10.1016/j.marmicro.2011.06.001; Pilarczyk JE, 2012, NAT HAZARDS, V63, P85, DOI 10.1007/s11069-010-9706-3; Plafker G., 1969, US GEOL SURV PROF I, V543-1, P1; Plant N.G., 2010, EOS, V91, P65; Round F.E., 1990, DIATOMS; Savage JC, 1998, J GEOPHYS RES-SOL EA, V103, P21275, DOI 10.1029/98JB02048; Sawai Y, 2004, QUATERNARY SCI REV, V23, P2467, DOI 10.1016/j.quascirev.2004.05.006; Sawai Y, 2001, QUATERNARY RES, V56, P231, DOI 10.1006/qres.2001.2258; Sawai Y, 2009, MAR MICROPALEONTOL, V73, P70, DOI 10.1016/j.marmicro.2009.07.003; Scott D.B., 1980, CUSHMAN FDN FORAMINI, V17, P58; Shennan I, 1999, QUATERN INT, V60, P55, DOI 10.1016/S1040-6182(99)00007-5; Sugawara D, 2009, ISL ARC, V18, P513, DOI 10.1111/j.1440-1738.2009.00677.x; Tanaka G, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051320; Vos P.C, 1993, HYDROBIOLOGA, P269; Wang K, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001721; Watcham EP, 2013, J QUATERNARY SCI, V28, P165, DOI 10.1002/jqs.2592; Willard DA, 2011, CLIMATIC CHANGE, V107, P59, DOI 10.1007/s10584-011-0078-9; Yeats R S, 1997, GEOLOGY EARTHQUAKES; Zong YQ, 1999, J QUATERNARY SCI, V14, P153, DOI 10.1002/(SICI)1099-1417(199903)14:2<153::AID-JQS425>3.0.CO;2-6; Zweck C, 2002, PHYS EARTH PLANET IN, V132, P5, DOI 10.1016/S0031-9201(02)00041-9	160	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0031-0182	1872-616X		PALAEOGEOGR PALAEOCL	Paleogeogr. Paleoclimatol. Paleoecol.	NOV 1	2014	413				SI		144	157		10.1016/j.palaeo.2014.06.033		14	Geography, Physical; Geosciences, Multidisciplinary; Paleontology	Physical Geography; Geology; Paleontology	AR1ME	WOS:000343348500010		
J	Wakatsuki, T; Stintzing, S; Zhang, W; Yang, DY; Azuma, M; Ning, Y; Yamauchi, S; Matsusaka, S; Volz, NB; Sunakawa, Y; Koizumi, W; Watanabe, M; Barzi, A; El Khoueiry, AB; Shah, MA; Lenz, HJ				Wakatsuki, Takeru; Stintzing, Sebastian; Zhang, Wu; Yang, Dongyun; Azuma, Mizutomo; Ning, Yan; Yamauchi, Shinichi; Matsusaka, Satoshi; Volz, Nico B.; Sunakawa, Yu; Koizumi, Wasaburo; Watanabe, Masahiko; Barzi, Afsaneh; El Khoueiry, Anthony B.; Shah, Manish A.; Lenz, Heinz-Josef			Single nucleotide polymorphisms in AREG and EREG are prognostic biomarkers in locally advanced gastric cancer patients after surgery with curative intent	PHARMACOGENETICS AND GENOMICS			English	Article						amphiregulin; gastric cancer; prognosis; single nucleotide polymorphism	GROWTH-FACTOR RECEPTOR; LABEL PHASE-3 TRIAL; ORAL FLUOROPYRIMIDINE; ADJUVANT CHEMOTHERAPY; III TRIAL; SURVIVAL; PATHWAY; OVEREXPRESSION; ADENOCARCINOMA; ANGIOGENESIS	Objective Amphiregulin (AREG) and epiregulin (EREG) are important ligands to the epithelial growth factor receptor, which is involved in the regulation of progression and stemness in gastric cancer (GC). This study investigated whether frequent single nucleotide polymorphisms (SNPs) in genes of AREG and EREG are associated with recurrence-free survival and overall survival in patients with locally advanced GC. Methods SNPs with a minor allele frequency of at least 10% were analyzed using direct DNA sequencing in two independent study populations. Results The minor allele of AREG rs1615111 was associated with a significantly higher 3-year recurrence rate and lower 3-year survival rate [hazard ratio (HR)=2.21 and 2.35, respectively] compared with patients homozygous for the dominant allele G. The value for overall survival could be validated with a HR of 2.54 (P=0.018) in an independent cohort. Patients homozygous for the minor allele A of EREG rs12641042 had a significantly higher 3-year survival rate than patients with allele C (HR 0.48; P=0.034), but significance was lost in multivariable analysis (P=0.066). The value of rs12641042 could not be validated (P=0.98). Exploratory multivariable subgroup analysis showed the strongest prognostic value for rs1615111 in tumors with a diffuse histology (P-for interaction=0.004). Conclusion AREG rs1615111, located in the AREG genomic region, can significantly define different prognostic cohorts in locally advanced GC. This value is most evident in GC patients with diffuse histology, which might be relevant as none of the trials testing epithelial growth factor receptor inhibitors has been enriched for diffuse histology or a molecularly defined population. (c) 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins.	[Wakatsuki, Takeru; Stintzing, Sebastian; Zhang, Wu; Yang, Dongyun; Ning, Yan; Yamauchi, Shinichi; Matsusaka, Satoshi; Volz, Nico B.; Sunakawa, Yu; Barzi, Afsaneh; El Khoueiry, Anthony B.; Lenz, Heinz-Josef] USC Norris Comprehens Canc Ctr, Sharon Carpenter Lab, Keck Sch Med, Los Angeles, CA 90033 USA; [Shah, Manish A.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Wakatsuki, Takeru] Canc Inst Hosp, Dept Gastroenterol Ctr, Tokyo, Japan; [Azuma, Mizutomo; Koizumi, Wasaburo] Kitasato Univ, Dept Gastroenterol, Sch Med, Sagamihara, Kanagawa 228, Japan; [Watanabe, Masahiko] Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa 228, Japan; [Stintzing, Sebastian] Univ Munich, Dept Hematol & Oncol, Univ Hosp Grosshadern, Munich, Germany	Lenz, HJ (reprint author), USC Norris Comprehens Canc Ctr, Sharon Carpenter Lab, Keck Sch Med, 1441 Eastlake Ave,Room 3456, Los Angeles, CA 90033 USA.	lenz@usc.edu			NCI CCSG [5P30CA014089-27S1]; Nancy Bernstein Research Fund; German Cancer Aid (Mildred-Scheel Foundation)	This study was supported by the NCI CCSG grant 5P30CA014089-27S1 and the Nancy Bernstein Research Fund. S. Stintzing is currently receiving a postdoctoral fellowship by the German Cancer Aid (Mildred-Scheel Foundation).	Chen C, 2013, ARCH MED RES, V44, P380, DOI 10.1016/j.arcmed.2013.07.001; Smyth EC, 2012, CURR TREAT OPTION ON, V13, P377, DOI 10.1007/s11864-012-0192-6; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; McWhinney SR, 2009, PHARMACOGENOMICS, V10, P489, DOI 10.2217/14622416.10.3.489; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Lurje G, 2010, ANN ONCOL, V21, P78, DOI 10.1093/annonc/mdp280; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Terashima M, 2012, CLIN CANCER RES, V18, P5992, DOI 10.1158/1078-0432.CCR-12-1318; Kim MA, 2008, HISTOPATHOLOGY, V52, P738, DOI 10.1111/j.1365-2559.2008.03021.x; Inoue M, 2005, POSTGRAD MED J, V81, P419, DOI 10.1136/pgmj.2004.029330; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Waddell T, 2013, LANCET ONCOL, V14, P481, DOI 10.1016/S1470-2045(13)70096-2; Lordick F, 2013, LANCET ONCOL, V14, P490, DOI 10.1016/S1470-2045(13)70102-5; Richards D, 2013, EUR J CANCER, V49, P2823, DOI 10.1016/j.ejca.2013.04.022; Schmidt B, 2013, J SURG ONCOL, V107, P259, DOI 10.1002/jso.23127; Han DS, 2012, J CLIN ONCOL, V30, P3834, DOI 10.1200/JCO.2012.41.8343; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Atmaca A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-524; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Benhaim L, 2014, PHARMACOGENOMICS J, V14, P135, DOI 10.1038/tpj.2013.21; Blum MA, 2013, J SURG ONCOL, V107, P265, DOI 10.1002/jso.23183; Howlader N, 2013, SEER CANC STAT REV 1; Hwang SH, 2009, ARCH SURG-CHICAGO, V144, P559, DOI 10.1001/archsurg.2009.110; IARC, GLOBOCAN 2008 IARC S; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053149; Kitajima S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000944; Lin HL, 2007, INT J CANCER, V121, P2547, DOI 10.1002/ijc.22963; Pietrantonio F, 2013, ANTICANCER RES, V33, P1257; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Tsuburaya A, 2005, JPN J CLIN ONCOL, V35, P672, DOI 10.1093/jjco/hyi179; Voon DCC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070427; Wilson PM, 2013, PHARMACOGENOMICS J, V13, P410, DOI 10.1038/tpj.2012.23; Zhang HF, 2008, HEPATO-GASTROENTEROL, V55, P1126	36	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1744-6872	1744-6880		PHARMACOGENET GENOM	Pharmacogenet. Genomics	NOV	2014	24	11					539	547		10.1097/FPC.0000000000000087		9	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	AR6AY	WOS:000343666300002		
J	Shimizu, D; Ishitsuka, Y; Miyata, K; Tomishima, Y; Kondo, Y; Irikura, M; Iwawaki, T; Oike, Y; Irie, T				Shimizu, Daisuke; Ishitsuka, Yoichi; Miyata, Keishi; Tomishima, Yoshiro; Kondo, Yuki; Irikura, Mitsuru; Iwawaki, Takao; Oike, Yuichi; Irie, Tetsumi			Protection afforded by pre- or post-treatment with 4-phenylbutyrate against liver injury induced by acetaminophen overdose in mice (vol 87, pg 26, 2014)	PHARMACOLOGICAL RESEARCH			English	Correction									[Shimizu, Daisuke; Ishitsuka, Yoichi; Tomishima, Yoshiro; Kondo, Yuki; Irie, Tetsumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Clin Chem & Informat, Chuo Ku, Kumamoto 8620973, Japan; [Miyata, Keishi; Oike, Yuichi] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Chuo Ku, Kumamoto 8608556, Japan; [Irikura, Mitsuru] Daiichi Univ, Coll Pharmaceut Sci, Lab Evidence Based Pharmacotherapy, Minami Ku, Fukuoka 8158511, Japan; [Iwawaki, Takao] Gunma Univ, Iwawaki Lab, Adv Sci Res Leaders Dev Unit, Maebashi, Gunma 3718511, Japan; [Irie, Tetsumi] Kumamoto Univ, Fac Pharmaceut Sci, Ctr Clin Pharmaceut Sci, Chuo Ku, Kumamoto 8620973, Japan	Ishitsuka, Y (reprint author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Clin Chem & Informat, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	y-zuka@gpo.kumamoto-u.ac.jp					Shimizu D, 2014, PHARMACOL RES, V87, P26, DOI 10.1016/j.phrs.2014.06.003	1	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-6618			PHARMACOL RES	Pharmacol. Res.	NOV	2014	89						57	58		10.1016/j.phrs.2014.07.002		2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AR5LM	WOS:000343626200007		
J	Takahashi, D; Sato, K; Shimomuki, M; Takata, M; Kurumizaka, H				Takahashi, Daisuke; Sato, Koichi; Shimomuki, Mayo; Takata, Minoru; Kurumizaka, Hitoshi			Expression and purification of human FANCI and FANCD2 using Escherichia coli cells	PROTEIN EXPRESSION AND PURIFICATION			English	Article						DNA interstrand crosslink; Fanconi anemia; FANCI-FANCD2 complex; Bacterial expression	CROSS-LINK REPAIR; DNA-REPAIR; ANEMIA PATHWAY; PROTEIN; COMPLEX; MONOUBIQUITINATION; MECHANISM; ALDEHYDES; BINDING; GENE	The DNA interstrand crosslink (ICL) is an extremely deleterious DNA lesion that covalently crosslinks complementary strands and prevents the strand-separation reaction. In higher eukaryotes, the Fanconi anemia proteins, FANCI and FANCD2, form a heterodimer and play essential roles in ICL repair. Human FANCI and FANCD2 are large proteins with molecular masses of 149 kDa and 164 kDa, respectively, and were reportedly purified using a baculovirus expression system with insect cells. We have established a novel expression and purification procedure for human FANCD2 and FANCI, using Escherichia coli cells. The human FANCD2 and FANCI proteins purified by this bacterial expression method formed a stable heterodimer, and exhibited DNA binding and histone chaperone activities, as previously reported for the proteins purified by the baculovirus system. Therefore, these purification methods for human FANCI and FANCD2 provide novel procedures to facilitate structural and biochemical studies of human FANCI and FANCD2. (C) 2014 Elsevier Inc. All rights reserved.	[Takahashi, Daisuke; Sato, Koichi; Shimomuki, Mayo; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Shinjuku Ku, Tokyo 1628480, Japan; [Takata, Minoru] Kyoto Univ, Dept Late Effects Studies, Ctr Radiat Biol, Lab DNA Damage Signaling, Kyoto 6068501, Japan	Kurumizaka, H (reprint author), Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.	kurumizaka@waseda.jp			JSPS KAKENHI [25250023, 24310042, 26830128]; MEXT KAKENHI [25116002, 23114010]; JSPS Research Fellowship for Young Scientists; Waseda University	This work was supported in part by JSPS KAKENHI Grant Numbers 25250023 [to H.K.], 24310042 [to M.T.], and 26830128 [to K.S.] and by MEXT KAKENHI Grant Numbers 25116002 [to H.K.] and 23114010 [to M.T.]. D.T. is supported by the JSPS Research Fellowship for Young Scientists. HK is a Research Fellow of the Waseda Research Institute of Science and Engineering, and is also supported by Waseda University.	Kitao H, 2011, INT J HEMATOL, V93, P417, DOI 10.1007/s12185-011-0777-z; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Hira A, 2013, BLOOD, V122, P3206, DOI 10.1182/blood-2013-06-507962; Longerich S, 2009, J BIOL CHEM, V284, P23182, DOI 10.1074/jbc.C109.038075; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Joo W, 2011, SCIENCE, V333, P312, DOI 10.1126/science.1205805; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Sato K, 2012, EMBO J, V31, P3524, DOI 10.1038/emboj.2012.197; Garner E, 2011, FEBS LETT, V585, P2853, DOI 10.1016/j.febslet.2011.04.078; Douwel DK, 2014, MOL CELL, V54, P460, DOI 10.1016/j.molcel.2014.03.015; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Osorio A, 2013, HUM MUTAT, V34, P1615, DOI 10.1002/humu.22438; Longerich S, 2014, NUCLEIC ACIDS RES, V42, P5657, DOI 10.1093/nar/gku198; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Ichikawa Y, 2013, PROTEIN EXPRES PURIF, V88, P207, DOI 10.1016/j.pep.2013.01.006; Kook H, 2005, HEMATOLOGY, V10, P108, DOI 10.1080/10245330512331390096; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Park WH, 2005, J BIOL CHEM, V280, P23593, DOI 10.1074/jbc.M503730200; Roques C, 2009, EMBO J, V28, P2400, DOI 10.1038/emboj.2009.193; Sato K, 2012, NUCLEIC ACIDS RES, V40, P4553, DOI 10.1093/nar/gks053; Yuan FH, 2009, J BIOL CHEM, V284, P24443, DOI 10.1074/jbc.M109.016006	32	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-5928	1096-0279		PROTEIN EXPRES PURIF	Protein Expr. Purif.	NOV	2014	103						8	15		10.1016/j.pep.2014.08.012		8	Biochemical Research Methods; Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	AR5PE	WOS:000343635400002		
J	Fuwa, N				Fuwa, Nobuhiko			Pro-girl Bias in Intra-household Allocation in the Rural Philippines: Revisiting the "Adult Goods" Approach	REVIEW OF DEVELOPMENT ECONOMICS			English	Article							HOUSEHOLD EXPENDITURE; DISCRIMINATION	This paper detects pro-girl (age 5-15) bias in intra-household allocation of consumption budget in the rural Philippines using Deaton's adult goods method. Based on additional checks (including those for endogeneity), the results appear to be robust. The paper also finds that a larger share of girls among household members is positively associated with a larger budget share on transportation, suggesting that parents pay more for girls' transportation, possibly because of safety concerns. The results also suggest that, despite some earlier results in the literature, the adult goods method is capable of detecting gender bias, although alcohol and tobacco may not be suitable for detecting gender bias.	[Fuwa, Nobuhiko] Waseda Univ, Grad Sch Asia Pacific Studies, Shinjuku Ku, Tokyo 1690051, Japan; [Fuwa, Nobuhiko] Int Rice Res Inst, Los Banos, Philippines	Fuwa, N (reprint author), Waseda Univ, Grad Sch Asia Pacific Studies, Shinjuku Ku, 1-21-1 Nishi Waseda, Tokyo 1690051, Japan.	nfuwa@waseda.jp					Kingdon GG, 2005, ECON DEV CULT CHANGE, V53, P409, DOI 10.1086/425379; Altonji JG, 2005, J POLIT ECON, V113, P151, DOI 10.1086/426036; HADDAD L, 1990, ECON J, V100, P866, DOI 10.2307/2233663; Asif Ahmad, 1993, 463 HARV I INT DEV D; Atkinson Jane Monnig, 1990, POWER DIFFERENCE GEN; Blanc-Szanton Cristina, 1990, POWER DIFFERENCE GEN; BROWNING M, 1992, J ECON LIT, V30, P1434; BROWNING M, 1994, J POLIT ECON, V102, P1067, DOI 10.1086/261964; Burgess Robin, 1996, DIMENSIONS GEN UNPUB; Case Ann, 2002, CONSUMPTION HL UNPUB; DEATON A, 1989, WORLD BANK ECON REV, V3, P1, DOI 10.1093/wber/3.1.1; Deaton A, 1997, ANAL HOUSEHOLD SURVE; Fuwa N, 2006, DEV ECON, V44, P398, DOI 10.1111/j.1746-1049.2006.00023.x; Fuwa Nobuhiko, 2006, I DEV EC JOINT RES P, V135; Fuwa Nobuhiko, 2005, REPORT 2003 LI UNPUB; Gibson John, 2003, J DEV STUD, V40, P115; Hausmann R., 2009, GLOBAL GENDER GAP RE; Marshall W. A., 1981, BODY WEIGHTS H UNPUB; Nakpil Carmen G., 1963, WOMEN ENOUGH OTHER E; Quisumbing A. R., 2004, LAND SCH TRANSFERRIN; Strauss John, 1996, 62 MICH STAT U INT D; Subramanian Shankar, 1991, SARVEKSHANA, V14, P1; World Bank, 2013, WOR DEV REP, P1, DOI 10.1596/978-0-8213-9575-2	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1363-6669	1467-9361		REV DEV ECON	Rev. Dev. Econ.	NOV	2014	18	4					727	740		10.1111/rode.12115		14	Economics; Planning & Development	Business & Economics; Public Administration	AR7DG	WOS:000343739400008		
J	Normizan, B; Yasunori, I				Normizan, Bakar; Yasunori, Ishii			Export Competition between Landlocked and Coastal Countries: An Analysis of Strategic Export Policies	REVIEW OF DEVELOPMENT ECONOMICS			English	Article							MARKET SHARE RIVALRY; TRADE; INFRASTRUCTURE; COSTS	This paper analyzes economic rivalry between two firms using an international Cournot duopoly model, where a firm from a landlocked country (LC) and a firm from a coastal country (CC) compete in a third-country market. It is assumed that the landlocked country firm adopts a transport-cost reducing R&D subsidized by its government, while the CC government imposes a toll fee on the LC firm. The findings show since a change in the LC's transport-cost reducing R&D subsidy has a positive effect on its export and a negative effect on the CC's export, both measures have effective strategic export policies.	[Normizan, Bakar] Univ Utara Malaysia, Sch Econ Finance & Banking, Sintok 06010, Kedah, Malaysia; [Yasunori, Ishii] Waseda Univ, Grad Sch Econ, Shinjuku Ku, Tokyo, Japan	Yasunori, I (reprint author), Waseda Univ, Grad Sch Econ, Shinjuku Ku, 1-6-1 Nishi Waseda, Tokyo, Japan.	normizan@uum.edu.my					Gries T, 2008, REV DEV ECON, V12, P248, DOI 10.1111/j.1467-9361.2007.00382.x; Frankel JA, 1999, AM ECON REV, V89, P379, DOI 10.1257/aer.89.3.379; Redding S, 2004, J INT ECON, V62, P53, DOI 10.1016/j.jinteco.2003.07.001; Hummels D, 2007, J ECON PERSPECT, V21, P131, DOI 10.1257/jep.21.3.131; BRANDER JA, 1985, J INT ECON, V18, P83, DOI 10.1016/0022-1996(85)90006-6; Limao N, 2001, WORLD BANK ECON REV, V15, P451, DOI 10.1093/wber/15.3.451; Collier P, 1999, J ECON PERSPECT, V13, P3, DOI 10.1257/jep.13.3.3; Arvis JF, 2010, DIR DEV, P1, DOI 10.1596/978-0-8213-8416-9; Billmeier A., 2004, PIPELINE GEORGIAS OI; Blyde J, 2007, REV DEV ECON, V11, P566, DOI 10.1111/j.1467-9361.2007.00375.x; Charlier J., 1995, J TRANSP GEOGR, V3, P87, DOI 10.1016/0966-6923(94)00007-C; Conrad K, 1997, REG SCI URBAN ECON, V27, P715, DOI 10.1016/S0166-0462(97)00005-7; Faye M. L., 2004, J HUMAN DEV, V5, P31, DOI 10.1080/14649880310001660201; Grigoriou C., 2007, 4258 WORLD BANK; Hummels D, 2009, J DEV ECON, V89, P84, DOI 10.1016/j.jdeveco.2008.05.001; Kim Y, 2013, COMMUNIS POST-COMMUN, V46, P275, DOI 10.1016/j.postcomstud.2013.03.005; Lewis D. J., 2008, ASIA PACIFIC RES TRA, V58; Raballand G., 2007, 4258 WORLD BANK; Redding S., 2002, NORDIC J POLITICAL E, V28, P93; Sangho Y., 2010, GROWING MALIS MANGO; SPENCER BJ, 1983, REV ECON STUD, V50, P707, DOI 10.2307/2297771; UNCTAD, 2006, LANDL DEV COUNTR FAC; Van Klink H. A., 1998, J TRANSP GEOGR, V6, P1, DOI DOI 10.1016/S0966-6923(97)00035-5; World Bank, 2008, IMPR TRAD TRANSP LAN	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1363-6669	1467-9361		REV DEV ECON	Rev. Dev. Econ.	NOV	2014	18	4					804	812		10.1111/rode.12120		9	Economics; Planning & Development	Business & Economics; Public Administration	AR7DG	WOS:000343739400013		
J	Schwehr, KA; Otosaka, S; Merchel, S; Kaplan, DI; Zhang, S; Xu, C; Li, HP; Ho, YF; Yeager, CM; Santschi, PH				Schwehr, Kathleen A.; Otosaka, Shigeyoshi; Merchel, Silke; Kaplan, Daniel I.; Zhang, Saijin; Xu, Chen; Li, Hsiu-Ping; Ho, Yi-Fang; Yeager, Chris M.; Santschi, Peter H.		ASTER Team	Speciation of iodine isotopes inside and outside of a contaminant plume at the Savannah River Site	SCIENCE OF THE TOTAL ENVIRONMENT			English	Article						Radioiodine (I-129); Iodide; Iodate; Organo-iodine; Accelerator mass spectrometer (AMS) Iodine speciation	ENVIRONMENTAL TRACER; MASS-SPECTROMETRY; RADIOIODINE I-129; ORGANIC-MATTER; GROUNDWATER; I-129/I-127; FACILITIES; MOBILITY; WATERS; AMS	A primary obstacle in understanding the fate and transport of the toxic radionuclide I-129 (a thyroid seeker) is an accurate method to distinguish it from the stable isotope, I-127, and to quantify the various species at environmentally relevant concentrations (similar to 10(-8) M). A pH-dependent solvent extraction and combustion method was paired with accelerator mass spectrometry (AMS) to measure ambient levels of I-129/I-127 isotope ratios and iodine speciation (iodide (I-), iodate (IO3-), and organo-I (OI)) in aquatic systems. The method exhibited an overall uncertainty of 10% or less for I- and IO3- and less than 30% for OI species concentrations and enabled I-129 measurements as low as 0.001 Bq/L (I Bq/L = 10(-13) M). The method was used to analyze groundwater from the Savannah River Site (SRS), South Carolina, USA, along a pH, redox potential (Eh), and organic carbon gradient (8-60 mu M DOC). The data confirmed that the I-129/I-127 ratios and species distribution were strongly pH dependent and varied in a systematic manner from the strongly acidic source. While I-129 speciation in plume samples containing total I concentrations >1.7 Bq/L was similar whether measured by AMS or GC-MS ([I-] >> [IO3-] = [OI]), AMS enabled I-129 speciation measurements at much lower concentrations than what was possible with GC-MS. AMS analyses demonstrated that groundwater samples minimally impacted by the plume were still orders of magnitude higher than ambient I-129 concentrations typically found elsewhere in the USA groundwaters and rivers. This is likely due to past atmospheric releases of volatile I-129 species by SRS nuclear reprocessing facilities near the study site. Furthermore, the results confirmed the existence of I-129 not only as I-, but also as OI and IO3- species. (C) 2014 Elsevier B.V. All rights reserved.	[Schwehr, Kathleen A.; Otosaka, Shigeyoshi; Zhang, Saijin; Xu, Chen; Li, Hsiu-Ping; Ho, Yi-Fang; Santschi, Peter H.] Texas A&M Univ, Dept Marine Sci, Lab Oceanog & Environm Res, Galveston, TX 77553 USA; [Otosaka, Shigeyoshi] Japan Atom Energy Agcy, Res Grp Environm Sci, Tokai, Ibaraki 3191195, Japan; [Merchel, Silke] Helmholtz Zentrum Dresden Rossendorf, D-01328 Dresden, Germany; [Kaplan, Daniel I.] Savannah River Natl Lab, Aiken, SC 29808 USA; [Yeager, Chris M.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [ASTER Team] Aix Marseille Univ, ASTER Team, CEREGE, CNRS IRD UM 34, F-13545 Aix En Provence, France	Schwehr, KA (reprint author), Texas A&M Univ, Dept Marine Sci, Lab Oceanog & Environm Res, OCSB 3029,200 Seawolf Pkwy, Galveston, TX 77553 USA.				INSU/CNRS; French Ministry of Research and Higher Education; IRD; CEA; German-French exchange program (DAAD) [500 888 61, 22077QC]; German-French exchange program (EGIDE) [500 888 61, 22077QC]; US Department of Energy's (DOE) Subsurface Biogeochemical Research (SBR) Program within the Office of Science [ER65222-1038426-0017532]	We would like to thank E. Nottoli for her valuable assistance during the AMS measurements that were performed at the French AMS national facility ASTER (CEREGE, Aix-en-Provence) which is supported by the INSU/CNRS, the French Ministry of Research and Higher Education, the IRD and the CEA. This work was partially funded by a German-French exchange program (DAAD and EGIDE) (500 888 61 and 22077QC), and the US Department of Energy's (DOE) Subsurface Biogeochemical Research (SBR) Program within the Office of Science (ER65222-1038426-0017532).	Xu C, 2011, GEOCHIM COSMOCHIM AC, V75, P5716, DOI 10.1016/j.gca.2011.07.011; Li HP, 2012, ENVIRON SCI TECHNOL, V46, P4837, DOI 10.1021/es203683v; Otosaka S, 2011, SCI TOTAL ENVIRON, V409, P3857, DOI 10.1016/j.scitotenv.2011.05.018; Arnold M, 2010, NUCL INSTRUM METH B, V268, P1954, DOI 10.1016/j.nimb.2010.02.107; FABRYKAMARTIN J, 1985, GEOCHIM COSMOCHIM AC, V49, P337, DOI 10.1016/0016-7037(85)90027-4; Arnold M, 2013, NUCL INSTRUM METH B, V294, P24, DOI 10.1016/j.nimb.2012.01.049; Snyder G, 2004, NUCL INSTRUM METH B, V223, P579, DOI 10.1016/j.nimb.2004.04.107; Emerson HP, 2014, APPL GEOCHEM, V45, P105, DOI 10.1016/j.apgeochem.2014.03.002; Dai M, 2002, ENVIRON SCI TECHNOL, V36, P3690, DOI 10.1021/es020025t; Muramatsu Y, 2008, QUAT GEOCHRONOL, V3, P291, DOI 10.1016/j.quageo.2007.08.002; EMERY JF, 1972, NUCL SCI ENG, V48, P319; Schwehr KA, 2005, APPL GEOCHEM, V20, P1461, DOI 10.1016/j.apgeochem.2005.02.003; Santschi PH, 2004, SCI TOTAL ENVIRON, V321, P257, DOI 10.1016/j.scitotenv.2003.09.003; Moran JE, 1999, ENVIRON SCI TECHNOL, V33, P2536, DOI 10.1021/es9900050; Hou XL, 2013, ENVIRON SCI TECHNOL, V47, P3091, DOI 10.1021/es304460k; Schwehr KA, 2009, ENVIRON SCI TECHNOL, V43, P7258, DOI 10.1021/es900795k; Kaplan DI, 2011, ENVIRON SCI TECHNOL, V45, P489, DOI 10.1021/es103314n; Szidat S, 2000, KERNTECHNIK, V65, P160; Xu C, 2011, ENVIRON SCI TECHNOL, V45, P9975, DOI 10.1021/es201343d; Hou X, 2008, ANAL CHIM ACTA, V632, P181; Hou X, 2009, 205 NSKB NORD NUCL S; Hou X, 2012, J ANAL SCI TECHNOL, V3, P135; Kantelo MV, 1990, WSRCRP904242; Kaplan DI, 2014, CRIT REV ENV SCI TEC, V44, P2287, DOI 10.1080/10643389.2013.828273; Lehto J, 2012, SCI TOTAL ENVIRON, V419, P61; Moran JE, 2002, WATER RESOUR RES, V38, P24; Santschi PH, 1996, DEEP-SEA RES PT I, V43, P259, DOI 10.1016/0967-0637(96)00005-2; Savannah River Nuclear Solutions LLC, 2008, WSRCRP20064074 LLC S; SCHINK DR, 1995, EARTH PLANET SC LETT, V135, P131, DOI 10.1016/0012-821X(95)00153-4; Schwehr KA, 2005, LIMNOL OCEANOGR-METH, V3, P326; Suzuki T, 2009, NUCL INSTRUM METH B, V259, P370; Zhang S, 2011, ENVIRON SCI TECHNOL, V45, P5543, DOI 10.1021/es1040442; Zhang S, 2010, ENVIRON SCI TECHNOL, V44, P9042, DOI 10.1021/es102047y	33	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0048-9697	1879-1026		SCI TOTAL ENVIRON	Sci. Total Environ.	NOV 1	2014	497						671	678		10.1016/j.scitotenv.2014.07.006		8	Environmental Sciences	Environmental Sciences & Ecology	AR5GM	WOS:000343613100072		
J	Shirabe, M				Shirabe, Masashi			Identifying SCI covered publications within non-patent references in US utility patents	SCIENTOMETRICS			English	Article						Non-patent references; US utility patents; Science citation; Automated matching	SCIENCE; TECHNOLOGY	In order to evaluate approaches for identifying science citation index (SCI) covered publications within non-patent references (NPRs), the author employs a computer science method that uses two key indicators, recall and precision, to evaluate the relevance of information retrieval systems. There are two primary reasons that this method is adequate: in contrast to the retrievability ratios used previously, first, this method can evaluate two dimensions of matching accuracy, and second, results of its evaluation are independent of the intermediate outcome. The author then proposes an approach for identifying SCI publications within NPRs that consists of five steps: (1) data collection, (2) creation of supervised and test data, (3) selection and execution of matching algorithms, (4) evaluation of algorithms and optimization of their combinations, and (5) evaluation of optimized combinations. A comparison of the proposed and conventional approaches showed that the proposed approach works well, with results far better (99 % precision and 95 % recall) than the target implicitly set in previous studies. The author also applied the approach to comprehensive NPR data in U.S. utility patents registered between 1992 and 2012 and checked the performance. Results showed that the approach could identify SCI publications from within millions of NPRs in an acceptable time (i.e., within a couple of weeks) and that it performs as expected from the evaluation in step 5. On the basis of these results, the proposed approach is considered of value in studies on relations and/or interactions between science publications and patents.	Tokyo Inst Technol, Meguro Ku, Tokyo 1528550, Japan	Shirabe, M (reprint author), Tokyo Inst Technol, Meguro Ku, Oookayama 2-12-1 S6-5, Tokyo 1528550, Japan.	shirabe.m.aa@m.titech.ac.jp	SHIRABE, Masashi/N-8986-2014	SHIRABE, Masashi/0000-0003-4569-6171	JSPS KAKENHI [22500848, 23500304]; JST/RISTEX research funding program "Science of Science, Technology and Innovation Policy''	This research is partly supported by JSPS KAKENHI (Grant Numbers: 22500848 and 23500304) and JST/RISTEX research funding program "Science of Science, Technology and Innovation Policy''.	Cassiman B, 2008, IND CORP CHANGE, V17, P611, DOI 10.1093/icc/dtn023; Narin F, 1997, RES POLICY, V26, P317, DOI 10.1016/S0048-7333(97)00013-9; Meyer M, 2000, SCIENTOMETRICS, V49, P93, DOI 10.1023/A:1005613325648; NARIN F, 1985, SCIENTOMETRICS, V7, P369, DOI 10.1007/BF02017155; Meyer M, 2000, RES POLICY, V29, P409, DOI 10.1016/S0048-7333(99)00040-2; Callaert J, 2006, SCIENTOMETRICS, V69, P3, DOI 10.1007/s11192-006-0135-8; Callaert J, 2014, SCIENTOMETRICS, V98, P1617, DOI 10.1007/s11192-013-1073-x; Callaert J, 2012, SCIENTOMETRICS, V91, P383, DOI 10.1007/s11192-011-0573-9; Shirabe M., 2008, 111 NISTEP 2, P1; Shirabe M, 2013, PRO INT CONF SCI INF, P123; Shishibori M., 2002, INFORM RETRIEVAL ALG; Tamada S., 2010, IND U COOPERATIVE IN; Tomizawa H., 2005, P 20 ANN M JSSPRM, P228; Tomizawa H., 2008, 111 NISTEP 2, P1; VANVIANEN BG, 1990, RES POLICY, V19, P61, DOI 10.1016/0048-7333(90)90034-4; Verbeek A., 2002, 204921 EUR EC; Verbeek A., 2002, 204922 EUR EC; Verbeek A., 2002, 204923 EUR EC	18	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0138-9130	1588-2861		SCIENTOMETRICS	Scientometrics	NOV	2014	101	2					999	1014		10.1007/s11192-014-1293-8		16	Computer Science, Interdisciplinary Applications; Information Science & Library Science	Computer Science; Information Science & Library Science	AR5FF	WOS:000343609900006		
J	Yamashita, Y; Yoshinaga, D				Yamashita, Yasuhiro; Yoshinaga, Daisuke			Influence of researchers' international mobilities on publication: a comparison of highly cited and uncited papers	SCIENTOMETRICS			English	Article						Researchers' international migration; Returnee; Curriculum vitae; Short Bios; Highly cited papers	BRAIN-DRAIN; PRODUCTIVITY; SCIENTISTS; EXPERIENCE; VITAE	Using curriculum vitae (CVs) or Short Bios in published resources such as the Internet enables us to analyze many issues concerning researchers' careers. However, analysis of CVs or Short Bios concerning researchers' life history, such as movement between countries, has rarely been conducted. In this paper, we pursue two purposes: to demonstrate which conditions (citation impact, countries or sectors) are favorable for the analysis, and to show structures of production of highly cited papers. To grasp more obvious tendencies, we compare two ``extreme'' samples: highly cited and uncited papers. First, we assess the identification rates of researchers' origin broken down by researchers' affiliation (countries and sectors). Then, we analyze the influence of these researchers' international movement based on their origin. The results show the full landscape of the movement's influence on national publication, the characteristics of each country in terms of researchers' countries of origin and the research experience of both internationally moved and domestic researchers. Moreover, we analyze the contributions of researchers who returned from abroad to their home countries. Finally, we assess the limitations of our research method and the topic to be addressed concerning this method.	[Yamashita, Yasuhiro] Yamagata Univ, Planning & Res Support Dept, Yamagata 998560, Japan; [Yoshinaga, Daisuke] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Engn Fundamentals & Strateg Planning, Meguro Ku, Tokyo 1528550, Japan	Yamashita, Y (reprint author), Yamagata Univ, Planning & Res Support Dept, 1-4-12 Kojirakawa Machi, Yamagata 998560, Japan.	yaya@jm.kj.yamagatau.ac.jp; yoshinaga.d.aa@m.titech.ac.jp			JST/RISTEX; JSPS KAKENHI [23500304]	This research was supported by the JST/RISTEX research funding program titled "Science of Science, Technology and Innovation Policy" and by JSPS KAKENHI Grant Number 23500304.	Jonkers K, 2008, SCIENTOMETRICS, V77, P309, DOI 10.1007/s11192-007-1971-x; Dietz JS, 2005, RES POLICY, V34, P349, DOI 10.1016/j.respol.2002.01.008; Lepori B, 2009, RES EVALUAT, V18, P125, DOI 10.3152/095820209X441772; Ackers L, 2008, MINERVA, V46, P411, DOI 10.1007/s11024-008-9110-2; Tang L, 2010, SCIENTOMETRICS, V84, P763, DOI 10.1007/s11192-010-0196-6; Corley E., 2003, LEARNING SCI TECHNOL, P293; Cruz-Castro L, 2010, RES POLICY, V39, P27, DOI 10.1016/j.respol.2009.11.008; Dietz JS, 2000, SCIENTOMETRICS, V49, P419, DOI 10.1023/A:1010537606969; Furukawa T, 2011, SCIENTOMETRICS, V87, P451, DOI 10.1007/s11192-011-0360-7; Ioannidis JPA, 2004, FASEB J, V18, P936, DOI 10.1096/fj.03-1394lfe; Jonkers K., 2008, 200805 MIREMAR EUR U; Jonkers K., 2010, MOBILITY MIGRATION C; Laudel G, 2003, SCIENTOMETRICS, V57, P215, DOI 10.1023/A:1024137718393; Lewison G, 2008, SCIENTOMETRICS, V75, P21, DOI 10.1007/s11192-007-1842-5; Sandstrom U, 2009, RES EVALUAT, V18, P135, DOI 10.3152/095820209X441790; Ueno S., 2007, J SCI POLICY RES MAN, V21, P70; Yamashita Y., 2010, 2010 4S JSSTS JOINT; Yamashita Y, 2011, 13 INT C SCIENT INF; Yamashita Y., 2007, 11 INT C SCIENT INF	19	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0138-9130	1588-2861		SCIENTOMETRICS	Scientometrics	NOV	2014	101	2					1475	1489		10.1007/s11192-014-1384-6		15	Computer Science, Interdisciplinary Applications; Information Science & Library Science	Computer Science; Information Science & Library Science	AR5FF	WOS:000343609900035		
J	Iwami, S; Mori, J; Sakata, I; Kajikawa, Y				Iwami, Shino; Mori, Junichiro; Sakata, Ichiro; Kajikawa, Yuya			Detection method of emerging leading papers using time transition	SCIENTOMETRICS			English	Article						Emerging technologies; Citation network; Network centrality; Time-series analysis	RESEARCH FRONTS; SCIENTIFIC PUBLICATIONS; CITATION; SCIENCE; NETWORKS; INDEXES; IMPACT	To survive worldwide competitions of research and development in the current rapid increase of information, decision-makers and researchers need to be supported to find promising research fields and papers. But finding those fields from an available data in too much heavy flood of information becomes difficult. We aim to develop a methodology supporting to find emerging leading papers with a bibliometric approach. The analyses in this work are about four academic domains using our time transition analysis. In the time transition analysis, after citation networks are constructed, centralities of each paper are calculated and their changes are tracked. Then, the centralities are plotted, and the features of the leading papers are extracted. Based on the features, we proposed ways to detect the leading papers by focusing on in-degree centrality and its transition. This work will contribute to finding the leading paper, and it is useful for decision-makers and researchers to decide the worthy research topic to invest their resources.	[Iwami, Shino; Mori, Junichiro; Sakata, Ichiro] Univ Tokyo, Grad Sch Engn, Dept Technol Management Innovat, Bunkyo Ku, Tokyo 1138658, Japan; [Kajikawa, Yuya] Tokyo Inst Technol, Grad Sch Innovat Management, Minato Ku, Tokyo 1080023, Japan	Iwami, S (reprint author), Univ Tokyo, Grad Sch Engn, Dept Technol Management Innovat, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138658, Japan.	iwami@ipr-ctr.t.u-tokyo.ac.jp; jmori@ipr-ctr.t.u-tokyo.ac.jp; isakata@ipr-ctr.t.u-tokyo.ac.jp; kajikawa@mot.titech.ac.jp	Iwami, Shino/B-1838-2015; Kajikawa, Yuya/C-1996-2015	Iwami, Shino/0000-0001-6783-7276; Kajikawa, Yuya/0000-0003-3577-5167			Chen CM, 2009, J INFORMETR, V3, P191, DOI 10.1016/j.joi.2009.03.004; Adams J, 2005, SCIENTOMETRICS, V63, P567, DOI 10.1007/s11192-005-0228-9; Chen SH, 2012, TECHNOL FORECAST SOC, V79, P1099, DOI 10.1016/j.techfore.2011.12.011; GARFIELD E, 1955, SCIENCE, V122, P108, DOI 10.1126/science.122.3159.108; Small H, 2006, SCIENTOMETRICS, V68, P595, DOI 10.1007/s11192-006-0132-y; Shibata N, 2008, TECHNOVATION, V28, P758, DOI 10.1016/j.technovation.2008.03.009; Shibata N, 2009, J AM SOC INF SCI TEC, V60, P571, DOI 10.1002/asi.20994; Shibata N, 2011, TECHNOL FORECAST SOC, V78, P274, DOI 10.1016/j.techfore.2010.07.006; Leydesdorff L, 2004, J DOC, V60, P371, DOI 10.1108/00220410410548144; Xu JX, 2000, ACM T INFORM SYST, V18, P79, DOI 10.1145/333135.333138; Vanclay JK, 2012, SCIENTOMETRICS, V92, P211, DOI 10.1007/s11192-011-0561-0; Borner K, 2003, ANNU REV INFORM SCI, V37, P179, DOI 10.1002/aris.1440370106; Carpineto C, 2001, ACM T INFORM SYST, V19, P1, DOI 10.1145/366836.366860; Gingras Y, 2010, SCIENTOMETRICS, V82, P401, DOI 10.1007/s11192-009-0035-9; Leydesdorff L, 2009, J AM SOC INF SCI TEC, V60, P348, DOI 10.1002/asi.20967; Ehrenberg M., 2008, GREEN FLUORESCENT PR; GARFIELD E, 1992, THEOR MED, V13, P117, DOI 10.1007/BF02163625; Leydesdorff L., 2012, SCIENTOMETRICS, V96, P731; Liu X, 2013, J INFORMETR, V7, P425, DOI 10.1016/j.joi.2013.01.003; Manh Cuong P., 2012, J ED TECHNOLOGY SOC, V15, P323; Nakamura H, 2011, SCIENTOMETRICS, V87, P221, DOI 10.1007/s11192-011-0341-x; The Royal Swedish Academy of Sciences, 2011, NOB PRIZ CHEM 2011 I; Tu YN, 2012, INFORM PROCESS MANAG, V48, P303, DOI 10.1016/j.ipm.2011.07.006	23	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0138-9130	1588-2861		SCIENTOMETRICS	Scientometrics	NOV	2014	101	2					1515	1533		10.1007/s11192-014-1380-x		19	Computer Science, Interdisciplinary Applications; Information Science & Library Science	Computer Science; Information Science & Library Science	AR5FF	WOS:000343609900037		
J	Fuchiwaki, Y; Yabe, Y; Adachi, Y; Tanaka, M; Abe, K; Kataoka, M; Ooie, T				Fuchiwaki, Y.; Yabe, Y.; Adachi, Y.; Tanaka, M.; Abe, K.; Kataoka, M.; Ooie, T.			Inkjet monitoring technique with quartz crystal microbalance (QCM) sensor for highly reproducible antibody immobilization	SENSORS AND ACTUATORS A-PHYSICAL			English	Article						Inkjet; QCM; Antibody immobilization; Microchip; Enzyme-linked immunosorbent assay	FABRICATION	We demonstrate that a calibrated amount of a biomolecule can be microdeposited using a commercially available quartz crystal microbalance (QCM) and a piezoelectric inkjet head with a flattened surface surrounding the ejection hole. Covering the QCM with a stainless-steel cover perforated with a precisely-machined hole both significantly decreased background noise due to external sources such as air flow and temperature fluctuations and allowed accurate droplet ejection at a constant temperature. Anti-c reactive protein antibody solution (anti-CRP; 1.0 mg/ml) was continuously ejected onto a microchannel target using a piezoelectric injector; its microdeposition was monitored shot-by-shot using a 30 MHz QCM. The dispersion of the QCM frequency change per shot decreased from 7.87 to 1.01 Hz when a perforated stainless-steel cover was installed. The primary antibody was precisely deposited on the target with high reproducibility. The variation in luminescence measured by enzyme-linked immunosorbant assay (ELISA) decreased from 9.67% to 1.16% when calibrating the amount of primary antibody deposition with this developed technique. (C) 2014 Published by Elsevier B.V.	[Fuchiwaki, Y.; Tanaka, M.; Abe, K.; Kataoka, M.; Ooie, T.] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa 7610395, Japan; [Fuchiwaki, Y.; Yabe, Y.; Adachi, Y.] Cluster Technol Co LTD, Dev Div, Higashiosaka, Osaka 5770836, Japan	Fuchiwaki, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, 2217-14 Hayashi Cho, Takamatsu, Kagawa 7610395, Japan.	yu-fuchiwaki@aist.go.jp			Amada Foundation for Laser Processing; Ministry of Education, Culture, Sports, Science and Technology, Japan [24710146]	This work was supported by the Amada Foundation for Laser Processing and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (24710146). The authors are grateful to Mr. Kenji Koizumi of Cluster Technology Co. Ltd. for piercing the hole in the stainless-steel cover.	Abe K., PLOS ONE, V8; Desai S, 2010, MATER SCI ENG B-ADV, V168, P127, DOI 10.1016/j.mseb.2009.11.006; Kim JD, 2010, POLYMER, V51, P2147, DOI 10.1016/j.polymer.2010.03.038; Morrin A, 2008, ELECTROCHIM ACTA, V53, P5092, DOI 10.1016/j.electacta.2008.02.010; Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011; Kwon KS, 2007, SENSOR ACTUAT A-PHYS, V140, P75, DOI 10.1016/j.sna.2007.06.010; Zheng QA, 2011, ANAL BIOCHEM, V410, P171, DOI 10.1016/j.ab.2010.10.024; Tanaka M, 2010, J LASER MICRO NANOEN, V5, P35; Setti L, 2005, BIOSENS BIOELECTRON, V20, P2019, DOI 10.1016/j.bios.2004.09.022; Kwon KS, 2009, SENSOR ACTUAT A-PHYS, V153, P50, DOI 10.1016/j.sna.2009.04.024; Kettle J, 2010, SURF COAT TECH, V204, P2103, DOI 10.1016/j.surfcoat.2009.10.035; Abe K, 2008, ANAL CHEM, V80, P6928, DOI 10.1021/ac800604v; Dohnal J, 2011, CHEM ENG SCI, V66, P3829, DOI 10.1016/j.ces.2011.05.007; de Pedro S, 2014, SENSOR ACTUAT A-PHYS, V215, P30, DOI 10.1016/j.sna.2014.01.021; Kwon KS, 2013, SENSOR ACTUAT A-PHYS, V201, P335, DOI 10.1016/j.sna.2013.07.027; Kwon KS, 2012, SENSOR ACTUAT A-PHYS, V180, P154, DOI 10.1016/j.sna.2012.04.009; Li EQ, 2010, SENSOR ACTUAT A-PHYS, V163, P315, DOI 10.1016/j.sna.2010.07.014; Matsusaki M, 2011, ANGEW CHEM INT EDIT, V50, P7557, DOI 10.1002/anie.201008204; Ooie T, 2011, J LASER MICRO NANOEN, V6, P44, DOI 10.2961/jlmn.2011.01.0010; Umezu S, 2011, SENSOR ACTUAT A-PHYS, V166, P251, DOI 10.1016/j.sna.2009.12.004; Watanabe M, 2007, SENSOR ACTUAT B-CHEM, V122, P141, DOI 10.1016/j.snb.2006.05.016; Yatsushiro S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018807	22	4	4	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0924-4247			SENSOR ACTUAT A-PHYS	Sens. Actuator A-Phys.	NOV 1	2014	219						1	5		10.1016/j.sna.2014.08.010		5	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	AR1OO	WOS:000343354700001		
J	Hattori, S; Hara, M; Nabae, H; Hwang, D; Higuchi, T				Hattori, Shinya; Hara, Masayuki; Nabae, Hiroyuki; Hwang, Donghyun; Higuchi, Toshiro			Design of an impact drive actuator using a shape memory alloy wire	SENSORS AND ACTUATORS A-PHYSICAL			English	Article						Shape memory alloy; Impact drive mechanism; Linear actuator		This paper introduces an impact drive mechanism (IDM) that utilizes the rapid contraction property of shape memory alloy (SMA) wire. In this study, possible structures for an SMA-wire-based IDM actuator are investigated, and a prototype actuator comprising a main body, an inertia body, an SMA wire, and a bias spring is developed. To verify the applicability of the prototype actuator as a positioning device, driving experiments were conducted under various conditions. The experimental results demonstrated that the prototype actuator enables bidirectional step-like movement with several step sizes by changing the profile of applied voltage, such as amplitude, duty cycle, and frequency. In addition, we developed PI-controller-based position control systems by using these three parameters as control input; the control characteristics and potential applications of each method were discussed. These results implied that the SMA-wire-based IDM actuator has the potential to be used as a new linear actuator in sub-millimeter order driving. (C) 2014 Elsevier B.V. All rights reserved.	[Hattori, Shinya; Hara, Masayuki; Nabae, Hiroyuki; Hwang, Donghyun; Higuchi, Toshiro] Univ Tokyo, Sch Engn, Dept Precis Engn, Bunkyo Ku, Tokyo 1138656, Japan	Hara, M (reprint author), Univ Tokyo, Sch Engn, Dept Precis Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	hattori@aml.t.u-tokyo.ac.jp; masayuki@aml.t.u-tokyo.ac.jp; nabae@aml.t.u-tokyo.ac.jp; donghyun@aml.t.u-tokyo.ac.jp; higuchi@aml.t.u-tokyo.ac.jp					Elahinia MH, 2002, J VIB ACOUST, V124, P566, DOI 10.1115/1.1501285; Zupan M, 2002, ADV ENG MATER, V4, P933, DOI 10.1002/adem.200290009; Morita T, 2003, SENSOR ACTUAT A-PHYS, V103, P291, DOI 10.1016/S0924-4247(02)00405-3; Madill DR, 1998, IEEE T CONTR SYST T, V6, P473, DOI 10.1109/87.701339; Dutta SM, 2005, IEEE-ASME T MECH, V10, P189, DOI 10.1109/TMECH.2005.844709; Hattori S., 2012, P 13 INT C NEW ACT, P500; Higuchi T., 1990, Proceedings. IEEE Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Robots (Cat. No.90CH2832-4), DOI 10.1109/MEMSYS.1990.110280; Higuchi T., 1989, Journal of the Japan Society of Precision Engineering, V55; Iwago Y., 2014, P 14 INT C NEW ACT A, P214; KAWAKATSU H, 1990, J VAC SCI TECHNOL A, V8, P319, DOI 10.1116/1.577097; Kornbluh R., 1988, P IEEE INT C ROB AUT, P2147; Kouklan M.H., 1999, J ROBOT MECHATRON, V11, P263; Kudoh K., 1990, J MAMM OVA RES, V7, P7; Mavroidis C, 2002, RES NONDESTRUCT EVAL, V14, P1, DOI 10.1007/s00164-001-0018-6; MCNICHOLS JL, 1987, J APPL PHYS, V61, P972, DOI 10.1063/1.338151; Micromotor Namiki Precision Jewel Co. Ltd., MICROMOTOR; Ohmichi O, 1997, J MICROELECTROMECH S, V6, P200, DOI 10.1109/84.623108; Otsuka K, 1999, SHAPE MEMORY MAT; Pozzi M, 2001, ENG SCI EDUC J, V10, P31, DOI 10.1049/esej:20010105; Uchino K., 1996, PIEZOELECTRIC ACTUAT, V1; Yamagata Y., 1994, Proceedings IEEE Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Robotic Systems (Cat. No.94CH3404-1), DOI 10.1109/MEMSYS.1994.555613; Yoshida R., 2002, Journal of the Japan Society of Precision Engineering, V68; Yoshida R., 1999, Journal of the Japan Society of Precision Engineering, V65; Zhang ZG, 2010, IEEE INTERNATIONAL SYMPOSIUM ON INDUSTRIAL ELECTRONICS (ISIE 2010), P464	24	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0924-4247			SENSOR ACTUAT A-PHYS	Sens. Actuator A-Phys.	NOV 1	2014	219						47	57		10.1016/j.sna.2014.08.013		11	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	AR1OO	WOS:000343354700007		
J	Jasim, AA; Hayashi, N; Harun, SW; Ahmad, H; Penny, R; Mizuno, Y; Nakamura, K				Jasim, A. A.; Hayashi, N.; Harun, S. W.; Ahmad, H.; Penny, R.; Mizuno, Y.; Nakamura, K.			Refractive index and strain sensing using inline Mach-Zehnder interferometer comprising perfluorinated graded-index plastic optical fiber	SENSORS AND ACTUATORS A-PHYSICAL			English	Article						Tapered fibers; Plastic optical fibers; Heat-and-pull technique; Inline Mach-Zehnder interferometry; Refractive-index sensing; Strain sensing	PHOTONIC-CRYSTAL-FIBER; FABRY-PEROT-INTERFEROMETER; SENSOR	This paper details the fabrication and performance evaluation of an inline Mach-Zehnder interferometer (MZI) consisting of a perfluorinated graded-index plastic optical fiber fabricated via a heat-and-pull tapering technique. This MZI exhibits interference fringes that are sufficiently sharp for usage as refractive-index (RI) and strain sensors. These interference fringes shift linearly with the RI of the surrounding medium, with a proportionality constant of 3.44 nm/RI unit. The measured strain sensitivity of 0.2 pm/mu epsilon suggests that the MZI may be viable for strain-sensing applications. (C) 2014 Elsevier B.V. All rights reserved.	[Jasim, A. A.; Harun, S. W.] Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur 50603, Malaysia; [Jasim, A. A.; Harun, S. W.; Ahmad, H.; Penny, R.] Univ Malaya, Photon Res Ctr, Kuala Lumpur 50603, Malaysia; [Hayashi, N.; Mizuno, Y.; Nakamura, K.] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan	Harun, SW (reprint author), Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur 50603, Malaysia.	swharun@gmail.com	JASIM, AA/I-9646-2014; Harun, S.W/A-3392-2009	JASIM, AA/0000-0003-1606-6322; Harun, S.W/0000-0003-4879-5853	University of Malaya; Ministry of Higher Education (MOHE) [UM.C/625/1/HIR/MOHE/SCI/29, RU002/2013, PG139-2012B]; Japan Society for the Promotion of Science (JSPS) [25709032, 26630180]; General Sekiyu Foundation; Iwatani Naoji Foundation; SCAT Foundation	The authors acknowledge the financial support from the University of Malaya and the Ministry of Higher Education (MOHE) under grants, UM.C/625/1/HIR/MOHE/SCI/29, RU002/2013 and PG139-2012B. This work was also partially supported by Grants-in-Aid for Young Scientists (A) (no. 25709032) and for Challenging Exploratory Research (no. 26630180) from the Japan Society for the Promotion of Science (JSPS), and research grants from the General Sekiyu Foundation, the Iwatani Naoji Foundation, and the SCAT Foundation. N.H. acknowledges a Grant-in-Aid for JSPS Fellows (No. 25007652).	Mizuno Y, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4863413; Tian ZB, 2008, OPT LETT, V33, P1105, DOI 10.1364/OL.33.001105; Hayashi N, 2012, OPT EXPRESS, V20, P21101, DOI 10.1364/OE.20.021101; Ding JF, 2005, IEEE PHOTONIC TECH L, V17, P1247, DOI 10.1109/LPT.2005.847437; Pulido C, 2010, SENSOR ACTUAT B-CHEM, V146, P190, DOI 10.1016/j.snb.2010.02.006; Beres C, 2011, BIOSENS BIOELECTRON, V30, P328, DOI 10.1016/j.bios.2011.09.024; Ferreira MS, 2012, OPT EXPRESS, V20, P21946, DOI 10.1364/OE.20.021946; Yang R, 2011, OPT LETT, V36, P4482, DOI 10.1364/OL.36.004482; Jeong Y, 2009, CURR APPL PHYS, V9, pE273, DOI 10.1016/j.cap.2009.07.013; Lu P, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3115029; Koike Y, 2009, NPG ASIA MATER, V1, P22, DOI 10.1038/asiamat.2009.2; Li C, 2012, IEEE PHOTONIC TECH L, V24, P1771, DOI 10.1109/LPT.2012.2214379; Kim B, 2009, OPT EXPRESS, V17, P15502, DOI 10.1364/OE.17.015502; Mizuno Y, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3463038; Arrue J, 2008, OPT EXPRESS, V16, P16616, DOI 10.1364/OE.16.016616; Ishigure T, 2000, J LIGHTWAVE TECHNOL, V18, P178, DOI 10.1109/50.822790; Liao CR, 2012, OPT EXPRESS, V20, P22813, DOI 10.1364/OE.20.022813; Leung A, 2008, SENSOR ACTUAT B-CHEM, V131, P640, DOI 10.1016/j.snb.2007.12.058; Wieduwilt T, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/7/075201; Bock WJ, 2009, J LIGHTWAVE TECHNOL, V27, P3933, DOI 10.1109/JLT.2009.2021282; Huang Q., 2014, PHOTONIC SENSORS, V4, P92; Ji WB, 2013, SENSORS-BASEL, V13, P14055, DOI 10.3390/s131014055; Kiesel S, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/3/034016; Koike Y., 1995, IEEE J LIGHTWAVE TEC, V13, P1475; Kuzyk M. G., 2006, POLYM FIBER OPTICS M; Villatoro J, 2009, OPT LETT, V34, P2441, DOI 10.1364/OL.34.002441	26	5	5	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0924-4247			SENSOR ACTUAT A-PHYS	Sens. Actuator A-Phys.	NOV 1	2014	219						94	99		10.1016/j.sna.2014.07.018		6	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	AR1OO	WOS:000343354700013		
J	Tsugita, T; Iwai, T				Tsugita, Tetsuya; Iwai, Toshiaki			Optical coherence tomography using images of hair structure and dyes penetrating into the hair	SKIN RESEARCH AND TECHNOLOGY			English	Article						OCT; RGB light sources; LED; hair dyes; hair structure image	IN-VIVO; RESOLUTION IMPROVEMENT; REFRACTIVE-INDEX; SKIN	Background/purposeHair dyes are commonly evaluated by the appearance of the hair after dyeing. However, this approach cannot simultaneously assess how deep the dye has penetrated into hair. MethodsFor simultaneous assessment of the appearance and the interior of hair, we developed a visible-range red, green, and blue (RGB) (three primary colors)-optical coherence tomography (OCT) using an RGB LED light source. We then evaluated a phantom model based on the assumption that the sample's absorbability in the vertical direction affects the tomographic imaging. ResultsConsistent with theory, our device showed higher resolution than conventional OCT with far-red light. In the experiment on the phantom model, we confirmed that the tomographic imaging is affected by absorbability unique to the sample. Furthermore, we verified that permeability can be estimated from this tomographic image. We also identified for the first time the relationship between penetration of the dye into hair and characteristics of wavelength by tomographic imaging of dyed hair. ConclusionWe successfully simultaneously assessed the appearance of dyed hair and inward penetration of the dye without preparing hair sections.	[Tsugita, Tetsuya] Kao Corp, Skin Beauty Res Labs, Sumida Ku, Tokyo 1318501, Japan; [Tsugita, Tetsuya; Iwai, Toshiaki] Tokyo Univ Agr & Technol, Grad Sch Engn, Div Bioapplicat & Syst Engn BASE, Tokyo, Japan	Tsugita, T (reprint author), Kao Corp, Skin Beauty Res Labs, Sumida Ku, 2-1-3 Bunka, Tokyo 1318501, Japan.	tsugita.tetsuya@kao.co.jp					SCHMITT JM, 1995, DERMATOLOGY, V191, P93; Gambichler T, 2005, J DERMATOL SCI, V40, P85, DOI 10.1016/j.jdermsci.2005.07.006; Hori Y, 2006, OPT EXPRESS, V14, P1862, DOI 10.1364/OE.14.001862; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Tripathi R, 2002, OPT LETT, V27, P406, DOI 10.1364/OL.27.000406; Mogensen M, 2007, BRIT J DERMATOL, V157, P894, DOI 10.1111/j.1365-2133.2007.08118.x; SWANSON EA, 1993, OPT LETT, V18, P1864, DOI 10.1364/OL.18.001864; Knuttel A, 2000, J BIOMED OPT, V5, P83, DOI 10.1117/1.429972; Gambichler T, 2005, CLIN EXP DERMATOL, V0, P78; Gambichler T, 2006, PHOTOCHEM PHOTOBIOL, V82, P1103, DOI 10.1562/2005-12-21-RA-757; IZATT JA, 1994, ARCH OPHTHALMOL-CHIC, V112, P1584; Pagnoni A, 1999, SKIN RES TECHNOL, V5, P83, DOI 10.1111/j.1600-0846.1999.tb00120.x; Saigusa H, 2008, APPL PHYS EXPRESS, V1; Sand M, 2006, SKIN RES TECHNOL, V12, P114, DOI 10.1111/j.0909-752X.2006.00144.x; SCHMITT JM, 1993, APPL OPTICS, V32, P6032, DOI 10.1364/AO.32.006032; Vogt M, 2003, BIOMED TECH, V48, P116, DOI 10.1515/bmte.2003.48.5.116; Watanabe Y, 2006, OPT COMMUN, V261, P376, DOI 10.1016/j.optcom.2005.12.030; Zhang Y, 2001, OPT LETT, V26, P205, DOI 10.1364/OL.26.000205; Zhang Y, 2001, OPT COMMUN, V192, P183, DOI 10.1016/S0030-4018(01)01197-X	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-752X	1600-0846		SKIN RES TECHNOL	Skin Res. Technol.	NOV	2014	20	4					389	398		10.1111/srt.12129		10	Dermatology	Dermatology	AR7JK	WOS:000343755400001		
J	Arai, KY; Sugimoto, M; Ito, K; Ogura, Y; Akutsu, N; Amano, S; Adachi, E; Nishiyama, T				Arai, Koji Y.; Sugimoto, Mami; Ito, Kanako; Ogura, Yuki; Akutsu, Nobuko; Amano, Satoshi; Adachi, Eijiro; Nishiyama, Toshio			Repeated folding stress-induced morphological changes in the dermal equivalent	SKIN RESEARCH AND TECHNOLOGY			English	Article						dermal equivalent; fibroblast; mechanical stress; skin furrow; wrinkle	COLLAGEN-MATRIX CONTRACTION; ENDOGENOUS CONTROL GENES; TIME QUANTITATIVE PCR; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR; FOCAL ADHESIONS; MECHANICAL SIGNALS; BASEMENT-MEMBRANE; TENASCIN-C; RHO-KINASE	Background/purposeRepeated mechanical stresses applied to the same region of the skin are thought to induce morphological changes known as wrinkle. However, the underlying mechanisms are not fully understood. To study the mechanisms, we examined effects of repeated mechanical stress on the dermal equivalent. MethodsWe developed a novel device to apply repeated folding stress to the dermal equivalent. After applying the mechanical stress, morphological changes of the dermal equivalent and expression of several genes related to extracellular matrix turn over and cell contraction were examined. ResultsThe repeated folding stress induced a noticeable decrease in the width of the dermal equivalent. The mechanical stress altered orientations of collagen fibrils. Hydroxyproline contents, dry weights and cell viability of the dermal equivalents were not affected by the mechanical stress. On the other hand, Rho-associated coiled-coil-containing kinase (ROCK) specific inhibitor Y27632 completely suppressed the decrease in the width of the dermal equivalent. ConclusionThe present results revealed that either degradation of collagen or changes in the number of cells were not responsible for the decrease in the width of the dermal equivalent and indicate that the repeated mechanical stress induces unidirectional contraction in the dermal equivalent through the RhoA-ROCK signaling pathway.	[Arai, Koji Y.; Sugimoto, Mami; Ito, Kanako; Nishiyama, Toshio] Tokyo Univ Agr & Technol, Fac Agr, Scleroprot Res Inst, Fuchu, Tokyo 1838509, Japan; [Ogura, Yuki; Akutsu, Nobuko; Amano, Satoshi] Shiseido Res Ctr, Yokohama, Kanagawa, Japan; [Adachi, Eijiro] Kitasato Univ, Grad Sch Med Sci, Dept Matrix Biol & Regenerat Med, Minato, Kanagawa, Japan	Nishiyama, T (reprint author), Tokyo Univ Agr & Technol, Fac Agr, Div Matrix Biol, Scleroprot Res Inst, Fuchu, Tokyo 1838509, Japan.	toshio_n@cc.tuat.ac.jp	ARAI, Koji/G-1144-2013; Nishiyama, Toshio/C-5434-2013		Ministry of Education, Culture, Sports, Science and Technology of Japan [16380227, 19580393]	Grants: This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant No. 16380227, 19580393)	Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Tsunenaga M, 1998, MATRIX BIOL, V17, P603, DOI 10.1016/S0945-053X(98)90111-1; RESNICK N, 1993, P NATL ACAD SCI USA, V90, P4591, DOI 10.1073/pnas.90.10.4591; Sarasa-Renedo A, 2006, EXP CELL RES, V312, P1361, DOI 10.1016/j.yexcr.2005.12.025; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Chiquet M, 1999, MATRIX BIOL, V18, P417, DOI 10.1016/S0945-053X(99)00039-6; Watanabe N, 1999, NAT CELL BIOL, V1, P136; Eckes B, 2004, CLIN EXP RHEUMATOL, V22, pS73; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Ma YH, 1999, BIOCHEM BIOPH RES CO, V265, P606, DOI 10.1006/bbrc.1999.1718; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002; Abe M, 2003, J BIOL CHEM, V278, P47707, DOI 10.1074/jbc.M306228200; Trachslin J, 1999, EXP CELL RES, V247, P320, DOI 10.1006/excr.1998.4363; Chiquet M, 2003, MATRIX BIOL, V22, P73, DOI 10.1016/S0945-053X(03)00004-0; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Peterson LJ, 2004, MOL BIOL CELL, V15, P3497, DOI 10.1091/mbc/.E03-09.0696; MONTESANO R, 1988, P NATL ACAD SCI USA, V85, P4894, DOI 10.1073/pnas.85.13.4894; Amano S, 2001, EXP CELL RES, V271, P249, DOI 10.1006/excr.2001.5387; Sarasa-Renedo A, 2005, SCAND J MED SCI SPOR, V15, P223, DOI 10.1111/j.1600-0838.2005.00461.x; Katoh K, 2011, J R SOC INTERFACE, V8, P305, DOI 10.1098/rsif.2010.0419; Wang JHC, 2007, GENE, V391, P1, DOI 10.1016/j.gene.2007.01.014; Grinnell F, 1999, J BIOL CHEM, V274, P918, DOI 10.1074/jbc.274.2.918; Ogura Y, 2008, BRIT J DERMATOL, V159, P49, DOI 10.1111/j.1365-2133.2008.08576.x; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Arai KY, 2009, BIOCHEM BIOPH RES CO, V385, P478, DOI 10.1016/j.bbrc.2009.05.104; Carmeliet G, 2001, CRIT REV EUKAR GENE, V11, P131; CHIQUETEHRISMANN R, 1994, J CELL BIOL, V127, P2093, DOI 10.1083/jcb.127.6.2093; CLARK RAF, 1989, J CLIN INVEST, V84, P1036, DOI 10.1172/JCI114227; Gutierrez JA, 1999, AM J PHYSIOL-GASTR L, V277, pG1074; Hillebrand GG, 2010, BRIT J DERMATOL, V162, P1233, DOI 10.1111/j.1365-2133.2010.09709.x; Kheirelseid EAH, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-12; Magnenat-Thalmann N, 2002, IEEE T INF TECHNOL B, V6, P317, DOI 10.1109/TITB.2002.806097; McNeill RE, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-107; Park SA, 2006, J BIOSCI BIOENG, V102, P402, DOI 10.1263/jbb.102.402; SATO Y, 1992, AM J PATHOL, V140, P775	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-752X	1600-0846		SKIN RES TECHNOL	Skin Res. Technol.	NOV	2014	20	4					399	408		10.1111/srt.12131		10	Dermatology	Dermatology	AR7JK	WOS:000343755400002		
J	Kojima, T; Yamada, H; Isobe, M; Yamamoto, T; Takeuchi, M; Aoki, D; Matsushita, Y; Fukushima, K				Kojima, Toru; Yamada, Hiromi; Isobe, Mitsuru; Yamamoto, Toshihiko; Takeuchi, Miyuki; Aoki, Dan; Matsushita, Yasuyuki; Fukushima, Kazuhiko			Compositional changes of human hair melanin resulting from bleach treatment investigated by nanoscale secondary ion mass spectrometry	SKIN RESEARCH AND TECHNOLOGY			English	Article						melanin; human hair; bleach; NanoSIMS; elemental mapping	RAMAN-SPECTROSCOPY; TOF-SIMS; ELECTRON-MICROSCOPY; STRUCTURAL-CHANGES; HYDROGEN-PEROXIDE; CHEMICAL-ANALYSIS; DAMAGE; BLACK; MELANOGENESIS; DEGRADATION	Background/purposeIt is important to understand the influence of bleach treatment on human hair because it is one of the most important chemical treatments in hair cosmetic processes. A comparison of the elemental composition of melanin between virgin hair and bleached hair would provide important information about the structural changes of melanin. To investigate the elemental composition of melanin granules in virgin black hair and bleached hair, these hair cross-sections are analyzed by using a nanoscale secondary ion mass spectrometry (NanoSIMS). MethodsThe virgin black hair and bleached hair samples were embedded in resin and smooth hair cross-sections were obtained using an ultramicrotome. NanoSIMS measurements were performed using a Cs+ primary ion beam to detect negative secondary ions. ResultsMore intensive O-16(-) ions were detected from the melanin granules of bleached hair than from those of virgin black hair in NanoSIMS O-16(-) ion image. In addition, it was indicated that O-16(-) ion intensity and O-16(-)/(CN-)-C-12-N-14 ion intensity ratio of melanin granules in bleached hair were higher than those in virgin black hair. ConclusionNanoscale secondary ion mass spectrometry analysis of the cross-sections of virgin black hair and bleached hair indicated that the oxygen content in melanin granules was increased by bleach treatment.	[Kojima, Toru; Yamada, Hiromi; Isobe, Mitsuru; Yamamoto, Toshihiko] Hoyu Co Ltd, Gen Res & Dev Inst, Nagakute, Aichi 4801136, Japan; [Takeuchi, Miyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Aoki, Dan; Matsushita, Yasuyuki; Fukushima, Kazuhiko] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Kojima, T (reprint author), Hoyu Co Ltd, Gen Res & Dev Inst, 1-12 Roboku, Nagakute, Aichi 4801136, Japan.	tooru_kojima@hoyu.co.jp	Aoki, Dan/I-6926-2014		Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [12024046]; NIH/NIBIB National Resource for Imaging Mass Spectrometry [NIH/NIBIB 5P41 EB001974-10]	A part of this work was supported by "Nanotechnology Platform"(project No. 12024046) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. This work was made possible in part by the OpenMIMS software whose development is funded by the NIH/NIBIB National Resource for Imaging Mass Spectrometry, NIH/NIBIB 5P41 EB001974-10.	Ito S, 2000, PIGM CELL RES, V13, P103, DOI 10.1034/j.1600-0749.13.s8.19.x; Imai Takehito, 2011, Okajimas Folia Anatomica Japonica, V88, P1; Saito K, 2012, PLANT J, V69, P542, DOI 10.1111/j.1365-313X.2011.04811.x; Morel OJX, 2011, CHEM REV, V111, P2537, DOI 10.1021/cr1000145; Clode PL, 2009, PLANT PHYSIOL, V151, P1751, DOI 10.1104/pp.109.141499; Clode PL, 2007, MICROSC RES TECHNIQ, V70, P220, DOI 10.1002/jemt.20409; TATE ML, 1993, J SOC COSMET CHEM, V44, P347; Boxer SG, 2009, ANNU REV BIOPHYS, V38, P53, DOI 10.1146/annurev.biophys.050708.133634; Ito S, 2011, PIGM CELL MELANOMA R, V24, P605, DOI 10.1111/j.1755-148X.2011.00864.x; Kuzuhara A, 2007, BIOPOLYMERS, V85, P274, DOI 10.1002/bip.20646; Liu Y, 2003, PIGM CELL RES, V16, P355, DOI 10.1034/j.1600-0749.2003.00059.x; KORYTOWSKI W, 1990, J BIOL CHEM, V265, P12410; Saito K, 2008, ANAL CHEM, V80, P1552, DOI 10.1021/ac7021162; Herrmann AM, 2007, SOIL BIOL BIOCHEM, V39, P1835, DOI 10.1016/j.soilbio.2007.03.011; Riley PA, 1997, INT J BIOCHEM CELL B, V29, P1235, DOI 10.1016/S1357-2725(97)00013-7; ARNAUD JC, 1981, J SOC COSMET CHEM, V32, P137; Ito S, 2008, PHOTOCHEM PHOTOBIOL, V84, P582, DOI 10.1111/j.1751-1097.2007.00238.x; Kojima T, 2013, COLLOID SURFACE B, V106, P140, DOI 10.1016/j.colsurfb.2013.01.028; Borges CR, 2001, ANAL BIOCHEM, V290, P116, DOI 10.1006/abio.2000.4976; Audinot JN, 2004, APPL SURF SCI, V231, P490, DOI 10.1016/j.apsusc.2004.03.192; Bantignies J.-L., 1998, International Journal of Cosmetic Science, V20, P381, DOI 10.1046/j.1467-2494.1998.177055.x; Bantignies JL, 2000, J COSMET SCI, V51, P73; Brown KC, 1997, HAIR HAIR CARE, P191; Hallegot P, 2004, J INVEST DERMATOL, V122, P381, DOI 10.1046/j.0022-202X.2004.22217.x; JACHOWICZ J, 1987, J SOC COSMET CHEM, V38, P263; Kempson IM, 2005, SCI TOTAL ENVIRON, V338, P213, DOI 10.1016/j.scitotenv.2004.07.017; Kojima T, 2012, INT J POLYM ANAL CH, V17, P21, DOI 10.1080/1023666X.2012.638435; Kojima T, 2011, SURF INTERFACE ANAL, V43, P562, DOI 10.1002/sia.3635; Kuzuhara A, 2013, J MOL STRUCT, V1047, P186, DOI 10.1016/j.molstruc.2013.04.079; Kuzuhara A, 2006, BIOPOLYMERS, V81, P506, DOI 10.1002/bip.20453; Kuzuhara A, 2005, BIOPOLYMERS, V77, P335, DOI 10.1002/bip.20221; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Marsh JM, 2012, PRACTICAL MODERN HAI, P117; Masukawa Y, 2005, J COSMET SCI, V56, P297; Masukawa Y, 2006, LIPIDS, V41, P197, DOI 10.1007/s11745-006-5088-4; Menkart J, 1966, J SOC COSMET CHEM, V17, P769; MENON IA, 1983, J INVEST DERMATOL, V80, P202, DOI 10.1111/1523-1747.ep12534045; Popescu C, 2007, CHEM SOC REV, V36, P1282, DOI 10.1039/b604537p; Prota G, 1997, PIGM CELL RES, V10, P5, DOI 10.1111/j.1600-0749.1997.tb00460.x; PROTA G, 1988, MED RES REV, V8, P525, DOI 10.1002/med.2610080405; Robbins C. R., 2012, CHEM PHYS BEHAV HUMA; Sakamoto O, 1978, J SOC COSMET CHEM JP, V12, P39; SLAWINSKA D, 1982, PHYSIOL CHEM PHYS M, V14, P363; Smart KE, 2009, J COSMET SCI, V60, P337; Swift JA, 1997, FORMATION STRUCTURE, P149; Takada K, 2003, J OLEO SCI, V10, P541; Williams Peter, 2006, J Biol, V5, P18, DOI 10.1186/jbiol49; WOLFRAM L J, 1970, Journal of the Society of Cosmetic Chemists, V21, P875; WORTMANN FJ, 1990, J SOC COSMET CHEM, V41, P123; Wortmann F-J, 1985, J SOC COSMET CHEM, V36, P87; Zvaik C, 1986, SCI HAIR CARE, P263; Zvaik C, 1986, SCI HAIR CARE, P1	52	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-752X	1600-0846		SKIN RES TECHNOL	Skin Res. Technol.	NOV	2014	20	4					416	421		10.1111/srt.12133		6	Dermatology	Dermatology	AR7JK	WOS:000343755400004		
J	Galzote, C; Estanislao, R; Suero, MO; Khaiat, A; Mangubat, MI; Moideen, R; Tagami, H; Wang, X				Galzote, C.; Estanislao, R.; Suero, M. O.; Khaiat, A.; Mangubat, M. I.; Moideen, R.; Tagami, H.; Wang, X.			Characterization of facial skin of various Asian populations through visual and non-invasive instrumental evaluations: influence of seasons	SKIN RESEARCH AND TECHNOLOGY			English	Article						Asian skin; seasons; melanin; moisture; TEWL; sebum; elasticity	STRATUM-CORNEUM; AGE; FLUORESCENCE; PIGMENTATION; ASSESSMENTS; HABITS; MARKER; WINTER; PH	Background/purposeThis multicenter study assessed the impact of two types of extreme seasons (i.e. summer and winter) on the facial skin of female subjects living in different regions of Asia. MethodsFacial skin of female subjects of various Asian ethnicities was characterized during summer and winter using dermatological assessments of the cheek and instrumental evaluations of the forehead and cheek. Approximately, 100 female subjects each from five cities in Asia (Harbin and Shanghai in China; New Delhi, India; Seoul, South Korea; and Sendai, Japan) ranging in age from 14 to 75years were included in this study. ResultsDermatologist assessments revealed a general decrease in severity of roughness, wrinkles, pigmentation, and lentigines during winter compared with summer. Instrumental assessments revealed significant differences in various parameters in winter vs. summer such as reductions in melanin index and skin surface hydration, and increases in transepidermal water loss, skin pH, redness, and sebum production. ConclusionFacial skin in female subjects living in different Asian cities exhibited a wide range of changes and worsening of various biophysical parameters in response to the low temperature and humidity during the winter season as compared with summer.	[Galzote, C.] Johnson & Johnson China Ltd, Shanghai, Peoples R China; [Estanislao, R.; Suero, M. O.] Johnson & Johnson Philippines Inc, Paranaque, Philippines; [Khaiat, A.] Johnson & Johnson Asia Pacific, Singapore, Singapore; [Mangubat, M. I.] Med Ctr, Manila, Philippines; [Moideen, R.] Skin & Cosmet Surg Res Ctr, Calicut, Kerala, India; [Tagami, H.] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Wang, X.] Shanghai Skin Dis Hosp, Shanghai, Peoples R China	Wang, X (reprint author), Shanghai Skin Dis Hosp, Skin & Cosmet Res Dept, Shanghai 200433, Peoples R China.	dermxmwang@163.com			Johnson & Johnson Asia-Pacific; Johnson Johnson	This study was funded by Johnson & Johnson Asia-Pacific. Carlos Galzote and Roderico Estanislao are employees of Johnson & Johnson in their respective countries. Michael Oliver Suero was employed by Johnson & Johnson (Philippines), Inc. at the time of the study but currently works for Johnson & Johnson Sdn. Bhd. (Petaling Jaya, Malaysia). Alain Khaiat was employed at Johnson & Johnson Asia-Pacific at the time of this study, but now works for Seers Consulting, a company that is not associated with this study. Maria Isabel Mangubat, Rafeeq Moideen, Hachiro Tagami, and Xuemin Wang were principal investigators and graders at study sites, with their participation in this study and analysis of the results funded by Johnson & Johnson. The authors would like to thank Zinnia Rivera for critically reviewing the study proposal, Hazel Guardian for statistics support, and Jun Li, Hyun Ok Kim, and Suja Thomas for site management (including coordination and recruitment) and data collection. The authors would also like to thank Joy Ramos, PhD for editorial support funded by Johnson & Johnson Asia-Pacific.	Man MQ, 2009, SKIN PHARMACOL PHYS, V22, P190, DOI 10.1159/000231524; Youn SW, 2005, SKIN RES TECHNOL, V11, P189, DOI 10.1111/j.1600-0846.2005.00119.x; Kikuchi K, 2008, BRIT J DERMATOL, V158, P969, DOI 10.1111/j.1365-2133.2008.08478.x; BAREL AO, 1995, SKIN PHARMACOL, V8, P186; Brancaleon L, 1999, J INVEST DERMATOL, V113, P977, DOI 10.1046/j.1523-1747.1999.00799.x; Qiu H, 2011, INT J COSMETIC SCI, V33, P377, DOI 10.1111/j.1468-2494.2011.00639.x; Stamatas GN, 2006, BRIT J DERMATOL, V154, P125, DOI 10.1111/j.1365-2133.2005.06949.x; Clarys P, 2000, SKIN RES TECHNOL, V6, P230, DOI 10.1034/j.1600-0846.2000.006004230.x; YOSHIKAWA N, 1994, DERMATOLOGY, V188, P207; Galzote C, 2013, SKIN RES TECHNOL, V19, P454, DOI 10.1111/srt.12069; Rogers J, 1996, ARCH DERMATOL RES, V288, P765, DOI 10.1007/BF02505294; Cheng Y, 2008, SKIN RES TECHNOL, V14, P45, DOI 10.1111/j.1600-0846.2007.00260.x; Clarys P, 1999, SKIN RES TECHNOL, V5, P14, DOI 10.1111/j.1600-0846.1999.tb00198.x; DesPaepe K, 2009, SKIN PHARMACOL PHYS, V22, P8; DIKSTEIN S, 1994, ACTA DERM-VENEREOL, P18; Hara M, 1993, J GERIATR DERMATOL, V1, P111; Huixia Q, 2012, INT J COSMETIC SCI, V34, P49, DOI 10.1111/j.1468-2494.2011.00680.x; Kikuchi K, 2002, EXOG DERMATOL, V1, P32, DOI 10.1159/000047989; Kobayashi Y., 2008, International Journal of Cosmetic Science, V30, P35, DOI 10.1111/j.1468-2494.2008.00422.x; Kollias N, 1998, J INVEST DERMATOL, V111, P776, DOI 10.1046/j.1523-1747.1998.00377.x; Li X, 2014, SKIN RES TECHNOL, V20, P14, DOI 10.1111/srt.12076; Macdonald HM, 2011, J CLIN ENDOCR METAB, V96, P1677, DOI 10.1210/jc.2010-2032; Qiu Huixia, 2013, Clin Cosmet Investig Dermatol, V6, P151, DOI 10.2147/CCID.S41578; Ruvolo E, 2009, PHOTODERMATOL PHOTO, V25, P298, DOI 10.1111/j.1600-0781.2009.00469.x; Tagami H, 2008, ARCH DERMATOL RES, V300, pS1, DOI 10.1007/s00403-007-0799-9; Tsukahara K, 2013, SKIN RES TECHNOL, V19, P279, DOI 10.1111/srt.12038; Wagner JK, 2002, PIGM CELL RES, V15, P379, DOI 10.1034/j.1600-0749.2002.02042.x	27	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-752X	1600-0846		SKIN RES TECHNOL	Skin Res. Technol.	NOV	2014	20	4					453	462		10.1111/srt.12140		10	Dermatology	Dermatology	AR7JK	WOS:000343755400010		
J	Hambsch, M; Jin, H; Clulow, AJ; Nelson, A; Yamada, NL; Velusamy, M; Yang, QY; Zhu, FR; Burn, PL; Gentle, IR; Meredith, P				Hambsch, Mike; Jin, Hui; Clulow, Andrew J.; Nelson, Andrew; Yamada, Norifumi L.; Velusamy, Marappan; Yang, Qingyi; Zhu, Furong; Burn, Paul L.; Gentle, Ian R.; Meredith, Paul			Improved stability of non-ITO stacked electrodes for large area flexible organic solar cells	SOLAR ENERGY MATERIALS AND SOLAR CELLS			English	Article						Blade coating; Organic photovoltaics; Organic semiconductors; Neutron reflectometry	DEHYDRATION; DEVICES; DESIGN; LAYER	We present ITO-free rigid and flexible monolithic organic solar cells with an active area of 25 cm2. The devices employ a transparent insulator/metal/insulator anode consisting of a molybdenum oxide/silver/ zinc sulfide stack that had a peak transmittance of 80% and a sheet resistance of 3.6 52/0. Neutron reflectometry showed that zinc sulfide formed a more stable capping layer at the air interface than molybdenum oxide. It was found that blade coating could be used to form good quality large area films on both rigid (glass) and flexible Epoly(ethylene terephthalate)I substrates with much reduced material consumption. Cells with an active layer comprised of a blend of poly[N-9"-heptadecany1-2,7-carbazole-alt-5,5-(4',7'-di-2-thienyl-2',1',3'-benzothiadiazole)] (PCDTBT) and 16,61-phenyl-C-71-butyric acid methyl ester (PC70BM) gave a power conversion efficiency of 2.7%, which was 40% higher than a standard ITObased device. No loss in efficiency was observed when a flexible substrate was used. (C) 2014 Elsevier B.V. All rights reserved.	[Hambsch, Mike; Jin, Hui; Clulow, Andrew J.; Velusamy, Marappan; Burn, Paul L.; Gentle, Ian R.; Meredith, Paul] Univ Queensland, Ctr Organ Photon & Elect, Brisbane, Qld 4072, Australia; [Nelson, Andrew] Australian Nucl Sci & Technol Org, Bragg Inst, Kirrawee DC, NSW 2232, Australia; [Yamada, Norifumi L.] KEK, High Energy Accelerator Res Org, Div Neutron Sci, Naka, Ibaraki 3191106, Japan; [Yang, Qingyi; Zhu, Furong] Hong Kong Baptist Univ, Dept Phys, Kowloon Tong, Hong Kong, Peoples R China; [Yang, Qingyi; Zhu, Furong] Hong Kong Baptist Univ, Inst Adv Mat, Kowloon Tong, Hong Kong, Peoples R China	Burn, PL (reprint author), Univ Queensland, Ctr Organ Photon & Elect, Brisbane, Qld 4072, Australia.	p.burn2@uq.edu.au; meredith@physics.uq.edu.au	Nelson, Andrew/C-2545-2012; Gentle, Ian/A-8975-2011; Burn, Paul/F-5347-2010; Hambsch, Mike/F-9528-2014; McKenzie, Warren/J-2137-2014	Nelson, Andrew/0000-0002-4548-3558; Gentle, Ian/0000-0001-5573-7868; Hambsch, Mike/0000-0002-8487-0972; 	Australian Research Council [DP1211572]; University of Queensland (Strategic Initiative Centre for Organic Photonics Electronics); Queensland Government (National and International Research Alliances Program); Inter-University Research Program on Neutron Scattering of IMSS, KEK; Australian Government through Australian Renewable Energy Agency (ARENA)	This work has been supported in part by the Australian Research Council (DP1211572). We acknowledge funding from the University of Queensland (Strategic Initiative Centre for Organic Photonics & Electronics) and the Queensland Government (National and International Research Alliances Program). This work was performed in part at the Queensland node of the Australian National Fabrication Facility (ANFF) a company established under the National Collaborative Research Infrastructure Strategy to provide nano and microfabrication facilities for Australia's researchers. The initial neutron reflectivity experiments were approved by the Neutron Science Proposal Review Committee of J-PARC/MLF (Proposal no. 2012B0200) and supported by the Inter-University Research Program on Neutron Scattering of IMSS, KEK. We also acknowledge the support of the Bragg Institute, the Australian Nuclear Science and Technology Organisation (ANSTO) and the Australian Institute for Nuclear Science and Engineering (AINSE) for providing the neutron research facilities used in the second round of reflectivity experiments. The authors would like to thank Jake McEwan for helping with the neutron reflectometry measurements and Dr. G.C. Schmidt for supplying the PET substrates. This Program has also been supported by the Australian Government through the Australian Renewable Energy Agency (ARENA). Responsibility for the views, information, or advice expressed herein is not accepted by the Australian Government.	PENFOLD J, 1990, J PHYS-CONDENS MAT, V2, P1369, DOI 10.1088/0953-8984/2/6/001; Green MA, 2013, PROG PHOTOVOLTAICS, V21, P1, DOI 10.1002/pip.2352; Galagan Y, 2011, CHEM ENG PROCESS, V50, P454, DOI 10.1016/j.cep.2010.07.012; Chang YH, 2009, ORG ELECTRON, V10, P741, DOI 10.1016/j.orgel.2009.03.001; Andersen TR, 2011, ACS NANO, V5, P4188, DOI 10.1021/nn200933r; Wang XZ, 2011, ORG ELECTRON, V12, P1429, DOI 10.1016/j.orgel.2011.05.012; Schubert S, 2013, ADV ENERGY MATER, V3, P438, DOI 10.1002/aenm.201200903; Hosel M, 2013, ENERGY TECHNOL-GER, V1, P102, DOI 10.1002/ente.201200029; Jin H, 2012, ADV ENERGY MATER, V2, P1338, DOI 10.1002/aenm.201200254; Kopola P, 2011, SOL ENERG MAT SOL C, V95, P1344, DOI 10.1016/j.solmat.2010.12.020; Kuzmin A, 2000, J PHYS-CONDENS MAT, V12, P1959, DOI 10.1088/0953-8984/12/9/301; Moon JS, 2012, ADV ENERGY MATER, V2, P304, DOI 10.1002/aenm.201100667; Sondergaard R, 2012, MATER TODAY, V15, P36; Bovill ESR, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4804294; Galagan Y, 2012, ADV ENERGY MATER, V2, P103, DOI 10.1002/aenm.201100552; Jin H, 2012, ADV MATER, V24, P2572, DOI 10.1002/adma.201104896; GUNTER JR, 1972, J SOLID STATE CHEM, V5, P354, DOI 10.1016/0022-4596(72)90079-5; Schilinsky P, 2006, ADV FUNCT MATER, V16, P1669, DOI 10.1002/adfm.200500581; James M, 2011, NUCL INSTRUM METH A, V632, P112, DOI 10.1016/j.nima.2010.12.075; Liu Y, 2013, SOL ENERG MAT SOL C, V112, P157, DOI 10.1016/j.solmat.2013.01.025; Nelson A, 2006, J APPL CRYSTALLOGR, V39, P273, DOI 10.1107/S0021889806005073; Manceau M, 2011, ORG ELECTRON, V12, P566, DOI 10.1016/j.orgel.2011.01.009; Auer G., 2009, ULLMANNS ENCY IND CH; Greenwood N.N., 1997, CHEM ELEMENTS; Ham J, 2013, J MATER CHEM A, V1, P3076, DOI 10.1039/c2ta00946c; Irfan I, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4748978; LI HH, 1984, J PHYS CHEM REF DATA, V13, P103; Sears VF, 1992, NEUTRON NEWS, V3, P26, DOI [10.1080/10448639208218770, DOI 10.1080/10448639208218770]; Vedraine S, 2013, ORG ELECTRON, V14, P1122, DOI 10.1016/j.orgel.2013.01.030; Yamada N.L., 2011, EUR PHYS J PLUS, V126, P13; Zhu FR, 1997, SOL ENERG MAT SOL C, V49, P163, DOI 10.1016/S0927-0248(97)00191-8	31	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0248	1879-3398		SOL ENERG MAT SOL C	Sol. Energy Mater. Sol. Cells	NOV	2014	130				SI		182	190		10.1016/j.solmat.2014.06.032		9	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	AR5GH	WOS:000343612600024		
J	Madsen, MV; Gevorgyan, SA; Pacios, R; Ajuria, J; Etxebarria, I; Kettle, J; Bristow, ND; Neophytou, M; Choulis, SA; Roman, LS; Yohannes, T; Cester, A; Cheng, P; Zhan, XW; Wu, J; Xie, ZY; Tu, WC; He, JH; Fell, CJ; Anderson, K; Hermenau, M; Bartesaghi, D; Koster, LJA; Machui, F; Gonzalez-Valls, I; Lira-Cantu, M; Khlyabich, PP; Thompson, BC; Gupta, R; Shanmugam, K; Kulkarni, GU; Galagan, Y; Urbina, A; Abad, J; Roesch, R; Hoppe, H; Morvillo, P; Bobeico, E; Panaitescu, E; Menon, L; Luo, Q; Wu, ZW; Ma, CQ; Hambarian, A; Melikyan, V; Hambsch, M; Burn, PL; Meredith, P; Rath, T; Dunst, S; Trimmel, G; Bardizza, G; Mullejans, H; Goryachev, AE; Misra, RK; Katz, EA; Takagi, K; Magaino, S; Saito, H; Aoki, D; Sommeling, PM; Kroon, JM; Vangerven, T; Manca, J; Kesters, J; Maes, W; Bobkova, OD; Trukhanov, VA; Paraschuk, DY; Castro, FA; Blakesley, J; Tuladhar, SM; Rohr, JA; Nelson, J; Xia, JB; Parlak, EA; Tumay, TA; Egelhaaf, HJ; Tanenbaum, DM; Ferguson, GM; Carpenter, R; Chen, HZ; Zimmermann, B; Hirsch, L; Wantz, G; Sun, ZQ; Singh, P; Bapat, C; Offermans, T; Krebs, FC				Madsen, Morten V.; Gevorgyan, Suren A.; Pacios, R.; Ajuria, J.; Etxebarria, I.; Kettle, Jeff; Bristow, Noel D.; Neophytou, Marios; Choulis, Stelios A.; Roman, Lucimara Stolz; Yohannes, Teketel; Cester, Andrea; Cheng, Pei; Zhan, Xiaowei; Wu, Jiang; Xie, Zhiyuan; Tu, Wei-Chen; He, Jr-Hau; Fell, Christopher J.; Anderson, Kenrick; Hermenau, Martin; Bartesaghi, Davide; Koster, L. Jan Anton; Machui, Florian; Gonzalez-Valls, Irene; Lira-Cantu, Monica; Khlyabich, Petr P.; Thompson, Barry C.; Gupta, Ritu; Shanmugam, Kiruthika; Kulkarni, Giridhar U.; Galagan, Yulia; Urbina, Antonio; Abad, Jose; Roesch, Roland; Hoppe, Harald; Morvillo, P.; Bobeico, E.; Panaitescu, Eugen; Menon, Latika; Luo, Qun; Wu, Zhenwu; Ma, Changqi; Hambarian, Artak; Melikyan, Varuzhan; Hambsch, M.; Burn, Paul L.; Meredith, Paul; Rath, Thomas; Dunst, Sebastian; Trimmel, Gregor; Bardizza, Giorgio; Muellejans, Harald; Goryachev, A. E.; Misra, Ravi K.; Katz, Eugene A.; Takagi, Katsuhiko; Magaino, Shinichi; Saito, Hidenori; Aoki, Daisuke; Sommeling, Paul M.; Kroon, Jan M.; Vangerven, Tim; Manca, Jean; Kesters, Jurgen; Maes, Wouter; Bobkova, Olga D.; Trukhanov, Vasily A.; Paraschuk, Dmitry Yu.; Castro, Fernando A.; Blakesley, James; Tuladhar, Sachetan M.; Roehr, Jason Alexander; Nelson, Jenny; Xia, Jiangbin; Parlak, Elif Alturk; Tumay, Tulay Ash; Egelhaaf, Hans-Joachim; Tanenbaum, David M.; Ferguson, Gretta Mae; Carpenter, Robert; Chen, Hongzheng; Zimmermann, Birger; Hirsch, Lionel; Wantz, Guillaume; Sun, Ziqi; Singh, Pradeep; Bapat, Chaitnya; Offermans, Ton; Krebs, Frederik C.			Worldwide outdoor round robin study of organic photovoltaic devices and modules	SOLAR ENERGY MATERIALS AND SOLAR CELLS			English	Article						OPV; Round robin; Interlaboratory study; Worldwide coverage; Organic photovoltaic; Efficiency reporting	SOLAR-CELLS; STABILITY; PERFORMANCE	Accurate characterization and reporting of organic photovoltaic (OPV) device performance reniains one of the important challenges in the field. The large spread among the efficiencies of devices with the same structure reported by different groups is significantly caused by different procedures and equipment used during testing. The presented article addresses this issue by offering a new method of device testing using "suitcase sample" approach combined with outdoor testing that limits the diversity of the equipment, and a strict measurement protocol. A round robin outdoor characterization of roll-to-roll coated OPV cells and modules conducted among 46 laboratories worldwide is presented, where the samples and the testing equipment were integrated in a compact suitcase that served both as a sample transportation tool and as a holder and test equipment during testing. In addition, an internet based coordination was used via plasticphotovoltaics.org that allowed fast and efficient communication among participants and provided a controlled reporting format for the results that eased the analysis of the data. The reported deviations among the laboratories were limited to 5% when compared to the Si reference device integrated in the suitcase and were up to 8% when calculated using the local irradiance data. Therefore, this method offers a fast, cheap and efficient tool for sample sharing and testing that allows conducting outdoor measurements of OPV devices in a reproducible manner. (C) 2014 Elsevier B.V. All rights reserved.	[Madsen, Morten V.; Gevorgyan, Suren A.; Krebs, Frederik C.] Tech Univ Denmark, Dept Energy Convers & Storage, DK-4000 Roskilde, Denmark; [Pacios, R.; Ajuria, J.; Etxebarria, I.] CIC Microgune, IK4 IKERLAN Microsyst, E-20500 Arrasate Mondragon, Spain; [Kettle, Jeff; Bristow, Noel D.] Bangor Univ, Sch Elect Engn, Bangor LL57 1UT, Gwynedd, Wales; [Neophytou, Marios; Choulis, Stelios A.] Cyprus Univ Technol, Mol Elect & Photon Res Unit, CY-3041 Limassol, Cyprus; [Roman, Lucimara Stolz] Univ Fed Parana, Dept Phys, BR-81531990 Curitiba, Parana, Brazil; [Yohannes, Teketel] Univ Addis Ababa, Dept Chem, Addis Ababa, Ethiopia; [Cester, Andrea] Univ Padua, Dept Informat Engn, I-35131 Padua, Italy; [Cheng, Pei; Zhan, Xiaowei] Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing 100871, Peoples R China; [Wu, Jiang; Xie, Zhiyuan] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Peoples R China; [Tu, Wei-Chen; He, Jr-Hau] Natl Taiwan Univ, Inst Photon & Optoelect, Taipei 10617, Taiwan; [Tu, Wei-Chen; He, Jr-Hau] Natl Taiwan Univ, Dept Elect Engn, Taipei 10617, Taiwan; [Fell, Christopher J.; Anderson, Kenrick] CSIRO Energy Technol, Newcastle, NSW 2300, Australia; [Hermenau, Martin] Tech Univ Dresden, Inst Angew Photophys, D-01069 Dresden, Germany; [Bartesaghi, Davide; Koster, L. Jan Anton] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Bartesaghi, Davide] Dutch Polymer Inst, NL-5600 AX Eindhoven, Netherlands; [Machui, Florian] Univ Erlangen Nurnberg, i MEET, Dept Mat Sci, D-91058 Erlangen, Germany; [Gonzalez-Valls, Irene; Lira-Cantu, Monica] Inst Catala Nanociencia & Nanotecnol, p1ICN2, Bellaterra 08193, Barcelona, Spain; [Khlyabich, Petr P.; Thompson, Barry C.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Khlyabich, Petr P.; Thompson, Barry C.] Univ So Calif, Loker Hydrocarbon Res Inst, Los Angeles, CA 90089 USA; [Gupta, Ritu; Shanmugam, Kiruthika; Kulkarni, Giridhar U.] Jawaharlal Nehru Ctr Adv Sci Res, Chem & Phys Mat Unit, Bangalore 560064, Karnataka, India; [Gupta, Ritu; Shanmugam, Kiruthika; Kulkarni, Giridhar U.] Jawaharlal Nehru Ctr Adv Sci Res, Themat Unit Nanochem, Bangalore 560064, Karnataka, India; [Galagan, Yulia] Holst Ctr Solliance, NL-5605 RN Eindhoven, Netherlands; [Urbina, Antonio; Abad, Jose] Tech Univ Cartagena, Cartagena 30202, Spain; [Roesch, Roland; Hoppe, Harald] Ilmenau Univ Technol, Inst Phys, D-98693 Ilmenau, Germany; [Morvillo, P.; Bobeico, E.] ENEA, I-80055 Portici, Napoli, Italy; [Panaitescu, Eugen; Menon, Latika] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Luo, Qun; Wu, Zhenwu; Ma, Changqi] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Printable Elect Res Ctr, Suzhou 215123, Jiangsu, Peoples R China; [Hambarian, Artak; Melikyan, Varuzhan] AUA, ERC, Yerevan, Armenia; [Hambsch, M.; Burn, Paul L.; Meredith, Paul] Univ Queensland, Ctr Organ Photon & Elect, Brisbane, Qld 4072, Australia; [Rath, Thomas; Dunst, Sebastian; Trimmel, Gregor] Graz Univ Technol, Inst Chem & Technol Mat, A-8010 Graz, Austria; [Bardizza, Giorgio; Muellejans, Harald] Commiss European Communities, Joint Res Ctr, Inst Energy & Transport, Renewable Energy Unit,European Solar Test Install, I-21027 Ispra, VA, Italy; [Goryachev, A. E.; Misra, Ravi K.; Katz, Eugene A.] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Dept Solar Energy & Environm Phys, IL-84990 Sede Boger Campus, Israel; [Takagi, Katsuhiko; Magaino, Shinichi; Saito, Hidenori; Aoki, Daisuke] Kanagawa Acad Sci &Technol, Kawasaki, Kanagawa 2130013, Japan; [Sommeling, Paul M.; Kroon, Jan M.] ECN Solar Energy, NL-1755 LE Petten, Netherlands; [Vangerven, Tim; Manca, Jean; Kesters, Jurgen; Maes, Wouter] Hasselt Univ, Inst Mat Res IMO, B-3590 Diepenbeek, Belgium; [Bobkova, Olga D.; Trukhanov, Vasily A.; Paraschuk, Dmitry Yu.] Moscow MV Lomonosov State Univ, Ctr Int Laser, Moscow 119991, Russia; [Bobkova, Olga D.; Trukhanov, Vasily A.; Paraschuk, Dmitry Yu.] Moscow MV Lomonosov State Univ, Fac Phys, Moscow 119991, Russia; [Castro, Fernando A.; Blakesley, James] Natl Phys Lab, Div Mat, Teddington TW11 0LW, Middx, England; [Tuladhar, Sachetan M.; Roehr, Jason Alexander; Nelson, Jenny] Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2AZ, England; [Xia, Jiangbin] Wuhan Univ, Coll Chem & Mol Sci, Wuhan 430072, Peoples R China; [Gonzalez-Valls, Irene; Lira-Cantu, Monica] CSIC, Bellaterra 08193, Barcelona, Spain; [Parlak, Elif Alturk; Tumay, Tulay Ash] Inst Chem, TUBITAK Marmara Res Ctr, TR-41470 Gebze, Kocaeli, Turkey; [Egelhaaf, Hans-Joachim] BELECTRIC OPV GmbH, D-90443 Nurnberg, Germany; [Tanenbaum, David M.; Ferguson, Gretta Mae] Pomona Coll, Dept Phys & Astron, Claremont, CA 91711 USA; [Carpenter, Robert] Inside2Outside Ltd, Cambridge, England; [Chen, Hongzheng] Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Zhejiang, Peoples R China; [Zimmermann, Birger] Fraunhofer Inst Solar Energy Syst ISE, D-79110 Freiburg, Germany; [Hirsch, Lionel; Wantz, Guillaume] Univ Bordeaux, Inst Polytech Bordeaux, Lab IMS, UMR CNRS 5218, F-33607 Pessac, France; [Sun, Ziqi] Univ Wollongong, Australian Inst Innovat Mat, Inst Superconducting & Elect Mat, North Wollongong, NSW 2500, Australia; [Singh, Pradeep; Bapat, Chaitnya] TU Chemnitz, D-09126 Chemnitz, Germany; [Offermans, Ton] CSEM Muttenz, CH-4132 Muttenz, Switzerland	Madsen, MV (reprint author), Tech Univ Denmark, Dept Energy Convers & Storage, Frederiksborgvej 399, DK-4000 Roskilde, Denmark.	mves@dtu.dk	cheng, pei/N-8517-2014; Hambsch, Mike/F-9528-2014; Hoppe, Harald/P-5293-2014; Sun, Ziqi/A-8122-2011; Madsen, Michael/B-2182-2015; Misra, Ravi/B-3422-2014; Panaitescu, Eugen/A-9237-2011; Zhan, Xiaowei/N-9140-2013; Paraschuk, Dmitry/H-4684-2011; Burn, Paul/F-5347-2010; Cester, Andrea/H-1683-2015; He, Jr-Hau/B-5141-2011; Castro, Fernando/A-4253-2008; McKenzie, Warren/J-2137-2014; Gonzalez-Valls, Irene/J-6512-2014; Bristow, Noel/J-5666-2014; Rath, Thomas/J-1885-2015	cheng, pei/0000-0002-1012-749X; Hambsch, Mike/0000-0002-8487-0972; Madsen, Michael/0000-0003-2789-4713; Cester, Andrea/0000-0001-6583-1735; He, Jr-Hau/0000-0003-1886-9241; Castro, Fernando/0000-0002-2409-8300; Gonzalez-Valls, Irene/0000-0002-9190-4210; Bristow, Noel/0000-0001-6783-6089; Lira-Cantu, Monica/0000-0002-3393-7436; Rath, Thomas/0000-0002-4837-7726	EUDP [64012-0202]; Danish National Research Foundation; Eurotech Universities Alliance project "Interface science for photovoltaics (ISPV)"; European Research Infrastructure (SOPHIA); European Energy Research Alliance (EERA); Danish Ministry of Science, Innovation and Higher Education under a Sapere Aude Top Scientist Grant [DFF - 1335-00037A]; Elite Scientist Grant [11-116028]; MICINN-Spain FEDER [MAT2010-21267-C02-02]; UK Department for Business, Innovation Skills; Royal Society; EPSRC [EP/G031088, EP/J500021, EP/K030671]; European Regional Development Fund; Republic of Cyprus through the Research Promotion Foundation (Strategic Infrastructure Project) [NEA gammaPiODeltaOMH/SigmaTPATH/0308/06]; European Commission [261936]	This work has been supported by the EUDP (j.no. 64012-0202), the Danish National Research Foundation, the Eurotech Universities Alliance project "Interface science for photovoltaics (ISPV)", the European Research Infrastructure (SOPHIA), the European Energy Research Alliance (EERA), the Danish Ministry of Science, Innovation and Higher Education under a Sapere Aude Top Scientist Grant no.(DFF - 1335-00037A), an Elite Scientist Grant no.(11-116028), MICINN-Spain(Grant # MAT2010-21267-C02-02) including FEDER funds, the UK Department for Business, Innovation & Skills, the Royal Society and the EPSRC for grants EP/G031088, EP/J500021 and EP/K030671.; MN and SAC acknowledge co-funding by the European Regional Development Fund and the Republic of Cyprus through the Research Promotion Foundation (Strategic Infrastructure Project NEA gamma Pi O Delta OMH/Sigma TPATH/0308/06). A. E. G., R. K. M. and E.A. K. thank a financial support from the European Commission's Seventh Framework Program under Grant agreement no. 261936.	Osterwald CR, 1999, PROG PHOTOVOLTAICS, V7, P287; Krebs FC, 2009, SOL ENERG MAT SOL C, V93, P1968, DOI 10.1016/j.solmat.2009.07.015; Angmo D, 2013, J APPL POLYM SCI, V130, P944, DOI 10.1002/app.39200; Snaith HJ, 2012, ENERG ENVIRON SCI, V5, P6513, DOI 10.1039/c2ee03429h; Gevorgyan SA, 2014, RENEW ENERG, V63, P376, DOI 10.1016/j.renene.2013.09.034; Jorgensen M, 2013, SOL ENERG MAT SOL C, V119, P84, DOI 10.1016/j.solmat.2013.05.034; Reese MO, 2011, SOL ENERG MAT SOL C, V95, P1253, DOI 10.1016/j.solmat.2011.01.036; Luber EJ, 2013, ACS NANO, V7, P4708, DOI 10.1021/nn402883g; Gevorgyan SA, 2013, SOL ENERG MAT SOL C, V116, P187, DOI 10.1016/j.solmat.2013.04.024; Gevorgyan SA, 2011, SOL ENERG MAT SOL C, V95, P1398, DOI 10.1016/j.solmat.2011.01.010; Gevorgyan SA, 2013, SOL ENERG MAT SOL C, V110, P24, DOI 10.1016/j.solmat.2012.11.020; Tanenbaum DM, 2012, SOL ENERG MAT SOL C, V97, P157, DOI 10.1016/j.solmat.2011.09.064; Betts T.R., 2006, P 21 EUR PHOT SOL EN, P2447; Herrmann W., 2007, P 22 EUR PHOT SOL EN, P2506; Larsen-Olsen TT, 2012, ADV ENERGY MATER, V2, P1091, DOI 10.1002/aenm.201200079; Metzdorf J., 1990, PTBOPT31; Metzdorf J., 1990, P 21 IEEE PHOT SPEC, P952; Ossenbrink H., 1985, RESULTS 1984 1985 IN, P943; Osterwald C.R., 1993, IEEE, V1, P1102; OSTERWALD CR, 1996, P 25 IEEE PHOT SPEC, P1263; Sondergaard RR, 2012, SOL ENERG MAT SOL C, V99, P292, DOI 10.1016/j.solmat.2011.12.013	21	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0248	1879-3398		SOL ENERG MAT SOL C	Sol. Energy Mater. Sol. Cells	NOV	2014	130				SI		281	290		10.1016/j.solmat.2014.07.021		10	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	AR5GH	WOS:000343612600036		
J	Tada, K				Tada, Kazuya			Solution-processed small molecular photocells with neat fullerene	SOLAR ENERGY MATERIALS AND SOLAR CELLS			English	Article						Organic photocells; Small molecules; Fullerenes; Solution-process; Halogen-free solvents	ORGANIC SOLAR-CELLS; PHOTOVOLTAIC PERFORMANCE; CONDUCTING POLYMER; MORPHOLOGY CONTROL; BUCKMINSTERFULLERENE; LUMINESCENCE; TRANSISTORS	Because of ease in ensuring chemical integrity and purification, small molecular materials are promising as alternatives for polymeric electron-donor materials in solution-processed bulk heterojunction (BHJ) photocells. On the other hand, replacement of modified fullerene with neat one potentially reduces both economical and environmental costs of the photocells. In this paper, solution-processed BHJ photocells with a small molecular electron-donor 7,7'[4,4-bis(2-ethylhexyl)-4H-silolo [3,2-b:4,5-b']dithiophene-2,6-diyl]bis[6-fluoro-4-(5'-hexyl-[2,2'-bithiophen]-5-yl)benzo[c][1,2,5]thiadiazole] (p-DTS(FBTTh2)(2)) and neat C-70 are studied. The devices showed a power conversion efficiency of approximately 1.3% after optimal thermal annealing. Analysis of current-voltage characteristics using an equivalent circuit model suggests that the thermal annealing enhances not only the generation but also the internal recombination of photocarriers. (C) 2014 Elsevier B.V. All rights reserved.	Univ Hyogo, Div Elect Engn, Himeji, Hyogo 6712280, Japan	Tada, K (reprint author), Univ Hyogo, Div Elect Engn, 2167 Shosha, Himeji, Hyogo 6712280, Japan.	tada@engu-hyogo.ac.jp			Sanyo Special Steel Cultural Promotion Foundation; JSPS KAKENHI Grant [26289094]	This work was partially supported by Sanyo Special Steel Cultural Promotion Foundation and JSPS KAKENHI Grant number 26289094.	Liu XF, 2012, J AM CHEM SOC, V134, P20609, DOI 10.1021/ja310483w; MORITA S, 1992, SOLID STATE COMMUN, V82, P249, DOI 10.1016/0038-1098(92)90636-N; Graham KR, 2011, ACS APPL MATER INTER, V3, P1210, DOI 10.1021/am2000328; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Heeger AJ, 2014, ADV MATER, V26, P10, DOI 10.1002/adma.201304373; Sakai J, 2009, SOL ENERG MAT SOL C, V93, P1149, DOI 10.1016/j.solmat.2009.02.007; Rath T, 2013, SOL ENERG MAT SOL C, V114, P38, DOI 10.1016/j.solmat.2013.02.024; Sakai K, 2008, MOL CRYST LIQ CRYST, V491, P284, DOI 10.1080/15421400802330960; Sharenko A, 2013, ADV MATER, V25, P4403, DOI 10.1002/adma.201301167; Sim M, 2013, CHEM PHYS LETT, V557, P88, DOI 10.1016/j.cplett.2012.11.087; Li G, 2012, NAT PHOTONICS, V6, P153, DOI 10.1038/NPHOTON.2012.11; Anthopoulos TD, 2005, J APPL PHYS, V98, DOI 10.1063/1.2034083; Coughlin JE, 2014, ACCOUNTS CHEM RES, V47, P257, DOI 10.1021/ar400136b; Huang Y, 2014, ADV MATER, V26, P4168, DOI 10.1002/adma.201400497; van der Poll TS, 2012, ADV MATER, V24, P3646, DOI 10.1002/adma.201201127; SARICIFTCI NS, 1992, SCIENCE, V258, P1474, DOI 10.1126/science.258.5087.1474; Hori T, 2011, SOL ENERG MAT SOL C, V95, P3087, DOI 10.1016/j.solmat.2011.06.039; Haddock JN, 2005, ORG ELECTRON, V6, P182, DOI 10.1016/j.orgel.2005.06.002; WAGNER HJ, 1982, J MATER SCI, V17, P2781, DOI 10.1007/BF00644652; Leong WL, 2012, CHEM SCI, V3, P2103, DOI 10.1039/c2sc20157g; Sharenko A, 2014, CHEM MATER, V26, P4109, DOI 10.1021/cm5010483; Shi QQ, 2012, ADV ENERGY MATER, V2, P63, DOI 10.1002/aenm.201100505; Krebs FC, 2009, SOL ENERG MAT SOL C, V93, P394, DOI 10.1016/j.solmat.2008.10.004; Yoshida H, 2014, ANAL BIOANAL CHEM, V406, P2231, DOI 10.1007/s00216-014-7659-1; Cowan S.R., 2011, ADV FUNCT MATER, V21, P3082; Gupta D., 2008, APPL PHYS LETT, V92; Ishiyama N., 2012, APPL PHYS LETT, V101; Kovacik P, 2013, SOL ENERG MAT SOL C, V117, P22, DOI 10.1016/j.solmat.2013.05.021; Kyaw A. K. K., 2013, SCI REPORTS, V3, p[1965, 1]; Rand BP, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.115327; Tada K., 2013, SOL ENERG MAT SOL C, V108, P82; Tada K., 2014, APPL PHYS EXPRESS, V5; Tang HW, 2010, IEEE J SEL TOP QUANT, V16, P1725, DOI 10.1109/JSTQE.2010.2042034; YOSHINO K, 1993, JPN J APPL PHYS 2, V32, pL357, DOI 10.1143/JJAP.32.L357	34	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0248	1879-3398		SOL ENERG MAT SOL C	Sol. Energy Mater. Sol. Cells	NOV	2014	130				SI		331	335		10.1016/j.solmat.2014.07.032		5	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	AR5GH	WOS:000343612600042		
J	Chantana, J; Hironiwa, D; Watanabe, T; Teraji, S; Kawamura, K; Minemoto, T				Chantana, Jakapan; Hironiwa, Daisuke; Watanabe, Taichi; Teraji, Seiki; Kawamura, Kazunori; Minemoto, Takashi			Investigation of Cu(In,Ga)Se-2 absorber by time-resolved photoluminescence for improvement of its photovoltaic performance	SOLAR ENERGY MATERIALS AND SOLAR CELLS			English	Article						Copper indium gallium selenide; Solar cells; Ga/(In plus Ga) profile; Average band-gap energy; Time-resolved photoluminescence; Multi-layer precursor method	FILM SOLAR-CELLS; THIN-FILMS; EFFICIENCY; SPECTROSCOPY	Time-resolved photoluminescence (TRPL) measurement has been performed on Cu(In,Ga)Se-2 (CIGS) absorbers. In this contribution, CIGS films on both rigid soda-lime glass and flexible stainless steel (SUS) substrates are fabricated by the so-called "multi-layer precursor method" consisting of Ga-Se/In-Se/Cu-Se stacks. The TRPL lifetime, demonstrating a positive relationship with PL intensity, exhibits a close correlation with all photovoltaic parameters. According to TRPL and sensitive capacitance measurements, the average band-gap energy (E-g) should be in a range of 1.25-1.30 eV, giving rise to sufficiently long TRPL lifetimes. Ultimately, CIGS absorber is fabricated with double graded E-g profile with a proper average E-g of 1.27 eV and back-surface field of 0.22 V/mu m, defined as a ratio of the change in E-g divided by the change in a depth range from 1 to 2 mu m from CIGS surface. This graded E-g profile results in the improvement of the efficiency of the CIGS solar cell on a flexible SUS substrate up to 16.22% without an anti-reflective layer. (C) 2014 Elsevier B.V. All rights reserved.	[Chantana, Jakapan; Hironiwa, Daisuke; Minemoto, Takashi] Ritsumeikan Univ, Dept Elect & Elect Engn, Kusatsu, Shiga 5258577, Japan; [Watanabe, Taichi; Teraji, Seiki; Kawamura, Kazunori] Nitto Denko Corp, Environm & Energy Res Ctr, Suita, Osaka 5650871, Japan	Chantana, J (reprint author), Ritsumeikan Univ, Dept Elect & Elect Engn, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	jakapan@fc.ritsumei.ac.jp; hironiwa@fc.ritsumei.ac.jp; taichi_watanabe@gg.nitto.co.jp; seiki_teraji@gg.nitto.co.jp; kazunori_kawamura@gg.nitto.co.jp; minemoto@se.ritsumei.ac.jp	Minemoto, Takashi/F-9342-2011; Chantana, Jakapan/O-5110-2015	Chantana, Jakapan/0000-0002-5711-4979	NEDO (New Energy and Industrial Technology Development Organization)	This work is partly supported by the NEDO (New Energy and Industrial Technology Development Organization).	Amin Nowshad, 2011, Journal of Applied Sciences, V11, DOI 10.3923/jas.2011.401.410; Ogawa Y, 1996, APPL SURF SCI, V92, P232, DOI 10.1016/0169-4332(95)00236-7; Heath JT, 2002, APPL PHYS LETT, V80, P4540, DOI 10.1063/1.1485301; Hsieh TP, 2011, SOLID STATE ELECTRON, V56, P175, DOI 10.1016/j.sse.2010.11.019; Shimakawa S, 2008, SOL ENERG MAT SOL C, V92, P1086, DOI 10.1016/j.solmat.2008.03.014; Siebentritt S, 2002, THIN SOLID FILMS, V403, P1, DOI 10.1016/S0040-6090(01)01525-5; Shirakata S, 2007, THIN SOLID FILMS, V515, P6151, DOI 10.1016/j.tsf.2006.12.040; Jung S, 2010, CURR APPL PHYS, V10, P990, DOI 10.1016/j.cap.2009.11.082; Romero MJ, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.165324; Chirila A, 2011, NAT MATER, V10, P857, DOI [10.1038/nmat3122, 10.1038/NMAT3122]; Rudmann D, 2003, THIN SOLID FILMS, V431, P37, DOI 10.1016/S0040-6090(03)00246-3; Hashimoto Y, 1996, JPN J APPL PHYS 1, V35, P4760, DOI 10.1143/JJAP.35.4760; LANG DV, 1974, J APPL PHYS, V45, P3023, DOI 10.1063/1.1663719; Jackson P, 2014, PHYS STATUS SOLIDI-R, V8, P219, DOI 10.1002/pssr.201409040; Contreras MA, 2005, PROG PHOTOVOLTAICS, V13, P209, DOI 10.1002/pip.626; Rau U, 1999, APPL PHYS A-MATER, V69, P131, DOI 10.1007/s003390050984; Contreras MA, 1999, PROG PHOTOVOLTAICS, V7, P311; Chantana J, 2014, THIN SOLID FILMS, V556, P499, DOI 10.1016/j.tsf.2014.01.009; Niles DW, 1997, J VAC SCI TECHNOL A, V15, P3044, DOI 10.1116/1.580902; Gabor AM, 1996, SOL ENERG MAT SOL C, V41-2, P247, DOI 10.1016/0927-0248(95)00122-0; Jackson P, 2011, PROG PHOTOVOLTAICS, V19, P894, DOI 10.1002/pip.1078; Chantana J., 2013, P 28 EU PVSEC, P2292; Chantana J, 2013, APPL PHYS LETT, V103; Chantana J, 2013, J APPL PHYS, V114; Chirila A, 2013, NAT MATER, V12, P1107, DOI [10.1038/nmat3789, 10.1038/NMAT3789]; Hamakawa Y, 2004, SPR S PHOTON, V13, P1; Hasoon E.S., 2005, APPL PHYS LETT, V87; Kessler J., 2000, P 16 EUR PHOT SOL EN, P2057; Nishitani M, 1997, J APPL PHYS, V82, P3572, DOI 10.1063/1.365675; Repins I, 2008, PROG PHOTOVOLTAICS, V16, P235, DOI 10.1002/pip.822; Sakurai T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.05FC01; Shirakata S, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NC13; Vallat-Sauvain E., 2006, THIN FILM SOLAR CELL, P1; Wallin E, 2012, PROG PHOTOVOLTAICS, V20, P851, DOI 10.1002/pip.2246	34	7	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0248	1879-3398		SOL ENERG MAT SOL C	Sol. Energy Mater. Sol. Cells	NOV	2014	130				SI		567	572		10.1016/j.solmat.2014.08.012		6	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	AR5GH	WOS:000343612600072		
J	Odden, JO; Lommasson, TC; Tayyib, M; Vedde, J; Buseth, T; Friestad, K; Date, H; Tronstad, R				Odden, J. O.; Lommasson, T. C.; Tayyib, M.; Vedde, J.; Buseth, T.; Friestad, K.; Date, H.; Tronstad, R.			Results on performance and ageing of solar modules based on Elkem Solar Silicon (ESS (TM)) from installations at various locations	SOLAR ENERGY MATERIALS AND SOLAR CELLS			English	Article						Compensated silicon; ESS (TM); Temperature coefficients; Field tests; Long term degradation	CELLS	The present study aims to present the current status of the results obtained using Elkem Solar Silicon (ESS (TM)) as feedstock basis for solar cell and modules. It is shown that solar cells based on ESS (TM) are able to follow the development of the solar industry obtaining comparable efficiencies to standard polysilicon based cells. The characteristics of ESS (TM) based solar cells, having normally higher V-oc and FF and lower I-sc, seem to give clear advantages in the field for solar modules located at high irradiance areas. Results from several locations show enhanced electricity production of ESS (TM) based solar modules compared to polysilicon at increasing solar irradiance. This is explained by beneficial temperature coefficients for ESS (TM) based solar cells. Lower electrical loss for ESS (TM) modules is also expected to contribute to the same beneficial performance under conditions of high solar irradiance. (C) 2014 Elsevier B.V. All rights reserved.	[Odden, J. O.; Buseth, T.; Friestad, K.; Tronstad, R.] Elkem Solar AS, N-4675 Kristiansand, Norway; [Lommasson, T. C.] Teknova AS, NO-4630 Kristiansand, Norway; [Tayyib, M.] Univ Agder, NO-4879 Grimstad, Norway; [Vedde, J.] SiCon, DK-3460 Birkerod, Denmark; [Date, H.] Elkem Japan KK, Chiyoda Ku, Tokyo 1000014, Japan	Odden, JO (reprint author), Elkem Solar AS, POB 8040, N-4675 Kristiansand, Norway.	Jan-ove.odden@elkem.no			Research Council of Norway (RCN)	The Research Council of Norway (RCN) is thanked for financing the phd-work included. Professor Ole Hansen at the DTU, Copenhagen is thanked for valuable input and discussions related to the temperature dependency. The Desert Knowledge, Australia is thanked for allowing us to use results from their Alice Springs test facilities. BVRIT and Titan Energy Systems Ltd are thanked for their contribution of maintaining and securing the test facilities and data from Hyderabad, India.	Altermatt PP, 2011, J COMPUT ELECTRON, V10, P314, DOI 10.1007/s10825-011-0367-6; Tanay F, 2011, PROG PHOTOVOLTAICS, V19, P966, DOI 10.1002/pip.1104; de Wild Scholten M., 2012, SILICON CHEM SOLAR I; Modanese C., 2012, PROG PHOTOVOLTAICS R; Odden J. O., 2008, SILICON CHEM SOLAR I; Petter K, 2011, ENRGY PROCED, V8, P365, DOI 10.1016/j.egypro.2011.06.151; Tayyib M., 2013, 28 EUPVSEC PAR FRANC; Tayyib M, 2013, ENRGY PROCED, V38, P626, DOI 10.1016/j.egypro.2013.07.326; Tayyib M., 2013, MAT PERSP ON FULL YE	9	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0248	1879-3398		SOL ENERG MAT SOL C	Sol. Energy Mater. Sol. Cells	NOV	2014	130				SI		673	678		10.1016/j.solmat.2014.04.002		6	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	AR5GH	WOS:000343612600086		
J	Nagao, M; Lanjakornsiripan, D; Itoh, Y; Kishi, Y; Ogata, T; Gotoh, Y				Nagao, Motoshi; Lanjakornsiripan, Darin; Itoh, Yasuhiro; Kishi, Yusuke; Ogata, Toru; Gotoh, Yukiko			High Mobility Group Nucleosome-Binding Family Proteins Promote Astrocyte Differentiation of Neural Precursor Cells	STEM CELLS			English	Article						Astrocytes; Neural stem cells; Chromatin; High mobility group nucleosome-binding proteins; STAT3 transcription factor	DEVELOPING SPINAL-CORD; CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; HMGN PROTEINS; DNA METHYLATION; GENE-EXPRESSION; FETAL-BRAIN; CHROMATIN; SOX9; GLIOGENESIS	Astrocytes are the most abundant cell type in the mammalian brain and are important for the functions of the central nervous system. Although previous studies have shown that the STAT signaling pathway or its regulators promote the generation of astrocytes from multipotent neural precursor cells (NPCs) in the developing mammalian brain, the molecular mechanisms that regulate the astrocytic fate decision have still remained largely unclear. Here, we show that the high mobility group nucleosome-binding (HMGN) family proteins, HMGN1, 2, and 3, promote astrocyte differentiation of NPCs during brain development. HMGN proteins were expressed in NPCs, Sox9(+) glial progenitors, and GFAP(+) astrocytes in perinatal and adult brains. Forced expression of either HMGN1, 2, or 3 in NPCs in cultures or in the late embryonic neocortex increased the generation of astrocytes at the expense of neurons. Conversely, knockdown of either HMGN1, 2, or 3 in NPCs suppressed astrocyte differentiation and promoted neuronal differentiation. Importantly, overexpression of HMGN proteins did not induce the phosphorylation of STAT3 or activate STAT reporter genes. In addition, HMGN family proteins did not enhance DNA demethylation and acetylation of histone H3 around the STAT-binding site of the gfap promoter. Moreover, knockdown of HMGN family proteins significantly reduced astrocyte differentiation induced by gliogenic signal ciliary neurotrophic factor, which activates the JAK-STAT pathway. Therefore, we propose that HMGN family proteins are novel chromatin regulatory factors that control astrocyte fate decision/differentiation in parallel with or downstream of the JAK-STAT pathway through modulation of the responsiveness to gliogenic signals.	[Nagao, Motoshi; Ogata, Toru] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Tokorozawa, Saitama 3598555, Japan; [Lanjakornsiripan, Darin; Itoh, Yasuhiro; Kishi, Yusuke; Gotoh, Yukiko] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan	Nagao, M (reprint author), Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, 4-1 Namiki, Tokorozawa, Saitama 3598555, Japan.	nagao-motoshi@rehab.go.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT	We thank C. L. Cepko (Harvard University), T. Matsuda (Kyoto University), T. Kitamura (The University of Tokyo), H. Song (Johns Hopkins University), K. Nakashima (Kyushu University), and J.F. Bromberg (Memorial Sloan-Kettering Cancer Center) for plasmids, K. Tyssowski for editing the manuscript, Y. Hirabayashi and H. Sakai for reagents and technical assistance, J. Yamauchi (National Research Institute for Child Health and Development) and members of the Gotoh laboratory for helpful discussion. This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas "Neural Diversity and Neocortical Organization" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and Grants-in-Aid for Scientific Research (C) of MEXT.	Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Deng T, 2013, MOL CELL BIOL, V33, P3377, DOI 10.1128/MCB.00435-13; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Furusawa T, 2006, MOL CELL BIOL, V26, P592, DOI 10.1128/MCB.26.2.592-604.2006; Kordes U, 2005, DEV BRAIN RES, V157, P209, DOI 10.1016/j.devbrainres.2005.03.009; Li XY, 2012, NEURON, V75, P1035, DOI 10.1016/j.neuron.2012.08.031; Rajan P, 1998, J NEUROSCI, V18, P3620; West KL, 2004, MOL CELL BIOL, V24, P3747, DOI 10.1128/MCB.24.9.3747-3756.2004; Kishi Y, 2012, NAT NEUROSCI, V15, P1127, DOI 10.1038/nn.3165; Furusawa T, 2010, BBA-GENE REGUL MECH, V1799, P69, DOI 10.1016/j.bbagrm.2009.11.011; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Molofsky AV, 2013, GLIA, V61, P1518, DOI 10.1002/glia.22538; Kugler JE, 2012, BBA-GENE REGUL MECH, V1819, P652, DOI 10.1016/j.bbagrm.2012.01.013; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Nakashima K, 1999, J NEUROSCI, V19, P5429; Shirakawa H, 2000, J BIOL CHEM, V275, P37937, DOI 10.1074/jbc.M000989200; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Postnikov Y, 2010, BBA-GENE REGUL MECH, V1799, P62, DOI 10.1016/j.bbagrm.2009.11.016; Nagao M, 2007, MOL CELL BIOL, V27, P3982, DOI 10.1128/MCB.00170-07; Namihira M, 2013, CURR OPIN NEUROBIOL, V23, P921, DOI 10.1016/j.conb.2013.06.002; Birger Y, 2003, EMBO J, V22, P1665, DOI 10.1093/emboj/cdg142; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Pompolo S, 2001, BRAIN RES, V906, P143, DOI 10.1016/S0006-8993(01)02574-4; Scott CE, 2010, NAT NEUROSCI, V13, P1181, DOI 10.1038/nn.2646; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Asano H, 2009, STEM CELLS, V27, P2744, DOI 10.1002/stem.176; Lu PPY, 2012, J NEUROSCI, V32, P8012, DOI 10.1523/JNEUROSCI.5633-11.2012; Abuhatzira L, 2011, J BIOL CHEM, V286, P42051, DOI 10.1074/jbc.M111.300541; Kang P, 2012, NEURON, V74, P79, DOI 10.1016/j.neuron.2012.01.024; Birger Y, 2005, CANCER RES, V65, P6711, DOI 10.1158/0008-5472.CAN-05-0310; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Urayama S, 2013, CELL STRUCT FUNCT, V38, P55; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Muroyama Y, 2005, NATURE, V438, P360, DOI 10.1038/nature04139; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Barkess G, 2012, BIOCHEM J, V442, P495, DOI 10.1042/BJ20111502; Birger Y, 2006, DIFFERENTIATION, V74, P19, DOI 10.1111/j.1432-0436.2006.00054.x; Furusawa T, 2009, GENE EXPR PATTERNS, V9, P289, DOI 10.1016/j.gep.2009.03.002; HOCKE GM, 1992, MOL CELL BIOL, V12, P2282; Ito Y, 2002, J HISTOCHEM CYTOCHEM, V50, P1273; Kohyama J, 2010, J CELL BIOL, V189, P159, DOI 10.1083/jcb.200908048; Lim JH, 2005, EMBO J, V24, P3038, DOI 10.1038/sj.emboj.7600768; Martini S, 2013, STEM CELLS, V31, P741, DOI 10.1002/stem.1320; Nagao M, 2008, J CELL BIOL, V183, P1243, DOI 10.1083/jcb.200807130; Pogna EA, 2010, BBA-GENE REGUL MECH, V1799, P93, DOI 10.1016/j.bbagrm.2009.11.018; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Ueda T, 2006, J BIOL CHEM, V281, P10182, DOI 10.1074/jbc.M600821200; West KL, 2001, J BIOL CHEM, V276, P25959, DOI 10.1074/jbc.M101692200; Zhu N, 2010, BBA-GENE REGUL MECH, V1799, P74, DOI 10.1016/j.bbagrm.2009.11.006	60	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	NOV	2014	32	11					2983	2997		10.1002/stem.1787		15	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	AR1BK	WOS:000343314400016		
J	Verardo, R; Piazza, S; Klaric, E; Ciani, Y; Bussadori, G; Marzinotto, S; Mariuzzi, L; Cesselli, D; Beltrami, AP; Mano, M; Itoh, M; Kawaji, H; Lassmann, T; Carninci, P; Hayashizaki, Y; Forrest, ARR; Beltrami, CA; Schneider, C				Verardo, Roberto; Piazza, Silvano; Klaric, Enio; Ciani, Yari; Bussadori, Giulio; Marzinotto, Stefania; Mariuzzi, Laura; Cesselli, Daniela; Beltrami, Antonio P.; Mano, Miguel; Itoh, Masayoshi; Kawaji, Hideya; Lassmann, Timo; Carninci, Piero; Hayashizaki, Yoshihide; Forrest, Alistair R. R.; Beltrami, Carlo A.; Schneider, Claudio		Fantom Consortium	Specific Mesothelial Signature Marks the Heterogeneity of Mesenchymal Stem Cells From High-Grade Serous Ovarian Cancer	STEM CELLS			English	Article						Mesenchymal stem cells; Tissue-specific stem cells; Genomics; Cancer; Adult stem cells; Cell biology	ENDOTHELIAL GROWTH-FACTOR; BONE-MARROW; BREAST-CANCER; MICROARRAY DATA; FALLOPIAN-TUBE; CD146 EXPRESSION; GENE-EXPRESSION; HUMAN ORGANS; IN-VITRO; FIBROBLASTS	Mesenchymal stem/stromal cells (MSCs) are the precursors of various cell types that compose both normal and cancer tissue microenvironments. In order to support the widely diversified parenchymal cells and tissue organization, MSCs are characterized by a large degree of heterogeneity, although available analyses of molecular and transcriptional data do not provide clear evidence. We have isolated MSCs from high-grade serous ovarian cancers (HG-SOCs) and various normal tissues (N-MSCs), demonstrated their normal genotype and analyzed their transcriptional activity with respect to the large comprehensive FANTOM5 sample dataset. Our integrative analysis conducted against the extensive panel of primary cells and tissues of the FANTOM5 project allowed us to mark the HG-SOC-MSCs CAGE-seq transcriptional heterogeneity and to identify a cell-type-specific transcriptional activity showing a significant relationship with primary mesothelial cells. Our analysis shows that MSCs isolated from different tissues are highly heterogeneous. The mesothelial-related gene signature identified in this study supports the hypothesis that HG-SOC-MSCs are bona fide representatives of the ovarian district. This finding indicates that HG-SOC-MSCs could actually derive from the coelomic mesothelium, suggesting that they might be linked to the epithelial tumor through common embryological precursors.	[Verardo, Roberto; Piazza, Silvano; Klaric, Enio; Ciani, Yari; Bussadori, Giulio; Schneider, Claudio] LNCIB, Trieste, Italy; [Marzinotto, Stefania; Mariuzzi, Laura; Cesselli, Daniela; Beltrami, Antonio P.] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy; [Mano, Miguel; Beltrami, Carlo A.; Schneider, Claudio] ICGEB, Trieste, Italy; [Itoh, Masayoshi; Kawaji, Hideya; Lassmann, Timo; Carninci, Piero; Hayashizaki, Yoshihide; Forrest, Alistair R. R.] RIKEN, OSC, Tsurumi ku, Yokohama, Kanagawa, Japan	Schneider, C (reprint author), Area Sci Pk,Padriciano 99, I-34149 Trieste, Italy.	schneide@lncib.it	Beltrami, Antonio Paolo/C-5291-2008; Mano, Miguel/A-4462-2013; 	Beltrami, Antonio Paolo/0000-0002-0679-2710; Mano, Miguel/0000-0003-1922-4824; Mariuzzi, Laura/0000-0002-1243-8398; Forrest, Alistair/0000-0003-4543-1675	Association for Cancer Research (AIRC); AIRC Special Program Molecular Clinical Oncology "5 per mille; FIRB "ONCODIET" project; National Technology Cluster project [CTN01_00177_817708]; Ministry for Education, University and Research (M.I.U.R); School of Molecular Biomedicine University of Trieste; FIRB "ONCODIET" project from the Ministry for Education, University and Research (M.I.U.R); FIRB project [RBAP11Z4Z9, RBAP11ETKA_007]; AIRC "5 per mille" Special Program [12214]; ERC-7FP SP 2 IDEAS QUIDPROQUO G.A. [269051]; FIRB Ministry for Education, University and Research (M.I.U.R) [RBAP11Z4Z9]; MEXT; MEXT, Japan	C.S. is supported by Italian Association for Cancer Research (AIRC), AIRC Special Program Molecular Clinical Oncology "5 per mille," FIRB "ONCODIET" project, and National Technology Cluster CTN01_00177_817708 project, both from the Ministry for Education, University and Research (M.I.U.R). Y.C. is supported by a Ph.D. Fellowship from the School of Molecular Biomedicine University of Trieste. S.P. is supported by the FIRB "ONCODIET" project from the Ministry for Education, University and Research (M.I.U.R). C.A.B. is supported by FIRB project RBAP11Z4Z9, 2012-2014, and AIRC "5 per mille" Special Program 2011, Pr. 12214. A.P.B. is supported by the FIRB project RBAP11ETKA_007. D.C. is supported by the ERC-7FP SP 2 IDEAS QUIDPROQUO G.A. n. 269051. M.M. is supported by the FIRB RBAP11Z4Z9 project from the Ministry for Education, University and Research (M.I.U.R). FANTOM5 was made possible by a Research Grant for RIKEN Omics Science Center from MEXT to Yoshihide Hayashizaki and a Grant of the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the MEXT, Japan to YH. We would like to thank all members of the FANTOM5 consortium for contributing to generation of samples and analysis of the dataset and thank GeNAS for data production. We thank Tom Freeman for preparing and authorizing the use of the original version of the sample ontology.	Touboul C, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-28; Anderson P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076979; Nombela-Arrieta C, 2011, NAT REV MOL CELL BIO, V12, P126, DOI 10.1038/nrm3049; Lis R, 2011, INT J CANCER, V128, P715, DOI 10.1002/ijc.25619; Berek JS, 2012, INT J GYNECOL OBSTET, V119, pS118, DOI 10.1016/S0020-7292(12)60025-3; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Lai CF, 2002, J BIOL CHEM, V277, P15514, DOI 10.1074/jbc.M200794200; Pelekanos RA, 2012, STEM CELL RES, V8, P58, DOI 10.1016/j.scr.2011.08.003; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Kim J, 2012, P NATL ACAD SCI USA, V109, P3921, DOI 10.1073/pnas.1117135109; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Chong JJH, 2011, CELL STEM CELL, V9, P527, DOI 10.1016/j.stem.2011.10.002; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; CONNELL ND, 1983, CELL, V34, P245, DOI 10.1016/0092-8674(83)90155-1; Bianco P, 2011, BLOOD, V117, P5281, DOI 10.1182/blood-2011-01-315069; Ksiazek K, 2009, AM J PATHOL, V174, P1230, DOI 10.2353/ajpath.2009.080613; Marx J, 2008, SCIENCE, V320, P38, DOI 10.1126/science.320.5872.38; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; Philip S, 2001, J BIOL CHEM, V276, P44926, DOI 10.1074/jbc.M103334200; Carvalho B, 2007, BIOSTATISTICS, V8, P485, DOI 10.1093/biostatistics/kxl042; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Zeppieri M, 2013, CURR EYE RES, V38, P451, DOI 10.3109/02713683.2012.763100; Taniguchi S, 2001, CANCER RES, V61, P7627; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Xu GW, 2005, J CLIN INVEST, V115, P1060; Espagnolle N, 2014, J CELL MOL MED, V18, P104, DOI 10.1111/jcmm.12168; Beltrami AR, 2007, BLOOD, V110, P3438, DOI 10.1182/blood-2006-11-055566; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rinkevich Y, 2012, NAT CELL BIOL, V14, P1251, DOI 10.1038/ncb2610; Bidlingmaier S, 2009, CANCER RES, V69, P1570, DOI 10.1158/0008-5472.CAN-08-1363; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Xu XM, 2011, J CANCER RES CLIN, V137, P495, DOI 10.1007/s00432-010-0908-6; Wang ZQ, 2013, CANCER LETT, V330, P150, DOI 10.1016/j.canlet.2012.11.049; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Cho ML, 2007, IMMUNOL LETT, V108, P121, DOI 10.1016/j.imlet.2006.11.005; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Karst AM, 2011, P NATL ACAD SCI USA, V108, P7547, DOI 10.1073/pnas.1017300108; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Sato A, 2010, MODERN PATHOL, V23, P1458, DOI 10.1038/modpathol.2010.134; Zeng QQ, 2012, P NATL ACAD SCI USA, V109, P1127, DOI 10.1073/pnas.1111053108; Yan XL, 2013, HEPATOLOGY, V57, P2274, DOI 10.1002/hep.26257; Park JH, 2007, J IMMUNOL, V179, P514; Tormin A, 2011, BLOOD, V117, P5067, DOI 10.1182/blood-2010-08-304287; Zhang CF, 2013, ONCOL LETT, V6, P1577, DOI 10.3892/ol.2013.1619; Aldovini D, 2006, INT J CANCER, V119, P1920, DOI 10.1002/ijc.22082; LAROCCA PJ, 1984, CANCER RES, V44, P2991; Auersperg Nelly, 2013, Front Biosci (Schol Ed), V5, P709; Barberis MC, ACTA CYTOL, V41, P1757; Bourkoula E, 2013, STEM CELLS; Cesselli D, 2009, CIRC RES, V104, P1225, DOI 10.1161/CIRCRESAHA.109.195859; da Silva ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932; Gaebel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015652; Gottschling S, 2013, LUNG CANCER, V80, P19, DOI 10.1016/j.lungcan.2012.12.015; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Kachali C, 2006, SEMIN DIAGN PATHOL, V23, P20, DOI 10.1053/j.semdp.2006.06.006; Kanamori-Katayama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025391; Kanamori-Katayama M, 2011, GENOME RES, V21, P1150, DOI 10.1101/gr.115469.110; Ko SY, 2012, J CLIN INVEST, V122, P3603, DOI 10.1172/JCI62229; Lis R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038340; Ren G, 2012, CELL STEM CELL; Sagi B, 2012, STEM CELLS DEV, V21, P814, DOI 10.1089/scd.2011.0551; Scadden DT, 2012, CELL STEM CELL, V10, P648, DOI 10.1016/j.stem.2012.05.011; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Tian Lin Li Hui, 2011, J Cell Physiol, V226, P1860, DOI 10.1002/jcp.22511; Tigrani DY, 2007, AM J CLIN PATHOL, V127, P580, DOI 10.1309/BME4VG11LDX8KMTN; Varoga D, 2006, J PATHOL, V210, P315, DOI 10.1002/path.2059	77	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	NOV	2014	32	11					2998	3011		10.1002/stem.1791		14	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	AR1BK	WOS:000343314400017		
J	Yokoyama, Y; Ebata, T; Igami, T; Sugawara, G; Mizuno, T; Nagino, M				Yokoyama, Yukihiro; Ebata, Tomoki; Igami, Tsuyoshi; Sugawara, Gen; Mizuno, Takashi; Nagino, Masato			The adverse effects of preoperative cholangitis on the outcome of portal vein embolization and subsequent major hepatectomies	SURGERY			English	Article							EXTENSIVE LIVER RESECTION; CHOLESTATIC RAT-LIVER; BILE-DUCT CARCINOMA; BILIARY CANCER; HEPATOBILIARY RESECTION; EXTENDED HEPATECTOMY; DIABETIC-RATS; REGENERATION; CHOLANGIOJEJUNOSTOMY; CHOLANGIOCARCINOMA	Background. The presence of cholangitis has been shown to impair liver regeneration capacity after major hepatectomy in a rat cholangitis model. It is unclear, however, whether the presence of cholangitis has any impact on liver generation in clinical settings. Objective. To determine the effects of preoperative cholangitis on hepatic regeneration rates after preoperative portal vein embolizations (PVEs) and postoperative courses after major hepatectomies in humans. Methods. From 1991 to 2012, 450 patients underwent preoperative PVEs and subsequent major hepatectomies. Among them, 72 patients (16.0%) had preoperative cholangitis. The volume change of the nonembolized lobe after PVE and the postoperative outcomes after a major hepatectomy were compared between cholangitis and noncholangitis groups. Results. The average volume increase in the nonembolized lobe after PVE was almost identical in both the cholangitis (10.0%) and noncholangitis (9.5%) groups. The average term required to acquire institutional safety criteria, however, was longer in the cholangitis group (24.3 days) compared with the noncholangitis group (18.3 days) (P < .001). The postoperative maximum serum total bilirubin levels (5.7 mg/dL vs 8.1 mg/dL, P = .035), morbidity rate (56% vs 78%, P = .001), and postoperative hospital stay (44 days vs 53 days, P = .021) were all greater in the cholangitis group compared with the noncholangitis group. With multivariate logistic regression analyses, the presence of preoperative cholangitis was identified as one of the independent risk factors for postoperative morbidity. Conclusion. These results indicate that patients with preoperative cholangitis should be carefully managed during their pen operative periods of PVE and after major hepatectomies.	[Yokoyama, Yukihiro; Ebata, Tomoki; Igami, Tsuyoshi; Sugawara, Gen; Mizuno, Takashi; Nagino, Masato] Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol, Nagoya, Aichi 4668550, Japan	Nagino, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol,Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	nagino@med.nagoya-u.ac.jp					Nagino M, 2006, ANN SURG, V243, P28, DOI 10.1097/01.sla.0000193604.72436.63; Yokoyama Y, 2010, BRIT J SURG, V97, P1260, DOI 10.1002/bjs.7084; Ebata T, 2012, DIGEST SURG, V29, P23, DOI 10.1159/000335718; Matsumoto T, 2003, J SURG RES, V110, P228, DOI 10.1006/jsre.2003.6611; NAGINO M, 1995, SURGERY, V117, P677, DOI 10.1016/S0039-6060(95)80012-3; Nagino M, 2006, ANN SURG, V243, P364, DOI 10.1097/01.sla.0000201482.11876.14; Koteish A, 2002, ALCOHOL CLIN EXP RES, V26, P1710, DOI 10.1097/01.ALC.0000036923.77613.59; Watanabe K, 2010, HPB, V12, P664, DOI 10.1111/j.1477-2574.2010.00229.x; Mizuno S, 1996, J SURG RES, V60, P249, DOI 10.1006/jsre.1996.0039; Sugawara G, 2013, SURGERY, V153, P200, DOI 10.1016/j.surg.2012.07.032; Nagino M, 1996, RADIOLOGY, V200, P559; BARRA R, 1977, J EXP ZOOL, V201, P93, DOI 10.1002/jez.1402010111; Natsume S, 2012, ANN SURG, V255, P754, DOI 10.1097/SLA.0b013e31824a8d82; Hussein O, 2002, DIGEST DIS SCI, V47, P1926, DOI 10.1023/A:1019679603042; Liatsos GD, 2003, DIGEST DIS SCI, V48, P1929, DOI 10.1023/A:1026157901805; Nagino M, 2007, BRIT J SURG, V94, P70, DOI 10.1002/bjs.5531; Nagino M, 2000, J VASC INTERV RADIOL, V11, P1063, DOI 10.1016/S1051-0443(07)61340-2; Nagino M, 2002, LANGENBECK ARCH SURG, V387, P188, DOI 10.1007/s00423-002-0304-z; Sakamoto E, 1995, HEPATO-GASTROENTEROL, V42, P501; SKULLMAN S, 1990, ACTA CHIR SCAND, V156, P717; SUZUKI H, 1994, HEPATOLOGY, V20, P1318, DOI 10.1016/0270-9139(94)90774-9; YAMADA T, 1977, ANN SURG, V185, P35, DOI 10.1097/00000658-197701000-00006; YOSHIDA S, 1995, J SURG RES, V59, P475, DOI 10.1006/jsre.1995.1194	23	3	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	NOV	2014	156	5					1190	1196		10.1016/j.surg.2014.04.036		7	Surgery	Surgery	AR7WG	WOS:000343787100018		
J	Sugimoto, M; Takahashi, S; Kojima, M; Gotohda, N; Kato, Y; Kawano, S; Ochiai, A; Konishi, M				Sugimoto, Motokazu; Takahashi, Shinichiro; Kojima, Motohiro; Gotohda, Naoto; Kato, Yuichiro; Kawano, Shingo; Ochiai, Atsushi; Konishi, Masaru			What is the nature of pancreatic consistency? Assessment of the elastic modulus of the pancreas and comparison with tactile sensation, histology, and occurrence of postoperative pancreatic fistula after pancreaticoduodenectomy	SURGERY			English	Article							YOUNGS MODULUS; ENDOSCOPIC ULTRASOUND; MECHANICAL-PROPERTIES; POISSONS RATIO; TISSUE; ELASTOGRAPHY; RISK; DIAGNOSIS; SKIN; AGE	Background. Although pancreatic consistency is a factor known to have an impact on the occurrence of postoperative pancreatic fistula (POPF) after pancreaticoduodenectomy (PD), it usually is assessed subjectively by the surgeon. Measurement of the elastic modulus (EM), a parameter characterizing the elasticity of a material, may be one approach for achieving objective and quantitative assessment of pancreatic consistency. This study was conducted to investigate the utility of determining the EM of the pancreas. Methods. Fifty-nine patients who underwent PD and measurement of the EM of the ex vivo pancreas were investigated. Data for EM were compared with the tactile evaluation made by surgeons, histologic findings, and the occurrence of POPE Results. The EM of the pancreas was correlated with the tactile evaluation made by the surgeon (soft pancreas, 1.4 +/- 2.1 kPa vs hard pancreas, 4.4 +/- 5.1 kPa; P < .001). An EM of > 3.0 kPa was correlated with histologic findings including increased ratios of azan-Mallory positivity (P = .003) and alpha-smooth muscle actin positivity (P = .006), a decreased lobular ratio (P = .021), and an increased vessel density (P < .001). Patients with a pancreatic EM of <3.0 kPa had an increased risk of POPF (hazard ratio, 9.333; P = .002). Conclusion. Assessment of the EM of the resected pancreas reflects the tactile evaluation made by the surgeon and histological degree of pancreatic fibrosis, and is correlated with the occurrence of POPE after PD.	[Sugimoto, Motokazu; Takahashi, Shinichiro; Gotohda, Naoto; Kato, Yuichiro; Konishi, Masaru] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Dept Hepatobiliary Pancreat Surg, Kashiwa, Chiba 2778577, Japan; [Sugimoto, Motokazu; Kojima, Motohiro; Kawano, Shingo; Ochiai, Atsushi] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Pathol, Kashiwa, Chiba 2778577, Japan	Takahashi, S (reprint author), Natl Canc Ctr Hosp East, 6-5-1 Kashiwa No Ha, Kashiwa, Chiba 2778577, Japan.	shtakaha@east.ncc.go.jp			Ministry of Health, Labour and Welfare of Japan	Supported in part by Health and Labour Sciences Research Grants for the Third Term Comprehensive Control Research for Cancer from the Ministry of Health, Labour and Welfare of Japan.	Lin JW, 2004, J GASTROINTEST SURG, V8, P951, DOI 10.1016/j.gassur.2004.09.044; Pailler-Mattei C, 2008, MED ENG PHYS, V30, P599, DOI 10.1016/j.medengphy.2007.06.011; Tsujino T, 2007, CLIN CANCER RES, V13, P2082, DOI 10.1158/1078-0432.CCR-06-2191; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Friess H, 1996, PANCREAS, V13, P202; Kaster T, 2011, J BIOMECH, V44, P1158, DOI 10.1016/j.jbiomech.2011.01.019; Choi APC, 2005, MED BIOL ENG COMPUT, V43, P258, DOI 10.1007/BF02345964; Hara Y, 2013, SKIN RES TECHNOL, V19, P339, DOI 10.1111/srt.12054; Kawai M, 2011, J HEPATO-BIL-PAN SCI, V18, P601, DOI 10.1007/s00534-011-0373-x; Tilleman TR, 2004, ISRAEL MED ASSOC J, V6, P753; D'Onofrio M, 2014, EUR J RADIOL, V83, P415, DOI 10.1016/j.ejrad.2013.04.020; Samani A, 2007, PHYS MED BIOL, V52, P1565, DOI 10.1088/0031-9155/52/6/002; Saftoiu A, 2011, ENDOSCOPY, V43, P596, DOI 10.1055/s-0030-1256314; Callery MP, 2013, J AM COLL SURGEONS, V216, P1, DOI 10.1016/j.jamcollsurg.2012.09.002; Mallory FB, 1900, J EXP MED, V5, P15, DOI 10.1084/jem.5.1.15; Iglesias-Garcia J, 2013, ENDOSCOPY, V45, P781, DOI 10.1055/s-0033-1344614; Itokawa F, 2011, J GASTROENTEROL, V46, P843, DOI 10.1007/s00535-011-0399-5; Leng HJ, 2013, BONE, V55, P288, DOI 10.1016/j.bone.2013.04.006; Hashimoto Y, 2010, SURGERY, V147, P503, DOI 10.1016/j.surg.2009.10.034; Storch KN, 2007, HISTOCHEM CELL BIOL, V127, P523, DOI 10.1007/s00418-007-0275-9; Yamaoka H, 2006, J BIOMED MATER RES A, V78A, P1, DOI 10.1002/jbm.a.30655; Ansorge C, 2012, BRIT J SURG, V99, P1076, DOI 10.1002/bjs.8784; Cherng S, 2008, J AM SCI, V4, P7; Diridollou S, 2001, Int J Cosmet Sci, V23, P353, DOI 10.1046/j.0412-5463.2001.00105.x; Feynman R.P., 1964, FEYNMAN LECT PHYS, V2, P2; Glozman T, 2010, J ULTRAS MED, V29, P387; Hertz H., 1881, J REINE ANGEW MATH, V92, P156, DOI DOI 10.1515/CRIL.1882.92.156>; Polyakov P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018887; SARLES H, 1989, ANNU REV MED, V40, P453; Sugimoto M, 2013, J GASTROINTEST SURG, V17, P1744, DOI 10.1007/s11605-013-2320-4	30	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	NOV	2014	156	5					1204	1211		10.1016/j.surg.2014.05.015		8	Surgery	Surgery	AR7WG	WOS:000343787100020		
J	Matsumoto, N; Morine, Y; Utsunomiya, T; Imura, S; Ikemoto, T; Arakawa, Y; Iwahashi, S; Saito, Y; Yamada, S; Ishikawa, D; Takasu, C; Miyake, H; Shimada, M				Matsumoto, Noriko; Morine, Yuji; Utsunomiya, Tolaru; Imura, Satoru; Ikemoto, Tetsuya; Arakawa, Yusuke; Iwahashi, Shuichi; Saito, Yu; Yamada, Shiniciro; Ishikawa, Daichi; Takasu, Chie; Miyake, Hidenori; Shimada, Mitsuo			Role of CD151 expression in gallbladder carcinoma	SURGERY			English	Article							TETRASPANIN CD151; GASTRIC-CANCER; INTRAHEPATIC CHOLANGIOCARCINOMA; CELL-PROLIFERATION; POOR-PROGNOSIS; MATRIX-METALLOPROTEINASE-9; SUPERFAMILY; METASTASIS; OVEREXPRESSION; ACTIVATION	Introduction. CD151 is a member of the tetraspanin family, which interacts with laminin-binding integrins and other tetraspanins. CD151 is involved in several pathologic activities associated with tumor progression, including metastasis and angiogenesis. The aim of this study was to clarify the clinical use of CD151 expression in gallbladder cancer (GBC). Methods. Forty-five patients with GBC who had undergone operative treatment were enrolled in this study. Expressions of CD151 in the resected GBC specimens were evaluated with anti-CD151 antibody. The patients were divided into positive and negative groups according to CD151 expression: CD151-positive group (n = 26) and CD151-negative group (n = 19). Clinicopathologic factors, including Ki-67 and matrix metallopeptidase 9, also were compared between the two groups. Results. CD151-positive expression was 58% and correlated with poorer prognosis; 5-year survival of CD151-positive and CD151-negative groups was 29% and 78%, respectively (P = .006). CD151 expression also correlated with lymphatic invasion and curability. Multivariate analysis revealed that CD151-positive expression was an independent prognostic factor (hazard ratio 2.97, P =.02). In addition, CD151 expression correlated with matrix metallopeptidase 9 expression (P < .05) but not with Ki67 expression. Conclusion. Those findings suggested that CD151-positive expression might be a potential prognostic indicator and one of the target molecules for the regulation of tumor metastasis for patients with GBC.	[Matsumoto, Noriko; Morine, Yuji; Utsunomiya, Tolaru; Imura, Satoru; Ikemoto, Tetsuya; Arakawa, Yusuke; Iwahashi, Shuichi; Saito, Yu; Yamada, Shiniciro; Ishikawa, Daichi; Takasu, Chie; Miyake, Hidenori; Shimada, Mitsuo] Univ Tokushima, Grad Sch, Dept Surg, Inst Hlth Biosci, Tokushima 7708503, Japan	Morine, Y (reprint author), Univ Tokushima, Grad Sch, Dept Surg, Inst Hlth Biosci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	ymorine@tokushima-u.ac.jp					Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031; Hashida H, 2003, BRIT J CANCER, V89, P158, DOI 10.1038/sj.bjc.6601015; Damodharan U, 2011, APPL BIOCHEM BIOTECH, V165, P1245, DOI 10.1007/s12010-011-9342-8; Haeuw JF, 2011, BIOCHEM SOC T, V39, P553, DOI 10.1042/BST0390553; Zhu AX, 2010, ONCOLOGIST, V15, P168, DOI 10.1634/theoncologist.2009-0302; Sincock PM, 1997, J HISTOCHEM CYTOCHEM, V45, P515; Testa JE, 1999, CANCER RES, V59, P3812; Srivastava K, 2011, MUTAT RES-REV MUTAT, V728, P67, DOI 10.1016/j.mrrev.2011.06.002; Tang Y, 2008, CLIN CANCER RES, V14, P2870, DOI 10.1158/1078-0432.CCR-07-4042; FRIDMAN R, 1995, CANCER RES, V55, P2548; Sadej R, 2009, MOL CANCER RES, V7, P787, DOI 10.1158/1541-7786.MCR-08-0574; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Ke AW, 2011, GASTROENTEROLOGY, V140, P1629, DOI 10.1053/j.gastro.2011.02.008; Yanez-Mo M, 2001, J CELL SCI, V114, P577; Tan ZJ, 2013, GENE, V528, P261, DOI 10.1016/j.gene.2013.06.064; Wilson CL, 1996, INT J BIOCHEM CELL B, V28, P123, DOI 10.1016/1357-2725(95)00121-2; Wright MD, 2004, MOL CELL BIOL, V24, P5978, DOI 10.1128/MCB.24.13.5978-5988.2004; Suzuki S, 2011, ANN SURG ONCOL, V18, P888, DOI 10.1245/s10434-010-1387-3; Boutros C, 2012, SURG ONCOL, V21, P183; FITTER S, 1995, BLOOD, V86, P1348; Ha SY, 2014, ANN SURG ONCOL, V21, P1099, DOI 10.1245/s10434-013-3339-1; Hong IK, 2006, J BIOL CHEM, V281, P24279, DOI 10.1074/jbc.M601209200; Huang XY, 2010, CANCER-AM CANCER SOC, V116, P5440, DOI 10.1002/cncr.25485; Japanese Society of Biliary Surgery, 2013, GEN RUL SURG PATH ST; Kang BW, 2013, J CANCER RES CLIN, V139, P1835, DOI 10.1007/s00432-013-1503-4; Liu Z, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-270; Nishi M, 2011, HEPATOL RES, V41, P64, DOI 10.1111/j.1872-034X.2010.00722.x; Ohno M, 2002, INT J CANCER, V343, P336; Shi GM, 2010, HEPATOLOGY, V52, P183, DOI 10.1002/hep.23661; Wang CG, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-41; Zhu GH, 2011, DIGEST DIS SCI, V56, P1090, DOI 10.1007/s10620-010-1416-x	31	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	NOV	2014	156	5					1212	1217		10.1016/j.surg.2014.04.053		6	Surgery	Surgery	AR7WG	WOS:000343787100021		
J	Sakamoto, S; Kanazawa, H; Shigeta, T; Uchida, H; Sasaki, K; Hamano, I; Fukuda, A; Nosaka, S; Egawa, H; Kasahara, M				Sakamoto, Seisuke; Kanazawa, Hiroyuki; Shigeta, Takanobu; Uchida, Hajime; Sasaki, Kengo; Hamano, Ikumi; Fukuda, Akinari; Nosaka, Shunsuke; Egawa, Hiroto; Kasahara, Mureo			Technical considerations of living donor hepatectomy of segment 2 grafts for infants	SURGERY			English	Article							MONOSEGMENTAL LIVER-TRANSPLANTATION; SINGLE-CENTER EXPERIENCE	Background. The selection of an adequate graft to mitigate the problems associated with a large-for-size graft is essential to ensure the success of liver transplantation for smaller children. Reduced left lateral segment (LLS) grafts have been introduced to overcome this issue. Methods. Five infants underwent living donor liver transplantation (LDLT) with segment 2 grafts. In the preoperative assessment, the graft-to-recipient weight ratio (GRWR) and the ratio of the thickness of the donor LLS were used as a reference index for graft size matching, and a 3-dimensional (3D) computer-generated model of the donor liver was used for the analysis of the intrahepatic vasculature. During the donor operation, the relevant portal vein branches feeding to the reduced part of segment 3 were first exposed and divided, and then the parenchymal transection was performed. Results. Segment 2 grafts were selected in 3 cases and reduced segment 2 grafts were selected in the other 2 cases. The graft reduction was achieved with 46.6 +/- 8.2% of the actual LLS, and thus the GRWR was reduced from 5.33 +/- 2.09% to 2.70 +/- 0.82%. The actual graft thickness was reduced by approximately half after the graft reduction. Primary abdominal closure was performed in all of the recipients. No surgical complications occurred in any of the donors or recipients. Conclusion. A segment 2 graft could be a valuable option for graft type selection in LDLT for smaller children. Precise planning using a 3D computer-generated model of the donor liver and meticulous operative procedures are necessary to obtain a viable graft.	[Sakamoto, Seisuke; Kanazawa, Hiroyuki; Shigeta, Takanobu; Uchida, Hajime; Sasaki, Kengo; Hamano, Ikumi; Fukuda, Akinari; Kasahara, Mureo] Natl Ctr Child Hlth & Dev, Div Transplant Surg, Tokyo 1578535, Japan; [Nosaka, Shunsuke] Natl Ctr Child Hlth & Dev, Div Radiol, Tokyo 1578535, Japan; [Egawa, Hiroto] Tokyo Womens Med Univ, Dept Surg, Tokyo, Japan	Sakamoto, S (reprint author), Natl Ctr Child Hlth & Dev, Div Transplant Surg, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	sakamoto-si@ncchd.go.jp			Scientific Research Fund of the Ministry of Education; Research Grant for Immunology, Allergy and Organ Transplant from the Ministry of Health, Labor and Welfare, Japan [25461968, 24-08, 25-06]	Supported in part by grants from the Scientific Research Fund of the Ministry of Education and by a Research Grant for Immunology, Allergy and Organ Transplant from the Ministry of Health, Labor and Welfare, Japan (No. 25461968, 24-08, and 25-06).	TANAKA K, 1993, ANN SURG, V217, P82, DOI 10.1097/00000658-199301000-00014; MAKUUCHI M, 1985, SURG GYNECOL OBSTET, V161, P346; Kiuchi T, 1999, TRANSPLANTATION, V67, P321, DOI 10.1097/00007890-199901270-00024; Zein NN, 2013, LIVER TRANSPLANT, V19, P1304, DOI 10.1002/lt.23729; Kasahara M, 2013, LIVER TRANSPLANT, V19, P226, DOI 10.1002/lt.23572; Ikegami T, 2013, NAT REV GASTRO HEPAT, V10, P697, DOI 10.1038/nrgastro.2013.195; Enne M, 2005, LIVER TRANSPLANT, V11, P564, DOI 10.1002/lt.20421; Kanazawa H, 2013, TRANSPLANTATION, V95, P750, DOI 10.1097/TP.0b013e31827a93b4; Kasahara M, 2003, TRANSPLANTATION, V76, P694, DOI 10.1097/01.TP.0000079446.94204.F9; Mentha G, 1996, TRANSPLANTATION, V62, P1176, DOI 10.1097/00007890-199610270-00026; Mizuta K, 2010, AM J TRANSPLANT, V10, P2547, DOI 10.1111/j.1600-6143.2010.03274.x; Noujaim HM, 2002, J PEDIATR SURG, V37, P159, DOI 10.1053/jpsu.2002.30242; Radtke A, 2012, TRANSPLANTATION, V94, P1138, DOI 10.1097/TP.0b013e31826e5970; Santibanes E, 2000, LIVER TRANSPLANT, V6, P108; Shehata MR, 2012, AM J TRANSPLANT, V12, P3406, DOI 10.1111/j.1600-6143.2012.04268.x; Srinivasan P, 1999, SURGERY, V126, P10, DOI 10.1067/msy.1999.98686; STRONG R, 1995, SURGERY, V118, P904, DOI 10.1016/S0039-6060(05)80283-1; Torzilli G, 2010, ANN SURG, V251, P229, DOI 10.1097/SLA.0b013e3181b7fdcd	18	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	NOV	2014	156	5					1232	1237		10.1016/j.surg.2014.05.003		6	Surgery	Surgery	AR7WG	WOS:000343787100024		
J	Miyata, H; Gotoh, M; Hashimoto, H; Motomura, N; Murakami, A; Tomotaki, A; Hirahara, N; Ono, M; Ko, C; Iwanaka, T				Miyata, Hiroaki; Gotoh, Mitsukazu; Hashimoto, Hideki; Motomura, Noboru; Murakami, Arata; Tomotaki, Ai; Hirahara, Norimichi; Ono, Minoru; Ko, Clifford; Iwanaka, Tadashi			Challenges and prospects of a clinical database linked to the board certification system	SURGERY TODAY			English	Review						Quality improvement; Database; General surgery; Cancer registry; Certification board for expert surgeons	BYPASS GRAFT-SURGERY; HEALTH-CARE; QUALITY; MANAGEMENT; DISEASE	In Japan, the National Clinical Database (NCD) was founded in April 2010 as the parent body of the database system linked to the board certification system. Registration began in 2011, and to date, more than 3,300 facilities have enrolled and more than one million cases are expected to enroll each year. Given the broad impact of this database initiative, considering the social implications of their activities is important. In this study, we identified and addressed issues arising from data collection and analysis, with a primary focus on providing high-quality healthcare to patients and the general public. Improvements resulting from NCD initiatives have been implemented in clinical settings throughout Japan. Clinical research using such database as well as evidence-based policy recommendations can impact businesses, the government and insurance companies. The NCD project is realistic in terms of effort and cost, and its activities are conducted lawfully and ethically with due consideration of its effects on society. Continuous evaluation on the whole system is essential. Such evaluation provides the validity of the framework of healthcare standards as well as ensures the reliability of collected data to guarantee the scientific quality in clinical databases.	[Miyata, Hiroaki; Gotoh, Mitsukazu; Hashimoto, Hideki; Motomura, Noboru; Murakami, Arata; Iwanaka, Tadashi] Natl Clin Database, Chiyoda Ku, Tokyo, Japan; [Miyata, Hiroaki; Hashimoto, Hideki; Tomotaki, Ai; Hirahara, Norimichi; Ono, Minoru; Iwanaka, Tadashi] Univ Tokyo, Grad Sch Med, Dept Healthcare Qual Assessment, Bunkyo Ku, Tokyo 1138655, Japan; [Ko, Clifford] Amer Coll Surg Natl Surg Qual Improvement Program, Chicago, IL USA	Miyata, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Healthcare Qual Assessment, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	hqa.submission@gmail.com					[Anonymous], 1994, PROGR EV STAND ASS E; Goetzel RZ, 2005, HEALTH CARE FINANC R, V26, P1; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; [Anonymous], 2003, MED CARE S; Hall BL, 2009, ANN SURG, V250, P363, DOI 10.1097/SLA.0b013e3181b4148f; Landon BE, 2003, JAMA-J AM MED ASSOC, V290, P1183, DOI 10.1001/jama.290.9.1183; Day Michael, 2007, BMJ, V334, P12, DOI 10.1136/bmj.39072.441620.DB; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Glickman SW, 2007, INT J QUAL HEALTH C, V19, P341, DOI 10.1093/intqhc/mzm047; Institute of Medicine, 2001, CROSSING QUALITY CHA; Iwanaka T, 2011, JAPN J CLIN MED NIPP, V69, P625; Iwanaka T, 2012, CLIN SURG RINSHO GEK, V67, P742; Jamtvedt G, 2003, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858; Japan Surgical Society, 2010, DISCL RES PROC ETH R; Japan Surgical Society, 2012, JAP SURG SOC; Japanese Society of Gastroenterological Surgery, NEW SYST BOARD CERT; Ministry of Education, 2008, ETH GUID EP RES; Miyata H, 2012, J THORAC CARDIOV SUR, V143, P1364, DOI 10.1016/j.jtcvs.2011.07.010; Miyata H, 2009, HEALTH POLICY, V91, P246, DOI 10.1016/j.healthpol.2008.11.003; Mori R, 2012, LANCET, V379, P12, DOI 10.1016/S0140-6736(11)60820-9; Okubo S, 2012, CLIN SURG RINSHO GEK, V67, P746; Porter ME, 2007, JAMA-J AM MED ASSOC, V297, P1003; Schneider EC, 1996, NEW ENGL J MED, V335, P251, DOI 10.1056/NEJM199607253350406; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Society of Thoracic Surgeons, 2004, GUID US STS NAT DAT; The Ministry of Education Culture Sports Science and Technology and the Ministry of Health Labor and Welfare, 2008, ETH GUID CLIN RES; The Ministry of Health Labour and Welfare, 2008, ADM CROSS COUNTR STU; The United States President's Commission, 1984, FIN REP ETH LEG PROB; Vaughan-Sarrazin MS, 2002, JAMA-J AM MED ASSOC, V288, P1859, DOI 10.1001/jama.288.15.1859	30	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					1991	1999		10.1007/s00595-013-0802-3		9	Surgery	Surgery	AR6WT	WOS:000343722300001		
J	Maeda, K; Koide, Y; Katsuno, H				Maeda, Kotaro; Koide, Yoshikazu; Katsuno, Hidetoshi			When is local excision appropriate for "early" rectal cancer?	SURGERY TODAY			English	Review						Early rectal cancer; T1 rectal cancer; T2 rectal cancer; Stage 1 cancer; Local excision	LYMPH-NODE METASTASIS; TRANSANAL ENDOSCOPIC MICROSURGERY; INVASIVE COLORECTAL-CARCINOMA; FACTORS AFFECTING SURVIVAL; LONG-TERM SURVIVAL; ENDORECTAL ULTRASONOGRAPHY; VILLOUS ADENOMAS; RISK-FACTORS; ENDOLUMINAL ULTRASOUND; COMPUTED-TOMOGRAPHY	Local excision is increasingly performed for "early stage'' rectal cancer in the US; however, local recurrence after local excision has become a controversial issue in Western countries. Local recurrence is considered to originate based on the type of tumor and procedure performed, and in surgical margin-positive cases. This review focuses on the inclusion criteria of "early" rectal cancers for local excision from the Western and Japanese points of view. "Early" rectal cancer is defined as T1 cancer in the rectum. Only the tumor grade and depth of invasion are the "high risk" factors which can be evaluated before treatment. T1 cancers with sm1 or submucosal invasion <1,000 mu m are considered to be "low risk" tumors with less than 3.2 % nodal involvement, and are considered to be candidates for local excision as the sole curative surgery. Tumors with a poor tumor grade should be excluded from local excision. Digital examination, endoscopy or proctoscopy with biopsy, a barium enema study and endorectal ultrasonography are useful for identifying "low risk" or excluding "high risk" factors pre-operatively for a comprehensive diagnosis. The selection of an initial local treatment modality is also considered to be important according to the analysis of the nodal involvement rate after initial local treatment and after radical surgery.	[Maeda, Kotaro; Koide, Yoshikazu; Katsuno, Hidetoshi] Fujita Hlth Univ, Dept Surg, Sch Med, Toyoake, Aichi 4701192, Japan	Maeda, K (reprint author), Fujita Hlth Univ, Dept Surg, Sch Med, 1-98 Kutsukake, Toyoake, Aichi 4701192, Japan.	kmaeda@fujita-hu.ac.jp					Akasu T, 2000, WORLD J SURG, V24, P1061; American Cancer Society, 2009, CANC FACTS 2009; Brown G, 2004, BRIT J CANCER, V91, P23, DOI 10.1038/sj.bjc.6601871; CRANLEY JP, 1986, GASTROENTEROLOGY, V91, P419; Bipat S, 2004, RADIOLOGY, V232, P773, DOI 10.1148/radiol.2323031368; CHIU YS, 1978, DIS COLON RECTUM, V21, P493, DOI 10.1007/BF02586734; Tominaga K, 2005, DIS COLON RECTUM, V48, P92, DOI 10.1007/S10350-004-0751-4; Paty PB, 2002, ANN SURG, V236, P522, DOI 10.1097/01.SLA.0000029001.10244.61; Kwok H, 2000, INT J COLORECTAL DIS, V15, P9, DOI 10.1007/s003840050002; Chok KSH, 2007, WORLD J SURG, V31, P1485, DOI 10.1007/s00268-007-9089-0; Yasuda K, 2007, DIS COLON RECTUM, V50, P1370, DOI 10.1007/s10350-007-0263-0; Kaneko I, 2007, DIS COLON RECTUM, V50, P13, DOI 10.1007/s10350-006-0745-5; Adams DR, 1999, DIS COLON RECTUM, V42, P159, DOI 10.1007/BF02237121; Gagliardi G, 2002, ARCH SURG-CHICAGO, V137, P447, DOI 10.1001/archsurg.137.4.447; Gopaul D, 2004, DIS COLON RECTUM, V47, P1780, DOI 10.1007/s10350-004-0678-9; Bernini A, 1996, ANN SURG ONCOL, V3, P131, DOI 10.1007/BF02305791; Tanaka S, 2006, GASTROINTEST ENDOSC, V64, P604, DOI 10.1016/j.gie.2006.06.007; Bretagnol F, 2007, DIS COLON RECTUM, V50, P523, DOI 10.1007/s70350-006-0819-4; NIVATVONGS S, 1980, SURGERY, V87, P549; Zorcolo L, 2009, SURG ENDOSC, V23, P1384, DOI 10.1007/s00464-009-0349-y; Sengupta S, 2001, DIS COLON RECTUM, V44, P1345, DOI 10.1007/BF02234796; Sitzler PJ, 1997, DIS COLON RECTUM, V40, P1472, DOI 10.1007/BF02070714; SHINYA H, 1979, ANN SURG, V190, P679, DOI 10.1097/00000658-197912000-00001; Nash GM, 2009, DIS COLON RECTUM, V52, P577, DOI 10.1007/DCR.0b013e3181a0adbd; CHAN TW, 1991, RADIOLOGY, V181, P461; Endreseth BH, 2005, DIS COLON RECTUM, V48, P1380, DOI 10.1007/s10350-005-0044-6; Kitajima K, 2004, J GASTROENTEROL, V39, P534, DOI 10.1007/s00535-004-1339-4; Tytherleigh MG, 2008, BRIT J SURG, V95, P409, DOI 10.1002/bjs.6127; Nascimbeni R, 2002, DIS COLON RECTUM, V45, P200, DOI 10.1007/s10350-004-6147-7; Saitoh Y, 1998, GASTROINTEST ENDOSC, V48, P362, DOI 10.1016/S0016-5107(98)70004-5; Greenberg JA, 2008, DIS COLON RECTUM, V51, P1185, DOI 10.1007/s10350-008-9231-6; You YN, 2007, ANN SURG, V245, P726, DOI 10.1097/01.sla.0000252590.95116.4f; POLLARD CW, 1992, DIS COLON RECTUM, V35, P933, DOI 10.1007/BF02253494; Santoro GA, 2009, DIS COLON RECTUM, V52, P1837, DOI 10.1007/DCR.0b013e3181b16ce9; Chambers WM, 2004, BRIT J SURG, V91, P457, DOI 10.1002/bjs.4504; Zenni GC, 1998, J SURG ONCOL, V67, P99, DOI 10.1002/(SICI)1096-9098(199802)67:2<99::AID-JSO5>3.3.CO;2-Q; WILLETT CG, 1994, CANCER, V73, P2716, DOI 10.1002/1097-0142(19940601)73:11<2716::AID-CNCR2820731111>3.0.CO;2-9; Son HJ, 2008, HEPATO-GASTROENTEROL, V55, P1293; Baxter NN, 2007, J CLIN ONCOL, V25, P1014, DOI 10.1200/JCO.2006.09.7840; Nelson H, 2001, J NATL CANCER I, V93, P583, DOI 10.1093/jnci/93.8.583; Glancy DG, 2005, COLORECTAL DIS, V7, P148, DOI 10.1111/j.1463-1318.2004.00728.x; GLASER F, 1990, BRIT J SURG, V77, P883, DOI 10.1002/bjs.1800770813; Lee W, 2003, SURG ENDOSC, V17, P1283, DOI 10.1007/s00464-002-8814-x; Bach SP, 2009, BRIT J SURG, V96, P280, DOI 10.1002/bjs.6456; Rasheed S, 2008, COLORECTAL DIS, V10, P231, DOI 10.1111/j.1463-1318.2007.01411.x; Borschitz T, 2006, DIS COLON RECTUM, V49, P1492, DOI 10.1007/s10350-006-0587-1; Nascimbeni R, 2004, DIS COLON RECTUM, V47, P1773, DOI 10.1007/s10350-004-0706-9; Leslie A, 2002, BRIT J SURG, V89, P845, DOI 10.1046/j.1365-2168.2002.02120.x; Ptok H, 2007, ARCH SURG-CHICAGO, V142, P649, DOI 10.1001/archsurg.142.7.649; BRODSKY JT, 1992, CANCER, V69, P322, DOI 10.1002/1097-0142(19920115)69:2<322::AID-CNCR2820690208>3.0.CO;2-B; Choi PW, 2008, WORLD J SURG, V32, P2089, DOI 10.1007/s00268-008-9628-3; Bentrem DJ, 2005, ANN SURG, V242, P472, DOI 10.1097/01.sla.0000183355.94322.db; Garcia-Aguilar J, 2000, ANN SURG, V231, P345, DOI 10.1097/00000658-200003000-00007; Garcia-Aguilar J, 2002, DIS COLON RECTUM, V45, P10, DOI 10.1007/s10350-004-6106-3; Folkesson J, 2007, BRIT J SURG, V94, P1421, DOI 10.1002/bjs.5715; RIFKIN MD, 1989, RADIOLOGY, V170, P319; Monson JRT, 2013, DIS COLON RECTUM, V56, P535, DOI 10.1097/DCR.0b013e31828cb66c; Sakuragi M, 2003, DIS COLON RECTUM, V46, P1626, DOI 10.1097/01.DCR.0000100821.53077.DD; Friel CM, 2010, DIS COLON RECTUM, V53, P1231, DOI 10.1007/DCR.0b013e3181e1a1ff; Johnston CF, 2013, DIS COLON RECTUM, V56, P400, DOI 10.1097/DCR.0b013e3182805eb8; KIKUCHI R, 1995, DIS COLON RECTUM, V38, P1286, DOI 10.1007/BF02049154; TANAKA S, 1995, J GASTROENTEROL, V30, P710, DOI 10.1007/BF02349636; Ueno H, 2004, GASTROENTEROLOGY, V127, P385, DOI 10.1053/S0016-5085(04)00717-6; Pigot F, 2003, DIS COLON RECTUM, V46, P1345, DOI 10.1097/01.DCR.0000089122.05565.C0; Lezoche E, 2007, DIGEST DIS, V25, P76, DOI 10.1159/000099173; Winde G, 1996, DIS COLON RECTUM, V39, P969, DOI 10.1007/BF02054683; Kajiwara Y, 2010, DIS COLON RECTUM, V53, P1393, DOI 10.1007/DCR.0b013e3181ec5f66; HASE K, 1993, DIS COLON RECTUM, V36, P627, DOI 10.1007/BF02238588; Suzuki T, 2003, DIS COLON RECTUM, V46, P203, DOI 10.1097/01.DCR.0000044728.97664.CB; Yamamoto S, 2004, HEPATO-GASTROENTEROL, V51, P998; Fang WL, 2005, HEPATO-GASTROENTEROL, V52, P1688; [Anonymous], 2010, GEN RUL CLIN PATH ST; Peng J, 2011, COLORECTAL DIS, V13, pe14, DOI 10.1111/j.1463-1318.2010.02424.x; Pahlman L, 2007, BRIT J SURG, V94, P1285, DOI 10.1002/bjs.5679; Landmann RG, 2007, DIS COLON RECTUM, V50, P1520, DOI 10.1007/s10350-007-9019-0; Balani A, 2000, J SURG ONCOL, V74, P158, DOI 10.1002/1096-9098(200006)74:2<158::AID-JSO15>3.0.CO;2-E; Benoist S, 1998, HEPATO-GASTROENTEROL, V45, P1546; BEYNON J, 1989, BRIT J SURG, V76, P276, DOI 10.1002/bjs.1800760320; BEYNON J, 1989, ANN ROY COLL SURG, V71, P131; BEYNON J, 1986, BRIT J SURG, V73, P1015, DOI 10.1002/bjs.1800731228; Blackstock A, 2010, CURR PROB CANCER, V34, P193; Bleday R, 1997, DIS COLON RECTUM, V40, P388, DOI 10.1007/BF02258381; Brown CJ, 2008, EXPERT REV ANTICANC, V8, P111, DOI 10.1586/14737140.8.1.111; CHRISTIANSEN J, 1979, ANN SURG, V189, P404; COLACCHIO TA, 1981, ANN SURG, V194, P704, DOI 10.1097/00000658-198112000-00008; De Graaf EJR, 2009, EJSO-EUR J SURG ONC, V35, P1280, DOI 10.1016/j.ejso.2009.05.001; Dooenebosch PG, 2009, ACTA ONCOL, V48, P343; GALANDIUK S, 1987, AM J SURG, V153, P41, DOI 10.1016/0002-9610(87)90199-1; Gao JD, 2003, WORLD J GASTROENTERO, V9, P871; Garcia-Aguilar J, 2010, SURG ONCOL CLIN N AM, V19, P743, DOI 10.1016/j.soc.2010.08.002; GILLESPIE PE, 1979, GUT, V20, P240, DOI 10.1136/gut.20.3.240; Glimelius B, 2010, ANN ONCOL, V21, P21; Goldstein NS, 1999, AM J CLIN PATHOL, V111, P51; GRAHAM RA, 1990, AM J SURG, V160, P306, DOI 10.1016/S0002-9610(06)80030-9; Haboubi NY, 2000, COLORECTAL DIS, V2, P2; HAGGITT R C, 1985, Gastroenterology, V89, P328; Hahlenberg MS, 2008, PRINCIPLES PRACTICE, P593; Hamamoto N, 2004, ITO CYO, V39, P1375; Hiderbrandt U, 1985, DIS COLON RECTUM, V28, P42; HOLDSWORTH PJ, 1988, BRIT J SURG, V75, P1019, DOI 10.1002/bjs.1800751022; HUDDY SPJ, 1993, BRIT J SURG, V80, P1457, DOI 10.1002/bjs.1800801135; Hurlstone D P, 2004, Colorectal Dis, V6, P369, DOI 10.1111/j.1463-1318.2004.00667.x; Inoue Y, 1998, NIPPON SYOUKAKI GEKA, V31, P2334; Inoue Y, 1998, GASTROENTEROL ENDOSC, V40, P205; JAHADI MR, 1975, AM J SURG, V130, P729, DOI 10.1016/0002-9610(75)90430-4; Jap Soc for Cancer of the Colon and Rectum, 1994, GEN RUL CLIN PATH ST; Jap Soc for Cancer of the Colon and Rectum, 1980, GEN RUL CLIN PATH ST; Jap Soc for Cancer of the Colon and Rectum, 2010, JSCCR GUID 2010 TREA, P57; Japanese Gastric Cancer Association, 2010, JAP CLASS GASTR CARC; Kesisonglou L, 2010, TECH COLOPROCTOL S, V14, ps33; Kim E, 2008, CLIN COLORECTAL CANC, V7, P376, DOI 10.3816/CCC.2008.n.050; Kim JH, 2004, EUR J RADIOL, V52, P78, DOI 10.1016/j.ejrad.2003.12.005; Kitagawa S, 2010, NIPPON SYOUKAKI GANN, V48, P67; Kodaira S, 1994, I TO CYO, V29, P1137; Koide Y, 2003, FUJITA IGAKKAISHI, V22, P279; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; Kulig J, 2006, ULTRASOUND MED BIOL, V32, P469, DOI 10.1016/j.ultrasmedbio.2005.12.014; Maeda K, 2004, J AM COLL SURGEONS, V199, P353, DOI 10.1016/j.jamcollsurg.2004.05.268; Masaki T, 2003, HEPATO-GASTROENTEROL, V50, P388; Matsuoka H, 2003, AM J SURG, V185, P328, DOI 10.1016/S0002-9610(02)01405-8; Mellgren A, 2000, DIS COLON RECTUM, V43, P1064, DOI 10.1007/BF02236551; Meyer Joshua E, 2009, Gastrointest Cancer Res, V3, P123; MORSON BC, 1966, P ROY SOC MED, V59, P607; Morson B C, 1970, Curr Probl Surg, P1; Muto T, 2003, DIS COLON RECTUM, V46, pS89, DOI 10.1097/01.DCR.0000083525.97708.B5; National Panhellenic Conference, 2012, NCCN CLIN PRACT GUID, P4; NICHOLLS RJ, 1982, BRIT J SURG, V69, P404, DOI 10.1002/bjs.1800690716; Nishigami T, 2000, SOUKIDAICYOUGAN, V4, P171; NISHIZAWA M, 1980, ENDOSCOPY, V12, P124, DOI 10.1055/s-2007-1021727; OLSON RO, 1969, ARCH SURG-CHICAGO, V98, P487; PARKS AG, 1973, BRIT J SURG, V60, P688, DOI 10.1002/bjs.1800600908; Peeples C, 2010, DIS COLON RECTUM, V53, P1517, DOI 10.1007/DCR.0b013e3181f20116; Perretta S, 2006, SURG ONCOL CLIN N AM, V15, P67, DOI 10.1016/j.soc.2005.10.001; Petrelli NJ, 1999, J SURG ONCOL, V71, P46, DOI 10.1002/(SICI)1096-9098(199905)71:1<46::AID-JSO9>3.0.CO;2-T; Pomerri F, 2009, EJSO-EUR J SURG ONC, V35, P168, DOI 10.1016/j.ejso.2008.02.006; QUAN SHQ, 1971, DIS COLON RECTUM, V14, P267, DOI 10.1007/BF02553199; RAFAELSEN SR, 1994, ACTA RADIOL, V35, P300; Saito Y, 2005, ITO CYO, V40, P1855; Sawai T, 2001, RINSYOUGEKA, V56, P241; Schaffzin David M, 2004, Clin Colorectal Cancer, V4, P124, DOI 10.3816/CCC.2004.n.015; Sobin LH, 2002, TNM CLASSIFICATION M; Starck M, 2003, Colorectal Dis, V5, P246, DOI 10.1046/j.1463-1318.2003.00416.x; STARCK M, 1995, EUR J SURG, V161, P841; Sticca RP, 1996, CANCER INVEST, V14, P491, DOI 10.3109/07357909609018907; Takahashi K, 2000, DIS COLON RECTUM, V43, pS40, DOI 10.1007/BF02237225; TANAKA S, 1995, DIS COLON RECTUM, V38, P959, DOI 10.1007/BF02049732; Taylor RH, 1998, AM J SURG, V175, P360, DOI 10.1016/S0002-9610(98)00038-5; WAIZER A, 1989, DIS COLON RECTUM, V32, P53, DOI 10.1007/BF02554726; Watari J, 1997, RADIOLOGY, V205, P67; Wexner SD, 2003, J AM COLL SURGEONS, V196, P95, DOI 10.1016/S1072-7515(02)01621-6; Yoshida N, 2010, GASTROENTEROL ENDOSC, V52, P1522	151	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2000	2014		10.1007/s00595-013-0766-3		15	Surgery	Surgery	AR6WT	WOS:000343722300002		
J	Ikeda, T				Ikeda, Tadashi			Re-sentinel node biopsy after previous breast and axillary surgery	SURGERY TODAY			English	Review						Breast cancer; Re-sentinel node biopsy; Sentinel node; Previous surgery	TUMOR RECURRENCE; LOCAL RECURRENCE; CANCER PATIENTS; TREATED BREAST; DISSECTION; THERAPY; WOMEN	There is no consensus regarding the strategy for managing the regional lymph nodes in patients with local breast cancer recurrence. This paper reviews the updated data on re-sentinel lymph node biopsy (re-SLNB) after previous surgery. The identification rate of re-SLNB varied from 29 to 100 % (mean 67 %). The success rate of re-SLNB depends on the method used for the previous axillary surgery and the number of lymph nodes harvested. Re-SLNB may be feasible even after mastectomy. A relationship between post-operative radiotherapy and identification of re-SLNB was not seen. A longer disease-free interval may correlate with a lower identification rate, but this finding is not definitive. Based on data regarding back-up dissection after re-SLNB, the accuracy of re-SLNB may be as good as SLNB in primary cases. Altered lymphatic drainage was reported in 2-89 % (mean 32 %) of cases. Because the altered lymphatic drainage can be detected only by lymphoscintigraphy, the radioisotope method, followed by lymphoscintigraphy, should be used. There are not many reported cases of axillary recurrence after re-SLNB, and the follow-up periods have been short. Because re-SLNB cases have a wide variety of backgrounds, it is necessary to accumulate a larger number of cases and to obtain data from longer follow-up period in order to make clear recommendations.	Teikyo Univ, Sch Med, Dept Surg, Itabashi Ku, Tokyo 1608582, Japan	Ikeda, T (reprint author), Teikyo Univ, Sch Med, Dept Surg, Itabashi Ku, 2-11-1 Kaga, Tokyo 1608582, Japan.	ikedat@med.teikyo-u.ac.jp					Agawal A, 2005, J SURG ONCOL, V92, P4; Boughey JC, 2006, CLIN BREAST CANCER, V7, P248, DOI 10.3816/CBC.2006.n.037; Schrenk P, 2008, EJSO-EUR J SURG ONC, V34, P851, DOI 10.1016/j.ejso.2007.11.006; Dinan D, 2005, AM J SURG, V190, P614, DOI 10.1016/j.amjsurg.2005.06.025; Cox CE, 2008, J AM COLL SURGEONS, V207, P57, DOI 10.1016/j.jamcollsurg.2008.01.017; Port ER, 2007, ANN SURG ONCOL, V14, P2209, DOI 10.1245/s10434-006-9237-z; Taback B, 2006, ANN SURG ONCOL, V13, P1099, DOI 10.1245/ASO.2006.08.026; Maaskant-Braat AJG, 2013, BREAST CANCER RES TR, V138, P13, DOI 10.1007/s10549-013-2409-1; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Roumen RMH, 2006, EJSO-EUR J SURG ONC, V32, P1076, DOI 10.1016/j.ejso.2006.08.007; Kuehn T, 2013, LANCET ONCOL, V14, P609, DOI 10.1016/S1470-2045(13)70166-9; Koizumi M, 2008, EJSO-EUR J SURG ONC, V34, P365, DOI 10.1016/j.ejso.2007.04.007; Maaskant-Braat AJG, 2013, ANN SURG ONCOL, V20, P620, DOI 10.1245/s10434-012-2625-7; Axelsson CK, 2008, EJSO-EUR J SURG ONC, V34, P626, DOI 10.1016/j.ejso.2007.09.004; Barone JL, 2007, AM J SURG, V194, P491, DOI 10.1016/j.amjsurg.2007.07.011; Cox Charles E, 2002, Breast J, V8, P88, DOI 10.1046/j.1524-4741.2002.08203.x; Darby S, 2011, LANCET, V378, P1707, DOI DOI 10.1016/S0140-6736(11)61629-2; Hattori M, 2011, SURG TODAY, V41, P247, DOI 10.1007/s00595-009-4241-0; Intra M, 2007, BRIT J SURG, V94, P1216, DOI 10.1002/bjs.5813; Jackson BM, 2006, CLIN BREAST CANCER, V6, P530, DOI 10.3816/CBC.2006.n.007; Karam A, 2008, J AM COLL SURGEONS, V207, P543, DOI 10.1016/j.jamcollsurg.2008.06.139; Kaur P, 2011, ANN SURG ONCOL, V18, P727, DOI 10.1245/s10434-010-1120-2; Lim Ilhan, 2004, Clin Nucl Med, V29, P346, DOI 10.1097/01.rlu.0000127087.12686.81; Luini A, 2005, BREAST CANCER RES TR, V89, P159, DOI 10.1007/s10549-004-1719-8; Newman EA, 2006, ANN SURG ONCOL, V13, P52, DOI 10.1245/ASO.2006.12.002; Saji S, 2012, BREAST CANCER-TOKYO, V19, P1, DOI 10.1007/s12282-011-0308-z; Sonoo H, 2008, BREAST CANCER-TOKYO, V15, P3, DOI 10.1007/s12282-007-0017-9; Sood A, 2004, CLIN NUCL MED, V29, P698, DOI 10.1097/00003072-200411000-00005; Tada K, 2005, EJSO, V31, P840, DOI 10.1016/j.ejso.2005.05.005; Tasevski R, 2009, BREAST, V18, P322, DOI 10.1016/j.breast.2009.09.009; van der Ploeg IMC, 2010, ANN SURG ONCOL, V17, P1069, DOI 10.1245/s10434-009-0841-6; Yamashita T, 2011, BREAST CANC	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2015	2021		10.1007/s00595-013-0783-2		7	Surgery	Surgery	AR6WT	WOS:000343722300003		
J	Onuki, T; Goto, Y; Kuramochi, M; Inagaki, M; Sato, Y				Onuki, Takuya; Goto, Yukinobu; Kuramochi, Masami; Inagaki, Masaharu; Sato, Yukio			Spontaneous hemopneumothorax: epidemiological details and clinical features	SURGERY TODAY			English	Article						Hemopneumothorax; Spontaneous pneumothorax; Epidemiology; Video-assisted thoracic surgery	ASSISTED THORACIC-SURGERY	Spontaneous hemopneumothorax (SHP) may cause life-threatening blood loss. The objective of this study was to elucidate the epidemiological and clinical features of SHP. We reviewed the records of 26 patients who underwent surgery for SHP between 1989 and 2010. We evaluated their epidemiology and clinical features by comparing them with those of 681 patients with spontaneous pneumothorax treated during the same period. The proportion of smokers in the SHP group was higher than that in the spontaneous pneumothorax group (P < 0.01). Seventeen cases (65.4 %) of SHP occurred on the left side. The most frequent bleeding area was the superior thoracic aperture (STA:17 cases, 65.4 %), followed by the left superior mediastinum (six cases, 23.1 %). Ten cases had intrathoracic clots greater than 500 mL, which could not be drained preoperatively. The postoperative stay of patients treated with video-assisted thoracic surgery (VATS) was shorter than that of patients treated with open thoracotomy (21 versus five cases; P < 0.05). A higher proportion of smokers was revealed in the SHP patients. VATS shortened the hospital stay of the patients. The particular areas that should be observed intraoperatively are the STA and the left superior mediastinum.	[Onuki, Takuya; Kuramochi, Masami; Inagaki, Masaharu] Tsuchiura Kyodo Gen Hosp, Dept Thorac Surg, Tsuchiura, Ibaraki 3000053, Japan; [Goto, Yukinobu; Sato, Yukio] Univ Tsukuba, Fac Med, Dept Gen Thorac Surg, Tsukuba, Ibaraki 3058575, Japan	Onuki, T (reprint author), Tsuchiura Kyodo Gen Hosp, Dept Thorac Surg, 11-7 Manabe Shincho, Tsuchiura, Ibaraki 3000053, Japan.	onukitakuya@hotmail.com					ABYHOLM FE, 1973, THORAX, V28, P376, DOI 10.1136/thx.28.3.376; Tatebe S, 1996, ANN THORAC SURG, V62, P1011, DOI 10.1016/0003-4975(96)00445-6; Hsu NY, 2005, ANN THORAC SURG, V80, P1859, DOI 10.1016/j.athoracsur.2005.04.052; Profita M, 2010, AM J PHYSIOL-LUNG C, V298, pL261, DOI 10.1152/ajplung.90593.2008; Chang YT, 2007, WORLD J SURG, V31, P19, DOI 10.1007/s00268-006-0354-4; Haciibrahimoglu G, 2005, THORAC CARDIOV SURG, V53, P240, DOI 10.1055/s-2005-837647; Homma T, 2009, SCAND J SURG, V98, P160; Hsiao CW, 2003, THORAC CARDIOV SURG, V51, P288; Hsu CC, 2005, EMERG MED J, V22, P415, DOI 10.1136/emj.2003.013441; Hwong TMT, 2004, EUR J CARDIO-THORAC, V26, P893, DOI 10.1016/j.ejcts.2004.05.014; Kakaris S, 2004, EUR J CARDIO-THORAC, V25, P856, DOI 10.1016/j.ejcts.2004.02.002; Kato T, 2012, SURG TODAY, V42, P903, DOI 10.1007/s00595-012-0136-6; Kim ES, 2008, ANN THORAC CARDIOVAS, V14, P149; Luh SP, 2007, RESPIROLOGY, V12, P443, DOI 10.1111/j.1440-1843.2006.01008.x; MURAGUCHI T, 1993, SURG TODAY, V23, P1119; de Perrot M, 2000, Swiss Surg, V6, P62, DOI 10.1024/1023-9332.6.2.62; Wu YC, 2002, CHEST, V122, P1844, DOI 10.1378/chest.122.5.1844	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2022	2027		10.1007/s00595-013-0746-7		6	Surgery	Surgery	AR6WT	WOS:000343722300004		
J	Miyoshi, S; Shien, K; Toyooka, S; Miyoshi, K; Yamamoto, H; Sugimoto, S; Soh, J; Hayama, M; Yamane, M; Oto, T				Miyoshi, Shinichiro; Shien, Kazuhiko; Toyooka, Shinichi; Miyoshi, Kentaroh; Yamamoto, Hiromasa; Sugimoto, Seiichiro; Soh, Junichi; Hayama, Makio; Yamane, Masaomi; Oto, Takahiro			Validity of using lobe-specific regional lymph node stations to assist navigation during lymph node dissection in early stage non-small cell lung cancer patients	SURGERY TODAY			English	Article						Non-small cell lung cancer; Lymphadenectomy; Lobe-specific regional lymph node station	VISCERAL PLEURAL INVASION; MEDIASTINAL LYMPHADENECTOMY; RANDOMIZED-TRIAL; METASTASIS; PROGNOSIS; CARCINOMA; INVOLVEMENT; RESECTION; SURVIVAL; SURGERY	Purpose The validity of our proposed lobe-specific regional lymph node stations (LSRLNS) was evaluated as a method for navigation during lymphadenectomy in patients with early stage non-small cell lung cancer (NSCLC). Methods A total of 725 NSCLC patients with c-T2N1M0 or less extensive disease who had undergone a curative operation with complete mediastinal lymph node dissection (MLND) were studied. The LSRLNS were #2, #3, #4 and #10 for the right upper lobe, #11i, #11s, #7 and #8 for the right lower lobe, #4, #5 and #6 for the left superior division, #11, #5 and #7 for the left lingular division and #11, #7 and #8 for the left lower lobe. Results If the LSRLNS were used for pathological examinations during surgery, 599 p-N0 and 39 p-N1 patients diagnosed with no metastasis would have been subjected to a selective MLND, while 20 p-N1 and 65 p-N2 patients who had a diagnosis of metastasis would have been navigated to a complete MLND. Two p-N2 patients with a diagnosis of no metastasis would have inappropriately undergone a selective MLND, resulting in the false negative rate at 0.3 %. Conclusion Intra-operative pathological examination using our LSRLNS may accurately reveal the status of metastasis, and appropriately lead to a selective or complete MLND in patients with c-T2N1M0 or less extensive disease.	[Miyoshi, Shinichiro; Shien, Kazuhiko; Toyooka, Shinichi; Miyoshi, Kentaroh; Yamamoto, Hiromasa; Sugimoto, Seiichiro; Soh, Junichi; Hayama, Makio; Yamane, Masaomi; Oto, Takahiro] Okayama Univ, Dept Gen Thorac Surg, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008558, Japan	Miyoshi, S (reprint author), Okayama Univ, Dept Gen Thorac Surg, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	smiyoshi@md.okayama-u.ac.jp	Shien, Kazuhiko/B-8560-2012	Shien, Kazuhiko/0000-0002-4959-4220			Riquet M, 2005, ANN THORAC SURG, V79, P225, DOI 10.1016/j.athoracsur.2004.06.081; Izbicki JR, 1998, ANN SURG, V227, P138, DOI 10.1097/00000658-199801000-00020; Okada M, 2006, ANN THORAC SURG, V81, P1028, DOI 10.1016/j.athoracsur.2005.09.078; Ishiguro F, 2010, J THORAC CARDIOV SUR, V139, P1001, DOI 10.1016/j.jtcvs.2009.07.024; Manac'h D, 2001, ANN THORAC SURG, V71, P1088, DOI 10.1016/S0003-4975(00)02649-7; NARUKE T, 1978, J THORAC CARDIOV SUR, V76, P832; Imai K, 2013, SURG TODAY, V43, P249, DOI 10.1007/s00595-012-0237-2; Shimizu K, 2005, J THORAC CARDIOV SUR, V130, P160, DOI 10.1016/j.jtcvs.2004.11.021; Darling GE, 2011, J THORAC CARDIOV SUR, V141, P662, DOI 10.1016/j.jtcvs.2010.11.008; Okada M, 1998, J THORAC CARDIOV SUR, V116, P949, DOI 10.1016/S0022-5223(98)70045-5; NARUKE T, 1988, J THORAC CARDIOV SUR, V96, P440; Asamura H, 1996, J THORAC CARDIOV SUR, V111, P1125, DOI 10.1016/S0022-5223(96)70213-1; Deslauriers Jean, 2012, Gen Thorac Cardiovasc Surg, V60, P724, DOI 10.1007/s11748-012-0086-3; FUNATSU T, 1992, J THORAC CARDIOV SUR, V104, P1688; Hata E., 1981, BEHANDLUNG BRONCHIAL, P27; MARTINI N, 1983, ANN SURG, V198, P386, DOI 10.1097/00000658-198309000-00015; Miyoshi S, 1997, HAIGAN, V37, P475; Oda M, 1998, LUNG CANCER-J IASLC, V22, P23, DOI 10.1016/S0169-5002(98)00070-1; Okiemy G, 2003, SURG RADIOL ANAT, V25, P32, DOI 10.1007/s00276-002-0081-y; Shien K, 2012, ANN SURG ONCOL, V19, P2685, DOI 10.1245/s10434-012-2302-x; Shimizu K, 2006, ANN THORAC SURG, V81, P1947, DOI 10.1016/j.athoracsur.2005.09.049; Sobin LH, 2002, TNM CLASSIFICATION M; The Japan Lung Cancer Society, 1995, GEN RUL CLIN PATH RE, P83; Toyooka S, 2012, INTERACT CARDIOV TH, V15, P954, DOI 10.1093/icvts/ivs412; WATANABE Y, 1991, CHEST, V100, P422, DOI 10.1378/chest.100.2.422; Yoshimasu T, 2005, J THORAC CARDIOV SUR, V130, P433, DOI 10.1016/j.jtcvs.2005.02.005	26	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2028	2036		10.1007/s00595-013-0772-5		9	Surgery	Surgery	AR6WT	WOS:000343722300005		
J	Takahashi, H; Fujii, T; Nakagawa, S; Inoue, Y; Akashi, M; Toh, U; Iwakuma, N; Takahashi, R; Takenaka, M; Fukuma, E; Shirouzu, K				Takahashi, Hiroki; Fujii, Teruhiko; Nakagawa, Shino; Inoue, Yuka; Akashi, Momoko; Toh, Uhi; Iwakuma, Nobutaka; Takahashi, Ryuji; Takenaka, Miki; Fukuma, Eisuke; Shirouzu, Kazuo			Usefulness of endoscopic breast-conserving surgery for breast cancer	SURGERY TODAY			English	Article						Breast cancer; Endoscopic breastconserving surgery; Surgical invasiveness; Cosmetic outcomes	VIDEO-ASSISTED BREAST; 20-YEAR FOLLOW-UP; MASTECTOMY; RECONSTRUCTION; RESPONSES	Purpose We compared the safety, invasiveness and cosmetic outcomes between endoscopic breast-conserving surgery (endoscopic group) and surgery under direct vision (direct vision group) for treating breast cancer. Methods We compared 100 cases of endoscopic surgery with 150 cases of direct vision surgery. The safety was evaluated in terms of the blood loss, length of the operation and presence or absence of complications, whereas the degree of invasiveness was assessed using preoperative and postoperative leukocyte counts, neutrophil counts, interleukin (IL-6) levels and fever. The cosmetic outcome was assessed on the basis of a breast evaluation by the medical staff and the patient's subjective satisfaction. Results In both groups, serious postoperative complications were absent. No significant differences were observed in the leukocyte counts, neutrophil counts, IL-6 level or fever between the groups. An evaluation of the cosmetic outcomes by the staff showed a more favorable breast size, breast shape and scar condition in the endoscopic group. A significantly higher level of patient satisfaction was also observed in the endoscopic group. Postoperative local recurrence was absent. Conclusions The endoscopic approach showed comparable safety and invasiveness, and provided better postoperative cosmetic outcomes than direct vision surgery. Our results suggest that endoscopic breast-conserving surgery is a potentially useful surgical method for the treatment of breast cancer.	[Takahashi, Hiroki; Nakagawa, Shino; Inoue, Yuka; Akashi, Momoko] Kyushu Med Ctr, Natl Hosp Org, Clin Res Inst, Breast Care Ctr, Fukuoka, Japan; [Takahashi, Hiroki; Toh, Uhi; Iwakuma, Nobutaka; Takahashi, Ryuji; Takenaka, Miki; Shirouzu, Kazuo] Kurume Univ, Dept Surg, Kurume, Fukuoka 8300011, Japan; [Fujii, Teruhiko] Kurume Univ, Multidisciplinary Canc Treatment Ctr, Kurume, Fukuoka 8300011, Japan; [Fukuma, Eisuke] Kameda Med Ctr, Breast Ctr, Kamogawa, Japan	Fujii, T (reprint author), Kurume Univ, Multidisciplinary Canc Treatment Ctr, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	tfujii@med.kurume-u.ac.jp					Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; EAVES FF, 1995, CLIN PLAST SURG, V22, P683; Gabay C, 1999, NEW ENGL J MED, V340, P448; Gurdal SO, 2013, SURG TODAY, V43, P55, DOI 10.1007/s00595-012-0137-5; Imamura Y, 1994, J JPN SURG SOC, V95, P485; JAKEWAYS MSR, 1994, BRIT J SURG, V81, P127, DOI 10.1002/bjs.1800810146; Kato M, 1997, J CLIN ANESTH, V9, P293, DOI 10.1016/S0952-8180(97)00006-8; Keshtgar Mohammed R S, 2009, Womens Health (Lond Engl), V5, P107, DOI 10.2217/17455057.5.2.107; Kitamura K, 2001, AM J SURG, V181, P211, DOI 10.1016/S0002-9610(01)00562-1; Lee EK, 2006, WORLD J SURG, V30, P957, DOI 10.1007/s00268-005-0202-y; Nakajima H, 2010, WORLD J SURG, V34, P2197, DOI 10.1007/s00268-010-0607-0; Nakajima H, 2009, ANN SURG ONCOL, V16, P1982, DOI 10.1245/s10434-009-0429-1; Owaki T, 2005, BREAST, V14, P57, DOI 10.1016/j.breast.2004.05.002; Takemura M, 1996, IGAKU TO YAKUGAKU, V36, P1071; Tamaki Y, 1998, SURG LAPAROSC ENDOSC, V8, P308, DOI 10.1097/00019509-199808000-00015; Yamashita K, 2008, AM J SURG, V196, P578, DOI 10.1016/j.amjsurg.2008.06.028; Yamashita Koji, 2006, Journal of Nippon Medical School, V73, P320, DOI 10.1272/jnms.73.320; Zaha H, 2010, WORLD J SURG, V34, P1782, DOI 10.1007/s00268-010-0535-z	19	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2037	2044		10.1007/s00595-013-0767-2		8	Surgery	Surgery	AR6WT	WOS:000343722300006		
J	Izumi, S; Nakamura, S; Mano, S; Onoda, Y				Izumi, Sadanobu; Nakamura, Satoko; Mano, Shohei; Onoda, Yuji			Well-differentiated pancreatic ductal adenocarcinomas measuring <= 1 cm exhibit early features of tumor progression: a report of five lesions and a comparative study with advanced lesions	SURGERY TODAY			English	Article						Pancreatic ductal adenocarcinoma; Early pancreatic cancer; Small pancreatic cancer; Desmoplasia; Molecular abnormalities	INTRAEPITHELIAL NEOPLASIA; DPC4 INACTIVATION; CANCER; EXPRESSION; HEDGEHOG; CARCINOMA	Purpose The purpose of this study was to clarify whether the features of well-differentiated pancreatic ductal adenocarcinomas (PDACs) measuring <= 1 cm are the same as those of early PDACs. Methods Five well-differentiated PDACs measuring <= 1 cm were clinicopathologically compared with 19 C 2 cm PDACs. Additionally, an immunohistochemical analysis for abnormalities in the expression of five molecular parameters: MUC1, p16, p53, Smad4 and sonic hedgehog, which are associated with tumor progression, was performed. Results The clinicopathological comparison revealed that well-differentiated PDACs measuring <= 1 cm were detected significantly more often without angiolymphatic invasion and with a sparse presence of cancer cells than were the >= 2 cm PDACs. On the other hand, in well-differentiated PDACs measuring <= 1 cm, the incidence of abnormal immunolabeling for MUC1, p16, p53 and sonic hedgehog was similar to that in >= 2 cm PDACs. However, the incidence of diffusely positive immunolabeling for MUC1 and the mean number of abnormally immunolabeled samples for the five parameters were significantly lower in well-differentiated <= 1 cm PDACs (20 % and 3 +/- 1) than in >= 2 cm PDACs (90 % and 4 +/- 1). Conclusion The current study revealed that as the tumor size increases, molecular abnormalities are accumulated, suggesting that well-differentiated PDACs measuring <= 1 cm are in an earlier stage of genetic progression than are >= 2 cm PDACs, and these lesions may exhibit early features of invasive PDACs.	[Izumi, Sadanobu; Onoda, Yuji] Kagawa Prefectural Cent Hosp, Dept Surg Gastroenterol, Takamatsu, Kagawa 7608557, Japan; [Nakamura, Satoko; Mano, Shohei] Kagawa Prefectural Cent Hosp, Dept Pathol, Takamatsu, Kagawa 7608557, Japan	Izumi, S (reprint author), Kagawa Prefectural Cent Hosp, Dept Surg Gastroenterol, 5-4-16 Banchou, Takamatsu, Kagawa 7608557, Japan.	s-izumi@chp-kagawa.jp					Adsay NV, 2002, MODERN PATHOL, V15, P1087, DOI 10.1097/01.MP.0000028647.98725.8B; Adsay NV, 2004, SEMIN DIAGN PATHOL, V21, P268, DOI 10.1053/j.semdp.2005.08.002; Egawa S, 2004, PANCREAS, V28, P235, DOI 10.1097/00006676-200404000-00004; Wilentz RE, 2000, AM J PATHOL, V156, P37, DOI 10.1016/S0002-9440(10)64703-7; Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Ishikawa O, 1999, HEPATO-GASTROENTEROL, V46, P8; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Hruban RH, 2000, AM J PATHOL, V156, P1821, DOI 10.1016/S0002-9440(10)65054-7; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Pour PM, 2003, PANCREAS, V26, P322, DOI 10.1097/00006676-200305000-00002; Wilentz RE, 1998, CANCER RES, V58, P4740; Maitra A, 2003, MODERN PATHOL, V16, P902, DOI 10.1097/01.MP.0000086072.56290.FB; Wilentz RE, 2000, CANCER RES, V60, P2002; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; Izumi S, 2009, SURG TODAY, V39, P1091, DOI 10.1007/s00595-009-3990-0; Izumi Sadanobu, 2011, JOP, V12, P464; Kimura W, 1998, CANCER, V82, P1839, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1839::AID-CNCR5>3.0.CO;2-I; Liu MS, 2007, PANCREAS, V34, P340, DOI 10.1097/mpa.0b013e3180333ab5; Yonezawa S, 2008, GUT LIVER, V2, P137, DOI 10.5009/gnl.2008.2.3.137	20	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2058	2064		10.1007/s00595-013-0804-1		7	Surgery	Surgery	AR6WT	WOS:000343722300009		
J	Kayashima, H; Shirabe, K; Matono, R; Yoshiya, S; Morita, K; Umeda, K; Ikegami, T; Yoshizumi, T; Soejima, Y; Maehara, Y				Kayashima, Hiroto; Shirabe, Ken; Matono, Rumi; Yoshiya, Shohei; Morita, Kazutoyo; Umeda, Kenji; Ikegami, Toru; Yoshizumi, Tomoharu; Soejima, Yuji; Maehara, Yoshihiko			Three-dimensional computed tomography analysis of variations in the middle hepatic vein tributaries: proposed new classification	SURGERY TODAY			English	Article						Congestion; Drainage vein; Living donor liver transplantation; Reconstruction; Right lobe graft	DONOR LIVER-TRANSPLANTATION; LIVING DONORS; VENOUS COLLATERALS; ANTERIOR SEGMENT; GRAFT SIZE; RECONSTRUCTION; DRAINAGE; IMPACT; REGENERATION; CONGESTION	To evaluate the anatomical variations in the middle hepatic vein tributaries (V5/V8) for determining the reconstruction strategy in right lobe living donor liver transplantation (LDLT). The V5/V8 variations were examined in 268 patients and were classified into three and two types, respectively. The reconstruction rate (RR), patency rate (PR) and clinical outcomes were retrospectively evaluated in 46 right lobe LDLT cases. In terms of V5 variations, the RR and PR were significantly higher for type 2 than type 3 (82.6 vs. 44.4 % and 73.7 vs. 25.0 %, respectively). The alanine aminotransferase level on postoperative day (POD) 5 in the V5 patent group was significantly lower than in the occluded group (123 vs. 191 IU/dL). Regarding V8 variations, the RR and PR were significantly higher for type 1 than type 2 (44.4 vs. 17.6 % and 75.0 vs. 33.3 %, respectively). The aspartate aminotransferase level on POD 3 was significantly lower in the V8 patent group than in the occluded group (50 vs. 121 IU/dL). For right lobe grafts with single large V5 (type 2) or V8 (type 1) variations, reconstruction is necessary. Our new classification of the MHV tributaries is useful for determining the reconstruction strategy to use in right lobe LDLT.	[Kayashima, Hiroto; Shirabe, Ken; Matono, Rumi; Yoshiya, Shohei; Morita, Kazutoyo; Umeda, Kenji; Ikegami, Toru; Yoshizumi, Tomoharu; Soejima, Yuji; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka 8128582, Japan	Kayashima, H (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hkaya@surg2.med.kyushu-u.ac.jp					Akamatsu N, 2003, TRANSPLANTATION, V76, P832, DOI 10.1097/01.TP.0000085080.37235.81; Brown RS, 2003, NEW ENGL J MED, V348, P818, DOI 10.1056/NEJMsa021345; Taketomi A, 2012, SURG TODAY, V42, P46, DOI 10.1007/s00595-011-0021-8; Ben-Haim M, 2001, LIVER TRANSPLANT, V7, P948, DOI 10.1053/jlts.2001.29033; Fan ST, 2003, TRANSPLANTATION, V75, pS25, DOI 10.1097/01.TP.0000046618.44722.BE; Kaneko T, 2000, TRANSPLANTATION, V70, P982, DOI 10.1097/00007890-200009270-00018; Lee S, 2001, TRANSPLANTATION, V71, P812, DOI 10.1097/00007890-200103270-00021; Kiuchi T, 1999, TRANSPLANTATION, V67, P321, DOI 10.1097/00007890-199901270-00024; Lo CM, 2004, ANN SURG, V240, P151, DOI 10.1097/01.sla.000012940.05238.a0; Umeshita K, 2003, LANCET, V362, P687, DOI 10.1016/S0140-6736(03)14230-4; Radtke A, 2009, BRIT J SURG, V96, P206, DOI 10.1002/bjs.6444; Kawasaki S, 1998, ANN SURG, V227, P269, DOI 10.1097/00000658-199802000-00017; Kayashima H, 2008, LIVER TRANSPLANT, V14, P1366, DOI 10.1002/lt.21547; Ito T, 2003, TRANSPLANTATION, V76, P158, DOI 10.1097/01.TP.0000072372.42396.47; Grewal HP, 1998, ANN SURG, V228, P214, DOI 10.1097/00000658-199808000-00011; RAIA S, 1989, LANCET, V2, P497; Yonemura Y, 2005, LIVER TRANSPLANT, V11, P1556, DOI 10.1002/lt.20537; Fukuhara T, 2009, TRANSPL INT, V22, P837, DOI 10.1111/j.1432-2277.2009.00880.x; Ikegami T, 2007, TRANSPLANTATION, V84, P836, DOI 10.1097/01.tp.0000282790.66889.a5; Ito T, 2004, TRANSPLANTATION, V77, P865, DOI 10.1097/01.TP.0000116415.21371.F9; Kayashima H, 2011, SURG TODAY, V41, P1266, DOI 10.1007/s00595-010-4464-0; Maema A, 2002, TRANSPLANTATION, V73, P765, DOI 10.1097/00007890-200203150-00019; Miller CM, 2001, ANN SURG, V234, P301, DOI 10.1097/00000658-200109000-00004; Mizuno S, 2006, CLIN TRANSPLANT, V20, P509, DOI 10.1111/j.1399-0012.2006.00515.x; Radtke A, 2010, AM J SURG, V199, P708, DOI 10.1016/j.amjsurg.2009.03.024; Soejima Y, 2006, AM J TRANSPLANT, V6, P1004, DOI 10.1111/j.1600-6143.2006.01284.x; Soejima Y, 2006, SURGERY, V139, P442, DOI 10.1016/j.surg.2005.08.005; Taketomi A, 2009, TRANSPLANTATION, V87, P445, DOI 10.1097/TP.0b013e3181943d46; Yan LN, 2008, J SURG RES, V146, P172, DOI 10.1016/j.jss.2007.05.017; Yu PF, 2007, HEPATOB PANCREAT DIS, V6, P358	30	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2077	2085		10.1007/s00595-014-0836-1		9	Surgery	Surgery	AR6WT	WOS:000343722300012		
J	Park, UJ; Kim, HT; Cho, WH; Kim, YH; Miyata, T				Park, Ui Jun; Kim, Hyoung Tae; Cho, Won Hyun; Kim, Young Hwan; Miyata, Tetsuro			Clinical course and angiographic changes of spontaneous isolated superior mesenteric artery dissection after conservative treatment	SURGERY TODAY			English	Article						Superior mesenteric artery; Dissection; Conservative treatment; Remodeling pattern; Clinical course	PERCUTANEOUS STENT PLACEMENT; FOLLOW-UP; MANAGEMENT; OPTIONS	Purpose The aim of this study was to evaluate the clinical course and angiographic changes of spontaneous isolated superior mesenteric artery dissection (SISMAD) after conservative treatment. Methods Twenty-four patients with SISMAD admitted from September 2006 through March 2013 were included in this study. The clinical characteristics, type and location of the dissection, clinical outcome and angiographic changes were analyzed retrospectively. Results The median follow-up was 18.7 months (range 1.4-67.5 months). Eighteen patients (75 %) were symptomatic, and the median duration of abdominal pain was 2.5 days. All of the patients were treated conservatively. Follow-up computed tomography angiography showed complete remodeling in six patients (25 %), partial remodeling in four patients (17 %), no changes in nine patients (38 %), progression to total occlusion in four patients (17 %) and aneurysmal changes of the false lumen in one patient (4 %). Endovascular intervention was performed in the patient with aneurysmal changes. There was no mortality or morbidity related to the dissection. Conclusion SISMAD represented variable angiographic changes, and its clinical course was benign in this study. For patients with SISMAD, if there is no evidence of bowel infarction, bleeding or aneurysmal changes, conservative treatment with close follow-up is sufficient and could reduce unnecessary endovascular interventions.	[Park, Ui Jun; Kim, Hyoung Tae; Cho, Won Hyun] Keimyung Univ, Sch Med, Dongsan Med Ctr, Dept Vasc Surg, Taegu 700712, South Korea; [Kim, Young Hwan] Keimyung Univ, Sch Med, Dongsan Med Ctr, Dept Intervent Radiol, Taegu 700712, South Korea; [Miyata, Tetsuro] Univ Tokyo, Grad Sch Med, Dept Surg, Div Vasc Surg, Tokyo, Japan	Park, UJ (reprint author), Keimyung Univ, Sch Med, Dongsan Med Ctr, Dept Vasc Surg, 56 Dalseong Ro, Taegu 700712, South Korea.	junapark@dsmc.or.kr; htkim@dsmc.or.kr		Park, Ui Jun/0000-0002-5203-4216			Gobble RM, 2009, J VASC SURG, V50, P1326, DOI 10.1016/j.jvs.2009.07.019; Yun WS, 2009, EUR J VASC ENDOVASC, V37, P572, DOI 10.1016/j.ejvs.2008.12.010; Morris JT, 2008, J VASC SURG, V47, P649, DOI 10.1016/j.jvs.2007.08.052; Subhas G, 2009, ANN VASC SURG, V23, P788, DOI 10.1016/j.avsg.2008.12.006; Casella IB, 2008, J VASC SURG, V47, P197, DOI 10.1016/j.jvs.2007.07.051; Lim EH, 2011, J VASC INTERV RADIOL, V22, P1206, DOI 10.1016/j.jvir.2011.01.446; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Takayama T, 2008, J VASC SURG, V48, P329, DOI 10.1016/j.jvs.2008.03.002; Sakamoto I, 2007, EUR J RADIOL, V64, P103, DOI 10.1016/j.ejrad.2007.05.027; Min SI, 2011, J VASC SURG, V54, P461, DOI 10.1016/j.jvs.2011.03.001; Cho BS, 2011, EUR J VASC ENDOVASC, V41, P780, DOI 10.1016/j.ejvs.2010.12.022; Park YJ, 2011, J VASC SURG, V54, P1727, DOI 10.1016/j.jvs.2011.07.052; Chu SY, 2012, CLIN RADIOL, V67, P32, DOI 10.1016/j.crad.2011.04.007; Furukawa Daisuke, 2009, Nihon Shokakibyo Gakkai Zasshi, V106, P1031; Jibiki M, 2013, SURG TODAY, V43, P260, DOI 10.1007/s00595-012-0304-8; Katsura M, 2011, WORLD J EMERG SURG, V6, DOI 10.1186/1749-7922-6-16; Matsushima K, 2006, J AM COLL SURGEONS, V203, P970, DOI 10.1016/j.jamcollsurg.2006.03.018; Nomura Y, 2011, J VASC SURG, V54, P1808, DOI 10.1016/j.jvs.2011.05.006; Sheldon PJ, 2001, CARDIOVASC INTER RAD, V24, P329, DOI 10.1007/s00270-001-2565-0; Solis M M, 1993, Ann Vasc Surg, V7, P457, DOI 10.1007/BF02002130; Suzuki S, 2004, ABDOM IMAGING, V29, P153, DOI 10.1007/s00261-003-0110-2; Tokue H, 2009, JPN J RADIOL, V27, P430, DOI 10.1007/s11604-009-0366-8; van Uden DJP, 2011, VASC MED, V16, P79, DOI 10.1177/1358863X10392475; Yang HJ, 2011, YONSEI MED J, V52, P859, DOI 10.3349/ymj.2011.52.5.859; Zerbib P, 2010, LANGENBECK ARCH SURG, V395, P437, DOI 10.1007/s00423-009-0537-1; Zhang XC, 2012, VASC ENDOVASC SURG, V46, P277, DOI 10.1177/1538574411434162	26	2	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2092	2097		10.1007/s00595-014-0849-9		6	Surgery	Surgery	AR6WT	WOS:000343722300014		
J	Kijima, Y; Yoshinaka, H; Hirata, M; Arima, H; Nakajo, A; Shinden, Y; Uenosono, Y; Okumura, H; Ishigami, S; Natsugoe, S				Kijima, Yuko; Yoshinaka, Heiji; Hirata, Munetsugu; Arima, Hideo; Nakajo, Akihiro; Shinden, Yoshiaki; Uenosono, Yoshikazu; Okumura, Hiroshi; Ishigami, Sumiya; Natsugoe, Shoji			Oncoplastic surgery combining partial mastectomy and immediate volume replacement using a thoracodorsal adipofascial cutaneous flap with a crescent-shaped dermis	SURGERY TODAY			English	Article						Breast cancer; Breast-conserving therapy; Oncoplastic surgery; Immediate reconstruction; Volume replacement; Thoracodorsal adipofascial cutaneous flap; Crescent-shaped dermis	BREAST-CANCER; SYSTEM	Purpose The treatment of early breast cancer using breast-conserving therapy commonly ensures local control and acceptable cosmetic results. We herein report a useful technique, including the use of a thoracodorsal adipofascial cutaneous flap for reconstructing defects in the outer quadrant area after partial mastectomy, which achieved excellent results. Methods We performed partial mastectomy followed by immediate volume replacement using a modified thoracodorsal adipofascial cutaneous flap with a crescent-shaped dermis in ten patients. Results The modified oncoplastic technique was performed without any complications in all patients. Sufficient blood flow to the cutaneous flap with the crescent-shaped dermis was visualized in two patients during the operation after the injection of indocyanine green. The oncological and cosmetic results were excellent to good in these patients. Conclusions Oncoplastic surgery using a modified thoracodorsal adipofascial flap with a crescent-shaped dermis was successfully performed in patients with early cancer lesions in the outer quadrant, and the cosmetic results obtained were excellent.	[Kijima, Yuko; Yoshinaka, Heiji; Hirata, Munetsugu; Arima, Hideo; Nakajo, Akihiro; Shinden, Yoshiaki; Uenosono, Yoshikazu; Okumura, Hiroshi; Ishigami, Sumiya; Natsugoe, Shoji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Digest Surg Breast & Thyroid Surg, Kagoshima 8908520, Japan	Kijima, Y (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Digest Surg Breast & Thyroid Surg, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	ykijima@m3.kufm.kagoshima-u.ac.jp					Kubota K, 2013, SURG TODAY, V43, P215, DOI 10.1007/s00595-012-0251-4; FISHER B, 1995, NEW ENGL J MED, V333, P1456, DOI 10.1056/NEJM199511303332203; LONGACRE JJ, 1954, PLAST RECONSTR SURG, V14, P431, DOI 10.1097/00006534-195412000-00005; Hughes LL, 2009, J CLIN ONCOL, V27, P5319, DOI 10.1200/JCO.2009.21.8560; Audretsch W, 1994, P 2 EUR C SEN OCT 2, P139; Audretsch W., 1998, PERSPECT PLAST SURG, V11, p71 ; BERRINO P, 1987, PLAST RECONSTR SURG, V79, P567, DOI 10.1097/00006534-198704000-00010; COOPERMAN AM, 1978, SURG CLIN N AM, V58, P869; Correa C, 2010, J NATL CANC I MONOGR, V41, P162, DOI DOI 10.1093/JNCIMONOGRAPHS/LGQ039; Handa Takemi, 2010, Gen Thorac Cardiovasc Surg, V58, P68, DOI 10.1007/s11748-009-0536-8; Hoffmann J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-108; Japanese Breast Cancer Society, 2004, 12 ANN M JAP BREAST, P107; Kijima Y, 2009, BREAST, V18, P126, DOI 10.1016/j.breast.2009.02.006; Kijima Y, 2011, SURG TODAY, V41, P390, DOI 10.1007/s00595-010-4294-0; Kijima Y, 2011, BREAST CANCER-TOKYO, V18, P273, DOI 10.1007/s12282-009-0190-0; Kijima Y, 2011, SURG TODAY, V41, P1461, DOI 10.1007/s00595-011-4490-6; Kijima Y, 2011, BREAST, V20, P464, DOI 10.1016/j.breast.2011.05.001; Kijima Y, 2012, SURG TODAY, V43, P456; Kijima Y, 2008, SURG TODAY, V38, P335, DOI 10.1007/s00595-007-3628-z; Sobin LH, 2009, TNM CLASSIFICATION M	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2098	2105		10.1007/s00595-013-0812-1		8	Surgery	Surgery	AR6WT	WOS:000343722300015		
J	Hotta, T; Takifuji, K; Yokoyama, S; Matsuda, K; Oku, Y; Nasu, T; Ieda, J; Yamamoto, N; Iwamoto, H; Takei, Y; Mizumoto, Y; Yamaue, H				Hotta, Tsukasa; Takifuji, Katsunari; Yokoyama, Shozo; Matsuda, Kenji; Oku, Yoshimasa; Nasu, Toru; Ieda, Junji; Yamamoto, Naoyuki; Iwamoto, Hiromitsu; Takei, Yoh; Mizumoto, Yuki; Yamaue, Hiroki			Impact of the post/preoperative serum CEA ratio on the survival of patients with rectal cancer	SURGERY TODAY			English	Article						Rectal cancer; CEA; Stage III; Prognosis	CARCINOEMBRYONIC ANTIGEN LEVEL; III COLON-CANCER; COLORECTAL-CANCER; CURATIVE RESECTION; FOLLOW-UP; METASTASES; RECURRENCE; CARCINOMA; SURGERY; CA19-9	This study demonstrated the usefulness of the post/preoperative serum carcinoembryonic antigen (CEA) ratio as a predictor of survival after surgery for stage III rectal cancer patients. One hundred and four patients with stage III rectal cancer who underwent surgery between 1991 and 2000 were enrolled. The ratio of the postoperative serum CEA value divided by the preoperative serum CEA value was defined as post/preoperative serum CEA ratio, and the patients were separated into two groups: post/preoperative serum CEA ratio a parts per thousand currency sign1 (n = 86) and > 1 (n = 18). The multivariate analyses demonstrated that the intraoperative blood loss, lack of a sphincter-saving procedure and a post/preoperative serum CEA ratio > 1 were independent factors predicting a poor prognosis for the overall and disease-free survival. The overall and disease-free survival rates among patients with a high preoperative serum CEA level (> 5 ng/ml) or patients with a high postoperative serum CEA (> 5 ng/ml) were longer in patients with a post/preoperative serum CEA ratio a parts per thousand currency sign1, in comparison to those with a post/preoperative serum CEA ratio > 1. Liver metastasis was observed more frequently in patients with a post/preoperative serum CEA ratio > 1. The post/preoperative serum CEA ratio may be a predictor of the prognosis after surgery for stage III rectal cancer patients.	[Hotta, Tsukasa; Takifuji, Katsunari; Yokoyama, Shozo; Matsuda, Kenji; Oku, Yoshimasa; Nasu, Toru; Ieda, Junji; Yamamoto, Naoyuki; Iwamoto, Hiromitsu; Takei, Yoh; Mizumoto, Yuki; Yamaue, Hiroki] Wakayama Med Univ, Sch Med, Dept Surg 2, Wakayama 6418510, Japan	Yamaue, H (reprint author), Wakayama Med Univ, Sch Med, Dept Surg 2, 811-1 Kimiidera, Wakayama 6418510, Japan.	yamaue-h@wakayama-med.ac.jp					Akasu T, 2006, JPN J CLIN ONCOL, V36, P237, DOI 10.1093/jjco/hyl014; Jang NY, 2011, DIS COLON RECTUM, V54, P245, DOI 10.1007/DCR.0b013e3181fcee68; Yakabe T, 2010, ANN SURG ONCOL, V17, P2349, DOI 10.1245/s10434-010-1004-5; Takagawa R, 2008, ANN SURG ONCOL, V15, P3433, DOI 10.1245/s10434-008-0168-8; Park IJ, 2009, ANN SURG ONCOL, V16, P3087, DOI 10.1245/s10434-009-0625-z; Huh JW, 2010, J SURG ONCOL, V101, P396, DOI 10.1002/jso.21495; Lin JK, 2011, INT J COLORECTAL DIS, V26, P1135, DOI 10.1007/s00384-011-1209-5; Topova L, 2011, DIS COLON RECTUM, V54, P401, DOI 10.1007/DCR.0b013e3182070efb; Hotta T, 2006, ONCOL REP, V16, P1369; Kobayashi H, 2006, SURGERY, V139, P516, DOI 10.1016/j.surg.2005.09.004; Akiyoshi T, 2012, SURG TODAY, V42, P713, DOI 10.1007/s00595-012-0223-8; Chen CC, 2005, J SURG RES, V124, P169, DOI 10.1016/j.jss.2004.08.013; Goldstein MJ, 2005, CANCER INVEST, V23, P338, DOI 10.1081/CNV-200058878; Ito K, 2002, JPN J CLIN ONCOL, V32, P54, DOI 10.1093/jjco/hyf011; Greene FL, 2002, ANN SURG, V236, P416, DOI 10.1097/01.SLA.0000029243.59219.7E; Park YA, 2006, ANN SURG ONCOL, V13, P645, DOI 10.1245/ASO.2006.03.090; Sun LC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-288; Choi Jin Sub, 1997, Yonsei Medical Journal, V38, P1; Dhar DK, 2005, J AM COLL SURGEONS, V200, P20, DOI 10.1016/j.jamcollsurg.2004.09.037; Kim CH, 2012, DIS COLON RECTUM, V55, P459, DOI 10.1097/DCR.0b013e318246b08d; Rapellino M., 1994, International Journal of Biological Markers, V9, P33; UICC, 1997, TNM CLASSIFICATION M, V5th; Wang JY, 2007, EUR SURG RES, V39, P245, DOI 10.1159/000101952	23	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2106	2115		10.1007/s00595-014-0852-1		10	Surgery	Surgery	AR6WT	WOS:000343722300016		
J	Hata, T; Yasui, M; Murata, K; Okuyama, M; Ohue, M; Ikeda, M; Ueshima, S; Kitani, K; Hasegawa, J; Tamagawa, H; Fujii, M; Ohkawa, A; Kato, T; Morita, S; Fukuzaki, T; Mizushima, T; Sekimoto, M; Nezu, R; Doki, Y; Mori, M				Hata, Taishi; Yasui, Masayoshi; Murata, Kohei; Okuyama, Masaki; Ohue, Masayuki; Ikeda, Masataka; Ueshima, Shigeyuki; Kitani, Kotaro; Hasegawa, Junichi; Tamagawa, Hiroshi; Fujii, Makoto; Ohkawa, Atsushi; Kato, Takeshi; Morita, Shunji; Fukuzaki, Takayuki; Mizushima, Tsunekazu; Sekimoto, Mitsugu; Nezu, Riichiro; Doki, Yuichiro; Mori, Masaki		Multictr Clinical Study Grp Osaka; Colorectal Canc Treatment Grp	Safety of fondaparinux to prevent venous thromboembolism in Japanese patients undergoing colorectal cancer surgery: a multicenter study	SURGERY TODAY			English	Article						Venous thromboembolism; Prophylaxis; Colorectal cancer patients; Fondaparinux; Japan	MOLECULAR-WEIGHT HEPARIN; MAJOR ABDOMINAL-SURGERY; DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; GENERAL-SURGERY; RISK-FACTORS; ENOXAPARIN; TRIAL; PROPHYLAXIS; EFFICACY	Purpose To investigate the safety and efficacy of fondaparinux (FPX) for venous thromboembolism (VTE) prophylaxis in Japanese patients undergoing colorectal cancer surgery. Methods The subjects of this multicenter, open-label, prospective observational study were patients undergoing resection of the colon/rectum for colorectal cancer. All patients were given FPX 2.5 or 1.5 mg by subcutaneous injection, once daily for 4-8 days, starting 24 h after surgery. The primary endpoint was any major bleeding event and the secondary endpoint was any symptomatic VTE event. Results Between February 2009 and December 2010, 619 patients from 23 institutions were enrolled in this study. The median duration of FPX prophylaxis was 4 days. The incidence of major bleeding was 0.81 % [5/619, 95 % confidence interval (CI) 0.3-1.9] and the incidence of minor bleeding was 9.5 % (59/619, 95 % CI 7.3-12.1). There was no fatal bleeding or symptomatic VTE. Multivariable analysis revealed the following to be risk factors for bleeding events: preoperative platelet count < 15 9 10(4)/mu l [odds ratio (OR) 4.521], male sex (OR 2.078), and blood loss during surgery < 50 ml (OR 2.019). Conclusion The administration of 2.5/1.5 mg FPX 24 h after colorectal cancer surgery is safe and effective.	[Hata, Taishi; Mizushima, Tsunekazu; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka, Japan; [Yasui, Masayoshi] Kaizuka City Hosp, Dept Surg, Kaizuka, Japan; [Murata, Kohei] Suita Municipal Hosp, Dept Surg, Suita, Osaka, Japan; [Okuyama, Masaki] Higashiosaka City Gen Hosp, Dept Surg, Higashiosaka, Osaka, Japan; [Ohue, Masayuki] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan; [Ikeda, Masataka; Sekimoto, Mitsugu] Osaka Natl Hosp, Natl Hosp Organaizat, Dept Surg, Chuo Ku, Osaka 5400006, Japan; [Ueshima, Shigeyuki] Osaka Police Hosp, Dept Surg, Osaka, Japan; [Kitani, Kotaro] Kinki Univ, Fac Med, Dept Surg, Nara Hosp, Osaka, Japan; [Hasegawa, Junichi] Osaka Rosai Hosp, Dept Surg, Osaka, Japan; [Tamagawa, Hiroshi] Osaka Gen Med Ctr, Dept Surg, Osaka, Japan; [Fujii, Makoto] Osaka Kouseinenkin Hosp, Dept Surg, Osaka, Japan; [Ohkawa, Atsushi] Higashi Takarazuka Satoh Hosp, Dept Surg, Takarazuka, Hyogo, Japan; [Kato, Takeshi] Kansai Rosai Hosp, Dept Surg, Amagasaki, Hyogo, Japan; [Morita, Shunji] Toyonaka City Hosp, Dept Surg, Toyonaka, Osaka, Japan; [Fukuzaki, Takayuki] Ikeda Municipal Hosp, Dept Surg, Ikeda, Osaka, Japan; [Nezu, Riichiro] Nishinomiya Municipal Cent Hosp, Dept Surg, Nishinomiya, Hyogo, Japan	Ikeda, M (reprint author), Osaka Natl Hosp, Natl Hosp Organaizat, Dept Surg, Chuo Ku, 2-1-14 Hoenzaka, Osaka 5400006, Japan.	mikeda@onh.go.jp			Supporting Center for Clinical Research and Education	We thank Dr. Hiroshi Kobayashi of the Department of Obstetrics and Gynecology, Nara Medical University, and Dr. Mashio Nakamura of the Department of Clinical Cardiovascular Research, Mie University Graduate School of Medicine, for acting as the safety and efficacy committee for this study. This study was supported by The Supporting Center for Clinical Research and Education.	Monreal M, 2006, J THROMB HAEMOST, V4, P1950, DOI 10.1111/j.1538-7836.2006.02082.x; McLeod RS, 2001, ANN SURG, V233, P438, DOI 10.1097/00000658-200103000-00020; Agnelli G, 2005, BRIT J SURG, V92, P1212, DOI 10.1002/bjs.5154; Turpie AGG, 2007, J THROMB HAEMOST, V5, P1854, DOI 10.1111/j.1538-7836.2007.02657.x; Shapiro R, 2011, DIS COLON RECTUM, V54, P1496, DOI 10.1097/DCR.0b013e31823302a1; Simonneau G, 2006, J THROMB HAEMOST, V4, P1693, DOI 10.1111/j.1538-7836.2006.02083.x; Sakon M, 2010, THROMB RES, V125, pE65, DOI 10.1016/j.thromres.2009.09.009; Bergqvist D, 2002, NEW ENGL J MED, V346, P975, DOI 10.1056/NEJMoa012385; Bergqvist David, 2006, Vasc Health Risk Manag, V2, P365, DOI 10.2147/vhrm.2006.2.4.365; Buchberg B, 2011, ARCH SURG-CHICAGO, V146, P739, DOI 10.1001/archsurg.2011.127; Cohen AT, 1997, AM J SURG, V174, P1, DOI 10.1016/S0002-9610(97)00050-0; Bergqvist D, 1997, BRIT J SURG, V84, P1099; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Gould MK, 2012, CHEST S, V141, pe227S; Ho YH, 1999, DIS COLON RECTUM, V42, P196, DOI 10.1007/BF02237127; KYZER S, 1992, INT J COLORECTAL DIS, V7, P125, DOI 10.1007/BF00360351; Mismetti P, 2001, BRIT J SURG, V88, P913, DOI 10.1046/j.0007-1323.2001.01800.x; Sakon M, 2008, RINSHO IYAKU, V24, P679; Sakon M, 2006, J THROMB HAEMOST, V4, P581, DOI 10.1111/j.1538-7836.2006.01786.x; Sakon M, 2004, SURG TODAY, V34, P805, DOI 10.1007/s00595-004-2842-1	20	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2116	2123		10.1007/s00595-014-0911-7		8	Surgery	Surgery	AR6WT	WOS:000343722300017		
J	Koizumi, M; Hosoya, Y; Dezaki, K; Yada, T; Hosoda, H; Kangawa, K; Nagai, H; Lefor, AT; Sata, N; Yasuda, Y				Koizumi, Masaru; Hosoya, Yoshinori; Dezaki, Katsuya; Yada, Toshihiko; Hosoda, Hiroshi; Kangawa, Kenji; Nagai, Hideo; Lefor, Alan T.; Sata, Naohiro; Yasuda, Yoshikazu			Serum ghrelin levels partially recover with the recovery of appetite and food intake after total gastrectomy	SURGERY TODAY			English	Article						Ghrelin; Gastrectomy; Weight loss	GASTRIC-CANCER PATIENTS; BODY-WEIGHT LOSS; NUTRITIONAL-STATUS; ACYLATED PEPTIDE; RECONSTRUCTION; HUMANS; RATS; ESOPHAGECTOMY; SECRETION; VAGOTOMY	Purpose Ghrelin may lead to weight gain by appetite stimulation. This prospective study investigated the association between weight loss and the ghrelin levels in patients after gastrectomy. Methods Thirty-three males and eight females were enrolled in the study. The average age was 66 years. Measurements of the serum ghrelin level and an appetite questionnaire were performed preoperatively and at one, three, six and 12 months postoperatively. Results The preoperative serum total ghrelin level was 51.6 +/- 31.9 (fmol/ml +/- SD), and that at one, three, six and 12 months postoperatively was 16.9 +/- 9.0, 21.2 +/- 16.0, 28.0 +/- 19.1 and 29.6 +/- 20.6 (fmol/ml +/- SD), respectively. The appetite score was 2.02 +/- 1.09 points at 1 month, and increased significantly to 2.61 +/- 1.00 by 12 months. Conclusions The ghrelin levels were reduced after gastrectomy and did not recover by 12 months postoperatively. Further studies are needed to evaluate these results as the basis of a therapeutic trial.	[Koizumi, Masaru; Hosoya, Yoshinori; Nagai, Hideo; Lefor, Alan T.; Sata, Naohiro; Yasuda, Yoshikazu] Jichi Med Univ, Sch Med, Dept Surg, Shimotsuke, Tochigi 3290498, Japan; [Koizumi, Masaru; Dezaki, Katsuya; Yada, Toshihiko] Jichi Med Univ, Sch Med, Dept Physiol, Div Integrat Physiol, Shimotsuke, Tochigi 3290498, Japan; [Hosoda, Hiroshi; Kangawa, Kenji] Natl Cardiovasc Ctr, Res Inst, Dept Biochem, Suita, Osaka 5658565, Japan; [Nagai, Hideo] Ibaraki Cent Hosp, Dept Surg, Kasama, Ibaraki 3091793, Japan	Lefor, AT (reprint author), Jichi Med Univ, Sch Med, Dept Surg, Yakushiji 3311-1, Shimotsuke, Tochigi 3290498, Japan.	alefor@jichi.ac.jp		Lefor, Alan/0000-0001-6673-5630			Adachi SR, 1999, SURG TODAY, V29, P301; Yamashita K, 2013, SURG TODAY, V43, P1013, DOI 10.1007/s00595-012-0388-1; Jeon TY, 2004, J CLIN ENDOCR METAB, V89, P5392, DOI 10.1210/jc.2004-0872; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Bae JM, 1998, WORLD J SURG, V22, P254; Hosoda H, 2000, BIOCHEM BIOPH RES CO, V279, P909, DOI 10.1006/bbrc.2000.4039; Masuda Y, 2000, BIOCHEM BIOPH RES CO, V276, P905, DOI 10.1006/bbrc.2000.3568; Shintani M, 2001, DIABETES, V50, P227, DOI 10.2337/diabetes.50.2.227; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; Yamamoto K, 2010, SURGERY, V148, P31, DOI 10.1016/j.surg.2009.11.026; Doki Y, 2006, SURGERY, V139, P797, DOI 10.1016/j.surg.2005.11.015; Neary NM, 2004, J CLIN ENDOCR METAB, V89, P2832, DOI 10.1210/jc.2003-031768; Takachi K, 2006, J SURG RES, V130, P1, DOI 10.1016/j.jss.2005.08.003; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Williams DL, 2003, ENDOCRINOLOGY, V144, P5184, DOI 10.1210/en.2003-1059; Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; Nakamura M, 2005, SURG TODAY, V35, P535, DOI 10.1007/s00595-005-2988-5; Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Fein M, 2008, ANN SURG, V247, P759, DOI 10.1097/SLA.0b013e318167748c; Bergh C, 2003, PHYSIOL BEHAV, V78, P143, DOI 10.1016/S0031-9384(02)00958-7; BRAGA M, 1988, BRIT J SURG, V75, P477; Hosoda H, 2003, J BIOL CHEM, V278, P64, DOI 10.1074/jbc.M205366200; Iesato H, 2000, HEPATO-GASTROENTEROL, V47, P756; Koizumi M, 2011, ANN THORAC SURG, V91, P1032, DOI 10.1016/j.athoracsur.2010.11.072; Leonetti F, 2003, J CLIN ENDOCR METAB, V88, P4227, DOI 10.1210/jc.2003-030133; le Roux CW, 2005, J CLIN ENDOCR METAB, V90, P4521, DOI 10.1210/jc.2004-2537; Liedman B, 1999, NUTRITION, V15, P677, DOI 10.1016/S0899-9007(99)00123-9; Melissas John, 2002, Obes Surg, V12, P399, DOI 10.1381/096089202321088246; Nagaya N, 2001, J CLIN ENDOCR METAB, V86, P5854, DOI 10.1210/jc.86.12.5854; Nakamura M, 2011, ANN SURG ONCOL, V18, P314, DOI 10.1245/s10434-010-1290-y	31	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2131	2137		10.1007/s00595-014-0873-9		7	Surgery	Surgery	AR6WT	WOS:000343722300019		
J	Migita, K; Takayama, T; Matsumoto, S; Wakatsuki, K; Tanaka, T; Ito, M; Nakajima, Y				Migita, Kazuhiro; Takayama, Tomoyoshi; Matsumoto, Sohei; Wakatsuki, Kohei; Tanaka, Tetsuya; Ito, Masahiro; Nakajima, Yoshiyuki			Impact of bacterial culture positivity of the drainage fluid during the early postoperative period on the development of intra-abdominal abscesses after gastrectomy	SURGERY TODAY			English	Article						Bacterial culture; Drainage fluid; Intra-abdominal abscess; Gastrectomy	ANASTOMOTIC LEAKAGE; LIVER RESECTION; GASTRIC-CANCER; MORTALITY; CRITERIA; SURGERY; REMOVAL; RISK	The aim of this study was to evaluate the impact of positive bacterial cultures of the drainage fluid (D-cultures) during the early postoperative period on the incidence of intra-abdominal abscess formation following gastrectomy. From January 2012 to June 2013, we prospectively performed D-cultures on postoperative day (POD) 1 in consecutive gastric cancer patients who underwent gastrectomy. The univariate and multivariate analyses were performed to identify the risk factors for intra-abdominal abscess formation without anastomotic leakage. The rate of positive D-cultures was 6.4 % on POD 1. According to a univariate analysis, the use of combined organ resection (P = 0.011), the drain amylase level on POD 1 (P = 0.016) and the D-culture status on POD 1 (P = 0.004) were found to be significantly associated with the incidence of intra-abdominal abscesses. A multivariate analysis demonstrated that D-culture positivity on POD 1 was the only independent predictor of intra-abdominal abscess formation (P = 0.011). The present study demonstrated that bacterial culture positivity of drainage fluid during the early postoperative period has a significant impact on the development of intra-abdominal abscesses after gastrectomy.	[Migita, Kazuhiro; Takayama, Tomoyoshi; Matsumoto, Sohei; Wakatsuki, Kohei; Tanaka, Tetsuya; Ito, Masahiro; Nakajima, Yoshiyuki] Nara Med Univ, Dept Surg, Kashihara, Nara 6348522, Japan	Migita, K (reprint author), Nara Med Univ, Dept Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	kmigita@naramed-u.ac.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Sierzega M, 2010, BRIT J SURG, V97, P1035, DOI 10.1002/bjs.7038; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Jiang XH, 2012, ANN SURG ONCOL, V19, P115, DOI 10.1245/s10434-011-1893-y; Tsujimoto H, 2009, ANN SURG ONCOL, V16, P311, DOI 10.1245/s10434-008-0249-8; MOSS JP, 1981, SURG GYNECOL OBSTET, V152, P517; Kawai M, 2006, ANN SURG, V244, P1, DOI 10.1097/01.sla.0000218077.14035.a6; Yamazaki S, 2012, BRIT J SURG, V99, P1584, DOI 10.1002/bjs.8916; Migita K, 2012, J GASTROINTEST SURG, V16, P1659, DOI 10.1007/s11605-012-1932-4; Sano T, 2004, J CLIN ONCOL, V22, P2767, DOI 10.1200/JCO.2004.10.184; Miki Y, 2011, J GASTROINTEST SURG, V15, P1969, DOI 10.1007/s11605-011-1628-1; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Iwata N, 2010, WORLD J SURG, V34, P1534, DOI 10.1007/s00268-010-0516-2; LEVY M, 1984, AM J SURG, V147, P309, DOI 10.1016/0002-9610(84)90156-9; Tanaka K, 2013, SURG TODAY, V43, P372, DOI 10.1007/s00595-012-0254-1; Japanese Gastric Cancer Association, 2010, GASTRIC CANCER, V14, P113, DOI DOI 10.1007/S10120-011-0042-4; Katai Hitoshi, 2005, Gastric Cancer, V8, P137, DOI 10.1007/s10120-005-0317-8; Nomura S, 2000, GASTRIC CANCER, V3, P97, DOI 10.1007/PL00011703; Okita Y, 2013, SURG TODAY, V43, P1095, DOI 10.1007/s00595-013-0504-x; Sano T, 1997, BRIT J SURG, V84, P1310; Sobin LH, 2010, UICC TNM CLASSIFICAT, V7th; Tanaka T, 2013, HEPATO-GASTROENTEROL, V60, P200, DOI 10.5754/hge12500; TRAVERSO LW, 1987, J SURG RES, V43, P220, DOI 10.1016/0022-4804(87)90074-6; Vaccaro MI, 1996, INT J PANCREATOL, V19, P49	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2138	2145		10.1007/s00595-014-0881-9		8	Surgery	Surgery	AR6WT	WOS:000343722300020		
J	Nakayama, Y; Gotohda, N; Shibasaki, H; Nomura, S; Kinoshita, T; Hayashi, R				Nakayama, Yusuke; Gotohda, Naoto; Shibasaki, Hidehito; Nomura, Shogo; Kinoshita, Takahiro; Hayashi, Ryuichi			Usefulness of the neutrophil/lymphocyte ratio measured preoperatively as a predictor of peritoneal metastasis in patients with advanced gastric cancer	SURGERY TODAY			English	Article						Gastric cancer; Peritoneal metastasis; Neutrophil/lymphocyte ratio	SYSTEMIC INFLAMMATORY RESPONSE; POTENTIALLY CURATIVE RESECTION; NEUTROPHIL-LYMPHOCYTE RATIO; COLORECTAL LIVER METASTASES; PROGNOSTIC INDICATOR; SERUM-ALBUMIN; POOR SURVIVAL; TUMOR; DISSEMINATION; CARCINOMA	Purpose The prognosis for gastric cancer patients with peritoneal metastasis is poor. Many studies have reported that the neutrophil/lymphocyte ratio (NLR) might be useful to predict the degree of progression of gastric cancer. In this study, we attempted to evaluate whether the NLR and other related laboratory parameters might be reliable predictors of the presence of peritoneal metastasis in patients with advanced gastric cancer. Methods The data of 359 patients who underwent gastric surgery between June 2008 and December 2011 were reviewed. A retrospective analysis of the preoperative blood data in relation to the presence of peritoneal metastasis was carried out. Results An increased serum C-reactive protein level (P = 0.022), APTT (P = 0.017) and NLR (P < 0.001), and a decreased serum Alb (P = 0.014) were significantly related to the presence of peritoneal metastasis. A multivariate analysis showed that a NLR >2.37 (OR = 2.59, 95 % CI = 1.38-4.93, P = 0.003) and clinical T4 stage (OR = 4.36, 95 % CI = 2.33-8.24, P < 0.001) were independent predictors of the presence of peritoneal metastasis. Conclusion Our results suggest that the preoperative NLR was a significant independent predictor of the presence of peritoneal metastasis in patients with advanced gastric cancer.	[Nakayama, Yusuke; Gotohda, Naoto; Shibasaki, Hidehito; Kinoshita, Takahiro] Natl Canc Ctr Hosp East, Div Surg Oncol, Kashiwa, Chiba 2778577, Japan; [Nakayama, Yusuke; Hayashi, Ryuichi] Juntendo Univ, Grad Sch Med, Tokyo, Japan; [Nomura, Shogo] Natl Canc Ctr, Dept Biostat, Kashiwa, Chiba, Japan; [Hayashi, Ryuichi] Natl Canc Ctr Hosp East, Div Head & Neck Surg, Kashiwa, Chiba 2778577, Japan	Gotohda, N (reprint author), Natl Canc Ctr Hosp East, Div Surg Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	yu_naka_yu0723@yahoo.co.jp; ngotohda@east.ncc.go.jp					Aizawa M, 2011, WORLD J SURG, V35, P2717, DOI 10.1007/s00268-011-1269-2; Onate-Ocana LF, 2007, ANN SURG ONCOL, V14, P381, DOI 10.1245/s10434-006-9093-x; Yamanaka T, 2007, ONCOLOGY-BASEL, V73, P215, DOI 10.1159/000127412; Jung MR, 2011, J SURG ONCOL, V104, P504, DOI 10.1002/jso.21986; Yamagata Y, 2013, HEPATO-GASTROENTEROL, V60, P751, DOI 10.5754/hge12900; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Halazun KJ, 2008, EJSO-EUR J SURG ONC, V34, P55, DOI 10.1016/j.ejso.2007.02.014; Glockzin G, 2012, SURG ONCOL CLIN N AM, V21, P625, DOI 10.1016/j.soc.2012.07.002; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Shamamian P, 2001, J CELL PHYSIOL, V189, P197, DOI 10.1002/jcp.10014; Fondevila C, 2004, BRIT J CANCER, V90, P206, DOI 10.1038/sj.bjc.6601455; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Mohri Y, 2010, WORLD J SURG, V34, P285, DOI 10.1007/s00268-009-0302-1; PETRIE HT, 1985, J IMMUNOL, V134, P230; Shimada H, 2010, GASTRIC CANCER, V13, P170, DOI 10.1007/s10120-010-0554-3; IKEGUCHI M, 1994, ANTICANCER RES, V14, P2131; Nozoe T, 2011, AM J SURG, V201, P186, DOI 10.1016/j.amjsurg.2010.01.030; Forrest LM, 2003, BRIT J CANCER, V89, P1028, DOI 10.1038/sj.bjc.6601242; Nozoe T, 2008, SURG TODAY, V38, P597, DOI 10.1007/s00595-007-3680-8; Emoto S, 2012, GASTRIC CANCER, V15, P154, DOI 10.1007/s10120-011-0091-8; Lien YC, 2004, J GASTROINTEST SURG, V8, P1041, DOI 10.1016/j.passur.2004.09.033; ELHAG A, 1987, J IMMUNOL, V139, P2406; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Roxburgh CSD, 2009, ANN SURG, V249, P788, DOI 10.1097/SLA.0b013e3181a3e738; Al-Shaiba R, 2004, BRIT J CANCER, V91, P205, DOI 10.1038/sj.bjc.6601886; Aliustaoglu M, 2010, MED ONCOL, V27, P1060, DOI 10.1007/s12032-009-9335-4; Chang Cheng-Chih, 2010, Chang Gung Med J, V33, P301; Crumley ABC, 2010, J GASTROINTEST SURG, V14, P781, DOI 10.1007/s11605-010-1162-6; Dutta S, 2012, AM J SURG, V204, P294, DOI 10.1016/j.amjsurg.2011.10.015; Kinoshita J, 2010, ONCOL LETT, V1, P989, DOI 10.3892/ol.2010.181; Kusumanto Yoka H., 2003, Angiogenesis, V6, P283, DOI 10.1023/B:AGEN.0000029415.62384.ba; Okano K, 2003, J SURG ONCOL, V82, P28, DOI 10.1002/jso.10188; Tomita M, 2011, ANN CANC RES THER, V19, P54; Yamashita H, 2010, WORLD J SURG, V34, P2399, DOI 10.1007/s00268-010-0703-1; Zahorec R, 2001, Bratisl Lek Listy, V102, P5	35	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2146	2152		10.1007/s00595-014-0917-1		7	Surgery	Surgery	AR6WT	WOS:000343722300021		
J	Kitajima, T; Tomizawa, K; Hanaoka, Y; Toda, S; Matoba, S; Kuroyanagi, H; Oota, Y				Kitajima, Toshihiro; Tomizawa, Kenji; Hanaoka, Yutaka; Toda, Shigeo; Matoba, Shuichiro; Kuroyanagi, Hiroya; Oota, Yasunori			Anastomotic stenosis of the descending colon caused by barium granuloma formation following barium peritonitis: report of a case	SURGERY TODAY			English	Article						Barium peritonitis; Barium granuloma; Anastomotic stenosis; Submucosa; Serosa	COMPLICATION; RECTUM	Anastomotic stricture reportedly often recurs following barium peritonitis, regardless of whether the anastomotic diameter is initially sufficient. However, the causes of repetitive stricture have not been clarified. We report a case that suggests the pathophysiology of recurrent anastomotic strictures following barium peritonitis. The patient was a 39-year-old Japanese man with idiopathic perforation of the descending colon after undergoing an upper gastrointestinal barium contrast study. After emergency peritoneal lavage and diverting colostomy, created using the perforated region, the patient recovered uneventfully and 3 months later, the colostomy was closed and the perforated colon was resected. However, 7 months after colostomy closure, abdominal distention gradually developed, and colonoscopy revealed an anastomotic stricture. The patient was referred to our hospital where he underwent resection of the anastomotic stricture. The surgical specimen exhibited barium granulomas not only in the subserosa of the entire specimen, but also in the submucosa and lamina propria localized in the anastomotic site. These findings suggest that barium was embedded in the submucosa and lamina propria with manipulation of the stapled anastomosis and that the barium trapped in the anastomotic site caused persistent inflammation, resulting in an anastomotic stricture.	[Kitajima, Toshihiro; Tomizawa, Kenji; Hanaoka, Yutaka; Toda, Shigeo; Matoba, Shuichiro; Kuroyanagi, Hiroya] Toranomon Gen Hosp, Dept Surg Gastroenterol, Tokyo, Japan; [Oota, Yasunori] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan	Kitajima, T (reprint author), Toranomon Gen Hosp, Dept Surg Gastroenterol, Tokyo, Japan.	t.kitajima0407@gmail.com					Aoyagi K., 1994, NIHON RINSHO S6, P609; BEDDOE HL, 1954, JAMA-J AM MED ASSOC, V154, P747; ELLOWAY RS, 1991, GASTROINTEST ENDOSC, V37, P586, DOI 10.1016/S0016-5107(91)70847-X; GARDINER H, 1973, AM J SURG, V125, P350, DOI 10.1016/0002-9610(73)90059-7; Karanikas ID, 1997, POSTGRAD MED J, V73, P297; LEWIS JW, 1975, ANN SURG, V181, P418, DOI 10.1097/00000658-197504000-00009; Nishina M, 1993, NIHON SHOKAKI GEKA G, V26, P1310; SISEL RJ, 1972, ARCH SURG-CHICAGO, V104, P765; Tajima Y, 2008, NIHON FUKUBUKYUKYU I, V28, P735; WESTFALL RH, 1966, AM J SURG, V112, P760, DOI 10.1016/0002-9610(66)90119-X; Williams S M, 1991, Curr Probl Diagn Radiol, V20, P123	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2153	2156		10.1007/s00595-013-0696-0		4	Surgery	Surgery	AR6WT	WOS:000343722300022		
J	Yamaguchi, E; Makino, Y; Sato, T; Uchida, M; Harada, Y; Maruyama, R				Yamaguchi, Emi; Makino, Yoshinari; Sato, Takashi; Uchida, Masaaki; Harada, Yuji; Maruyama, Riruke			CA19-9-producing lung metastasis after surgery for papillary thyroid carcinoma: report of a case	SURGERY TODAY			English	Article						Papillary thyroid carcinoma; CA19-9-producing tumor; Metachronous metastasis	ANAPLASTIC CARCINOMA; TRANSFORMATION; EXPRESSION; MARKERS	Measuring tumor marker levels following cancer treatment can be useful. Although serum thyroglobulin is a useful marker after total thyroidectomy for papillary thyroid carcinoma (PTC), it is not a reliable marker for patients with a high titer of anti-thyroglobulin antibodies or when transformation to undifferentiated carcinoma has occurred. The female patient in this case report underwent total thyroidectomy and oral I-131 therapy for PTC at the age of 47 years, followed by cervical lymph node and lung resections for metastases, 3 and 11 years later, respectively. She also received oral I-131 therapy and external beam radiotherapy for mediastinal lymph node metastases. The lymphadenopathy lesions progressed and multiple lung metastases were detected when she was 61 years of age. She died at the age of 62 years. The serum CA19-9 level had gradually increased in association with enlargement of the recurrent lesions and immunostaining of CA19-9 in the pulmonary metastasis was intense. Thus, we consider that measuring the level of serum CA19-9 is an effective tool for evaluating disease status after surgery for PTC.	[Yamaguchi, Emi] Izumo City Gen Med Ctr, Dept Surg, Izumo, Shimane 6910003, Japan; [Yamaguchi, Emi; Makino, Yoshinari; Sato, Takashi; Uchida, Masaaki] Matsue Seikyo Hosp, Dept Surg, Matsue, Shimane 6908522, Japan; [Harada, Yuji] Shimane Univ, Fac Med, Organ Pathol Unit, Dept Pathol, Izumo, Shimane 6938501, Japan; [Maruyama, Riruke] Shimane Univ Hosp, Lab Surg Pathol, Izumo, Shimane 6938501, Japan	Yamaguchi, E (reprint author), Izumo City Gen Med Ctr, Dept Surg, 613 Nadabun Cho, Izumo, Shimane 6910003, Japan.	emi-med-ml@poppy.ocn.ne.jp					VENKATESH YSS, 1990, CANCER, V66, P321, DOI 10.1002/1097-0142(19900715)66:2<321::AID-CNCR2820660221>3.0.CO;2-A; CRILE G, 1959, SURG GYNECOL OBSTET, V108, P357; HASHIMOTO T, 1990, ENDOCRINOL JAPON, V37, P247; Hoshi S, 2000, Nihon Kokyuki Gakkai Zasshi, V38, P391; Matuura B, 1991, ENDOCRIONOL JAPON, V38, P565; NOMIZU T, 1984, Journal of Japan Society for Cancer Therapy, V19, P1289; Ogawa M, 2005, PEDIATR BLOOD CANCER, V45, P64, DOI 10.1002/pbc.20375; Ohsumi S, 1996, GAN RINSHO, V42, P267; Seshimo T, 1991, NIHON RINSHO GEKAIKA, V52, P74; VIERBUCHEN M, 1989, LAB INVEST, V60, P726; Wiseman SM, 2007, ARCH SURG-CHICAGO, V142, P717, DOI 10.1001/archsurg.142.8.717	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2157	2161		10.1007/s00595-013-0820-1		5	Surgery	Surgery	AR6WT	WOS:000343722300023		
J	Gunji, S; Okabe, H; Obama, K; Sakai, Y				Gunji, Shutaro; Okabe, Hiroshi; Obama, Kazutaka; Sakai, Yoshiharu			Aortoenteric fistula at the site of esophagojejunostomy after laparoscopic total gastrectomy: report of a case	SURGERY TODAY			English	Article						Aortoenteric fistula; Laparoscopic total gastrectomy; Overlap anastomosis	GASTRIC-CANCER; NEOADJUVANT CHEMOTHERAPY; AORTOESOPHAGEAL FISTULA; SURGICAL-TREATMENT; COMPLICATIONS; SURGERY; TRIAL; ESOPHAGECTOMY; ANASTOMOSIS; DISSECTION	A fistula between the aorta and the digestive tract is a rare complication of gastrointestinal tract or vascular surgery. There are occasional reports of aortoesophageal fistula as a fatal complication after esophagectomy or esophageal stent implantation and of aortoenteric fistula (AEF) as a complication after aortic or other vascular procedures. However, AEF after gastrointestinal surgery is rare. We report a case of AEF after laparoscopic total gastrectomy for advanced gastric cancer, using the so-called overlap method of esophagojejunal anastomosis. The patient was a 77-year-old Japanese woman who underwent laparoscopic total gastrectomy and esophagojejunal anastomosis with Roux-en-Y reconstruction for advanced gastric cancer. Bacterial peritonitis was diagnosed 5 days after the operation, manifesting as partial necrosis and perforation of the small intestine. The patient was treated successfully with laparoscopic partial resection of the small intestine, but ultimately died of massive hematemesis caused by the AEF 30 days after her primary surgery.	[Gunji, Shutaro; Okabe, Hiroshi; Obama, Kazutaka; Sakai, Yoshiharu] Kyoto Univ, Grad Sch Med, Dept Surg, Sakyo Ku, Kyoto, Japan	Gunji, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Surg, Sakyo Ku, 54 Kawahara Cho, Kyoto, Japan.	shutaro@kuhp.kyoto-u.ac.jp; hokabe@kuhp.kyoto-u.ac.jp					ALADGEM D, 1988, POSTGRAD MED J, V64, P636; Schuhmacher C, 2010, J CLIN ONCOL, V28, P5210, DOI 10.1200/JCO.2009.26.6114; An JY, 2012, ANN SURG ONCOL, V19, P2452, DOI 10.1245/s10434-012-2267-9; BONENKAMP JJ, 1995, LANCET, V345, P745, DOI 10.1016/S0140-6736(95)90637-1; Danneels MIL, 2006, EUR J VASC ENDOVASC, V32, P27, DOI 10.1016/j.ejvs.2005.11.031; Topal B, 2008, SURG ENDOSC, V22, P980, DOI 10.1007/s00464-007-9549-5; Ge L, 2012, WORLD J GASTROENTERO, V18, P7384, DOI 10.3748/wjg.v18.i48.7384; Song Y, 2008, SURGERY, V143, P43, DOI 10.1016/j.surg.2007.06.036; Bonenkamp JJ, 1999, NEW ENGL J MED, V340, P908, DOI 10.1056/NEJM199903253401202; Cuschieri A, 1999, BRIT J CANCER, V79, P1522, DOI 10.1038/sj.bjc.6690243; Sano T, 2004, J CLIN ONCOL, V22, P2767, DOI 10.1200/JCO.2004.10.184; Sato O, 1999, SURG TODAY, V29, P431; Okabe H, 2009, SURG ENDOSC, V23, P2167, DOI 10.1007/s00464-008-9987-8; Misra S, 2012, J SURG RES, V178, P623, DOI 10.1016/j.jss.2012.04.062; Antinori CH, 1996, AM SURGEON, V62, P344; Budisin N, 2001, J SURG ONCOL, V77, P35, DOI 10.1002/jso.1063; Inaba K, 2010, J AM COLL SURGEONS, V211, pE25, DOI 10.1016/j.jamcollsurg.2010.09.005; KATYAL D, 1993, CAN J SURG, V36, P480; Kawaguchi Y, 2011, GASTROINTEST ENDOSC, V74, P922, DOI 10.1016/j.gie.2011.06.010; Leroux BT, 1961, BR J SURG, V49; LEVINE MS, 1991, AM J ROENTGENOL, V157, P1189; Schweigert M, 2011, ANN THORAC SURG, V92, P513, DOI 10.1016/j.athoracsur.2011.02.083; Simon T, 2011, CASE REP MED; Singh S, 2012, DIGEST DIS SCI, V57, P625, DOI 10.1007/s10620-011-1945-y; SOWA M, 1992, ANTICANCER RES, V12, P1427; Tsujimoto H, 2012, LANGENBECK ARCH SURG, V397, P833, DOI 10.1007/s00423-012-0939-3; Unosawa S, 2008, SURG TODAY, V38, P62, DOI 10.1007/s00595-007-3569-6; Villalba MR, 2009, OBES SURG, V19, P265, DOI 10.1007/s11695-008-9620-x	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2162	2166		10.1007/s00595-014-0834-3		5	Surgery	Surgery	AR6WT	WOS:000343722300024		
J	Yoshino, M; Sekine, Y; Koh, E; Kume, Y; Saito, H; Kimura, S; Hamada, H; Wu, D; Hiroshima, K				Yoshino, Mitsuru; Sekine, Yasuo; Koh, Eitetsu; Kume, Yuta; Saito, Hiroyuki; Kimura, Sho; Hamada, Hiromichi; Wu, Di; Hiroshima, Kenzo			Pericardial synovial sarcoma: a case report and review of the literature	SURGERY TODAY			English	Article						Synovial sarcoma; Pericardium; Heart; Intrapericardial tumor; SYT-SSX	SYT-SSX; TUMORS; MULTICENTER; DIAGNOSIS; HEART	Primary pericardial synovial sarcoma is a rare disease. We herein report a case of synovial sarcoma that originated in the epicardium. A 13-year-old male visited our hospital with a fever and chest pain. Copious pericardial effusion and a large intrapericardial tumor were detected. An open-chest tumor resection was performed. A solid nodular tumor was observed in the pericardial cavity. The tumor was a polypoid mass that was pedunculated and grew from the inner surface of the pericardium near the origin of the SVC and ascending aorta. Histologically, the tumor cells were uniformly spindle shaped, with an ovoid or oval nucleus, and formed solid, compact sheets and fascicles. A storiform pattern was also observed. Based on the histopathological and immunohistochemical findings, and the fluorescence in situ hybridization detection of rearrangement of the SYT gene, a monophasic synovial sarcoma was diagnosed. We discuss the diagnosis and treatment of this case and review the pertinent literature.	[Yoshino, Mitsuru; Sekine, Yasuo; Koh, Eitetsu] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Thorac Surg, Chiba 2768524, Japan; [Kume, Yuta; Saito, Hiroyuki] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Cardiovasc Surg, Chiba 2768524, Japan; [Kimura, Sho; Hamada, Hiromichi] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Pediat, Chiba 2768524, Japan; [Wu, Di; Hiroshima, Kenzo] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Pathol, Chiba 2768524, Japan	Sekine, Y (reprint author), Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Thorac Surg, 477-96 Owada Shinden, Chiba 2768524, Japan.	ysekine@tymc.twmu.ac.jp					Anand AK, 2003, CLIN ONCOL-UK, V15, P186, DOI 10.1016/S0963-6555(02)00215-7; KARN CM, 1994, CANCER, V73, P74, DOI 10.1002/1097-0142(19940101)73:1<74::AID-CNCR2820730114>3.0.CO;2-I; Constantinou LL, 1996, EUR HEART J, V17, P1766; Katakura H, 2009, THORAC CARDIOV SURG, V57, P183, DOI 10.1055/s-2006-955886; Palmerini E, 2009, CANCER, V115, P2988, DOI 10.1002/cncr.24370; Begueret H, 2005, AM J SURG PATHOL, V29, P339; Hing SN, 2007, J PEDIAT HEMATOL ONC, V29, P492, DOI 10.1097/MPH.0b013e3180640d2e; SREEKANTAIAH C, 1994, AM J PATHOL, V144, P1121; Al-Rajhi N, 1999, J SURG ONCOL, V70, P194, DOI 10.1002/(SICI)1096-9098(199903)70:3<194::AID-JSO10>3.0.CO;2-8; Moorjani N, 2009, J CARDIAC SURG, V24, P349, DOI 10.1111/j.1540-8191.2009.00827.x; Okcu MF, 2003, J CLIN ONCOL, V21, P1602, DOI 10.1200/JCO.2003.07.008; BURKE AP, 1992, CANCER, V69, P387, DOI 10.1002/1097-0142(19920115)69:2<387::AID-CNCR2820690219>3.0.CO;2-N; Nicholson AG, 1998, HISTOPATHOLOGY, V33, P508; Oizumi S, 1999, JPN CIRC J, V63, P330, DOI 10.1253/jcj.63.330; Yano M, 2004, LUNG CANCER-J IASLC, V44, P391, DOI 10.1016/j.lungcan.2003.11.011; Thway K, 2010, J CLIN PATHOL, V63, P508, DOI 10.1136/jcp.2010.076133; Kojima KY, 1999, AM J ROENTGENOL, V173, P246; Guillou L, 2004, J CLIN ONCOL, V22, P4040, DOI 10.1200/JCO.2004.11.093; Jagdis A, 2009, AM J SURG PATHOL, V33, P1743, DOI 10.1097/PAS.0b013e3181b7ed36; Reynen K, 1996, AM J CARDIOL, V77, P107, DOI 10.1016/S0002-9149(97)89149-7; Burke AP, 1996, TUMORS CARDIOVASCULA, P9; Cheng YF, 2012, AM J CLIN PATHOL, V137, P142, DOI 10.1309/AJCP34ZVFLAUTMGL; Gu F, 2010, ONCOL LETT, V1, P885, DOI 10.3892/ol_00000157; Korula A, 2009, SINGAP MED J, V50, pE26; Langner K, 1998, PATHOLOGE, V19, P442, DOI 10.1007/s002920050310; McAllistar HA, 1978, ATLAS TUMOUR PATHO 2, P325; Schumann C, 2007, Int J Cardiol, V118, pe83, DOI 10.1016/j.ijcard.2007.01.029; Sun B, 2008, CANCER SCI, V99, P1355, DOI 10.1111/j.1349-7006.2008.00830.x; Takeda K, 2012, SURG TODAY, V42, P479, DOI 10.1007/s00595-011-0022-7; Van der Mieren Gerry, 2004, Ann Thorac Surg, V78, pe41, DOI 10.1016/j.athoracsur.2004.02.011; Yokouchi Y, 2011, PATHOL INT, V61, P150, DOI 10.1111/j.1440-1827.2010.02631.x	31	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2167	2173		10.1007/s00595-013-0720-4		7	Surgery	Surgery	AR6WT	WOS:000343722300025		
J	Ogawa, N; Iseki, H; Tsunozaki, H; Hayashi, M; Baba, H; Matsuyama, T; Uetake, H; Sugihara, K				Ogawa, Norihito; Iseki, Hideaki; Tsunozaki, Hidefumi; Hayashi, Mikiko; Baba, Hironobu; Matsuyama, Takatoshi; Uetake, Hiroyuki; Sugihara, Kenichi			An intra-abdominal desmoid tumor difficult to distinguish from a gastrointestinal stromal tumor: report of two cases	SURGERY TODAY			English	Article						Desmoid tumor; Gastrointestinal stromal tumor; Beta-catenin; CD117; KIT	FAMILIAL ADENOMATOUS POLYPOSIS; DIFFERENTIAL-DIAGNOSIS; FIBROMATOSIS; MUTATIONS	Desmoid tumors are benign fibroblastic neoplasms with no metastatic potential, but a propensity for local recurrence even after complete surgical resection. These lesions can develop at any site in the body, and commonly occur in the intra-abdominal area. Intra-abdominal desmoid tumors usually occur at the mesentery or retroperitoneum, and may morphologically mimic gastrointestinal stromal tumors (GISTs). Distinguishing between these tumors is important, because the therapies differ substantially, but is often difficult even with the use of CD117 staining. We herein report the cases of two patients with sporadic intra-abdominal desmoid tumors that were differentiated from GIST by immunohistological examination using beta-catenin and CD34. Desmoid tumors specifically express nuclear beta-catenin, and show no expression of CD34. We recommend staining for beta-catenin and CD34 when an intra-abdominal desmoid tumor is suspected.	[Ogawa, Norihito; Baba, Hironobu; Matsuyama, Takatoshi; Sugihara, Kenichi] Tokyo Med & Dent Univ, Grad Sch, Dept Surg Oncol, Bunkyo Ku, Tokyo 1138519, Japan; [Ogawa, Norihito; Iseki, Hideaki; Tsunozaki, Hidefumi; Hayashi, Mikiko] Toshiba Hosp, Dept Surg, Tokyo, Japan; [Uetake, Hiroyuki] Tokyo Med & Dent Univ, Dept Translat Oncol, Tokyo 1138519, Japan	Ogawa, N (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Surg Oncol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	goodd_luck@hotmail.co.jp					REITAMO JJ, 1982, AM J CLIN PATHOL, V77, P665; Tran T, 2005, AM J GASTROENTEROL, V100, P162, DOI 10.1111/j.1572-0241.2005.40709.x; Ballo MT, 1999, J CLIN ONCOL, V17, P158; Church J, 2008, DIS COLON RECTUM, V51, P897, DOI 10.1007/s10350-008-9232-5; Montgomery E, 2002, AM J SURG PATHOL, V26, P1296, DOI 10.1097/01.PAS.0000027594.30911.DA; Corless CL, 2005, J CLIN ONCOL, V23, P5357, DOI 10.1200/JCO.2005.14.068; Lucas DR, 2003, AM J CLIN PATHOL, V119, P339, DOI 10.1309/AN4E2ETCJ4R6JJUY; Yantiss RK, 2000, AM J SURG PATHOL, V24, P947, DOI 10.1097/00000478-200007000-00006; Debiec-Rychter M, 2004, J PATHOL, V202, P430, DOI 10.1002/path.1546; Tejpar S, 1999, ONCOGENE, V18, P6615, DOI 10.1038/sj.onc.1203041; Clark SK, 1999, BRIT J SURG, V86, P1185, DOI 10.1046/j.1365-2168.1999.01222.x; Kang YN, 2010, CANCER RES TREAT, V42, P135, DOI 10.4143/crt.2010.42.3.135; Huang HY, 2007, SURGERY, V141, P748, DOI 10.1016/j.surg.2007.01.024; Hwangbo Y, 2011, SURG TODAY, V41, P1085, DOI 10.1007/s00595-010-4434-6; van Graadt Roggen JF, 2001, J CLIN PATHOL, V54, P96; Yamaguchi U, 2004, VIRCHOWS ARCH, V445, P142, DOI 10.1007/s00428-004-1055-8	16	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2174	2179		10.1007/s00595-013-0681-7		6	Surgery	Surgery	AR6WT	WOS:000343722300026		
J	Shoji, M; Yoshimitsu, Y; Maeda, T; Sakuma, H; Nakai, M; Ueda, H				Shoji, Masatoshi; Yoshimitsu, Yutaka; Maeda, Tsutomu; Sakuma, Hiroshi; Nakai, Masuo; Ueda, Hiroshi			Perforated gastrointestinal stromal tumor (GIST) in a true jejunal diverticulum in adulthood: report of a case	SURGERY TODAY			English	Article						Perforation; GIST; Jejunal diverticulum	SMALL-BOWEL; MECKELS-DIVERTICULUM; RISK	A 61-year-old man was referred to us for investigation of acute abdominal pain. Computed tomography showed a 5.9 x 5.3 x 5.0 cm lump of food residue in the jejunum, and a large amount of free air and ascites around the liver and right paracolic gutter. He underwent emergency laparotomy for suspected peritonitis from perforation by a foreign body in the small intestine. We identified purulent exudate in the abdominal cavity and perforation of a jejunal cystic mass, attached similar to 40 cm from Treitz's ligament at the anti-mesenteric side of the jejunum. Based on a diagnosis of jejunal duplication with perforation, we resected that part of the small intestine and performed intra-abdominal drainage. Pathological findings confirmed the diagnosis of a perforated gastrointestinal stromal tumor (GIST) in a true jejunal diverticulum. Histopathological evidence suggests that intestinal pressure and/or hemorrhage can cause perforation in the background of a true jejunal diverticulum. To our knowledge, this is the first case report of a perforated GIST in a true jejunal diverticulum.	[Shoji, Masatoshi; Yoshimitsu, Yutaka; Maeda, Tsutomu; Sakuma, Hiroshi; Nakai, Masuo; Ueda, Hiroshi] Hoju Mem Hosp, Dept Surg, Nomi, Ishikawa 9231226, Japan	Shoji, M (reprint author), Hoju Mem Hosp, Dept Surg, 11-71 Midorigaoka, Nomi, Ishikawa 9231226, Japan.	pignite@me.com					Agaimy A, 2012, INT J CLIN EXP PATHO, V5, P12; ANDERSEN LP, 1988, SCAND J GASTROENTERO, V23, P672, DOI 10.3109/00365528809093930; Furuya K, 2012, SURG TODAY, V42, P1234, DOI 10.1007/s00595-012-0135-7; Cunningham SC, 2005, AM J SURG, V190, P37, DOI 10.1016/j.amjsurg.2005.03.024; Joensuu H, 2012, LANCET ONCOL, V13, P265, DOI 10.1016/S1470-2045(11)70299-6; Szentpali K, 2004, CAN J SURG, V47, P70; Joensuu H, 2012, JAMA-J AM MED ASSOC, V307, P1265, DOI 10.1001/jama.2012.347; Beham AW, 2012, INT J COLORECTAL DIS, V27, P689, DOI 10.1007/s00384-011-1353-y; Bhat N A, 2001, Trop Gastroenterol, V22, P33; Caricato M, 2010, ANN ITAL CHIR, V81, P449; CHIN NW, 1989, AM J GASTROENTEROL, V84, P972; Chou Yueh-Hung, 2011, Chang Gung Med J, V34, P56; Chow D C, 1997, Gastroenterologist, V5, P78; de la Morena Lopez F, 2007, GASTROENTEROL HEPATO, V30, P534; Dogrul AB, 2010, AM J MED SCI, V340, P156, DOI 10.1097/MAJ.0b013e3181dfbb94; Durai R, 2008, THESCIENTIFICWORLDJO, V8, P934, DOI 10.1100/tsw.2008.118; Fronticelli CM, 1996, SURG TODAY, V26, P192; Hager M, 2005, J GASTROINTEST SURG, V9, P809, DOI 10.1016/j.gassur.2004.12.005; Ladd WE, 1940, SURG GYNECOL OBSTET, V70, P295; LONGO WE, 1992, DIS COLON RECTUM, V35, P381, DOI 10.1007/BF02048119; Lorusso R, 2003, Ann Ital Chir, V74, P707; Makris K, 2009, J CLIN GASTROENTEROL, V43, P201, DOI 10.1097/MCG.0b013e3181919261; Mitura Kryspin, 2012, Pol Przegl Chir, V84, P258, DOI 10.2478/v10035-012-0043-y; Nannini Margherita, 2013, Int J Surg Case Rep, V4, P7, DOI 10.1016/j.ijscr.2012.07.019; Neugut AI, 1998, CANCER EPIDEM BIOMAR, V7, P243; Prost ALDJ, 2008, HEPATO-GASTROENTEROL, V55, P1657; Sadaf A, 2010, CASE REP ONCOL, V3, P19; Schepers S, 2009, JBR-BTR, V92, P23; SKANDALAKIS J E, 1960, Int Abstr Surg, V110, P209; Soemmering ST BM, 1794, VOSSICHE BUCHHANDLUN, P1; WARDELL S, 1990, J CLIN GASTROENTEROL, V12, P681, DOI 10.1097/00004836-199012000-00018	31	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2180	2186		10.1007/s00595-013-0732-0		7	Surgery	Surgery	AR6WT	WOS:000343722300027		
J	Otowa, Y; Kanemitsu, K; Sumi, Y; Nakamura, T; Suzuki, S; Kuroda, D; Kakeji, Y				Otowa, Yasunori; Kanemitsu, Kiyonori; Sumi, Yasuo; Nakamura, Tetsu; Suzuki, Satoshi; Kuroda, Daisuke; Kakeji, Yoshihiro			Laparoscopic trans-peritoneal hernioplasty (TAPP) is useful for obturator hernias: report of a Case	SURGERY TODAY			English	Article						Obturator hernia; TAPP; Prosthetic mesh	TRANSABDOMINAL PREPERITONEAL; COMPUTED-TOMOGRAPHY; INGUINAL-HERNIA; MESH REPAIR; MANAGEMENT; DIAGNOSIS	A 71-year-old female presented to our hospital due to pain from the right hip joint to the lower abdomen. The pain had suddenly appeared and spontaneously disappeared more than 10 times during the past 2 years. She had visited many hospitals, but remained undiagnosed. The patient underwent a computed tomography (CT) scan of the pelvis, and a soft tissue shadow was seen between the external obturator and pectineal muscles. She was diagnosed with a right obturator hernia and underwent elective repair by laparoscopic trans-peritoneal hernioplasty (TAPP). 1 year has passed since the surgery, without any recurrence of the abdominal pain. Obturator hernias are rare, and most cases are found as incarcerated hernias. It is rare to find an obturator hernia without intestinal obstruction, or with the recurrent pain as in our case. We herein report a case in which an obturator hernia was undiagnosed and intermittent pain was experienced for 2 years prior to TAPP, which appears to have successfully treated the hernia.	[Otowa, Yasunori; Kanemitsu, Kiyonori; Sumi, Yasuo; Nakamura, Tetsu; Suzuki, Satoshi; Kuroda, Daisuke; Kakeji, Yoshihiro] Kobe Univ, Grad Sch Med, Div Gastrointestinal Surg,Dept Surg, Chuo Ku, Kobe, Hyogo 6500017, Japan	Otowa, Y (reprint author), Kobe Univ, Grad Sch Med, Div Gastrointestinal Surg,Dept Surg, Chuo Ku, Kusunoki Chou 7-5-2, Kobe, Hyogo 6500017, Japan.	otoway@med.kobe-u.ac.jp					Abrahamson J, 1997, MAINGOTS ABDOMINAL O, P479; Deeba S, 2011, J MINIM ACCESS SURG, V7, P201, DOI 10.4103/0972-9941.85642; Kammori M, 2004, AM J SURG, V187, P549, DOI 10.1016/j.amjsurg.2003.12.041; BJORK KJ, 1988, SURG GYNECOL OBSTET, V167, P217; Nasir BS, 2012, HERNIA, V16, P315, DOI 10.1007/s10029-011-0895-9; Yokoyama Y, 1999, WORLD J SURG, V23, P214; SINHA SN, 1983, AUST NZ J SURG, V53, P349, DOI 10.1111/j.1445-2197.1983.tb02461.x; Mahon D, 2003, SURG ENDOSC, V17, P1386, DOI 10.1007/s00464-002-9223-x; Yokoyama T, 2011, WORLD J SURG, V35, P2323, DOI 10.1007/s00268-011-1211-7; Neumayer L, 2004, NEW ENGL J MED, V350, P1819, DOI 10.1056/NEJMoa040093; Legnani GL, 2008, HERNIA, V12, P185, DOI 10.1007/s10029-007-0305-5; Ijiri R, 1996, SURGERY, V119, P137, DOI 10.1016/S0039-6060(96)80160-7; Hunt L, 2009, HERNIA, V13, P313, DOI 10.1007/s10029-008-0438-1; Kim JJ, 2005, SURG LAPARO ENDO PER, V15, P106, DOI 10.1097/01.sle.0000160296.08783.68; Mesci A, 2012, SURG TODAY, V42, P157, DOI 10.1007/s00595-011-0017-4; Rodriguez-Hermosa JI, 2008, HERNIA, V12, P289, DOI 10.1007/s10029-007-0328-y; Skandalakis JE, 1989, HERNIA SURG ANATOMY, P174	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2187	2190		10.1007/s00595-013-0694-2		4	Surgery	Surgery	AR6WT	WOS:000343722300028		
J	Ida, S; Watanabe, M; Yamao, T; Ishimoto, T; Nagai, Y; Iwatsuki, M; Baba, Y; Iwagami, S; Sakamoto, Y; Miyamoto, Y; Baba, H				Ida, Satoshi; Watanabe, Masayuki; Yamao, Takanobu; Ishimoto, Takatsugu; Nagai, Yohei; Iwatsuki, Masaaki; Baba, Yoshifumi; Iwagami, Shirou; Sakamoto, Yasuo; Miyamoto, Yuji; Baba, Hideo			False-positive F-18-fluorodeoxyglucose positron emission tomography (FDG-PET) findings of bone metastasis from esophagogastric cancer: report of two cases	SURGERY TODAY			English	Article						Gastrointestinal cancer; Bone metastasis; FDG-PET	ESOPHAGEAL-CARCINOMA; GASTRIC-CANCER; BREAST-CANCER; SCINTIGRAPHY	We report two cases of F-18-fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET-CT) fusion imaging showing false-positive findings of bone metastases from esophagogastric cancer. Although multiple bone metastases from esophagogastric cancer were suggested by several images, ultimately, degeneration of the bone marrow was diagnosed histologically. We discuss the value of imaging modalities and the importance of a comprehensive diagnosis based on a combination of physical examination, laboratory test results, and imaging studies.	[Ida, Satoshi; Watanabe, Masayuki; Yamao, Takanobu; Ishimoto, Takatsugu; Nagai, Yohei; Iwatsuki, Masaaki; Baba, Yoshifumi; Iwagami, Shirou; Sakamoto, Yasuo; Miyamoto, Yuji; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto 8608556, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp					Ahn Jae Bong, 2011, J Gastric Cancer, V11, P38, DOI 10.5230/jgc.2011.11.1.38; Fischer B, 2009, NEW ENGL J MED, V361, P32, DOI 10.1056/NEJMoa0900043; Kato H, 2005, ANTICANCER RES, V25, P4439; QUINT LE, 1995, CANCER, V76, P1120, DOI 10.1002/1097-0142(19951001)76:7<1120::AID-CNCR2820760704>3.0.CO;2-W; Kato H, 2005, CANCER, V103, P148, DOI 10.1002/cncr.20724; Ohta M, 2001, NUCL MED COMMUN, V22, P875, DOI 10.1097/00006231-200108000-00005; Yang HL, 2011, EUR RADIOL, V21, P2604, DOI 10.1007/s00330-011-2221-4; Cook GJ, 1998, J CLIN ONCOL, V16, P3375; Yoshioka T, 2003, J NUCL MED, V44, P690; Rosen RS, 2006, J NUCL MED, V47, P1274; Bar-Shalom R, 2000, SEMIN NUCL MED, V30, P150, DOI 10.1053/snuc.2000.7439; VOGLER JB, 1988, RADIOLOGY, V168, P679; Yeh SDJ, 1996, NUCL MED BIOL, V23, P693, DOI 10.1016/0969-8051(96)00044-3; Chen WT, 2001, RADIOLOGY, V220, P213; Hironaka S-I, 2000, GASTRIC CANCER, V3, P19, DOI 10.1007/PL00011684; MEYER M, 1994, CLIN NUCL MED, V19, P13, DOI 10.1097/00003072-199401000-00004; Nakajima Y, 2012, SURG TODAY, V42, P376, DOI 10.1007/s00595-011-0009-4; Nakamoto Y, 2003, CLIN NUCL MED, V28, P302, DOI 10.1097/01.RLU.0000057556.54046.7A; YOSHIKAWA K, 1983, JPN J SURG, V13, P173, DOI 10.1007/BF02469472	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2191	2194		10.1007/s00595-014-0947-8		4	Surgery	Surgery	AR6WT	WOS:000343722300029		
J	Hibi, Y; Ohye, T; Ogawa, K; Shimizu, Y; Shibata, M; Kagawa, C; Mizuno, Y; Uchino, S; Kosugi, S; Kurahashi, H; Iwase, K				Hibi, Yatsuka; Ohye, Tamae; Ogawa, Kimio; Shimizu, Yoshimi; Shibata, Masahiro; Kagawa, Chikara; Mizuno, Yutaka; Uchino, Shinya; Kosugi, Shinji; Kurahashi, Hiroki; Iwase, Katsumi			Pheochromocytoma as the first manifestation of MEN2A with RET mutation S891A: report of a case	SURGERY TODAY			English	Article						MEN2A; RET; Pheochromocytoma	MEDULLARY-THYROID CARCINOMA; NEOPLASIA TYPE 2A; GERMLINE MUTATIONS; CODON 634; PROTOONCOGENE; GENOTYPE; DOMAIN; TYPE-2; GENE; PENETRANCE	We report a rare case with pheochromocytoma as the first manifestation of multiple endocrine neoplasia type 2A with RET mutation S891A. Bilateral pheochromocytomas were identified in a 54-year-old woman. Screening for RET revealed a rare S891A mutation located in the intracellular tyrosine kinase domain. This mutation was previously recognized as one of the mutations only in cases manifesting solely medullary thyroid carcinomas (MTCs). Since calcitonin stimulation test indicated positive result, total thyroidectomy was performed 1 year after the bilateral adrenalectomy, and C-cell hyperplasia was diagnosed by histopathological examination. Our report suggests that cases with S891A mutation, akin to those with other RET mutations, require screening for pheochromocytoma. In addition, it is indicated that calcitonin stimulation test should be performed even in the unaffected elder cases with S891A mutation although the mutation is classified as lowest risk group on MTC in guidelines.	[Hibi, Yatsuka; Ogawa, Kimio; Shimizu, Yoshimi; Shibata, Masahiro; Kagawa, Chikara; Mizuno, Yutaka; Iwase, Katsumi] Fujita Hlth Univ, Sch Med, Dept Endocrine Surg, Toyoake, Aichi 4701192, Japan; [Ohye, Tamae; Kurahashi, Hiroki] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Mol Genet, Toyoake, Aichi 4701192, Japan; [Uchino, Shinya] Noguchi Thyroid Clin & Hosp Fdn, Dept Surg, Beppu, Oita 8740932, Japan; [Uchino, Shinya; Kosugi, Shinji] MEN Consortium Japan, Kyoto, Japan; [Kosugi, Shinji] Kyoto Univ, Grad Sch Publ Hlth, Dept Med Eth & Med Genet, Kyoto 6068501, Japan	Hibi, Y (reprint author), Fujita Hlth Univ, Sch Med, Dept Endocrine Surg, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	hibichan@fujita-hu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labour and Welfare of Japan	The authors wish to deeply thank Dr. Noguchi for his helpful input with discussion. These studies were supported by a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and that from the Ministry of Health, Labour and Welfare of Japan.	Imai T, 2013, EUR J ENDOCRINOL, V168, P683, DOI 10.1530/EJE-12-1106; Yip L, 2003, ARCH SURG-CHICAGO, V138, P409, DOI 10.1001/archsurg.138.4.409; Machens A, 2005, J CLIN ENDOCR METAB, V90, P3999, DOI 10.1210/jc.2005-0064; Schulte KM, 2010, J CLIN ENDOCR METAB, V95, pE92, DOI 10.1210/jc.2010-0375; DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851; Jimenez C, 2004, J CLIN ENDOCR METAB, V89, P4142, DOI 10.1210/jc.2004-0041; Machens A, 2007, WORLD J SURG, V31, P957, DOI 10.1007/s00268-006-0769-y; Asari R, 2006, ARCH SURG-CHICAGO, V141, P1199, DOI 10.1001/archsurg.141.12.1199; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; Kloos RT, 2009, THYROID, V19, P565, DOI 10.1089/thy.2008.0403; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Schuffenecker I, 1998, J CLIN ENDOCR METAB, V83, P487, DOI 10.1210/jc.83.2.487; Brandi ML, 2001, J CLIN ENDOCR METAB, V86, P5658, DOI 10.1210/jc.86.12.5658; Frank-Raue K, 2006, EUR J ENDOCRINOL, V155, P229, DOI 10.1530/eje.1.02216; Elisei R, 2007, J CLIN ENDOCR METAB, V92, P4725, DOI 10.1210/jc.2007-1005; Cranston A, 2006, MOL ENDOCRINOL, V20, P1633, DOI 10.1210/me.2004-0147; Dang GT, 1999, MOL CELL PROBE, V13, P77, DOI 10.1006/mcpr.1998.0220; Hofstra RMW, 1997, J CLIN ENDOCR METAB, V82, P4176, DOI 10.1210/jc.82.12.4176; Iwashita T, 1999, ONCOGENE, V18, P3919, DOI 10.1038/sj.onc.1202742; Machens A, 2008, CLIN ENDOCRINOL, V69, P81, DOI 10.1111/j.1365-2265.2007.03153.x; Paszko Z, 2007, CANCER INVEST, V25, P742, DOI 10.1080/07357900701518735; Plaza Menacho Ivan, 2005, Cancer Res, V65, P1729, DOI 10.1158/0008-5472.CAN-04-2363; Wohllk N, 2001, REV MED CHILE, V129, P713	23	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2195	2200		10.1007/s00595-013-0826-8		6	Surgery	Surgery	AR6WT	WOS:000343722300030		
J	Hori, T; Yagi, S; Okamua, Y; Iida, T; Ogawa, K; Tanaka, H; Kageyama, S; Hirao, H; Hata, T; Kirino, I; Nagai, K; Kubora, T; Jobara, K; Endo, K; Uemoto, S				Hori, Tomohide; Yagi, Shintaro; Okamua, Yusuke; Iida, Taku; Ogawa, Kohei; Tanaka, Hirokazu; Kageyama, Shoichi; Hirao, Hirofumi; Hata, Toshiyuki; Kirino, Izumi; Nagai, Kazuyuki; Kubora, Toyonari; Jobara, Kanta; Endo, Kosuke; Uemoto, Shinji			How to successfully resect 70 % of the liver in pigs to model an extended hepatectomy with an insufficient remnant or liver transplantation with a small-for-size graft	SURGERY TODAY			English	Article						Liver resection; Pig; Animal model	PORCINE MODEL	An insufficient remnant in extended hepatectomy and small-for-size graft in liver transplantation are critical matters in the field of liver surgery, and reliable and reproducible animal models that can provide clinically relevant and reliable data are needed. We herein describe our detailed surgical procedures for performing 70 % hepatectomy in pigs, and discuss the critical anatomical features, key techniques and pitfalls based on our experience. The porcine liver is divided into four lobes. The right lateral lobe (RLL) accounts for 30 % of the liver volume. Important points, such as selective temporal clamping of the arterial branch, confirmation of a related demarcation line, a two-step process to skeletonize Glisson's capsules during liver resection and selective ligation of the portal venous branch to the right medial lobe without inducing any subtle injuries to Glisson's capsules from the RLL to common bile duct, are discussed.	[Hori, Tomohide; Yagi, Shintaro; Okamua, Yusuke; Iida, Taku; Ogawa, Kohei; Tanaka, Hirokazu; Kageyama, Shoichi; Hirao, Hirofumi; Hata, Toshiyuki; Kirino, Izumi; Nagai, Kazuyuki; Kubora, Toyonari; Jobara, Kanta; Endo, Kosuke; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Div Hepatobiliary Pancreat & Transplant Surg,Dept, Sakyo Ku, Kyoto 6068507, Japan	Hori, T (reprint author), Kyoto Univ, Grad Sch Med, Div Hepatobiliary Pancreat & Transplant Surg,Dept, Sakyo Ku, 54 Shogoinkawara Cho, Kyoto 6068507, Japan.	horit@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science, Tokyo, Japan [MEXT/JSPS 24591877]; Uehara Memorial Foundation, Tokyo, Japan [200940051]	We are grateful to Kentaro Taniguchi, Chiduru Yamamoto, Reo Sakakura and Kenji Nakamura (First Department of Surgery, Mie University Graduate School of Medicine, Tsu, Japan) for their support in establishing this model. This work was partially supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, Tokyo, Japan (MEXT/JSPS 24591877 to S. Yagi) and by a grant from the Uehara Memorial Foundation, Tokyo, Japan (No. 200940051 to T. Hori).	Yamamoto Y, 1999, WORLD J SURG, V23, P1032; Itoh S, 2012, SURG TODAY, V42, P1176, DOI 10.1007/s00595-012-0306-6; Arkadopoulos N, 2011, J SURG RES, V170, pE233, DOI 10.1016/j.jss.2011.06.006; Goralczyk AD, 2011, J HEPATO-BIL-PAN SCI, V18, P436, DOI 10.1007/s00534-010-0347-4; Hanaoka J, 2013, SURG TODAY, V43, P300, DOI 10.1007/s00595-012-0248-z; Hori T, 2012, ANN GASTROENTEROL, V25, P147; Hori T, 2013, SURG TODAY, V43, P1079, DOI 10.1007/s00595-013-0601-x; Iida T, 2007, J SURG RES, V143, P238, DOI 10.1016/j.jss.2006.11.020; Ishizaki Y, 2008, AM J SURG, V196, P353, DOI 10.1016/j.amjsurg.2007.09.046; Tanaka K, 2003, LIVING DONOR LIVER T, P67; Tanaka K, 2003, LIVING DONOR LIVER T, P33; Tucker ON, 2005, CURR OPIN CRIT CARE, V11, P150, DOI 10.1097/01.ccx.0000157080.11117.45; Xia Q, 2008, HEPATOB PANCREAT DIS, V7, P601; Zhang SC, 2012, HEPATO-GASTROENTEROL, V59, P2602, DOI 10.5754/hge11872	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	NOV	2014	44	11					2201	2207		10.1007/s00595-014-0862-z		7	Surgery	Surgery	AR6WT	WOS:000343722300031		
J	Okada, A; Kodaira, A; Hanyu, S; Izume, S; Ohya, K; Fukushi, H				Okada, Ayaka; Kodaira, Akari; Hanyu, Sachiko; Izume, Satoko; Ohya, Kenji; Fukushi, Hideto			Intracellular localization of Equine herpesvirus type 1 tegument protein VP22	VIRUS RESEARCH			English	Article						Equine herpesvirus 1; Tegument; VP22; Localization	SIMPLEX-VIRUS; BOVINE HERPESVIRUS-1; NUCLEAR-LOCALIZATION; UL49 HOMOLOG; GENE; INFECTION; MUTANTS; ABSENCE; GROWTH; CELLS	Intracellular localization of Equine herpesvirus type 1 (EHV-1) tegument protein VP22 was examined by using a plasmid that expressed VP22 fused with an enhanced green fluorescent protein (EGFP). Also a recombinant EHV-1 expressing VP22 fused with a red fluorescent protein (mCherry) was constructed to observe the localization of VP22 in infected cells. When EGFP-fused VP22 was overexpressed in the cells, VP22 localized in the cytoplasm and nucleus. Live cell imaging suggested that the fluorescently tagged VP22 also localized in the cytoplasm and nucleus. These results show that VP22 localizes in the cytoplasm and nucleus independently of other viral proteins. Experiments with truncation mutants of pEGFP-VP22 suggested that 154-188 aa might be the nuclear localization signal of EHV-1 VP22. (C) 2014 Elsevier B.V. All rights reserved.	[Okada, Ayaka; Kodaira, Akari; Hanyu, Sachiko; Izume, Satoko; Ohya, Kenji; Fukushi, Hideto] Gifu Univ, United Grad Sch Vet Sci, Dept Appl Vet Sci, Gifu 5011193, Japan; [Ohya, Kenji; Fukushi, Hideto] Gifu Univ, Fac Appl Biol Sci, Lab Vet Microbiol, Gifu 5011193, Japan	Fukushi, H (reprint author), Gifu Univ, Fac Appl Biol Sci, Lab Vet Microbiol, 1-1 Yanagido, Gifu 5011193, Japan.	hfukushi@gifu-u.ac.jp			JSPS KAKENHI Grant [24380165]	We thank Dr. Ken Maeda for kindly providing FHK Tcl3 cells. We also thank Kiyotada Naitou for technical support for making antibody. This work was supported JSPS KAKENHI Grant Number 24380165.	Aints A, 2001, GENE THER, V8, P1051, DOI 10.1038/sj.gt.3301493; Dorange F, 2002, J VIROL, V76, P1959, DOI 10.1128/JVI.76.4.1959-1970.2002; Maringer K, 2012, J VIROL, V86, P12971, DOI 10.1128/JVI.01913-12; BARNETT BC, 1992, J GEN VIROL, V73, P2167, DOI 10.1099/0022-1317-73-8-2167; Duffy C, 2006, J VIROL, V80, P8664, DOI 10.1128/JVI.00498-06; LIANG XP, 1995, J VIROL, V69, P3863; HEINE JW, 1974, J VIROL, V14, P640; Che XB, 2008, J VIROL, V82, P5825, DOI 10.1128/JVI.00303-08; Mettenleiter TC, 2002, J VIROL, V76, P1537, DOI 10.1128/JVI.76.4.1537-1547.2002; Lunn DP, 2009, J VET INTERN MED, V23, P450, DOI 10.1111/j.1939-1676.2009.0304.x; Roizman B, 1996, P NATL ACAD SCI USA, V93, P11307, DOI 10.1073/pnas.93.21.11307; Liang XP, 1997, VACCINE, V15, P1057, DOI 10.1016/S0264-410X(97)00008-X; Kasem S, 2010, VIROLOGY, V400, P259, DOI 10.1016/j.virol.2010.02.012; Harms JS, 2000, J VIROL, V74, P3301, DOI 10.1128/JVI.74.7.3301-3312.2000; Pomeranz LE, 2000, J VIROL, V74, P10041, DOI 10.1128/JVI.74.21.10041-10054.2000; Pomeranz LE, 1999, J VIROL, V73, P6769; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kelly BJ, 2009, VIRUS RES, V145, P173, DOI 10.1016/j.virusres.2009.07.007; Sugimoto K, 2008, J VIROL, V82, P5198, DOI 10.1128/JVI.02681-07; ELLIOTT GD, 1992, J GEN VIROL, V73, P723, DOI 10.1099/0022-1317-73-3-723; Blouin A, 2001, VIRUS RES, V81, P57, DOI 10.1016/S0168-1702(01)00355-0; Elliott G, 1996, VIROLOGY, V226, P140, DOI 10.1006/viro.1996.0638; Lobanov VA, 2010, VIROLOGY, V396, P189, DOI 10.1016/j.virol.2009.10.022; Maeda K, 2007, J VET MED SCI, V69, P989, DOI 10.1292/jvms.69.989; Ren XD, 2001, J VIROL, V75, P8251, DOI 10.1128/JVI.75.17.8251-8258.2001; Zheng C, 2005, J VIROL, V79, P11864, DOI 10.1128/JVI.79.18.11864-11872.2005; Zhu Jun, 2005, J Biol Chem, V280, P16038, DOI 10.1074/jbc.M500054200	27	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-1702	1872-7492		VIRUS RES	Virus Res.	NOV	2014	192						103	113		10.1016/j.virusres.2014.08.006		11	Virology	Virology	AR5LN	WOS:000343626300012		
J	Yoshino, K; Suzuki, M; Kawarai, Y; Sakuma, Y; Inoue, G; Orita, S; Yamauchi, K; Aoki, Y; Ishikawa, T; Miyagi, M; Kamoda, H; Kubota, G; Oikawa, Y; Inage, K; Sainoh, T; Sato, J; Nakamura, J; Toyone, T; Takahashi, K; Ohtori, S				Yoshino, Kensuke; Suzuki, Miyako; Kawarai, Yuya; Sakuma, Yoshihiro; Inoue, Gen; Orita, Sumihisa; Yamauchi, Kazuyo; Aoki, Yasuchika; Ishikawa, Tetsuhiro; Miyagi, Masayuki; Kamoda, Hiroto; Kubota, Gou; Oikawa, Yasuhiro; Inage, Kazuhide; Sainoh, Takeshi; Sato, Jun; Nakamura, Junichi; Toyone, Tomoaki; Takahashi, Kazuhisa; Ohtori, Seiji			Increase of TRPV1-Immunoreactivity in Dorsal Root Ganglia Neurons Innervating the Femur in a Rat Model of Osteoporosis	YONSEI MEDICAL JOURNAL			English	Article						Osteoporosis; pain; transient receptor potential vanilloid 1; femur	SKELETAL PAIN; SYMPATHETIC INNERVATION; CANCER PAIN; BONE; EXPRESSION; DISEASE; BISPHOSPHONATES; DENSITY; TRPV1	Purpose: Transient receptor potential vanilloid 1 (TRPV1) is a ligand-gated nonselective cation channel, which can be activated by capsaicin and other noxious stimuli. Recently, an association between bone pain and TRPV1 has been reported. However, the influence of osteoporosis on TRPV1 in the sensory system innervating the femur has not been reported. Materials and Methods: TRPV1-immunoreactive (ir) in dorsal root ganglia (DRG) neurons labeled with neurotracer [FluoroGold (FG)] innervating the femurs of Sprague Dawley rats were examined in control, sham, and ovariectomized (OVX) rats. We evaluated osteoporosis in the femurs and compared the proportion of TRPV1-ir DRG neurons innervating femur between the 3 groups of rats. Results: OVX rats showed osteoporotic cancellous bone in the femur. FG labeled neurons were distributed from Li to L6 DRG, but there was no significant difference in the proportion of labeled neurons between the 3 groups (p>0.05). The proportions of FG labeled TRPV1-ir DRG neurons were 1.7%, 1.7%, and 2.8% of DRG neurons innervating the femur, in control, sham-operated, and OVX rats, respectively. The proportion of TRPV1-ir neurons in DRG innervating the femur in OVX rats was significantly higher than that in control and sham-operated rats (p<0.05). Conclusion: Under physiological conditions, DRG neurons innervating femurs in rats contain TRPV1. Osteoporosis increases the numbers of TRPV1-ir neurons in DRG innervating osteoporotic femurs in rats. These findings suggest that TRPV1 may have a role in sensory perception of osteoporotic femurs.	[Yoshino, Kensuke; Suzuki, Miyako; Kawarai, Yuya; Sakuma, Yoshihiro; Inoue, Gen; Orita, Sumihisa; Yamauchi, Kazuyo; Aoki, Yasuchika; Ishikawa, Tetsuhiro; Miyagi, Masayuki; Kamoda, Hiroto; Kubota, Gou; Oikawa, Yasuhiro; Inage, Kazuhide; Sainoh, Takeshi; Sato, Jun; Nakamura, Junichi; Toyone, Tomoaki; Takahashi, Kazuhisa; Ohtori, Seiji] Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chiba 2608670, Japan	Ohtori, S (reprint author), Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	sohtori@faculty.chiba-u.jp					Mantyh WG, 2010, NEUROSCIENCE, V171, P588, DOI 10.1016/j.neuroscience.2010.08.056; Luo D, 2008, REGUL PEPTIDES, V150, P66, DOI 10.1016/j.regpep.2008.05.007; Ohtori S, 2010, J CLIN NEUROSCI, V17, P209, DOI 10.1016/j.jocn.2009.06.013; Liu JG, 2012, REPROD SCI, V19, P1110, DOI 10.1177/1933719112443876; Ralston SH, 2012, CALCIFIED TISSUE INT, V91, P97, DOI 10.1007/s00223-012-9599-0; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Fulfaro F, 1998, PAIN, V78, P157, DOI 10.1016/S0304-3959(98)00135-3; Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x; Brown MF, 1997, J BONE JOINT SURG BR, V79B, P147, DOI 10.1302/0301-620X.79B1.6814; Niiyama Y, 2007, NEUROSCIENCE, V148, P560, DOI 10.1016/j.neuroscience.2007.05.049; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; Bonabello A, 2001, PAIN, V91, P269, DOI 10.1016/S0304-3959(00)00447-4; Constantin CE, 2008, J NEUROSCI, V28, P5072, DOI 10.1523/JNEUROSCI.4476-07.2008; Freeman KT, 2008, ANESTHESIOLOGY, V108, P473, DOI 10.1097/ALN.0b013e3181649351; Iwamoto Jun, 2003, J Orthop Sci, V8, P532, DOI 10.1007/s00776-003-0655-5; Jimenez-Andrade JM, 2012, NEUROBIOL AGING, V33, P921, DOI 10.1016/j.neurobiolaging.2010.08.008; Kochukov MY, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-49; Niiyama Y, 2009, BRIT J ANAESTH, V102, P251, DOI 10.1093/bja/aen347; Orita S, 2010, SPINE, V35, P1974, DOI 10.1097/BRS.0b013e3181d5959e; Suzuki M, 2013, SPINE, V38, P2085, DOI 10.1097/BRS.0000000000000001; Van Offel JF, 2001, CLIN EXP RHEUMATOL, V19, P13; Varenna M, 2000, J RHEUMATOL, V27, P1477; Yang CJ, 2011, NEUROSCI LETT, V490, P175, DOI 10.1016/j.neulet.2010.12.027; Yu L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-61	24	0	0	YONSEI UNIV COLL MEDICINE	SEOUL	50-1 YONSEI-RO, SEODAEMUN-GU, SEOUL 120-752, SOUTH KOREA	0513-5796	1976-2437		YONSEI MED J	Yonsei Med. J.	NOV 1	2014	55	6					1600	1605		10.3349/ymj.2014.55.6.1600		6	Medicine, General & Internal	General & Internal Medicine	AR7UL	WOS:000343785100018		
J	Matsuoka, S; Yamashiro, T; Matsushita, S; Kotoku, A; Fujikawa, A; Yagihashi, K; Tomita, H; Sakamoto, S; Saito, Y; Saruya, S; Nakajima, Y				Matsuoka, Shin; Yamashiro, Tsuneo; Matsushita, Shoichiro; Kotoku, Akiyuki; Fujikawa, Atsuko; Yagihashi, Kunihiro; Tomita, Hayato; Sakamoto, Shingo; Saito, Yuki; Saruya, Shinji; Nakajima, Yasuo			Usefulness of Coronall Reconstruction CT Images for Quantitative Evaluation of the Cross-Sectional Area of Small Pulmonary Vessels	ACADEMIC RADIOLOGY			English	Article						Pulmonary vessels; pulmonary perfusion; quantitative; reconstruction; computed tomography	SEVERE EMPHYSEMA; HELICAL CT; PERFUSION; DISEASE; HYPERTENSION	Rationale and Objectives: Cross-sectional area <5 mm(2) (CSA<5) is a computed tomography (CT) metric that has been used for the evaluation of pulmonary vessel alterations and perfusion. CSA<5 is calculated from three axial slices; thus, whether CSA<5 represents the small pulmonary vessel alterations in the whole lung remains unclear. The purpose of this study was to compare the measurements of CSA<5 using three axial slices and coronal reconstructed slices in the relationship between the measured CSA<5 and pulmonary perfusion measured using lung perfusion scintigraphy. Materials and Methods: This study comprised 28 subjects who underwent both noncontrast CT and lung perfusion scintigraphy. The present study measured CSA<5 using both three axial CT images and coronal reconstruction images and then obtained the percentage of the CSA in right lung to that in whole lung (R/W-CSA<5). Using anteroposterior and posteroanterior projections on technetium-99m macroaggregated albumin (MAA) lung perfusion scintigraphy, we obtained right and total lung counts and calculated the percentage of the right to whole lung counts (R/W-MAA). The correlations of the R/W-CSA<5 calculated using three axial slices (R/W-CSA(Ax)<5) and coronal reconstructed slices (R/W-CSA(COR)<5) with R/W-MAA were evaluated using Spearman rank correlation analysis. Results: Both R/W-CSA(Ax)<5 and R/W-CSA(COR)<5 were significantly correlated with R/W-MAA; however, the correlation coefficient with R/W-CSA(COR)<5 (rho = 0.842, P < .0001) was greater than that with R/W-CSA(Ax)<5 (rho = 0.631, P = .0004). Conclusions: Coronal reconstruction images appear suitable for quantitative measurement of CSA of small pulmonary vessels.	[Yamashiro, Tsuneo; Kotoku, Akiyuki; Fujikawa, Atsuko; Yagihashi, Kunihiro; Tomita, Hayato; Sakamoto, Shingo; Saito, Yuki; Saruya, Shinji; Nakajima, Yasuo] St Marianna Univ, Sch Med, Dept Radiol, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan; [Yamashiro, Tsuneo] Univ Ryukyus, Grad Sch Med Sci, Dept Radiol, Nishihara, Ryukyu 9030213, Japan	Matsuoka, S (reprint author), St Marianna Univ, Sch Med, Dept Radiol, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	shin4114@mac.com					Kubo K, 2000, RESP PHYSIOL, V120, P71, DOI 10.1016/S0034-5687(00)00090-6; Estepar RSJ, 2013, AM J RESP CRIT CARE, V188, P231, DOI 10.1164/rccm.201301-0162OC; BARBERA JA, 1994, AM J RESP CRIT CARE, V149, P423; Ando K, 2012, EUR J RADIOL, V81, P3925, DOI 10.1016/j.ejrad.2012.05.033; Park KJ, 1999, RADIOLOGY, V211, P541; Matsuoka S, 2010, AM J RESP CRIT CARE, V181, P218, DOI 10.1164/rccm.200908-1189OC; Ando K, 2013, LUNG, V191, P585, DOI 10.1007/s00408-013-9513-1; BOYSEN PG, 1977, CHEST, V72, P422, DOI 10.1378/chest.72.4.422; Coffin V, 2005, EUR RESPIR J, V26; DEMEESTE.TR, 1974, ANN THORAC SURG, V18, P61; Fleischmann D, 2000, RADIOLOGY, V216, P185; HALE KA, 1980, AM REV RESPIR DIS, V122, P273; Kauczor HU, 1998, AM J ROENTGENOL, V171, P1091; Matsuoka S, 2011, ACAD RADIOL, V18, P40, DOI 10.1016/j.acra.2010.08.013; Matsuoka S, 2010, ACAD RADIOL, V17, P93, DOI 10.1016/j.acra.2009.07.022; Matsuoka S, 2014, AM J ROENTGENOL, V202, P719, DOI 10.2214/AJR.13.11027; Matsuura Y, 2013, EUR J RADIOL, V82, P1804, DOI 10.1016/j.ejrad.2013.05.022; Uejima I, 2011, JPN J RADIOL, V29, P251, DOI 10.1007/s11604-010-0551-9	18	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1076-6332	1878-4046		ACAD RADIOL	Acad. Radiol.	NOV	2014	21	11					1411	1415		10.1016/j.acra.2014.05.024		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AR1MW	WOS:000343350300008		
J	Imai, K; Beppu, T; Yamao, T; Okabe, H; Hayashi, H; Nitta, H; Hashimoto, D; Mima, K; Nakagawa, S; Sakamoto, K; Chikamoto, A; Ishiko, T; Baba, H				Imai, Katsunori; Beppu, Toru; Yamao, Takanobu; Okabe, Hirohisa; Hayashi, Hiromitsu; Nitta, Hidetoshi; Hashimoto, Daisuke; Mima, Kosuke; Nakagawa, Shigeki; Sakamoto, Keita; Chikamoto, Akira; Ishiko, Takatoshi; Baba, Hideo			Clinicopathological and Prognostic Significance of Preoperative Serum Zinc Status in Patients with Hepatocellular Carcinoma After Initial Hepatectomy	ANNALS OF SURGICAL ONCOLOGY			English	Article							CHRONIC HEPATITIS-C; LIVER-DISEASE; SUPPLEMENTATION IMPROVES; INTERFERON THERAPY; CANCER; CLASSIFICATION; ABLATION; CRITERIA; PROTEIN; IRON	The purpose of this study was to determine the relationship between serum zinc (Zn) level and clinicopathological profiles in patients with hepatocellular carcinoma (HCC). Furthermore, we investigate the influence of serum Zn level on the long-term prognosis after hepatectomy. A retrospective analysis was conducted of 310 patients who underwent initial hepatectomy for HCC. The correlation between serum Zn level and preoperative liver functional indicator, pathological features, including the degree of hepatic fibrosis, and perioperative outcome were evaluated. The patients were divided into two groups (serum Zn a parts per thousand currency sign 65 mg/dL; n = 71 and Zn > 65 mg/dL; n = 239), and their long-term prognosis were compared. There were strong correlations between preoperative serum Zn level and serum albumin (r = 0.47, P < 0.0001), branched-chain amino acids (r = 0.28, P < 0.0001), and hyaluronic acid level (r = -0.33, P < 0.0001). The patients with low Zn group were characterized as hepatitis C virus (HCV) infection, impaired liver function, background hepatic fibrosis, and pathological vascular invasion. The disease-free and overall survivals in the low Zn group were significantly lower than those in the high Zn group, especially in subgroup with HCV-related liver disease (P = 0.041 and 0.0004, respectively). Multivariate analyses showed that serum Zn level was an independent prognostic factor for overall survival (hazard ratio 1.79, P = 0.038). Serum Zn level reflects liver function and is useful for predicting the hepatic fibrosis before surgery. The prognosis of patients with HCC was found to be associated with preoperative serum Zn level, especially in patients with HCV-related chronic liver disease.	[Imai, Katsunori; Beppu, Toru; Yamao, Takanobu; Okabe, Hirohisa; Hayashi, Hiromitsu; Nitta, Hidetoshi; Hashimoto, Daisuke; Mima, Kosuke; Nakagawa, Shigeki; Sakamoto, Keita; Chikamoto, Akira; Ishiko, Takatoshi; Baba, Hideo] Kumamoto Univ, Grad Sch Life Sci, Dept Surg Gastroenterol, Kumamoto, Japan; [Beppu, Toru] Kumamoto Univ Hosp, Dept Multidisciplinary Treatment Gastroenterol Ca, Kumamoto, Japan	Imai, K (reprint author), Kumamoto Univ, Grad Sch Life Sci, Dept Surg Gastroenterol, Kumamoto, Japan.	hdobaba@kumamoto-u.ac.jp					Grattan BJ, 2012, NUTRIENTS, V4, P648, DOI 10.3390/nu4070648; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Wu TJ, 2004, ANN EPIDEMIOL, V14, P195, DOI 10.1016/S1047-2797(03)00119-4; Stamoulis I, 2007, DIGEST DIS SCI, V52, P1595, DOI 10.1007/s10620-006-9462-0; Takahashi M, 2007, HEPATOL RES, V37, P405, DOI 10.1111/j.1872-034X.2007.00065.x; Qiao L, 2013, CANCER CAUSE CONTROL, V24, P1175, DOI 10.1007/s10552-013-0197-x; Beppu T, 2012, HEPATO-GASTROENTEROL, V59, P542, DOI 10.5754/hge09737; Balzan S, 2005, ANN SURG, V242, P824, DOI 10.1097/01.sla.0000189131.90876.9e; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Takagi H, 2001, J VIRAL HEPATITIS, V8, P367, DOI 10.1046/j.1365-2893.2001.00311.x; Matsuoka S, 2009, J CLIN BIOCHEM NUTR, V45, P292, DOI [10.3164/jcbn.08-246, 10.3164/jcbn.jcbn08-246]; Himoto T, 2010, EXP THER MED, V1, P707, DOI 10.3892/etm_00000109; Yuasa K, 2006, LIVER INT, V26, P1111, DOI 10.1111/j.1478-3231.2006.013252.x; Balzan S, 2005, ANN SURG, V242, P828, DOI DOI 10.1097/01.SLA.0000189131.90876.9E; BODE JC, 1988, HEPATOLOGY, V8, P1605, DOI 10.1002/hep.1840080622; Brown K.H., 2004, FOOD NUTR BULL, V25, pS99; Coon JT, 2004, J HEPATOL, V40, P491, DOI 10.1016/j.jhep.2003.11.014; Epstein MM, 2011, AM J CLIN NUTR, V93, P586, DOI 10.3945/ajcn.110.004804; Feng P, 2002, PROSTATE, V52, P311, DOI 10.1002/pros.10128; Goyal M M, 2006, Indian J Clin Biochem, V21, P208, DOI 10.1007/BF02913100; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; Imai K, 2009, J SURG ONCOL, V100, P121, DOI 10.1002/jso.21302; Imai K, 2013, HEPATOL RES, V43, P853, DOI 10.1111/hepr.12035; Ishikawa T, 2012, WORLD J GASTROENTERO, V18, P3196, DOI 10.3748/wjg.v18.i25.3196; The Liver Cancer Study Group of Japan, 1994, CANCER, V74, P2772; Matsumura H, 2012, J CLIN BIOCHEM NUTR, V51, P178, DOI 10.3164/jcbn.12-11; Meksawan K, 2014, ANTICANCER RES, V34, P295; Moriyama M, 2006, DIGEST DIS SCI, V51, P1967, DOI 10.1007/s10620-005-9051-7; Powell SR, 2000, J NUTR, V130, p1447S; Tellinghuisen TL, 2006, J VIROL, V80, P7450, DOI 10.1128/JVI.00358-06; VALLEE BL, 1957, NEW ENGL J MED, V257, P1055, DOI 10.1056/NEJM195711282572201	32	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	NOV	2014	21	12					3817	3826		10.1245/s10434-014-3786-3		10	Oncology; Surgery	Oncology; Surgery	AQ8OD	WOS:000343085600023		
J	Yamada, S; Okumura, N; Wei, L; Fuchs, BC; Fujii, T; Sugimoto, H; Nomoto, S; Takeda, S; Tanabe, KK; Kodera, Y				Yamada, Suguru; Okumura, Norio; Wei, Lan; Fuchs, Bryan C.; Fujii, Tsutomu; Sugimoto, Hiroyuki; Nomoto, Shuji; Takeda, Shin; Tanabe, Kenneth K.; Kodera, Yasuhiro			Epithelial to Mesenchymal Transition is Associated with Shorter Disease-Free Survival in Hepatocellular Carcinoma	ANNALS OF SURGICAL ONCOLOGY			English	Article							BREAST-CANCER CELLS; E-CADHERIN; PANCREATIC-CANCER; TUMOR-METASTASIS; TWIST EXPRESSION; GROWTH-FACTOR; LIVER-CANCER; STEM-CELLS; SNAIL; INTERLEUKIN-6	Epithelial to mesenchymal transition (EMT) is involved in cancer cell invasion and metastasis as well as chemoresistance. Elucidation of EMT in hepatocellular carcinoma (HCC) might contribute to deeper understanding of its biology. Overall, 100 patients with HCC, who underwent resection, were analyzed. The messenger RNA (mRNA) expression of the epithelial marker E-cadherin and the mesenchymal marker Vimentin were measured, and the EMT status of each patient was determined as follows: Vimentin/E-cadherin < 2 = Epithelial (E), Vimentin/E-cadherin a parts per thousand yen2 = Mesenchymal (M). The correlation between these values and clinicopathological factors and prognosis were analyzed statistically. Moreover, the expression of transcription factors involved in EMT (Twist-1, Snail, Slug, Zeb-1, and Zeb-2) were measured and the role of interleukin (IL)-6 in inducing EMT and chemoresistance was examined. Patients with a mesenchymal tumor were more prone to have an earlier recurrence than those with an epithelial tumor. EMT-inducing transcription factors were more highly expressed in mesenchymal tumors than in epithelial tumors, and Twist-1 and Zeb-2 were significantly overexpressed. alpha-Fetoprotein (AFP) values were significantly higher in patients with epithelial tumors, and AFP-expressing HCC cell lines were more responsive to sorafenib. IL-6 expression was significantly higher in mesenchymal tumors, and knockdown of IL-6 in mesenchymal HCC cell lines increased E-cadherin expression and sensitivity to sorafenib. Analysis of surgically resected tumors suggests that EMT is involved in early disease recurrence in HCC. Twist-1 and Zeb-2 might be important for inducing EMT, and IL-6 might be a potential therapeutic target for alleviating the chemoresistance of mesenchymal HCC tumors.	[Yamada, Suguru; Okumura, Norio; Fujii, Tsutomu; Sugimoto, Hiroyuki; Nomoto, Shuji; Takeda, Shin; Kodera, Yasuhiro] Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Nagoya, Aichi 4648601, Japan; [Wei, Lan; Fuchs, Bryan C.; Tanabe, Kenneth K.] Massachusetts Gen Hosp, Ctr Canc, Div Surg Oncol, Boston, MA USA; [Wei, Lan; Fuchs, Bryan C.; Tanabe, Kenneth K.] Harvard Univ, Sch Med, Boston, MA USA	Yamada, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Nagoya, Aichi 4648601, Japan.	suguru@med.nagoya-u.ac.jp					Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Studebaker AW, 2008, CANCER RES, V68, P9087, DOI 10.1158/0008-5472.CAN-08-0400; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Giannelli G, 2005, GASTROENTEROLOGY, V129, P1375, DOI 10.1053/j.gastro.2005.09.055; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; ElMoneim HMA, 2011, CLINICS, V66, P1765, DOI 10.1590/S1807-59322011001000015; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Wong VWS, 2009, INT J CANCER, V124, P2766, DOI 10.1002/ijc.24281; Porta C, 2008, ANN ONCOL, V19, P353, DOI 10.1093/annonc/mdm448; Sasser AK, 2007, FASEB J, V21, P3763, DOI 10.1096/fj.07-8832com; Lee TK, 2006, CANCER RES, V66, P9948, DOI 10.1158/0008-5472.CAN-06-1092; Lee TK, 2006, CLIN CANCER RES, V12, P5369, DOI 10.1158/1078-0432.CCR-05-2722; Yau T, 2011, ONCOLOGIST, V16, P1270, DOI 10.1634/theoncologist.2011-0105; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Liu AN, 2012, MOL CELL BIOCHEM, V367, P195, DOI 10.1007/s11010-012-1333-8; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Zhao H, 2012, MOL CANCER THER, V11, P503, DOI 10.1158/1535-7163.MCT-11-0327; Shao YY, 2010, CANCER-AM CANCER SOC, V116, P4590, DOI 10.1002/cncr.25257; Deshmukh M, 2013, HEPATOLOGY, V58, P2207, DOI 10.1002/hep.26407; Kurrey NK, 2005, GYNECOL ONCOL, V97, P155, DOI 10.1016/j.ygyno.2004.12.043; Matsuo N, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-240; Nishioka R, 2010, EXP MOL PATHOL, V89, P149, DOI 10.1016/j.yexmp.2010.05.008; Sasaki K, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-158; Shackel Nicholas A, 2008, Hepatology, V47, P2134, DOI 10.1002/hep.22369; Shen CH, 2011, J BUON, V16, P733; Smith BN, 2012, CELL ADHES MIGR, V6, P433, DOI 10.4161/cam.21687; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822	39	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	NOV	2014	21	12					3882	3890		10.1245/s10434-014-3779-2		9	Oncology; Surgery	Oncology; Surgery	AQ8OD	WOS:000343085600032		
J	Kikuchi, H; Kamiya, K; Hiramatsu, Y; Miyazaki, S; Yamamoto, M; Ohta, M; Baba, S; Konno, H				Kikuchi, Hirotoshi; Kamiya, Kinji; Hiramatsu, Yoshihiro; Miyazaki, Shinichiro; Yamamoto, Masayoshi; Ohta, Manabu; Baba, Satoshi; Konno, Hiroyuki			Laparoscopic Narrow-Band Imaging for the Diagnosis of Peritoneal Metastasis in Gastric Cancer	ANNALS OF SURGICAL ONCOLOGY			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MAGNIFYING ENDOSCOPY; MICROVASCULAR ARCHITECTURE; CONVENTIONAL COLONOSCOPY; PROGNOSTIC-SIGNIFICANCE; DIFFERENTIAL-DIAGNOSIS; CHAIN-REACTION; TUMOR-CELLS; PHASE-I; S-1	Staging laparoscopy (SL) is often used to diagnose peritoneal metastasis in patients with advanced gastric cancer, but accurate detection of metastasis can be difficult. We evaluated the usefulness of laparoscopic narrow-band imaging (NBI) versus conventional laparoscopic white-light imaging (WLI) for the diagnosis of peritoneal metastasis. We excised 37 white nodules from the parietal peritoneum of 26 patients with gastric cancer and suspected peritoneal metastasis. The WLI and NBI findings were compared with the pathological findings. All the peritoneal lesions examined were observed as white nodules on WLI. Intranodular vessels were evaluated by WLI and NBI for (1) vessel dilatation, (2) vessel tortuousness, (3) vessel heterogeneity, and (4) brown spots. Each individual abnormal finding had a diagnostic accuracy of less than 79 % with or without NBI. Detection of any one abnormal finding had a sensitivity, specificity, and accuracy of 47.8, 85.7, and 62.2 %, respectively, on WLI and 91.3, 71.4, and 83.8 %, respectively, on NBI, for detection of peritoneal metastasis. Detection of any one abnormal finding on NBI plus clear demarcation of the nodule on WLI had a sensitivity of 91.3 %, specificity of 92.9 %, and accuracy of 91.9 % for detection of peritoneal metastasis. Pathological examination showed that a brown spot detected on NBI correlated with dilated vessels around cancer cells. Vascular endothelial growth factor was expressed in 76.2 % of peritoneal metastases. NBI was more sensitive for the detection of dilated vessels than WLI. NBI could be a useful tool for the diagnosis of peritoneal metastasis during SL.	[Kikuchi, Hirotoshi; Kamiya, Kinji; Hiramatsu, Yoshihiro; Miyazaki, Shinichiro; Yamamoto, Masayoshi; Konno, Hiroyuki] Hamamatsu Univ Sch Med, Dept Surg 2, Hamamatsu, Shizuoka 4313192, Japan; [Ohta, Manabu] Hamamatsu Univ Sch Med, Ctr Oncol, Hamamatsu, Shizuoka 4313192, Japan; [Baba, Satoshi] Hamamatsu Univ Sch Med, Dept Pathol, Hamamatsu, Shizuoka 4313192, Japan	Kikuchi, H (reprint author), Hamamatsu Univ Sch Med, Dept Surg 2, Hamamatsu, Shizuoka 4313192, Japan.	kikuchih@hama-med.ac.jp					Ishigami H, 2010, ONCOLOGY-BASEL, V79, P269, DOI 10.1159/000323272; Nakayoshi T, 2004, ENDOSCOPY, V36, P1080, DOI 10.1055/s-2004-825961; Machida H, 2004, ENDOSCOPY, V36, P1094, DOI 10.1055/s-2004-826040; Smyth EC, 2011, WORLD J GASTROENTERO, V17, P5059, DOI 10.3748/wjg.v17.i46.5059; Yao K, 2002, GASTROINTEST ENDOSC, V56, P279, DOI 10.1067/mge.2002.126061; Muto M, 2009, J GASTROENTEROL, V44, P13, DOI 10.1007/s00535-008-2291-5; Ishigami H, 2009, ONCOLOGY-BASEL, V76, P311, DOI 10.1159/000209277; Kim SJ, 2009, RADIOLOGY, V253, P407, DOI 10.1148/radiol.2532082272; Hirata M, 2007, GASTROINTEST ENDOSC, V65, P988, DOI 10.1016/j.gie.2006.07.046; Kaise M, 2009, ENDOSCOPY, V41, P310, DOI 10.1055/s-0028-1119639; Watanabe A, 2008, OTOLARYNG HEAD NECK, V138, P446, DOI 10.1016/j.otohns.2007.12.034; Jerby BL, 1998, ONCOLOGY-NY, V12, P1353; Yoshida T, 2004, GASTROINTEST ENDOSC, V59, P288, DOI 10.1016/S0016-5107(03)02532-X; Ishigami H, 2010, ANN ONCOL, V21, P67, DOI 10.1093/annonc/mdp260; Sugarbaker PH, 2000, ONCOLOGY-BASEL, V58, P96, DOI 10.1159/000012086; Su MY, 2006, AM J GASTROENTEROL, V101, P2711, DOI 10.1111/j.1572-0241.2006.00932.x; Chiu HM, 2007, GUT, V56, P373, DOI 10.1136/gut.2006.099614; Chang L, 2009, SURG ENDOSC, V23, P231, DOI 10.1007/s00464-008-0099-2; Goda K, 2007, GASTROINTEST ENDOSC, V65, P36, DOI 10.1016/j.gie.2006.03.938; Nekarda H, 1999, BRIT J CANCER, V79, P611, DOI 10.1038/sj.bjc.6690096; Fushida S, 2013, ONCOTARGETS THER, V6, P1445, DOI 10.2147/OTT.S51916; Okabe H, 2009, ANN SURG ONCOL, V16, P3227, DOI 10.1245/s10434-009-0706-z; Gono K, 2004, J BIOMED OPT, V9, P568, DOI 10.1117/1.1695563; Broll R, 2001, LANGENBECK ARCH SURG, V386, P285; Contreras CM, 2009, J SURG ONCOL, V100, P663, DOI 10.1002/jso.21402; Glockzin G, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-5; Ina K, 2008, ONCOL REP, V20, P259, DOI 10.3892/or_00000001; Ishizone S, 2006, CHEMOTHERAPY, V52, P301, DOI 10.1159/000096002; Kitayama Joji, 2012, Gastrointest Cancer Res, V5, pS10; Kodera Y, 2002, ANN SURG, V235, P499, DOI 10.1097/00000658-200204000-00007; Kondo K, 2007, BIOL PHARM BULL, V30, P633, DOI 10.1248/bpb.30.633; Kumagai Y, 2002, ENDOSCOPY, V34, P369, DOI 10.1055/s-2002-25285; Lee CC, 2003, HEPATO-GASTROENTEROL, V50, P1720; Lehnert T, 2002, BRIT J SURG, V89, P471, DOI 10.1046/j.0007-1323.2002.02067.x; Muto M, 2004, CANCER, V101, P1375, DOI 10.1002/cncr.20482; Sakakura C, 2004, BRIT J CANCER, V90, P665, DOI 10.1038/sj.bjc.6601544; Shim JH, 2011, SURG ENDOSC, V25, P3338, DOI 10.1007/s00464-011-1722-1; Soma D, 2009, CANCER SCI, V100, P1979, DOI 10.1111/j.1349-7006.2009.01265.x; Tamura S, 2008, INT J CLIN ONCOL, V13, P536, DOI 10.1007/s10147-008-0836-5; Watanabe A, 2009, EUR ARCH OTO-RHINO-L, V266, P1017, DOI 10.1007/s00405-008-0835-1; Yoshikawa T, 2006, ANTICANCER RES, V26, P3849; Zhu ZG, 2006, DIGEST SURG, V23, P93, DOI 10.1159/000093778	42	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	NOV	2014	21	12					3954	3962		10.1245/s10434-014-3781-8		9	Oncology; Surgery	Oncology; Surgery	AQ8OD	WOS:000343085600041		
J	Tanaka, N; Kikuchi, E; Kanao, K; Matsumoto, K; Shirotake, S; Miyazaki, Y; Kobayashi, H; Kaneko, G; Hagiwara, M; Ide, H; Obata, J; Hoshino, K; Hayakawa, N; Kosaka, T; Hara, S; Oyama, M; Momma, T; Nakajima, Y; Jinzaki, M; Oya, M				Tanaka, Nobuyuki; Kikuchi, Eiji; Kanao, Kent; Matsumoto, Kazuhiro; Shirotake, Suguru; Miyazaki, Yasumasa; Kobayashi, Hiroaki; Kaneko, Gou; Hagiwara, Masayuki; Ide, Hiroki; Obata, Jun; Hoshino, Katsura; Hayakawa, Nozomi; Kosaka, Takeo; Hara, Satoshi; Oyama, Masafumi; Momma, Tetsuo; Nakajima, Yosuke; Jinzaki, Masahiro; Oya, Mototsugu			A Multi-Institutional Validation of the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio for Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy	ANNALS OF SURGICAL ONCOLOGY			English	Article							RENAL-CELL CARCINOMA; EUROPEAN COHORT; BLADDER-CANCER; SURVIVAL; RECURRENCE; CYSTECTOMY; PREDICTS; OUTCOMES; DISEASE; TUMORS	To externally validate the prognostic impact of preoperative neutrophil-lymphocyte ratio (pre-NLR) in patients with upper tract urothelial carcinoma (UTUC) following radical nephroureterectomy (RNU). A total of 665 patients from 12 institutions were included. The median follow-up was 28 months. Associations between pre-NLR level and outcome were assessed using multivariate analysis. A pre-NLR level of > 3.0 was defined as elevated. Pre-NLR levels were elevated in 184 patients (27.7 %), and pre-NLR elevation was significantly associated with worse pathological features such as tumor grade 3, advanced pT stage, positive lymphovascular invasion (LVI), and lymph node involvement in RNU specimens. The 5-year recurrence-free and cancer-specific survival rates were 57.0 % (p < 0.001) and 60.2 % (p < 0.001), respectively, in patients with elevated pre-NLR, and 69.2 and 77.3 %, respectively, in their counterparts. Multivariate analysis showed that elevated pre-NLR was an independent risk factor for predicting subsequent disease recurrence (p = 0.037; hazard ratio (HR) 1.38) and cancer-specific mortality (p = 0.036;, HR 1.47), although the addition of pre-NLR slightly improved the accuracies of the base model for predicting both disease recurrence and cancer-specific mortality to 79.8 % (p = 0.041) and 83.0 % (p = 0.039), respectively (gain in predictive accuracy: 0.2 and 0.1 %, respectively). This multi-institutional study revealed that elevated pre-NLR was significantly associated with worse pathological features such as tumor grade 3, advanced pT stage, positive LVI, and lymph node involvement in RNU specimens, and elevated pre-NLR was an independent risk factor of disease recurrence and cancer-specific mortality in UTUC patients treated with RNU.	[Tanaka, Nobuyuki; Kikuchi, Eiji; Kanao, Kent; Matsumoto, Kazuhiro; Shirotake, Suguru; Miyazaki, Yasumasa; Kobayashi, Hiroaki; Kaneko, Gou; Hagiwara, Masayuki; Ide, Hiroki; Obata, Jun; Hoshino, Katsura; Hayakawa, Nozomi; Kosaka, Takeo; Oya, Mototsugu] Keio Univ, Sch Med, Dept Urol, Tokyo, Japan; [Matsumoto, Kazuhiro; Hayakawa, Nozomi] Saiseikai Cent Hosp, Dept Urol, Tokyo, Japan; [Shirotake, Suguru; Oyama, Masafumi] Saitama Med Univ, Int Med Ctr, Ctr Comprehens Canc, Dept Urol, Hidaka, Japan; [Momma, Tetsuo] Saitama Hosp, Natl Hosp Org, Dept Urol, Saitama, Japan; [Nakajima, Yosuke] Saiseikai Yokohamashi Tobu Hosp, Dept Urol, Yokohama, Kanagawa, Japan; [Kobayashi, Hiroaki] Kyosai Tachikawa Hosp, Dept Urol, Tokyo, Japan; [Kaneko, Gou; Hara, Satoshi] Kawasaki City Hosp, Dept Urol, Tokyo, Japan; [Tanaka, Nobuyuki] Musashino Yowakai Hosp, Dept Urol, Tokyo, Japan; [Hagiwara, Masayuki] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Urol, Ichikawa, Japan; [Miyazaki, Yasumasa] Ogikubo Hosp, Dept Urol, Tokyo, Japan; [Ide, Hiroki] Inagi City Hosp, Dept Urol, Tokyo, Japan; [Kosaka, Takeo] Irumagawa Hosp, Dept Urol, Saitama, Japan; [Jinzaki, Masahiro] Keio Univ, Sch Med, Dept Diagnost Radiol, Tokyo, Japan	Kikuchi, E (reprint author), Keio Univ, Sch Med, Dept Urol, Tokyo, Japan.	eiji-k@kb3.so-net.ne.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [26462429]	Members of the Keio Collaboration Study of Urothelial Carcinoma participated in this study: Keishiro Fukumoto, Keio University School of Medicine, Tokyo, Japan; So Nakamura, Saiseikai Central Hospital, Tokyo, Japan; Takeshi Masuda, Saitama Municipal Hospital, Saitama, Japan; Shintaro Hasegawa, National Hospital Organization Tochigi Hospital, Tochigi, Japan; Atsushi Uchida, Kyosai Tachikawa Hospital, Tokyo, Japan; Kazuhiko Nagakura, Musashino Yowakai Hospital, Tokyo, Japan; Masakazu Ohashi, Ogikubo Hospital, Tokyo, Japan; Shoji Matsuzaki, Inagi Municipal Hospital, Tokyo, Japan; Kazutoyo Miyata, Irumagawa Hospital, Saitama, Japan. This work was supported in part by Grants-in-Aid for Scientific Research (#26462429 to Nobuyuki Tanaka) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Andrews B, 2002, J UROLOGY, V167, P1475, DOI 10.1016/S0022-5347(05)65348-7; Hashimoto T, 2013, WORLD J UROL, V31, P953, DOI 10.1007/s00345-012-0942-x; De Larco JE, 2004, CLIN CANCER RES, V10, P4895, DOI 10.1158/1078-0432.CCR-03-0760; Tanaka N, 2013, BJU INT, V111, P857, DOI 10.1111/j.1464-410X.2012.11353.x; Can C, 2012, UROL INT, V89, P468, DOI 10.1159/000343278; de Martino M, 2013, J UROLOGY, V190, P1999, DOI 10.1016/j.juro.2013.06.082; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224; Yates DR, 2012, BRIT J CANCER, V106, P1083, DOI 10.1038/bjc.2012.64; Cha EK, 2012, EUR UROL, V61, P818, DOI 10.1016/j.eururo.2012.01.021; Lughezzani G, 2012, EUR UROL, V62, P100, DOI 10.1016/j.eururo.2012.02.030; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Roupret M, 2013, EUR UROL, V63, P1059, DOI 10.1016/j.eururo.2013.03.032; Gondo T, 2012, UROLOGY, V79, P1085, DOI 10.1016/j.urology.2011.11.070; Rink M, 2012, EUR UROL, V61, P854, DOI 10.1016/j.eururo.2011.12.055; Krane LS, 2013, J ENDOUROL, V27, P1046, DOI 10.1089/end.2012.0606; Proctor MJ, 2012, BRIT J CANCER, V107, P695, DOI 10.1038/bjc.2012.292; Dalpiaz O, 2014, BRIT J CANCER, V110, P2531, DOI 10.1038/bjc.2014.180; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Pichler M, 2013, BRIT J CANCER, V108, P901, DOI 10.1038/bjc.2013.28; Gakis G, 2011, BJU INT, V108, P1800, DOI 10.1111/j.1464-410X.2011.10234.x; Azab B, 2012, ANN SURG ONCOL, V19, P217, DOI 10.1245/s10434-011-1814-0; Ouzzane A, 2011, EUR UROL, V60, P1258, DOI 10.1016/j.eururo.2011.05.049; Margulis V, 2009, CANCER, V115, P1224, DOI 10.1002/cncr.24135; Azuma T, 2013, CLIN GENITOURIN CANC, V11, P337, DOI 10.1016/j.clgc.2013.04.003; Dalpiaz O, 2014, BJU INT, V114, P334, DOI 10.1111/bju.12441; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Luo HL, 2014, BJU INT, V113, pE144, DOI 10.1111/bju.12582; Rink M, 2012, ANN SURG ONCOL, V19, P4337, DOI 10.1245/s10434-012-2499-8; Tanaka N, 2013, ANN SURG ONCOL, V21, P1038	30	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	NOV	2014	21	12					4041	4048		10.1245/s10434-014-3830-3		8	Oncology; Surgery	Oncology; Surgery	AQ8OD	WOS:000343085600053		
J	Brahmajothi, MV; Tinch, BT; Wempe, MF; Endou, H; Auten, RL				Brahmajothi, Mulugu V.; Tinch, Brian T.; Wempe, Michael F.; Endou, Hitoshi; Auten, Richard L.			Hyperoxia Inhibits Nitric Oxide Treatment Effects in Alveolar Epithelial Cells via Effects on L-Type Amino Acid Transporter-1	ANTIOXIDANTS & REDOX SIGNALING			English	Article							PERSISTENT PULMONARY-HYPERTENSION; S-NITROSOTHIOLS; NEWBORN RATS; LAT1; EXPRESSION; INVOLVEMENT; CYSTEINE; RELEASE	Aims: The aims of this study were to determine hyperoxia effects on S-nitrosothiol (SNO) accumulation and L-type amino acid transporter 1 (LAT1) expression/function in alveolar epithelium and to determine whether hyperoxia impairs exogenous nitric oxide (NO) treatment effects in alveolar epithelium through effects on LAT1 expression and/or function. Results: SNO accumulation in vitro and in vivo after NO treatment was dependent on the LAT1 system transport. Hyperoxia (60% or 90%) impaired NO effects on SNO accumulation and soluble guanylyl cyclase activation in proportion to the magnitude of hyperoxia and the duration of exposure, up to 12 h, in type I-like (R3/1) and type II-like (L2) rat and human (A549) alveolar epithelial cells. LAT function, determined by sodium-independent H-3-leucine uptake, was impaired in a parallel manner. Hyperoxia impaired LAT1 expression in alveolar epithelial cells, determined by immunoblots and immunofluorescence, and in newborn rats exposed to 60% O-2 for 4 days, determined by immunohistochemistry. Innovation: Despite significant preclinical evidence, inhaled NO has shown disappointing limitations in clinical applications. Our studies suggest an important explanation: oxidative stress, a common feature of diseases in which therapeutic NO would be considered, impairs LAT1 expression and function, blocking a major route for inhaled NO (iNO) action, that is, the uptake of S-nitrosocysteine via LAT1. Conclusions: SNO uptake after NO treatment is dependent on LAT1. Hyperoxia impairs SNO uptake and NO effects during NO exposure and impairs LAT system function and LAT1 expression. Effects on SNO formation and transport must be considered for rational optimization of NO-based therapeutics. Antioxid. Redox Signal. 21, 1823-1836.	[Brahmajothi, Mulugu V.; Tinch, Brian T.; Auten, Richard L.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Wempe, Michael F.] Univ Colorado Denver, Sch Pharm, Dept Pharmaceut Sci, Aurora, CO USA; [Endou, Hitoshi] J Pharma Co Ltd, Yokohama, Kanagawa, Japan	Auten, RL (reprint author), Duke Univ, Med Ctr, Dept Pediat, DUMC Box 3373, Durham, NC 27710 USA.	auten@duke.edu			March of Dimes; Children's Miracle Network	This work was supported by the March of Dimes and the Children's Miracle Network. The authors acknowledge the technical assistance of Mr. S. Nicholas Mason and are grateful for the gift of the JPH 203 compound from J-Pharma Company, Ltd.	Cole FS, 2011, PEDIATRICS, V127, P363, DOI 10.1542/peds.2010-3507; Bennett-Guerrero E, 2007, P NATL ACAD SCI USA, V104, P17063, DOI 10.1073/pnas.0708160104; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016; Boado RJ, 2005, BBA-BIOMEMBRANES, V1715, P104, DOI 10.1016/j.bbamem.2005.07.007; Brahmajothi MV, 2013, AM J RESP CELL MOL, V48, P230, DOI 10.1165/rcmb.2012-0305OC; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Steinhorn RH, 2001, AM J RESP CRIT CARE, V164, P834; Afolayan AJ, 2012, AM J PHYSIOL-LUNG C, V303, pL870, DOI 10.1152/ajplung.00098.2012; Brahmajothi MV, 2010, FREE RADICAL BIO MED, V49, P294, DOI 10.1016/j.freeradbiomed.2010.04.020; Auten RL, 2007, AM J RESP CRIT CARE, V176, P291, DOI 10.1164/rccm.200605-6620C; Auten RL, 2001, AM J PHYSIOL-LUNG C, V281, pL336; Broer S, 2008, PHYSIOLOGY, V23, P95, DOI 10.1152/physiol.00045.2007; DINSDALE D, 1992, HISTOCHEM J, V24, P144, DOI 10.1007/BF01047464; Finer NN, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000399.pub2; Granillo OM, 2008, AM J PHYSIOL-LUNG C, V295, pL38, DOI 10.1152/ajplung.00280.2007; Hayashi K, 2013, J IMMUNOL, V191, P4080, DOI 10.4049/jimmunol.1300923; Ignarro L. J., 2000, NITRIC OXIDE BIOL PA; Kanai Y, 2001, CURR DRUG METAB, V2, P339, DOI 10.2174/1389200013338324; Koslowski R, 2004, HISTOCHEM CELL BIOL, V121, P509, DOI 10.1007/s00418-004-0662-4; Kuhne A, 2007, PHARMACOGENET GENOM, V17, P505; Lancaster JR., 2000, NITRIC OXIDE BIOL PA, P209, DOI 10.1016/B978-012370420-7/50014-9; Li S, 2005, J BIOL CHEM, V280, P20102, DOI 10.1074/jbc.M413164200; Luo JQ, 2013, NUTRITION, V29, P284, DOI 10.1016/j.nut.2012.05.008; Nemoto T, 2001, NEUROSCI LETT, V311, P117, DOI 10.1016/S0304-3940(01)02151-6; Poncet N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089547; Satoh S, 1997, J NEUROCHEM, V69, P2197; Steinhorn RH, 2009, J PEDIAT, V155, p[841, e1]; Torok JA, 2012, AM J RESP CELL MOL, V47, P37, DOI 10.1165/rcmb.2011-0439OC; Wempe MF, 2012, DRUG METAB PHARMACOK, V27, P155, DOI 10.2133/dmpk.DMPK-11-RG-091; Yi M, 2004, AM J RESP CRIT CARE, V170, P1188, DOI 10.1164/rccm.200402-215OC	30	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1523-0864	1557-7716		ANTIOXID REDOX SIGN	Antioxid. Redox Signal.	NOV 1	2014	21	13					1823	1836		10.1089/ars.2013.5664		14	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	AR0WD	WOS:000343293100003		
J	Duru, O; Bulut, E				Duru, Okan; Bulut, Emrah			A non-linear clustering method for fuzzy time series: Histogram damping partition under the optimized cluster paradox	APPLIED SOFT COMPUTING			English	Article						Fuzzy time series; Length of intervals; Cluster optimization	FORECASTING ENROLLMENTS; ERROR MEASURES; INTERVALS; ACCURACY; MODEL	The aim of this paper is to investigate the problem of finding the efficient number of clusters in fuzzy time series. The clustering process has been discussed in the existing literature, and a number of methods have been suggested. These methods have several drawbacks, especially the lack of cluster shape and quantity optimization. There are two critical dimensions in a fuzzy time series clustering: the selection of a proper interval for fuzzy clusters and the optimization of the membership degrees among the fuzzy cluster set. The existing methods for the interval selection assume that the intended data has a short-tailed distribution, and the cluster intervals are established in identical lengths (e.g. Song and Chissom, 1994; Chen, 1996; Yolcu et al., 2009). However, the time series data (particularly in economic research) is rarely short-tailed and mostly converges to long-tail distribution because of the boom-bust market behavior. This paper proposes a novel clustering method named histogram damping partition (HDP) to define sub-clusters on the standard deviation intervals and truncate the histogram of the data by a constraint based on the coefficient of variation. The HDP approach can be used for many different kinds of fuzzy time series models at the clustering stage. (C) 2014 Elsevier B.V. All rights reserved.	[Duru, Okan] Izmir Katip Celebi Univ, Dept Ship & Marine Technol, TR-35620 Izmir, Turkey; [Bulut, Emrah] Yildiz Tekn Univ, Dept Business Adm, TR-34349 Istanbul, Turkey; [Duru, Okan] Kobe Univ, Int Maritime Res Ctr IMaRC, Kobe, Hyogo 6580022, Japan	Duru, O (reprint author), Izmir Katip Celebi Univ, Dept Ship & Marine Technol, TR-35620 Izmir, Turkey.	duruokan@yahoo.com		Duru, Okan/0000-0001-7966-0025			DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Huarng K, 2001, FUZZY SET SYST, V123, P387, DOI 10.1016/S0165-0114(00)00057-9; Mao JC, 1996, IEEE T NEURAL NETWOR, V7, P16, DOI 10.1109/72.478389; ARMSTRONG JS, 1992, INT J FORECASTING, V8, P69, DOI 10.1016/0169-2070(92)90008-W; SONG Q, 1994, FUZZY SET SYST, V62, P1, DOI 10.1016/0165-0114(94)90067-1; DAVE RN, 1992, PATTERN RECOGN, V25, P713, DOI 10.1016/0031-3203(92)90134-5; Bulut E, 2014, EXPERT SYST APPL, V41, P1806, DOI 10.1016/j.eswa.2013.08.079; Hyndman RJ, 2006, INT J FORECASTING, V22, P679, DOI 10.1016/j.ijforecast.2006.03.001; Chen SM, 2011, EXPERT SYST APPL, V38, P10594, DOI 10.1016/j.eswa.2011.02.098; Yolcu U, 2009, APPL SOFT COMPUT, V9, P647, DOI 10.1016/j.asoc.2008.09.002; Duru O, 2010, EXPERT SYST APPL, V37, P5372, DOI 10.1016/j.eswa.2010.01.019; Batchelor R, 2007, INT J FORECASTING, V23, P101, DOI 10.1016/j.ijforecast.2006.07.004; Chen SM, 1996, FUZZY SET SYST, V81, P311, DOI 10.1016/0165-0114(95)00220-0; SONG Q, 1993, FUZZY SET SYST, V54, P1, DOI 10.1016/0165-0114(93)90355-L; Chen SM, 2011, EXPERT SYST APPL, V38, P15425, DOI 10.1016/j.eswa.2011.06.019; Bulut E, 2012, MARIT ECON LOGIST, V14, P300, DOI 10.1057/mel.2012.9; Makridakis S, 2000, INT J FORECASTING, V16, P451, DOI 10.1016/S0169-2070(00)00057-1; Armstrong J.S., 2001, PRINCIPLES FORECASTI; Bezdek J. C., 1981, PATTERN RECOGNITION; BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1; Box G.E.P., 1994, TIME SERIES ANAL FOR; CHATFIELD C, 1992, INT J FORECASTING, V8, P100, DOI 10.1016/0169-2070(92)90011-W; Coleman C.D., 2007, J ECON SOC MEAS, V32, P219; Diday E., 1973, International Journal of Computer & Information Sciences, V2, DOI 10.1007/BF00987153; Dunn J. C., 1973, Journal of Cybernetics, V3; DURU Okan, 2010, The Asian Journal of Shipping and Logistics, V26, P205; Duru O., 2012, COMPUTATIONAL INTELL; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; Goodwin P, 1999, INT J FORECASTING, V15, P405, DOI 10.1016/S0169-2070(99)00007-2; Liao TW, 2005, PATTERN RECOGN, V38, P1857, DOI 10.1016/j.patcog.2005.01.025; MacQueen J.B., 1967, P 5 BERK S MATH STAT, P281; MAKRIDAKIS S, 1993, INT J FORECASTING, V9, P527, DOI 10.1016/0169-2070(93)90079-3; Tashman L.J., 2000, INT J FORECASTING, V16, P437, DOI 10.1016/S0169-2070(00)00065-0; Zadeh L. A., 1979, MACH INTELL, V9, P149	34	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-4946	1872-9681		APPL SOFT COMPUT	Appl. Soft. Comput.	NOV	2014	24						742	748		10.1016/j.asoc.2014.08.038		7	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications	Computer Science	AQ9CI	WOS:000343138500063		
J	Binh, HTT; Lam, BT; Ha, NST; Ishibuchi, H				Huynh Thi Thanh Binh; Bui Thu Lam; Nguyen Sy Thai Ha; Ishibuchi, Hisao			A multi-objective approach for solving the survivable network design problem with simultaneous unicast and anycast flows	APPLIED SOFT COMPUTING			English	Article						Survivable network design; Anycast; Unicast; A-SNDP; NSGA-II	CONNECTION-ORIENTED NETWORKS; OPTIMIZATION	In this paper, we consider the survivable network design problem for simultaneous unicast and anycast flow requests. We assume that the network is modeled by a connected and undirected graph. This problem aims at finding a set of connections with a minimized network cost in order to protect the network against any single failure. The cost is computed using the all capacities modular cost (ACMC) model and a set of flow demands. We name it as ACMC-based survivable network design problem (A-SNDP). It is proved that the problem is NP-hard. We introduce a multi-objective approach to solve A-SNDP. The objectives are to minimize the network cost (NCost) and the network failure (NFail). Extensive simulation results on instances of Polska, Germany and Atlanta networks showed the efficiency of the multi-objective approach for solving A-SNDP. (C) 2014 Elsevier B.V. All rights reserved.	[Huynh Thi Thanh Binh; Nguyen Sy Thai Ha] Hanoi Univ Sci & Technol, Sch Informat & Commun Technol, Hanoi, Vietnam; [Bui Thu Lam] Le Quy Don Tech Univ, Fac Informat Technol, Hanoi, Vietnam; [Ishibuchi, Hisao] Osaka Prefecture Univ, Dept Comp Sci & Intelligent Syst, Sakai, Osaka 591, Japan	Binh, HTT (reprint author), Hanoi Univ Sci & Technol, Sch Informat & Commun Technol, Hanoi, Vietnam.	binh.huynhthithanh@hust.edu.vn	Ishibuchi, Hisao/B-3599-2009	Ishibuchi, Hisao/0000-0001-9186-6472	project "Models for the next generation of a robust Internet" - Ministry of Science and Technology [12/2012/HD-NDT]; Vietnam National Foundation for Science and Technology Development (NAFOSTED) [107.04.2011.09]	This work was supported by the project "Models for the next generation of a robust Internet," grant number 12/2012/HD-NDT, funded by the Ministry of Science and Technology, and Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 107.04.2011.09.	Walkowiak K, 2006, LECT NOTES COMPUT SC, V4263, P424; Walkowiak K, 2008, LECT NOTES COMPUT SC, V5073, P797; Batriti Roberto, 2008, DIVE SEARCH IRILELLI; Bind Huynh Thi Thanh, 2012, ICIC, P137; Binh Huynh Thi Thanh, 2013, BIC TA, P1237; Carrano Eduardo G., IEEE T POWER DELIVER, V21, P995; Deb K, 2001, MULTIOBJECTIVE OPTIM; Gladysz Jakub, 2010, INT J ELECT TELECOMM, V56, P41; Gladysz Jakub, 2009, ICUMT POL, P1; Grover W. D., 2004, MESH BASED SURVIVABL; Herve Kerivin A., 2005, J NETW, V46, P1; Johnson DDP, 2013, INT SECURITY, V38, P7, DOI 10.1162/ISEC_a_00149; Kasprzak A., 1989, ALGORITHMS FLOW CAPA; Nissen Volker, 2008, SUCCESS EVOLUTIONARY, P203; Ploto M., 2004, ROUTING FLOW CAPACIT; Sharma V., 2003, 3469 RFC; Vasseur J., 2004, NETWORK RECOVERY PRO; Walkowiak K, 2007, COMM COM INF SC, V1, P378, DOI 10.1007/978-3-540-73986-9_32; Zitzler E., 2004, METAHEURISTICS MULTI, P3	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-4946	1872-9681		APPL SOFT COMPUT	Appl. Soft. Comput.	NOV	2014	24						1145	1154		10.1016/j.asoc.2014.06.001		10	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications	Computer Science	AQ9CI	WOS:000343138500095		
J	Inomata, S; Sato, K; Hirokawa, J; Sakamoto, Y; Tanimoto, H; Okumura, M; Tohno, S; Imamura, T				Inomata, Satoshi; Sato, Kei; Hirokawa, Jun; Sakamoto, Yosuke; Tanimoto, Hiroshi; Okumura, Motonori; Tohno, Susumu; Imamura, Takashi			Analysis of secondary organic aerosols from ozonolysis of isoprene by proton transfer reaction mass spectrometry	ATMOSPHERIC ENVIRONMENT			English	Article						Criegee intermediate; Isoprene ozonolysis; Partitioning; Proton transfer reaction mass spectrometry; Secondary organic aerosol	GAS-PHASE OZONOLYSIS; PTR-MS; CRIEGEE INTERMEDIATE; SOA FORMATION; ENOL ETHERS; OZONE; PHOTOOXIDATION; METHACROLEIN; ATMOSPHERE; CHEMISTRY	To understand the mechanism of formation of the secondary organic aerosols (SOAs) produced by the ozonolysis of isoprene, proton transfer reaction mass spectrometry (PTR-MS) was used to identify the semi-volatile organic compounds (SVOCs) produced in both the gaseous and the aerosol phases and to estimate the gas aerosol partitioning of each SVOC in chamber experiments. To aid in the identification of the SVOCs, the products were also studied with negative ion-chemical ionization mass spectrometry (NI-CIMS), which can selectively detect carboxylic acids and hydroperoxides. The gaseous products were observed by on-line PTR-MS and NI-CIMS, whereas the SVOCs in SOAs collected on a filter were vaporized by heating the filter and were then analysed by off-line PTR-MS and NI-CIMS. The formation of oligomeric hydroperoxides involving a Criegee intermediate as a chain unit was observed in both the gaseous and the aerosol phases by NI-CIMS. PTR-MS also detected oligomeric hydroperoxides as protonated molecules from which a H2O molecule was eliminated, [M-OH](+). In the aerosol phase, oligomers involving formaldehyde and methacrolein as chain units were observed by PTR-MS in addition to oligomeric hydroperoxides. The gas-aerosol partitioning of each component was calculated from the ion signals in the gaseous and aerosol phases measured by PTR-MS. From the gas-aerosol partitioning, the saturated vapour pressures of the oligomeric hydroperoxides were estimated. Measurements by a fastmobility-particle-sizer spectrometer revealed that the increase of the number density of the particles was complete within a few hundred seconds from the start of the reaction. (C) 2014 Elsevier Ltd. All rights reserved.	[Inomata, Satoshi; Sato, Kei; Tanimoto, Hiroshi; Imamura, Takashi] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Hirokawa, Jun; Sakamoto, Yosuke] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan; [Sakamoto, Yosuke] Japan Soc Promot Sci, Tokyo, Japan; [Okumura, Motonori; Tohno, Susumu] Kyoto Univ, Grad Sch Energy Sci, Sakyo Ku, Kyoto 6068501, Japan	Inomata, S (reprint author), Natl Inst Environm Studies, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	ino@nies.go.jp	Sato, Kei/A-7202-2012; Inomata, Satoshi/E-7364-2010; Tanimoto, Hiroshi/E-6779-2010		Ministry of Education, Culture, Sports, Science and Technology of Japan [20120003, FY 2008-2012, 20120005, 20120007]; Steel Industry Foundation for the Advancement of Environmental Protection Technology [05-06Taiki-157, FY2005-2006]; Sumitomo Foundation [123449, FY2012-2013]; JSPS	This work was financially supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 20120003, FY 2008-2012; No. 20120005, FY 2008-2012; No. 20120007, FY 2008-2012), by a grant from the Steel Industry Foundation for the Advancement of Environmental Protection Technology (05-06Taiki-157, FY2005-2006), and by a Grant for Environmental Research Projects from The Sumitomo Foundation (No. 123449, FY2012-2013). Y.S. was supported by a research fellowship from the JSPS for young scientists.	AKIMOTO H, 1979, ENVIRON SCI TECHNOL, V13, P471, DOI 10.1021/es60152a014; Mauldin RL, 2012, NATURE, V488, P193, DOI 10.1038/nature11278; Sadezky A, 2008, ATMOS CHEM PHYS, V8, P2667; Ng NL, 2008, ATMOS CHEM PHYS, V8, P4117; Orzechowska GE, 2005, J PHYS CHEM A, V109, P5358, DOI 10.1021/jp050166s; Carlton AG, 2009, ATMOS CHEM PHYS, V9, P4987; Kroll JH, 2008, ATMOS ENVIRON, V42, P3593, DOI 10.1016/j.atmosenv.2008.01.003; Blake RS, 2009, CHEM REV, V109, P861, DOI 10.1021/cr800364q; Holzinger R, 2010, ATMOS CHEM PHYS, V10, P2257; Volkamer R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026899; Warneke C, 2003, ENVIRON SCI TECHNOL, V37, P2494, DOI 10.1021/es026266i; Paulot F, 2009, SCIENCE, V325, P730, DOI 10.1126/science.1172910; Paulot F, 2009, ATMOS CHEM PHYS, V9, P1479; GROSJEAN D, 1993, ENVIRON SCI TECHNOL, V27, P830, DOI 10.1021/es00042a004; Lindinger W, 1998, CHEM SOC REV, V27, P347, DOI 10.1039/a827347z; Inomata S, 2008, ATMOS CHEM PHYS, V8, P273; Klotz B, 2004, PHYS CHEM CHEM PHYS, V6, P1725, DOI 10.1039/b315997c; Lane TE, 2008, ATMOS ENVIRON, V42, P7439, DOI 10.1016/j.atmosenv.2008.06.026; de Gouw J, 2007, MASS SPECTROM REV, V26, P223, DOI 10.1002/mas.20119; Sadezky A, 2006, ATMOS CHEM PHYS, V6, P5009; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155; Kanakidou M, 2005, ATMOS CHEM PHYS, V5, P1053; Fuzzi S, 2006, ATMOS CHEM PHYS, V6, P2017; Odum JR, 1996, ENVIRON SCI TECHNOL, V30, P2580, DOI 10.1021/es950943+; Liu YJ, 2013, ATMOS CHEM PHYS, V13, P5715, DOI 10.5194/acp-13-5715-2013; Jang MS, 2002, SCIENCE, V298, P814, DOI 10.1126/science.1075798; Camredon M., 2010, ATMOSPHERIC CHEM PHY, V10, P27837; Guenther A., 2006, ATMOSPHERIC CHEM PHY, V6, P3138; Hasson AS, 2001, J GEOPHYS RES-ATMOS, V106, P34143, DOI 10.1029/2001JD000598; Hellen H, 2008, ENVIRON SCI TECHNOL, V42, P7347, DOI 10.1021/es801279m; Hirokawa J, 2009, ANAL CHEM, V81, P8380, DOI 10.1021/ac901117b; Inomata S, 2010, ATMOS CHEM PHYS, V10, P7085, DOI 10.5194/acp-10-7085-2010; Kleindienst TE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027485; Neeb P, 1998, INT J CHEM KINET, V30, P769, DOI 10.1002/(SICI)1097-4601(1998)30:10<769::AID-KIN9>3.0.CO;2-T; Nguyen TB, 2010, ATMOS ENVIRON, V44, P1032, DOI 10.1016/j.atmosenv.2009.12.019; Sakamoto Y, 2013, J PHYS CHEM A, V117, P12912, DOI 10.1021/jp408672m; Sato K, 2005, CHEM LETT, V34, P1584, DOI 10.1246/cl.2005.1584; Sato K, 2013, ATMOS ENVIRON, V79, P147, DOI 10.1016/j.atmosenv.2013.06.036; Seinfeld J.H., 1997, ATMOSPHERIC CHEM PHY; Tanimoto H, 2007, INT J MASS SPECTROM, V263, P1, DOI 10.1016/j.ijms.2007.01.009; Wyche KP, 2005, RAPID COMMUN MASS SP, V19, P3356, DOI 10.1002/rcm.2202	41	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	NOV	2014	97				SI		397	405		10.1016/j.atmosenv.2014.03.045		9	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AR1HQ	WOS:000343336700041		
J	Takahashi, K; Nansai, K; Tohno, S; Nishizawa, M; Kurokawa, J; Ohara, T				Takahashi, Kei; Nansai, Keisuke; Tohno, Susumu; Nishizawa, Masato; Kurokawa, Jun-ichi; Ohara, Toshimasa			Production-based emissions, consumption-based emissions and consumption-based health impacts of PM2.5 carbonaceous aerosols in Asia	ATMOSPHERIC ENVIRONMENT			English	Article						Premature deaths; Organic carbon; Black carbon; Consumption-based accounting; Multiregional input-output analysis; Source-receptor relationship	INTERNATIONAL-TRADE; RESPONSIBILITY; SYSTEM; CHINA; INVENTORY; FOOTPRINT; CONSUMER; ACCOUNTS; NATIONS; DRIVES	This study determined the production-based emissions, the consumption-based emissions, and the consumption-based health impact of primary carbonaceous aerosols (black carbon: BC, organic carbon: OC) in nine countries and regions in Asia (Indonesia, Malaysia, the Philippines, Singapore, Thailand, China, Taiwan, South Korea, and Japan) in 2008. For the production-based emissions, sectoral emissions inventory of BC and OC for the year of 2008 based on the Asian international input output tables (AIIOT) was compiled including direct emissions from households. Then, a multiregional environmental input output analysis with the 2008 AIIOT which was originally developed by updating the table of 2000 was applied for calculating the consumption-based emissions for each country and region. For the production-based emissions, China had the highest BC and OC emissions of 4520 Gg-C in total, which accounted for 75% of the total emissions in the nine countries and regions. For consumption-based emissions, China was estimated to have had a total of 4849 Gg-C of BC and OC emissions, which accounted for 77% of the total emissions in the Asia studied. We also quantified how much countries and regions induced emissions in other countries and regions. Furthermore, taking account of the source receptor relationships of BC and OC among the countries and regions, we converted their consumption-based emissions into the consumption-based health impact of each country and region. China showed the highest consumption-based health impact of BC and OC totaling 111 x 10(3) premature deaths, followed by Indonesia, Japan, Thailand and South Korea. China accounted for 87% of the sum total of the consumption-based health impacts of the countries/regions, indicating that China's contribution to consumption-based health impact in Asia was greater than its consumption-based emissions. By elucidating the health impacts that each country and region had on other countries and from which country the impacts were received, we demonstrated that the characteristics of the consumption-based health impact varied significantly by country and region. We also determined the difference in the health	[Takahashi, Kei; Tohno, Susumu] Kyoto Univ, Grad Sch Energy Sci, Sakyo Ku, Kyoto 6068501, Japan; [Nansai, Keisuke] Natl Inst Environm Studies, Ctr Mat Cycles & Waste Management Res, Tsukuba, Ibaraki 3058506, Japan; [Nishizawa, Masato; Ohara, Toshimasa] Natl Inst Environm Studies, Ctr Reg Environm Res, Tsukuba, Ibaraki 3058506, Japan; [Kurokawa, Jun-ichi] Asia Ctr Air Pollut Res, Nishi Ku, Niigata 9502144, Japan	Takahashi, K (reprint author), Kyoto Univ, Grad Sch Energy Sci, Sakyo Ku, Kyoto 6068501, Japan.	takahashi.kei.84s@st.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [20120005, 25281065]	This work was financially supported by a Grant-in-Aid for Scientific Research on Innovative Areas (No. 20120005) and a Grant-in-Aid for Scientific Research (B) (No. 25281065) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Cao GL, 2006, ATMOS ENVIRON, V40, P6516, DOI 10.1016/j.atmosenv.2006.05.070; Byun D, 2006, APPL MECH REV, V59, P51, DOI 10.1115/1.2128636; Zhang Q, 2008, ENVIRON POLLUT, V151, P39, DOI 10.1016/j.envpol.2007.03.011; Peters GP, 2008, ECOL ECON, V65, P13, DOI 10.1016/j.ecolecon.2007.10.014; Nansai K, 2012, ENVIRON SCI TECHNOL, V46, P155, DOI 10.1021/es202007b; Hertwich EG, 2011, ECON SYST RES, V23, P27, DOI 10.1080/09535314.2010.536905; Davis SJ, 2010, P NATL ACAD SCI USA, V107, P5687, DOI 10.1073/pnas.0906974107; Daniels PL, 2011, ECON SYST RES, V23, P353, DOI 10.1080/09535314.2011.633500; Weinzettel J, 2013, GLOBAL ENVIRON CHANG, V23, P433, DOI 10.1016/j.gloenvcha.2012.12.010; Hertwich EG, 2009, ENVIRON SCI TECHNOL, V43, P6414, DOI 10.1021/es803496a; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419; Lenzen M, 2012, NATURE, V486, P109, DOI 10.1038/nature11145; Cao GL, 2008, CHINESE SCI BULL, V53, P784, DOI 10.1007/s11434-008-0145-4; Nansai K, 2012, ENVIRON SCI TECHNOL, V46, P9146, DOI 10.1021/es2043257; Steen-Olsen K, 2012, ENVIRON SCI TECHNOL, V46, P10883, DOI 10.1021/es301949t; FAO, 2011, FOOD AGR COMM PROD; IDE-JETRO, 2006, AS INT I O TABL 2000; International Energy Agency, 2011, EN BAL OECD REG; International Energy Agency, 2011, EN BAL NONOECD REG, pIL99; Lenzen M, 2008, ECOL ECON, V66, P547, DOI 10.1016/j.ecolecon.2008.03.012; Lenzen M, 2007, ECOL ECON, V64, P19, DOI 10.1016/j.ecolecon.2007.06.025; Lin J., 2014, CHINAS INT TRADE AIR; Mori T., 2007, BANK JAPAN WORKING P, V07-E-26, P2; Munksgaard J, 2001, ENERG POLICY, V29, P327, DOI 10.1016/S0301-4215(00)00120-8; National Bureau of Statistics of China, 2006, CHIN STAT YB 2006; National Bureau of Statistics of China, 2009, CHIN STAT YB 2009; NIES (National Institute for Environmental Studies Japan), 2010, GREENH GAS INV OFF; Nishizawa M., 2012, INT S AER E AS THEIR, P94; Skamarock W.C., 2008, NCAR TECH NOTES 475; Skelton A, 2011, ENVIRON SCI TECHNOL, V45, P10516, DOI 10.1021/es202313e; Stone R. A., 1962, COMPUTABLE MODEL EC; Streets DG, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003093; Streets DG, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004902	33	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	NOV	2014	97				SI		406	415		10.1016/j.atmosenv.2014.04.028		10	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AR1HQ	WOS:000343336700042		
J	Kaneyasu, N; Yamamoto, S; Sato, K; Takami, A; Hayashi, M; Hara, K; Kawamoto, K; Okuda, T; Hatakeyama, S				Kaneyasu, Naoki; Yamamoto, Shigekazu; Sato, Kei; Takami, Akinori; Hayashi, Masahiko; Hara, Keiichiro; Kawamoto, Kazuaki; Okuda, Tomoaki; Hatakeyama, Shiro			Impact of long-range transport of aerosols on the PM2.5 composition at a major metropolitan area in the northern Kyushu area of Japan	ATMOSPHERIC ENVIRONMENT			English	Article						PM2.5; Long-range transport; East Asia; Sulfate; Metallic element; NAAQS	SULFUR-DIOXIDE EMISSIONS; EAST-ASIA; BACKGROUND OZONE; TRACE-ELEMENTS; AIR-POLLUTION; CHINA; POLLUTANTS; MORTALITY; PACIFIC; ISLANDS	In view of the recent rapid economic growth and accompanying energy consumption in the East Asian region, particularly in China, there is much concern about the effects of emitted particulate pollutants on human health. We have thus investigated the impact of long-range transport of aerosols on urban air quality in the upwind areas of Japan by comparing the PM2.5 composition collected for multiple years in Fukuoka, a representative metropolis in the Kyushu area, and in Fukue Island, located 190 km southwest of Fukuoka. Daily averaged PM2.5 concentrations in Fukuoka and Fukue were almost identical. PM2.5 concentrations at these sites were dominated by sulfate and particulate organics, and their fluctuation patterns were similar except for organics in the warm season. In contrast, those of nitrate and elemental carbon differed substantially between the sites. In addition, the ratios of Pb/Zn and Cd/Pb in Fukuoka were close to the reported values in Beijing. Non-sea-salt sulfate concentration in Fukuoka measured in this study and reported in the past measurements apparently coincided with the decadal SO2 emission change in China reported in a recent emission inventory. Therefore, we conclude that even in a city as large as Fukuoka, the PM2.5 concentration in the northern part of the Kyushu area is primarily dominated by the inflow of long-range transported aerosols throughout the year, except in the summer, rather than local air pollution emitted at each site. (C) 2014 Elsevier Ltd. All rights reserved.	[Kaneyasu, Naoki] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058569, Japan; [Yamamoto, Shigekazu] Fukuoka Inst Hlth & Environm Sci, Fukuoka 8180135, Japan; [Sato, Kei; Takami, Akinori] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Hayashi, Masahiko; Hara, Keiichiro] Fukuoka Univ, Fac Sci, Jonan Ku, Fukuoka 8140180, Japan; [Kawamoto, Kazuaki] Nagasaki Univ, Fac Environm Sci, Nagasaki 8528521, Japan; [Okuda, Tomoaki] Keio Univ, Fac Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Hatakeyama, Shiro] Tokyo Univ Agr & Technol, Fuchu, Tokyo 1838509, Japan	Kaneyasu, N (reprint author), Natl Inst Adv Ind Sci & Technol, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	kane.n@aist.go.jp; yamamoto@fihes.pref.fukuoka.jp; kei@nies.go.jp; takamia@nies.go.jp; mhayashi@fukuoka-u.ac.jp; harakei@fukuoka-u.ac.jp; kazukawa@nagasaki-u.ac.jp; okuda@applc.keio.ac.jp; hatashir@cc.tuat.ac.jp	Sato, Kei/A-7202-2012; Okuda, Tomoaki/D-1934-2014; Hatakeyama, Shiro/D-2001-2010	Hatakeyama, Shiro/0000-0002-9357-4091	Ministry of Education, Culture, Sport Science and Technology (MEXT), Japan [20120007]	The authors appreciate the support of Dr. S. Hasegawa and Dr. S. Yonemochi (Center for Environmental Science in Saitama) in the weighing of aerosol filters. This research was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Impacts of Aerosols in East Asia on Plants and Human Health" (Grant No. 20120007) funded by the Ministry of Education, Culture, Sport Science and Technology (MEXT), Japan.	Li C, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042594; Hsu SC, 2005, SCI TOTAL ENVIRON, V347, P111, DOI 10.1016/j.1016/j.scitotenv.2004.12.021; Li P, 2013, ENVIRON SCI POLLUT R, V20, P6433, DOI 10.1007/s11356-013-1688-8; Cooper OR, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016095; Shang Y, 2013, ENVIRON INT, V54, P100, DOI 10.1016/j.envint.2013.01.010; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419; Lu Z, 2010, ATMOS CHEM PHYS, V10, P6311, DOI 10.5194/acp-10-6311-2010; Chan CK, 2008, ATMOS ENVIRON, V42, P1, DOI 10.1016/j.atmosenv.2007.09.003; Parrish DD, 2010, ATMOS CHEM PHYS, V10, P10093, DOI 10.5194/acp-10-10093-2010; Kaneyasu N, 2000, J GEOPHYS RES-ATMOS, V105, P17361, DOI 10.1029/2000JD900138; Shimohara T, 2001, ATMOS ENVIRON, V35, P667, DOI 10.1016/S1352-2310(00)00340-X; Kusunoki K, 2012, WATER AIR SOIL POLL, V223, P1151, DOI 10.1007/s11270-011-0932-4; Pan YP, 2013, SCI TOTAL ENVIRON, V461, P761, DOI 10.1016/j.scitotenv.2013.04.065; Chen LL, 1997, J GEOPHYS RES-ATMOS, V102, P28551, DOI 10.1029/97JD01431; Hatakeyama S, 2014, ATMOS ENVIRON, V97, P456, DOI 10.1016/j.atmosenv.2014.02.040; Hayami H, 2005, ATMOS ENVIRON, V39, P2243, DOI 10.1016/j.atmosenv.2004.12.038; Huang M, 2010, ATMOS CHEM PHYS, V10, P6947, DOI 10.5194/acp-10-6947-2010; Hyogo Prefecture, 2011, YEARL VAR MET EL SUS; Ikeda K., 2013, J AIR WASTE IN PRESS; Itahashi S, 2012, ATMOS CHEM PHYS, V12, P2631, DOI 10.5194/acp-12-2631-2012; Kaneyasu N, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004137; Kaneyasu N., 2010, J JPN SOC ATMOS ENV, V45, P171; MUKAI H, 1990, ATMOS ENVIRON A-GEN, V24, P1379, DOI 10.1016/0960-1686(90)90044-N; Oishi O., 2009, P 9 ANN M KYUSH BRAN, P25; Okuda T, 2008, CHEMOSPHERE, V72, P917, DOI 10.1016/j.chemosphere.2008.03.033; Okuda T, 2013, AEROSOL AIR QUAL RES, V13, P436, DOI 10.4209/aaqr.2012.09.0250; Park MH, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004110; Takami A, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008120; Yonemochi S., 2013, J JPN SOC ATMOS ENV, V48, P140, DOI 10.11298/taiki.48.140	29	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	NOV	2014	97				SI		416	425		10.1016/j.atmosenv.2014.01.029		10	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AR1HQ	WOS:000343336700043		
J	Zaizen, Y; Naoe, H; Takahashi, H; Igarashi, Y				Zaizen, Yuji; Naoe, Hiroaki; Takahashi, Hiroshi; Igarashi, Yasuhito			Reprint of: Number concentrations and elemental compositions of aerosol particles observed at Mt. Kiso-Komagatake in central Japan, 2010-2013	ATMOSPHERIC ENVIRONMENT			English	Article						Particle number concentration; Elemental composition; The free troposphere	ASIAN DUST; FREE TROPOSPHERE; BOUNDARY-LAYER; CHEMICAL-COMPOSITION; SIZE DISTRIBUTION; SEA-SALT; MODEL; SIMULATION; TRANSPORT; TATEYAMA	Aerosols in the lower troposphere over Japan are considered being influenced by those transported from Asian continent by westerly winds. In this study, we investigated the seasonal variation of aerosol number concentrations measured by means of optical particle counters at Mt. Kiso-Komagatake (2610 m altitude) in central Japan during the period from January 2010 to May 2013. We also collected aerosol samples in different seasons during part of the observation period and investigated their elemental compositions using transmission electron microscopy (TEM) combined with energy dispersive X-ray spectroscopy (EDX). The seasonal variation of the number concentrations suggested that accumulation-mode particles (particle diameter > 0.3 mu m) increased during late spring perhaps owing to gas-to-particle conversion by means of photochemical reactions. The number concentrations of supermicron particles (>1 mu m) were highest in spring, during which Asian dust events were frequent. Short-duration spikes in aerosol number concentrations, which were attributed to long-range transport from the Asian continent, were frequently observed in all seasons except summer. TEM analysis indicated that sulfate was the predominant component of accumulation-mode particles throughout the year. The number fraction of carbonaceous particles was also considerable, especially in samples in fall. The predominant components of supermicron particles collected during winter, spring and fall, and summer were sulfate, minerals, and sea salt, respectively. Our results suggest that the lower tropospheric air over central Japan is strongly influenced by long-range transport of aerosols in all seasons except summer. (C) 2014 Elsevier B.V. All rights reserved.	[Zaizen, Yuji; Naoe, Hiroaki; Takahashi, Hiroshi; Igarashi, Yasuhito] Meteorol Res Inst, Tsukuba, Ibaraki 3050052, Japan	Zaizen, Y (reprint author), Meteorol Res Inst, 1-1 Nagamine, Tsukuba, Ibaraki 3050052, Japan.	yzaizen@mri-jma.go.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [201200061, A02-P05]	The present work was supported by a Grant-in-Aid for Scientific Research (no. 201200061(AKENHI) in Innovative Areas (Impacts of Aerosols in East Asia on Plants and Human Health) within the research group A02-P05 (Study of the Distribution and Movement of Aerosols Using Lidar and Ground-Based Monitoring Networks) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors are very grateful to Dr. Sugimoto and to the National Institute for Environmental Studies, Japan for the lidar data. The authors also thank Dr. Takemura and the Research Institute for Applied Mechanics Kyushu for permitting the use of figures calculated by SPRINTARS. We also especially thank Chuo Alps Kanko Co. for help with observations.	Takami A, 2005, ATMOS ENVIRON, V39, P4913, DOI 10.1016/j.atmosenv.2005.04.038; Henne S, 2004, ATMOS CHEM PHYS, V4, P497; Takemura T, 2000, J GEOPHYS RES-ATMOS, V105, P17853, DOI 10.1029/2000JD900265; CLIFF G, 1975, J MICROSC-OXFORD, V103, P203; Takemura T, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005029; Weiss-Penzias P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006522; Osada K, 2009, ATMOS CHEM PHYS, V9, P9111; Saleeby SM, 2010, J ATMOS SCI, V67, P3916, DOI 10.1175/2010JAS3528.1; Nishizawa T, 2011, J QUANT SPECTROSC RA, V112, P254, DOI 10.1016/j.jqsrt.2010.06.002; Cozic J, 2008, ATMOS CHEM PHYS, V8, P407; Sugimoto N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016349; Yang CY, 2005, INHAL TOXICOL, V17, P817, DOI 10.1080/08958370500241254; Donahue NM, 2013, ENVIRON CHEM, V10, P151, DOI 10.1071/EN13022; Nakajima T, 2000, APPL OPTICS, V39, P4869, DOI 10.1364/AO.39.004869; Takemura T, 2002, J CLIMATE, V15, P333, DOI 10.1175/1520-0442(2002)015<0333:SSAARF>2.0.CO;2; Kanatani KT, 2010, AM J RESP CRIT CARE, V182, P1475, DOI 10.1164/rccm.201002-0296OC; Sugimoto N, 2010, SOLA, V6, P93, DOI 10.2151/sola.2010-024; Dokiya Y., 2001, ANAL SCI           S, V17, pi809; Hatakeyama S, 2011, AEROSOL AIR QUAL RES, V11, P497, DOI 10.4209/aaqr.2011.06.0076; Hess Draxler, 2004, 224 ERL ARL; Igarashi I., 2009, EAROZORU KENKYU, V24, P90; Kajino K., 2013, ATMOS ENVIRON, V79, P67; Naoe H, 2012, ATMOS RES, V118, P170, DOI 10.1016/j.atmosres.2012.06.014; Naoe H, 2003, ATMOS ENVIRON, V37, P3047, DOI 10.1016/S1352-2310(03)00295-4; Niimura N, 1998, J METEOROL SOC JPN, V76, P275; Nishizawa T, 2010, ATMOS RES, V96, P602, DOI 10.1016/j.atmosres.2010.02.002; Raes F, 1997, J GEOPHYS RES-ATMOS, V102, P21315, DOI 10.1029/97JD01122; Shimizu A, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2002JD003253; Takahashi H, 2010, ATMOS ENVIRON, V44, P4638, DOI 10.1016/j.atmosenv.2010.08.007; TSUTSUMI Y, 1994, GEOPHYS RES LETT, V21, P1727, DOI 10.1029/94GL01107; Watanabe K, 2013, J ATMOS CHEM, V70, P115, DOI 10.1007/s10874-013-9258-5; Weber RJ, 1996, J GEOPHYS RES-ATMOS, V101, P14767, DOI 10.1029/95JD02271; Yamashita K, 2011, J METEOROL SOC JPN, V89, P581, DOI 10.2151/jmsj.2011-512; Zaizen Y., 2013, ATMOSPHERIC EN UNPUB	34	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	NOV	2014	97				SI		426	434		10.1016/j.atmosenv.2014.08.055		9	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AR1HQ	WOS:000343336700044		
J	Zaizen, Y; Naoe, H; Takahashi, H; Okada, K				Zaizen, Yuji; Naoe, Hiroaki; Takahashi, Hiroshi; Okada, Kikuo			Modification of Asian-dust particles transported by different routes - A case study	ATMOSPHERIC ENVIRONMENT			English	Article						Asian dust; Electron microscopy; Size distribution; Mineral aerosol; Mixing state	MARINE BOUNDARY-LAYER; NORTH PACIFIC-OCEAN; MINERAL DUST; SIZE DISTRIBUTIONS; STORM PARTICLES; MT. HARUNA; AEROSOL; EVENTS; CHINA; JAPAN	Two separate Asian dust events occurred before and after the passage of a cold front over Japan on 21 March 2010. According to back trajectories and a model simulation, the two dusty air-masses originated from the same region in Mongoria or northern China and were transported over different routes to Japan. Samples of aerosol particles from both airmasses were collected at Tsukuba and Mt. Haruna and examined by single-particle analysis using a transmission electron microscope and an energy dispersive X-ray analyzer. The mixing properties of mineral aerosol were quite different in the two airmasses and size ranges. In the prefrontal airmass, which were associated with pollution, most of fine (<1 mu m) mineral aerosol was internally mixed with sulfate. On the contrary, mineral aerosols in the postfront airmass, which were relatively natural, were mostly externally mixed. In the latter case, the internal mixing was associated with Ca, however in the former case, mixing processes not concerning mineralogy was suggested. (C) 2014 Elsevier Ltd. All rights reserved.	[Zaizen, Yuji; Naoe, Hiroaki; Takahashi, Hiroshi; Okada, Kikuo] Meteorol Res Inst, Tsukuba, Ibaraki 3050052, Japan	Zaizen, Y (reprint author), Meteorol Res Inst, 1-1 Nagamine, Tsukuba, Ibaraki 3050052, Japan.	yzaizen@mri-jma.go.jp; hnaoe@met.kishou.gajp; htakahas@mri-jma.go.jp; kokada@kni.biglobe.ne.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [20120006, A02-P05]	The present work was supported by a Grant-in-Aid (grant number: 20120006) for Scientific Research (KAKENHI) in Innovative Areas, "Impacts of Aerosols in East Asia on Plants and Human Health", within the research group A02-P05: "Study of the distribution and movement of aerosols using lidar and ground-based monitoring networks. "from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	UEMATSU M, 1983, J GEOPHYS RES-OC ATM, V88, P5343, DOI 10.1029/JC088iC09p05343; Matsuki A, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024176; Egerton RF, 2004, MICRON, V35, P399, DOI 10.1016/j.micron.2004.02.003; Klein H, 2010, ATMOS CHEM PHYS, V10, P10211, DOI 10.5194/acp-10-10211-2010; Zhang DZ, 1999, ATMOS ENVIRON, V33, P3213, DOI 10.1016/S1352-2310(99)00116-8; Matsumoto K, 2003, J GEOPHYS RES-ATMOS, V108, DOI [10.1029/2003JD003426, 10.1029/2002JD003426]; CLIFF G, 1975, J MICROSC-OXFORD, V103, P203; DALMEIDA GA, 1983, J CLIM APPL METEOROL, V22, P233, DOI 10.1175/1520-0450(1983)022<0233:NMAVDO>2.0.CO;2; Uematsu M, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000333; Posfai M, 2013, ATMOS RES, V122, P347, DOI 10.1016/j.atmosres.2012.12.001; Posfai M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002291; Vester BP, 2007, ATMOS ENVIRON, V41, P6102, DOI 10.1016/j.atmosenv.2007.04.021; Sugimoto N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016349; Yang CY, 2005, INHAL TOXICOL, V17, P817, DOI 10.1080/08958370500241254; Karydis VA, 2011, J GEOPHYS RES-ATMOS, V116, DOI [10.1029/20113D016283, 10.1029/2011JD016283]; Kanatani KT, 2010, AM J RESP CRIT CARE, V182, P1475, DOI 10.1164/rccm.201002-0296OC; Chun Y, 2001, ATMOS ENVIRON, V35, P2715, DOI 10.1016/S1352-2310(00)00404-0; DeMott PJ, 2003, P NATL ACAD SCI USA, V100, P14655, DOI 10.1073/pnas.2532677100; Wurzler S, 2000, J GEOPHYS RES-ATMOS, V105, P4501, DOI 10.1029/1999JD900980; Sullivan RC, 2007, ATMOS ENVIRON, V41, P7166, DOI 10.1016/j.atmosenv.2007.05.047; Bates TS, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004094; Dentener FJ, 1996, J GEOPHYS RES-ATMOS, V101, P22869, DOI 10.1029/96JD01818; Draxler R.R., 2004, ARL224 ERL NAT OC AT; DUCE R A, 1991, Global Biogeochemical Cycles, V5, P193, DOI 10.1029/91GB01778; Falkovich AH, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003919; Inomata Y, 2011, ATMOS ENVIRON, V45, P4429, DOI 10.1016/j.atmosenv.2011.05.038; IWASAKA Y, 1988, Tellus Series B Chemical and Physical Meteorology, V40, P494; Koehler KA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037348; Kojima T, 2006, ATMOS RES, V82, P698, DOI 10.1016/j.atmosres.2006.02.024; Niimura N, 1998, J METEOROL SOC JPN, V76, P275; OKADA K, 1990, ATMOS ENVIRON A-GEN, V24, P1369, DOI 10.1016/0960-1686(90)90043-M; OKADA K, 1995, J METEOROL SOC JPN, V73, P947; Osada K, 2013, ATMOS RES, V124, P101, DOI 10.1016/j.atmosres.2013.01.001; SHIMIZU A, 2004, J GEOPHYS RES-ATMOS, V109, P19517, DOI DOI 10.1029/2002JD003253; SVIRIDENKOV MA, 1993, ATMOS ENVIRON A-GEN, V27, P2481, DOI 10.1016/0960-1686(93)90019-U; Takahashi H, 2010, ATMOS ENVIRON, V44, P4638, DOI 10.1016/j.atmosenv.2010.08.007; Tanaka T.Y., 2003, PAP METEOROL GEOPHYS, V53, P119, DOI DOI 10.2467/MRIPAPERS.53.119; Tegan I., 1996, NATURE, V380, P419; Twohy CH, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035846; Usher CR, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002051; Yaacov M., 1989, J AEROSOL SCI, V20, P303; Yoshioka M., 2005, J GEOPHYS RES, V110, P1; ZAIZEN Y, 1995, J METEOROL SOC JPN, V73, P891; Zhang DZ, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005305; Zhang DZ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003869	45	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	NOV	2014	97				SI		435	446		10.1016/j.atmosenv.2014.05.005		12	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AR1HQ	WOS:000343336700045		
J	Hidemori, T; Nakayama, T; Matsumi, Y; Kinugawa, T; Yabushita, A; Ohashi, M; Miyoshi, T; Irei, S; Takami, A; Kaneyasu, N; Yoshino, A; Suzuki, R; Yumoto, Y; Hatakeyama, S				Hidemori, Takehiro; Nakayama, Tomoki; Matsumi, Yutaka; Kinugawa, Takashi; Yabushita, Akihiro; Ohashi, Masafumi; Miyoshi, Takao; Irei, Satoshi; Takami, Akinori; Kaneyasu, Naoki; Yoshino, Ayako; Suzuki, Ryota; Yumoto, Yayoi; Hatakeyama, Shiro			Characteristics of atmospheric aerosols containing heavy metals measured on Fukue Island, Japan	ATMOSPHERIC ENVIRONMENT			English	Article						Particulate matter; Single-particle mass spectrometer; Lead; Vanadium; Concentration-weighted trajectory analysis	PARTICLE MASS-SPECTROMETRY; ATLANTA SUPERSITE PROJECT; PARTICULATE MATTER; SOURCE APPORTIONMENT; SIZE DISTRIBUTIONS; TRACE-ELEMENTS; AIR-QUALITY; LEAD; EMISSIONS; IMPACT	To investigate transport and chemical compositions of fine aerosols in the East Asian region, aerosol chemical components and their mixing states were measured at Fukue Island in the spring of 2010. Offline chemical analyses using an ion chromatographic analyzer and an inductively coupled plasma mass spectrometer for the aerosols sampled by a high volume sampler have also been conducted. The mixing state and temporal variation of number concentrations of the particles containing lead (Pb) and vanadium (V) were studied by using a laser ionization single particle aerosol mass spectrometer (LISPA-MS). The temporal variation of number concentrations of particles containing Pb measured by the LISPA-MS is well consistent with those obtained by the chemical analysis of the aerosols sampled by the high volume sampler. The Pb-containing particles were classified into four types from the statistical analysis on the basis of the single-particle mass spectra with assists of laboratory experiments. It is estimated that 52% of observed particles containing Pb were originated from coal combustion. The concentration-weighted trajectory (CWT) analysis suggests that these particles are mainly transported from China continent. The V-containing particles were classified into three types. The 41% of V-containing particles were internally mixed with sea salt and the result of CWT analysis suggests that the potentially anthropogenic V-containing particles possibility emitted from ships are mixing with sea salt in the region that is highly loaded with sea salt in the Pacific Ocean. (C) 2014 Elsevier Ltd. All rights reserved.	[Hidemori, Takehiro; Nakayama, Tomoki; Matsumi, Yutaka] Nagoya Univ, Solar Terr Environm Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Hidemori, Takehiro; Nakayama, Tomoki; Matsumi, Yutaka] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Kinugawa, Takashi; Yabushita, Akihiro] Kyoto Univ, Grad Sch Engn, Kyoto 6158510, Japan; [Ohashi, Masafumi] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan; [Miyoshi, Takao; Irei, Satoshi; Takami, Akinori] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Yoshino, Ayako; Suzuki, Ryota; Yumoto, Yayoi; Hatakeyama, Shiro] Tokyo Univ Agr & Technol, Grad Sch Agr & Technol, Fuchu, Tokyo 1838509, Japan; [Yabushita, Akihiro] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan	Hidemori, T (reprint author), Nagoya Univ, Solar Terr Environm Lab, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	hidemori.takehiro@stelab.nagoya-u.ac.jp	Nakayama, Tomoki/I-6230-2014; Hatakeyama, Shiro/D-2001-2010	Nakayama, Tomoki/0000-0002-5554-1272; Hatakeyama, Shiro/0000-0002-9357-4091	Impacts of Aerosols in East Asia on Plants and Human Health [20120007]; Steel Foundation for Environmental Protection Technology	This work was supported by a Grant-in-Aid on Innovative Areas "Impacts of Aerosols in East Asia on Plants and Human Health" (Grant No. 20120007). A.Y. appreciates financial support from the Steel Foundation for Environmental Protection Technology.	Song XH, 1999, ANAL CHEM, V71, P860, DOI 10.1021/ac9809682; Takami A, 2005, ATMOS ENVIRON, V39, P4913, DOI 10.1016/j.atmosenv.2005.04.038; Duan JC, 2013, ATMOS ENVIRON, V74, P93, DOI 10.1016/j.atmosenv.2013.03.031; Schleicher NJ, 2011, ATMOS ENVIRON, V45, P7248, DOI 10.1016/j.atmosenv.2011.08.067; Zhao PS, 2013, ATMOS CHEM PHYS, V13, P4631, DOI 10.5194/acp-13-4631-2013; Agrawal H, 2008, ATMOS ENVIRON, V42, P5504, DOI 10.1016/j.atmosenv.2008.02.053; Jung CH, 2004, WASTE MANAGE, V24, P381, DOI 10.1016/S0956-053X(03)00137-5; Ng NL, 2010, ATMOS CHEM PHYS, V10, P4625, DOI 10.5194/acp-10-4625-2010; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419; Moreno T, 2013, ATMOS CHEM PHYS, V13, P1411, DOI 10.5194/acp-13-1411-2013; Zhang YP, 2009, CHEMOSPHERE, V74, P501, DOI 10.1016/j.chemosphere.2008.10.004; Duan JC, 2012, J ENVIRON SCI-CHINA, V24, P87, DOI 10.1016/S1001-0742(11)60731-6; Murphy DM, 2007, ATMOS CHEM PHYS, V7, P3195; Watson JG, 2008, J AIR WASTE MANAGE, V58, P265, DOI 10.3155/1047-3289.58.2.265; ANDREAE MO, 1986, SCIENCE, V232, P1620, DOI 10.1126/science.232.4758.1620; Ault AP, 2009, ENVIRON SCI TECHNOL, V43, P3500, DOI 10.1021/es8018918; Chen JM, 2008, J HAZARD MATER, V156, P36, DOI 10.1016/j.jhazmat.2007.11.122; Cho SH, 2011, ATMOS ENVIRON, V45, P5005, DOI 10.1016/j.atmosenv.2011.05.009; DRAXLER RR, 1991, J APPL METEOROL, V30, P1466; Draxler R.R., 2003, HYSPLIT HYBRID SINGL; Furutani H, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015867; Hayami H, 2005, ATMOS ENVIRON, V39, P2243, DOI 10.1016/j.atmosenv.2004.12.038; Healy RM, 2010, ATMOS CHEM PHYS, V10, P9593, DOI 10.5194/acp-10-9593-2010; *IPCS, 2005, CONCISE INTERNATIONA; Kaneyasu N, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004137; Kaneyasu N, 2014, ATMOS ENVIRON, V97, P416, DOI 10.1016/j.atmosenv.2014.01.029; Kim KH, 2009, ENVIRON SCI POLLUT R, V16, P565, DOI 10.1007/s11356-009-0104-x; Lee SH, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000011; Lewtas J, 2007, MUTAT RES-REV MUTAT, V636, P95, DOI 10.1016/j.mrrev.2007.08.003; Lighty JS, 2000, J AIR WASTE MANAGE, V50, P1565; Matsumoto J, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025782; Middlebrook AM, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000660; Mizohata A., 1986, J AEROSOL RES JPN, V1, P274; Phares DJ, 2001, ANAL CHEM, V73, P2338, DOI 10.1021/ac0015063; Reinard MS, 2007, ATMOS ENVIRON, V41, P9397, DOI 10.1016/j.atmosenv.2007.09.001; WEDEPOHL KH, 1971, GEOCHEMISTRY, P65	36	5	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	NOV	2014	97				SI		447	455		10.1016/j.atmosenv.2014.05.008		9	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AR1HQ	WOS:000343336700046		
J	Hatakeyama, S; Ikeda, K; Hanaoka, S; Watanabe, I; Arakaki, T; Bandow, H; Sadanaga, Y; Kato, S; Kajii, Y; Zhang, DZ; Okuyama, K; Ogi, T; Fujimoto, T; Seto, T; Shimizu, A; Sugimoto, N; Takami, A				Hatakeyama, Shiro; Ikeda, Keisuke; Hanaoka, Sayuri; Watanabe, Izumi; Arakaki, Takemitsu; Bandow, Hiroshi; Sadanaga, Yasuhiro; Kato, Shungo; Kajii, Yoshizumi; Zhang, Daizhou; Okuyama, Kikuo; Ogi, Takashi; Fujimoto, Toshiyuki; Seto, Takafumi; Shimizu, Atsushi; Sugimoto, Nobuo; Takami, Akinori			Aerial observations of air masses transported from East Asia to the Western Pacific: Vertical structure of polluted air masses	ATMOSPHERIC ENVIRONMENT			English	Article						Aerial observation; Asian dust; East China Sea; Ionic aerosol component; Metallic element	PARTICLES; CHINA; MISSION; AREAS	There has been only limited information about the vertical chemical structure of the atmosphere, so far. We conducted aerial observations on 11, 12, and 14 December 2010 over the northern part of the East China Sea to analyze the spatial distribution of atmospheric pollutants from East Asia and to elucidate transformation processes of air pollutants during the long-range transport. On 11 December, a day on which Asian dust created hazy conditions, the average PM10 concentration was 40.69 mu g m(-3), and we observed high concentrations of chemical components such as Ca2+, NO3-, SO42-, Al, Ca, Fe, and Zn. The height of the boundary layer was about 1200 m, and most species of pollutants (except for dust particles and SO2) had accumulated within the boundary layer. In contrast, concentrations of pollutants were low in the boundary layer (up to 1000 m) on 12 December because clean Pacific air from the southeast had diluted the haze. However, we observed natural chemical components (Na+, Cl-, Al, Ca, and Fe) at 3000 m, the indication being that dust particles, including halite, were present in the lower free troposphere. On 14 December, peak concentrations of SO2 and black carbon were measured within the boundary layer (up to 700 m) and at 2300 m. The concentrations of anthropogenic chemical components such as NO3-, NH4+, and Zn were highest at 500 m, and concentrations of both anthropogenic and natural chemical components (SO42-, Pb, Ca2+, Ca, Al, and Fe) were highest at 2000 m. Thus, it was clearly indicated that the air above the East China Sea had a well-defined, layered structure below 3000 m. (C) 2014 The Authors. Published by Elsevier Ltd.	[Hatakeyama, Shiro; Ikeda, Keisuke; Hanaoka, Sayuri; Watanabe, Izumi] Tokyo Univ Agr & Technol, Fac Agr, Dept Environm & Nat Resource Sci, Fuchu, Tokyo 1838509, Japan; [Arakaki, Takemitsu] Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, Nishihara Town, Okinawa 9030213, Japan; [Bandow, Hiroshi; Sadanaga, Yasuhiro] Osaka Prefecture Univ, Dept Appl Chem, Fac Engn, Naka Ku, Sakai, Osaka 5998531, Japan; [Kato, Shungo; Kajii, Yoshizumi] Tokyo Metropolitan Univ, Fac Urban Environm Sci, Div Appl Chem, Hachioji, Tokyo 1920397, Japan; [Zhang, Daizhou] Prefectural Univ Kumamoto, Fac Environm & Symbiot Sci, Dept Environm Resources, Higashi Ku, Kumamoto 8628502, Japan; [Okuyama, Kikuo; Ogi, Takashi] Hiroshima Univ, Dept Chem Engn, Fac Engn, Higashihiroshima, Hiroshima 7398527, Japan; [Fujimoto, Toshiyuki] Muroran Inst Technol, Dept Appl Chem, Muroran, Hokkaido 0508585, Japan; [Seto, Takafumi] Kanazawa Univ, Sch Nat Syst, Coll Sci & Engn, Kanazawa, Ishikawa 9201192, Japan; [Shimizu, Atsushi; Sugimoto, Nobuo; Takami, Akinori] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan	Hatakeyama, S (reprint author), Tokyo Univ Agr & Technol, Fac Agr, Dept Environm & Nat Resource Sci, 3-5-8 Saiwaicho, Fuchu, Tokyo 1838509, Japan.	hatashir@cc.tuat.ac.jp	Seto, Takafumi/D-2874-2012; okuyama, kikuo/F-6092-2010; Shimizu, Atsushi/C-2810-2009; Sugimoto, Nobuo/C-5189-2015; Watanabe, Izumi/C-2086-2013; Hatakeyama, Shiro/D-2001-2010; Ogi, Takashi/F-4138-2010	Shimizu, Atsushi/0000-0002-7306-7412; Sugimoto, Nobuo/0000-0002-0545-1316; Watanabe, Izumi/0000-0003-2319-9713; Hatakeyama, Shiro/0000-0002-9357-4091; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [4003]	This research was supported by Grant-in-Aid for Scientific Research on Innovative Areas No. 4003 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Li C, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012245; Aikawa M, 2010, ATMOS ENVIRON, V44, P381, DOI 10.1016/j.atmosenv.2009.10.025; Huebert BJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003550; Hatakeyama S, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004271; Yuba A, 2010, ANAL CHEM, V82, P8916, DOI 10.1021/ac101704w; Akimoto H, 2003, SCIENCE, V302, P1716, DOI 10.1126/science.1092666; Uno I, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003252; He H, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016473; Liang Q, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2005JD005788; Jacob DJ, 2003, J GEOPHYS RES-ATMOS, V108, P1, DOI 10.1029/2002JD003276; Draxler R.R., 2003, HYSPLIT HYBRID SINGL; Hatakeyama S, 2011, AEROSOL AIR QUAL RES, V11, P497, DOI 10.4209/aaqr.2011.06.0076; Hatakeyama S, 2005, ATMOS ENVIRON, V39, P5893, DOI 10.1016/j.atmonsenv.2005.06.025; Hatakeyama S., 2001, WATER AIR SOIL POLL, V130, P373; Hioki T., 2009, J JAPAN SOC ATMOSPHE, V44, P91; Hoell JM, 1997, J GEOPHYS RES-ATMOS, V102, P28223, DOI 10.1029/97JD02581; Kaneyasu N, 2011, J JPN SOC ATMOS ENV, V46, P111; Liu J., 2008, ATMOSPHERIC CHEM PHY, V8, P5537; Maxwell-Meier K, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004464; Mizohata A., 1980, J JAPAN SOC AIR POLL, V15, P198; Ohara T., 2007, ATMOS CHEM PHYS DISC, V7, P6843, DOI DOI 10.5194/ACPD-7-6843-2007; Okada K, 2004, ATMOS ENVIRON, V38, P6927, DOI 10.1016/j.atmosenv.2004.03.078; Wang W, 2008, ATMOS ENVIRON, V42, P5715, DOI 10.1016/j.atmosenv.2008.03.042; Wang W, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006753	24	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	NOV	2014	97				SI		456	461		10.1016/j.atmosenv.2014.02.040		6	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AR1HQ	WOS:000343336700047		
J	Fujiwara, H; Sadanaga, Y; Urata, J; Masui, Y; Bandow, H; Ikeda, K; Hanaoka, S; Watanabe, I; Arakaki, T; Kato, S; Kajii, Y; Zhang, DZ; Hara, K; Fujimoto, T; Seto, T; Okuyama, K; Ogi, T; Takami, A; Shimizu, A; Hatakeyama, S				Fujiwara, Hiroshi; Sadanaga, Yasuhiro; Urata, Junki; Masui, Yoshihiko; Bandow, Hiroshi; Ikeda, Keisuke; Hanaoka, Sayuri; Watanabe, Izumi; Arakaki, Takemitsu; Kato, Shungo; Kajii, Yoshizumi; Zhang, Daizhou; Hara, Kazutaka; Fujimoto, Toshiyuki; Seto, Takafumi; Okuyama, Kikuo; Ogi, Takashi; Takami, Akinori; Shimizu, Atsushi; Hatakeyama, Shiro			Aerial observation of nitrogen compounds over the East China Sea in 2009 and 2010	ATMOSPHERIC ENVIRONMENT			English	Article						Aerial observation; Nitrate; Total odd nitrogen species; East Asia	DRY DEPOSITION; NITRIC-ACID; CHEMILUMINESCENCE METHOD; OZONE CHEMILUMINESCENCE; CHEMICAL-COMPOSITION; PARTICULATE NITRATE; AIR-POLLUTANTS; UNITED-STATES; FUKUE ISLAND; JAPAN	Aerial observations of atmospheric pollutants were made over the East China Sea to analyze the transport of air pollutants, especially nitrogen oxides, from East Asia. Three flights each were conducted in October 2009 (autumn) and December 2010 (winter). Onboard measurements of gaseous total odd nitrogen species, gaseous nitric acid (HNO3(g)), O-3, SO2, CO and black carbon were made and particles were collected on filters for ionic and metal component analyses. The NO3-(p)/T.NO3 (T.NO3 = HNO3(g) NO3-(p); NOT(p) indicates particulate nitrate) ratios were less than 0.5 in most cases. Exceptions were 17 October and 11 December, when high concentrations of dust particles (Rosa) were transported. The average T.NO3/NOy (NOy indicates total odd nitrogen species) ratio in winter was 0.59, and that in autumn was 0.71. In addition, positive and negative correlations between NOy - T.NO3 and ozone were observed in autumn and winter, respectively. These results indicate that the main components of NOy - T.NO3 are NOx and its descendant photochemical products, such as peroxyacyl nitrates and alkyl nitrates, in winter and autumn, respectively. Ratios of Na+ to Cl- + NO3- in particles were close to the seawater ratio for observations in both autumn and winter, save for the Rosa events. The main NO3-(p) formation process was the reaction of HNO3(g) with sea salt aerosols during autumn and winter. On the other hand, NO3-(p) was generated by the reaction of HNO3(g) with dust particles and sea salt during the Rosa events. The fraction of NH4NO3 in NO3-(p) was very small. (C) 2014 Elsevier Ltd. All rights reserved.	[Fujiwara, Hiroshi; Sadanaga, Yasuhiro; Urata, Junki; Masui, Yoshihiko; Bandow, Hiroshi] Osaka Prefecture Univ, Grad Sch Engn, Naka Ku, Sakai, Osaka 5998531, Japan; [Ikeda, Keisuke; Hanaoka, Sayuri; Watanabe, Izumi; Hatakeyama, Shiro] Tokyo Univ Agr & Technol, Inst Symbiot Sci & Technol, Fuchu, Tokyo 1838509, Japan; [Arakaki, Takemitsu] Univ Ryukyus, Fac Sci, Nishihara, Okinawa 9030213, Japan; [Kato, Shungo; Kajii, Yoshizumi] Tokyo Metropolitan Univ, Fac Urban Environm Sci, Hachioji, Tokyo 1920397, Japan; [Zhang, Daizhou; Hara, Kazutaka] Prefectural Univ Kumamoto, Fac Environm & Symbiot Sci, Higashi Ku, Kumamoto 8628502, Japan; [Fujimoto, Toshiyuki] Muroran Inst Technol, Dept Div Appl Sci, Muroran, Hokkaido 0508585, Japan; [Seto, Takafumi] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Okuyama, Kikuo; Ogi, Takashi] Hiroshima Univ, Grad Sch Engn, Higashihiroshima, Hiroshima 7398527, Japan; [Takami, Akinori; Shimizu, Atsushi] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan	Sadanaga, Y (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	sadanaga@chem.osakafu-u.ac.jp	Seto, Takafumi/D-2874-2012; okuyama, kikuo/F-6092-2010; Shimizu, Atsushi/C-2810-2009; Watanabe, Izumi/C-2086-2013; Hatakeyama, Shiro/D-2001-2010; Ogi, Takashi/F-4138-2010	Shimizu, Atsushi/0000-0002-7306-7412; Watanabe, Izumi/0000-0003-2319-9713; Hatakeyama, Shiro/0000-0002-9357-4091; 	Impacts of Aerosols in East Asia on Plants and Human Health (ASEPH)	The authors are grateful to Dr. Sin-Young Lee, Mr. Ryo Tsutsui (Hiroshima University) and Mr. Sotaro Azechi (University of the Ryukyus) for help with the observations. Solar radiation data at he ground-based air monitoring station at Fukue Island were provided by SKYNET FUKUEJIMA (http://atmos.cr.chiba-u.ac.jp/). This research has been supported by Grant-in-Aid for Scientific Research on Innovative Areas "Impacts of Aerosols in East Asia on Plants and Human Health (ASEPH)."	Zhang Q, 2009, ATMOS CHEM PHYS, V9, P5131; Liu Y, 2007, J PHYS CHEM A, V111, P10026, DOI 10.1021/jp072005p; Takami A, 2005, ATMOS ENVIRON, V39, P4913, DOI 10.1016/j.atmosenv.2005.04.038; Huebert BJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003550; Hatakeyama S, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004271; Granier C, 2011, CLIMATIC CHANGE, V109, P163, DOI [10.1007/s10584-011-0154-1, 10.1007/S10584-011-0154-1]; Klimont Z, 2009, TELLUS B, V61, P602, DOI 10.1111/j.1600-0889.2009.00428.x; Singh HB, 2009, ATMOS CHEM PHYS, V9, P2301; Bikkes M, 2001, J ANAL ATOM SPECTROM, V16, P74, DOI 10.1039/b005931p; Pratt GC, 1996, ENVIRON SCI TECHNOL, V30, P2168, DOI 10.1021/es9505558; Lee T, 2008, ATMOS ENVIRON, V42, P2720, DOI 10.1016/j.atmosenv.2007.05.016; Yuba A, 2010, ANAL CHEM, V82, P8916, DOI 10.1021/ac101704w; Kim HS, 2007, ATMOS ENVIRON, V41, P6762, DOI 10.1016/j.atmosenv.2007.04.060; Sadanaga Y, 2010, ANAL CHEM, V82, P9234, DOI 10.1021/ac101703z; Kim JH, 2005, J RES NATL INST STAN, V110, P31, DOI 10.6028/jres.110.005; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419; Jordan CE, 2003, J GEOPHYS RES-ATMOS, V108, P1, DOI 10.1029/2002JD003101; KLEINMAN L, 1994, J GEOPHYS RES-ATMOS, V99, P3469, DOI 10.1029/93JD02991; Hole LR, 2008, ENVIRON POLLUT, V154, P473, DOI 10.1016/j.envpol.2007.06.061; Arnold JR, 2007, ATMOS ENVIRON, V41, P4227, DOI 10.1016/j.atmosenv.2006.07.059; Shimohara T, 2001, ATMOS ENVIRON, V35, P667, DOI 10.1016/S1352-2310(00)00340-X; Zhu L, 2013, ATMOS ENVIRON, V69, P131, DOI 10.1016/j.atmosenv.2012.12.028; Mori I, 2003, ATMOS ENVIRON, V37, P4253, DOI 10.1016/S1352-2310(03)00535-1; Barile PJ, 2005, MAR POLLUT BULL, V50, P1262, DOI 10.1016/j.marpolbul.2005.04.031; Chou CCK, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010446; Hatakeyama S, 2011, AEROSOL AIR QUAL RES, V11, P497, DOI 10.4209/aaqr.2011.06.0076; Hatakeyama S, 2005, ATMOS ENVIRON, V39, P5893, DOI 10.1016/j.atmonsenv.2005.06.025; Hatakeyama S, 2014, ATMOS ENVIRON, V97, P456, DOI 10.1016/j.atmosenv.2014.02.040; HATAKEYAMA S, 1995, J GEOPHYS RES-ATMOS, V100, P23143, DOI 10.1029/95JD02269; Hinds WC, 1999, AEROSOL TECHNOLOGY; Lide D. R., 2008, CRC HDB CHEM PHYS; Marple V.A., 2011, AEROSOL MEASUREMENT, Vthird, P129; Matsumoto J, 2006, ATMOS ENVIRON, V40, P3230, DOI 10.1016/j.atmosenv.2006.02.002; Matsumoto K, 1996, ATMOS ENVIRON, V30, P639, DOI 10.1016/1352-2310(95)00290-1; Sadanaga Y, 2008, ANAL SCI, V24, P967, DOI 10.2116/analsci.24.967; Sadanaga Y, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035557; Sievering H, 2001, ATMOS ENVIRON, V35, P3851, DOI 10.1016/S1352-2310(01)00156-X; Takami A, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008120; Takiguchi Y, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009462; Tanner RL, 1998, J GEOPHYS RES-ATMOS, V103, P22387, DOI 10.1029/98JD00110; Wang GH, 2007, ENVIRON SCI TECHNOL, V41, P3115, DOI 10.1021/es062601h; Wang W, 2008, ATMOS ENVIRON, V42, P5715, DOI 10.1016/j.atmosenv.2008.03.042; Wang W, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006753; Yuba A, 2014, ATMOS ENVIRON, V97, P471, DOI 10.1016/j.atmosenv.2014.04.010	44	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	NOV	2014	97				SI		462	470		10.1016/j.atmosenv.2014.01.064		9	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AR1HQ	WOS:000343336700048		
J	Yuba, A; Sadanaga, Y; Takami, A; Hatakeyama, S; Mosui, Y; Ohara, T; Yonemura, S; Kato, S; Kajii, Y; Bandow, H				Yuba, Akie; Sadanaga, Yasuhiro; Takami, Akinori; Hatakeyama, Shiro; Mosui, Yoshihiko; Ohara, Toshimasa; Yonemura, Seiichiro; Kato, Shungo; Kajii, Yoshizumi; Bandow, Hiroshi			Concentration variations of total reactive nitrogen and total nitrate during transport to Fukue Island and to Cape Hedo, Japan in the marine boundary layer	ATMOSPHERIC ENVIRONMENT			English	Article						Total reactive nitrogen; Long-range transport; Removal rate; Lifetime; East Asia	OZONE CHEMILUMINESCENCE METHOD; HETEROGENEOUS REACTION; ATMOSPHERIC NITROGEN; SCRUBBER DIFFERENCE; DRY DEPOSITION; GASEOUS HNO3; PARTICLES; SITES; HUMIDITY; AEROSOLS	We conducted continuous measurements of NO and total nitrate (T.NO3 = HNO3 + NO3(-)(p)) at Fukue Island, Nagasaki, and Cape Hedo, Okinawa, Japan. We compared variations of NO or T.NO3 concentrations measured at two remote sites when the air masses were originated from the same regions of the Asian Continent. Long-range transport events from the Asian Continent were extracted by CO concentration peaks at Fukue and Hedo and backward trajectory analyses. We compared the transport time difference at two sites from the Asian continent with the ratios of NO at Hedo to that at Fukue (=R(NOy)) to find the predominant factor in NO removal. R(NO) were less than unity and decreased with the transport time difference. The ratios of NOy/CO at Redo to those at Fukue (R(NOy/CO)) was assumed to be affected by the deposition process. R(NOy/CO) showed negative correlation with transport time difference as the same the case of R(NOy). This indicates that NOy, was mainly removed by deposition rather than dilution. Air mass ages were classified by the ratio of T.NO3 to NO at Fukue: T.NO3/NOy < 0.2 was fresh air, 02-0.4 was middle-aged, and greater than 0.4 was aged. The ratios of T.NO3/NOy at Redo to those at Fukue (R(T.NO3/NOy)) in the fresh air mass were greater than unity. In contrast, R(T.NO3/NOy) values in the aged air mass were unity and were less correlated with transport time difference. This indicates that T.NO3 generation proceeded in fresh air mass. On the other hand, T.NO3 generation rate was comparable to removal rate in the aged air mass. According to the relationship between R(NOy/CO) and transport time difference, the removal rate constant and NO lifetime were (1.24 +/- 0.33) x 10(-5) s(-1) and 18-31 h, respectively. (C) 2014 Elsevier Ltd. All rights reserved.	[Yuba, Akie; Sadanaga, Yasuhiro; Mosui, Yoshihiko; Bandow, Hiroshi] Osaka Prefecture Univ, Grad Sch Engn, Naka Ku, Sakai, Osaka 5998531, Japan; [Takami, Akinori; Ohara, Toshimasa] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Hatakeyama, Shiro] Tokyo Univ Agr & Technol, Inst Symbiot Sci & Technol, Fuchu, Tokyo 1838509, Japan; [Yonemura, Seiichiro] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3508604, Japan; [Kato, Shungo; Kajii, Yoshizumi] Tokyo Metropolitan Univ, Fac Urban Environm Sci, Hachioji, Tokyo 1920397, Japan	Yuba, A (reprint author), Nagoya Univ, Solar Terr Environm Lab, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	yuba-a@stelab.nagoya-u.ac.jp; sadanaga@chem.osakafu-u.ac.jp; takamia@nies.go.jp; hatashir@cc.tuat.ac.jp; tohara@nies.go.jp; yone@affrc.go.jp; shungo@tmu.ac.jp; kajii.yoshizumi.7e@kyoto-u.ac.jp; bandow@chem.osakafu-u.ac.jp	Hatakeyama, Shiro/D-2001-2010	Hatakeyama, Shiro/0000-0002-9357-4091	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23120706, 21120508]; Western Pacific Air-Sea Interaction Study (WPASS) [18067011]	We are grateful to Mr. Yuji Takeda (National Institute for Environmental Studies) for help with observations at the CHAAMS. This research was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Impact of Aerosols in East Asia on Plants and Human Health (ASEPH)" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, under Grant No. 23120706 and 21120508, and Grant-in-Aid for Scientific Research in Priority Areas "Western Pacific Air-Sea Interaction Study (WPASS)" under Grant No. 18067011. This research is a contribution to the Surface Ocean Lower Atmosphere Study (SOLAS) Core Project of the International Geosphere-Biosphere Programme (IGBP). The NOAA Air Resources Laboratory (ARL) is acknowledged for provision of the HYSPLIT 4 model and READY website.	Liu Y, 2007, J PHYS CHEM A, V111, P10026, DOI 10.1021/jp072005p; Stohl A, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000519; [Anonymous], 2003, J GEOPHYS RES, DOI [DOI 10.1029/2002JD003093, 10.1029/2002JD003093]; Takami A, 2005, ATMOS ENVIRON, V39, P4913, DOI 10.1016/j.atmosenv.2005.04.038; Koike M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003284; Monks PS, 1998, ATMOS ENVIRON, V32, P3647, DOI 10.1016/S1352-2310(98)00084-3; Bikkes M, 2001, J ANAL ATOM SPECTROM, V16, P74, DOI 10.1039/b005931p; Brown SS, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019412; Yuba A, 2010, ANAL CHEM, V82, P8916, DOI 10.1021/ac101704w; Doney SC, 2007, P NATL ACAD SCI USA, V104, P14580, DOI 10.1073/pnas.0702218104; Dalsoren SB, 2009, ATMOS CHEM PHYS, V9, P2171; Bertram TH, 2009, ATMOS CHEM PHYS, V9, P8351; Yeatman SG, 2001, ATMOS ENVIRON, V35, P1321, DOI 10.1016/S1352-2310(00)00452-0; Takegawa N, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004866; Liu Y, 2008, J PHYS CHEM A, V112, P1561, DOI 10.1021/jp076169h; Atkinson R, 1997, J PHYS CHEM REF DATA, V26, P521; Barile PJ, 2005, MAR POLLUT BULL, V50, P1262, DOI 10.1016/j.marpolbul.2005.04.031; Deutsch D., 2007, NATURE, V445; Draxler R.R., 2013, HYSPLIT HYBIRD SINGL; Hayami H, 2005, ATMOS ENVIRON, V39, P2243, DOI 10.1016/j.atmosenv.2004.12.038; Horii CV, 2006, AGR FOREST METEOROL, V136, P159, DOI 10.1016/j.agrformet.2006.03.005; Huber G., 1992, J GEOPHYS RES, V97, P10427; Kanaya YG, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007987; Kanaya Y, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000858; Kawakami N., 2008, J GEOPHYS RES, V113; MacCabe D.C., 2001, GEOPHYS RES LETT, V28, P3135; Matsumoto K, 1998, ATMOS ENVIRON, V32, P1931, DOI 10.1016/S1352-2310(97)00499-8; Nowak JB, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004488; Osthoff HD, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007593; PARRISH DD, 1991, J GEOPHYS RES-ATMOS, V96, P9309, DOI 10.1029/91JD00047; Rolph G.D., 2013, REAL TIME ENV APPL D; Sadanaga Y, 2008, ANAL SCI, V24, P967, DOI 10.2116/analsci.24.967; Sadanaga Y, 2006, CHEM PHYS LETT, V419, P474, DOI 10.1016/j.cplett.2005.12.026; Sadanaga Y, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035557; Shepon A, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007458; Sievering H, 2001, ATMOS ENVIRON, V35, P3851, DOI 10.1016/S1352-2310(01)00156-X; Smith SC, 2006, ATMOS CHEM PHYS, V6, P1435; Takiguchi Y., 2008, J GEOPHYS RES, V113; Williams EJ, 1998, J GEOPHYS RES-ATMOS, V103, P22261, DOI 10.1029/98JD00074; Xia LL, 2010, MAR CHEM, V119, P77, DOI 10.1016/j.marchem.2010.01.002; Yamamoto M, 2001, ATMOS ENVIRON, V35, P5339, DOI 10.1016/S1352-2310(01)00297-7; Yonemura S, 1999, TELLUS B, V51, P688, DOI 10.1034/j.1600-0889.1999.t01-2-00009.x; Zhang GS, 2007, J ATMOS CHEM, V57, P41, DOI 10.1007/s10874-007-9060-3	43	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	NOV	2014	97				SI		471	478		10.1016/j.atmosenv.2014.04.010		8	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AR1HQ	WOS:000343336700049		
J	Arakaki, T; Azechi, S; Somada, Y; Ijyu, M; Nakaema, F; Hitomi, Y; Handa, D; Oshiro, Y; Miyagi, Y; Tsuhako, A; Murayama, H; Higaonna, Y; Tanahara, A; Itoh, A; Fukushima, S; Higashi, K; Henza, Y; Nishikawa, R; Shinjo, H; Wang, HY				Arakaki, Takemitsu; Azechi, Sotaro; Somada, Yuka; Ijyu, Moriaki; Nakaema, Fumiya; Hitomi, Yuya; Handa, Daishi; Oshiro, Yoshito; Miyagi, Youichi; Tsuhako, Ai; Murayama, Hitomi; Higaonna, Yumi; Tanahara, Akira; Itoh, Akihide; Fukushima, Soko; Higashi, Kazuaki; Henza, Yui; Nishikawa, Rin; Shinjo, Hibiki; Wang, Hongyan			Spatial and temporal variations of chemicals in the TSP aerosols simultaneously collected at three islands in Okinawa, Japan	ATMOSPHERIC ENVIRONMENT			English	Article						Water-soluble chemicals; Aerosol; East Asia; Okinawa	WATER-SOLUBLE FRACTION; BEIJING OLYMPIC GAMES; PHOTOCHEMICAL FORMATION; AIR-QUALITY; CARBON; SEA	East Asia's rapid economic growth has led to concerns about the emission of air pollutants. We collected total suspended particle (TSP) aerosol samples simultaneously at three islands in Okinawa, Japan, which are downwind of East Asia, during the Asian dust season, to examine the spatial and temporal variations and chemical transformations of major chemicals in the aerosols. Weekly samples were collected from July 2008 to June 2010, and the concentrations of water-soluble cations, anions, and organic carbon (WSOC) were determined (n = 303). Spatial distribution analysis showed that monthly mean concentrations of non-sea-salt (nss)-SO42- in the spring (Asian dust season) decreased with increasing distance from Asia, while the trend for NO3- was less evident, suggesting that chemical transformation affected the long-range transport of certain chemicals. Temporal variation analysis showed that concentrations of nss-SO42-, NO3-, and WSOC during the spring were about 2.0, 2.4, and 1.8 times those in the summer (cleaner air mass from the Pacific Ocean), respectively. This study demonstrated that air pollutants were transported from the Asian continent to the Okinawa islands and affected the air quality in the region. There may also be impacts on ecosystems, because increased concentrations of particulate NO3- could increase nutrient levels around the Okinawa islands. (C) 2014 Elsevier Ltd. All rights reserved.	[Arakaki, Takemitsu; Ijyu, Moriaki] Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, Nishihara, Okinawa 9030213, Japan; [Azechi, Sotaro; Somada, Yuka; Nakaema, Fumiya; Hitomi, Yuya; Handa, Daishi; Oshiro, Yoshito; Miyagi, Youichi; Tsuhako, Ai; Murayama, Hitomi; Higaonna, Yumi] Univ Ryukyus, Grad Sch Engn & Sci, Nishihara, Okinawa 9030213, Japan; [Tanahara, Akira] Univ Ryukyus, Instrument Res Ctr, Nishihara, Okinawa 9030213, Japan; [Itoh, Akihide] Univ Ryukyus, Fac Educ, Dept Sci Educ, Nishihara, Okinawa 9030213, Japan; [Henza, Yui; Nishikawa, Rin; Shinjo, Hibiki] Minamidaito Jr High Sch, Minamidaito, Okinawa 9013806, Japan; [Wang, Hongyan] Univ Maryland, Univ Coll Asia, Fussa, Tokyo 1970001, Japan; [Itoh, Akihide] Azabu Univ, Sch Life & Environm Sci, Dept Environm Sci, Sagamihara, Kanagawa, Japan	Arakaki, T (reprint author), Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, 1 Senbaru Nishihara Cho, Nishihara, Okinawa 9030213, Japan.	arakakit@sci.u-ryukyu.ac.jp			(KAKENHI) Ministry of Education, Culture, Sports, Science and Technology of Japan [20310013, 24651013]; Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [(B-0903];  [4003]	We thank Prof. Hatakeyama of Tokyo University of Agriculture and Technology and Dr. Takami of NIES, Japan for the use of CHAAMS. This study was supported by the Grant-in-Aid for Scientific Research on Innovative Areas (No. 4003) and partially by a Grant-in-Aid for Scientific Research (KAKENHI) (#20310013, #24651013) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Environment Research and Technology Development Fund (B-0903) of the Ministry of the Environment, Japan.	LATHAM J, 1990, NATURE, V347, P372, DOI 10.1038/347372a0; Wang X, 2009, ATMOS ENVIRON, V43, P4535, DOI 10.1016/j.atmosenv.2009.06.054; Streets DG, 2007, ATMOS ENVIRON, V41, P480, DOI 10.1016/j.atmosenv.2006.08.046; Arakaki T, 2013, ENVIRON SCI TECHNOL, V47, P8196, DOI 10.1021/es401927b; Arakaki T, 2006, ATMOS ENVIRON, V40, P4764, DOI 10.1016/j.atmosenv.2006.04.035; Blanchard D. C., 1980, ANN NY ACAD SCI, V338, P330, DOI DOI 10.1111/J.1749-6632.1980.TB17130.X; Branis M, 2010, AEROSOL AIR QUAL RES, V10, P102, DOI 10.4209/aaqr.2009.09.0055; Finlayson-Pitts B., 2000, CHEM UPPER LOWER ATM; Fujiwara H, 2014, ATMOS ENVIRON, V97, P462, DOI 10.1016/j.atmosenv.2014.01.064; Handa D, 2010, NUCL INSTRUM METH B, V268, P1125, DOI 10.1016/j.nimb.2009.10.115; Kondo Y, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004203; Millero F. J, 1996, CHEM OCEANOGRAPHY; Mochida M, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013216; Nakajima H, 2008, ATMOS ENVIRON, V42, P3046, DOI 10.1016/j.atmosenv.2007.12.045; Okada K, 2006, ENVIRON SCI TECHNOL, V40, P7790, DOI 10.1021/es061649s; Okuda T, 2011, ATMOS ENVIRON, V45, P2789, DOI 10.1016/j.atmosenv.2011.01.053; Takami A, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008120; Takiguchi Y, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009462; Verma RL, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015830; Watanabe K, 2006, ATMOS RES, V82, P652, DOI 10.1016/j.atmosres.2006.02.021	20	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	NOV	2014	97				SI		479	485		10.1016/j.atmosenv.2014.04.040		7	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AR1HQ	WOS:000343336700050		
J	Kobayashi, H; Hayashi, M; Shiraishi, K; Nakura, Y; Enomoto, T; Miura, K; Takahashi, H; Igarashi, Y; Naoe, H; Kaneyasu, N; Nishizawa, T; Sugimoto, N				Kobayashi, Hiroshi; Hayashi, Masahiko; Shiraishi, Koichi; Nakura, Yoshinobu; Enomoto, Takayuki; Miura, Kazuhiko; Takahashi, Hiroshi; Igarashi, Yasuhito; Naoe, Hiroaki; Kaneyasu, Naoki; Nishizawa, Tomoaki; Sugimoto, Nobuo			Development of a polarization optical particle counter capable of aerosol type classification	ATMOSPHERIC ENVIRONMENT			English	Article						Polarization; Particle shape; Mineral dust; Aerosol type; Optical particle counter	SCATTERING MATRICES	We developed a polarization optical particle counter (POPC) for measuring the concentrations of aerosol types, which were classified using polarization information from particle-scattered light. Polarization sensors that detect P and S polarization components of scattered light were placed at a scattering angle of 120. The polarization ratio is calculated as the ratio of the S component to the sum of the S and P components, and it is used to help distinguish proposed aerosol types. The POPC field observation was conducted in Fukuoka, located in the western part of Japan, in 2012. The classification rule for three aerosol types (mineral dust, air pollution, and sea-salt particles) was determined empirically on the basis of measurements during typical conditions dominated by each aerosol type. The mass concentration of each aerosol type was estimated from the POPC measurement with some assumptions. The results indicate independent seasonal variation in each aerosol mass concentration. Using black carbon as an indicator of anthropogenic aerosols, we show a correlation of 0.770 with our estimated pollution aerosol type. (C) 2014 Elsevier Ltd. All rights reserved.	[Kobayashi, Hiroshi] Univ Yamanashi, Kofu, Yamanashi 4008510, Japan; [Hayashi, Masahiko; Shiraishi, Koichi] Fukuoka Univ, Jonan Ku, Fukuoka 8140180, Japan; [Nakura, Yoshinobu] Yamanashi Gijyutsu Kobo, Minami Alps 4000311, Japan; [Enomoto, Takayuki; Miura, Kazuhiko] Tokyo Univ Sci, Shinjuku Ku, Tokyo 1628601, Japan; [Takahashi, Hiroshi; Igarashi, Yasuhito] Meteorol Res Inst, Tsukuba, Ibaraki 3050052, Japan; [Naoe, Hiroaki] Japan Meteorol Agcy, Chiyoda Ku, Tokyo 1008122, Japan; [Kaneyasu, Naoki] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058569, Japan; [Nishizawa, Tomoaki; Sugimoto, Nobuo] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan	Kobayashi, H (reprint author), Univ Yamanashi, 4-4-37 Takeda, Kofu, Yamanashi 4008510, Japan.	kobachu@yamanashi.ac.jp	Sugimoto, Nobuo/C-5189-2015	Sugimoto, Nobuo/0000-0002-0545-1316	JSPS KAKENHI [20120006, 24560660]; Sumitomo Foundation for Environmental Science	This research was supported by JSPS KAKENHI Grant numbers 20120006 and 24560660 and by the Sumitomo Foundation for Environmental Science.	West RA, 1997, J GEOPHYS RES-ATMOS, V102, P16871, DOI 10.1029/96JD02584; Reddington CL, 2013, ATMOS CHEM PHYS, V13, P4917, DOI 10.5194/acp-13-4917-2013; Volten H, 2001, J GEOPHYS RES-ATMOS, V106, P17375, DOI 10.1029/2001JD900068; Chun Y, 2001, ATMOS ENVIRON, V35, P2715, DOI 10.1016/S1352-2310(00)00404-0; Munoz O, 2011, J QUANT SPECTROSC RA, V112, P1646, DOI 10.1016/j.jqsrt.2011.02.005; Draxler R.R., 2014, HYSPLIT HYBRID SINGL; Glen A, 2013, ATMOS CHEM PHYS, V13, P1345, DOI 10.5194/acp-13-1345-2013; Hinds W. C., 1999, AEROSOL TECHNOLOGY P; Iwasaka Y., 2003, WATER AIR SOIL POLL, V3, P129, DOI 10.1023/A:1023282221749; Kim YS, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2002JD003269; PERRY RJ, 1978, APPL OPTICS, V17, P2700, DOI 10.1364/AO.17.002700; Rolph G.D., 2012, REAL TIME ENV APPL D	12	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	NOV	2014	97				SI		486	492		10.1016/j.atmosenv.2014.05.006		7	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AR1HQ	WOS:000343336700051		
J	Yamaguchi, M; Otani, Y; Li, PR; Nagao, H; Lenggoro, IW; Ishida, A; Yazaki, K; Noguchi, K; Nakaba, S; Yamane, K; Kuroda, K; Sano, Y; Funada, R; Izuta, T				Yamaguchi, Masahiro; Otani, Yoko; Li, Peiran; Nagao, Hiroshi; Lenggoro, I. Wuled; Ishida, Atsushi; Yazaki, Kenichi; Noguchi, Kyotaro; Nakaba, Satoshi; Yamane, Kenichi; Kuroda, Katsushi; Sano, Yuzou; Funada, Ryo; Izuta, Takeshi			Effects of long-term exposure to ammonium sulfate particles on growth and gas exchange rates of Fagus crenata, Castanopsis sieboldii, Larix kaempferi and Cryptomeria japonica seedlings	ATMOSPHERIC ENVIRONMENT			English	Article						Ammonium sulfate particles; Forest tree species; Physiological function; Plant growth; PM2.5	LEAF LIFE-SPAN; DRY DEPOSITION; PARTICULATE POLLUTION; FOREST CANOPY; AEROSOLS; LEAVES; TREES; VEGETATION; RESPONSES; CAPTURE	To clarify the effects of long-term exposure to ammonium sulfate (AS) particles on growth and physiological functions of forest tree species, seedlings of Fagus crenata, Castanopsis sieboldii, Larix kaempferi and Cryptomeria japonica were exposed to submicron-size AS particles during two growing seasons from 3 June 2011 to 8 October 2012. The mean sulfate concentration in PM2.5, increased during the exposure inside the chamber in 2011 and 2012 by 2.73 and 4.32 mu g SO42- m(-3), respectively. No significant effects of exposure to AS particles were detected on the whole-plant dry mass of the seedlings. These results indicate that the exposure to submicrometer AS particles at the ambient level for two growing seasons did not significantly affect the growth of the seedlings. No significant effects of exposure to AS particles were found on the net photosynthetic rate in the leaves or needles of E crenata, C sieboldii and L. kaempferi seedlings. Also, in the previous-year needles of C. japonica seedlings, exposure to AS particles significantly reduced the net photosynthetic rate, which may be caused by the reduction in the concentration of ribulose-1, 5-bisphosphate carboxylase/oxygenase (Rubisco). On the contrary, in current year needles of C japonica seedlings, net photosynthetic rate significantly increased with exposure to AS particles, which may be the result of increases in stomatal conductance and concentrations of Rubisco and chlorophyll. Furthermore, exposure to AS particles correlated with an increase in concentrations of NH4+, free amino acid and total soluble protein, suggesting that AS particles may be deliquesced, absorbed into the leaves and metabolized into amino acid and protein. These results suggest that net photosynthesis in the needles of C japonica is relatively sensitive to submicron-size AS particles as compared with the other three tree species.	[Yamaguchi, Masahiro; Otani, Yoko; Li, Peiran; Nagao, Hiroshi; Nakaba, Satoshi; Yamane, Kenichi] Tokyo Univ Agr & Technol, Fac Agr, Fuchu, Tokyo 1838509, Japan; [Lenggoro, I. Wuled] Tokyo Univ Agr & Technol, Inst Engn, Koganei, Tokyo 1848588, Japan; [Ishida, Atsushi] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; [Yazaki, Kenichi; Kuroda, Katsushi] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Noguchi, Kyotaro] Forestry & Forest Prod Res Inst, Shikoku Res Ctr, Kochi 7808077, Japan; [Sano, Yuzou] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan; [Funada, Ryo; Izuta, Takeshi] Tokyo Univ Agr & Technol, Inst Agr, Fuchu, Tokyo 1838509, Japan	Izuta, T (reprint author), Tokyo Univ Agr & Technol, Inst Agr, Fuchu, Tokyo 1838509, Japan.	izuta@cc.tuat.ac.jp	Lenggoro, Wuled/B-8629-2009; Nakaba, Satoshi/C-3482-2013; Funada, Ryo/C-2020-2013; Izuta, Takeshi/C-9404-2013	Lenggoro, Wuled/0000-0002-0048-8486; 	 [20120009];  [2020010]	The authors are greatly indebted to Dr. Tsumugu Totsuka and Dr. Takejiro Takamatsu for their invaluable advice. The authors also acknowledge Dr. Naoto Murao (Hokkaido University), Dr. Hiroyuki Sase (Asia Center for Air Pollution Research), Dr. Kazuhide Matsuda and Mr. Akito Seki (both of the Tokyo University of Agriculture and Technology) for their valuable suggestions and technical support. This research was funded by Grants-in-Aid for Scientific Research on Innovative Areas (No. 20120009, No. 2020010).	Adriaenssens S, 2011, WATER AIR SOIL POLL, V219, P43, DOI 10.1007/s11270-010-0682-8; Larssen T, 2006, ENVIRON SCI TECHNOL, V40, P418, DOI 10.1021/es0626133; Grantz DA, 2003, ENVIRON INT, V29, P213, DOI 10.1016/S0160-4120(02)00181-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Sjogren S, 2007, J AEROSOL SCI, V38, P157, DOI 10.1016/j.jaerosci.2006.11.005; Freer-Smith PH, 2004, WATER AIR SOIL POLL, V155, P173, DOI 10.1023/B:WATE.0000026521.99552.fd; HANSON PJ, 1991, ATMOS ENVIRON A-GEN, V25, P1615, DOI 10.1016/0960-1686(91)90020-8; Chin M, 2007, ATMOS CHEM PHYS, V7, P5501; Burkhardt J, 2010, ECOL MONOGR, V80, P369, DOI 10.1890/09-1988.1; BARNES JD, 1992, ENVIRON EXP BOT, V32, P85, DOI 10.1016/0098-8472(92)90034-Y; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419; Balster NJ, 2000, TREE PHYSIOL, V20, P1191; Hori M, 2003, J AEROSOL SCI, V34, P419, DOI 10.1016/S0021-8502(02)00190-8; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; Topping DO, 2005, ATMOS CHEM PHYS, V5, P1205; Cordell S, 2001, OECOLOGIA, V127, P198, DOI 10.1007/s004420000588; Hwang HJ, 2011, ATMOS ENVIRON, V45, P6987, DOI 10.1016/j.atmosenv.2011.09.019; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Beckett KP, 2000, GLOB CHANGE BIOL, V6, P995, DOI 10.1046/j.1365-2486.2000.00376.x; Brooks SD, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014733; CHEVONE BI, 1986, JAPCA J AIR WASTE MA, V36, P813; Colvile R.N., 2002, AIR POLLUTION PLANT, P23; Fowler D., 2002, AIR POLLUTION PLANT, P43; GMUR NF, 1983, ATMOS ENVIRON, V17, P715, DOI 10.1016/0004-6981(83)90418-3; Horvath H, 2000, J ENVIRON RADIOACTIV, V51, P5; Larcher W, 2003, PHYSL PLANT ECOLOGY; LINDBERG SE, 1992, ATMOS ENVIRON A-GEN, V26, P1477, DOI 10.1016/0960-1686(92)90133-6; LINDBERG SE, 1985, ENVIRON SCI TECHNOL, V19, P238, DOI 10.1021/es00133a003; MARTIN CE, 1992, ATMOS ENVIRON A-GEN, V26, P381, DOI 10.1016/0960-1686(92)90324-E; Matsuda K, 2010, ATMOS ENVIRON, V44, P4582, DOI 10.1016/j.atmosenv.2010.08.015; Network Center for EANET, 2013, AC DEP MON NETW E AS, P180; Petroff A, 2008, ATMOS ENVIRON, V42, P3654, DOI 10.1016/j.atmosenv.2007.12.060; Sase H, 1998, CAN J FOREST RES, V28, P87, DOI 10.1139/cjfr-28-1-87; MOORE S, 1954, J BIOL CHEM, V211, P907; Takami A, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008120; Yamaguchi M, 2012, TREES-STRUCT FUNCT, V26, P1859, DOI 10.1007/s00468-012-0755-y; Yamaguchi Masahiro, 2012, Asian Journal of Atmospheric Environment, V6, P259, DOI 10.5572/ajae.2012.6.4.259	37	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	NOV	2014	97				SI		493	500		10.1016/j.atmosenv.2014.01.023		8	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AR1HQ	WOS:000343336700052		
J	Katata, G; Kajino, M; Matsuda, K; Takahashi, A; Nakaya, K				Katata, Genki; Kajino, Mizuo; Matsuda, Kazuhide; Takahashi, Akira; Nakaya, Ko			A numerical study of the effects of aerosol hygroscopic properties to dry deposition on a broad-leaved forest	ATMOSPHERIC ENVIRONMENT			English	Article						Sulfate aerosols; Dry deposition; Relative humidity; Hygroscopic growth; Multi-layer land surface model; SOLVEG	PARTICLE; MODEL; CANOPY; SIZE; ATMOSPHERE; GROWTH; WATER	To investigate the impact of hygroscopic growth on dry deposition onto forest canopies, numerical simulations of PM2.5 sulfate deposition using a multi-layer atmosphere-SOIL-VEGetation model (SOLVEG) ware performed. The scheme of particle dry deposition in SOLVEG was extended for application to a broad-leaved forest. An aerosol hygroscopic model based on the widely used k-Kohler theory was incorporated into the model to calculate water uptake by the aerosols. The model accurately reproduced essential turbulent exchange fluxes (momentum, heat, and water vapor) over the canopies and the soil temperature and moisture for a deciduous broad-leaved forest in central Japan. Temporal variations in the measured PM2.5 sulfate deposition velocity were generally reproduced by the model. By considering an increase in particle diameter due to hygroscopic growth, the prediction accuracy of the modeled deposition velocity under humid conditions was improved. Numerical experiments for varying aerosol size distributions and hygroscopic properties showed that the geometric mean diameter and hygroscopicity of particles have a large influence on hygroscopic growth levels. The results also suggested that the deposition velocity of wet particles increased due to hygroscopic growth when the relative humidity (RH) was approximately 50%, and that the velocity reached five times greater than that under dry conditions when RH exceeded 95%. (C) 2013 Elsevier Ltd. All rights reserved.	[Katata, Genki] Japan Atom Energy Agcy, Res Grp Environm Sci, Naka, Ibaraki 3191195, Japan; [Kajino, Mizuo] Japan Meteorol Agcy, Meteorol Res Inst, Tsukuba, Ibaraki 3050052, Japan; [Matsuda, Kazuhide] Tokyo Univ Agr & Technol, Fac Agr, Field Sci Ctr, Fuchu, Tokyo 1838509, Japan; [Takahashi, Akira; Nakaya, Ko] Cent Res Inst Elect Power Ind, Abiko, Chiba 2701194, Japan	Katata, G (reprint author), Japan Atom Energy Agcy, Res Grp Environm Sci, Naka, Ibaraki 3191195, Japan.	katata.genki@jaea.go.jp	Matsuda, Kazuhide/C-2041-2013		Japan Society for the Promotion of Science (JSPS) [21120512]	The authors express their gratitude to Dr. D. Fowler at the Centre for Ecology 8,2 Hydrology (CEH), UK and Dr. Q. Zhang at the University of California, Davis, USA for their helpful comments and suggestions. The data on inorganic gas and particle concentrations collected by filter packs were partially provided by Dr. K. Hayashi of the National Institute for Agro-Environmental Sciences, Japan. This study was partly supported by a Grant-in-Aid for Scientific Research, No. 21120512, provided by the Japan Society for the Promotion of Science (JSPS).	Petroff A, 2009, J AEROSOL SCI, V40, P218, DOI 10.1016/j.jaerosci.2008.11.006; Tammet H, 2001, ATMOS ENVIRON, V35, P3413, DOI 10.1016/S1352-2310(01)00119-4; SLINN SA, 1980, ATMOS ENVIRON, V14, P1013, DOI 10.1016/0004-6981(80)90032-3; GREENFIELD SM, 1957, J METEOROL, V14, P115, DOI 10.1175/1520-0469(1957)014<0115:RSORPM>2.0.CO;2; Fountoukis C, 2007, ATMOS CHEM PHYS, V7, P4639; Gallagher MW, 1997, ATMOS ENVIRON, V31, P359, DOI 10.1016/S1352-2310(96)00057-X; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419; Gronholm T, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010663; Petters MD, 2007, ATMOS CHEM PHYS, V7, P1961; Zhang LM, 2001, ATMOS ENVIRON, V35, P549, DOI 10.1016/S1352-2310(00)00326-5; BATCHELOR GK, 1985, J COLLOID INTERF SCI, V107, P21, DOI 10.1016/0021-9797(85)90145-6; Birmili W, 2009, BOREAL ENVIRON RES, V14, P458; Davidovits P, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020835; Erisman J. W., 1995, STUDIES ENV SCI, V63, P55; FITZGERALD JW, 1975, J APPL METEOROL, V14, P1044, DOI 10.1175/1520-0450(1975)014<1044:AFFTES>2.0.CO;2; Fuchs N. A., 1971, TOPICS CURRENT AEROS, V2, P1; Fuchs N.A., 1964, MECHANICS AEROSOLS, P408; Katata G, 2008, J APPL METEOROL CLIM, V47, P2129, DOI 10.1175/2008JAMC1758.1; Katata G, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015552; Katata G., 2009, IMPROVEMENT LAND SUR, P64; Katata G., 2011, PROG NUCL SCI TECHNO, V2, P530; Katul GG, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012853; Kobayashi T., 1996, EVALUATION DRY DEPOS, V28, P37; LOVETT GM, 1990, ATMOS ENVIRON A-GEN, V24, P2767, DOI 10.1016/0960-1686(90)90164-I; Matsuda K, 2010, ATMOS ENVIRON, V44, P4582, DOI 10.1016/j.atmosenv.2010.08.015; Nakaya K, 2007, AGR FOREST METEOROL, V145, P97, DOI 10.1016/j.agrformet.2007.04.005; Ruijgrok W, 1997, ATMOS ENVIRON, V31, P399, DOI 10.1016/S1352-2310(96)00089-1; Seinfeld J. H., 2006, ATMOSPHERIC CHEM PHY, P1203; Waldmann L., 1966, AEROSOL SCI, P137; Watanabe M, 2008, ATMOS ENVIRON, V42, P7339, DOI 10.1016/j.atmosenv.2008.07.015; YAMADA T, 1982, J METEOROL SOC JPN, V60, P439	31	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	NOV	2014	97				SI		501	510		10.1016/j.atmosenv.2013.11.028		10	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AR1HQ	WOS:000343336700053		
J	Hara, H; Kashiwakura, T; Kitayama, K; Bellingrath-Kimura, SD; Yoshida, T; Takayanagi, M; Yamagata, S; Murao, N; Okouchi, H; Ogata, H				Hara, Hiroshi; Kashiwakura, Takumi; Kitayama, Kyo; Bellingrath-Kimura, Sonoko Deothea; Yoshida, Tomohiro; Takayanagi, Masao; Yamagata, Sadamu; Murao, Naoto; Okouchi, Hiroshi; Ogata, Hiroko			Foliar rinse study of atmospheric black carbon deposition to leaves of konara oak (Quercus serrata) standse	ATMOSPHERIC ENVIRONMENT			English	Article						Aerosol; Black carbon; Dry deposition; Foliar rinsing; Forest; Japan	MONTSENY NE SPAIN; DRY DEPOSITION; SURROGATE SURFACES; FOREST CANOPY; NITRIC-ACID; LEAF; VEGETATION; JAPAN; INDIA	Dry deposition of Black Carbon (BC) to the actual leaves of konara oak (Quercus serrata) was evaluated in a foliar rinse method in an experimental forest in the suburbs of Tokyo, Japan in order to explore deposition levels and vertical profile within the forest. At three heights of the forest of 20 m height, 20 m, 15 m, and 6 m or 4 m, leaves were sampled on a weekly basis for a couple of months in 2011 and 2012 and subjected to rinsing with water and chloroform. The BC in the rinse solution was collected on a quartz fiber filter and determined by spectrophotometry. The BC mass deposited to leaves increased with height and this profile pattern was generally maintained in the study period. The specific BC mass deposited to leaves showed considerable fluctuations with time, but the deposited BC increased rapidly with time in the bud flushing stage, then attained to a plateau, and began to decrease as the defoliation advanced. The plateau is a result of a simple accumulation with time and occasional removal due to rainfall and strong winds. The maximum BC mass deposited to leaves per leaf surface unit area occurred in June where the level was 10-15 mg-BC m(-2). The rate of BC mass deposited to leaves at the time of leaves growing was determined to be 0.237 and 0.277 mg-BC m(-2) day(-1) for measurements in 2011 and 2012, respectively. On the basis of the observed BC mass deposited to the leaves, BC mass deposited to leaves per forest floor unit area estimated with LAI showed a strong seasonality. The BC mass deposited to leaves per forest floor unit area was compared to the deposition flux from the atmosphere to the forest canopy, which would be interpreted as indicating that 30% of atmospheric BC deposition to the canopy was retained on the leaves in time of leaves growing. (C) 2014 Elsevier Ltd. All rights reserved.	[Hara, Hiroshi; Bellingrath-Kimura, Sonoko Deothea; Yoshida, Tomohiro; Takayanagi, Masao] Tokyo Univ Agr & Technol, Fuchu, Tokyo, Japan; [Kashiwakura, Takumi] Sophia Univ, Chiyoda Ku, Tokyo 102, Japan; [Kitayama, Kyo] Fukushima Univ, Fukushima, Japan; [Yamagata, Sadamu; Murao, Naoto] Hokkaido Univ, Kita Ku, Sapporo, Hokkaido, Japan; [Okouchi, Hiroshi; Ogata, Hiroko] Waseda Univ, Shinjuku Ku, Tokyo, Japan	Kitayama, K (reprint author), Fukushima Univ, Kanayagawa 1, Fukushima, Japan.	r653@ipc.fukushima-u.ac.jp	Takayanagi, Masao/E-7100-2013; Yoshida, Tomohiro/D-8013-2013		Ministry of Education, Culture, Sports, Science, and Technology [23120701]; Tokyu Foundation for Better Environment	This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (23120701) from the Ministry of Education, Culture, Sports, Science, and Technology, and also by Tokyu Foundation for Better Environment.	Acker K., 2004, MANUAL GAW PRECIPITA, V161; Adachi K., 2014, EAROZORU KENKYU, V29, P10; Akimoto H., 2006, PERIODIC REPORT ST 1, P269; Akimoto H., 2011, 2 AC DEP MON NETW E, P270; Alefani A., 1996, J PLANT PHYSL, V148, P243; Andersen HV, 1999, FOREST ECOL MANAG, V114, P5, DOI 10.1016/S0378-1127(98)00378-8; Petroff A, 2008, ATMOS ENVIRON, V42, P3625, DOI 10.1016/j.atmosenv.2007.09.043; HANSON PJ, 1991, ATMOS ENVIRON A-GEN, V25, P1615, DOI 10.1016/0960-1686(91)90020-8; Burkhardt J, 2010, ECOL MONOGR, V80, P369, DOI 10.1890/09-1988.1; BYTNEROWICZ A, 1987, ATMOS ENVIRON, V21, P1749, DOI 10.1016/0004-6981(87)90114-4; Fowler D, 2009, ATMOS ENVIRON, V43, P5193, DOI 10.1016/j.atmosenv.2009.07.068; Rodrigo A, 1999, ATMOS ENVIRON, V33, P359, DOI 10.1016/S1352-2310(98)00167-8; Kumar R, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003194; BYTNEROWICZ A, 1991, ATMOS ENVIRON A-GEN, V25, P2203, DOI 10.1016/0960-1686(91)90095-O; Chiwa M, 2003, ATMOS ENVIRON, V37, P327, DOI 10.1016/S1352-2310(02)00889-0; Dentener F., 2006, ATMOS CHEM PHYS DISC, V6, P2703; Erisman J.W., 1995, STUDIES ENV SCI, V63, P49; Feliciano MS, 2001, ATMOS ENVIRON, V35, P3633, DOI 10.1016/S1352-2310(00)00539-2; Finlayson-Pitts B., 2000, CHEM UPPER LOWER ATM; Gupta A, 2004, CHEMOSPHERE, V55, P1097, DOI 10.1016/j.chemosphere.2003.08.035; Hara H., 2010, TECHNICAL MANUAL WET, P113; Janson R, 1999, AGR FOREST METEOROL, V98-9, P683, DOI 10.1016/S0168-1923(99)00133-1; Japan Meteorological Agency, MET DAT; Katata Genki, 2013, Asian Journal of Atmospheric Environment, V7, P17, DOI 10.5572/ajae.2013.7.1.017; Kato H., 2004, ENV ENG RES, V41, P111; Kimura SD, 2009, WATER AIR SOIL POLL, V202, P369, DOI 10.1007/s11270-009-9983-1; LINDBERG SE, 1985, ENVIRON SCI TECHNOL, V19, P238, DOI 10.1021/es00133a003; Moteki N., 2014, EAROZORU KENKYU, V29, P15; Oshima N., 2014, EAROZORU KENKYU, V29, P23; Ozawa H, 2000, TREES-STRUCT FUNCT, V14, P206, DOI 10.1007/PL00009764; Rodrigo A, 2002, WATER AIR SOIL POLL, V136, P269, DOI 10.1023/A:1015220726924; Sase Hiroyuki, 2012, Asian Journal of Atmospheric Environment, V6, P246, DOI 10.5572/ajae.2012.6.4.246; Seinfeld J. H., 2006, ATMOSPHERIC CHEM PHY; SHANLEY JB, 1989, ATMOS ENVIRON, V23, P403, DOI 10.1016/0004-6981(89)90586-6; Summers P.W., 1986, WATER AIR SOIL POLL, V31, P525; Takamatsu T., 2000, GLOBAL ENV RES, V4, P49; THOM AS, 1971, Q J ROY METEOR SOC, V97, P414, DOI 10.1256/smsqj.41403; Tonokura K, 2014, EAROZORU KENKYU, V29, P5; Watanabe M, 2008, ATMOS ENVIRON, V42, P7339, DOI 10.1016/j.atmosenv.2008.07.015; Watanabe Yoko, 2013, Asian Journal of Atmospheric Environment, V7, P1, DOI 10.5572/ajae.2013.7.1.001; Yamaguchi Masahiro, 2012, Asian Journal of Atmospheric Environment, V6, P268, DOI 10.5572/ajae.2012.6.4.268; Yamaguchi Masahiro, 2012, Asian Journal of Atmospheric Environment, V6, P259, DOI 10.5572/ajae.2012.6.4.259; Yamaguchi Takashi, 2013, Asian Journal of Atmospheric Environment, V7, P8, DOI 10.5572/ajae.2013.7.1.008; Yamane Kenichi, 2012, Asian Journal of Atmospheric Environment, V6, P275, DOI 10.5572/ajae.2012.6.4.275	44	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	NOV	2014	97				SI		511	518		10.1016/j.atmosenv.2014.04.015		8	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AR1HQ	WOS:000343336700054		
J	Lu, SL; Yi, F; Hao, XJ; Yu, S; Ren, JJ; Wu, MH; Feng, JL; Yonemochi, S; Wang, QY				Lu, Senlin; Yi, Fei; Hao, Xiaojie; Yu, Shang; Ren, Jingjing; Wu, Minghong; Feng Jialiang; Yonemochi, Shinich; Wang, Qingyue			Physicochemical properties and ability to generate free radicals of ambient coarse, fine, and ultrafine particles in the atmosphere of Xuanwei, China, an area of high lung cancer incidence	ATMOSPHERIC ENVIRONMENT			English	Article						Size-resolved ambient particles; Chemical elements; Free radicals; Oxidative potential; Xuanwei; China	AIR-POLLUTION; COMBUSTION EMISSIONS; PARTICULATE MATTER; IN-VITRO; OXIDATIVE DAMAGE; COAL; WEI; EXPOSURE; PM10; NANOPARTICLES	The link between the high incidence of lung cancer and harmful pollutants emitted by local coal combustion in Xuanwei, Yunnan province, China, has been a focus of study since the 1980s. However, the mechanisms responsible for the high lung cancer rate remain unclear, necessitating further study. Since a close relationship between ambient air particle pollution and respiratory diseases exists, we sampled size-resolved ambient particles from the atmosphere of Xuanwei. In our indoor experiment, cutting-edge methods, including scanning electron microscopy coupled with energy dispersive X-ray detection (SEMI/EDX), particle-induced X-ray emission (PIXE), electronic paramagnetic resonance (EPR) and the cell-free DCFH-DA assay, were employed to investigate the physicochemical properties, the potential to generate free radicals and the oxidative potential of ambient coarse (diameter, 1.8-10 mu m), fine (diameter, 0.1-1.8 mu m), and ultrafine (diameter, <0.1 gm) particles. We found the total mass concentrations of the size resolved particles collected in spring were higher than that in early winter. Mass percentage of fine particles accounted for 68% and 61% of the total particulate mass in spring and in early winter samples, respectively, indicating that fine particles were the major component of the Xuanwei ambient particulate matters. On the other hand, the results of SEM/EDX analysis showed that the coarse particles were dominated by minerals, the fine particles by soot aggregates and fly ashes, and the ultrafine particles by soot particles and unidentified particles. Our PIXE results revealed that crustal elements (Ca, Ti Si, Fe) were mainly distributed in coarse particles, while trace metals (Cr, Mn, Ni, Cu, Zn, Pb) dominated in the fine particle fraction, and S, a typical element emitted by coal combustion, mainly resided in fine particles collected from the winter atmosphere. EPR results indicated that the magnitude of free radical intensity caused by size-resolved particles followed these patterns: fine particles > coarse particles > ultrafine particles for spring samples and ultrafine particles > fine particles > coarse particles for winter samples. Cell-free DCFH assay results conclusively showed that all of the measured particle suspensions displayed a higher oxidative potential than the negative control. The correlation coefficient (R-2) between free radical intensity and fluorescent intensity generated by the size-resolved particles was 0.535 and 0.507 for the spring and winter seasons, respectively, implying that ambient air particles in the Xuanwei atmosphere have the ability to generate free radicals, and fine and ultrafine particles could be hazardous to local residents. (C) 2013 Elsevier Ltd. All rights reserved.	[Lu, Senlin; Yi, Fei; Hao, Xiaojie; Wu, Minghong] Shanghai Univ, Sch Environm & Chem Engn, Shanghai 200444, Peoples R China; [Lu, Senlin; Yi, Fei; Hao, Xiaojie; Yu, Shang; Ren, Jingjing; Wu, Minghong; Feng Jialiang] Shanghai Univ, Inst Environm Pollut & Hlth, Shanghai 200444, Peoples R China; [Yonemochi, Shinich] Ctr Environm Sci Saitama, Saitama 3740115, Japan; [Wang, Qingyue] Saitama Univ, Sch Sci & Engn, Saitama 3388570, Japan	Wang, QY (reprint author), Saitama Univ, Sch Sci & Engn, Saitama 3388570, Japan.	senlinlv@staff.shu.edu.cn; seiyo@mail.saitama-u.ac.jp			NSFC [41273127, 41073073]; Shanghai Municipal Education Commission [11ZZ80]; Shanghai Leading Academic Discipline [S30109]	This research was supported by the NSFC (Grant No. 41273127, 41073073) and by the Shanghai Pujiang Talent Program, Innovation Program of Shanghai Municipal Education Commission (11ZZ80), Shanghai Leading Academic Discipline Project (No. S30109).	MUMFORD JL, 1989, ENVIRON INT, V15, P315, DOI 10.1016/0160-4120(89)90044-5; Donaldson K, 1997, ENVIRON HEALTH PERSP, V105, P1285, DOI 10.2307/3433548; McNeilly JD, 2004, TOXICOL APPL PHARM, V196, P95, DOI 10.1016/j.taap.2003.11.021; Lan Q, 2001, J OCCUP ENVIRON MED, V43, P226, DOI 10.1097/00043764-200103000-00010; Large DJ, 2009, ENVIRON SCI TECHNOL, V43, P9016, DOI 10.1021/es902033j; MUMFORD JL, 1987, SCIENCE, V235, P217, DOI 10.1126/science.3798109; Dellinger B, 2001, CHEM RES TOXICOL, V14, P1371, DOI 10.1021/tx010050x; Shen M, 2009, ENVIRON HEALTH PERSP, V117, P261, DOI 10.1289/ehp.11521; Shi TM, 2003, J ENVIRON MONITOR, V5, P550, DOI 10.1039/b303928p; Wei F, 1999, ENVIRON SCI TECHNOL, V33, P4188, DOI 10.1021/es9904944; Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646; Pavagadhi S, 2013, ENVIRON SCI POLLUT R, V20, P2569, DOI 10.1007/s11356-012-1157-9; HE XZ, 1991, ENVIRON HEALTH PERSP, V94, P9, DOI 10.2307/3431286; Li N, 2003, CLIN IMMUNOL, V109, P250, DOI 10.1016/j.clim.2003.08.006; Lu SL, 2009, ENVIRON HEALTH PERSP, V117, P241, DOI 10.1289/ehp.11811; Artaxo P, 1999, NUCL INSTRUM METH B, V150, P409, DOI 10.1016/S0168-583X(98)01078-7; Zhao Y, 2006, SCI TOTAL ENVIRON, V366, P500, DOI 10.1016/j.scitotenv.2005.10.010; Foucaud L, 2007, TOXICOL LETT, V174, P1, DOI 10.1016/j.toxlet.2007.08.001; Lan Q, 2004, CARCINOGENESIS, V25, P2177, DOI 10.1093/carcin/bgh240; Lan Q, 2008, INT J CANCER, V123, P2164, DOI 10.1002/ijc.23748; Betha R, 2012, ATMOS ENVIRON, V61, P23, DOI 10.1016/j.atmosenv.2012.06.086; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479; [初钧晗 Chu Junhan], 2012, [北京师范大学学报. 自然科学版, Journal of Beijing Normal University. Natural Science], V48, P40; Donaldson Ken, 2005, Part Fibre Toxicol, V2, P10, DOI 10.1186/1743-8977-2-10; Duan Q., 2013, ATMOS ENVIRON, V74, P93; Duffin R, 2001, TOXICOL APPL PHARM, V176, P10, DOI 10.1006/taap.2001.9268; [郝建华 HAO Jian-hua], 2009, [中国全科医学, Chinese General Practice], V12, P2279; Huang Meifeng, 2007, J CLIN PULM MED, V12, P665; Lewtas J, 2007, MUTAT RES-REV MUTAT, V636, P95, DOI 10.1016/j.mrrev.2007.08.003; Lin Zhou, 2010, THESIS CHINA U COAL; Lu S., 2007, ENVIRON MONIT ASSESS, V133, P79; Lu SL, 2013, J PHYS CONF SER, V430, DOI 10.1088/1742-6596/430/1/012098; Lu SL, 2011, ATMOS ENVIRON, V45, P736, DOI 10.1016/j.atmosenv.2010.09.020; Lv J.G., 2009, CHINESE SCI BULL, V54, P3528; Miranda R., 2002, ATMOS ENVIRON, V36, P345; Murr LE, 2009, ATMOS ENVIRON, V43, P2683, DOI 10.1016/j.atmosenv.2009.03.002; National Air Quality Standard of China. China State Environmental Protection Administration (SEPA), 1996, AMB AIR QUAL STAND; Shao LY, 2013, ATMOS ENVIRON, V77, P959, DOI 10.1016/j.atmosenv.2013.05.079; Smyth AM, 2013, ATMOS ENVIRON, V73, P124, DOI 10.1016/j.atmosenv.2013.03.014; Tian L., 2005, THESIS U CALIFORNIA; Tian LW, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-398; Wang X., 2001, J BEIJING NORM U NAT, V37, P213; Zhang LinLin, 2012, Chinese Journal of Lung Cancer, V15, P159; Zhu G, 2000, CLIMATE ENV RES, V5, P30; Zhu GH, 1998, NUCL INSTRUM METH B, V136, P966, DOI 10.1016/S0168-583X(97)00756-8	45	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	NOV	2014	97				SI		519	528		10.1016/j.atmosenv.2013.11.047		10	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AR1HQ	WOS:000343336700055		
J	Koike, E; Yanagisawa, R; Takano, H				Koike, Eiko; Yanagisawa, Rie; Takano, Hirohisa			Toxicological effects of polycyclic aromatic hydrocarbons and their derivatives on respiratory cells	ATMOSPHERIC ENVIRONMENT			English	Article						Polycyclic aromatic hydrocarbons; Bronchial epithelial cells; Proinflammatory cytokines; Intracellular signaling pathway	DIESEL EXHAUST PARTICLES; ALLERGIC AIRWAY INFLAMMATION; BRONCHIAL EPITHELIAL-CELLS; ORGANIC EXTRACT; POLLUTION; ASSOCIATION; EXPRESSION; COMPONENTS; MORTALITY; RECEPTOR	Polycyclic aromatic hydrocarbons (PAHs) are found in ambient aerosols and particulate matter. Experimental studies have shown that PAHs and related chemicals can induce toxicological effects. The present study aimed to investigate the effects of PAHs and their derivatives on the respiratory and immune systems and the underlying mechanisms. The human bronchial epithelial cell line BEAS-2B was exposed to PAHs and their derivatives, and the cytotoxicity and proinflammatory protein expression were then investigated. A cytotoxic effect was observed in BEAS-2B exposed to PAH derivatives such as naphthoquinone (NQ), phenanthrenequinone (PQ), 1-nitropyrene (1-NP), and 1-aminopyrene (1-AP). In addition, 1,2-NQ and 9,10-PQ showed more effective cytotoxicity than 1,4-NQ and 1,4-PQ respectively. Pyrene showed a weak cytotoxic effect. On the other hand, naphthalene and phenanthrene showed no significant effects. Pyrene, 1-NP, and 1-AP also increased intercellular adhesion molecule-1 expression and interleukin-6 production in BEAS-2B. The increase was partly suppressed by protein kinase inhibitors such as the epidermal growth factor receptor-selective tyrosine kinase inhibitor and nuclear receptor antagonists such as the thyroid hormone receptor antagonist. The present study suggests that the toxicological effects of chemicals may be related to the different activities resulting from their structures, such as numbers of benzene rings and functional groups. Furthermore, the chemical-induced increase in proinflammatory protein expression in bronchial epithelial cells was possibly a result of the activation of protein kinase pathways and nuclear receptors. The increase may partly contribute to the adverse health effects of atmospheric PAHs. (C) 2014 Elsevier Ltd. All rights reserved.	[Koike, Eiko; Yanagisawa, Rie] Natl Inst Environm Studies, Ctr Environm Hlth Sci, Tsukuba, Ibaraki 3058506, Japan; [Takano, Hirohisa] Kyoto Univ, Grad Sch Engn, Nishikyo Ku, Kyoto 6158530, Japan	Koike, E (reprint author), Natl Inst Environm Studies, Ctr Environm Hlth Sci, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	ekoike@nies.go.jp			MEXT KAKENHI [20120014]; National Institute for Environmental Studies [1115AA082]	This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (MEXT KAKENHI 20120014) and in part by grants from the National Institute for Environmental Studies (1115AA082). The authors would like to thank Ms. Satomi Abe for technical assistance and Enago (www.enagojp) for the English language review.	Swedenborg E, 2010, TOXICOLOGY, V268, P132, DOI 10.1016/j.tox.2009.09.007; George IJ, 2010, NAT CHEM, V2, P713, DOI [10.1038/nchem.806, 10.1038/NCHEM.806]; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Hart JE, 2011, AM J RESP CRIT CARE, V183, P73, DOI 10.1164/rccm.200912-1903OC; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Yanagisawa R, 2006, CLIN EXP ALLERGY, V36, P386, DOI 10.1111/j.1365-2222.2006.02452.x; Podechard N, 2008, TOXICOL LETT, V177, P130, DOI 10.1016/j.toxlet.2008.01.006; Sint T, 2008, INHAL TOXICOL, V20, P25, DOI 10.1080/08958370701758759 ; CYBULSKY MI, 1991, SCIENCE, V251, P788, DOI 10.1126/science.1990440; Navas JM, 2000, AQUAT TOXICOL, V51, P79, DOI 10.1016/S0166-445X(00)00100-4; Sacks JD, 2011, ENVIRON HEALTH PERSP, V119, P446, DOI 10.1289/ehp.1002255; Baulig A, 2009, TOXICOLOGY, V261, P126, DOI 10.1016/j.tox.2009.05.007; Jenerowicz D, 2012, ANN AGR ENV MED, V19, P475; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669; Koike E, 2004, TOXICOL APPL PHARM, V201, P178, DOI 10.1016/j.taap.2004.05.006; Dergham M, 2012, CHEM RES TOXICOL, V25, P904, DOI 10.1021/tx200529v; Monaco C, 2004, CARDIOVASC RES, V61, P671, DOI 10.1016/j.cardiores.2003.11.038; Motoyama Y, 2009, J HEALTH SCI, V55, P845; Ho KF, 2002, ATMOS ENVIRON, V36, P57, DOI 10.1016/S1352-2310(01)00475-7; Andreou G, 2009, J HAZARD MATER, V172, P363, DOI 10.1016/j.jhazmat.2009.07.023; Shima H, 2006, TOXICOL SCI, V91, P218, DOI 10.1093/toxsci/kfj119; Fu PP, 2012, J ENVIRON SCI HEAL C, V30, P1, DOI 10.1080/10590501.2012.653887; Diaz Sanchez D, 1997, ALLERGY, V52, P52; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Hiyoshi K, 2005, CLIN EXP ALLERGY, V35, P1243, DOI 10.1111/j.1365-2222.2005.02297.x; Kawasaki S, 2001, AM J RESP CELL MOL, V24, P419; Koike E, 2005, TOXICOL APPL PHARM, V209, P277, DOI 10.1016/j.taap.2005.04.017; Koike E., 2013, EAROZORU KENKYU, V28, P34; Mascanfroni I, 2008, FASEB J, V22, P1032, DOI 10.1096/fj.07-8652com; Schober W, 2007, INHAL TOXICOL, V19, P151, DOI 10.1080/08958370701496046; Takano H., 2014, EAROZORU KENKYU, V29, P190; Tsien A, 1997, TOXICOL APPL PHARM, V142, P256, DOI 10.1006/taap.1996.8063; Umannova L, 2011, TOXICOL LETT, V206, P121, DOI 10.1016/j.toxlet.2011.06.029; Yano K, 2003, J HEALTH SCI, V49, P195	34	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	NOV	2014	97				SI		529	536		10.1016/j.atmosenv.2014.04.003		8	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AR1HQ	WOS:000343336700056		
J	Higashi, T; Kambayashi, Y; Ohkura, N; Fujimura, M; Nakanishi, S; Yoshizaki, T; Saijoh, K; Hayakawa, K; Kobayashi, F; Michigami, Y; Hitomi, Y; Nakamura, H				Higashi, Tomomi; Kambayashi, Yasuhiro; Ohkura, Noriyuki; Fujimura, Masaki; Nakanishi, Sayaka; Yoshizaki, Tomokazu; Saijoh, Kiyofumi; Hayakawa, Kazuichi; Kobayashi, Fumihisa; Michigami, Yoshimasa; Hitomi, Yoshiaki; Nakamura, Hiroyuki			Exacerbation of daily cough and allergic symptoms in adult patients with chronic cough by Asian dust: A hospital-based study in Kanazawa	ATMOSPHERIC ENVIRONMENT			English	Article						Allergic symptoms; Asian dust; Asthma; Chronic cough; Daily cough symptom	JAPANESE CEDAR POLLINOSIS; LONG-RANGE TRANSPORT; STORM EVENTS; SAND DUST; VARIANT ASTHMA; DESERT DUST; PARTICLES; RHINITIS; TAIWAN; TAIPEI	The health effects associated with Asian dust have attracted attention due to the rapid increase in the number of Asian dust events in East Asia in recent years. The aim of this study was to investigate the associations between Asian dust and daily cough, as well as allergic symptoms, in adult patients who suffer from chronic cough. We enrolled 86 adult patients from Kanazawa University Hospital, Japan, who were diagnosed with asthma, cough variant asthma, atopic cough or a combination of these conditions. From January to June 2011, subjects recorded their symptoms in a diary every day. Asian dust and non-Asian dust periods were defined according to the dust extinction coefficient, measured using the light detection and ranging (LIDAR). The daily levels of total suspended particulates, polycyclic aromatic hydrocarbons (PAHs) and coexisting factors related to allergies, such as the Japanese cedar pollen count, were measured. McNemar's test showed that there were significantly more cough-positive patients during Asian dust periods than during the non-Asian dust period (p = 0.022). In addition, during Asian dust periods when the daily levels of Japanese cedar pollen, Japanese cypress pollen and PAHs were elevated, there were significantly more patients who experienced itchy eyes than during the non-Asian dust period (p < 0.05). On the other hand, there were no significant differences in the allergic symptoms, including sneezing or a runny nose and nasal congestion. This is the first report to show that Asian dust triggers cough and allergic symptoms in adult patients with chronic cough. (C) 2014 Elsevier Ltd. All rights reserved.	[Higashi, Tomomi] Kanazawa Univ, Grad Sch Med Sci, Dept Hyg, Kanazawa, Ishikawa 9208640, Japan; [Kambayashi, Yasuhiro; Hitomi, Yoshiaki; Nakamura, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Environm & Prevent Med, Kanazawa, Ishikawa 9208640, Japan; [Ohkura, Noriyuki; Fujimura, Masaki] Kanazawa Univ, Grad Sch Med Sci, Dept Resp Med Cellular Transplantat Biol, Kanazawa, Ishikawa 9208640, Japan; [Nakanishi, Sayaka; Yoshizaki, Tomokazu] Kanazawa Univ, Grad Sch Med Sci, Dept Otolaryngol Head & Neck Surg, Kanazawa, Ishikawa 9208640, Japan; [Hayakawa, Kazuichi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9208640, Japan; [Kobayashi, Fumihisa] Kanazawa Univ, Coll Sci & Engn, Kanazawa, Ishikawa 9208640, Japan; [Michigami, Yoshimasa] Kanazawa Univ, Environm Preservat Ctr, Kanazawa, Ishikawa 9208640, Japan; [Ohkura, Noriyuki] Ishikawa Prefectural Cent Hosp, Kanazawa, Ishikawa, Japan; [Fujimura, Masaki] Natl Hosp Org, Nanao Hosp, Nanao, Japan	Higashi, T (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Hyg, Takaramachi 13-1, Kanazawa, Ishikawa 9208640, Japan.	tomotomo@med.kanazawa-u.ac.jp	Higashi, Tomomi/C-4712-2015	Higashi, Tomomi/0000-0001-6590-9264	Ministry of Education, Culture, Sports, Science and Technology of Japan [23120703, 22510027]; Global Environment Research Fund of the Ministry of the Environment, Japan [B-0901, C-1155]	We thank all the patients who participated in our study. The LIDAR data were provided by Dr. Nobuo Sugimoto from the National Institute for Environmental Studies. This study was supported in part by a Grant-in-Aid for Scientific Research in Innovative Areas (No. 23120703) and a Grant for Scientific Research (No. 22510027) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the Global Environment Research Fund (B-0901 and C-1155) of the Ministry of the Environment, Japan.	Tobo Y, 2010, P NATL ACAD SCI USA, V107, P17905, DOI 10.1073/pnas.1008235107; Yang XY, 2007, ATMOS ENVIRON, V41, P2710, DOI 10.1016/j.atmosenv.2006.11.052; Fukutomi Y, 2010, INT ARCH ALLERGY IMM, V153, P280, DOI 10.1159/000314369; McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535; Maki T, 2010, SCI TOTAL ENVIRON, V408, P4556, DOI 10.1016/j.scitotenv.2010.04.002; Griffin DW, 2007, CLIN MICROBIOL REV, V20, P459, DOI 10.1128/CMR.00039-06; Sugimoto N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016349; Lei YC, 2004, ENVIRON RES, V95, P71, DOI 10.1016/S0013-9351(03)00136-1; Ichinose T, 2008, INHAL TOXICOL, V20, P685, DOI 10.1080/08958370801935133 ; Yang CY, 2005, INHAL TOXICOL, V17, P817, DOI 10.1080/08958370500241254; Chang CC, 2006, J TOXICOL ENV HEAL A, V69, P229, DOI 10.1080/15287390500227415; Kanatani KT, 2010, AM J RESP CRIT CARE, V182, P1475, DOI 10.1164/rccm.201002-0296OC; Ueda K, 2012, INHAL TOXICOL, V24, P858, DOI 10.3109/08958378.2012.724729; Hiyoshi K, 2005, ENVIRON RES, V99, P361, DOI 10.1016/j.envres.2005.03.008; Watanabe Masanari, 2011, Allergology International, V60, P267, DOI 10.2332/allergolint.10-OA-0239; Irwin RS, 1997, ARCH INTERN MED, V157, P1981, DOI 10.1001/archinte.157.17.1981; Okubo Kimihiro, 2011, Allergology International, V60, P171, DOI [10.2332/allergolint. 11-RAI-0334, 10.2332/allergolint.11-RAI-0334]; CORRAO WM, 1979, NEW ENGL J MED, V300, P633, DOI 10.1056/NEJM197903223001201; Ohta Ken, 2011, Allergology International, V60, P115, DOI 10.2332/allergolint.11-RAI-0327; DURHAM OC, 1946, J ALLERGY, V17, P79, DOI 10.1016/0021-8707(46)90025-1; FUJIMURA M, 1992, THORAX, V47, P441, DOI 10.1136/thx.47.6.441; Fujimura M, 2005, RESPIROLOGY, V10, P201, DOI 10.1111/j.1440-1843.2005.00686.x; Ichinose T, 2009, INHAL TOXICOL, V21, P985, DOI 10.1080/08958370802672883; Iwasaka Y, 2004, ENVIRON MONIT ASSESS, V92, P5, DOI 10.1023/B:EMAS.0000014505.43198.48; Iwasaka Y, 2003, J GEOPHYS RES-ATMOS, V108, P1, DOI 10.1029/2002JD003270; Kaneko Y, 2005, INT ARCH ALLERGY IMM, V136, P365, DOI 10.1159/000084256; Kohno S, 2006, RESPIROLOGY, V11, pS135, DOI 10.1111/j.1400-1843.2006.00920.x; Kurosaki Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047494; Matsumoto H, 2012, ALLERGOL INT, V61, P123, DOI 10.2332/allergolint.10-OA-0295; Minoura H, 1998, J METEOROL SOC JPN, V76, P13; Nakamura H, 2003, J ALLERGY CLIN IMMUN, V112, P1127, DOI 10.1016/j.jaci.2003.08.051; Otani S, 2012, INT J ENV RES PUB HE, V9, P4606, DOI 10.3390/ijerph9124606; Park JW, 2005, RESPIROLOGY, V10, P470, DOI 10.1111/j.1440-1843.2005.00728.x; Shimizu A, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2002JD003253; Sugimoto N, 2011, SOLA, V7A, P13, DOI 10.2151/sola.7A-004; Ternesten-Hasséus Ewa, 2011, Cough, V7, P6, DOI 10.1186/1745-9974-7-6; Yang CY, 2006, J TOXICOL ENV HEAL A, V69, P1673, DOI 10.1080/15287390600630096	37	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	NOV	2014	97				SI		537	543		10.1016/j.atmosenv.2014.01.041		7	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AR1HQ	WOS:000343336700057		
J	Higashi, T; Kambayashi, Y; Ohkura, N; Fujimura, M; Nakai, S; Honda, Y; Saijoh, K; Hayakawa, K; Kobayashi, F; Michigami, Y; Olando, AE; Hitomi, Y; Nakamura, H				Higashi, Tomomi; Kambayashi, Yasuhiro; Ohkura, Noriyuki; Fujimura, Masaki; Nakai, Satoshi; Honda, Yasushi; Saijoh, Kiyofumi; Hayakawa, Kazuichi; Kobayashi, Fumihisa; Michigami, Yoshimasa; Olando, Anyenda Enoch; Hitomi, Yoshiaki; Nakamura, Hiroyuki			Effects of Asian dust on daily cough occurrence in patients with chronic cough: A panel study (Reprinted from Atmospheric Environment vol 92, pg 506)	ATMOSPHERIC ENVIRONMENT			English	Reprint						Asian dust; Kosa; Chronic cough; Daily cough symptom; PM2.5	CAUSE-SPECIFIC MORTALITY; PARTICULATE MATTER; AIR-POLLUTION; SAHARAN DUST; SURFACE OBSERVATIONS; HOSPITAL ADMISSIONS; VARIANT ASTHMA; LIDAR NETWORK; SAND DUST; JAPAN	Asian dust, known as kosa in Japanese, is a major public health concern. In this panel study, we evaluated the effects of exposure to kosa on daily cough occurrence. The study subjects were 86 patients being treated for asthma, cough variant asthma, or atopic cough in Kanazawa University Hospital from January 2011 to June 2011. Daily mean concentrations of kosa and spherical particles were obtained from light detection and ranging (LIDAR) measurements, and were categorized from Grade 1 (0 mu g/m(3)) to 5 (over 100 mu g/m(3)). The association between kosa and cough was analyzed by logistic regression with a generalized estimating equation. Kosa effects on cough were seen for all Grades with potential time lag effect. Particularly at Lag 0 (the day of exposure), a dose-response relationship was observed: the odds ratios for Grades 2, 3, 4, and 5 above the referent (Grade 1) were 1.111 (95% confidence interval (Cl): 0.995-1.239), 1.171 (95% CI: 1.006-1.363), 1.357 (95% CI: 1.029-1.788), and 1.414 (95% CI: 0.983-2.036), respectively. Among the patients without asthma, the association was higher: the odds ratios for Grades 2, 3, 4 and 5 were 1.223 (95% CI: 0.999-1.497), 1.309(95% CI: 0.987-1.737), 1.738 (95% CI: 1.029-2.935) and 2.403 (95% Cl: 1.158-4.985), respectively. These associations remained after adjusting for the concentration of spherical particles or particulate matter with an aerodynamic diameter of less than 2.5 mu m (PM2.5). Our findings demonstrate that kosa is an environmental factor which induces cough in a doseresponse relationship. (C) 2014 Elsevier B.V. All rights reserved.	[Higashi, Tomomi; Saijoh, Kiyofumi] Kanazawa Univ, Grad Sch Med Sci, Dept Hyg, Kanazawa, Ishikawa 9208640, Japan; [Kambayashi, Yasuhiro; Olando, Anyenda Enoch; Hitomi, Yoshiaki; Nakamura, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Environm & Prevent Med, Kanazawa, Ishikawa 9208640, Japan; [Ohkura, Noriyuki; Fujimura, Masaki] Kanazawa Univ, Grad Sch Med Sci, Dept Resp Med Cellular Transplantat Biol, Kanazawa, Ishikawa 9208640, Japan; [Nakai, Satoshi] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa, Japan; [Honda, Yasushi] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki 305, Japan; [Hayakawa, Kazuichi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9208640, Japan; [Kobayashi, Fumihisa] Kanazawa Univ, Coll Sci & Engn, Kanazawa, Ishikawa 9208640, Japan; [Michigami, Yoshimasa] Kanazawa Univ, Environm Preservat Ctr, Kanazawa, Ishikawa 9208640, Japan; [Fujimura, Masaki] Natl Hosp Org, Nanao Hosp, Nanao, Japan	Higashi, T (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Hyg, Takaramachi 13-1, Kanazawa, Ishikawa 9208640, Japan.	tomotomo@med.kanazawa-u.ac.jp	Higashi, Tomomi/C-4712-2015	Higashi, Tomomi/0000-0001-6590-9264			Janes H, 2008, ANN EPIDEMIOL, V18, P792, DOI 10.1016/j.annepidem.2008.06.004; Leisenring W, 1997, STAT MED, V16, P1263, DOI 10.1002/(SICI)1097-0258(19970615)16:11<1263::AID-SIM550>3.0.CO;2-M; Kashima S, 2012, OCCUP ENVIRON MED, V69, P908, DOI 10.1136/oemed-2012-100797; Cesaroni G, 2008, OCCUP ENVIRON MED, V65, P683, DOI 10.1136/oem.2007.037846; Barnett AG, 2012, INT J BIOMETEOROL, V56, P719, DOI 10.1007/s00484-011-0473-y; Fukutomi Y, 2010, INT ARCH ALLERGY IMM, V153, P280, DOI 10.1159/000314369; Mallone S, 2011, ENVIRON HEALTH PERSP, V119, P1409, DOI [10.12989/ehp.1003026, 10.1289/ehp.1003026]; Maki T, 2010, SCI TOTAL ENVIRON, V408, P4556, DOI 10.1016/j.scitotenv.2010.04.002; Gehring U, 2010, AM J RESP CRIT CARE, V181, P596, DOI 10.1164/rccm.200906-0858OC; Sugimoto N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016349; Lei YC, 2004, ENVIRON RES, V95, P71, DOI 10.1016/S0013-9351(03)00136-1; Ichinose T, 2008, INHAL TOXICOL, V20, P685, DOI 10.1080/08958370801935133 ; Jimenez E, 2010, SCI TOTAL ENVIRON, V408, P5729, DOI 10.1016/j.scitotenv.2010.08.049; Peng RD, 2008, JAMA-J AM MED ASSOC, V299, P2172, DOI 10.1001/jama.299.18.2172; Yang CY, 2005, INHAL TOXICOL, V17, P817, DOI 10.1080/08958370500241254; Alessandrini ER, 2013, OCCUP ENVIRON MED, V70, P432, DOI 10.1136/oemed-2012-101182; Onishi K, 2012, ATMOS ENVIRON, V49, P94, DOI 10.1016/j.atmosenv.2011.12.018; Kanatani KT, 2010, AM J RESP CRIT CARE, V182, P1475, DOI 10.1164/rccm.201002-0296OC; Bell ML, 2008, OCCUP ENVIRON MED, V65, P104, DOI 10.1136/oem.2006.031500; BRUNEKREEF B, 1995, ENVIRON HEALTH PERSP, V103, P3, DOI 10.2307/3432443; Hiyoshi K, 2005, ENVIRON RES, V99, P361, DOI 10.1016/j.envres.2005.03.008; Perez L, 2012, ENVIRON INT, V48, P150, DOI 10.1016/j.envint.2012.07.001; Irwin RS, 1997, ARCH INTERN MED, V157, P1981, DOI 10.1001/archinte.157.17.1981; CORRAO WM, 1979, NEW ENGL J MED, V300, P633, DOI 10.1056/NEJM197903223001201; Janssen KJM, 2010, J CLIN EPIDEMIOL, V63, P721, DOI 10.1016/j.jclinepi.2009.12.008; Ohta Ken, 2011, Allergology International, V60, P115, DOI 10.2332/allergolint.11-RAI-0327; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; FUJIMURA M, 1992, THORAX, V47, P441, DOI 10.1136/thx.47.6.441; Fujimura M, 2005, RESPIROLOGY, V10, P201, DOI 10.1111/j.1440-1843.2005.00686.x; Higashi T, 2014, ATMOS ENVIRON, V97, P537, DOI 10.1016/j.atmosenv.2014.01.041; HIGASHI T, ATMOSPHERIC ENV, V92, P506; Iwasaka Y., 2003, WATER AIR SOIL POLL, V3, P129, DOI 10.1023/A:1023282221749; Iwasaka Y, 2004, ENVIRON MONIT ASSESS, V92, P5, DOI 10.1023/B:EMAS.0000014505.43198.48; JENNRICH RI, 1986, BIOMETRICS, V42, P805, DOI 10.2307/2530695; Kohno S, 2006, RESPIROLOGY, V11, pS135, DOI 10.1111/j.1400-1843.2006.00920.x; Lipsitz SR, 1999, STAT MED, V18, P2435, DOI 10.1002/(SICI)1097-0258(19990915/30)18:17/18<2435::AID-SIM267>3.3.CO;2-2; Ma L, 2008, J EPIDEMIOL, V18, P97, DOI 10.2188/jea.JE2007432; Martus P, 2004, STAT MED, V23, P1377, DOI 10.1002/sim.1745; Matsumoto H, 2012, ALLERGOL INT, V61, P123, DOI 10.2332/allergolint.10-OA-0295; Minoura H, 1998, J METEOROL SOC JPN, V76, P13; Park JW, 2005, RESPIROLOGY, V10, P470, DOI 10.1111/j.1440-1843.2005.00728.x; POPE CA, 1995, ENVIRON HEALTH PERSP, V103, P472, DOI 10.2307/3432586; Shimizu A, 2011, SOLA, V7A, P1, DOI 10.2151/sola.7A-001; Shimizu A, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2002JD003253; Sugimoto N, 2013, ASIA-PAC J ATMOS SCI, V49, P27, DOI 10.1007/s13143-013-0004-3; Sugimoto N, 2011, SOLA, V7A, P13, DOI 10.2151/sola.7A-004; Ternesten-Hasséus Ewa, 2011, Cough, V7, P6, DOI 10.1186/1745-9974-7-6; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	48	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	NOV	2014	97				SI		544	551		10.1016/j.atmosenv.2014.08.054		8	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AR1HQ	WOS:000343336700058		
J	Okuda, T; Schauer, JJ; Shafer, MM				Okuda, Tomoaki; Schauer, James J.; Shafer, Martin M.			Improved methods for elemental analysis of atmospheric aerosols for evaluating human health impacts of aerosols in East Asia	ATMOSPHERIC ENVIRONMENT			English	Article						EDXRF; Microvolume microwave-assisted acid digestion; Particulate matter; SF-ICP-MS; Trace elements	PARTICULATE MATTER; LOADED FILTERS; COMBUSTION; PARTICLES; DIESEL; FUEL	This paper provides improved elemental analysis methods for the characterization of atmospheric particulate matter (PM) samples. With the aim of developing an approach for comprehensive trace element analysis of small mass of PM samples, we coupled an enhanced microwave-assisted acid digestion method with high-resolution magnetic sector inductively coupled plasma-mass spectrometry (SF-ICP-MS). We also propose a rapid and simple method using energy dispersive X-ray fluorescence spectrometry (EDXRF) that has secondary targets and three-dimensional polarization optics for screening elemental composition of PM. We obtained the concentrations of 44 elements ranged from 10(-3) to 10(5) mu g/g by SF-ICP-MS, and 16 elements ranged from 10(1) to 10(5) mu g/g by EDXRF. The analytic results obtained by these two methods agreed well. Comprehensive analysis for a large set of elements was demonstrated by using the improved SF-ICP-MS method, while EDXRF coupled with fundamental parameter (FP) quantification method can analyze several selected elements as fast as 900 s (15 min) per sample with only minimal sample pretreatment. We provide two possible choices of analysis methods for elucidating elemental composition of PM according to the number of samples, target elements, sample amounts, time and cost for analysis required. (C) 2014 Elsevier Ltd. All rights reserved.	[Okuda, Tomoaki] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Schauer, James J.; Shafer, Martin M.] Univ Wisconsin, Environm Chem & Technol Program, Madison, WI 53706 USA	Okuda, T (reprint author), Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	okuda@applc.keio.ac.jp	Okuda, Tomoaki/D-1934-2014		JSPS/MEXT KAKENHI [22710016, 23120707]; Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [B-0904]; Steel Industry Foundation for the Advancement of Environmental Protection Technology; Mizuho Foundation for the Promotion of Sciences	This research was supported partly by JSPS/MEXT KAKENHI Grant Numbers 22710016 and 23120707, the Environment Research and Technology Development Fund (B-0904) of the Ministry of the Environment, Japan, Steel Industry Foundation for the Advancement of Environmental Protection Technology, and Mizuho Foundation for the Promotion of Sciences.	Spolnik Z, 2005, APPL SPECTROSC, V59, P1465, DOI 10.1366/000370205775142647; Herner JD, 2006, ENVIRON SCI TECHNOL, V40, P1925, DOI 10.1021/es052315q; Zhang NN, 2012, ATMOS RES, V107, P76, DOI 10.1016/j.atmosres.2011.12.012; Okuda T, 2009, ENERG FUEL, V23, P4974, DOI 10.1021/ef900370v; Zhang YX, 2008, ENVIRON SCI TECHNOL, V42, P7502, DOI 10.1021/es800126y; Baron P. A., 2001, AEROSOL MEASUREMENT; Beckhoff B., 2006, HDB PRACTICAL XRAY F; Hamad SH, 2012, SCI WORLD J, DOI 10.1100/2012/246059; Magara-Gomez KT, 2012, ATMOS ENVIRON, V50, P307, DOI 10.1016/j.atmosenv.2011.12.007; Niu JJ, 2010, ATMOS ENVIRON, V44, P235, DOI 10.1016/j.atmosenv.2009.10.009; Okuda Tomoaki, 2013, Asian Journal of Atmospheric Environment, V7, P169, DOI 10.5572/ajae.2013.7.3.169; Okuda T, 2013, AEROSOL AIR QUAL RES, V13, P1864, DOI 10.4209/aaqr.2012.11.0308; Okuda T., 2014, EAROZORU KE IN PRESS; Okuda T, 2013, AEROSOL AIR QUAL RES, V13, P436, DOI 10.4209/aaqr.2012.09.0250; Okuda T., 2013, EAROZORU KENKYU, V28, P214; Okuda T., 2013, J JAPAN SOC ATMOSPHE, V48, P268; Schauer J.J., 2010, 153 HLTH EFF I; Simpson CD, 2005, ENVIRON SCI TECHNOL, V39, P631, DOI 10.1021/es0486871; Steinhoff G, 2000, FRESEN J ANAL CHEM, V366, P174, DOI 10.1007/s002160050034; Yatkin S, 2012, ATMOS ENVIRON, V54, P568, DOI 10.1016/j.atmosenv.2012.02.062	20	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	NOV	2014	97				SI		552	555		10.1016/j.atmosenv.2014.01.043		4	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AR1HQ	WOS:000343336700059		
J	Jang, S; Ohtani, K; Fukuoh, A; Mori, K; Yoshizaki, T; Kitamoto, N; Kim, Y; Suzuki, Y; Wakamiya, N				Jang, SeongJae; Ohtani, Katsuki; Fukuoh, Atsushi; Mori, Kenichiro; Yoshizaki, Takayuki; Kitamoto, Noritoshi; Kim, YounUck; Suzuki, Yasuhiko; Wakamiya, Nobutaka			Scavenger receptor CL-P1 mediates endocytosis by associating with AP-2 mu 2	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						Scavenger Receptors; Endocytosis; Adaptor complex; Collectin; Tyrosine motif	LOW-DENSITY-LIPOPROTEIN; NITRIC-OXIDE SYNTHASE; ENDOTHELIAL-CELLS; EXPRESSION CLONING; SORTING SIGNALS; CLASS-B; SR-BI; INTERNALIZATION; CLATHRIN; BINDING	Background: Scavenger receptor CL-P1 (collectin placenta 1) has been found recently as a first membrane-type collectin which is mainly expressed in vascular endothelial cells. CL-P1 can endocytose OxLDL as well as microbes but in general, the endocytosis mechanism of a scavenger receptor is not well elucidated. Methods: We screened a placental cDNA library using a yeast two-hybrid system to detect molecules associated with the cytoplasmic domain of CL-P1 We analyzed the binding and endocytosis of several ligands in CL-P1 transfectants and performed the inhibition study using tyrphostin A23 which is a specific inhibitor of tyrosine kinase, especially in mu 2-dependent endocytosis and the site-directed mutagenesis in the endocytosis YXX Phi motif in CL-P1 cytoplasmic region. Furthermore, the SiRNA study of clathrin, adaptor AP-2 and dynamin-2 during the endocytosis of OxLDL in CL-P1 transfectant cells was carried out. Results: We identified mu 2 subunit of the AP-2 adaptor complex as a molecule associated with the cytoplasmic region of CL-P1. We demonstrated that AP-2 mu 2 was essential for CL-P1 mediated endocytosis of OxLDL in CL-P1 transfectant cells and its endocytosis was also mediated by clathrin, dynamin and adaptin complex molecules. Conclusions: Tyrosine-based YXX Phi sequences play an important role in CL-P1 -mediated OxLDL endocytosis associated with AP-2 mu 2. General Significance: This might be the first finding of the clear endocytosis mechanism in scavenger receptor CL-P1. (C) 2014 Elsevier B.V. All rights reserved.	[Jang, SeongJae; Ohtani, Katsuki; Fukuoh, Atsushi; Mori, Kenichiro; Yoshizaki, Takayuki; Kim, YounUck; Wakamiya, Nobutaka] Asahikawa Med Univ, Dept Microbiol & Immunochem, Asahikawa, Hokkaido 0788510, Japan; [Kitamoto, Noritoshi] Univ Hyogo, Sch Human Sci & Environm, Dept Microbiol, Himeji, Hyogo 6700092, Japan; [Suzuki, Yasuhiko] Hokkaido Univ, Dept Bioresources, Res Ctr Zoonosis Control, Sapporo, Hokkaido 0010020, Japan; [Kim, YounUck] Univ Sun Moon, Dept Biomed Sci, Asan 336708, South Korea	Wakamiya, N (reprint author), Asahikawa Med Univ, Dept Microbiol & Immunochem, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	wakamiya@asahikawa-med.ac.jp			"Knowledge Cluster Initiative" (Sapporo Biocluster Bio-S), a project of the Japan of Ministry of Education, Culture, Sports, Science, and Technology [22390113, 26293124]; Fuso Pharmaceutical Industries, Ltd.; Smoking Research Foundation; Takeda Science Foundation; Mizutani Foundation for Glycoscience	This work was supported by grants from Grants-in-Aid for Scientific Research (22390113, 26293124) and from the "Knowledge Cluster Initiative" (Sapporo Biocluster Bio-S), a project of the Japan of Ministry of Education, Culture, Sports, Science, and Technology. This work was also supported by grants from Fuso Pharmaceutical Industries, Ltd., the Smoking Research Foundation, the Takeda Science Foundation, and the Mizutani Foundation for Glycoscience.	Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; Adachi H, 1997, J BIOL CHEM, V272, P31217, DOI 10.1074/jbc.272.50.31217; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Greaves DR, 1998, CURR OPIN LIPIDOL, V9, P425, DOI 10.1097/00041433-199810000-00006; Chen Y, 2006, ARTERIOSCL THROM VAS, V26, P1317, DOI 10.1161/01.ATV.0000220171.50282.0c; Zhu XD, 2011, J BIOL CHEM, V286, P8231, DOI 10.1074/jbc.M110.145888; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Jang S, 2009, J BIOL CHEM, V284, P3956, DOI 10.1074/jbc.M807477200; Li RM, 2011, AM J PHYSIOL-GASTR L, V300, pG71, DOI 10.1152/ajpgi.00215.2010; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; Sorensen KK, 2012, AM J PHYSIOL-REG I, V303, pR1217, DOI 10.1152/ajpregu.00686.2011; Murphy JE, 2008, J CELL SCI, V121, P2136, DOI 10.1242/jcs.020917; Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Tiruppathi C, 1997, J BIOL CHEM, V272, P25968, DOI 10.1074/jbc.272.41.25968; Ohtani K, 2001, J BIOL CHEM, V276, P44222, DOI 10.1074/jbc.M103942200; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; Eckhardt ERM, 2006, J BIOL CHEM, V281, P4348, DOI 10.1074/jbc.M513154200; Harasaki K, 2005, TRAFFIC, V6, P1014, DOI 10.1111/j.1600-0854.2005.00341.x; Koyama S, 2011, BBA-GEN SUBJECTS, V1810, P836, DOI 10.1016/j.bbagen.2011.06.013; Li XA, 2002, J BIOL CHEM, V277, P11058, DOI 10.1074/jbc.M110985200; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; Oteiza A, 2011, AM J PHYSIOL-GASTR L, V301, pG684, DOI 10.1152/ajpgi.00347.2010; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; Zeng YC, 2003, J BIOL CHEM, V278, P45931, DOI 10.1074/jbc.M307722200	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	NOV	2014	1840	11					3226	3237		10.1016/j.bbagen2014.07.019		12	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AR1LL	WOS:000343346600004		
J	Ueki, T; Uwagaki, M; Yamamoto, S; Michibata, H				Ueki, Tatsuya; Uwagaki, Masayuki; Yamamoto, Sohei; Michibata, Hitoshi			Participation of thioredoxin in the V(V)-reduction reaction by Vanabin2	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						Ascidian; Vanadium; Reductase; Metal; Redox	ASCIDIA-SYDNEIENSIS-SAMEA; VANADIUM-BINDING PROTEINS; DENSITY-GRADIENT CENTRIFUGATION; CIONA-INTESTINALIS; BLOOD-CELLS; ARSENATE REDUCTASE; VANADOCYTES; EXPRESSION; GEMMATA; SYSTEMS	Background: It is well-understood that ascidians accumulate high levels of vanadium, a reduced form of V(III), in an extremely acidic vacuole in their blood cells. Vanabins are small cysteine-rich proteins that have been identified only from vanadium-rich ascidians. A previous study revealed that Vanabin2 can act as a V(V)-reductase in the glutathione cascade. Methods: AsTrx1, a thioredoxin gene, was cloned from the vanadium-rich ascidian, Ascidia sydneiensis samea, by PCR AsTix1 and Vanabin2 were prepared as recombinant proteins, and V(V)-reduction by Vanabin2 was assessed by ESR and ion-exchange column chromatography. Site-directed mutagenesis was performed to examine the direct involvement of cysteine residues. Tissue expression of AsTrx1 was also examined by RT-PCR. Results: When reduced AsTrx1 and Vanabin2 were combined, Vanabin2 adopted an SS/SH intermediate structure while V(V) was reduced to V(IV). The loss of cysteine residues in either Vanabin2 or AsTrx1 caused a significant loss of reductase activity. V-app and K-app values for Vanabin2-catalyzed V(V)-reduction in the thioredoxin cascade were 0.066 mol-V(IV)/min/mol-Vanabin2 and 0.19 mM, respectively. The K-app value was 2.7-fold lower than that observed in the glutathione cascade. The AsTrx1 gene was expressed at a very high level in blood cells, in which Vanabins 1-4 were co-expressed. Conclusions: AsTrx1 may contribute to a significant part of the redox cascade for V(V)-reduction by Vanabin2 in the cytoplasm of vanadocytes, but prevails only at low V(V) concentrations. General significance: This study is the first to report the reduction of V(V) in the thioredoxin cascade. (C) 2014 Elsevier B.V. All rights reserved.	[Ueki, Tatsuya; Uwagaki, Masayuki; Yamamoto, Sohei; Michibata, Hitoshi] Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Mol Physiol Lab, Higashihiroshima 7398526, Japan; [Ueki, Tatsuya] Hiroshima Univ, Marine Biol Lab, Grad Sch Sci, Onomichi, Hiroshima 7220073, Japan; [Michibata, Hitoshi] Hiroshima Univ, Onomichi, Hiroshima 7220073, Japan	Ueki, T (reprint author), Hiroshima Univ, Marine Biol Lab, Grad Sch Sci, 2445 Mukaishima, Onomichi, Hiroshima 7220073, Japan.	ueki@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [20570070, 21570077, 22224011, 25120508, 25440170]	We would like to thank the staff at the International Coastal Research Center, AORI, University of Tokyo, Otsuchi, Iwate, Japan, and the staff at Kojima Port, Okayama, Japan, for their help in collecting adult ascidians. We also thank Prof. Manabu Abe, at the Department of Chemistry, Graduate School of Science, Hiroshima University, for his help with ESR measurements, which were accomplished using the ELEXSYS-II E500 CW-ESR instrument at the Natural Science Center for Basic Research and Development (N-BARD), Hiroshima University. A portion of the DNA sequencing analyses was also performed at the N-BARD. This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Nos. 20570070, 21570077, 22224011, 25120508 and 25440170).	HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; JI GY, 1994, BIOCHEMISTRY-US, V33, P7294, DOI 10.1021/bi00189a034; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.biochem.54.1.237; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Hamada T, 2005, J AM CHEM SOC, V127, P4216, DOI 10.1021/ja042687j; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Kitayama H, 2013, DALTON T, V42, P11921, DOI 10.1039/c3dt50404b; Shida K, 2003, BIOCHEM BIOPH RES CO, V302, P207, DOI 10.1016/S0006-291X(03)00113-X; Spyrou G, 1997, J BIOL CHEM, V272, P2936; Muller EGD, 1996, MOL BIOL CELL, V7, P1805; Li XK, 2009, J BACTERIOL, V191, P4924, DOI 10.1128/JB.00197-09; Fukui K, 2003, J AM CHEM SOC, V125, P6352, DOI 10.1021/ja034507w; Cheng ZY, 2011, CHEM REV, V111, P5768, DOI 10.1021/cr100006x; Jensen KS, 2009, ANTIOXID REDOX SIGN, V11, P1047, DOI 10.1089/ARS.2008.2297; Ueki T, 2003, BBA-GENE STRUCT EXPR, V1626, P43, DOI 10.1016/S0167-4781(03)00036-8; GLADYSHEVA TB, 1994, BIOCHEMISTRY-US, V33, P7288, DOI 10.1021/bi00189a033; Henze M., 1911, Z PHYSL CHEM, V72, P494; HIRATA J, 1991, J EXP ZOOL, V257, P160, DOI 10.1002/jez.1402570204; Hirota K, 2002, ANN NY ACAD SCI, V957, P189; Kawakami N, 2009, BBA-PROTEINS PROTEOM, V1794, P674, DOI 10.1016/j.bbapap.2009.01.007; Kume S, 2012, BIOMETALS, V25, P1037, DOI 10.1007/s10534-012-9569-z; MICHIBATA H, 1991, J EXP ZOOL, V257, P306, DOI 10.1002/jez.1402570304; Samino S, 2012, MAR BIOTECHNOL, V14, P143, DOI 10.1007/s10126-011-9396-1; Trivedi S, 2003, BBA-GENE STRUCT EXPR, V1630, P64, DOI 10.1016/j.bbaexp.2003.09.007; Ueki T, 2000, BBA-GENE STRUCT EXPR, V1494, P83, DOI 10.1016/S0167-4781(00)00222-0; Ueki T, 2008, BBA-GEN SUBJECTS, V1780, P1010, DOI 10.1016/j.bbagen.2008.04.001; Uyama T, 1998, ZOOL SCI, V15, P441, DOI 10.2108/0289-0003(1998)15[441:GDITPP]2.0.CO;2; Uyama T, 1998, J BIOCHEM-TOKYO, V124, P377; Yamaguchi N, 2004, MAR BIOTECHNOL, V6, P165, DOI 10.1007/s10126-003-0024-6; Yamamoto S, 2014, INORG CHIM ACTA, V420, P47, DOI 10.1016/j.ica.2013.11.023; Yoshihara M, 2005, BBA-GENE STRUCT EXPR, V1730, P206, DOI 10.1016/j.bbaexp.2005.07.002	34	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	NOV	2014	1840	11					3238	3245		10.1016/j.bbagen.2014.07.023		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AR1LL	WOS:000343346600005		
J	Ringden, O; Brazauskas, R; Wang, ZW; Ahmed, I; Atsuta, Y; Buchbinder, D; Burns, LJ; Cahn, JY; Duncan, C; Hale, GA; Halter, J; Hayashi, RJ; Hsu, JW; Jacobsohn, DA; Kamble, RT; Kamani, NR; Kasow, KA; Khera, N; Lazarus, HM; Loren, AW; Marks, DI; Myers, KC; Ramanathan, M; Saber, W; Savani, BN; Schouten, HC; Socie, G; Sorror, ML; Steinberg, A; Popat, U; Wingard, JR; Mattsson, J; Majhail, NS				Ringden, Olle; Brazauskas, Ruta; Wang, Zhiwei; Ahmed, Ibrahim; Atsuta, Yoshiko; Buchbinder, David; Burns, Linda J.; Cahn, Jean-Yves; Duncan, Christine; Hale, Gregory A.; Halter, Joerg; Hayashi, Robert J.; Hsu, Jack W.; Jacobsohn, David A.; Kamble, Rammurti T.; Kamani, Naynesh R.; Kasow, Kimberly A.; Khera, Nandita; Lazarus, Hillard M.; Loren, Alison W.; Marks, David I.; Myers, Kasiani C.; Ramanathan, Muthalagu; Saber, Wael; Savani, Bipin N.; Schouten, Harry C.; Socie, Gerard; Sorror, Mohamed L.; Steinberg, Amir; Popat, Uday; Wingard, John R.; Mattsson, Jonas; Majhail, Navneet S.			Second Solid Cancers after Allogeneic Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						Hematopoietic cell transplantation; Reduced-intensity conditioning; Nonmyeloablative conditioning; Second cancers; Solid tumors	BONE-MARROW-TRANSPLANTATION; MALIGNANT NEOPLASMS; SECONDARY CANCERS; MYELOID-LEUKEMIA; APLASTIC-ANEMIA; RISK; CHEMOTHERAPY; CHILDHOOD; SURVIVORS; ADULTS	We examined risk of second solid cancers after allogeneic hematopoietic cell transplantation (AHCT) using reduced-intensity/nonmyeloablative conditioning (RIC/NMC). RIC/NMC recipients with leukemia/myelodysplastic syndrome (MDS) (n = 2833) and lymphoma (n = 1436) between 1995 and 2006 were included. In addition, RIC/NMC recipients 40 to 60 years of age (n = 2138) were compared with patients of the same age receiving myeloablative conditioning (MAC, n = 6428). The cumulative incidence of solid cancers was 3.35% at 10 years. There was no increase in overall cancer risk compared with the general population (leukemia/MDS: standardized incidence ratio [SIR] .99, P = 1.00; lymphoma: SIR .92, P = .75). However, risks were significantly increased in leukemia/MDS patients for cancers of lip (SIR 14.28), tonsil (SIR 8.66), oropharynx (SIR 46.70), bone (SIR 23.53), soft tissue (SIR 12.92), and vulva (SIR 18.55) and skin melanoma (SIR 3.04). Lymphoma patients had significantly higher risks of oropharyngeal cancer (SIR 67.35) and skin melanoma (SIR 3.52). Among RIC/NMC recipients, age >50 years was the only independent risk factor for solid cancers (hazard ratio [HR] 3.02, P < .001). Among patients ages 40 to 60 years, when adjusted for other factors, there was no difference in cancer risks between RIC/NMC and MAC in leukemia/MDS patients (HR .98, P = .905). In lymphoma patients, risks were lower after RIC/NMC (HR .51, P = .047). In conclusion, the overall risks of second solid cancers in RIC/NMC recipients are similar to the general population, although there is an increased risk of cancer at some sites. Studies with longer follow-up are needed to realize the complete risks of solid cancers after RIC/NMC AHCT. (C) 2014 American Society for Blood and Marrow Transplantation.	[Ringden, Olle; Mattsson, Jonas] Karolinka Univ Hosp, Ctr Allogene Stem Cell Transplantat, Stockholm, Sweden; [Brazauskas, Ruta] Med Coll Wisconsin, Div Biostat, Milwaukee, WI 53226 USA; [Wang, Zhiwei; Saber, Wael] Med Coll Wisconsin, Ctr Int Bone & Marrow Transplant Res, Milwaukee, WI 53226 USA; [Ahmed, Ibrahim] Univ New Mexico, Dept Pediat Hematol & Oncol, Albuquerque, NM 87131 USA; [Atsuta, Yoshiko] Nagoya Univ, Grad Sch Med, Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi 4648601, Japan; [Buchbinder, David] Childrens Hosp Orange Cty, Div Pediat Hematol, Orange, CA 92668 USA; [Burns, Linda J.] Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN USA; [Cahn, Jean-Yves] Univ Hosp, Clin Univ Hematol, Grenoble, France; [Duncan, Christine] Dana Farber Canc Inst, Pediat Stem Cell Transplantat Program, Boston, MA 02115 USA; [Hale, Gregory A.] Univ S Florida, All Childrens Hosp, Dept Hematol Oncol, St Petersburg, FL 33701 USA; [Halter, Joerg] Univ Basel Hosp, Dept Hematol, CH-4031 Basel, Switzerland; [Hayashi, Robert J.] Washington Univ, St Louis Childrens Hosp, Div Pediat Hematol Oncol, St Louis, MO 63110 USA; [Hsu, Jack W.; Wingard, John R.] Univ Florida, Shands HealthCare, Div Hematol & Oncol, Gainesville, FL USA; [Jacobsohn, David A.] Childrens Natl Med Ctr, Div Blood & Marrow Transplantat, Washington, DC 20010 USA; [Kamble, Rammurti T.] Baylor Coll Med, Ctr Cell & Gene Therapy, Ctr Gene Therapy, Houston, TX 77030 USA; [Kamani, Naynesh R.] AABB Ctr Cellular Therapies, Bethesda, MD USA; [Kasow, Kimberly A.] Univ North Carolina Hosp, Pediat Bone Marrow Transplantat Program, Chapel Hill, NC USA; [Khera, Nandita] Mayo Clin Arizona, Dept Hematol Oncol, Phoenix, AZ USA; [Lazarus, Hillard M.] Univ Hosp Cleveland, Case Med Ctr, Seidman Canc Ctr, Div Hematol & Oncol, Cleveland, OH 44106 USA; [Loren, Alison W.] Univ Penn, Perelman Sch Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Marks, David I.] Bristol Childrens Hosp, Adult BMT Unit, Bristol, Avon, England; [Myers, Kasiani C.] Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA; [Ramanathan, Muthalagu] UMass Mem Med Ctr, Div Hematol Oncol, Worcester, MA USA; [Savani, Bipin N.] Vanderbilt Univ, Med Ctr, Div Hematol Oncol, Nashville, TN USA; [Schouten, Harry C.] Acad Ziekenhuis Maastricht, Dept Med & Hematol, Maastricht, Netherlands; [Socie, Gerard] Hop St Louis, Serv Hematol Greffe de Moelle, Paris, France; [Sorror, Mohamed L.] Univ Washington, Sch Med, Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA USA; [Sorror, Mohamed L.] Univ Washington, Sch Med, Dept Med, Div Med Oncol, Seattle, WA 98195 USA; [Steinberg, Amir] Mt Sinai Med Ctr, Dept Hematol & Med Oncol, Los Angeles, CA USA; [Popat, Uday] Univ Texas Houston, MD Anderson Canc Ctr, Dept Stem Cell Transplantat, Houston, TX 77030 USA; [Majhail, Navneet S.] Cleveland Clin, Blood & Marrow Transplant Program, Cleveland, OH 44195 USA	Majhail, NS (reprint author), Cleveland Clin, Taussig Canc Inst, 9500 Euclid Ave,Desk R35, Cleveland, OH 44195 USA.			Mattsson, Jonas/0000-0002-2163-6644	National Cancer Institute (NCI) [U24-CA76518]; National Heart, Lung and Blood Institute (NHLBI); National Institute of Allergy and Infectious Diseases; NHLBI [5U01HL069294]; National Cancer Institute; US Health Resources and Services Administration [HHSH234200637015C]; US Office of Naval Research [N00014-06-1-0704, N00014-08-1-0058]; Allos, Inc.; Amgen, Inc.; Angioblast; Anonymous donation to the Medical College of Wisconsin; Ariad Pharmaceuticals; Be the Match Foundation; Blue Cross and Blue Shield Association; Bailey Family Foundation; Terumo BCT; Celgene; CellGenix; Children's Leukemia Research Association; Fresenius-Biotech North America, Inc.; Gamida Cell Teva Joint Venture Ltd.; Genentech, Inc.; Genzyme Corporation; GlaxoSmithKline; HistoGenetics, Inc.; Kiadis Pharma; Leukemia & Lymphoma Society; Medical College of Wisconsin; Merck Co, Inc.; Millennium: The Takeda Oncology Co.; Milliman USA, Inc.; Miltenyi Biotec, Inc.; National Marrow Donor Program; Optum Healthcare Solutions, Inc.; Osiris Therapeutics, Inc.; Otsuka America Pharmaceutical, Inc.; RemedyMD; Sanofi; Seattle Genetics; Sigma-Tau Pharmaceuticals; Soligenix, Inc.; StemCyte, A Global Cord Blood Therapeutics Co.; Stemsoft Software, Inc.; Swedish Orphan Biovitrum; Tarix Pharmaceuticals; Teva Neuroscience, Inc.; Texas Instruments Inc.; WellPoint, Inc.	The CIBMTR is supported by Public Health Service Grant/Cooperative Agreement U24-CA76518 from the National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI), and the National Institute of Allergy and Infectious Diseases; Grant/Cooperative Agreement 5U01HL069294 from the NHLBI and National Cancer Institute; a contract (HHSH234200637015C) with the US Health Resources and Services Administration; 2 grants (N00014-06-1-0704 and N00014-08-1-0058) from the US Office of Naval Research; and grants from Allos, Inc.; Amgen, Inc.; Angioblast; Anonymous donation to the Medical College of Wisconsin; Ariad Pharmaceuticals; Be the Match Foundation; Blue Cross and Blue Shield Association; The Bailey Family Foundation; Terumo BCT; Celgene; CellGenix; Children's Leukemia Research Association; Fresenius-Biotech North America, Inc.; Gamida Cell Teva Joint Venture Ltd.; Genentech, Inc.; Genzyme Corporation; GlaxoSmithKline; HistoGenetics, Inc.; Kiadis Pharma; The Leukemia & Lymphoma Society; The Medical College of Wisconsin; Merck & Co, Inc.; Millennium: The Takeda Oncology Co.; Milliman USA, Inc.; Miltenyi Biotec, Inc.; National Marrow Donor Program; Optum Healthcare Solutions, Inc.; Osiris Therapeutics, Inc.; Otsuka America Pharmaceutical, Inc.; RemedyMD; Sanofi; Seattle Genetics; Sigma-Tau Pharmaceuticals; Soligenix, Inc.; StemCyte, A Global Cord Blood Therapeutics Co.; Stemsoft Software, Inc.; Swedish Orphan Biovitrum; Tarix Pharmaceuticals; Teva Neuroscience, Inc.; Texas Instruments Inc.; and WellPoint, Inc. The views expressed in this article do not reflect the official policy or position of the National Institutes of Health, the Department of the Navy, the Department of Defense, or any other agency of the US Government.	Curtis RE, 1997, NEW ENGL J MED, V336, P897, DOI 10.1056/NEJM199703273361301; Hegenbart U, 2006, J CLIN ONCOL, V24, P444, DOI 10.1200/JCO.2005.03.1765; Khouri IF, 1998, J CLIN ONCOL, V16, P2817; Travis LB, 1999, NEW ENGL J MED, V340, P351, DOI 10.1056/NEJM199902043400504; Bhatia S, 1996, BLOOD, V87, P3633; Baron F, 2005, J CLIN ONCOL, V23, P1993, DOI 10.1200/JCO.2005.08.0136; Bornhauser M, 2012, LANCET ONCOL, V13, P1035, DOI 10.1016/S1470-2045(12)70349-2; Majhail NS, 2011, BLOOD, V117, P316, DOI 10.1182/blood-2010-07-294629; Majhail NS, 2012, BIOL BLOOD MARROW TR, V18, P348, DOI 10.1016/j.bbmt.2011.12.519; Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004; Le Deley MC, 2003, J CLIN ONCOL, V21, P1074, DOI 10.1200/JCO.2003.04.100; Garwicz S, 2000, INT J CANCER, V88, P672, DOI 10.1002/1097-0215(20001115)88:4<672::AID-IJC24>3.0.CO;2-N; Yokota A, 2012, BONE MARROW TRANSPL, V47, P95, DOI 10.1038/bmt.2011.23; COX DR, 1972, J R STAT SOC B, V34, P187; Rizzo JD, 2009, BLOOD, V113, P1175, DOI 10.1182/blood-2008-05-158782; Friedman DL, 2008, BLOOD, V111, P939, DOI 10.1182/blood-2007-07-099283; Baker KS, 2003, J CLIN ONCOL, V21, P1352, DOI 10.1200/JCO.2003.05.108; Clark TG, 2002, LANCET, V359, P1309, DOI 10.1016/S0140-6736(02)08272-7; Maris MB, 2003, BLOOD, V102, P2021, DOI 10.1182/blood-2003-02-0482; Giralt S, 1997, BLOOD, V89, P4531; Shimoni A, 2013, LEUKEMIA, V27, P829, DOI 10.1038/leu.2012.299; Socie G, 2000, J CLIN ONCOL, V18, P348; Weisdorf D, 2008, BIOL BLOOD MARROW TR, V14, P748, DOI 10.1016/j.bbmt.2008.04.003; Ringden O, 2009, J CLIN ONCOL, V27, P4570, DOI 10.1200/JCO.2008.20.9692; Majhail NS, 2011, BRIT J HAEMATOL, V154, P301, DOI 10.1111/j.1365-2141.2011.08756.x; WITHERSPOON RP, 1989, NEW ENGL J MED, V321, P784, DOI 10.1056/NEJM198909213211203; Breslow NE, 1987, INT AGENCY RES CANC, V82; Curado MP, 2007, INT AGENCY RES CANC, V160; Horner MJ, 2009, SEER CANC STAT REV 1; Majhail Navneet S, 2008, Hematology Am Soc Hematol Educ Program, P142, DOI 10.1182/asheducation-2008.1.142; McSweeney P A, 1999, Biol Blood Marrow Transplant, V5, P192, DOI 10.1053/bbmt.1999.v5.pm10465099; Pasquini MCWZ, 2012, CIBMTR SUMMARY SLIDE; Ringden O, 2013, J INTERN MED, V274, P153, DOI 10.1111/joim.12056; SOCIE G, 1993, NEW ENGL J MED, V329, P1152, DOI 10.1056/NEJM199310143291603; VANLEEUWEN FE, 1994, J CLIN ONCOL, V12, P1063	35	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	NOV	2014	20	11					1777	1784		10.1016/j.bbmt.2014.07.009		8	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	AR1SG	WOS:000343364300018		
J	Takami, A; Yano, S; Yokoyama, H; Kuwatsuka, Y; Yamaguchi, T; Kanda, Y; Morishima, Y; Fukuda, T; Miyazaki, Y; Nakamae, H; Tanaka, J; Atsuta, Y; Kanamori, H				Takami, Akiyoshi; Yano, Shingo; Yokoyama, Hiroki; Kuwatsuka, Yachiyo; Yamaguchi, Takuhiro; Kanda, Yoshinobu; Morishima, Yasuo; Fukuda, Takahiro; Miyazaki, Yasushi; Nakamae, Hirohisa; Tanaka, Junji; Atsuta, Yoshiko; Kanamori, Heiwa			Donor Lymphocyte Infusion for the Treatment of Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis by the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						Acute myeloid leukemia; Donor lymphocyte infusion; Complete remission	BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; LEUKOCYTE INFUSIONS; PROSPECTIVE TRIAL; RISK-FACTORS; EX-VIVO; CHEMOTHERAPY; MALIGNANCIES; BLOOD	Because the efficacy of donor lymphocyte infusion (DLI) for acute myeloid leukemia (AML) relapse after allogeneic hematopoietic stem cell transplantation (HSCT) remains uncertain, especially in the Asian population, a nationwide registry study was retrospectively performed by the Adult AML Working Group of the Japan Society for Hematopoietic Cell Transplantation to identify the factors affecting the patient survival after DLI. Among 143 adult AML patients who received DLI for the treatment of first hematological relapse after HSCT, the overall survival rates at 1 year, 2 years, and 5 years were 32% +/- 4%, 17% +/- 3%, and 7% +/- 3%, respectively. Complete remission (CR) at the time of DLL which was obtained in 8% of the patients, was the strongest predictive factor for survival after DLL Therefore, long-term survival after DLI was achieved almost exclusively in patients who successfully achieved a CR before DLI, indicating the limited efficacy of DLI in a minority of patients. (C) 2014 American Society for Blood and Marrow Transplantation.	[Takami, Akiyoshi] Aichi Med Univ, Sch Med, Dept Internal Med, Div Hematol, Nagakute, Aichi 4801195, Japan; [Takami, Akiyoshi] Kanazawa Univ Hosp, Dept Hematol, Kanazawa, Ishikawa, Japan; [Yano, Shingo; Yokoyama, Hiroki] Jikei Univ, Sch Med, Dept Internal Med, Div Clin Oncol & Hematol, Tokyo, Japan; [Kuwatsuka, Yachiyo] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Yamaguchi, Takuhiro] Tohoku Univ, Grad Sch Med, Div Biostat, Sendai, Miyagi 980, Japan; [Kanda, Yoshinobu] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Japan; [Morishima, Yasuo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Fukuda, Takahiro] Natl Canc Ctr, Hematopoiet Stem Cell Transplantat Unit, Tokyo, Japan; [Miyazaki, Yasushi] Nagasaki Univ Hosp, Dept Hematol, Nagasaki, Japan; [Nakamae, Hirohisa] Osaka City Univ, Grad Sch Med, Osaka 558, Japan; [Tanaka, Junji] Tokyo Womens Med Univ, Dept Hematol, Tokyo, Japan; [Atsuta, Yoshiko] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan; [Atsuta, Yoshiko] Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Nagoya, Aichi 4648601, Japan; [Kanamori, Heiwa] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Kanagawa 2410815, Japan	Takami, A (reprint author), Aichi Med Univ, Sch Med, Dept Internal Med, Div Hematol, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	takami-knz@umin.ac.jp			Ministry of Health, Labour, and Welfare of Japan; Ministry of Education, Culture, Sports and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan [H23-010]	This study was supported by grants from the Ministry of Health, Labour, and Welfare of Japan, the Ministry of Education, Culture, Sports and Technology of Japan. This work was supported in part by a Research on Allergic Disease and Immunology (H23-010) in Health and Labor Science Grant from the Ministry of Health, Labour, and Welfare of Japan. The funders played no role in the study design, data collection and analysis, the,decision to publish, or the preparation of the manuscript.	Atsuta Y, 2007, INT J HEMATOL, V86, P269, DOI 10.1532/IJH97.06239; Forman SJ, 2013, BLOOD, V121, P1077, DOI 10.1182/blood-2012-08-234492; Kolb HJ, 2004, BLOOD, V103, P767, DOI 10.1182/blood-2003-02-0342; Kumar AJ, 2013, BIOL BLOOD MARROW TR, V19, P1094, DOI 10.1016/j.bbmt.2013.04.021; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; Breems DA, 2005, J CLIN ONCOL, V23, P1969, DOI 10.1200/JCO.2005.06.027; Bar M, 2013, BIOL BLOOD MARROW TR, V19, P949, DOI 10.1016/j.bbmt.2013.03.001; Kurosawa S, 2013, BONE MARROW TRANSPL, V48, P529, DOI 10.1038/bmt.2012.172; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; Schmid C, 2012, BLOOD, V119, P1599, DOI 10.1182/blood-2011-08-375840; SULLIVAN KM, 1991, SEMIN HEMATOL, V28, P250; Collins RH, 1997, J CLIN ONCOL, V15, P433; Schmid C, 2007, J CLIN ONCOL, V25, P4938, DOI 10.1200/JCO.2007.11.6053; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Slovak ML, 2000, BLOOD, V96, P4075; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; KOLB HJ, 1995, BLOOD, V86, P2041; Huff CA, 2006, BIOL BLOOD MARROW TR, V12, P414, DOI 10.1016/j.bbmt.2005.11.520; Eapen M, 2004, BONE MARROW TRANSPL, V34, P721, DOI 10.1038/sj.bmt.1704645; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Levine JE, 2002, J CLIN ONCOL, V20, P405, DOI 10.1200/JCO.20.2.405; Porter DL, 1996, BONE MARROW TRANSPL, V18, P975; Porter DL, 2006, BLOOD, V107, P1325, DOI 10.1182/blood-2005-08-3373; Porter D L, 1999, Biol Blood Marrow Transplant, V5, P253, DOI 10.1053/bbmt.1999.v5.pm10465105; Shiobara S, 2000, BONE MARROW TRANSPL, V26, P769, DOI 10.1038/sj.bmt.1702596; Takami A, 2005, INT J HEMATOL, V82, P449, DOI 10.1532/IJH97.05086; Tan YM, 2014, TRANSFUSION, V54, P1493, DOI 10.1111/trf.12524; van den Brink Marcel R M, 2010, Biol Blood Marrow Transplant, V16, pS138, DOI 10.1016/j.bbmt.2009.10.023	28	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	NOV	2014	20	11					1785	1790		10.1016/j.bbmt.2014.07.010		6	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	AR1SG	WOS:000343364300019		
J	Watanabe, Y; Kitazawa, S; Fujii, H; Nemoto, T; Hirayama, S; Iwai, T; Gouda, H; Hirono, S; Nagasea, H				Watanabe, Yoshikazu; Kitazawa, Shota; Fujii, Hideaki; Nemoto, Toru; Hirayama, Shigeto; Iwai, Takashi; Gouda, Hiroaki; Hirono, Shuichi; Nagasea, Hiroshi			Design, synthesis, and structure-activity relationship of novel opioid kappa receptor selective agonists: alpha-Iminoamide derivatives with an azabicyclo[2.2.2]octene skeleton	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						alpha-Iminoamide; kappa agonist; Nalfurafine; Azabicyclo[2.2.2]octene skeleton	PHARMACOLOGIES; LIGANDS; MU; TRK-820; AMINES	The alpha-iminoamide derivative, 4b was designed and synthesized as a novel agonist selective for the opioid kappa receptor. The amide was constrained to an orientation horizontal to the F-ring of the azabicyclo[2.2.2]octane skeleton, which remarkably improved its affinity, selectivity, and agonistic activity for the kappa receptor. This finding was newly established by chemical modification of the nitrogen atom at the 8-position in the azabicyclo[2.2.2]octane skeleton. This modification would never have been found with KNT-63, a derivation of oxabicyclo[2.2.2]octane. These results may provide valuable information for the future development of novel kappa selective agonists. (C) 2014 Elsevier Ltd. All rights reserved.	[Watanabe, Yoshikazu; Kitazawa, Shota; Fujii, Hideaki; Nemoto, Toru; Hirayama, Shigeto; Iwai, Takashi; Nagasea, Hiroshi] Kitasato Univ, Sch Pharm, Minato Ku, Tokyo 1088641, Japan; [Watanabe, Yoshikazu] Nippon Chemiphar Co Ltd, Discovery Res Labs, Saitama 3410005, Japan; [Gouda, Hiroaki] Showa Univ, Sch Pharm, Shinagawa Ku, Tokyo 1428555, Japan; [Gouda, Hiroaki; Hirono, Shuichi] Kitasato Univ, Sch Pharm, Lab Phys Chem Drug Design, Minato Ku, Tokyo 1088641, Japan; [Nagasea, Hiroshi] Univ Tsukuba, Int Inst Integrat Sleep Med, Tsukuba, Ibaraki 3058577, Japan	Nagasea, H (reprint author), Kitasato Univ, Sch Pharm, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.						Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Nakao K, 2009, DRUG TODAY, V45, P323, DOI 10.1358/dot.2009.45.5.1362067; Ida Y, 2012, BIOORGAN MED CHEM, V20, P949, DOI 10.1016/j.bmc.2011.11.047; Nagase H, 2011, TOP CURR CHEM, V299, P29, DOI 10.1007/128_2010_74; MILLAN MJ, 1990, TRENDS PHARMACOL SCI, V11, P70, DOI 10.1016/0165-6147(90)90321-X; Seki T, 1999, EUR J PHARMACOL, V376, P159, DOI 10.1016/S0014-2999(99)00369-6; Kawai K, 2008, BIOORGAN MED CHEM, V16, P9188, DOI 10.1016/j.bmc.2008.09.011; Nemoto T, 2008, BIOORG MED CHEM LETT, V18, P6398, DOI 10.1016/j.bmcl.2008.10.081; SZMUSZKOVICZ J, 1982, J MED CHEM, V25, P1125, DOI 10.1021/jm00352a005; Yamaotsu N, 2010, BIOORGAN MED CHEM, V18, P4446, DOI 10.1016/j.bmc.2010.04.069; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Nagase H, 2010, BIOORG MED CHEM LETT, V20, P121, DOI 10.1016/j.bmcl.2009.11.027; Wang Y, 2005, J PHARMACOL EXP THER, V312, P220, DOI 10.1124/jpet.104.073668; Dhawan BN, 1996, PHARMACOL REV, V48, P567; Nagase H, 1998, CHEM PHARM BULL, V46, P366; Fujii H., 2012, PHARMACOLOGY, P81; LARSEN J, 1992, J CHEM SOC PERK T 2, P1213, DOI 10.1039/p29920001213; Nagase H., 2011, TOP CURR CHEM, V299, P277; Nemoto T, 2013, BIOORGAN MED CHEM, V21, P7628, DOI 10.1016/j.bmc.2013.10.032; Nemoto T, 2008, BIOORGAN MED CHEM, V16, P4304, DOI 10.1016/j.bmc.2008.02.082; Ochiai M., 1988, TETRAHEDRON LETT, V29, P6920; Watanabe Y, 2012, BIOORG MED CHEM LETT, V22, P2689, DOI 10.1016/j.bmcl.2012.03.001; Watanabe Y, 2013, BIOORGAN MED CHEM, V21, P3032, DOI 10.1016/j.bmc.2013.03.026	23	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	NOV 1	2014	24	21					4980	4983		10.1016/j.bmcl.2014.09.029		4	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	AR1AA	WOS:000343309800012		
J	Huang, WL; Wang, WL; Shi, WS; Lei, ZF; Zhang, ZY; Chen, RZ; Zhou, BB				Huang, Wenli; Wang, Wenlong; Shi, Wansheng; Lei, Zhongfang; Zhang, Zhenya; Chen, Rongzhi; Zhou, Beibei			Use low direct current electric field to augment nitrification and structural stability of aerobic granular sludge when treating low COD/NH4-N wastewater	BIORESOURCE TECHNOLOGY			English	Article						Aerobic granules; Electric field; Nitrification; Free ammonia; Extracellular polymeric substances (EPS)	EXTRACELLULAR POLYMERIC SUBSTANCES; FREE AMMONIA; INHIBITION; METABOLISM; STRENGTH; BACTERIA; REMOVAL; REACTOR; SURFACE	This study explored the effect of low direct current (DC, <= 5 V) electric field on aerobic granules by using two identical square sequencing batch reactors (SBRs) when influent chemical oxygen demand to ammonia nitrogen (COD/NH4-N) ratio decreased from 6 to 1.2 (with COD fixed at 600 mg/L). Results showed that the granules from the electro-augmentation SBR had a more compact and dense microbial structure with enriched Actinobacteria, Bacteroidia, Betaproteobacteria, and Nitrospira. Compared to the control, these granules produced 17.4% and 21.5% more proteins and polysaccharides respectively in the extracellular polymeric substances (EPS), with their integrity coefficient stabilized at 3.3-5.2% during 120 days' operation. Interestingly, more di- and tri-valent metals were accumulated in the electro-augmented granules. In addition, greater than 99% nitrification especially with stably high nitratation efficiency was realized in this new system. (C) 2014 Elsevier Ltd. All rights reserved.	[Huang, Wenli; Wang, Wenlong; Shi, Wansheng; Lei, Zhongfang; Zhang, Zhenya] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Chen, Rongzhi] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing 100049, Peoples R China; [Zhou, Beibei] Shanghai Biotechnol Corp, Shanghai 201203, Peoples R China	Zhang, ZY (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	zhang.zhenya.fu@u.tsukuba.ac.jp	Lei, Zhongfang/B-3611-2014				Adav S.S., 2008, BIOTECHNOL ADV, V26, P41; Adav SS, 2008, J HAZARD MATER, V154, P1120, DOI 10.1016/j.jhazmat.2007.11.058; Alshawabkeh A.N., 2004, ENVIRON ENG SCI, V21, P32; Qin L, 2004, PROCESS BIOCHEM, V39, P579, DOI 10.1016/S0032-9592(03)00125-0; Ren TT, 2008, WATER RES, V42, P3343, DOI 10.1016/j.watres.2008.04.015; Pankiewicz U, 2014, FOOD CHEM, V157, P125, DOI 10.1016/j.foodchem.2014.02.028; Ghangrekar MM, 2005, WATER RES, V39, P1123, DOI 10.1016/j.watres.2004.12.018; Zhang JX, 2012, WATER RES, V46, P3535, DOI 10.1016/j.watres.2012.03.059; Adav SS, 2008, WATER RES, V42, P1644, DOI 10.1016/j.watres.2007.10.013; Vadivelu VM, 2007, WATER RES, V41, P826, DOI 10.1016/j.watres.2006.11.030; Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6; Luo QS, 2005, APPL ENVIRON MICROB, V71, P423, DOI 10.1128/AEM.71.1.423-427.2005; Zhao YG, 2013, BIORESOURCE TECHNOL, V143, P439, DOI 10.1016/j.biortech.2013.06.020; ANTHONISEN AC, 1976, J WATER POLLUT CON F, V48, P835; Wang XH, 2012, BIORESOURCE TECHNOL, V110, P105, DOI 10.1016/j.biortech.2012.01.108; Liu YW, 2011, WATER RES, V45, P1258, DOI 10.1016/j.watres.2010.10.002; Muda K, 2010, WATER RES, V44, P4341, DOI 10.1016/j.watres.2010.05.023; Show KY, 2012, APPL BIOCHEM BIOTECH, V167, P1622, DOI 10.1007/s12010-012-9609-8; Jackman SA, 1999, ENZYME MICROB TECH, V24, P316, DOI 10.1016/S0141-0229(98)00128-8; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Liu L, 2010, J HAZARD MATER, V181, P382, DOI 10.1016/j.jhazmat.2010.05.021; Miller DN, 2009, J CONTAM HYDROL, V103, P182, DOI 10.1016/j.jconhyd.2008.10.011; Wilen BM, 2003, WATER RES, V37, P2127, DOI 10.1016/S0043-1354(02)00629-2; Yu XN, 2014, ENVIRON TECHNOL, V35, P1785, DOI 10.1080/09593330.2014.882992; Allen MS, 2004, ENVIRON MICROBIOL, V6, P780, DOI 10.1111/j.1462-2920.2004.00615.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Thrash JC, 2008, ENVIRON SCI TECHNOL, V42, P3921, DOI 10.1021/es702668w; Shi YJ, 2011, BIORESOURCE TECHNOL, V102, P2536, DOI 10.1016/j.biortech.2010.11.081; APHA, 1998, STANDARD METHODS EXA; Jiang HL, 2006, ENVIRON SCI TECHNOL, V40, P6137, DOI 10.1021/es0609295; Liu YW, 2011, BIORESOURCE TECHNOL, V102, P2578, DOI 10.1016/j.biortech.2010.11.109; Yang SF, 2004, BIOCHEM ENG J, V17, P41, DOI 10.1016/S1369-703X(03)00122-0; Zheng XL, 2013, BIORESOURCE TECHNOL, V148, P343, DOI 10.1016/j.biortech.2013.08.100	33	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	NOV	2014	171						139	144		10.1016/j.biortech.2014.08.043		6	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	AQ8PX	WOS:000343091700020		
J	He, LL; Huang, H; Lei, ZF; Liu, CG; Zhang, ZY				He, Leilei; Huang, He; Lei, Zhongfang; Liu, Chunguang; Zhang, Zhenya			Enhanced hydrogen production from anaerobic fermentation of rice straw pretreated by hydrothermal technology	BIORESOURCE TECHNOLOGY			English	Article						Rice straw; Hydrothermal treatment (HTT); Holding time; Biohydrogen production	LIGNOCELLULOSIC BIOMASS; WHEAT-STRAW; BIOHYDROGEN PRODUCTION; SUPERCRITICAL WATER; SUBCRITICAL WATER; ACID; KINETICS; COMPOST; BIOFUEL; ETHANOL	This study tested the effect of hydrothermal treatment (HTT) at different peak temperatures (150 degrees C and 210 degrees C, i.e. HTT150 and HTT210, respectively) and holding time (0-30 min) on the solubilization of rice straw at total solids (TS) of 20% and then subsequent H-2 production from resultant substrates. No obvious degradation was detected in lignin content under all tested HTT conditions which did open up the surface structure and have efficient solubilization effect on rice straw. Soluble carbohydrates produced from straw particles during HTT210 was found to have strongly (r = 0.9987) positive correlation with the subsequent H-2 yield. The maximum soluble carbohydrates, 80 mg per gram of volatile solids (VS) was achieved under HTT210 and 0 min of holding condition, correspondingly yielding the highest hydrogen production (28 ml/g-VS), about 93-fold higher than the control. Results suggest that holding time is crucial for HTT pretreatment when taking subsequent H-2 production into consideration. (C) 2014 Elsevier Ltd. All rights reserved.	[He, Leilei; Huang, He; Lei, Zhongfang; Liu, Chunguang; Zhang, Zhenya] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Zhang, ZY (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	zhang.zhenya.fu@u.tsukuba.ac.jp	Lei, Zhongfang/B-3611-2014		Japan Society for the Promotion of Science (JSPS) [25281048]	The authors would like to thank the financial support from the Japan Society for the Promotion of Science (JSPS), Grants-in-Aid for Scientific Research (B) No. 25281048.	Hamelinck CN, 2005, BIOMASS BIOENERG, V28, P384, DOI 10.1016/j.biombioe.2004.09.002; Guo XM, 2010, INT J HYDROGEN ENERG, V35, P10660, DOI 10.1016/j.ijhydene.2010.03.008; Ivanova G, 2009, INT J HYDROGEN ENERG, V34, P3659, DOI 10.1016/j.ijhydene.2009.02.082; Rogalinski T, 2008, J SUPERCRIT FLUID, V46, P335, DOI 10.1016/j.supflu.2007.09.037; PAMPULHA ME, 1989, APPL MICROBIOL BIOT, V31, P547; Ren NQ, 2009, BIOTECHNOL ADV, V27, P1051, DOI 10.1016/j.biotechadv.2009.05.007; Lim JS, 2012, RENEW SUST ENERG REV, V16, P3084, DOI 10.1016/j.rser.2012.02.051; Kabyemela BM, 1997, IND ENG CHEM RES, V36, P1552, DOI 10.1021/ie960250h; Srokol Z, 2004, CARBOHYD RES, V339, P1717, DOI 10.1016/j.carres.2004.04.018; Sevilla M, 2009, CHEM-EUR J, V15, P4195, DOI 10.1002/chem.200802097; Cao GL, 2010, INT J HYDROGEN ENERG, V35, P13475, DOI 10.1016/j.ijhydene.2009.11.127; Yuan XZ, 2011, BIORESOURCE TECHNOL, V102, P9007, DOI 10.1016/j.biortech.2011.06.045; Monlau F, 2012, ENVIRON SCI TECHNOL, V46, P12217, DOI 10.1021/es303132t; Asghari FS, 2006, IND ENG CHEM RES, V45, P2163, DOI 10.1021/ie051088y; Peterson AA, 2008, ENERG ENVIRON SCI, V1, P32, DOI 10.1039/b810100k; Quemeneur M, 2012, INT J HYDROGEN ENERG, V37, P10639, DOI 10.1016/j.ijhydene.2012.04.083; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Petersen MO, 2009, BIOMASS BIOENERG, V33, P834, DOI 10.1016/j.biombioe.2009.01.004; Nasirian N, 2011, INT J HYDROGEN ENERG, V36, P411, DOI 10.1016/j.ijhydene.2010.09.073; Wilson CA, 2009, WATER RES, V43, P4489, DOI 10.1016/j.watres.2009.07.022; Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027; Merali Z, 2013, BIORESOURCE TECHNOL, V131, P226, DOI 10.1016/j.biortech.2012.12.023; APHA, 2005, STANDARD METHODS EXA; Chandra R, 2012, APPL ENERG, V94, P129, DOI 10.1016/j.apenergy.2012.01.027; Donoso-Bravo A, 2011, BIORESOURCE TECHNOL, V102, P660, DOI 10.1016/j.biortech.2010.08.035; Fan YT, 2006, BIORESOURCE TECHNOL, V97, P500, DOI 10.1016/j.biortech.2005.02.049; Herbert D., 1971, METHODS MICROBIOLO B, V5, P265; MENDEL B, 1954, BIOCHEM J, V56, P639; Nakhshiniev B, 2014, BIORESOURCE TECHNOL, V151, P306, DOI 10.1016/j.biortech.2013.10.083; Shi XX, 2010, INT J ENERG RES, V34, P662, DOI 10.1002/er.1570; UNEP, 2009, CONV WAST AGR BIOM E; Ververis C, 2007, BIORESOURCE TECHNOL, V98, P296, DOI 10.1016/j.biortech.2006.01.007; Zheng Y, 2014, PROG ENERG COMBUST, V42, P35, DOI 10.1016/j.pecs.2014.01.001	33	4	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	NOV	2014	171						145	151		10.1016/j.biortech.2014.08.049		7	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	AQ8PX	WOS:000343091700021		
J	Oshita, K; Okumura, T; Takaoka, M; Fujimori, T; Appels, L; Dewil, R				Oshita, Kazuyuki; Okumura, Takuya; Takaoka, Masaki; Fujimori, Takashi; Appels, Lise; Dewil, Raf			Methane and nitrous oxide emissions following anaerobic digestion of sludge in Japanese sewage treatment facilities	BIORESOURCE TECHNOLOGY			English	Article						Sewage sludge; Anaerobic digestion; Methane; Nitrous oxide; Dewatering	WASTE-WATER TREATMENT; GREENHOUSE-GAS EMISSIONS; LIFE-CYCLE ASSESSMENT; ENERGY RECOVERY; ACTIVATED-SLUDGE; TREATMENT PLANTS; BIOGAS	Methane (CH4) and nitrous oxide (N2O) are potent greenhouse gases with global warming potentials (expressed in terms of CO2-equivalents) of 28 and 265, respectively. When emitted to the atmosphere, they significantly contribute to climate change. It was previously suggested that in wastewater treatment facilities that apply anaerobic sludge digestion, CH4 continues to be emitted from digested sludge after leaving the anaerobic digester. This paper studies the CH4 and N2O emissions from anaerobically digested sludge in the subsequent sludge treatment steps. Two full-scale treatment plants were monitored over a 1-year period. Average emissions of CH4 and N2O were 509 +/- 72 mg/m(3)-influent (wastewater) and 7.1 +/- 2.6 mg/m(3)-influent, respectively. These values accounted for 22.4 +/- 3.8% of the indirect reduction in CO2-emissions when electricity was generated using biogas. They are considered to be significant. (C) 2014 Elsevier Ltd. All rights reserved.	[Oshita, Kazuyuki; Takaoka, Masaki; Fujimori, Takashi] Kyoto Univ, Grad Sch Global Environm Studies, Cluster C, Nishikyo Ku, Kyoto 6158540, Japan; [Okumura, Takuya] Kyoto Univ, Grad Sch Engn, Cluster C, Nishikyo Ku, Kyoto 6158540, Japan; [Oshita, Kazuyuki; Appels, Lise; Dewil, Raf] Katholieke Univ Leuven, Dept Chem Engn, B-2860 St Katelijne Waver, Belgium	Oshita, K (reprint author), Kyoto Univ, Grad Sch Global Environm Studies, Cluster C, Nishikyo Ku, Kyoto 6158540, Japan.	oshita@epsehost.env.kyoto-u.ac.jp	Dewil, Raf/A-6890-2008	Dewil, Raf/0000-0003-4717-5484	Japan Society for the Promotion of Science (JSPS)	We thank the staff members of sewage treatment facility H and N who supported us in the sampling process. Part of this study was supported financially by a grant for strategic international research network program for vitalizing brain circulation from the Japan Society for the Promotion of Science (JSPS).	AMERICAN PUBLIC HEALTH ASSOCIATION-APHA, 1992, STANDARD METHODS EXA; Patterson T, 2011, BIORESOURCE TECHNOL, V102, P7313, DOI 10.1016/j.biortech.2011.04.063; CZEPIEL P, 1995, ENVIRON SCI TECHNOL, V29, P2352, DOI 10.1021/es00009a030; CZEPIEL PM, 1993, ENVIRON SCI TECHNOL, V27, P2472, DOI 10.1021/es00048a025; Rolfe MD, 2012, J BACTERIOL, V194, P686, DOI 10.1128/JB.06112-11; [Anonymous], 2007, 5801 ISO; Kampschreur MJ, 2009, WATER RES, V43, P4093, DOI 10.1016/j.watres.2009.03.001; Uggetti E, 2012, WATER RES, V46, P1755, DOI 10.1016/j.watres.2011.12.049; WIESENBURG DA, 1979, J CHEM ENG DATA, V24, P356, DOI 10.1021/je60083a006; Astbury GR, 2008, PROCESS SAF ENVIRON, V86, P397, DOI 10.1016/j.psep.2008.05.001; Appels L, 2008, PROG ENERG COMBUST, V34, P755, DOI 10.1016/j.pecs.2008.06.002; Brown S, 2010, ENVIRON SCI TECHNOL, V44, P9509, DOI 10.1021/es101210k; Hatamoto M, 2010, WATER RES, V44, P1409, DOI 10.1016/j.watres.2009.11.021; Tallec G, 2008, BIORESOURCE TECHNOL, V99, P2200, DOI 10.1016/j.biortech.2007.05.025; Scherson YD, 2014, ENVIRON SCI TECHNOL, V48, P5612, DOI 10.1021/es501009j; Venkatesh G, 2013, ENERGY, V58, P220, DOI 10.1016/j.energy.2013.05.025; Toyoda S, 2011, ENVIRON SCI TECHNOL, V45, P917, DOI 10.1021/es102985u; Daelman MRJ, 2012, WATER RES, V46, P3657, DOI 10.1016/j.watres.2012.04.024; WEISS RF, 1980, MAR CHEM, V8, P347, DOI 10.1016/0304-4203(80)90024-9; Cao YC, 2013, BIORESOURCE TECHNOL, V127, P81, DOI 10.1016/j.biortech.2012.09.135; Horio M, 2009, WASTE MANAGE, V29, P2195, DOI 10.1016/j.wasman.2009.01.010; IPCC, 2006, GUIDELINES NATL GREE, V5; IPCC, 2013, 5 IPCC, P731; IPCC, 2002, IPCC EXP M GOOD PRAC, P441; Japan Sewage Works Association, 2010, JAP SEW STAT 2008 FY; Maulini-Duran C, 2013, BIORESOURCE TECHNOL, V147, P43, DOI 10.1016/j.biortech.2013.07.118; Ministry of the Environment Japan, 2006, INV COMM GREENH GAS, P82; Sato K., 1992, REPORTS GLOBAL ENV R, P45; Takeishi K., 1993, REPORTS GLOBAL ENV R, P253; US EPA, 2009, 430R09004 US EPA; U.S. EPA, 2000, BIOS TECHN FACT SHEE	31	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	NOV	2014	171						175	181		10.1016/j.biortech.2014.08.081		7	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	AQ8PX	WOS:000343091700025		
J	Sen, BK; Deshmukh, DK; Deb, MK; Verma, D; Pal, J				Sen, Bhupendra K.; Deshmukh, Dhananjay K.; Deb, Manas K.; Verma, Devsharan; Pal, Jolly			Removal of Phenolic Compounds from Aqueous Phase by Adsorption onto Polymer Supported Iron Nanoparticles	BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY			English	Article						Adsorption; Phenolic compounds; Adsorption isotherm; Iron nanoparticles; Polyvinylpyrrolidone	ACTIVATED CARBON; SORPTION; WATER	The removal of phenolic compounds, i.e., o-cresol, m-cresol, and p-cresol from aqueous solution have been evaluated employing activated carbon (AC) coated with polymer supported iron nanoparticles (FeNPs). The synthesized FeNPs were characterized by scanning electron microscope and X-ray diffraction analysis. High correlation coefficient values indicated that the adsorption of phenolic compounds onto AC coated with polyvinylpyrrolidon (PVP) supported FeNPs obey Freundlich and Langmuir adsorption isotherms. Higher Freundlich and Langmuir constant values for AC coated with PVP supported FeNPs indicated its greater efficiency than AC. The adsorption data are well represented by both the Freundlich and Langmuir isotherms, indicating favourable adsorption of cresols by the adsorbents. Cresols were effectively removed (90 %) by adsorption process from aqueous solution using AC coated with FeNPs. The percentage removal of above phenolic compounds was studied under varying experimental conditions such as pH, temperature, adsorbent dosage, and contact time. The adsorption of phenolic compounds is quite sensitive to pH of the suspension and optimum uptake value was found at pH 7.0. Temperature also has a favorable effect on adsorption when varied from 20 to 50A degrees C. On the contrary, beyond 30A degrees C, a decrease in the adsorption was noticed.	[Sen, Bhupendra K.; Deb, Manas K.; Pal, Jolly] PT Ravishankar Shukla Univ, Sch Studies Chem, Raipur 492010, Madhya Pradesh, India; [Deshmukh, Dhananjay K.] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan; [Verma, Devsharan] Cent Groundwater Board, Nagpur 440001, Maharashtra, India	Deshmukh, DK (reprint author), Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan.	deshmukh@pop.lowtem.hokudai.ac.jp					Rezaee A, 2008, IRAN J ENVIRON HEALT, V5, P305; Shah B, 2012, J DISPER SCI TECHNOL, V33, P41, DOI 10.1080/01932691.2010.530079; Pal J, 2014, J EXP NANOSCI, V9, P432, DOI 10.1080/17458080.2012.667160; Babel S, 2003, J HAZARD MATER, V97, P219, DOI 10.1016/S0304-3894(02)00263-7; Wu B, 2010, B ENVIRON CONTAM TOX, V84, P46, DOI 10.1007/s00128-009-9900-8; Babel S, 2007, INT J ENVIRON SCI TE, V4, P99, DOI 10.1007/BF03325967; Djebbar M, 2012, APPL WATER SCI, V2, P77; Fei Q, 2007, B ENVIRON CONTAM TOX, V78, P265, DOI 10.1007/s00128-007-9127-5; Jasper A, 2010, ENVIRON ENG SCI, V27, P85, DOI 10.1089/ees.2009.0234; Jiang HL, 2006, ENVIRON SCI TECHNOL, V40, P6137, DOI 10.1021/es0609295; Seddigi ZS, 2010, B ENVIRON CONTAM TOX, V84, P564, DOI 10.1007/s00128-010-9995-y; US Environmental Protection Agency (USEPA), 2002, EPA635R02006	12	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0007-4861	1432-0800		B ENVIRON CONTAM TOX	Bull. Environ. Contam. Toxicol.	NOV	2014	93	5					549	554		10.1007/s00128-014-1381-8		6	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	AQ8AO	WOS:000343043000008		
J	Johansson, H; Kanis, JA; Oden, A; Leslie, WD; Fujiwara, S; Glur, CC; Kroger, H; LaCroix, AZ; Lau, E; Melton, LJ; Eisman, JA; O'Neill, TW; Goltzman, D; Reid, DM; McCloskey, E				Johansson, H.; Kanis, J. A.; Oden, A.; Leslie, W. D.; Fujiwara, S.; Gluer, C. C.; Kroger, H.; LaCroix, A. Z.; Lau, E.; Melton, L. J., III; Eisman, J. A.; O'Neill, T. W.; Goltzman, D.; Reid, D. M.; McCloskey, E.			Impact of Femoral Neck and Lumbar Spine BMD Discordances on FRAX Probabilities in Women: A Meta-analysis of International Cohorts	CALCIFIED TISSUE INTERNATIONAL			English	Article						FRAX; BMD; Discordance; Reclassification; Fracture risk	BONE-MINERAL DENSITY; BAND ULTRASOUND ATTENUATION; FRACTURE RISK-ASSESSMENT; OSTEOPOROTIC FRACTURES; POSTMENOPAUSAL WOMEN; VERTEBRAL DEFORMITY; MULTIPLE SITES; US ADULTS; MEN; PREDICTION	There are occasional marked discordances in BMD T-scores at the lumbar spine (LS) and femoral neck (FN). We investigated whether such discordances could contribute independently to fracture prediction using FRAX. We studied 21,158 women, average age 63 years, from 10 prospective cohorts with baseline FRAX variables as well as FN and LS BMD. Incident fractures were collected by self-report and/or radiographic reports. Extended Poisson regression examined the relationship between differences in LS and FN T-scores (Delta LS-FN) and fracture risk, adjusted for age, time since baseline and other factors including FRAX 10-year probability for major osteoporotic fracture calculated using FN BMD. To examine the effect of an adjustment for Delta LS-FN on reclassification, women were separated into risk categories by their FRAX major fracture probability. High risk was classified using two approaches: being above the National Osteoporosis Guideline Group intervention threshold or, separately, being in the highest third of each cohort. The absolute Delta LS-FN was greater than 2 SD for 2.5 % of women and between 1 and 2 SD for 21 %. Delta LS-FN was associated with a significant risk of fracture adjusted for baseline FRAX (HR per SD change = 1.09; 95 % CI = 1.04-1.15). In reclassification analyses, only 2.3-3.2 % of the women moved to a higher or lower risk category when using FRAX with Delta LS-FN compared with FN-derived FRAX alone. Adjustment of estimated fracture risk for a large LS/FN discrepancy (> 2SD) impacts to a large extent on only a relatively small number of individuals. More moderate (1-2SD) discordances in FN and LS T-scores have a small impact on FRAX probabilities. This might still improve clinical decision-making, particularly in women with probabilities close to an intervention threshold.	[Johansson, H.; Kanis, J. A.] Univ Sheffield, WHO Collaborating Ctr Metab Bone Dis, Sheffield S5 7AU, S Yorkshire, England; [Oden, A.] Consulting Statistician, Gothenburg, Sweden; [Leslie, W. D.] Univ Manitoba, Dept Med, Winnipeg, MB, Canada; [Fujiwara, S.] Hiroshima Atom Bomb Casualty Council, Hlth Management & Promot Ctr, Hiroshima, Japan; [Gluer, C. C.] Univ Klinikum Schleswig Holstein, Sekt Biomed Bildgebung, Radiol Diagnost Klin, Campus Kiel, Germany; [Kroger, H.] Kuopio Univ Hosp, Dept Orthopaed, SF-70210 Kuopio, Finland; [Kroger, H.] Univ Eastern Finland, BCRU, Joensuu, Finland; [LaCroix, A. Z.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Lau, E.] CCBR, Hong Kong, Hong Kong, Peoples R China; [Melton, L. J., III] Mayo Clin, Div Epidemiol, Coll Med, Rochester, MN USA; [Eisman, J. A.] Univ Notre Dame Australia, Garvan Inst Med Res, St Vincents Hosp, UNSW Australia, Sydney, NSW, Australia; [O'Neill, T. W.] Univ Manchester, Arthrit Res UK Epidemiol Unit, Sch Translat Med Musculoskeletal Res Grp, Manchester, Lancs, England; [Goltzman, D.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Reid, D. M.] Univ Aberdeen, Sch Med, Sch Med & Dent, Aberdeen AB9 2ZD, Scotland; [McCloskey, E.] Univ Sheffield, Acad Unit Bone Metab, No Gen Hosp, Metab Bone Ctr, Sheffield S5 7AU, S Yorkshire, England; [McCloskey, E.] Univ Sheffield, Mellanby Ctr Bone Res, No Gen Hosp, Metab Bone Ctr, Sheffield S5 7AU, S Yorkshire, England	McCloskey, E (reprint author), Univ Sheffield, Acad Unit Bone Metab, No Gen Hosp, Metab Bone Ctr, Herries Rd, Sheffield S5 7AU, S Yorkshire, England.	e.v.mccloskey@sheffield.ac.uk		Leslie, William/0000-0002-1056-1691	National Institute of Musculoskeletal and Skin Diseases [R01 AR27065]; U.S. Public Health Service; Japanese Ministry of Health, Labour and Welfare (MHLW); U.S. Department of Energy (DOE) [DE-HS0000031]; Canadian Institutes for Health Research (CIHR); Amgen, Merck Frosst Canada Ltd; Eli Lilly and Company; Academy of Finland; National Heart, Lung, and Blood Institute; National Institutes of Health; US Department of Health and Human Services; National Health and Medical Research Council of Australia; Amgen; GE-LUNAR; Lilly; Novartis; Merck Sharp and Dohme; Sanofi-Aventis and Servier	The Rochester study was supported by the National Institute of Musculoskeletal and Skin Diseases (R01 AR27065), U.S. Public Health Service. The AHS has been conducting at the Radiation Effects Research Foundation (RERF), Hiroshima and Nagasaki, Japan, which is a private, non-profit foundation funded by the Japanese Ministry of Health, Labour and Welfare (MHLW) and the U.S. Department of Energy (DOE), the latter in part through DOE Award DE-HS0000031 to the National Academy of Sciences. CaMos is currently funded by the Canadian Institutes for Health Research (CIHR), with additional support from Amgen, Merck Frosst Canada Ltd, and Eli Lilly and Company. The OSTPRE study was supported by the Academy of Finland. The Women's Health Initiative programme is funded by the National Heart, Lung, and Blood Institute, the National Institutes of Health, and the US Department of Health and Human Services. Mr OS (Hong Kong) is also supported by National Institutes of Health funding. The Dubbo Osteoporosis Epidemiology study has been supported by the National Health and Medical Research Council of Australia and by untied educational grants from Amgen, GE-LUNAR, Lilly, Merck Sharp and Dohme, Novartis, Sanofi-Aventis and Servier.	Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Lekamwasam S, 2012, OSTEOPOROSIS INT, V23, P2257, DOI 10.1007/s00198-012-1958-1; Fujiwara S, 2003, J BONE MINER RES, V18, P1547, DOI 10.1359/jbmr.2003.18.8.1547; Lunt M, 1997, OSTEOPOROSIS INT, V7, P175, DOI 10.1007/BF01622286; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; Leslie WD, 2011, OSTEOPOROSIS INT, V22, P839, DOI 10.1007/s00198-010-1461-5; Leslie WD, 2011, J BONE MINER RES, V26, P460, DOI 10.1002/jbmr.248; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Melton LJ, 2003, J BONE MINER RES, V18, P312, DOI 10.1359/jbmr.2003.18.2.312; Melton LJ, 1998, J BONE MINER RES, V13, P1915, DOI 10.1359/jbmr.1998.13.12.1915; Honkanen RJ, 2000, OSTEOPOROSIS INT, V11, P265, DOI 10.1007/s001980050291; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701; Leslie WD, 2007, ARCH INTERN MED, V167, P1641, DOI 10.1001/archinte.167.15.1641; Kreiger N, 1999, CAN J AGING, V18, P376, DOI 10.1017/S0714980800009934; Fujiwara S, 1997, J BONE MINER RES, V12, P998, DOI 10.1359/jbmr.1997.12.7.998; Baim S, 2008, J CLIN DENSITOM, V11, P75, DOI 10.1016/j.jocd.2007.12.007; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; ONeill TW, 1996, J BONE MINER RES, V11, P1010; Kanis JA, 2013, OSTEOPOROSIS INT, V24, P23, DOI 10.1007/s00198-012-2074-y; Compston J, 2009, MATURITAS, V62, P105, DOI 10.1016/j.maturitas.2008.11.022; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; NGUYEN T, 1993, BRIT MED J, V307, P1111; Kanis JA, 2006, OSTEOPOROSIS INT, V17, P527, DOI 10.1007/s00198-005-0014-9; Blake GM, 2003, J BONE MINER RES, V18, P1955, DOI 10.1359/jbmr.2003.18.11.1955; Faulkner KG, 1999, J CLIN DENSITOM, V2, P343, DOI 10.1385/JCD:2:3:343; Gluer CC, 2004, J BONE MINER RES, V19, P782, DOI 10.1359/JBMR.040304; JONES G, 1994, OSTEOPOROSIS INT, V4, P277, DOI 10.1007/BF01623352; Kanis J., 2008, TECHNICAL REPORT; Kwok AWL, 2013, OSTEOPOROSIS INT, V24, P877, DOI 10.1007/s00198-012-2040-8; Looker AC, 2012, OSTEOPOROSIS INT, V23, P1351, DOI 10.1007/s00198-011-1693-z; Lunt M, 1997, J BONE MINER RES, V12, P1883, DOI 10.1359/jbmr.1997.12.11.1883; Marshall D, 1996, BRIT MED J, V312, P1254; McCloskey Eugene V, 2009, Curr Osteoporos Rep, V7, P77; MCCLOSKEY EV, 1990, CLIN SCI, V78, P227; National Osteoporosis Foundation, 2008, CLIN GUID PREV TREAT; Papaioannou A, 2010, CAN MED ASSOC J, V182, P1864, DOI 10.1503/cmaj.100771; Stewart A, 1996, ANN RHEUM DIS, V55, P140, DOI 10.1136/ard.55.2.140; Stewart A, 2006, BONE, V39, P609, DOI 10.1016/j.bone.2006.02.072	38	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0171-967X	1432-0827		CALCIFIED TISSUE INT	Calcif. Tissue Int.	NOV	2014	95	5					428	435		10.1007/s00223-014-9911-2		8	Endocrinology & Metabolism	Endocrinology & Metabolism	AQ8OW	WOS:000343088500006		
J	Ogawa, T; Vandamme, K; Zhang, XL; Naert, I; Possemiers, T; Chaudhari, A; Sasaki, K; Duyck, J				Ogawa, Toru; Vandamme, Katleen; Zhang, Xiaolei; Naert, Ignace; Possemiers, Tine; Chaudhari, Amol; Sasaki, Keiichi; Duyck, Joke			Stimulation of Titanium Implant Osseointegration Through High-Frequency Vibration Loading is Enhanced when Applied at High Acceleration	CALCIFIED TISSUE INTERNATIONAL			English	Article						Titanium implant osseointegration; Whole body vibration; Frequency; Acceleration; Rat tibia	WHOLE-BODY VIBRATION; LOW-MAGNITUDE; MECHANICAL SIGNALS; OVARIECTOMIZED RATS; MUSCLE STRENGTH; BONE-FORMATION; CORTICAL BONE; LOW-AMPLITUDE; LOW-LEVEL; MASS	Low-magnitude high-frequency loading, applied by means of whole body vibration (WBV), affects the bone. Deconstructing a WBV loading stimulus into its constituent elements and investigating the effects of frequency and acceleration individually on bone tissue kinetics around titanium implants were aimed for in this study. A titanium implant was inserted in the tibia of 120 rats. The rats were divided into 1 control group (no loading) and 5 test groups with low (L), medium (M) or high (H) frequency ranges and accelerations [12-30 Hz at 0.3xg (F (L) A (H)); 70-90 Hz at 0.075xg (F (M) A (M)); 70-90 Hz at 0.3xg (F (M) A (H)); 130-150 Hz at 0.043xg (F (H) A (L)); 130-150 Hz at 0.3xg (F (H) A (H))]. WBV was applied for 1 or 4 weeks. Implant osseointegration was evaluated by quantitative histology (bone-to-implant contact (BIC) and peri-implant bone formation (BV/TV)). A 2-way ANOVA (duration of experimental period; loading mode) with alpha = 0.05 was performed. BIC significantly increased over time and under load (p < 0.0001). The highest BICs were found for loading regimes at high acceleration with medium or high frequency (F (M) A (H) and F (H) A (H)), and significantly differing from F (L) A (H) and F (M) A (M) (p < 0.02 and p < 0.005 respectively). BV/TV significantly decreased over time (p < 0.0001). Loading led to a site-specific BV/TV increase (p < 0.001). The highest BV/TV responses were found for F (M) A (H) and F (H) A (H), significantly differing from F (M) A (M) (p < 0.005). The findings reveal the potential of high-frequency vibration loading to accelerate and enhance implant osseointegration, in particular when applied at high acceleration. Such mechanical signals hold great, though untapped, potential to be used as non-pharmacologic treatment for improving implant osseointegration in compromised bone.	[Ogawa, Toru; Vandamme, Katleen; Zhang, Xiaolei; Naert, Ignace; Possemiers, Tine; Chaudhari, Amol; Duyck, Joke] Katholieke Univ Leuven, BIOMAT KU Leuven, Dept Oral Hlth Sci, B-3000 Leuven, Belgium; [Ogawa, Toru; Vandamme, Katleen; Zhang, Xiaolei; Naert, Ignace; Possemiers, Tine; Chaudhari, Amol; Duyck, Joke] Katholieke Univ Leuven, Dent Clin, B-3000 Leuven, Belgium; [Ogawa, Toru; Vandamme, Katleen; Zhang, Xiaolei; Naert, Ignace; Possemiers, Tine; Chaudhari, Amol; Duyck, Joke] Univ Hosp Leuven, B-3000 Leuven, Belgium; [Ogawa, Toru; Sasaki, Keiichi] Tohoku Univ, Div Adv Prosthet Dent, Grad Sch Dent, Sendai, Miyagi 980, Japan; [Zhang, Xiaolei] Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China	Duyck, J (reprint author), Katholieke Univ Leuven, BIOMAT KU Leuven, Dept Oral Hlth Sci, Kapucijnenvoer 7,POB 7001, B-3000 Leuven, Belgium.	Joke.Duyck@uzleuven.be			Research Council of the Katholieke Universiteit Leuven (Belgium) [OT07/059]; Fund for Scientific Research Flanders [G.0726.09]	This work was supported by the Research Council of the Katholieke Universiteit Leuven (Belgium) (OT07/059) and the Fund for Scientific Research Flanders (G.0726.09). We would like to thank Dr. H. van Lenthe for his scientific advice.	Akca Kivanc, 2007, Head Face Med, V3, P28, DOI 10.1186/1746-160X-3-28; Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122; Sehmisch S, 2009, OSTEOPOROSIS INT, V20, P1999, DOI 10.1007/s00198-009-0892-3; Leucht P, 2007, BONE, V40, P919, DOI 10.1016/j.bone.2006.10.027; van der Jagt OP, 2012, J BONE MINER METAB, V30, P40, DOI 10.1007/s00774-011-0293-5; Kontulainen S, 2003, J BONE MINER RES, V18, P352, DOI 10.1359/jbmr.2003.18.2.352; Verschueren SMP, 2004, J BONE MINER RES, V19, P352, DOI 10.1359/JBMR.0301245; Tezval M, 2011, CALCIFIED TISSUE INT, V88, P33, DOI 10.1007/s00223-010-9423-7; Luo J, 2005, SPORTS MED, V35, P23, DOI 10.2165/00007256-200535010-00003; Jeyabalan J, 2012, J ENDOCRINOL, V212, P277, DOI 10.1530/JOE-11-0306; Shi HF, 2010, BONE, V46, P1299, DOI 10.1016/j.bone.2009.11.028; Gilsanz V, 2006, J BONE MINER RES, V21, P1464, DOI 10.1359/JBMR.060612; Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x; Frost HM, 2004, ANGLE ORTHOD, V74, P3; Vico L, 2000, LANCET, V355, P1607, DOI 10.1016/S0140-6736(00)02217-0; Duyck J, 2006, ARCH ORAL BIOL, V51, P1, DOI 10.1016/j.archoralbio.2005.04.003; Rubin C, 2006, AGE AGEING, V35, P32, DOI 10.1093/ageing/afl082; Chen BL, 2012, J ORTHOP RES, V30, P733, DOI 10.1002/jor.22004; Rubin CT, 2001, DRUG DISCOV TODAY, V6, P848, DOI 10.1016/S1359-6446(01)01872-4; Mavrogenis AF, 2009, J MUSCULOSKEL NEURON, V9, P61; Oxlund BS, 2003, BONE, V32, P69, DOI 10.1016/S8756-3282(02)00916-X; Ward K, 2004, J BONE MINER RES, V19, P360, DOI 10.1359/JBMR.040129; RYD L, 1995, J BONE JOINT SURG BR, V77B, P377; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; Judex S, 2009, ORTHOD CRANIOFAC RES, V12, P94, DOI 10.1111/j.1601-6343.2009.01442.x; Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025; Esposito M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003878.pub4; De Smet E, 2006, EUR J ORAL SCI, V114, P232, DOI 10.1111/j.1600-0722.2006.00355.x; Cardinale M, 2005, BRIT J SPORT MED, V39, P585, DOI 10.1136/bjsm.2005.016857; Pollock RD, 2010, CLIN BIOMECH, V25, P840, DOI 10.1016/j.clinbiomech.2010.05.004; Goodship AE, 2009, J ORTHOP RES, V27, P922, DOI 10.1002/jor.20824; Castillo AB, 2006, BONE, V39, P1087, DOI 10.1016/j.bone.2006.04.026; Duyck J, 2010, CLIN ORAL IMPLAN RES, V21, P877, DOI 10.1111/j.1600-0501.2010.01895.x; Hwang SJ, 2009, CLIN ORTHOP RELAT R, V467, P1083, DOI 10.1007/s11999-008-0552-5; Ogawa T, 2011, CLIN ORAL IMPLAN RES, V22, P302, DOI 10.1111/j.1600-0501.2010.02020.x; Ogawa T, 2011, J CLIN PERIODONTOL, V38, P180, DOI 10.1111/j.1600-051X.2010.01637.x; Omar H, 2008, J ORAL MAXIL SURG, V66, P1104, DOI 10.1016/j.joms.2008.01.048; Ozawa S, 2002, BONE, V30, P137, DOI 10.1016/S8756-3282(01)00646-9; RUBIN CT, 1994, CLIN ORTHOP RELAT R, P165; Rubinacci A, 2008, CALCIFIED TISSUE INT, V82, P316, DOI 10.1007/s00223-008-9115-8; Vandamme K, 2011, BIOMATERIALS, V32, P3547, DOI 10.1016/j.biomaterials.2011.01.056; Xu B, 2009, J DENT RES, V88, P1003, DOI 10.1177/0022034509346928; Zhang XL, 2012, J R SOC INTERFACE, V9, P1697, DOI 10.1098/rsif.2011.0820	43	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0171-967X	1432-0827		CALCIFIED TISSUE INT	Calcif. Tissue Int.	NOV	2014	95	5					467	475		10.1007/s00223-014-9896-x		9	Endocrinology & Metabolism	Endocrinology & Metabolism	AQ8OW	WOS:000343088500010		
J	Patil, NM; Sasaki, T; Bhanage, BM				Patil, Nilesh M.; Sasaki, Takehiko; Bhanage, Bhalchandra M.			Chemoselective Transfer Hydrogenation of alpha,beta-Unsaturated Carbonyls Using Palladium Immobilized Ionic Liquid Catalyst	CATALYSIS LETTERS			English	Article						Transfer hydrogenation; Chemoselective; Immobilization; Palladium Heterogeneous catalyst		This work reports a simple and highly efficient protocol for chemoselective transfer hydrogenation of alpha,beta-unsaturated carbonyls using immobilized palladium metal-containing ionic liquid as a versatile heterogeneous catalyst with an excellent conversion and chemoselectivity (up to 100 %). The influence of various reaction parameters such as the effect of hydrogen donor, solvent, temperature, and time were studied. The catalyst was recycled for four consecutive cycles without significant loss in the catalytic activity. The developed protocol is more advantageous due to the use of HCOONH4 as a hydrogen source, mild reaction conditions, and simple workup procedure and applicable for a wide range of substrates.	[Patil, Nilesh M.; Bhanage, Bhalchandra M.] Inst Chem Technol, Dept Chem, Bombay 400019, Maharashtra, India; [Sasaki, Takehiko] Univ Tokyo, Grad Sch Frontier Sci, Dept Complex Sci & Engn, Kashiwa, Chiba 2778561, Japan	Bhanage, BM (reprint author), Inst Chem Technol, Dept Chem, N Parekh Marg, Bombay 400019, Maharashtra, India.	bm.bhanage@ictmumbai.edu.in	Sasaki, Takehiko/E-8160-2014	Sasaki, Takehiko/0000-0001-6190-4087	UGC-SAP (University Grant Commission, India); JSPS; DST under the Japan-India Science Cooperative Program	The author (N. M. Patil) is greatly thankful to the UGC-SAP (University Grant Commission, India) for providing the Senior Research Fellowship. XPS measurements were conducted at the Research Hub for Advanced Nano Characterization, the University of Tokyo, supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. This work is supported by JSPS and DST under the Japan-India Science Cooperative Program.	Andrea S, 2013, GREEN CHEM, V15, P1857; Gallezot P, 1998, CATAL REV, V40, P81, DOI 10.1080/01614949808007106; Anuj S, 2006, ADV SYNTH CATAL, V348, P354; Boqiang D, 2013, ORG LETT, V15, P3690; Dattatraya BB, 2011, GREEN CHEM, V13, P1490; David SH, 1996, ORG CHEM, V61, P6751; Ehud K, 1986, J AM CHEM SOC, V108, P7314; Fang ZS, 2008, CHEM COMMUN, V30, P3531; Hidehito O, 2007, CHEM COMMUN, V18, P1819; Huai GC, 1995, INT J PEPT PROT RES, V45, P1; Lunxiang Y., 2007, CHEM REV, V107, P133; Mannepalli LK, 2012, ADV SYNTH CATAL, V354, P663; Masuko K, 1997, CANC LETT, V119, P207; Mayur VK, 2014, J MOL CATAL A-CHEM, V385, P91; Mayur VK, 2013, ACS CATAL, V3, P287; Saidulu G, 2013, RSC ADV, V3, P11533; Sanjit KM, 2014, CHEMCATCHEM, V6, P1419; Takehiko S, 2005, CHEM COMMUN, V19, P2506; Takehiko S, 2008, J MOL CATAL A-CHEM, V279, P200; Wei-Jing L, 2008, ANGEW CHEM INT EDIT, V47, P10133; Xuefeng L, 2010, J ORG CHEM, V75, P2981; Yoel S, 1975, J ORG CHEM, V40, P1887; Zoltan B, 2009, GREEN CHEM, V11, P1937	23	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1011-372X	1572-879X		CATAL LETT	Catal. Lett.	NOV	2014	144	11					1803	1809		10.1007/s10562-014-1362-x		7	Chemistry, Physical	Chemistry	AQ9BN	WOS:000343136100004		
J	Soma, K; Iwase, A; Kudo, A				Soma, Kota; Iwase, Akihide; Kudo, Akihiko			Enhanced Activity of BiVO4 Powdered Photocatalyst Under Visible Light Irradiation by Preparing Microwave-Assisted Aqueous Solution Methods	CATALYSIS LETTERS			English	Article						Photocatalysis; Oxidation; Heterogeneous catalysis	PHOTOELECTROCHEMICAL PROPERTIES; SOLID-SOLUTION; WATER; EVOLUTION; O-2; NANOCRYSTALS; SEPARATION; SRTIO3; DRIVEN; H-2	BiVO4 has extensively been studied as a promising photocatalyst and a photoanode aiming at highly efficient solar water splitting. We have successfully demonstrated the effectiveness of microwave assistance for the rapid preparation of a BiVO4 photocatalyst with high quality in an aqueous medium. The BiVO4 was highly crystalline polyhedral particles which reflect its crystal structure. Moreover, the present BiVO4 powdered photocatalyst showed higher activities for water oxidation to O-2 in the presence of a sacrificial reagent under visible light and simulated sunlight irradiation than BiVO4 prepared by the aqueous solution methods with the traditional external heating.	[Soma, Kota; Iwase, Akihide; Kudo, Akihiko] Tokyo Univ Sci, Fac Sci, Dept Appl Chem, Shinjuku Ku, Tokyo 1628601, Japan; [Iwase, Akihide; Kudo, Akihiko] Tokyo Univ Sci, Res Inst Sci & Technol, Photocatalysis Int Res Ctr, Noda, Chiba 2788510, Japan	Kudo, A (reprint author), Tokyo Univ Sci, Fac Sci, Dept Appl Chem, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	a-kudo@rs.kagu.tus.ac.jp	Iwase, Akihide/E-9218-2010	Iwase, Akihide/0000-0002-6395-9556	Ministry of Education, Culture, Sports, Science & Technology in Japan [24107001, 24107004, 2406]	This work was supported by a Grant in Aid (No. 24107001 and 24107004) for Scientific Research on Innovative Areas (No. 2406) from the Ministry of Education, Culture, Sports, Science & Technology in Japan.	Abdi FF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3195; Lee YG, 2007, CHEM MATER, V19, P2120, DOI 10.1021/cm062980d; Kudo A, 1998, CATAL LETT, V53, P229, DOI 10.1023/A:1019034728816; Konta R, 2004, J PHYS CHEM B, V108, P8992, DOI 10.1021/jp049556p; Baghbanzadeh M, 2011, ANGEW CHEM INT EDIT, V50, P11312, DOI 10.1002/anie.201101274; Sayama K, 2001, CHEM COMMUN, P2416, DOI 10.1039/b107673f; Kim TW, 2014, SCIENCE, V343, P990, DOI 10.1126/science.1246913; Maeda K, 2011, J PHYS CHEM C, V115, P3057, DOI 10.1021/jp110025x; Ohno T, 2002, NEW J CHEM, V26, P1167, DOI 10.1039/b202140d; Asai R, 2014, CHEM COMMUN, V50, P2543, DOI 10.1039/c3cc49279f; Tokunaga S, 2001, CHEM MATER, V13, P4624, DOI 10.1021/cm0103390; Ye H, 2010, J PHYS CHEM C, V114, P13322, DOI 10.1021/jp104343b; Jia QX, 2012, P NATL ACAD SCI USA, V109, P11564, DOI 10.1073/pnas.1204623109; Maeda K, 2010, J AM CHEM SOC, V132, P5858, DOI 10.1021/ja1009025; Sasaki Y, 2013, J AM CHEM SOC, V135, P5441, DOI 10.1021/ja400238r; Kudo A, 2009, CHEM SOC REV, V38, P253, DOI 10.1039/b800489g; Iwase A, 2010, J MATER CHEM, V20, P7536, DOI 10.1039/c0jm00961j; Kudo A, 1999, J AM CHEM SOC, V121, P11459, DOI 10.1021/ja992541y; Kohtani S, 2002, CHEM LETT, P660, DOI 10.1246/cl.2002.660; Maeda K, 2005, J AM CHEM SOC, V127, P8286, DOI 10.1021/ja0518777; Long MC, 2008, J PHYS CHEM C, V112, P548, DOI 10.1021/jp075605x; Kato H, 2013, J MATER CHEM A, V1, P12327, DOI 10.1039/c3ta12803b; Yu JQ, 2006, ADV FUNCT MATER, V16, P2163, DOI 10.1002/adfm.200500799; Sayama K, 2006, J PHYS CHEM B, V110, P11352, DOI 10.1021/jp057539+; Iwase A, 2010, J SOL ENERG-T ASME, V132, DOI 10.1115/1.4001172; Li RG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2401; Obregon S, 2012, APPL CATAL B-ENVIRON, V117, P59, DOI 10.1016/j.apcatb.2011.12.037; Pihosh Y, 2014, SMALL, V10, P3692, DOI 10.1002/smll.201400276; Yokote Y, 2008, JAP CHEM SOC SPRING, V88, P657; Zhang HM, 2008, J NANOPART RES, V10, P767, DOI 10.1007/s11051-007-9310-y	30	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1011-372X	1572-879X		CATAL LETT	Catal. Lett.	NOV	2014	144	11					1962	1967		10.1007/s10562-014-1361-y		6	Chemistry, Physical	Chemistry	AQ9BN	WOS:000343136100022		
J	Yasuda, S; Yoshida, M; Yamagata, H; Iwanaga, Y; Suenaga, H; Ishikawa, K; Nakano, M; Okuyama, S; Furukawa, Y; Furukawa, S; Ishikawa, T				Yasuda, Seiko; Yoshida, Mitsuhiro; Yamagata, Hirotaka; Iwanaga, Yasutake; Suenaga, Hiromi; Ishikawa, Kozo; Nakano, Masako; Okuyama, Satoshi; Furukawa, Yoshiko; Furukawa, Shoei; Ishikawa, Toshizo			Imipramine Ameliorates Pain-related Negative Emotion via Induction of Brain-derived Neurotrophic Factor	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Chronic pain; Pain-related negative emotion; 5-HT; BDNF; pERK1/2	ANTERIOR CINGULATE CORTEX; DEPRESSION-LIKE BEHAVIOR; SIGNAL-REGULATED KINASE; NEUROPATHIC PAIN; ANTIDEPRESSANT TREATMENTS; HIPPOCAMPAL NEUROGENESIS; DESCENDING CONTROL; MAJOR DEPRESSION; PERSISTENT PAIN; FACTOR BDNF	Depression-like behavior is often complicated by chronic pain. Antidepressants including imipramine (IMI) are widely used to treat chronic pain, but the mechanisms are not fully understood. Brain-derived neurotrophic factor (BDNF) is a neuromodulator that reduces depression by regulating synaptic transmission. We aimed to characterize the antidepressant effects of IMI without analgesia based on BDNF (trkB)-mediated signaling and gene expression in chronic pain. A chronic constriction injury (CCI) model was constructed in Sprague-Dawley (SD) rats. IMI (5 mg/kg, i.p.) was administered from day 10 after CCI. The pain response was assessed using the paw withdrawal latency (PWL) and depression was judged from the immobility time in a forced swim test. Anti-BDNF antibody, K252a, or 5,7-dihydroxytryptamine (5,7-DHT) were used to examine the antidepressant effects of imipramine. Changes in pERK1/2 (immunohistochemistry), 5-HT and BDNF (ELISA), and BDNF mRNA (RTPCR) were measured in the anterior cingulate cortex (ACC), rostral ventromedial medulla (RVM), and spinal cord. After CCI, rats showed decreased PWL and increased immobility time. A low dose of IMI reduced the immobility time without having analgesic effects. This antidepressant effect was reversed by anti-BDNF antibody, K252a, and 5,7-DHT. IMI reduced excessive activation of pERK1/2 associated with decreased pCREB and BDNF mRNA, and these changes were reversed by 5,7-DHT. These results show that IMI reduces pain-related negative emotion without influencing pain and that this effect is diminished by denervation of 5-HT neurons and by anti-BDNF treatment. IMI also normalizes derangement of ERK/CREB coupling, which leads to induction of BDNF. This suggests a possible interaction between 5-HT and BDNF.	[Yasuda, Seiko; Yoshida, Mitsuhiro; Iwanaga, Yasutake; Suenaga, Hiromi; Ishikawa, Kozo; Ishikawa, Toshizo] Yamaguchi Univ, Grad Sch Med, Div Neurosci, Ube, Yamaguchi 7558505, Japan; [Yoshida, Mitsuhiro] Kyushu Dent Univ, Dept Control Phys Funct, Div Dent Anesthesiol, Kitakyushu, Fukuoka 8038580, Japan; [Yamagata, Hirotaka] Yamaguchi Univ, Grad Sch Med, Dept Psychiat, Ube, Yamaguchi 7558505, Japan; [Ishikawa, Kozo; Nakano, Masako] Sapporo Med Univ, Dept Anat 2, Chuou Ku, Sapporo, Hokkaido 0608556, Japan; [Okuyama, Satoshi; Furukawa, Yoshiko] Matsuyama Univ, Coll Pharmaceut Sci, Dept Pharmaceut Pharmacol, Matsuyama, Ehim 7908578, Japan; [Furukawa, Shoei] Gifu Pharmaceut Univ, Dept Biofunct Anal, Mol Biol Lab, Gifu 5011196, Japan	Ishikawa, T (reprint author), Yamaguchi Univ, Grad Sch Med, Div Neurosci, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	medlibn@yamaguchi-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15390475]	This study was supported in part by Scientific Research Grant No. 15390475 to TI from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Tripp A, 2012, AM J PSYCHIAT, V169, P1194, DOI 10.1176/appi.ajp.2012.12020248; Cao H, 2012, NEUROSCI BULL, V28, P77, DOI 10.1007/s12264-012-1060-x; Bremner JD, 2000, AM J PSYCHIAT, V157, P115; Seifert F, 2009, CELL MOL LIFE SCI, V66, P375, DOI 10.1007/s00018-008-8428-0; Kafitz KW, 1999, NATURE, V401, P918; Hosang GM, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-7; Sindrup SH, 2005, BASIC CLIN PHARMACOL, V96, P399, DOI 10.1111/j.1742-7843.2005.pto_96696601.x; Fumagalli F, 2005, J NEUROCHEM, V93, P1551, DOI 10.1111/j.1471-4159.2005.03149.x; Blendy JA, 2006, BIOL PSYCHIAT, V59, P1144, DOI 10.1016/j.biopsych.2005.11.003; Takano K, 2012, J PHARMACOL SCI, V120, P176, DOI 10.1254/jphs.12039FP; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; Gustin SM, 2010, PAIN, V148, P438, DOI 10.1016/j.pain.2009.12.001; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Larsen MH, 2010, J PSYCHIATR RES, V44, P808, DOI 10.1016/j.jpsychires.2010.01.005; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Zeng Q, 2008, BRAIN RES, V1200, P27, DOI 10.1016/j.brainres.2008.01.038; Alkon DL, 2005, P NATL ACAD SCI USA, V102, P16432, DOI 10.1073/pnas.0508001102; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Vanegas H, 2004, BRAIN RES REV, V46, P295, DOI 10.1016/j.brainresrev.2004.07; Zhang L, 2005, EUR J NEUROSCI, V22, P1141, DOI 10.1111/j.1460-9568.2005.04302.x; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; D'Sa C, 2002, BIPOLAR DISORD, V4, P183, DOI 10.1034/j.1399-5618.2002.01203.x; Fukuhara K, 2012, CELL MOL NEUROBIOL, V32, P971, DOI 10.1007/s10571-011-9782-2; Cao H, 2009, J NEUROSCI, V29, P3307, DOI 10.1523/JNEUROSCI.4300-08.2009; Moisset X, 2007, NEUROIMAGE, V37, pS80, DOI 10.1016/j.neuroimage.2007.03.054; Gao YJ, 2004, PAIN, V110, P343, DOI 10.1016/j.pain.2004.04.030; Duric V, 2006, J PAIN, V7, P544, DOI 10.1016/j.jpain.2006.01.458; Palhagen S, 2010, J NEUROL, V257, P524, DOI 10.1007/s00415-009-5353-6; BECK T, 1994, J CEREBR BLOOD F MET, V14, P689; Cejas PJ, 2000, PAIN, V86, P195, DOI 10.1016/S0304-3959(00)00245-1; Gardier AM, 2013, FRONT PHARM, V8, P98; Ishikawa K, 2011, B YAMAGUCHI MED SCH, V57, P49; Ishikawa K, 2014, NEUROREPORT, V25, P226, DOI 10.1097/WNR.0000000000000072; Kuhn M, 2014, RESTOR NEUROL NEUROS, V32, P25, DOI 10.3233/RNN-139005; Moisset X, 2010, EUR J PAIN, V14, P142, DOI 10.1016/j.ejpain.2009.04.011; Murphy GM, 2013, PHARMACOGENET GENOM, V23, P301, DOI 10.1097/FPC.0b013e328360b175; Nagata K., 2009, MOL PAIN, V23, P20; Paxinos G, 1998, RAT BRAIN STEREOTAXI; Pilar-Cuellar F., 2013, CURR PHARM DES; Pinnock SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013652; Schwenkreis P, 2009, AM J NEURORADIOL, V30, P1279, DOI 10.3174/ajnr.A1630; Sun Miao-Kun, 2002, Current Drug Targets - CNS and Neurological Disorders, V1, P575, DOI 10.2174/1568007023338860	45	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	NOV	2014	34	8					1199	1208		10.1007/s10571-014-0097-y		10	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	AQ9XJ	WOS:000343211900013		
J	Yamanaka, Y; Nakamura, T; Sato, K; Toyama, Y				Yamanaka, Yoshiaki; Nakamura, Toshiyasu; Sato, Kazuki; Toyama, Yoshiaki			How Does Ulnar Shortening Osteotomy Influence Morphologic Changes in the Triangular Fibrocartilage Complex?	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							DISTAL RADIOULNAR JOINT; TEARS; LESIONS; AGREEMENT; REPAIR	Ulnar shortening osteotomy often is indicated for treatment of injuries to the triangular fibrocartilage complex (TFCC). However, the effect of ulnar shortening osteotomy on the changes in shape of the TFCC is unclear. In our study, quantitative evaluations were performed using MRI to clarify the effect of ulnar shortening on triangular fibrocartilage (TFC) thickness attributable to disc regeneration of the TFC and TFC angle attributable to the suspension effect of ulnar shortening on the TFC. The purposes of this study were (1) to compare preoperative and postoperative TFC thickness and TFC angle on MR images to quantitatively evaluate the effect of ulnar shortening osteotomy on disc regeneration and the suspension effect on the TFC; and (2) to assess whether changes in TFC thickness and TFC angle correlated with the Mayo wrist score. Between 1995 and 2008, 256 patients underwent ulnar shortening osteotomy for TFCC injuries. The minimum followup was 24 months (mean, 51 months; range, 24-210 months). A total of 79 patients (31%) with complete followup including preoperative and postoperative MR images and the Mayo wrist score was included in this retrospective study. Evaluation of the postoperative MR images and the Mayo wrist score were performed at the final followup. The remaining 177 patients did not undergo postoperative MRI, or they had a previous fracture, large tears of the disc proper, or were lost to followup. Two orthopaedists, one of whom performed the surgeries, measured the TFC thickness and the TFC angle on coronal MR images before and after surgery for each patient. Correlations of the percent change in the TFC thickness and the magnitude of TFC angle change with age, sex, postoperative MR images, extent of ulnar shortening, preoperative ulnar variance, and postoperative Mayo wrist score were assessed. Stepwise regression analysis showed a correlation between the percent change in TFC thickness and preoperative ulnar variance (R-2 = 0.21; beta = -0.33; 95% CI, -0.11 to 0.01; p = 0.01) and between the magnitude of change in the TFC angle and the extent of ulnar shortening (R-2 = 0.18; beta = -0.29; 95% CI, -5.8 to 0.29; p = 0.03). The Mayo wrist score was not correlated with the percent change in TFC thickness or the magnitude of change in the TFC angle. These results suggest that, in patients with TFCC injury with a smaller preoperative ulnar variance, a high residual potential for regeneration in the disc proper was seen after ulnar shortening osteotomy, and correlated with the extent of ulnar shortening and the suspension effect on TFC. However, there was no correlation between disc regeneration or the suspension effect on TFC and the Mayo wrist score. Level IV, therapeutic study. See the Instructions for Authors for a complete description of levels of evidence.	[Yamanaka, Yoshiaki; Nakamura, Toshiyasu; Sato, Kazuki; Toyama, Yoshiaki] Keio Univ, Sch Med, Dept Orthopaed Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Yamanaka, Yoshiaki] Univ Occupat & Environm Hlth, Sch Med, Dept Orthopaed Surg, Fukuoka, Japan	Nakamura, T (reprint author), Keio Univ, Sch Med, Dept Orthopaed Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	tosiyasu@sc.itc.keio.ac.jp					Minami A, 1998, J HAND SURG-AM, V23A, P904, DOI 10.1016/S0363-5023(98)80171-8; Nishiwaki M, 2008, J HAND SURG-AM, V33A, P198, DOI 10.1016/j.jhsa.2007.11.024; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Nishiwaki M, 2005, J HAND SURG-AM, V30A, P719, DOI 10.1016/j.jhsa.2005.04.015; Karanicolas PJ, 2009, J BONE JOINT SURG AM, V91A, P99, DOI 10.2106/JBJS.H.01624; COONEY WP, 1994, J HAND SURG-AM, V19A, P143, DOI 10.1016/0363-5023(94)90238-0; DARROW JC, 1985, J HAND SURG-AM, V10A, P482; Bednar JM, 1999, HAND CLIN, V15, P479; BOULAS HJ, 1990, J HAND SURG-AM, V15A, P415; Kim Byung Sung, 2011, Clin Orthop Surg, V3, P184, DOI 10.4055/cios.2011.3.3.184; Loh YC, 1999, J HAND SURG-BRIT EUR, V24B, P316, DOI 10.1054/jhsb.1999.0062; PALMER AK, 1989, J HAND SURG-AM, V14A, P594, DOI 10.1016/0363-5023(89)90174-3; Tatebe M, 2007, J HAND SURG-AM, V32A, P445, DOI 10.1016/j.jhsa.2007.01.013; Tatebe M, 2012, J HAND SURG-AM, V37A, P2468, DOI 10.1016/j.jhsa.2012.09.011; Unglaub F, 2008, ARTHROSCOPY, V24, P299, DOI 10.1016/j.arthro.2007.09.006; Unglaub F, 2010, ARCH ORTHOP TRAUM SU, V130, P953, DOI 10.1007/s00402-009-0883-z; Wolf MB, 2010, ARCH ORTHOP TRAUM SU, V130, P301, DOI 10.1007/s00402-008-0719-2	17	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	NOV	2014	472	11					3489	3494		10.1007/s11999-014-3854-9		6	Orthopedics; Surgery	Orthopedics; Surgery	AQ9DO	WOS:000343143900039		
J	Liu, Q; Xing, HL; Ju, Y; Ou, ZY; Li, Q				Liu, Qiang; Xing, Huanlin; Ju, Yang; Ou, Zhengyan; Li, Qing			Quasi-static axial crushing and transverse bending of double hat shaped CFRP tubes	COMPOSITE STRUCTURES			English	Article						CFRP tube; Crashworthiness; Axial crushing; Transverse bending	ENERGY-ABSORPTION CAPABILITY; REINFORCED COMPOSITE TUBES; SQUARE TUBES; CRASHWORTHINESS; COLLAPSE; BEHAVIOR; VEHICLE; ELEMENT; IMPACT	This paper aims to explore the failure modes and crashworthiness characteristics of double hat shaped tubes made of weave carbon fiber reinforced plastic (CFRP) subjected to quasi-static axial crushing and transverse bending. Experimental investigations were carried out into three different thicknesses of the composite tubes fabricated by the bladder molding process. Three distinct failure modes, classified as progressive end crushing (I), unstable local buckling (II) and mid-length collapse (III), were observed in the axial crushing tests, whereas only one similar progressive collapse mode was observed in transverse bending tests. It is shown that the thickness is a critical parameter affecting the failure mode and energy absorption capability, leading to the increase in the peak load and specific energy absorption (SEA) during the tests. The SEA of the tested double hat shaped tubes under axial crushing ranges from 60 to 90 J/g, which is marginally higher than that of regular sectional CFRP tubes but over 2 times of that of conventional metallic tubes. By comparison, the load bearing and energy absorption capabilities of the tubes under transverse bending are much lower than those of the axially compressed tubes (less than 10% and 1%, respectively). (C) 2014 Elsevier Ltd. All rights reserved.	[Liu, Qiang; Xing, Huanlin; Ou, Zhengyan] Sun Yat Sen Univ, Sch Engn, Guangzhou 510006, Guangdong, Peoples R China; [Liu, Qiang; Ju, Yang] Nagoya Univ, Dept Mech Sci & Engn, Nagoya, Aichi 4648603, Japan; [Ou, Zhengyan] Sun Yat Sen Univ, Inst Dongguan, Dongguan 523808, Peoples R China; [Li, Qing] Univ Sydney, Sch Aerosp Mech & Mechatron Engn, Sydney, NSW 2006, Australia	Liu, Q (reprint author), Sun Yat Sen Univ, Sch Engn, Guangzhou 510006, Guangdong, Peoples R China.	liu5168198110@126.com			National Natural Science Foundation of China [51205422]; China Scholarship Council Foundation [201306385025]; Daiko Foundation; Pearl River Nova Program of Guangzhou [2014J2200005]; Fundamental Research Funds for the Central Universities [12Igpy46]; Dongguan Municipal Science and Technology Program [2012108102020]; Science Fund of State Key Laboratory of Advanced Design and Manufacturing for Vehicle Body [31315009]	This investigation was financially supported by the National Natural Science Foundation of China (51205422), the China Scholarship Council Foundation (201306385025), the Daiko Foundation, the Pearl River Nova Program of Guangzhou (2014J2200005), the Fundamental Research Funds for the Central Universities (12Igpy46), the Dongguan Municipal Science and Technology Program (2012108102020) and the Science Fund of State Key Laboratory of Advanced Design and Manufacturing for Vehicle Body (31315009).	Abdewia EF, 2008, THIN WALL STRUCT, V46, P320, DOI 10.1016/j.tws.2007.07.018; Alkateb M, 2004, COMPOS STRUCT, V66, P495, DOI [10.1016/j.compstruct.2004.04.078, 10.1016/j.comprstruct.2004.04.078]; McGregor C, 2010, INT J IMPACT ENG, V37, P662, DOI 10.1016/j.ijimpeng.2009.09.005; Mamalis AG, 2006, COMPOS STRUCT, V74, P213, DOI 10.1016/j.compstruct.2005.04.006; Lau STW, 2012, COMPOS STRUCT, V94, P803, DOI 10.1016/j.compstruct.2011.09.013; Zhang X, 2009, THIN WALL STRUCT, V47, P1469, DOI 10.1016/j.tws.2009.07.003; Greve L, 2008, COMPOS PART B-ENG, V39, P1221, DOI 10.1016/j.compositesb.2008.02.002; Yin HF, 2011, MATER DESIGN, V32, P4449, DOI 10.1016/j.matdes.2011.03.060; Liu Q, 2014, COMPOS STRUCT, V111, P332, DOI 10.1016/j.compstruct.2014.01.018; Jung DW, 2009, COMPOS PART A-APPL S, V40, P1558, DOI 10.1016/j.compositesa.2009.06.015; Joosten MW, 2011, COMPOS STRUCT, V93, P682, DOI 10.1016/j.compstruct.2010.08.011; FARLEY GL, 1992, J COMPOS MATER, V26, P37, DOI 10.1177/002199839202600103; Palanivelu S, 2010, POLYM TEST, V29, P381, DOI 10.1016/j.polymertesting.2010.01.003; Liu Q, 2013, COMPOS STRUCT, V97, P231, DOI 10.1016/j.compstruct.2012.09.052; HULL D, 1991, COMPOS SCI TECHNOL, V40, P377, DOI 10.1016/0266-3538(91)90031-J; Shin KC, 2002, COMPOS STRUCT, V57, P279, DOI 10.1016/S0263-8223(02)00094-6; Tarlochan F, 2012, COMPOS STRUCT, V94, P904, DOI 10.1016/j.compstruct.2011.10.010; Abosbaia AS, 2005, COMPOS STRUCT, V70, P356, DOI 10.1016/j.compstruct.2004.08.039; Eksi S, 2013, THIN WALL STRUCT, V73, P329, DOI 10.1016/j.tws.2013.09.001; Bouchet J, 2000, COMPOS SCI TECHNOL, V60, P1891, DOI 10.1016/S0266-3538(00)00058-0; Feraboli P, 2011, COMPOS PART A-APPL S, V42, P1809, DOI 10.1016/j.compositesa.2011.08.004; Helenon F, 2013, COMPOS PART A-APPL S, V54, P182, DOI 10.1016/j.compositesa.2013.07.015; Huang JC, 2009, COMPOS STRUCT, V91, P222, DOI 10.1016/j.compstruct.2009.05.006; Jacob Amanda, 2010, Reinforced Plastics, V54, DOI 10.1016/S0034-3617(10)70173-9; MAMALIS AG, 1994, COMPOSITES, V25, P47, DOI 10.1016/0010-4361(94)90066-3; MAMALIS AG, 1992, COMPOSITES, V23, P425, DOI 10.1016/0010-4361(92)90005-F; Mamalis AG, 2004, COMPOS STRUCT, V63, P347, DOI 10.1016/S0263-8223(03)00183-1; Mandi E, 2001, COMPOS STRUCT, V51, P211; Mandi ES, 2008, COMPOS STRUCT, V83, P399; Ochelski S, 2009, COMPOS STRUCT, V87, P215, DOI 10.1016/j.compstruct.2008.01.010; Wu WY, 2013, COMPOS STRUCT, V106, P581, DOI 10.1016/j.compstruct.2013.07.009; Zhang Y.Y., 2012, P IASS 2012 ANN S, V38, P38	32	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0263-8223	1879-1085		COMPOS STRUCT	Compos. Struct.	NOV	2014	117						1	11		10.1016/j.compstruct.2014.06.024		11	Materials Science, Composites	Materials Science	AQ6ZA	WOS:000342961200001		
J	Okuro, M; Morimoto, S				Okuro, Masashi; Morimoto, Shigeto			Sleep apnea in the elderly	CURRENT OPINION IN PSYCHIATRY			English	Review						continuous positive airway pressure; elderly; Epworth sleepiness scale; international classification of sleep disorders 3; sleep apnea syndrome	POSITIVE AIRWAY PRESSURE; CARDIOVASCULAR MORTALITY; AMERICAN ACADEMY; BLOOD-PRESSURE; HEART-FAILURE; RISK; HYPERTENSION; STROKE; CPAP; RECOMMENDATIONS	Purpose of review Sleep apnea syndrome (SAS) in the elderly presents varied clinical symptoms and also has many complications. Moreover, there are many hospital departments related to these symptoms. This article uses literature to provide an outline on SAS observed in the elderly. Recent findings SAS sufferers often have complications with so-called lifestyle-related diseases, such as hypertension, hyperlipidemia, diabetes mellitus and metabolic syndrome. These symptoms, along with SAS, recede as a result of continuous positive airway pressure treatment. Some have also reported recession of depression symptoms and delay in deterioration of cognitive functions. Summary The elderly tends to develop SAS through coexistence of chronic respiratory organ disorders, increase in upper airway collapse, strokes, cardiovascular diseases, hypertension, diabetes mellitus and other physiological anatomical changes that accompany aging. However, judgment on the severity and effects regarding prognosis by each remedy used in the diagnosis and treatment of SAS in the elderly is still being developed, and it is considered necessary to accumulate more evidence and establish new standards.	[Okuro, Masashi; Morimoto, Shigeto] Kanazawa Med Univ, Dept Geriatr Med, Uchinadamachi, Ishikawa Prefec 9200293, Japan	Okuro, M (reprint author), Kanazawa Med Univ, Dept Geriatr Med, 1-1 Daigaku, Uchinadamachi, Ishikawa Prefec 9200293, Japan.	okuro@kanazawa-med.ac.jp					Flemons WW, 1999, SLEEP, V22, P667; Ankichetty Saravanan, 2011, J Anaesthesiol Clin Pharmacol, V27, P447, DOI 10.4103/0970-9185.86574; Su VYF, 2014, CAN MED ASSOC J, V186, P415, DOI 10.1503/cmaj.131547; Tishler PV, 2003, JAMA-J AM MED ASSOC, V289, P2230, DOI 10.1001/jama.289.17.2230; Rosenberg RS, 2013, J CLIN SLEEP MED, V9, P81, DOI 10.5664/jcsm.2350; Sharma SK, 2011, NEW ENGL J MED, V365, P2277, DOI 10.1056/NEJMoa1103944; Anandam A, 2013, RESPIROLOGY, V18, P1184, DOI 10.1111/resp.12140; Morimoto S, 2012, J INT MED RES, V40, P601; Bakker JP, 2014, J CLIN SLEEP MED, V10, P365, DOI 10.5664/jcsm.3604; Campos-Rodriguez F, 2014, AM J RESP CRIT CARE, V189, P1544, DOI 10.1164/rccm.201311-2012OC; GUILLEMINAULT C, 1976, ANNU REV MED, V27, P465, DOI 10.1146/annurev.me.27.020176.002341; Strollo PJ, 2014, NEW ENGL J MED, V370, P139, DOI 10.1056/NEJMoa1308659; Martinez-Garcia MA, 2012, AM J RESP CRIT CARE, V186, P909, DOI 10.1164/rccm.201203-0448OC; Parati G, 2013, EUR RESPIR J, V41, P523, DOI 10.1183/09031936.00226711; Grigg-Damberger MM, 2012, J CLIN SLEEP MED, V8, P323, DOI 10.5664/jcsm.1928; Martinez-Garcia MA, 2013, JAMA-J AM MED ASSOC, V310, P2407, DOI 10.1001/jama.2013.281250; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Yumino D, 2013, AM J RESP CRIT CARE, V187, P433, DOI 10.1164/rccm.201205-0894OC; SULLIVAN CE, 1981, LANCET, V1, P862; Kaneko Y, 2003, NEW ENGL J MED, V348, P1233, DOI 10.1056/NEJMoa022479; Bucks RS, 2013, RESPIROLOGY, V18, P61, DOI 10.1111/j.1440-1843.2012.02255.x; Gagnadoux F, 2014, CHEST, V145, P1025, DOI 10.1378/chest.13-2373; [Anonymous], 2013, ICSD3 DIAGNOSTIC AND; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Berry RB, 2012, THE AASM MANUAL FOR; Bonsignore Maria R, 2013, Eur Respir Rev, V22, P353, DOI 10.1183/09059180.00003413; Bun Leong W, 2014, J CLIN ENDOCR METAB, pE1; Camilo MR, 2014, SLEEP MED, V14, P192; Chabolle F, 1998, Ann Otolaryngol Chir Cervicofac, V115, P196; JOHNS MW, 1991, SLEEP, V14, P540; Kendzerska T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001599; Khan MS, 2014, RISK ASSESSMENT FOR; Malhotra A, 2006, AM J MED, V119; Nemeth D, 2012, J SLEEP RES, V21, P396, DOI 10.1111/j.1365-2869.2011.00983.x; Rosenberg RS, 2014, J CLIN SLEEP MED, V10, P447, DOI 10.5664/jcsm.3630; Surani Salim R, 2014, World J Diabetes, V5, P381, DOI 10.4239/wjd.v5.i3.381; Tosur Z, 2014, SLEEP MED, V14, P155; Troussiere AC, 2014, J NEUROL NEUROSUR PS, V14, P1; Young D, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0305-6; Zamarron C, 1999, RESPIRATION, V66, P317, DOI 10.1159/000029401	42	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0951-7367	1473-6578		CURR OPIN PSYCHIATR	Curr. Opin. Psychiatr.	NOV	2014	27	6					472	477		10.1097/YCO.0000000000000105		6	Psychiatry	Psychiatry	AQ8AM	WOS:000343042700015		
J	Nishiwaki, S; Izumi, J				Nishiwaki, Satoshi; Izumi, Junichi			Complete nationwide survey on umbilical cord blood freezing bag breakage in Japan	CYTOTHERAPY			English	Article						cord blood bank; cord blood transplantation; nationwide survey; umbilical cord blood bag breakage	EX-VIVO EXPANSION; BONE-MARROW; UNRELATED DONORS; TRANSPLANTATION; CONSEQUENCES; LEUKEMIA; ADULTS; CELLS; UNIT	Background aims. Although umbilical cord blood (UCB) has now become a common stem cell source, UCB bag breakage is a known risk in UCB transplantation (UCBT). This survey provides the first comprehensive data on the frequency and causes of UCB bag breakage in Japan. Methods. Data regarding UCB bag breakage from all causes, identified between April 1, 2010, and September 3, 2013, were collected from all transplant centers registered for UCBT (209 hospitals) and all public cord blood banks (CBBs) (8 CBBs) in Japan. Results. Seventeen incidents of UCB bag breakage at CBBs were confirmed, none of which resulted in bags being shipped to transplant centers. From among 3836 UCBT, 16 incidents (0.4%) of UCB bag breakage were confirmed at transplant centers. Although all these bags were used for transplantation, no direct health hazard was reported. The major cause of UCB bag breakage confirmed at transplant centers was considered to be external force (75%). In addition, 11 incidents of unexplained UCB bag breakage at sealing between compartments were reported. Conclusions. UCB bag breakage was confirmed at both CBBs and transplant centers. UCB bags should be handled with particular care and attention.	[Nishiwaki, Satoshi; Izumi, Junichi] Minist Hlth Labour & Welf, Off Transplantat Med, Tokyo 1008916, Japan	Nishiwaki, S (reprint author), Minist Hlth Labour & Welf, Off Transplantat Med, Hlth Serv Bur, Chiyoda Ku, 1-2-2 Kasumigaseki, Tokyo 1008916, Japan.	n-3104@tf7.so-net.ne.jp					Clark P, 2014, TRANSFUSION, V54, P532, DOI 10.1111/trf.12323; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; [Anonymous], 2013, STAND CELL THER SERV; [Anonymous], 2013, NETCORD FACT INT STA; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Oran B, 2012, HEMATOL-AM SOC HEMAT, P215, DOI 10.1182/asheducation-2012.1.215; Gratwohl A, 2010, JAMA-J AM MED ASSOC, V303, P1617, DOI 10.1001/jama.2010.491; Broxmeyer HE, 2011, BLOOD, V117, P4773, DOI 10.1182/blood-2011-01-330514; Takahashi S, 2004, BLOOD, V104, P3813, DOI 10.1182/blood-2004-03-1001; Khuu HM, 2002, CYTOTHERAPY, V4, P539, DOI 10.1080/146532402761624700; Larrea L, 2008, TRANSFUSION, V48, P1282, DOI 10.1111/j.1537-2995.2008.01753.x; Nakahata T, 2001, INT J HEMATOL, V73, P6; SUI XW, 1995, P NATL ACAD SCI USA, V92, P2859, DOI 10.1073/pnas.92.7.2859; Thyagarajan B, 2008, TRANSFUSION, V48, P1138, DOI 10.1111/j.1537-2995.2008.01688.x	14	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1465-3249	1477-2566		CYTOTHERAPY	Cytotherapy	NOV	2014	16	11					1590	1594		10.1016/j.jcyt.2014.06.006		5	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Hematology; Medicine, Research & Experimental	Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research & Experimental Medicine	AR1PC	WOS:000343356100015		
J	Takino, K; Ohsawa, S; Igaki, T				Takino, Kyoko; Ohsawa, Shizue; Igaki, Tatsushi			Loss of Rab5 drives non-autonomous cell proliferation through TNF and Ras signaling in Drosophila	DEVELOPMENTAL BIOLOGY			English	Article						Tissue growth regulation; Cell-cell interaction; Tumorigenesis; Rab5; Drosophila	ORGAN SIZE CONTROL; TUMOR SUPPRESSORS; ESCRT-II; EPITHELIAL POLARITY; CANCER DEVELOPMENT; HIPPO PATHWAY; ENDOCYTOSIS; COMPETITION; APOPTOSIS; VPS25	Deregulation of the endocytic machinery has been implicated in human cancers. However, the mechanism by which endocytic defects drive cancer development remains to be clarified. Here, we find through a genetic screen in Drosophila that loss of Rab5, a protein required for early endocytic trafficking, drives non-autonomous cell proliferation in imaginal epithelium. Our genetic data indicate that dysfunction of Rab5 leads to cell-autonomous accumulation of Eiger (a TNF homolog) and EGF receptor (EGFR), which causes activation of downstream JNK and Ras signaling, respectively. JNK signaling and its downstream component Cdc42 cooperate with Ras signaling to induce upregulation of a secreted growth factor Upd (an IL-6 homolog) through inactivation of the Hippo pathway. Such non-autonomous tissue growth triggered by Rab5 defect could contribute to epithelial homeostasis as well as cancer development within heterogeneous tumor microenvironment. (C) 2014 Published by Elsevier Inc.	[Takino, Kyoko; Ohsawa, Shizue; Igaki, Tatsushi] Kyoto Univ, Genet Lab, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; [Takino, Kyoko] Kobe Univ, Grad Sch Med, Div Genet, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Igaki, Tatsushi] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Igaki, T (reprint author), Kyoto Univ, Genet Lab, Grad Sch Biostudies, Sakyo Ku, Yoshida Konoecho Cho, Kyoto 6068501, Japan.	igaki@lif.kyoto-u.ac.jp			Japanese Ministry of Education, Science, Sports, Culture and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Japan Science and Technology Agency; G-COE program for Global Center for Education and Research in Integrative Membrane Biology; Shiseido Female Researcher Science	We thank Aya Betsumiya, Toshiharu Sawada, Mayumi Akatsuka, Yoshiaki Kanemoto, and Yoshitaka Sato for technical support; AHM Alam for comments on the manuscript; Masato Enomoto and Mikio Furuse for discussions; Marcos Gonzalez-Gaitan, Douglas Harrison, Masayuki Miura, Iswar Hariharan for antibodies; Takashi Adachi-Yamada, Masayuki Miura, Willis Li, Henry Sun, Tian Xu, the Bloomington Stock Center, the Vienna Drosophila RNAi Center, the National Institute of Genetics Stock Center (NIG-FLY), and the Drosophila Genetic Resource Center (DGRC, Kyoto Institute of Technology) for fly stocks. This work was supported in part by grants from the Japanese Ministry of Education, Science, Sports, Culture and Technology to S.O and T.I, Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan to S.O and T.I, the Japan Society for the Promotion of Science to T.I, the Japan Science and Technology Agency to T.I, the G-COE program for Global Center for Education and Research in Integrative Membrane Biology to K.T, S.O and T.I, R1 (1:250), mouse anti-phospho-or fly stocks., D. Bilder, Pernille Rorth abtibody 1 antibody R1 (1:250), mouse anti-phospho-, Tomizawa Jun-ichi & Keiko Fund of Molecular Biology Society of Japan for Young Scientist to S.O, the Novartis Foundation for the Promotion of Science to S.O., the Nakajima Foundation to S.O., the Inoue Science Research Award to S.O., the Takeda Science Foundation to S.O and T.I, the Senri Life Science Foundation to S.O. and T.I, the Kao Function for Art and Science to S.O, the Shiseido Female Researcher Science grant to S.O., Uehara Memorial Foundation to S.O. and T.I., Suzuken Memorial Foundation to T.I., Inamori Foundation to T.I., and the Human Frontier Science Program Career Development Award to T. I. K.T is a JSPS Fellow.	Ohsawa S, 2012, NATURE, V490, P547, DOI 10.1038/nature11452; Tseng ASK, 2007, CURR BIOL, V17, P728, DOI 10.1016/j.cub.2007.03.023; Morata G, 2011, DEV GROWTH DIFFER, V53, P168, DOI 10.1111/j.1440-169X.2010.01225.x; Vincent JP, 2013, NAT REV MOL CELL BIO, V14, P581, DOI 10.1038/nrm3639; Jacks T, 2002, CELL, V111, P923, DOI 10.1016/S0092-8674(02)01229-1; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; XU T, 1993, DEVELOPMENT, V117, P1223; Sun GP, 2011, DEV BIOL, V350, P139, DOI 10.1016/j.ydbio.2010.11.036; Karim FD, 1998, DEVELOPMENT, V125, P1; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; Bao YJ, 2011, J BIOCHEM, V149, P361, DOI 10.1093/jb/mvr021; Chia WJ, 2009, BBA-REV CANCER, V1795, P110, DOI 10.1016/j.bbcan.2008.10.001; Ohsawa S, 2011, DEV CELL, V20, P315, DOI 10.1016/j.devcel.2011.02.007; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Mollereau B, 2013, CELL DEATH DIFFER, V20, P181, DOI 10.1038/cdd.2012.82; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Herz HM, 2006, DEVELOPMENT, V133, P1871, DOI 10.1242/dev.02356; Brumby AM, 2005, NAT REV CANCER, V5, P626, DOI 10.1038/nrc1671; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; de Beco S, 2012, DEV DYNAM, V241, P831, DOI 10.1002/dvdy.23783; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; HAYNIE JL, 1977, ROUX ARCH DEV BIOL, V183, P85; Tamori Y, 2011, J GENET GENOMICS, V38, P483, DOI 10.1016/j.jgg.2011.09.006; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Vaccari T, 2009, J CELL SCI, V122, P2413, DOI 10.1242/jcs.046391; Pastor-Pareja JC, 2013, ANNU REV GENET, V47, P51, DOI 10.1146/annurev-genet-110711-155414; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Floyd S, 1998, TRENDS CELL BIOL, V8, P299, DOI 10.1016/S0962-8924(98)01316-6; Chan SW, 2011, J CELL PHYSIOL, V226, P928, DOI 10.1002/jcp.22435; Ballesteros-Arias L., 2013, ONCOGENE; Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; Fernandez L.A., 2010, CELL CYCLE, V9, P2292, DOI DOI 10.4161/CC.9.12.11919; Giebel B, 2006, CURR BIOL, V16, pR91, DOI 10.1016/j.cub.2006.01.022; Haider G., 2011, DEVELOPMENT, V138, P9; Herz HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004165; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Morrison HA, 2008, MOL BIOL CELL, V19, P4167, DOI 10.1091/mbc.E08-07-0716; Reginensi A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003380	52	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	NOV 1	2014	395	1					19	28		10.1016/j.ydbio.2014.09.003		10	Developmental Biology	Developmental Biology	AQ9SC	WOS:000343195000003		
J	Jones, C; Qian, D; Kim, SM; Li, SD; Ren, DD; Knapp, L; Sprinzak, D; Avraham, KB; Matsuzaki, F; Chi, FL; Chen, P				Jones, Chonnettia; Qian, Dong; Kim, Sun Myoung; Li, Shuangding; Ren, Dongdong; Knapp, Lindsey; Sprinzak, David; Avraham, Karen B.; Matsuzaki, Fumio; Chi, Fanglu; Chen, Ping			Ankrd6 is a mammalian functional homolog of Drosophila planar cell polarity gene diego and regulates coordinated cellular orientation in the mouse inner ear	DEVELOPMENTAL BIOLOGY			English	Article						PCP; Inner ear; Ankrd6; Diversin; Inversin; Diego	WNT-SIGNALING PATHWAYS; HAIR-CELLS; CONVERGENT EXTENSION; STRABISMUS/VAN-GOGH; PCP PATHWAY; BASAL BODY; POLARIZATION; MECHANISMS; CILIARY; VANGL2	The coordinated polarization of neighboring cells within the plane of the tissue, known as planar cell polarity (PCP), is a recurring theme in biology. It is required for numerous developmental processes for the form and function of many tissues and organs across species. The genetic pathway regulating PCP was first discovered in Drosophila, and an analogous but distinct pathway is emerging in vertebrates. It consists of membrane protein complexes known as core PCP proteins that are conserved across species. Here we report that the over-expression of the murine Ankrd6 (mAnkrd6) gene that shares homology with Drosophila core PCP gene diego causes a typical PCP phenotype in Drosophila, and mAnkrd6 can rescue the loss of function of diego in Drosophila. In mice, mAnkrd6 protein is asymmetrically localized in cells of the inner ear sensory organs, characteristic of components of conserved core PCP complexes. The loss of mAnkrd6 causes PCP defects in the inner ear sensory organs. Moreover, canonical Wnt signaling is significantly increased in mouse embryonic fibroblasts from mAnkrd6 knockout mice in comparison to wild type controls. Together, these results indicated that mAnkrd6 is a functional homolog of the Drosophila diego gene for mammalian PCP regulation and act to suppress canonical Wnt signaling. (C) 2014 Elsevier Inc. All rights reserved.	[Jones, Chonnettia; Qian, Dong; Kim, Sun Myoung; Li, Shuangding; Knapp, Lindsey; Chen, Ping] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; [Ren, Dongdong; Chi, Fanglu] Fudan Univ, Dept Otolaryngol, Eye Ear Nose & Throat Hosp, Shanghai 200433, Peoples R China; [Sprinzak, David] Tel Aviv Univ, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel; [Avraham, Karen B.] Tel Aviv Univ, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Matsuzaki, Fumio] RIKEN, Ctr Dev Biol, Lab Cell Asymmetry, Kobe, Hyogo, Japan	Chen, P (reprint author), Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA.	C.Jones@wellcome.ac.uk; ping.chen@emory.edu		Sprinzak, David/0000-0001-6776-6957; Jones, Chonnettia/0000-0003-3430-8110	NIH/NIDCD [DC 005213 RO1, DC008731 F32]; Human Frontier Science Program [RGP0012/2012Chen]; National Natural Science Foundation of China [81271084, 2011CB504500, 2011CB504506, 81370022]; Innovation Project of Shanghai Municipal Science and Technology Commission [11411952300]; Training Program of the Excellent Young Talents of the Shanghai Municipal Health System [XYQ2013084];  [5T32GM008367]	We would like to thank the support of DC 005213 RO1 Grant from NIH/NIDCD to P.C.; DC008731 F32 training Grant from NIH/NIDCD to C.J.; Human Frontier Science Program RGP0012/2012Chen to P.C., K.A., D.S., F.M.; 5T32GM008367 to L.K.; National Natural Science Foundation of China 81271084, 2011CB504500, 2011CB504506, and Innovation Project of Shanghai Municipal Science and Technology Commission (11411952300) to F.C.; National Natural Science Foundation of China 81370022 and Training Program of the Excellent Young Talents of the Shanghai Municipal Health System (XYQ2013084) to D.R.	MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; Peng Y, 2012, CURR TOP DEV BIOL, V101, P33, DOI 10.1016/B978-0-12-394592-1.00002-8; Tarchini B, 2013, DEV CELL, V27, P88, DOI 10.1016/j.devcel.2013.09.011; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Matis M, 2013, GENE DEV, V27, P2207, DOI 10.1101/gad.228098.113; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Chacon-Heszele MF, 2012, DEVELOPMENT, V139, P968, DOI 10.1242/dev.065326; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; KORNBERG T, 1981, P NATL ACAD SCI-BIOL, V78, P1095, DOI 10.1073/pnas.78.2.1095; Schwarz-Romond T, 2002, GENE DEV, V16, P2073, DOI 10.1101/gad.230402; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Jenny A, 2005, NAT CELL BIOL, V7, P691, DOI 10.1038/ncb1271; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Yasunaga T, 2011, MECH DEVELOP, V128, P376, DOI 10.1016/j.mod.2011.07.004; Das G, 2004, DEVELOPMENT, V131, P4467, DOI 10.1242/dev.01317; Ezan J, 2013, SEMIN CELL DEV BIOL, V24, P499, DOI 10.1016/j.semcdb.2013.03.012; Adler PN, 2012, CURR TOP DEV BIOL, V101, P1, DOI 10.1016/B978-0-12-394592-1.00001-6; Deans MR, 2007, J NEUROSCI, V27, P3139, DOI 10.1523/JNEUROSCI.5151-06.2007; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Rida PCG, 2009, SEMIN CELL DEV BIOL, V20, P978, DOI 10.1016/j.semcdb.2009.02.007; Wu J, 2009, TRENDS CELL BIOL, V19, P295, DOI 10.1016/j.tcb.2009.04.003; Itoh K, 2009, J CELL SCI, V122, P3791, DOI 10.1242/jcs.057067; van Amerongen R, 2010, ONCOGENE, V29, P93, DOI 10.1038/onc.2009.310; Bayly R, 2011, NAT REV GENET, V12, P385, DOI 10.1038/nrg2956; Copley CO, 2013, J NEUROSCI, V33, P14001, DOI 10.1523/JNEUROSCI.1307-13.2013; Feiguin F, 2001, DEV CELL, V1, P93, DOI 10.1016/S1534-5807(01)00010-7; Itoh K., 2011, J VIS EXP; Kelly M, 2007, INT J DEV BIOL, V51, P535, DOI 10.1387/ijdb.072344mk; Lawrence PA, 2013, DEV BIOL, V377, P1, DOI 10.1016/j.ydbio.2013.01.030; Li S., 2012, P NATL ACAD SCI USA, V108, P2264; Moeller H, 2006, P NATL ACAD SCI USA, V103, P15900, DOI 10.1073/pnas.0603808103; Ren DD, 2013, DEV DYNAM, V242, P1454, DOI 10.1002/dvdy.24042; Sipe CW, 2011, DEVELOPMENT, V138, P3441, DOI 10.1242/dev.065961; Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407	44	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	NOV 1	2014	395	1					62	72		10.1016/j.ydbio.2014.08.029		11	Developmental Biology	Developmental Biology	AQ9SC	WOS:000343195000007		
J	Hayashino, Y; Mashitani, T; Tsujii, S; Ishii, H				Hayashino, Yasuaki; Mashitani, Tsuyoshi; Tsujii, Satoru; Ishii, Hitoshi		Tenri Study Grp	Serum High-Sensitivity C-Reactive Protein Levels Are Associated With High Risk of Development, Not Progression, of Diabetic Nephropathy Among Japanese Type 2 Diabetic Patients: A Prospective Cohort Study (Diabetes Distress and Care Registry at Tenri [DDCRT7])	DIABETES CARE			English	Article							LOW-GRADE INFLAMMATION; GLYCEMIC CONTROL; ENDOTHELIAL DYSFUNCTION; ALBUMIN EXCRETION; URINARY ALBUMIN; MELLITUS; DISEASE; INTERLEUKIN-6; PREVENTION; MARKERS	OBJECTIVE To assess the prospective association between baseline serum hs-CRP concentration and the subsequent risk of development or progression of diabetic nephropathy. RESEARCH DESIGN AND METHODS Longitudinal data were obtained from 2,518 patients with type 2 diabetes registered in a Japanese diabetes registry. To assess the independent correlations between serum baseline hs-CRP and either the development or progression of diabetic nephropathy 1 year later, the Cox proportional hazards model was used and adjusted for potential confounders. RESULTS The mean patient age, BMI, and HbA(1c) level were 66.1 years, 24.6 kg/m(2), and 7.5% (57.6 mmol/mol), respectively. Baseline serum hs-CRP levels were significantly associated with the urinary albumin-to-creatinine ratio at baseline (P < 0.001). Multivariable adjusted hazard ratio for the development from normoalbuminuria to microalbuminuria was 1.31 (95% CI 0.80-2.17; P = 0.286), 1.55 (1.16-2.08; P = 0.003), and 1.57 (1.22-2.03; P = 0.001), respectively, for the second, third, and fourth quartiles of serum hs-CRP levels, showing a statistically significant linear trend across categories (P < 0.001). We did not observe a significant association between hs-CRP levels and the subsequent risk of diabetic nephropathy progression (P for trend = 0.575). CONCLUSIONS Serum hs-CRP levels, independent of possible confounders, were associated with a subsequent risk of developing, not progressing, diabetic nephropathy in type 2 diabetic patients. Serum hs-CRP may be useful for predicting the future risk of developing diabetic nephropathy.	[Hayashino, Yasuaki; Tsujii, Satoru; Ishii, Hitoshi] Tenri Hosp, Dept Endocrinol, Tenri, Nara 632, Japan; [Mashitani, Tsuyoshi] Nara Med Univ, Dept Diabetol, Kashihara, Nara 634, Japan	Hayashino, Y (reprint author), Tenri Hosp, Dept Endocrinol, Tenri, Nara 632, Japan.	hayasino-y@umin.net		Hayashino, Yasuaki/0000-0002-2932-8478	Manpei Suzuki Diabetes Foundation; JSPS KAKENHI [25460641]	This study was partially supported by the Manpei Suzuki Diabetes Foundation and JSPS KAKENHI (grant 25460641).	Navarro JF, 2006, NEPHROL DIAL TRANSPL, V21, P3428, DOI 10.1093/ndt/gfl469; Weir MR, 2007, CLIN J AM SOC NEPHRO, V2, P581, DOI 10.2215/CJN.03190906; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Pickup JC, 1997, DIABETOLOGIA, V40, P1286, DOI 10.1007/s001250050822; Buckley DI, 2009, ANN INTERN MED, V151, P483; Stehouwer CDA, 2002, DIABETES, V51, P1157, DOI 10.2337/diabetes.51.4.1157; Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506; Navarro JF, 2003, AM J KIDNEY DIS, V42, P53, DOI 10.1016/S0272-6386(03)00408-6; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Bertoni AG, 2010, DIABETES CARE, V33, P804, DOI 10.2337/dc09-1679; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; HESS KR, 1995, STAT MED, V14, P1707, DOI 10.1002/sim.4780141510; DOSEMECI M, 1990, AM J EPIDEMIOL, V132, P746; Saraheimo M, 2003, DIABETOLOGIA, V46, P1402, DOI 10.1007/s00125-003-1194-5; Schalkwijk CG, 1999, DIABETOLOGIA, V42, P351, DOI 10.1007/s001250051162; Caramori ML, 2000, DIABETES, V49, P1399, DOI 10.2337/diabetes.49.9.1399; Elmarakby Ahmed A, 2010, EPMA J, V1, P117, DOI 10.1007/s13167-010-0004-7; Hayashino Y, 2012, DIABETES RES CLIN PR, V97, P405, DOI 10.1016/j.diabres.2012.04.005; Mashitani T, 2013, DIABETES RES CLIN PR, V100, P189, DOI 10.1016/j.diabres.2013.03.006; Molitch Mark E, 2004, Diabetes Care, V27 Suppl 1, pS79; Rossing Peter, 2006, Curr Diab Rep, V6, P479, DOI 10.1007/s11892-006-0083-y; Rossing P, 2006, DIABETOLOGIA, V49, P11, DOI 10.1007/s00125-005-0077-3; Scott DP, 2010, INTERN MED J, V40, P275, DOI 10.1111/j.1445-5994.2009.01941.x; Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x; Wada T, 2013, CLIN EXP NEPHROL	29	1	2	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0149-5992	1935-5548		DIABETES CARE	Diabetes Care	NOV	2014	37	11					2947	2952		10.2337/dc14-1357		6	Endocrinology & Metabolism	Endocrinology & Metabolism	AR4XD	WOS:000343588500020		
J	Kotani, K; Tanaka, K; Managi, S				Kotani, Koji; Tanaka, Kenta; Managi, Shunsuke			Cooperative choice and its framing effect under threshold uncertainty in a provision point mechanism	ECONOMICS OF GOVERNANCE			English	Article						Cooperative choice; Framing effects; Threshold uncertainty; Provision point mechanism	PUBLIC GOOD PROVISION; ANTARCTIC ICE-SHEET; COLD-PRICKLE; GOOD GAMES; WARM-GLOW; GOODS	This paper explores how threshold uncertainty affects cooperative behaviors in the provision of public goods and the prevention of public bads. The following facts motivate our study. First, environmental (resource) problems are either framed as public bads prevention or public goods provision. Second, the occurrence of these problems is characterized by thresholds that are interchangeably represented as "nonconvexity," "bifurcation," "bi-stability," or "catastrophes." Third, the threshold location is mostly unknown. We employ a provision point mechanism with threshold uncertainty and analyze the responses of cooperative behaviors to uncertainty and to the framing for each type of social preferences categorized by a value orientation test. We find that aggregate framing effects are negligible, although the response to the frame is the opposite depending on the type of social preferences. "Cooperative" subjects become more cooperative in negative frames than in positive frames, whereas "individualistic" subjects are less cooperative in negative frames than in positive ones. This finding implies that the insignificance of aggregate framing effects arises from behavioral asymmetry. We also find that the percentage of cooperative choices non-monotonically varies with the degree of threshold uncertainty, irrespective of framing and value orientation. Specifically, the degree of cooperation is highest at intermediate levels of threshold uncertainty and decreases as the uncertainty becomes sufficiently large.	[Kotani, Koji] Kochi Univ Technol, Dept Management, Kami, Kochi 7828502, Japan; [Tanaka, Kenta] Musashi Univ, Fac Econ, Nerima Ku, Tokyo 1768534, Japan; [Managi, Shunsuke] Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, Sendai, Miyagi 9808579, Japan	Kotani, K (reprint author), Kochi Univ Technol, Dept Management, 185 Miyanokuchi, Kami, Kochi 7828502, Japan.	kojikotani757@gmail.com; tanaka58.tin@gmail.com; managi.s@gmail.com	Kotani, Koji/C-6896-2011; Managi, Shunsuke /G-1740-2013	Kotani, Koji/0000-0003-0667-1895; Managi, Shunsuke /0000-0001-7883-1427			ANDREONI J, 1995, Q J ECON, V110, P1, DOI 10.2307/2118508; Ulph A, 1997, ECON J, V107, P636, DOI 10.1111/1468-0297.00181; Marks MB, 1999, PUBLIC CHOICE, V99, P103, DOI 10.1023/A:1018316500800; BAGNOLI M, 1989, REV ECON STUD, V56, P583, DOI 10.2307/2297502; Carpenter SR, 1999, ECOL APPL, V9, P751, DOI 10.2307/2641327; Brekke KA, 2003, J PUBLIC ECON, V87, P1967, DOI 10.1016/S0047-2727(01)00222-5; Gifford R, 2011, GLOBAL ENVIRON CHANG, V21, P1301, DOI 10.1016/j.gloenvcha.2011.06.004; Oppenheimer M, 1998, NATURE, V393, P325, DOI 10.1038/30661; Sonnemans J, 1998, J ECON BEHAV ORGAN, V34, P143, DOI 10.1016/S0167-2681(97)00042-5; Marks M, 1998, J PUBLIC ECON, V67, P195, DOI 10.1016/S0047-2727(97)00067-4; Rondeau D, 2005, J PUBLIC ECON, V89, P1581, DOI 10.1016/j.jpubeco.2004.06.014; Park ES, 2000, J ECON BEHAV ORGAN, V43, P405, DOI 10.1016/S0167-2681(00)00128-1; Cadsby CB, 1999, J PUBLIC ECON, V71, P53, DOI 10.1016/S0047-2727(98)00049-8; Clark C. W., 1990, MATH BIOECONOMICS; Cookson C, 2009, FINANCIAL TIMES; Davis DD, 1992, EXPT EC; Kakinaka M, 2011, PUBLIC CHOICE, V147, P29, DOI 10.1007/s11127-010-9602-0; LIEBRAND WBG, 1984, EUR J SOC PSYCHOL, V14, P239, DOI 10.1002/ejsp.2420140302; McBride M, 2010, ECON GOV, V11, P77, DOI 10.1007/s10101-009-0069-8; McBride M, 2006, J PUBLIC ECON, V90, P1181, DOI 10.1016/j.jpubeco.2005.09.012; Naevdal E, 2007, RESOUR ENERGY ECON, V29, P262, DOI 10.1016/j.reseneeco.2007.01.003; Naevdal E, 2006, J ECON DYN CONTROL, V30, P1131, DOI 10.1016/j.jedc.2005.04.004; NITZAN S, 1990, J PUBLIC ECON, V42, P357, DOI 10.1016/0047-2727(90)90021-9; Samuelson Larry, 1997, EVOLUTIONARY GAMES E; Suleiman R, 2001, GROUP DECIS NEGOT, V10, P253, DOI 10.1023/A:1011205901283; Suleiman R, 1997, RATION SOC, V9, P163, DOI 10.1177/104346397009002002; Willinger M, 1999, ECON LETT, V65, P323, DOI 10.1016/S0165-1765(99)00177-9; Wit A, 1998, EUR J SOC PSYCHOL, V28, P249, DOI 10.1002/(SICI)1099-0992(199803/04)28:2<249::AID-EJSP868>3.0.CO;2-J	28	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1435-6104			ECON GOV	Econ. Gov.	NOV	2014	15	4					329	353		10.1007/s10101-014-0147-4		25	Economics	Business & Economics	AQ9YK	WOS:000343215400002		
J	Miyazaki, T				Miyazaki, Takeshi			Municipal consolidation and local government behavior: evidence from Japanese voting data on merger referenda	ECONOMICS OF GOVERNANCE			English	Article						Boundary reform; Economies of scale; Local referenda; Median voter model; Municipal consolidation	SCHOOL-DISTRICT CONSOLIDATION; PUBLIC-GOOD PROVISION; PARTIAL OBSERVABILITY; COSTS; SIZE; POLITICS; NATIONS; GOODS; MODEL	The empirical literature investigating the role of key features of local governments regarding decisions on consolidation tends to use a dummy dependent variable that takes 1 if both adjacent local governments decide to merge and 0 if one of them does not approve consolidation. Under this estimation method, however, it is difficult to know which governments refused to consolidate, as consolidation was not realized. The current study empirically tests the effects of economies of scale, population size, heterogeneity of preferences, and financial factors on municipal preferences for consolidation. It uses voting data from Japanese local referenda to identify preferences of specific individual municipalities, thus allowing a richer examination of local government behavior. The results obtained herein are as follows. Municipalities that could enjoy large economies of scale from consolidation prefer consolidation, while large and small municipalities are likely to merge. Moreover, municipalities receiving large unconditional grants from the central government are unlikely to merge.	Kyushu Univ, Dept Econ, Higashi Ku, Fukuoka 8128581, Japan	Miyazaki, T (reprint author), Kyushu Univ, Dept Econ, Higashi Ku, 6-19-1 Hakozaki, Fukuoka 8128581, Japan.	tmiyazak@econ.kyushu-u.ac.jp					Akizuki K, 2001, LOCAL GOVT DEV POSTW, P63; Alesina Alberto, 2003, SIZE NATIONS; Andrews M, 2002, ECON EDUC REV, V21, P245, DOI 10.1016/S0272-7757(01)00006-1; Johansson E, 2003, J PUBLIC ECON, V87, P883, DOI 10.1016/S0047-2727(01)00148-7; POIRIER DJ, 1980, J ECONOMETRICS, V12, P209, DOI 10.1016/0304-4076(80)90007-X; Besley T, 2003, J PUBLIC ECON, V87, P2611, DOI 10.1016/S0047-2727(02)00141-X; Lockwood B, 2002, REV ECON STUD, V69, P313, DOI 10.1111/1467-937X.00207; Alesina A, 2004, J POLIT ECON, V112, P348, DOI 10.1086/381474; Sorensen RJ, 2006, PUBLIC CHOICE, V127, P75, DOI 10.1007/s11127-006-7106-8; Hinnerich BT, 2009, J PUBLIC ECON, V93, P721, DOI 10.1016/j.jpubeco.2009.01.003; Duncombe W, 2007, EDUC FINANC POLICY, V2, P341, DOI 10.1162/edfp.2007.2.4.341; Austin DA, 1999, J URBAN ECON, V45, P501, DOI 10.1006/juec.1998.2102; Bolton P, 1997, Q J ECON, V112, P1057, DOI 10.1162/003355300555420; Brasington DM, 2003, ECONOMICA, V70, P673, DOI 10.1046/j.0013-0427.2003.01046.x; Brasington DM, 1999, J PUBLIC ECON, V73, P373, DOI 10.1016/S0047-2727(99)00018-3; Brasington DM, 2003, REV ECON STAT, V85, P874, DOI 10.1162/003465303772815781; Brink A., 2004, ECON GOV, V5, P119; CLAIR (Council of Local Authorities for International Relations), 2009, CLAIR FACT SHEET; Dur R, 2008, REG SCI URBAN ECON, V38, P160, DOI 10.1016/j.regsciurbeco.2008.01.005; Ellingsen T, 1998, J PUBLIC ECON, V68, P251, DOI 10.1016/S0047-2727(97)00090-X; Ferris J, 1988, J URBAN AFF, V10, P273, DOI 10.1111/j.1467-9906.1988.tb00544.x; Gordon N, 2009, J PUBLIC ECON, V93, P752, DOI 10.1016/j.jpubeco.2009.02.007; Hirota H, 2007, KEIKAKUGYOSEI, V30, P75; Konishi S, 2003, JICHI KENKYU, V79, P22; MENG CL, 1985, INT ECON REV, V26, P71, DOI 10.2307/2526528; MIC, 2006, WHITE PAPER ON LOCAL; MIC, 2005, WHITE PAPER ON LOCAL; MIC, 2002, SHICHOSON ZEI KAZEI; MIC, 2012, WHITE PAPER ON LOCAL; MIC, 2006, DIG ARCH MERG DAM; MIC, 2010, HEIS GAPP TSUIT; MIC, 2002, SHICHOSON KESSAN JOK; MIC (Ministry of Internal Affairs and Communications), 2000, KOKUSEI CHOSA; Miyashita T, 2009, ZAISEIKENKYU, V5, P254; Miyazaki T., 2006, JCER EC J, V54, P20; Miyazaki T, 2013, DISCUSSION PAPERS A, V588; Mochida N, 2001, LOCAL GOVT DEV POSTW, P85; Mochida N, 2006, PUBLIC SECTOR GOVERN; NELSON MA, 1990, SOUTHERN ECON J, V57, P443, DOI 10.2307/1060622; Nishikawa M, 2002, JCER EC J, V46, P61; Oates W. E., 1972, FISCAL FEDERALISM; OECD (Organization for Economic Co-operation and Development), 2005, EC SURV JAP; Reed S, 2001, INTRGOVERNMENTAL FIS, P112; Reschovsky A., 2007, INTERGOVERNMENTAL FI, P397; Alesina A, 1997, Q J ECON, V112, P1027, DOI 10.1162/003355300555411; Weese E, 2008, GLOBAL COE HISTAT DI, V017; Workshop on Regional System and Town and Village, 2008, ZENKOKU CHOSONKAI; Yokomichi K, 2007, COSLOG DATE DOUCMENT	48	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1435-6104			ECON GOV	Econ. Gov.	NOV	2014	15	4					387	410		10.1007/s10101-014-0145-6		24	Economics	Business & Economics	AQ9YK	WOS:000343215400004		
J	Gutierrez-Mazariegos, J; Nadendla, EK; Lima, D; Pierzchalski, K; Jones, JW; Kane, M; Nishikawa, JI; Hiromori, Y; Nakanishi, T; Santos, MM; Castro, LFC; Bourguet, W; Schubert, M; Laudet, V				Gutierrez-Mazariegos, Juliana; Nadendla, Eswar Kumar; Lima, Daniela; Pierzchalski, Keely; Jones, Jace W.; Kane, Maureen; Nishikawa, Jun-Ichi; Hiromori, Youhei; Nakanishi, Tsuyoshi; Santos, Miguel M.; Castro, L. Filipe C.; Bourguet, William; Schubert, Michael; Laudet, Vincent			A Mollusk Retinoic Acid Receptor (RAR) Ortholog Sheds Light on the Evolution of Ligand Binding	ENDOCRINOLOGY			English	Article							VERTEBRATE SEX STEROIDS; X-RECEPTOR; DNA-BINDING; ENDOGENOUS RETINOIDS; 9-CIS-RETINOIC ACID; ESTROGEN-RECEPTOR; ALL-TRANS; RXR; RECOGNITION; GASTROPODS	Nuclear receptors are transcription factors that regulate networks of target genes in response to small molecules. There is a strong bias in our knowledge of these receptors because they were mainly characterized in classical model organisms, mostly vertebrates. Therefore, the evolutionary origins of specific ligand-receptor couples still remain elusive. Here we present the identification and characterization of a retinoic acid receptor (RAR) from the mollusk Nucella lapillus (NlRAR). We show that this receptor specifically binds to DNA response elements organized in direct repeats as a heterodimer with retinoid X receptor. Surprisingly, we also find that NlRAR does not bind all-trans retinoic acid or any other retinoid we tested. Furthermore, NlRAR is unable to activate the transcription of reporter genes in response to stimulation by retinoids and to recruit coactivators in the presence of these compounds. Three-dimensional modeling of the ligand-binding domain of NlRAR reveals an overall structure that is similar to vertebrate RARs. However, in the ligand-binding pocket (LBP) of the mollusk receptor, the alteration of several residues interacting with the ligand has apparently led to an overall decrease in the strength of the interaction with the ligand. Accordingly, mutations of NlRAR at key positions within the LBP generate receptors that are responsive to retinoids. Altogether our data suggest that, in mollusks, RAR has lost its affinity for all-trans retinoic acid, highlighting the evolutionary plasticity of its LBP. When put in an evolutionary context, our results reveal new structural and functional features of nuclear receptors validated by millions of years of evolution that were impossible to reveal in model organisms.	[Gutierrez-Mazariegos, Juliana; Laudet, Vincent] Univ Lyon 1, Ecole Normale Super Lyon, CNRS, Inst Genom Fonct Lyon,UMR 5242,Mol Zool Team, F-69364 Lyon 07, France; [Nadendla, Eswar Kumar; Bourguet, William] Univ Montpellier I, Ctr Biochim Struct, CNRS, INSERM,U1054,UMR 5048, F-34967 Montpellier, France; [Nadendla, Eswar Kumar; Bourguet, William] Univ Montpellier 2, Ctr Biochim Struct, CNRS, INSERM,U1054,UMR 5048, F-34967 Montpellier, France; [Nadendla, Eswar Kumar] Univ Madras, CAS Crystallog & Biophys, Chennai 600005, Tamil Nadu, India; [Lima, Daniela; Santos, Miguel M.; Castro, L. Filipe C.] Univ Porto, Ctr Marine & Environm Res, Interdisciplinary Ctr Marine & Environm Res, Fac Sci,FCUP Dept Biol, P-4050123 Oporto, Portugal; [Pierzchalski, Keely; Jones, Jace W.; Kane, Maureen] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Nishikawa, Jun-Ichi] Mukogawa Womens Univ, Lab Hlth Sci, Sch Pharm & Pharmaceut Sci, Nishinomiya, Hyogo 6638179, Japan; [Hiromori, Youhei; Nakanishi, Tsuyoshi] Gifu Pharmaceut Univ, Lab Hygien Chem & Mol Toxicol, Gifu 5011196, Japan; Univ Paris 06, Univ Sorbonne, Observ Oceanol Villefranche Sur Mer, CNRS,UMR 7009,Lab Biol Dev Villefranche Sur Mer, F-06230 Villefranche Sur Mer, France	Laudet, V (reprint author), Ecole Normale Super Lyon, Inst Genom Fonct Lyon, 46 Allee Italie, F-69364 Lyon 07, France.	michael.schubert@obs-vlfr.fr; vincent.laudet@ens-lyon.fr	Scientific output, CIIMAR/E-5122-2012; Bourguet, William/I-5569-2013; 	Scientific output, CIIMAR/0000-0001-6270-2153; Bourguet, William/0000-0002-0643-7719; Castro, Luis Filipe/0000-0001-7697-386X; Pierzchalski, Keely/0000-0002-2456-0382	Centre National de la Recherche Scientifique; ENS de Lyon; MENRT; Agence Nationale de la Recherche [ANR-11-JSV2-002-01]; FCT [PTDC/MAR/105199/2008, PTDC/MAR/115199/2009]; KAKENHI [21590143]; National Institute of Allergy and Infectious Diseases [HHSN272202000046C]; University of Maryland, School of Pharmacy, Mass Spectrometry Center [SOP1841-IQB2014]	V.L. is supported by the Centre National de la Recherche Scientifique, the ENS de Lyon, and the MENRT. M. S. is supported by the Centre National de la Recherche Scientifique and by Grant ANR-11-JSV2-002-01 awarded by the Agence Nationale de la Recherche. L. F. C. C. and M. M. S. are supported by the FCT (Grants PTDC/MAR/105199/2008 and PTDC/MAR/115199/2009). J.-I.N. is supported by the KAKENHI (Grant 21590143). M. K. received support from the National Institute of Allergy and Infectious Diseases Contract HHSN272202000046C and from the University of Maryland, School of Pharmacy, Mass Spectrometry Center (Grant SOP1841-IQB2014).	Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; ZECHEL C, 1994, EMBO J, V13, P1425; Pons JL, 2009, NUCLEIC ACIDS RES, V37, pW485, DOI 10.1093/nar/gkp368; Ross SA, 2000, PHYSIOL REV, V80, P1021; Albalat R, 2009, CHEM-BIOL INTERACT, V178, P188, DOI 10.1016/j.cbi.2008.09.017; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Moutier E, 2012, J BIOL CHEM, V287, P26328, DOI 10.1074/jbc.M112.361790; Gesto M, 2013, AQUAT TOXICOL, V142, P96, DOI 10.1016/j.aquatox.2013.08.001; Nishikawa J, 2004, ENVIRON SCI TECHNOL, V38, P6271, DOI 10.1021/es049593u; Harms MJ, 2013, P NATL ACAD SCI USA, V110, P11475, DOI 10.1073/pnas.1303930110; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; le Maire A, 2010, NAT STRUCT MOL BIOL, V17, P801, DOI 10.1038/nsmb.1855; Markov GV, 2009, P NATL ACAD SCI USA, V106, P11913, DOI 10.1073/pnas.0812138106; Scott AP, 2012, STEROIDS, V77, P1450, DOI 10.1016/j.steroids.2012.08.009; ZECHEL C, 1994, EMBO J, V13, P1414; SMITH WC, 1991, EMBO J, V10, P2223; ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Scott AP, 2013, STEROIDS, V78, P268, DOI 10.1016/j.steroids.2012.11.006; Chambon P, 1996, FASEB J, V10, P940; Bouton D, 2005, J MOL ENDOCRINOL, V34, P567, DOI 10.1677/jme.1.01766; Egea PF, 2002, MOL ENDOCRINOL, V16, P987, DOI 10.1210/me.16.5.987; Dmetrichuk JM, 2008, J NEUROSCI, V28, P13014, DOI 10.1523/JNEUROSCI.3192-08.2008; Urushitani H, 2013, AQUAT TOXICOL, V142, P403, DOI 10.1016/j.aquatox.2013.09.008; Balmer JE, 2005, J STEROID BIOCHEM, V96, P347, DOI 10.1016/j.jsbmb.2005.05.005; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Claremont M, 2013, MOL PHYLOGENET EVOL, V66, P91, DOI 10.1016/j.ympev.2012.09.014; Nahoum V, 2007, P NATL ACAD SCI USA, V104, P17323, DOI 10.1073/pnas.0705356104; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Barco A, 2010, MOL PHYLOGENET EVOL, V56, P1025, DOI 10.1016/j.ympev.2010.03.008; Bridgham JT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004058; Campo-Paysaa F, 2008, GENESIS, V46, P640, DOI 10.1002/dvg.20444; Canestro C, 2006, EVOL DEV, V8, P394, DOI 10.1111/j.1525-142X.2006.00113.x; Castro FC, 2007, AQUAT TOXICOL, V85, P57; CRETON R, 1993, DEV GROWTH DIFFER, V35, P357; Dmetrichuk JM, 2006, DEV BIOL, V294, P39, DOI 10.1016/j.ydbio.2006.02.018; DURAND B, 1992, CELL, V71, P73, DOI 10.1016/0092-8674(92)90267-G; Escriva H, 2006, PLOS GENET, V2, P955, DOI 10.1371/journal.pgen.0020102; Gesto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035138; Gutierrez-Mazariegos J, 2014, SUBCELL BIOCHEM, V70, P55, DOI 10.1007/978-94-017-9050-5_4; Kane MA, 2010, METHODS MOL BIOL, V652, P1, DOI 10.1007/978-1-60327-325-1_1; Kane MA, 2012, BBA-MOL CELL BIOL L, V1821, P10, DOI 10.1016/j.bbalip.2011.09.012; Laudet V., 2002, NUCL RECEPTOR FACTS; Lecroisey C, 2012, BRIEF FUNCT GENOMICS, V11, P156, DOI 10.1093/bfgp/els008; LEID M, 1994, J BIOL CHEM, V269, P14175; Marletaz F, 2006, INT J BIOL SCI, V2, P38; OSTROWSKI J, 1995, P NATL ACAD SCI USA, V92, P1812, DOI 10.1073/pnas.92.6.1812; Paris M, 2008, CURR BIOL, V18, P825, DOI 10.1016/j.cub.2008.04.078; Paris M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-219; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Simoes-Costa MS, 2008, J EXP ZOOL PART B, V310B, P54, DOI 10.1002/jez.b.21139; TATE BF, 1995, J BIOL CHEM, V270, P20258; Urushitani H, 2011, AQUAT TOXICOL, V103, P101, DOI 10.1016/j.aquatox.2011.02.012; WILSON TE, 1992, SCIENCE, V256, P107, DOI 10.1126/science.1314418	55	4	4	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	NOV	2014	155	11					4275	4286		10.1210/en.2014-1181		12	Endocrinology & Metabolism	Endocrinology & Metabolism	AR2MY	WOS:000343422800018		
J	Murakami, K; Lee, YH; Lucas, ES; Chan, YW; Durairaj, RP; Takeda, S; Moore, JD; Tan, BK; Quenby, S; Chan, JKY; Gargett, CE; Brosens, JJ				Murakami, Keisuke; Lee, Yie Hou; Lucas, Emma S.; Chan, Yi-Wah; Durairaj, Ruban Peter; Takeda, Satoru; Moore, Jonathan D.; Tan, Bee K.; Quenby, Siobhan; Chan, Jerry K. Y.; Gargett, Caroline E.; Brosens, Jan J.			Decidualization Induces a Secretome Switch in Perivascular Niche Cells of the Human Endometrium	ENDOCRINOLOGY			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; LEUKEMIA INHIBITORY FACTOR; MESENCHYMAL STEM-CELLS; SEQUENCE COUNT DATA; DOMAIN-CONTAINING 2; STROMAL CELLS; MENSTRUAL-CYCLE; IN-VITRO; RNA-SEQ; PROGESTERONE	The endometrial perivascular microenvironment is rich in mesenchymal stem-like cells that express type 1 integral membrane protein Sushi domain containing 2 (SUSD2) but the role of these cells in the decidual transformation of this tissue in pregnancy is unknown. We used an antibody directed against SUSD2 (W5C5) to isolate perivascular (W5C5(-)) and nonperivascular (W5C5(+)) fibroblasts from mid-luteal biopsies. We show that SUSD2 expression, and hence the ratio of W5C5(+) : W5C5(-) cells, changes in culture depending on cell-cell contact and activation of the Notch signaling pathway. RNA sequencing revealed that cultures derived from W5C5(+) progenitor cells remain phenotypically distinct by the enrichment of novel and established endometrial perivascular signature genes. In an undifferentiated state, W5C5(+)-derived cells produced lower levels of various chemokines and inflammatory modulators when compared with their W5C5(-) counterparts. This divergence in secretomes was switched and became more pronounced upon decidualization, which transformed perivascular W5C5(+) cells into the dominant source of a range of chemokines and cytokines, including leukemia inhibitory factor and chemokine (C-C motif) ligand 7. Our findings suggest that the decidual response is spatially organized at the embryo-maternal interface with differentiating perivascular cells establishing distinct cytokine and chemokine profiles that could potentially direct trophoblast toward maternal vessels and govern local immune responses in pregnancy.	[Murakami, Keisuke; Lucas, Emma S.; Durairaj, Ruban Peter; Moore, Jonathan D.; Quenby, Siobhan; Brosens, Jan J.] Univ Warwick, Warwick Med Sch, Clin Sci Res Labs, Div Reprod Hlth, Coventry CV2 2DX, W Midlands, England; [Murakami, Keisuke; Takeda, Satoru] Juntendo Univ, Fac Med, Dept Obstet & Gynaecol, Tokyo 1138421, Japan; [Lee, Yie Hou] Singapore MIT Alliance Res & Technol, Interdisciplinary Res Grp BioSyst & Micromech, Singapore 138602, Singapore; [Lee, Yie Hou] Singapore MIT Alliance Res & Technol, Interdisciplinary Res Grp Infect Dis, Singapore 138602, Singapore; [Chan, Yi-Wah; Moore, Jonathan D.] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Chan, Jerry K. Y.] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore 229899, Singapore; [Chan, Jerry K. Y.] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore 169857, Singapore; [Gargett, Caroline E.] Monash Univ, Inst Med Res, Monash Inst Med Res, Ritchie Ctr,Prince Henrys Inst, Clayton, Vic 3168, Australia; Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia	Brosens, JJ (reprint author), Univ Warwick, Warwick Med Sch, Clin Sci Res Labs, Div Reprod Hlth, Coventry CV2 2DX, W Midlands, England.	j.j.brosens@warwick.ac.uk	Moore, Jonathan/D-1796-2013	Moore, Jonathan/0000-0002-5486-0407	Biomedical Research Unit in Reproductive Health; Australian National Health and Medical Research Council [1042298]; Victorian Government's Operational Infrastructure Support Program	This work was supported by the Biomedical Research Unit in Reproductive Health, a joint initiative between the University Hospitals Coventry and Warwickshire National Health Service Trust and Warwick Medical School. C. E. G. also received funding from The Australian National Health and Medical Research Council for a Senior Research Fellowship 1042298 and the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the article.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; BROSENS I, 1967, J PATHOL BACTERIOL, V93, P569, DOI 10.1002/path.1700930218; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Sugahara T, 2007, CANCER SCI, V98, P900, DOI 10.1111/j.1349-7006.2007.00466.x; Buhring HJ, 2007, ANN NY ACAD SCI, V1106, P262, DOI 10.1196/annals.1392.000; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Masuda H, 2007, P NATL ACAD SCI USA, V104, P1925, DOI 10.1073/pnas.0604310104; Wolff EF, 2007, REPROD SCI, V14, P524, DOI 10.1177/1933719107306896; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; RAMSEY EM, 1976, AM J OBSTET GYNECOL, V124, P647; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Wolff EF, 2011, J CELL MOL MED, V15, P747, DOI 10.1111/j.1582-4934.2010.01068.x; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; Lockwood CJ, 2009, THROMB RES, V124, P516, DOI 10.1016/j.thromres.2009.07.017; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scadden DT, 2014, CELL, V157, P41, DOI 10.1016/j.cell.2014.02.013; Tapia A, 2008, HUM REPROD, V23, P1724, DOI 10.1093/humrep/den121; Brosens JJ, 2002, AM J OBSTET GYNECOL, V187, P1416, DOI 10.1067/mob.2022.127305; Leitao B, 2010, FASEB J, V24, P1541, DOI 10.1096/fj.09-149153; Gonzalez M, 2011, MOL HUM REPROD, V17, P421, DOI 10.1093/molehr/gar015; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Blanks AM, 2013, BIOESSAYS, V35, P412, DOI 10.1002/bies.201300022; Cattaruzza S, 2013, J MOL CELL BIOL, V5, P176, DOI 10.1093/jmcb/mjt010; Rollins BJ, 1997, BLOOD, V90, P909; Labied S, 2006, MOL ENDOCRINOL, V20, P35, DOI 10.1210/me.2005-0275; Masuda H, 2012, CELL TRANSPLANT, V21, P2201, DOI 10.3727/096368911X637362; Jalkanen S, 2008, ARTERIOSCL THROM VAS, V28, P18, DOI 10.1161/ATVBAHA.107.153130; Finn CA, 1998, Q REV BIOL, V73, P163, DOI 10.1086/420183; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Emera D, 2012, BIOESSAYS, V34, P26, DOI 10.1002/bies.201100099; Watson AP, 2013, MOL CANCER RES, V11, P74, DOI 10.1158/1541-7786.MCR-12-0501-T; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; FINN CA, 1984, J ENDOCRINOL, V100, P295, DOI 10.1677/joe.0.1000295; Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030; Henriet P, 2012, MOL CELL ENDOCRINOL, V358, P197, DOI 10.1016/j.mce.2011.07.042; Brosens JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03894; Brosens JJ, 2009, AM J OBSTET GYNECOL, V200, P615; Evans J, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.108175; Gargett CE, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.05.004; Gellersen B, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106724; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Jones MC, 2006, P NATL ACAD SCI USA, V103, P16272, DOI 10.1073/pnas.0603002103; Kajihara T, 2006, MOL ENDOCRINOL, V20, P2444, DOI 10.1210/me.2006-0118; Kuroda K, 2013, MOL ENDOCRINOL, V27, P192, DOI 10.1210/me.2012-1247; Lake RJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004204; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lockwood CJ, 2007, SEMIN THROMB HEMOST, V33, P111, DOI 10.1055/s-2006-958469; MARTIN RD, 2007, AM J PHYS ANTHR S45, V50, P59, DOI DOI 10.1002/AJPA.20734; Menten P, 2001, EUR CYTOKINE NETW, V12, P554; Miyazaki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050749; Murakami K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082582; Salker MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052252; Sivasubramaniyan K, 2013, STEM CELLS DEV, V22, P1944, DOI 10.1089/scd.2012.0584; Schwab KE, 2005, FERTIL STERIL, V84, P1124, DOI 10.1016/j.fertnstert.2005.02.056; Shuya LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025288; Spitzer TLB, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095885; Sugahara T, 2007, CANCER SCI, V98, P909, DOI 10.1111/j.1349-7006.2007.00467.x; Teklenburg G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010258; Weimar CHE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041424	65	4	4	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	NOV	2014	155	11					4542	4553		10.1210/en.2014-1370		12	Endocrinology & Metabolism	Endocrinology & Metabolism	AR2MY	WOS:000343422800041		
J	Deng, SQ; Yin, N; Guan, QW; Katoh, M				Deng, Songqiu; Yin, Na; Guan, Qingwei; Katoh, Masato			Dynamic response of the scenic beauty value of different forests to various thinning intensities in central eastern China	ENVIRONMENTAL MONITORING AND ASSESSMENT			English	Article						Scenic forest; Thinning management; Landscape value; Neural network model; Impact factor	URBAN GREEN SPACES; LANDSCAPE PREFERENCES; PACIFIC-NORTHWEST; TREE STAND; QUALITY; PERCEPTIONS; PREDICTION; MANAGEMENT; LEVEL; MASSACHUSETTS	Forest management has a significant influence on the preferences of people for forest landscapes. This study sought to evaluate the dynamic effects of thinning intensities on the landscape value of forests over time. Five typical stands in Wuxiangsi National Forest Park in Nanjing, China, were subjected to a thinning experiment designed with four intensities: unthinned, light thinning, moderate thinning, and heavy thinning. People's preferences for landscape photographs taken in plots under various thinning intensities were assessed through scenic beauty estimation (SBE) at 2 and 5 years after thinning. The differences in scenic beauty value between different thinning intensities were then analyzed with a paired samples t test for the two periods. The results indicated that the landscape value of all of the thinned plots significantly exceeded that of the unthinned plots 2 years after thinning (p < 0.01) and that the heavily thinned plots were most appreciated, showing an average improvement of 9.71 % compared with the control plots. Additionally, the heavily thinned plots were judged to be more beautiful than the lightly thinned and moderately thinned plots, whereas there was no significant difference between moderate thinning and light thinning. At 5 years after thinning, however, the moderately thinned plots received the highest preference scores among the four intensities, displaying an average improvement of 11.32 % compared with the unthinned plots. A multiple linear regression (MLR) model indicated that landscape value improved with increases in the average diameter at breast height (DBH) and with the improvement of environmental cleanliness in the stand, whereas the value decreased with an increasing stem density, species diversity, litter coverage, and canopy density. In addition, we found that the performance of a neural network model based on a multilayer perception (MLP) algorithm for predicting scenic beauty was slightly better than that of the MLR model. The findings of our study suggest that moderate to heavy thinning should be recommended to manage forests for the improvement of forest landscape value.	[Deng, Songqiu; Katoh, Masato] Shinshu Univ, Fac Agr, Forest Measurement & Planning Lab, Kamiina Dtrct, Nagano 3994598, Japan; [Deng, Songqiu; Yin, Na; Guan, Qingwei] Nanjing Forestry Univ, Fac Forest Resources & Environm, Nanjing 210037, Jiangsu, Peoples R China; [Yin, Na] Shinshu Univ, Fac Agr, Forest Environm & Ecol Lab, Kamiina Dtrct, Nagano 3994598, Japan	Guan, QW (reprint author), Nanjing Forestry Univ, Fac Forest Resources & Environm, 159 Longpan Rd, Nanjing 210037, Jiangsu, Peoples R China.	guanjapan999@163.com			National Basic Research Program of China (973 program) [2012CB416904]; Special Public Interest Forestry Project of the State Forestry Administration of China [201104075]	This study was supported by the National Basic Research Program of China (973 program, 2012CB416904) and the Special Public Interest Forestry Project of the State Forestry Administration of China (No. 201104075). We gratefully acknowledge all the staff members of the State-owned Forest Farm of Lishui Prefecture, Nanjing City for their support in the field survey and thinning experiment, and we thank all of the workers who helped perform the thinning treatments. We would like to thank a number of students from Nanjing Forestry University for their support in the field, in the plot investigations, and with the assessment experiments. In addition, we wish to acknowledge the helpful comments of the anonymous reviewers and editor.	Lothian A, 1999, LANDSCAPE URBAN PLAN, V44, P177, DOI 10.1016/S0169-2046(99)00019-5; BROWN TC, 1986, FOREST SCI, V32, P471; Hunziker M, 1999, LANDSCAPE ECOL, V14, P161, DOI 10.1023/A:1008079715913; Blasco Elena, 2009, Journal of Forestry Research (Harbin), V20, P73, DOI 10.1007/s11676-009-0013-3; SHAFER EL, 1969, J LEISURE RES, V1, P1; Harrod RJ, 2009, FOREST ECOL MANAG, V258, P712, DOI 10.1016/j.foreco.2009.05.011; SCHROEDER H, 1981, FOREST SCI, V27, P71; Jim CY, 2009, CITIES, V26, P187, DOI 10.1016/j.cities.2009.03.003; Kim YS, 2005, J FOREST, V103, P146; Ode A, 2009, J ENVIRON MANAGE, V90, P375, DOI 10.1016/j.jenvman.2007.10.013; Ribe RG, 2005, LANDSCAPE URBAN PLAN, V73, P277, DOI 10.1016/j.landurbplan.2004.07.003; Gundersen Vegard Sverre, 2008, Urban Forestry & Urban Greening, V7, P241, DOI 10.1016/j.ufug.2008.05.001; Schirpke U, 2013, LANDSCAPE URBAN PLAN, V111, P1, DOI 10.1016/j.landurbplan.2012.11.010; Seiwa K, 2012, J FOREST RES-JPN, V17, P468, DOI 10.1007/s10310-011-0316-z; Dramstad WE, 2006, LANDSCAPE URBAN PLAN, V78, P465, DOI 10.1016/j.landurbplan.2005.12.006; Tahvanainen L, 2001, LANDSCAPE URBAN PLAN, V53, P53, DOI 10.1016/S0169-2046(00)00137-7; Hartig T, 2003, J ENVIRON PSYCHOL, V23, P109, DOI 10.1016/S0272-4944(02)00109-3; Senanayake IP, 2013, URBAN FOR URBAN GREE, V12, P307, DOI 10.1016/j.ufug.2013.03.011; Palmer JF, 2004, LANDSCAPE URBAN PLAN, V69, P201, DOI 10.1016/j.landurbplan.2003.08.010; SWANSON FJ, 1992, ECOL APPL, V2, P262, DOI 10.2307/1941860; Faryadi S, 2009, INT J ENVIRON RES, V3, P199; Daniel TC, 2001, LANDSCAPE URBAN PLAN, V54, P267, DOI 10.1016/S0169-2046(01)00141-4; Arnberger Arne, 2006, Urban Forestry & Urban Greening, V4, P135, DOI 10.1016/j.ufug.2006.01.004; ARTHUR LM, 1977, FOREST SCI, V23, P151; BERGEN SD, 1995, J ENVIRON PSYCHOL, V15, P135, DOI 10.1016/0272-4944(95)90021-7; BRUNSON M, 1992, J FOREST, V90, P37; BRUSH RO, 1979, FOREST SCI, V25, P495; BUHYOFF GJ, 1986, FOREST SCI, V32, P769; CHOKOR BA, 1992, J ENVIRON MANAGE, V34, P237, DOI 10.1016/S0301-4797(11)80001-0; Daniel T.C., 1976, RM167 USDA FOR SERV; Debell D. S., 1993, J FOREST, V91, P26; Deng S., 2010, J NE FORESTRY U, V38, P46; Deng SongQiu, 2010, Journal of Northeast Forestry University, V38, P31; Deng SQ, 2013, J FOREST RES-JPN, V18, P209, DOI 10.1007/s10310-012-0342-5; DUFFIELD JW, 1970, J FOREST, V68, P464; Echelberger H. E., 1979, OUR NATL LANDSCAPE, P524; Gobster P. H., 1999, LANDSCAPE J, V18, P54, DOI DOI 10.3368/1J.18.1.54; Hansen HS, 2010, LANDSCAPE URBAN PLAN, V98, P141, DOI 10.1016/j.landurbplan.2010.08.018; Hayes JP, 2003, ECOL APPL, V13, P1222, DOI 10.1890/02-5068; HULL RB, 1984, FOREST SCI, V30, P1084; Hull R. B., 1987, LANDSCAPE J, V6, P113; HULL RB, 1986, FOREST SCI, V32, P271; Karjalainen E., 1996, LANDSCAPE RES, V21, P159, DOI 10.1080/01426399608706483; Liao W., 1999, J FOREST RES, V4, P93, DOI DOI 10.1007/BF02762232; LITTON RB, 1974, J FOREST, V72, P392; Mao Zhihong, 2006, Shengtaixue Zazhi, V25, P1201; Pukkala T, 1988, SCAND J FOREST RES, V3, P533, DOI 10.1080/02827588809382538; RIBE RG, 1989, ENVIRON MANAGE, V13, P55, DOI 10.1007/BF01867587; Ribe RG, 2009, J ENVIRON MANAGE, V91, P245, DOI 10.1016/j.jenvman.2009.08.014; Ribe RG, 2006, J ENVIRON PSYCHOL, V26, P100, DOI 10.1016/j.jenvp.2006.05.004; Saastamoinen O., 1982, COMMUNICATIONES I FO, V104, P1; SCHROEDER HW, 1983, J LEISURE RES, V15, P156; Shelby B, 2003, J FOREST, V101, P30; Sheppard S, 2003, FOREST CHRON, V79, P865; Silvennoinen H, 2002, SCAND J FOREST RES, V17, P263, DOI 10.1080/028275802753742936; Silvennionen H, 2001, LANDSCAPE URBAN PLAN, V56, P11, DOI 10.1016/S0169-2046(01)00163-3; Tyrvainen Liisa, 2003, Urban Forestry & Urban Greening, V1, P135, DOI 10.1078/1618-8667-00014; VODAK MC, 1985, FOREST SCI, V31, P289; [韦翠鸾 Wei Cuiluan], 2004, [内蒙古农业大学学报. 自然科学版, Journal of Inner Mongolia Agicultural University], V25, P114; XinhuaNet, 2012, XINHUANET; YARROW C, 1966, FORESTRY, V39, P59, DOI 10.1093/forestry/39.1.59; YEISER JL, 1978, J FOREST, V76, P497	62	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6369	1573-2959		ENVIRON MONIT ASSESS	Environ. Monit. Assess.	NOV	2014	186	11					7413	7429		10.1007/s10661-014-3937-9		17	Environmental Sciences	Environmental Sciences & Ecology	AQ8CU	WOS:000343051400033		
J	Guo, YM; Gasparrini, A; Armstrong, B; Li, SS; Tawatsupa, B; Tobias, A; Lavigne, E; Coelho, MDZS; Leone, M; Pan, XC; Tong, SL; Tian, LW; Kim, H; Hashizume, M; Honda, Y; Guo, YLL; Wu, CF; Punnasiri, K; Yi, SM; Michelozzi, P; Saldiva, PHN; Williams, G				Guo, Yuming; Gasparrini, Antonio; Armstrong, Ben; Li, Shanshan; Tawatsupa, Benjawan; Tobias, Aurelio; Lavigne, Eric; Zanotti Stagliorio Coelho, Micheline de Sousa; Leone, Michela; Pan, Xiaochuan; Tong, Shilu; Tian, Linwei; Kim, Ho; Hashizume, Masahiro; Honda, Yasushi; Guo, Yue-Liang Leon; Wu, Chang-Fu; Punnasiri, Kornwipa; Yi, Seung-Muk; Michelozzi, Paola; Nascimento Saldiva, Paulo Hilario; Williams, Gail			Global Variation in the Effects of Ambient Temperature on Mortality A Systematic Evaluation	EPIDEMIOLOGY			English	Article							LAG NONLINEAR MODELS; 15 EUROPEAN CITIES; CLIMATE-CHANGE; PUBLIC-HEALTH; UNITED-STATES; HEAT WAVES; COLD; IMPACT; METAANALYSIS; POLLUTION	Background: Studies have examined the effects of temperature on mortality in a single city, country, or region. However, less evidence is available on the variation in the associations between temperature and mortality in multiple countries, analyzed simultaneously. Methods: We obtained daily data on temperature and mortality in 306 communities from 12 countries/regions (Australia, Brazil, Thailand, China, Taiwan, Korea, Japan, Italy, Spain, United Kingdom, United States, and Canada). Two-stage analyses were used to assess the nonlinear and delayed relation between temperature and mortality. In the first stage, a Poisson regression allowing overdispersion with distributed lag nonlinear model was used to estimate the community-specific temperature-mortality relation. In the second stage, a multivariate meta-analysis was used to pool the nonlinear and delayed effects of ambient temperature at the national level, in each country. Results: The temperatures associated with the lowest mortality were around the 75th percentile of temperature in all the countries/regions, ranging from 66th (Taiwan) to 80th (UK) percentiles. The estimated effects of cold and hot temperatures on mortality varied by community and country. Meta-analysis results show that both cold and hot temperatures increased the risk of mortality in all the countries/regions. Cold effects were delayed and lasted for many days, whereas heat effects appeared quickly and did not last long. Conclusions: People have some ability to adapt to their local climate type, but both cold and hot temperatures are still associated with increased risk of mortality. Public health strategies to alleviate the impact of ambient temperatures are important, in particular in the context of climate change.	[Guo, Yuming; Li, Shanshan; Williams, Gail] Univ Queensland, Sch Populat Hlth, Dept Epidemiol & Biostat, Brisbane, Qld 4006, Australia; [Gasparrini, Antonio] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [Armstrong, Ben] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England; [Tawatsupa, Benjawan; Punnasiri, Kornwipa] Minist Publ Heath, Hlth Impact Assessment Div, Dept Heath, Nonthaburi, Thailand; [Tobias, Aurelio] Spanish Council Sci Res, Inst Environm Assessment & Water Res, Barcelona, Spain; [Lavigne, Eric] Publ Hlth Agcy Canada, Environm Issues Div, Ottawa, ON, Canada; [Lavigne, Eric] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada; [Zanotti Stagliorio Coelho, Micheline de Sousa; Nascimento Saldiva, Paulo Hilario] Univ Sao Paulo, Sch Med, Lab Expt Air Pollut, Dept Pathol, Sao Paulo, Brazil; [Leone, Michela; Michelozzi, Paola] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy; [Pan, Xiaochuan] Peking Univ, Dept Occupat & Environm Hlth, Sch Publ Hlth, Beijing 100871, Peoples R China; [Tong, Shilu] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld 4001, Australia; [Tong, Shilu] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Tian, Linwei] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Kim, Ho; Yi, Seung-Muk] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Kim, Ho; Yi, Seung-Muk] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Hashizume, Masahiro] Nagasaki Univ, Dept Pediat Infect Dis, Inst Trop Med, Nagasaki 852, Japan; [Honda, Yasushi] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan; [Guo, Yue-Liang Leon] Natl Taiwan Univ, Dept Environm & Occupat Med, Taipei 10764, Taiwan; [Wu, Chang-Fu] Natl Taiwan Univ, Dept Publ Hlth, Taipei 10764, Taiwan	Guo, YM (reprint author), Univ Queensland, Sch Populat Hlth, Dept Epidemiol & Biostat, Brisbane, Qld 4006, Australia.	y.guo1@uq.edu.au	Gasparrini, Antonio/F-7627-2012; Tian, Linwei/A-9736-2009; Lavigne, Eric/E-2948-2013; 	Gasparrini, Antonio/0000-0002-2271-3568; Tian, Linwei/0000-0002-4739-1534; GUO, Yue Leon/0000-0002-8530-4809; Lavigne, Eric/0000-0001-6146-9839; Wu, Chang-fu/0000-0003-2244-1934	Australia National Health and Medical Research Council [APP1030259]; Chinese Meteorological Administration [GYHY201206027]; National Natural Science Foundation of China [81172745]; Centre for Air Quality and Health Research and Evaluation; School of Population Health, University of Queensland; Research Methodology fellowship by Medical Research Council, UK [G1002296]; Ministry of Education of the Spanish Government	This work was supported by the Australia National Health and Medical Research Council (APP1030259), the Chinese Meteorological Administration (GYHY201206027), and the National Natural Science Foundation of China (81172745). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Y.G. was supported by Centre for Air Quality and Health Research and Evaluation, and School of Population Health, The University of Queensland. A. G. was supported by a Research Methodology fellowship by Medical Research Council, UK (G1002296). A. T. was supported by Salvador Madariaga's grant of the Ministry of Education of the Spanish Government.	Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Goodman PG, 2004, ENVIRON HEALTH PERSP, V112, P179, DOI 10.1289/ehp.6451; Jackson D, 2011, STAT MED, V30, P2481, DOI 10.1002/sim.4172; Chung JY, 2009, SCI TOTAL ENVIRON, V408, P390, DOI 10.1016/j.scitotenv.2009.09.009; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; Bouchama A, 2007, ARCH INTERN MED, V167, P2170, DOI 10.1001/archinte.167.20.ira70009; Huang CR, 2012, NAT CLIM CHANGE, V2, P265, DOI [10.1038/NCLIMATE1369, 10.1038/nclimate1369]; Kinney PL, 2008, ENVIRON SCI POLICY, V11, P87, DOI 10.1016/j.envsci.2007.08.001; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Ebi KL, 2006, ENVIRON HEALTH PERSP, V114, P1930, DOI 10.1289/ehp.8430; Gasparrini A, 2012, STAT MED, V31, P3821, DOI 10.1002/sim.5471; Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598; Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Armstrong BG, 2011, J EPIDEMIOL COMMUN H, V65, P340, DOI 10.1136/jech.2009.093161; Dominici F, 2003, INT STAT REV, V71, P243; McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Astrom DO, 2013, NAT CLIM CHANGE, V3, P1050, DOI [10.1038/NCLIMATE2022, 10.1038/nclimate2022]; Ballester J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1360; Basu R., 2009, ENV HLTH, V8, P1; Dear KBG, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2807; Gasparrini A, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-1; Guo YM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00830; Guo YM, 2013, ENVIRON RES, V120, P55, DOI 10.1016/j.envres.2012.09.001; Huynen MMTE, 2001, ENVIRON HEALTH PERSP, V109, P463, DOI 10.2307/3454704; Martin SL, 2012, INT J BIOMETEOROL, V56, P605, DOI 10.1007/s00484-011-0449-y; Tawatsupa B, 2012, INT J BIOMETEOROL, V58, P1	29	7	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1044-3983	1531-5487		EPIDEMIOLOGY	Epidemiology	NOV	2014	25	6					781	789		10.1097/EDE.0000000000000165		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AQ8XJ	WOS:000343122000001		
J	Kubo, K; Kawada, N; Nakajima, T; Hirayae, K; Fujita, M				Kubo, Katashi; Kawada, Naoyuki; Nakajima, Takashi; Hirayae, Kazuyuki; Fujita, Masaya			Field evaluation of resistance to kernel infection and mycotoxin accumulation caused by Fusarium head blight in western Japanese wheat (Triticum aestivum L.) cultivars	EUPHYTICA			English	Article						Bread wheat; Kernel infection; Mycotoxin accumulation; Resistance; Scab	MARKER-ASSISTED SELECTION; WINTER-WHEAT; FHB RESISTANCE; SPRING WHEAT; DEOXYNIVALENOL CONTENT; CEREAL RESISTANCE; CLIMATE-CHANGE; BREAD WHEAT; SUMAI 3; QTL	Fusarium head blight (FHB) remains a serious problem that causes yield and grain quality losses, and mycotoxin accumulation in wheat production in western Japan. A 3-year field trial with artificial FHB inoculation was conducted to evaluate varietal characteristics of FHB resistance among 31 wheat cultivars/lines cultivated in western Japan, including one standard line. Severity of FHB, frequency of Fusarium-damaged kernels (FDK), deoxynivalenol concentration (DON), nivalenol concentration (NIV), and grain yield showed significant differences among years and among cultivars/lines. Interaction between years and cultivars/lines was also significant in these traits, but F values were larger for cultivars/lines than for the interaction. Correlation analysis showed that cultivars/lines with lower FHB severities tended to have lower FDK, DON and NIV, and a higher yield. Resistance to kernel infection (RKI), residuals calculated by regressing FDK against FHB severity, and resistance to mycotoxin accumulation (RTA), residuals calculated by regressing DON + NIV against FDK, also differed significantly among cultivars/lines. These results indicated that varietal differences in response to FHB symptom development, RKI and RTA exist among wheat cultivars/lines in western Japan. Such information is important to aid producers in controlling the disease and for breeders to improve FHB resistance and reduce mycotoxin accumulation in commercial wheat cultivars.	[Kubo, Katashi; Kawada, Naoyuki; Fujita, Masaya] Natl Agr & Food Res Org NARO, Kyushu Okinawa Agr Res Ctr KARC, Lowland Farming & Hort Res Div, Fukuoka 8330041, Japan; [Nakajima, Takashi; Hirayae, Kazuyuki] NARO KARC, Agroenvironm Res Div, Kumamoto 8611192, Japan; [Nakajima, Takashi] NARO Headquarters, Tsukuba, Ibaraki 3058517, Japan	Kubo, K (reprint author), NARO Tohoku Agr Res Ctr TARC, Agr Radiat Res Ctr, 50 Harajukuminami, Fukushima 9602156, Japan.	ktskubo@affrc.go.jp			MAFF of Japan	We are grateful to Dr A. Kawakami, Dr M. Yoshida, Mr K. Hatta and Mr H. Matsunaka, NARO/KARC, and Dr T. Ban and Dr S. Niwa, Kihara Institute for Biological Research, Yokohama City University, for providing valuable advice. We also thank Mr Y. Okubo, Mr T. Miike, Mr K. Miike, M. Murakami, Mr M. Nakajima, and Mr K. Nakamura, NARO/KARC, for field management. Ms K. Nakamura assisted with phenotypic evaluation in the field and in the laboratory. Dr T. Shinano, NARO/TARC, Dr T. Yoshida, Ministry of Agriculture, Forestry, and Fisheries (MAFF) of Japan, and Dr C. Masumoto, National Institute of Agrobiological Science (present address NARO/KARC), assisted with preparation of the manuscript. This study was conducted as part of the project 'Development and Evaluation of Management Methods for Supplying Safe, Reliable and Functional Food and Farm Produce' funded by the MAFF of Japan.	Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Rudd JC, 2001, CROP SCI, V41, P620; Doohan FM, 2003, EUR J PLANT PATHOL, V109, P755, DOI 10.1023/A:1026090626994; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Liu SY, 2009, CROP SCI, V49, P1955, DOI 10.2135/cropsci2009.03.0115; Cuthbert PA, 2007, THEOR APPL GENET, V114, P429, DOI 10.1007/s00122-006-0439-3; Anderson JA, 2007, CROP SCI, V47, pS112, DOI 10.2135/cropsci2007.04.0006IPBS; Li T, 2012, EUPHYTICA, V185, P93, DOI 10.1007/s10681-012-0631-2; Blandino M, 2012, FIELD CROP RES, V133, P139, DOI 10.1016/j.fcr.2012.04.004; Yang J, 2005, THEOR APPL GENET, V111, P1571, DOI 10.1007/s00122-005-0087-z; Toth B, 2008, PLANT BREEDING, V127, P1; Abate ZA, 2008, CROP SCI, V48, P1408, DOI 10.2135/cropsci2007.07.0411; Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Jones RK, 2000, PLANT DIS, V84, P1021, DOI 10.1094/PDIS.2000.84.9.1021; Yu JB, 2006, THEOR APPL GENET, V113, P308, DOI 10.1007/s00122-006-0297-z; Shi JR, 2008, GENETICA, V133, P77, DOI 10.1007/s10709-007-9186-x; Dexter JE, 1996, CEREAL CHEM, V73, P695; Boutigny AL, 2008, EUR J PLANT PATHOL, V121, P411, DOI 10.1007/s10658-007-9266-x; BECHTEL DB, 1985, CEREAL CHEM, V62, P191; Li CJ, 2008, EUPHYTICA, V163, P185, DOI 10.1007/s10681-007-9626-9; Walter S, 2010, NEW PHYTOL, V185, P54, DOI 10.1111/j.1469-8137.2009.03041.x; Lori GA, 2009, CROP PROT, V28, P495, DOI 10.1016/j.cropro.2009.01.012; Paul PA, 2006, PHYTOPATHOLOGY, V96, P951, DOI 10.1094/PHYTO-96-0951; Yoshizawa T, 2004, BIOSCI BIOTECH BIOCH, V68, P2076, DOI 10.1271/bbb.68.2076; Bonin CM, 2009, CROP SCI, V49, P1304, DOI 10.2135/cropsci2008.08.0459; Klahr A, 2007, EUPHYTICA, V154, P17, DOI 10.1007/s10681-006-9264-7; Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Karlovsky P, 2011, APPL MICROBIOL BIOT, V91, P491, DOI 10.1007/s00253-011-3401-5; Magan N, 2011, PLANT PATHOL, V60, P150, DOI 10.1111/j.1365-3059.2010.02412.x; Dill-Macky R, 2000, PLANT DIS, V84, P71, DOI 10.1094/PDIS.2000.84.1.71; Ban T, 2000, EUPHYTICA, V113, P87, DOI 10.1023/A:1003951509797; Ruckenbauer P, 2001, EUPHYTICA, V119, P121, DOI 10.1023/A:1017598523085; Basnet BR, 2012, EUPHYTICA, V186, P91, DOI 10.1007/s10681-011-0495-x; Simpson DR, 2001, EUR J PLANT PATHOL, V107, P421, DOI 10.1023/A:1011225817707; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Yu JB, 2008, CROP SCI, V48, P1090, DOI 10.2135/cropsci2007.10.0554; MILUS EA, 1994, PLANT DIS, V78, P697; McCartney CA, 2007, MOL BREEDING, V20, P209, DOI 10.1007/s11032-007-9084-z; Jayatilake D, 2011, THEOR APPL GENET, V122, P1189, DOI 10.1007/s00122-010-1523-2; Draeger R, 2007, THEOR APPL GENET, V115, P617, DOI 10.1007/s00122-007-0592-3; Anderson JA, 2007, INT J FOOD MICROBIOL, V119, P51, DOI 10.1016/j.ijfoodmicro.2007.07.025; Li T, 2011, THEOR APPL GENET, V122, P1497, DOI 10.1007/s00122-011-1549-0; Loffler M, 2009, MOL BREEDING, V23, P473, DOI 10.1007/s11032-008-9250-y; Maiorano A, 2008, CROP PROT, V27, P182, DOI 10.1016/j.cropro.2007.05.004; Chakraborty S, 2011, PLANT PATHOL, V60, P2, DOI 10.1111/j.1365-3059.2010.02411.x; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Mesterhazy A, 1999, PLANT BREEDING, V118, P97, DOI 10.1046/j.1439-0523.1999.118002097.x; BAI GH, 1994, PLANT DIS, V78, P760; Buerstmayr M, 2011, THEOR APPL GENET, V123, P293, DOI 10.1007/s00122-011-1584-x; Burlakoti RR, 2010, EUPHYTICA, V172, P197, DOI 10.1007/s10681-009-0035-0; Champeil A, 2004, CROP PROT, V23, P531, DOI 10.1016/j.cropro.2003.10.011; Gautam P., 2011, American Journal of Agricultural and Biological Sciences, V6, P231, DOI 10.3844/ajabssp.2011.231.241; Handa H, 2008, MOL BREEDING, V22, P71, DOI 10.1007/s11032-008-9157-7; Horevaj P, 2011, J APPL MICROBIOL, V111, P396, DOI 10.1111/j.1365-2672.2011.05049.x; Kosova K, 2009, CZECH J GENET PLANT, V45, P87; Kubo K, 2012, B NARO KYUSHU OKINAW, V57, P21; Kubo K, 2013, J PHYTOPATHOL, V161, P308, DOI 10.1111/jph.12060; Kubo K, 2009, BREEDING SCI, V59, P261, DOI 10.1270/jsbbs.59.261; Kubo K, 2013, JARQ-JPN AGR RES Q, V47, P9; Kubo K, 2010, BREEDING SCI, V60, P405, DOI 10.1270/jsbbs.60.405; McCartney CA, 2004, THEOR APPL GENET, V109, P261, DOI 10.1007/s00122-004-1640-x; Mesterhazy A, 1995, PLANT BREEDING, V114, P377, DOI 10.1111/j.1439-0523.1995.tb00816.x; Miedaner T, 2003, CROP SCI, V43, P519; Nakajima T., 2007, Mycotoxins, V57, P129, DOI 10.2520/myco.57.129; Niwa S, 2012, P 4 INT S FUS HEAD B, P54; Noriduki H., 2007, Mycotoxins, V57, P115, DOI 10.2520/myco.57.115; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Rossi V., 2001, Journal of Plant Pathology, V83, P189; Shen X, 2006, PLANT BREEDING, V125, P424, DOI 10.1111/j.1439-0523.2006.01274.x; Shen Xiaorong, 2004, Theor Appl Genet, V108, P808, DOI 10.1007/s00122-003-1492-9; Sneller C, 2012, PHYTOPATHOLOGY, V102, P306, DOI 10.1094/PHYTO-05-11-0143; SNIJDERS CHA, 1990, EUPHYTICA, V50, P171, DOI 10.1007/BF00023642; Sobrova Pavlina, 2010, Interdiscip Toxicol, V3, P94, DOI 10.2478/v10102-010-0019-x; Steed A, 2005, THEOR APPL GENET, V111, P521, DOI 10.1007/s00122-005-2043-3; TEICH AH, 1985, APPL ENVIRON MICROB, V49, P1429; Yabwalo DN, 2011, PLANT BREEDING, V130, P521, DOI 10.1111/j.1439-0523.2011.01883.x; YOSHIZAWA T, 1995, FOOD ADDIT CONTAM, V12, P689; Zhang JX, 2008, CROP SCI, V48, P223, DOI 10.2135/cropsci2007.02.0116	81	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0014-2336	1573-5060		EUPHYTICA	Euphytica	NOV	2014	200	1					81	93		10.1007/s10681-014-1148-7		13	Agronomy; Plant Sciences; Horticulture	Agriculture; Plant Sciences	AQ9CK	WOS:000343138700008		
J	Sato, J; Kitagawa, Y; Yamazaki, Y; Hata, H; Asaka, T; Miyakoshi, M; Okamoto, S; Shiga, T; Shindoh, M; Kuge, Y; Tamaki, N				Sato, Jun; Kitagawa, Yoshimasa; Yamazaki, Yutaka; Hata, Hironobu; Asaka, Takuya; Miyakoshi, Masaaki; Okamoto, Shozo; Shiga, Tohru; Shindoh, Masanobu; Kuge, Yuji; Tamaki, Nagara			Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Article						Hypoxia; FMISO-PET; FDG-PET; Preoperative chemotherapy; HIF-1 alpha; Oral squamous cell carcinoma	POSITRON-EMISSION-TOMOGRAPHY; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; NECK-CANCER; TUMOR HYPOXIA; MOLECULAR MARKERS; F-18-FLUOROMISONIDAZOLE PET; INTRAARTERIAL CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; F-18 FLUOROMISONIDAZOLE; OROPHARYNGEAL CANCER	Purpose Hypoxia, a prognostic factor in many types of cancer, can be detected by F-18-fluoromisonidazole (FMISO) positron emission tomography (PET). It is unclear whether hypoxia reflects the response to chemotherapy in patients with oral squamous cell carcinoma (OSCC). The correlations of FMISO-PET and FDG-PET with histological response to preoperative chemotherapy were therefore assessed in patients with OSCC. Methods This study enrolled 22 patients with OSCC undergoing preoperative chemotherapy. The T-stages were T2 in 6 patients, T3 in 3, and T4a in 13, and the N-stages were N0 in 14 patients, N1 in 3, and N2 in 5. Each patient was evaluated by both FMISO-PET and FDG-PET before surgery, and the maximum standardized uptake value (SUVmax) of FDG- and FMISO-PET and tumor-muscle ratio (TMR) of FMISO-PET were measured. The threshold for the hypoxic volume based on TMR was set at 1.25. The histological response to preoperative chemotherapy was evaluated using operative materials. Results FMISO-PET and FDG-PET detected uptake by primary OSCCs in 15 (68%) and 21 (95%) patients, respectively, and median SUV(max)s of FMISO- and FDG-PET in the primary site were 2.0 (range, 1.3-3.5) and 16.0 (range, 1.0-32.2), respectively. The median of FMISO TMR was 1.5 (range, 0.99-2.96). There were five cases whose FMISO TMR was less than 1.25. Histological evaluation showed good response to preoperative chemotherapy in 7 patients (32%) and poor response in 15 (68%). Good response was significantly more prevalent in patients with negative than positive FMISO uptake (P<0.001) and without the hypoxic area evaluated by FMISO-PET TMR (P=0.04), whereas FDG uptake was not significantly correlated with response to chemotherapy response. Multivariate logistic regression analysis showed that FMISO uptake was an independent significant predictor of response to preoperative chemotherapy (P=0.03, odds ratio=0.06, 95% confidence interval=0.004-0.759). Conclusions An advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with OSCC was observed.	[Sato, Jun; Kitagawa, Yoshimasa; Yamazaki, Yutaka; Hata, Hironobu; Asaka, Takuya; Miyakoshi, Masaaki] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Pathobiol Sci, Kita Ku, Sapporo, Hokkaido 0608586, Japan; [Okamoto, Shozo; Shiga, Tohru; Tamaki, Nagara] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Sapporo, Hokkaido 0608586, Japan; [Shindoh, Masanobu] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Pathol & Biol, Sapporo, Hokkaido 0608586, Japan; [Kuge, Yuji] Hokkaido Univ, Cent Inst Isotope Sci, Sapporo, Hokkaido 0608586, Japan	Sato, J (reprint author), Hokkaido Univ, Grad Sch Dent Med, Dept Oral Pathobiol Sci, Kita Ku, North 13,West 7, Sapporo, Hokkaido 0608586, Japan.	jun-s@den.hokudai.ac.jp	Shindoh, Masanobu/A-4799-2012	Shindoh, Masanobu/0000-0002-7782-5823	 [22592203]	This study was partially supported by a Grant-in-Aid for Scientific Research (2010-2011: 22592203).	Ak I, 2000, J CANCER RES CLIN, V126, P560, DOI 10.1007/PL00008466; Yoshiba S, 2009, ORAL ONCOL, V45, P109, DOI 10.1016/j.oraloncology.2008.04.002; Okamoto S, 2013, J NUCL MED, V54, P201, DOI 10.2967/jnumed.112.109330; Fillies T, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-84; Roh JL, 2009, ORAL ONCOL, V45, P63, DOI 10.1016/j.oraloncology.2008.03.017; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Sato J, 2013, J NUCL MED, V54, P1060, DOI 10.2967/jnumed.112.114355; Swisher SG, 2004, CANCER, V101, P1776, DOI 10.1002/cncr.20585; Harada H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1786; Nehmeh SA, 2008, INT J RADIAT ONCOL, V70, P235, DOI 10.1016/j.ijrobp.2007.08.036; Han MW, 2012, HEAD NECK-J SCI SPEC, V34, P1395, DOI 10.1002/hed.21945; Tian M, 2004, EUR J NUCL MED MOL I, V31, P5, DOI 10.1007/s00259-003-1316-9; Sasabe E, 2005, CANCER SCI, V96, P394, DOI 10.1111/j.1349-7006.2005.00065.x; Hawkins DS, 2002, CANCER, V94, P3277, DOI 10.1002/cncr.10599; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Schliephake H, 2003, INT J ORAL MAX SURG, V32, P233, DOI 10.1054/ijom.2002.0383; Song XR, 2006, CANCER CHEMOTH PHARM, V58, P776, DOI 10.1007/s00280-006-0224-7; Dierckx RA, 2008, EUR J NUCL MED MOL I, V35, P1544, DOI 10.1007/s00259-008-0758-5; Zimny M, 2006, EUR J NUCL MED MOL I, V33, P1426, DOI 10.1007/s00259-006-0175-6; Rajendran JG, 2004, CLIN CANCER RES, V10, P2245, DOI 10.1158/1078-0432.CCR-0688-3; Rajendran JG, 2003, EUR J NUCL MED MOL I, V30, P695, DOI 10.1007/s00259-002-1096-7; Janssen HL, 2005, HEAD NECK-J SCI SPEC, V27, P622, DOI 10.1002/hed.20223; KOH WJ, 1992, INT J RADIAT ONCOL, V22, P199; OLIVE PL, 1994, CANCER METAST REV, V13, P121, DOI 10.1007/BF00689632; Moreno-Galindo C, 2014, ORAL ONCOL, V50, P128, DOI 10.1016/j.oraloncology.2013.10.018; Kitagawa Y, 2003, EUR J NUCL MED MOL I, V30, P63, DOI 10.1007/s00259-002-0978-z; Nordsmark M, 2005, RADIOTHER ONCOL, V77, P18, DOI 10.1016/j.radonc.2005.06.038; Comerford KM, 2002, CANCER RES, V62, P3387; Toma-Dasu I, 2009, ADV EXP MED BIOL, V645, P267, DOI 10.1007/978-0-387-85998-9_40; Birner P, 2001, CLIN CANCER RES, V7, P1661; Sasabe E, 2007, INT J CANCER, V120, P268, DOI 10.1002/ijc.22294; Lin PY, 2008, J ORAL PATHOL MED, V37, P18, DOI 10.1111/j.1600-0714.2007.0057.x; Kong CB, 2013, EUR J NUCL MED MOL I, V40, P728, DOI 10.1007/s00259-013-2344-8; Rasey JS, 1996, INT J RADIAT ONCOL, V36, P417, DOI 10.1016/S0360-3016(96)00325-2; Miyagaki H, 2012, BRIT J CANCER, V106, P947, DOI 10.1038/bjc.2012.35; Busk M, 2008, EUR J NUCL MED MOL I, V35, P2294, DOI 10.1007/s00259-008-0888-9; YAMAMOTO E, 1983, CANCER, V51, P2175, DOI 10.1002/1097-0142(19830615)51:12<2175::AID-CNCR2820511205>3.0.CO;2-M; Lee ST, 2007, SEMIN NUCL MED, V37, P451, DOI 10.1053/j.semnuclmed.2007.07.00.1; Eschmann SM, 2007, RADIOTHER ONCOL, V83, P406, DOI 10.1016/j.radonc.2007.05.014; Barnes L, 2005, WHO CLASSIFICATION T; Jansen JFA, 2010, INT J RADIAT ONCOL, V77, P1403, DOI 10.1016/j.ijrobp.2009.07.009; Japan Society for Head and Neck Cancer, 2012, GEN RUL CLIN STUD HE, P68; Kalz S, 2009, BIOCHIM BIOPHYS ACTA, V1795, P162; Kitagawa Y, 1999, J NUCL MED, V40, P1132; Lowe VJ, 1997, HEAD NECK-J SCI SPEC, V19, P666, DOI 10.1002/(SICI)1097-0347(199712)19:8<666::AID-HED4>3.0.CO;2-3; Miyawaki A, 2010, ONCOL REP, V23, P1205, DOI 10.3892/or_00000751; Nemeth Z, 2005, NEOPLASMA, V52, P95; Shimosato Y, 1971, JPN J CLIN ONCOL, V1, P19; Silva P, 2008, INT J RADIAT ONCOL, V72, P1551, DOI 10.1016/j.ijrobp.2008.07.051; Sobin LH, 1997, TNM CLASSIFICATION M, P17; TEICHER BA, 1994, CANCER METAST REV, V13, P139, DOI 10.1007/BF00689633; van den Broek GB, 2009, INT J CANCER, V124, P2643, DOI 10.1002/ijc.24254; Wang WL, 2010, J NUCL MED, V51, P37, DOI 10.2967/jnumed.109.067009; Yamane T, 2011, MOL IMAGING BIOL, V13, P227, DOI 10.1007/s11307-010-0365-2; Yamasaki M, 2010, ANN SURG ONCOL, V17, P634, DOI 10.1245/s10434-009-0851-4	55	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	NOV	2014	41	11					2031	2041		10.1007/s00259-014-2810-y		11	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AQ8CX	WOS:000343051700005		
J	Tsukada, H; Nishiyama, S; Ohba, H; Kanazawa, M; Kakiuchi, T; Harada, N				Tsukada, Hideo; Nishiyama, Shingo; Ohba, Hiroyuki; Kanazawa, Masakatsu; Kakiuchi, Takeharu; Harada, Norihiro			Comparing amyloid-beta deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Article						Mitochondrial complex I; Amyloid-beta; Inflammation; F-18-BCPP-EF; C-11-PIB; C-11-DPA-713	MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; RATE CONSTANTS; RAT-BRAIN; F-18-BCPP-EF; ISOFLURANE; MACAQUES; BINDING; LIGAND	Purpose The aim of the present study was to compare amyloid-beta (A beta) deposition, translocator protein (TSPO) activity, regional cerebral metabolic rate of glucose (rCMRglc), and mitochondrial complex I (MC-I) activity in the brain of aged monkeys. Methods PET scans with C-11-PIB (A beta), F-18-BCPP-EF (MC-I), C-11-DPA-713 (TSPO), and F-18-FDG (rCMRglc) were performed in aged monkeys (Macaca mulatta) in the conscious state and under isoflurane anaesthesia. C-11-PIB binding to A beta and C-11-DPA-713 binding to TSPO were evaluated in terms of standard uptake values (SUV). The total volume of distribution (V-T) of F-18-BCPP-EF and rCMRglc with F-18-FDG were calculated using arterial blood sampling. Results Isoflurane did not affect MC-I activity measured in terms of F-18-BCPP-EF uptake in living brain. There was a significant negative correlation between F-18-BCPP-EF binding (V-T) and C-11-PIB uptake (SUVR), and there was a significant positive correlation between C-11-DPA-713 uptake (SUV) and C-11-PIB uptake. In contrast, there was no significant correlation between rCMRglc ratio and C-11-PIB uptake. Conclusion F-18-BCPP-EF could be a potential PET probe for quantitative imaging of impaired MC-I activity that is correlated with A beta deposition in the living brain.	[Tsukada, Hideo; Nishiyama, Shingo; Ohba, Hiroyuki; Kanazawa, Masakatsu; Kakiuchi, Takeharu; Harada, Norihiro] Hamamatsu Photon KK, Cent Res Lab, Hamakita, Shizuoka 4348601, Japan	Tsukada, H (reprint author), Hamamatsu Photon KK, Cent Res Lab, 5000 Hirakuchi, Hamakita, Shizuoka 4348601, Japan.	tsukada@crl.hpk.co.jp		Harada, Norihiro/0000-0003-4558-6917			Tsukada H, 2002, SYNAPSE, V45, P207, DOI 10.1002/syn.10102; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Edison P, 2007, NEUROLOGY, V68, P501, DOI 10.1212/01.wnl.0000244749.20056.d4; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Boutin H, 2007, J NUCL MED, V48, P573, DOI 10.2967/jnumed.106.036764; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Silva DF, 2012, ADV PHARMACOL, V64, P83, DOI 10.1016/B978-0-12-394816-8.00003-9; Kemppainen NM, 2007, NEUROLOGY, V68, P1603, DOI 10.1212/01.wnl.0000260969.94695.56; Swomley AM, 2014, BBA-MOL BASIS DIS, V1842, P1248, DOI 10.1016/j.bbadis.2013.09.015; Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Winkeler A, 2010, J NUCL MED, V51, P1, DOI 10.2967/jnumed.109.065680; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Finch CE, 2012, AGE, V34, P1075, DOI 10.1007/s11357-011-9355-9; Noda A, 2008, SYNAPSE, V62, P472, DOI 10.1002/syn.20508; REIVICH M, 1985, J CEREBR BLOOD F MET, V5, P179; WARBURG O, 1956, SCIENCE, V124, P269; Manczak M, 2005, J NEUROCHEM, V92, P494, DOI 10.1111/j.1471-4159.2004.02884.x; Mosconi L, 2013, J ALZHEIMERS DIS, V35, P509, DOI 10.3233/JAD-121867; Nicholls DG, 2000, PHYSIOL REV, V80, P315; Hanley PJ, 2002, J PHYSIOL-LONDON, V544, P687, DOI 10.1113/jphysiol.2002.025015; Baek BS, 1999, ARCH PHARM RES, V22, P361, DOI 10.1007/BF02979058; Bains R, 2009, ACTA ANAESTH SCAND, V53, P85, DOI 10.1111/j.1399-6576.2008.01823.x; Bratic A, 2013, J CLIN INVEST, V123, P952; CHOI BH, 1995, NEUROBIOL AGING, V16, P675, DOI 10.1016/0197-4580(95)00065-M; Dukart J, 2005, J CEREB BLOOD FLOW M, V25, P1528; Furst AJ, 2010, NEUROBIOL AGING, V49, P1490; Harada N, 2013, J LABELLED COMPD RAD, V56, P553, DOI 10.1002/jlcr.3056; Jones EG, 2011, ANN NY ACAD SCI, V1225, pE147, DOI 10.1111/j.1749-6632.2011.06009.x; Kannurpatti SS, 2004, NEUROCHEM INT, V44, P361, DOI 10.1016/S0197-0186(03)00164-5; Kumar A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-232; Lenaz G, 1998, BIOFACTORS, V8, P195; LOGAN J, 1994, J CEREBR BLOOD F MET, V14, P995; Monson NL, 2014, J CEREBR BLOOD F MET, V34, P30, DOI 10.1038/jcbfm.2013.183; Noda A, 2003, J CEREBR BLOOD F MET, V23, P1441, DOI 10.1097/01.WCB.0000090623.86921.47; OBERDORFER F, 1986, APPL RADIAT ISOTOPES, V37, P695; Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4; Tsukada H, 2014, J CEREBR BLOOD F MET, V34, P708, DOI 10.1038/jcbfm.2014.5; Tsukada H, 2014, J NUCL MED, V55, P473, DOI 10.2967/jnumed.113.125328; Tsukada H, 2014, EUR J NUCL MED MOL I, V41, P755, DOI 10.1007/s00259-013-2628-z	41	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	NOV	2014	41	11					2127	2136		10.1007/s00259-014-2821-8		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AQ8CX	WOS:000343051700016		
J	Kawaguchi, A; Tanina, K				Kawaguchi, Akira; Tanina, Koji			Genetic groups of Clavibacter michiganensis subsp michiganensis identified by DNA fingerprinting and the effects of inoculation methods on disease development	EUROPEAN JOURNAL OF PLANT PATHOLOGY			English	Article						Clavibacter michiganensis subsp.; michiganensis; Tomato bacterial canker; Phylogenetic analysis; Kaplan-Meier survival analysis	TOMATO; PCR; DISSEMINATION; GREENHOUSES; SURVIVAL; SPREAD	Clavibacter michiganensis subsp. michiganensis (CMM) strains collected in nine different prefectures in Japan were fingerprinted by inter-simple sequence repeats-polymerase chain reaction (PCR) and repetitive sequence-based PCR. Forty-three CMM strains corresponded to 22 DNA fingerprinting patterns, indicating that the CMM population in Japan has high genetic diversity. Tomato plants were inoculated with CMM by two different methods: defoliation using infected scissors and planting in soil containing infected plant debris. Defoliation resulted in a larger number of diseased plants, disease developed earlier, and plants survived for significantly fewer days. Upon planting in the infected soil, 33.3 % of plants were infected and 6.7 % were diseased, i.e., 20.1 % of infected plants developed disease symptoms. These results indicate that some plants are infected with CMM through plant debris in the soil as the primary inoculum and most infected plants maintain latent infection. Thus, growers may unwittingly carry out disbudding and defoliation of latently infected plants, resulting in secondary inoculum.	[Kawaguchi, Akira; Tanina, Koji] Okayama Prefectural Technol Ctr Agr Forestry & Fi, Inst Agr Res, Okayama 7090801, Japan	Kawaguchi, A (reprint author), Okayama Prefectural Technol Ctr Agr Forestry & Fi, Inst Agr Res, 1174-1 Koudaoki, Okayama 7090801, Japan.	akira_kawaguchi@pref.okayama.lg.jp					Alves A, 2004, PLANT PATHOL, V53, P629, DOI 10.1111/j.1365-3059.2004.01069.x; Baysal O, 2011, PHYSIOL MOL PLANT P, V75, P113, DOI 10.1016/j.pmpp.2010.10.002; Sharabani G, 2013, PLANT PATHOL, V62, P578, DOI 10.1111/j.1365-3059.2012.02673.x; GLEASON ML, 1993, PLANT DIS, V77, P1069; DREIER J, 1995, PHYTOPATHOLOGY, V85, P462, DOI 10.1094/Phyto-85-462; HULTON CSJ, 1991, MOL MICROBIOL, V5, P825, DOI 10.1111/j.1365-2958.1991.tb00755.x; de Leon L, 2011, PLANT DIS, V95, P1328, DOI 10.1094/PDIS-02-11-0091; CHANG RJ, 1991, PHYTOPATHOLOGY, V81, P1276, DOI 10.1094/Phyto-81-1276; Fatmi M, 2002, PLANT PATHOL, V51, P149, DOI 10.1046/j.1365-3059.2002.00675.x; Louws FJ, 1998, PHYTOPATHOLOGY, V88, P862, DOI 10.1094/PHYTO.1998.88.8.862; Jahr H, 1999, ENVIRON MICROBIOL, V1, P113, DOI 10.1046/j.1462-2920.1999.00011.x; Kawaguchi A, 2010, PLANT PATHOL, V59, P76, DOI 10.1111/j.1365-3059.2009.02207.x; Rich JT, 2010, OTOLARYNG HEAD NECK, V143, P331, DOI 10.1016/j.otohns.2010.05.007; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Biggerstaff CM, 2000, SEED SCI TECHNOL, V28, P261; Carlton W. M., 1992, Phytopathology, V82, P1153; Gitaitis R. D., 1991, COMPENDIUM TOMATO DI, P25; GLEASON ML, 1991, PHYTOPATHOLOGY, V81, P1519, DOI 10.1094/Phyto-81-1519; GROGAN RG, 1967, PHYTOPATHOLOGY, V57, P28; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kawaguchi A, 2013, J GEN PLANT PATHOL, V79, P46, DOI 10.1007/s10327-012-0416-4	21	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0929-1873	1573-8469		EUR J PLANT PATHOL	Eur. J. Plant Pathol.	NOV	2014	140	3					399	406		10.1007/s10658-014-0475-9		8	Agronomy; Plant Sciences; Horticulture	Agriculture; Plant Sciences	AQ9CN	WOS:000343139200001		
J	Iizuka, Y; Matsuo, Y; Umeoka, S; Nakamoto, Y; Ueki, N; Mizowaki, T; Togashi, K; Hiraoka, M				Iizuka, Yusuke; Matsuo, Yukinori; Umeoka, Shigeaki; Nakamoto, Yuji; Ueki, Nami; Mizowaki, Takashi; Togashi, Kaori; Hiraoka, Masahiro			Prediction of clinical outcome after stereotactic body radiotherapy for non-small cell lung cancer using diffusion-weighted MRI and F-18-FDG PET	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Diffusion weighted MRI; FDG-PET; Stereotactic body radiotherapy; Lung cancers	POSITRON-EMISSION-TOMOGRAPHY; UTERINE CERVICAL-CANCER; FDG-PET; TUMOR; COEFFICIENT; RECURRENCE; CARCINOMA; CHEMORADIOTHERAPY; CHEMORADIATION; CELLULARITY	Purpose/objectives: To evaluate the use of diffusion-weighted magnetic resonance imaging (DW-MRI) and 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) for predicting disease progression (DP) among patients with non-small cell lung carcinoma (NSCLC) treated with stereotactic body radiotherapy (SBRT). Materials/methods: Fifteen patients with histologically confirmed stage I NSCLC who underwent pretreatment DW-MRI and PET and were treated with SBRT were enrolled. The mean apparent diffusion coefficient (ADC) value and maximum standardised uptake value (SUVmax) were measured at the target lesion and evaluated for correlations with DP. Results: The median pre-treatment ADC value was 1.04 x 10(-3) (range 0.83-1.29 x 10(-3)) mm(2)/s, and the median pre-treatment SUVmax was 9.9 (range 1.6-30). There was no correlation between the ADC value and SUV,T,a. The group with the lower ADC value (<= 1.05 x 10(-3) mm(2)/s) and that with a higher SUVmax (>= 7.9) tended to have poor DP, but neither trend was statistically significant (p = 0.09 and 0.32, respectively). The combination of the ADC value and SUVmax was a statistically significant predictor of DP (p = 0.036). Conclusion: A low ADC value on pre-treatment DW-MRI and a high SUV,Tiax may be associated with poor DP in NSCLC patients treated with SBRT. Using both values in combination was a better predictor. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Iizuka, Yusuke; Matsuo, Yukinori; Ueki, Nami; Mizowaki, Takashi; Hiraoka, Masahiro] Kyoto Univ, Dept Radiat Oncol & Image Appl Therapy, Grad Sch Med, Kyoto, Japan; [Umeoka, Shigeaki; Nakamoto, Yuji; Togashi, Kaori] Kyoto Univ, Dept Diagnost Imaging & Nucl Med, Grad Sch Med, Kyoto, Japan	Matsuo, Y (reprint author), Kyoto Univ, Dept Radiat Oncol & Image Appl Therapy, Grad Sch Med, Kyoto, Japan.	ymatsuo@kuhp.kyoto-u.ac.jp	Matsuo, Yukinori/O-6200-2014	Matsuo, Yukinori/0000-0002-4372-8259			Hoopes DJ, 2007, LUNG CANCER, V56, P229, DOI 10.1016/j.lungcan.2006.12.009; Rezaei MK, 2013, SEMIN RESP CRIT CARE, V34, P770, DOI 10.1055/s-0033-1358558; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Takeda A, 2014, J THORAC ONCOL, V9, P65, DOI 10.1097/JTO.0000000000000031; Heo SH, 2013, KOREAN J RADIOL, V14, P616, DOI 10.3348/kjr.2013.14.4.616; Onimaru R, 2003, INT J RADIAT ONCOL, V56, P126, DOI 10.1016/S0630-3016(03)00095-6; Baumann P, 2009, J CLIN ONCOL, V27, P3290, DOI 10.1200/JCO.2008.21.5681; Huang K, 2012, RADIOTHER ONCOL, V102, P335, DOI 10.1016/j.radonc.2011.12.018; Liu Y, 2009, CLIN RADIOL, V64, P1067, DOI 10.1016/j.crad.2009.07.010; Ueki N, 2014, RADIOTHER ONCOL, V110, P523, DOI 10.1016/j.radonc.2014.01.014; Higashi K, 2002, J NUCL MED, V43, P39; Sunaga N, 2008, LUNG CANCER, V59, P203, DOI 10.1016/j.lungcan.2007.08.012; Mori T, 2008, J THORAC ONCOL, V3, P358, DOI 10.1097/JTO.0b013e318168d9ed; Yoshida S, 2013, EUR RADIOL, V23, P2206, DOI 10.1007/s00330-013-2805-2; Clarke K, 2012, RADIOTHER ONCOL, V104, P62, DOI 10.1016/j.radonc.2012.04.019; Dunlap NE, 2010, J THORAC CARDIOV SUR, V140, P583, DOI 10.1016/j.jtcvs.2010.01.046; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Weber WA, 2003, J CLIN ONCOL, V21, P2651, DOI 10.1200/JCO.2003.12.004; Imanishi S, 2013, DIGEST SURG, V30, P240, DOI 10.1159/000351435; Matsuo Y, 2011, INT J RADIAT ONCOL, V79, P1104, DOI 10.1016/j.ijrobp.2009.12.022; Ohno Y, 2012, AM J ROENTGENOL, V198, P75, DOI 10.2214/AJR.11.6525; Matoba M, 2007, RADIOLOGY, V243, P570, DOI 10.1148/radiol.2432060131; van Elmpt W, 2011, EUR J NUCL MED MOL I, V38, P843, DOI 10.1007/s00259-010-1716-6; Burdick MJ, 2010, INT J RADIAT ONCOL, V78, P1033, DOI 10.1016/j.ijrobp.2009.09.081; Grutters JPC, 2010, RADIOTHER ONCOL, V95, P32, DOI 10.1016/j.radonc.2009.08.003; Manenti G, 2008, RADIOL MED, V113, P199, DOI 10.1007/s11547-008-0246-9; Micco M, 2014, EUR J RADIOL, V83, P1169, DOI 10.1016/j.ejrad.2014.03.024; Ohnishi K, 2011, J RADIAT RES, V52, P522, DOI 10.1269/jrr.10178; Onishi H, 2007, J THORAC ONCOL, V2, pS94, DOI 10.1097/JTO.0b013e318074de34; R CORE TEAM, 2012, LANG ENV STAT COMP; Takayama K, 2005, INT J RADIAT ONCOL, V61, P1565, DOI 10.1016/j.ijrobp.2004.12.066	31	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	NOV	2014	83	11					2087	2092		10.1016/j.ejrad.2014.07.018		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AQ8UR	WOS:000343110500014		
J	Inoue, T; Ohbayashi, T; Fujikawa, Y; Yoshida, H; Akama, TO; Noda, K; Horiguchi, M; Kameyama, K; Hata, Y; Takahashi, K; Kusumoto, K; Nakamura, T				Inoue, Tadashi; Ohbayashi, Tetsuya; Fujikawa, Yusuke; Yoshida, Hideyuki; Akama, Tomoya O.; Noda, Kazuo; Horiguchi, Masahito; Kameyama, Katsuro; Hata, Yoshio; Takahashi, Kanji; Kusumoto, Kenji; Nakamura, Tomoyuki			Latent TGF-beta binding protein-2 is essential for the development of ciliary zonule microfibrils	HUMAN MOLECULAR GENETICS			English	Article							PRIMARY CONGENITAL GLAUCOMA; IN-VIVO; SECONDARY GLAUCOMA; LTBP2 MUTATIONS; GENE; FIBRILLIN; FIBULIN-5/DANCE; MEGALOCORNEA; PURIFICATION; EXPRESSION	Latent TGF-beta-binding protein-2 (LTBP-2) is an extracellular matrix protein associated with microfibrils. Homozygous mutations in LTBP2 have been found in humans with genetic eye diseases such as congenital glaucoma and microspherophakia, indicating a critical role of the protein in eye development, although the function of LTBP-2 in vivo has not been well understood. In this study, we explore the in vivo function of LTBP-2 by generating Ltbp2(-/-) mice. Ltbp2(-/-) mice survived to adulthood but developed lens luxation caused by compromised ciliary zonule formation without a typical phenotype related to glaucoma, suggesting that LTBP-2 deficiency primarily causes lens dislocation but not glaucoma. The suppression of LTBP2 expression in cultured human ciliary epithelial cells by siRNA disrupted the formation of the microfibril meshwork by the cells. Supplementation of recombinant LTBP-2 in culture medium not only rescued the microfibril meshwork formation in LTBP2-suppressed ciliary epithelial cells but also restored unfragmented and bundled ciliary zonules in Ltbp2(-/-) mouse eyes under organ culture. Although several reported human mutant LTBP-2 proteins retain normal domain structure and keep the fibrillin-1-binding site intact, none of these mutant proteins were secreted from their producing cells, suggesting secretion arrest occurred to the LTBP-2mutants owing to conformational alteration. The findings of this study suggest that LTBP-2 is an essential component for the formation of microfibril bundles in ciliary zonules.	[Inoue, Tadashi; Fujikawa, Yusuke; Yoshida, Hideyuki; Akama, Tomoya O.; Noda, Kazuo; Nakamura, Tomoyuki] Kansai Med Univ, Dept Pharmacol, Hirakata, Osaka 5731010, Japan; [Inoue, Tadashi; Kusumoto, Kenji] Kansai Med Univ, Dept Plast & Reconstruct Surg, Hirakata, Osaka 5731010, Japan; [Fujikawa, Yusuke] Kansai Med Univ, Dept Cardiol, Hirakata, Osaka 5731010, Japan; [Yoshida, Hideyuki; Takahashi, Kanji] Kansai Med Univ, Dept Ophthalmol, Hirakata, Osaka 5731010, Japan; [Ohbayashi, Tetsuya] Tottori Univ, Grad Sch Med Sci, Res Ctr Biosci & Technol, Div Lab Anim Sci, Yonago, Tottori 6838503, Japan; [Kameyama, Katsuro; Hata, Yoshio] Tottori Univ, Grad Sch Med Sci, Div Integrat Biosci, Inst Regenerat Med & Biofunct, Yonago, Tottori 6838503, Japan; [Akama, Tomoya O.] Sanford Burnham Med Res Inst, Tumor Microenvironm Program, La Jolla, CA 92037 USA; [Noda, Kazuo] Kyoto Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Kyoto 6068507, Japan; [Horiguchi, Masahito] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	Nakamura, T (reprint author), Kansai Med Univ, Dept Pharmacol, Hirakata, Osaka 5731010, Japan.	nakamtom@hirakata.kmu.ac.jp			NEXT Program in Japan [LS120]; Japan Society for the Promotion of Science [26670147, 25462741]; Japan Science and Technology Agency [08090019]; NIH [EY014620]; Vehicle Racing Commemorative Foundation; Takeda Science Foundation	This work was supported by NEXT Program in Japan (LS120 to T.N.), Japan Society for the Promotion of Science (26670147 to T.N., 25462741 to T.O.A.), Japan Science and Technology Agency (08090019 to T.N.), NIH grant R01 (EY014620 to T.O.A), The Vehicle Racing Commemorative Foundation (T.N.) and Takeda Science Foundation (T.N.).	Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Kuchtey J, 2014, J OCUL PHARMACOL TH, V30, P170, DOI 10.1089/jop.2013.0184; Kumar A, 2010, HUM GENET, V128, P365, DOI 10.1007/s00439-010-0858-8; Abu-Amero KK, 2011, MOL VIS, V17, P2911; Noda K, 2013, P NATL ACAD SCI USA, V110, P2852, DOI 10.1073/pnas.1215779110; NIWA H, 1993, J BIOCHEM-TOKYO, V113, P343; Khan AO, 2011, MOL VIS, V17, P2570; Mohanty K, 2013, MOL VIS, V19, P78; GIBSON MA, 1995, MOL CELL BIOL, V15, P6932; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Narooie-Nejad M, 2009, HUM MOL GENET, V18, P3969, DOI 10.1093/hmg/ddp338; Desir J, 2010, EUR J HUM GENET, V18, P761, DOI 10.1038/ejhg.2010.11; Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Saharinen J, 2000, MOL BIOL CELL, V11, P2691; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Cain SA, 2006, PROTEOMICS, V6, P111, DOI 10.1002/pmic.200401340; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Sterner-Kock A, 2002, GENE DEV, V16, P2264, DOI 10.1101/gad.229102; Hirai M, 2007, EMBO J, V26, P3283, DOI 10.1038/sj.emboj.7601768; Haji-Seyed-Javadi R, 2012, HUM MUTAT, V33, P1182, DOI 10.1002/humu.22105; Hirai M, 2007, J CELL BIOL, V176, P1061, DOI 10.1083/jcb.200611026; Kitahama S, 2000, BONE, V27, P61, DOI 10.1016/S8756-3282(00)00292-1; SAKAI LY, 1991, J BIOL CHEM, V266, P14763; Hirani R, 2007, MATRIX BIOL, V26, P213, DOI 10.1016/j.matbio.2006.12.006; Shipley JM, 2000, MOL CELL BIOL, V20, P4879, DOI 10.1128/MCB.20.13.4879-4887.2000; Davis EC, 2002, J STRUCT BIOL, V139, P65, DOI 10.1016/S1047-8477(02)00559-2; Ashworth JL, 2000, BRIT J OPHTHALMOL, V84, P1312, DOI 10.1136/bjo.84.11.1312; Azmanov DN, 2011, EUR J HUM GENET, V19, P326, DOI 10.1038/ejhg.2010.181; Dureau P, 2008, CURR OPIN OPHTHALMOL, V19, P27, DOI 10.1097/ICU.0b013e3282f29f01; Kielty CM, 1998, ANAL BIOCHEM, V255, P108, DOI 10.1006/abio.1997.2442; Lim S.-H., 2013, AM J OPHTHALMOL, V155, P508; Sharafieh R, 2013, OPHTHALMIC GENET, V34, P14, DOI 10.3109/13816810.2012.716486	33	5	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	NOV 1	2014	23	21					5672	5682		10.1093/hmg/ddu283		11	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	AQ9UX	WOS:000343203600008		
J	Ohtsu, N; Hirano, M; Arai, H				Ohtsu, Naofumi; Hirano, Mitsuhiro; Arai, Hirofumi			Response of osteoblast-like MC3T3-E1 cells on bioactive titanium fabricated by a chemical treatment process using a calcium-phosphate slurry	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A			English	Article						titanium; chemical treatment; hydroxyapatite; MC3T3-E1 cell; calcification	HYDROXYAPATITE COATINGS; BONE; SURFACE; HYDROXYLAPATITE; TOPOGRAPHY; NANOMETER; ADHESION; FILMS; TI	We recently developed a chemical treatment process using a calcium-phosphate slurry for fabricating new layers consisting of hydroxyapatite and titanium dioxide (TiO2) on titanium (Ti) substrate. In this study, the response of osteoblast-like MC3T3-E1 cells on Ti substrate treated with a calcium-phosphate slurry was investigated to elucidate its behavior in a biological environment. The cellular adhesiveness and proliferation capacity did not differ significantly between the treated and untreated Ti substrates, suggesting that the slurry treatment did not cause cytotoxicity. The slurry treatment did not affect the increase in alkaline phosphatase activity after the induction of cell differentiation, whereas it was found to be significantly advantageous for the calcification behavior on the slurry-treated Ti substrate. In consequence, the hard-tissue compatibility of Ti is expected to be improved by the chemical treatment process using a calcium-phosphate slurry. (C) 2013 Wiley Periodicals, Inc.	[Ohtsu, Naofumi; Hirano, Mitsuhiro] Kitami Inst Technol, Instrumental Anal Ctr, Kitami, Hokkaido 0908507, Japan; [Arai, Hirofumi] Kitami Inst Technol, Dept Biotechnol & Environm Chem, Kitami, Hokkaido 0908507, Japan	Ohtsu, N (reprint author), Kitami Inst Technol, Instrumental Anal Ctr, 165 Koen Cho, Kitami, Hokkaido 0908507, Japan.	nohtsu@mail.kitami-it.ac.jp			Ministry of Education, Science, Sports, and Culture (MEXT) of Japan [24560841]	Contract grant sponsor: Ministry of Education, Science, Sports, and Culture (MEXT) of Japan; contract grant number: 24560841	ONG JL, 1994, BIOMATERIALS, V15, P337, DOI 10.1016/0142-9612(94)90245-3; Zhang ZX, 2012, APPL SURF SCI, V258, P6504, DOI 10.1016/j.apsusc.2012.03.067; Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011; Ohtsu N, 2011, SURF COAT TECH, V205, P3785, DOI 10.1016/j.surfcoat.2011.01.035; Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009; Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x; Narushima T, 2005, MATER TRANS, V46, P2246, DOI 10.2320/matertrans.46.2246; Gross KA, 1998, J BIOMED MATER RES, V39, P407, DOI 10.1002/(SICI)1097-4636(19980305)39:3<407::AID-JBM9>3.0.CO;2-N; Oya K, 2009, BIOMATERIALS, V30, P1281, DOI 10.1016/j.biomaterials.2008.11.030; KUBOKI Y, 1992, CALCIFIED TISSUE INT, V50, P473, DOI 10.1007/BF00296780; ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1071, DOI 10.1002/jbm.820290907; Cleries L, 2000, BIOMATERIALS, V21, P967, DOI 10.1016/S0142-9612(99)00240-9; Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016; Wei M, 2002, BIOMATERIALS, V23, P167, DOI 10.1016/S0142-9612(01)00092-8; Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004; Ohtsu N, 2008, SURF COAT TECH, V202, P5110, DOI 10.1016/j.surfcoat.2008.05.035; vanDijk K, 1996, BIOMATERIALS, V17, P405, DOI 10.1016/0142-9612(96)89656-6; Hamada K, 2002, BIOMATERIALS, V23, P2265, DOI 10.1016/S0142-9612(01)00361-1; Frauchiger VM, 2004, BIOMATERIALS, V25, P593, DOI 10.1016/S0142-9612(03)00560-X; Kaciulis S, 1999, APPL SURF SCI, V151, P1, DOI 10.1016/S0169-4332(99)00267-6; YOSHINARI M, 1994, BIOMATERIALS, V15, P529, DOI 10.1016/0142-9612(94)90019-1; Metikos-Hukovic M, 2003, SURF COAT TECH, V165, P40, DOI 10.1016/S0257-8972(02)00732-6; Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L; Ban S, 1997, J BIOMED MATER RES, V36, P9, DOI 10.1002/(SICI)1097-4636(199707)36:1<9::AID-JBM2>3.0.CO;2-P; DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203; GEESINK RGT, 1990, CLIN ORTHOP RELAT R, P39; Isama K, 2003, BIOMATERIALS, V24, P3303, DOI 10.1016/S0142-9612(03)00216-3; Ohtsu N, 2011, PROG ORG COAT, V70, P353, DOI 10.1016/j.porgcoat.2010.11.015; Ohtsu N, 2012, SURF COAT TECH, V206, P2616, DOI 10.1016/j.surfcoat.2011.11.022; Ohtsu N, 2007, MATER TRANS, V48, P105, DOI 10.2320/matertrans.48.105; Ohtsu N, 2007, J BIOMED MATER RES A, V82A, P304, DOI 10.1002/jbm.a.31136; Palka V, 1998, BIOMATERIALS, V19, P1763, DOI 10.1016/S0142-9612(98)00087-8; Weng WJ, 1998, BIOMATERIALS, V19, P125	33	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1549-3296	1552-4965		J BIOMED MATER RES A	J. Biomed. Mater. Res. Part A	NOV	2014	102	11					3838	3845		10.1002/jbm.a.35053		8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AQ7PC	WOS:000343010100007		
J	Kobayashi, J; Hayashi, M; Ohno, T; Nishi, M; Arisaka, Y; Matsubara, Y; Kakidachi, H; Akiyama, Y; Yamato, M; Horii, A; Okano, T				Kobayashi, Jun; Hayashi, Masaki; Ohno, Takahiro; Nishi, Masanori; Arisaka, Yoshinori; Matsubara, Yoshinori; Kakidachi, Hiroshi; Akiyama, Yoshikatsu; Yamato, Masayuki; Horii, Akihiro; Okano, Teruo			Surface design of antibody-immobilized thermoresponsive cell culture dishes for recovering intact cells by low-temperature treatment	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A			English	Article						poly(N-isopropylacrylamide); thermoresponsive cell culture surface; cell sheet; antibody; adipose tissue-derived cell	ADIPOSE-TISSUE; REGENERATIVE MEDICINE; MOLECULAR RECOGNITION; SHEETS; POLYMER; DETACHMENT; THY-1; TRANSPLANTATION; POLYSTYRENE; FABRICATION	Antibody-immobilized thermoresponsive poly(N-isopropylacrylamide-co-2-carboxyisopropylacrylamide) [poly (IPAAm-co-CIPAAm)]-grafted cell culture surfaces were designed to enhance both the initial adhesion of weakly adhering cells and the ability of cells to detach in response to low temperature through the regulation of affinity binding between immobilized antibodies and antigens on the cellular surface. Ty-82 cells and neonatal normal human dermal fibroblasts (NHDFs), which express CD90 on the cell surface, adhered to anti-CD90 antibody-immobilized thermoresponsive surfaces at 37 degrees C, a condition at which the grafted thermoresponsive polymer chains shrank. Adherent Ty-82 cells were detached from the surfaces by lowering the temperature to 20 degrees C and applying external forces, such as pipetting, whereas cultured NHDF sheets spontaneously detached themselves from the surface in response to reduced temperature alone. When the temperature was decreased to 20 degrees C, the swelling of grafted thermoresponsive polymer chains weakened the affinity binding between immobilized antibody and antigen on the cells due to the increasing steric hindrance of the polymer chains around the antigen-recognition site of the immobilized antibodies. No contamination was detected on cells harvested from covalently immobilized antibodies on the culture surfaces by low-temperature treatment, whereas a carry over of the antibody and avidin from the avidin-biotin binding surface was observed. Furthermore, the initial adhesion of adipose tissue-derived cells, which adhere weakly to PIPAAm-grafted surfaces, was enhanced on the antibody -immobilized thermoresponsive surfaces. (C) 2013 Wiley Periodicals, Inc.	[Kobayashi, Jun; Nishi, Masanori; Arisaka, Yoshinori; Akiyama, Yoshikatsu; Yamato, Masayuki; Okano, Teruo] Tokyo Womens Med Univ TWIns, Inst Adv Biomed Engn & Sci, Shinjuku Ku, Tokyo 1628666, Japan; [Hayashi, Masaki; Ohno, Takahiro; Matsubara, Yoshinori; Kakidachi, Hiroshi; Horii, Akihiro] Olympus Corp, Corp R&D Ctr, Hachioji, Tokyo 1928512, Japan	Okano, T (reprint author), Tokyo Womens Med Univ TWIns, Inst Adv Biomed Engn & Sci, Shinjuku Ku, 8-1 Kawadacho, Tokyo 1628666, Japan.	tokano@abmes.twmu.ac.jp	Kobayashi, Junjiro/J-8547-2015		MEXT, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems CSTEC; Japan Society for the Promotion of Science (JSPS) [23106009]; MEXT, Global COE Program, Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM); JSPS [25750179]	Contract grant sponsor: Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT), Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems "Cell Sheet Tissue Engineering Center (CSTEC)"; Contract grant sponsor: The Japan Society for the Promotion of Science (JSPS), Grant-in-Aid for Scientific Research on Innovative Areas "Bio Assembler"; contract grant number: 23106009; Contract grant sponsor: MEXT, Global COE Program, Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM); Contract grant sponsor: JSPS, Grant-in-Aid for Young Scientists (B); contract grant number: 25750179	Yamato M, 2007, PROG POLYM SCI, V32, P1123, DOI 10.1016/j.progpolymsci.2007.06.002; Yamato M, 1999, J BIOMED MATER RES, V44, P44, DOI 10.1002/(SICI)1097-4636(199901)44:1<44::AID-JBM5>3.0.CO;2-X; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Saalbach A, 1998, ARCH DERMATOL RES, V290, P360, DOI 10.1007/s004030050318; Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7; Jung Y, 2008, ANALYST, V133, P697, DOI 10.1039/b800014j; Ebihara G, 2012, BIOMATERIALS, V33, P3846, DOI 10.1016/j.biomaterials.2012.01.056; Tamura A, 2012, BIOMATERIALS, V33, P3803, DOI 10.1016/j.biomaterials.2012.01.060; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859; OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005; Washio K, 2010, CELL TISSUE RES, V341, P397, DOI 10.1007/s00441-010-1009-1; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Sawa Y, 2012, SURG TODAY, V42, P181, DOI 10.1007/s00595-011-0106-4; BUTLER JE, 1992, J IMMUNOL METHODS, V150, P77, DOI 10.1016/0022-1759(92)90066-3; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Haraguchi Y, 2012, NAT PROTOC, V7, P850, DOI 10.1038/nprot.2012.027; Yamato M, 2004, MATER TODAY, V7, P42, DOI 10.1016/S1369-7021(04)00234-2; Meliga E, 2007, CELL TRANSPLANT, V16, P963, DOI 10.3727/096368907783338190; Burillon C, 2012, INVEST OPHTH VIS SCI, V53, P1325, DOI 10.1167/iovs.11-7744; Sekine H, 2011, TISSUE ENG PT A, V17, P2973, DOI 10.1089/ten.tea.2010.0659; Iwata T, 2009, BIOMATERIALS, V30, P2716, DOI 10.1016/j.biomaterials.2009.01.032; YAMADA N, 1990, MAKROMOL CHEM-RAPID, V11, P571; Lu B, 1996, ANALYST, V121, pR29, DOI 10.1039/an996210029r; Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050; OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E; Lin K, 2008, CYTOTHERAPY, V10, P417, DOI 10.1080/14653240801982979; Hou S, 2013, ADV MATER, V25, P1547, DOI 10.1002/adma.201203185; Aoyagi T, 2000, J BIOMAT SCI-POLYM E, V11, P101, DOI 10.1163/156856200743526; Arisaka Y, 2013, BIOMATERIALS, V34, P4214, DOI 10.1016/j.biomaterials.2013.02.056; Brogan KL, 2005, LANGMUIR, V21, P3054, DOI 10.1021/la047922q; Butler J. E., 1993, Molecular Immunology, V30, P1165, DOI 10.1016/0161-5890(93)90135-X; Cao T, 2007, BIOTECHNOL BIOENG, V98, P1109, DOI 10.1002/bit.21503; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; Harlow E.D., 1988, ANTIBODIES LAB MANUA; Heskins M.a.G.J.E., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI DOI 10.1080/10601326808051910; KUZUME T, 1992, INT J CANCER, V50, P259, DOI 10.1002/ijc.2910500216; MCKENZIE JL, 1981, J IMMUNOL, V126, P843; Ohashi K, 2012, CELL MED, V3, P113	41	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1549-3296	1552-4965		J BIOMED MATER RES A	J. Biomed. Mater. Res. Part A	NOV	2014	102	11					3883	3893		10.1002/jbm.a.35064		11	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AQ7PC	WOS:000343010100012		
J	Sato, K; Yuki, M; Norasakkunkit, V				Sato, Kosuke; Yuki, Masaki; Norasakkunkit, Vinai			A Socio-Ecological Approach to Cross-Cultural Differences in the Sensitivity to Social Rejection: The Partially Mediating Role of Relational Mobility	JOURNAL OF CROSS-CULTURAL PSYCHOLOGY			English	Article						culture; socio-ecology; rejection sensitivity; allocentric social anxiety; Taijin Kyofusho	ANXIETY DISORDERS; PHOBIA SYMPTOMS; TAIJIN-KYOFUSHO; UNITED-STATES; SELF; JAPAN; ECOLOGY; SIMILARITY; MOTIVATION; COGNITION	The authors propose that cross-cultural differences in sensitivity to social rejection, or the extent to which one is alert to potential rejection from significant others, can be understood as an adaptation to different social ecological contexts varying in the degrees of relational mobility. In societies low in relational mobility, such as East Asia, relationships and group memberships are stable and exclusive, and thus it is difficult for individuals to recover once rejected from current relationships or groups. In these contexts, one would expect people to be continuously paying attention to negative feedback from others to avoid potential rejection. In contrast, this type of anxiety will be less pronounced in societies high in relational mobility, such as North America, because there are a greater number of relationship alternatives available, even if individuals were to be excluded from a particular relationship. Results from two cross-national studies showed that, as expected, individuals' perceptions of relational mobility partially mediated rejection sensitivity (Study 1) and Taijin Kyofusho, an allocentric subtype of social anxiety (Study 2).	[Sato, Kosuke] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Yuki, Masaki] Hokkaido Univ, Sapporo, Hokkaido, Japan; [Norasakkunkit, Vinai] Gonzaga Univ, Spokane, WA 99258 USA	Sato, K (reprint author), Nagoya Univ, Ctr Student Counseling, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	sato.kosuke@i.mbox.nagoya-u.ac.jp					American Psychiatric Association, 1994, DIAGN STAT MAN MENT; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Kim J, 2008, DEPRESS ANXIETY, V25, P601, DOI 10.1002/da.20345; Markus HR, 2010, PERSPECT PSYCHOL SCI, V5, P420, DOI 10.1177/1745691610375557; Downey G, 1996, J PERS SOC PSYCHOL, V70, P1327, DOI 10.1037//0022-3514.70.6.1327; Dinnel DL, 2002, J PSYCHOPATHOL BEHAV, V24, P75, DOI 10.1023/A:1015316223631; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Yamagishi T, 1999, ADV GROUP, V16, P161; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Falk CF, 2009, EUR J PERSONALITY, V23, P183, DOI 10.1002/per.715; Kleinknecht RA, 1997, J ANXIETY DISORD, V11, P157, DOI 10.1016/S0887-6185(97)00004-2; Schug J, 2010, PSYCHOL SCI, V21, P1471, DOI 10.1177/0956797610382786; Sznycer D, 2012, EVOL PSYCHOL-US, V10, P352; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; Oishi S, 2010, PERSPECT PSYCHOL SCI, V5, P5, DOI 10.1177/1745691609356781; Eisenberger NI, 2004, TRENDS COGN SCI, V8, P294, DOI 10.1016/j.tics.2004.05.010; Chen J, 2009, J PERS SOC PSYCHOL, V97, P851, DOI 10.1037/a0015950; Yamagishi T, 2008, PSYCHOL SCI, V19, P579, DOI 10.1111/j.1467-9280.2008.02126.x; Adams G, 2005, J PERS SOC PSYCHOL, V88, P948, DOI 10.1037/0022-3514.88.6.948; Schug J, 2009, ASIAN J SOC PSYCHOL, V12, P95, DOI 10.1111/j.1467-839X.2009.01277.x; Matsumoto D, 2006, PERSPECT PSYCHOL SCI, V1, P234, DOI 10.1111/j.1745-6916.2006.00014.x; Downey G, 1998, J PERS SOC PSYCHOL, V75, P545, DOI 10.1037/0022-3514.75.2.545; Kitayama S, 2009, J PERS SOC PSYCHOL, V97, P236, DOI 10.1037/a0015999; Oishi S, 2010, PERSPECT PSYCHOL SCI, V5, P356, DOI 10.1177/1745691610374588; Bahns AJ, 2012, GROUP PROCESS INTERG, V15, P119, DOI 10.1177/1368430211410751; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; BUSS DM, 1990, J SOC CLIN PSYCHOL, V9, P196, DOI 10.1521/jscp.1990.9.2.196; Chang S C, 1997, Depress Anxiety, V5, P115, DOI 10.1002/(SICI)1520-6394(1997)5:3<115::AID-DA1>3.0.CO;2-D; Choy Yujuan, 2008, Depress Anxiety, V25, P230, DOI 10.1002/da.20295; Downey G, 2004, PSYCHOL SCI, V15, P668, DOI 10.1111/j.0956-7976.2004.00738.x; Garris C. P., 2011, J CROSS CULTURAL PSY, V42, P1068; Hofstede G. H., 1980, CULTURES CONSEQUENCE; Leary M, 1995, SOCIAL ANXIETY; MARKS IM, 1994, ETHOL SOCIOBIOL, V15, P247, DOI 10.1016/0162-3095(94)90002-7; Matsumoto D., 1999, ASIAN J SOC PSYCHOL, V2, P289, DOI DOI 10.1111/1467-839X.00042; Nisbett R. E., 1996, CULTURE HONOR; Norasakkunkit V, 2012, J CROSS CULT PSYCHOL, V43, P742, DOI 10.1177/0022022111405658; RUSSELL JG, 1989, CULT MED PSYCHIAT, V13, P391, DOI 10.1007/BF00052047; Sasagawa T., 2012, MEJIERO J PSYCHOL, V8, P15; Sato K., 2011, ANNAL HOKKAIDO PSYCH, V34, P21; Schug J., 2010, 11 ANN M SOC PERS SO; SINGELIS TM, 1994, PERS SOC PSYCHOL B, V20, P580, DOI 10.1177/0146167294205014; Triandis Harry C., 1995, INDIVIDUALISM COLLEC; Tsuji R., 2002, MATH SOC JAPAN AM 2; Vriends N., 2013, FRONT PSYCHOL, V4, P1; YAMAGISHI T, 1994, MOTIV EMOTION, V18, P129, DOI 10.1007/BF02249397; Yamagishi T., 1998, ASIAN J SOC PSYCHOL, V1, P315, DOI 10.1111/1467-839X.00020; YAMAGUCHI S, 1995, J CROSS CULT PSYCHOL, V26, P658, DOI 10.1177/002202219502600609; Yuki M, 2013, J EXP SOC PSYCHOL, V49, P741, DOI 10.1016/j.jesp.2013.02.006; Yuki M., 2012, NEW DIRECTIONS CLOSE, P137; Yuki M., 2007, DEV SCALE MEASURE PE	52	2	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0221	1552-5422		J CROSS CULT PSYCHOL	J. Cross-Cult. Psychol.	NOV	2014	45	10					1549	1560		10.1177/0022022114544320		12	Psychology, Social	Psychology	AR0EX	WOS:000343242300003		
J	Zhou, BR; Lacroix, F; Sasaki, J; Peng, YS; Wang, X; Ryder, AG				Zhou, Biru; Lacroix, Franca; Sasaki, Jun; Peng, Yunshi; Wang, Xia; Ryder, Andrew G.			Unpacking Cultural Variations in Social Anxiety and the Offensive-Type of Taijin Kyofusho Through the Indirect Effects of Intolerance of Uncertainty and Self-Construals	JOURNAL OF CROSS-CULTURAL PSYCHOLOGY			English	Article						social anxiety; offensive-type TKS; multiple mediation; intolerance of uncertainty	COLLEGE-STUDENTS; PHOBIA SYMPTOMS; DEPRESSION; DISORDER; SUBTYPE; JAPAN; FEAR	This article presents two studies that aim to unpack cultural variations in general social anxiety (SA) and the offensive-type of Taijin Kyofusho (OTKS)a type of SA characterized by the extreme fear of offending others. Cultural variations in the expression and manifestation of SA are well established; however, the mechanisms underpinning this relation are unclear. The present studies use the Parallel Multiple Mediation Model to study how SA and OTKS are jointly shaped by self-construal and intolerance of uncertainty (IU). Study 1 compared Euro-Canadians and Chinese migrants in Canada. Results showed a mean group difference in OTKS, but not SA, with the difference mediated by IU. Study 2 tested this pattern of multiple mediations in Japanese, Chinese, and Euro-Canadian cultural contexts. Results showed significant differences among these three cultural groups on both SA and OTKS via multiple mediators (e.g., independent vs. interdependent self-construals and IU). Findings in both studies revealed that OTKS seems to be a psychopathology that is not specific to Japanese participants. The underlying mechanisms and processes of OTKS are also significantly different from SA. Significant cultural variations in SA and OTKS between Chinese versus Japanese cultural contexts were observed in Study 2. These studies demonstrate the conceptual and empirical advantages of using more complex models to unpack the psychological mechanisms shaping cultural variations in SA and OTKS.	[Zhou, Biru; Lacroix, Franca; Ryder, Andrew G.] Concordia Univ, Montreal, PQ H4B 1R6, Canada; [Sasaki, Jun] Osaka Univ, Suita, Osaka 565, Japan; [Peng, Yunshi; Wang, Xia] Hunan Normal Univ, Changsha, Hunan, Peoples R China; [Ryder, Andrew G.] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada	Zhou, BR (reprint author), Concordia Univ, PY-146,7141 Sherbrooke West, Montreal, PQ H4B 1R6, Canada.	b_zho@live.concordia.ca	Ryder, Andrew/A-1108-2008	Ryder, Andrew/0000-0003-3041-7168			Alon I., 2003, CHINESE CULTURE ORG; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Carleton RN, 2012, J ANXIETY DISORD, V26, P468, DOI 10.1016/j.janxdis.2012.01.011; Markus HR, 2010, PERSPECT PSYCHOL SCI, V5, P420, DOI 10.1177/1745691610375557; Heinrichs N, 2006, BEHAV RES THER, V44, P1187, DOI 10.1016/j.brat.2005.09.006; Hong JJ, 2007, BEHAV RES THER, V45, P1779, DOI 10.1016/j.brat.2007.01.011; Dinnel DL, 2002, J PSYCHOPATHOL BEHAV, V24, P75, DOI 10.1023/A:1015316223631; TAKAHASHI T, 1989, COMPR PSYCHIAT, V30, P45, DOI 10.1016/0010-440X(89)90117-X; Boelen PA, 2009, J ANXIETY DISORD, V23, P130, DOI 10.1016/j.janxdis.2008.04.007; McEvoy PM, 2012, BEHAV THER, V43, P533, DOI 10.1016/j.beth.2011.02.007; Dugas MJ, 2004, COGNITIVE THER RES, V28, P835, DOI 10.1007/s10608-004-0669-0; Hayes AF, 2007, BEHAV RES METHODS, V39, P709, DOI 10.3758/BF03192961; Kleinknecht RA, 1997, J ANXIETY DISORD, V11, P157, DOI 10.1016/S0887-6185(97)00004-2; Buhr K, 2002, BEHAV RES THER, V40, P931, DOI 10.1016/S0005-7967(01)00092-4; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; Carleton RN, 2010, J ANXIETY DISORD, V24, P189, DOI 10.1016/j.janxdis.2009.10.007; Norenzayan A, 2005, PSYCHOL BULL, V131, P763, DOI 10.1037/0033-2909.131.5.763; Okazaki S, 1997, J ABNORM PSYCHOL, V106, P52, DOI 10.1037/0021-843X.106.1.52; Nagata T, 2006, DEPRESS ANXIETY, V23, P168, DOI 10.1002/da.20153; Choy Yujuan, 2008, Depress Anxiety, V25, P230, DOI 10.1002/da.20295; Clarvit SR, 1996, J CLIN PSYCHIAT, V57, P523, DOI 10.4088/JCP.v57n1104; Draguns JG, 2003, BEHAV RES THER, V41, P755, DOI 10.1016/S0005-7967(02)00190-0; Good B. J., 1985, ANXIETY ANXIETY DISO, P297; Harkness J. A., 2003, CROSS CULTURAL SURVE, P35; Hayes A. F., 2013, INTRO MEDIATION MODE; Hendry Joy, 2003, UNDERSTANDING JAPANE; Hofmann Stefan G, 2010, Depress Anxiety, V27, P1117, DOI 10.1002/da.20759; Hofstede G., 2010, CULTURES ORG SOFTWAR; Hofstede G., 2001, CULTURES CONSEQUENCE; Hofstede Geert H., 1984, CULTURES CONSEQUENCE; Iwase M, 2000, PSYCHIAT CLIN NEUROS, V54, P67, DOI 10.1046/j.1440-1819.2000.00639.x; Kasahara Y., 1987, P 1 CULT PSYCH S JAP, P3; Kasahara Y., 1974, JAPANESE CULTURE BEH, P396; Kashima Y., 2011, PSYCHOL STUD, V56, P12, DOI 10.1007/s12646-011-0071-4; KIRMAYER LJ, 1991, J NERV MENT DIS, V179, P19, DOI 10.1097/00005053-199101000-00005; Lin T, 2013, INTERCULTURAL COMMUN, V22, P151; Louie K, 2008, CAMBRIDGE COMPANION; Matsumoto D., 2002, NEW JAPAN DEBUNKING; McKnight P. E., 2007, MISSING DATA GENTLE; Nakane Chie, 1970, JAPANESE SOC; Norasakkunkit V, 2012, J CROSS CULT PSYCHOL, V43, P742, DOI 10.1177/0022022111405658; Okazaki Sumie, 2002, Cultur Divers Ethnic Minor Psychol, V8, P234, DOI 10.1037//1099-9809.8.3.234; Ono Y., 2001, TRANSCULT PSYCHIATRY, V38, P506, DOI 10.1177/136346150103800408; Plaut VC, 2012, PERS SOC PSYCHOL B, V38, P1644, DOI 10.1177/0146167212458125; Rector NA, 2006, COGNITIVE THER RES, V30, P279, DOI 10.1007/s10608-006-9050-9; Ryder A. G., 2011, SOCIAL PERSONALITY P, V5, P960, DOI [10.1111/j.1751-9004.2011.00404.x, DOI 10.1111/J.1751-9004.2011.00404.X]; SINGELIS TM, 1994, PERS SOC PSYCHOL B, V20, P580, DOI 10.1177/0146167294205014; Sugimoto Y., 2009, CAMBRIDGE COMPANION; Xie D, 2008, ASIAN J SOC PSYCHOL, V11, P163, DOI 10.1111/j.1467-839X.2008.00253.x	50	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0221	1552-5422		J CROSS CULT PSYCHOL	J. Cross-Cult. Psychol.	NOV	2014	45	10					1561	1578		10.1177/0022022114548483		18	Psychology, Social	Psychology	AR0EX	WOS:000343242300004		
J	Takemura, K				Takemura, Kosuke			Being Different Leads to Being Connected: On the Adaptive Function of Uniqueness in "Open" Societies	JOURNAL OF CROSS-CULTURAL PSYCHOLOGY			English	Article						cultural psychology; uniqueness; independence; relational mobility; life satisfaction	UNITED-STATES; INDIVIDUALISM-COLLECTIVISM; RESIDENTIAL-MOBILITY; CULTURE; SELF; SCALE; JAPAN; NEED; INDEPENDENCE; ASSIMILATION	The current research proposes that high need for uniqueness (NFU) brings individuals positive life outcomes by helping them be connected with, rather than isolated from, others in societies where social relationships are mobile and generally open to outsiders. In societies characterized by a high mobility of relationships (relational mobility) that may result in market-like competitive circumstances (e.g., America), NFU may increase chances of social success by leading individuals to develop their unique selling points. In contrast, high NFU may bring worse results in closed societies (e.g., Japan) because of the associated risk of being ostracized. This hypothesis was examined and confirmed by three studies that employed cross-national as well as cross-regional comparisons within a single nation. A pilot study first confirmed that for societies higher in relational mobility, a high NFU person was viewed more favorably as a friend. Studies 1 and 2 found that NFU was more positively associated with life satisfaction, relationship satisfaction (Study 2), as well as income (Study 2) in societies higher in relational mobility.	[Takemura, Kosuke] Shiga Univ, Hikone, Shiga 5228522, Japan	Takemura, K (reprint author), Shiga Univ, Fac Econ, 1-1-1 Banba, Hikone, Shiga 5228522, Japan.	boz.takemura@gmail.com					Anderson SL, 2008, J PERS SOC PSYCHOL, V95, P352, DOI 10.1037/0022-3514.95.2.352; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Kitayama S, 2006, J PERS SOC PSYCHOL, V91, P369, DOI 10.1037/0022-3514.91.3.369; Aaker J, 2001, J CROSS CULT PSYCHOL, V32, P561, DOI 10.1177/0022022101032005003; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Fischer R, 2009, J CROSS CULT PSYCHOL, V40, P187, DOI 10.1177/0022022109332738; Pickett CL, 2001, J EXP SOC PSYCHOL, V37, P341, DOI 10.1006/jesp.2000.1469; BURNS DJ, 1992, J SOC PSYCHOL, V132, P487; FISCHER CS, 1975, AM J SOCIOL, V80, P1319, DOI 10.1086/225993; Falk CF, 2009, EUR J PERSONALITY, V23, P183, DOI 10.1002/per.715; Kim HS, 2006, PERS SOC PSYCHOL B, V32, P1595, DOI 10.1177/0146167206291991; Uskul AK, 2008, P NATL ACAD SCI USA, V105, P8552, DOI 10.1073/pnas.0803874105; Schug J, 2010, PSYCHOL SCI, V21, P1471, DOI 10.1177/0956797610382786; Sznycer D, 2012, EVOL PSYCHOL-US, V10, P352; Oishi S, 2010, J PERS SOC PSYCHOL, V98, P980, DOI 10.1037/a0019389; Allik J, 2004, J CROSS CULT PSYCHOL, V35, P29, DOI 10.1177/0022022103260381; Vignoles VL, 2000, PERS SOC PSYCHOL REV, V4, P337, DOI 10.1207/S15327957PSPR0404_4; SNYDER CR, 1977, J ABNORM PSYCHOL, V86, P518, DOI 10.1037/0021-843X.86.5.518; Oishi S, 2010, PERSPECT PSYCHOL SCI, V5, P5, DOI 10.1177/1745691609356781; Oishi S, 2012, PSYCHOL SCI, V23, P1542, DOI 10.1177/0956797612446708; Bond R, 1996, PSYCHOL BULL, V119, P111, DOI 10.1037/0033-2909.119.1.111; Chen J, 2009, J PERS SOC PSYCHOL, V97, P851, DOI 10.1037/a0015950; Kim H, 1999, J PERS SOC PSYCHOL, V77, P785, DOI 10.1037/0022-3514.77.4.785; Yamagishi T, 2008, PSYCHOL SCI, V19, P579, DOI 10.1111/j.1467-9280.2008.02126.x; BREWER MB, 1991, PERS SOC PSYCHOL B, V17, P475, DOI 10.1177/0146167291175001; Griskevicius V, 2006, J PERS SOC PSYCHOL, V91, P281, DOI 10.1037/0022-3514.91.2.281; Schug J, 2009, ASIAN J SOC PSYCHOL, V12, P95, DOI 10.1111/j.1467-839X.2009.01277.x; Boyd R., 1985, CULTURE EVOLUTIONARY; DIENER E, 1995, J PERS SOC PSYCHOL, V69, P851, DOI 10.1037//0022-3514.69.5.851; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Guelzkow H, 1951, GROUPS LEADERSHIP ME, P177; Heine S. J., 2012, CULTURAL PSYCHOL; Kashy D.A., 1998, HDB SOCIAL PSYCHOL, P233; Kim HS, 2008, PERS SOC PSYCHOL B, V34, P47, DOI 10.1177/0146167207309198; Naoi A., 2004, SOCIAL RES DATABASE; Sato K., 2008, 19 INT C INT ASS CRO; SHAFFER JP, 1986, J AM STAT ASSOC, V81, P826, DOI 10.2307/2289016; Shimizu H., 2006, I ELECT INFORM COMMU, V106, P1; Slotter EB, 2014, J EXP SOC PSYCHOL, V52, P71, DOI 10.1016/j.jesp.2014.01.001; Triandis Harry C., 1995, INDIVIDUALISM COLLEC; YAMAGISHI T, 1994, MOTIV EMOTION, V18, P129, DOI 10.1007/BF02249397; Yamagishi T., 1998, ASIAN J SOC PSYCHOL, V1, P315, DOI 10.1111/1467-839X.00020; Yuki M., 2007, WORKING PAPERS SERIE, V75; Yuki M, 2013, J EXP SOC PSYCHOL, V49, P741, DOI 10.1016/j.jesp.2013.02.006; Yuki M., 2012, RELATIONSHIP SCI INT, P137, DOI DOI 10.1037/13489-007	45	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0221	1552-5422		J CROSS CULT PSYCHOL	J. Cross-Cult. Psychol.	NOV	2014	45	10					1579	1593		10.1177/0022022114548684		15	Psychology, Social	Psychology	AR0EX	WOS:000343242300005		
J	Dann, HM; Tucker, HA; Cotanch, KW; Krawczel, PD; Mooney, CS; Grant, RJ; Eguchi, T				Dann, H. M.; Tucker, H. A.; Cotanch, K. W.; Krawczel, P. D.; Mooney, C. S.; Grant, R. J.; Eguchi, T.			Evaluation of lower-starch diets for lactating Holstein dairy cows	JOURNAL OF DAIRY SCIENCE			English	Article						starch; lactation performance; dairy cow	HIGH-MOISTURE CORN; PURINE DERIVATIVES; MILK-PRODUCTION; CATTLE; DIGESTION; SYSTEM; FEED; PERFORMANCE; EXCRETION; AMYLASE	The objective of this experiment was to measure ruminal and lactational responses of Holstein dairy cows fed diets containing 3 different starch levels: 17.7 (low; LS), 21.0 (medium; MS), or 24.6% (high; HS). Twelve multiparous cows (118 +/- 5 d in milk) were assigned randomly to dietary treatment sequence in a replicated 3 x 3 Latin square design with 3-wk periods. All diets were fed as total mixed rations and contained approximately 30.2% corn silage, 18.5% grass silage, and 5.0% chopped alfalfa hay. Dietary starch content was manipulated by increasing dry ground corn inclusion (% of dry matter) from 3.4 (LS) to 10.1 (MS) and 16.9 (HS) and decreasing inclusion of beet pulp and wheat middlings from 6.7 and 13.4 (LS) to 3.4 and 10.1 (MS) or 0 and 6.8 (HS). In vitro 6-h starch digestibility of the diet increased as nonforage sources of fiber replaced corn grain (% of dry matter; 73.6, HS; 77.3, MS; 82.5, LS) resulting in rumen-fermentable starch content by 14.6, 16.2, and 18.1% for the LS, MS, and HS diets, respectively. Diets had similar neutral detergent fiber from forage and particle size distributions. Dry matter intake, solids-corrected milk yield, and efficiency of solids-corrected milk production were unaffected by diet, averaging 26.5 +/- 0.8, 40.8 +/- 1.6, and 1.54 +/- 0.05 kg/d, respectively. Reducing dietary starch did not affect chewing time (815 +/- 23 min/d), mean ruminal pH over 24 h (6.06 +/- 0.12), acetate-to-propionate ratio (2.4 +/- 0.3), or microbial.N synthesized in the rumen (585 +/- 24 g/d). Total tract organic matter digestibility was higher for HS compared with MS and LS diets (69.2, 67.3, and 67.0%, respectively), but crude protein, neutral detergent fiber, and starch digestibilities were unaffected. As dietary starch content decreased, in vitro ruminal starch fermentability increased and, consequently, the range between HS and LS in rumen-fermentable starch (3.5 percentage units) was less than the range in starch content (6.9 percentage units). Under these conditions, dietary starch content had no measurable effect on ruminal fermentation or short-term lactational performance of high-producing Holstein dairy cows.	[Dann, H. M.; Tucker, H. A.; Cotanch, K. W.; Krawczel, P. D.; Mooney, C. S.; Grant, R. J.] William H Miner Agr Res Inst, Chazy, NY 12921 USA; [Eguchi, T.] Zen Noh Natl Federat Agr Cooperat Assoc, Tokyo 1006832, Japan	Dann, HM (reprint author), William H Miner Agr Res Inst, Chazy, NY 12921 USA.	dann@whminer.com					FERGUSON JD, 1994, J DAIRY SCI, V77, P2695; Hristov AN, 2005, J ANIM SCI, V83, P408; Ferraretto LF, 2011, J DAIRY SCI, V94, P1490, DOI 10.3168/jds.2010-3736; BEAUCHEMIN KA, 1991, VET CLIN N AM-FOOD A, V7, P439; Vallimont JE, 2004, J DAIRY SCI, V87, P4221; Penner GB, 2006, J DAIRY SCI, V89, P2132; Mitlohner FM, 2001, J ANIM SCI, V79, P1189; Oba M, 2003, J DAIRY SCI, V86, P195, DOI 10.3168/jds.S0022-0302(03)73600-5; Ferraretto LF, 2013, J DAIRY SCI, V96, P533, DOI 10.3168/jds.2012-5932; Valadares RFD, 1999, J DAIRY SCI, V82, P2686; AOAC, 2000, OFFICIAL METHODS ANA; AOAC International, 2006, OFFICIAL METHODS ANA; BAUER ML, 1995, J ANIM SCI, V73, P3445; Blasi D. A., 1995, P S ALT FEEDS DAIR B, P49; Boddugari K, 2001, J DAIRY SCI, V84, P873; Bradford BJ, 2012, J DAIRY SCI, V95, P4735, DOI 10.3168/jds.2012-5393; Chase L. E, 2007, P CORN NUTR C FEED M, P213; CHEN XB, 1990, BRIT J NUTR, V63, P131, DOI 10.1079/BJN19900098; Cotanch KW, 2006, J ANIM SCI, V84, P373; Firkins J. L., 2001, J ANIM SCI S, V79, pE218; Gencoglu H, 2010, J DAIRY SCI, V93, P723, DOI 10.3168/jds.2009-2673; Hall M. B., 2001, Journal of Dairy Science, V84, P200; Hindrichsen IK, 2006, ANIM FEED SCI TECH, V126, P43, DOI 10.1016/j.anifeedsci.2005.06.004; Ipharraguerre IR, 2003, J DAIRY SCI, V86, P1052; Linton JAV, 2007, J DAIRY SCI, V90, P4770, DOI 10.3168/jds.2007-0100; MAYNARD LA, 1979, ANIMAL NUTR, P21; Mertens DR, 1997, J DAIRY SCI, V80, P1463; NRC, 2001, NUTR REQ DAIR CATTL; USDA, 2013, FEED GRAINS YB TABL; Van Soest P. J., 1970, AGR HDB, V379; Voelker JA, 2003, J DAIRY SCI, V86, P3553, DOI 10.3168/jds.S0022-0302(03)73960-5; Voelker JA, 2003, J DAIRY SCI, V86, P3542, DOI 10.3168/jds.S0022-0302(03)73959-9	32	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-0302	1525-3198		J DAIRY SCI	J. Dairy Sci.	NOV	2014	97	11					7151	7161		10.3168/jds.2014-8341		11	Agriculture, Dairy & Animal Science; Food Science & Technology	Agriculture; Food Science & Technology	AQ8JN	WOS:000343071900051		
J	Sato, T; Yamamoto, T; Araki, N; Konishi, Y				Sato, Takao; Yamamoto, Toru; Araki, Nozomu; Konishi, Yasuo			Performance-Adaptive Generalized Predictive Control-Based Proportional-Integral-Derivative Control System and Its Application	JOURNAL OF DYNAMIC SYSTEMS MEASUREMENT AND CONTROL-TRANSACTIONS OF THE ASME			English	Article							SELF-TUNING CONTROL; PID CONTROLLER; FEEDER; DESIGN	In the present paper, we discuss a new design method for a proportional-integral-derivative (PID) control system using a model predictive approach. The PID compensator is designed based on generalized predictive control (GPC). The PID parameters are adaptively updated such that the control performance is improved because the design parameters of GPC are selected automatically in order to attain a user-specified control performance. In the proposed scheme, the estimated plant parameters are updated only when the prediction error increases. Therefore, the control system is not updated frequently. The control system is updated only when the control performance is sufficiently improved. The effectiveness of the proposed method is demonstrated numerically. Finally, the proposed method is applied to a weigh feeder, and experimental results are presented.	[Sato, Takao; Araki, Nozomu; Konishi, Yasuo] Univ Hyogo, Grad Sch Engn, Himeji, Hyogo 6712280, Japan; [Yamamoto, Toru] Hiroshima Univ, Inst Engn, Hiroshima 7398527, Japan	Sato, T (reprint author), Univ Hyogo, Grad Sch Engn, 2167 Shosha, Himeji, Hyogo 6712280, Japan.	tsato@eng.u-hyogo.ac.jp; yama@hiroshima-u.ac.jp; araki@eng.u-hyogo.ac.jp; konishi@eng.u-hyogo.ac.jp			JSPS [25820186]	The authors are grateful to Yamato Scale Co., Ltd. for providing the experimental setup. The present study was supported by JSPS Grant-in-Aid for Young Scientists (B) Grant No. 25820186.	Aicha F. B., 2013, INT J APPL COMPUT SC, V23, P35; Peng JY, 2014, IEEE-ASME T MECH, V19, P88, DOI 10.1109/TMECH.2012.2222428; Hopkins M, 2006, MEAS CONTROL-UK, V39, P237; CLARKE DW, 1979, P I ELECTR ENG, V126, P633; Astrom K. J., 1997, COMPUTER CONTROLLED; Bobal V., 2005, DIGITAL SELF TUNING; Boloa Y., 2014, IEEE T CONTR SYST T, V22, P468; Camacho E. F., 2000, MODEL PREDICTIVE CON; CLARKE DW, 1987, AUTOMATICA, V23, P149, DOI 10.1016/0005-1098(87)90088-4; CLARKE DW, 1987, AUTOMATICA, V23, P137, DOI 10.1016/0005-1098(87)90087-2; CLARKE DW, 1984, AUTOMATICA, V20, P501, DOI 10.1016/0005-1098(84)90003-7; Haefner H., 1996, WORLD CEMENT, V27, P19; Heinrici H., 2000, AUFBEREIT TECH, V41, P376; IFAC, 2012, P IFAC C ADV PID CON; Keesman KJ, 2011, ADV TXB CONTR SIG PR, P1, DOI 10.1007/978-0-85729-522-4_1; Kitano Shohei, 2012, ICIC Express Letters, V6; Landau ID, 2011, COMMUN CONTROL ENG, P1, DOI 10.1007/978-0-85729-664-1; Moradi M. H., 2005, PID CONTROL NEW IDEN; O'Dwyer A., 2003, HDB PI PID CONTROLLE; Sato Takao, 2011, International Journal of Advanced Mechatronic Systems, V3; Sato T, 2009, International Journal of Advanced Mechatronic Systems, V1, DOI 10.1504/IJAMECHS.2009.023201; Sato T, 2010, CONTROL ENG PRACT, V18, P105, DOI 10.1016/j.conengprac.2009.12.001; Silva G. J., 2005, PID CONTROLLERS TIME; strom KJ, 1995, PID CONTROLLERS THEO; Tan KK, 2000, ISA T, V39, P57, DOI 10.1016/S0019-0578(99)00036-1; Tan KK, 2002, IND ENG CHEM RES, V41, P2013, DOI 10.1021/ei010480i; VERMYLEN J, 1985, Food Processing (Itasca), V46, P138; Vilanova Ramon, 2012, PID CONTROL 3 MILLEN; Visioli A, 2006, ADV IND CONTROL, P1; Wood R., 1995, ADV INSTRUMENTATION; Yamamoto T., 2007, IEEJ T EIS, V127, P2101, DOI 10.1541/ieejeiss.127.2101; Yu Cheng-Ching, 2006, AUTOTUNING PID CONTR	32	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0022-0434	1528-9028		J DYN SYST-T ASME	J. Dyn. Syst. Meas. Control-Trans. ASME	NOV	2014	136	6							061003	10.1115/1.4027923		9	Automation & Control Systems; Instruments & Instrumentation	Automation & Control Systems; Instruments & Instrumentation	AQ8DW	WOS:000343054900003		
J	Kawada, T				Kawada, Tomoyuki			Combination effect of hypertension and diabetes mellitus on urinary protein excretion	JOURNAL OF HYPERTENSION			English	Letter									Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					Hsueh WA, 2011, J CLIN HYPERTENS, V13, P224, DOI 10.1111/j.1751-7176.2011.00449.x; Fonseca Vivian A, 2006, J Clin Hypertens (Greenwich), V8, P713, DOI 10.1111/j.1524-6175.2006.05583.x; Ohara N, 2014, J HYPERTENS, V32, P432, DOI 10.1097/HJH.0000000000000019; Yang CW, 2011, NEPHROL DIAL TRANSPL, V26, P3249, DOI 10.1093/ndt/gfr011	4	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0263-6352	1473-5598		J HYPERTENS	J. Hypertens.	NOV	2014	32	11					2277	2277		10.1097/HJH.0000000000000352		1	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AR0FS	WOS:000343245200022		
J	Ohara, N; Hanyu, O; Sone, H				Ohara, Nobumasa; Hanyu, Osamu; Sone, Hirohito			Combination effect of hypertension and diabetes mellitus on urinary protein excretion Reply	JOURNAL OF HYPERTENSION			English	Letter							IMMUNOGLOBULIN-G; CERULOPLASMIN; TRANSFERRIN		[Ohara, Nobumasa; Hanyu, Osamu; Sone, Hirohito] Niigata Univ, Fac Med, Dept Hematol Endocrinol & Metab, Niigata 9518510, Japan	Ohara, N (reprint author), Niigata Univ, Fac Med, Dept Hematol Endocrinol & Metab, Chuo Ku, Niigata 9518510, Japan.	oharan@med.niigata-u.ac.jp					Narita T, 2006, DIABETES CARE, V29, P142, DOI 10.2337/diacare.29.01.06.dc05-1063; Kawada T, 2014, J HYPERTENS, V32, P2277, DOI 10.1097/HJH.0000000000000352; Ohara N, 2014, J HYPERTENS, V32, P432, DOI 10.1097/HJH.0000000000000019	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0263-6352	1473-5598		J HYPERTENS	J. Hypertens.	NOV	2014	32	11					2278	2278		10.1097/HJH.0000000000000353		1	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AR0FS	WOS:000343245200023		
J	Denda, M				Denda, Mitsuhiro			Newly Discovered Olfactory Receptors in Epidermal Keratinocytes Are Associated with Proliferation, Migration, and Re-Epithelialization of Keratinocytes	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Editorial Material							SYSTEM	Skin contains receptors for various environmental factors. In this issue of the Journal, Busse et al. cloned a new olfactory receptor, OR2AT4, in keratinocytes. They show that the activation of OR2AT4 induces phosphorylation of extracellular signal regulated kinases and p38 mitogen activated protein kinases, and that it accelerates wound healing. OR2AT4 may be a promising candidate as a target in clinical drug development.	[Denda, Mitsuhiro] Shiseido Res Ctr, Tuzuki Ku, Yokohama, Kanagawa 2248558, Japan; [Denda, Mitsuhiro] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Denda, M (reprint author), Shiseido Res Ctr, Tuzuki Ku, 2-2-1 Hayabuchi, Yokohama, Kanagawa 2248558, Japan.	mitsuhiro.denda@to.shiseido.co.jp					Amano T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033922; Denda M, 2011, ADV EXP MED BIOL, V704, P847, DOI 10.1007/978-94-007-0265-3_44; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Cheng XP, 2010, CELL, V141, P331, DOI 10.1016/j.cell.2010.03.013; Busse D, 2014, J INVEST DERMATOL, V134, P2823, DOI 10.1038/jid.2014.273; Denda M, 2007, EXP DERMATOL, V16, P157, DOI 10.1111/j.1600-0625.2006.00529.x; Denda M, 2000, BRIT J DERMATOL, V142, P1007, DOI 10.1046/j.1365-2133.2000.03486.x; Denda M, 2012, ATOPIC DERMATITIS, P197; Oohashi T, 2006, BRAIN RES, V1073, P339, DOI 10.1016/j.brainres.2005.12.096; Zhang Xiaoying, 2011, Front Biosci (Schol Ed), V3, P777, DOI 10.2741/s186	10	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	NOV	2014	134	11					2677	2679		10.1038/jid.2014.229		3	Dermatology	Dermatology	AR0OM	WOS:000343271200005		
J	Kabashima, K; Egawa, G				Kabashima, Kenji; Egawa, Gyohei			Intravital Multiphoton Imaging of Cutaneous Immune Responses	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							DERMAL DENDRITIC CELLS; REGULATORY T-CELLS; IN-VIVO; 2-PHOTON MICROSCOPY; LANGERHANS CELLS; TRANSGENIC MICE; BLOOD-VESSELS; MOUSE; SKIN; MIGRATION	Varieties of immune cells orchestrate cutaneous immune responses. To capture such dynamic phenomena, intravital imaging is an important technique and it may provide substantial information that is not available using the conventional histological analysis. Multiphoton microscopy enables the direct, three-dimensional, and minimally invasive imaging of biological samples with high spatio-temporal resolution, and it has now become the leading method for in vivo imaging studies. Using fluorescent dyes and transgenic reporter animals, not only skin structures but also cell- and humor-mediated cutaneous immune responses have been visualized.	[Kabashima, Kenji; Egawa, Gyohei] Kyoto Univ, Dept Dermatol, Grad Sch Med, Kyoto 6068507, Japan	Kabashima, K (reprint author), Kyoto Univ, Dept Dermatol, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawara, Kyoto 6068507, Japan.	kaba@kuhp.kyoto-u.ac.jp					Li JL, 2012, NAT PROTOC, V7, P221, DOI 10.1038/nprot.2011.438; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Boissonnas A, 2013, NEOPLASIA, V15, P85, DOI 10.1593/neo.121572; Celli S, 2011, NAT MED, V17, P744, DOI 10.1038/nm.2376; Choi I, 2011, BLOOD, V117, P362, DOI 10.1182/blood-2010-07-298562; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Hyun YM, 2012, J EXP MED, V209, P1349, DOI 10.1084/jem.20111426; Abtin A, 2014, NAT IMMUNOL, V15, P45, DOI 10.1038/ni.2769; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Matsushima H, 2010, J INVEST DERMATOL, V130, P1571, DOI 10.1038/jid.2010.11; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; Shulman Z, 2012, NAT IMMUNOL, V13, P67, DOI 10.1038/ni.2173; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Wang XN, 2014, J INVEST DERMATOL, V134, P965, DOI 10.1038/jid.2013.481; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Lin KL, 2014, BLOOD, V123, P1604, DOI 10.1182/blood-2013-09-526020; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Ballou B, 2004, BIOCONJUGATE CHEM, V15, P79, DOI 10.1021/bc034153y; Chakraverty R, 2006, J EXP MED, V203, P2021, DOI 10.1084/jem.20060376; Egawa G, 2013, J DERMATOL SCI, V70, P143, DOI 10.1016/j.jdermsci.2013.01.005; Egawa G, 2011, J INVEST DERMATOL, V131, P977, DOI 10.1038/jid.2010.386; Egawa G, 2013, J DERMATOL SCI, V70, P139, DOI 10.1016/j.jdermsci.2013.02.009; Egawa G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01932; Graf BW, 2013, BIOMED OPT EXPRESS, V4, P1817, DOI 10.1364/BOE.4.001817; Hillen F, 2008, BIOCHEM BIOPH RES CO, V368, P364, DOI 10.1016/j.bbrc.2008.01.080; Murata T, 2013, J DERMATOL SCI, V72, P199, DOI 10.1016/j.jdermsci.2013.06.016; Ng LG, 2011, J INVEST DERMATOL, V131, P2058, DOI 10.1038/jid.2011.179; Nishibu A, 2007, J DERMATOL SCI, V45, P23, DOI 10.1016/j.jdermsci.2006.10.003; Nowotschin S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-49; Overstreet MG, 2013, NAT IMMUNOL, V14, P949, DOI 10.1038/ni.2682; Ra H, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3432627; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Sen D, 2010, P NATL ACAD SCI USA, V107, P8334, DOI 10.1073/pnas.0912817107; Tsai TH, 2009, J DERMATOL SCI, V56, P1, DOI 10.1016/j.jdermsci.2009.06.008; Zhang JH, 2007, EXP HEMATOL, V35, P490, DOI 10.1016/j.exphem.2006.11.011	38	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	NOV	2014	134	11					2680	2684		10.1038/jid.2014.225		5	Dermatology	Dermatology	AR0OM	WOS:000343271200006		
J	Shimizuhira, C; Otsuka, A; Honda, T; Kitoh, A; Egawa, G; Nakajima, S; Nakashima, C; Watarai, H; Miyachi, Y; Kabashima, K				Shimizuhira, Chihiro; Otsuka, Atsushi; Honda, Tetsuya; Kitoh, Akihiko; Egawa, Gyohei; Nakajima, Saeko; Nakashima, Chisa; Watarai, Hiroshi; Miyachi, Yoshiki; Kabashima, Kenji			Natural Killer T Cells Are Essential for the Development of Contact Hypersensitivity in BALB/c Mice	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							INVARIANT NKT CELLS; DENDRITIC CELLS; IN-VIVO; ANTIGEN PRESENTATION; ACQUIRED-IMMUNITY; LYMPH-NODES; TNF-ALPHA; MATURATION; APOPTOSIS; REQUIREMENT	Contact hypersensitivity (CHS) has been widely used to study cutaneous immune responses, as a prototype of delayed-type hypersensitivity. Although natural killer T (NKT) cells have been assumed to have an important role in CHS, their role is controversial. Here, we report the role of NKT cells in the sensitization phase of CHS, by promoting the survival and maturation of dendritic cells (DCs) in the draining lymph nodes (LNs). The CHS response was attenuated with Cd1d1(-/-) and Traj18(-/-) BALB/c mice in which NKT cells were absent. In the draining LNs, the number of effector T cells and cytokine production were significantly reduced with NKT cell-deficient mice. NKT cells activated and colocalized with DCs in the draining LNs after sensitization. The number of migrated and mature DCs was reduced in NKT cell deficient mice 72 hours after FITC application. In in vitro experiments, activated NKT cells enhanced bone marrow derived DC (BMDC) survivability via tumor necrosis factor (TNF) production from BMDCs. In addition, TNF production from BMDCs was partially suppressed by the neutralizing anti-CD54 or CD154 antibodies. Our data demonstrate that DC NKT interaction has a pivotal role in the sensitization phase of CHS.	[Shimizuhira, Chihiro; Otsuka, Atsushi; Honda, Tetsuya; Kitoh, Akihiko; Egawa, Gyohei; Nakajima, Saeko; Nakashima, Chisa; Miyachi, Yoshiki; Kabashima, Kenji] Kyoto Univ Grad Sch Med, Dept Dermatol, Kyoto 6068507, Japan; [Watarai, Hiroshi] Japan Sci & Technol Agcy, PRESTO, Tokyo, Japan; [Watarai, Hiroshi] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Therapy, Tokyo, Japan	Otsuka, A (reprint author), Kyoto Univ Grad Sch Med, Dept Dermatol, 54 Shogoin Kawara, Kyoto 6068507, Japan.	otsukamn@kuhp.kyoto-u.ac.jp; kaba@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare of Japan	We thank Ms Kaori Tomari, Ms Kiiko Kumagai, and Ms Hiromi Doi for technical assistance. No additional external funding was received for this study. This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labour and Welfare of Japan.	Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Hermans IF, 2003, J IMMUNOL, V171, P5140; Suto H, 2006, J IMMUNOL, V176, P4102; Nieuwenhuis EES, 2005, EXP DERMATOL, V14, P250, DOI 10.1111/j.0906-6705.2005.00289.x; Taniguchi M, 2003, NAT IMMUNOL, V4, P1164, DOI 10.1038/ni1203-1164; Nishimura T, 2000, INT IMMUNOL, V12, P987, DOI 10.1093/intimm/12.7.987; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Lehner M, 2012, J IMMUNOL, V188, P4810, DOI 10.4049/jimmunol.1101610; Campos RA, 2003, J EXP MED, V198, P1785, DOI 10.1084/jem.20021562; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Goubier A, 2013, J INVEST DERMATOL, V133, P980, DOI 10.1038/jid.2012.404; Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Askenase PW, 2011, SCAND J IMMUNOL, V73, P465, DOI 10.1111/j.1365-3083.2011.02522.x; De Smedt T, 1998, J IMMUNOL, V161, P4476; Egawa G, 2011, J INVEST DERMATOL, V131, P2178, DOI 10.1038/jid.2011.198; Kabashima K, 2007, BIOCHEM BIOPH RES CO, V361, P1012, DOI 10.1016/j.bbre.2007.07.128; KRIPKE ML, 1990, J IMMUNOL, V145, P2833; LUDEWIG B, 1995, EUR J IMMUNOL, V25, P1943, DOI 10.1002/eji.1830250722; Nakajima S, 2010, J IMMUNOL, V184, P5595, DOI 10.4049/jimmunol.0903260; Otsuka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025538; Otsuka A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2740; Prussin C, 1997, J IMMUNOL, V159, P5862; Rogers PR, 2004, J IMMUNOL METHODS, V285, P197, DOI 10.1016/j.jim.2003.12.003; Wan CK, 2013, IMMUNITY, V38, P514, DOI 10.1016/j.immuni.2013.02.011; Watarai H, 2008, NAT PROTOC, V3, P70, DOI 10.1038/nprot.2007.515	32	3	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	NOV	2014	134	11					2709	2718		10.1038/jid.2014.200		10	Dermatology	Dermatology	AR0OM	WOS:000343271200010		
J	Uemura, T; Takamatsu, K; Okada, M; Ikeda, M; Nakamura, H				Uemura, Takuya; Takamatsu, Kiyohito; Okada, Mitsuhiro; Ikeda, Mikinori; Nakamura, Hiroaki			Entrapment of Digital Nerves due to an Embedded Ring: A Case Report	JOURNAL OF RECONSTRUCTIVE MICROSURGERY			English	Letter							FINGER; CHILD		[Uemura, Takuya; Okada, Mitsuhiro; Ikeda, Mikinori; Nakamura, Hiroaki] Osaka City Univ, Grad Sch Med, Dept Orthopaed Surg, Osaka 5458585, Japan; [Takamatsu, Kiyohito] Osaka City Gen Hosp, Dept Orthopaed Surg, Osaka, Japan	Uemura, T (reprint author), Osaka City Univ, Grad Sch Med, Dept Orthopaed Surg, 1-4-3 Asahimachi Abeno Ku, Osaka 5458585, Japan.	t-uemura@med.osaka-cu.ac.jp					Awan Bassim, 2013, Hand Surg, V18, P125, DOI 10.1142/S0218810413720118; BENNETT KG, 1995, ANN PLAS SURG, V34, P76, DOI 10.1097/00000637-199501000-00015; Deshmukh N V, 2003, Hand Surg, V8, P103, DOI 10.1142/S0218810403001492; Drake D A, 1977, J Hand Surg Am, V2, P111; FREEDMAN BJ, 1947, BRIT MED J, V2, P1034; KUSCHNER SH, 1992, CLIN ORTHOP RELAT R, P192; Leung YF, 2002, BRIT J PLAST SURG, V55, P353, DOI 10.1054/bjps.2002.3835; Sleilati F, 2004, PLAST RECONSTR SURG, V114, P1674, DOI 10.1097/01.PRS.0000141485.83476.89; Witt PD, 2007, PLAST RECONSTR SURG, V119, P1631, DOI 10.1097/01.prs.0000256524.38562.48; Zeng Bo-Wei, 2006, J Chin Med Assoc, V69, P95	10	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0743-684X	1098-8947		J RECONSTR MICROSURG	J. Reconstr. Microsurg.	NOV	2014	30	9					659	661		10.1055/s-0034-1370362		3	Surgery	Surgery	AQ9RC	WOS:000343192000009		
J	Kawaguchi, T; Lassila, LVJ; Sasaki, H; Takahashi, Y; Vallittu, PK				Kawaguchi, Tomohiro; Lassila, Lippo V. J.; Sasaki, Hirono; Takahashi, Yutaka; Vallittu, Pekka K.			Effect of heat treatment of polymethyl methacrylate powder on mechanical properties of denture base resin	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Heat treatment; PMMA; Denture base polymer; Flexural property; Interpenetrating polymer network	RESIDUAL MONOMER; REINFORCEMENT; WATER	Objectives: The aim of this research was to investigate the effects of heat treatment of polymethyl methacrylate powder on mechanical properties of denture base resin. Methods: PMMA powder was applied after heat treatment at 100 degrees C for 2 h (code: HT100) or 130 degrees C for 2 h (code: HT130). The test specimens were fabricated from autopolymerizing resin to investigate the flexural properties of denture base resin cross-linked with methacrylated dendrimer, the surface microhardness of PMMA beads, and the thickness of the swollen layer of PMMA beads. The specimens were autopolymerized, and all specimens were stored in 37 degrees C water for 24 h. Half of the specimens were immersed in 37 degrees C water for an additional 6 months (water storage period: 24 h and 6 months). The flexural strength and flexural modulus (n=10/group) were measured with a three point bending test. Statistical analysis was performed using ANOVA and the Newman-Keuls test at a significance level of 0.05. Results: Heat treatment and the water storage period had a significant effect on flexural strength. The flexural strength of HT130 showed significantly higher values than in other groups. The surface microhardness of PMMA beads of HT130 showed a significantly greater microhardness than other groups. The thickness of a swollen layer of PMMA beads of HT100 and HT130 was significantly decreased. Conclusions: The flexural strength and the surface microhardness were increased after heat treatment at 130 degrees C. The thickness of a swollen layer of PMMA beads was decreased after heat treatment. (C) 2014 Elsevier Ltd. All rights reserved.	[Kawaguchi, Tomohiro; Lassila, Lippo V. J.; Vallittu, Pekka K.] Univ Turku, Inst Dent, Dept Biomat Sci, BioCity Turku Biomat Res Program, Turku, Finland; [Kawaguchi, Tomohiro; Sasaki, Hirono; Takahashi, Yutaka] Fukuoka Dent Coll, Dept Oral Rehabil, Div Removable Prosthodont, Fukuoka 8140193, Japan	Kawaguchi, T (reprint author), Fukuoka Dent Coll, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan.	tomokawa@college.fdcnet.ac.jp			Japan Society for the Promotion of Science [25861875]	This work was supported by Grants-in-Aid for Young Scientists (B) Grant number 25861875 from the Japan Society for the Promotion of Science.	Lung CYK, 2005, DENT MATER, V21, P1119, DOI 10.1016/j.dental.2005.0-3.003; Kawaguchi T, 2011, DENT MATER, V27, P755, DOI 10.1016/j.dental.2011.03.015; Boeckler AF, 2008, DENT MATER, V24, P1602, DOI 10.1016/j.dental.2008.03.019; DARBAR UR, 1994, BRIT DENT J, V176, P342, DOI 10.1038/sj.bdj.4808449; DOGAN A, 1995, J DENT, V23, P313, DOI 10.1016/0300-5712(94)00002-W; Anusavice K.J., 2013, PHILLIPS SCI DENT MA, P92; Bural C, 2011, DENT MATER, V27, P1135, DOI 10.1016/j.dental.2011.08.007; Jagger DC, 1999, J ORAL REHABIL, V26, P185, DOI 10.1046/j.1365-2842.1999.00375.x; JAGGER RG, 1995, J PROSTHET DENT, V74, P542, DOI 10.1016/S0022-3913(05)80359-2; Jerolimov V, 1991, Acta Stomatol Croat, V25, P17; Keh ES, 2002, DENT MATER J, V21, P373; Narva KK, 2001, INT J PROSTHODONT, V14, P219; Ohyama A, 2000, Dent Mater J, V19, P346; Takahashi JMFK, 2009, GERODONTOLOGY, V26, P232, DOI 10.1111/j.1741-2358.2008.00270.x; Takahashi Y, 2013, ACTA ODONTOL SCAND, V71, P716, DOI 10.3109/00016357.2012.715196; Vallittu PK, 1997, INT J PROSTHODONT, V10, P254; VALLITTU PK, 1992, J ORAL REHABIL, V19, P225, DOI 10.1111/j.1365-2842.1992.tb01096.x; VALLITTU PK, 1993, ACTA ODONTOL SCAND, V51, P363, DOI 10.3109/00016359309040587; VALLITTU PK, 2009, INTERPENETRATING POL, P63; Vuorinen Anne-Maria, 2008, Dent Mater, V24, P708, DOI 10.1016/j.dental.2007.07.003; Wendt S L Jr, 1987, Quintessence Int, V18, P265	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	NOV	2014	39						73	78		10.1016/j.jmbbm.2014.07.012		6	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AR1IL	WOS:000343338800007		
J	Arahira, T; Todo, M				Arahira, Takaaki; Todo, Mitsugu			Effects of Proliferation and Differentiation of Mesenchymal Stem Cells on Compressive Mechanical Behavior of Collagen/beta-TCP Composite Scaffold	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article							TISSUE ENGINEERING APPLICATIONS; MARROW STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; GENE-EXPRESSION; HYBRID SPONGE; IN-VITRO; FABRICATION; ANGIOGENESIS; OSTEOBLASTS	The primary aim of this study is to characterize the effects of cell culture on the compressive mechanical behavior of the collagen/beta-tricalcium phosphate (TCP) composite scaffold. The composite and pure collagen scaffolds were fabricated by the solid liquid phase separation technique and the subsequent freeze-drying method. Rat bone marrow mesenchymal stem cells (rMSCs) were then cultured in these scaffolds up to 28 days. Compression test of the scaffolds with rMSCs were conducted periodically. Biological properties such as cell number, alkaline phosphatase (ALP) activity, and gene expressions of osteogenetic bone markers were evaluated during cell culture. The microstructural changes in the scaffolds during cell culture were also examined using a scanning electron microscope. The compressive elastic modulus was then correlated with those of the biological properties and microstructures to understand the mechanism of variational behavior of the macroscopic elastic property. The composite scaffold exhibited higher ALP activity and more active generation of osteoblastic markers than the collagen scaffold, indicating that beta-TCP can activate the differentiation of rMSCs into osteoblasts and extracellular matrix (ECM) formation such as type I collagen and the following mineralization. The variational behavior of the compressive modulus of the composite scaffold was affected by both the material degradation and the proliferation of cells and the ECM formation. In the first stage, the modulus of the composite scaffold tended to increase due to cell proliferation and the following formation of network structure. In the second stage, the modulus tended to decrease because the material degradation such as ductile deformation of collagen and decomposition of beta-TCP were more effective on the property than the ECM formation. In the third stage, active calcification by formation and growth of mineralized nodules resulted in the recovery of modulus. It is concluded that the introduction of beta-TCP powder into the porous collagen matrix is very effective to improve the mechanical and biological properties of collagen scaffold prepared for bone tissue engineering. Furthermore, the compressive modulus of the composite scaffold is strongly affected by the material degradation and the ECM formation by stem cells under in vitro culture condition. (C) 2014 Elsevier Ltd. All rights reserved.	[Arahira, Takaaki] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Fukuoka 8168580, Japan; [Todo, Mitsugu] Kyushu Univ, Appl Mech Res Inst, Fukuoka 8168580, Japan	Todo, M (reprint author), Kyushu Univ, Appl Mech Res Inst, Fukuoka 8168580, Japan.	todo@riam.kyushu-u.ac.jp	Kyushu, RIAM/F-4018-2015				Akkouch A, 2011, J BIOMED MATER RES A, V96A, P693, DOI 10.1002/jbm.a.33033; Arpornmaeklong P, 2008, INT J ORAL MAX SURG, V37, P357, DOI 10.1016/j.ijom.2007.11.014; Lu HX, 2011, BIOMATERIALS, V32, P9658, DOI 10.1016/j.biomaterials.2011.08.091; Park JE, 2011, J MATER SCI-MATER M, V22, P1171, DOI 10.1007/s10856-011-4289-4; Matsuno T, 2006, DENT MATER J, V25, P138; Porter JR, 2009, BIOMATERIALS, V30, P780, DOI 10.1016/j.biomaterials.2008.10.022; Lohan A, 2011, HISTOCHEM CELL BIOL, V136, P57, DOI 10.1007/s00418-011-0822-2; Heinemann C, 2008, BIOMACROMOLECULES, V9, P2913, DOI 10.1021/bm800693d; Zhang X, 2011, J MATER SCI-MATER M, V22, P371, DOI 10.1007/s10856-010-4198-y; Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063; Hiraoka Y, 2003, TISSUE ENG, V9, P1101, DOI 10.1089/10763270360728017; Salerno A, 2011, BIOTECHNOL BIOENG, V108, P963, DOI 10.1002/bit.23018; Girotto D, 2003, BIOMATERIALS, V24, P3265, DOI 10.1016/S0142-9612(03)00160-1; Wiria FE, 2008, J MATER SCI-MATER M, V19, P989, DOI 10.1007/s10856-007-3176-5; Chen GP, 2000, J BIOMED MATER RES, V51, P273, DOI 10.1002/(SICI)1097-4636(200008)51:2<273::AID-JBM16>3.0.CO;2-O; Kang YQ, 2012, BIOMATERIALS, V33, P6998, DOI 10.1016/j.biomaterials.2012.06.061; Liang WH, 2010, J BIOMED MATER RES A, V94A, P1050, DOI 10.1002/jbm.a.32774; Fujita M, 2005, TISSUE ENG, V11, P1346, DOI 10.1089/ten.2005.11.1346; Poffyn B, 2011, INT ORTHOP, V35, P889, DOI 10.1007/s00264-010-1098-1; Roohani-Esfahani SI, 2012, ACTA BIOMATER, V8, P302, DOI 10.1016/j.actbio.2011.10.009; Wang YC, 2003, TISSUE ENG, V9, P1205, DOI 10.1089/10763270360728116; Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031; Bonanomi A, 2003, J IMMUNOL METHODS, V283, P27, DOI 10.1016/j.jim.2003.08.002; Keogh MB, 2010, ACTA BIOMATER, V6, P4305, DOI 10.1016/j.actbio.2010.06.001; Correlo VM, 2009, J BIOMED MATER RES A, V91A, P489, DOI 10.1002/jbm.a.32221; Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J; Udoh K, 2010, DENT MATER J, V29, P154; Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024; Wang L, 2010, BIOMATERIALS, V31, P9452, DOI 10.1016/j.biomaterials.2010.08.036; Pabbruwe MB, 2010, BIOMATERIALS, V31, P2583, DOI 10.1016/j.biomaterials.2009.12.023; Lohfeld S, 2012, ACTA BIOMATER, V8, P3446, DOI 10.1016/j.actbio.2012.05.018; Bretcanu O, 2009, MATER CHEM PHYS, V118, P420, DOI 10.1016/j.matchemphys.2009.08.011; Capanna R, 2011, CLIN ORTHOP RELAT R, V469, P2905, DOI 10.1007/s11999-011-1882-2; CAPLAN AI, 1991, J ORTHOPAED RES, V9, P641, DOI 10.1002/jor.1100090504; Collins AM, 2009, ADV MATER, V21, P75, DOI 10.1002/adma.200802239; Gerard C, 2010, J BIOMED MATER RES A, V93A, P615, DOI 10.1002/jbm.a.32568; He XM, 2010, TISSUE ENG PART C-ME, V16, P329, DOI 10.1089/ten.TEC.2008.0703; Lu HX, 2010, BIOMATERIALS, V31, P5825, DOI 10.1016/j.biomaterials.2010.04.019; Sang L, 2011, MAT SCI ENG C-MATER, V31, P262, DOI 10.1016/j.msec.2010.09.008; Tiwari Akshay, 2012, J Clin Orthop Trauma, V3, P4, DOI 10.1016/j.jcot.2012.04.004; Yamasaki N, 2009, J BIOMED MATER RES B, V91B, P788, DOI 10.1002/jbm.b.31457	41	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	NOV	2014	39						218	230		10.1016/j.jmbbm.2014.07.013		13	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AR1IL	WOS:000343338800020		
J	Puppulin, L; Leto, A; Hasegawa, M; Pezzotti, G				Puppulin, Leonardo; Leto, Andrea; Hasegawa, Masahiro; Pezzotti, Giuseppe			A comparative microstructural study of vitamin-E blended and infused highly crosslinked UHMWPE for total knee arthroplasty	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						UHMWPE; Knee replacement; Raman spectroscopy; Vitamin-E; Microstructure; Annealing; Remelting; Irradiation	MOLECULAR-WEIGHT POLYETHYLENE; TOTAL HIP-ARTHROPLASTY; RAMAN-SPECTROSCOPY; POLARIZED RAMAN; LOW WEAR; ORIENTATION; RESISTANCE; CRYSTALLINITY; COMPONENTS; CREEP	The impact of adding antioxidant vitamin-E (alpha-tocopherol) to the microstructure of ultrahigh molecular weight polyethylene (UHMWPE) for total knee arthroplasty has been studied in detail by means of Raman microprobe spectroscopy. Three tibial insert samples prepared by different manufacturing methods were investigated, as follows: (A) a sample manufactured without blending with vitamin E which did not receive any irradiation dose after consolidation but underwent final sterilization in ethylene oxide (EtO); (B) a sample blended with 0.3 wt% of alpha-tocopherol, an isomer of vitamin E, and manufactured as sample (A); and, (C) a sample in which vitamin E was diffused after being irradiated with 100 kGy dose of gamma-ray. Clear microstructural differences were observed in terms of phase contents (i.e., amorphous, crystalline, and intermediate phase fraction), molecular orientation, and the degree of anisotropy between the investigated tibial plates. Vitamin E in the starting resin promoted chain mobility leading to reorganization of the molecular chains. The spectroscopic characterizations helps to rationalize the complex effect of vitamin-E on the UHMWPE microstructure and gives useful information on how significantly any single step of the manufacturing procedures might affect the mechanical properties of the final orthopedic component. (C) 2014 Elsevier Ltd. All rights reserved.	[Puppulin, Leonardo; Pezzotti, Giuseppe] Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 6068585, Japan; [Puppulin, Leonardo; Pezzotti, Giuseppe] Kyoto Inst Technol, Res Inst Nanosci, Sakyo Ku, Kyoto 6068585, Japan; [Leto, Andrea] Piezotech Japan Ltd, Sakyo Ku, Kyoto 6068126, Japan; [Hasegawa, Masahiro] Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie 5148507, Japan	Pezzotti, G (reprint author), Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 6068585, Japan.	pezzotti@kit.ac.jp					Addiego F, 2011, CLIN ORTHOP RELAT R, V469, P2318, DOI 10.1007/s11999-010-1716-7; Oral E, 2009, BIOMATERIALS, V30, P1870, DOI 10.1016/j.biomaterials.2008.12.029; Teramura S, 2008, J ORTHOP RES, V26, P460, DOI 10.1002/jor.20514; Bracco P, 2011, CLIN ORTHOP RELAT R, V469, P2286, DOI 10.1007/s11999-010-1717-6; Oral E, 2004, BIOMATERIALS, V25, P5515, DOI 10.1016/j.biomaterials.2003.12.048; Oral E, 2012, J BIOMED MATER RES B, V100B, P742, DOI 10.1002/jbm.b.32507; Oral E, 2006, BIOMATERIALS, V27, P917, DOI 10.1016/j.bomaterials.2005.06.025; PIGEON M, 1991, MACROMOLECULES, V24, P5687, DOI 10.1021/ma00020a032; Dorr LD, 2005, J BONE JOINT SURG AM, V87A, P1816, DOI 10.2106/JBJS.D.01915; Wang A, 1997, WEAR, V203, P230, DOI 10.1016/S0043-1648(96)07362-0; LOUDON R, 1964, ADV PHYS, V13, P423, DOI 10.1080/00018736400101051; Lewis G, 2001, BIOMATERIALS, V22, P371, DOI 10.1016/S0142-9612(00)00195-2; Bellare A, 1996, BIOMATERIALS, V17, P2325, DOI 10.1016/S0142-9612(96)00086-5; Digas G, 2004, CLIN ORTHOP RELAT R, P6, DOI 10.1097/01.blo.0000150314.70919.e3; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; RULL F, 1993, J RAMAN SPECTROSC, V24, P545, DOI 10.1002/jrs.1250240813; McKellop H, 1999, J ORTHOP RES, V17, P157, DOI 10.1002/jor.1100170203; STROBL GR, 1978, J POLYM SCI POL PHYS, V16, P1181, DOI 10.1002/pol.1978.180160704; Bergstrom JS, 2005, J ORTHOP RES, V23, P367, DOI 10.1016/j.orthres.2004.08.014; CITRA MJ, 1995, MACROMOLECULES, V28, P4007, DOI 10.1021/ma00115a037; HUBER J, 1995, BIOMED TECH, V40, P88, DOI 10.1515/bmte.1995.40.4.88; MAXFIELD J, 1978, J POLYM SCI POL PHYS, V16, P37, DOI 10.1002/pol.1978.180160104; MCDONALD MD, 1995, J BIOMED MATER RES, V29, P1, DOI 10.1002/jbm.820290102; Muratoglu OK, 2010, J BONE JOINT SURG AM, V92A, P2809, DOI 10.2106/JBJS.I.01017; Nikolaeva GYU, 1997, LASER PHYS, V7, P403; Nylor C.C., 1995, MACROMOLECULES, V28, P2969; Oonishi H, 1997, J MATER SCI-MATER M, V8, P11, DOI 10.1023/A:1018582027349; Oonishi H., 1998, T 44 ANN M ORTH RES, V97, P17; Perez R., 2008, J APPL PHYS, V103; Puertolas JA, 2011, J APPL POLYM SCI, V120, P2282, DOI 10.1002/app.33454; Puppulin L, 2011, J RAMAN SPECTROSC, V42, P482, DOI 10.1002/jrs.2725; Puppulin L, 2011, ACTA BIOMATER, V7, P1150, DOI 10.1016/j.actbio.2010.10.014; Scott M, 2005, J BIOMED MATER RES B, V73B, P325, DOI 10.1002/jbm.b.30213; Shibata N., 2006, J BIOMECH SCI ENG, V1, P107, DOI 10.1299/jbse.1.107; Takahashi Y, 2010, ACTA BIOMATER, V6, P3583, DOI 10.1016/j.actbio.2010.02.051; Turrell G., 1989, PRACTICAL RAMAN SPEC, P1	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	NOV	2014	39						247	256		10.1016/j.jmbbm.2014.07.029		10	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AR1IL	WOS:000343338800023		
J	Kusama, K; Itoh, T				Kusama, Kaori; Itoh, Takayuki			Abstract picture generation and zooming user interface for intuitive music browsing	MULTIMEDIA TOOLS AND APPLICATIONS			English	Article						Musical feature; Clustering; Abstract picture; Zooming user interface		Today many people store music media files in personal computers or portable audio players, thanks to recent evolution of multimedia technologies. The more music media files these devices store, the messier it is to search for tunes that users want to listen to. We propose MusCat, a music browser to interactively search for the tunes according to features, not according to metadata (e. g. title, artist name). The technique firstly calculates features of tunes, and then hierarchically clusters the tunes according to the features. It then automatically generates abstract pictures, so that users can recognize characteristics of tunes more instantly and intuitionally. It finally visualizes the tunes by using abstract pictures. MusCat enables intuitive music selection with the zooming user interface.	[Kusama, Kaori; Itoh, Takayuki] Ochanomizu Univ, Bunkyo Ku, Tokyo 1128610, Japan	Itoh, T (reprint author), Ochanomizu Univ, Bunkyo Ku, 2-1-1 Ohtsuka, Tokyo 1128610, Japan.	itot@is.ocha.ac.jp; kaori@itolab.is.ocha.ac.jp					Gomi A, 2008, IEEE INT CON INF VIS, P82; Goto M, 2005, P ISMIR 2005, P404; Kobayashi S, 2001, COLOR SYSTEM; Kolhoff P, 2006, SIBGRAPI, P289; Lamere P, 2007, P 8 INT C MUS INF RE, P173; Lartillot O, 2011, MIRTOOLBOX; Oda M, 2007, MIST MUSIC ICON SELE; Shiizuka H., 2008, J KANSEI ENG, V7, P659	8	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-7501	1573-7721		MULTIMED TOOLS APPL	Multimed. Tools Appl.	NOV	2014	73	2					995	1010		10.1007/s11042-012-1108-y		16	Computer Science, Information Systems; Computer Science, Software Engineering; Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	AQ8MX	WOS:000343080700023		
J	Sato, YD; Aihara, K				Sato, Yasuomi D.; Aihara, Kazuyuki			Changes of Firing Rate Induced by Changes of Phase Response Curve in Bifurcation Transitions	NEURAL COMPUTATION			English	Article							1ST-ORDER DIFFERENTIAL-EQUATIONS; MULTIPLE-PARAMETER SPACE; PYRAMIDAL NEURONS; CHOLINERGIC NEUROMODULATION; HOPF BIFURCATIONS; CORTICAL-NEURONS; MODEL; DYNAMICS; CORTEX; OSCILLATORS	We study dynamical mechanisms responsible for changes of the firing rate during four different bifurcation transitions in the two-dimensional Hindmarsh-Rose (2DHR) neuron model: the saddle node on an invariant circle (SNIC) bifurcation to the supercritical Andronov-Hopf (AH) one, the SNIC bifurcation to the saddle-separatrix loop (SSL) one, the AH bifurcation to the subcritical AH (SAH) one, and the SSL bifurcation to the AH one. For this purpose, we study slopes of the firing rate curve with respect to not only an external input current but also temperature that can be interpreted as a timescale in the 2DHR neuron model. These slopes are mathematically formulated with phase response curves (PRCs), expanding the firing rate with perturbations of the temperature and external input current on the one-dimensional space of the phase SI in the 2DHR oscillator. By analyzing the two different slopes of the firing rate curve with respect to the temperature and external input current, we find that during changes of the firing rate in all of the bifurcation transitions, the calculated slope with respect to the temperature also changes. This is largely dependent on changes in the PRC size that is also related to the slope with respect to the external input current. Furthermore, we find phase transition like switches of the firing rate with a possible increase of the temperature during the SSL-to-AH bifurcation transition.	[Sato, Yasuomi D.] Kyushu Inst Technol, Dept Brain Sci & Engn, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka 8080196, Japan; [Sato, Yasuomi D.] Goethe Univ Frankfurt, Frankfurt Inst Adv Studies, D-60438 Frankfurt, Germany; [Sato, Yasuomi D.; Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Sato, YD (reprint author), Kyushu Inst Technol, Dept Brain Sci & Engn, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka 8080196, Japan.	sato-y@brain.kyutech.ac.jp; aihara@sat.t.u-tokyo.ac.jp			JSPS [25540110]; Aihara Project; FIRST program from JSPS; CSTP	This research was partially supported by a grant-in-aid for Challenging Exploratory Research (25540110) from JSPS (Y.D.S.), and the Aihara Project, the FIRST program from JSPS, initiated by CSTP (K.A.). We thank K. Natsume, K. Tateno at the Kyushu Institute of Technology, S. Tsuji at the Oita National College of Technology, and H. Nakao at the Tokyo Institute of Technology for fruitful and active discussions.	Adair RK, 1999, P NATL ACAD SCI USA, V96, P11825, DOI 10.1073/pnas.96.21.11825; AIHARA K, 1983, BIOPHYS J, V41, P87; Brown E, 2004, NEURAL COMPUT, V16, P673, DOI 10.1162/089976604322860668; Wu S, 2002, NEURAL COMPUT, V14, P999, DOI 10.1162/089976602753633367; Netoff TI, 2005, J NEUROPHYSIOL, V93, P1197, DOI 10.1152/jn.00982.2004; Tsubo Y, 2007, EUR J NEUROSCI, V25, P3429, DOI 10.1111/j.1460-9568.2007.05579.x; Fukai H, 2000, BIOL CYBERN, V82, P215, DOI 10.1007/s004220050021; Tateno T, 2006, J NEUROPHYSIOL, V95, P2650, DOI 10.1152/jn.00683.2005; Prescott SA, 2008, J NEUROPHYSIOL, V100, P3030, DOI 10.1152/jn.90634.2008; Sato YD, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.041903; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Golomb D, 1997, J NEUROPHYSIOL, V78, P1199; HANSEL D, 1995, NEURAL COMPUT, V7, P307, DOI 10.1162/neco.1995.7.2.307; Touboul J, 2009, SIAM J APPL DYN SYST, V8, P1462, DOI 10.1137/080742762; Tsuji S, 2007, INT J BIFURCAT CHAOS, V17, P985, DOI 10.1142/S0218127407017707; Tateno T, 2004, J NEUROPHYSIOL, V92, P2283, DOI 10.1152/jn.00109.2004; Schwemmer MA, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.031906; Schultheiss NW, 2010, J NEUROSCI, V30, P2767, DOI 10.1523/JNEUROSCI.3959-09.2010; Shlizerman E, 2012, NEURAL COMPUT, V24, P2078, DOI 10.1162/NECO_a_00308; MORRIS C, 1981, BIOPHYS J, V35, P193; Izhikevich EM, 2000, INT J BIFURCAT CHAOS, V10, P1171, DOI 10.1142/S0218127400000840; Wang HT, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.021915; FITZHUGH R, 1961, BIOPHYS J, V1, P445; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500; HINDMARSH JL, 1982, NATURE, V296, P162, DOI 10.1038/296162a0; Ding L, 2010, NONLINEAR DYNAM, V60, P131, DOI 10.1007/s11071-009-9585-x; Ermentrout B., 2002, SIMULATING ANAL ANIM; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; Feudel U, 2000, CHAOS, V10, P231, DOI 10.1063/1.166488; Fink C. G., 2012, THEORY EXPT ANAL; FitzHugh R., 1969, BIOL ENG, P1; Fukai H, 2000, BIOL CYBERN, V82, P223, DOI 10.1007/s004220050022; HINDMARSH JL, 1984, PROC R SOC SER B-BIO, V221, P87, DOI 10.1098/rspb.1984.0024; Hoppensteadt F. C., 1997, WEAKLY CONNECTED NEU; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574; Izhikevich E M, 2007, DYNAMICAL SYSTEMS NE; Izhikevich E.M., 2006, ENCY MATH PHYS, V5, P448; Josic K., 2006, SCHOLARPEDIA, V1, P1361; KAWATO M, 1981, J MATH BIOL, V12, P13; KAWATO M, 1978, BIOL CYBERN, V30, P241, DOI 10.1007/BF00361045; Keener JP, 1998, MATH PHYSL; Koch C., 1999, BIOPHYSICS COMPUTATI; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Lecar H., 2007, SCHOLARPEDIA, V2, P1333; LONG RR, 1977, J NEUROPHYSIOL, V40, P489; Matsubara T., 2012, LNCS, V7552, P231; Mehrotra A, 2004, NOISE ANAL RADIO FRE; Schultheiss NW, 2012, SPR SER COMPUT NEURO, V6, P1, DOI 10.1007/978-1-4614-0739-3; Prescott SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000198; ROSE RM, 1989, PROC R SOC SER B-BIO, V237, P267, DOI 10.1098/rspb.1989.0049; Sato Y. D., 2012, RES NEUROSCIENCE, V1, P8; Sato Y. D, 2012, INT J MODERN ENG RES, V2, P2728; Sato YD, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.031910; Sato YD, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011909; Sterratt D., 2011, PRINCIPLES COMPUTATI; Stiefel KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003947; Stiefel KM, 2009, J COMPUT NEUROSCI, V26, P289, DOI 10.1007/s10827-008-0111-9; Tsubo Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228101; Wilson HR, 1999, J THEOR BIOL, V200, P375, DOI 10.1006/jtbi.1999.1002; Winfree A. T., 1980, GEOMETRY BIOL TIME; Xie Y, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061921	61	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0899-7667	1530-888X		NEURAL COMPUT	Neural Comput.	NOV	2014	26	11					2395	2418		10.1162/NECO_a_00653		24	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	AQ9PB	WOS:000343186700002		
J	Matsui, H; Zheng, MH; Hoshino, O				Matsui, Hiroakira; Zheng, Meihong; Hoshino, Osamu			Facilitation of Neuronal Responses by Intrinsic Default Mode Network Activity	NEURAL COMPUTATION			English	Article							CEREBELLAR GRANULE CELLS; CENTRAL-NERVOUS-SYSTEM; GABA(A) RECEPTORS; AMBIENT GABA; GABAERGIC GLIOTRANSMISSION; AMINO-ACIDS; GLIA; INHIBITION; BRAIN; RAT	Default mode network (DMN) shows intrinsic, high-level activity at rest. We tested a hypothesis proposed for its role in sensory information processing: Intrinsic DMN activity facilitates neural responses to sensory input. A neural network model, consisting of a sensory network (Nsen) and a DMN, was simulated. The Nsen contained cell assemblies. Each cell assembly comprised principal cells, GABAergic intemeurons (Ia, Ib), and glial cells. We let the Nsen carry out a perceptual task: detection of sensory stimuli. During DMN activation, glial cells were hyperpolarized by la-to-glia circuitry, by which glial membrane transporters imported GABA molecules from the extracellular space and decreased ambient GABA concentration. Acting on extrasynaptic GABA receptors, the decrease in ambient GABA concentration reduced inhibitory current in a tonic manner. This depolarized principal cells below their firing threshold during the ongoing spontaneous time period and accelerated their reaction speed to a sensory stimulus. During the stimulus presentation period, the Nsen inhibited the DMN and caused DMN deactivation. The DMN deactivation made Nsen Ia cells cease firing, thereby stopping the glial membrane hyperpolarization, quitting the GABA import, returning to the basal ambient GABA level, and thus enhancing global inhibition. Notably, the stimulus-relevant P cell firing could be maintained when GABAergic gliotransmission via la-glia signaling worked, decreasing ambient GABA concentration around the stimulus-relevant P cells. This enabled the Nsen to reliably detect the stimulus. We suggest that intrinsic default model network activity may accelerate the reaction speed of the sensory network by modulating its ongoing-spontaneous activity in a subthreshold manner. Ambient GABA contributes to achieve an optimal ongoing spontaneous subthreshold neuronal state, in which GABAergic gliotransmission triggered by the intrinsic default model network activity may play an important role.	[Matsui, Hiroakira; Hoshino, Osamu] Ibaraki Univ, Dept Intelligent Syst Engn, Hitachi, Ibaraki 3168511, Japan; [Zheng, Meihong] Tsinghua Univ, Dept Psychol, Beijing 100084, Peoples R China	Matsui, H (reprint author), Ibaraki Univ, Dept Intelligent Syst Engn, Hitachi, Ibaraki 3168511, Japan.	rinnakyarotto@hotmail.co.jp; zhengmh@mail.tsinghua.edu.cn; hoshino@mx.ibaraki.ac.jp					Lin SC, 2004, NAT NEUROSCI, V7, P24, DOI 10.1038/nn1162; Kozlov AS, 2006, P NATL ACAD SCI USA, V103, P10058, DOI 10.1073/pnas.0603741103; Hoshino O, 2007, NEURAL COMPUT, V19, P3310, DOI 10.1162/neco.2007.19.12.3310; MACONOCHIE DJ, 1994, NEURON, V12, P61, DOI 10.1016/0896-6273(94)90152-X; LERMA J, 1986, BRAIN RES, V384, P145, DOI 10.1016/0006-8993(86)91230-8; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Scimemi A, 2005, J NEUROSCI, V25, P10016, DOI 10.1523/JNEUROSCI.2520-05.2005; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753; TOSSMAN U, 1986, ACTA PHYSIOL SCAND, V127, P533, DOI 10.1111/j.1748-1716.1986.tb07938.x; Scimemi A, 2006, EUR J NEUROSCI, V24, P1157, DOI 10.1111/j.1460-9568.2006.04989.x; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Hoshino O, 2009, NEURAL COMPUT, V21, P1683, DOI 10.1162/neco.2009.05-08-778; Wu YM, 2003, J NEUROPHYSIOL, V89, P2021, DOI 10.1152/jn.00856.2002; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Hoshino O, 2010, NEURAL COMPUT, V22, P1358, DOI 10.1162/neco.2010.02-09-969; Saxena NC, 1996, MOL PHARMACOL, V49, P567; Drasbek KR, 2006, CEREB CORTEX, V16, P1134, DOI 10.1093/cercor/bhj055; Hoshino O, 2012, NEURAL COMPUT, V24, P2964, DOI 10.1162/NECO_a_00356; Soltesz I, 2001, NATURE, V409, P24, DOI 10.1038/35051187; Verkhratsky A, 2010, NEUROCHEM INT, V57, P332, DOI 10.1016/j.neuint.2010.02.002; Harris KD, 2013, NATURE, V503, P51, DOI 10.1038/nature12654; Velez-Fort M, 2012, NEUROSCIENTIST, V18, P237, DOI 10.1177/1073858411403317; Bezzi P, 2001, CURR OPIN NEUROBIOL, V11, P387, DOI 10.1016/S0959-4388(00)00223-3; Richerson GB, 2003, J NEUROPHYSIOL, V90, P1363, DOI 10.1152/jn.00317.2003; Ortinski PI, 2006, J NEUROSCI, V26, P9323, DOI 10.1523/JNEUROSCI.2610-06.2006; Hoshino O, 2013, NEURAL COMPUT, V25, P1164, DOI 10.1162/NECO_a_00431; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Hoshino O, 2011, NEURAL COMPUT, V23, P958, DOI 10.1162/NECO_a_00096; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Wu YM, 2007, NEURON, V56, P851, DOI 10.1016/j.neuron.2007.10.021; Eulenburg V, 2010, BRAIN RES REV, V63, P103, DOI 10.1016/j.brainresrev.2010.01.003; SOMOGYI P, 1989, J NEUROSCI, V9, P2197; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Koch U, 2009, CURR OPIN NEUROBIOL, V19, P305, DOI 10.1016/j.conb.2009.03.006; Hoshino O, 2011, NEURAL COMPUT, V23, P3205, DOI 10.1162/NECO_a_00211; Maya-Vetencourt JF, 2012, NEURAL PLAST, DOI 10.1155/2012/250421; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Barakat L, 2002, J NEUROPHYSIOL, V88, P1407, DOI 10.1152/jn.01002.2001; Angulo MC, 2008, PROG NEUROBIOL, V86, P297, DOI 10.1016/j.pneurobio.2008.08.002; Hoshino O, 2007, NEURAL COMPUT, V19, P351, DOI 10.1162/neco.2007.19.2.351; Hoshino O, 2008, NEURAL COMPUT, V20, P3055, DOI 10.1162/neco.2008.08-07-589; Bianchi MT, 2002, NEUROPHARMACOLOGY, V43, P492, DOI 10.1016/S0028-3908(02)00163-6; Bianchi MT, 2001, J NEUROSCI, V21, P1127; Destexhe A., 1998, METHODS NEURONAL MOD, P1; Hoshino O, 2013, NEURAL COMPUT, V25, P3235, DOI 10.1162/NECO_a_00519; NUSSER Z, 1995, J NEUROSCI, V15, P2948; Overstreet LS, 2005, TRENDS NEUROSCI, V28, P59, DOI 10.1016/j.tins.2004.11.010; Raichle Marcus E, 2007, Neuroimage, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Richerson George B, 2004, Epilepsy Curr, V4, P239, DOI 10.1111/j.1535-7597.2004.46008.x; Zheng MH, 2014, NEURAL COMPUT, V26, P1690, DOI 10.1162/NECO_a_00612	52	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0899-7667	1530-888X		NEURAL COMPUT	Neural Comput.	NOV	2014	26	11					2441	2464		10.1162/NECO_a_00660		24	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	AQ9PB	WOS:000343186700004		
J	Takeda, A; Fujiwara, S; Kanamori, T				Takeda, Akiko; Fujiwara, Shuhei; Kanamori, Takafumi			Extended Robust Support Vector Machine Based on Financial Risk Minimization	NEURAL COMPUTATION			English	Article							VALUE-AT-RISK	Financial risk measures have been used recently in machine learning. For example, v-support vector machine (v-SVM) minimizes the conditional value at risk (CVaR) of margin distribution. The measure is popular in finance because of the subadditivity property, but it is very sensitive to a few outliers in the tail of the distribution. We propose a new classification method, extended robust SVM (ER-SVM), which minimizes an intermediate risk measure between the CVaR and value at risk (VaR) by expecting that the resulting model becomes less sensitive than v-SVM to outliers. We can regard ER-SVM as an extension of robust SVM, which uses a truncated hinge loss. Numerical experiments imply the ER-SVM's possibility of achieving a better prediction performance with proper parameter setting.	[Takeda, Akiko; Fujiwara, Shuhei] Univ Tokyo, Dept Math Informat, Bunkyo Ku, Tokyo 1138656, Japan; [Kanamori, Takafumi] Nagoya Univ, Dept Comp Sci & Math Informat, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Takeda, A (reprint author), Univ Tokyo, Dept Math Informat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	takeda@mist.i.u-tokyo.ac.jp; shuhei_fujiwara@mist.i.u-tokyo.ac.jp; kanamori@is.nagoya-u.ac.jp					Rockafellar RT, 2002, J BANK FINANC, V26, P1443, DOI 10.1016/S0378-4266(02)00271-6; Artzner P, 1999, MATH FINANC, V9, P203, DOI 10.1111/1467-9965.00068; Takeda A, 2013, NEURAL COMPUT, V25, P759, DOI 10.1162/NECO_a_00412; Xu H, 2009, IEEE DECIS CONTR P, P4655, DOI 10.1109/CDC.2009.5400598; Wu YC, 2007, J AM STAT ASSOC, V102, P974, DOI 10.1198/016214507000000617; Scholkopf B, 2000, NEURAL COMPUT, V12, P1207, DOI 10.1162/089976600300015565; Shen XT, 2003, J AM STAT ASSOC, V98, P724, DOI 10.1198/016214503000000639; Brooks JP, 2011, OPER RES, V59, P467, DOI 10.1287/opre.1100.0854; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Tsyurmasto P, 2014, J COMB OPTIM, V28, P218, DOI 10.1007/s10878-013-9678-9; Bennett K.P., 2000, P 17 INT C MACH LEAR, P57; BenTal A, 2009, PRINC SER APPL MATH, P1; Bishop C. M., 2006, PATTERN RECOGNITION; Blake C., 1998, UCI REPOSITORY MACHI; Briec W, 1997, J OPTIMIZ THEORY APP, V93, P301, DOI 10.1023/A:1022697822407; Chang C.C., 2001, LIBSVM LIB SUPPORT V; Collobert R., 2006, P 23 INT C MACH LEAR, P129; Crisp DJ, 2000, ADV NEUR IN, V12, P244; Fukunaga K., 1990, INTRO STAT PATTERN R; Lanckriet G. R. G., 2002, J MACHINE LEARNING R, V3, P555; Larsen N., 2002, FINANCIAL ENG E COMM, P129; Perez-Cruz F, 2003, NATO SCI 3, V190, P179; Smola A., 2002, LEARNING KERNELS; Takeda A., 2012, P 29 ANN INT C MACH, P129; Takeda A., 2008, P 25 INT C MACH LEAR, P1056, DOI 10.1145/1390156.1390289; Xu L., 2006, P 21 NATL C ART INT, V1, P536; Yu Y., 2010, ADV NEURAL INFORM PR, V10, P2532	27	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0899-7667	1530-888X		NEURAL COMPUT	Neural Comput.	NOV	2014	26	11					2541	2569		10.1162/NECO_a_00647		29	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	AQ9PB	WOS:000343186700008		
J	Morichi, S; Yamanaka, G; Ishida, Y; Oana, S; Kashiwagi, Y; Kawashima, H				Morichi, Shinichiro; Yamanaka, Gaku; Ishida, Yu; Oana, Shingo; Kashiwagi, Yasuyo; Kawashima, Hisashi			Brain-Derived Neurotrophic Factor and Interleukin-6 Levels in the Serum and Cerebrospinal Fluid of Children with Viral Infection-Induced Encephalopathy	NEUROCHEMICAL RESEARCH			English	Article						BDNF; Neurotrophin; Interleukin-6; Acute encephalopathy; Pediatrics	SIGNALING PATHWAYS; UP-REGULATION; FACTOR BDNF; EXPRESSION; MENINGITIS; PLASMA; ENCEPHALITIS; DISORDERS; EPILEPSY; RECEPTOR	We investigated changes in the brain-derived neurotrophic factor (BDNF) and interleukin (IL)-6 levels in pediatric patients with central nervous system (CNS) infections, particularly viral infection-induced encephalopathy. Over a 5-year study period, 24 children hospitalized with encephalopathy were grouped based on their acute encephalopathy type (the excitotoxicity, cytokine storm, and metabolic error types). Children without CNS infections served as controls. In serum and cerebrospinal fluid (CSF) samples, BDNF and IL-6 levels were increased in all encephalopathy groups, and significant increases were noted in the influenza-associated and cytokine storm encephalopathy groups. Children with sequelae showed higher BDNF and IL-6 levels than those without sequelae. In pediatric patients, changes in serum and CSF BDNF and IL-6 levels may serve as a prognostic index of CNS infections, particularly for the diagnosis of encephalopathy and differentiation of encephalopathy types.	[Morichi, Shinichiro; Yamanaka, Gaku; Ishida, Yu; Oana, Shingo; Kashiwagi, Yasuyo; Kawashima, Hisashi] Tokyo Med Univ, Dept Pediat, Shinjuku Ku, Tokyo 1600023, Japan	Morichi, S (reprint author), Tokyo Med Univ, Dept Pediat, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	shinichiro-m@hotmail.co.jp					Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Al-Ayadhi LY, 2012, NEUROCHEM RES, V37, P394, DOI 10.1007/s11064-011-0624-x; Shirayama Y, 2002, J NEUROSCI, V22, P3251; Simonato M, 2006, TRENDS PHARMACOL SCI, V27, P631, DOI 10.1016/j.tips.2006.10.002; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; BARDE YA, 1982, EMBO J, V1, P549; Kawano G, 2011, ARCH DIS CHILD, V96, P936, DOI 10.1136/adc.2009.180554; Aronica E, 2001, ACTA NEUROPATHOL, V101, P383; Zhang YJ, 2010, NEUROCHEM RES, V35, P480, DOI 10.1007/s11064-009-0084-8; Qu WS, 2010, NEUROCHEM RES, V35, P1716, DOI 10.1007/s11064-010-0234-z; Ma HY, 2012, NEUROCHEM RES, V37, P69, DOI 10.1007/s11064-011-0584-1; Chiaretti A, 2013, INT J INFECT DIS, V17, pE1186, DOI 10.1016/j.ijid.2013.07.006; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003; Mizuguchi M, 2007, ACTA NEUROL SCAND, V115, P45, DOI 10.1111/j.1600-0404.2007.00809.x; Hsieh CC, 2009, CHILD NERV SYST, V25, P461, DOI 10.1007/s00381-008-0715-4; Azmitia EC, 2001, BRAIN DEV-JPN, V23, pS1, DOI 10.1016/S0387-7604(01)00368-0; Chiaretti A, 2004, ACTA PAEDIATR, V93, P1178, DOI 10.1080/08035250410031314; Katsuragi Shinji, 2011, No To Hattatsu, V43, P265; Kizawa-Ueda M, 2011, EUR NEUROL, V653, P138; Mizuno Y, 2000, J CHILD NEUROL, V15, P19, DOI 10.1177/088307380001500104; Morichi S, 2013, INT J NEUROSCI, V123, P17, DOI 10.3109/00207454.2012.721829; Sellner J, 2005, MOL BRAIN RES, V137, P267, DOI 10.1016/j.molbrainres.2005.03.011; Stoica G, 2008, BRAIN RES, V1208, P204, DOI 10.1016/j.brainres.2008.02.085; Tokunaga Y, 2002, PEDIATR NEUROL, V27, P102, DOI 10.1016/S0887-8994(02)00387-9; Wang Y, 2013, INT J NEUROSCI, V123, P191, DOI 10.3109/00207454.2012.744755; Yoshimura R, 2010, HUM PSYCHOPHARM CLIN, V25, P566, DOI 10.1002/hup.1155	27	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	NOV	2014	39	11					2143	2149		10.1007/s11064-014-1409-9		7	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	AR0WC	WOS:000343293000014		
J	Nakao, A; Morimoto, R; Kato, Y; Kakinoki, Y; Ogawa, K; Katsuyama, T				Nakao, Akira; Morimoto, Ryuji; Kato, Yuya; Kakinoki, Yoshiaki; Ogawa, Kosuke; Katsuyama, Toshio			Integrated waveguide-type red-green-blue beam combiners for compact projection-type displays	OPTICS COMMUNICATIONS			English	Article						Optical multiplexer; Laser beam combiner; Optical integrated circuit; Optical waveguide; Color image display; Retinal imaging display	MULTIPLEXER	We propose and analyze a new integrated waveguide-type red-green-blue (RGB) beam combiner that can contribute to a miniaturization of the compact projection-type displays such as an eyewear projector. The essential point of this beam combiner is that it is composed of three individual waveguides for RGB light inputs, and three directional couplers. The combined output light can be obtained from the single waveguide. The waveguide supports the single mode transmission. The efficiency for output light is as high as 96%, and the size is as small as 0.06 x 7.8 mm. In addition, the small dependence of the output efficiency on the wavelength and the relatively large fabrication tolerance are obtained. (C) 2014 Elsevier B.V. All rights reserved.	[Nakao, Akira; Morimoto, Ryuji; Kato, Yuya; Kakinoki, Yoshiaki; Ogawa, Kosuke; Katsuyama, Toshio] Univ Fukui, Grad Sch Engn, Fukui 9108507, Japan	Katsuyama, T (reprint author), Univ Fukui, Grad Sch Engn, Bunkyo 3-9-1, Fukui 9108507, Japan.	t-katsu@u-fukui.ac.jp					Pan JW, 2008, APPL OPTICS, V47, P3406, DOI 10.1364/AO.47.003406; Billinghurst M, 1999, COMPUTER, V32, P57, DOI 10.1109/2.738305; de Peralta LG, 2003, IEEE PHOTONIC TECH L, V15, P1398, DOI 10.1109/LPT.2003.818223; Hosomi K, 2006, J VAC SCI TECHNOL B, V24, P1226, DOI 10.1116/1.2194942; Kim SC, 2006, OPT COMMUN, V266, P55, DOI 10.1016/j.optcom.2006.04.018; Kimura J., 2012, P INT DISPL WORKSH I, V19, P1355; Miller J., 2012, P 1 LAS DISPL C LDC; Ren EE, 2009, OPT COMMUN, V282, P2818, DOI 10.1016/j.optcom.2009.03.076; Tamura H., 2012, P INT DISPL WORKSH I, V19, P7	9	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0030-4018	1873-0310		OPT COMMUN	Opt. Commun.	NOV 1	2014	330						45	48		10.1016/j.optcom.2014.05.024		4	Optics	Optics	AR1GG	WOS:000343333100009		
J	Freeman, S; Otero-Colina, G; Rodriguez-Alvarado, G; Fernandez-Pavia, S; Maymon, M; Ploetz, RC; Aoki, T; O'Donnell, K				Freeman, S.; Otero-Colina, G.; Rodriguez-Alvarado, G.; Fernandez-Pavia, S.; Maymon, M.; Ploetz, R. C.; Aoki, T.; O'Donnell, K.			First Report of Mango Malformation Disease Caused by Fusarium pseudocircinatum in Mexico	PLANT DISEASE			English	News Item									[Freeman, S.; Maymon, M.] Agr Res Org, Dept Plant Pathol & Weed Res, Volcani Ctr, IL-50250 Bet Dagan, Israel; [Otero-Colina, G.] Colegio Postgrad, Montecillo 56230, Texcoco, Mexico; [Rodriguez-Alvarado, G.; Fernandez-Pavia, S.] Univ Michoacana, Morelia 58880, Michoacan, Mexico; [Ploetz, R. C.] Univ Florida, Dept Plant Pathol, Trop Res & Educ Ctr, Homestead, FL 33031 USA; [Aoki, T.] Natl Inst Agrobiol Sci, Genet Resources Ctr MAFF, Tsukuba, Ibaraki 3058602, Japan; [O'Donnell, K.] ARS, Bacterial Foodborne Pathogens & Mycol Res Unit, NCAUR, USDA, Peoria, IL 61604 USA	Freeman, S (reprint author), Agr Res Org, Dept Plant Pathol & Weed Res, Volcani Ctr, POB 6, IL-50250 Bet Dagan, Israel.						Freeman S, 1999, PHYTOPATHOLOGY, V89, P456, DOI 10.1094/PHYTO.1999.89.6.456; Lima CS, 2012, MYCOLOGIA, V104, P1408, DOI 10.3852/12-052; Marasas WFO, 2006, PHYTOPATHOLOGY, V96, P667, DOI 10.1094/PHYTO-96-0667; Otero-Colina G, 2010, PHYTOPATHOLOGY, V100, P1176, DOI 10.1094/PHYTO-01-10-0029	4	0	0	AMER PHYTOPATHOLOGICAL SOC	ST PAUL	3340 PILOT KNOB ROAD, ST PAUL, MN 55121 USA	0191-2917	1943-7692		PLANT DIS	PLANT DIS.	NOV	2014	98	11					1583	1583		10.1094/PDIS-04-14-0375-PDN		1	Plant Sciences	Plant Sciences	AR1QI	WOS:000343359300034		
J	Takao, S; Hirawake, T; Hashida, G; Sasaki, H; Hattori, H; Suzuki, K				Takao, Shintaro; Hirawake, Toru; Hashida, Gen; Sasaki, Hiroshi; Hattori, Hiroshi; Suzuki, Koji			Phytoplankton community composition and photosynthetic physiology in the Australian sector of the Southern Ocean during the austral summer of 2010/2011	POLAR BIOLOGY			English	Article						Phytoplankton community composition; Photosynthetic physiology; Diatoms; FIRe fluorometry; Southern Ocean	LIGHT-SATURATED PHOTOSYNTHESIS; HPLC PIGMENT SIGNATURES; SUB-ARCTIC PACIFIC; PRIMARY PRODUCTIVITY; ROSS-SEA; IRON FERTILIZATION; ANTARCTIC PHYTOPLANKTON; ASSEMBLAGE COMPOSITION; MARINE-PHYTOPLANKTON; ENERGY-CONVERSION	Phytoplankton population dynamics play an important role in biogeochemical cycles in the Southern Ocean during austral summer. However, the relationship between phytoplankton community composition and primary productivity remains elusive in this region. We investigated the community composition and photosynthetic physiology of surface phytoplankton assemblages in the Australian sector of the Southern Ocean from December 2010 to January 2011. There were significant latitudinal variations in hydrographic and biological parameters along 110A degrees E and 140A degrees E. Surface (5 m) chlorophyll a (chl a) concentrations measured with high-performance liquid chromatography varied between 0.18 and 0.99 mg m(-3). The diatom contribution to the surface chl a biomass increased in the south, as estimated with algal chemotaxonomic pigment markers, while the contributions of haptophytes and chlorophytes decreased. In our photosynthesis-irradiance (P-E) curve experiment, the maximum photosynthetic rate normalized to chl a (), initial slope (alpha (*)), the maximum quantum yield of carbon fixation (I broken vertical bar (c max)), and the photoinhibition index (beta (*)) were higher in the region where diatoms contributed > 50 % to the chl a biomass. In addition, there were statistically significant correlations between the diatom contribution to the chl a biomass and the P-E parameters. These results suggested that the changes in the phytoplankton community composition, primarily in diatoms, could strongly affect photosynthetic physiology in the Australian sector of the Southern Ocean.	[Takao, Shintaro; Suzuki, Koji] Hokkaido Univ, Grad Sch Environm Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Takao, Shintaro; Suzuki, Koji] Hokkaido Univ, Fac Environm Earth Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Hirawake, Toru] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; [Hashida, Gen] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan; [Sasaki, Hiroshi] Ishinomaki Senshu Univ, Dept Biol Sci, Ishinomaki, Miyagi 9868580, Japan; [Hattori, Hiroshi] Hokkaido Tokai Univ, Dept Marine Sci & Technol, Minami Ku, Sapporo, Hokkaido 0058601, Japan; [Suzuki, Koji] Japan Sci & Technol Agcy, CREST, Kita Ku, Sapporo, Hokkaido 0600810, Japan	Takao, S (reprint author), Hokkaido Univ, Grad Sch Environm Sci, Kita Ku, North 10 West 5, Sapporo, Hokkaido 0600810, Japan.	takao@ees.hokudai.ac.jp	Suzuki, Koji/A-4349-2013	Suzuki, Koji/0000-0001-5354-1044	Japan Society for the Promotion of Science (JSPS); JARE RAMEEC project; JAXA GCOM-C RA4 [JX-PSPC-381949]	We are grateful to the captain and crew of the TR/V Umitaka-Maru, Dr. M. Moteki (Tokyo University of Marine Science and Technology), and many other colleagues on board for their assistance in collecting samples during cruises. We thank Dr. T. Odate (National Institute of Polar Research) for giving a chance to join the JARE RAMEEC (Responses of Antarctic Marine Ecosystems to global Environmental Changes with Carbonate systems) project. We also thank the Distributed Active Archive Center (DAAC) at the Goddard Space Flight Center (GSFC) for the production and distribution of satellite data. We appreciate the editor, Dr. A.-C. Alderkamp, and two anonymous reviewers for providing valuable comments that improved the manuscript significantly. This work was supported in part by the Japan Society for the Promotion of Science (JSPS), the JARE RAMEEC project, and the JAXA GCOM-C RA4 (JX-PSPC-381949).	Alderkamp A-C, 2010, LIMNOL OCEANOGR, V55, P248; Schoemann V, 2005, J SEA RES, V53, P43, DOI 10.1016/j.seares.2004.01.008; Seeyave S, 2007, DEEP-SEA RES PT II, V54, P2020, DOI 10.1016/j.dsr2.2007.06.010; DEBAAR HJW, 1995, NATURE, V373, P412, DOI 10.1038/373412a0; de Salas MF, 2011, DEEP-SEA RES PT II, V58, P2135, DOI 10.1016/j.dsr2.2011.05.032; GREENE RM, 1992, PLANT PHYSIOL, V100, P565, DOI 10.1104/pp.100.2.565; Suggett DJ, 2009, MAR ECOL PROG SER, V376, P1, DOI 10.3354/meps07830; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; NELSON DM, 1991, LIMNOL OCEANOGR, V36, P1650; KOLBER ZS, 1994, NATURE, V371, P145, DOI 10.1038/371145a0; HAMA T, 1983, MAR BIOL, V73, P31, DOI 10.1007/BF00396282; Arrigo KR, 1999, SCIENCE, V283, P365, DOI 10.1126/science.283.5400.365; KISHINO M, 1985, B MAR SCI, V37, P634; MARTIN JH, 1990, NATURE, V345, P156, DOI 10.1038/345156a0; Behrenfeld MJ, 2004, J PHYCOL, V40, P4, DOI 10.1046/j.1529-8817.2004.03083.x; Gervais F, 2002, LIMNOL OCEANOGR, V47, P1324; Moline MA, 1998, ANTARCT SCI, V10, P45; Sakshaug E, 1997, J PLANKTON RES, V19, P1637, DOI 10.1093/plankt/19.11.1637; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; McNeil BI, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2007GB002991; MITCHELL BG, 1991, DEEP-SEA RES, V38, P981, DOI 10.1016/0198-0149(91)90093-U; Suzuki K, 2009, DEEP-SEA RES PT II, V56, P2733, DOI 10.1016/j.dsr2.2009.06.001; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Korb RE, 2005, J MARINE SYST, V57, P231, DOI 10.1016/j.jmarsys.2005.04.009; Zapata M, 2004, MAR ECOL PROG SER, V270, P83, DOI 10.3354/meps270083; MITCHELL BG, 1991, LIMNOL OCEANOGR, V36, P1662; Uitz J, 2009, DEEP-SEA RES PT I, V56, P541, DOI 10.1016/j.dsr.2008.11.006; Dong S, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC004051; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; KOLBER Z, 1988, PLANT PHYSIOL, V88, P923, DOI 10.1104/pp.88.3.923; Vaillancourt RD, 2003, DEEP-SEA RES PT II, V50, P1415, DOI 10.1016/S0967-0645(03)00077-8; CLEVELAND JS, 1993, LIMNOL OCEANOGR, V38, P1321; Wright SW, 1996, MAR ECOL PROG SER, V144, P285, DOI 10.3354/meps144285; Wright SW, 2010, DEEP-SEA RES PT II, V57, P758, DOI 10.1016/j.dsr2.2009.06.015; DAVISON IR, 1991, J PHYCOL, V27, P2, DOI 10.1111/j.0022-3646.1991.00002.x; Zubkov MV, 1998, DEEP-SEA RES PT I, V45, P1339, DOI 10.1016/S0967-0637(98)00015-6; Venables H, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005361; Sarthou G, 2005, J SEA RES, V53, P25, DOI 10.1016/j.seares.2004.01.007; Bowie AR, 2004, LIMNOL OCEANOGR-METH, V2, P42; Claustre H, 1997, J GEOPHYS RES-OCEANS, V102, P25047, DOI 10.1029/96JC02439; Takao S, 2012, BIOGEOSCIENCES, V9, P3875, DOI 10.5194/bg-9-3875-2012; PLATT T, 1980, J MAR RES, V38, P687; NELSON DM, 1992, MAR ECOL PROG SER, V80, P255, DOI 10.3354/meps080255; Smith WO, 2001, DEEP-SEA RES PT I, V48, P137, DOI 10.1016/S0967-0637(00)00045-5; Lannuzel D, 2007, MAR CHEM, V106, P18, DOI 10.1016/j.marchem.2006.06.010; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985; SUKENIK A, 1987, BIOCHIM BIOPHYS ACTA, V891, P205, DOI 10.1016/0005-2728(87)90216-7; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Boyd PW, 2001, DEEP-SEA RES PT II, V48, P2529, DOI 10.1016/S0967-0645(01)00007-8; Bracher AU, 1999, MAR ECOL PROG SER, V190, P1, DOI 10.3354/meps190001; Cota CF, 1994, LIMNOL OCEANOGR, V39, P948; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; Falkowski PG, 1992, OCEANOGRAPHY, V5, P84; Falkowski PG, 1994, PHOTOINHIBITION PHOT; Fouilland E, 1999, POLAR BIOL, V21, P90, DOI 10.1007/s003000050339; Goffart A, 2000, J MARINE SYST, V27, P161, DOI 10.1016/S0924-7963(00)00065-8; Gorbunov MY, 1999, PHOTOSYNTH RES, V62, P141, DOI 10.1023/A:1006360005033; Goyet C., 1994, HDB METHODS ANAL VAR; Hirawake T, 2000, POLAR BIOSCIENCE, V13, P28; Hiscock MR, 2008, P NATL ACAD SCI USA, V105, P4775, DOI 10.1073/pnas.0705006105; Isada T, 2009, J PLANKTON RES, V31, P1009, DOI 10.1093/plankt/fbp050; Lance VP, 2007, DEEP-SEA RES PT I, V54, P747, DOI 10.1016/j.dsr.2007.02.008; MacIntyre HL, 1996, MAR ECOL PROG SER, V144, P247, DOI 10.3354/meps144247; Marchant HJ, 1987, P NIPR S POLAR BIOL, V1, P1; Moore CM, 2007, DEEP-SEA RES PT II, V54, P2045, DOI 10.1016/j.dsr2.2007.06.011; Odate T, 1995, POLAR BIOL, V8, P86; Scott FJ, 2005, ANTARCTIC MARINE PRO, P572; Sedwick PN, 2008, DEEP-SEA RES PT I, V55, P911, DOI 10.1016/j.dsr.2008.03.011; Sohrin Y, 2000, DEEP-SEA RES PT I, V47, P55, DOI 10.1016/S0967-0637(99)00049-7; Strutton PG, 2000, DEEP-SEA RES PT II, V47, P2327, DOI 10.1016/S0967-0645(00)00028-X; Suzuki K, 2005, PROG OCEANOGR, V64, P167, DOI 10.1016/j.pocean.2005.02.007; Suzuki K, 2002, LIMNOL OCEANOGR, V47, P1581; Suzuki Koji, 1998, Journal of Oceanography, V54, P517, DOI 10.1007/BF02742453; TILZER MM, 1986, POLAR BIOL, V5, P105, DOI 10.1007/BF00443382; Tomas C.R., 1997, IDENTIFYING MARINE P; van Hilst CM, 2002, MAR ECOL PROG SER, V226, P1, DOI 10.3354/meps226001; Westwood KJ, 2010, DEEP-SEA RES PT II, V57, P794, DOI 10.1016/j.dsr2.2008.08.020; Wright SW, 2000, DEEP-SEA RES PT II, V47, P2363, DOI 10.1016/S0967-0645(00)00029-1; Yoshie N, 2010, MAR ECOL PROG SER, V399, P39, DOI 10.3354/meps08329; Yoshikawa T, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030736	81	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0722-4060	1432-2056		POLAR BIOL	Polar Biol.	NOV	2014	37	11					1563	1578		10.1007/s00300-014-1542-6		16	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	AQ9DA	WOS:000343141300002		
J	Takeshima, N; Matoda, M; Abe, M; Hirashima, Y; Kai, K; Nasu, K; Takano, M; Furuya, K; Sato, S; Itamochi, H; Tsubamoto, H; Hasegawa, K; Terao, K; Otsuki, T; Kuritani, K; Ito, K				Takeshima, Nobuhiro; Matoda, Maki; Abe, Masakazu; Hirashima, Yasuyuki; Kai, Kentaro; Nasu, Kaei; Takano, Masashi; Furuya, Kenichi; Sato, Seiya; Itamochi, Hiroaki; Tsubamoto, Hiroshi; Hasegawa, Kosei; Terao, Kiminari; Otsuki, Takeo; Kuritani, Keiko; Ito, Kimihiko			Efficacy and safety of triple therapy with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy for gynecological cancer: KCOG-G1003 phase II trial	SUPPORTIVE CARE IN CANCER			English	Article						Aprepitant; Palonosetron; Nausea; Vomiting; CINV; Cisplatin	MODERATELY EMETOGENIC CHEMOTHERAPY; PLACEBO-CONTROLLED TRIAL; HIGH-DOSE CISPLATIN; ANTAGONIST APREPITANT; ANTIEMETIC TREATMENT; RECEPTOR ANTAGONIST; DOUBLE-BLIND	Prevention of chemotherapy-induced nausea and vomiting (CINV) is crucial for maintaining the quality of life of cancer patients. Female patients have been underrepresented in previous clinical studies of aprepitant or palonosetron. We performed a prospective multicenter study to investigate the efficacy and safety of triple therapy comprising these two agents and dexamethasone in female cancer patients receiving chemotherapy that included cisplatin (a parts per thousand yen50 mg/m(2)). Aprepitant was administered at a dose of 125 mg before chemotherapy on day 1 and at 80 mg on days 2 and 3. Palonosetron (0.75 mg) was given before chemotherapy on day 1. Dexamethasone was administered at a dose of 9.9 mg before chemotherapy on day 1 and at 6.6 mg on days 2-4. The primary endpoint was the the proportion of patients with a complete response (CR no vomiting and no use of rescue medication) throughout the overall period (0-120 h post-chemotherapy). Ninety-six women (median age 55 years) were enrolled. The overall CR rate was 54.2 %. CR was obtained during the acute phase (0-24 h post-chemotherapy) and the delayed phase (24-120 h post-chemotherapy) in 87.5 and 56.3 % of the patients, respectively. The most common adverse reactions were constipation and fatigue (reported by three patients each). Exhibition of a favorable overall CR rate over existing two-drug combinations suggests that the triple therapy regimen used in the present study is effective and tolerable in patients with gynecological malignancies receiving cisplatin-based chemotherapy. Female patients may have a higher risk of developing CINV.	[Takeshima, Nobuhiro; Matoda, Maki] Canc Inst Hosp, Dept Gynecol, Koto Ku, Tokyo 1358550, Japan; [Abe, Masakazu; Hirashima, Yasuyuki] Shizuoka Canc Ctr Hosp, Div Gynecol, Nagaizumi, Shizuoka 4118777, Japan; [Kai, Kentaro; Nasu, Kaei] Oita Univ, Fac Med, Dept Obstet & Gynecol, Yufu, Oita 8795593, Japan; [Takano, Masashi; Furuya, Kenichi] Natl Def Med Coll, Dept Obstet & Gynecol, Tokorozawa, Saitama 3598513, Japan; [Sato, Seiya; Itamochi, Hiroaki] Tottori Univ, Sch Med, Dept Obstet & Gynecol, Yonago, Tottori 6838504, Japan; [Tsubamoto, Hiroshi] Hyogo Coll Med, Dept Obstet & Gynecol, Nishinomiya, Hyogo 6638501, Japan; [Hasegawa, Kosei] Saitama Med Univ, Int Med Ctr, Dept Gynecol Oncol, Hidaka, Saitama 3501298, Japan; [Terao, Kiminari] Miyazaki Prefectural NOBEOKA Hosp, Nobeoka, Miyazaki 8820835, Japan; [Otsuki, Takeo] Tohoku Univ, Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 9808574, Japan; [Kuritani, Keiko; Ito, Kimihiko] Kansai Rosai Hosp, Amagasaki, Hyogo 6608511, Japan	Matoda, M (reprint author), Canc Inst Hosp, Dept Gynecol, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	nobuhiro.takeshima@jfcr.or.jp; maki.matsumura@jfcr.or.jp; ma.abe@scchr.jp; y.hirashima@scchr.jp; kenta9sp@oita-u.ac.jp; nasu@oita-u.ac.jp; mastkn@ndmc.ac.jp; furuyac@nifty.com; sseiya@med.tottori-u.ac.jp; itamochi@hotmail.com; tsuba@hyo-med.ac.jp; koseih@gmail.com; k-terao@pref-hp.nobeoka.miyazaki.jp; takeootsuki@med.tohoku.ac.jp; keiko0630@bcb.bai.ne.jp; kimihiko-ito@kanrou.net					Longo F, 2011, SUPPORT CARE CANCER, V19, P1159, DOI 10.1007/s00520-010-0930-x; Poli-Bigelli S, 2003, CANCER, V97, P3090, DOI 10.1002/cncr.11433; Bloechl-Daum B, 2006, J CLIN ONCOL, V24, P4472, DOI 10.1200/JCO.2006.05.6382; RICHARDSON JL, 1988, J CLIN ONCOL, V6, P1746; Hesketh PJ, 2003, J CLIN ONCOL, V21, P4112, DOI 10.1200/JCO.2003.01.095; Saito M, 2009, LANCET ONCOL, V10, P115, DOI 10.1016/S1470-2045(08)70313-9; Hesketh PJ, 2010, SUPPORT CARE CANCER, V18, P1171, DOI 10.1007/s00520-009-0737-9; Miura S, 2013, SUPPORT CARE CANCER, V21, P2575, DOI 10.1007/s00520-013-1835-2; Rojas C, 2008, ANESTH ANALG, V107, P469, DOI 10.1213/ane.0b013e318172fa74; Chawla SP, 2003, CANCER, V97, P2290, DOI 10.1002/cncr.11320; Basch E, 2011, J CLIN ONCOL, V29, P4189, DOI 10.1200/JCO.2010.34.4614; Schmoll HJ, 2006, ANN ONCOL, V17, P1000, DOI 10.1093/annonc/mdl019; Warr DG, 2005, J CLIN ONCOL, V23, P2822; Hashimoto H, 2013, ASCO2013 ANN M; Huskey SEW, 2003, DRUG METAB DISPOS, V31, P785, DOI 10.1124/dmd.31.6.785; Japan Society of Clinical Oncology, 2010, GUID PROP US AN VERS; National Comprehensive Cancer Network Inc, 2014, NCCN CLIN PRACT GUID; Navari Rudolph M, 2011, J Support Oncol, V9, P188, DOI 10.1016/j.suponc.2011.05.002; Takahashi T, 2011, CANCER SCI, V11, P2455; WONG EHF, 1995, BRIT J PHARMACOL, V114, P851	20	2	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-4355	1433-7339		SUPPORT CARE CANCER	Support. Care Cancer	NOV	2014	22	11					2891	2898		10.1007/s00520-014-2280-6		8	Oncology; Health Care Sciences & Services; Rehabilitation	Oncology; Health Care Sciences & Services; Rehabilitation	AQ8DN	WOS:000343053700003		
J	Saito, H; Watanabe, Y; Sato, K; Ikawa, H; Yoshida, Y; Katakura, A; Takayama, S; Sato, M				Saito, Hirokazu; Watanabe, Yutaka; Sato, Kazumichi; Ikawa, Hiroaki; Yoshida, Yoshifumi; Katakura, Akira; Takayama, Shin; Sato, Michio			Effects of professional oral health care on reducing the risk of chemotherapy-induced oral mucositis	SUPPORTIVE CARE IN CANCER			English	Article						Oral health care; Breast cancer; Cancer chemotherapy; Oral mucositis; Randomized controlled study; Quality of life	HEMATOPOIETIC-CELL TRANSPLANTATION; BONE-MARROW; CANCER-PATIENTS; STEM-CELL; RADIOTHERAPY; MANAGEMENT; RADIATION; THERAPY; TRIAL; INDEX	Recent years have seen remarkable progress in cancer therapy, although treatment-induced adverse reactions and complications are not uncommon. Approximately 40 % of patients undergoing chemotherapy for cancer experience adverse reactions in the oral cavity, with nearly half of them developing severe oral mucositis that necessitates postponing therapy and/or changing the drug dosage. The objective of this study was to assess the usefulness of prophylactic professional oral health care (POHC) for preventing mucositis in patients undergoing chemotherapy. Twenty-six female patients scheduled for chemotherapy for breast cancer were included in this study and randomized to the self-care or POHC groups. Assessment parameters included oral cavity photographs, plaque control records, Saxon test scores, Oral Assessment Guide scores, and grading using the Common Terminology Criteria for Adverse Events. Beginning before surgery and continuing through the completion of chemotherapy, the POHC patient group received weekly professional oral health care, including scaling, professional cleaning of the tooth surfaces, brushing instructions, and nutritional and lifestyle guidance. More patients in the self-care group developed oral mucositis than in the POHC group. The Oral Assessment Guide score, which was used as an index of oral mucositis, was also significantly lower in the POHC group. Based on the Oral Assessment Guide and plaque control records, there was almost no deterioration of the oral environment in the POHC group, whereas deterioration was observed in the self-care group. These findings demonstrate the efficacy of regular POHC in reducing the risk of oral mucositis in breast cancer patients undergoing chemotherapy.	[Saito, Hirokazu; Yoshida, Yoshifumi; Katakura, Akira] Tokyo Dent Coll, Dept Oral Med Oral & Maxillofacial Surg, Ichikawa, Chiba 2728513, Japan; [Watanabe, Yutaka] Natl Ctr Geriatr & Gerontol, Dept Oral Dis Res, Obu City, Aichi 4748511, Japan; [Sato, Kazumichi] Tokyo Dent Coll, Oral Canc Ctr, Ichikawa, Chiba 2728513, Japan; [Ikawa, Hiroaki] Natl Inst Radiol Sci, Res Ctr Hosp Charged Particle Therapy, Inage Ku, Chiba 2638555, Japan; [Takayama, Shin; Sato, Michio] Tokyo Dent Coll, Dept Surg, Ichikawa, Chiba 2728513, Japan	Watanabe, Y (reprint author), Natl Ctr Geriatr & Gerontol, Dept Oral Dis Res, 35 Gengo,Morioka Machi, Obu City, Aichi 4748511, Japan.	ywata@ncgg.go.jp					Akintoye SO, 2002, ORAL SURG ORAL MED O, V94, P581, DOI 10.1067/moe.2002.128960; Sonis ST, 1998, ORAL ONCOL, V34, P39, DOI 10.1016/S1368-8375(97)00053-5; Keefe DM, 2007, CANCER, V109, P820, DOI 10.1002/cncr.22484; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Sonis ST, 2004, CANCER, V100, P1995, DOI 10.1002/cncr.20162; Sonis ST, 1999, CANCER, V85, P2103, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0; Raber-Durlacher JE, 2000, SUPPORT CARE CANCER, V8, P366, DOI 10.1007/s005200050004; McGuire DB, 2013, SUPPORT CARE CANCER, V21, P3165, DOI 10.1007/s00520-013-1942-0; Hovan AJ, 2010, SUPPORT CARE CANCER, V18, P1081, DOI 10.1007/s00520-010-0902-1; [Anonymous], 2006, COMM TERM CRIT ADV E; Sugiura Y, 2008, SUPPORT CARE CANCER, V16, P421, DOI 10.1007/s00520-007-0391-z; Raber-Durlacher JE, 2002, SUPPORT CARE CANCER, V10, P466, DOI 10.1007/s00520-002-0346-3; Yoneyama T, 1999, LANCET, V354, P515, DOI 10.1016/S0140-6736(05)75550-1; Soga Y, 2011, SUPPORT CARE CANCER, V19, P303, DOI 10.1007/s00520-010-1002-y; Barber C, 2007, SUPPORT CARE CANCER, V15, P427, DOI 10.1007/s00520-006-0171-1; McGuire DB, 2002, CANCER INVEST, V20, P893, DOI 10.1081/CNV-120005902; Jellema AP, 2007, INT J RADIAT ONCOL, V69, P751, DOI 10.1016/j.ijrobp.2007.04.021; Borowski B, 1994, Eur J Cancer B Oral Oncol, V30B, P93, DOI 10.1016/0964-1955(94)90059-0; Eilers J, 1988, Oncol Nurs Forum, V15, P325; Greene FL, 2002, AJCC CANC STAGING MA; Japanese Society of Oral and Maxillofacial Surgeons, 2011, SURV INV HOSP OR MAX; Katsura K, 2009, JAPAN J HEAD NECK CA, V35, P266; Kennedy HF, 2000, J MED MICROBIOL, V49, P367; Kobayashi M, 2007, J JPN DENT SOC ORIEN, V25, P1; Koshino Miki, 2009, Gan To Kagaku Ryoho, V36, P447; Majorana A, 2000, SUPPORT CARE CANCER, V8, P353, DOI 10.1007/s005200050003; Myers RA, 1990, NATL CANCER I MONOGR, V9, P151; SCHUBERT MM, 1992, CANCER, V69, P2469, DOI 10.1002/1097-0142(19920515)69:10<2469::AID-CNCR2820691015>3.0.CO;2-W; Seki S, 2003, JAPAN J REHABIL MED, V40, P858; Tamura Y, 2009, NIIGATA DENT J, V39, P35	30	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-4355	1433-7339		SUPPORT CARE CANCER	Support. Care Cancer	NOV	2014	22	11					2935	2940		10.1007/s00520-014-2282-4		6	Oncology; Health Care Sciences & Services; Rehabilitation	Oncology; Health Care Sciences & Services; Rehabilitation	AQ8DN	WOS:000343053700008		
J	Inoue, D; Pang, JQ; Matsuda, M; Sei, K; Nishida, K; Ike, M				Inoue, Daisuke; Pang, Junqin; Matsuda, Masami; Sei, Kazunari; Nishida, Kei; Ike, Michihiko			Development of a whole community genome amplification-assisted DNA microarray method to detect functional genes involved in the nitrogen cycle	WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY			English	Article						Activated sludge; DNA microarray analysis; Nitrogen cycle; Nitrogen cycling microorganisms; River water; Whole community genome amplification	AMMONIA-OXIDIZING BACTERIA; 16S RIBOSOMAL-RNA; LOWER SEINE RIVER; OLIGONUCLEOTIDE MICROARRAY; DIVERSITY; WATER; ENVIRONMENT; EUTROPHICATION; TERRESTRIAL; CULTIVATION	A novel DNA microarray analysis targeting key functional genes involved in most nitrogen cycling reactions was developed to comprehensively analyze microbial populations associated with the nitrogen cycle. The developed microarray contained 876 oligonucleotide probes based on the nucleotide sequences of the nif, amo, hao/hzo, nap, nar, nirK, nirS, nrf, cnor, qnor and nos genes. An analytical method combining detection by the designed microarray with whole community genome amplification was then applied to monitor the nitrogen cycling microorganisms in river water and wastewater treatment sludge samples. The developed method revealed that nitrogen cycling microorganisms in river water appeared to become less diverse in response to input of effluent from municipal wastewater treatment plants. Additionally, the nitrogen cycling community associated with anaerobic ammonium oxidation and partial nitrification reactors could be reasonably analyzed by the developed method. However, the results obtained for two activated sludge samples from municipal wastewater treatment plants with almost equivalent wastewater treatment performance differed greatly from each other. These results suggested that the developed method is useful for comprehensive analysis of nitrogen cycling microorganisms, although its applicability to complex samples with abundant untargeted populations should be further examined.	[Inoue, Daisuke; Sei, Kazunari] Kitasato Univ, Dept Hlth Sci, Sagamihara, Kanagawa 2520373, Japan; [Inoue, Daisuke; Pang, Junqin; Matsuda, Masami; Sei, Kazunari; Ike, Michihiko] Osaka Univ, Div Sustainable Energy & Environm Engn, Suita, Osaka 5650871, Japan; [Nishida, Kei] Univ Yamanashi, Int Res Ctr River Basin Environm, Kofu, Yamanashi 4008511, Japan	Ike, M (reprint author), Osaka Univ, Div Sustainable Energy & Environm Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	ike@see.eng.osaka-u.ac.jp			Global COE Program, "Evaluation of Research and Education on Integrated River Basin Management in Asian Region" of the University of Yamanashi - Japan Society for the Promotion of Science (JSPS); Kurita Water Environment Foundation, Japan	This study was partly supported by the Global COE Program, "Evaluation of Research and Education on Integrated River Basin Management in Asian Region" of the University of Yamanashi, which was sponsored by the Japan Society for the Promotion of Science (JSPS) and by a grant from the Kurita Water Environment Foundation, Japan. We thank Dr. Kazuichi Isaka from Hitachi Plant Technologies, Ltd., Japan (Presently, Hitachi, Ltd., Japan) for kindly providing the partial nitrification sludge samples.	Abell GCJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051542; Smith VH, 1999, ENVIRON POLLUT, V100, P179, DOI 10.1016/S0269-7491(99)00091-3; Wu LY, 2001, APPL ENVIRON MICROB, V67, P5780, DOI 10.1128/AEM.67.12.5780-5790.2001; FARRELLY V, 1995, APPL ENVIRON MICROB, V61, P2798; Hashimoto K, 2014, J BIOSCI BIOENG, V118, P64, DOI 10.1016/j.jbiosc.2013.12.008; Bartossek R, 2010, ENVIRON MICROBIOL, V12, P1075, DOI 10.1111/j.1462-2920.2010.02153.x; He ZL, 2012, CURR OPIN BIOTECH, V23, P49, DOI 10.1016/j.copbio.2011.11.001; Edgcomb VP, 1999, APPL ENVIRON MICROB, V65, P1516; Yergeau E, 2007, ISME J, V1, P163, DOI 10.1038/ismej.2007.24; Prosser JI, 2002, ANTON LEEUW INT J G, V81, P165, DOI 10.1023/A:1020598114104; Wu LY, 2006, APPL ENVIRON MICROB, V72, P4931, DOI 10.1128/AEM.02738-05; AMANN RI, 1995, MICROBIOL REV, V59, P143; Cebron A, 2005, WATER RES, V39, P4979, DOI 10.1016/j.watres.2005.10.006; Park S, 2008, APPL ENVIRON MICROB, V74, P5475, DOI 10.1128/AEM.00500-08; Yang XE, 2008, J ZHEJIANG UNIV-SC B, V9, P197, DOI 10.1631/jzus.B0710626; Moisander PH, 2007, ENVIRON MICROBIOL, V9, P1823, DOI 10.1111/j.1462-2920.2007.01304.x; Zhang L, 2007, MICROB ECOL, V53, P456, DOI 10.1007/s00248-006-9126-9; Quan ZX, 2008, ENVIRON MICROBIOL, V10, P3130, DOI 10.1111/j.1462-2920.2008.01642.x; Inoue D, 2010, WATER RES, V44, P2409, DOI 10.1016/j.watres.2010.01.005; Cebron A, 2004, APPL ENVIRON MICROB, V70, P6726, DOI 10.1128/AEM.70.11.6726-6737.2004; Schmid M, 2000, SYST APPL MICROBIOL, V23, P93; Casciotti KL, 2005, FEMS MICROBIOL ECOL, V52, P197, DOI 10.1016/j.femsec.2004.11.002; Casciotti KL, 2001, APPL ENVIRON MICROB, V67, P2213, DOI 10.1128/AEM.67.5.2213-2221.2001; Duc L, 2009, ENVIRON MICROBIOL, V11, P2179, DOI 10.1111/j.1462-2920.2009.01945.x; Garbeva P, 2007, FEMS MICROBIOL LETT, V266, P83, DOI 10.1111/j.1574-6968.2006.00517.x; Guschin DY, 1997, APPL ENVIRON MICROB, V63, P2397; Nakagawa Y, 2011, P 1 INT AN S, P311; Philippot L, 2006, BIOCHEM SOC T, V34, P101; Philippot L, 2002, BBA-GENE STRUCT EXPR, V1577, P355, DOI 10.1016/S0167-4781(02)00420-7; Sei K, 2009, WATER SCI TECHNOL, V59, P97, DOI 10.2166/wst.2009.575; Sei K, 2000, JPN J WATER TREAT BI, V36, P193; Seviour R, 2010, MICROBIAL ECOLOGY OF ACTIVATED SLUDGE, P1; Shinozaki H, 2002, J GEN APPL MICROBIOL, V48, P173, DOI 10.2323/jgam.48.173; Song B, 2011, METHOD ENZYMOL, V496, P63, DOI 10.1016/B978-0-12-386489-5.00003-8; Taroncher-Oldenburg G, 2003, APPL ENVIRON MICROB, V69, P1159, DOI 10.1128/AEM.69.2.1159-1171.2003; Van Nostrand JD, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00339; Ward BB, 2007, ENVIRON MICROBIOL, V9, P2522, DOI 10.1111/j.1462-2920.2007.01371.x	37	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0959-3993	1573-0972		WORLD J MICROB BIOT	World J. Microbiol. Biotechnol.	NOV	2014	30	11					2907	2915		10.1007/s11274-014-1718-9		9	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	AQ9BF	WOS:000343134900013		
J	Togashi, T; Sugitani, I; Toda, K; Kawabata, K; Takahashi, S				Togashi, Takafumi; Sugitani, Iwao; Toda, Kazuhisa; Kawabata, Kazuyoshi; Takahashi, Sugata			Surgical Management of Retropharyngeal Nodes Metastases from Papillary Thyroid Carcinoma	WORLD JOURNAL OF SURGERY			English	Article							TRANSORAL RESECTION; CANCER	Papillary thyroid carcinoma (PTC) often metastasizes to the central and lateral neck lymph nodes, but rarely affects retropharyngeal nodes (RPN). We retrospectively reviewed 12 patients (three men, nine women) with PTC who underwent dissection of RPN metastases between 1994 and 2012. Mean age at dissection was 65 years (range 23-77). Dissection was performed with the initial surgery for PTC in eight patients, while the remaining four patients underwent dissection as secondary surgery. RPN metastases arose from an ipsilateral primary in nine patients, bilateral in two, and contralateral in one, with primaries located at the superior pole of the thyroid lobe in nine patients. All patients showed simultaneous or previous lymph node metastases in the upper jugular chain. A transcervical approach was applied for RPN dissection in 11 patients, while a transcervical-transparotid approach was applied in the remaining patient. No patients needed mandibulotomy or showed severe complications. Median duration of follow-up after RPN dissection was 48 months (range 3-206). No recurrences in the retropharyngeal space were identified. Two patients died of the disease, one died from other carcinoma, and five survived with distant metastases from PTC. The remaining four patients remain free of the disease as at the time of writing. If lymph node metastases are identified in the upper jugular chain, the possibility of RPN metastases should be checked. Most RPN metastases from PTC can be dissected safely without mandibulotomy. In particular, low-risk patients can expect favorable outcomes.	[Togashi, Takafumi; Takahashi, Sugata] Niigata Univ, Dept Otolaryngol Head & Neck Surg, Fac Med, Chuo Ku, Niigata 9518520, Japan; [Sugitani, Iwao] Nippon Med Sch, Dept Surg, Div Endocrine Surg, Tokyo 113, Japan; [Toda, Kazuhisa; Kawabata, Kazuyoshi] Japanese Fdn Canc Res, Canc Inst Hosp, Div Head & Neck Surg, Tokyo, Japan	Togashi, T (reprint author), Niigata Univ, Dept Otolaryngol Head & Neck Surg, Fac Med, Chuo Ku, 1-754 Asahimachidori, Niigata 9518520, Japan.	ta-kun@msi.biglobe.ne.jp	TODA, KENJI/D-7286-2015	TODA, KENJI/0000-0001-8359-477X			Wang XL, 2012, CHINESE MED J-PEKING, V125, P3635, DOI 10.3760/cma.j.issn.0366-6.999.2012.20.007; Desuter G, 2004, EUR J SURG ONCOL, V30, P80, DOI 10.1016/j.ejso.2003.10.004; Sugitani I, 2004, SURGERY, V135, P139, DOI 10.1016/S0039-6060(03)00384-2; Andrews GA, 2011, HEAD NECK-J SCI SPEC, V33, P166, DOI 10.1002/hed.21415; Coskun HH, 2011, HEAD NECK-J SCI SPEC, V33, P1520, DOI 10.1002/hed.21526; Kainuma K, 2011, ACTA OTO-LARYNGOL, V131, P1341, DOI 10.3109/00016489.2011.607844; MCCORMAC.KR, 1970, CANCER, V26, P1366, DOI 10.1002/1097-0142(197012)26:6<1366::AID-CNCR2820260627>3.0.CO;2-V; Miura K, 2004, ENDOCR SURG, V21, P33; Otsuki N, 2007, HEAD NECK-J SCI SPEC, V29, P508, DOI 10.1002/hed.20536; Rouviere H, 1938, ANATOMY HUMAN LYMPHA, P5; Shellenberger T, 2007, HEAD NECK-J SCI SPEC, V29, P258, DOI 10.1002/hed.20513	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	NOV	2014	38	11					2831	2837		10.1007/s00268-014-2707-8		7	Surgery	Surgery	AQ8CB	WOS:000343048900014		
J	Akutsu, Y; Kono, T; Uesato, M; Hoshino, I; Murakami, K; Aoyagi, T; Ota, T; Toyozumi, T; Suito, H; Kobayashi, H; Harada, R; Uno, T; Matsubara, H				Akutsu, Yasunori; Kono, Tsuguaki; Uesato, Masaya; Hoshino, Isamu; Murakami, Kentaro; Aoyagi, Tomoyoshi; Ota, Takumi; Toyozumi, Takeshi; Suito, Hiroshi; Kobayashi, Hiroki; Harada, Rintaro; Uno, Takashi; Matsubara, Hisahiro			Is the Outcome of a Salvage Surgery for T4 Thoracic Esophageal Squamous Cell Carcinoma Really Poor?	WORLD JOURNAL OF SURGERY			English	Article							NEOADJUVANT CHEMORADIOTHERAPY; LYMPH-NODES; CANCER; CHEMORADIATION; THERAPY; NUMBER; TRIAL	Among patients with T4 thoracic esophageal squamous cell carcinoma (TESCC), it is unclear whether the outcomes of late responders who undergo high-dose chemoradiotherapy (CRT) followed by salvage esophagectomy differs from those of early responders who undergo low-dose CRT followed by esophagectomy. A total of 153 patients with T4 TESCC were treated with CRT. The first evaluation was performed after 40 Gy of CRT for downstaging. Of these, 28 patients could be downstaged, and underwent subsequent surgery (early responders). For the remaining patients, additional CRT was administered, and patients were re-evaluated after treatment and underwent salvage surgery. In total, 40 patients (early + late responders) were analyzed. The primary tumors exhibited a grade 3 response in six (21.4 %) of the early responders and two (16.7 %) of the late responders (p = 1.000). The rate of residual tumor in the primary tumor was 80 % (32/40 patients). The proportions of resected lymph nodes and positive metastatic nodes were similar between early and late responders (p = 0.406 and p = 0.859, respectively). The 5-year overall survival rates among the early and late responders were 25.9 and 36.5 %, respectively, and the median survival times were 24.8 and 24.3 months (p = 0.925), respectively. The 5-year cause-specific survival rates in the early and late responder groups were 61.5 and 72.9 % (p = 0.425), respectively. The outcomes of both early and late responders to CRT were similar, and salvage surgery for T4 TESCC outweighs the risks in patients with T4 TESCC.	[Akutsu, Yasunori; Kono, Tsuguaki; Uesato, Masaya; Hoshino, Isamu; Murakami, Kentaro; Aoyagi, Tomoyoshi; Ota, Takumi; Toyozumi, Takeshi; Suito, Hiroshi; Matsubara, Hisahiro] Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chuo Ku, Chiba 2608670, Japan; [Kobayashi, Hiroki; Harada, Rintaro; Uno, Takashi] Chiba Univ, Grad Sch Med, Dept Radiol, Chiba 2608670, Japan	Akutsu, Y (reprint author), Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	yakutsu@faculty.chiba-u.jp					Akutsu Y, 2009, WORLD J SURG, V33, P1002, DOI 10.1007/s00268-008-9899-8; Akutsu Yasunori, 2013, Gen Thorac Cardiovasc Surg, V61, P397, DOI 10.1007/s11748-013-0237-1; Akutsu Y, 2013, ANN SURG, V257, P102; Minsky BD, 2002, J CLIN ONCOL, V20, P1167, DOI 10.1200/JCO.20.5.1167; Markar SR, 2014, ANN SURG ONCOL, V21, P922, DOI 10.1245/s10434-013-3364-0; Cooper JS, 1999, JAMA-J AM MED ASSOC, V281, P1623, DOI 10.1001/jama.281.17.1623; Seto Y, 2007, CANCER SCI, V98, P937, DOI 10.1111/j.1349-7006.2007.00479.x; Miyata H, 2009, J SURG ONCOL, V100, P442, DOI 10.1002/jso.21353; Crosby TDL, 2004, BRIT J CANCER, V90, P70, DOI 10.1038/sj.bjc.6601461; Akutsu Y, 2012, J SURG ONCOL, V105, P756, DOI 10.1002/jso.23007; Shimada H, 2008, J AM COLL SURGEONS, V206, P48, DOI 10.1016/j.jamcollsurg.2007.06.013; Welsh J, 2012, CANCER-AM CANCER SOC, V118, P2632, DOI 10.1002/cncr.26586; Piessen G, 2013, ANN SURG, V258, P793, DOI 10.1097/SLA.0000000000000228; Ozawa S, 2012, ESOPHAGUS-TOKYO, V9, P75, DOI 10.1007/s10388-012-0327-7; Shimoji H, 2013, WORLD J SURG, V37, P2180, DOI 10.1007/s00268-013-2074-x; Makino T, 2011, ANN THORAC CARDIOVAS, V17, P221, DOI 10.5761/atcs.ra.11.01676; Aoyagi T, 2010, EXP THER MED, V1, P847, DOI 10.3892/etm.2010.112; De Manzoni G, 2007, J SURG ONCOL, V95, P261, DOI 10.1002/jso.20640; Miyoshi N, 2009, J SURG ONCOL, V99, P302, DOI 10.1002/jso.21235; Murphy CC, 2013, J GASTROINTEST SURG, V17, P1359, DOI 10.1007/s11605-013-2223-4; Nabeya Y, 2005, DIS ESOPHAGUS, V18, P388, DOI 10.1111/j.1442-2050.2005.00521.x; Shimada H, 2006, WORLD J SURG, V30, P1441, DOI 10.1007/s00268-005-0462-6; Tachibana M, 2002, DYSPHAGIA, V17, P255, DOI 10.1007/s00455-002-0069-9; Takubo K, 2009, ESOPHAGUS-TOKYO, V6, P1, DOI 10.1007/s10388-009-0169-0; Takubo K, 2009, ESOPHAGUS, V6, P71	25	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	NOV	2014	38	11					2891	2897		10.1007/s00268-014-2668-y		7	Surgery	Surgery	AQ8CB	WOS:000343048900022		
J	Kawamura, M; Nakada, K; Konishi, H; Iwasaki, T; Murakami, K; Mitsumori, N; Hanyu, N; Omura, N; Yanaga, K				Kawamura, Masahiko; Nakada, Koji; Konishi, Hideo; Iwasaki, Taizo; Murakami, Keishiro; Mitsumori, Norio; Hanyu, Nobuyoshi; Omura, Nobuo; Yanaga, Katsuhiko			Assessment of Motor Function of the Remnant Stomach by C-13 Breath Test With Special Reference to Gastric Local Resection	WORLD JOURNAL OF SURGERY			English	Article							LYMPH-NODE METASTASIS; PYLORUS-PRESERVING GASTRECTOMY; CANCER; SURGERY; ACID; DISSECTION; NAVIGATION; HUMANS; TUMOR; AGE	Indications for gastric local resection (LR) include gastrointestinal stromal tumors, neuroendocrine tumors, and early gastric cancer. LR is expected to preserve physiological function and ameliorate postgastrectomy syndrome. Gastric emptying was assessed by the C-13-acetate breath test in 20 healthy volunteers (HVs) and 60 gastrectomized patients [distal gastrectomy with Billroth I reconstruction (DGBI) in 26 patients, LR in 34 patients]. For the C-13 breath test, 100 mg of C-13-acetate sodium salt was mixed in a test meal. Breath samples were collected before intake and during the next 3 h. We compared the gastric reservoir capacity using the gastric retention rate at 5 min (RR5) and gastric emptying by the half emptying time (TA1/2). Patients completed a questionnaire survey about their symptoms, dietary intake, body weight, and restriction of activities of daily living [reflecting quality of life (QOL)]. The RR5 values for the HV, LR, and DGBI groups were 93.7, 90.0, and 45.3* %, respectively (*compared to HV and LR, p < 0.0001). The TA1/2 values were 23.3, 20.2, and 5.9* min, respectively. Dietary intake and body weight change were significantly more reduced in the DGBI group than the LR group (p < 0.05). Subgroup analysis indicated that the reservoir capacity in those with LR at the lesser curvature was more disturbed than that in patients with LR at the greater curvature. The questionnaire showed no differences in those patients' QOL. Because the reservoir capacity, the gastric emptying and QOL were maintained, LR is an option for selected patients with early gastric cancer.	[Kawamura, Masahiko; Nakada, Koji; Konishi, Hideo; Iwasaki, Taizo; Murakami, Keishiro; Mitsumori, Norio; Hanyu, Nobuyoshi; Omura, Nobuo; Yanaga, Katsuhiko] Jikei Univ, Dept Surg, Sch Med, Minato Ku, Tokyo 1058461, Japan	Kawamura, M (reprint author), Jikei Univ, Dept Surg, Sch Med, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	masahiko7877@jikei.ac.jp			MEXT (Ministry of Education, Culture, Sports, Science and Technology)-Supported Program for the Strategic Research Foundation at Private Universities	This study was supported by a grant from MEXT (Ministry of Education, Culture, Sports, Science and Technology)-Supported Program for the Strategic Research Foundation at Private Universities, (2011-2013). The authors thank all the patients whose cooperation made this study possible.	Kitagawa Y, 2005, J SURG ONCOL, V90, P147, DOI 10.1002/jso.20220; Kitamura K, 1997, J SURG ONCOL, V64, P42, DOI 10.1002/(SICI)1096-9098(199701)64:1<42::AID-JSO9>3.0.CO;2-P; Yamao T, 1996, CANCER, V77, P602, DOI 10.1002/(SICI)1097-0142(19960215)77:4<602::AID-CNCR3>3.0.CO;2-I; Nunobe S, 2012, GASTRIC CANCER, V15, P338, DOI 10.1007/s10120-012-0146-5; Fujishiro M, 2006, GASTROINTEST ENDOSC, V63, P243, DOI 10.1016/j.gie.2005.08.002; Mine S, 2010, J AM COLL SURGEONS, V211, P628, DOI 10.1016/j.jamcollsurg.2010.07.003; Sanaka M, 2006, CLIN EXP PHARMACOL P, V33, P1239, DOI 10.1111/j.1440-1681.2006.04516.x; MOORE JG, 1983, DIGEST DIS SCI, V28, P340, DOI 10.1007/BF01324951; Sanaka M, 2007, CLIN EXP PHARMACOL P, V34, P641, DOI 10.1111/j.1440-1681.2007.04624.x; Nimura H, 2004, BRIT J SURG, V91, P575, DOI 10.1002/bjs.4470; HOROWITZ M, 1984, CLIN SCI, V67, P213; GHOOS YF, 1993, GASTROENTEROLOGY, V104, P1640; Hiki N, 2008, SURG ENDOSC, V22, P1729, DOI 10.1007/s00464-007-9696-8; Barden B, 1995, GASTROENTEROLOGY, V108, P1048; Gotoda Takuji, 2005, Clin Gastroenterol Hepatol, V3, pS71, DOI 10.1016/S1542-3565(05)00251-X; Gotoda T, 2000, GASTRIC CANCER, V3, P219, DOI 10.1007/PL00011720; Grundy D, 1984, GASTRIC GASTRODUODEN, P21; Japanese Gastric Cancer Association, 2011, GASTRIC CANCER, V14, P13; Katsube T, 2007, HEPATO-GASTROENTEROL, V54, P639; KITAOKA H, 1984, JPN J CLIN ONCOL, V14, P283; Kono Y, 2003, AM J SURG, V185, P150; Nishikawa K, 2002, SURGERY, V131, P613, DOI 10.1067/msy.2002.124630; Nomura E, 2003, HEPATO-GASTROENTEROL, V50, P2246; Ohdaira H, 2007, GASTRIC CANCER, V10, P117, DOI 10.1007/s10120-007-0419-6; Sanaka Masaki, 2010, Journal of Smooth Muscle Research, V46, P267; SANO T, 1992, BRIT J SURG, V79, P241, DOI 10.1002/bjs.1800790319; Seto Y, 2001, Gastric Cancer, V4, P34, DOI 10.1007/s101200100014; Song XY, 2004, AM J SURG, V187, P270, DOI 10.1016/j.amjsurg.2003.11.013; Wang LB, 2008, J GASTROINTEST SURG, V12, P1359, DOI 10.1007/s11605-008-0498-7	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	NOV	2014	38	11					2898	2903		10.1007/s00268-014-2660-6		6	Surgery	Surgery	AQ8CB	WOS:000343048900023		
J	Lim, C; Mise, Y; Sakamoto, Y; Yamamoto, S; Shindoh, J; Ishizawa, T; Aoki, T; Hasegawa, K; Sugawara, Y; Makuuchi, M; Kokudo, N				Lim, Chetana; Mise, Yoshihiro; Sakamoto, Yoshihiro; Yamamoto, Satoshi; Shindoh, Junichi; Ishizawa, Takeaki; Aoki, Taku; Hasegawa, Kiyoshi; Sugawara, Yasuhiko; Makuuchi, Masatoshi; Kokudo, Norihiro			Above 5 cm, Size Does Not Matter Anymore in Patients with Hepatocellular Carcinoma	WORLD JOURNAL OF SURGERY			English	Article							LIVER-TRANSPLANTATION; SURGICAL-TREATMENT; HEPATIC RESECTION; VASCULAR INVASION; RISK-FACTORS; HEPATECTOMY; MANAGEMENT; LARGER; EXPERIENCE; RECURRENCE	Solitary hepatocellular carcinoma (HCC) is a good candidate for surgical resection. However, the significance of the size of the tumor in solitary HCC remains unclear. The aim of this study was to evaluate the impact of tumor size on overall and recurrence-free survival of patients with solitary HCC. We retrospectively reviewed 616 patients with histologically confirmed solitary HCC who underwent curative surgical resection between 1994 and 2010. The characteristics and prognosis of patients with HCC were analyzed stratified by tumor size. A total of 403 patients (65 %) had tumors < 5 cm, 172 (28 %) had tumors between 5 and 10 cm, and 41 (7 %) had tumors > 10 cm. The incidence of microvascular invasion, satellite nodules, and advanced tumor grade significantly increased with tumor size. The 5-year overall and recurrence-free survival rates of HCC < 5 cm were 69.6 % and 32 %, respectively, which were significantly better than those of HCC between 5 and 10 cm (58 % and 26 %, respectively) and HCC > 10 cm (53 % and 24 %, respectively). On multivariate analysis, cirrhosis (p = 0.0307), Child-Pugh B (p = 0.0159), indocyanine green retention rate at 15 min > 10 % (p = 0.0071), microvascular invasion (p < 0.0001), and satellite nodules (p = 0.0009) were independent predictors of poor survival, whereas tumor size > 5 cm was not. Although recurrence rates are high, surgical resection for solitary HCC offers good overall survival. Tumor size was not a prognostic factor. Solitary large HCC > 10 cm would be a good candidate for hepatectomy as well as solitary HCC between 5 and 10 cm.	[Lim, Chetana; Mise, Yoshihiro; Sakamoto, Yoshihiro; Yamamoto, Satoshi; Shindoh, Junichi; Ishizawa, Takeaki; Aoki, Taku; Hasegawa, Kiyoshi; Sugawara, Yasuhiko; Kokudo, Norihiro] Univ Tokyo, Hepatobiliary Pancreat Surg Div, Artificial Organ & Transplantat Div, Grad Sch Med,Dept Surg,Bunkyo Ku, Tokyo 1138655, Japan; [Lim, Chetana] Henri Mondor Hosp, Dept Hepatobiliary Pancreat Surg & Liver Transpla, Creteil, France; [Makuuchi, Masatoshi] Japanese Red Cross Med Ctr, Div Hepatobiliary Pancreat Surg, Tokyo, Japan	Kokudo, N (reprint author), Univ Tokyo, Hepatobiliary Pancreat Surg Div, Artificial Organ & Transplantat Div, Grad Sch Med,Dept Surg,Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.	chetana.lim@gmail.com; KOKUDO-2SU@h.u-tokyo.ac.jp					American Joint Committee on Cancer (AJCC), 2009, CANC STAGING MANUAL; Pawlik TM, 2005, LIVER TRANSPLANT, V11, P1086, DOI 10.1002/lt.20472; Vauthey JN, 2002, J CLIN ONCOL, V20, P1527, DOI 10.1200/JCO.20.6.1527; Shah SA, 2007, J GASTROINTEST SURG, V11, P589, DOI 10.1007/s11605-007-0154-7; Aoki T, 2004, ARCH SURG-CHICAGO, V139, P766, DOI 10.1001/archsurg.139.7.766; MAKUUCHI M, 1985, SURG GYNECOL OBSTET, V161, P346; Liau KH, 2005, CANCER, V104, P1948, DOI 10.1002/cncr.21415; Imamura H, 1999, HEPATOLOGY, V29, P1099, DOI 10.1002/hep.510290415; Mok KT, 2003, J AM COLL SURGEONS, V197, P730, DOI 10.1016/S1072-7515(03)00919-0; Shindoh J, 2013, HPB, V15, P31, DOI 10.1111/j.1477-2574.2012.00552.x; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; Nagano Y, 2005, WORLD J SURG, V29, P66, DOI 10.1007/s00268-004-7509-y; Yeh CN, 2003, ANN SURG ONCOL, V10, P1070, DOI 10.1245/ASO.2003.03.072; Liu CL, 2001, J CLIN ONCOL, V19, P3725; Rahbari NN, 2011, ANN SURG, V253, P453, DOI 10.1097/SLA.0b013e31820d944f; MAKUUCHI M, 1993, SEMIN SURG ONCOL, V9, P298, DOI 10.1002/ssu.2980090404; Jonas S, 2001, HEPATOLOGY, V33, P1080, DOI 10.1053/jhep.2001.23561; Tsai TJ, 2000, SURGERY, V127, P603, DOI 10.1067/msy.2000.105498; Lee NH, 1998, BRIT J SURG, V85, P1654; Ariizumi S, 2012, J SURG ONCOL, V107, P408; Chen XP, 2004, BRIT J SURG, V91, P322, DOI 10.1002/bjs.4413; European Association for the Study of the Liver European Organisation for Research and Treatment of Cancer, 2012, J HEPATOL, V56, P908; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Lee SG, 2007, BRIT J SURG, V94, P320, DOI 10.1002/bjs.5622; Liver Cancer Study Group of Japan, 2008, GEN RUL CLIN PATH ST; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Shimada K, 2008, LANGENBECK ARCH SURG, V393, P521, DOI 10.1007/s00423-007-0264-4; Shindoh J, 2012, ANN SURG ONCOL, V20, P1223; Strasberg SM, 2012, ANN SURG, V257, P377; TAKAYAMA T, 1991, SURGERY, V109, P226; Wang Y, 2010, ANN SURG ONCOL, V20, P914	31	4	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	NOV	2014	38	11					2910	2918		10.1007/s00268-014-2704-y		9	Surgery	Surgery	AQ8CB	WOS:000343048900025		
J	Sudo, T; Murakami, Y; Uemura, K; Hashimoto, Y; Kondo, N; Nakagawa, N; Ohge, H; Sueda, T				Sudo, Takeshi; Murakami, Yoshiaki; Uemura, Kenichiro; Hashimoto, Yasushi; Kondo, Naru; Nakagawa, Naoya; Ohge, Hiroki; Sueda, Taijiro			Perioperative Antibiotics Covering Bile Contamination Prevent Abdominal Infectious Complications After Pancreatoduodenectomy in Patients With Preoperative Biliary Drainage	WORLD JOURNAL OF SURGERY			English	Article							SURGICAL INFECTIONS; PANCREATIC FISTULA; CULTURES; PROPHYLAXIS; MORBIDITY; MORTALITY; OUTCOMES; SURGERY; IMPACT; HEAD	Although bile contamination caused by preoperative biliary drainage (PBD) is a risk factor for infectious complications after pancreatoduodenectomy, the appropriate perioperative antibiotic regimen remains unclear. We evaluated a perioperative antibiotic strategy targeting bile contamination associated with PBD procedures for preventing abdominal infectious complications after pancreatoduodenectomy. Consecutive patients (n = 254) underwent pancreatoduodenectomy at a single center. Perioperative antibiotics were mainly cefazolin in non-PBD cases (n = 116) and cefozopran in internal-PBD cases (n = 87). They were based on preoperative bile cultures in 51 of the external-PBD cases. Intraoperative bile cultures were examined prospectively. Morbidity and abdominal infectious complication rates were evaluated. The incidence of positive intraoperative bile cultures was significantly higher in the internal-PBD (85 %) and external-PBD (90 %) cases than in the non-PBD cases (26 %) (p < 0.001). The 91 % susceptibility to cefazolin for non-PBD was significantly higher than the 61 % for internal-PBD or 45 % for external-PBD (p < 0.001). Overall morbidity rates (23, 23, and 25 %) and abdominal infectious complications (13, 17, and 14 %) did not differ among the non-PBD, internal-PBD, and external-PBD cases, respectively. Only susceptibility to perioperative antibiotics of biliary microorganisms classified as resistant was a significant independent risk factor for abdominal infectious complications (p = 0.003). A perioperative antibiotic strategy particular to PBD procedures is valid for covering biliary microorganisms during pancreatoduodenectomy. Perioperative antibiotics covering bile contamination may prevent abdominal infectious complications after pancreatoduodenectomy in patients with and without PBD.	[Sudo, Takeshi; Murakami, Yoshiaki; Uemura, Kenichiro; Hashimoto, Yasushi; Kondo, Naru; Nakagawa, Naoya; Ohge, Hiroki; Sueda, Taijiro] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Surg, Minami Ku, Hiroshima 7348551, Japan	Sudo, T (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Surg, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	tsudo@hiroshima-u.ac.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Donald GW, 2013, SURGERY, V154, P190, DOI 10.1016/j.surg.2013.04.001; Pisters PWT, 2001, ANN SURG, V234, P47, DOI 10.1097/00000658-200107000-00008; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Gouma DJ, 2000, ANN SURG, V232, P786, DOI 10.1097/00000658-200012000-00007; Limongelli P, 2007, SURGERY, V142, P313, DOI 10.1016/j.surg.2007.04.022; Cortes A, 2006, J AM COLL SURGEONS, V202, P93, DOI 10.1016/j.jamcollsurg.2005.09.006; Sewnath ME, 2002, ANN SURG, V236, P17, DOI 10.1097/01.SLA.0000018565.87010.B8; Kwon W, 2013, INFECTION, V41, P93, DOI 10.1007/s15010-012-0358-y; Herzog T, 2009, J CLIN GASTROENTEROL, V43, P457, DOI 10.1097/MCG.0b013e318186b19b; Jagannath P, 2005, BRIT J SURG, V92, P356, DOI 10.1002/bjs.4864; Duffas JP, 2005, AM J SURG, V189, P720, DOI 10.1016/j.amjsurg.2005.03.015; Rerknimitr R, 2002, GASTROINTEST ENDOSC, V56, P885, DOI 10.1067/mge.2002.129604; Sudo T, 2007, WORLD J SURG, V31, P2230, DOI 10.1007/s00268-007-9210-4; Murakami Y, 2008, J GASTROINTEST SURG, V12, P1081, DOI 10.1007/s11605-008-0483-1; Buchler MW, 2000, BRIT J SURG, V87, P883, DOI 10.1046/j.1365-2168.2000.01465.x; van der Gaag NA, 2010, NEW ENGL J MED, V362, P129, DOI 10.1056/NEJMoa0903230; deVera ME, 1996, ARCH SURG-CHICAGO, V131, P338; Povoski SP, 1999, ANN SURG, V230, P131, DOI 10.1097/00000658-199908000-00001; Augenstein VA, 2010, J SURG ONCOL, V102, P478, DOI 10.1002/jso.21612; BARIE PS, 1990, ANN SURG, V212, P155, DOI 10.1097/00000658-199008000-00007; DeOliveira ML, 2006, ANN SURG, V244, P931, DOI 10.1097/01.sla.0000246856.03918.9a; DeOliveira ML, 2006, ANN SURG, V244, P937, DOI DOI 10.1097/01.SLA.0000246856.03918.9A; Isla AM, 2007, LANGENBECK ARCH SURG, V392, P67, DOI 10.1007/s00423-006-0102-0; Kondo K, 2013, J HEPATO-BIL-PAN SCI, V20, P286, DOI 10.1007/s00534-012-0515-9; Mezhir JJ, 2009, J GASTROINTEST SURG, V13, P2163, DOI 10.1007/s11605-009-1046-9; Murakami Y, 2008, J SURG ONCOL, V97, P205, DOI 10.1002/jso.20903; Negm AA, 2010, GASTROINTEST ENDOSC, V72, P284, DOI 10.1016/j.gie.2010.02.043; Povoski SP, 1999, J GASTROINTEST SURG, V3, P496, DOI 10.1016/S1091-255X(99)80103-6; Sourrouille I, 2012, HPB OXFORD, V15, P473; Ueno T, 2005, J HEPATO-BILIARY-PAN, V12, P304, DOI 10.1007/s00534-005-0975-2	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	NOV	2014	38	11					2952	2959		10.1007/s00268-014-2688-7		8	Surgery	Surgery	AQ8CB	WOS:000343048900031		
J	Okada, K; Kawai, M; Tani, M; Hirono, S; Miyazawa, M; Shimizu, A; Kitahata, Y; Yamaue, H				Okada, Ken-ichi; Kawai, Manabu; Tani, Masaji; Hirono, Seiko; Miyazawa, Motoki; Shimizu, Atsushi; Kitahata, Yuji; Yamaue, Hiroki			Preservation of the Left Gastric Artery on the Basis of Anatomical Features in Patients Undergoing Distal Pancreatectomy with Celiac Axis En-bloc Resection (DP-CAR)	WORLD JOURNAL OF SURGERY			English	Article							INTERNATIONAL STUDY-GROUP; BODY CANCER; SURGERY ISGPS; TRUNK; DEFINITION	The incidence of delayed gastric emptying (DGE) is high in patients undergoing distal pancreatectomy with celiac axis en-bloc resection (DP-CAR). The medical records of 37 consecutive patients who underwent DP-CAR were evaluated for the incidence of DGE in 23 patients (62 %) with left gastric artery (LGA)-resecting DP-CAR (conventional DP-CAR) compared with 14 patients (38 %) who underwent distal pancreatectomy with resection of the common hepatic artery and splenic artery, with preservation of the LGA (modified DP-CAR) for pancreatic carcinoma. The patients with tumors situated more than 10 mm away from the antecedent branching LGA underwent modified DP-CAR. Antecedent branching of the LGA was found in 19 patients (51 %) in this series. In the conventional DP-CAR group, the LGA was involved in 20 patients (87.0 %). The International Study Group of Pancreatic Surgery (ISGPS) grades for the conventional DP-CAR group were as follows: no DGE = 43 %, grade A = 26 %, B = 13 %, and C = 17 %. In the modified DP-CAR group, they were as follows: no DGE = 93 %, grade A = 7 %, and grade B/C = 0 %. The R0 rate was higher in the modified DP-CAR group (79 %) than in the conventional DP-CAR group (43 %) (p = 0.048). Univariate analyses revealed resection of LGA, residual tumor status (R1), and clinically relevant (Grade B, C) pancreatic fistula increased the risk of DGE. On multivariate analysis, resection of the LGA was an independent risk factor for increased incidence of DGE. Modified DP-CAR, when it is feasible, significantly reduces the incidence of DGE in comparison with conventional DP-CAR.	[Okada, Ken-ichi; Kawai, Manabu; Tani, Masaji; Hirono, Seiko; Miyazawa, Motoki; Shimizu, Atsushi; Kitahata, Yuji; Yamaue, Hiroki] Wakayama Med Univ, Dept Surg 2, Wakayama, Japan	Yamaue, H (reprint author), Wakayama Med Univ, Dept Surg 2, 811-1 Kimiidera, Wakayama, Japan.	yamaue-h@wakayama-med.ac.jp					Kawai M, 2011, ANN SURG, V253, P495, DOI 10.1097/SLA.0b013e31820d98f1; Okada K, 2013, SURGERY, V153, P365, DOI 10.1016/j.surg.2012.07.036; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Wente MN, 2007, SURGERY, V142, P20, DOI 10.1016/j.surg.2007.02.001; Tani M, 2006, ANN SURG, V243, P316, DOI 10.1097/01.sla.0000201479.84934.ca; Hirano S, 2007, ANN SURG, V246, P46, DOI 10.1097/01.sla.0000258608.52615.5a; Lipshutz B, 1917, ANN SURG, V65, P159, DOI 10.1097/00000658-191702000-00006; Kondo S, 2000, HEPATO-GASTROENTEROL, V47, P1447; Yamamoto Y, 2012, SURGERY, V151, P61, DOI 10.1016/j.surg.2011.06.030; Kondo S, 2003, HEPATO-GASTROENTEROL, V50, P305; Wente MN, 2007, SURGERY, V142, P761, DOI 10.1016/j.surg.2007.05.005; Cavdar S, 1997, CLIN ANAT, V10, P231, DOI 10.1002/(SICI)1098-2353(1997)10:4<231::AID-CA2>3.0.CO;2-V; Cavdar S, 1998, Kaibogaku Zasshi, V73, P505; Eaton PB, 1917, ANAT REC, V13, P369, DOI 10.1002/ar.1090130605; Forrest AS, 2006, AM J PHYSIOL-GASTR L, V290, pG486, DOI 10.1152/ajpgi.00349.2005; Kondo S, 2004, SURG TODAY, V34, P337, DOI 10.1007/s00595-003-2707-z; Malnar D, 2010, COLLEGIUM ANTROPOL, V34, P917; MICHELS NA, 1951, ANN SURG, V133, P503, DOI 10.1097/00000658-195113340-00009; da Silveira LA, 2009, ACTA CIR BRAS, V24, P43, DOI 10.1590/S0102-86502009000100009; Sobin LH, 2009, TNM CLASSIFICATION M; Takahashi H, 2013, WORLD J SURG, V37, P430, DOI 10.1007/s00268-012-1860-1; VANDAMME JPJ, 1985, ACTA ANAT, V122, P110	22	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	NOV	2014	38	11					2980	2985		10.1007/s00268-014-2702-0		6	Surgery	Surgery	AQ8CB	WOS:000343048900035		
J	Okabayashi, T; Shima, Y; Iwata, J; Morita, S; Sumiyoshi, T; Kozuki, A; Tokumaru, T; Iiyama, T; Kosaki, T; Kobayashi, M; Hanazaki, K				Okabayashi, Takehiro; Shima, Yasuo; Iwata, Jun; Morita, Sojiro; Sumiyoshi, Tatsuaki; Kozuki, Akihito; Tokumaru, Teppei; Iiyama, Tatsuo; Kosaki, Takuhiro; Kobayashi, Michiya; Hanazaki, Kazuhiro			S-1 vs. Gemcitabine as an Adjuvant Therapy after Surgical Resection for Ductal Adenocarcinoma of the Pancreas	WORLD JOURNAL OF SURGERY			English	Article							RANDOMIZED CONTROLLED-TRIAL; PLUS S-1; CANCER; CHEMOTHERAPY; PANCREATICODUODENECTOMY; LYMPHADENECTOMY; CHEMORADIATION; FLUOROURACIL; MORTALITY; SURVIVAL	Pancreatectomy with regional lymphadenectomy remains the only curative treatment option for pancreatic cancer. There is no clear consensus on what type of adjuvant therapy should be used for patients with pancreatic cancer. Our objective was to retrospectively evaluate whether postoperative adjuvant chemotherapy using S-1 is clinically beneficial in managing resectable pancreatic cancer. Patients were divided into three groups: those undergoing surgery alone, those receiving gemcitabine infusion, and those receiving S-1 orally. Of 189 studied patients, the median overall survival was 15.0 months after surgery alone, 33.0 months in the gemcitabine group, and 45.0 months in patients receiving S-1. A multivariate analysis identified regional lymph node metastasis, positive surgical margins, and absence of adjuvant chemotherapy as independent negative prognostic factors. S-1 was not inferior to gemcitabine in terms of survival outcomes and showed a favorable hazard ratio compared with gemcitabine in the subsets of patients with positive vascular invasion. There was no difference between adjuvant chemotherapy with S-1 and gemcitabine in overall survival for patients with curative pancreatic cancer. Our results suggested that S-1 can be used as a second agent to gemcitabine after surgical resection for ordinary adenocarcinoma of the pancreas.	[Okabayashi, Takehiro; Shima, Yasuo; Sumiyoshi, Tatsuaki; Kozuki, Akihito; Tokumaru, Teppei] Kochi Hlth Sci Ctr, Dept Surg Gastroenterol, Kochi 7818555, Japan; [Iwata, Jun] Kochi Hlth Sci Ctr, Dept Diagnost Pathol, Kochi 7818555, Japan; [Morita, Sojiro] Kochi Hlth Sci Ctr, Dept Radiol, Kochi 7818555, Japan; [Iiyama, Tatsuo] Kochi Med Sch, Dept Biostat, Kochi, Japan; [Kosaki, Takuhiro] Kochi Med Sch, Dept Gastroenterol & Hepatol, Kochi, Japan; [Kobayashi, Michiya; Hanazaki, Kazuhiro] Kochi Med Sch, Dept Surg, Kochi, Japan	Okabayashi, T (reprint author), Kochi Hlth Sci Ctr, Dept Surg Gastroenterol, 2125-1 Ike, Kochi 7818555, Japan.	takehiro_okabayashi@khsc.or.jp			Kochi Organization for Medical Reformation and Renewal Grants	This work was supported by the Kochi Organization for Medical Reformation and Renewal Grants.	Mollberg N, 2011, ANN SURG, V254, P882, DOI 10.1097/SLA.0b013e31823ac299; Okusaka T, 2008, CANCER CHEMOTH PHARM, V61, P615, DOI 10.1007/s00280-007-0514-8; Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Michalski CW, 2007, BRIT J SURG, V94, P265, DOI 10.1002/bjs.5716; Haller DG, 2008, J CLIN ONCOL, V26, P2118, DOI 10.1200/JCO.2007.15.2090; Chuah B, 2011, CANCER SCI, V102, P478, DOI 10.1111/j.1349-7006.2010.01793.x; Berger AC, 2008, J CLIN ONCOL, V26, P5918, DOI 10.1200/JCO.2008.18.6288; Regine WF, 2008, JAMA-J AM MED ASSOC, V299, P1019, DOI 10.1001/jama.299.9.1019; Yeo CJ, 2002, ANN SURG, V236, P355, DOI 10.1097/01.SLA.0000027272.08464.0B; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Ueno H, 2005, ONCOLOGY-BASEL, V69, P421, DOI 10.1159/000089997; Murakami Y, 2012, J SURG ONCOL, V106, P174, DOI 10.1002/jso.23068; Jemal A, 2006, CA-CANCER J CLIN, V56, P106; Konstantinidis IT, 2013, ANN SURG, V257, P731, DOI 10.1097/SLA.0b013e318263da2f; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Cascinu S, 2009, ANN ONCOL, V20, P37, DOI 10.1093/annonc/mdp123; Chaulagain Chakra P, 2013, JOP, V14, P119, DOI 10.6092/1590-8577/1461; Choti MA, 2004, NEW ENGL J MED, V350, P1249, DOI 10.1056/NEJMe048002; Cox DR, 1972, J R STAT SOC, V187, p34B; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Murakami Y, 2013, CANCER CHEMOTH PHARM, V71, P419, DOI 10.1007/s00280-012-2029-1; Neoptolemos JP, 2003, ANN ONCOL, V14, P675, DOI 10.1093/annonc/mdg207; Uesaka K, 2012, J CLIN ONCOL S34, V30	26	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	NOV	2014	38	11					2986	2993		10.1007/s00268-014-2703-z		8	Surgery	Surgery	AQ8CB	WOS:000343048900036		
J	Ohtsuka, T; Matsunaga, T; Kimura, H; Watanabe, Y; Tamura, K; Ideno, N; Aso, T; Miyasaka, Y; Ueda, J; Takahata, S; Osoegawa, T; Igarashi, H; Ito, T; Ushijima, Y; Ookubo, F; Oda, Y; Mizumoto, K; Tanaka, M				Ohtsuka, Takao; Matsunaga, Taketo; Kimura, Hideyo; Watanabe, Yusuke; Tamura, Koji; Ideno, Noboru; Aso, Teppei; Miyasaka, Yoshihiro; Ueda, Junji; Takahata, Shunichi; Osoegawa, Takashi; Igarashi, Hisato; Ito, Tetsuhide; Ushijima, Yasuhiro; Ookubo, Fumihiko; Oda, Yoshinao; Mizumoto, Kazuhiro; Tanaka, Masao			Role of Pancreatic Juice Cytology in the Preoperative Management of Intraductal Papillary Mucinous Neoplasm of the Pancreas in the Era of International Consensus Guidelines 2012	WORLD JOURNAL OF SURGERY			English	Article							DUCTAL CARCINOMA; REMNANT PANCREAS; FOLLOW-UP; RESECTION; PREDICTORS; MALIGNANCY; IPMN; ADENOCARCINOMAS; CONCOMITANT; RECURRENCE	Routine endoscopic retrograde pancreatography (ERP) for pancreatic juice cytology (PJC) during management of intraductal papillary mucinous neoplasm (IPMN) is not recommended in the international consensus guidelines 2012. The aim of the present study was to investigate the roles of PJC in relation to the new stratification of clinical findings in the consensus guidelines 2012. Medical records of 70 consecutive patients who underwent preoperative PJC, subsequent pancreatectomy, and a pathological diagnosis of IPMN were reviewed. Diagnostic ability of PJC to detect malignant lesions was calculated by the stratification of clinical findings. Forty patients had malignant lesions, including 29 with malignant IPMN, 10 with concomitant pancreatic adenocarcinoma, and one with both. Accuracies of PJC in all 70 patients and in 59 patients with IPMN alone were 77 and 80 %, respectively. The sensitivity and accuracy of PJC in patients with "worrisome features" were 100 and 94 %, respectively. Eight of 11 patients with concomitant pancreatic adenocarcinoma had non-malignant IPMN without risk factors, and 3 significant lesions could be diagnosed only by ERP/PJC. In addition, the management plan based on imaging study changed from observation to resection in two patients who had the single "worrisome feature" of branch duct IPMN and positive PJC results. As a result, PJC altered the management plan in 5 patients. Pancreatic juice cytology potentially has important roles to determine the adequate treatment choice in patients with IPMNs with "worrisome features," and to detect significant lesions that could not be detected by other imaging modalities.	[Ohtsuka, Takao; Matsunaga, Taketo; Kimura, Hideyo; Watanabe, Yusuke; Tamura, Koji; Ideno, Noboru; Aso, Teppei; Miyasaka, Yoshihiro; Ueda, Junji; Takahata, Shunichi; Mizumoto, Kazuhiro; Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Surg, Higashi Ku, Fukuoka 8128582, Japan; [Ohtsuka, Takao; Matsunaga, Taketo; Kimura, Hideyo; Watanabe, Yusuke; Tamura, Koji; Ideno, Noboru; Aso, Teppei; Miyasaka, Yoshihiro; Ueda, Junji; Takahata, Shunichi; Mizumoto, Kazuhiro; Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Oncol, Higashi Ku, Fukuoka 8128582, Japan; [Osoegawa, Takashi; Igarashi, Hisato; Ito, Tetsuhide] Kyushu Univ, Grad Sch Med Sci, Dept Med, Higashi Ku, Fukuoka 8128582, Japan; [Osoegawa, Takashi; Igarashi, Hisato; Ito, Tetsuhide] Kyushu Univ, Grad Sch Med Sci, Dept Bioregulatory Sci, Higashi Ku, Fukuoka 8128582, Japan; [Ushijima, Yasuhiro] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, Fukuoka 8128582, Japan; [Ookubo, Fumihiko] Kyushu Univ Hosp, Div Diagnost Pathol, Fukuoka 8128582, Japan; [Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Higashi Ku, Fukuoka 8128582, Japan	Tanaka, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	takao-o@surg1.med.kyushu-u.ac.jp; masaotan@med.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [25298285]	This study was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 25298285. The findings were presented during International Surgical Week 2013 in Helsinki, Finland.	Adsay V, 2010, WHO CLASSIFICATION T, P304; Furukawa T, 2011, GUT, V60, P509, DOI 10.1136/gut.2010.210567; Yamaguchi K, 2011, PANCREAS, V40, P571, DOI 10.1097/MPA.0b013e318215010c; Tamura K, 2014, ANN SURG, V259, P360, DOI 10.1097/SLA.0b013e3182a690ff; Tanno S, 2010, PANCREATOLOGY, V10, P173, DOI 10.1159/000231982; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Yamaguchi K, 1997, INT J PANCREATOL, V22, P227; Hibi Y, 2007, PANCREAS, V34, P197, DOI 10.1097/MPA.0b013e31802dea0; Ohtsuka T, 2012, SURGERY, V151, P76, DOI 10.1016/j.surg.2011.07.009; Rodriguez JR, 2007, GASTROENTEROLOGY, V133, P72, DOI 10.1053/j.gastro.2007.05.010; Ohno E, 2009, ANN SURG, V249, P628, DOI 10.1097/SLA.0b013e3181a189a8; Chari ST, 2002, GASTROENTEROLOGY, V123, P1500, DOI 10.1053/gast.2002.36552; Ohtsuka T, 2012, AM J SURG, V204, P44, DOI 10.1016/j.amjsurg.2011.04.007; Maguchi H, 2011, PANCREAS, V40, P364, DOI 10.1097/MPA.0b013e31820a5975; Salvia R, 2004, ANN SURG, V239, P678, DOI 10.1097/01.sla.0000124386.54496.15; Uehara H, 2008, GUT, V57, P1561, DOI 10.1136/gut.2007.145631; Tanaka M, 1997, GASTROINTEST ENDOSC, V46, P447, DOI 10.1016/S0016-5107(97)70039-7; Shimizu Y, 2013, PANCREAS, V42, P883, DOI 10.1097/MPA.0b013e31827a7b84; Yamaguchi K, 2005, PANCREATOLOGY, V5, P416, DOI 10.1159/000086555; Shimamoto T, 2010, PANCREAS, V39, P879, DOI 10.1097/MPA.0b013e3181d6ba04; Hirono S, 2012, ANN SURG, V255, P517, DOI 10.1097/SLA.0b013e3182444231; Mino-Kenudson M, 2011, GUT, V60, P1712, DOI 10.1136/gut.2010.232272; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Poultsides GA, 2010, ANN SURG, V251, P470, DOI 10.1097/SLA.0b013e3181cf8a19; Yamaguchi T, 2005, CANCER, V104, P2830, DOI 10.1002/cncr.21565; Ohtsuka T, 2013, J HEPATO-BIL-PAN SCI, V20, P356, DOI 10.1007/s00534-012-0541-7; Ingkakul T, 2010, ANN SURG, V251, P70, DOI 10.1097/SLA.0b013e3181c5ddc3; Barron MR, 2014, J GASTROINTEST SURG, V18, P447, DOI 10.1007/s11605-013-2444-6; Ideno N, 2013, ANN SURG, V258, P141, DOI 10.1097/SLA.0b013e31828cd008; Inoue H, 2001, CANCER, V91, P35, DOI 10.1002/1097-0142(20010101)91:1<35::AID-CNCR5>3.0.CO;2-A; Japan Pancreas Society, 2011, CLASS PANCR CARC; Kamata K, 2014, ENDOSCOPY, V46, P22, DOI 10.1055/s-0033-1353603; Kanda M, 2013, GUT, V62, P719; Shindo Koji, 2013, Case Rep Gastroenterol, V7, P449, DOI 10.1159/000355939	34	2	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	NOV	2014	38	11					2994	3001		10.1007/s00268-014-2684-y		8	Surgery	Surgery	AQ8CB	WOS:000343048900037		
J	Yasuhara, H; Fukatsu, K; Komatsu, T; Murakoshi, S; Saito, Y; Uetera, Y				Yasuhara, Hiroshi; Fukatsu, Kazuhiko; Komatsu, Takami; Murakoshi, Satoshi; Saito, Yuhei; Uetera, Yushi			Occult Risk of Broken Instruments for Endoscopy-assisted Surgery	WORLD JOURNAL OF SURGERY			English	Article							INSULATION FAILURE; LAPAROSCOPIC INSTRUMENT; ORTHOPEDIC PROCEDURES; MAUDE DATABASE; BREAKAGE	The influence of broken sophisticated surgical instruments on the safety of surgery has yet to be determined, in spite of an assumption that breakage of surgical instruments is not associated with critical incidents. The purpose of the present study was to delineate the risk from breakage of surgical instruments used in surgery assisted by endoscopy. A retrospective analysis was conducted to determine the frequency of breakage of instruments used in 39,817 operations from 2007 to 2011. Data of breakage were collected using incident/near-incident reports and the request forms for repair of broken instruments. During the study period, 441 instruments were reported to be broken intraoperatively, and 7,541 were found to be broken on inspection. The incidence of breakage adjusted by the number of operations and the number of uses suggested that instruments for endoscopy-assisted surgery are broken more frequently intraoperatively than are any other type of instruments (visceral surgery: 0.039 versus 0.017, P = 0.0002, RR = 2.318; obstetrics/gynecology: 0.023 versus 0.0067, P < 0.0001, RR = 3.461; thoracic surgery: 0.019 versus 0.004, P = 0.0772, RR = 5.212). Inappropriate use and wearing out were two major possible causes of breakage of instruments. The predominant adverse events were suggested to be attributable to parts falling off broken instruments because of inappropriate use. Our results demonstrated that surgery assisted by endoscopy has its own occult risk, which has not been previously highlighted. Minimally invasive surgery is not necessarily safe with respect to breakage of surgical instruments. Our data provide substantial evidence for higher risk of instrument breakage in endoscopy-assisted surgery, as well as its possible detrimental effect on patient safety.	[Yasuhara, Hiroshi; Fukatsu, Kazuhiko; Komatsu, Takami; Murakoshi, Satoshi; Saito, Yuhei; Uetera, Yushi] Tokyo Univ Hosp, Surg Ctr, Bunkyo Ku, Tokyo 1138655, Japan	Yasuhara, H (reprint author), Tokyo Univ Hosp, Surg Ctr, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yasuhart-tky@umin.ac.jp					Andonian S, 2008, CAN J UROL, V15, P3912; Yazdani A, 2007, J MINIM INVAS GYN, V14, P228, DOI 10.1016/j.jmig.2006.10.009; Nayyar R, 2010, BJU INT, V105, P1710, DOI 10.1111/j.1464-410X.2009.09039.x; Price MV, 2002, INT ORTHOP, V26, P185, DOI 10.1007/s00264-002-0344-6; Mues AC, 2011, UROLOGY, V77, P104, DOI 10.1016/j.urology.2010.01.093; Pichler W, 2008, J BONE JOINT SURG AM, V90A, P2652, DOI 10.2106/JBJS.H.00163; Friedman DCW, 2013, SURG ENDOSC, V27, P1503, DOI 10.1007/s00464-012-2659-8; AORN, 2002, AORN J, V75, P627; BABB JR, 1995, J HOSP INFECT, V30, P543, DOI 10.1016/0195-6701(95)90061-6; Chan D, 2000, J UROLOGY, V164, P319, DOI 10.1016/S0022-5347(05)67349-1; Curfman GD, 2009, NEW ENGL J MED, V360, P1550, DOI 10.1056/NEJMe0902377; Deardorf MA, 1991, AORN J, V54, P35; Kim WT, 2009, UROLOGY, V74, P1234, DOI 10.1016/j.urology.2009.05.071; Montero PN, 2010, SURG ENDOSC, V24, P462, DOI 10.1007/s00464-009-0601-5; Ostrzenski A, 1997, AM J OBSTET GYNECOL, V176, P726, DOI 10.1016/S0002-9378(97)70583-0; Steelman VM, 2012, ARCH SURG-CHICAGO, V147, P955, DOI 10.1001/archsurg.2012.1556; Yasuhara H, 2011, SURGERY, V151, P153	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	NOV	2014	38	11					3015	3022		10.1007/s00268-014-2666-0		8	Surgery	Surgery	AQ8CB	WOS:000343048900040		
J	Mise, Y; Kokudo, N				Mise, Yoshihiro; Kokudo, Norihiro			The Extent of Hepatectomy Does Not Affect Physical QOL in Patients with HCC: Reply	WORLD JOURNAL OF SURGERY			English	Letter							QUALITY-OF-LIFE; HEPATOCELLULAR-CARCINOMA; LIVER-REGENERATION; RESECTION; DONORS		[Mise, Yoshihiro; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Hepatobiliary Pancreat Surg Div, Dept Surg,Bunkyo Ku, Tokyo 1138655, Japan	Kokudo, N (reprint author), Univ Tokyo, Grad Sch Med, Hepatobiliary Pancreat Surg Div, Dept Surg,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	KOKUDO-2SU@h.u-tokyo.ac.jp					Kele PG, 2012, BRIT J SURG, V99, P1113, DOI 10.1002/bjs.8807; Aoki T, 2011, J GASTROINTEST SURG, V15, P1594, DOI 10.1007/s11605-011-1590-y; Poon RTP, 2001, ARCH SURG-CHICAGO, V136, P693, DOI 10.1001/archsurg.136.6.693; Pomfret EA, 2003, TRANSPLANTATION, V76, P5, DOI 10.1097/01.TP.0000079064.08263.8E; Di Carlo I, 2014, WORLD J SURG, V38, P3035, DOI 10.1007/s00268-014-2677-x; Haga J, 2008, LIVER TRANSPLANT, V14, P1718, DOI 10.1002/lt.21622; Mise Y, 2013, WORLD J SURG, V38, P958; Toro A, 2012, SURG ONCOL, V21, pE23, DOI 10.1016/j.suronc.2011.10.005	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	NOV	2014	38	11					3036	3037		10.1007/s00268-014-2730-9		2	Surgery	Surgery	AQ8CB	WOS:000343048900045		
J	Murai, T; Takakusa, H; Nakai, D; Kamiyama, E; Taira, T; Kimura, T; Jimbo, T; Bathala, M; Pickersgill, F; Zahir, H; Tokui, T; Savage, RE; Ashwell, MA; Izumi, T				Murai, Takahiro; Takakusa, Hideo; Nakai, Daisuke; Kamiyama, Emi; Taira, Tomoe; Kimura, Tomoko; Jimbo, Takeshi; Bathala, Mohinder; Pickersgill, Fraser; Zahir, Hamim; Tokui, Taro; Savage, Ronald E.; Ashwell, Mark A.; Izumi, Takashi			Metabolism and disposition of [C-14]tivantinib after oral administration to humans, dogs and rats	XENOBIOTICA			English	Article						Absorption; ADME; excretion; metabolite identification; oncology; pharmacokinetics; species comparison; tivantinib	CELL LUNG-CANCER; TIVANTINIB ARQ 197; SELECTIVE INHIBITOR; TYROSINE KINASE; PHASE-I; MET; ERLOTINIB; TUMORS; PLACEBO	1. The biotransformation and disposition of tivantinib in humans, dogs and rats was examined after a single oral administration of [C-14]tivantinib. Tivantinib constituted no more than one-third of the plasma radioactivity in all species, demonstrating significant contribution of the metabolites to plasma radioactivity. The major circulating metabolites in all species were M4 and M5, hydroxylated metabolites at the benzyl position of the tricyclic ring, accounting for 19.3 and 12.2% of the AUC of the total radioactivity, respectively, in humans. 2. The majority of radioactivity was excreted to the feces via bile. Tivantinib was detected at trace levels in urine, feces and bile, demonstrating extensive metabolism prior to biliary excretion and nearly complete tivantinib absorption under fed conditions. 3. Seven metabolic pathways were identified for tivantinib and included six oxidations (M4, M5, M7, M8, M9 and M11) and one glucuronidation (M23). The major metabolic and excretory pathways were found to be common among all species. Species differences in the metabolic pathways included lactam metabolite (M8) formation in humans and dehydrogenated metabolite (M11) formation in animals. 4. None of the metabolites identified in this work are believed to significantly impact the efficacy or toxicity of tivantinib in humans.	[Murai, Takahiro; Takakusa, Hideo; Nakai, Daisuke; Kamiyama, Emi; Izumi, Takashi] Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, Tokyo 1408710, Japan; [Taira, Tomoe; Kimura, Tomoko; Jimbo, Takeshi] Daiichi Sankyo Co Ltd, Oncol Res Labs, Shinagawa Ku, Tokyo 1408710, Japan; [Bathala, Mohinder; Pickersgill, Fraser; Zahir, Hamim] Daiichi Sankyo Pharma Dev, Edison, NJ USA; [Tokui, Taro] Daiichi Sankyo Co Ltd, Translat Med & Clin Pharmacol Dept, Shinagawa Ku, Tokyo 1408710, Japan; [Savage, Ronald E.; Ashwell, Mark A.] ArQule Inc, Woburn, MA USA	Nakai, D (reprint author), Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	nakai.daisuke.jf@daiichisankyo.co.jp					Yamamoto N, 2013, BRIT J CANCER, V109, P2803, DOI 10.1038/bjc.2013.588; Munshi N, 2010, MOL CANCER THER, V9, P1544, DOI 10.1158/1535-7163.MCT-09-1173; Rosen LS, 2011, CLIN CANCER RES, V17, P7754, DOI 10.1158/1078-0432.CCR-11-1002; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Eathiraj S, 2011, J BIOL CHEM, V286, P20666, DOI 10.1074/jbc.M110.213801; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Wagner AJ, 2012, CANCER-AM CANCER SOC, V118, P5894, DOI 10.1002/cncr.27582; Sequist LV, 2011, J CLIN ONCOL, V29, P3307, DOI 10.1200/JCO.2010.34.0570; Yap TA, 2011, J CLIN ONCOL, V29, P1271, DOI 10.1200/JCO.2010.31.0367; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; Yokozaki H, 2000, PATHOL INT, V50, P767, DOI 10.1046/j.1440-1827.2000.01117.x; Adjei AA, 2011, ONCOLOGIST, V16, P788, DOI 10.1634/theoncologist.2010-0380; Santoro A, 2013, LANCET ONCOL, V14, P55, DOI 10.1016/S1470-2045(12)70490-4; Zenser TV, 1999, DRUG METAB DISPOS, V27, P1064	14	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0049-8254	1366-5928		XENOBIOTICA	Xenobiotica	NOV	2014	44	11					996	1008		10.3109/00498254.2014.926572		13	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	AQ8MY	WOS:000343080900005		
J	Sawamura, R; Kazui, M; Kurihara, A; Izumi, T				Sawamura, Ryoko; Kazui, Miho; Kurihara, Atsushi; Izumi, Takashi			Absorption, distribution, metabolism and excretion of loxoprofen after dermal application of loxoprofen gel to rats	XENOBIOTICA			English	Article						NSAID; pharmacokinetics; safety; skin; topical application	PHOTOALLERGIC CONTACT-DERMATITIS; PERCUTANEOUS-ABSORPTION; STRATUM-CORNEUM; PHARMACOKINETICS; DICLOFENAC; DRUG; KETOPROFEN; INVITRO; SKIN	1. Loxoprofen (LX), is a prodrug of the pharmacologically active form, trans-alcohol metabolite (trans-OH form), which shows very potent analgesic effect. In this study, the pharmacokinetics and metabolism of [C-14]LX-derived radioactivity after dermal application of [C-14]LX gel (LX-G) to rats were evaluated. 2. The area under concentration-time curve (AUC(0-infinity)) of radioactivity in the plasma after the dermal application was 13.6% of that of the oral administration (p < 0.05). 3. After the dermal application, the radioactivity remained in the skin and skeletal muscle at the treated site for 168 h, whereas the AUC(0-168) (h) of the radioactivity concentration in every tissue examined except the treated site was statistically lower than that after the oral administration (p < 0.05). 4. The trans-OH form was observed at high levels in the treated skin site at 0.5 h. Metabolite profiles in plasma, non-treated skin site and urine after the dermal application were comparable with those after the oral administration. 5. Renal excretion was the main route of elimination after the dermal application. 6. In conclusion, compared to the oral administration, the dermal application of [C-14]LX-G showed lower systemic and tissue exposure with higher exposure in the therapeutic target site. The radioactivity revealed similar metabolite profiles in both administration routes.	[Sawamura, Ryoko; Kazui, Miho; Kurihara, Atsushi; Izumi, Takashi] Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, Tokyo 1408710, Japan	Sawamura, R (reprint author), Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	sawamura.ryoko.yi@daiichisankyo.co.jp					Sanchez-Borges M, 2010, MED CLIN N AM, V94, P853, DOI 10.1016/j.mcna.2010.03.005; Heyneman CA, 2000, DRUGS, V60, P555, DOI 10.2165/00003495-200060030-00004; VanDerKlauw MM, 1996, CLIN EXP ALLERGY, V26, P1355, DOI 10.1046/j.1365-2222.1996.d01-300.x; Harirforoosh S, 2009, EXPERT OPIN DRUG SAF, V8, P669, DOI 10.1517/14740330903311023; Trommer H, 2006, SKIN PHARMACOL PHYS, V19, P106, DOI 10.1159/000091978; SIOUFI A, 1994, BIOPHARM DRUG DISPOS, V15, P441, DOI 10.1002/bdd.2510150602; Bastien M, 1997, ANN DERMATOL VENER, V124, P523; Honma M., 1994, J CLIN THER MED, V10, P2107; Hotchkiss SAM, 1998, DRUGS PHARM SCI, V91, P43; Kanazawa M, 1997, EUR J RHEUMATOL INFL, V8, P117; Koo TS, 2005, J PHARM SCI-US, V94, P2187, DOI 10.1002/jps.20451; Kowalzick L, 2006, CONTACT DERMATITIS, V54, P348, DOI 10.1111/j.0105-1873.2006.0645f.x; Koyama K, 2010, XENOBIOTICA, V40, P207, DOI 10.3109/00498250903447691; Lacroix I, 2004, FUND CLIN PHARMACOL, V18, P201, DOI 10.1111/j.1472-8206.2004.00224.x; Matsubara T, 2011, PAIN CLINIC, V32, P715; MATSUDA K, 1984, BIOCHEM PHARMACOL, V33, P2473, DOI 10.1016/0006-2952(84)90720-2; Montoro J, 2003, CONTACT DERMATITIS, V48, P115, DOI 10.1034/j.1600-0536.2003.480212_1.x; Shah AK, 1996, PHARMACEUT RES, V13, P168, DOI 10.1023/A:1016014308638; Singh G, 2000, Am J Ther, V7, P115, DOI 10.1097/00045391-200007020-00008; TSAI JC, 1991, INT J PHARM, V68, P127; Yamakawa N, 2013, DRUG METAB PHARMACOK, V28, P118, DOI 10.2133/dmpk.DMPK-12-RG-050	21	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0049-8254	1366-5928		XENOBIOTICA	Xenobiotica	NOV	2014	44	11					1026	1038		10.3109/00498254.2014.926571		13	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	AQ8MY	WOS:000343080900008		
J	Suzuki, M; Komura, H; Yoshikawa, T; Enya, S; Nagao, A; Takubo, H; Kogayu, M				Suzuki, Motoya; Komura, Hiroshi; Yoshikawa, Tomonori; Enya, Seiji; Nagao, Akemi; Takubo, Hiroaki; Kogayu, Motohiro			Characterization of gastrointestinal absorption of digoxin involving influx and efflux transporter in rats: application of mdr1a knockout (-/-) rats into absorption study of multiple transporter substrate	XENOBIOTICA			English	Article						Absorption; digoxin; knockout rat; oatp; P-glycoprotein; quinidine	SMALL-INTESTINAL METABOLISM; DRUG-DRUG INTERACTIONS; P-GLYCOPROTEIN; IN-VITRO; SPECIES-DIFFERENCES; PHARMACOKINETICS; INHIBITION; EXPRESSION; BRAIN; DISPOSITION	1. This study was aimed to characterize gastrointestinal absorption of digoxin using wild-type (WT) and multidrug resistance protein 1a [mdr1a; P-glycoprotein (P-gp)] knockout (-/-) rats. 2. In WT rats, the area under the plasma concentration-time curve (AUC) of oral digoxin increased after oral pretreatment with quinidine at 30 mg/kg compared with non-treatment, but the increasing ratio tended to decrease at a high dose of 100 mg/kg. In mdr1a (-/-) rats, however, quinidine pretreatment caused a dose-dependent decrease in the AUC. 3. Quinidine pretreatment did not alter the hepatic availability of digoxin, indicating that the changes in the digoxin AUC were attributable to inhibition of the absorption process by quinidine; i.e. inhibition of influx by quinidine in mdr1a (-/-) rats and inhibition of efflux and influx by quinidine in WT rats. 4. An in situ rat intestinal closed loop study using naringin implied that organic anion transporting peptide (Oatp) 1a5 may be a responsible transporter in the absorption of digoxin. 5. These findings imply that the rat absorption behavior of digoxin is possibly governed by Oatp1a5-mediated influx and P-gp-mediated efflux. The mdr1a (-/-) rat is therefore a useful in vivo tool to investigate drug absorption associated with multiple transporters including P-gp.	[Suzuki, Motoya; Komura, Hiroshi; Yoshikawa, Tomonori; Enya, Seiji; Nagao, Akemi; Takubo, Hiroaki; Kogayu, Motohiro] Japan Tobacco Inc, Cent Pharmaceut Res Inst, Drug Metab & Pharmacokinet Res Labs, Osaka, Japan	Suzuki, M (reprint author), Japan Tobacco Inc, Cent Pharmaceut Res Inst, 1-1 Murasaki Cho, Takatsuki, Osaka 5691125, Japan.	motoya.suzuki@jt.com					JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Tsuda M, 2009, J PHARMACOL EXP THER, V329, P185, DOI 10.1124/jpet.108.147918; Koitabashi Y, 2006, LIFE SCI, V78, P2852, DOI 10.1016/j.lfs.2005.11.006; Bourdet DL, 2005, J PHARMACOL EXP THER, V315, P1288, DOI 10.1124/jpet.105.091223; Chiba M, 2009, AAPS J, V11, P262, DOI 10.1208/s12248-009-9103-6; Yarim M, 2005, BIOORGAN MED CHEM, V13, P463, DOI 10.1016/j.bmc.2004.10.009; Fromm MF, 1999, CIRCULATION, V99, P552; Balimane PV, 2004, EUR J PHARM BIOPHARM, V58, P99, DOI 10.1016/j.ejpb.2004.02.014; Bentz J, 2013, DRUG METAB DISPOS, V41, P1347, DOI 10.1124/dmd.112.050500; Sakaeda T, 2001, PHARMACEUT RES, V18, P1400, DOI 10.1023/A:1012244520615; Komura H, 2008, J PHARM SCI-US, V97, P1775, DOI 10.1002/jps.21121; Ming X, 2009, DRUG METAB DISPOS, V37, P424, DOI 10.1124/dmd.108.024083; Shirasaka Y, 2009, PHARM RES-DORDR, V26, P560, DOI 10.1007/s11095-008-9771-4; Fenner KS, 2009, CLIN PHARMACOL THER, V85, P173, DOI 10.1038/clpt.2008.195; Augustine LM, 2005, DRUG METAB DISPOS, V33, P182, DOI 10.1124/dmd.104.001024; Shirasaka Y, 2010, J PHARMACOL EXP THER, V332, P181, DOI 10.1124/jpet.109.159756; Lin JH, 2007, EXPERT OPIN DRUG MET, V3, P81, DOI 10.1517/17425255.3.1.81; Sugimoto H, 2011, DRUG METAB DISPOS, V39, P8, DOI 10.1124/dmd.110.035774; Cummins CL, 2002, J PHARMACOL EXP THER, V300, P1036, DOI 10.1124/jpet.300.3.1036; Chandra P, 2004, PHARM RES, V21, P719, DOI 10.1023/B:PHAM.0000026420.79421.8f; Chen CP, 2003, CURR DRUG METAB, V4, P272, DOI 10.2174/1389200033489415; DOHERTY JE, 1962, AM HEART J, V63, P528, DOI 10.1016/0002-8703(62)90310-1; Funakoshi S, 2005, J PHARM SCI-US, V94, P1196, DOI 10.1002/jps.20346; Gao Bo, 1999, Journal of Histochemistry and Cytochemistry, V47, P1255; Goralski KB, 2003, BRIT J PHARMACOL, V139, P35, DOI 10.1038/sj.bjp.0705227; Gramatte T, 1996, CLIN PHARMACOL THER, V59, P541, DOI 10.1016/S0009-9236(96)90182-4; HARRISON LI, 1976, DRUG METAB DISPOS, V4, P88; Kallem Rajareddy, 2012, Drug Metab Lett, V6, P134; Kato Motohiro, 2003, Drug Metab Pharmacokinet, V18, P365, DOI 10.2133/dmpk.18.365; Komura H, 2011, DRUG METAB REV, V43, P476, DOI 10.3109/03602532.2011.597401; Lam JL, 2004, DRUG METAB DISPOS, V32, P1311; Lumen AA, 2013, PLOS ONE, V8, P1; Minematsu T, 2010, DRUG METAB DISPOS, V38, P1, DOI 10.1124/dmd.109.028142; Nader AM, 2014, J CLIN PHARMACOL, V54, P3, DOI 10.1002/jcph.200; Nishimura T, 2008, PHARM RES-DORDR, V25, P2467, DOI 10.1007/s11095-008-9658-4; PEDERSEN KE, 1981, CLIN PHARMACOL THER, V30, P311; Salphati L, 1999, XENOBIOTICA, V29, P171, DOI 10.1080/004982599238722; Salphati L, 1998, PHARMACOLOGY, V56, P308, DOI 10.1159/000028214; Su SF, 1996, DRUG METAB DISPOS, V24, P142; Sun H, 2004, DRUG METAB DISPOS, V32, P1239, DOI 10.1124/dmd.104.000521; Tachibana T, 2012, PHARM RES-DORDR, V29, P651, DOI 10.1007/s11095-011-0579-2; THIEBAUT F, 1989, J HISTOCHEM CYTOCHEM, V37, P159; Walters HC, 2000, AM J PHYSIOL-GASTR L, V279, pG1188; Weiss M, 2010, PHARM RES-DORDR, V27, P1999, DOI 10.1007/s11095-010-0204-9; Zhang HJ, 2003, ARCH PHARM RES, V26, P768, DOI 10.1007/BF02976689	46	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0049-8254	1366-5928		XENOBIOTICA	Xenobiotica	NOV	2014	44	11					1039	1045		10.3109/00498254.2014.920551		7	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	AQ8MY	WOS:000343080900009		
J	Sperber, AD; Gwee, KA; Hungin, AP; Corazziari, E; Fukudo, S; Gerson, C; Ghoshal, UC; Kang, JY; Levy, RL; Schmulson, M; Dumitrascu, D; Gerson, MJ; Chen, M; Myung, SJ; Quigley, EMM; Whorwell, PJ; Zarzar, K; Whitehead, WE				Sperber, A. D.; Gwee, K. A.; Hungin, A. P.; Corazziari, E.; Fukudo, S.; Gerson, C.; Ghoshal, U. C.; Kang, J. -Y.; Levy, R. L.; Schmulson, M.; Dumitrascu, D.; Gerson, M. -J.; Chen, M.; Myung, S. -J.; Quigley, E. M. M.; Whorwell, P. J.; Zarzar, K.; Whitehead, W. E.			Conducting multinational, cross-cultural research in the functional gastrointestinal disorders: issues and recommendations. A Rome Foundation working team report	ALIMENTARY PHARMACOLOGY & THERAPEUTICS			English	Review							IRRITABLE-BOWEL-SYNDROME; SEVERITY INDEX; SYNDROME IBS; DOUBLE-BLIND; TRANSLATION; ADAPTATION; VALIDATION; PATTERNS; CARE	BackgroundCross-cultural, multinational research can advance the field of functional gastrointestinal disorders (FGIDs). Cross-cultural comparative research can make a significant contribution in areas such as epidemiology, genetics, psychosocial modulators, symptom reporting and interpretation, extra-intestinal co-morbidity, diagnosis and treatment, determinants of disease severity, health care utilisation, and health-related quality of life, all issues that can be affected by geographical region, culture, ethnicity and race. AimsTo identify methodological challenges for cross-cultural, multinational research, and suggest possible solutions. MethodsThis report, which summarises the full report of a working team established by the Rome Foundation that is available on the Internet, reflects an effort by an international committee of FGID clinicians and researchers. It is based on comprehensive literature reviews and expert opinion. ResultsCross-cultural, multinational research is important and feasible, but has barriers to successful implementation. This report contains recommendations for future research relating to study design, subject recruitment, availability of appropriate study instruments, translation and validation of study instruments, documenting confounders, statistical analyses and reporting of results. ConclusionsAdvances in study design and methodology, as well as cross-cultural research competence, have not matched technological advancements. The development of multinational research networks and cross-cultural research collaboration is still in its early stages. This report is intended to be aspirational rather than prescriptive, so we present recommendations, not guidelines. We aim to raise awareness of these issues and to pose higher standards, but not to discourage investigators from doing what is feasible in any particular setting.	[Sperber, A. D.] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Gwee, K. A.] Natl Univ Singapore, Singapore 117548, Singapore; [Hungin, A. P.] Univ Durham, Wolfson Res Inst, Durham, England; [Corazziari, E.] Univ Roma La Sapienza, I-00185 Rome, Italy; [Fukudo, S.] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Gerson, C.] Mt Sinai Sch Med, New York, NY USA; [Ghoshal, U. C.] Sanjay Gandhi Postgrad Inst Med Sci, Lucknow, Uttar Pradesh, India; [Kang, J. -Y.] St George Hosp, London, England; [Levy, R. L.] Univ Washington, Seattle, WA 98195 USA; [Schmulson, M.] Univ Nacl Autonoma Mexico, Mexico City 04510, DF, Mexico; [Dumitrascu, D.] Univ Med & Pharm Iuliu, Cluj Napoca, Romania; [Gerson, M. -J.] NYU, Postdoctoral Program Psychotherapy & Psychoanal, New York, NY USA; [Chen, M.] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Myung, S. -J.] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea; [Quigley, E. M. M.] Houston Methodist Hosp, Houston, TX USA; [Quigley, E. M. M.] Weill Cornell Med Coll, Houston, TX USA; [Whorwell, P. J.] Wythenshawe Hosp, Manchester M23 9LT, Lancs, England; [Zarzar, K.] TransPeerfect Inc, Chapel Hill, NC USA; [Whitehead, W. E.] Univ N Carolina, Chapel Hill, NC USA	Sperber, AD (reprint author), Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel.	amiroie@me.com			Rome Foundation, a nonprofit organisation	Declaration of funding interests: The Rome Foundation, a nonprofit organisation, supported the working team by providing funding for its meetings and conference calls.	Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; Hungin APS, 2003, ALIMENT PHARM THERAP, V17, P643, DOI 10.1046/j.0269-2813.2003.01456.x; Kellow J, 2003, GUT, V52, P671, DOI 10.1136/gut.52.5.671; SPERBER AD, 1994, J CROSS CULT PSYCHOL, V25, P501, DOI 10.1177/0022022194254006; Gerson MJ, 2006, SOC SCI MED, V62, P2838, DOI 10.1016/j.socscimed.2005.10.019; Gwee KA, 2010, J GASTROEN HEPATOL, V25, P1189, DOI 10.1111/j.1440-1746.2010.06353.x; Patrick DL, 1998, DIGEST DIS SCI, V43, P400, DOI 10.1023/A:1018831127942; Kulis D, 2011, EXPERT REV PHARM OUT, V11, P307, DOI [10.1586/erp.11.27, 10.1586/ERP.11.27]; Muller-Lissner S, 2010, NEUROGASTROENT MOTIL, V22, P991, DOI 10.1111/j.1365-2982.2010.01533.x; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; DROSSMAN DA, 1995, DIGEST DIS SCI, V40, P986, DOI 10.1007/BF02064187; Toner BB, 1998, PSYCHOSOM MED, V60, P492; Brislin R.W., 1980, HDB CROSS CULTURAL P, V2, P389; Brislin RW, 1973, CROSS CULTURAL RES M, P32; Conway K, 2014, QUAL LIFE RES, V23, P1199, DOI 10.1007/s11136-013-0572-9; Derogatis L. R., 1983, SCL90R CLIN PSYCH RE; Diaz-Loving R, 1998, J CROSS CULT PSYCHOL, V29, P104, DOI 10.1177/0022022198291006; FDA & US Department of Health and Human Services, 2009, GUID IND PAT REP OUT; Francis CY, 1997, ALIMENT PHARM THERAP, V11, P395, DOI 10.1046/j.1365-2036.1997.142318000.x; Kanazawa M, 2012, GASTROENTEROLOGY, V142, pS10; Longstreth GF, 2006, ROME 3 FUNCTIONAL GA, P487; Palsson OS, 2002, GASTROENTEROLOGY, V122, pA502; PRINCE R, 1967, INT J SOC PSYCHIATR, V13, P229, DOI 10.1177/002076406701300308; Schmulson M, 2014, NEUROGASTROENTEROL M; Seifert B, 2008, DIGEST LIVER DIS, V40, P659, DOI 10.1016/j.dld.2008.02.020; Shah S S, 2001, Indian J Gastroenterol, V20, P103; Sperber A, 2014, ROME FDN WORKING TEA; Sperber AD, 2000, AM J GASTROENTEROL, V95, P995; Sperber AD, 2005, CLIN GASTROENTEROL H, V3, P342, DOI 10.1053/S1542-3565(04)00553-1; United Nations, 2005, STESASTATSERF96 UN; ZUCKERMAN MJ, 1995, DIGEST DIS SCI, V40, P1763, DOI 10.1007/BF02212699	31	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-2813	1365-2036		ALIMENT PHARM THER	Aliment. Pharmacol. Ther.	NOV	2014	40	9					1094	1102		10.1111/apt.12942		9	Gastroenterology & Hepatology; Pharmacology & Pharmacy	Gastroenterology & Hepatology; Pharmacology & Pharmacy	AQ6EU	WOS:000342903400010		
J	Nakazawa, K; Kizawa, Y; Maeno, T; Takayashiki, A; Abe, Y; Hamano, J; Maeno, T				Nakazawa, Kazuhiro; Kizawa, Yoshiyuki; Maeno, Takami; Takayashiki, Ayumi; Abe, Yasushi; Hamano, Jun; Maeno, Tetsuhiro			Palliative Care Physicians' Practices and Attitudes Regarding Advance Care Planning in Palliative Care Units in Japan: A Nationwide Survey	AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE			English	Article						advance care planning; advance directives; attitude; palliative medicine; palliative care; neoplasms; Japan	CANCER-PATIENTS; LIFE DECISIONS; END; DIRECTIVES	To clarify physicians' practices and attitudes regarding advance care planning (ACP) in palliative care units (PCUs) in Japan, we conducted a self-completed questionnaire survey of 203 certificated PCUs in 2010. Ninety-nine physicians participated in the survey. Although most Japanese palliative care physicians recognized the importance of ACP, many failed to implement aspects of patient-directed ACP that they acknowledged to be important, such as recommending completion of advance directives (ADs), designation of health care proxies, and implementing existing ADs. The physicians' general preference for family-centered decision making and their feelings of difficulty and low confidence regarding ACP most likely underlie these results. The discrepancy between physicians' practices and their recognition of the importance of ACP suggests an opportunity to improve end-of-life care.	[Nakazawa, Kazuhiro; Maeno, Takami; Takayashiki, Ayumi; Hamano, Jun; Maeno, Tetsuhiro] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Primary Care & Med Educ, Tsukuba, Ibaraki, Japan; [Kizawa, Yoshiyuki] Kobe Univ, Grad Sch Med, Dept Palliat Med, Kobe, Hyogo 6500017, Japan; [Abe, Yasushi] Asahikawa Med Univ, Dept Palliat Care, Asahikawa, Hokkaido, Japan	Kizawa, Y (reprint author), Kobe Univ, Grad Sch Med, Dept Palliat Med, Chuo Ku, 7-5-1 Kusunokicho, Kobe, Hyogo 6500017, Japan.	kizawa-ysyk@umin.org			Health and Labor Sciences Research Grant for Clinical Cancer Research from the Ministry of Health, Labor and Welfare, Japan	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This survey was supported by the Health and Labor Sciences Research Grant for Clinical Cancer Research from the Ministry of Health, Labor and Welfare, Japan.	Akechi T, 2012, PALLIATIVE MED, V26, P768, DOI 10.1177/0269216312437214; Hu WY, 2010, SOC SCI MED, V70, P1701, DOI 10.1016/j.socscimed.2010.02.011; Sanjo M, 2007, ANN ONCOL, V18, P1539, DOI 10.1093/annonc/mdm199; Singer PA, 1996, CAN MED ASSOC J, V155, P1689; Asai A, 1998, EUR J CANCER, V34, P1582, DOI 10.1016/S0959-8049(98)00148-8; Coleman AM, 2012, AM J HOSP PALLIAT CA; DAVIDSON KW, 1989, JAMA-J AM MED ASSOC, V262, P2415, DOI 10.1001/jama.262.17.2415; Davis A J, 2002, Int Nurs Rev, V49, P226, DOI 10.1046/j.1466-7657.2002.00126.x; Detering KM, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1345; Hilden HM, 2004, J MED ETHICS, V30, P362, DOI 10.1136/jme.2002.001081; HUGHES DL, 1992, CAN MED ASSOC J, V146, P1937; Kizawa Y, 2012, AM J HOSP PALLIAT CA; NILCHAIKOVIT T, 1993, GEN HOSP PSYCHIAT, V15, P41, DOI 10.1016/0163-8343(93)90090-B; Sittisombut S, 2009, NURS HEALTH SCI, V11, P23, DOI 10.1111/j.1442-2018.2008.00416.x; Voltz R, 1998, J PAIN SYMPTOM MANAG, V16, P153, DOI 10.1016/S0885-3924(98)00067-0	15	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-9091	1938-2715		AM J HOSP PALLIAT ME	Am. J. Hosp. Palliat. Med.	NOV	2014	31	7					699	709		10.1177/1049909113507328		11	Health Care Sciences & Services	Health Care Sciences & Services	AQ7JT	WOS:000342990800002		
J	Terui, T; Koike, K; Hirayama, Y; Kusakabe, T; Ono, K; Mihara, H; Kobayashi, K; Takahashi, Y; Nakajima, N; Kato, J; Ishitani, K				Terui, Takeshi; Koike, Kazuhiko; Hirayama, Yasuo; Kusakabe, Toshiro; Ono, Kaoru; Mihara, Hiroyoshi; Kobayashi, Kenji; Takahashi, Yuji; Nakajima, Nobuhisa; Kato, Junji; Ishitani, Kunihiko			Recent Advances in Palliative Cancer Care at a Regional Hospital in Japan	AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE			English	Article						palliative cancer care; multidisciplinary team; length of stay; universal health care system in Japan; cancer refugees; malignant tumor hospital		More than 30 years have passed since the introduction of the concept of palliative care in cancer care in Japan. However, the majority of the estimated three million cancer patients in Japan do not receive palliative care. Higashi Sapporo Hospital was established in 1983 as a hospital specialized in cancer care. The palliative care unit of our hospital currently consists of 58 beds. Our hospital is one of the largest hospitals in Japan in terms of the number of palliative care beds. On admission to our hospital, all patients are evaluated for palliative care by a multi-disciplinary team and some patients who undergo anticancer therapy receive palliative care when necessary. There are about 65 patients on average (28.3%) who are receiving only palliative care. In 2011, 793 patients died of cancer while admitted at our hospital. This number of cancer deaths accounted for 15% of the 5,324 cancer deaths in Sapporo City in the same year. Our hospital has played an active role according to the philosophy that `` palliative cancer care is part of cancer medical care''. We here report the current status of the contribution of our hospital to overcoming problems in palliative care and cancer care in Japan.	[Terui, Takeshi; Hirayama, Yasuo; Kusakabe, Toshiro; Ono, Kaoru; Mihara, Hiroyoshi; Ishitani, Kunihiko] Higashi Sapporo Hosp, Dept Internal Med, Sapporo, Hokkaido 0038585, Japan; [Koike, Kazuhiko; Kobayashi, Kenji; Takahashi, Yuji; Nakajima, Nobuhisa] Higashi Sapporo Hosp, Dept Palliat Med, Sapporo, Hokkaido 0038585, Japan; [Ono, Kaoru; Kato, Junji] Sapporo Med Univ, Sch Med, Dept Med Oncol & Hematol, Sapporo, Hokkaido, Japan	Terui, T (reprint author), Higashi Sapporo Hosp, Shiroishi Ku, 3-7-35 Higashi Sapporo, Sapporo, Hokkaido 0038585, Japan.	terui@hsh.or.jp					Kawamata M, 1996, PAIN, V64, P597, DOI 10.1016/0304-3959(95)00189-1; Minagawa H, 1996, CANCER, V78, P1131, DOI 10.1002/(SICI)1097-0142(19960901)78:5<1131::AID-CNCR26>3.3.CO;2-J; Brody H, 1981, ETHICAL DECISION MED; Callaway M, 2007, J PAIN SYMPTOM MANAG, V33, P483, DOI 10.1016/j.jpainsymman.2007.02.030; Doyle D., 2009, OXFORD TXB PALLIATIV, P1529; Hatake K, 1996, LANCET, V348, P548, DOI 10.1016/S0140-6736(05)64708-3; Ishitani K, 1998, CURRENT PERSPECTIVES AND FUTURE DIRECTIONS IN PALLIATIVE MEDICINE, P177; Ishitani K, 1990, P WORKSH CANC PAIN R, P64; Koike K, PALLIAT SUP IN PRESS; Kondo A, 1990, Am J Hosp Palliat Care, V7, P36, DOI 10.1177/104990919000700211; Ministry of Health and Welfare, ANN HLTH LAB WELF RE; Petteraon WB, 1994, J CLIN ONCOL, V7, P1516; Reich MR, 2011, LANCET, V378, P1051, DOI 10.1016/S0140-6736(11)60274-2; Shimizu T., 2012, ENCY APPL ETHICS, P328; Smith JT, 2012, J CLIN ONCOL, V30, P880; World Health Organization (WHO), DEF PALL CAR	16	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-9091	1938-2715		AM J HOSP PALLIAT ME	Am. J. Hosp. Palliat. Med.	NOV	2014	31	7					717	722		10.1177/1049909113502118		6	Health Care Sciences & Services	Health Care Sciences & Services	AQ7JT	WOS:000342990800004		
J	Sonoda, H; Yamaguchi, T; Matsumoto, M; Hisahara, K				Sonoda, Hiroshi; Yamaguchi, Takashi; Matsumoto, Mina; Hisahara, Ko			Validation of the Palliative Prognostic Index and Palliative Prognostic Score in a Palliative Care Consultation Team Setting for Patients With Advanced Cancers in an Acute Care Hospital in Japan	AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE			English	Article						validation; prognosis; predictive scale; patients with cancer; palliative care consultation team; general hospital; acute care hospital	TERMINALLY-ILL PATIENTS; SURVIVAL PREDICTION; ACCURACY; SERVICE; PAP	This study aims to clarify the predictive value of two prognostic prediction tools, the palliative prognostic index (PPI) and the palliative prognostic score (PaPS), in a setting of general hospital palliative care team for patients with advanced cancers in an acute care hospital in Japan. The retrospective observational study includes 247 patients for the PPI analysis and 187 patients for the PaPS analysis, all patients are older than 18 years, hospitalized with an advanced cancer, and referred to the palliative care team in an acute care hospital in Japan. The study successfully show that both the PPI and PaPS have an ability to divide patients into three groups, each with significantly different survival length (p<0.001). However, there are discrepancies in the results for predicting the length of survival between the study and the original studies conducted in hospice settings. The results suggest that although PPI and PaPS successfully divide patients into three groups with significantly different survival times, discrepancies exist in predicting the actual length of survival.	[Sonoda, Hiroshi; Yamaguchi, Takashi] Teine Keijinkai Hosp, Dept Gen Internal Med, Sapporo, Hokkaido, Japan; [Sonoda, Hiroshi; Yamaguchi, Takashi; Matsumoto, Mina; Hisahara, Ko] Teine Keijinkai Hosp, Palliat Care Team, Sapporo, Hokkaido, Japan; [Yamaguchi, Takashi] Kobe Univ, Grad Sch Med, Dept Palliat Med, Kobe, Hyogo 657, Japan	Yamaguchi, T (reprint author), Teine Keijinkai Hosp, Dept Gen Internal Med, 12-1-40 Maeda1jyo, Sapporo, Hokkaido, Japan.	ikagoro@pop06.odn.ne.jp					American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Naylor C, 2010, J PAIN SYMPTOM MANAG, V39, P69, DOI 10.1016/j.jpainsymman.2009.05.020; Glare P, 2001, J PAIN SYMPTOM MANAG, V22, P891, DOI 10.1016/S0885-3924(01)00341-4; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Morita T, 1999, SUPPORT CARE CANCER, V7, P128, DOI 10.1007/s005200050242; Stone PC, 2007, ANN ONCOL, V18, P971, DOI 10.1093/annonc/md1343; Alshemmari S, 2012, J PALLIAT MED, V15, P200, DOI 10.1089/jpm.2011.0253; Tassinari D, 2008, SUPPORT CARE CANCER, V16, P359, DOI 10.1007/s00520-007-0302-3; Stiel S, 2010, SUPPORT CARE CANCER, V18, P43, DOI 10.1007/s00520-009-0628-0; Anderson F, 1996, J PALLIATIVE CARE, V12, P5; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Pirovano M, 1999, J PAIN SYMPTOM MANAG, V17, P231, DOI 10.1016/S0885-3924(98)00145-6; Maltoni M, 1999, J PAIN SYMPTOM MANAG, V17, P240, DOI 10.1016/S0885-3924(98)00146-8; Stone CA, 2008, J PAIN SYMPTOM MANAG, V35, P617, DOI 10.1016/j.jpainsymman.2007.07.006; Glare PA, 2004, J CLIN ONCOL, V22, P4823, DOI 10.1200/JCO.2004.12.056; Crawley LM, 2002, ANN INTERN MED, V136, P673; Karnofsky D.A., 1949, EVALUATION CHEMOTHER; Morita T, 2001, PALLIATIVE MED, V15, P419, DOI 10.1191/026921601680419474; Numico G, 2011, SUPPORT CARE CANCER, V19, P1823, DOI 10.1007/s00520-010-1024-5; Tarumi Y, 2011, J PAIN SYMPTOM MANAG, V42, P419, DOI 10.1016/j.jpainsymman.2010.12.013	20	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-9091	1938-2715		AM J HOSP PALLIAT ME	Am. J. Hosp. Palliat. Med.	NOV	2014	31	7					730	734		10.1177/1049909113506034		5	Health Care Sciences & Services	Health Care Sciences & Services	AQ7JT	WOS:000342990800007		
J	Guerrini, MM; Takayanagi, H				Guerrini, Matteo M.; Takayanagi, Hiroshi			The immune system, bone and RANKL	ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS			English	Review						Osteoimmunology; RANKL; Rheumatoid arthritis; T and B lymphocytes	TUMOR-NECROSIS-FACTOR; OSTEOCLASTOGENESIS-INHIBITORY FACTOR; DENDRITIC-CELL-FUNCTION; FACTOR FAMILY-MEMBER; REGULATORY T-CELLS; B LIGAND RANKL; RECEPTOR ACTIVATOR; ESTROGEN DEFICIENCY; IN-VIVO; DIFFERENTIATION FACTOR	Bone and immune systems are tightly linked. In the past years, many molecules originally believed to belong to the immune system were found to function in bone cells. It is now evident that the two systems are coregulated by many shared cytokines and signaling molecules. Here we exemplify the complex interaction between bone metabolism and immune response focusing on the multifaceted role of receptor activator of NF-kappa B ligand (RANKL). RANKL is expressed by cells of both systems, is an essential regulator of bone degradation and exerts either pro or anti-inflammatory effects on the immune response. In the present review, we summarize the multiple functions of RANKL in bone and in the immune systems, aiming to provide an overview of the field of osteoimmunology. (C) 2014 Published by Elsevier Inc.	[Takayanagi, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; [Takayanagi, Hiroshi] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; Japan Sci & Technol Agcy JST, Explorat Res Adv Technol ERATO Program, Takayanagi Osteonetwork Project, Bunkyo Ku, Tokyo 1130033, Japan	Takayanagi, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	takayana@m.u-tokyo.ac.jp					Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; Josien R, 2000, J EXP MED, V191, P495, DOI 10.1084/jem.191.3.495; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Williamson E, 2002, J IMMUNOL, V169, P3606; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Gao YH, 2004, P NATL ACAD SCI USA, V101, P16618, DOI 10.1073/pnas.0404888101; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Yun TJ, 1998, J IMMUNOL, V161, P6113; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Vondenhoff MF, 2009, J IMMUNOL, V182, P5439, DOI 10.4049/jimmunol.0801165; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; Kim HJ, 2009, P NATL ACAD SCI USA, V106, P2325, DOI 10.1073/pnas.0806963106; Takayanagi H, 2012, NAT REV RHEUMATOL, V8, P684, DOI 10.1038/nrrheum.2012.167; Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Yoshida H, 2002, IMMUNITY, V17, P823, DOI 10.1016/S1074-7613(02)00479-X; Roggia C, 2001, P NATL ACAD SCI USA, V98, P13960, DOI 10.1073/pnas.251534698; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Yang SY, 2007, GENE DEV, V21, P1803, DOI 10.1101/gad.1544107; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Xu YK, 2007, J IMMUNOL, V179, P7577; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Bachmann MF, 1999, J EXP MED, V189, P1025, DOI 10.1084/jem.189.7.1025; Wada T, 2005, NAT MED, V11, P394, DOI 10.1038/nm1203; Guerrini MM, 2008, AM J HUM GENET, V83, P64, DOI [10.1016/j.ajhg.2008.06.015, 10.1016/j.ajhg.2008.06.01S]; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Pangrazio A, 2012, J BONE MINER RES, V27, P342, DOI 10.1002/jbmr.559; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Oda T, 2005, J ORTHOP SCI, V10, P70, DOI 10.1007/s00776-004-0851-y; Perlot T, 2012, J IMMUNOL, V188, P1201, DOI 10.4049/jimmunol.1102063; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Sobacchi C, 2007, NAT GENET, V39, P960, DOI 10.1038/ng2076; Green EA, 2002, IMMUNITY, V16, P183, DOI 10.1016/S1074-7613(02)00279-0; Gravallese EM, 1998, AM J PATHOL, V152, P943; Miyamoto K, 2011, J EXP MED, V208, P2175, DOI 10.1084/jem.20101890; Ashcroft AJ, 2003, IMMUNITY, V19, P849, DOI 10.1016/S1074-7613(03)00326-1; Knoop KA, 2009, J IMMUNOL, V183, P5738, DOI 10.4049/jimmunol.0901563; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Takayanagi H, 2000, ARTHRITIS RHEUM, V43, P259, DOI 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W; Hashizume M, 2008, RHEUMATOLOGY, V47, P1635, DOI 10.1093/rheumatology/ken363; BROMLEY M, 1984, ARTHRITIS RHEUM, V27, P968, DOI 10.1002/art.1780270902; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Briggs TA, 2011, NAT GENET, V43, P127, DOI 10.1038/ng.748; Das S, 2013, DRUG DES DEV THER, V7, P435, DOI 10.2147/DDDT.S31504; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Takayanagi H, 2000, NATURE, V408, P600; Onal M, 2012, J BIOL CHEM, V287, P29851, DOI 10.1074/jbc.M112.377945; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Lausch E, 2011, NAT GENET, V43, P132, DOI 10.1038/ng.749; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; Kong YY, 1999, NATURE, V402, P304; Maruyama K, 2012, J BIOL CHEM, V287, P29114, DOI 10.1074/jbc.M112.347799; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Kong YY, 1999, NATURE, V397, P315; Bai ST, 2005, J CLIN INVEST, V115, P2742, DOI 10.1172/JCI24921; HANAOKA H, 1979, CLIN ORTHOP RELAT R, P252; Kanazawa K, 2005, J BONE MINER RES, V20, P2053, DOI 10.1359/JBMR.050706; Kanematsu M, 2000, J BONE MINER RES, V15, P1321, DOI 10.1359/jbmr.2000.15.7.1321; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Lee SK, 2006, J BONE MINER RES, V21, P1704, DOI 10.1359/JBMR.060726; Li Y, 2007, J CELL BIOCHEM, V100, P1370, DOI 10.1002/jcb.21121; Miyaura C, 1997, P NATL ACAD SCI USA, V94, P9360, DOI 10.1073/pnas.94.17.9360; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Onoe Y, 2000, J BONE MINER RES, V15, P541, DOI 10.1359/jbmr.2000.15.3.541; SHIOI A, 1991, J CELL BIOCHEM, V47, P272, DOI 10.1002/jcb.240470313; Yi T, 2008, J CELL PHYSIOL, V217, P409, DOI 10.1002/jcp.21511	81	6	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-9861	1096-0384		ARCH BIOCHEM BIOPHYS	Arch. Biochem. Biophys.	NOV 1	2014	561				SI		118	123		10.1016/j.abb.2014.06.003		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AQ5QI	WOS:000342863300014		
J	Watanabe, H; Katayama, N; Yano, E; Sugiyama, R; Nishikawa, S; Endou, T; Watanabe, K; Takabayashi, J; Ozawa, R				Watanabe, Hiroshi; Katayama, Noboru; Yano, Eizi; Sugiyama, Ryohei; Nishikawa, Shoko; Endou, Takuya; Watanabe, Kaori; Takabayashi, Junji; Ozawa, Rika			Effects of aphid honeydew sugars on the longevity and fecundity of the aphidophagous gall midge Aphidoletes aphidimyza	BIOLOGICAL CONTROL			English	Article						Eggplant; Aphis gossypii; Sucrose; Rhopalosiphum padi; Melanaphis sacchari	PSEUDACTEON-TRICUSPIS DIPTERA; HYMENOPTERA-BRACONIDAE; NATURAL ENEMIES; PEA APHID; NECTAR; COLEOPTERA; BEHAVIOR; SUCROSE; ALFALFA; CECIDOMYIIDAE	The predatory gall midge Aphidoletes aphidimyza, which is used for augmentative biological control of aphids in greenhouses, uses aphid honeydew as an energy source. Currently, Rhopalosiphum padi on barley plants and Melanaphis sacchari on sorghum plants are used as the banker plant systems for A. aphidimyza to control Aphis gossypii on eggplant in Japan. We analyzed the sugar components of the honeydew of these three species by HPLC. The major components of honeydew were sucrose, fructose, and melezitose for A. gossypii; glucose and fructose for R. padi; and glucose, fructose, and melezitose for M. sacchari. Maltose and trehalose were minor components of the honeydew of these species. We investigated the influence of sugars, including three artificial aphid honeydews, six sugar components, and distilled water, on the longevity of unmated A. aphidimyza. Both females and males attained the greatest longevity on sucrose and artificial honeydew of A. gossypii. Mean longevities of both females and males were shortest when they were provided only with water. We conducted another experiment in which a mated female was released in a cage with an eggplant seedling infested with A. gossypii and fed with sucrose or only water. Females fed with sucrose lived significantly longer and had higher lifetime fecundity than those fed only water. (C) 2014 Elsevier Inc. All rights reserved.	[Watanabe, Hiroshi; Yano, Eizi; Sugiyama, Ryohei; Nishikawa, Shoko; Endou, Takuya; Watanabe, Kaori] Kinki Univ, Fac Agr, Entomol Lab, Nara 6318505, Japan; [Katayama, Noboru; Takabayashi, Junji; Ozawa, Rika] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan	Yano, E (reprint author), Kinki Univ, Fac Agr, Entomol Lab, 3327-204 Nakamachi, Nara 6318505, Japan.	yano@nara.kindai.ac.jp	Takabayashi, Junji/G-2212-2010		Ministry of Agriculture, Forestry and Fisheries of Japan	We thank Dr. Ikuo Kandori of Kinki University for his advice. We also thank Junichiro Abe of NARO Western Region Agricultural Research Center for providing the image of Aphidoletes aphidimyza and Kiyoshi Tanaka for providing me the image of Aphis gossypii. This work was supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (research and development projects for application in promoting new policy of agriculture, forestry and fisheries, 2021).	Abe J., 2011, ANN REPT KANSAI PL P, V53, P37; Kishimoto H, 2010, APPL ENTOMOL ZOOL, V45, P621, DOI 10.1303/aez.2010.621; Hogervorst PAM, 2007, ENTOMOL EXP APPL, V122, P223, DOI 10.1111/j.1570-7458.2006.00505.x; Evans EW, 1996, ECOL APPL, V6, P920, DOI 10.2307/2269495; Idris AB, 1995, ENVIRON ENTOMOL, V24, P1726; Wackers FL, 2008, BIOL CONTROL, V45, P176, DOI 10.1016/j.biocontrol.2008.01.007; Crafts-Brandner SJ, 2002, J INSECT PHYSIOL, V48, P33, DOI 10.1016/S0022-1910(01)00140-8; Sandstrom JP, 2001, PHYSIOL ENTOMOL, V26, P202, DOI 10.1046/j.0307-6962.2001.00235.x; HENDRIX DL, 1992, COMP BIOCHEM PHYS B, V101, P23, DOI 10.1016/0305-0491(92)90153-I; Wackers FL, 2000, OIKOS, V90, P197, DOI 10.1034/j.1600-0706.2000.900124.x; Frank SD, 2010, BIOL CONTROL, V52, P8, DOI 10.1016/j.biocontrol.2009.09.011; Yukawa J, 1998, APPL ENTOMOL ZOOL, V33, P185; Abe J, 2011, JPN J APPL ENTOMOL Z, V55, P227, DOI 10.1303/jjaez.2011.227; Evans EW, 2000, ENTOMOL EXP APPL, V94, P141, DOI 10.1023/A:1003914509181; Wackers FL, 2001, J INSECT PHYSIOL, V47, P1077, DOI 10.1016/S0022-1910(01)00088-9; Belliure B, 2001, ANN ENTOMOL SOC AM, V94, P91, DOI 10.1603/0013-8746(2001)094[0091:BABOPC]2.0.CO;2; Van Driesche RG, 2008, FLA ENTOMOL, V91, P583; Stapel JO, 1997, ENVIRON ENTOMOL, V26, P617; BEERWINKLE KR, 1993, ENVIRON ENTOMOL, V22, P554; Bennison J. A., 1992, Mededelingen van de Faculteit Landbouwwetenschappen Universiteit Gent, V57, P457; Bennison J.A., 1993, IOBC WPRS B, V16, P5; Chen L, 2005, ENVIRON ENTOMOL, V34, P246; England S, 1997, ENVIRON ENTOMOL, V26, P1437; Fadamiro HY, 2005, BIOL CONTROL, V34, P73, DOI 10.1016/j.biocontrol.2005.04.006; Hagen K.S., 1986, INTERACTIONS PLANT R, P153; Hansen L.S, 1983, IOBC WPRS B, V6, P146; HARRIS KM, 1973, B ENTOMOL RES, V63, P305; Heimpel GE, 2005, PLANT-PROVIDED FOOD FOR CARNIVOROUS INSECTS: PROTECTIVE MUTUALISM AND ITS APPLICATIONS, P267, DOI 10.1017/CBO9780511542220.010; Karley AJ, 2005, J INSECT PHYSIOL, V51, P1313, DOI 10.1016/j.jinsphys.2005.08.001; Katayama N, 2013, ANN ENTOMOL SOC AM, V106, P761, DOI 10.1603/AN13089; Kuo-Sell H.-L., 1987, P151; Lungren J.G, 2009, RELATIONSHIPS NATURA; Maeda S, 2002, JPN J APPL ENTOMOL Z, V46, P169, DOI 10.1303/jjaez.2002.169; Makkula M., 1985, BIOL PEST CONTROL GL, P74; MCEWEN PK, 1993, ENTOMOPHAGA, V38, P241, DOI 10.1007/BF02372559; Nijveldt W., 1988, APHIDS THEIR BIOL B, V2B, P271; Richards DR, 1998, ANN ENTOMOL SOC AM, V91, P632; Schuster M.F., 1986, P84; Sell P., 1975, THESIS U GOTTINGEN G; Sheldon J.K., 1971, PSYCHE           MAR, P107; Sisterson MS, 2002, J INSECT BEHAV, V15, P571, DOI 10.1023/A:1016389402543; Swirski K., 1980, ENTOMOPHAGA, V25, P415; van Rijn PCJ, 2013, BIOL CONTROL, V67, P32, DOI 10.1016/j.biocontrol.2013.06.014; Wackers F. L., 2003, IOBC WPRS B, V26, P203; Wackers FL, 2005, PLANT-PROVIDED FOOD FOR CARNIVOROUS INSECTS: PROTECTIVE MUTUALISM AND ITS APPLICATIONS, P17, DOI 10.1017/CBO9780511542220.003	45	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1049-9644	1090-2112		BIOL CONTROL	Biol. Control	NOV	2014	78						55	60		10.1016/j.biocontrol.2014.07.007		6	Biotechnology & Applied Microbiology; Entomology	Biotechnology & Applied Microbiology; Entomology	AQ2LL	WOS:000342617500008		
J	Nakamura, Y; Ishii, J; Kondo, A				Nakamura, Yasuyuki; Ishii, Jun; Kondo, Akihiko			Construction of a Yeast-Based Signaling Biosensor for Human Angiotensin II Type 1 Receptor via Functional Coupling Between Asn295-Mutated Receptor and Gpa1/G(i3) Chimeric G alpha	BIOTECHNOLOGY AND BIOENGINEERING			English	Article						G-protein-coupled receptor; angiotensin II type 1 receptor; G-protein signaling; Saccharomyces cerevisiae; peptide screening; green fluorescent protein	AT(1) RECEPTOR; SACCHAROMYCES-CEREVISIAE; CONSTITUTIVE ACTIVATION; ASPARAGINE RESIDUES; PROTEIN; AGONIST; SYSTEM; CELLS; IDENTIFICATION; SPECIFICITY	Angiotensin II (Ang II) type 1 receptor (AGTR1) is a G-protein-coupled receptor (GPCR). Its natural ligand, Ang II, is an important effector molecule controlling blood pressure and volume in the cardiovascular system, and is consequently involved in various diseases such as hypertension and heart failure. Thus, the signaling mediator, AGTR1, is a significant molecular target in medicinal and therapeutic fields. Yeast is a useful organism for sensing GPCR signaling because it provides a simplified version of the complicated machinery used by mammalian cells for signal transduction. Although yeast cells can successfully transmit a signal through a variety of human GPCRs expressed in the cell membrane, there have been no reports of the functional activation of AGTR1-mediated signaling in yeast cells. In the present study, we introduced a single mutation into human AGTR1 and used yeast-human chimeric G alpha to exert the functional activation of AGTR1 in yeast cells. The engineered yeast cells expressing AGTR1 mutated at Asn295 and the chimeric G alpha successfully transmitted the signal inside the yeast cells in response to Ang II peptide and its analogs (Ang III and Ang IV peptides) added to the assay medium. Further, we demonstrated that the autocrine Ang II peptide and its analog, produced and secreted by the engineered yeast cells, could by themselves promote AGTR1-mediated signaling. This means that screening for agonistic peptides with various sequences from a self-produced genetic library would be a viable strategy. Thus, the constructed yeast biosensor, integrating an Asn295-mutated AGTR1 receptor, will be valuable in the design of drugs to treat AGTR1-related diseases. (C) 2014 Wiley Periodicals, Inc.	[Nakamura, Yasuyuki; Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, Kobe, Hyogo 6578501, Japan; [Ishii, Jun] Kobe Univ, Org Adv Sci & Technol, Kobe, Hyogo 6578501, Japan	Kondo, A (reprint author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	akondo@kobe-u.ac.jp	Kondo, Akihiko/A-2130-2015		Japanese Society for the Promotion of Science; Naito Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Contract grant sponsor: Japanese Society for the Promotion of Science; Contract grant sponsor: The Naito Foundation; Contract grant sponsor: Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Ishii J, 2009, J BIOCHEM, V145, P701, DOI 10.1093/jb/mvp028; Iguchi Y, 2010, J BIOCHEM, V147, P875, DOI 10.1093/jb/mvq023; Balmforth AJ, 1997, J BIOL CHEM, V272, P4245; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; Noda K, 1996, BIOCHEMISTRY-US, V35, P16435, DOI 10.1021/bi961593m; Ishii J, 2008, J BIOCHEM, V143, P667, DOI 10.1093/jb/mvn018; Hur EM, 2002, CELL SIGNAL, V14, P397, DOI 10.1016/S0898-6568(01)00258-3; Brachmann CB, 1998, YEAST, V14, P115; Minic J, 2005, CURR MED CHEM, V12, P961, DOI 10.2174/0929867053507261; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Dumas F, 1999, FEBS LETT, V458, P271, DOI 10.1016/S0014-5793(99)01148-5; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Le MT, 2002, J BIOL CHEM, V277, P23107, DOI 10.1074/jbc.C200201200; Feng YH, 2005, MOL PHARMACOL, V68, P347, DOI 10.1124/mol.105.011601; Wright JW, 2008, PROG NEUROBIOL, V84, P157, DOI 10.1016/j.pneurobio.2007.10.009; PRINTZ MP, 1972, NATURE-NEW BIOL, V237, P135; Baenziger JE, 2000, J BIOL CHEM, V275, P777, DOI 10.1074/jbc.275.2.777; Dzau VJ, 2005, J CLIN INVEST, V115, P2319, DOI 10.1117/JCI.26384; Griendling KK, 1996, ANNU REV PHARMACOL, V36, P281, DOI 10.1146/annurev.pharmtox.36.1.281; Groblewski T, 1997, J BIOL CHEM, V272, P1822; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Ishii J, 2010, FEBS J, V277, P1982, DOI 10.1111/j.1742-4658.2010.07625.x; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; Fukuda N, 2011, ANAL BIOCHEM, V417, P182, DOI 10.1016/j.ab.2011.06.006; Fukutani Y, 2012, BIOTECHNOL BIOENG, V109, P3143, DOI 10.1002/bit.24589; Ishii J, 2006, BIOTECHNOL PROGR, V22, P954, DOI 10.1021/bp0601387; Ishii J, 2012, ANAL BIOCHEM, V426, P129, DOI 10.1016/j.ab.2012.04.012; Ishii J, 2014, ANAL BIOCHEM, V446, P37, DOI 10.1016/j.ab.2013.10.016; Ishii J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037136; Lagane B, 2000, J BIOL CHEM, V275, P33197, DOI 10.1074/jbc.C000576200; MacLellan WR, 1998, CIRCULATION, V97, P1433; Manfredi JP, 1996, MOL CELL BIOL, V16, P4700; McKinsey TA, 1999, CURR OPIN GENET DEV, V9, P267, DOI 10.1016/S0959-437X(99)80040-9; Nakamura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066793; Nakamura Y, 2014, BIOTECHNOL BIOENG, V111, P586, DOI 10.1002/bit.25125; Nakamura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082237; Parnot C, 2000, P NATL ACAD SCI USA, V97, P7615, DOI 10.1073/pnas.110142297; Salhan D, 2012, CELL SIGNAL, V24, P734, DOI 10.1016/j.cellsig.2011.11.007; Togawa S, 2010, J BIOCHEM, V147, P867, DOI 10.1093/jb/mvq022	40	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0006-3592	1097-0290		BIOTECHNOL BIOENG	Biotechnol. Bioeng.	NOV	2014	111	11					2220	2228		10.1002/bit.25278		9	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	AQ5EM	WOS:000342829000009		
J	Wang, CC; Yang, KC; Lin, KH; Wu, CC; Liu, YL; Lin, FH; Chen, IH				Wang, Chen-Chie; Yang, Kai-Chiang; Lin, Keng-Hui; Wu, Chang-Chin; Liu, Yen-Liang; Lin, Feng-Huei; Chen, Ing-Ho			A Biomimetic Honeycomb-Like Scaffold Prepared by Flow-Focusing Technology for Cartilage Regeneration	BIOTECHNOLOGY AND BIOENGINEERING			English	Article						cartilage tissue engineering; gelatin; flow-focusing; microfluidic; scaffold	COLLAGEN-GLYCOSAMINOGLYCAN SCAFFOLDS; 3-DIMENSIONAL ALGINATE SCAFFOLD; GENE-EXPRESSION; PORE-SIZE; IN-VITRO; MECHANICAL-PROPERTIES; POROUS STRUCTURES; CROSS-LINKING; TISSUE; PROLIFERATION	A tissue engineering chondrocytes/scaffold construct provides a promise to cartilage regeneration. The architecture of a scaffold such as interconnections, porosities, and pore sizes influences the fates of seeding cells including gene expression, survival, migration, proliferation, and differentiation thus may determine the success of this approach. Scaffolds of highly ordered and uniform structures are desirable to control cellular behaviors. In this study, a newly designed microfluidic device based on flow-focusing geometry was developed to fabricate gelatin scaffolds of ordered pores. In comparison with random foam scaffolds made by the conventional freeze-dried method, honeycomb-like scaffolds exhibit higher swelling ratio, porosity, and comparable compressive strength. In addition, chondrocytes grown in the honeycomb-like scaffolds had good cell viability, survival rate, glycosaminoglycans production, and a better proliferation than ones in freeze-dried scaffolds. Real-time PCR analysis showed that the mRNA expressions of aggrecan and collagen type II were up-regulated when chondrocytes cultured in honeycomb-like scaffolds rather than cells cultured as monolayer fashion. Oppositely, chondrocytes expressed collagen type II as monolayer culture when seeded in freeze-dried scaffolds. Histologic examinations revealed that cells produced proteoglycan and distributed uniformly in honeycomb-like scaffolds. Immunostaining showed protein expression of S-100 and collagen type II but negative for collagen type I and X, which represents the chondrocytes maintained normal phenotype. In conclusion, a highly ordered and honeycomb-like scaffold shows superior performance in cartilage tissue engineering. (C) 2014 Wiley Periodicals, Inc.	[Wang, Chen-Chie] Buddhist Tzu Chi Med Fdn, Dept Orthoped Surg, Taipei Tzu Chi Hosp, New Taipei City, Taiwan; [Wang, Chen-Chie; Chen, Ing-Ho] Tzu Chi Univ, Sch Med, Dept Orthoped, Hualien 97004, Taiwan; [Yang, Kai-Chiang] Taipei Med Univ, Coll Oral Med, Sch Dent Technol, Taipei, Taiwan; [Yang, Kai-Chiang] Kyoto Univ, Inst Frontier Med Sci, Dept Organ Reconstruct, Kyoto, Japan; [Lin, Keng-Hui] Acad Sinica, Inst Phys, Taipei, Taiwan; [Lin, Keng-Hui] Acad Sinica, Res Ctr Appl Sci, Taipei, Taiwan; [Wu, Chang-Chin] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Orthoped, Taipei 10764, Taiwan; [Wu, Chang-Chin] En Chu Kong Hosp, Dept Orthoped, New Taipei City, Taiwan; [Liu, Yen-Liang] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Lin, Feng-Huei] Natl Taiwan Univ, Coll Engn, Inst Biomed Engn, Taipei 10764, Taiwan; [Lin, Feng-Huei] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chen, Ing-Ho] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Orthoped Surg, Hualien 970, Taiwan	Chen, IH (reprint author), Tzu Chi Univ, Sch Med, Dept Orthoped, Hualien 97004, Taiwan.	ing.ho@msa.hinet.net			National Science Council, Taiwan [NSC102-2320-B-303-001-MY3]	Contract grant sponsor: National Science Council, Taiwan; Contract grant number: NSC102-2320-B-303-001-MY3	Chang WH, 2002, ENDOCRINOLOGY, V143, P1467, DOI 10.1210/en.143.4.1467; Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056; Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269; Zhang HF, 2005, NAT MATER, V4, P787, DOI 10.1038/nmat1487; Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI 10.1089/ten.TEB.2009.0639; Stenhamre H, 2011, J TISSUE ENG REGEN M, V5, P578, DOI 10.1002/term.350; Miot S, 2005, BIOMATERIALS, V26, P2479, DOI 10.1016/j.biomaterials.2004.06.048; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Wu X, 2010, ACTA BIOMATER, V6, P1167, DOI 10.1016/j.actbio.2009.08.041; Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475; Hangody L, 2008, INJURY, V39, pS32, DOI 10.1016/j.injury.2008.01.041; Lin YJ, 2009, J BIOMED MATER RES A, V88A, P23, DOI 10.1002/jbm.a.31841; Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647; Dai WD, 2010, BIOMATERIALS, V31, P2141, DOI 10.1016/j.biomaterials.2009.11.070; Wang YK, 2012, STEM CELLS DEV, V21, P1176, DOI 10.1089/scd.2011.0293; Chen YL, 2008, BIOTECHNOL BIOENG, V101, P821, DOI 10.1002/bit.21953; Wang CC, 2011, BIOMATERIALS, V32, P7118, DOI 10.1016/j.biomaterials.2011.06.018; Hsieh TM, 2010, BIOMATERIALS, V31, P7648, DOI 10.1016/j.biomaterials.2010.06.029; Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020; Ko YG, 2010, MACROMOL BIOSCI, V10, P860, DOI 10.1002/mabi.200900468; Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023; Mukaida T, 2005, J ORTHOP SCI, V10, P521, DOI 10.1007/s00776-005-0930-8; Lee M, 2012, METHODS MOL BIOL, V868, P257, DOI 10.1007/978-1-61779-764-4_15; Lee CR, 2001, BIOMATERIALS, V22, P3145, DOI 10.1016/S0142-9612(01)00067-9; Zhang H, 2007, ADV MATER, V19, P1529, DOI 10.1002/adma.200700154; Dehghani F, 2011, CURR OPIN BIOTECH, V22, P661, DOI 10.1016/j.copbio.2011.04.005; Chiang TS, 2012, BIOMATERIALS, V33, P5187, DOI 10.1016/j.biomaterials.2012.04.014; Chung KY, 2009, BIOMICROFLUIDICS, V3, DOI 10.1063/1.3122665; Fan FY, 2014, J MED BIOL ENG, V34, P211, DOI 10.5405/jmbe.1516; Freyria AM, 2009, TISSUE ENG PT A, V15, P1233, DOI 10.1089/ten.tea.2008.0114; Griffon DJ, 2006, ACTA BIOMATER, V2, P313, DOI 10.1016/j.actbio.2005.12.007; Harada Y, 2002, TISSUE ENG, V8, P969, DOI 10.1089/107632702320934065; Lu HX, 2010, BIOMATERIALS, V31, P5825, DOI 10.1016/j.biomaterials.2010.04.019; Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.TEA.2010.0590, 10.1089/ten.tea.2010.0590]; Minas T, 2000, Am J Knee Surg, V13, P41; Sgaglione NA, 2005, ORTHOP CLIN N AM, V36, P485, DOI 10.1016/j.ocl.2005.05.006; Tsai WB, 2006, J MATER SCI-MATER M, V17, P337, DOI 10.1007/s10856-006-8234-x; Wang CC, 2012, BIOMATERIALS, V33, P120, DOI 10.1016/j.biomaterials.2011.09.042; Wu CC, 2012, PROCESS BIOCHEM, V47, P922, DOI 10.1016/j.procbio.2012.02.020; Yamane S, 2007, J BIOMED MATER RES A, V81A, P586, DOI 10.1002/jbm.a.31095; Yang KC, 2013, J BIOMED MATER RES A, V101, P2273, DOI 10.1002/jbm.a.34547; Zhang WJ, 2011, J CELL MOL MED, V15, P1878, DOI 10.1111/j.1582-4934.2010.01189.x	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0006-3592	1097-0290		BIOTECHNOL BIOENG	Biotechnol. Bioeng.	NOV	2014	111	11					2338	2348		10.1002/bit.25295		11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	AQ5EM	WOS:000342829000019		
J	Kawanaka, H; Akahoshi, T; Kinjo, N; Iguchi, T; Ninomiya, M; Yamashita, YI; Ikegami, T; Yoshizumi, T; Shirabe, K; Maehara, Y				Kawanaka, H.; Akahoshi, T.; Kinjo, N.; Iguchi, T.; Ninomiya, M.; Yamashita, Y-I; Ikegami, T.; Yoshizumi, T.; Shirabe, K.; Maehara, Y.			Effect of laparoscopic splenectomy on portal haemodynamics in patients with liver cirrhosis and portal hypertension	BRITISH JOURNAL OF SURGERY			English	Article							NITRIC-OXIDE; ENDOTHELIN-1; TRANSPLANTATION; HYPERSPLENISM; THROMBOSIS; VARICES; SPLEEN; VEIN; RAT	Background: The effect of splenomegaly in patients with liver cirrhosis and portal hypertension is not fully understood. This study was designed to determine the effect of laparoscopic splenectomy on portal haemodynamics in these patients. Methods: Patients with liver cirrhosis and portal hypertension who underwent laparoscopic splenectomy in Kyushu University Hospital from January 2006 to March 2009 were evaluated retrospectively. Correlations between splenic size and portal haemodynamics, and changes in portal haemodynamics and in levels of the vasoactive agents endothelin (ET) 1 and nitric oxide metabolites (NOx) before and 7-10 days after laparoscopic splenectomy were analysed. Results: Portal venous (PV) blood flow, PV cross-sectional area and PV congestion index correlated significantly with splenic size (P < 0.050). All three were significantly reduced following splenectomy in 59 patients. The hepatic venous pressure gradient, measured in 18 patients, decreased by 25 per cent after splenectomy (P < 0.001). Portal vascular resistance was also reduced, by 21 per cent (P = 0.009). The peripheral blood concentration of ET-1 decreased from 2.95 to 2.11 pg/ml (P < 0.001), and that of NOx tended to decrease (from 29.2 to 25.0 pg/ml; P = 0.068). In hepatic venous blood, the level of ET-1 decreased from 2.37 to 1.83 pg/ml (P = 0.006), whereas NOx concentration tended to increase (from 24.5 to 30.9 pg/ml; P = 0.067). Conclusion: In patients with liver cirrhosis and portal hypertension, splenectomy reduced portal venous pressure. A decrease in splanchnic blood flow, by eliminating splenic blood flow, and reduction in intrahepatic vascular resistance, by normalizing hepatic concentrations of ET-1 and NOx, may both have contributed.	[Kawanaka, H.] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Multidisciplinary Treatment, Fukuoka 8128582, Japan; [Kawanaka, H.; Akahoshi, T.; Kinjo, N.; Iguchi, T.; Ninomiya, M.; Yamashita, Y-I; Ikegami, T.; Yoshizumi, T.; Shirabe, K.; Maehara, Y.] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan	Kawanaka, H (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Multidisciplinary Treatment, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	harrykw@v102.vaio.ne.jp			Japan Society for the Promotion of Science [25893166]	This work was supported partly by a Grant-in-Aid for Scientific Research (grant no. 25893166) from the Japan Society for the Promotion of Science.	Akahoshi T, 2012, J GASTROEN HEPATOL, V27, P286, DOI 10.1111/j.1440-1746.2011.06870.x; MORIYASU F, 1986, AM J ROENTGENOL, V146, P735; Merkel C, 2000, HEPATOLOGY, V32, P930, DOI 10.1053/jhep.2000.19322; Hennenberg M, 2008, GUT, V57, P1300, DOI 10.1136/gut.2007.144584; Liu SL, 2005, NAT MED, V11, P952, DOI 10.1038/nm1289; Anegawa G, 2008, HEPATOLOGY, V47, P966, DOI 10.1002/hep.22089; Bolognesi M, 2002, DIGEST LIVER DIS, V34, P144, DOI 10.1016/S1590-8658(02)80246-8; Iwakiri Y, 2012, LIVER INT, V32, P199, DOI 10.1111/j.1478-3231.2011.02579.x; Vaughan RB, 2003, GUT, V52, P1505, DOI 10.1136/gut.52.10.1505; Tajiri T, 2010, DIGEST ENDOSC, V22, P1, DOI 10.1111/j.1443-1661.2009.00929.x; Rockey DC, 1998, HEPATOLOGY, V27, P472, DOI 10.1002/hep.510270222; Kawanaka H, 2010, ANN SURG, V251, P76, DOI 10.1097/SLA.0b013e3181bdf8ad; Kinjo N, 2010, BRIT J SURG, V97, P910, DOI 10.1002/bjs.7002; Kawanaka H, 2009, J HEPATO-BILIARY-PAN, V16, P749, DOI 10.1007/s00534-009-0149-8; Tripathi D, 2006, GUT, V55, P1290, DOI 10.1136/gut.2005.077453; Angus PW, 2006, GUT, V55, P1230, DOI 10.1136/gut.2005.088633; Banti G., 1883, ARCH SCUOLA ANAT PAT, V2, P53; Ikegami T, 2008, HEPATOL RES, V38, P1159, DOI 10.1111/j.1872-034X.2008.00384.x; Jiao LR, 2000, BRIT J SURG, V87, P984, DOI 10.1046/j.1365-2168.2000.01512.x; MILLER EM, 1951, ANN SURG, V134, P815, DOI 10.1097/00000658-195113450-00004; Nagasue N, 2000, HEPATOLOGY, V31, P1107, DOI 10.1053/he.2000.6596; Smith Mitchell, 2012, Semin Intervent Radiol, V29, P135, DOI 10.1055/s-0032-1312575; Tomikawa M, 2002, SURGERY, V131, pS171, DOI 10.1067/msy.2002.119500; Tsugawa K, 2000, SCAND J GASTROENTERO, V35, P1097; Yokomori H, 2001, AM J PATHOL, V159, P1353, DOI 10.1016/S0002-9440(10)62522-9; Yoshizumi T, 2008, TRANSPL INT, V21, P833, DOI 10.1111/j.1432-2277.2008.00678.x	26	4	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1323	1365-2168		BRIT J SURG	Br. J. Surg.	NOV	2014	101	12					1585	1593		10.1002/bjs.9622		9	Surgery	Surgery	AQ6HQ	WOS:000342911800016		
J	Nishimura, K; Tokida, M; Katsuyama, H; Nakagawa, H; Matsuo, S				Nishimura, Kazuhiko; Tokida, Masahiro; Katsuyama, Hideaki; Nakagawa, Hiroshi; Matsuo, Saburo			The effect of hemin-induced oxidative stress on erythropoietin production in HepG2 cells	CELL BIOLOGY INTERNATIONAL			English	Article						erythropoietin production; iron; oxidative stress	GENE-EXPRESSION; SIRTUIN 1; HYPOXIA; HIF-1-ALPHA; RESPONSES; DEGRADATION; PATHWAY; DISEASE; ANEMIA; INJURY	Erythropoietin (EPO) and iron are both indispensable hematopoietic factors and are often studied in humans and rodents. Iron activates prolyl hydroxylases (PHDs) and promotes the degradation of the -subunit of hypoxia inducible factor (HIF), which regulates EPO production. Iron also causes oxidative stress. Oxidative stress leads to alterations in the levels of multiple factors that regulate HIF and EPO production. It is thought that iron influences EPO production by altering two pathways, namely PHDs activity and oxidative stress. We studied the differential effect of varying concentrations of hemin, an iron-containing porphyrin, on EPO production in HepG2 cells. Hemin at 100 mu M reduced EPO mRNA expression. The hemin-induced reduction of EPO mRNA levels was attenuated at concentrations greater than 200 mu M and EPO production increased in the presence of 500 mu M hemin. In comparison, protoporphyrin IX, iron-free hemin did not influence EPO mRNA expression. Additionally, malondialdehyde (MDA) concentrations and superoxide dismutase (SOD) activity significantly increased with 300 mu M hemin. Importantly, the antioxidant tempol inhibited the hemin-induced (500 mu M) increase in EPO mRNA levels. In conclusion, these results suggest that restraint of EPO production by hemin was offset by the promotion of EPO production by hemin-induced oxidative stress at hemin concentrations greater than 300 mu M.	[Nishimura, Kazuhiko; Tokida, Masahiro; Katsuyama, Hideaki; Nakagawa, Hiroshi; Matsuo, Saburo] Osaka Prefecture Univ, Grad Sch Life Environm Sci, Lab Bioenvironm Sci, Course Vet Sci, Izumisano, Osaka 5988531, Japan	Nishimura, K (reprint author), Osaka Prefecture Univ, Grad Sch Life Environm Sci, Lab Bioenvironm Sci, Course Vet Sci, 1-58 Rinku Ohrai Kita, Izumisano, Osaka 5988531, Japan.	nisimura@vet.osakafu-u.ac.jp					Lee JM, 2012, INT J CANCER, V130, P716, DOI 10.1002/ijc.26075; Olson N, 2011, NITRIC OXIDE-BIOL CH, V25, P125, DOI 10.1016/j.niox.2010.12.010; Katavetin P, 2007, KIDNEY INT, V72, pS10, DOI 10.1038/sj.ki.5002482; Dongiovanni P, 2008, AM J PATHOL, V172, P738, DOI 10.2353/ajpath.2008.070097; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Siddiq A, 2007, NEUROCHEM RES, V32, P931, DOI 10.1007/s11064-006-9268-7; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Maiese K, 2008, CURR NEUROVASC RES, V5, P125, DOI 10.2174/156720208784310231; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; KRANTZ SB, 1991, BLOOD, V77, P419; TOYOKUNI S, 1994, P NATL ACAD SCI USA, V91, P2616, DOI 10.1073/pnas.91.7.2616; Pak M, 2006, BLOOD, V108, P3730, DOI 10.1182/blood-2006-06-028787; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Jomova K, 2011, CURR PHARM DESIGN, V17, P3460; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Stockmann C, 2006, CLIN EXP PHARMACOL P, V33, P968, DOI 10.1111/j.1440-1681.2006.04474.x; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P387, DOI 10.2174/156720205774962683; Li Y, 2007, J CEREBR BLOOD F MET, V27, P1043, DOI 10.1038/sj.jcbfm.9600417; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Lacombe C, 1998, HAEMATOLOGICA, V83, P724; Chateauvieux S, 2011, BIOCHEM PHARMACOL, V82, P1291, DOI 10.1016/j.bcp.2011.06.045; Canbolat O, 1998, RESP PHYSIOL, V114, P175, DOI 10.1016/S0034-5687(98)00080-2; Webb JD, 2009, CELL MOL LIFE SCI, V66, P3539, DOI 10.1007/s00018-009-0147-7; Kuo MT, 2009, ANTIOXID REDOX SIGN, V11, P99, DOI 10.1089/ars.2008.2095; Haase VH, 2010, AM J PHYSIOL-RENAL, V299, pF1, DOI 10.1152/ajprenal.00174.2010; Yeo EJ, 2008, ANN HEMATOL, V87, P11, DOI 10.1007/s00277-007-0359-6; Jin WS, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-61; Lee KH, 2006, BIOCHIMIE, V88, P163, DOI 10.1016/j.biochi.2005.07.011; Li NJ, 2007, AM J PHYSIOL-RENAL, V292, pF207, DOI 10.1152/ajprenal.00457.2005; Masugi F, 1977, VITAMINS, V51, P21; MCCAFFREY TA, 1995, J CLIN INVEST, V95, P446, DOI 10.1172/JCI117684; Neumcke I, 1999, ENDOCRINOLOGY, V140, P641, DOI 10.1210/en.140.2.641; Ramadori P, 2010, LIVER INT, V30, P55, DOI 10.1111/j.1478-3231.2009.02131.x; Schmeding M, 2008, J GASTROEN HEPATOL, V23, P1125, DOI 10.1111/j.1440-1746.2007.05265.x; Szenajch J, 2010, BBA-REV CANCER, V1806, P82, DOI 10.1016/j.bbcan.2010.04.002; Tajima H, 1999, NEUROREPORT, V10, P2029, DOI 10.1097/00001756-199907130-00007; Takahashi-Makise N, 2012, NATURE CHEM BIOL, V5, P874; Tang WH, 2008, FREE RADICAL BIO MED, V45, P602, DOI 10.1016/j.freeradbiomed.2008.05.003; WATKINS PC, 1986, CYTOGENET CELL GENET, V42, P214, DOI 10.1159/000132281	41	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-6995	1095-8355		CELL BIOL INT	Cell Biol. Int.	NOV	2014	38	11					1321	1329		10.1002/cbin.10329		9	Cell Biology	Cell Biology	AQ4VM	WOS:000342798200011		
J	Mori, S; Yamashita, T; Takaya, T; Kinugasa, M; Takamine, S; Shigeru, M; Ito, T; Fujiwara, S; Nishii, T; Kono, AK; Hirata, K				Mori, Shumpei; Yamashita, Tomoya; Takaya, Tomofumi; Kinugasa, Mitsuo; Takamine, Sachiko; Shigeru, Mayumi; Ito, Tatsuro; Fujiwara, Sei; Nishii, Tatsuya; Kono, Atsushi K.; Hirata, Ken-ichi			Association Between the Rotation and Three-Dimensional Tortuosity of the Proximal Ascending Aorta	CLINICAL ANATOMY			English	Article						ascending aorta; tortuosity; rotation; torsion; elongation	CARDIOVASCULAR-DISEASE ENTERPRISES; AGE-RELATED-CHANGES; MAJOR SHAREHOLDERS; CORONARY-ARTERIES; THORACIC AORTA; RIGHT ATRIUM; DISSECTION; ELONGATION; COMPRESSION; STIFFNESS	Age-related morphological changes of the aorta, including dilatation and elongation, have been reported. However, rotation has not been fully investigated. We focused on the rotation of the ascending aorta and investigated its relationship with tortuosity. One hundred and two consecutive patients who underwent computed tomography coronary angiography were studied. The angle at which the en face view of the volume-rendered image of the right coronary aortic sinus (RCS) was obtained without foreshortening was defined as the rotation index. It was defined as zero if the RCS was squarely visible in the frontal view, positive if it rotated clockwise toward the left anterior oblique (LAO) direction, and negative if it rotated counter-clockwise toward the right anterior oblique (RAO) direction. The tortuosity was evaluated by measuring the biplane tilt angles formed between the ascending aorta and the horizontal line. The mean rotation index, posterior tilt angle viewed fromthe RAO direction (alpha(RAO)), and anterior tilt angle viewed from the LAO direction (alpha(LAO)) were 4.8 +/- 16.3, 60.7 +/- 7.0 degrees, and 63.6 +/- 9.0 degrees, respectively. Although no correlation was observed between the rotation index and the alpha(LAO) (beta=-0.0761, P=0.1651), there was a significant negative correlation between the rotation index and alpha(RAO) (beta=-0.1810, P<0.0001). In multivariate regression analysis, the rotation index was an independent predictor of the alpha(RAO) (beta=-0.1274, P50.0008). Clockwise rotation of the proximal ascending aorta exacerbates the tortuosity by tilting the aorta toward the posterior direction. (C) 2014 Wiley Periodicals, Inc.	[Mori, Shumpei; Yamashita, Tomoya; Takaya, Tomofumi; Kinugasa, Mitsuo; Takamine, Sachiko; Shigeru, Mayumi; Ito, Tatsuro; Fujiwara, Sei; Hirata, Ken-ichi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 6500017, Japan; [Nishii, Tatsuya; Kono, Atsushi K.] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 6500017, Japan	Mori, S (reprint author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	shumpei_8@hotmail.com		Takaya, Tomofumi/0000-0001-5775-8072			Akagi S, 2005, CIRCULATION, V112, pE252, DOI 10.1161/CIRCULATIONHA.104.513770; Allaire E, 2009, EUR J VASC ENDOVASC, V37, P531, DOI 10.1016/j.ejvs.2009.02.002; Anderson RH, 2009, CLIN ANAT, V22, P64, DOI 10.1002/ca.20645; Goyal S, 2008, INT J NONLIN MECH, V43, P1121, DOI 10.1016/j.ijnonlinmec.2008.06.013; Rogers WJ, 2001, J AM COLL CARDIOL, V38, P1123, DOI 10.1016/S0735-1097(01)01504-2; Sugawara J, 2008, JACC-CARDIOVASC IMAG, V1, P739, DOI 10.1016/j.jcmg.2008.06.010; Dougherty G, 2000, MED ENG PHYS, V22, P567, DOI 10.1016/S1350-4533(00)00074-6; McMahon MA, 2010, RADIOGRAPHICS, V30, P445, DOI 10.1148/rg.302095104; APTER JT, 1966, CIRC RES, V19, P104; Redheuil A, 2011, J AM COLL CARDIOL, V58, P1262, DOI 10.1016/j.jacc.2011.06.012; Kasel AM, 2013, JACC-CARDIOVASC IMAG, V6, P274, DOI 10.1016/j.jcmg.2012.06.014; Patel HJ, 2008, CIRCULATION, V118, P188, DOI 10.1161/CIRCULATIONAHA.107.690933; Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Azadani AN, 2012, ANN THORAC SURG, V93, P87, DOI 10.1016/j.athoracsur.2011.08.002; Callewaert BL, 2008, HUM MUTAT, V29, P150, DOI 10.1002/humu.20623; Nemes A, 2013, INT J CARDIOL, V168, P5008, DOI 10.1016/j.ijcard.2013.07.118; Duprey A, 2010, EUR J VASC ENDOVASC, V39, P700, DOI 10.1016/j.ejvs.2010.02.015; Morrison TM, 2009, J VASC SURG, V49, P1029, DOI 10.1016/j.jvs.2008.11.056; O'Rourke M, 2008, JACC-CARDIOVASC IMAG, V1, P749, DOI 10.1016/j.jcmg.2008.08.002; Shirali AS, 2013, JACC-CARDIOVASC IMAG, V6, P349, DOI 10.1016/j.jcmg.2012.07.018; Blanche C, 2013, EUR J INTERN MED, V24, P813, DOI 10.1016/j.ejim.2013.08.698; Nathan DP, 2011, ANN THORAC SURG, V91, P458, DOI 10.1016/j.athoracsur.2010.10.042; BRINKMAN AM, 1994, ANN BIOMED ENG, V22, P34, DOI 10.1007/BF02368220; Codreanu I, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-48; Della Corte A, 2008, J THORAC CARDIOV SUR, V135, P8, DOI 10.1016/j.jtcvs.2007.09.009; DOBRIN PB, 1988, SURGERY, V104, P568; Giannoglou G, 2006, ANGIOLOGY, V57, P487, DOI 10.1177/0003319706290741; Jakob M, 1996, CATHETER CARDIO DIAG, V38, P25; KIMBALL BP, 1990, CAN J CARDIOL, V6, P327; Loukas M, 2009, CLIN ANAT, V22, P114, DOI 10.1002/ca.20761; Mochida M, 2006, ANGIOLOGY, V57, P85, DOI 10.1177/000331970605700112; Mori S, 2012, J CARDIOVASC ELECTR, V23, P881, DOI 10.1111/j.1540-8167.2011.02245.x; Pappu S, 2008, ANN VASC SURG, V22, P88, DOI 10.1016/j.avsg.2007.09.004; Popp G, 1997, CHEST, V112, P1682, DOI 10.1378/chest.112.6.1682; Poultis MR, 2008, EUR J CARDIO-THORAC, V33, P995, DOI 10.1016/j.ejcts.2008.02.029; Rogers DPS, 2006, J INTERV CARD ELECTR, V17, P29, DOI 10.1007/s10840-006-9058-9; SMEDBY O, 1993, J VASC RES, V30, P181, DOI 10.1159/000158993; Stump DM, 2001, INT J SOLIDS STRUCT, V38, P795, DOI 10.1016/S0020-7683(00)00043-3; TAHARA Y, 1991, J ELECTROCARDIOL, V24, P239, DOI 10.1016/0022-0736(91)90029-L; VOLLEBERGH FEMG, 1977, BRIT HEART J, V39, P1006; WENN C M, 1990, Australasian Physical and Engineering Sciences in Medicine, V13, P67	42	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0897-3806	1098-2353		CLIN ANAT	Clin. Anat.	NOV	2014	27	8					1200	1211		10.1002/ca.22452		12	Anatomy & Morphology	Anatomy & Morphology	AQ6IQ	WOS:000342914700017		
J	Fujikawa, K; Migita, K; Shigemitsu, Y; Umeda, M; Nonaka, F; Tamai, M; Nakamura, H; Mizokami, A; Tsukada, T; Origuchi, T; Yonemitsu, N; Yasunami, M; Kawakami, A; Eguchi, K				Fujikawa, K.; Migita, K.; Shigemitsu, Y.; Umeda, M.; Nonaka, F.; Tamai, M.; Nakamura, H.; Mizokami, A.; Tsukada, T.; Origuchi, T.; Yonemitsu, N.; Yasunami, M.; Kawakami, A.; Eguchi, K.			MEFV gene polymorphisms and TNFRSF1A mutation in patients with inflammatory myopathy with abundant macrophages	CLINICAL AND EXPERIMENTAL IMMUNOLOGY			English	Article						autoinflammatory syndrome; IMAM; MEFV; TNFRSF1A	FAMILIAL MEDITERRANEAN FEVER; ACTIVATION SYNDROME; MYOFASCIITIS; CHILDREN; MYALGIA; DISEASE	Inflammatory myopathy with abundant macrophages (IMAM) has recently been proposed as a new clinical condition. Although IMAM shares certain similarities with other inflammatory myopathies, the mechanisms responsible for this condition remain unknown. Patients with familial Mediterranean fever (FMF) and tumour necrosis factor receptor-associated periodic syndrome (TRAPS) also often develop myalgia. We therefore investigated the polymorphisms or mutations of MEFV and TNFRSF1A genes in patients with IMAM to identify their potential role in this condition. We analysed the clinical features of nine patients with IMAM and sequenced exons of the MEFV and TNFRSF1A genes. The patients with IMAM had clinical symptoms such as myalgia, muscle weakness, erythema, fever and arthralgia. Although none of the patients were diagnosed with FMF or TRAPS, seven demonstrated MEFV polymorphisms (G304R, R202R, E148Q, E148Q-L110P and P369S-R408Q), and one demonstrated a TNFRSF1A mutation (C43R). These results suggest that MEFV gene polymorphisms and TNFRSF1A mutation are susceptibility and modifier genes in IMAM.	[Fujikawa, K.; Shigemitsu, Y.; Tsukada, T.] Isahaya Gen Hosp, Japan Community Hlth Care Org, Dept Rheumatol, Isahaya 8548501, Japan; [Migita, K.] NHO Natl Nagasaki Med Ctr, Dept Rheumatol, Omura, Japan; [Umeda, M.] Sasebo Chuo Hosp, Dept Rheumatol, Sasebo, Japan; [Yonemitsu, N.] Sasebo Chuo Hosp, Dept Pathol, Sasebo, Japan; [Nonaka, F.; Eguchi, K.] Sasebo Municipal Hosp, Dept Internal Med, Sasebo, Japan; [Tamai, M.; Nakamura, H.; Origuchi, T.; Kawakami, A.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Unit Translat Med, Nagasaki 852, Japan; [Yasunami, M.] Nagasaki Univ, Inst Trop Med, Dept Immunogenet, Nagasaki 852, Japan; [Mizokami, A.] Nagasaki Municipal Hosp, Dept Internal Med, Nagasaki, Japan	Fujikawa, K (reprint author), Isahaya Gen Hosp, Japan Community Hlth Care Org, Dept Rheumatol, 24-1 Eishohigashi Machi, Isahaya 8548501, Japan.	keitafj@gmail.com			Ministry of Health, Labor, and Welfare of Japan	This work was supported by a Grant-in-Aid for Research on intractable diseases from the Ministry of Health, Labor, and Welfare of Japan.	Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Rossi-Semerano L, 2011, ARTHRIT CARE RES, V63, P780, DOI 10.1002/acr.20418; Rayavarapu S, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-13; Gherardi RK, 1998, LANCET, V352, P347, DOI 10.1016/S0140-6736(98)02326-5; Kirino Y, 2013, P NATL ACAD SCI USA, V110, P8134, DOI 10.1073/pnas.1306352110; Sawhney S, 2001, ARCH DIS CHILD, V85, P421, DOI 10.1136/adc.85.5.421; Bassez G, 2003, J NEUROPATH EXP NEUR, V62, P464; Shoenfeld Y, 2011, J AUTOIMMUN, V36, P4, DOI 10.1016/j.jaut.2010.07.003; Brunn A, 2009, ACTA NEUROPATHOL, V118, P793, DOI 10.1007/s00401-009-0570-8; Horneff Gerd, 2013, Clin Exp Rheumatol, V31, P99; Hull KM, 2002, ARTHRITIS RHEUM, V46, P2189, DOI 10.1002/art.10448; Kimberley FC, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2197; Kumpfel T, 2007, ARTHRITIS RHEUM, V56, P2774, DOI 10.1002/art.22795; Majeed HA, 2000, SEMIN ARTHRITIS RHEU, V30, P138, DOI 10.1053/sarh.2000.16646; Migita K, 2012, J RHEUMATOL, V39, P875, DOI 10.3899/jrheum.110700; Rigante D, 2007, ARTHRITIS RHEUM, V56, P658, DOI 10.1002/art.22409; SCHAPIRA D, 1988, ANN RHEUM DIS, V47, P80, DOI 10.1136/ard.47.1.80; Tanaka M, 2007, CLIN EXP RHEUMATOL, V25, P792; Tsuda H, 1997, INT J HEMATOL, V65, P215	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9104	1365-2249		CLIN EXP IMMUNOL	Clin. Exp. Immunol.	NOV	2014	178	2					224	228		10.1111/cei.12407		5	Immunology	Immunology	AQ6IY	WOS:000342915800003		
J	Inoue, Y; Watanabe, M; Inoue, N; Kagawa, T; Shibutani, S; Otsu, H; Saeki, M; Takuse, Y; Hidaka, Y; Iwatani, Y				Inoue, Y.; Watanabe, M.; Inoue, N.; Kagawa, T.; Shibutani, S.; Otsu, H.; Saeki, M.; Takuse, Y.; Hidaka, Y.; Iwatani, Y.			Associations of single nucleotide polymorphisms in precursor-microRNA (miR)-125a and the expression of mature miR-125a with the development and prognosis of autoimmune thyroid diseases	CLINICAL AND EXPERIMENTAL IMMUNOLOGY			English	Article						autoimmune thyroid disease; intractability; miR-125a; polymorphism; severity	SYSTEMIC-LUPUS-ERYTHEMATOSUS; CIRCULATING MICRORNAS; CANCER CELLS; ANTIBODIES; REGULATORS; MIRNA; GENE	It is important to search the biomarker to predict the development and prognosis of autoimmune thyroid diseases (AITDs) such as Hashimoto's disease (HD) and Graves' disease (GD). MicroRNA (miR) bind directly to the 3' untranslated region of specific target mRNAs to suppress the expression of proteins, promote the degradation of target mRNAs and regulate immune response. miR-125a is known to be a negative regulator of regulated upon activation normal T cell expressed and secreted (RANTES), interleukin (IL)-6 and transforming growth factor (TGF)-beta; however, its association with AITDs remains unknown. To clarify the association between AITDs and miR-125a, we genotyped the rs12976445 C/T, rs10404453 A/G and rs12975333 G/T polymorphisms in the MIR125A gene, which encodes miR-125a, using direct sequencing and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) methods in 155 patients with GD, 151 patients with HD and 118 healthy volunteers. We also examined the expression of miR-125a in peripheral blood mononuclear cells (PBMCs) from 55 patients with GD, 79 patients with HD and 38 healthy volunteers using quantitative real-time PCR methods. We determined that the CC genotype and C allele of the rs12976445 C/T polymorphism were significantly more frequent in patients with HD compared with control subjects (P < 0.05) and in intractable GD compared with GD in remission (P < 0.05). The expression of miR-125a was correlated negatively with age (P = 0.0010) and down-regulated in patients with GD compared with control subjects (P = 0.0249). In conclusion, miR-125a expression in PBMCs and the rs12976445 C/T polymorphism were associated with AITD development and prognosis.	[Inoue, Y.; Watanabe, M.; Inoue, N.; Kagawa, T.; Shibutani, S.; Otsu, H.; Saeki, M.; Takuse, Y.; Iwatani, Y.] Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Biomed Informat, Suita, Osaka 5650871, Japan; [Hidaka, Y.] Osaka Univ, Grad Sch Med, Dept Lab Med, Suita, Osaka 5650871, Japan	Iwatani, Y (reprint author), Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Biomed Informat, Yamadaoka 1-7, Suita, Osaka 5650871, Japan.	iwatani@sahs.med.osaka-u.ac.jp					AMINO N, 1976, CLIN ENDOCRINOL, V5, P115, DOI 10.1111/j.1365-2265.1976.tb02822.x; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Lehmann TP, 2013, ONCOL LETT, V5, P569, DOI 10.3892/ol.2012.1040; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Yamada H, 2008, CLIN EXP IMMUNOL, V151, P379, DOI 10.1111/j.1365-2249.2007.03575.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Odar K, 2012, HISTOPATHOLOGY, V61, P257, DOI 10.1111/j.1365-2559.2012.04242.x; Mendell JT, 2005, CELL CYCLE, V4, P1179; Jiang LL, 2011, EXP LUNG RES, V37, P387, DOI 10.3109/01902148.2010.492068; Nanba T, 2009, THYROID, V19, P495, DOI 10.1089/thy.2008.0423; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Dahl KDC, 2009, NEOPLASIA, V11, P1208, DOI 10.1593/neo.09942; Hu Y, 2011, RNA BIOL, V8, P861, DOI 10.4161/rna.8.5.16034; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Zhao X, 2010, ARTHRITIS RHEUM-US, V62, P3425, DOI 10.1002/art.27632; Wang HL, 2012, TRANSL RES, V160, P198, DOI 10.1016/j.trsl.2012.04.002; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Davies T., 2000, THYROID FUNDAMENTAL, P518; Inoue N, 2011, CLIN EXP IMMUNOL, V163, P318, DOI 10.1111/j.1365-2249.2010.04306.x; Nishida N, 2011, CLIN CANCER RES, V17, P2725, DOI 10.1158/1078-0432.CCR-10-2132; Volpe R., 2001, PRINCIPLES PRACTICE, P1770; Yamada H, 2014, CLIN ENDOCRINOL, V81, P276, DOI 10.1111/cen.12432; YOSHIDA H, 1978, J CLIN ENDOCR METAB, V46, P859	27	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9104	1365-2249		CLIN EXP IMMUNOL	Clin. Exp. Immunol.	NOV	2014	178	2					229	235		10.1111/cei.12410		7	Immunology	Immunology	AQ6IY	WOS:000342915800004		
J	Uzawa, A; Mori, M; Taniguchi, J; Kuwabara, S				Uzawa, A.; Mori, M.; Taniguchi, J.; Kuwabara, S.			Modulation of the kallikrein/kinin system by the angiotensin-converting enzyme inhibitor alleviates experimental autoimmune encephalomyelitis	CLINICAL AND EXPERIMENTAL IMMUNOLOGY			English	Article						angiotensin-converting enzyme inhibitor; bradykinin; enalapril; experimental autoimmune encephalomyelitis; multiple sclerosis	CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; RECEPTOR; INFLAMMATION; CELLS; CAPTOPRIL	Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS). Bradykinin is the end-product of the kallikrein/kinin system, which has been recognized as an endogenous target for combating CNS inflammation. Angiotensin-converting enzyme (ACE) inhibitors influence the kallikrein/kinin system and reportedly have immunomodulatory characteristics. The objectives of this study were to determine whether bradykinin is involved in the pathogenesis of experimental autoimmune encephalomyelitis (EAE), an animal model of MS, and whether bradykinin control by the ACE inhibitor could be a therapeutic target in MS. The ACE inhibitor enalapril (1.0 or 0.2 mg/kg/day) was administered orally to EAE mice and the serum levels of bradykinin and cytokines in EAE mice were analysed. As a result, the administration of enalapril increased serum bradykinin levels, decreased the clinical and pathological severity of EAE and attenuated interleukin-17-positive cell invasion into the CNS. Additionally, bradykinin receptor antagonist administration reduced the favourable effects of enalapril. Our results suggest that bradykinin is involved in the pathomechanism underlying CNS inflammation in EAE, possibly through inhibiting cell migration into CNS. Control of the kallikrein/kinin system using ACE inhibitors could be a potential therapeutic strategy in MS.	[Uzawa, A.; Mori, M.; Taniguchi, J.; Kuwabara, S.] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba 2608670, Japan	Uzawa, A (reprint author), Chiba Univ, Grad Sch Med, Dept Neurol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	auzawa@chiba-u.jp			Ministry of Education, Science, and Technology	This work was supported partly by research grants from the Ministry of Education, Science, and Technology (A.U.).	Komiyama Y, 2006, J IMMUNOL, V177, P566; Schulze-Topphoff U, 2009, NAT MED, V15, P788, DOI 10.1038/nm.1980; da Cunha V, 2005, ATHEROSCLEROSIS, V178, P9, DOI 10.1016/j.atherosclerosis.2004.08.023; Quintana A, 2009, J IMMUNOL, V183, P2079, DOI 10.4049/jimmunol.0900242; Stegbauer J, 2009, P NATL ACAD SCI USA, V106, P14942, DOI 10.1073/pnas.0903602106; Eugster HP, 1998, EUR J IMMUNOL, V28, P2178, DOI 10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D; Lanz TV, 2010, J CLIN INVEST, V120, P2782, DOI 10.1172/JCI41709; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Marceau F, 2004, NAT REV DRUG DISCOV, V3, P845, DOI 10.1038/nrd1522; Prat A, 2000, J NEUROPATH EXP NEUR, V59, P896; Gullestad L, 1999, J AM COLL CARDIOL, V34, P2061, DOI 10.1016/S0735-1097(99)00495-7; CONSTANTINESCU CS, 1995, IMMUNOPHARM IMMUNOT, V17, P471, DOI 10.3109/08923979509016382; Constantinescu CS, 1997, ARCH NEUROL-CHICAGO, V54, P1012; Constantinescu CS, 1998, IMMUNOL LETT, V62, P25, DOI 10.1016/S0165-2478(98)00025-X; Doerner M, 2014, EUR NEUROL, V71, P173, DOI 10.1159/000355530; Kim MP, 2005, J LEUKOCYTE BIOL, V78, P195, DOI 10.1189/jlb.1204715; Lovrecic L, 2006, ACTA NEUROL SCAND, V114, P374, DOI 10.1111/j.1600-0404.2006.00711.x; Matsushita T, 2010, J NEUROL SCI, V295, P41, DOI 10.1016/j.jns.2010.05.014; Platten M, 2009, P NATL ACAD SCI USA, V106, P14948, DOI 10.1073/pnas.0903958106; Schieffer B, 2004, J AM COLL CARDIOL, V44, P362, DOI 10.1016/j.jacc.2004.03.065; Uzawa A, 2013, CLIN EXP IMMUNOL, V172, P37, DOI 10.1111/cei.12036	21	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9104	1365-2249		CLIN EXP IMMUNOL	Clin. Exp. Immunol.	NOV	2014	178	2					245	252		10.1111/cei.12413		8	Immunology	Immunology	AQ6IY	WOS:000342915800006		
J	Tanaka, H; Zhang, W; Yang, GX; Ando, Y; Tomiyama, T; Tsuneyama, K; Leung, P; Coppel, RL; Ansari, AA; Lian, ZX; Ridgway, WM; Joh, T; Gershwin, ME				Tanaka, H.; Zhang, W.; Yang, G-X.; Ando, Y.; Tomiyama, T.; Tsuneyama, K.; Leung, P.; Coppel, R. L.; Ansari, A. A.; Lian, Z. X.; Ridgway, W. M.; Joh, T.; Gershwin, M. E.			Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3(+) regulatory T cells	CLINICAL AND EXPERIMENTAL IMMUNOLOGY			English	Article						autoimmunity; cholangitis; colitis; murine models; primary biliary cirrhosis	PRIMARY BILIARY-CIRRHOSIS; GROWTH-FACTOR-BETA; DOMINANT-NEGATIVE FORM; TGF-BETA; II MICE; IN-VIVO; CUTTING EDGE; RECEPTOR; INDUCTION; TOLERANCE	Treatment of primary biliary cirrhosis (PBC) has lagged behind that of other autoimmune diseases. In this study we have addressed the potential utility of immunotherapy using regulatory T cells (T-reg) to treat murine autoimmune cholangitis. In particular, we have taken advantage of our ability to produce portal inflammation and bile duct cell loss by transfer of CD8(+) T cells from the dominant negative form of transforming growth factor beta receptor type II (dnTGF-beta RII) mice to recombination-activating gene (Rag)1(-/-) recipients. We then used this robust established adoptive transfer system and co-transferred CD8(+) T cells from dnTGF-beta RII mice with either C57BL/6 or dnTGF-beta RII forkhead box protein 3 (FoxP3(+)) T cells. Recipient mice were monitored for histology, including portal inflammation and intralobular biliary cell damage, and also included a study of the phenotypical changes in recipient lymphoid populations and local and systemic cytokine production. Importantly, we report herein that adoptive transfer of T-reg from C57BL/6 but not dnTGF-beta RII mice significantly reduced the pathology of autoimmune cholangitis, including decreased portal inflammation and bile duct damage as well as down-regulation of the secondary inflammatory response. Further, to define the mechanism of action that explains the differential ability of C57BL/6 T-reg versus dnTGF-beta RII T-reg on the ability to down-regulate autoimmune cholangitis, we noted significant differential expression of glycoprotein A repetitions predominant (GARP), CD73, CD101 and CD103 and a functionally significant increase in interleukin (IL)-10 in T-reg from C57BL/6 compared to dnTGF-beta RII mice. Our data reflect the therapeutic potential of wild-type CD4(+) FoxP3(+) T-reg in reducing the excessive T cell responses of autoimmune cholangitis, which has significance for the potential immunotherapy of PBC.	[Tanaka, H.; Zhang, W.; Yang, G-X.; Tomiyama, T.; Leung, P.; Gershwin, M. E.] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA; [Ansari, A. A.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Ridgway, W. M.] Univ Cincinnati, Coll Med, Div Immunol Allergy & Rheumatol, Cincinnati, OH USA; [Tanaka, H.; Joh, T.] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan; [Ando, Y.; Tomiyama, T.] Kansai Med Univ, Div Gastroenterol & Hepatol, Dept Internal Med 3, Osaka, Japan; [Tsuneyama, K.] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Diagnost Pathol, Toyama 930, Japan; [Coppel, R. L.] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia; [Lian, Z. X.] Univ Sci & Technol China, Inst Immunol, Hefei 230026, Peoples R China; [Lian, Z. X.] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China	Gershwin, ME (reprint author), Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Sch Med, 451 Hlth Sci Dr,Suite 6510, Davis, CA 95616 USA.	megershwin@ucdavis.edu			National Institutes of Health [DK090019]	The authors thank Bridget McLaughlin, Jonathan Van Dyke, Kazuhito Kawata, Masanobu Tsuda, Bin Liu, Jinjun Wang, Jun Zhang, Chen-Yen Yang, Kerstien Padgett and Tom P. Kenny for technical support in this experiment. We also thank Ms. Nikki Phipps for support in preparing this paper. Financial support was provided in part by National Institutes of Health grant DK090019.	Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Oertelt S, 2006, J IMMUNOL, V177, P1655; Ando Y, 2012, HEPATOLOGY, V56, P1418, DOI 10.1002/hep.25803; Sojka DK, 2009, EUR J IMMUNOL, V39, P1544, DOI 10.1002/eji.200838603; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Yao Y, 2014, J AUTOIMMUN, V51, P99, DOI 10.1016/j.jaut.2014.02.009; Yoshida K, 2009, HEPATOLOGY, V50, P1494, DOI 10.1002/hep.23132; Regateiro FS, 2011, EUR J IMMUNOL, V41, P2955, DOI 10.1002/eji.201141512; Huang WT, 2014, J AUTOIMMUN, V50, P123, DOI 10.1016/j.jaut.2014.01.034; Edwards JP, 2013, J IMMUNOL, V190, P5506, DOI 10.4049/jimmunol.1300199; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Yang CY, 2014, HEPATOLOGY, V59, P1944, DOI 10.1002/hep.26979; Cobbold SP, 2004, J IMMUNOL, V172, P6003; Kawata K, 2013, HEPATOLOGY, V58, P1094, DOI 10.1002/hep.26418; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Chang LY, 2012, J IMMUNOL, V189, P567, DOI 10.4049/jimmunol.1200266; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Reynolds LA, 2012, J IMMUNOL, V189, P1113, DOI 10.4049/jimmunol.1200991; Chen RCY, 2013, HEPATOLOGY, V57, P1498, DOI 10.1002/hep.26157; Lin XH, 2013, INT J CLIN EXP PATHO, V6, P116; Paust S, 2004, P NATL ACAD SCI USA, V101, P10398, DOI 10.1073/pnas.0403342101; Lan RY, 2006, HEPATOLOGY, V43, P729, DOI 10.1002/hep.21123; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Suffia I, 2005, J IMMUNOL, V174, P5444; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Trivedi PJ, 2013, J AUTOIMMUN, V46, P97, DOI 10.1016/j.jaut.2013.06.013; Tanaka H, 2013, CLIN EXP IMMUNOL, V174, P364, DOI 10.1111/cei.12193; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Hudspeth K, 2013, J AUTOIMMUN, V46, P55, DOI 10.1016/j.jaut.2013.07.003; Tsuda M, 2013, HEPATOLOGY, V57, P806, DOI 10.1002/hep.25829; Chang CH, 2014, CLIN EXP IMMUNOL, V177, P373, DOI 10.1111/cei.12298; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Dhamne C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00253; d'Hennezel E, 2011, METHODS MOL BIOL, V707, P199, DOI 10.1007/978-1-61737-979-6_13; Fantini MC, 2004, J IMMUNOL, V172, P5149; Fort MM, 2010, TOXICOL SCI, V117, P253, DOI 10.1093/toxsci/kfq136; Invernizzi P, 2013, J AUTOIMMUN, V46, P1, DOI 10.1016/j.jaut.2013.08.006; Ishigame H, 2013, J IMMUNOL, V190, P6340, DOI 10.4049/jimmunol.1300397; Jin QL, 2012, HEPATOLOGY, V55, P1495, DOI 10.1002/hep.25511; Leung PSC, 2013, J AUTOIMMUN, V41, P79, DOI 10.1016/j.jaut.2012.12.007; Lleo A, 2014, HEPATOLOGY, V60, P1314, DOI 10.1002/hep.27230; Robinson PW, 2001, IMMUNOLOGY, V103, P146, DOI 10.1046/j.1365-2567.2001.01232.x; Rong GH, 2013, CLIN EXP IMMUNOL, V172, P95, DOI 10.1111/cei.12046; Sakuraba K, 2013, J IMMUNOL, V190, P1560, DOI 10.4049/jimmunol.1202464; Schneider-Hohendorf T, 2010, EUR J IMMUNOL, V40, P3581, DOI 10.1002/eji.201040558; Takahashi T, 2012, HEPATOLOGY, V55, P846, DOI 10.1002/hep.24757; Yang GX, 2008, HEPATOLOGY, V47, P1974, DOI 10.1002/hep.22226; Zhou AX, 2013, J IMMUNOL, V190, P5057, DOI 10.4049/jimmunol.1300065	53	12	13	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9104	1365-2249		CLIN EXP IMMUNOL	Clin. Exp. Immunol.	NOV	2014	178	2					253	261		10.1111/cei.12415		9	Immunology	Immunology	AQ6IY	WOS:000342915800007		
J	Inoue, N; Watanabe, M; Ishido, N; Katsumata, Y; Kagawa, T; Hidaka, Y; Iwatani, Y				Inoue, N.; Watanabe, M.; Ishido, N.; Katsumata, Y.; Kagawa, T.; Hidaka, Y.; Iwatani, Y.			The functional polymorphisms of VDR, GC and CYP2R1 are involved in the pathogenesis of autoimmune thyroid diseases	CLINICAL AND EXPERIMENTAL IMMUNOLOGY			English	Article						autoimmune thyroid disease; intractability; polymorphism; severity; vitamin D	GENOME-WIDE ASSOCIATION; RECEPTOR GENE POLYMORPHISMS; VITAMIN-D INSUFFICIENCY; D-BINDING PROTEIN; GRAVES-DISEASE; HASHIMOTOS-DISEASE; MULTIPLE-SCLEROSIS; FOKI POLYMORPHISM; IMMUNE-SYSTEM; TH17 CELLS	Vitamin D is a multi-functional immune regulator, and a low serum concentration of vitamin D promotes autoimmune inflammation. In this study, we evaluate the association between the prognosis of autoimmune thyroid disease (AITD) and the functional polymorphisms of genes that regulate vitamin D metabolism. For 139 Graves' disease (GD) patients, 116 Hashimoto's disease (HD) patients and 76 control subjects, we genotyped the following polymorphisms using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP): vitamin D receptor (VDR): rs731236, rs7975232, rs2228570 and rs1544410; group-specific component (GC): rs7041 and rs4588; and CYP2R1: rs10741657. The frequency of the TT genotype for the rs731236 polymorphism was higher in GD patients than in HD patients (P = 0.0147). The frequency of the C allele for the rs7975232 polymorphism was higher in GD patients than in control subjects (P = 0.0349). The proportion of GD patients whose anti-thyrotrophin receptor antibody (TRAb) level was > 51% was higher in those with the CC genotype than in those with the CA+AA genotypes (P = 0.0065). The frequency of the CC genotype for the rs2228570 polymorphism was higher in HD patients than in control subjects (P = 0.0174) and GD patients (P = 0.0149). The frequency of the Gc1Gc1 genotype for the GC polymorphism and the AG genotype for the CYP2R1 polymorphism were lower in intractable GD than in GD in remission (P = 0.0093 and 0.0268, respectively). In conclusion, genetic differences in the VDR gene may be involved in the development of AITD and the activity of GD, whereas the genetic differences in the GC and CYP2R1 genes may be involved with the intractability of GD.	[Inoue, N.; Watanabe, M.; Ishido, N.; Katsumata, Y.; Kagawa, T.; Iwatani, Y.] Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Biomed Informat, Suita, Osaka 5650871, Japan; [Hidaka, Y.] Osaka Univ, Grad Sch Med, Dept Lab Med, Suita, Osaka 5650871, Japan	Iwatani, Y (reprint author), Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Biomed Informat, Yamadaoka 1-7, Suita, Osaka 5650871, Japan.	iwatani@sahs.med.osaka-u.ac.jp					Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Guillot X, 2010, JOINT BONE SPINE, V77, P552, DOI 10.1016/j.jbspin.2010.09.018; ARNAUD J, 1993, HUM GENET, V92, P183; Inoue N, 2012, J CLIN IMMUNOL, V32, P1243, DOI 10.1007/s10875-012-9721-0; van Etten E, 2007, EUR J IMMUNOL, V37, P395, DOI 10.1002/eji.200636043; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Almerighi C, 2009, CYTOKINE, V45, P190, DOI 10.1016/j.cyto.2008.12.009; Inoue N, 2009, CLIN EXP IMMUNOL, V156, P199, DOI 10.1111/j.1365-2249.2009.03884.x; Abbas S, 2008, CANCER EPIDEM BIOMAR, V17, P1339, DOI 10.1158/1055-9965.EPI-08-0162; Agliardi C, 2011, BRAIN BEHAV IMMUN, V25, P1460, DOI 10.1016/j.bbi.2011.05.015; Lauridsen AL, 2005, CALCIFIED TISSUE INT, V77, P15, DOI 10.1007/s00223-004-0227-5; Inoue N, 2010, CLIN EXP IMMUNOL, V162, P402, DOI 10.1111/j.1365-2249.2010.04229.x; Ito C, 2006, ENDOCR J, V53, P473, DOI 10.1507/endocrj.K06-015; Shimada A, 2008, J AUTOIMMUN, V30, P207, DOI 10.1016/j.jaut.2007.09.002; Nanba T, 2009, THYROID, V19, P495, DOI 10.1089/thy.2008.0423; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Bu FX, 2010, HUM GENET, V128, P549, DOI 10.1007/s00439-010-0881-9; Peelen E, 2011, AUTOIMMUN REV, V10, P733, DOI 10.1016/j.autrev.2011.05.002; Ramos-Lopez E, 2007, DIABETES-METAB RES, V23, P631, DOI 10.1002/dmrr.719; Ban Y, 2001, THYROID, V11, P607, DOI 10.1089/105072501750302967; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Kivity S, 2011, CELL MOL IMMUNOL, V8, P243, DOI 10.1038/cmi.2010.73; Hayashi F, 2009, CLIN EXP IMMUNOL, V158, P281, DOI 10.1111/j.1365-2249.2009.04034.x; Ban Y, 2000, J CLIN ENDOCR METAB, V85, P4639, DOI 10.1210/jc.85.12.4639; Tamer G, 2011, THYROID, V21, P891, DOI 10.1089/thy.2009.0200; Chen RH, 2007, J CLIN LAB ANAL, V21, P173, DOI 10.1002/jcla.20163; Inoue N, 2011, CLIN EXP IMMUNOL, V163, P318, DOI 10.1111/j.1365-2249.2010.04306.x; Li K, 2012, BRIT J DERMATOL, V167, P815, DOI 10.1111/j.1365-2133.2012.11132.x; Menconi F, 2008, DIAGNOSTIC CRITERIA IN AUTOIMMUNE DISEASES, P231, DOI 10.1007/978-1-60327-285-8_44; Morita M, 2011, AUTOIMMUNITY, V45, P129; Nanba T, 2008, CLIN CHEM, V54, P621, DOI 10.1373/clinchem.2007.099739; Samee ER, 2011, ENDOCR PRACT, V18, P132; Smolders J, 2009, AUTOIMMUN REV, V8, P621, DOI 10.1016/j.autrev.2009.02.009; Tomizawa R, 2011, CLIN EXP IMMUNOL, V165, P141, DOI 10.1111/j.1365-2249.2011.04414.x; Watanabe M, 2002, THYROID, V12, P801, DOI 10.1089/105072502760339370; Weetman AP, 2000, THYROID FUNDAMENTAL, P721; Zhang Hong, 2013, Eur J Microbiol Immunol (Bp), V3, P237, DOI 10.1556/EuJMI.3.2013.4.1	37	2	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9104	1365-2249		CLIN EXP IMMUNOL	Clin. Exp. Immunol.	NOV	2014	178	2					262	269		10.1111/cei.12420		8	Immunology	Immunology	AQ6IY	WOS:000342915800008		
J	Higaki, N; Goto, T; Ishida, Y; Watanabe, M; Tomotake, Y; Ichikawa, T				Higaki, Nobuaki; Goto, Takaharu; Ishida, Yuichi; Watanabe, Megumi; Tomotake, Yoritoki; Ichikawa, Tetsuo			Do sensation differences exist between dental implants and natural teeth?: a meta-analysis	CLINICAL ORAL IMPLANTS RESEARCH			English	Review						implant; meta-analysis; sensation; tactile; thickness	SUPPORTED PROSTHESES; COMPLICATION RATES; BRAIN-STEM; SURVIVAL; OSSEOPERCEPTION	Objective: The purpose of this systematic review was to survey evidence pertaining to the sensation differences between natural teeth and osseointegrated dental implants. Material and methods: Using the MEDLINE (online PubMed) database, Cochrane Library, and Scientific Citation index, we performed a systematic search of articles. We used the following search terms: "perception or sensation and dental implant." The systematic review of the extracted articles was performed to see the sensation differences between natural teeth and dental implants. Results: A total of six studies on oral sensation, "tactile sensibility," and "thickness discrimination" were included in the meta-analysis. As to the " tactile sensibility", all studies indicated the threshold levels of the implants were about 4-20 times higher than that of natural teeth. The tactile sensibility of an implant was significantly higher than that of a natural tooth, with an standardized mean difference (SMD) of 8.3619 (95% CI, 6.3920-10.3317) and a P < 0.0001. As to the " thickness discrimination", all studies indicated the threshold levels of implants were about 1.2-2.3 times higher than that of natural teeth. The thickness discrimination was significantly higher than that of natural teeth with an SMD of 1.2368 (95% CI, 0.8699-1.6038) and a P < 0.0001. Conclusion: This meta-analysis suggested that both tactile sensibility and thickness discrimination thresholds of implants were significantly higher than those of natural teeth. This meta-analysis reconfirms that sensation differences between dental implants and natural teeth exist.	[Higaki, Nobuaki; Goto, Takaharu; Ishida, Yuichi; Watanabe, Megumi; Tomotake, Yoritoki; Ichikawa, Tetsuo] Univ Tokushima, Inst Hlth Biosci, Dept Oral & Maxillofacial Prosthodont & Oral Impl, Tokushima 7708504, Japan	Goto, T (reprint author), Univ Tokushima, Inst Hlth Biosci, Dept Oral & Maxillofacial Prosthodont & Oral Impl, 3-18-15 Kuramoto, Tokushima 7708504, Japan.	tak510@tokushima-u.ac.jp					Anderson K, 2002, J ORAL REHABIL, V29, P689, DOI 10.1046/j.1365-2842.2002.00862.x; Krall E, 1998, J AM DENT ASSOC, V129, P1261; Yamashiro T, 2001, J DENT RES, V80, P461; NAKAMURA Y, 1995, NEUROSCI RES, V23, P1, DOI 10.1016/0168-0102(95)00925-J; HAMMERLE CHF, 1995, CLIN ORAL IMPLAN RES, V6, P83, DOI 10.1034/j.1600-0501.1995.060203.x; Pjetursson BE, 2004, CLIN ORAL IMPLAN RES, V15, P625, DOI 10.1111/j.1600-0501.2004.01117.x; Trulsson M, 2006, J ORAL REHABIL, V33, P262, DOI 10.1111/j.1365-2842.2006.01629.x; BRANEMARK PI, 1995, CLIN ORAL IMPLAN RES, V6, P227, DOI 10.1034/j.1600-0501.1995.060405.x; Jung RE, 2008, CLIN ORAL IMPLAN RES, V19, P119, DOI 10.1111/j.1600-0501.2007.01453.x; Batista M, 2008, CLIN ORAL IMPLAN RES, V19, P565, DOI 10.1111/j.1600-0501.2008.01529.x; Buser D, 1997, CLIN ORAL IMPLAN RES, V8, P161, DOI 10.1034/j.1600-0501.1997.080302.x; Enkling N, 2007, CLIN ORAL IMPLAN RES, V18, P231, DOI 10.1111/j.1600-0501.2006.01321.x; Fay RA, 1997, BRAIN RES REV, V25, P255, DOI 10.1016/S0165-0173(97)00026-X; Garrett N. R., 1992, International Journal of Prosthodontics, V5, P515; Grieznis Linards, 2010, Stomatologija, V12, P80; Habre-Hallage P, 2010, CLIN ORAL INVEST, V14, P161, DOI 10.1007/s00784-009-0272-6; Jacobs R, 1991, CLIN ORAL IMPLAN RES, V2, P75, DOI 10.1034/j.1600-0501.1991.020205.x; Jacobs R, 2001, Clin Implant Dent Relat Res, V3, P148, DOI 10.1111/j.1708-8208.2001.tb00135.x; Keller D, 1996, CLIN ORAL IMPLAN RES, V7, P48, DOI 10.1034/j.1600-0501.1996.070106.x; Klineberg I, 1999, Adv Dent Res, V13, P120; Linden P, 1989, Dysphagia, V4, P146, DOI 10.1007/BF02408037; Linden R.W., 1993, J PHYSL, V465, P581; LUND J P, 1991, Critical Reviews in Oral Biology and Medicine, V2, P33; Mericske-Stern R, 1995, Int J Oral Maxillofac Implants, V10, P345; Mühlbradt L, 1989, Int J Oral Maxillofac Implants, V4, P125; TZAKIS M G, 1990, International Journal of Oral and Maxillofacial Implants, V5, P107; van Oirschot BAJA, 2013, CLIN ORAL IMPLAN RES, V24, P355, DOI 10.1111/clr.12063; van Steenberghe D, 2000, J DENT RES, V79, P1833; Wada S, 2001, CLIN ORAL IMPLAN RES, V12, P219, DOI 10.1034/j.1600-0501.2001.012003219.x; Weiner S, 2004, INT J ORAL MAX IMPL, V19, P44	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7161	1600-0501		CLIN ORAL IMPLAN RES	Clin. Oral Implant. Res.	NOV	2014	25	11					1307	1310		10.1111/clr.12271		4	Dentistry, Oral Surgery & Medicine; Engineering, Biomedical	Dentistry, Oral Surgery & Medicine; Engineering	AQ6FI	WOS:000342905100014		
J	Aoki, T; Ogasawara, T; Okubo, Y; Yoshida, K; Yano, T				Aoki, Takuya; Ogasawara, Toshio; Okubo, Yosuke; Yoshida, Katsumi; Yano, Toyohiko			Fabrication and properties of Si-Hf alloy melt-infiltrated Tyranno ZMI fiber/Sic-based matrix composites	COMPOSITES PART A-APPLIED SCIENCE AND MANUFACTURING			English	Article						Ceramic-matrix composites (CMCs); Mechanical properties; Microstructures; Liquid metal infiltration	SIC/SIC COMPOSITES; CRACKING	The fabrication of Tyranno ZMI fiber/SiC-based matrix composites by a melt infiltration (MI) process using Si-8.5 at%Hf alloy was investigated. The Si-Hf alloy was utilized instead of pure Si for MI processing in order to lower the MI temperature to below 1400 degrees C as well as to inhibit the thermal degradation of amorphous SiC fibers. Microstructural characterization revealed that the composite fabricated by Si-8.5 at%Hf alloy MI at 1375 degrees C had a highly dense matrix comprising reaction-formed SiC and unreacted Si-HfSi2 phases. The S-Hf alloy melt-infiltrated composite exhibited approximately 35% higher bending strength than a conventional Si melt-infiltrated composite fabricated at 1450 degrees C. Further, it was confirmed that Si-Hf alloy melt-infiltrated composite maintained its strength up to 1200 degrees C in an Ar atmosphere. These results clearly demonstrated that the Si-8.5 at%Hf alloy offers sufficient infiltration ability and reactivity to form a dense SiC-based matrix at 1375 degrees C. (C) 2014 Elsevier Ltd. All rights reserved.	[Aoki, Takuya; Ogasawara, Toshio] Japan Aerosp Explorat Agcy, Inst Aeronaut Technol, Adv Composite Res Ctr, Mitaka, Tokyo 1810015, Japan; [Okubo, Yosuke; Yoshida, Katsumi; Yano, Toyohiko] Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, Tokyo 1528550, Japan	Aoki, T (reprint author), Japan Aerosp Explorat Agcy, Inst Aeronaut Technol, Adv Composite Res Ctr, 6-13-1 Osawa, Mitaka, Tokyo 1810015, Japan.	takuya@chofu.jaxa.jp	Ogasawara, Toshio/O-1238-2014; Yano, Toyohiko/F-7801-2014; Yoshida, Katsumi/H-9680-2014	Ogasawara, Toshio/0000-0003-1074-0427; Yano, Toyohiko/0000-0002-2111-9049; Yoshida, Katsumi/0000-0002-2735-2263			Murthy PLN, 2008, COMPOS PART B-ENG, V39, P694, DOI 10.1016/j.compositesb.2007.05.006; Riccardi B, 2002, J MATER SCI, V37, P5029, DOI 10.1023/A:1021087632155; Ogasawara T, 2003, J AM CERAM SOC, V86, P830; Morscher GN, 2007, COMPOS SCI TECHNOL, V67, P1009, DOI 10.1016/j.compscitech.2006.06.007; Wang YX, 2004, CARBON, V42, P1833, DOI 10.1016/j.carbon.2004.03.018; Naslain R, 2004, COMPOS SCI TECHNOL, V64, P155, DOI 10.1016/S0266-3538(03)00230-6; Corman GS, 2002, J ENG GAS TURB POWER, V124, P459, DOI 10.1115/1.1455637; DiCarlo JA, 2005, HANDBOOK OF CERAMIC COMPOSITES, P33, DOI 10.1007/0-387-23986-3_2; Ffiglein E, 2012, APPL NOTE; Gokhale A.B., 1989, B ALLOY PHASE DIAGRA, V10, P390, DOI 10.1007/BF02877595; Gokhale AB, 1986, B ALLOY PHASE DIAGR, V7, P485, DOI 10.1007/BF02867814; Gowayed Y, 2010, COMPOS SCI TECHNOL, V70, P435, DOI 10.1016/j.compscitech.2009.11.016; Morscher GN, 2005, J AM CERAM SOC, V88, P146, DOI 10.1111/j.1551-2916.2004.00029.x; Norrsih K., 1962, CLAY MINERALS B, V5, P98, DOI 10.1180/claymin.1962.005.28.06; Okamoto H., 1990, B ALLOY PHASE DIAGRA, V11, P513, DOI 10.1007/BF02898272; ostling M, 1995, PROPERTIES METAL SIL, P15; TANAKA T, 1995, NIPPON SERAM KYO GAK, V103, P1	17	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-835X	1878-5840		COMPOS PART A-APPL S	Compos. Pt. A-Appl. Sci. Manuf.	NOV	2014	66						155	162		10.1016/j.compositesa.2014.07.009		8	Engineering, Manufacturing; Materials Science, Composites	Engineering; Materials Science	AQ6WW	WOS:000342955600017		
J	Jeon, EB; Fujimura, T; Takahashi, K; Kim, HS				Jeon, Eun-Beom; Fujimura, Takahiro; Takahashi, Kosuke; Kim, Hak-Sung			An investigation of contact resistance between carbon fiber/epoxy composite laminate and printed silver electrode for damage monitoring	COMPOSITES PART A-APPLIED SCIENCE AND MANUFACTURING			English	Article						Carbon fiber; Adhesion; Electrical properties; Sintering		An addressable conducting network (ACN) enables the structural condition to be monitored by the electrical resistance between electrodes on surface of CFRP (carbon fiber reinforced polymer) structure. To improve the reliability of ACN for damage detection, the contact resistance between the electrodes and CFRP laminates needs to be minimized. In this paper, the silver nanoparticles electrodes were fabricated via printed electronics techniques on CFRP composite. The contact resistance between the silver electrodes and CFRP was measured with respect to various fabrication conditions such as the sintering temperature of silver nanoink and the surface roughness of CFRP laminates. The interfaces between silver electrode and carbon fibers were observed using scanning electron microscope (SEM). From the study, it was found that the lowest contact resistance of 0.3664 Omega could be achieved when the sintering temperature of the silver nanoink and surface roughness were 120 degrees C and 230 nm, respectively. (C) 2014 Elsevier Ltd. All rights reserved.	[Jeon, Eun-Beom; Kim, Hak-Sung] Hanyang Univ, Dept Mech Engn, Seoul 133791, South Korea; [Fujimura, Takahiro; Takahashi, Kosuke] Tokyo Inst Technol, Dept Mech Sci & Engn, Meguro Ku, Tokyo 1528550, Japan; [Kim, Hak-Sung] Hanyang Univ, Inst Nano Sci & Technol, Seoul 133791, South Korea	Kim, HS (reprint author), Hanyang Univ, Dept Mech Engn, Seoul 133791, South Korea.	kima@hanyang.ac.kr	Takahashi, Kosuke/C-2867-2015	Takahashi, Kosuke/0000-0002-7399-3774	National Research Foundation of Korea (NRF) - Ministry of Education [2012R1A6A1029029]; JSPS under the Japan-Korea Basic Scientific Cooperation Program [2012K2A2A4017699]; NRF under the Japan-Korea Basic Scientific Cooperation Program [2012K2A2A4017699]; Technology Development Program for Strategic Core Materials - Ministry of Trade, Industry 82 Energy, Republic of Korea [10047758]	This work was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2012R1A6A1029029). Also, this project was supported by JSPS and NRF under the Japan-Korea Basic Scientific Cooperation Program (2012K2A2A4017699). This research was also supported by a grant from the Technology Development Program for Strategic Core Materials funded by the Ministry of Trade, Industry 82 Energy, Republic of Korea (Project No. 10047758).	Chen XX, 2003, MACROMOLECULES, V36, P1802, DOI 10.1021/ma0210675; Zhu JH, 2010, POLYMER, V51, P2643, DOI 10.1016/j.polymer.2010.04.019; Crinon E, 1998, MAT SCI ENG A-STRUCT, V242, P121, DOI 10.1016/S0921-5093(97)00508-X; [Anonymous], 2004, AM SOC TEST MAT, pD3359; [Anonymous], 2004, AM SOC TEST MAT, pG171; Kim KS, 2011, J NANOSCI NANOTECHNO, V11, P1493, DOI 10.1166/jnn.2011.3368; Bergman SD, 2008, J MATER CHEM, V18, P41, DOI 10.1039/b713953p; Jang S, 2010, SCRIPTA MATER, V62, P258, DOI 10.1016/j.scriptamat.2009.11.011; Park JS, 2009, COMPOS SCI TECHNOL, V69, P1082, DOI 10.1016/j.compscitech.2009.01.031; Chen XX, 2002, SCIENCE, V295, P1698, DOI 10.1126/science.1065879; Zhu JH, 2010, J MATER CHEM, V20, P4937, DOI 10.1039/c0jm00063a; Avasarala B, 2009, J POWER SOURCES, P576; Deng H, 1997, J APPL PHYS, V81, P5396, DOI 10.1063/1.364551; Kogut L, 2003, J APPL PHYS, V94, P3153, DOI 10.1063/1.1592628; Kwok N, 2007, J COMPOS MATER, V41, P635; Park JS, 2008, J COMPOS MATER, V42, P2869, DOI 10.1177/0021998308097280; Park JS, 2008, J COMPOS MATER, P1; STEINMANN PA, 1987, THIN SOLID FILMS, V154, P333, DOI 10.1016/0040-6090(87)90377-4; Takahashi K, 2013, COMPOS B, V43, P833; Takahashi K, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/10/105023; Takahashi K, 2013, STRUCT HLTH MONIT, V11, P367; Todoroki Akira, 2010, Journal of Solid Mechanics and Materials Engineering, V4, DOI 10.1299/jmmp.4.1; Werner RG, 1999, INTERNATIONAL SYMPOSIUM ON ADVANCED PACKAGING MATERIALS: PROCESSES, PROPERTIES AND INTERFACES, PROCEEDINGS, P246; Zeng F, 2011, IEEE, P509; Zhu Jianzhong, 2013, J ELECTROCHEM SOC, V160, P507	25	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-835X	1878-5840		COMPOS PART A-APPL S	Compos. Pt. A-Appl. Sci. Manuf.	NOV	2014	66						193	200		10.1016/j.compositesa.2014.08.002		8	Engineering, Manufacturing; Materials Science, Composites	Engineering; Materials Science	AQ6WW	WOS:000342955600021		
J	Liu, K; Zhang, XZ; Takagi, H; Yang, ZM; Wang, D				Liu, Ke; Zhang, Xiaozhe; Takagi, Hitoshi; Yang, Zhimao; Wang, Dong			Effect of chemical treatments on transverse thermal conductivity of unidirectional abaca fiber/epoxy composite	COMPOSITES PART A-APPLIED SCIENCE AND MANUFACTURING			English	Article						Fibers; Polymer-matrix composites (PMCs); Thermal properties; Transverse cracking	MECHANICAL-PROPERTIES; FIBER COMPOSITES; EPOXY COMPOSITES; ALKALI TREATMENT; NATURAL FIBER; BIOCOMPOSITES; CELLULOSE; FLAX	Present paper investigated the effect of mercerization and silane treatments on the transverse thermal conduction properties of unidirectional abaca fiber epoxy composite fabricated by resin transfer molding. As indicated by FTIR, XRD and SEM, the changes in chemical composition, crystalline and lumen structure of abaca fibers were introduced by chemical treatments. Transverse tensile test showed that the weakest linkage of unidirectional composite changed from interface between abaca fiber bundle and epoxy resin for untreated abaca fiber to interface between elementary fibers treated by mercerization and silanization. With the increasing of weakest linkages strength and the decreasing of void content, the transverse thermal conductivity (TCC) of the composite presents increasing trend. The changing of interfaces, cell wall and lumen derived from chemical treatments are the mainly factors affecting TTC. It was concluded that the abaca fiber composite with controllable transverse thermal conduction property can be designed by proper chemical treatment. (C) 2014 Elsevier Ltd. All rights reserved.	[Liu, Ke; Wang, Dong] Wuhan Text Univ, Coll Mat Sci & Engn, Wuhan 430073, Hubei, Peoples R China; [Zhang, Xiaozhe; Yang, Zhimao] Xi An Jiao Tong Univ, MOE Key Lab Nonequilibrium Synth & Modulat Conden, Sch Sci, Xian 710049, Shaanxi, Peoples R China; [Takagi, Hitoshi] Univ Tokushima, Inst Sci & Technol, Tokushima 7708506, Japan	Wang, D (reprint author), Wuhan Text Univ, Coll Mat Sci & Engn, Wuhan 430073, Hubei, Peoples R China.	wangdon08@126.com	Takagi, erしtyofTokushima/E-8946-2012		Nature Science Foundation of Hubei Province [2013CFB312]; Scientific Research Projects of Hebei Province Department of Education [Q20141601]; University of Tokushima (Japan); Xi'an Jiaotong University (China)	This work was supported by Nature Science Foundation of Hubei Province (2013CFB312), Scientific Research Projects of Hebei Province Department of Education (Q20141601), the Double-Degree Exchanged Program between The University of Tokushima (Japan) and Xi'an Jiaotong University (China). The authors also thank Toho Tokushu Pulp Co., Ltd., Japan for supplying abaca fibers.	Liu K, 2012, COMPOS PART A-APPL S, V43, P1234, DOI 10.1016/j.compositesa.2012.02.020; Paul SA, 2008, COMPOS PART A-APPL S, V39, P1582, DOI 10.1016/j.compositesa.2008.06.004; Summerscales J, 2010, COMPOS PART A-APPL S, V41, P1329, DOI 10.1016/j.compositesa.2010.06.001; Ganan P, 2005, POLYM COMPOSITE, V26, P121, DOI 10.1002/pc.20083; Rong MZ, 2001, COMPOS SCI TECHNOL, V61, P1437, DOI 10.1016/S0266-3538(01)00046-X; Mohanty AK, 2000, MACROMOL MATER ENG, V276, P1, DOI 10.1002/(SICI)1439-2054(20000301)276:1<1::AID-MAME1>3.0.CO;2-W; Tomczak F, 2007, COMPOS PART A-APPL S, V38, P1710, DOI 10.1016/j.compositesa.2007.02.004; [Anonymous], 2005, BAST OTHER PLANT FIB; Satyanarayana KG, 2009, PROG POLYM SCI, V34, P982, DOI 10.1016/j.progpolymsci.2008.12.002; Liu K, 2013, COMPOS PART A-APPL S, V45, P14, DOI 10.1016/j.compositesa.2012.09.006; Shen DK, 2011, RSC ADV, V1, P1641, DOI 10.1039/c1ra00534k; Li X, 2008, COMPOS SCI TECHNOL, V68, P1753, DOI 10.1016/j.compscitech.2008.02.016; Gu JW, 2009, POLYM BULL, V62, P689, DOI 10.1007/s00289-009-0045-z; Takagi H, 2007, ADV COMPOS MATER, V16, P377, DOI 10.1163/156855107782325186; Behzad T, 2007, POLYM ENG SCI, V47, P977, DOI 10.1002/pen.20632; Sreenivasan S, 1996, J MATER SCI, V31, P721, DOI 10.1007/BF00367891; Kymalainen HR, 2008, BUILD ENVIRON, V43, P1261, DOI 10.1016/j.buildenv.2007.03.006; Rahman MR, 2009, COMPOS PART A-APPL S, V40, P511, DOI 10.1016/j.compositesa.2009.01.013; Gassan J, 1999, J APPL POLYM SCI, V71, P623, DOI 10.1002/(SICI)1097-4628(19990124)71:4<623::AID-APP14>3.0.CO;2-K; ASTM, 2011, D7205D7205M06 ASTM; ASTM, 2011, E146111 ASTM; Courtney TH, 2004, COMPOSITE MAT; Dong CS, 2014, COMPOS PART B-ENG, V58, P418, DOI 10.1016/j.compositesb.2013.10.032; Groot BD, 1994, HOLZFORSCHUNG, V48, P207; Hamidi YK, 2009, J ENG MATER-T ASME, V131, DOI 10.1115/1.3030944; Hintermann M., 2005, C RIKO 2005 HANN GER, P21; Lee CL, 2000, J APPL POLYM SCI, V77, P2149, DOI 10.1002/1097-4628(20000906)77:10<2149::AID-APP7>3.0.CO;2-J; Liu K, 2012, COMPOS SCI TECHNOL, V72, P633, DOI 10.1016/j.compscitech.2012.01.009; Matthieu B, 2009, COMPOS SCI TECHNOL, V69, P1131; Munawar SS, 2007, J WOOD SCI, V53, P103; Peralta AG, 1996, TAPPI J, V79, P263; Ramadevi P, 2012, BIORESOURCES, V7, P3515	32	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-835X	1878-5840		COMPOS PART A-APPL S	Compos. Pt. A-Appl. Sci. Manuf.	NOV	2014	66						227	236		10.1016/j.compositesa.2014.07.018		10	Engineering, Manufacturing; Materials Science, Composites	Engineering; Materials Science	AQ6WW	WOS:000342955600025		
J	Akira, S				Akira, Shizuo			Regnase-1, a ribonuclease involved in the inflammatory and immune responses	CYTOKINE			English	Meeting Abstract	2nd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS)	OCT 26-29, 2014	Melbourne, AUSTRALIA	Int Cytokine & Interferon Soc					[Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, Osaka, Japan			Akira, Shizuo/C-3134-2009					0	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	NOV	2014	70	1				S-1	21	21		10.1016/j.cyto.2014.07.221		1	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	AQ7TI	WOS:000343021700004		
J	Ozato, K; Kamada, R; Patel, M; Fujita, T; Zhang, YB; Tamura, T; Zhu, J				Ozato, Keiko; Kamada, Rui; Patel, Mira; Fujita, Takashi; Zhang, Yubo; Tamura, Tomohiko; Zhu, Jun			Epigenetic regulation of interferon response	CYTOKINE			English	Meeting Abstract	2nd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS)	OCT 26-29, 2014	Melbourne, AUSTRALIA	Int Cytokine & Interferon Soc					[Ozato, Keiko; Kamada, Rui; Patel, Mira] NICHD, Program Genom Differentiat, NIH, Bethesda, MD USA; [Fujita, Takashi] Kyoto Univ, Inst Virus Res, Kyoto 606, Japan; [Zhang, Yubo; Zhu, Jun] Okohama City Univ, Sch Med, Yokohama, Kanagawa, Japan; [Tamura, Tomohiko] NHLBI, DNA Sequencing & Computat Biol Core, NIH, Bethesda, MD USA			Patel, Mira/A-3013-2015					0	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	NOV	2014	70	1				S-19	25	25		10.1016/j.cyto.2014.07.239		1	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	AQ7TI	WOS:000343021700022		
J	Hsu, A; Parsons, K; Fujita, T; Hansbro, P; Wark, P				Hsu, Alan; Parsons, Kristy; Fujita, Takashi; Hansbro, Phil; Wark, Peter			Critical role of PKR in antiviral stress granule and IFN-beta enhanceosome formation, and is impaired in chronic obstructive pulmonary disease	CYTOKINE			English	Meeting Abstract	2nd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS)	OCT 26-29, 2014	Melbourne, AUSTRALIA	Int Cytokine & Interferon Soc					[Hsu, Alan; Parsons, Kristy; Hansbro, Phil; Wark, Peter] Univ Newcastle, Prior Res Ctr Asthma & Resp Dis, New Lambton Hts, NSW, Australia; [Fujita, Takashi] Kyoto Univ, Inst Virus Res, Kyoto 606, Japan								0	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	NOV	2014	70	1				81	47	47		10.1016/j.cyto.2014.07.088		1	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	AQ7TI	WOS:000343021700111		
J	Irving, A; Mimuro, H; Kufer, T; Lo, C; Turner, L; Thomas, B; Bertin, J; Boneca, I; Sasakawa, C; Philpott, D; Ferrero, R; Kaparakis-Liaskos, M				Irving, Aaron; Mimuro, Hitomi; Kufer, Thomas; Lo, Camden; Turner, Lorinda; Thomas, Belinda; Bertin, John; Boneca, Ivo; Sasakawa, Chihiro; Philpott, Dana; Ferrero, Richard; Kaparakis-Liaskos, Maria			Identification of the intracellular location and mechanisms of NOD1-dependent inflammatory responses	CYTOKINE			English	Meeting Abstract	2nd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS)	OCT 26-29, 2014	Melbourne, AUSTRALIA	Int Cytokine & Interferon Soc					[Irving, Aaron] MIMR PHI Inst Med Res, Ctr Canc Res, Clayton, Vic, Australia; [Mimuro, Hitomi] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Div Bacteriol,Dept Infect Dis Control, Tokyo, Japan; [Kufer, Thomas] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50931 Cologne, Germany; [Lo, Camden] Monash Micro Imaging, Clayton, Vic, Australia; [Turner, Lorinda; Thomas, Belinda; Ferrero, Richard; Kaparakis-Liaskos, Maria] MIMR PHI Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [Bertin, John] GlaxoSmithKline, Collegeville, PA USA; [Boneca, Ivo] Inst Pasteur, Paris, France; [Sasakawa, Chihiro] Univ Tokyo, Inst Med Sci, Div Bacterial Infect Biol, Tokyo, Japan; [Philpott, Dana] Univ Toronto, Dept Immunol, Toronto, ON, Canada			Boneca, Ivo/H-1677-2014; Kufer, Thomas/I-5146-2015	Kufer, Thomas/0000-0003-4563-0412			Irving AT, 2014, CELL HOST MICROBE, V15, P623, DOI 10.1016/j.chom.2014.04.001	1	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	NOV	2014	70	1				93	50	50		10.1016/j.cyto.2014.07.100		1	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	AQ7TI	WOS:000343021700123		
J	Kato, H				Kato, Hiroki			A viral sensor MDA5 and autoimmune diseases	CYTOKINE			English	Meeting Abstract	2nd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS)	OCT 26-29, 2014	Melbourne, AUSTRALIA	Int Cytokine & Interferon Soc					[Kato, Hiroki] Kyoto Univ, Inst Virus Res, Kyoto 6068501, Japan								0	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	NOV	2014	70	1				94	50	50		10.1016/j.cyto.2014.07.101		1	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	AQ7TI	WOS:000343021700124		
J	Kubo, Y; Yashima, Y; Kamiyama, H; Izumida, M; Sato, H; Yamamoto, N; Hayashi, H; Matsuyama, T				Kubo, Yoshinao; Yashima, Yuka; Kamiyama, Haruka; Izumida, Mai; Sato, Hironori; Yamamoto, Naoki; Hayashi, Hideki; Matsuyama, Toshifumi			Identification of a novel interferon-stimulated gene whose product significantly restricts retrovirus replication	CYTOKINE			English	Meeting Abstract	2nd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS)	OCT 26-29, 2014	Melbourne, AUSTRALIA	Int Cytokine & Interferon Soc					[Kubo, Yoshinao; Yashima, Yuka; Kamiyama, Haruka; Izumida, Mai; Sato, Hironori; Yamamoto, Naoki; Hayashi, Hideki; Matsuyama, Toshifumi] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan								0	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	NOV	2014	70	1				103	52	52		10.1016/j.cyto.2014.07.110		1	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	AQ7TI	WOS:000343021700133		
J	Lee, S; Ripley, B; Chinen, I; Millrine, D; Kishimoto, T				Lee, Soyoung; Ripley, Barry; Chinen, Ichino; Millrine, David; Kishimoto, Tadamitsu			Aryl hydrocarbon receptor negatively regulates type I interferon production and the development of murine lupus	CYTOKINE			English	Meeting Abstract	2nd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS)	OCT 26-29, 2014	Melbourne, AUSTRALIA	Int Cytokine & Interferon Soc					[Lee, Soyoung; Ripley, Barry; Chinen, Ichino; Millrine, David; Kishimoto, Tadamitsu] Osaka Univ, Immunol Frontier Res Ctr, Osaka, Japan								0	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	NOV	2014	70	1				111	54	54		10.1016/j.cyto.2014.07.118		1	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	AQ7TI	WOS:000343021700141		
J	Millrine, D; Ripley, B; Kishimoto, T				Millrine, David; Ripley, Barry; Kishimoto, Tadamitsu			Pomalidomide disrupts the association between Cereblon and Rabex-5 resulting in the suppression of TLR induced cytokine production	CYTOKINE			English	Meeting Abstract	2nd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS)	OCT 26-29, 2014	Melbourne, AUSTRALIA	Int Cytokine & Interferon Soc					[Millrine, David; Ripley, Barry; Kishimoto, Tadamitsu] Osaka Univ, Suita, Osaka, Japan								0	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	NOV	2014	70	1				131	59	59		10.1016/j.cyto.2014.07.138		1	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	AQ7TI	WOS:000343021700161		
J	Wiltzer, L; Brice, A; Lieu, K; Harrison, A; Oksayan, S; Bell, T; Whelan, D; Hossain, A; Shillling, P; Okada, K; Yamaoka, S; Larrous, F; Bourhy, H; Ose, T; Gooley, P; Jans, DA; Blondel, D; Ito, N; Moseley, G				Wiltzer, Linda; Brice, Aaron; Lieu, Kim; Harrison, Angela; Oksayan, Sibil; Bell, Toby; Whelan, Donna; Hossain, Alamgir; Shillling, Patrick; Okada, Kazuma; Yamaoka, Satoko; Larrous, Florence; Bourhy, Herve; Ose, Toyoyuki; Gooley, Paul; Jans, David A.; Blondel, Danielle; Ito, Naoto; Moseley, Gregory			Mechanisms of lyssavirus evasion of innate immunity and roles in lethal rabies disease	CYTOKINE			English	Meeting Abstract	2nd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS)	OCT 26-29, 2014	Melbourne, AUSTRALIA	Int Cytokine & Interferon Soc			P-PROTEIN		[Wiltzer, Linda; Oksayan, Sibil; Jans, David A.; Moseley, Gregory] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Brice, Aaron; Hossain, Alamgir; Shillling, Patrick; Gooley, Paul; Moseley, Gregory] Univ Melbourne, Dept Biochem & Mol Biol, Inst Bio21, Parkville, Vic 3052, Australia; [Lieu, Kim] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Harrison, Angela; Bell, Toby; Whelan, Donna] Monash Univ, Sch Chem, Clayton, Vic 3168, Australia; [Okada, Kazuma; Yamaoka, Satoko; Ito, Naoto] Gifu Univ, Lab Zoonot Dis, Gifu, Japan; [Larrous, Florence; Bourhy, Herve] Inst Pasteur, Unit Lyssavirus Dynam & Host Adaptat, Paris, France; [Ose, Toyoyuki] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 060, Japan; [Blondel, Danielle] CNRS, Lab Virol Mol & Struct, Paris, France							Lieu KG, 2013, J VIROL, V87, P8261, DOI 10.1128/JVI.00989-13; Ito N, 2010, J VIROL, V84, P6699, DOI 10.1128/JVI.00011-10; Wiltzer L, 2012, J VIROL, V86, P10194, DOI 10.1128/JVI.01249-12; Wiltzer L, 2014, J INFECT DIS, V209, P1744, DOI 10.1093/infdis/jit829	4	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	NOV	2014	70	1				133	60	60		10.1016/j.cyto.2014.07.140		1	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	AQ7TI	WOS:000343021700163		
J	Nosaka, M; Ishida, Y; Kimura, A; Kuninaka, Y; Mukaida, N; Kondo, T				Nosaka, Mizuho; Ishida, Yuko; Kimura, Akihiko; Kuninaka, Yumi; Mukaida, Naofumi; Kondo, Toshikazu			Absence of IL-6 accelerates thrombus formation through reduced MMPs and uPA expression in murine deep vein thrombosis model	CYTOKINE			English	Meeting Abstract	2nd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS)	OCT 26-29, 2014	Melbourne, AUSTRALIA	Int Cytokine & Interferon Soc					[Nosaka, Mizuho; Ishida, Yuko; Kimura, Akihiko; Kuninaka, Yumi; Kondo, Toshikazu] Wakayama Med Univ, Dept Forens Med, Wakayama, Japan; [Mukaida, Naofumi] Kanazawa Univ, Canc Res Inst, Div Mol Bioregulat, Kanazawa, Ishikawa 920, Japan			Mukaida, Naofumi/D-7623-2011					0	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	NOV	2014	70	1				138	61	61		10.1016/j.cyto.2014.07.145		1	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	AQ7TI	WOS:000343021700168		
J	Takemoto, N; Matsumoto, T; Serada, S; Fujimoto, M; Naka, T				Takemoto, Norihiko; Matsumoto, Tomoshige; Serada, Satoshi; Fujimoto, Minoru; Naka, Tetsuji			Leucine-rich alpha 2 glycoprotein promotes TGF beta 1-induced apoptosis in the lewis lung carcinoma cell lines	CYTOKINE			English	Meeting Abstract	2nd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS)	OCT 26-29, 2014	Melbourne, AUSTRALIA	Int Cytokine & Interferon Soc					[Takemoto, Norihiko; Serada, Satoshi; Fujimoto, Minoru; Naka, Tetsuji] Natl Inst Biomed Innovat, Lab Immune Signal, Osaka, Japan; [Takemoto, Norihiko] Osaka Univ, Suita, Osaka, Japan; [Matsumoto, Tomoshige] Osaka AntiTB Assoc Osaka Hosp, Dept Clin Lab, Neyagawa, Osaka, Japan								0	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	NOV	2014	70	1				178	71	71		10.1016/j.cyto.2014.07.185		1	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	AQ7TI	WOS:000343021700208		
J	Yi, M				Yi, Min			Regulatory effect of interleukin-4 in the innate immune and inflammatory responses to Rhodococcus aurantiacus infection in mice	CYTOKINE			English	Meeting Abstract	2nd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS)	OCT 26-29, 2014	Melbourne, AUSTRALIA	Int Cytokine & Interferon Soc					[Yi, Min] Hokkaido Univ, Grad Sch Med, Dept Adv Med, Sapporo, Hokkaido, Japan								0	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	NOV	2014	70	1				204	77	77		10.1016/j.cyto.2014.07.211		1	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	AQ7TI	WOS:000343021700234		
J	Kubota, M; Iizasa, E; Kiyohara, H; Nakama, Y; Hara, H; Yoshida, H				Kubota, Mio; Iizasa, Ei'ichi; Kiyohara, Hideyasu; Nakama, Yasushi; Hara, Hiromitsu; Yoshida, Hiroki			Mycobacterium tuberculosis-derived mycolic acid shows an adjuvant activity by activation of the ITAM receptor/CARD9-mediated innate immunity	CYTOKINE			English	Meeting Abstract	2nd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS)	OCT 26-29, 2014	Melbourne, AUSTRALIA	Int Cytokine & Interferon Soc					[Kubota, Mio; Iizasa, Ei'ichi; Hara, Hiromitsu; Yoshida, Hiroki] Saga Univ, Fac Med, Saga 840, Japan; [Kiyohara, Hideyasu; Nakama, Yasushi] Japan BCG Lab, Tokyo, Japan								0	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	NOV	2014	70	1				207	78	78		10.1016/j.cyto.2014.07.214		1	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	AQ7TI	WOS:000343021700237		
J	Young, HA; Hanson, C; Sanford, M; Matsunaga, K; Kimoto, M; Hirao, I				Young, Howard A.; Hanson, Charlotte; Sanford, Michael; Matsunaga, Ken-ichiro; Kimoto, Michiko; Hirao, Ichiro			Inhibiting cytokine activity - The use of modified DNA aptamers as an alternative to neutralizing antibodies	CYTOKINE			English	Meeting Abstract	2nd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS)	OCT 26-29, 2014	Melbourne, AUSTRALIA	Int Cytokine & Interferon Soc					[Young, Howard A.; Hanson, Charlotte; Sanford, Michael] NCI, Frederick, MD 21701 USA; [Matsunaga, Ken-ichiro; Kimoto, Michiko; Hirao, Ichiro] TagCyx Biotechon, Yokohama, Kanagawa, Japan; [Matsunaga, Ken-ichiro; Kimoto, Michiko; Hirao, Ichiro] RIKEN Ctr Life Sci Technol, Yokohama, Kanagawa, Japan								0	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	NOV	2014	70	1				208	78	78		10.1016/j.cyto.2014.07.215		1	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	AQ7TI	WOS:000343021700238		
J	Fujii, M; Hayashi, K; Ito, H; Ooba, M				Fujii, Minoru; Hayashi, Kiichiro; Ito, Hideyuki; Ooba, Makoto			The resource occupancy to capacity ratio indicator A common unit to measure sustainability	ECOLOGICAL INDICATORS			English	Article						Environment; Indicator; Resource; Sustainability; Tradeoff	LIFE-CYCLE ASSESSMENT; UNRESOLVED PROBLEMS	Measuring consumption may not be the best method of determining whether society is progressing toward sustainability. We have been developing an indicator, the resource occupancy to capacity ratio (ROC ratio), that uses the concept of "resource occupancy" of important multidimensional aspects related to sustainability such as materials, land use, pollution, and labor. Resource occupancy is defined as the product of an amount of potentially reversible use of something such as a piece of land or material and a period of time of use. The ROC ratio is the ratio of resource occupancy of a material or other resource for a specified time period relative to the total capacity of that material or resource to provide a product or service. The ROC ratio of each aspect is expressed in a common unit (years), thereby improving our ability to compare tradeoffs between the different aspects of sustainability and to evaluate the various alternatives used to develop a sustainable society. Two example alternatives are explored as case studies in a comparison of the ROC ratio and monetary value analyses. The ROC ratio offers a different interpretation of the effects of the two alternatives on each aspect, allowing a new perspective on the effectiveness and costs of alternatives used to foster sustainable development. (C) 2014 Elsevier Ltd. All rights reserved.	[Fujii, Minoru] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Hayashi, Kiichiro] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Ito, Hideyuki] Nihon Univ, Funabashi, Chiba 2748501, Japan; [Ooba, Makoto] Tokyo Univ Agr, Setagaya Ku, Tokyo 1568502, Japan	Fujii, M (reprint author), Natl Inst Environm Studies, Onogawa 16-2, Tsukuba, Ibaraki 3058506, Japan.	m-fujii@nies.go.jp; maruhaya@esi.nagoya-u.ac.jp; ito.hideyuki@nihon-u.ac.jp; m3oba@nodai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; EcoTopia Science Institute, Nagoya University [K122024]; Environment Research and Technology Development Fund from the Ministry of the Environment, Japan [K122024]	This study was supported in part by a grant from the "Design of a cascade utilization system for unused biological resources in the Tokai area" from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by the joint research program of the EcoTopia Science Institute, Nagoya University, and The Environment Research and Technology Development Fund (K122024) from the Ministry of the Environment, Japan.	Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; [Anonymous], 2006, 14040 ISO; Reap J, 2008, INT J LIFE CYCLE ASS, V13, P290, DOI 10.1007/s11367-008-0008-x; Blengini GA, 2010, ENERG BUILDINGS, V42, P869, DOI 10.1016/j.enbuild.2009.12.009; Fujii M, 2012, RESOUR CONSERV RECY, V63, P1, DOI 10.1016/j.resconrec.2012.03.002; Jaffe AB, 2005, ECOL ECON, V54, P164, DOI 10.1016/j.ecolecon.2004.12.027; Tasaki Tomohiro, 2010, International Journal of Sustainable Development, V13, P337, DOI 10.1504/IJSD.2010.038173; Reap J, 2008, INT J LIFE CYCLE ASS, V13, P374, DOI 10.1007/s11367-008-0009-9; Itsubo N, 2004, INT J LIFE CYCLE ASS, V9, P196, DOI 10.1065/lca2003.11.142; Guinee JB, 2011, ENVIRON SCI TECHNOL, V45, P90, DOI 10.1021/es101316v; ANRE (Agency for Natural Resources and Energy), 2011, COMPR EN STAT; Daly H. E., 1990, Ecological Economics, V2, P1, DOI 10.1016/0921-8009(90)90010-R; Dilly O, 2009, ENVIRON SCI POLICY, V12, P1168, DOI 10.1016/j.envsci.2009.09.002; Eurostat, 2007, EUR METH WORK PAP; Fujii M., 2010, J SOC ENV SCI JPN, V23, P410; Goedkoop M., 2000, ECOINDICATOR 99 DAMA; IPCC, 2001, 3 IPCC; JIE (The Japan Institute of Energy), 2008, JIE AS BIOM HDB GUID; MIC (Ministry of Internal Affairs and Communications), 2012, MIC STAT HDB JAP 201; MIC (Ministry of Internal Affairs and Communications), 2008, STAT BUR HOUS LAND S; MLIT (Ministry of Land Infrastructure Transport and Tourism), 2008, SURV DEM CONSTR MAT; NEDO (New Energy and Industrial Technology Development Organization), 2006, 050021140 NEDO; NIMS (National Institute for Materials Science), 2004, LCA BAS INV TECHN SC; OECD (Organisation for Economic Co-operation and Development), 2000, MEAS SUST DEV INT EC; Rees W., 1992, ENVIRON URBAN, V4, P121, DOI DOI 10.1177/095624789200400212; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Steen B., 1999, 1999 CPM CHALM U TEC, V4; UNDG, 2003, IND MON MILL DEV GOA; USGS, 2011, MIN COMM SUMM 2011	29	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1470-160X	1872-7034		ECOL INDIC	Ecol. Indic.	NOV	2014	46						52	58		10.1016/j.ecolind.2014.06.001		7	Biodiversity Conservation; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	AQ2YO	WOS:000342656100005		
J	Cao, RY; Shen, MG; Chen, J; Tang, YH				Cao, Ruyin; Shen, Miaogen; Chen, Jin; Tang, Yanhong			A simple method to simulate diurnal courses of PAR absorbed by grassy canopy	ECOLOGICAL INDICATORS			English	Article						Alpine wetland; Curve fitting method; Diffuse light; Diurnal FAPAR; Light penetration model; Qinghai-Tibetan Plateau	PHOTOSYNTHETICALLY ACTIVE RADIATION; LEAF-AREA INDEX; CYCLOPES GLOBAL PRODUCTS; TERRESTRIAL ECOSYSTEMS; THEORETICAL ANALYSIS; VEGETATION; LIGHT; MODEL; MODIS; ALGORITHM	The fraction of photosynthetically active radiation absorbed by vegetation (FAPAR) quantifies the efficiency of absorbing PAR by plants. Accurate estimation of diurnal variation of FAPAR however remains a challenge because of the dynamic changes of incident light conditions and its interaction with canopy structure. Based on a field experiment, we characterized the effects of solar zenith angle (SZA) and fraction of diffuse light (fdPAR) on diurnal FAPAR in an alpine wetland on the Tibetan plateau. We found an obvious nonlinear change pattern of FAPAR against SZA with a maximum value of FAPAR at the SZA of about 30 degrees, and opposite responses of FAPAR to fdPAR outside of a SZA range between 21 degrees and 30 degrees. A cuive fitting (CF) method was proposed to estimate diurnal FAPAR in a rapid and accurate way. The CF method accounting for the interactions of SZA and fdPAR on FAPAR can successfully describe the diurnal dynamics of FAPAR under clear and cloudy sky conditions. The estimation deviation of daily FAPAR was only -0.28% for a period of about eight days with various sky conditions. The new method requires only very simple field measurements, but has higher accuracy than the widely-used light penetration model, which is expected to be widely used in grassy vegetations. (C) 2014 Elsevier Ltd. All rights reserved.	[Cao, Ruyin; Chen, Jin] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Cao, Ruyin; Tang, Yanhong] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Shen, Miaogen] Chinese Acad Sci, Lab Alpine Ecol & Biodivers, Inst Tibetan Plateau Res, Beijing 100101, Peoples R China	Chen, J (reprint author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	chenjin@bnu.edu.cn	Shen, Miaogen/A-8374-2011; Chen, Jin/A-6417-2011	Shen, Miaogen/0000-0001-5742-8807; 	project of "early detection and prediction of climate warming based on the long-term monitoring of fragile ecosystems in East Asia" - Ministry of Environment, Japan; "Strategic Priority Research Program (B)" - Chinese Academy of Sciences [XDB03030404]	This study was supported by the project of "early detection and prediction of climate warming based on the long-term monitoring of fragile ecosystems in East Asia" funded by the Ministry of Environment, Japan, and the "Strategic Priority Research Program (B)" funded by the Chinese Academy of Sciences (Grant No. XDB03030404).	ANDERSON MC, 1966, J APPL ECOL, V3, P41, DOI 10.2307/2401665; WELLES JM, 1991, AGRON J, V83, P818; Govind A, 2013, ECOL MODEL, V251, P114, DOI 10.1016/j.ecolmodel.2012.11.014; Nouvellon Y, 2000, AGR FOREST METEOROL, V105, P21, DOI 10.1016/S0168-1923(00)00194-5; Kaminski T, 2012, BIOGEOSCIENCES, V9, P3173, DOI 10.5194/bg-9-3173-2012; Widlowski JL, 2010, AGR FOREST METEOROL, V150, P1501, DOI 10.1016/j.agrformet.2010.07.011; Roderick ML, 2001, OECOLOGIA, V129, P21, DOI 10.1007/s004420100760; Yang WZ, 2006, IEEE T GEOSCI REMOTE, V44, P1829, DOI 10.1109/TGRS.2006.871214; Weiss M, 2007, REMOTE SENS ENVIRON, V110, P317, DOI 10.1016/j.rse.2007.03.001; Alton PB, 2008, AGR FOREST METEOROL, V148, P1641, DOI 10.1016/j.agrformet.2008.05.014; Gu LH, 2003, SCIENCE, V299, P2035, DOI 10.1126/science.1078366; Zhang QY, 2009, REMOTE SENS ENVIRON, V113, P880, DOI 10.1016/j.rse.2009.01.002; NILSON T, 1971, AGR METEOROL, V8, P25, DOI 10.1016/0002-1571(71)90092-6; Baret F, 2007, REMOTE SENS ENVIRON, V110, P275, DOI 10.1016/j.rse.2007.02.018; MONTEITH JL, 1972, J APPL ECOL, V9, P747, DOI 10.2307/2401901; GOWARD SN, 1992, REMOTE SENS ENVIRON, V39, P119, DOI 10.1016/0034-4257(92)90131-3; Olesen B, 2002, MAR ECOL PROG SER, V236, P89, DOI 10.3354/meps236089; Gower ST, 1999, REMOTE SENS ENVIRON, V70, P29, DOI 10.1016/S0034-4257(99)00056-5; Kobayashi H, 2008, REMOTE SENS ENVIRON, V112, P173, DOI 10.1016/j.rse.2007.04.0l; Knyazikhin Y, 1998, J GEOPHYS RES-ATMOS, V103, P32257, DOI 10.1029/98JD02462; Kim HS, 2011, TREE PHYSIOL, V31, P30, DOI 10.1093/treephys/tpq098; BEGUE A, 1992, REMOTE SENS ENVIRON, V40, P219, DOI 10.1016/0034-4257(92)90004-4; CAMPBELL GS, 1986, AGR FOREST METEOROL, V36, P317, DOI 10.1016/0168-1923(86)90010-9; Chen J, 2009, J PLANT ECOL-UK, V2, P173, DOI 10.1093/jpe/rtp020; Enriquez S, 2005, OECOLOGIA, V145, P235, DOI 10.1007/s00442-005-0111-7; FAO, 2007, DEV STAND ESS CLIM V; Farquhar GD, 2003, SCIENCE, V299, P1997, DOI 10.1126/science.1080681; GALLO KP, 1986, AGRON J, V78, P752; Gobron N, 2006, ADV SPACE RES, V38, P2196, DOI 10.1016/j.asr.2003.07.079; Gu L., 1999, J GEOPHYS RES, V104, P421; HANAN NP, 1995, AGR FOREST METEOROL, V74, P155, DOI 10.1016/0168-1923(94)02196-Q; LANG ARG, 1986, AUST J BOT, V34, P349, DOI 10.1071/BT9860349; Li Gang, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P217; McCallum Ian, 2010, Remote Sensing of Environment, V114, DOI 10.1016/j.rse.2009.12.009; Meroni M., 2012, IEEE T GEOSCI REMOTE, V51, P1951; Nanjing Institute of Soil Science Chinese Academy of Sciences, 1978, SOIL MAP CHIN; PEARCY RW, 1990, AGR FOREST METEOROL, V52, P359, DOI 10.1016/0168-1923(90)90092-K; Posada JM, 2009, ANN BOT-LONDON, V103, P795, DOI 10.1093/aob/mcn265; [乔艳丽 Qiao Yanli], 2008, [南开大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Nankaiensis], V41, P69; Resifsnyder W.E., 1971, AGR METEOROL, V9, P21; Running SW, 2000, METHODS IN ECOSYSTEM SCIENCE, P44; Sellers PJ, 1996, J CLIMATE, V9, P676, DOI 10.1175/1520-0442(1996)009<0676:ARLSPF>2.0.CO;2; Shabanov NV, 2003, REMOTE SENS ENVIRON, V85, P410, DOI 10.1016/S0034-4257(03)00017-8; Sun H., 1996, FORMATION EVOLUTION, P1; Warren Wilson J, 1960, NEW PHYTOL, V58, P92; [赵景学 Zhao Jingxue], 2010, [生态环境学报, Ecology and Environmental Sciences], V19, P2795	46	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1470-160X	1872-7034		ECOL INDIC	Ecol. Indic.	NOV	2014	46						129	137		10.1016/j.ecolind.2014.06.017		9	Biodiversity Conservation; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	AQ2YO	WOS:000342656100015		
J	Hayashi, M				Hayashi, Masayoshi			The political economy of transnational tax reform: the Shoup mission to Japan in historical context	ECONOMIC HISTORY REVIEW			English	Book Review									[Hayashi, Masayoshi] Univ Tokyo, Tokyo 1138654, Japan	Hayashi, M (reprint author), Univ Tokyo, Tokyo 1138654, Japan.		Hayashi, Masayoshi/A-2845-2015				Brownlee WE, 2013, POLITICAL ECONOMY OF TRANSNATIONAL TAX REFORM: THE SHOUP MISSION TO JAPAN IN HISTORICAL CONTEXT, P1, DOI 10.1017/CBO9781139519427	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-0117	1468-0289		ECON HIST REV	Econ. Hist. Rev.	NOV	2014	67	4			SI		1192	1193		10.1111/1468-0289.12089_29		2	Economics; History; History Of Social Sciences	Business & Economics; History; Social Sciences - Other Topics	AQ5CQ	WOS:000342821800038		
J	Okazaki, T				Okazaki, Tetsuji			Capital as will and imagination: Schumpeter's guide to the postwar Japanese miracle	ECONOMIC HISTORY REVIEW			English	Book Review									[Okazaki, Tetsuji] Univ Tokyo, Tokyo 1138654, Japan	Okazaki, T (reprint author), Univ Tokyo, Tokyo 1138654, Japan.						Metzler M., 2013, CAPITAL WILL IMAGINA	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-0117	1468-0289		ECON HIST REV	Econ. Hist. Rev.	NOV	2014	67	4			SI		1193	1195		10.1111/1468-0289.12089_30		3	Economics; History; History Of Social Sciences	Business & Economics; History; Social Sciences - Other Topics	AQ5CQ	WOS:000342821800039		
J	Aoe, K; Takigawa, N; Hotta, K; Maeda, T; Kishino, D; Nogami, N; Tabata, M; Harita, S; Okada, T; Kubo, T; Hosokawa, S; Fujiwara, K; Gemba, K; Yasugi, M; Kozuki, T; Kato, Y; Katsui, K; Kanazawa, S; Ueoka, H; Tanimoto, M; Kiura, K				Aoe, Keisuke; Takigawa, Nagio; Hotta, Katsuyuki; Maeda, Tadashi; Kishino, Daizo; Nogami, Naoyuki; Tabata, Masahiro; Harita, Shingo; Okada, Toshiaki; Kubo, Toshio; Hosokawa, Shinobu; Fujiwara, Keiichi; Gemba, Kenichi; Yasugi, Masayuki; Kozuki, Toshiyuki; Kato, Yuka; Katsui, Kuniaki; Kanazawa, Susumu; Ueoka, Hiroshi; Tanimoto, Mitsune; Kiura, Katsuyuki			A phase II study of S-1 chemotherapy with concurrent thoracic radiotherapy in elderly patients with locally advanced non-small-cell lung cancer: The Okayama Lung Cancer Study Group Trial 0801	EUROPEAN JOURNAL OF CANCER			English	Article						Elderly patients; S-1; Radiation	CISPLATIN; RADIATION; COMBINATION	Background: Although thoracic irradiation (TRT) is a standard treatment for elderly patients with locally advanced non-small-cell lung cancer (LA-NSCLC), treatment outcomes are poor. We previously reported a phase I trial combining S-1, an oral 5-fluorouracil derivative, and thoracic radiation, which yielded safe and effective outcomes. Methods: In this phase II trial, 30 patients aged 76 years or older with LA-NSCLC received S-1 (80 mg/m(2) on days 1-14 and 29-42) and TRT (60 Gy). The primary end-point was the response rate. Results: The median age and pre-treatment Charlson score were 79 years and 1, respectively. The mean proportions of the actual doses of S-1 and TRT delivered relative to the planned doses were 95% and 98%, respectively. Partial responses were observed in 19 patients (63%; 95% confidence interval: 45-82%), which did not attain the end-point. At a median follow-up time of 23.7 months, the median progression-free survival and median survival times were 13.0 months and 27.9 months, respectively. No difference in efficacy was observed upon stratification by tumour histology. Toxicities were generally mild, except for grade 3 or greater febrile neutropenia and pneumonitis in 7% and 10% of patients, respectively. No patient developed severe oesophagitis. Conclusions: Although the primary end-point was not met, concurrent S-1 chemotherapy and radiotherapy yielded favourable survival data. Also, the combined treatment was well-tolerated in elderly patients with LA-NSCLC. (c) 2014 Elsevier Ltd. All rights reserved.	[Aoe, Keisuke; Maeda, Tadashi; Kishino, Daizo; Ueoka, Hiroshi] NHO Yamaguchi Ube Med Ctr, Dept Med Oncol, Ube, Yamaguchi, Japan; [Takigawa, Nagio] Kawasaki Hosp, Kawasaki Med Sch, Dept Gen Internal Med 4, Okayama, Japan; [Hotta, Katsuyuki; Tanimoto, Mitsune] Okayama Univ Hosp, Dept Hematol & Oncol, Okayama 7008558, Japan; [Nogami, Naoyuki; Kozuki, Toshiyuki] NHO Shikoku Canc Ctr, Dept Thorac Oncol & Med, Matsuyama, Ehime, Japan; [Tabata, Masahiro; Kubo, Toshio; Kato, Yuka; Kiura, Katsuyuki] Okayama Univ Hosp, Dept Resp Med, Okayama 7008558, Japan; [Harita, Shingo; Okada, Toshiaki; Kubo, Toshio] Chugoku Cent Hosp, Dept Resp Med, Fukuyama, Hiroshima, Japan; [Hosokawa, Shinobu] Okayama Red Cross Hosp, Dept Resp Med, Okayama, Japan; [Fujiwara, Keiichi] NHO Okayama Med Ctr, Dept Resp Med, Okayama, Japan; [Gemba, Kenichi] Okayama Rosai Hosp, Dept Resp Med, Okayama, Japan; [Gemba, Kenichi; Yasugi, Masayuki] NHO Fukuyama Med Ctr, Dept Resp Med, Fukuyama, Hiroshima, Japan; [Katsui, Kuniaki; Kanazawa, Susumu] Okayama Univ Hosp, Dept Radiol, Okayama 7008558, Japan	Hotta, K (reprint author), Okayama Univ Hosp, Dept Hematol & Oncol, Kita Ku, 2-5-1 Shikatacho, Okayama 7008558, Japan.	khotta@md.okayama-u.ac.jp					Atagi S, 2012, LANCET ONCOL, V13, P671, DOI 10.1016/S1470-2045(12)70139-0; Fukushima M, 2005, EJC SUPPL, V3, P343; Kaira K, 2013, LUNG CANCER, V82, P449, DOI 10.1016/j.lungcan.2013.09.004; Chikamori K, 2009, LUNG CANCER, V65, P74, DOI 10.1016/j.lungcan.2008.10.019; Fujiwara Y, 2011, ANN ONCOL, V22, P376, DOI 10.1093/annonc/mdq360; Harada H, 2013, CLIN LUNG CANCER, V14, P440, DOI 10.1016/j.cllc.2013.01.003; Harada K, 2004, ORAL ONCOL, V40, P713, DOI 10.1016/j.oraloncology.2004.01.013; Ichinose Y, 2011, J THORAC ONCOL, V6, P2069, DOI 10.1097/JTO.0b013e3182307e5a; Ochi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042798; Ohyanagi F, 2009, BRIT J CANCER, V101, P225, DOI 10.1038/sj.bjc.6605152; Segawa Y, 2010, J THORAC ONCOL, V5, P1430, DOI 10.1097/JTO.0b013e3181e3248e; Shiroyama T, 2012, CANCER CHEMOTH PHARM, V70, P783, DOI 10.1007/s00280-012-1958-z; Takigawa N, 2011, LUNG CANCER, V71, P60, DOI 10.1016/j.lungcan.2010.04.012	13	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-8049	1879-0852		EUR J CANCER	Eur. J. Cancer	NOV	2014	50	16					2783	2790		10.1016/j.ejca.2014.07.024		8	Oncology	Oncology	AQ3NT	WOS:000342701500005		
J	Ito, K				Ito, Kazuhide			Integrated numerical approach of computational fluid dynamics and epidemiological model for multi-scale transmission analysis in indoor spaces	INDOOR AND BUILT ENVIRONMENT			English	Article						Computational fluid dynamics; Epidemiological model; Integrated numerical approach; Airborne transmission; Nesting; Hospital environment	HUMAN-BODY; AIRBORNE INFECTIONS; AEROSOL DEPOSITION; AIR-DISTRIBUTION; FLOW; CFD; TURBULENCE; QUALITY; HEALTH; HOMES	The indoor environment can play a significant role in the airborne transmission of diseases, such as those caused by influenza virus and tuberculosis virus. The airborne route of transmission is considered to be critically important for evaluating the risk to occupants' health due to exposure to these contaminants. In this paper, an analytical procedure coupling with the computational fluid dynamics (CFD)-based prediction has been proposed for the determination of the unsteady and non-uniform contaminant concentration distribution within an indoor environment. A basic epidemiological model (here, SIR model) is used to evaluate the health risk. This numerical procedure can be used to predict exposure risk of residents, i.e. airborne transmission in two-dimensional horizontal space in a hospital. Furthermore, an integrated simulation procedure is also proposed for prediction of the concentration of an infectious contaminant using a multi-nesting method connecting to a building space, a micro-climate around a human body, and respiratory air tract in a human body, in order to provide quantitative and qualitative information for estimating contaminant dose that could have been taken up by the residents due to indoor exposure. On the basis of this numerical simulation, detailed information on the unsteady spatial distribution of contaminant concentration, the breathing concentration of infectious contaminant, and the non-uniform distribution of contaminant adsorption/deposition in respiratory air tract could be provided to enable suitable design of a heating, ventilation and air-conditioning (HVAC) system for an acceptable indoor environment fit for a particular medical provision such as in a hospital.	[Ito, Kazuhide] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan	Ito, K (reprint author), Kyushu Univ, 6-1 Kasuga Koen, Kasuga, Fukuoka 8168580, Japan.	ito@kyudai.jp			JSPS KAKENHI [21676005]	This research was partly supported by a Grant-in-Aid for Scientific Research (JSPS KAKENHI for Young Scientists (S), 21676005).	RILEY EC, 1978, AM J EPIDEMIOL, V107, P421; Rudnick SN, 2003, INDOOR AIR, V13, P237, DOI 10.1034/j.1600-0668.2003.00189.x; Beggs CB, 2003, INDOOR BUILT ENVIRON, V12, P9, DOI 10.1177/142032603032201; Weschler CJ, 2004, INDOOR AIR, V14, P184, DOI 10.1111/j.1600-0668.2004.00287.x; Gupta JK, 2009, INDOOR AIR, V19, P517, DOI 10.1111/j.1600-0668.2009.00619.x; Sorensen DN, 2003, BUILD ENVIRON, V38, P753, DOI 10.1016/S0360-1323(03)00027-1; Stapleton KW, 2000, J AEROSOL SCI, V31, P739, DOI 10.1016/S0021-8502(99)00547-9; Li Y, 2005, INDOOR AIR, V15, P83, DOI 10.1111/j.1600-0668.2004.00317.x; Murakami S, 1999, J WIND ENG IND AEROD, V83, P393, DOI 10.1016/S0167-6105(99)00088-4; Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022; Jones AP, 1999, ATMOS ENVIRON, V33, P4535, DOI 10.1016/S1352-2310(99)00272-1; Yu CWF, 2012, INDOOR BUILT ENVIRON, V21, P5, DOI 10.1177/1420326X11431907; [Anonymous], 1994, ANN ICRP, V66; Qian H, 2009, BUILD ENVIRON, V44, P1651, DOI 10.1016/j.buildenv.2008.11.002; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Park JS, 2006, INDOOR AIR, V16, P129, DOI 10.1111/j.1600-0668.2005.00408.x; Zhang Z, 2007, HVAC&R RES, V13, P871, DOI 10.1080/10789669.2007.10391460; Longest PW, 2007, J BIOMECH, V40, P305, DOI 10.1016/j.jbiomech.2006.01.006; Tang JW, 2011, J HOSP INFECT, V77, P213, DOI 10.1016/j.jhin.2010.09.037; Hofmann W, 2011, J AEROSOL SCI, V42, P693, DOI 10.1016/j.jaerosci.2011.05.007; Schroeter JD, 2011, J AEROSOL SCI, V42, P52, DOI 10.1016/j.jaerosci.2010.11.002; Chen SC, 2006, INDOOR AIR, V16, P469, DOI 10.1111/j.1600-0668.2006.00443.x; Deschamps T, 2004, P ANN INT IEEE EMBS, V26, P3933; FINE PEM, 1993, EPIDEMIOL REV, V15, P265; Gupta JK, 2009, INDOOR AIR, V20, P31, DOI DOI 10.1111/J.1600-0668.2009.00623.X; Ito K, 2006, T SHASE SOC HEATING, V113, P27; Ma B, 2009, ANN BIOMED ENG, V37, P271, DOI 10.1007/s10439-008-9620-y; Murakami S, 1997, ASHRAE TRAN, V103, P3; Nielsen P. V., 2003, BENCHMARK TESTS COMP; Noakes CJ, 2006, EPIDEMIOL INFECT, V134, P1082, DOI 10.1017/S0950268806005875; Park JS, 2004, INDOOR AIR, V14, P413, DOI 10.1111/j.1600-0668.2004.00266.x; Research Institute of Tuberculosis/JATA, 2009, ANN REP 2009 RES I T; Tanabe S, 1994, ASHRAE T, V100, P39; Topp C, 2002, ASHRAE T, V108, P1084; United States. Environmental Protection Agency, 1990, RED RISK SETT PRIOR; Wells WF, 1955, AIRBORNE CONTAGION A; World Health Organization, 1989, EURO REP STUD I; Yakhot V., 1986, Journal of Scientific Computing, V1, DOI 10.1007/BF01061452; Zhai ZJ, 2007, HVAC&R RES, V13, P853, DOI 10.1080/10789669.2007.10391459; Zheng Q, 2011, INDOOR BUILT ENVIRON, V20, P26, DOI 10.1177/1420326X10393719	40	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1420-326X	1423-0070		INDOOR BUILT ENVIRON	Indoor Built Environ.	NOV	2014	23	7					1029	1049		10.1177/1420326X13516658		21	Construction & Building Technology; Engineering, Environmental; Public, Environmental & Occupational Health	Construction & Building Technology; Engineering; Public, Environmental & Occupational Health	AQ8DY	WOS:000343055100012		
J	Choi, JH; Kawamura, K; Kimoto, K; Ichikawa, Y; Chae, BG				Choi, Jung Hae; Kawamura, Katsuyuki; Kimoto, Kazushi; Ichikawa, Yasuaki; Chae, Byung-Gon			Multi-species diffusion analysis in porous media under various dry density and temperature conditions: molecular dynamics simulation, homogenization analysis, and finite element method	INTERNATIONAL JOURNAL FOR NUMERICAL AND ANALYTICAL METHODS IN GEOMECHANICS			English	Article						multi-species diffusion; finite element method; molecular dynamics; homogenization analysis	MONT-TERRI; BENTONITE; COEFFICIENTS; CL-36; IONS; HTO	In porous media, chemical species that dissolve in pore water can be transported via diffusion mechanisms or advective fluxes, close to or far away from where precipitation occurs. In the case of a high-level radioactive waste disposal system, compacted bentonite is used in a buffer material in an engineering barrier system to minimize the amount of specific nuclides that breach into the surrounding host rock. To minimize breaching, it is very important to understand the transport mechanism of multiple chemical species in porous media. In the following research, we introduced FEM analysis methods using the results of the molecular dynamics simulation and homogenization analysis (MD/HA) method. First, the diffusion coefficients of ions (Cl-, I-, and Na+) in different water layers of Na-beidellite were calculated using the MD/HA procedure under various dry density (1.2, 1.6, and 2.0Mg/m(3)) and temperature (293, 323, and 363K) conditions. Next, using FEM analysis that used the MD/HA results as input parameters, the diffusion behaviors of ions in porous media were calculated. The results indicate that the diffusion coefficients of the interlayer water in Na-beidellite are different from the diffusion coefficients under dry density conditions. Further, the concentration profiles (C-t/C-0) of iodine and chloride are proportional to temperature but inversely proportional to dry density. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Choi, Jung Hae; Chae, Byung-Gon] Korea Inst Geosci & Mineral Resources, Geol Hazards Dept, Taejon 305350, South Korea; [Kawamura, Katsuyuki; Kimoto, Kazushi; Ichikawa, Yasuaki] Okayama Univ, Dept Urban Environm Dev, Okayama 7008530, Japan	Chae, BG (reprint author), Korea Inst Geosci & Mineral Resources, Geol Hazards Dept, Taejon 305350, South Korea.	bgchae@kigam.re.kr			Radioactive Waste Management of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant - Korea government Ministry of Knowledge Economy [2012171020001B]	This work was supported by the Radioactive Waste Management of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant funded by the Korea government Ministry of Knowledge Economy (2012171020001B).	Wersin P, 2004, APPL CLAY SCI, V26, P123, DOI 10.1016/j.clay.2003.09.007; Van Loon LR, 2003, J CONTAM HYDROL, V61, P73, DOI 10.1016/S0169-7722(02)00114-6; KUMAGAI N, 1994, MOL SIMULAT, V12, P177, DOI 10.1080/08927029408023028; Appelo CAJ, 2008, J CONTAM HYDROL, V101, P67, DOI 10.1016/j.jconhyd.2008.07.009; Bastug T, 2005, CHEM PHYS LETT, V408, P84, DOI 10.1016/j.cplett.2005.04.012; Choi JH, 2009, INT J NUMER ANAL MET, V33, P687, DOI 10.1002/nag.744; Garcia-Gutierrez M, 2004, APPL CLAY SCI, V26, P65, DOI 10.1016/j.clay.2003.09.012; Ichikawas Y, 2002, INT J NUMERICAL METH, V55, P1717; Kawamuras K, 1997, P SCI BAS NUCL WAST, P359; Kawamuras K, 2001, B EARTHQ RES I TOKYO, V76, P311; Kawamuras K, 2004, TJ84002004028 JAP NU; Mitchells JK, 1992, FUNDAMENTALS SOIL BE, P1; Molera M, 2003, APPL CLAY SCI, V23, P69, DOI 10.1016/S0169-1317(03)00088-7; PATIL SF, 1986, APPL RADIAT ISOTOPES, V37, P37; Stumm W., 1996, AQUATIC CHEM CHEM EQ, P1; Stumm W., 1992, CHEM SOLID WATER INT, P87; Szanto Z, 2002, J RADIOANAL NUCL CH, V252, P133, DOI 10.1023/A:1015256308843	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0363-9061	1096-9853		INT J NUMER ANAL MET	Int. J. Numer. Anal. Methods Geomech.	NOV	2014	38	16					1744	1760		10.1002/nag.2303		17	Engineering, Geological; Materials Science, Multidisciplinary; Mechanics	Engineering; Materials Science; Mechanics	AQ6IG	WOS:000342913400006		
J	Islam, T				Islam, Tanvir			The scattering simulation of DSDs and the polarimetric radar rainfall algorithms at C-band frequency	JOURNAL OF ATMOSPHERIC AND SOLAR-TERRESTRIAL PHYSICS			English	Article						Dual polarization radar; Drop size distribution (DSD); Disdrometer; Precipitation estimation; Reflectivity; Propagation phase; Hydrology	DUAL-POLARIZED RADAR; DIFFERENTIAL PROPAGATION PHASE; JOSS-WALDVOGEL DISDROMETER; DROP SIZE DISTRIBUTIONS; WEATHER RADAR; ATTENUATION CORRECTION; PROFILING ALGORITHM; MELTING-LAYER; DOPPLER RADAR; REFLECTIVITY	This study explores polarimetric radar rainfall algorithms at C-band frequency using a total of 162,4151-min raindrop spectra from an extensive disdrometer dataset. Five different raindrop shape models have been tested to simulate polarimetric radar variables-the reflectivity factor (Z), differential reflectivity (Z(dr)) and specific differential phase (K-dp), through the T-matrix microwave scattering approach. The polarimetric radar rainfall algorithms are developed in the form of R(Z), R(K-dp), R(Z, Z(dr)) and R(Z(dr), K-dp) combinations. Based on the best fitted raindrop spectra models rain rate retrieval information using disdrometer derived rain rate as a reference, the algorithms are further explored in view of stratiform and convective rain regimes. Finally, an "artificial" algorithm is proposed which considers the developed algorithms for stratiform and convective regimes and uses R(Z), R(K-dp) and R(Z, Z(dr)) in different scenarios. The artificial algorithm is applied to and evaluated by the Thurnham C-band dual polarized radar data in 6 storm cases perceiving the rationalization in terms of rainfall retrieval accuracy as compared to the operational Marshall-Palmer algorithm (Z=200R(1.6)). A dense network of 73 tipping bucket rain gauges is employed for the evaluation, and the result demonstrates that the artificial algorithm outperforms the Marshall-Palmer algorithm showing R-2=0.84 and MAE=0.82 mm as opposed to R-2=0.79 and MAE=0.86 mm respectively. (C) 2014 Elsevier Ltd. All rights reserved.	[Islam, Tanvir] Univ Bristol, Dept Civil Engn, Bristol BS8 1TR, Avon, England; [Islam, Tanvir] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Islam, Tanvir] Nagasaki Univ, Dept Civil Engn, Nagasaki 852, Japan	Islam, T (reprint author), Univ Bristol, Dept Civil Engn, Bristol BS8 1TR, Avon, England.	tanvir.islam@bristol.ac.uk	Islam, Tanvir/F-6922-2011; 	Islam, Tanvir/0000-0003-2429-3074			Cao Q, 2008, J APPL METEOROL CLIM, V47, P2238, DOI 10.1175/2008JAMC1732.1; Rico-Ramirez MA, 2008, IEEE T GEOSCI REMOTE, V46, P1892, DOI 10.1109/TGRS.2008.916979; Ryzhkov AV, 2005, J APPL METEOROL, V44, P502, DOI 10.1175/JAM2213.1; Ryzhkov AV, 2005, B AM METEOROL SOC, V86, P809, DOI 10.1175/BAMS-86-6-809; Rico-Ramirez MA, 2007, METEOROL APPL, V14, P117, DOI 10.1002/met.13; Illingworth AJ, 2002, J APPL METEOROL, V41, P286, DOI 10.1175/1520-0450(2002)041<0286:TNTRRS>2.0.CO;2; Rico-Ramirez MA, 2005, ATMOS SCI LETT, V6, P40, DOI 10.1002/asl.89; Islam T, 2012, ATMOS RES, V108, P57, DOI 10.1016/j.atmosres.2012.01.013; Harrison DL, 2000, METEOROL APPL, V7, P135, DOI 10.1017/S1350482700001468; Matrosov SY, 2002, J APPL METEOROL, V41, P941, DOI 10.1175/1520-0450(2002)041<0941:XBPRMO>2.0.CO;2; Heinselman PL, 2006, WEATHER FORECAST, V21, P839, DOI 10.1175/WAF956.1; Bringi VN, 2009, J ATMOS OCEAN TECH, V26, P2107, DOI 10.1175/2009JTECHA1258.1; Brandes EA, 2002, J APPL METEOROL, V41, P674, DOI 10.1175/1520-0450(2002)041<0674:EIREWA>2.0.CO;2; Zhang JA, 2010, J HYDROMETEOROL, V11, P1157, DOI 10.1175/2010JHM1201.1; Islam T, 2012, ADV SPACE RES, V50, P1383, DOI 10.1016/j.asr.2012.07.011; Vulpiani G, 2008, J ATMOS OCEAN TECH, V25, P1118, DOI 10.1175/2007JTECHA936.1; SHEPPARD BE, 1994, J ATMOS OCEAN TECH, V11, P874, DOI 10.1175/1520-0426(1994)011<0874:CORSDM>2.0.CO;2; Islam T, 2012, ATMOS RES, V109, P95, DOI 10.1016/j.atmosres.2012.02.007; Thurai M, 2010, J ATMOS OCEAN TECH, V27, P932, DOI 10.1175/2010JTECHA1349.l; Cao Q, 2010, J APPL METEOROL CLIM, V49, P973, DOI 10.1175/2009JAMC2227.1; BEARD KV, 1987, J ATMOS SCI, V44, P1509, DOI 10.1175/1520-0469(1987)044<1509:ANMFTE>2.0.CO;2; Matrosov SY, 2007, J APPL METEOROL CLIM, V46, P154, DOI 10.1175/JAM2508.1; Montopoli M, 2008, IEEE T GEOSCI REMOTE, V46, P466, DOI 10.1109/TGRS.2007.909102; Steiner M, 2004, J ATMOS SCI, V61, P1114, DOI 10.1175/1520-0469(2004)061<1114:AMIORR>2.0.CO;2; Gourley JJ, 2009, J ATMOS OCEAN TECH, V26, P689, DOI 10.1175/2008JTECHA1152.1; Gosset M, 2010, Q J ROY METEOR SOC, V136, P243, DOI 10.1002/qj.556; Thurai M, 2007, J ATMOS OCEAN TECH, V24, P1019, DOI 10.1175/JTECH2051.1; Bringi VN, 2011, J HYDROMETEOROL, V12, P935, DOI 10.1175/JHM-D-10-05013.1; Matrosov SY, 2005, J HYDROMETEOROL, V6, P248, DOI 10.1175/JHM424.1; Mishchenko MI, 2000, APPL OPTICS, V39, P1026, DOI 10.1364/AO.39.001026; Cifelli R, 2011, J ATMOS OCEAN TECH, V28, P352, DOI 10.1175/2010JTECHA1488.1; Carey LD, 2000, J APPL METEOROL, V39, P1405, DOI 10.1175/1520-0450(2000)039<1405:CPEICB>2.0.CO;2; Bringi VN, 2001, IEEE T GEOSCI REMOTE, V39, P1906, DOI 10.1109/36.951081; Lee G, 2005, J APPL METEOROL, V44, P634, DOI 10.1175/JAM2222.1; Testud J, 2000, J ATMOS OCEAN TECH, V17, P332, DOI 10.1175/1520-0426(2000)017<0332:TRPAAT>2.0.CO;2; Andsager K, 1999, J ATMOS SCI, V56, P2673, DOI 10.1175/1520-0469(1999)056<2673:LMOARF>2.0.CO;2; Ryzhkov A, 1996, J APPL METEOROL, V35, P2080, DOI 10.1175/1520-0450(1996)035<2080:AORMTU>2.0.CO;2; Bringi VN, 2006, J METEOROL SOC JPN, V84, P705, DOI 10.2151/jmsj.84.705; ATLAS D, 1977, J APPL METEOROL, V16, P1322, DOI 10.1175/1520-0450(1977)016<1322:PAAIRM>2.0.CO;2; Brandes EA, 1999, J ATMOS OCEAN TECH, V16, P1264, DOI 10.1175/1520-0426(1999)016<1264:ACORRE>2.0.CO;2; Chandrasekar V., 2001, POLARIMETRIC DOPPLER; Diss S, 2009, ADV WATER RESOUR, V32, P975, DOI 10.1016/j.advwatres.2009.01.004; GODDARD JWF, 1994, INT GEOSCI REMOTE SE, P369, DOI 10.1109/IGARSS.1994.399128; Gorgucci E, 1996, J APPL METEOROL, V35, P1221, DOI 10.1175/1520-0450(1996)035<1221:OMOROT>2.0.CO;2; Islam T, 2013, THEOR APPL CLIMATOL, V112, P317, DOI 10.1007/s00704-012-0721-z; Islam T, 2014, PROG PHYS GEOG, V38, P55, DOI 10.1177/0309133313514993; Islam T, 2014, ATMOS RES, V135, P143, DOI 10.1016/j.atmosres.2013.09.003; Islam T, 2012, ATMOS SCI LETT, V13, P139, DOI 10.1002/asl.376; Kalogiros J, 2014, IEEE T GEOSCI REMOTE, V52, P1369, DOI 10.1109/TGRS.2013.2250979; Lee G, 2006, J ATMOS OCEAN TECH, V23, P1005, DOI 10.1175/JTECH1899.1; Marshall JS, 1955, ADV GEOPHYS, V2, P1, DOI DOI 10.1016/S0065-2687(08)60310-6; May PT, 1999, J APPL METEOROL, V38, P750, DOI 10.1175/1520-0450(1999)038<0750:PRMOTR>2.0.CO;2; MEISCHNER PF, 1991, MON WEATHER REV, V119, P678, DOI 10.1175/1520-0493(1991)119<0678:ASLISG>2.0.CO;2; Mishchenko MI, 2000, LIGHT SCATTERING NON; Petersen W., 2009, P 23 C HYDR; Qi Y., 2013, J GEOPHYS RES ATMOS; Rico-Ramirez MA, 2009, METEOROL APPL, V16, P227, DOI 10.1002/met.112; Rosenfeld D., 2003, METEOROL MONOGR, V30, P237, DOI DOI 10.1175/0065-9401(2003)030<0237:CMPPAR>2.0.CO;2; Silvestro F, 2009, J HYDROMETEOROL, V10, P227, DOI 10.1175/2008JHM1015.1; Tan J., 1995, IET, V2, P336; Teschl F., 2008, ADV GEOSCI, V16, P27; Thompson R., 2008, 5 EUR C RAD MET HYDR; Vulpiani G, 2009, J APPL METEOROL CLIM, V48, P2022, DOI 10.1175/2009JAMC2172.1; Zhang C.F., 2001, IEEE T GEOSCI REMOTE, V39, P830; Zrnic DS, 1996, J ATMOS OCEAN TECH, V13, P454, DOI 10.1175/1520-0426(1996)013<0454:AORMUS>2.0.CO;2	65	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1364-6826	1879-1824		J ATMOS SOL-TERR PHY	J. Atmos. Sol.-Terr. Phys.	NOV	2014	119						42	52		10.1016/j.jastp.2014.06.008		11	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	AQ6AQ	WOS:000342890100005		
J	Reisin, ER; Scheer, J; Dyrland, ME; Sigernes, F; Deehr, CS; Schmidt, C; Hoppner, K; Bittner, M; Ammosov, PP; Gavrilyeva, GA; Stegman, J; Perminov, VI; Semenov, AI; Knieling, P; Koppmann, R; Shiokawa, K; Lowe, RP; Lopez-Gonzalez, MJ; Rodriguez, E; Zhao, Y; Taylor, MJ; Buriti, RA; Espy, PJ; French, WJR; Eichmann, KU; Burrows, JP; von Savigny, C				Reisin, E. R.; Scheer, J.; Dyrland, M. E.; Sigernes, F.; Deehr, C. S.; Schmidt, C.; Hoeppner, K.; Bittner, M.; Ammosov, P. P.; Gavrilyeva, G. A.; Stegman, J.; Perminov, V. I.; Semenov, A. I.; Knieling, P.; Koppmann, R.; Shiokawa, K.; Lowe, R. P.; Lopez-Gonzalez, M. J.; Rodriguez, E.; Zhao, Y.; Taylor, M. J.; Buriti, R. A.; Espy, P. J.; French, W. J. R.; Eichmann, K. -U.; Burrows, J. P.; von Savigny, C.			Traveling planetary wave activity from mesopause region airglow temperatures determined by the Network for the Detection of Mesospheric Change (NDMC)	JOURNAL OF ATMOSPHERIC AND SOLAR-TERRESTRIAL PHYSICS			English	Article						Traveling planetary wave activity; Ground-based airglow observations; Rotational temperature; Network for the Detection of Mesospheric Change (NDMC)	HYDROXYL ROTATIONAL TEMPERATURE; LOWER THERMOSPHERE; OH(6-2) AIRGLOW; STRATOSPHERE; OSCILLATIONS; ANTARCTICA; SIGNATURES; SCIAMACHY; PERIOD; DAVIS	The global distribution of traveling planetary wave (PW) activity in the mesopause region is estimated for the first time from ground-based airglow measurements. Monthly and total mean climatologies of PW power are determined from rotational temperatures measured at 19 sites from 78 degrees N to 76 degrees S which contribute to the Network for the Detection of Mesospheric Change (NDMC). Wave power is expressed as the standard deviation of nocturnal mean temperature around the seasonal temperature variation. The results from 20 degrees N confirm the SABER traveling PW proxy by Offermann et al. (2009, J. Geophys. Res. 114, D06110) at two altitudes. Most sites between 69 degrees S and 69 degrees N show total mean traveling PW activity of about 6 K, and only some high latitude sites have considerably higher activity levels. At the two tropical sites, there is practically no seasonal variation of PW activity. At 70% of the midlatitude sites, the seasonal variation is moderate for most of the year, but it is quite appreciable at all high latitude sites. Results about traveling PW activity at 87 km and 95 km available from several sites signal similar behavior at both altitudes. The total mean climatological results here obtained have further been used to separate the traveling PW contribution from the superposition of wave types contained in OH rotational temperature fluctuations measured by the SCIAMACHY instrument on Envisat. A narrow equatorial wave activity maximum is probably caused by gravity waves, while a tendency towards greater activity at higher northern latitudes may be due to stationary planetary waves. (C) 2014 Elsevier Ltd. All rights reserved.	[Reisin, E. R.; Scheer, J.] CONICET UBA, Inst Astron & Fis Espacio, Buenos Aires, DF, Argentina; [Dyrland, M. E.; Sigernes, F.] Univ Ctr Svalbard, Birkeland Ctr Space Sci, Longyearbyen, Norway; [Deehr, C. S.] Univ Alaska Fairbanks, Inst Geophys, Fairbanks, AK USA; [Schmidt, C.; Hoeppner, K.; Bittner, M.] Deutsch Zentrum Luft & Raumfahrt DLR, Oberpfaffenhofen, Germany; [Ammosov, P. P.; Gavrilyeva, G. A.] Inst Cosmophys Res & Aeron SB RAS, Yakutsk, Russia; [Stegman, J.] Stockholm Univ, Meteorologiska Inst, Stockholm, Sweden; [Perminov, V. I.; Semenov, A. I.] Russian Acad Sci, Obukhov Inst Atmospher Phys, Moscow, Russia; [Knieling, P.; Koppmann, R.] Univ Wuppertal, Dept Phys, Wuppertal, Germany; [Shiokawa, K.] Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan; [Lowe, R. P.] Univ Western Ontario, London, ON, Canada; [Lopez-Gonzalez, M. J.; Rodriguez, E.] CSIC, Inst Astrofis Andalucia, Granada, Spain; [Zhao, Y.; Taylor, M. J.] Utah State Univ, Ctr Atmospher & Space Sci, Logan, UT 84322 USA; [Buriti, R. A.] Univ Fed Campina Grande, Unidade Acad Fis, Campina Grande, Paraiba, Brazil; [Espy, P. J.] Norges Teknisk Nat Vitenskapelige Univ, Trondheim, Norway; [Espy, P. J.] Birkeland Ctr Space Sci, Bergen, Norway; [French, W. J. R.] Australian Antarctic Div, Kingston, Tas, Australia; [Eichmann, K. -U.; Burrows, J. P.] Univ Bremen, Inst Umweltphys, D-28359 Bremen, Germany; [von Savigny, C.] Ernst Moritz Arndt Univ Greifswald, Inst Phys, Greifswald, Germany	Reisin, ER (reprint author), CONICET UBA, Inst Astron & Fis Espacio, Buenos Aires, DF, Argentina.	ereisin@iafe.uba.ar			CONICET, Argentina [PIP 112-200801-00287]; Research Council of Norway (RCN) [204993]; Norwegian and Russian Upper Atmosphere Cooperation On Svalbard part 2 (NORUSCA2) [196173/S30]; Atmospheric Sciences Division of the US National Science Foundation; RFBR; Spanish MICINN [AYA2011-23552]; Priority Area-764 of MEXT, Japan [13136201]; NSF [ATM-03-38425, ATM-0003218, ATM-1110215]; Australian Antarctic Science Advisory Committee (ASAC) [AAS701];  [11440145];  [13573006]	We thank Marianna Shepherd and Alok Taori for supplying data from Eureka and Gadanki, which regretably were still insufficient to pass the selection criteria and so yielded no usable results. Helpful comments by Dirk Offermann and by the anonymous reviewers of previous manuscript versions are gratefully acknowledged. E.R.R. and J.Sch. acknowledge funding by CONICET, Argentina Grant PIP 112-200801-00287. M.E.D and F.S. would like to acknowledge financial support from the Research Council of Norway (RCN) through the projects: High-Arctic Gravity waves and their impact on middle atmospheric circulation and temperature (#204993), and Norwegian and Russian Upper Atmosphere Cooperation On Svalbard part 2 # 196173/S30 (NORUSCA2). C.S.D. acknowledges support to the Geophysical Institute by Atmospheric Sciences Division of the US National Science Foundation. V.I.P. and A.I.S. are grateful to RFBR for support of the airglow observations at Zvenigorod station. M.J.L.G. and E.R. acknowledge funding by the Spanish MICINN under Project AYA2011-23552 and thank the staff of Sierra Nevada Observatory for assistance with the SATI instrument. K.S. thanks M. Satoh, Y. Katoh, Y. Hamaguchi, and Y. Yamamoto of STEL, Nagoya Univ., for their helpful support of the photometer operation at RIK and STA, and acknowledges support by Grant-in-Aid for Scientific Research (11440145, 13573006) and by Priority Area-764 (13136201) of MEXT, Japan. Financial support for the MTM observations and data analysis as part of the Maui-MALT program and Cerro Pachon Program was provided by NSF Grants ATM-03-38425, ATM-0003218 and ATM-1110215. Observations at Davis are supported by the Australian Antarctic Science Advisory Committee (ASAC) under AAS701 and we thank the Davis wintering science teams for their dedicated observatory support. SCIAMACHY is jointly funded by Germany, the Netherlands, and Belgium. The analysis of SCIAMACHY data is supported by the Universities of Bremen and Greifswald, and the SCIAMACHY Level 1 data were kindly provided by ESA.	Ammosov PP, 2000, INSTRUM EXP TECH+, V43, P792, DOI 10.1023/A:1026680119998; Takahashi H, 2006, ANN GEOPHYS-GERMANY, V24, P3343; Pancheva D, 2010, J ATMOS SOL-TERR PHY, V72, P26, DOI 10.1016/j.jastp.2009.10.005; Espy PJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016452; Bittner M, 2002, J ATMOS SOL-TERR PHY, V64, P1147, DOI 10.1016/S1364-6826(02)00065-2; Bittner M, 2010, NAT HAZARD EARTH SYS, V10, P1431, DOI 10.5194/nhess-10-1431-2010; Offermann D, 2006, J ATMOS SOL-TERR PHY, V68, P1709, DOI 10.1016/j.jastp.2006.01.013; Bittner M, 2000, J GEOPHYS RES-ATMOS, V105, P2045, DOI 10.1029/1999JD900307; Bovensmann H, 1999, J ATMOS SCI, V56, P127, DOI 10.1175/1520-0469(1999)056<0127:SMOAMM>2.0.CO;2; Sassi F, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001525; BURROWS JP, 1995, ACTA ASTRONAUT, V35, P445, DOI 10.1016/0094-5765(94)00278-T; Offermann D, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013363; Schmidt C, 2013, J ATMOS SOL-TERR PHY, V102, P125, DOI 10.1016/j.jastp.2013.05.001; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Mukhtarov P, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA015156; Chandran A, 2014, ADV SPACE RES, V53, P1265, DOI 10.1016/j.asr.2014.02.005; Achatz U, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012967; Murphy D, 2007, J ATMOS SOL-TERR PHY, V69, P2118, DOI 10.1016/j.jastp.2007.06.008; Reisin ER, 2004, J ATMOS SOL-TERR PHY, V66, P655, DOI 10.1016/j.jastp.2004.01.017; von Savigny C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053563; Pancheva D, 2009, J ATMOS SOL-TERR PHY, V71, P75, DOI 10.1016/j.jastp.2008.09.027; Buriti RA, 2004, J ATMOS SOL-TERR PHY, V66, P567, DOI 10.1016/j.jastp.2004.01.009; Buriti RA, 2005, ADV SPACE RES-SERIES, V35, P2031, DOI 10.1016/j.asr.2005.07.012; Espy PJ, 1997, J GEOPHYS RES-ATMOS, V102, P1983, DOI 10.1029/96JD02717; Espy PJ, 2002, PHYS CHEM EARTH, V27, P543, DOI 10.1016/S1474-7065(02)00036-0; French WJR, 2004, J ATMOS SOL-TERR PHY, V66, P493, DOI 10.1016/j.jastp.2004.01.027; Greet PA, 1998, ANN GEOPHYS-ATM HYDR, V16, P77, DOI 10.1007/s00585-997-0077-3; Jacobi C, 2008, ANN GEOPHYS-GERMANY, V26, P1221; Khomich V. Y., 2008, AIRGLOW INDICATOR UP; Liu GP, 2006, J ATMOS SOL-TERR PHY, V68, P1018, DOI 10.1016/j.jastp.2005.12.004; Lopez-Gonzalez MJ, 2004, ANN GEOPHYS-GERMANY, V22, P819; Lopez-Gonzalez MJ, 2009, ANN GEOPHYS-GERMANY, V27, P3645; LOWE RP, 1995, GEOPHYS RES LETT, V22, P2813, DOI 10.1029/95GL02671; McDonald AJ, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014719; Offermann D, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010662; Offermann D, 2006, J ATMOS SOL-TERR PHY, V68, P1924, DOI 10.1016/j.jastp.2006.03.007; Reisin ER, 2009, ADV SPACE RES, V44, P401, DOI 10.1016/j.asr.2009.04.007; SCHEER J, 1994, J ATMOS TERR PHYS, V56, P1701, DOI 10.1016/0021-9169(94)90005-1; Scheer J, 2001, ADV SPACE RES-SERIES, V27, P1153, DOI 10.1016/S0273-1177(01)00150-8; Scheer J, 2005, J ATMOS SOL-TERR PHY, V67, P611, DOI 10.1016/j.jastp.2004.12.007; Shepherd GG, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000390; Shiokawa K, 2007, EARTH PLANETS SPACE, V59, P585; Sigernes F, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2001JA009023; Smith AK, 2012, SURV GEOPHYS, V33, P1177, DOI 10.1007/s10712-012-9196-9; Taylor MJ, 2001, ADV SPACE RES, V27, P1171, DOI 10.1016/S0273-1177(01)00153-3; von Savigny C, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020410; von Savigny C, 2012, ATMOS CHEM PHYS, V12, P8813, DOI 10.5194/acp-12-8813-2012	47	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1364-6826	1879-1824		J ATMOS SOL-TERR PHY	J. Atmos. Sol.-Terr. Phys.	NOV	2014	119						71	82		10.1016/j.jastp.2014.07.002		12	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	AQ6AQ	WOS:000342890100008		
J	Nagai, M; Iwasaki, K; Umezu, M; Ozaki, M				Nagai, Mirei; Iwasaki, Kiyotaka; Umezu, Mitsuo; Ozaki, Makoto			Simultaneous comparison of thrombogenic reactions to different combinations of anticoagulants, activated clotting times, and materials	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS			English	Article						in vitro thrombogenicity test; anticoagulant; activated clotting time; platelet activation; total plasma protein adsorption	HEPARIN-INDUCED THROMBOCYTOPENIA; CARDIAC-SURGERY; IN-VITRO; CARDIOPULMONARY BYPASS; PROTEIN ADSORPTION; WHOLE-BLOOD; ARGATROBAN; PATIENT; BIOMATERIALS; MANAGEMENT	Thrombogenic reactions under multiple interactions of pharmacological agents, doses, and materials have not been well understood yet. The aim of this study was to investigate the ability to simultaneously compare thrombogenic reactions to different combinations of anticoagulants, doses, and blood-contacting materials, in a single human blood using an in vitro test method. Four venous blood samples were drawn from each of six healthy volunteers into syringes that contained two different amounts of heparin and argatroban to set the activated clotting time (ACT) to approximately 200 or 500 s, respectively. The four blood samples from each volunteer were immediately poured into two clinical-grade extracorporeal circulation tubes: a polyvinyl chloride (PVC) tube and a poly(2-methoxyethyl acrylate)-coated (PMEA) PVC tube. These tubes with an inner diameter of 12.7 mm were rotated at 183 rpm in a 37 degrees C chamber for 10 min. The results indicated that the in vitro thrombogenicity test method was capable of assessing differences in platelet factor 4 and beta-thromboglobulin increases among different combinations of the two materials, two anticoagulants, and two ACTs. Higher amounts of total plasma proteins were absorbed on PVC tubes than on PMEA-coated tubes when using the same anticoagulant and dose. These data elucidate that the in vitro thrombogenicity test method is useful for the simultaneous quantitative evaluation of the influences of various combinations of materials, pharmacological agents, and doses on thrombogenicity in a single human blood. (C) 2014 Wiley Periodicals, Inc.	[Nagai, Mirei; Ozaki, Makoto] Tokyo Womens Med Univ, Dept Anesthesiol, Tokyo, Japan; [Iwasaki, Kiyotaka; Umezu, Mitsuo] Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo, Japan; [Iwasaki, Kiyotaka; Umezu, Mitsuo] Tokyo Womens Med Univ Univ Joint Inst TWIns, Ctr Adv Biomed Sci, Tokyo, Japan	Iwasaki, K (reprint author), Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo, Japan.	iwasaki@waseda.jp			Ministry of Health, Labour and Welfare, Initiative for Accelerating Regulatory Science in Innovative Drug, Medical Device, and Regenerative Medicine; Japan Society for the Promotion of Science [24659639]	Contract grant sponsor: Ministry of Health, Labour and Welfare, Initiative for Accelerating Regulatory Science in Innovative Drug, Medical Device, and Regenerative Medicine, Contract grant sponsor: Japan Society for the Promotion of Science Grant-in-Aid for Exploratory Research; contract grant number: 24659639	Alatri A, 2012, THROMB RES, V129, P426, DOI 10.1016/j.thromres.2011.11.041; Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5; Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C; Tanaka M, 2004, J BIOMED MATER RES A, V68A, P684, DOI 10.1002/jbm.a.20088; Weitz JI, 2002, CIRCULATION, V105, P1004, DOI 10.1161/hc0802.104331; Bexborn F, 2009, J BIOMED MATER RES A, V89A, P951, DOI 10.1002/jbm.a.32034; Dhillon S, 2009, AM J CARDIOVASC DRUG, V9, P261, DOI 10.2165/1120090-000000000-00000; Follis F, 2010, INTERACT CARDIOV TH, V10, P592, DOI 10.1510/icvts.2009.215848; Genzen JR, 2010, TRANSFUSION, V50, P801, DOI 10.1111/j.1537-2995.2009.02531.x; Hursting MJ, 2006, J PEDIAT HEMATOL ONC, V28, P4, DOI 10.1097/01.mph.0000195296.48319.38; Kopp R, 2005, INT J ARTIF ORGANS, V28, P1272; Levy JH, 2010, CURR OPIN ANESTHESIO, V23, P74, DOI 10.1097/ACO.0b013e328334dd2f; Linkins L, 2012, CHEST S, V141, pe495S; Martin ME, 2007, EUR J HAEMATOL, V78, P161, DOI 10.1111/j.1600-0609.2006.00786.x; Murphy GS, 2007, J CARDIOTHOR VASC AN, V21, P113, DOI 10.1053/j.jvca.2006.08.011; Schiel L, 2001, CAN PERFUSION, V11, P8; Smith AI, 2008, EUR J CARDIO-THORAC, V34, P1113, DOI 10.1016/j.ejcts.2008.07.035; Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4973	1552-4981		J BIOMED MATER RES B	J. Biomed. Mater. Res. Part B	NOV	2014	102	8					1605	1612		10.1002/jbm.b.33145		8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AQ7PM	WOS:000343011400001		
J	Akimoto, J; Arauchi, A; Nakayama, M; Kanaya, R; Iwase, Y; Takagi, S; Yamato, M; Okano, T				Akimoto, Jun; Arauchi, Ayumi; Nakayama, Masamichi; Kanaya, Ryo; Iwase, Yuko; Takagi, Soichi; Yamato, Masayuki; Okano, Teruo			Facile cell sheet manipulation and transplantation by using in situ gelation method	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS			English	Article						cell sheet; cell manipulation; transplantation; gelatin hydrogel; tissue engineering	RESPONSIVE CULTURE SURFACES; FIBRONECTIN; DETACHMENT	Cell sheets harvested from temperature-responsive cell culture dishes (TRDs) has attracted considerable attention as effective tools for reconstructing the lost functions of tissues and organs in the regenerative medicine field. However, because of their thinness, handling problems sometimes arise when transferring cell sheets from a TRD to a target surface. In this study, we developed a facile cell transfer method referred to as in situ gelation by using both gelatin hydrogel and a support membrane. Gelation and low-temperature processes were simultaneously performed on TRD. Confluent cultured cells were efficiently harvested from TRD in less than 5 min by decreasing the incubation temperature to 20 degrees C. Harvested cells were found to maintain their cell viability, extracellular matrix, and original shape, thus allowing transfer of the cells to another surface with a short incubation time at 37 degrees C. This method is applicable for various cell types regardless of the formation of tight cell-cell junctions. In addition, because of the high flexibility of the gelatin-coated membrane, cells were efficiently transferred to the surface of a mouse subcutis and liver. When compared with conventional cell sheet manipulation methods, the interaction between the cell surface and membrane was reinforced by the uniformly formed gelatin gel layer without using a special device. Therefore, the in situ gelation method is a promising technique for cell sheet-based tissue engineering and regenerative medicine. (C) 2014 Wiley Periodicals, Inc.	[Akimoto, Jun; Arauchi, Ayumi; Nakayama, Masamichi; Kanaya, Ryo; Iwase, Yuko; Takagi, Soichi; Yamato, Masayuki; Okano, Teruo] Tokyo Womens Med Univ TWIns, Inst Adv Biomed Engn & Sci, Shinjuku Ku, Tokyo 1628666, Japan; [Kanaya, Ryo] Kowa Co Ltd, Naka Ku, Nagoya, Aichi 4608625, Japan	Okano, T (reprint author), Tokyo Womens Med Univ TWIns, Inst Adv Biomed Engn & Sci, Shinjuku Ku, Tokyo 1628666, Japan.	tokano@twmu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [25282145]; Global Center of Excellence Program "Multidisciplinary Education and Research Center for the Establishment of Regenerative Medicine" from MEXT, Japan; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems "Cell Sheet Tissue Engineering Center (CSTEC)" from MEXT, Japan	Contract grant sponsor: Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; contract grant number: 25282145; Contract grant sponsor: The Global Center of Excellence Program "Multidisciplinary Education and Research Center for the Establishment of Regenerative Medicine" and the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems "Cell Sheet Tissue Engineering Center (CSTEC)" from MEXT, Japan	Akimoto J, J TISSUE ENG REGEN M, DOI [10.1002/term.1850, DOI 10.1002/TERM.1850]; Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7; Yamato M, 2000, BIOMATERIALS, V21, P981, DOI 10.1016/S0142-9612(99)00239-2; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Akiyama Y, 2004, LANGMUIR, V20, P5506, DOI 10.1021/la036139f; Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307; Asakawa N, 2010, BIOMATERIALS, V31, P3903, DOI 10.1016/j.biomaterials.2010.01.105; Kirkpatrick CJ, 2007, BIOMATERIALS, V28, P5193, DOI 10.1016/j.biomaterials.2007.08.012; Xue CY, 2012, ADV FUNCT MATER, V22, P2394, DOI 10.1002/adfm.201103056; Kushida A, 2001, J BIOMED MATER RES, V54, P37, DOI 10.1002/1097-4636(200101)54:1<37::AID-JBM5>3.0.CO;2-7; Haraguchi Y, 2012, RSC ADV, V2, P2184, DOI 10.1039/c2ra00704e; Takahashi H, 2011, BIOMACROMOLECULES, V12, P1414, DOI 10.1021/bm2000956; MICHON C, 1993, RHEOL ACTA, V32, P94, DOI 10.1007/BF00396681; YAMADA N, 1990, MAKROMOL CHEM-RAPID, V11, P571; OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E; Sasagawa T, 2010, BIOMATERIALS, V31, P1646, DOI 10.1016/j.biomaterials.2009.11.036; GRINNELL F, 1982, J BIOL CHEM, V257, P4888; Heskins M.a.G.J.E., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI DOI 10.1080/10601326808051910; Itoga K, 2006, BIOMATERIALS, V27, P3005, DOI 10.1016/j.biomaterials.2005.12.023; Lanza R., 2011, PRINCIPLES TISSUE EN; Sato K, 2006, J BIOMECHANICAL SCI, V1, P204, DOI 10.1299/jbse.1.204	21	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4973	1552-4981		J BIOMED MATER RES B	J. Biomed. Mater. Res. Part B	NOV	2014	102	8					1659	1668		10.1002/jbm.b.33148		10	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AQ7PM	WOS:000343011400007		
J	Shinozaki, Y; Toda, M; Ohno, J; Kawaguchi, M; Kido, H; Fukushima, T				Shinozaki, Yosuke; Toda, Masako; Ohno, Jun; Kawaguchi, Minoru; Kido, Hirofumi; Fukushima, Tadao			Evaluation of bone formation guided by DNA/protamine complex with FGF-2 in an adult rat calvarial defect model	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS			English	Article						DNA; protamine; fibroblast growth factor-2; bone regeneration; elderly	DNA-CHITOSAN COMPLEXES; CRITICAL-SIZE; MINERALIZATION; MICROSPHERES; REGENERATION; EXPRESSION; PROTAMINE; BMP-2; PASTE	DNA/protamine complex paste (D/P) and D/P complex paste with Fibroblast Growth Factor-2 (FGF-2) (D/P-FGF) were prepared to investigate their new bone formation abilities using an similar to 40-week-old rat calvarial defect model. It was found that D/P could release FGF-2 proportionally in an in vitro experiment with an enzyme-linked immunosorbent assay. It was also found that aging adversely affected self-bone healing of rats by comparison with the results in a previous study using 10-week-old rats. Microcomputed tomography and histopathological examinations showed that new bone formation abilities of D/P and D/P-FGF were superior to that of the control (sham operation). Control, D/P and D/P-FGF showed newly formed bone areas of 6.7, 58.3, and 67.0%, respectively, 3 months after the operation. Moreover, it was found that FGF-2 could support the osteoanagenesis ability of D/P. It was considered that FGF-2 could play an important role in new bone formation at early stages because it induced the genes such as collagen I, CBFA, OSX, and OPN, which are initiated first in the process of osteogenesis. Therefore, D/P-FGF will be a useful injectable biomaterial with biodegradable properties for the repair of bone defects in the elderly. (C) 2014 Wiley Periodicals, Inc.	[Shinozaki, Yosuke; Kido, Hirofumi] Fukuoka Dent Coll, Oral Implantol sect, Dept Oral Rehabil, Fukuoka, Japan; [Toda, Masako] Fukuoka Dent Coll, Div Pediat Dent, Dept Oral Growth & Dev, Fukuoka, Japan; [Ohno, Jun] Fukuoka Dent Coll, Pathol Sect, Dept Morphol Biol, Fukuoka, Japan; [Kawaguchi, Minoru] Fukuoka Dent Coll, Bioengn Sect, Dept Dent Engn, Fukuoka, Japan; [Fukushima, Tadao] Fukuoka Dent Coll, Ctr Regenerat Med, Fukuoka, Japan	Shinozaki, Y (reprint author), Fukuoka Dent Coll, Oral Implantol sect, Dept Oral Rehabil, Fukuoka, Japan.	silver33@college.fdcnet.ac.jp			 [23390455]	Contract grant sponsor: Grant-in-aid for Scientific Research (B); contract grant number: 23390455	Fukushima T, 2011, J MATER SCI-MATER M, V22, P2607, DOI 10.1007/s10856-011-4446-9; Shinozaki Y, 2013, J HARD TISSUE BIOL, V22, P401; Mori N, 2013, J BIOMED MATER RES B, V101B, P743, DOI 10.1002/jbm.b.32877; Kawai K, 2000, BIOMATERIALS, V21, P489, DOI 10.1016/S0142-9612(99)00207-0; Fukushima T, 2010, DENT MATER J, V29, P529, DOI 10.4012/dmj.2009-131; Cooper GM, 2010, PLAST RECONSTR SURG, V125, P1685, DOI 10.1097/PRS.0b013e3181cb63a3; Cowan CM, 2007, TISSUE ENG, V13, P501, DOI 10.1089/ten.2006.0141; Eto H, 2012, LAB INVEST, V92, P214, DOI 10.1038/labinvest.2011.127; Kitamura M, 2011, J DENT RES, V90, P35, DOI 10.1177/0022034510384616; Bosh C, 1998, J CRANIOFAC SURG, V9, P310; Fukushima T, 2006, J BIOMED MATER RES B, V76B, P121, DOI 10.1002/jbm.b.30334; Fukushima T, 2009, J BIOMED MATER RES B, V91B, P746, DOI 10.1002/jbm.b.31451; Fukushima T, 2008, J ORAL TISSUE ENG, V6, P24; Hughes-Fulford M, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-8; Ichinohe N, 2008, TISSUE ENG PT A, V14, P1663, DOI 10.1089/ten.tea.2006.0350; Messora MR, 2008, J PERIODONTAL RES, V43, P723, DOI 10.1111/j.1600-0765.2008.01084.x; Tanaka T, 2012, Open Biomed Eng J, V6, P98, DOI 10.2174/1874120701206010098; Yun YR, 2010, J TISSUE ENG, V2010, DOI DOI 10.4061/2010/218142; Zhou LM, 2013, GENE, V516, P228, DOI 10.1016/j.gene.2012.12.056	19	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4973	1552-4981		J BIOMED MATER RES B	J. Biomed. Mater. Res. Part B	NOV	2014	102	8					1669	1676		10.1002/jbm.b.33143		8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AQ7PM	WOS:000343011400008		
J	Takahashi, Y; Sugano, N; Puppulin, L; Zhu, WL; Pezzotti, G				Takahashi, Yasuhito; Sugano, Nobuhiko; Puppulin, Leonardo; Zhu, Wenliang; Pezzotti, Giuseppe			Raman spectroscopic study of remelting and annealing-induced effects on microstructure and compressive deformation behavior of highly crosslinked UHMWPE for total hip arthroplasty	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS			English	Article						polyethylene (UHMWPE); hip prosthesis; crystallinity; morphology; strain	MOLECULAR-WEIGHT POLYETHYLENE; TOTAL JOINT REPLACEMENT; RADIOSTEREOMETRIC ANALYSIS; MECHANICAL-PROPERTIES; WEAR; CRYSTALLINITY; RESISTANCE; PROSTHESES; MORPHOLOGY	Three-dimensional crystallographic morphologies were studied by means of confocal/polarized Raman spectroscopy as developed upon manufacturing in three different types of first and second generation highly crosslinked UHMWPE (HXLPE) acetabular liners. The impact of such microstructural characteristics on the deformation behavior of the liners was also evaluated and discussed from the viewpoint of molecular chain mobility. All the investigated liners showed similar microstructural transitions within the first 35 mu pm below their surfaces in terms of crystallinity, molecular orientation, and crystalline anisotropy. Interestingly, different postirradiation heat treatments (remelting or annealing in single step or in sequential steps) led to clear differences in the subsurface microstructure among the three liners. Remelted liner possessed both lower bulk crystallinity and degree of molecular orientation as compared to the annealed liners. Sequentially, irradiated/annealed liner showed the highest degree of crystallinity and orientation among the studied liners. The peculiar microstructure of this latter liner exhibited the highest restoring (shape-recovery) force against the applied uniaxial strain. Accordingly, the present study suggests that the sequential irradiation and annealing offers an efficient way to obtain microstructure quite suitable for attaining high creep resistance. However, all the investigated liners exhibited the significantly low values of surface anisotropy, which could be equally efficient in minimizing strain-softening-assisted wear phenomena. (C) 2014 Wiley Periodicals, Inc.	[Takahashi, Yasuhito; Puppulin, Leonardo; Pezzotti, Giuseppe] Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Matsugasaki, Kyoto 6068585, Japan; [Takahashi, Yasuhito] Tokyo Med Univ, Dept Orthopaed Surg, Shinjuku Ku, Tokyo 1600023, Japan; [Sugano, Nobuhiko; Zhu, Wenliang] Osaka Univ, Grad Sch Med, Dept Orthopaed Med Engn, Suita, Osaka 5650871, Japan; [Pezzotti, Giuseppe] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan	Pezzotti, G (reprint author), Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Matsugasaki, Kyoto 6068585, Japan.	pezzotti@kit.ac.jp					Kurtz SM, 2006, BIOMATERIALS, V27, P24, DOI 10.1016/j.biomaterials.2005.05.102; Wang A, 2006, J PHYS D APPL PHYS, V39, P3213, DOI 10.1088/0022-3727/39/15/S12; Barron D, 2008, POLYMER, V49, P3111, DOI 10.1016/j.polymer.2008.05.004; Dumbleton JH, 2006, CLIN ORTHOP RELAT R, P265, DOI 10.1097/01.blo.0000238856.61862.7d; Oral E, 2006, BIOMATERIALS, V27, P917, DOI 10.1016/j.bomaterials.2005.06.025; Nakahara I, 2011, ARCH ORTHOP TRAUM SU, V131, P1731, DOI 10.1007/s00402-011-1360-z; Dorr LD, 2005, J BONE JOINT SURG AM, V87A, P1816, DOI 10.2106/JBJS.D.01915; Meyer RW, 2001, POLYMER, V42, P5293, DOI 10.1016/S0032-3861(00)00626-1; Muratoglu OK, 1999, BIOMATERIALS, V20, P1463, DOI 10.1016/S0142-9612(99)00039-3; Lewis G, 2001, BIOMATERIALS, V22, P371, DOI 10.1016/S0142-9612(00)00195-2; BARTCZAK Z, 1992, MACROMOLECULES, V25, P4692, DOI 10.1021/ma00044a034; Campbell DG, 2010, CLIN ORTHOP RELAT R, V468, P2704, DOI 10.1007/s11999-010-1259-y; Digas G, 2004, CLIN ORTHOP RELAT R, P6, DOI 10.1097/01.blo.0000150314.70919.e3; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Thomas GER, 2011, J BONE JOINT SURG AM, V93A, P716, DOI 10.2106/JBJS.J.00287; RULL F, 1993, J RAMAN SPECTROSC, V24, P545, DOI 10.1002/jrs.1250240813; Kurtz SM, 1999, BIOMATERIALS, V20, P1659, DOI 10.1016/S0142-9612(99)00053-8; McKellop H, 1999, J ORTHOP RES, V17, P157, DOI 10.1002/jor.1100170203; STROBL GR, 1978, J POLYM SCI POL PHYS, V16, P1181, DOI 10.1002/pol.1978.180160704; D'Antonio JA, 2005, CLIN ORTHOP RELAT R, P143, DOI 10.1097/01.blo.0000194090.77500.b4; Dumbleton JH, 2009, UHMWPE BIOMATERIALS HANDBOOK: ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE IN TOTAL JOINT REPLACEMENT AND MEDICAL DEVICES, 2ND EDITION, P205, DOI 10.1016/B978-0-12-374721-1.00014-6; Gurp M.V., 1995, COLLOID POLYM SCI, V273, P607, DOI 10.1007/BF00652253; Morrison ML, 2009, J BIOMED MATER RES B, V90B, P87, DOI 10.1002/jbm.b.31257; Oonishi H, 1997, J MATER SCI-MATER M, V8, P11, DOI 10.1023/A:1018582027349; Oonishi H, 1998, 44 ANN M ORTH RES SO, P17; Perez R, 2008, J APPL PHYS, V103, DOI 10.1063/1.2885347; PHILIP M, 1986, J MATER SCI, V21, P879, DOI 10.1007/BF01117368; Puppulin L, 2011, J RAMAN SPECTROSC, V42, P482, DOI 10.1002/jrs.2725; Puppulin L, 2010, ACTA BIOMATER, V7, P1150; Takahashi Y, 2010, ACTA BIOMATER, V6, P3583, DOI 10.1016/j.actbio.2010.02.051; Wang A, 1997, J TEST EVAL, V25, P239; Wang A, 1996, Proc Inst Mech Eng H, V210, P141, DOI 10.1243/PIME_PROC_1996_210_407_02; ZHAO Y, 1993, J APPL POLYM SCI, V50, P1797, DOI 10.1002/app.1993.070501015	33	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4973	1552-4981		J BIOMED MATER RES B	J. Biomed. Mater. Res. Part B	NOV	2014	102	8					1762	1770		10.1002/jbm.b.33164		9	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AQ7PM	WOS:000343011400017		
J	Inoue, M; Sakane, M; Taguchi, T				Inoue, Motoki; Sakane, Masataka; Taguchi, Tetsushi			Fabrication of reactive poly(vinyl alcohol) membranes for prevention of bone cement leakage	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS			English	Article						poly(vinyl alcohol); glycidyl methacrylate; PMMA-based bone cement; balloon kyphoplasty	VERTEBRAL COMPRESSION FRACTURES; KYPHOPLASTY; BODY; AUGMENTATION; HYDROGELS; VERTEBROPLASTY	Leakage of bone cement into the spinal canal has been reported to cause many adverse effects. In this study, we designed an implantable balloon kyphoplasty material that avoids cement leakage through the formation of covalent bonds with the bone cement. For this purpose, glycidyl methacrylate (GMA) was used as a reactive functional group attached to the poly(vinyl alcohol) (PVA) membrane. The prepared membrane adhered to poly(methyl methacrylate) (PMMA)-based bone cements within 10 min, which is the time required for PMMA polymerization in the bone cement. The bonding strength between the GMA PVA membrane and the PMMA-based bone cement was higher than that for the original PVA membrane, likely because vinyl bonds form between the surface of the GMA PVA membrane and the bone cement. Since the GMA PVA membrane adhered firmly to the PMMA-based bone cement, the membrane was able to completely cover the PMMA-based bone cement. (C) 2014 Wiley Periodicals, Inc.	[Inoue, Motoki; Taguchi, Tetsushi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, Nanolife Field, Biomat Unit, Tsukuba, Ibaraki 3050044, Japan; [Sakane, Masataka] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan	Taguchi, T (reprint author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, Nanolife Field, Biomat Unit, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	taguchi.tetsushi@nims.go.jp			Ibaraki Biomedical Engineering research	We thank Ms. Hiroko Imai of the Biomaterial unit, National Institute for Materials Science of Japan, for her technical support. This research was supported by the Ibaraki Biomedical Engineering research to clinical application program.	PEPPAS NA, 1977, J BIOMED MATER RES, V11, P423, DOI 10.1002/jbm.820110309; COOPER C, 1992, J BONE MINER RES, V7, P221; Kettler A, 2006, CLIN BIOMECH, V21, P676, DOI 10.1016/j.clinbiomech.2006.02.005; Bader RA, 2008, J BIOMED MATER RES A, V86A, P494, DOI 10.1002/jbm.a.31637; Zheng ZM, 2007, SPINE, V32, P2076, DOI 10.1097/BRS.0b013e3181453f64; Garfin SR, 2001, SPINE, V26, P1511, DOI 10.1097/00007632-200107150-00002; Lieberman IH, 2001, SPINE, V26, P1631, DOI 10.1097/00007632-200107150-00026; HYON SH, 1989, POLYM BULL, V22, P119, DOI 10.1007/BF00255200; [Anonymous], 1995, BONE S, V17, p505S; TANAHASHI M, 1994, J AM CERAM SOC, V77, P2805, DOI 10.1111/j.1151-2916.1994.tb04508.x; Rotter R, 2010, EUR SPINE J, V19, P916, DOI 10.1007/s00586-010-1341-x; Lin EP, 2004, AM J NEURORADIOL, V25, P175; Dudeney S, 2002, J CLIN ONCOL, V20, P2382, DOI 10.1200/JCO.2002.09.097; Fujimoto K, 1993, ACS SYM SER, P228; Ghofrani H, 2010, SPINE, V35, pE768, DOI 10.1097/BRS.0b013e3181d260bf; Kim C, 2007, J SPINAL DISORD TECH, V20, P604; Martin JB, 1999, BONE, V25, p11S, DOI 10.1016/S8756-3282(99)00126-X; NOGUCHI T, 1991, J APPL BIOMATER, V2, P101, DOI 10.1002/jab.770020205; OKA M, 1990, Clinical Materials, V6, P361, DOI 10.1016/0267-6605(90)90053-X; Song P, 2007, J MATER SCI, V42, P2775, DOI 10.1007/s10853-006-1356-1; TABATA Y, 1986, BIOMATERIALS, V7, P234, DOI 10.1016/0142-9612(86)90110-9; Taguchi T, 1998, CHEM LETT, P711, DOI 10.1246/cl.1998.711; Theodorou DJ, 2002, CLIN IMAG, V26, P1, DOI 10.1016/S0899-7071(01)00350-3; Verlaan JJ, 2006, BIOMATERIALS, V27, P290, DOI 10.1016/j.biomaterials.2005.07.028	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4973	1552-4981		J BIOMED MATER RES B	J. Biomed. Mater. Res. Part B	NOV	2014	102	8					1786	1791		10.1002/jbm.b.33165		6	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AQ7PM	WOS:000343011400020		
J	Matsumoto, R; Nara, R; Andou, T; Mie, M; Kobatake, E				Matsumoto, Rie; Nara, Rieko; Andou, Takashi; Mie, Masayasu; Kobatake, Eiry			Targeting of EGF-displayed protein nanoparticles with anticancer drugs	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS			English	Article						elastin-like polypeptide; protein-based nanoparticle; drug delivery system; targeting; epidermal growth factor	ELASTIN-LIKE POLYPEPTIDE; LUNG-CANCER; IN-VIVO; POLYMER; PURIFICATION; BIOCOMPATIBILITY; MUTATIONS; GEFITINIB; DELIVERY; RECEPTOR	The development of protein-based carriers for drug delivery has been well studied. We previously constructed a protein-based nanoparticle consisting of genetically engineered elastin-like polypeptides (ELPs) with a fused polyaspartic acid tail (ELPD). The size of the self-assembled ELPD nanoparticles was regulated by charged repulsion of the poly-aspartic acid chains. In the present study, epidermal growth factor (EGF) was genetically fused to the C-terminus of ELPD to impart an active targeting ability to the ELPD nanoparticles. We examined the nanoparticle formation with EGF as well as its targeting ability. ELPD with fused EGF was found to form nanoparticles that displayed multivalent EGFs on their surface. EGF-displayed nanoparticles loaded with the anti-cancer drug paclitaxel were internalized into cells overexpressing the EGF receptor, and induced cell death. (C) 2014 Wiley Periodicals, Inc.	[Matsumoto, Rie; Nara, Rieko; Andou, Takashi; Mie, Masayasu; Kobatake, Eiry] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Environm Chem & Engn, Midori Ku, Yokohama, Kanagawa 2268502, Japan	Kobatake, E (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Environm Chem & Engn, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	kobatake.e.aa@m.titech.ac.jp	Mie, Masayasu/C-5995-2015	Mie, Masayasu/0000-0003-2255-3346	Japan Society for the Promotion of Science (JSPS)	Contract grant sponsor: Japan Society for the Promotion of Science (JSPS)	McPherson DT, 1996, PROTEIN EXPRES PURIF, V7, P51, DOI 10.1006/prep.1996.0008; Simnick AJ, 2010, ACS NANO, V4, P2217, DOI 10.1021/nn901732h; Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100; Rincon AC, 2006, J BIOMED MATER RES A, V78A, P343, DOI 10.1002/jbm.a.30702; URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306; Kost J, 2012, ADV DRUG DELIVER REV, V64, P327, DOI 10.1016/j.addr.2012.09.014; Dreher MR, 2008, J AM CHEM SOC, V130, P687, DOI 10.1021/ja0764862; Betre H, 2006, J CONTROL RELEASE, V115, P175, DOI 10.1016/j.jconrel.2006.07.022; Fujita Y, 2009, BIOMATERIALS, V30, P3450, DOI 10.1016/j.biomaterials.2009.03.012; Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972; Simnick AJ, 2011, J CONTROL RELEASE, V155, P144, DOI 10.1016/j.jconrel.2011.06.044; Oh JK, 2008, PROG POLYM SCI, V33, P448, DOI 10.1016/j.progpolymsci.2008.01.002; Hassouneh W, 2012, BIOMACROMOLECULES, V13, P1598, DOI 10.1021/bm300321n; Sun GY, 2011, J CONTROL RELEASE, V155, P218, DOI 10.1016/j.jconrel.2011.06.010; Herrero-Vanrell R, 2005, J CONTROL RELEASE, V102, P113, DOI 10.1016/j.jconrel.2004.10.001; Kojima C, 2010, EXPERT OPIN DRUG DEL, V7, P307, DOI 10.1517/17425240903530651; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; BRESSAN GM, 1986, J ULTRA MOL STRUCT R, V94, P209, DOI 10.1016/0889-1605(86)90068-6; Ciofani G, 2014, MACROMOL BIOSCI, V14, P632, DOI 10.1002/mabi.201300361; DAUTRYVARSAT A, 1986, BIOCHIMIE, V68, P375, DOI 10.1016/S0300-9084(86)80004-9; De Campos Vidal B, 1978, J Histochem Cytochem, V26, P196; Hassouneh W, 2013, BIOMACROMOLECULES, V14, P2347, DOI 10.1021/bm400464s; Meyer DE, 2001, BIOTECHNOL PROGR, V17, P720, DOI 10.1021/bp010049o; Sarangthem V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081891; Yui H, 2005, LANGMUIR, V21, P721, DOI 10.1021/la040109a	26	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4973	1552-4981		J BIOMED MATER RES B	J. Biomed. Mater. Res. Part B	NOV	2014	102	8					1792	1798		10.1002/jbm.b.33162		7	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AQ7PM	WOS:000343011400021		
J	Haishima, Y; Hasegawa, C; Nomura, Y; Kawakami, T; Yuba, T; Shindo, T; Sakaguchi, K; Tanigawa, T; Inukai, K; Takenouchi, M; Isama, K; Matsuoka, A; Niimi, S				Haishima, Yuji; Hasegawa, Chie; Nomura, Yusuke; Kawakami, Tsuyoshi; Yuba, Toshiyasu; Shindo, Tomoko; Sakaguchi, Keisuke; Tanigawa, Takahiro; Inukai, Kaori; Takenouchi, Mika; Isama, Kazuo; Matsuoka, Atsuko; Niimi, Shingo			Development and performance evaluation of a positive reference material for hemolysis testing	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS			English	Article						hemolysis test; positive control; biological safety evaluation; guidance	NONIONIC SURFACTANTS; AROMATIC DISULFIDES; TOXICITY; VENOMS; TOXIN	This study deals with the development and performance evaluation of a positive reference material for hemolysis testing, which is used for evaluating the biological safety of medical devices. Genapol X-080, a nonionic detergent, was selected as a candidate hemolytic substance in a survey of 23 chemical compounds; it showed significant hemolytic activity against rabbit defibrinated blood at concentrations more than 20 mu g/mL. A polyvinyl chloride (PVC) sheet spiked with 0.6% (w/w) of the compound exhibited weak hemolytic activity in direct contact and/or extract-based assays after 4 h incubation at 37 degrees C. A PVC sheet containing 5.8% (w/w) Genapol X-080 induced complete hemolysis in both assays. The amount of Genapol X-080 eluted from each PVC sheet during hemolysis testing using the direct contact method increased time-dependently and reached 25.6 (former sheet) or 1154 (later sheet) mu g/mL after 4 h incubation, which was similar to or much higher than the critical micelle concentration, respectively. Similar elution behavior was observed using the extract-based method, and the Genapol X-080 content in test solutions prepared by autoclave extraction of both sheets was 22.5 and 358 mu g/mL, respectively, indicating a clear relationship between the degree of hemolytic activity and the eluted amount of Genapol X-080. Thus, a PVC sheet spiked with a compound exhibiting different hemolytic activity depending on its concentration may be useful as a positive reference material to validate the hemolysis tests. (C) 2014 Wiley Periodicals, Inc.	[Haishima, Yuji; Hasegawa, Chie; Nomura, Yusuke; Niimi, Shingo] Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, Tokyo 1588501, Japan; [Kawakami, Tsuyoshi; Isama, Kazuo] Natl Inst Hlth Sci, Div Environm Chem, Setagaya Ku, Tokyo 1588501, Japan; [Yuba, Toshiyasu] Kawasumi Labs Inc, Corp Res & Dev Div, Minato Ku, Tokyo 1086109, Japan; [Shindo, Tomoko] Hatano Res Inst, Food & Drug Safety Ctr, Hadano, Kanagawa 2578523, Japan; [Sakaguchi, Keisuke; Tanigawa, Takahiro; Inukai, Kaori; Takenouchi, Mika] Terumo Co Ltd, Evaluat Ctr, R&D Headquarters, Nakai, Kanagawa 2590151, Japan; [Matsuoka, Atsuko] Pharmaceut & Med Devices Agcy, Off Stand & Guidelines Dev, Chiyoda Ku, Tokyo 1000013, Japan	Haishima, Y (reprint author), Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	haishima@nihs.go.jp			Health and Labor Sciences Research Grants (Japanese Ministry of Health, Labor, and Welfare) [H23-CHIKYUKIBO-SHITEI-003, H25-CHIKYUKIBO-SHITEI-008]	Contract grant sponsor: Health and Labor Sciences Research Grants (Japanese Ministry of Health, Labor, and Welfare); contract grant number: H23-CHIKYUKIBO-SHITEI-003 and H25-CHIKYUKIBO-SHITEI-008	WATALA C, 1990, COMP BIOCHEM PHYS C, V97, P187, DOI 10.1016/0742-8413(90)90191-B; MUNDAY R, 1985, J APPL TOXICOL, V5, P409, DOI 10.1002/jat.2550050614; [Anonymous], 1099312009 ISO; [Anonymous], 149712007 ISO; [Anonymous], F756082008 ASTM; HEBERT GA, 1985, J CLIN MICROBIOL, V22, P409; [Anonymous], 2006, 1099342002AMD12006 I; GOLDSTEIN S, 1975, ANAL BIOCHEM, V64, P130, DOI 10.1016/0003-2697(75)90414-5; INOUE K, 1976, INFECT IMMUN, V13, P337; MUNDAY R, 1985, J APPL TOXICOL, V5, P414, DOI 10.1002/jat.2550050615; Fiume MM, 2012, INT J TOXICOL, V31, p169S, DOI 10.1177/1091581812444141; Halatek T, 2009, TOXICOL APPL PHARM, V239, P193, DOI 10.1016/j.taap.2009.04.022; HOFLAND HEJ, 1992, J PHARM PHARMACOL, V44, P287; HOSHINO H, 1984, TALANTA, V31, P525, DOI 10.1016/0039-9140(84)80133-2; Japanese Industrial Standards Committee, 2007, K0133 JIS; JENG TW, 1978, P NATL ACAD SCI USA, V75, P600, DOI 10.1073/pnas.75.2.600; Liwarska-Bizukojc E, 2005, CHEMOSPHERE, V58, P1249, DOI 10.1016/j.chemosphere.2004.10.031; Lock RA, 1996, MICROB PATHOGENESIS, V21, P71, DOI 10.1006/mpat.1996.0044; Matsuoka M, 2013, BASIC PRINCIPLES BIO, P189; Matsuoka M, 2013, BASIC PRINCIPLES BIO, P11; National Institute of Health, 1977, DHEW PUBL, P77; Ogra Y, 2005, ANAL CHIM ACTA, V554, P123, DOI 10.1016/j.aca.2005.08.021; Yamashita M, 1988, CHUDOKU KENKYU, V1, P149	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4973	1552-4981		J BIOMED MATER RES B	J. Biomed. Mater. Res. Part B	NOV	2014	102	8					1809	1816		10.1002/jbm.b.33169		8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AQ7PM	WOS:000343011400023		
J	Tsuji, S; Nishikawa, K; Mazuka, R				Tsuji, Sho; Nishikawa, Kenya; Mazuka, Reiko			Segmental distributions and consonant-vowel association patterns in Japanese infant- and adult-directed speech	JOURNAL OF CHILD LANGUAGE			English	Article							SERIAL ORGANIZATION; LEARNING INFANTS; MOTHERS SPEECH; ACQUISITION; ENGLISH; INPUT	Japanese infant-directed speech (IDS) and adult-directed speech (ADS) were compared on their segmental distributions and consonant-vowel association patterns. Consistent with findings in other languages, a higher ratio of segments that are generally produced early was found in IDS compared to ADS: more labial consonants and low-central vowels, but fewer fricatives. Consonant-vowel associations also favored the early produced labial-central, coronal-front, coronal-central, and dorsal-back patterns. On the other hand, clear language-specific patterns included a higher frequency of dorsals, affricates, geminates, and moraic nasals in IDS. These segments are frequent in adult Japanese, but not in the early productions or the IDS of other studied languages. In combination with previous results, the current study suggests that both fine-tuning (an increased use of early produced segments) and highlighting (an increased use of language-specifically relevant segments) might modify IDS on the segmental level.	[Tsuji, Sho] Radboud Univ Nijmegen, Int Max Planck Res Sch Language Sci, NL-6525 ED Nijmegen, Netherlands; [Tsuji, Sho; Nishikawa, Kenya; Mazuka, Reiko] RIKEN, Brain Sci Inst, Lab Language Dev, Wako, Saitama, Japan; [Mazuka, Reiko] Duke Univ, Durham, NC 27706 USA	Tsuji, S (reprint author), Radboud Univ Nijmegen, Int Max Planck Res Sch Language Sci, NL-6525 ED Nijmegen, Netherlands.						MacNeilage PF, 2000, SCIENCE, V288, P527, DOI 10.1126/science.288.5465.527; Kitamura C, 2002, INFANT BEHAV DEV, V24, P372; MacNeilage PF, 2000, CHILD DEV, V71, P153, DOI 10.1111/1467-8624.00129; Soderstrom M, 2007, DEV REV, V27, P501, DOI 10.1016/j.dr.2007.06.002; McLeod S, 2001, AM J SPEECH-LANG PAT, V10, P99, DOI 10.1044/1058-0360(2001/011); Shi RS, 2001, PSYCHOL SCI, V12, P70, DOI 10.1111/1467-9280.00312; Trainor LJ, 2000, PSYCHOL SCI, V11, P188, DOI 10.1111/1467-9280.00240; Werker JF, 2007, COGNITION, V103, P147, DOI 10.1016/j.cognition.2006.03.006; FERNALD A, 1993, CHILD DEV, V64, P637; Beckman M. E., 2003, J PHONETIC SOC JAPAN, V7, P18; Bernhardt B., 1998, HDB PHONOLOGICAL DEV; Boysson-Bardies B., 1991, LANGUAGE, V67, P297; Chen LM, 2005, J CHILD LANG, V32, P507, DOI 10.1017/S0305000905006896; Cohen J., 2003, APPL MULTIPLE REGRES; Cristia A., 2013, LANGUAGE LINGUISTICS, V7, P157, DOI 10.1111/lnc3.12015; Cross T, 1977, TALKING CHILDREN LAN, P151; Daland R., 2012, J CHILD LANGUAGE, DOI 10.1017/S0305000912000372; DAVIS BL, 1990, J SPEECH HEAR RES, V33, P16; Dyson A. T., 2007, INT GUIDE SPEECH ACQ, P288; Edwards J., 2008, LANGUAGE LEARNING DE, V4, P122, DOI 10.1080/15475440801922115; Ferguson Charles A., 1977, TALKING CHILDREN LAN, P209; Fikkert P., 1994, LINGUISTICS NETHERLA, P37; Fox A. V., 2007, INT GUIDE SPEECH ACQ, P386; Goldstein B. A., 2007, INT GUIDE SPEECH ACQ, P539; Hamano S., 1998, STUDIES JAPANESE LIN, V10; Howard S., 2007, INT GUIDE SPEECH ACQ, P188; Ingram David, 1999, DEV LANGUAGE, P73; Jakobson R., 1941, CHILD LANGUAGE APHAS; Kent R. D., 1992, PHONOLOGICAL DEV MOD, P65; Kunnari S., 2007, INT GUIDE SPEECH ACQ, P351; Lee S, 2008, J CHILD LANG, V35, P591, DOI 10.1017/S0305000908008684; Lee S, 2007, PHONETICA, V64, P217, DOI 10.1159/000121374; Lee S, 2000, PROC ANN BUCLD, P486; Lee SAS, 2010, J CHILD LANG, V37, P767, DOI 10.1017/S0305000909009568; Lorwatanapongsa P., 2007, INT GUIDE SPEECH ACQ, P554; Maekawa K., 2003, P ISCA IEEE WORKSH S, P7; Mazuka R., 2006, IEIC TECHNICAL REPOR, V106, P11; Mazuka R, 2008, ORIGINS LANGUAGE, P39, DOI 10.1007/978-4-431-79102-7_4; McLeod S., 2007, INT GUIDE SPEECH ACQ, P313; Mennen I., 2007, INT GUIDE SPEECH ACQ, P398; Murase T., 1992, ANN B SHIMANE U FACU, V17, P37; Ramus F., 2000, COGNITION, V75, pAD3, DOI 10.1016/S0010-0277(00)00101-3; Ratner N. B., 1996, SIGNAL SYNTAX BOOTST, P35; Rose Y., 2007, INT GUIDE SPEECH ACQ, P364; Saito Y., 1997, NIHONGO NO ONSEIGAKU; Smit A. B., 2007, INT GUIDE SPEECH ACQ, P128; SNOW CE, 1977, J CHILD LANG, V4, P1; Uno A., 2007, KOTOBA TO KOKORO NO; Vance Timothy J., 1987, INTRO JAPANESE PHONO; Vihman M. M., 1992, PHONOLOGICAL DEV MOD, P393; VIHMAN MM, 1994, DEV PSYCHOL, V30, P651; VIHMAN MM, 1993, J PHONETICS, V21, P61	52	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0305-0009	1469-7602		J CHILD LANG	J. Child Lang.	NOV	2014	41	6					1276	1304		10.1017/S0305000913000469		29	Psychology, Developmental; Linguistics; Psychology, Experimental	Psychology; Linguistics	AQ6JW	WOS:000342918600004		
J	Syrett, K; Kawahara, S				Syrett, Kristen; Kawahara, Shigeto			Production and perception of listener-oriented clear speech in child language	JOURNAL OF CHILD LANGUAGE			English	Article							CROSS-LINGUISTIC EVIDENCE; INFANT-DIRECTED SPEECH; MOTHERS SPEECH; FALSE-BELIEF; YOUNG-CHILDREN; REPRESENTATION; HYPERSPEECH; REGISTER; PROSODY	In this paper, we ask whether children are sensitive to the needs of their interlocutor, and, if so, whether they - like adults - modify acoustic characteristics of their speech as part of a communicative goal. In a production task, preschoolers participated in a word learning task that favored the use of clear speech. Children produced vowels that were longer, more intense, more dispersed in the vowel space, and had a more expanded F. range than normal speech. Two perception studies with adults showed that these acoustic differences were perceptible and were used to distinguish normal and clear speech styles. We conclude that preschoolers are sensitive to aspects of the speaker-hearer relationship calling upon them to modify their speech in ways that benefit their listener.	[Syrett, Kristen] Rutgers State Univ, New Brunswick, NJ 08901 USA; [Kawahara, Shigeto] Keio Univ, Tokyo 108, Japan	Syrett, K (reprint author), Rutgers State Univ, Dept Linguist, 18 Seminary Pl, New Brunswick, NJ 08901 USA.	k-syrett@ruccs.rutgers.edu		Syrett, Kristen/0000-0002-3773-3035			Andersen E. S., 1992, SPEAKING STYLE; Andersen E. S., 1996, SOCIAL INTERACTION S, P125; Andersen ES, 1999, J PRAGMATICS, V31, P1339, DOI 10.1016/S0378-2166(98)00108-8; Rubio-Fernandez P, 2013, PSYCHOL SCI, V24, P27, DOI 10.1177/0956797612447819; Kuhl PK, 1997, SCIENCE, V277, P684, DOI 10.1126/science.277.5326.684; Syrett K, 2010, J SEMANT, V27, P1, DOI 10.1093/jos/ffp011; Surian L, 1999, BRIT J DEV PSYCHOL, V17, P141, DOI 10.1348/026151099165203; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; SNOW CE, 1972, CHILD DEV, V43, P549, DOI 10.1111/j.1467-8624.1972.tb01123.x; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Fernald A, 2000, PHONETICA, V57, P242, DOI 10.1159/000028477; GOPNIK A, 1988, CHILD DEV, V59, P26, DOI 10.2307/1130386; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; FERNALD A, 1991, DEV PSYCHOL, V27, P209, DOI 10.1037/0012-1649.27.2.209; FERNALD A, 1984, DEV PSYCHOL, V20, P104, DOI 10.1037//0012-1649.20.1.104; Bradlow AR, 1996, SPEECH COMMUN, V20, P255, DOI 10.1016/S0167-6393(96)00063-5; Dale PS, 1996, BEHAV RES METH INS C, V28, P125, DOI 10.3758/BF03203646; Krause JC, 2004, J ACOUST SOC AM, V115, P362, DOI 10.1121/1.1635842; FERNALD A, 1989, J CHILD LANG, V16, P477; LESLIE AM, 1987, PSYCHOL REV, V94, P412, DOI 10.1037/0033-295X.94.4.412; BELL A, 1984, LANG SOC, V13, P145; Boersma P., 2007, PRAAT DOING PHONETIC; Cruttenden A., 1994, INPUT INTERACTION LA, P135; Davis BL, 2001, EMERGING COGNITIVE ABILITIES IN EARLY INFANCY, P135; EBELING KS, 1994, CHILD DEV, V65, P1178; Ferguson C. A., 1977, TALKING CHILDREN LAN, P219; Fernald A., 1992, NONVERBAL VOCAL COMM, P262; FISHER C, 1995, J MEM LANG, V34, P287, DOI 10.1006/jmla.1995.1013; Fisher C, 1996, CHILD DEV, V67, P3192, DOI 10.1111/j.1467-8624.1996.tb01909.x; Foulkes P, 2005, LANGUAGE, V81, P177, DOI 10.1353/lan.2005.0018; GELMAN SA, 1989, CHILD DEV, V60, P920, DOI 10.1111/j.1467-8624.1989.tb03524.x; Igarashi Y, 2008, PROC ANN BUCLD, P177; Kitahara M., 2009, WORKSH PROS INF STRU; Lee S, 2008, J CHILD LANG, V35, P591, DOI 10.1017/S0305000908008684; Lee S., 2009, J CHILD LANG, V37, P767; Lindblom B., 1990, SPEECH PRODUCTION SP, V55, P403; Liu HM, 2003, DEVELOPMENTAL SCI, V6, pF1, DOI 10.1111/1467-7687.00275; Macmillan N. A., 2005, DETECTION THEORY USE; McFarland DA, 2013, AM J SOCIOL, V118, P1596, DOI 10.1086/670240; Newport E. L., 1977, TALKING CHILDREN LAN, P109; Pardo J., 2012, LANGUAGE LINGUISTICS, V6, P743; PERNER J, 1987, BRIT J DEV PSYCHOL, V5, P125; Piaget J, 1951, CHILDS CONCEPTION WO; Pickering M. J., 2006, RES LANGUAGE COMPUTA, V4, P203, DOI DOI 10.1007/S11168-006-9004-0; Redford MA, 2009, J SPEECH LANG HEAR R, V52, P1434, DOI 10.1044/1092-4388(2009/07-0223); Shatz M., 1977, TALKING TO CHILDREN, P189; Shatz Marilyn, 1973, MONOGRAPHS SOC RES C, V152; SHOCKEY L, 1980, PHONETICA, V37, P267; Smiljanic R., 2009, LANGUAGE LINGUISTICS, V3, P236, DOI DOI 10.1111/J.1749-818X.2008.00112.X; Snow C. E., 1995, HDB CHILD LANGUAGE, P180; SWANSON LA, 1994, J SPEECH HEAR RES, V37, P1394; Uchanski RM, 2005, BLACKW HBK LINGUIST, P207, DOI 10.1002/9780470757024.ch9; Wagner L, 2010, CHILD DEV, V81, P1678, DOI 10.1111/j.1467-8624.2010.01502.x; Wassink AB, 2007, J PHONETICS, V35, P363, DOI 10.1016/j.wocn.2006.07.002; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594; Wonnacott E., 2008, COGNITION, V107, P1092	56	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0305-0009	1469-7602		J CHILD LANG	J. Child Lang.	NOV	2014	41	6					1373	1389		10.1017/S0305000913000482		17	Psychology, Developmental; Linguistics; Psychology, Experimental	Psychology; Linguistics	AQ6JW	WOS:000342918600008		
J	Gubinelli, M; Hiroshima, F; Lorinczi, J				Gubinelli, Massimiliano; Hiroshima, Fumio; Lorinczi, Jozsef			Ultraviolet renormalization of the Nelson Hamiltonian through functional integration	JOURNAL OF FUNCTIONAL ANALYSIS			English	Article						Nelson model; Ultraviolet cutoff; Energy renormalization; Feynman-Kac representation	QUANTIZED SCALAR FIELD; WEAK-COUPLING LIMIT; GROUND-STATE; NONRELATIVISTIC PARTICLES; GIBBS MEASURES; BOSE FIELD; MODEL; CUTOFF	Starting from the N-particle Nelson Hamiltonian defined by imposing an ultraviolet cutoff, we perform ultraviolet renormalization by showing that in the ultraviolet cutoff limit a self-adjoint operator exists after a logarithmically divergent term is subtracted from the original Hamiltonian. We obtain this term as the diagonal part of a pair interaction appearing in the density of a Gibbs measure derived from the Feynman-Kac representation of the Hamiltonian. Also, we show existence of a weak coupling limit of the renormalized Hamiltonian and derive an effective Yukawa interaction potential between the particles. (C) 2014 Elsevier Inc. All rights reserved.	[Gubinelli, Massimiliano] Univ Paris 09, CEREMADE, UMR 7534, F-75775 Paris 16, France; [Hiroshima, Fumio] Kyushu Univ, Fac Math, Fukuoka 8190395, Japan; [Lorinczi, Jozsef] Univ Loughborough, Dept Math, Loughborough LE11 3TU, Leics, England	Hiroshima, F (reprint author), Kyushu Univ, Fac Math, 744 Motooka, Fukuoka 8190395, Japan.	massimiliano.gubinelli@ceremade.dauphine.fr; hiroshima@math.kyushu-u.ac.jp; J.Lorinczi@lboro.ac.uk		Gubinelli, Massimiliano/0000-0002-4014-2949	JSPS [20340032]	FH acknowledges support of Grant-in-Aid for Science Research (B) 20340032 from JSPS, and thanks the hospitality of Universite d'Aix-Marseille-Luminy, and Universite de Rennes 1, and Jozsef Lorinczi for an invitation on the workshop Lieb-Thirring-Type Bounds for Perturbations of Feller Processes held at Institut Mittag-Leffler in July 2013, where part of this work has been done. JL thanks IHES, Bures-sur-Yvette, for a visiting fellowship, where part of this work has been done, and gratefully thanks Fumio Hiroshima for an invitation to the workshop Quantum Field Theory and Related Topics, held at RIMS Kyoto in November 2012.	AIZENMAN M, 1982, COMMUN PUR APPL MATH, V35, P209, DOI 10.1002/cpa.3160350206; Bach V, 1998, ADV MATH, V137, P299, DOI 10.1006/aima.1998.1734; NELSON E, 1964, J MATH PHYS, V5, P1190, DOI 10.1063/1.1704225; Gubinelli M, 2009, COMMUN PUR APPL MATH, V62, P1, DOI 10.1002/cpa.20260; Arai A, 2001, REV MATH PHYS, V13, P1075, DOI 10.1142/S0129055X01000934; Betz V, 2002, REV MATH PHYS, V14, P173, DOI 10.1142/S0129055X02001119; Betz V, 2009, INFIN DIMENS ANAL QU, V12, P135; Cycon H., 2008, SCHRODINGER OPERATOR; DAVIES EB, 1979, J MATH PHYS, V20, P345, DOI 10.1063/1.524082; Flandoli F, 2002, PROBAB THEORY REL, V122, P317, DOI 10.1007/s004400100163; Gerard C, 2000, ANN HENRI POINCARE, V1, P443, DOI 10.1007/s000230050002; Gerard C, 2012, LETT MATH PHYS, V101, P305, DOI 10.1007/s11005-012-0577-2; Hirokawa M, 2005, ADV MATH, V191, P339, DOI 10.1016/j.aim.2004.03.011; Hirokawa M, 2006, PUBL RES I MATH SCI, V42, P897, DOI 10.2977/prims/1166642191; Hiroshima F, 1999, J MATH PHYS, V40, P1215, DOI 10.1063/1.532796; Le Gall J. F., 1994, LECT NOTES MATH, V1583, P172; Le Gall J. F., 1985, LECT NOTES MATH, V1123, P314; Lorinczi J., 2011, DEGRUYTER STUD MATH, V34; Lorinczi J., 2002, ANN HENRI POINCARE, V3, P1; Nelson E., 1964, P C AN FUNCT SPAC, P87; Sasaki I, 2005, J MATH PHYS, V46, DOI 10.1063/1.2050507; SPOHN H, 1987, ANN PHYS-NEW YORK, V175, P278, DOI 10.1016/0003-4916(87)90211-9; Spohn H, 1998, LETT MATH PHYS, V44, P9, DOI 10.1023/A:1007473300274; YOR M, 1986, LECT NOTES MATH, V1204, P543; Yor M., 1985, LECT NOTES MATH, V1123, P350; Yor M., 1985, LECT NOTES MATH, V1123, P332	26	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-1236	1096-0783		J FUNCT ANAL	J. Funct. Anal.	NOV 1	2014	267	9					3125	3153		10.1016/j.jfa.2014.08.002		29	Mathematics	Mathematics	AQ7SP	WOS:000343019800002		
J	Iizuka, Y; Iizuka, H; Nagano, K; Tsutsumi, S; Nakajima, T; Takagishi, K				Iizuka, Yoichi; Iizuka, Haku; Nagano, Kenichi; Tsutsumi, Satoshi; Nakajima, Takashi; Takagishi, Kenji			Laminoplasty preserving the deep extensor musculature for a pediatric cervicothoracic epidural hematoma case of hemophilia A	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						extensor musculature into the C2 spinous process; laminoplasty; pediatric cervical lesion	CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD COMPRESSION; OSTEOPLASTIC LAMINOTOMY; CONSERVATIVE MANAGEMENT; INTRAMEDULLARY TUMORS; COLUMN DEFORMITY; CERVICAL-SPINE; CHILDREN; INFANT; SURGERY	Postoperative malalignment after either a laminectomy or a laminoplasty in pediatric cases is a well-known complication. A 5-year-old boy with a history of hemophilia A presented with severe paresis. MRI showed an extensive epidural hematoma extending from C2 to T1. We performed decompression of the spinal cord using laminoplasty, preserving the insertion of the deep extensors. The patient completely recovered from the paresis. Even 7 years after the surgery we could not find any kyphotic deformities. The use of laminoplasty preserving the deep extensor musculature may be crucial for maintaining the postoperative cervical alignment in pediatric patients. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Iizuka, Yoichi; Iizuka, Haku; Nagano, Kenichi; Tsutsumi, Satoshi; Nakajima, Takashi; Takagishi, Kenji] Gunma Univ, Grad Sch Med, Dept Orthopaed Surg, Maebashi, Gumma 3718511, Japan	Iizuka, Y (reprint author), Gunma Univ, Grad Sch Med, Dept Orthopaed Surg, 3-39-22 Showa, Maebashi, Gumma 3718511, Japan.	yiizuka@med.gunma-u.ac.jp					ABBOTT R, 1992, PEDIATR NEUROSURG, V18, P153, DOI 10.1159/000120656; ABDELAAL MA, 1994, CLIN RADIOL, V49, P573, DOI 10.1016/S0009-9260(05)82941-1; Aggeler PM, 1944, J NERV MENT DIS, V99, P475, DOI 10.1097/00005053-194405000-00004; Takeshita K, 2005, SPINE, V30, P1294, DOI 10.1097/01.brs.0000163881.32008.13; Yeh JS, 2001, PEDIATR NEUROSURG, V35, P318, DOI 10.1159/000050444; Holtas S, 1996, RADIOLOGY, V199, P409; LUNARDI P, 1993, ACTA NEUROCHIR, V120, P59, DOI 10.1007/BF02001471; Iizuka H, 2001, SPINE, V26, P2220, DOI 10.1097/00007632-200110150-00013; Takeuchi K, 2005, SPINE, V30, P2544, DOI 10.1097/01.brs.0000186332.66490.ba; YASUOKA S, 1982, J NEUROSURG, V57, P441, DOI 10.3171/jns.1982.57.4.0441; Papagelopoulos PJ, 1997, SPINE, V22, P442, DOI 10.1097/00007632-199702150-00019; RAIMONDI AJ, 1976, J NEUROSURG, V45, P555, DOI 10.3171/jns.1976.45.5.0555; Balkan C, 2006, HAEMOPHILIA, V12, P437, DOI 10.1111/j.1365-2516.2006.01286.x; Bisson EF, 2007, CAN J NEUROL SCI, V34, P488; Borkar Sachin A, 2011, J Pediatr Neurosci, V6, P131, DOI 10.4103/1817-1745.92837; Chretiennot-Bara C, 2001, ARCH PEDIATRIE, V8, P828, DOI 10.1016/S0929-693X(01)00542-5; Connolly ES, 1996, SPINE, V21, P1694, DOI 10.1097/00007632-199607150-00016; CROMWELL LD, 1977, AM J ROENTGENOL, V128, P847; Cuvelier GDE, 2006, HAEMOPHILIA, V12, P683, DOI 10.1111/j.1365-2516.2006.01323.x; PINTO MD, 1992, HAEMOSTASIS, V22, P259; DOUGLAS A S, 1956, Scott Med J, V1, P270; Eftekhar Behzad, 2003, BMC Neurol, V3, P2, DOI 10.1186/1471-2377-3-2; FAILLACE WJ, 1989, CLIN PEDIATR, V28, P136, DOI 10.1177/000992288902800307; FESSEY BM, 1966, BRIT MED J, V2, P211; Fujimura Y, 1996, ARCH ORTHOP TRAUM SU, V115, P203, DOI 10.1007/BF00434554; HAMRE MR, 1992, AM J PEDIAT HEMATOL, V14, P166; Heer JS, 2008, J EMERG MED, V34, P159, DOI 10.1016/j.jemermed.2007.02.061; Hutt J, 1996, J PEDIAT, V128, P704; Iizuka H, 2007, J NEUROSURG-SPINE, V7, P610, DOI 10.3171/SPI-07/12/610; Irwin SL, 2001, PEDIATR EMERG CARE, V17, P40, DOI 10.1097/00006565-200102000-00012; Ito T, 1985, SPINE, V10, P729; Iwamuro H, 2004, ACTA NEUROCHIR, V146, P1263, DOI 10.1007/s00701-004-0358-5; JONES RK, 1956, ANN SURG, V144, P1029, DOI 10.1097/00000658-195612000-00013; JOST W, 1990, MONATSSCHR KINDERH, V138, P36; Kalina Peter, 2008, Emerg Radiol, V15, P281, DOI 10.1007/s10140-007-0667-0; KEELY ML, 1972, ARCH DIS CHILD, V47, P826; Kiehna EN, 2010, J NEUROSURG-PEDIATR, V6, P43, DOI 10.3171/2010.4.PEDS09537; MACFARLANE RG, 1957, LANCET, V2, P251; McGirt MJ, 2008, J NEUROS-PEDIATR, V1, P57, DOI 10.3171/PED-08/01/057; NARAWONG D, 1988, PEDIATR NEUROL, V4, P169, DOI 10.1016/0887-8994(88)90006-9; NOTH I, 1993, AM J PEDIAT HEMATOL, V15, P131; Priest WM, 1935, LANCET, V2, P1289; Raab P, 2008, INT ORTHOP, V32, P355, DOI 10.1007/s00264-007-0325-x; Rathi N, 2010, BMJ CASE REP, DOI [10.1136/bcr.05.2010.2997, DOI 10.1136/BCR.05.2010.2997]; Groen RJM, 1996, NEUROSURGERY, V39, P494, DOI 10.1097/00006123-199609000-00012; Rois PV, 2009, CHILD NERV SYST, V25, P987, DOI 10.1007/s00381-009-0861-3; SCHILLER F, 1948, Lancet, V2, P842; SHEIKH AA, 1994, PEDIATR EMERG CARE, V10, P26, DOI 10.1097/00006565-199402000-00008; STANLEY P, 1983, PEDIATR RADIOL, V13, P241, DOI 10.1007/BF00973167; Steinbok P, 2008, CHILD NERV SYST, V24, P369, DOI 10.1007/s00381-007-0530-3; Tagaya A, 2010, PEDIATR INT, V52, P296, DOI 10.1111/j.1442-200X.2010.03033.x; Travis SF, 1996, J PEDIAT HEMATOL ONC, V18, P308, DOI 10.1097/00043426-199608000-00016; TSUJI H, 1982, SPINE, V7, P28, DOI 10.1097/00007632-198200710-00002; VISCONTI EB, 1980, PAEDIATRICIAN, V9, P127	54	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	NOV	2014	23	6					584	588		10.1097/BPB.0000000000000095		5	Orthopedics; Pediatrics	Orthopedics; Pediatrics	AQ4LQ	WOS:000342768900004		
J	Saito, K; Kikuchi, Y; Saito, R				Saito, Koichi; Kikuchi, Yuu; Saito, Rieko			Solid-phase dispersive extraction method for analysis of benzodiazepine drugs in serum and urine samples	JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS			English	Article						Solid-phase dispersive extraction; Benzodiazepine; LC/TOF-MS; Abused prescription drug; Forensic science	MICROEXTRACTION; CHROMATOGRAPHY; METABOLITES; ETIZOLAM; SOLVENT; PLASMA; SINGLE; MS	A simple yet highly efficient pretreatment method called solid-phase dispersive extraction (SPDE) was developed and used in combination with liquid chromatography/time-of-flight mass spectrometry (LC/TOF-MS) for the analysis of benzodiazepines (BZPs) in serum and urine samples. By using a custommade centrifugal filter, SPDE could be performed in a closed system, thereby minimizing exposure to infectious microbes or hazardous chemicals. The limit of detection and the limit of quantification of nine BZPs were 1-10 and 5-50 ng/mL, respectively. The average recoveries of BZPs from pooled serum samples spiked at 50 and 500 ng/mL were 89.6-105.0% (RSD: 2.1-6.8%) and 93.6-110.4% (RSD: 2.1-4.2%), respectively, and those from urine samples were 88.7-105.5% (RSD: 2.9-6.4%) and 91.5-101.1% (RSD: 3.6-5.5%), respectively. SPDE-LC/TOF-MS has potential application in forensic science and emergency medicine. (C) 2014 Elsevier B.V. All rights reserved.	[Saito, Koichi; Kikuchi, Yuu; Saito, Rieko] Hoshi Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Shinagawa Ku, Tokyo 1428501, Japan	Saito, K (reprint author), Hoshi Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.	k-saitok@hoshi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [20590043]	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant No. 20590043).	Rezaee M, 2006, J CHROMATOGR A, V1116, P1, DOI 10.1016/j.chroma.2006.03.007; Tienpont B, 2003, J PHARMACEUT BIOMED, V32, P569, DOI 10.1016/S0731-7085(03)00164-X; He Y, 1997, ANAL CHEM, V69, P4634, DOI 10.1021/ac970242q; Marin SJ, 2008, J ANAL TOXICOL, V32, P491; Baltussen E, 1999, J MICROCOLUMN SEP, V11, P737, DOI 10.1002/(SICI)1520-667X(1999)11:10<737::AID-MCS7>3.0.CO;2-4; Anastassiades M, 2003, J AOAC INT, V86, P412; Nakamura M, 2009, BIOMED CHROMATOGR, V23, P357, DOI 10.1002/bmc.1122; Reubsaet KJ, 1998, J PHARMACEUT BIOMED, V18, P667; ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019; Bidlingmeyer B.A., 1984, LC MAG, V2, P578; FRACASSO C, 1991, EUR J CLIN PHARMACOL, V40, P181; Leoung M.I., 2008, J CHROMATOGR A, V1211, P8; Nakamae T, 2008, FORENSIC SCI INT, V182, pE1, DOI 10.1016/j.forsciint.2008.08.012; Saito R., 2010, P 54 S PHARM SOC JAP, P107; Sakamoto Y, 2014, ANAL SCI, V30, P271; Ugland HG, 2000, J CHROMATOGR B, V749, P85, DOI 10.1016/S0378-4347(00)00382-0	16	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0731-7085	1873-264X		J PHARMACEUT BIOMED	J. Pharm. Biomed. Anal.	NOV	2014	100						28	32		10.1016/j.jpba.2014.07.020		5	Chemistry, Analytical; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	AQ7TC	WOS:000343021100004		
J	Ajiro, H; Ueyama, T; Akashi, M				Ajiro, Hiroharu; Ueyama, Tatsuaki; Akashi, Mitsuru			Temperature Effect on Template Polymerization of Methacrylic Acid Using Stereocomplex Formation on Quartz Crystal Microbalance Substrates	JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY			English	Article						infrared spectroscopy; stereospecific polymers; surfaces; templates	ISOTACTIC POLY(METHYL METHACRYLATE); METHYL-METHACRYLATE; THIN-FILMS; RADICAL POLYMERIZATION; STEREOREGULAR TEMPLATE; FUNCTIONAL MONOMERS; POLYMERS; SOLVENT; RECOGNITION; ASSEMBLIES	The radical polymerization of methacrylic acid (MAA) at 0, 20, 40, and 70 degrees C was achieved in porous isotactic (it-) poly (methyl methacrylate) (PMMA) films on quartz crystal microbalance (QCM) substrates, which were prepared by layer-by-layer assembled stereocomplex films of it-PMMA and syndiotactic (st-) poly(methacrylic acid) (PMAA), followed by the subsequent extraction of st-PMAA. The MAA polymerization yields increased from 35 to 75%, as the polymerization temperature increased from 0 to 70 degrees C. Furthermore, infrared spectroscopy revealed that a higher polymerization temperature is necessary to form it-PMMA/st-PMAA stereocomplexes via stereoregular polymerization manner that resemble native it-PMMA/st-PMAA stereocomplexes. X-ray diffraction pattern of porous it-PMMA were also investigated for reaction fields. (c) 2014 Wiley Periodicals, Inc.	[Ajiro, Hiroharu; Ueyama, Tatsuaki; Akashi, Mitsuru] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Ajiro, Hiroharu; Akashi, Mitsuru] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan	Akashi, M (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	akashi@chem.eng.osaka-u.ac.jp			Sekisui-Kagaku Research-Aid Program on "The Nature-Guided Materials Processing"; Ministry of Education, Culture, Sports, Science and Technology [23225004, 26620182]; MEXT project, "Creating Hybrid Organs of the future" at Osaka University	This work was partially supported by Sekisui-Kagaku Research-Aid Program on "The Nature-Guided Materials Processing" and a Grant-in-Aid for Scientific Research (S) (23225004) and a Grant-in-Aid for Challenging Exploratory Research (26620182) from the Ministry of Education, Culture, Sports, Science and Technology. This work was also supported in part by the MEXT project, "Creating Hybrid Organs of the future" at Osaka University.	Ajiro H, 2012, MACROMOLECULES, V45, P7660, DOI 10.1021/ma301418u; Ajiro H, 2008, J POLYM SCI POL CHEM, V46, P5879, DOI 10.1002/pola.22905; Ajiro H, 2010, J POLYM SCI POL CHEM, V48, P3265, DOI 10.1002/pola.24103; Ajiro H, 2009, POLYM J, V41, P90, DOI 10.1295/polymj.PJ2008192; Ajiro H, 2009, MACROMOLECULES, V42, P3019, DOI 10.1021/ma8028634; Ajiro H, 2012, J POLYM SCI POL CHEM, V50, P1469, DOI 10.1002/pola.25925; AKASHI M, 1979, J POLYM SCI POL CHEM, V17, P747, DOI 10.1002/pol.1979.170170312; AKASHI M, 1979, J POLYM SCI POL CHEM, V17, P905, DOI 10.1002/pol.1979.170170327; Hamada K, 2005, MACROMOLECULES, V38, P6759, DOI 10.1021/ma050963o; Polowinski S, 2002, PROG POLYM SCI, V27, P537, DOI 10.1016/S0079-6700(01)00035-1; Serizawa T, 2001, MACROMOLECULES, V34, P1996, DOI 10.1021/ma001705o; Serizawa T, 2004, NATURE, V429, P52, DOI 10.1038/nature02525; Ajiro H, 2013, MACROMOL CHEM PHYS, V214, P1590, DOI 10.1002/macp.201300207; Ren JM, 2014, ANGEW CHEM INT EDIT, V53, P459, DOI 10.1002/anie.201308366; KITAYAMA T, 1995, POLYM J, V27, P314, DOI 10.1295/polymj.27.314; Asai S, 2007, POLYMER, V48, P5116, DOI 10.1016/j.polymer.2007.06.065; BUTER R, 1973, J POLYM SCI POL CHEM, V11, P1013, DOI 10.1002/pol.1973.170110508; BUTER R, 1973, J POLYM SCI POL CHEM, V11, P2975, DOI 10.1002/pol.1973.170111116; CHALLA G, 1981, PURE APPL CHEM, V53, P627, DOI 10.1351/pac198153030627; Corenkamp E. J., 1979, POLYMER, V20, P59; Escude NC, 2012, POLYM CHEM-UK, V3, P3247, DOI 10.1039/c2py20525d; FOX TG, 1958, J AM CHEM SOC, V80, P1768, DOI 10.1021/ja01540a068; Goh TK, 2009, ANGEW CHEM INT EDIT, V48, P8707, DOI 10.1002/anie.200903932; HATADA K, 1985, POLYM J, V17, P977, DOI 10.1295/polymj.17.977; Kamei D, 2010, POLYM J, V42, P131, DOI 10.1038/pj.2009.324; Kamei D, 2010, J POLYM SCI POL CHEM, V48, P3651, DOI 10.1002/pola.24148; Kamei D, 2009, LANGMUIR, V25, P280, DOI 10.1021/la802466p; Kamei D., 2008, CHEM LETT, V37, P332, DOI 10.1246/cl.2008.332; Kida T, 2012, LANGMUIR, V28, P15378, DOI 10.1021/la303120t; Kida T, 2006, ANGEW CHEM INT EDIT, V45, P7534, DOI 10.1002/anie.200602116; Kumaki J., 2007, ANGEW CHEM INT EDIT, V46, P5328; KUSY RP, 1976, J POLYM SCI POL CHEM, V14, P1527, DOI 10.1002/pol.1976.170140619; Maegawa M, 2013, POLYM J, V45, P898, DOI 10.1038/pj.2012.236; MIHAILOV M, 1973, MACROMOLECULES, V6, P511, DOI 10.1021/ma60034a008; Nishiura T, 2010, POLYM J, V42, P868, DOI 10.1038/pj.2010.91; SCHOMAKER E, 1989, MACROMOLECULES, V22, P3337, DOI 10.1021/ma00198a025; Serizawa T, 2003, ANGEW CHEM INT EDIT, V42, P1118, DOI 10.1002/anie.200390294; Serizawa T, 2000, LANGMUIR, V16, P7112, DOI 10.1021/la000241k; Serizawa T., 2000, J AM CHEM SOC, V122, P1897; Woo EM, 2012, MACROMOL CHEM PHYS, V213, P1688, DOI 10.1002/macp.201200111	40	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-624X	1099-0518		J POLYM SCI POL CHEM	J. Polym. Sci. Pol. Chem.	NOV 1	2014	52	21					3032	3036		10.1002/pola.27350		5	Polymer Science	Polymer Science	AQ5FA	WOS:000342830600004		
J	Itsuno, S; Hashimoto, Y; Haraguchi, N				Itsuno, Shinichi; Hashimoto, Yosuke; Haraguchi, Naoki			Synthesis of Chiral Iridium Complexes Immobilized on Amphiphilic Polymers and Their Application to Asymmetric Catalysis	JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY			English	Article						asymmetric transfer hydrogenation; catalysts; chiral Ir complex; crosslinking; cyclic amine; cyclic imine; polymeric catalyst; polystyrens	TRANSFER HYDROGENATION; SULTAM AUXILIARIES; IMINES; KETONES; WATER; ENANTIOSELECTIVITY; POLYMERIZATION; RUTHENIUM(II); REDUCTION; EFFICIENT	This article details the enantioselective catalytic performance of crosslinked, polymer immobilized, Ir-based, chiral complexes for transfer hydrogenation of cyclic imines to chiral amines. Polymerization of the achiral vinyl monomer, divinylbenzene, and a polymerizable chiral 1,2-diamine monosulfonamide ligand followed by complexation with [IrCl2Cp*](2) affords the crosslinked polymeric chiral complex, which can be successfully applied to asymmetric transfer hydrogenation of cyclic imines. Polymeric catalysts prepared from amphiphilic achiral monomers have high catalytic activity in the reaction and can be used both in organic solvents and water to give chiral cyclic amines with a high level of enantioselectivity (up to 98% ee). The asymmetric reaction allows for reuse of the heterogeneous catalyst without any loss in activity or enantioselectivity over several runs. (c) 2014 Wiley Periodicals, Inc.	[Itsuno, Shinichi; Hashimoto, Yosuke; Haraguchi, Naoki] Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi 4418580, Aichi, Japan	Itsuno, S (reprint author), Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi 4418580, Aichi, Japan.	itsuno@ens.tut.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [25102515]	This work was partially supported by a Grant-in-Aid for Scientific Research on Innovative Areas "New Polymeric Materials Based on Element-Blocks" (No. 25102515) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Han J, 2011, CHEM COMMUN, V47, P4004, DOI 10.1039/c0cc05289b; Tang ZL, 2012, ACS MACRO LETT, V1, P261, DOI 10.1021/mz200161s; Haraguchi N, 2009, ORG BIOMOL CHEM, V7, P69, DOI 10.1039/b815407b; Mao JM, 1999, ORG LETT, V1, P841, DOI 10.1021/ol990098q; Uematsu N, 1996, J AM CHEM SOC, V118, P4916, DOI 10.1021/ja960364k; Dimroth J, 2010, ADV SYNTH CATAL, V352, P2497, DOI 10.1002/adsc.201000340; Cai JL, 2013, RSC ADV, V3, P18661, DOI 10.1039/c3ra42076k; Gao XS, 2014, CHEM-EUR J, V20, P1515, DOI 10.1002/chem.201302797; Parvez MM, 2014, MACROMOLECULES, V47, P1922, DOI 10.1021/ma5001018; Rueping M, 2005, ORG LETT, V7, P3781, DOI 10.1021/ol0515964; Cortez NA, 2008, TETRAHEDRON-ASYMMETR, V19, P1304, DOI 10.1016/j.tetasy.2008.04.036; Ahn KH, 1997, J ORG CHEM, V62, P7047, DOI 10.1021/jo970917p; Ikariya T, 2007, ACCOUNTS CHEM RES, V40, P1300, DOI 10.1021/ar700134q; HASHIGUCHI S, 1995, J AM CHEM SOC, V117, P7562, DOI 10.1021/ja00133a037; ISHIZONE T, 1992, MACROMOLECULES, V25, P4840, DOI 10.1021/ma00045a002; Sugie H, 2014, J ORGANOMET CHEM, V751, P711, DOI 10.1016/j.jorganchem.2013.09.008; OPPOLZER W, 1990, TETRAHEDRON LETT, V31, P4117, DOI 10.1016/S0040-4039(00)97557-9; Kobayashi S, 1999, CHEM REV, V99, P1069, DOI 10.1021/cr980414z; Arakawa Y, 2008, ADV SYNTH CATAL, V350, P2295, DOI 10.1002/adsc.200800362; Arakawa Y, 2006, TETRAHEDRON LETT, V47, P3239, DOI 10.1016/j.tetlet.2006.03.041; Brunel J. M., 2003, RECENT RES DEV ORG C, V7, P155; Cobley C. J., 2003, ADV SYNTH CATAL, V345, P95; Cornils B., 2004, AQUEOUS PHASE ORGANO, P351; Haraguchi N., 2011, POLYM CHIRAL CATALYS, P17; Haraguchi N., 2010, J POLYM SCI A, P3340; Hoffmann S, 2005, ANGEW CHEM INT EDIT, V44, P7424, DOI 10.1002/anie.200503062; Itsuno S., 2008, HDB ASYMMETRIC HETER, P73, DOI 10.1002/9783527623013.ch3; Li YZ, 2005, ORG BIOMOL CHEM, V3, P2513, DOI 10.1039/b505943g; Liu PN, 2004, CHEM COMMUN, P2070, DOI 10.1039/b408533g; Luis S. V., 2011, POLYMERIC CHIRAL CAT, P125; Noyori R, 1997, ACCOUNTS CHEM RES, V30, P97, DOI 10.1021/ar9502341; Rueping M, 2006, ANGEW CHEM INT EDIT, V45, P3683, DOI 10.1002/anie.200600191; terHalle R, 1997, SYNLETT, P1257; Verdaguer X, 1998, ANGEW CHEM INT EDIT, V37, P1103, DOI 10.1002/(SICI)1521-3773(19980504)37:8<1103::AID-ANIE1103>3.0.CO;2-M; Wu JS, 2006, CHEM COMMUN, P1766, DOI 10.1039/b600496b	35	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-624X	1099-0518		J POLYM SCI POL CHEM	J. Polym. Sci. Pol. Chem.	NOV 1	2014	52	21					3037	3044		10.1002/pola.27351		8	Polymer Science	Polymer Science	AQ5FA	WOS:000342830600005		
J	Hayashi, S; Koizumi, T				Hayashi, Shotaro; Koizumi, Toshio			Solubility Switching of Fluorescent Polymer Films via Lewis Acid-Base Vapor Treatments	JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY			English	Article						charge transfer; conjugated polymers; fluorescence; UV-vis spectroscopy	PYRIDINE; IMPURITIES; BEHAVIOR			Hayashi, S (reprint author), 1-10-20 Hashirimizu, Yokosuka, Kanagawa 2398686, Japan.	shayashi@nda.ac.jp			 [24750116]	The authors of this article thank Grant-in-Aid for Young Scientists (B), No. 24750116, for financial support of this research.	Smith ZC, 2012, ACS MACRO LETT, V1, P825, DOI 10.1021/mz300216s; Chen SH, 2005, MACROMOLECULES, V38, P379, DOI 10.1021/ma048162t; Yoon SJ, 2010, J AM CHEM SOC, V132, P13675, DOI 10.1021/ja1044665; Kosa T, 2012, NATURE, V485, P347, DOI 10.1038/nature11122; Zalar P, 2012, ANGEW CHEM INT EDIT, V51, P7495, DOI 10.1002/anie.201202570; Henckens A, 2006, POLYMER, V47, P123, DOI 10.1016/j.polymer.2005.11.007; Sagara Y, 2009, NAT CHEM, V1, P605, DOI [10.1038/nchem.411, 10.1038/NCHEM.411]; Beaujuge PM, 2008, NAT MATER, V7, P795, DOI 10.1038/nmat2272; Chi ZG, 2012, CHEM SOC REV, V41, P3878, DOI 10.1039/c2cs35016e; Bouffard J, 2010, MACROMOLECULES, V43, P1425, DOI 10.1021/ma902442r; Cugola R, 2006, THIN SOLID FILMS, V511, P489, DOI 10.1016/j.tsf.2005.12.092; Erwin MM, 2002, THIN SOLID FILMS, V409, P198, DOI 10.1016/S0040-6090(02)00124-4; Hayashi S, 2012, CHEM LETT, V41, P979, DOI 10.1246/cl.2012.979; Hayashi S, 2013, RSC ADV, V3, P7375, DOI 10.1039/c3ra40945g; Hayashi S, 2011, POLYM CHEM-UK, V2, P2764, DOI 10.1039/c1py00363a; Johnson RS, 2011, CHEM COMMUN, V47, P3936, DOI 10.1039/c1cc00090j; Muramatsu Y, 2001, POLYMER, V42, P6673, DOI 10.1016/S0032-3861(01)00136-7; Rep DBA, 2003, J APPL PHYS, V93, P2082, DOI 10.1063/1.1538338; Tanaka D, 2013, POLYM J, V45, P1153, DOI 10.1038/pj.2013.46	19	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-624X	1099-0518		J POLYM SCI POL CHEM	J. Polym. Sci. Pol. Chem.	NOV 1	2014	52	21					3142	3145		10.1002/pola.27366		4	Polymer Science	Polymer Science	AQ5FA	WOS:000342830600016		
J	Miyamoto, S; Jarskog, LF; Fleischhacker, WW				Miyamoto, Seiya; Jarskog, L. Fredrik; Fleischhacker, W. Wolfgang			New therapeutic approaches for treatment-resistant schizophrenia: A look to the future	JOURNAL OF PSYCHIATRIC RESEARCH			English	Review						Schizophrenia; Treatment-resistant schizophrenia; Clozapine; Electroconvulsive therapy; Repetitive transcranial magnetic; stimulation; Transcranial direct current stimulation	TRANSCRANIAL MAGNETIC STIMULATION; AUDITORY VERBAL HALLUCINATIONS; PLACEBO-CONTROLLED-TRIAL; TOPIRAMATE ADD-ON; DOUBLE-BLIND; ELECTROCONVULSIVE-THERAPY; LAMOTRIGINE AUGMENTATION; CLOZAPINE; METAANALYSIS; CORTEX	Schizophrenia for many patients is a lifelong mental disorder with significant consequences on most functional domains. One fifth to one third of patients with schizophrenia experience persistent psychotic symptoms despite adequate trials of antipsychotic treatment, and are considered to have treatment-resistant schizophrenia (TRS). Clozapine is the only medication to demonstrate efficacy for psychotic symptoms in such patients. However, clozapine is not effective in 40%-70% of patients with TRS and it has significant limitations in terms of potentially life-threatening side effects and the associated monitoring. Accordingly, a number of pharmacological and non-pharmacological biological approaches for clozapine-resistant TRS have emerged. This article provides a brief updated critical review of recent therapeutic strategies for TRS, particularly for clozapine-resistant TRS, which include pharmacotherapy, electroconvulsive therapy, repetitive transcranial magnetic stimulation, and transcranial direct current stimulation. (C) 2014 Elsevier Ltd. All rights reserved.	[Miyamoto, Seiya] St Marianna Univ, Sch Med, Dept Neuropsychiat, Kawasaki, Kanagawa 2168511, Japan; [Jarskog, L. Fredrik] Univ N Carolina, North Carolina Psychiat Res Ctr, Dept Psychiat, Chapel Hill, NC USA; [Fleischhacker, W. Wolfgang] Med Univ Innsbruck, Dept Psychiat & Psychotherapy, A-6020 Innsbruck, Austria	Miyamoto, S (reprint author), St Marianna Univ, Sch Med, Dept Neuropsychiat, Miyamae Ku, 2-16-1,Sugao, Kawasaki, Kanagawa 2168511, Japan.	s2miya@marianna-u.ac.jp; jarskog@med.unc.edu; wolfgang.fleischhacker@i-med.ac.at			Otsuka; Genentech; Amgen; Sunovion; Janssen Cilag; Reckitt Benckiser; Pfizer; Sanofi; Janssen; Roche; Lundbeck	Dr. Miyamoto is a consultant for Dainippon Sumitomo Pharmaceutical. He has received advisory board honoraria from Chugai Pharmaceutical and speaking fees from Otsuka. Dr. Jarskog has received grant support from Genentech, Amgen, and Sunovion. He has been a member of a Data Monitoring Committee for Janssen. Dr. Fleischhacker has received research grants from Janssen Cilag, Otsuka, Reckitt Benckiser, and Pfizer. He has received speaking fees from Sanofi, Janssen, Roche, Lundbeck, Otsuka and advisory board honoraria from Otsuka, Merck, Janssen, Amgen, Lundbeck, Endo, Roche, and Targacept.	Afshar H, 2009, J PSYCHOPHARMACOL, V23, P157, DOI 10.1177/0269881108089816; Andrade C, 2013, J CLIN PSYCHIAT, V74, pE1054, DOI 10.4088/JCP.13f08826; KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; Tiihonen J, 2009, SCHIZOPHR RES, V109, P10, DOI 10.1016/j.schres.2009.01.002; Hoogendam JM, 2010, BRAIN STIMUL, V3, P95, DOI 10.1016/j.brs.2009.10.005; Slotema CW, 2010, J CLIN PSYCHIAT, V71, P873, DOI 10.4088/JCP.08m04872gre; Barbui C, 2009, SCHIZOPHRENIA BULL, V35, P458, DOI 10.1093/schbul/sbn030; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Lieberman JA, 1999, J CLIN PSYCHIAT, V60, P9; Brunelin J, 2012, AM J PSYCHIAT, V169, P719, DOI 10.1176/appi.ajp.2012.11071091; Nielsen J, 2012, J CLIN PSYCHOPHARM, V32, P173, DOI 10.1097/JCP.0b013e318248dfb8; Lieberman JA, 1997, NEUROPSYCHOPHARMACOL, V17, P205, DOI 10.1016/S0893-133X(97)00045-6; Stewart PT, 2011, INT J NEUROPSYCHOPH, V14, P585, DOI 10.1017/S1461145710001458; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Shank RP, 2000, EPILEPSIA, V41, pS3, DOI 10.1111/j.1528-1157.2000.tb06045.x; Tiihonen J, 2005, J CLIN PSYCHIAT, V66, P1012; Sommer IEC, 2012, SCHIZOPHRENIA BULL, V38, P704, DOI 10.1093/schbul/sbs034; Cunningham MO, 2000, NEUROPHARMACOLOGY, V39, P2139, DOI 10.1016/S0028-3908(00)00051-4; Conley RR, 2001, BIOL PSYCHIAT, V50, P898, DOI 10.1016/S0006-3223(01)01271-9; Laruelle M, 2000, BRAIN RES REV, V31, P371, DOI 10.1016/S0165-0173(99)00054-5; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Siebner HR, 2003, EXP BRAIN RES, V148, P1, DOI 10.1007/s00221-002-1234-2; Miyamoto S, 2012, MOL PSYCHIATR, V17, P1206, DOI 10.1038/mp.2012.47; Slotema CW, 2012, SCHIZOPHR RES, V142, P40, DOI 10.1016/j.schres.2012.08.025; Turkington D, 2008, SCHIZOPHR RES, V98, P1, DOI 10.1016/j.schres.2007.09.026; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199; Goff DC, 2001, J CLIN PSYCHOPHARM, V21, P484, DOI 10.1097/00004714-200110000-00005; Antal A, 2006, BRAIN RES BULL, V68, P459, DOI 10.1016/j.brainresbull.2005.10.006; Wexler BE, 2005, SCHIZOPHRENIA BULL, V31, P931, DOI 10.1093/schbul/sbi038; Slotema CW, 2014, BIOL PSYCHIAT, V76, P101, DOI 10.1016/j.biopsych.2013.09.038; HAFNER H, 1991, PSYCHIAT RES, V38, P125, DOI 10.1016/0165-1781(91)90038-Q; Hasan A, 2012, WORLD J BIOL PSYCHIA, V13, P318, DOI 10.3109/15622975.2012.696143; Taylor DM, 2012, ACTA PSYCHIAT SCAND, V125, P15, DOI 10.1111/j.1600-0447.2011.01792.x; Arnone D, 2005, ANN GEN PSYCHIATR, V4, P5, DOI 10.1186/1744-859X-4-5; Bandelow B, 2008, WORLD J BIOL PSYCHIA, V9, P242, DOI 10.1080/15622970802456590; BARKER AT, 1985, LANCET, V1, P1106; Barretto EMD, 2009, J NERV MENT DIS, V197, P865, DOI 10.1097/NMD.0b013e3181be7422; Behdani F, 2011, ARCH IRAN MED, V14, P270, DOI 0011144/AIM.009; Bellucci DM, 2003, SCHIZOPHR RES, V59, P225, DOI 10.1016/S0920-9964(01)00402-9; Braga RJ, 2009, BIOL PSYCHIAT, V64, p212S; Buchanan Robert W, 2010, Schizophr Bull, V36, P71, DOI 10.1093/schbul/sbp116; Coyle JT, 1996, HARVARD REV PSYCHIAT, V3, P241, DOI 10.3109/10673229609017192; de Jesus DR, 2011, PSYCHIAT RES, V188, P203, DOI 10.1016/j.psychres.2010.11.022; Fasano A, 2009, EXPERT OPIN PHARMACO, V10, P2883, DOI 10.1517/14656560903386292; FRANKENBURG FR, 1993, CONVULSIVE THER, V9, P176; Hahn Margaret K, 2013, Clin Schizophr Relat Psychoses, V6, P186, DOI 10.3371/CSRP.HACO.01062013; Hoffman RE, 1999, BIOL PSYCHIAT, V46, P130, DOI 10.1016/S0006-3223(98)00358-8; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Kho KH, 2004, EUR ARCH PSY CLIN N, V254, P372, DOI 10.1007/s00406-004-0517-y; Kulkarni J., 2014, MOL PSYCHIAT; [蓝光心 LAN GuangXin], 2006, [中国心理卫生杂志, Chinese Mental Health Journal], V20, P696; LINGJAERDE O, 1963, ACTA PSYCHIAT SCAND, V39, P1; LOLAS F, 1977, BIOL PSYCHIAT, V12, P37; Lyon GJ, 2011, SCHIZOPHRENIA BULL, V37, P108, DOI 10.1093/schbul/sbp010; Masoudzadeh A, 2007, Pak J Biol Sci, V10, P4287; Matheson SL, 2010, SCHIZOPHR RES, V118, P201, DOI 10.1016/j.schres.2010.01.002; McIlwain ME, 2011, NEUROPSYCH DIS TREAT, V7, P135; Miyamoto Seiya, 2003, Mol Interv, V3, P27, DOI 10.1124/mi.3.1.27; Mizuno Y, 2014, SCHIZOPHR B; Muscatello MRA, 2011, J PSYCHOPHARMACOL, V25, P667, DOI 10.1177/0269881110372548; Petrides G., 2010, NEW CLIN DRUG EV UN; Porcelli S, 2012, EUR NEUROPSYCHOPHARM, V22, P165, DOI 10.1016/j.euroneuro.2011.08.005; Poulet E, 2006, SCHIZOPHR RES, V84, P183, DOI 10.1016/j.schres.2006.02.014; Remington G, 2012, J CLIN PSYCHOPHARM, V32, P95, DOI 10.1097/JCP.0b013e31823f913e; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Sommer IE, 2012, SCHIZOPHRENIA BULL, V38, P1003, DOI 10.1093/schbul/sbr004; Thirthalli J, 2008, SCHIZOPHR RES, V100, P351, DOI 10.1016/j.schres.2008.01.003; Vayisoglu S, 2013, SCHIZOPHR RES, V143, P207, DOI 10.1016/j.schres.2012.11.006; Zoccali R, 2007, SCHIZOPHR RES, V93, P109, DOI 10.1016/j.schres.2007.02.009	69	6	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	NOV	2014	58						1	6		10.1016/j.jpsychires.2014.07.001		6	Psychiatry	Psychiatry	AQ5RL	WOS:000342866200001		
J	Fujii, T; Ota, M; Hori, H; Hattori, K; Teraishi, T; Sasayama, D; Higuchi, T; Kunugi, H				Fujii, Takashi; Ota, Miho; Hori, Hiroaki; Hattori, Kotaro; Teraishi, Toshiya; Sasayama, Daimei; Higuchi, Teruhiko; Kunugi, Hiroshi			Association between the common functional FKBP5 variant (rs1360780) and brain structure in a non-clinical population	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						FK506 binding protein 5; Post-traumatic stress disorder; Magnetic resonance imaging; Diffusion tensor imaging; Dorsal anterior cingulate cortex; Posterior cingulate cortex	POSTTRAUMATIC-STRESS-DISORDER; INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; MAJOR DEPRESSIVE DISORDER; PITUITARY-ADRENAL AXIS; DIFFUSION-TENSOR MRI; TALAIRACH ATLAS; DSM-IV; GENE; POLYMORPHISMS; MINI	FK506 binding protein 5 (FKBP5) is induced by stress and regulates glucocorticoid receptor sensitivity. The T allele of the single nucleotide polymorphism (SNP) FKBP5 rs1360780 (C/T) is associated with an increased risk of post-traumatic stress disorder (PTSD) and reduced hippocampal volume in traumatized or depressed subjects. To examine whether this SNP affects brain structures that regulate stress response, we obtained magnetic resonance imaging data of the brain in 162 healthy subjects using a 1.5 T system. Gray matter volumes and diffusion tensor imaging data were compared between individuals with and without the T allele, using optimized voxel-based morphometry. We found that the dorsal anterior cingulate cortex (dACC) volume was smaller in T carriers than in non-T carriers (P < 0.001). T carriers also showed significantly higher mean diffusivity values in the dACC and posterior cingulate cortex (PCC) compared with non-T carriers (P < 0.001). Our results suggest that carrying the T allele of FKBP5 rs1360780 is associated with smaller gray matter volumes in the dACC and altered white matter integrity in the dACC and PCC in the non-clinical population, which might constitute the structural basis of stress-related psychiatric disorders including PTSD. (C) 2014 Elsevier Ltd. All rights reserved.	[Fujii, Takashi; Ota, Miho; Hori, Hiroaki; Hattori, Kotaro; Teraishi, Toshiya; Sasayama, Daimei; Kunugi, Hiroshi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Kodaira, Tokyo 1878502, Japan; [Higuchi, Teruhiko] Natl Ctr Neurol & Psychiat, Kodaira, Tokyo 1878502, Japan; [Kunugi, Hiroshi] JST Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan	Kunugi, H (reprint author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.	hkunugi@ncnp.go.jp			Japan Society for the Promotion of Science (JSPS) [26461729, 23791371, 20790870]; Japan Human Sciences Foundation; National Center of Neurology and Psychiatry, Japan [24-11]; Strategic Research Program for Brain Sciences by Ministry of Education, Culture, Sports, Science and Technology of Japan [10102837]	This study was supported by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS; Grant Numbers 26461729 [T.F.], 23791371[T.F.], and 20790870 [T.F.]), Japan Human Sciences Foundation (T.F.), Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry, Japan (Grant Numbers 24-11[H.K.]), and the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan (Understanding of molecular and environmental bases for brain health) (Grant Numbers 10102837[H.K.]). These agencies had no role in study design, acquisition and interpretation of data or writing the report.	Roy A, 2010, NEUROPSYCHOPHARMACOL, V35, P1674, DOI 10.1038/npp.2009.236; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Fujii T, 2012, J PSYCHIATR RES, V46, P555, DOI 10.1016/j.jpsychires.2012.01.012; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Ising M, 2008, EUR J NEUROSCI, V28, P389, DOI 10.1111/j.1460-9568.2008.06332.x; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Kantarci K, 2001, RADIOLOGY, V219, P101; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Kunugi H, 2010, PSYCHIAT CLIN NEUROS, V64, P447, DOI 10.1111/j.1440-1819.2010.02135.x; Yassa MA, 2009, NEUROIMAGE, V44, P319, DOI 10.1016/j.neuroimage.2008.09.016; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100; Zimmermann P, 2011, AM J PSYCHIAT, V168, P1107, DOI 10.1176/appi.ajp.2011.10111577; Fujii T, 2011, J PSYCHIATR RES, V45, P47, DOI 10.1016/j.jpsychires.2010.05.004; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Ota M, 2013, J PSYCHIATR RES, V47, P1383, DOI 10.1016/j.jpsychires.2013.06.010; Kuhn S, 2013, BIOL PSYCHIAT, V73, P70, DOI 10.1016/j.biopsych.2012.06.029; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Zobel A, 2010, INT J NEUROPSYCHOPH, V13, P649, DOI 10.1017/S1461145709991155; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Minelli A, 2013, DEPRESS ANXIETY, V30, P1170, DOI 10.1002/da.22158; Kohli MA, 2011, NEURON, V70, P252, DOI 10.1016/j.neuron.2011.04.005; Koenen KC, 2005, MOL PSYCHIATR, V10, P1058, DOI 10.1038/sj.mp.4001727; Yehuda R, 2001, J CLIN PSYCHIAT, V62, P41; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Appel K, 2011, NEUROPSYCHOPHARMACOL, V36, P1982, DOI 10.1038/npp.2011.81; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1006/jmrb.1996.0086; Binder EB, 2009, PSYCHONEUROENDOCR S1, V34, P5186; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Fani N, 2012, NEUROPSYCHOPHARMACOL, V37, P2740; Fani N, 2013, JAMA PSYCHIAT, V70, P392; Fani N, 2013, NEUROPSYCHOPHARMACOL, V39, P1206; Fujii T, 2014, PSYCHONEUROENDOCRINO; Grossman R, 2003, AM J PSYCHIAT, V160, P1291, DOI 10.1176/appi.ajp.160.7.1291; Holz NE, 2014, BRAIN STRUCT FUNCT; Ota M, 2011, PROG NEURO-PSYCHOPH, V35, P1877, DOI 10.1016/j.pnpbp.2011.07.012; Ota M, 2013, NEUROPSYCHOBIOLOGY, V68, P205, DOI 10.1159/000355298; Pagliaccio D, 2014, NEUROPSYCHOPHARMACOL, V39, P1245, DOI 10.1038/npp.2013.327; Snook L, 2007, NEUROIMAGE, V34, P243, DOI 10.1016/j.neuroimage.2006.07.021; Trentani A, 2002, EUR J NEUROSCI, V15, P1681, DOI 10.1046/j.1460-9568.2002.02000.x	44	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	NOV	2014	58						96	101		10.1016/j.jpsychires.2014.07.009		6	Psychiatry	Psychiatry	AQ5RL	WOS:000342866200014		
J	Omata, M; Nishiguchi, S; Ueno, Y; Mochizuki, H; Izumi, N; Ikeda, F; Toyoda, H; Yokosuka, O; Nirei, K; Genda, T; Umemura, T; Takehara, T; Sakamoto, N; Nishigaki, Y; Nakane, K; Toda, N; Ide, T; Yanase, M; Hino, K; Gao, B; Garrison, KL; Dvory-Sobol, H; Ishizaki, A; Omote, M; Brainard, D; Knox, S; Symonds, WT; McHutchison, JG; Yatsuhashi, H; Mizokami, M				Omata, Masao; Nishiguchi, Shuhei; Ueno, Yoshiyuki; Mochizuki, Hitoshi; Izumi, Namiki; Ikeda, Fusao; Toyoda, Hidenori; Yokosuka, Osamu; Nirei, Kazushige; Genda, Takuya; Umemura, Takeji; Takehara, Tetsuo; Sakamoto, Naoya; Nishigaki, Yoichi; Nakane, Kunio; Toda, Nobuo; Ide, Tatsuya; Yanase, Mikio; Hino, Keisuke; Gao, Bing; Garrison, Kimberly L.; Dvory-Sobol, Hadas; Ishizaki, Akinobu; Omote, Masa; Brainard, Diana; Knox, Steven; Symonds, William T.; McHutchison, John G.; Yatsuhashi, Hiroshi; Mizokami, Masashi			Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial	JOURNAL OF VIRAL HEPATITIS			English	Article						Hepatitis C virus; HCV genotype 2; direct-acting antiviral agents; nucleotide polymerase inhibitor	C VIRUS-INFECTION; CHRONIC HEPATITIS	Genotype 2 hepatitis C virus (HCV) accounts for up to 30% of chronic HCV infections in Japan. The standard of care for patients with genotype 2 HCV - peginterferon and ribavirin for 24 weeks - is poorly tolerated, especially among older patients and those with advanced liver disease. We conducted a phase 3, open-label study to assess the efficacy and safety of an all-oral combination of the NS5B polymerase inhibitor sofosbuvir and ribavirin in patients with chronic genotype 2 HCV infection in Japan. We enrolled 90 treatment-naive and 63 previously treated patients at 20 sites in Japan. All patients received sofosbuvir 400 mg plus ribavirin (weight-based dosing) for 12 weeks. The primary endpoint was sustained virologic response at 12 weeks after therapy (SVR12). Of the 153 patients enrolled and treated, 60% had HCV genotype 2a, 11% had cirrhosis, and 22% were over the aged 65 or older. Overall, 148 patients (97%) achieved SVR12. Of the 90 treatment-naive patients, 88 (98%) achieved SVR12, and of the 63 previously treated patients, 60 (95%) achieved SVR12. The rate of SVR12 was 94% in patients with cirrhosis and in those aged 65 and older. No patients discontinued study treatment due to adverse events. The most common adverse events were nasopharyngitis, anaemia and headache. Twelve weeks of sofosbuvir and ribavirin resulted in high rates of SVR12 in treatment-naive and previously treated patients with chronic genotype 2 HCV infection. The treatment was safe and well tolerated by patients, including the elderly and those with cirrhosis.	[Omata, Masao; Mochizuki, Hitoshi] Yamanashi Prefectural Hosp Org, Kofu, Yamanashi 4000027, Japan; [Nishiguchi, Shuhei] Hyogo Coll Med, Nishinomiya, Hyogo, Japan; [Ueno, Yoshiyuki] Yamagata Univ, Yamagata 990, Japan; [Izumi, Namiki] Musashino Red Cross Hosp, Tokyo, Japan; [Ikeda, Fusao] Okayama Univ, Okayama, Japan; [Toyoda, Hidenori] Ogaki Municipal Hosp, Gifu, Japan; [Yokosuka, Osamu] Chiba Univ, Chiba, Japan; [Nirei, Kazushige] Nihon Univ, Tokyo, Japan; [Genda, Takuya] Juntendo Univ, Tokyo, Japan; [Umemura, Takeji] Shinshu Univ, Nagano, Japan; [Takehara, Tetsuo] Osaka Univ, Osaka, Japan; [Sakamoto, Naoya] Hokkaido Univ, Sapporo, Hokkaido 060, Japan; [Nishigaki, Yoichi] Gifu Municipal Hosp, Gifu, Japan; [Nakane, Kunio] Akita City Hosp, Akita, Japan; [Toda, Nobuo] Mitsui Mem Hosp, Tokyo 101, Japan; [Ide, Tatsuya] Kurume Univ, Kurume, Fukuoka 830, Japan; [Yanase, Mikio; Mizokami, Masashi] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Hino, Keisuke] Kawasaki Med Univ, Okayama, Japan; [Gao, Bing; Garrison, Kimberly L.; Dvory-Sobol, Hadas; Ishizaki, Akinobu; Omote, Masa; Brainard, Diana; Knox, Steven; Symonds, William T.; McHutchison, John G.] Gilead Sci Inc, Foster City, CA 94404 USA; [Yatsuhashi, Hiroshi] Natl Hosp Org, Nagasaki Med Ctr, Nagasaki, Japan	Omata, M (reprint author), Yamanashi Prefectural Hosp Org, 1-1-1 Fujimi, Kofu, Yamanashi 4000027, Japan.	momata-tky@umin.ac.jp			Gilead Sciences	Supported by Gilead Sciences. We thank the patients and their families, as well as the investigators and site personnel. In addition, we thank Juan Betular, Camilla Lau and Ellen Milner of Gilead Sciences for their contributions to study conduct. Writing assistance was provided by David McNeel of Gilead Sciences.	Kanda T, 2011, DIGEST DIS SCI, V56, P3335, DOI 10.1007/s10620-011-1750-7; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Chung H, 2010, INTERVIROLOGY, V53, P39, DOI 10.1159/000252782; [Anonymous], 2013, SOV SOF TABL US PRES; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691; Tanaka J, 2004, INTERVIROLOGY, V47, P32, DOI 10.1159/000076640; Inoue Y, 2010, J VIRAL HEPATITIS, V17, P336, DOI 10.1111/j.1365-2893.2009.01182.x; Kirby B, 2013, AASLD ANN M 2013; Kumada H, 2010, HEPATOL RES, V40, P8, DOI 10.1111/j.1872-034X.2009.00634.x; Mizokami Masashi, 2006, Intervirology, V49, P28, DOI 10.1159/000087260; Toyoda H, 2014, EPIDEMIOL INFECT; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145	14	9	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1352-0504	1365-2893		J VIRAL HEPATITIS	J. Viral Hepatitis	NOV	2014	21	11					762	768		10.1111/jvh.12312		7	Gastroenterology & Hepatology; Infectious Diseases; Virology	Gastroenterology & Hepatology; Infectious Diseases; Virology	AQ5JT	WOS:000342844900005		
J	Hara, T; Suzuki, F; Kawamura, Y; Sezaki, H; Hosaka, T; Akuta, N; Kobayashi, M; Suzuki, Y; Saitoh, S; Arase, Y; Ikeda, K; Kobayashi, M; Watahiki, S; Mineta, R; Kumada, H				Hara, T.; Suzuki, F.; Kawamura, Y.; Sezaki, H.; Hosaka, T.; Akuta, N.; Kobayashi, M.; Suzuki, Y.; Saitoh, S.; Arase, Y.; Ikeda, K.; Kobayashi, M.; Watahiki, S.; Mineta, R.; Kumada, H.			Long-term entecavir therapy results in falls in serum hepatitis B surface antigen levels and seroclearance in nucleos(t)ide-naive chronic hepatitis B patients	JOURNAL OF VIRAL HEPATITIS			English	Article						chronic hepatitis; entecavir; hepatitis B surface antigen; hepatitis B virus	VIRUS GENOTYPES; LAMIVUDINE; ALPHA-2A; MARKERS	Entecavir (ETV) is reported to result in suppression of hepatitis B virus DNA (HBV DNA) replication with minimal drug resistance. However, information on the long-term effect of such therapy on serum hepatitis B surface antigen (HBsAg) level and elimination of HBsAg is not available. ETV therapy was started in 553 nucleos(t)ide-naive patients with chronic hepatitis B infection (HBeAg positive: 45%) in our hospital. Serum HBsAg levels were measured serially by the Architect assay. The median baseline HBsAg was 2180 IU/mL (0.12-243 000 IU/mL), and median follow-up period was 3.0 years, with 529, 475, 355, 247 and 163 patients followed-up for 1, 2, 3, 4 and 5 years, respectively. At year 5, the mean log HBsAg decline from baseline was -0.48 log IU/mL, and the cumulative HBsAg clearance rate was 3.5%. Multivariate analysis identified HBV DNA level at baseline (<3.0 log copies IU/mL, odd ratio = 10.2; 95% confidence interval = 1.87-55.5, P = 0.007) and HBsAg level (<500 IU/mL, odd ratio = 29.4; 95% confidence interval = 2.80-333, P = 0.005) as independent predictors of HBsAg seroclearance. These results indicate that although serum HBsAg level declines gradually during ETV therapy, HBsAg seroclearance remains a rare event.	[Hara, T.; Suzuki, F.; Kawamura, Y.; Sezaki, H.; Hosaka, T.; Akuta, N.; Kobayashi, M.; Suzuki, Y.; Saitoh, S.; Arase, Y.; Ikeda, K.; Kumada, H.] Toranomon Gen Hosp, Dept Hepatol, Tokyo 1058470, Japan; [Kobayashi, M.; Watahiki, S.; Mineta, R.] Toranomon Gen Hosp, Res Inst Hepatol, Tokyo 1058470, Japan	Suzuki, F (reprint author), Toranomon Gen Hosp, Dept Hepatol, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.	fumitakas@toranomon.gr.jp			Ministry of Health, Labor and Welfare, Japan	This study was supported in part by a Grant-in-Aid from the Ministry of Health, Labor and Welfare, Japan.	Chang TT, 2010, HEPATOLOGY, V51, P422, DOI 10.1002/hep.23327; Thompson AJV, 2010, HEPATOLOGY, V51, P1933, DOI 10.1002/hep.23571; Hosaka T, 2013, J GASTROENTEROL, V48, P930, DOI 10.1007/s00535-012-0688-7; Gish RG, 2010, J VIRAL HEPATITIS, V17, P16, DOI 10.1111/j.1365-2893.2009.01146.x; Chu CM, 2007, HEPATOLOGY, V45, P1187, DOI 10.1002/hep.21612; Ono A, 2012, J HEPATOL, V57, P508, DOI 10.1016/j.jhep.2012.04.037; Jaroszewicz J, 2011, ANTIVIR THER, V16, P915, DOI 10.3851/IMP1866; Reijnders JGP, 2011, J HEPATOL, V54, P449, DOI 10.1016/j.jhep.2010.07.046; Liaw YF, 2009, GASTROENTEROLOGY, V136, P486, DOI 10.1053/j.gastro.2008.10.026; Lee JM, 2011, HEPATOLOGY, V53, P1486, DOI 10.1002/hep.24221; Heathcote EJ, 2011, GASTROENTEROLOGY, V140, P132, DOI 10.1053/j.gastro.2010.10.011; Seto WK, 2012, HEPATOLOGY, V56, P812, DOI 10.1002/hep.25718; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Moucari R, 2009, HEPATOLOGY, V49, P1151, DOI 10.1002/hep.22744; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Tadokoro K, 2006, J VIROL METHODS, V138, P30, DOI 10.1016/j.jviromet.2006.07.014; Fung J, 2011, AM J GASTROENTEROL, V106, P1766, DOI 10.1038/ajg.2011.253; Yokosuka O, 2010, J HEPATOL, V52, P791, DOI 10.1016/j.jhep.2009.12.036; Usuda S, 1999, J VIROL METHODS, V80, P97, DOI 10.1016/S0166-0934(99)00039-7; Brunetto MR, 2009, HEPATOLOGY, V49, P1141, DOI 10.1002/hep.22760; Kobayashi M, 2007, J MED VIROL, V79, P1472, DOI 10.1002/jmv.20994; Kobayashi M, 2014, J GASTROENTEROL, V49, P538, DOI 10.1007/s00535-013-0821-2; Seto WK, 2013, HEPATOLOGY, V58, P923, DOI 10.1002/hep.26376	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1352-0504	1365-2893		J VIRAL HEPATITIS	J. Viral Hepatitis	NOV	2014	21	11					802	808		10.1111/jvh.12211		7	Gastroenterology & Hepatology; Infectious Diseases; Virology	Gastroenterology & Hepatology; Infectious Diseases; Virology	AQ5JT	WOS:000342844900010		
J	Mori, K; Tamate, S				Mori, Kenji; Tamate, Shintaro			PASINETTI AFTER SEN: TOWARDS A CAPABILITY APPROACH TO STRUCTURAL DYNAMICS OF CONSUMPTION	METROECONOMICA			English	Article							PROFILES; MODEL	Pasinetti's theory of structural dynamics has, as well as the capability approach, normative implications about income distribution and economic growth. Compared with the latter, however, the individual character of consumption is rather neglected in Pasinetti's framework, but the macro-economic viability is examined here more intensively as a main issue. In this paper, we will show it possible and fruitful to consistently integrate both complementary approaches and present an analytical foundation of a normative theory of the structural dynamics of consumption.	[Mori, Kenji; Tamate, Shintaro] Tohoku Univ, Grad Sch Econ & Management, Aoba Ku, Sendai, Miyagi 9808576, Japan	Mori, K (reprint author), Tohoku Univ, Grad Sch Econ & Management, Aoba Ku, 27-1 Kawauchi, Sendai, Miyagi 9808576, Japan.	mori@econ.tohoku.ac.jp; jade4dear@gmail.com					Nussbaum MC, 2003, FEM ECON, V9, P33, DOI 10.1080/1354570022000077926; Echavarri RA, 2008, SOC CHOICE WELFARE, V31, P521, DOI 10.1007/s00355-007-0294-4; Benbaji Y, 2006, EUR J PHILOS, V14, P327, DOI 10.1111/j.1468-0378.2006.00228.x; Bidard C., 2010, ANAL LINEAR EC SYSTE; D'Agata A, 2010, METROECONOM, V61, P333, DOI 10.1111/j.1467-999X.2009.04060.x; D'Agata A, 2005, METROECONOMICA, V56, P182, DOI 10.1111/j.1467-999X.2005.00212.x; D'Agata Antonio, 2012, Structural Change and Economic Dynamics, V23, DOI 10.1016/j.strueco.2012.03.003; Deneulin Severine, 2002, REV POLITICAL EC, V14, P497, DOI DOI 10.1080/0953825022000009924; Gasper D, 1997, J INT DEV, V9, P281, DOI 10.1002/(SICI)1099-1328(199703)9:2<281::AID-JID438>3.0.CO;2-K; Gotoh R, 2003, ECON THEOR, V22, P63, DOI 10.1007/s00199-002-0280-0; Gualerzi D, 2012, STRUCTURAL DYNAMICS AND ECONOMIC GROWTH, P181; Herrero C., 1996, EC DESIGN, V2, P69, DOI 10.1007/BF02499125; Herrero C, 1998, MATH SOC SCI, V35, P273, DOI 10.1016/S0165-4896(98)00003-1; Martins N., 2007, REV POLITICAL EC, V19, P37, DOI 10.1080/09538250601080768; Matsuyama J, 2011, METROECONOMICA, V62, P494, DOI 10.1111/j.1467-999X.2011.04118.x; Mori K, 2008, METROECONOMICA, V59, P511, DOI 10.1111/j.1467-999X.2008.00315.x; Pasinetti L. L., 2007, KEYNES CAMBRIDGE KEY; Pasinetti L.L., 1981, STRUCTURAL CHANGE EC; Pasinetti Luigi L., 1993, STRUCTURAL EC DYNAMI; Sen A., 1993, QUALITY LIFE; Sen A., 1980, TANNER LECT HUMAN VA, V1; Sen A, 1999, DEV FREEDOM; Sen A, 1985, COMMODITIES CAPABILI; Sen A. K., 1997, EC INEQUALITY; Smith A, 1904, INQUIRY NATURE CAUSE; Walsh V., 2008, REV POLITICAL EC, V20, P199, DOI 10.1080/09538250701819677; Walsh V., 2003, REV POLITICAL EC, V15, P315, DOI 10.1080/09538250308434; Walsh Vivian, 2000, REV POLITICAL EC, V12, P5, DOI 10.1080/095382500106795	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0026-1386	1467-999X		METROECONOMICA	Metroeconomica	NOV	2014	65	4					690	716		10.1111/meca.12056		27	Economics	Business & Economics	AQ4LK	WOS:000342768300008		
J	Katayama, K; Saito, M; Kawaguchi, T; Endo, R; Sawara, K; Nishiguchi, S; Kato, A; Kohgo, H; Suzuki, K; Sakaida, I; Ueno, Y; Habu, D; Ito, T; Moriwaki, H; Suzuki, K				Katayama, Kazuhiro; Saito, Masanori; Kawaguchi, Takumi; Endo, Ryujin; Sawara, Kei; Nishiguchi, Shuhei; Kato, Akinobu; Kohgo, Hiroshi; Suzuki, Kazutomo; Sakaida, Isao; Ueno, Yoshiyuki; Habu, Daiki; Ito, Toshifumi; Moriwaki, Hisataka; Suzuki, Kazuyuki			Effect of zinc on liver cirrhosis with hyperammonemia: A preliminary randomized, placebo-controlled double-blind trial	NUTRITION			English	Article						Zinc acetate; Trace element; Ammonia metabolism; Hepatic encephalopathy; Nutritional intervention	CHAIN AMINO-ACID; HEPATIC-ENCEPHALOPATHY; NITROGEN-METABOLISM; PROGNOSTIC VALUE; FINGER PROTEINS; SUPPLEMENTATION; DISEASE; DEFICIENCY; SURVIVAL; AMMONIA	Objective: To our knowledge, no randomized study has shown whether zinc replacement therapy is effective for hyperammonemia in liver cirrhosis; therefore, we performed a double-blind, placebo-controlled trial to examine efficacy and safety of the zinc replacement therapy. Methods: Patients with liver cirrhosis and hyperammonemia (at or above the institutional reference value) and hypozincemia (<= 65 mu g/dL) were enrolled in the outpatient units of the participating institutions and were randomly divided to receive placebo (P group) or zinc acetate preparation at a dose of 3 capsules/d for a total zinc content of 150 mg/d (Z group) by the envelope method. Of the 18 enrolled patients, 6 dropped out; thus, the analyses included 12 patients (5 in the P group and 7 in the Z group). Variations in blood concentrations of zinc and ammonia as well as liver function test results were compared. Results: Blood zinc levels significantly increased in the Z group (P = 0.0037; Friedman test) but not the P group. Blood ammonia levels significantly decreased in the Z group (P = 0.0114; Friedman test) but not the P group. The percent change in blood ammonia level also revealed significant reduction at the eighth week in the Z group (P = 0.0188: Mann-Whitney test). No serious adverse events attributable to the zinc preparation were noted. Conclusion: Although this study is preliminary and includes a small sample, it is, to our knowledge, the first randomized controlled trial to show that zinc supplementation for 3 mo seems effective and safe for treating hyperammonemia in liver cirrhosis. Studies with a larger sample size are needed to confirm our findings. (C) 2014 Elsevier Inc. All rights reserved.	[Katayama, Kazuhiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan; [Saito, Masanori; Nishiguchi, Shuhei] Hyogo Coll Med, Div Hepatobiliary & Pancreat Dis, Nishinomiya, Hyogo 6638501, Japan; [Kawaguchi, Takumi] Kurume Univ, Sch Med, Div Gastroenterol, Dept Med & Digest Dis Informat & Res, Kurume, Fukuoka 830, Japan; [Endo, Ryujin; Sawara, Kei] Iwate Med Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Morioka, Iwate 020, Japan; [Kato, Akinobu] Morioka Municipal Hosp, Dept Internal Med, Morioka, Iwate, Japan; [Kohgo, Hiroshi] Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido, Japan; [Suzuki, Kazutomo] Dokkyo Med Univ, Koshigaya Hosp, Dept Gastroenterol & Hepatol, Koshigaya, Japan; [Sakaida, Isao] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Ube, Yamaguchi 755, Japan; [Ueno, Yoshiyuki] Yamagata Univ, Fac Med, Dept Gastroenterol, Yamagata 990, Japan; [Habu, Daiki] Osaka City Univ, Grad Sch Human Life Sci, Dept Med Nutr, Osaka 558, Japan; [Ito, Toshifumi] Osaka Koseinenkin Hosp, Dept Internal Med, Osaka, Japan; [Moriwaki, Hisataka] Gifu Univ, Grad Sch Med, Dept Gastroenterol, Gifu, Japan; [Suzuki, Kazuyuki] Morioka Univ, Dept Nutr Sci, Morioka, Iwate, Japan	Katayama, K (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan.	katayama-ka@mc.pref.osaka.jp			Ministry of Health, Labour and Welfare, Japan [H20-heptitis-general-005]	This work was supported by a Grant-in-Aid for research on refractory hepatitis from Ministry of Health, Labour and Welfare, Japan (H20-heptitis-general-005). KK, SN, HK, KS, IS, YU, DH, HM, and KS were responsible for the conception and design of the study. KK, MS, TK, RE, KS, AK, and TI were responsible for generation, collection, assembly, and/or interpretation. KK drafted the manuscript. HM and KS revised the manuscript. All authors read and approved the final version of the manuscript. The authors have no conflicts of interest to declare.	Kawaguchi T, 2014, CLIN GASTROENTEROL H, V12, P1012, DOI 10.1016/j.cgh.2013.08.050; Alberino F, 2001, NUTRITION, V17, P445, DOI 10.1016/S0899-9007(01)00521-4; Plank LD, 2008, HEPATOLOGY, V48, P557, DOI 10.1002/hep.22367; Stamoulis I, 2007, DIGEST DIS SCI, V52, P1595, DOI 10.1007/s10620-006-9462-0; Hayashi M, 2007, HEPATOL RES, V37, P615, DOI 10.1111/j.1872-034X.2007.00095.x; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Ganss B, 2004, CRIT REV ORAL BIOL M, V15, P282; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; VALLEE BL, 1995, NEUROCHEM INT, V27, P23, DOI 10.1016/0197-0186(94)00165-Q; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Prasad AS, 1998, MOL CELL BIOCHEM, V188, P63, DOI 10.1023/A:1006868305749; Muto Y, 2006, HEPATOL RES, V35, P204, DOI 10.1016/j.hepres.2006.04.007; Fargion S, 2010, HEPATOLOGY, V51, P1119, DOI 10.1002/hep.23541; VALLEE BL, 1993, PHYSIOL REV, V73, P79; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; Muto Y, 2005, CLIN GASTROENTEROL H, V3, P705, DOI 10.1053/S1542-3565(05)00017-0; Roberts EA, 2008, HEPATOLOGY, V47, P2089, DOI 10.1002/hep.22261; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Brewer GJ, 1998, J LAB CLIN MED, V132, P264, DOI 10.1016/S0022-2143(98)90039-7; Chiba M, 2013, HEPATOL RES, V43, P365, DOI 10.1111/j.1872-034X.2012.01093.x; CHRISTENSEN E, 1984, HEPATOLOGY, V4, P430, DOI 10.1002/hep.1840040313; Colvin RA, 2003, EUR J PHARMACOL, V479, P298; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; FISCHER JE, 1971, LANCET, V2, P75; Kambe T, 2004, CELL MOL LIFE SCI, V61, P298; Katayama K, 2011, OPEN J GASTROENTEROL, V1, P22; Katayama K, 2004, HEPATOL RES, V30, pS71, DOI 10.1016/j.hepres.2004.08.013; Licastro F, 2001, BRAIN RES BULL, V55, P313, DOI 10.1016/S0361-9230(01)00476-2; Marchesini G, 1996, HEPATOLOGY, V23, P1084; PRASAD AS, 1978, ANN INTERN MED, V89, P483; PRASAD AS, 1995, NUTRITION, V11, P93; RABBANI P, 1978, AM J PHYSIOL, V235, pE203; REDING P, 1984, LANCET, V2, P493; RIGGIO O, 1992, HEPATOLOGY, V16, P785, DOI 10.1002/hep.1840160326; RIGGIO O, 1991, DIGEST DIS SCI, V36, P1204, DOI 10.1007/BF01307509; Tajika M, 2002, NUTRITION, V18, P229, DOI 10.1016/S0899-9007(01)00754-7; Tesdale G, 1974, LANCET, V2, P81; VANDERRIJT CCD, 1991, GASTROENTEROLOGY, V100, P1114; WALRAVENS PA, 1979, WESTERN J MED, V130, P133	40	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007	1873-1244		NUTRITION	Nutrition	NOV-DEC	2014	30	11-12					1409	1414		10.1016/j.nut.2014.04.018		6	Nutrition & Dietetics	Nutrition & Dietetics	AQ7AE	WOS:000342964200027		
J	Moriwaki, Y; Otani, J; Okuda, J; Niwano, T; Sawada, Y; Nitta, T; Ohshima, C				Moriwaki, Yoshihiro; Otani, Jun; Okuda, Junzo; Niwano, Toshiyuki; Sawada, Yoshiyuki; Nitta, Tachiko; Ohshima, Chiaki			Successful nutritional support for a dysphagic patient with massive cirrhotic ascites and intrathoracic stomach using percutaneous endoscopic gastrostomy (PEG)	NUTRITION			English	Article						Percutaneous endoscopic gastrostomy (PEG); Peritoneal-venous shunting; Massive scirrhotic ascitis; Esophageal sliding hernia; Nutritional support	RANDOMIZED-TRIAL; GUIDELINES	Although massive cirrhotic ascites is generally considered a contraindication for the placement of percutaneous endoscopic gastrostomy (PEG), such patients are usually poorly nourished. Preceding paracentesis of ascites is one method for controlling ascites and allowing the safe placement of PEG, but it often results in overuse of albumin. Preceding peritoneal-venous (P-V) shunting can avoid excessive use of albumin, but this introduces the risk of infectious contamination. We encountered an 88-y-old woman with massive cirrhotic ascites, a giant esophageal hernia with dislocation of the proximal stomach into the mediastinum, hypertrophy of the lateral segment of the liver, and malnutrition who had suffered from appetite loss and a swallowing disorder for 4 mo. She underwent PEG using a staged sequential introduction method using a Funada-style gastric wall fixation kit as follows: 1) full stretching and pushing out of the stomach from the mediastinum into the peritoneal cavity by deep insertion and a turning-over procedure of the endoscope, 2) full distention by air to adhere the gastric wall to the peritoneal wall without migration of the colon, 3) four-point square fixation under gastroenterological endoscopy without migration of the visceral organ, and 4) puncture of the needle introducer of the PEG tube in the center of the fixations under repeated gastroenterological endoscopy 3 d after the fixation. She underwent P-V shunting under local anesthesia on the 28th day after placement of PEG and enteral nutrition. Her case shows that we can achieve proper enteral nutritional support even for patients with massive cirrhotic ascites. (C) 2014 Elsevier Inc. All rights reserved.	[Moriwaki, Yoshihiro; Otani, Jun; Okuda, Junzo; Niwano, Toshiyuki; Sawada, Yoshiyuki; Nitta, Tachiko; Ohshima, Chiaki] Unnan City Hosp, Unnan, Shimane, Japan	Moriwaki, Y (reprint author), Unnan City Hosp, Unnan, Shimane, Japan.	yoshimoriwaki@gmail.com					Moore KP, 2006, GUT, V55, P1, DOI 10.1136/gut.2006.099580; [Anonymous], 2005, CLIN NUTR, V24, P848; Gines A, 1996, GASTROENTEROLOGY, V111, P1002, DOI 10.1016/S0016-5085(96)70068-9; Rosemurgy AS, 2004, ANN SURG, V239, P883, DOI 10.1097/01.sla.0000128309.36393.71	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007	1873-1244		NUTRITION	Nutrition	NOV-DEC	2014	30	11-12					1456	1459		10.1016/j.nut.2014.05.007		4	Nutrition & Dietetics	Nutrition & Dietetics	AQ7AE	WOS:000342964200033		
J	Shimakage, M				Shimakage, Misuzu			Significant role of macrophages in human cancers associated with Epstein-Barr virus (Review)	ONCOLOGY REPORTS			English	Review						Epstein-Barr virus; human cancer; macrophages; tumor-associated macrophages; in situ hybridization	LARGE-CELL LYMPHOMA; TUMOR-ASSOCIATED MACROPHAGES; IN-SITU HYBRIDIZATION; POLYMERASE-CHAIN-REACTION; PROTEIN 1 LMP1; NASOPHARYNGEAL CARCINOMA; VIRAL INTERLEUKIN-10; HUMAN-PAPILLOMAVIRUS; MYCOSIS-FUNGOIDES; EPITHELIAL-CELLS	Epstein-Barr virus (EBV) is a ubiquitous pathogen that was first identified as a human cancer virus. Many human cancers are associated with EBV, and we demonstrated that EBV infects macrophages. Macrophages infected with EBV show a close correlation with many human cancers, and thus more attention must be given to the role of macrophages infiltrating into cancer tissues associated with EBV. In this review, I discuss the role of macrophages in the process of EBV-associated oncogenesis with regard to interleukin-10.	Wakayama Natl Hosp, Natl Hosp Org, Dept Pediat, Mihama, Wakayama 6440044, Japan	Shimakage, M (reprint author), Wakayama Natl Hosp, Natl Hosp Org, Dept Pediat, 1138 Wada, Mihama, Wakayama 6440044, Japan.	misuzu_s@wakayama2.hosp.go.jp					Agarwal S, 2002, HUM PATHOL, V33, P146, DOI 10.1053/hupa.2002.31925; ALLAN GJ, 1992, J GEN VIROL, V73, P1547, DOI 10.1099/0022-1317-73-6-1547; Andereesen R, 1989, AM J PATHOL, V134, P187; HSU DH, 1990, SCIENCE, V250, P830, DOI 10.1126/science.2173142; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Liotti F, 2012, AM J CANCER RES, V2, P286; Jalouli J, 2012, ANTICANCER RES, V32, P571; Shimakage M, 2004, HUM PATHOL, V35, P862, DOI 10.1016/j.humpath.2004.03.017; Thomas TO, 2013, INT J RADIAT ONCOL, V85, P747, DOI 10.1016/j.ijrobp.2012.05.034; Komano J, 1999, J VIROL, V73, P9827; Kim KR, 2000, ONCOGENE, V19, P1764, DOI 10.1038/sj.onc.1203502; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Thorley-Lawson DA, 2005, J ALLERGY CLIN IMMUN, V116, P251, DOI 10.1016/j.jaci.2005.05.038; Frangou P, 2005, J INFECT DIS, V191, P238, DOI 10.1086/426823; Herling M, 2004, HUM PATHOL, V35, P455, DOI 10.1016/j.humpath.2003.10.013; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Park CK, 1996, BRIT J DERMATOL, V134, P488, DOI 10.1111/j.1365-2133.1996.tb16235.x; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Kuze T, 1996, J PATHOL, V180, P236; Fu DX, 2008, NAT MED, V14, P1118, DOI 10.1038/nm.1864; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Betge J, 2011, ONCOL REP, V26, P567, DOI 10.3892/or.2011.1346; Shair KHY, 2012, J VIROL, V86, P5352, DOI 10.1128/JVI.07035-11; Walling DM, 2007, J VIROL, V81, P7249, DOI 10.1128/JVI.02754-06; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Sakata N, 2008, PEDIATR BLOOD CANCER, V50, P924, DOI 10.1002/pbc.21249; Sasagawa T, 2000, HUM PATHOL, V31, P318, DOI 10.1016/S0046-8177(00)80245-2; SWAMINATHAN S, 1991, P NATL ACAD SCI USA, V88, P1546, DOI 10.1073/pnas.88.4.1546; Slots J, 2006, J PERIODONTAL RES, V41, P235, DOI 10.1111/j.1600-0765.2006.00865.x; Shimakage M, 2010, EXP THER MED, V1, P285, DOI 10.3892/etm_00000044; Lee CH, 2011, J VIROL, V85, P7333, DOI 10.1128/JVI.00182-11; Szkaradkiewicz A, 2002, CLIN EXP MED, V2, P137, DOI 10.1007/s102380200019; VIEIRA P, 1991, P NATL ACAD SCI USA, V88, P1172, DOI 10.1073/pnas.88.4.1172; Tugizov S, 2007, J VIROL, V81, P5484, DOI 10.1128/JVI.00171-07; Komohara Y, 2011, CANCER SCI, V102, P1424, DOI 10.1111/j.1349-7006.2011.01945.x; Feng WH, 2002, CANCER RES, V62, P1920; Rosato P, 2012, LEUKEMIA, V26, P2343, DOI 10.1038/leu.2012.108; Zheng H, 2007, CELL MOL IMMUNOL, V4, P185; Portal D, 2013, P NATL ACAD SCI USA, V110, P18537, DOI 10.1073/pnas.1317608110; Arke O, 1999, INT J CANCER, V82, P1; BAICHWAL VR, 1988, ONCOGENE, V2, P461; Chao Y, 2011, J MED VIROL, V83, P644, DOI 10.1002/jmv.22091; CHATANI M, 1991, LARYNGOSCOPE, V101, P626; Copur MS, 2005, CROAT MED J, V46, P458; Csire M, 2007, PATHOL ONCOL RES, V13, P157; de Martel Catherine, 2012, LANCET ONCOL, V13, P607; de Waal Malefyt R, 1991, J Exp Med, V174, P915, DOI 10.1084/jem.174.4.915; Erkek E, 2001, J EUR ACAD DERMATOL, V15, P422, DOI 10.1046/j.1468-3083.2001.00309.x; FEND F, 1995, MODERN PATHOL, V8, P622; Ghosh SK, 2012, ADV VIROL, V5, DOI [10.1155/2012/509296, DOI 10.1155/2012/509296]; Gonzalez-Moles MA, 2002, LARYNGOSCOPE, V112, P482, DOI 10.1097/00005537-200203000-00014; Hamada I, 2002, ANTICANCER RES, V22, P4281; Hellier I, 2001, EUR J DERMATOL, V11, P203; Herrmann K, 2002, J GEN VIROL, V83, P2995; Holl K, 2008, APMIS, V116, P816, DOI 10.1111/j.1600-0463.2008.00983.x; Houmani JL, 2009, J VIROL, V83, P9844, DOI 10.1128/JVI.01014-09; Huang J, 2003, J VIROL, V77, P13267, DOI 10.1128/JVI.77.24.13267-13274.2003; Hwang KK, 2012, BLOOD, V119, pE35, DOI 10.1182/blood-2011-08-371203; Jeziorski E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003262; Jochum S, 2012, PLOS PATHOG, V5; Kanai K, 2007, VIRUS GENES, V35, P563, DOI 10.1007/s11262-007-0153-5; Kasai K, 1998, PATHOL INT, V48, P171, DOI 10.1111/j.1440-1827.1998.tb03889.x; Kim KH, 2005, BJU INT, V96, P547, DOI 10.1111/j.1464-410X.2005.05682.x; Kim NR, 2005, J KOREAN MED SCI, V20, P636; Kim YC, 2006, INT J DERMATOL, V45, P1312, DOI 10.1111/j.1365-4632.2006.02951.x; Kitahama S, 1996, CLIN ENDOCRINOL, V45, P357, DOI 10.1046/j.1365-2265.1996.8020819.x; Kobayashi I, 1999, J PATHOL, V189, P34, DOI 10.1002/(SICI)1096-9896(199909)189:1<34::AID-PATH391>3.0.CO;2-4; LABRECQUE LG, 1995, CANCER RES, V55, P39; Lee JH, 2013, CANCER RES, V73, P3604, DOI 10.1158/0008-5472.CAN-12-4563; Li H, 2008, J VIROL, V82, P8500, DOI 10.1128/JVI.00186-08; Liou Peter, 2013, Vasc Cell, V5, P5, DOI 10.1186/2045-824X-5-5; LOPATEGUI JR, 1995, AM J SURG PATHOL, V19, P42, DOI 10.1097/00000478-199501000-00006; Ma L, 2011, INT J CLIN EXP PATHO, V4, P100; Mantovani A, 2011, NAT MED, V17, P285, DOI 10.1038/nm0311-285; Masy E, 2002, J VIROL, V76, P6460, DOI 10.1128/JVI.76.13.6460-6472.2002; MIYAZAKI I, 1993, J EXP MED, V178, P439, DOI 10.1084/jem.178.2.439; Murata Takayuki, 2013, Frontiers in Genetics, V4, P53, DOI 10.3389/fgene.2013.00053; Nakajima H, 2006, EUR J NEUROL, V13, pE4, DOI 10.1111/j.1468-1331.2006.01377.x; Noorali S, 2004, PATHOL RES PRACT, V200, P669, DOI 10.1016/j.prp.2004.08.004; Novelli M, 2009, J INVEST DERMATOL, V129, P1556, DOI 10.1038/jid.2008.396; Pan SH, 2009, CARCINOGENESIS, V30, P366, DOI 10.1093/carcin/bgn291; Peng RS, 2005, J VIROL, V79, P4492, DOI 10.1128/JVI.79.7.4492-4505.2005; RAJPERTDEMEYTS E, 1994, APMIS, V102, P38; Salek-Ardakani S, 2004, J IMMUNOL, V173, P321; Sano H, 2013, INTERVIROLOGY, V56, P114, DOI 10.1159/000343753; Santos NBM, 2009, ONCOL REP, V21, P403, DOI 10.3892/or_00000236; Sasikala PS, 2010, INT J LAB HEMATOL, V32, P56, DOI 10.1111/j.1751-553X.2008.01125.x; Shamaa AA, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-45; Shimakage M, 1996, J UROLOGY, V156, P253, DOI 10.1016/S0022-5347(01)66011-7; Shimakage M, 1997, HUM PATHOL, V28, P1415, DOI 10.1016/S0046-8177(97)90232-X; Shimakage M, 2002, HUM PATHOL, V33, P608, DOI 10.1053/hupa.2002.129786; Shimakage M, 1999, HUM PATHOL, V30, P3071; Shimakage M, 2007, ONCOL REP, V17, P1347; Shimakage M, 2001, J VIROL METHODS, V93, P23, DOI 10.1016/S0166-0934(00)00271-8; Shimakage M, 1999, ARCH VIROL, V144, P157, DOI 10.1007/s007050050492; Shimakage M, 1996, INT J CANCER, V68, P612; SHIMAKAGE M, 1993, INTERVIROLOGY, V36, P215; Shimakage M, 2007, ONCOL REP, V18, P41; Shimakage M, 2006, NEW DEVELOPMENTS IN EPSTEIN-BARR VIRUS RESEARCH, P261; SHIMAKAGE M, 1995, FEBS LETT, V371, P245, DOI 10.1016/0014-5793(95)00889-H; Shimakage M, 2001, INT J CANCER, V92, P226, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1172>3.0.CO;2-O; Shimakage M, 2003, HUM PATHOL, V34, P1170, DOI 10.1053/S0046-8177(03)00467-2; SUZUKI T, 1995, J EXP MED, V182, P477, DOI 10.1084/jem.182.2.477; Szostek S, 2009, ACTA BIOCHIM POL, V56, P337; Tazzari PL, 1999, HAEMATOLOGICA, V84, P988; Tierney R, 2011, J VIROL, V85, P12363; Wang ZY, 2012, BLOOD, V10, P2003; Weiss Lawrence M, 2013, Methods Mol Biol, V999, P223, DOI 10.1007/978-1-62703-357-2_16; Wu Y, 2007, J VIROL, V81, P11236, DOI 10.1128/JVI.00579-07	111	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	NOV	2014	32	5					1763	1771		10.3892/or.2014.3475		9	Oncology	Oncology	AQ3SO	WOS:000342714000001		
J	Yabusaki, M; Sato, J; Kohyama, A; Kojima, T; Nobuoka, D; Yoshikawa, T; Sawada, Y; Murakami, K; Gohda, K; Okegawa, T; Nakamura, M; Takamatsu, K; Ito, M; Kaneko, K; Nakatsura, T				Yabusaki, Mina; Sato, Jun; Kohyama, Atsushi; Kojima, Takashi; Nobuoka, Daisuke; Yoshikawa, Toshiaki; Sawada, Yu; Murakami, Katsuhiro; Gohda, Keigo; Okegawa, Takatsugu; Nakamura, Masaru; Takamatsu, Kiyoshi; Ito, Masaaki; Kaneko, Kazuhiro; Nakatsura, Tetsuya			Detection and preliminary evaluation of circulating tumor cells in the peripheral blood of patients with eight types of cancer using a telomerase-specific adenovirus	ONCOLOGY REPORTS			English	Article						adenovirus; circulating tumor cells; OBP-401; telomerase	REPLICATION-SELECTIVE ADENOVIRUS; BREAST-CANCER; CHEMOTHERAPY; SYSTEM; IMPACT; AGENT	We developed a detection method for circulating tumor cells (CTCs) using the telomerase-specific adenovirus OBP-401. This recombinant virus has a telomerase promoter at the 5'-end of the viral genome and GFP at the 3'-end. To date, CTC enumeration using OBP-401 has shown prognostic impact for gastric and small cell lung cancer patients. In the present study, peripheral blood samples from patients with eight types of cancer, including some cancers previously untested with OBP-401 (i.e., esophagus, pancreas, and prostate cancers) were subjected to this method in order to evaluate its versatility. It was recently discovered that some white blood cells (WBCs) false-positively react with OBP-401. Although anti-CD45 antibodies can absorb these adverse cells from peripheral blood, the simplicity of the OBP-401 method would be diminished by the introduction of antibody treatment. Therefore, we evaluated another approach to minimize the false positivity of WBCs. Seven anti-CD antibodies were employed to stain the species of WBCs that false-positively reacted with OBP-401. We revealed that the false-positively reacted WBCs were monocytes in the peripheral blood of both healthy subjects and cancer patients. Based on a size distribution analysis of the GFP-positive monocytes, the size criterion for CTCs using OBP-401 was defined to be a cellular diameter >8.4 mu m. In total, 43% of 86 cancer patients examined in the present study were CTC-positive using this definition. CTCs were enumerated from peripheral blood samples collected from patients with each of the eight types of cancer; the detectability of CTCs for esophagus, pancreas and prostate cancers by the OBP-401 method was confirmed for the first time in the present study. However, no clear correlation between CTC positivity and the clinical characteristics of patients with any type of cancer was observed because of the small number of patients with each type of cancer. An additional clinical study will be conducted to confirm the clinical meaning of CTCs enumerated by OBP-401.	[Yabusaki, Mina; Sato, Jun; Murakami, Katsuhiro; Gohda, Keigo] Sysmex Corp, Cent Res Labs, Kobe, Hyogo, Japan; [Yabusaki, Mina; Sato, Jun; Nobuoka, Daisuke; Yoshikawa, Toshiaki; Sawada, Yu; Nakatsura, Tetsuya] Natl Canc Ctr, Div Canc Immunotherapy, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba 2778577, Japan; [Kohyama, Atsushi; Ito, Masaaki] Natl Canc Ctr Hosp East, Div Colorectal & Pelv Surg, Kashiwa, Chiba, Japan; [Kojima, Takashi; Kaneko, Kazuhiro] Natl Canc Ctr Hosp East, Endoscopy Div, Dept Gastroenterol, Kashiwa, Chiba, Japan; [Nobuoka, Daisuke] Okayama Univ, Dept Surg Gastroenterol, Okayama, Japan; [Okegawa, Takatsugu] Kyorin Univ, Sch Med, Dept Urol, Mitaka, Tokyo 181, Japan; [Nakamura, Masaru; Takamatsu, Kiyoshi] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Obstet & Gynecol, Ichikawa, Chiba, Japan	Nakatsura, T (reprint author), Natl Canc Ctr, Div Canc Immunotherapy, Exploratory Oncol Res & Clin Trial Ctr, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	tnakatsu@east.ncc.go.jp					BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Davis JW, 2008, J UROLOGY, V179, P2187, DOI 10.1016/j.juro.2008.01.102; Zheng SY, 2011, BIOMED MICRODEVICES, V13, P203, DOI 10.1007/s10544-010-9485-3; Pierga JY, 2008, CLIN CANCER RES, V14, P7004, DOI 10.1158/1078-0432.CCR-08-0030; Lin HK, 2010, CLIN CANCER RES, V16, P5011, DOI 10.1158/1078-0432.CCR-10-1105; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Hou JM, 2009, AM J PATHOL, V175, P808, DOI 10.2353/ajpath.2009.090078; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Vona G, 2004, HEPATOLOGY, V39, P792, DOI 10.1002/hep.20091; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Kim SJ, 2011, BREAST CANCER RES TR, V128, P765, DOI 10.1007/s10549-011-1603-2; Bilsland AE, 2007, CANCER RES, V67, P1299, DOI 10.1158/0008-5472.CAN-06-3000; Fujiwara T, 2006, INT J CANCER, V119, P432, DOI 10.1002/ijc.21846; Havenga MJE, 2002, J VIROL, V76, P4612, DOI 10.1128/JVI.76.9.4612-4620.2002; Igawa S, 2014, ONCOL LETT, V7, P1469, DOI 10.3892/ol.2014.1940; Ito H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-346; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kishimoto H, 2006, NAT MED, V12, P1213, DOI 10.1038/nm1404; Kojima T, 2009, J CLIN INVEST, V119, P3172, DOI 10.1172/JCI38609; Parkinson DR, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-138; Takakura M, 2012, BRIT J CANCER, V107, P448, DOI 10.1038/bjc.2012.276	22	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	NOV	2014	32	5					1772	1778		10.3892/or.2014.3436		7	Oncology	Oncology	AQ3SO	WOS:000342714000002		
J	Miyahara, N; Shoda, J; Kawamoto, T; Ishida, H; Ueda, T; Akimoto, Y; Kawakami, H; Irimura, T				Miyahara, Naoki; Shoda, Junichi; Kawamoto, Toru; Ishida, Hiroyasu; Ueda, Tetsuya; Akimoto, Yoshihiro; Kawakami, Hayato; Irimura, Tatsuro			Interaction of Muc4 and ErbB2 in a transgenic mouse model of gallbladder carcinoma: Potential pathobiological implications	ONCOLOGY REPORTS			English	Article						carcinogenesis; gallbladder; Muc4; erbB2; cell signaling	GROWTH-FACTOR RECEPTOR; IN-SITU HYBRIDIZATION; GENE-EXPRESSION; INTRAHEPATIC CHOLANGIOCARCINOMA; CONSTITUTIVE EXPRESSION; MUC4/SIALOMUCIN COMPLEX; INTRAMEMBRANE MODULATOR; KINASE ACTIVATION; SIGNALING NETWORK; TYROSINE KINASE	The molecular mechanism of gallbladder carcinogenesis and cancer growth remains unknown. BK5.erbB2 transgenic mice in which erbB2 is overexpressed and activated in the biliary epithelia develop adenocarcinoma of the gallbladder at a high incidence. Although it has been reported that erbB2 plays an important role in tumorigenesis, little is known about the involvement of its ligand(s). The expression level of Muc4, a potential functional ligand for erbB2, and its interaction with erbB2 in the gallbladder of BK5.erbB2 mice were determined. By immunohistochemistry and in situ-hybridization, both Muc4 mRNA and protein levels were strongly expressed in the cancerous epithelia of gallbladder from BK5.erbB2 mice. Also, in the hyperplastic (precancerous) epithelia, the protein levels were modestly expressed. Immunostaining with Muc4 (ASGP2) Ab overlapped with that with erbB2 Ab in the apical membranous components of the cancerous epithelia, indicating the co-localization of Muc4 and erbB2. Immunoprecipitation experiments revealed an interaction between Muc4 and erbB2 in the gallbladders. The interaction was associated with the hyperphosphorylation of erbB2, MAPK and Akt, and also with the overexpression of cyclooxygenase-2. However, in other organs that overexpressed erbB2 (trachea, esophagus and forestomach), Muc4 was expressed in only trace or modest amounts, and erbB2 was not hyperphosphorylated. Collectively, Muc4 is upregulated and interacts with erbB2 in gallbladders from BK5.erbB2 mice. It is likely that Muc4 plays an important role during gallbladder carcinogenesis and/or cancer growth by potentiating erbB2 signaling.	[Miyahara, Naoki] Ushiku Aiwa Gen Hosp, Dept Gastroenterol, Ushiku, Ibaraki, Japan; [Shoda, Junichi] Univ Tsukuba, Div Med Sci, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Kawamoto, Toru] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Shinjyuku Ku, Tokyo, Japan; [Ishida, Hiroyasu] Natl Hosp Org Mito Med Ctr, Dept Gastroenterol, Ibaraki, Japan; [Ueda, Tetsuya] Mitsubishi Kagaku Bioclin Labs Inc, Dept Pharmaceut Res, Itabashi Ku, Tokyo, Japan; [Akimoto, Yoshihiro; Kawakami, Hayato] Kyorin Univ, Sch Med, Dept Anat, Mitaka, Tokyo 181, Japan; [Irimura, Tatsuro] St Lukes Int Med Ctr, Inst Med Innovat, Chuo Ku, Tokyo, Japan	Shoda, J (reprint author), Univ Tsukuba, Div Med Sci, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	shodaj@md.tsukuba.ac.jp			Ministry of Education, Science and Culture [15590618, 23390318, 24390323]	The authors would like to thank Dr Kaoru Kiguchi and Professor John DiGiovanni, the University of Texas, MD Anderson Cancer Center, Science Park Research Division, Smithville, Texas, USA, for their kind supply of biological tissue specimens of BK5.erbB2 transgenic mice. This study was supported by grants-in-aid (nos. 15590618, 23390318 and 24390323) for scientific research from the Ministry of Education, Science and Culture.	Carraway KL, 2003, BIOESSAYS, V25, P66, DOI 10.1002/bies.10201; Price-Schiavi SA, 2002, INT J CANCER, V99, P783, DOI 10.1002/ijc.10410; Shibahara H, 2004, HEPATOLOGY, V39, P220, DOI 10.1002/hep.20031; Jepson S, 2002, ONCOGENE, V21, P7524, DOI 10.1038/sj.onc.1205970; QIAN XL, 1994, P NATL ACAD SCI USA, V91, P1500, DOI 10.1073/pnas.91.4.1500; Sirica AE, 2002, SEMIN LIVER DIS, V22, P303, DOI 10.1055/s-2002-34507; Kiguchi K, 2001, CANCER RES, V61, P6971; DIMARCO E, 1990, MOL CELL BIOL, V10, P3247; Kamei D, 2003, J BIOL CHEM, V278, P19396, DOI 10.1074/jbc.M213290200; Carraway KL, 1999, J BIOL CHEM, V274, P5263, DOI 10.1074/jbc.274.9.5263; Kiguchi K, 2000, ONCOGENE, V19, P4243, DOI 10.1038/sj.onc.1203778; Buisine MP, 2000, J HISTOCHEM CYTOCHEM, V48, P1667; BALAGUE C, 1995, GASTROENTEROLOGY, V109, P953, DOI 10.1016/0016-5085(95)90406-9; Itoi T, 1996, PATHOL INT, V46, P333, DOI 10.1111/j.1440-1827.1996.tb03618.x; Ukita Y, 2002, J HEPATOL, V36, P780, DOI 10.1016/S0168-8278(02)00057-0; LOWENFELS AB, 1985, J NATL CANCER I, V75, P77; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Lenferink AEG, 1998, EMBO J, V17, P3385, DOI 10.1093/emboj/17.12.3385; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Braissant O., 1998, BIOCHEMICA, V1, P10; CUBERTAFOND P, 1994, ANN SURG, V219, P275, DOI 10.1097/00000658-199403000-00007; HENSON DE, 1992, CANCER, V70, P1493, DOI 10.1002/1097-0142(19920915)70:6<1493::AID-CNCR2820700608>3.0.CO;2-U; Kawamoto T, 2005, TANDO, V19, P550; Kiguchi K, 2005, CLIN CANCER RES, V11, P5572, DOI 10.1158/1078-0432.CCR-04-2603; KIMURA K, 1985, GASTROENTEROLOGY, V89, P1258; Klapper LN, 2000, ADV CANCER RES, V77, P25; Komatsu M, 2001, ONCOGENE, V20, P461, DOI 10.1038/sj.onc.1204106; Lai GH, 2003, MOL CANCER THER, V2, P265; Lai GH, 2005, GASTROENTEROLOGY, V129, P2047, DOI 10.1053/j.gastro.2005.10.010; Miyahara N, 2008, EUR J CANCER, V44, P1048, DOI 10.1016/j.ejca.2008.03.007; Murali R, 1996, P NATL ACAD SCI USA, V93, P6252, DOI 10.1073/pnas.93.13.6252; Pandey M, 2002, EUR J CANCER PREV, V11, P365, DOI 10.1097/00008469-200208000-00008; Ruckert JC, 1996, HEPATO-GASTROENTEROL, V43, P527; Suzuki H, 2000, J Hepatobiliary Pancreat Surg, V7, P206, DOI 10.1007/s005340050177; SUZUKI T, 1993, PATHOL RES PRACT, V189, P283; Vadlamudi R, 1999, ONCOGENE, V18, P305, DOI 10.1038/sj.onc.1202307; Yoshida S, 2003, P AM ASSOC CANC RES, V43, P786; YUKAWA M, 1993, HUM PATHOL, V24, P37, DOI 10.1016/0046-8177(93)90060-T	38	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	NOV	2014	32	5					1796	1802		10.3892/or.2014.3443		7	Oncology	Oncology	AQ3SO	WOS:000342714000005		
J	Hamatani, K; Eguchi, H; Koyama, K; Mukai, M; Nakachi, K; Kusunoki, Y				Hamatani, Kiyohiro; Eguchi, Hidetaka; Koyama, Kazuaki; Mukai, Mayumi; Nakachi, Kei; Kusunoki, Yoichiro			A novel RET rearrangement (ACBD5/RET) by pericentric inversion, inv(10)(p12.1;q11.2), in papillary thyroid cancer from an atomic bomb survivor exposed to high-dose radiation	ONCOLOGY REPORTS			English	Article						RET rearrangements; pericentric inversion; atomic bomb survivors	TYROSINE KINASE; MOLECULAR CHARACTERIZATION; CARCINOMA; GENE; PROTOONCOGENE; FUSION; ACTIVATION; CHERNOBYL; ONCOGENE; PROTEIN	During analysis of RET/PTC rearrangements in papillary thyroid cancer (PTC) among atomic bomb survivors, a cDNA fragment of a novel type of RET rearrangement was identified in a PTC patient exposed to a high radiation dose using the improved 5' RACE method. This gene resulted from the fusion of the 3' portion of RET containing tyrosine kinase domain to the 5' portion of the acyl-coenzyme A binding domain containing 5 (ACBD5) gene, by pericentric inversion inv(10)(p12.1;q11.2); expression of the fusion gene was confirmed by RT-PCR. ACBD5 gene is ubiquitously expressed in various human normal tissues including thyroid. Full-length cDNA of the ACBD5-RET gene was constructed and then examined for tumorigenicity. Enhanced phosphorylation of ERK proteins in the MAPK pathway was observed in NIH3T3 cells transfected with expression vector encoding the full-length ACBD5/RET cDNA, while this was not observed in the cells transfected with empty expression vector. Stable NIH3T3 transfectants with ACBD5-RET cDNA induced tumor formation after their injection into nude mice. These findings suggest that the ACBD5-RET rearrangement is causatively involved in the development of PTC.	[Hamatani, Kiyohiro; Koyama, Kazuaki; Mukai, Mayumi; Nakachi, Kei; Kusunoki, Yoichiro] Radiat Effects Res Fdn, Dept Radiobiol Mol Epidemiol, Hiroshima, Japan; [Mukai, Mayumi] Radiat Effects Res Fdn, Dept Genet, Hiroshima, Japan; [Eguchi, Hidetaka] Saitama Med Univ, Res Ctr Genom Med, Div Translat Res, Saitama, Japan	Hamatani, K (reprint author), Radiat Effects Res Fdn, Dept Radiobiol Mol Epidemiol, Minami Ku, 5-2 Hijiyama Pk, Hiroshima 7320815, Japan.	hamatani@rerf.or.jp			Japanese Ministry of Health, Labour and Welware (MHLW); US Department of Energy (DOE); DOE [DE-HS0000031]; Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare of Japan; Research Grant for the Princess Takamatsu Cancer Research Fund [08-24015]; RERF Research Protocols [RP 5-02]	The Radiation Effects Research Foundation (RERF), Hiroshima and Nagasaki, Japan, is a public interest foundation funded by the Japanese Ministry of Health, Labour and Welware (MHLW), and the US Department of Energy (DOE). This study was funded in part through DOE award DE-HS0000031 to the National Academy Sciences, and in part by a Grant-in-Aid for Science Research from the Ministry of Education, Culture, Sports, Science and Technology, and a Grant-in Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan, as well as a Research Grant for the Princess Takamatsu Cancer Research Fund (08-24015). This publication was supported by RERF Research Protocols RP 5-02. The views of the authors do not necessarily reflect those of the two governments.	Albert L, 2003, J CELL PHYSIOL, V195, P168, DOI 10.1002/jcp.10252; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; Klugbauer S, 2000, CANCER RES, V60, P7028; Arighi E, 2005, CYTOKINE GROWTH F R, V16, P441, DOI 10.1016/j.cytogfr.2005.05.010; Klugbauer S, 1999, ONCOGENE, V18, P4388, DOI 10.1038/sj.onc.1202824; AVANTAGGIATO V, 1994, CELL GROWTH DIFFER, V5, P305; Hamatani K, 2008, CANCER RES, V68, P7176, DOI 10.1158/0008-5472.CAN-08-0293; Ciampi R, 2007, ENDOCR-RELAT CANCER, V14, P445, DOI 10.1677/ERC-07-0039; Kodama Y, 2005, CANCER SCI, V96, P143, DOI 10.1111/j.1349-7006.2005.00023.x; BONGARZONE I, 1993, MOL CELL BIOL, V13, P358; Hamatani K, 2006, J HISTOCHEM CYTOCHEM, V54, P773, DOI 10.1369/jhc.5A6859.2006; Corvi R, 2000, ONCOGENE, V19, P4236, DOI 10.1038/sj.onc.1203772; Salassidis K, 2000, CANCER RES, V60, P2786; Hamatani K, 2012, THYROID, V22, P1153, DOI 10.1089/thy.2011.0511; SANTORO M, 1994, ONCOGENE, V9, P509; Klugbauer S, 1998, CANCER RES, V58, P198; Saenko V, 2003, MUTAT RES-FUND MOL M, V527, P81, DOI 10.1016/S0027-5107(03)00056-3; BONGARZONE I, 1994, CANCER RES, V54, P2979; Fugazzola L, 1996, ONCOGENE, V13, P1093; Hamatani K, 2010, THYROID, V20, P43, DOI 10.1089/thy.2009.0098; Pachinis V, 1993, DEVELOPMENT, V19, P1005; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Tallini G, 2001, ADV ANAT PATHOL, V8, P345, DOI 10.1097/00125480-200111000-00005; Tong Q, 1997, J BIOL CHEM, V272, P9043; Young RW, 2005, REASSESSMENT ATOMIC, V1	25	1	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	NOV	2014	32	5					1809	1814		10.3892/or.2014.3449		6	Oncology	Oncology	AQ3SO	WOS:000342714000007		
J	Hayashi, Y; Sasaki, H; Takeshita, S; Nishikawa, R; Nishikawa, H; Arakawa, A; Yamashita, Y; Takahashi, S; Sugiura-Ogasawara, M				Hayashi, Yuko; Sasaki, Hidefumi; Takeshita, Sho; Nishikawa, Ryutaro; Nishikawa, Hiroshi; Arakawa, Atsushi; Yamashita, Yoriko; Takahashi, Satoru; Sugiura-Ogasawara, Mayumi			Usefulness of immunohistochemistry for the detection of the BRAF V600E mutation in ovarian serous borderline tumors	ONCOLOGY REPORTS			English	Article						BRAF mutation; immunohistochemistry; V600E expression; serous borderline tumor; ovary; CAST-PCR	LUNG ADENOCARCINOMA; KRAS; CARCINOMA; CANCER; PCR; PERITONEUM; SAMPLES; EGFR	Serous borderline tumors and low-grade serous adenocarcinomas typically exhibit a low mitotic index and are largely resistant to chemotherapy. They are characterized by specific mutations, including mutations of KRAS and BRAF, which target specific cell signaling pathways. Mutational analyses may provide further insight into the development sequence of low-grade serous carcinomas. There are 3 methods to detect BRAF mutations: direct sequencing, such as Sanger sequencing (Sas); immunohistochemistry (IHC); and competitive allele-specific hydrolysis probe (TaqMan) PCR technology (CAST-PCR). In the present study, we matched the results of these 3 methods in ovarian serous borderline tumor cases. This study was carried out in 11 surgically removed ovarian serous borderline tumors. Detection of the BRAF V600E mutation was carried out by the FLEX detection system using the VE1 clone antibody and the results were compared with those of Sas and CAST-PCR. The autostainer IHC VE1 assay was positive in 3 of the 11 ovarian serous borderline tumors and negative in the remaining 8 tumors. CAST-PCR demonstrated a BRAF V600E mutation ratio of 16.4, 17.7 and 12.7%, respectively, in the 3 IHC-positive cases. Sas detected the BRAF V600E mutation in only 2 cases, while revealing wild-type BRAF in the remaining 9 cases. Sas revealed KRAS mutations in 2 of these 9 cases with wild-type BRAF. Our data suggest a high concordance rate of the results between CAST-PCR and IHC. Thus, IHC using the VE1 clone and FLEX linker is a specific method for the detection of BRAF V600E and may be an alternative to molecular-biologic techniques for the detection of mutations in ovarian serous borderline tumors. This method may be a useful screening method for the BRAF mutation.	[Hayashi, Yuko; Takeshita, Sho; Nishikawa, Hiroshi; Arakawa, Atsushi; Sugiura-Ogasawara, Mayumi] Nagoya City Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Nagoya, Aichi 4678601, Japan; [Sasaki, Hidefumi] Nagoya City Univ, Grad Sch Med Sci, Dept Oncol Immunol & Surg, Nagoya, Aichi 4678601, Japan; [Yamashita, Yoriko; Takahashi, Satoru] Nagoya City Univ, Grad Sch Med Sci, Dept Pathol & Tumor Biol, Nagoya, Aichi 4678601, Japan; [Nishikawa, Ryutaro] Nagoya City East Med Ctr, Dept Obstet & Gynecol, Nagoya, Aichi 4648547, Japan	Hayashi, Y (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, 1 Kawasumi, Nagoya, Aichi 4678601, Japan.	yuhayashi0120@hotmail.co.jp	Yamashita, Yoriko/B-9810-2011		Japan Society for the Promotion of Science (JSPS) [24592097, 25293303]	This study was supported by Grants-in-Aid for Scientific Research, the Japan Society for the Promotion of Science (JSPS) (nos. 24592097 and 25293303). The authors thank Mr. Yoichi Tani, who was responsible for immunostaining.	Crispens MA, 2002, OBSTET GYNECOL, V99, P3, DOI 10.1016/S0029-7844(01)01649-0; Sieben NLG, 2004, J PATHOL, V202, P336, DOI 10.1002/path.1521; Anderson S, 2012, ARCH PATHOL LAB MED, V136, P1385, DOI 10.5858/arpa.2011-0505-OA; Mayr D, 2006, GYNECOL ONCOL, V103, P883, DOI 10.1016/j.ygyno.2006.05.029; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Raab SS, 2000, ARCH PATHOL LAB MED, V124, P1185; Didelot A, 2012, EXP MOL PATHOL, V92, P275, DOI 10.1016/j.yexmp.2012.03.001; Bosmuller H, 2013, HUM PATHOL, V44, P329, DOI 10.1016/j.humpath.2012.07.010; Wong KK, 2010, AM J PATHOL, V177, P1611, DOI 10.2353/ajpath.2010.100212; Brevet M, 2010, J MOL DIAGN, V12, P169, DOI 10.2353/jmoldx.2010.090140; Capper D, 2012, ACTA NEUROPATHOL, V123, P223, DOI 10.1007/s00401-011-0887-y; Nakayama N, 2008, BRIT J CANCER, V99, P2020, DOI 10.1038/sj.bjc.6604783; Sasaki H, 2013, LUNG CANCER, V82, P51, DOI 10.1016/j.lungcan.2013.06.014; Grisham RN, 2013, CANCER-AM CANCER SOC, V119, P548, DOI 10.1002/cncr.27782; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Jones S, 2012, J PATHOL, V226, P413, DOI 10.1002/path.3967; Singer G, 2003, J NATL CANCER I, V95, P484; Rossle M, 2013, VIRCHOWS ARCH, V463, P623, DOI 10.1007/s00428-013-1492-3; Capper D, 2011, ACTA NEUROPATHOL, V122, P11, DOI 10.1007/s00401-011-0841-z; Schmeler KM, 2008, GYNECOL ONCOL, V108, P510, DOI 10.1016/j.ygyno.2007.11.013; Gershenson DM, 2009, GYNECOL ONCOL, V114, P48, DOI 10.1016/j.ygyno.2009.03.001; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Shvartsman HS, 2007, GYNECOL ONCOL, V105, P625, DOI 10.1016/j.ygyno.2007.01.030; Farley J, 2013, LANCET ONCOL, V14, P134, DOI 10.1016/S1470-2045(12)70572-7; Huang Tiangui, 2013, Biomark Res, V1, P3, DOI 10.1186/2050-7771-1-3; Lamy A, 2009, MODERN PATHOL, V24, P1090; Pohl G, 2005, CANCER RES, V65, P1994, DOI 10.1158/0008-5472.CAN-04-3625; Sahm F, 2011, HISTOPATHOLOGY, V58, P1167, DOI 10.1111/j.1365-2559.2011.03823.x; Yancovitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029336	29	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	NOV	2014	32	5					1815	1819		10.3892/or.2014.3442		5	Oncology	Oncology	AQ3SO	WOS:000342714000008		
J	Hino, A; Tanaka, T; Takaishi, M; Fujii, Y; Palomares-Rius, JE; Hasegawa, K; Maruyama, H; Kikuchi, T				Hino, Akina; Tanaka, Teruhisa; Takaishi, Maho; Fujii, Yumiko; Palomares-Rius, Juan E.; Hasegawa, Koichi; Maruyama, Haruhiko; Kikuchi, Taisei			Karyotype and reproduction mode of the rodent parasite Strongyloides venezuelensis	PARASITOLOGY			English	Article						parthenogenesis; parasitic nematodes; karyotype	FREE-LIVING GENERATION; NORTH-AMERICAN SCIURIDS; CHROMATIN DIMINUTION; GENUS STRONGYLOIDES; RATTI; PAPILLOSUS; NEMATODA; TEMPERATURE; INFECTION; SEX	Strongyloides venezuelensis is a parasitic nematode that infects rodents. Although Strongyloides species described to date are known to exhibit parthenogenetic reproduction in the parasitic stage of their life cycle and sexual reproduction in the free-living stage, we did not observe any free-living males in S. venezuelensis in our strain, suggesting that the nematode is likely to depend on parthenogenetic reproduction. We confirmed by cytological analysis that S. venezuelensis produces eggs by parthenogenesis during the parasitic stage of its life cycle. Phylogenetic analysis using nearly the full length of 18S and D3 region of 28S ribosomal RNA gene suggested that S. venezuelensis is distantly related to another rodent parasite, namely Strongyloides ratti, but more closely related to a ruminant parasite, Strongyloides papillosus. Karyotype analysis revealed S. venezuelensis reproduces with mitotic parthenogenesis, and has the same number of chromosomes as S. papillosus (2n = 4), but differs from S. ratti (2n = 6) in this regard. These results, taken together, suggest that S. venezuelensis evolved its parasitism for rodents independently from S. ratti and, therefore, is likely to have a different reproductive strategy.	[Hino, Akina; Takaishi, Maho; Fujii, Yumiko; Palomares-Rius, Juan E.; Maruyama, Haruhiko; Kikuchi, Taisei] Miyazaki Univ, Fac Med, Div Parasitol, Miyazaki 8891692, Japan; [Tanaka, Teruhisa] Univ Ryukyus, Fac Med, Dept Infect Resp & Digest Med, Okinawa 9030213, Japan; [Hasegawa, Koichi] Chubu Univ, Coll Biosci & Biotechnol, Dept Environm Biol, Kasugai, Aichi 4878501, Japan	Kikuchi, T (reprint author), Miyazaki Univ, Fac Med, Div Parasitol, Miyazaki 8891692, Japan.	taisei_kikuchi@med.miyazaki-u.ac.jp	Palomares-Rius, Juan /K-8004-2015; 	Palomares-Rius, Juan Emilio/0000-0003-1776-8131	JSPS KAKENHI [24780044, 24659190, 26292178, 26460510]; Association for Preventive Medicine of Japan	The authors thank Mark Viney and Yasunobu Maeda for reading and commenting on the manuscript, Nancy Holroyd, Matthew Berriman, Warwick Grant, Ayako Yoshida and Yoichiro Horii for supplying DNA or other biological materials, and Valerie Williamson for valuable suggestions about embryo observation. This study was partly supported by JSPS KAKENHI [grant numbers 24780044, 24659190, 26292178 and 26460510]. AH was supported by the Association for Preventive Medicine of Japan.	ALBERTSON DG, 1979, CHROMOSOMA, V75, P75, DOI 10.1007/BF00330626; Dorris M, 2002, INT J PARASITOL, V32, P1507, DOI 10.1016/S0020-7519(02)00156-X; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; TAKAMURE A, 1995, INT J PARASITOL, V25, P907, DOI 10.1016/0020-7519(95)00014-S; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Viney ME, 1996, P ROY SOC B-BIOL SCI, V263, P201, DOI 10.1098/rspb.1996.0032; Wilkes CP, 2007, PARASITE IMMUNOL, V29, P339, DOI 10.1111/j.1365-3024.2007.00945.x; Streit A, 2008, PARASITOLOGY, V135, P285, DOI 10.1017/S003118200700399X; Nemetschke L, 2010, CURR BIOL, V20, P1687, DOI 10.1016/j.cub.2010.08.014; YAMADA M, 1991, J PARASITOL, V77, P592, DOI 10.2307/3283165; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Nunn GB, 1996, J MOL EVOL, V42, P211, DOI 10.1007/BF02198847; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; ARIZONO N, 1976, Japanese Journal of Parasitology, V25, P328; BARTLETT CM, 1995, FOLIA PARASIT, V42, P102; Brauchle M, 2009, DEV BIOL, V335, P253, DOI 10.1016/j.ydbio.2009.07.033; Brumpt E., 1934, PRECIS PARASITOLOGIE; CHITWOOD B. G., 1940, JOUR PARASITOL, V26, P183, DOI 10.2307/3272206; Eberhardt AG, 2007, INT J PARASITOL, V37, P989, DOI 10.1016/j.ijpara.2007.01.010; EL-Malky MA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-148; Harvey SC, 2000, P ROY SOC B-BIOL SCI, V267, P2057, DOI 10.1098/rspb.2000.1249; HASEGAWA H, 1988, Japanese Journal of Parasitology, V37, P429; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/mls044; LITTLE MD, 1966, J PARASITOL, V52, P69, DOI 10.2307/3276396; Matsumoto M, 2013, INFECT IMMUN, V81, P2518, DOI 10.1128/IAI.00285-13; Minato K, 2008, PARASITOL RES, V102, P315, DOI 10.1007/s00436-007-0773-7; MONCOL DJ, 1978, J PARASITOL, V64, P220, DOI 10.2307/3279660; NWAORGU OC, 1983, VET PARASITOL, V13, P213, DOI 10.1016/0304-4017(83)90058-4; Pina-Martins F, 2008, MOL ECOL RESOUR, V8, P1254, DOI 10.1111/j.1755-0998.2008.02164.x; Sakamoto M, 2013, PARASITOL RES, V112, P4009, DOI 10.1007/s00436-013-3591-0; Sato H, 2007, J PARASITOL, V93, P1476, DOI 10.1645/GE-1106.1; SATO Y, 1990, INT J PARASITOL, V20, P63, DOI 10.1016/0020-7519(90)90174-L; Shaham S, 2006, WORMBOOK, DOI [10.1895/wormbook.1.49.1, DOI 10.1895/WORMBOOK.1.49.1]; TRIANTAPHYLLOU AC, 1977, J PARASITOL, V63, P961, DOI 10.2307/3279827; Viney Mark E, 2007, WormBook, P1; VINEY ME, 1994, PARASITOLOGY, V109, P511; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; WERTHEIM G, 1964, J Helminthol, V38, P393; Wilgenbusch JC, 2003, CURR PROTOC BIOINFOR, DOI [10.1002/0471250953.bi0604s00, DOI 10.1002/0471250953.BI0604S00]; ZAFFAGNI.F, 1973, CHROMOSOMA, V40, P443, DOI 10.1007/BF00399433	40	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0031-1820	1469-8161		PARASITOLOGY	Parasitology	NOV	2014	141	13					1736	1745		10.1017/S0031182014001036		10	Parasitology	Parasitology	AQ6KE	WOS:000342919500007		
J	Meany, HJ; London, WB; Ambros, PF; Matthay, KK; Monclair, T; Simon, T; Garaventa, A; Berthold, F; Nakagawara, A; Cohn, SL; Pearson, AD; Park, JR				Meany, Holly J.; London, Wendy B.; Ambros, Peter F.; Matthay, Katherine K.; Monclair, Tom; Simon, Thorsten; Garaventa, Alberto; Berthold, Frank; Nakagawara, Akira; Cohn, Susan L.; Pearson, Andrew D. J.; Park, Julie R.			Significance of Clinical and Biologic Features in Stage 3 Neuroblastoma: A Report from the International Neuroblastoma Risk Group Project	PEDIATRIC BLOOD & CANCER			English	Article						biologic factor; neuroblastoma; treatment outcome	CHILDRENS ONCOLOGY GROUP; PATHOLOGY CLASSIFICATION; MYCN AMPLIFICATION; N-MYC; 13-CIS-RETINOIC ACID; PROGNOSTIC IMPACT; CHROMOSOME 1P; CANCER GROUP; TUMORS; AGE	BackgroundInternational Neuroblastoma Staging System (INSS) Stage 3 neuroblastoma is a heterogeneous disease. Data from the International Neuroblastoma Risk Group (INRG) database were analyzed to define patient and tumor characteristics predictive of outcome. ProcedureOf 8,800 patients in the INRG database, 1,483 with INSS Stage 3 neuroblastoma and complete follow-up data were analyzed. Secondary analysis was performed in 1,013 patients (68%) with MYCN-non-amplified (NA) tumors. Significant prognostic factors were identified via log-rank test comparisons of survival curves. Multivariable Cox proportional hazards regression model was used to identify factors independently predictive of event-free survival (EFS). ResultsAge at diagnosis (P<0.0001), tumor MYCN status (P<0.0001), and poorly differentiating/undifferentiated histology (P=0.03) were independent predictors of EFS. Compared to other Stage 3 subgroups, outcome was inferior for patients 547 days with MYCN-NA neuroblastoma (P<0.0001), and within this cohort, serum ferritin 96ng/ml was associated with inferior EFS (P=0.02). For patients <547 days of age with MYCN-NA tumors, serum ferritin levels were prognostic of overall survival (OS) (P=0.04) and chromosome 11q aberration was prognostic of EFS (P=0.03). ConclusionsAmong patients with INSS Stage 3 neuroblastoma patients, age at diagnosis, MYCN status and histology predict outcome. Patients <547 days of age with MYCN-NA tumors that lack chromosome 11q aberrations or those with serum ferritin <96ng/ml have excellent prognosis and should be considered for therapy reduction. Prospective clinical trials are needed to identify optimal therapy for those patients 547 days of age with undifferentiated histology or elevated serum ferritin. Pediatr Blood Cancer 2014;61:1932-1939. (c) 2014 Wiley Periodicals, Inc.	[Meany, Holly J.] Childrens Natl Med Ctr, Dept Hematol Oncol, Washington, DC 20010 USA; [London, Wendy B.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston Childrens Hosp, Boston, MA 02115 USA; [Ambros, Peter F.] St Anna Kinderkrebsforsch, Childrens Canc Res Inst, Vienna, Austria; [Matthay, Katherine K.] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; [Matthay, Katherine K.] Benioff Childrens Hosp, San Francisco, CA USA; [Monclair, Tom] Univ Oslo, Rikshosp, Univ Hosp, Div Surg,Sect Paediat Surg, N-0027 Oslo, Norway; [Simon, Thorsten; Berthold, Frank] Univ Cologne, Dept Pediat Oncol & Hematol, D-50931 Cologne, Germany; [Garaventa, Alberto] Giannina Gaslini Inst, Dept Paediat Hematol Oncol, Genoa, Italy; [Nakagawara, Akira] Chiba Canc Ctr, Japan Neuroblastoma Study Grp JNBSG, Chiba 2608717, Japan; [Nakagawara, Akira] Chiba Canc Ctr, Div Biochem & Innovat Canc Therapeut, Chiba 2608717, Japan; [Cohn, Susan L.] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA; [Pearson, Andrew D. J.] Royal Marsden NHS Fdn Trust, Inst Canc Res, Div Canc Therapeut & Clin Studies, Sutton, Surrey, England; [Pearson, Andrew D. J.] Royal Marsden NHS Fdn Trust, Children & Young Peoples Unit, Sutton, Surrey, England; [Park, Julie R.] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Childrens Hosp, Dept Hematol Oncol, Seattle, WA 98195 USA	Meany, HJ (reprint author), Childrens Natl Med Ctr, Dept Hematol Oncol, 111 Michigan Ave NW, Washington, DC 20010 USA.	hmeany@childrensnational.org			William Guy Forbeck Research Foundation; Little Heroes Cancer Research Fund; Children's Neuroblastoma Cancer Foundation; Neuroblastoma Children's Cancer Foundation; St. Baldrick's Foundation; Super Jake Foundation; Dougherty; Campini Foundations; Mildred V. Strouss chair; Cancer Research UK Life Chair and Programme Grant; NIHR RM/ICR Biomedical Research Centre; Bushnell Towne Wilkerson Endowed Chair in Pediatric Neuroblastoma	Grant sponsor: William Guy Forbeck Research Foundation; Grant sponsor: Little Heroes Cancer Research Fund; Grant sponsor: Children's Neuroblastoma Cancer Foundation; Grant sponsor: Neuroblastoma Children's Cancer Foundation; Grant sponsor: St. Baldrick's Foundation; Grant sponsor: Super Jake Foundation; Grant sponsor: Dougherty; Grant sponsor: Campini Foundations; Grant sponsor: Mildred V. Strouss chair; Grant sponsor: Cancer Research UK Life Chair and Programme Grant; Grant sponsor: NIHR RM/ICR Biomedical Research Centre; Grant sponsor: Bushnell Towne Wilkerson Endowed Chair in Pediatric Neuroblastoma	Ambros I, 2012, ADV NEUR RES ANN M; Park JR, 2009, PEDIATR BLOOD CANCER, V52, P44, DOI 10.1002/pbc.21784; London WB, 2005, J CLIN ONCOL, V23, P6459, DOI 10.1200/JCO.2005.05.571; Kohler JA, 2013, EUR J CANCER, V49, P3671, DOI 10.1016/j.ejca.2013.07.002; Hero B, 2008, J CLIN ONCOL, V26, P1504, DOI 10.1200/JCO.2007.12.3349; Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Schleiermacher G, 2012, BRIT J CANCER, V107, P1418, DOI 10.1038/bjc.2012.375; Park JR, 2010, HEMATOL ONCOL CLIN N, V24, P65, DOI 10.1016/j.hoc.2009.11.011; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Goto S, 2001, CANCER, V92, P2699, DOI 10.1002/1097-0142(20011115)92:10<2699::AID-CNCR1624>3.0.CO;2-A; Oberthuer A, 2010, J CLIN ONCOL, V28, P3506, DOI 10.1200/JCO.2009.27.3367; Baker DL, 2010, NEW ENGL J MED, V363, P1313, DOI 10.1056/NEJMoa1001527; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Rubie H, 2011, J CLIN ONCOL, V29, P449, DOI 10.1200/JCO.2010.29.5196; Moroz V, 2011, EUR J CANCER, V47, P561, DOI 10.1016/j.ejca.2010.10.022; Shimada H, 1999, CANCER, V86, P364, DOI 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7; Evans AE, 2005, J CLIN ONCOL, V23, P6443, DOI 10.1200/JCO.2005.05.005; Bown N, 2001, MED PEDIATR ONCOL, V36, P14, DOI 10.1002/1096-911X(20010101)36:1<14::AID-MPO1005>3.0.CO;2-G; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Caron H, 1996, NEW ENGL J MED, V334, P225, DOI 10.1056/NEJM199601253340404; Cohn SL, 2004, EUR J CANCER, V40, P2639, DOI 10.1016/j.ejca.2004.07.025; Defferrari R, 2012, ADV NEUR RES ANN M; De Preter K, 2010, CLIN CANCER RES, V16, P1532, DOI 10.1158/1078-0432.CCR-09-2607; GARAVENTA A, 1993, J CLIN ONCOL, V11, P1770; HANN HWL, 1985, CANCER RES, V45, P2843; Ladenstein R, 1996, KLIN PADIATR, V208, P210, DOI 10.1055/s-2008-1046476; Lastowska M, 2001, J CLIN ONCOL, V19, P3080; Luttikhuis MEMO, 2001, BRIT J CANCER, V85, P531, DOI 10.1054/bjoc.2001.1960; Matthay KK, 1998, J CLIN ONCOL, V16, P1256; Modak S, 2009, EUR J CANCER, V45, P90, DOI 10.1016/j.ejca.2008.09.016; Sano H, 2006, EUR J CANCER, V42, P1113, DOI 10.1016/j.ejca.2005.11.031; Schleiermacher G, 2007, BRIT J CANCER, V97, P238, DOI 10.1038/sj.bjc.6603820; Schleiermacher G, 1996, INT J CANCER, V69, P73, DOI 10.1002/(SICI)1097-0215(19960422)69:2<73::AID-IJC1>3.0.CO;2-S; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SHAPIRO DN, 1993, AM J PATHOL, V142, P1339; SHIMADA H, 1984, J NATL CANCER I, V73, P405; Spitz R, 2006, CLIN CANCER RES, V12, P3368, DOI 10.1158/1078-0432.CCR-05-2495; Spitz R, 2003, MED PEDIATR ONCOL, V41, P30, DOI 10.1002/mpo.10313; Ye Qi-dong, 2010, Zhonghua Yi Xue Za Zhi, V90, P1556	40	2	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	NOV	2014	61	11					1932	1939		10.1002/pbc.25134		8	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	AQ3WD	WOS:000342723300006		
J	Al-Kzayer, LFY; Sakashita, K; Al-Jadiry, MF; Al-Hadad, SA; Uyen, LTN; Liu, TT; Matsuda, K; Abdulkadhim, JMH; Al-Shujairi, TA; Matti, ZIIK; Hasan, JG; Al-Abdullah, HMS; Inoshita, T; Kamata, M; Sughayer, MA; Madanat, FF; Koike, K				Al-Kzayer, Lika'a Fasih Y.; Sakashita, Kazuo; Al-Jadiry, Mazin Faisal; Al-Hadad, Salma Abbas; Uyen, Le T. N.; Liu, Tingting; Matsuda, Kazuyuki; Abdulkadhim, Jaafar M. H.; Al-Shujairi, Tariq Abadi; Matti, Zead Ismael I. K.; Hasan, Janan Ghalib; Al-Abdullah, Hussam M. Salih; Inoshita, Toshi; Kamata, Minoru; Sughayer, Maher A.; Madanat, Faris F.; Koike, Kenichi			Frequent Coexistence of RAS Mutations in RUNX1-Mutated Acute Myeloid Leukemia in Arab Asian Children	PEDIATRIC BLOOD & CANCER			English	Article						RUNX1; AML1; RAS; AML; FTA; MDS; C-terminal; N-terminal	JUVENILE MYELOMONOCYTIC LEUKEMIA; POINT MUTATIONS; GENE-MUTATIONS; AML1 GENE; AML1/PEBP2-ALPHA-B GENE; ACQUIRED TRISOMY-21; SOMATIC MUTATIONS; RUNX1/AML1 GENE; AML1/RUNX1 GENE; RUNT DOMAIN	BackgroundRUNX1 mutation plays an important role in adult leukemic transformation. However, its contribution to the development of childhood leukemia remains unclear. In the present study, we analyzed point mutations of RUNX1 gene in children and adolescents with acute myeloid leukemia (AML) from Iraq and Jordan. ProcedureBone marrow and/or peripheral blood samples were collected from 178 patients of Arab Asian ethnicity (aged 17 years) newly diagnosed with AML: 145 samples from Iraq and 33 samples from Jordan. Direct DNA sequencing was performed on six genes including RUNX1 gene (exons 3-8). ResultsRUNX1 point mutations were identified in 10 (5.6%) of 178 patients. One patient possessed biallelic mutations of RUNX1 gene. C-terminal area was the predominant site of RUNX1 mutations (eight in C-terminal and two in N-terminal). Patients with RUNX1 mutations were significantly older than those with wild-type of the gene. Additionally, AML M0 subtype was more frequently found in patients with RUNX1 mutations. Both RUNX1 mutations and RAS mutations were identified in 4 of 10 children. Three patients with RUNX1 mutation had FLT3-ITD. On the other hand, 36 (21.4%) and 25 (14.9%) of 168 patients with wild-type of the gene had a RAS mutation and FLT3-ITD, respectively. Eight of 10 patients with RUNX1 mutations died of hematological relapse. ConclusionThe incidence of RUNX1 mutations in Arab Asian children and adolescents with AML was 5.6%. Further studies are required to clarify whether RAS mutations contribute to the development of pediatric AML associated with RUNX1 mutations. Pediatr Blood Cancer 2014;61:1980-1985. (c) 2014 Wiley Periodicals, Inc.	[Al-Kzayer, Lika'a Fasih Y.; Sakashita, Kazuo; Uyen, Le T. N.; Liu, Tingting; Koike, Kenichi] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 3908621, Japan; [Al-Jadiry, Mazin Faisal; Al-Hadad, Salma Abbas] Univ Baghdad, Coll Med, Dept Pediat, Baghdad, Iraq; [Al-Jadiry, Mazin Faisal; Al-Hadad, Salma Abbas] Childrens Welf Teaching Hosp, Dept Pediat Oncol, Baghdad, Iraq; [Matsuda, Kazuyuki] Shinshu Univ Hosp, Dept Lab Med, Matsumoto, Nagano, Japan; [Abdulkadhim, Jaafar M. H.; Al-Shujairi, Tariq Abadi; Matti, Zead Ismael I. K.] Cent Teaching Hosp Children, Dept Pediat Oncol, Baghdad, Iraq; [Hasan, Janan Ghalib; Al-Abdullah, Hussam M. Salih] Basra Childrens Specialty Hosp, Dept Pediat Oncol, Basra, Iraq; [Inoshita, Toshi] Japan Iraq Med Network, Tokyo, Japan; [Kamata, Minoru] Japan Chernobyl Fdn, Matsumoto, Nagano, Japan; [Sughayer, Maher A.] King Hussein Canc Ctr, Dept Pathol, Amman, Jordan; [Madanat, Faris F.] King Hussein Canc Ctr, Dept Pediat, Amman, Jordan	Sakashita, K (reprint author), Shinshu Univ, Sch Med, Dept Pediat, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	sakasita@shinshu-u.ac.jp			Japan Chernobyl Foundation (JCF), NGO (non-govermental organization), Matsumoto, Nagano, Japan	Grant sponsor: Japan Chernobyl Foundation (JCF), NGO (non-govermental organization), Matsumoto, Nagano, Japan	Barletta E, 2004, CARCINOGENESIS, V25, P749, DOI 10.1093/carcin/bgh057; Harada H, 2003, BLOOD, V101, P673, DOI 10.1182/blood-2002-04-1010; Al-Kzayer LFY, 2012, PEDIATR BLOOD CANCER, V59, P461, DOI 10.1002/pbc.24055; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Osato M, 1999, BLOOD, V93, P1817; Langabeer SE, 2002, GENE CHROMOSOME CANC, V34, P24, DOI 10.1002/gcc.10031; Al-Kzayer LFY, 2014, ANN HEMATOL, V93, P949, DOI 10.1007/s00277-014-2007-2; Roumier C, 2003, LEUKEMIA, V17, P9, DOI 10.1038/sj.leu.2402766; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; Matsuda K, 2010, BLOOD, V115, P5429, DOI 10.1182/blood-2009-12-260729; Preudhomme C, 2000, BLOOD, V96, P2862; Renneville A, 2008, LEUKEMIA, V22, P915, DOI 10.1038/leu.2008.19; Harada H, 2004, BLOOD, V103, P2316, DOI 10.1182/blood-2003-09-3074; Testi AM, 2006, HAEMATOL-HEMATOL J, V91, P509; Gaidzik VI, 2011, J CLIN ONCOL, V29, P1364, DOI 10.1200/JCO.2010.30.7926; Dicker F, 2007, BLOOD, V110, P1308, DOI 10.1182/blood-2007-02-072595; Matsuda K, 2007, BLOOD, V109, P5477, DOI 10.1182/blood-2006-09-046649; Tang JL, 2009, BLOOD, V114, P5352, DOI 10.1182/blood-2009-05-223784; Yamagata T, 2005, INT J HEMATOL, V82, P1, DOI 10.1532/IJH97.05075; Satoh Y, 2012, LEUKEMIA, V26, P303, DOI 10.1038/leu.2011.202; Auewarakul CU, 2006, HAEMATOL-HEMATOL J, V91, P675; Barbaric D, 2007, BLOOD, V109, P2314, DOI 10.1182/blood-2005-11-025536; Bravo J, 2001, NAT STRUCT BIOL, V8, P371, DOI 10.1038/86264; Matsuno N, 2003, LEUKEMIA, V17, P2492, DOI 10.1038/sj.leu.2403160; Migas A, 2011, PEDIATR BLOOD CANCER, V57, P583, DOI 10.1002/pbc.22980; Osato M, 2001, INT J HEMATOL, V74, P245, DOI 10.1007/BF02982056; Roumier C, 2006, LEUKEMIA, V20, P433, DOI 10.1038/sj.leu.2404097; Roumier C, 2003, BLOOD, V101, P1277, DOI 10.1182/blood-2002-05-1474; Taketani T, 2003, GENE CHROMOSOME CANC, V38, P1, DOI 10.1002/gcc.10246	30	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	NOV	2014	61	11					1980	1985		10.1002/pbc.25151		6	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	AQ3WD	WOS:000342723300013		
J	Sarashina, T; Kobayashi, R; Yoshida, M; Toriumi, N; Suzuki, D; Sano, H; Azuma, H				Sarashina, Takeo; Kobayashi, Ryoji; Yoshida, Makoto; Toriumi, Naohisa; Suzuki, Daisuke; Sano, Hirozumi; Azuma, Hiroshi			Randomized Trial of Cefozopran Versus Cefepime as Empirical Antibiotic Treatment of Febrile Neutropenia in Pediatric Cancer Patients	PEDIATRIC BLOOD & CANCER			English	Article						cefepime; cefozopran; empirical therapy; febrile neutropenia	ANTIMICROBIAL AGENTS; PLUS AMIKACIN; SOLID TUMORS; MONOTHERAPY; THERAPY; METAANALYSIS; CHILDREN; FEVER; PIPERACILLIN/TAZOBACTAM; CEFTAZIDIME	BackgroundFebrile neutropenia (FN) is a common and serious complication of cancer chemotherapy associated with significant morbidity and mortality. Cefozopran (CZOP) is a potential candidate for empirical monotherapy in FN. However, studies on the use of CZOP as empirical treatment for pediatric patients with FN are quite limited. The purpose of this study was to compare the efficacy and safety of CZOP with cefepime (CFPM) empirical monotherapy in pediatric cancer patients with FN. ProceduresA total of 64 patients with 224 episodes of FN were randomly assigned to receive antibiotic therapy with either CZOP (100mg/kg/day) or CFPM (100mg/kg/day). Of these episodes, 223 were considered eligible for the study. Success was defined as resolution of febrile episodes and clinical signs of infection within 120hr following the start of antibiotic therapy. ResultsThe success rate was not significantly different between the CZOP (64.0%) and CFPM (56.3%) groups (P=0.275). Duration of fever, duration of antibiotic therapy, and the success rate in patients with blood stream infection did not differ between the two groups. There was no infection-related mortality in the study period. ConclusionBoth CZOP and CFPM as monotherapy appear to be effective and safe in pediatric patients. This study suggests that CZOP has satisfactory efficacy and is well tolerated as initial empirical therapy for pediatric cancer patients with FN. Pediatr Blood Cancer 2014;61:1992-1995. (c) 2014 Wiley Periodicals, Inc.	[Sarashina, Takeo; Yoshida, Makoto; Toriumi, Naohisa; Azuma, Hiroshi] Asahikawa Med Univ, Dept Pediat, Asahikawa, Hokkaido 0788510, Japan; [Kobayashi, Ryoji; Suzuki, Daisuke; Sano, Hirozumi] Sapporo Hokuyu Hosp, Dept Pediat, Sapporo, Hokkaido, Japan	Sarashina, T (reprint author), Asahikawa Med Univ, Dept Pediat, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan.	sara5p@asahikawa-med.ac.jp					Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Furno P, 2002, LANCET INFECT DIS, V2, P231, DOI 10.1016/S1473-3099(02)00241-4; Paul M, 2006, J ANTIMICROB CHEMOTH, V57, P176, DOI 10.1093/jac/dki448; SCHIMPFF S, 1971, NEW ENGL J MED, V284, P1061, DOI 10.1056/NEJM197105132841904; Paul M, 2003, BRIT MED J, V326, P1111, DOI 10.1136/bmj.326.7399.1111; Yahav D, 2007, LANCET INFECT DIS, V7, P338, DOI 10.1016/S1473-3099(07)70109-3; Hughes WT, 2002, CLIN INFECT DIS, V34, P730, DOI 10.1086/339215; Corapcioglu F, 2006, PEDIATR HEMAT ONCOL, V23, P177, DOI 10.1080/08880010500506370; Corapcioglu F, 2005, PEDIATR HEMAT ONCOL, V22, P59, DOI 10.1080/08880010590896297; Ichikawa M, 2011, PEDIATR BLOOD CANCER, V57, P1159, DOI 10.1002/pbc.23106; Ikawa Kazuro, 2009, Jpn J Antibiot, V62, P435; Kebudi R, 2001, MED PEDIATR ONCOL, V36, P434, DOI 10.1002/mpo.1107; Kutluk T, 2004, PEDIATR BLOOD CANCER, V42, P284, DOI 10.1002/pbc.10442; Pereira CAP, 2009, J MICROBIOL IMMUNOL, V42, P141; Ramphal Reuben, 1996, American Journal of Medicine, V100, p83S, DOI 10.1016/S0002-9343(96)00113-1; Sato T, 2008, PEDIATR BLOOD CANCER, V51, P774, DOI 10.1002/pbc.21692; Uygun V, 2009, PEDIATR BLOOD CANCER, V53, P610, DOI 10.1002/pbc.22100	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	NOV	2014	61	11					1992	1995		10.1002/pbc.25148		4	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	AQ3WD	WOS:000342723300015		
J	Ito, R; Matsuoka, A; Tomii, T; Suzuki, K; Kitazawa, H; Ogura, T; Okada, M; Horikoshi, Y; Kudo, K				Ito, Rieko; Matsuoka, Akina; Tomii, Toshihiro; Suzuki, Kyogo; Kitazawa, Hironobu; Ogura, Taemi; Okada, Masayuki; Horikoshi, Yasuo; Kudo, Kazuko			PITFALLS IN THE DIAGNOSIS OF GASTROINTESTINAL TRACT LANGERHANS CELL HISTIOCYTOSIS	PEDIATRIC BLOOD & CANCER			English	Meeting Abstract									[Ito, Rieko; Matsuoka, Akina; Tomii, Toshihiro; Suzuki, Kyogo; Kitazawa, Hironobu; Ogura, Taemi; Okada, Masayuki; Horikoshi, Yasuo; Kudo, Kazuko] Shizuoka Childrens Hosp, Div Hematol & Oncol, Shizuoka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	NOV	2014	61	11					2134	2134				1	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	AQ3WD	WOS:000342723300074		
J	Kitoh, T; Akiyama, M; Taki, T; Shimomura, Y; Hori, T; Tsurusawa, M; Terashima, T; Yokoi, T				Kitoh, Toshiyuko; Akiyama, Masaharu; Taki, Tomohiko; Shimomura, Yasuto; Hori, Toshinari; Tsurusawa, Masahito; Terashima, Tsuyoshi; Yokoi, Toyoharu			AGGRESSIVE LANGERHANS CELL HISTIOCYTOSIS FOLLOWING T-ALL: CLONALLY RELATED NEOPLASMS WITHOUT BRAF V600E MUTATION AND SUFFICIENT EXPRESSION OF ASPARAGINE SYNTHETASE	PEDIATRIC BLOOD & CANCER			English	Meeting Abstract									Aichi Med Univ, Dept Pediat, Aichi, Japan; Jikei Univ, Sch Med, Dept Pediat, Tokyo, Japan; Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi, Japan; Kyoto Prefectural Univ Med, Dept Mol Lab Med, Kyoto, Japan; Shiga Med Ctr Adults, Dept Pathol, Shiga, Japan; Aichi Med Univ Hosp, Dept Pathol, Aichi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	NOV	2014	61	11					2134	2134				1	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	AQ3WD	WOS:000342723300073		
J	Maeda, M; Ishii, E; Ishida, Y; Ohta, S; Okamura, T; Kanegane, H; Kito, T; Kogawa, K; Suzuki, N				Maeda, Miho; Ishii, Eiichi; Ishida, Yasushi; Ohta, Shigeru; Okamura, Takayuki; Kanegane, Hirokazu; Kito, Toshiyuki; Kogawa, Kazuhiro; Suzuki, Nobuhiro			A SURVEY OF DISSEMINATED JUVENILE VANTHOGRANULOMA IN JAPAN	PEDIATRIC BLOOD & CANCER			English	Meeting Abstract									[Maeda, Miho] Nippon Med Sch, Tokyo 113, Japan; [Ishii, Eiichi] Ehime Univ, Matsuyama, Ehime 790, Japan; [Ishida, Yasushi] Ehime Cent Hosp, Matsuyama, Ehime, Japan; [Ohta, Shigeru] Shiga Med Univ, Shiga, Japan; [Okamura, Takayuki] Sakai City Hosp, Sakai, Osaka, Japan; [Kanegane, Hirokazu] Toyama Univ, Toyama 930, Japan; [Kito, Toshiyuki] Aichi Med Univ, Aichi, Japan; [Kogawa, Kazuhiro] Tsuchiya Childrens Hosp, Kuki, Saitama, Japan; [Suzuki, Nobuhiro] Hokkaido Childrens Hosp, Sapporo, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	NOV	2014	61	11					2135	2135				1	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	AQ3WD	WOS:000342723300078		
J	Nagai, K; Ishii, E; Yasukawa, M				Nagai, Kozo; Ishii, Eiichi; Yasukawa, Masaki		Histiocytosis Comm Japanese Soc Pe	PATHOGENESIS AND OUTCOMES OF CHEDIAK-HIGASHI SYNDROME, A LYTIC GRANULE DISORDER OF LYMPHOCYTES IN JAPAN	PEDIATRIC BLOOD & CANCER			English	Meeting Abstract									[Nagai, Kozo; Ishii, Eiichi] Ehime Univ, Grad Sch Med, Dept Pediat, Matsuyama, Ehime 790, Japan; [Nagai, Kozo] Saga Univ, Grad Sch Med, Dept Pediat, Saga 840, Japan; [Yasukawa, Masaki] Ehime Univ, Grad Sch Med, Dept Bioregulatory Med, Matsuyama, Ehime 790, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	NOV	2014	61	11					2137	2137				1	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	AQ3WD	WOS:000342723300085		
J	Oh, Y; Morimoto, A; Shioda, Y; Imamura, T; Kudo, K; Imashuku, S				Oh, Yukiko; Morimoto, Akira; Shioda, Yoko; Imamura, Toshihiko; Kudo, Kazuko; Imashuku, Shinsaku			ANALYSIS OF SERUM OSTEOPONTIN LEVELS IN PEDIATRIC PATIENTS WITH LANGERHANS CELL HISTIOCYTOSIS	PEDIATRIC BLOOD & CANCER			English	Meeting Abstract									Jichi Med Univ, Sch Med, Shimotsuke, Tochigi, Japan; Natl Ctr Child Hlth & Dev, Tokyo, Japan; Kyoto Prefectural Univ Med, Kyoto, Japan; Shizuoka Childrens Hosp, Shizuoka, Japan; Takasago Seibu Hosp, Takasago, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	NOV	2014	61	11					2137	2137				1	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	AQ3WD	WOS:000342723300084		
J	Shioda, Y; Morimoto, A; Imamura, T; Kudo, K; Imashuku, S				Shioda, Yoko; Morimoto, Akira; Imamura, Toshihiko; Kudo, Kazuko; Imashuku, Shinsaku		Japan LCH Study Grp	ANALYSIS OF PERMANENT CONSEQUENCES IN PEDIATRIC PATIENTS WITH LANGERHANS CELL HISTIOCYTOSIS: DATA OF THE JLSG-96 AND JLSG-02 STUDIES IN JAPAN	PEDIATRIC BLOOD & CANCER			English	Meeting Abstract									[Shioda, Yoko] Natl Ctr Child Hlth & Dev, Tokyo, Japan; [Morimoto, Akira] Jichi Med Univ, Sch Med, Shimotsuke, Tochigi, Japan; [Imamura, Toshihiko] Kyoto Prefectural Univ Med, Kyoto, Japan; [Kudo, Kazuko] Shizuoka Childrens Hosp, Shizuoka, Japan; [Imashuku, Shinsaku] Takasago Seibu Hosp, Takasago, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	NOV	2014	61	11					2140	2140				1	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	AQ3WD	WOS:000342723300097		
J	Tsurusawa, M				Tsurusawa, Masahito			Improved treatment results of children with B-cell non-Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 Study (vol 61, pg 1215, 2014)	PEDIATRIC BLOOD & CANCER			English	Correction									Aichi Med Univ, Adv Res Ctr, Nagakute, Aichi 48011, Japan	Tsurusawa, M (reprint author), Aichi Med Univ, Adv Res Ctr, Nagakute, Aichi 48011, Japan.	mtsuru@aichi-med-u.ac.jp					Tsurusawa M, 2014, PEDIATR BLOOD CANCER, V61, P1215, DOI [10.1002/pbc.24975, 10.1002/pbc.24968]	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	NOV	2014	61	11					2144	2144		10.1002/pbc.25293		1	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	AQ3WD	WOS:000342723300108		
J	Kamei, K; Ogura, M; Miyazaki, O; Nosaka, S; Ito, S				Kamei, Koichi; Ogura, Masao; Miyazaki, Osamu; Nosaka, Shunsuke; Ito, Shuichi			Aneurysmal dilatation associated with arteriovenous fistula in a transplanted kidney after renal biopsies	PEDIATRIC TRANSPLANTATION			English	Article						aneurysmal dilatation; arteriovenous fistula; transcatheter arterial embolization; renal biopsy; transplant kidney	CODED DOPPLER SONOGRAPHY; NATIVE KIDNEYS; NEEDLE-BIOPSY; ALLOGRAFTS; DUPLEX; PSEUDOANEURYSMS; COMPLICATIONS; DIAGNOSIS	AVF is a known complication of renal biopsy in both native and transplanted kidneys. A 20-yr-old woman with bilateral hypoplastic kidneys due to branchio-oto-renal syndrome had received living-donor renal transplantation from her father at the age of 11. She had undergone allograft renal biopsies six times and all puncture sites were at the lower pole of her kidney from the first to the fifth biopsy. AVF with aneurysmal dilation (30mm) had developed at the puncture site after the fifth biopsy. TAE was successfully performed with 11 platinum coils in the branch of the renal artery feeding the aneurysm. According to a review of the literature, the incidence of AVF is higher in transplanted kidneys than in native kidneys (7.5% vs. 2.1%) because transplanted kidneys, as single kidneys, are likely to be punctured repeatedly at the same site. When renal biopsy of a transplanted kidney is performed, previous biopsy puncture sites should be considered and the biopsy should be performed at a different site, if possible, to prevent the development of AVF.	[Kamei, Koichi; Ogura, Masao; Ito, Shuichi] Natl Ctr Child Hlth & Dev, Dept Nephrol & Rheumatol, Tokyo 1578535, Japan; [Miyazaki, Osamu; Nosaka, Shunsuke] Natl Ctr Child Hlth & Dev, Dept Radiol, Tokyo 1578535, Japan	Kamei, K (reprint author), Natl Ctr Child Hlth & Dev, Dept Nephrol & Rheumatol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	kamei-k@ncchd.go.jp					GAINZA FJ, 1995, CLIN NEPHROL, V43, P303; OZBEK SS, 1995, J CLIN ULTRASOUND, V23, P239, DOI 10.1002/jcu.1870230406; Bilge I, 1999, NEPHROL DIAL TRANSPL, V14, P2726, DOI 10.1093/ndt/14.11.2726; BOSCHIERO LB, 1992, UROL INT, V48, P130; Brandenburg VM, 2002, CLIN NEPHROL, V58, P398; DEANE C, 1992, UROL RADIOL, V13, P211; HARRISON KL, 1994, J AM SOC NEPHROL, V5, P1300; HUBSCH PJS, 1990, J ULTRAS MED, V9, P95; MERKUS JWS, 1993, BRIT J SURG, V80, P310, DOI 10.1002/bjs.1800800313; RENOWDEN SA, 1992, CLIN RADIOL, V45, P233, DOI 10.1016/S0009-9260(05)80003-0; Riccabona M, 1998, J ULTRAS MED, V17, P505; ROLLINO C, 1994, NEPHROL DIAL TRANSPL, V9, P1260; Schwarz A, 2008, AM J TRANSPLANT, V8, P826, DOI 10.1111/j.1600-6143.2008.02160.x; Shimmura H, 1998, TRANSPLANT P, V30, P2990, DOI 10.1016/S0041-1345(98)00900-2; TUNG KT, 1992, CLIN RADIOL, V46, P111, DOI 10.1016/S0009-9260(05)80314-9	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1397-3142	1399-3046		PEDIATR TRANSPLANT	Pediatr. Transplant.	NOV	2014	18	7					E216	E219		10.1111/petr.12326		4	Pediatrics; Transplantation	Pediatrics; Transplantation	AQ5KT	WOS:000342848100001		
J	Sato, Y; Kurosawa, H; Fukushima, K; Okuya, M; Yabe, H; Arisaka, O				Sato, Yuya; Kurosawa, Hidemitsu; Fukushima, Keitaro; Okuya, Mayuko; Yabe, Hiromasa; Arisaka, Osamu			Necessary stem cell transplantation using myeloablative therapy for myelodysplastic syndrome with progression of genotypic abnormalities and TP53 dysfunction in a young adult	PEDIATRIC TRANSPLANTATION			English	Article						myelodysplastic syndrome; chromosomal abnormality; TP53; myeloablative therapy	MUTATIONS; LEUKEMIA	A 14-yr-old male was admitted to our hospital with MDS and the chromosomal abnormality 45,XY,der(5;17)(p10;q10). He rapidly developed karyotype abnormalities, accompanied by the loss of tumor suppressor gene TP53 function. He suffered an early relapse after reduced-intensity-conditioning SCT and ultimately required myeloablative therapy before a second SCT. We consider that the analysis of TP53 mutations is essential when planning the treatment of patients with MDS.	[Sato, Yuya; Kurosawa, Hidemitsu; Fukushima, Keitaro; Okuya, Mayuko; Arisaka, Osamu] Dokkyo Med Univ, Dept Pediat, Mibu, Tochigi 3210207, Japan; [Yabe, Hiromasa] Tokai Univ, Sch Med, Dept Cell Transplantat & Regenerat Med, Isehara, Kanagawa 25911, Japan	Sato, Y (reprint author), Dokkyo Med Univ, Dept Pediat, 880 Kita Kobayashi, Mibu, Tochigi 3210207, Japan.	syuya@dokkyomed.ac.jp					Kulasekararaj AG, 2013, BRIT J HAEMATOL, V160, P660, DOI 10.1111/bjh.12203; Mallo M, 2013, BRIT J HAEMATOL, V162, P74, DOI 10.1111/bjh.12354; Bejar R, 2012, J CLIN ONCOL, V30, P3376, DOI 10.1200/JCO.2011.40.7379; Castro PD, 2000, BLOOD, V95, P2138; Greenberg P, 2002, ASH ED PROGRAM BOOK, V2002, P136; Greenberg PL, 2012, INT J LAB HEMATOL, V34, P215, DOI 10.1111/j.1751-553X.2011.01390.x; Kita-Sasai Y, 2001, BRIT J HAEMATOL, V115, P309, DOI 10.1046/j.1365-2141.2001.03073.x; LAI JL, 1995, LEUKEMIA, V9, P370; Saito S, 2011, LEUKEMIA RES, V35, P1578, DOI 10.1016/j.leukres.2011.06.027; Wahl GM, 1997, CANCER SURV, V29, P183; Zhanga R, 2013, J BIOMED RES, V27, P254	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1397-3142	1399-3046		PEDIATR TRANSPLANT	Pediatr. Transplant.	NOV	2014	18	7					E255	E257		10.1111/petr.12334		3	Pediatrics; Transplantation	Pediatrics; Transplantation	AQ5KT	WOS:000342848100009		
J	Uchida, H; Sakamoto, S; Matsunami, M; Sasaki, K; Shigeta, T; Kanazawa, H; Fukuda, A; Nakazawa, A; Miyazaki, O; Nosaka, S; Kasahara, M				Uchida, Hajime; Sakamoto, Seisuke; Matsunami, Masatoshi; Sasaki, Kengo; Shigeta, Takanobu; Kanazawa, Hiroyuki; Fukuda, Akinari; Nakazawa, Atsuko; Miyazaki, Osamu; Nosaka, Shunsuke; Kasahara, Mureo			Hepatic artery reconstruction preserving the pancreaticoduodenal arcade in pediatric liver transplantation with celiac axis compression syndrome: Report of a case	PEDIATRIC TRANSPLANTATION			English	Article						celiac artery compression syndrome; hepatic artery thrombosis; median arcuate ligament; pediatric liver transplantation	ARCUATE LIGAMENT SYNDROME	CACS is rare, although it has been reported to be a potential risk factor for hepatic artery thrombosis following LT. We herein present the case of a 14-yr-old male with stenosis of the origin of the celiac trunk. Preoperative CT and color ultrasonography showed narrowing of the proximal celiac artery. The patient underwent DDLT with standard arterial reconstruction without dividing the gastroduodenal artery. His postoperative course was uneventful, with an excellent hepatic artery flow on Doppler ultrasonography. Applying a meticulous preoperative evaluation and the appropriate surgical technique is crucial in patients with CACS.	[Uchida, Hajime; Sakamoto, Seisuke; Matsunami, Masatoshi; Sasaki, Kengo; Shigeta, Takanobu; Kanazawa, Hiroyuki; Fukuda, Akinari; Kasahara, Mureo] Natl Ctr Child Hlth & Dev, Transplantat Ctr, Tokyo 1578535, Japan; [Nakazawa, Atsuko] Natl Ctr Child Hlth & Dev, Div Clin Pathol, Tokyo 1578535, Japan; [Miyazaki, Osamu; Nosaka, Shunsuke] Natl Ctr Child Hlth & Dev, Div Radiol, Tokyo 1578535, Japan	Uchida, H (reprint author), Natl Ctr Child Hlth & Dev, Transplantat Ctr, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	uchida-h@ncchd.go.jp					Agnes S, 2001, TRANSPLANT P, V33, P1438, DOI 10.1016/S0041-1345(00)02544-6; Scholbach T, 2006, J ULTRAS MED, V25, P299; MORI K, 1992, TRANSPLANTATION, V54, P263, DOI 10.1097/00007890-199208000-00014; Mak GZ, 2013, J PEDIATR SURG, V48, P2261, DOI 10.1016/j.jpedsurg.2013.03.003; Ito T, 2003, TRANSPLANTATION, V75, P1313, DOI 10.1097/01.TP.0000063707.90525.10; Armstrong MB, 2014, ANN VASC SURG, V28; Choi JY, 2007, J CLIN ULTRASOUND, V35, P483, DOI 10.1002/jcu.20384; DelsGaudio M, 2005, CLIN TRANSPLANT, V19, P399; HARJOLA P T, 1963, Ann Chir Gynaecol Fenn, V52, P547; Hongsakul K, 2012, CASE REPORT VASC MED, V2012; Huang TL, 2000, TRANSPLANT P, V32, P2097, DOI 10.1016/S0041-1345(00)01585-2; Jiang ZJ, 2008, HEPATOB PANCREAT DIS, V7, P433; JURIM O, 1993, ANN SURG, V218, P10, DOI 10.1097/00000658-199307000-00003; LINDNER HH, 1971, ARCH SURG-CHICAGO, V103, P600; Lubrano J, 2008, TRANSPL P, V40, P3532, DOI 10.1016/j.transproceed.2008.07.133; PAULSEN AW, 1992, HEPATOLOGY, V16, P100, DOI 10.1002/hep.1840160118; Reuter S R, 1965, Radiology, V85, P616; Zamboni F, 2002, DIGEST LIVER DIS, V34, P122, DOI 10.1016/S1590-8658(02)80241-9	18	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1397-3142	1399-3046		PEDIATR TRANSPLANT	Pediatr. Transplant.	NOV	2014	18	7					E232	E235		10.1111/petr.12329		4	Pediatrics; Transplantation	Pediatrics; Transplantation	AQ5KT	WOS:000342848100004		
J	Ueki, H; Igarashi, S; Kimura, S; Tsuchimochi, T; Furudate, K; Sakurai, A; Noguchi, Y; Sunami, S				Ueki, Hideaki; Igarashi, Shunji; Kimura, Shunsuke; Tsuchimochi, Taichiro; Furudate, Kazuki; Sakurai, Ayako; Noguchi, Yasushi; Sunami, Shosuke			Evans syndrome after unrelated bone marrow transplantation for refractory cytopenia of childhood	PEDIATRIC TRANSPLANTATION			English	Article						Evans syndrome; bone marrow transplantation; refractory cytopenia of childhood; rituximab; romiplostim	STEM-CELL TRANSPLANTATION; AUTOIMMUNE-DISEASES; CHILDREN	Post-transplant ES, which is often resistant to therapies, has seldom been described. This report describes a case of ES after UBMT for RCC. A five-yr-old boy developed RCC with no evidence of monosomy 7. Because no matching family donors were available for SCT and immunosuppressive therapy was ineffective, UBMT was performed when he was sixyr old. The conditioning regimen included TAI (3Gy) and administration of FLU, CY, and rabbit antithymocyte globulin. The recovery of blood cells was good. He displayed grade II acute GVHD involving only the skin. ES developed on day 66, with positive results for Epstein-Barr virus DNA and HHV 6. Cytopenia was resolved with treatment with RTX, GCV, an escalated dose of steroids, high-dose gammaglobulin, and romiplostim. No relapse has occurred since discontinuing steroids on day 177 and romiplostim on day 268. Post-SCT ES after UBMT is rare, and the risk factors and therapies are unclear. Prospective analysis and collection of cases from multiple centers are required for clarification.	[Ueki, Hideaki; Igarashi, Shunji; Kimura, Shunsuke; Tsuchimochi, Taichiro; Furudate, Kazuki; Sakurai, Ayako; Noguchi, Yasushi; Sunami, Shosuke] Japanese Red Cross Narita Hosp, Dept Pediat, Narita, Japan	Ueki, H (reprint author), Japanese Red Cross Narita Hosp, Dept Pediat, 90-1 Iida Cho, Chiba 2868523, Japan.	uekih0209@gmail.com					Niemeyer CM, 2008, BRIT J HAEMATOL, V140, P610, DOI 10.1111/j.1365-2141.2007.06958.x; Holbro A, 2012, BRIT J HAEMATOL, V157, P281, DOI 10.1111/j.1365-2141.2012.09070.x; Minamimura K, 2006, J IMMUNOL, V176, P4125; Rocha V, 1998, BRIT J HAEMATOL, V103, P243, DOI 10.1046/j.1365-2141.1998.00949.x; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Baumann I, 2008, WHO CLASSIFICATION T, P104; Chen RL, 2007, J PEDIAT HEMATOL ONC, V29, P348, DOI 10.1097/MPH.0b013e3180556467; Dovat S, 1999, BONE MARROW TRANSPL, V24, P321, DOI 10.1038/sj.bmt.1701888; Faraci M, 2014, BIOL BLOOD MARROW TR, V20, P272, DOI 10.1016/j.bbmt.2013.11.014; Klumpp TR, 1996, BONE MARROW TRANSPL, V18, P559; Loh Y, 2007, BLOOD, V109, P2643, DOI 10.1182/blood-2006-07-035766; O'Brien TA, 2004, BRIT J HAEMATOL, V127, P67, DOI 10.1111/j.1365-2141.2004.05138.x; Sanz J, 2007, BONE MARROW TRANSPL, V39, P555, DOI 10.1038/sj.bmt.1705641; Urban C, 2004, EUR J HAEMATOL, V72, P444, DOI 10.1111/j.1600-0609.2004.00256.x; Winiarski J, 1996, ACTA PAEDIATR, V85, P327, DOI 10.1111/j.1651-2227.1996.tb14026.x	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1397-3142	1399-3046		PEDIATR TRANSPLANT	Pediatr. Transplant.	NOV	2014	18	7					E246	E251		10.1111/petr.12323		6	Pediatrics; Transplantation	Pediatrics; Transplantation	AQ5KT	WOS:000342848100007		
J	Fuks-Janczarek, I; Kobayashi, K; Chen, XM; Oyama, M; Wojciechowski, A; Pepczynska, M; Chrunik, M; Majchrowski, A; Jaroszewicz, LR; Klosowicz, S; Kityk, IV				Fuks-Janczarek, I.; Kobayashi, K.; Chen, X. M.; Oyama, M.; Wojciechowski, A.; Pepczynska, M.; Chrunik, M.; Majchrowski, A.; Jaroszewicz, L. R.; Klosowicz, S.; Kityk, I. V.			Nonlinear optical features of delta-BiB3O6/PVA polymer nanocomposites deposited on aluminum-doped zinc oxide substrates containing Ag nanoparticles	PHYSICA E-LOW-DIMENSIONAL SYSTEMS & NANOSTRUCTURES			English	Article						Nanocomposite; Optical property; Borate nanocrystallites	OLYGOETHER PHOTOPOLYMER MATRICES; SINGLE-BEAM; GENERATION; ABSORPTION; SQUARAINE; KINETICS; SILVER; DYES	For the first time the Z-scan measurements and second harmonic generation of delta-BiB3O6:Pr3+ large-size nanocrystallites embedded into the polyvinyl alcohol (PVA) polymer matrices and deposited on AlZnO substrates decorated with Ag NP were studied. The comparison of the second and third order NLO is presented. The Z-scan measurements were done by 5 ns Nd:YAG laser and the second harmonic generation was measured using the 25 ns Nd:YAG laser with frequency repetition about 10 Hz. The measurements have shown that both second as well as third-order susceptibilities are sensitive to the sizes of the Ag NP deposited on the AlZnO substrate. The obtained results confirm a principal role of the Ag NP on the output nonlinear optical properties which may be a consequence of the contribution of the low-dimensional nano-trapping levels. (C) 2014 Elsevier B.V. All rights reserved.	[Fuks-Janczarek, I.] J Dlugosz Univ, Inst Phys, Czestochowa, Poland; [Kobayashi, K.] Kyoto Univ, Hakubi Ctr Adv Res, Nishikyo Ku, Kyoto 6158520, Japan; [Kobayashi, K.] Kyoto Univ, Grad Sch Engn, Dept Elect Sci & Engn, Nishikyo Ku, Kyoto 6158520, Japan; [Chen, X. M.; Oyama, M.] Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Nishikyo Ku, Kyoto 6158520, Japan; [Wojciechowski, A.; Kityk, I. V.] Czestochowa Technol Univ, Dept Elect Engn, Czestochowa, Poland; [Pepczynska, M.; Chrunik, M.; Majchrowski, A.; Jaroszewicz, L. R.; Klosowicz, S.] Mil Univ Technol, Inst Appl Phys, PL-00908 Warsaw, Poland	Wojciechowski, A (reprint author), Czestochowa Technol Univ, Dept Elect Engn, Aleja Armii Krajowej 17-19, Czestochowa, Poland.	awojciech2013@wp.pl	Oyama, Munetaka/D-6541-2014; Kityk, Iwan/M-4032-2015	Oyama, Munetaka/0000-0001-7422-9914; 	Polish Ministry of Sciences and Higher Education Key Project [POIG.01.03.01-14-016/08]	This work was partially supported by the Polish Ministry of Sciences and Higher Education Key Project POIG.01.03.01-14-016/08 "New Photonic Materials and their Advanced Applications".	Adamiv VT, 1997, OPT MATER, V8, P207, DOI 10.1016/S0925-3467(97)00017-7; SHEIKBAHAE M, 1989, OPT LETT, V14, P955, DOI 10.1364/OL.14.000955; Srinivas K, 2007, J PHYS CHEM A, V111, P3378, DOI 10.1021/jp067410f; SHEIKBAHAE M, 1990, IEEE J QUANTUM ELECT, V26, P760, DOI 10.1109/3.53394; Liu XM, 2012, OPT EXPRESS, V20, P13457, DOI 10.1364/OE.20.013457; Aziz MA, 2012, MATER LETT, V74, P226, DOI 10.1016/j.matlet.2012.01.108; Righini GC, 2007, GLASS TECHNOL-PART A, V48, P200; Kacperski M., 2002, POLIMERY, V47, P11; Nouneh K, 2011, J ALLOY COMPD, V509, P2631, DOI 10.1016/j.jallcom.2010.11.172; Kityk IV, 2006, PHYSICA E, V31, P38, DOI 10.1016/j.physe.2005.08.012; Kityk IV, 2005, PHIL MAG LETT, V85, P549, DOI 10.1080/09500830500385519; Lukasiewicz T, 2011, J ALLOY COMPD, V509, P3473, DOI 10.1016/j.jallcom.2010.12.172; Mago Gaurav, 2011, J NANOMATER; Majchrowski A, 2000, OPT MATER, V15, P51, DOI 10.1016/S0925-3467(00)00002-1; Majchrowski A, 2014, J MATER SCI-MATER EL, V25, P2426, DOI 10.1007/s10854-014-1884-4; Mefleh A, 2001, J MATER SCI, V36, P219, DOI 10.1023/A:1004822010773; Pagacz J., 2009, CZAS TECH, V1, P95; Stalmashonak A., 2013, ULTRA SHORT PULSED L; Su XY, 2010, DYES PIGMENTS, V87, P69, DOI 10.1016/j.dyepig.2010.02.006; Webster S, 2008, CHEM PHYS, V348, P143, DOI 10.1016/j.chemphys.2008.02.062	20	5	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1386-9477	1873-1759		PHYSICA E	Physica E	NOV	2014	64						1	6		10.1016/j.physe.2014.06.015		6	Nanoscience & Nanotechnology; Physics, Condensed Matter	Science & Technology - Other Topics; Physics	AQ6WY	WOS:000342955800001		
J	Zhang, ML; Chen, Y; Qiu, CJ; Fan, XF; Chen, CL; Wang, ZC				Zhang, Manli; Chen, Yong; Qiu, Changjun; Fan, Xiangfang; Chen, Chunlin; Wang, Zhongchang			Synthesis and atomic-scale characterization of CeO2 nano-octahedrons	PHYSICA E-LOW-DIMENSIONAL SYSTEMS & NANOSTRUCTURES			English	Article						Ceria; Hydrothermal method; Nano-octahedron; Atomic-resolution imaging	THIN-FILMS; HYDROTHERMAL SYNTHESIS; CONTROLLABLE SYNTHESIS; OPTICAL-PROPERTIES; FACILE SYNTHESIS; CERIA; NANOSTRUCTURES; ARCHITECTURES; NANOCRYSTALS; FABRICATION	We report the synthesis of ceria nano-octahedrons using a simple yet efficient hydrothermal technique free of surfactant and template. A comprehensive microscopic characterization reveals that the nano-octahedrons exposed with eight {1 1 1} planes have shape corners and well-defined edges at the nanoscale. Atomic-resolution imaging uncovers that a couple of atomic layers are disappeared at corner, the atomic density of oxygen is reduced at surface, and there occur stacking faults inside the nano-octahedrons, which should have implications for our understanding of catalytic activity of ceria. We also propose a growth mechanism for the nano-octahedrons and provide an explanation to the easy formation of nano-octahedrons with the eight {1 1 1} facets. (C) 2014 Elsevier B.V. All rights reserved.	[Zhang, Manli; Chen, Yong; Qiu, Changjun; Fan, Xiangfang] Univ South China, Sch Mech Engn, Hengyang 421001, Peoples R China; [Chen, Chunlin; Wang, Zhongchang] Tohoku Univ, Adv Inst Mat Res, Aoba Ku, Sendai, Miyagi 980, Japan	Chen, Y (reprint author), Univ South China, Sch Mech Engn, Hengyang 421001, Peoples R China.	chenyongisnt@163.com; zcwang@wpi-aimr.tohoku.ac.jp	Chen, ChunLin/N-4611-2013		Construct Program of the Key Discipline of Hunan province; National Science Foundation of China [11332013]; JGC-S Foundation; Kurata Memorial Hitachi Science and Technology Foundation;  [24686069]	Y.C. thanks the financial support by the Construct Program of the Key Discipline of Hunan province. Z.W. thanks financial supports from National Science Foundation of China (grant no. 11332013), Grant-in-Aid for Young Scientists (A) (grant no. 24686069), JGC-S Foundation, and Kurata Memorial Hitachi Science and Technology Foundation.	Yu R, 2008, J PHYS CHEM C, V112, P19896, DOI 10.1021/jp806092q; Gallage R, 2009, J ELECTROCERAM, V22, P33, DOI 10.1007/s10832-008-9464-8; Porqueras I, 2003, SOLID STATE IONICS, V165, P131, DOI 10.1016/j.ssi.2003.08.025; Niederberger M, 2007, INT J NANOTECHNOL, V4, P263, DOI 10.1504/IJNT.2007.013473; Sun CW, 2005, NANOTECHNOLOGY, V16, P1454, DOI 10.1088/0957-4484/16/9/006; Chen Y, 2013, MATER LETT, V96, P210, DOI 10.1016/j.matlet.2013.01.069; Wu ZL, 2012, ACS CATAL, V2, P2224, DOI 10.1021/cs300467p; Charitidis C, 2005, J PHYS CONF SER, V10, P226, DOI 10.1088/1742-6596/10/1/056; Yan L, 2008, CRYST GROWTH DES, V8, P1474, DOI 10.1021/cg800117v; Elidrissi B, 2000, THIN SOLID FILMS, V379, P23, DOI 10.1016/S0040-6090(00)01404-8; Zhang CJ, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.075433; Yan L, 2007, PHYSICA B, V390, P59, DOI 10.1016/j.physb.2006.07.062; Chen Y, 2008, SURF SCI, V602, P1736, DOI 10.1016/j.susc.2008.02.036; Lawrence NJ, 2011, NANO LETT, V11, P2666, DOI 10.1021/nl200722z; Campbell CT, 2005, SCIENCE, V309, P713, DOI 10.1126/science.1113955; Zhou F, 2007, J PHYS CHEM C, V111, P1651, DOI 10.1021/jp0660435; Wu Q, 2008, J PHYS CHEM C, V112, P17076, DOI 10.1021/jp804140e; Bravais A., 1886, ETUDES CRISTALLOGRAP; Chen Y, 2013, MATER LETT, V92, P7, DOI 10.1016/j.matlet.2012.10.068; Chen Y, 2014, MATER LETT, V122, P90, DOI 10.1016/j.matlet.2014.01.178; Chen Y, 2014, J PHYS CHEM C, V118, P4437, DOI 10.1021/jp410625n; Cui QZ, 2008, J RARE EARTH, V26, P664, DOI 10.1016/S1002-0721(08)60158-1; Gu FB, 2007, MAT SCI ENG B-SOLID, V139, P62, DOI 10.1016/j.mseb.2007.01.051; GUO S, 1995, J APPL PHYS, V77, P5369, DOI 10.1063/1.359225; Kuchibhatla SVNT, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/7/075303; La RJ, 2004, MAT SCI ENG A-STRUCT, V368, P145, DOI 10.1016/j.msea.2003.10.279; Miao JJ, 2005, J CRYST GROWTH, V281, P525, DOI 10.1016/j.jcrysgro.2005.04.058; Tatar B, 2008, J MATER SCI, V43, P5102, DOI 10.1007/s10853-008-2750-7; Trovarelli A, 1996, CATAL REV, V38, P439, DOI 10.1080/01614949608006464; Yang PD, 2012, NATURE, V482, P41, DOI 10.1038/482041a	30	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1386-9477	1873-1759		PHYSICA E	Physica E	NOV	2014	64						218	223		10.1016/j.physe.2014.08.002		6	Nanoscience & Nanotechnology; Physics, Condensed Matter	Science & Technology - Other Topics; Physics	AQ6WY	WOS:000342955800037		
J	Hossain, HMZ; Hossain, QH; Monir, MMU; Ahmed, MT				Hossain, H. M. Zakir; Hossain, Quazi Hasna; Monir, Md. Minhaj Uddin; Ahmed, Md. Tofayal			Municipal solid waste (MSW) as a source of renewable energy in Bangladesh: Revisited	RENEWABLE & SUSTAINABLE ENERGY REVIEWS			English	Review						Renewable energy; Municipal solid waste; Mega-cities; Bangladesh	ELECTRICITY-GENERATION; CHINA	With radically increased population, rapid economic growth and expansion of urbanization and industrialization, mega-cities of Bangladesh are faces the complexity of municipal solid waste (MSW) management. The purpose of this paper is to review the types of MSW that are currently being used for renewable energy sources. To meet up the power supply for city dwellers and reducing space for new landfills, waste-to-energy (WTE) incineration is playing a vital role for renewable energy production from discarded MSW. Incineration of MSW is complex owing to its low calorific value (similar to 3000 kJ/kg) and high water content (similar to 60%). MSW in Bangladesh contains relatively high proportion of organic matter (74.6%) than paper (9.1%) and plastic (3.5%). Using landfill gas recovery process, generation of electricity from MSW in six mega-cities is similar to 186,408 kW h/day. Therefore, WTE incineration system contributes greater supply of renewable energy in Bangladesh. (C) 2014 Elsevier Ltd. All rights reserved.	[Hossain, H. M. Zakir; Monir, Md. Minhaj Uddin; Ahmed, Md. Tofayal] Jessore Univ Sci & Technol, Dept Petr & Min Engn, Jessore 7408, Bangladesh; [Hossain, Quazi Hasna] Shimane Univ, Dept Geosci, Matsue, Shimane 6908504, Japan	Hossain, HMZ (reprint author), Jessore Univ Sci & Technol, Dept Petr & Min Engn, Jessore 7408, Bangladesh.	zakirgsd@yahoo.com					Alamgir M., 2007, Iranian Journal of Environmental Health Science & Engineering, V4, P67; Amoo O. M., 2013, INT J ENERGY ENV ENG, V4, P42, DOI DOI 10.1186/2251-6832-4-42; Cheng HF, 2010, BIORESOURCE TECHNOL, V101, P3816, DOI 10.1016/j.biortech.2010.01.040; PARKIN GF, 1986, J ENVIRON ENG-ASCE, V112, P867; Cheng HF, 2007, ENVIRON SCI TECHNOL, V41, P7509, DOI 10.1021/es071416g; Mondal MAH, 2010, RENEW SUST ENERG REV, V14, P2401, DOI 10.1016/j.rser.2010.05.006; Bangladesh Bureau of Statistics, 2011, POP HOUS CENS REP; BBS (Bangladesh Bureau of Statistics), 2001, BBS CENS REP; BPDB (Bangladesh Power Development Board), 2008, ANN REP 2006 2007; Eddine BT, 2012, INT J ENERGY ENV ENG, V3, P17; Haider AK, 2008, CHALLENGES SUSTAINAB; Halder PK, 2014, INT J RENEWABLE ENER, V4, P168; IEA, 2007, IEA EN TECHN ESS; Islam MS, 2006, B GEOL SCI, V11, P25; Islam MS, 2008, J SCI CULTURE, V74, P251; Kaplan PO, 2009, ENVIRON SCI TECHNOL, V43, P1711, DOI 10.1021/es802395e; Mondal MAH, 2014, ENERGY STRATEGY REV, V2, P307; Population Council, 2010, BANGL FAST FACTS; Pratt B, 1992, DEV GUIDEL, V7, P126; PREGA, 2005, PORM REN EN EN EFF G; Reddy PJ, 2011, MUNICIPAL SOLID WAST, P449; Rouf MA, 2011, 2 INT C ENV ENG APPL, V17; Ryu C, 2010, J AIR WASTE MANAGE, V60, P176, DOI 10.3155/1047-3289.60.2.176; Uddin MM, 2011, J SEL AREAS RENE OCT; US Environmental Protection Authority, 2006, SOL WAST MAN GREENH; Wazed MA, 2010, ENG E T, V5, P61	26	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1364-0321			RENEW SUST ENERG REV	Renew. Sust. Energ. Rev.	NOV	2014	39						35	41		10.1016/j.rser.2014.07.007		7	Energy & Fuels	Energy & Fuels	AQ1GN	WOS:000342530000004		
J	Gan, PY; Li, ZD				Gan, Peck Yean; Li, Zhi Dong			Econometric study on Malaysia's palm oil position in the world market to 2035	RENEWABLE & SUSTAINABLE ENERGY REVIEWS			English	Review						Malaysia; Palm oil; Export potential	LIFE-CYCLE ASSESSMENT; SUSTAINABLE DEVELOPMENT; RENEWABLE ENERGY; BIODIESEL; BIOFUEL; FUEL; IMPLEMENTATION; CHALLENGES; OUTLOOK; ASIA	Malaysia is currently the world's second largest producer of palm oil. With its large and growing palm oil industry, combined with a strong global demand for palm oil, Malaysia has the potential to play a major role in the world food and biofuel markets. As a result of environmental concerns and reservations concerning the net effect of deforestation in some countries such as Indonesia, a restricted expansion of palm oil plantation area has been analyzed. This paper aims to perform a quantitative analysis on (1) the domestic supply and demand outlook for Malaysia's palm oil, including biodiesel demand and (2) its ability to supply the global markets by 2035, in the context of restricted plantation area. Domestic palm oil production is projected to rise by about 50% to 26.6 million tons in 2035. Domestic demand of palm oil for food consumption, industrial non-food uses and biodiesel is anticipated to increase by more than 200% to 1.4 million tons in 2035, up from 0.4 million tons in 2009. Domestic demand, however, amounts to only a very small portion (5%) of total palm oil production in 2035, with an expected exportable surplus of over 25 million tons. With such surplus capacity, Malaysia will become a formidable competitor in the world vegetable oil and biofuel markets. (C) 2014 Elsevier Ltd. All rights reserved.	[Gan, Peck Yean] Inst Energy Econ, Global Environm & Sustainable Dev Unit, Energy Conservat Grp, Chuo Ku, Tokyo 1040054, Japan; [Li, Zhi Dong] Nagaoka Univ Technol, Dept Management & Informat Syst Sci, Nagaoka, Niigata 9402188, Japan	Gan, PY (reprint author), Inst Energy Econ, Global Environm & Sustainable Dev Unit, Energy Conservat Grp, Chuo Ku, Inui Bldg,Kachidoki 13-1,Kachidoki 1 Chome, Tokyo 1040054, Japan.	pyean@tky.ieej.or.jp					Adnan H, 2013, STAR ONLINE     0212; Adnan H, 2011, STAR ONLINE     0628; Adnan H, 2012, STAR ONLINE     1120; Adnan H, 2013, STAR ONLINE     0129; Jayed MH, 2009, RENEW SUST ENERG REV, V13, P2452, DOI 10.1016/j.rser.2009.06.023; [Anonymous], 2011, AGR OUTL 2011 2020; Yusoff MHM, 2013, ENERG POLICY, V62, P456, DOI 10.1016/j.enpol.2013.08.009; Hosseini SE, 2012, RENEW SUST ENERG REV, V16, P5732, DOI 10.1016/j.rser.2012.05.025; Yusoff S, 2007, INT J LIFE CYCLE ASS, V12, P50, DOI 10.1065/lca2005.08.226; Lam MK, 2009, RENEW SUST ENERG REV, V13, P1456, DOI 10.1016/j.rser.2008.09.009; Mekhilef S, 2011, RENEW SUST ENERG REV, V15, P1937, DOI 10.1016/j.rser.2010.12.012; Adenle AA, 2013, ENERG POLICY, V61, P182, DOI 10.1016/j.enpol.2013.05.088; Wicke B, 2008, BIOMASS BIOENERG, V32, P1322, DOI 10.1016/j.biombioe.2008.04.001; Hassan MNA, 2011, ENERG POLICY, V39, P2615, DOI 10.1016/j.enpol.2011.02.030; Wicke B, 2011, LAND USE POLICY, V28, P193, DOI 10.1016/j.landusepol.2010.06.001; Lim S, 2012, RENEW SUST ENERG REV, V16, P1790, DOI 10.1016/j.rser.2012.01.010; de Souza SP, 2010, RENEW ENERG, V35, P2552, DOI 10.1016/j.renene.2010.03.028; Lim S, 2010, RENEW SUST ENERG REV, V14, P938, DOI 10.1016/j.rser.2009.10.027; Zhou A, 2009, APPL ENERG, V86, pS11, DOI 10.1016/j.apenergy.2009.04.028; Iribarren D, 2012, FUEL, V97, P812, DOI 10.1016/j.fuel.2012.02.053; Borrion AL, 2012, RENEW SUST ENERG REV, V16, P4638, DOI 10.1016/j.rser.2012.04.016; Ahmad AL, 2011, RENEW SUST ENERG REV, V15, P584, DOI 10.1016/j.rser.2010.09.018; Di Lucia L, 2012, ENVIRON SCI POLICY, V16, P9, DOI 10.1016/j.envsci.2011.11.004; Brennan L, 2010, RENEW SUST ENERG REV, V14, P557, DOI 10.1016/j.rser.2009.10.009; Janaun J, 2010, RENEW SUST ENERG REV, V14, P1312, DOI 10.1016/j.rser.2009.12.011; Abdullah AZ, 2009, ENERG POLICY, V37, P5440, DOI 10.1016/j.enpol.2009.08.012; Department of Statistics Malaysia, 2013, MAL EC STAT TIM SER; Dharshini D, 2013, ENERG POLICY, V62, P1128; Dunmore C, 2011, REUTERS         1005; European Commission (EC), 2010, REP COMM IND LAND US; European Commission (EC), 2010, LIT REV; FAO, 2012, 1203 FAO ESA; FAO, 2008, STAT FOOD AGR BIOF P; Food and Agricultural Organization of the United Nations (FAO), 2010, REV PAP ALG BAS BIOF; Food and Agricultural Organization of the United Nations Statistics Division (FAOSTAT), TIM SER STAT; Food and Agricultural Policy Research Institute-Iowa State University (FAPRI-ISU), 2011, WORLD AGR OUTL; Food and Agriculture Organization of the United Nations (FAO), 2003, WORLD AGR 2015 2030; Friends of the Earth (FOE), 2004, GREAS PALMS EUR BUYE, P8; Gan PY, 2006, FIELD STUDY HEARING; Gan PY, 2008, ENERG POLICY, V36, P890, DOI 10.1016/j.enpol.2007.11.003; Gan PY, 2013, RENEW SUST ENERG REV, V21, P432, DOI 10.1016/j.rser.2012.12.041; Gan Peck Yean, 2008, International Journal of Global Energy Issues, V29, DOI 10.1504/IJGEI.2008.018014; Gerasimchuk I, 2013, BIOFUELS POLICIES FE; Helsema A, 2013, BIOFUEL MANDATES EU; IEA (International Energy Agency) Technology Roadmap, 2011, BIOF TRANSP; Lee KT, 2009, INT PALM OIL LIF CYC; Licht FO, 2013, WORLD ETHANOL BIOFUE, V11, P362; Licht FO, 2013, WORLD ETH BIOF REP, V11; Licht F.O., WORLD ETHANOL BIOFUE; Malaysia Palm Oil Board (MPOB), EC IND DEV DIV STAT; Malaysia Palm Oil Council (MPOC), 2007, FACT SHEETS MAL PALM; Mielke T., 2013, MAL MYANM PALM OIL T; MPIC, 2011, STAT COMM 2011; Pakiam R, 2014, BLOOMBERG; PEMANDU, 2010, EC TRANSF PROGR ROAD; Sekularac I, 2013, REUTERS; Teoh C., 2002, PALM OIL IND MALAYSI; Thukral N., 2008, REUTERS; Timilsina GR, 2012, ENERGY, V36, P2055; United States Department of Agriculture (USDA), 2013, MAL BIOF ANN 2013; United States Environmental Protection Agency (EPA), 2011, EPA ISS NOT RE FUELS; USDA (U.S. Department of Agriculture), 2011, USDA AGR PROJ 2020; WWF Germany, 2007, RAIN FOR BIOD EC EFF	63	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1364-0321			RENEW SUST ENERG REV	Renew. Sust. Energ. Rev.	NOV	2014	39						740	747		10.1016/j.rser.2014.07.059		8	Energy & Fuels	Energy & Fuels	AQ1GN	WOS:000342530000053		
J	Hamada, K; Yanagihara, M				Hamada, Kojun; Yanagihara, Mitsuyoshi			Donor Altruism and the Transfer Paradox in an Overlapping Generations Model	REVIEW OF INTERNATIONAL ECONOMICS			English	Article							INTERNATIONAL TRANSFERS; GENERALIZED THEORY; TRANSPORT COSTS; FOREIGN-AID; TIED AID; WELFARE; TRADE; IMPEDIMENTS; INVESTMENT	This paper examines the transfer problem between two countries when a donor exhibits altruistic utility toward a recipient in a one-sector overlapping generations model. We demonstrate that if the donor has a larger marginal propensity to save than the recipient, the donor's altruism never contributes to donor enrichment irrespective of the degree of the donor's altruism. Donor enrichment occurs only if the donor has a smaller marginal propensity to save and a sufficiently high level of altruism. These findings imply that the altruism of a donor toward a recipient does not necessarily explain the motivation to voluntarily provide a transfer.	[Yanagihara, Mitsuyoshi] Nagoya Univ, Grad Sch Econ, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Hamada, Kojun] Niigata Univ, Fac Econ, Niigata, Japan	Hamada, K (reprint author), Niigata Univ, Fac Econ, Niigata, Japan.	yanagi@soec.nagoya-u.ac.jp					Samuelson PA, 1952, ECON J, V62, P278, DOI 10.2307/2227005; BUITER WH, 1981, J POLIT ECON, V89, P769, DOI 10.1086/261002; Samuelson PA, 1954, ECON J, V64, P264, DOI 10.2307/2226834; BHAGWATI JN, 1985, Q J ECON, V100, P697, DOI 10.2307/1884375; BHAGWATI JN, 1983, AM ECON REV, V73, P606; Brakman S, 1998, EC INT TRANSFERS; Cremers ET, 2008, J ECON DYN CONTROL, V32, P1995, DOI 10.1016/j.jedc.2007.06.017; DIAMOND PA, 1965, AM ECON REV, V55, P1126; Djajic S, 1999, ECON J, V109, P698, DOI 10.1111/1468-0297.00469; GALOR O, 1987, REV ECON STUD, V54, P147, DOI 10.2307/2297450; HAAPARANTA P, 1989, J INT ECON, V26, P371, DOI 10.1016/0022-1996(89)90010-X; Hamada K., 2012, INT EC, V15, P96; KEMP MC, 1993, J DEV ECON, V42, P197, DOI 10.1016/0304-3878(93)90079-3; Kemp MC, 2002, JPN ECON REV, V53, P290, DOI 10.1111/1468-5876.00229; KEMP MC, 1985, INT ECON REV, V26, P721, DOI 10.2307/2526716; LAHIRI S, 1995, J INT ECON, V39, P297, DOI 10.1016/0022-1996(95)01374-2; Lahiri S., 1999, FOREIGN AID NEW PERS, P21; Ministry of Foreign Affairs of Japan, 1989, JAP PFF DEV ASS; Ministry of Foreign Affairs of Japan, 2011, JAP OFF DEV ASS WHIT; NEARY JP, 1995, CAN J ECON, V28, pS4, DOI 10.2307/136168; SCHWEINBERGER AG, 1990, INT ECON REV, V31, P457, DOI 10.2307/2526850; SIBERT AC, 1985, REV ECON STUD, V52, P331, DOI 10.2307/2297625; Tan K.-H., 1998, REV INT ECON, V6, P461, DOI 10.1111/1467-9396.00118; Yanagihara M., 1998, J INT TRAD EC DEV, V7, P175, DOI 10.1080/09638199800000010; Yanagihara M., 2006, EC B, V6, P1; YANO M, 1983, J INT ECON, V15, P277, DOI 10.1016/S0022-1996(83)80005-1	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0965-7576	1467-9396		REV INT ECON	Rev. Int. Econ.	NOV	2014	22	5					905	922		10.1111/roie.12142		18	Economics	Business & Economics	AQ6DV	WOS:000342899900003		
J	Lambson, V; Takagi, S; Kozuru, I				Lambson, Val; Takagi, Shinji; Kozuru, Issei			Foreign Exchange Intervention and Monetary Policy: A Tale of Two Agencies with Conflicting Objectives	REVIEW OF INTERNATIONAL ECONOMICS			English	Article								In several industrial countries, the government is responsible for foreign exchange intervention while the central bank is given operational independence in conducting domestic monetary policy. We model the interaction between the two agencies when their views differ and generate empirical implications using lattice-theoretic techniques. Japanese data from 2001-2004 support the model's predictions with respect to central bank behavior. The evidence is less conclusive as to whether the massive intervention of 2001-2004 by the Ministry of Finance caused the Bank of Japan to raise the monetary target.	[Lambson, Val] Brigham Young Univ, Dept Econ, Provo, UT 84604 USA; [Takagi, Shinji] Osaka Univ, Grad Sch Econ, Toyonaka, Osaka 5600043, Japan; [Takagi, Shinji] Int Monetary Fund, Independent Evaluat Off, Washington, DC 20431 USA; [Kozuru, Issei] Kosei Secur, Chuo Ku, Osaka 5410041, Japan	Lambson, V (reprint author), Brigham Young Univ, Dept Econ, Provo, UT 84604 USA.	vlambson@byu.edu					BARRO RJ, 1983, J POLIT ECON, V91, P589, DOI 10.1086/261167; Kaminsky GL, 1996, J MONETARY ECON, V37, P285, DOI 10.1016/S0304-3932(96)90038-0; Amir R, 2000, REV ECON STUD, V67, P235, DOI 10.1111/1467-937X.00129; TOPKIS DM, 1978, OPER RES, V26, P305, DOI 10.1287/opre.26.2.305; Sarno L, 2001, J ECON LIT, V39, P839, DOI 10.1257/jel.39.3.839; Destler I. M., 1989, DOLLAR POLITICS EXCH; Edison Hali J., 1993, SPECIAL PAPERS INT E, V18; Fatum Rasmus, 2005, INT EC EC POLICY, V2, P241, DOI 10.1007/s10368-005-0036-y; Ito Takatoshi, 2005, INT EC EC POLICY, V2, P219, DOI 10.1007/s10368-005-0034-0; Ito T, 2007, INT J FINANC ECON, V12, P133, DOI 10.1002/ijfe.336; Iwata Kazumasa, 2010, DEFURE TONO TATAKAI; Lybek Tonny, 2004, 04226 INT MON FUND; Maeda Eiji, 2005, 05E3 BANK JAP; Milgrom Paul, 1994, ECONOMETRICA, V84, P441; Moser-Boehm Paul, 2005, BIS PAPERS, V24; Shirakawa Masaaki, 2008, GENDAI NO KINYU SEIS; Takagi Shinji, 2014, J REV GLOBAL EC, V3, P84; Umeda Masanobu, 2011, NICHIGIN NO SEISAKU; US Federal Reserve Board (FRB), 2005, FED RES SYST PURP FU; Watanabe T, 2013, J INT MONEY FINANC, V32, P428, DOI 10.1016/j.jimonfin.2012.05.002	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0965-7576	1467-9396		REV INT ECON	Rev. Int. Econ.	NOV	2014	22	5					976	991		10.1111/roie.12153		16	Economics	Business & Economics	AQ6DV	WOS:000342899900006		
J	Tsuchiyama, T; Tsuboi, K; Iwanaga, S; Masumura, T; Macadre, A; Nakada, N; Takaki, S				Tsuchiyama, Toshihiro; Tsuboi, Koichi; Iwanaga, Shuichi; Masumura, Takuro; Macadre, Arnaud; Nakada, Nobuo; Takaki, Setsuo			Suppression of hydrogen embrittlement by formation of a stable austenite layer in metastable austenitic stainless steel	SCRIPTA MATERIALIA			English	Article						Solution nitriding; Martensitic transformation; Stability of austenite; Hydrogen embrittlement; Stainless steel	PERMEATION	Solution nitriding was applied to a metastable austenitic stainless steel plate (Fe-18Cr-8Ni alloy) to stabilize the austenite near the plate surface. After cold rolling, the interior austenite almost entirely transformed to martensite, but the stabilized surface austenite remained unchanged. The interior deformation-induced martensite contributes to the material's high strength and the surface stable austenite-layer plays an important role in preventing hydrogen permeation. As a result, the resistance to hydrogen embrittlement was significantly improved for the cold-rolled specimen. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Tsuchiyama, Toshihiro; Tsuboi, Koichi; Iwanaga, Shuichi; Masumura, Takuro; Macadre, Arnaud; Nakada, Nobuo; Takaki, Setsuo] Kyushu Univ, Dept Mat Sci & Engn, Nishi Ku, Fukuoka 8190395, Japan; [Tsuchiyama, Toshihiro; Tsuboi, Koichi; Nakada, Nobuo; Takaki, Setsuo] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Fukuoka 8190395, Japan	Tsuchiyama, T (reprint author), Kyushu Univ, Dept Mat Sci & Engn, Nishi Ku, 744 Moto Oka, Fukuoka 8190395, Japan.	toshi@zaiko.kyushu-u.ac.jp			World Premier International Research Center Initiative (WPI), MEXT, Japan	This work was supported by World Premier International Research Center Initiative (WPI), MEXT, Japan.	Nagumo M, 2004, MATER SCI TECH-LOND, V20, P940, DOI 10.1179/026708304225019687; Han G, 1998, ACTA MATER, V46, P4559, DOI 10.1016/S1359-6454(98)00136-0; FORCEY KS, 1991, J NUCL MATER, V182, P36, DOI 10.1016/0022-3115(91)90413-2; HOLLENBERG GW, 1995, FUSION ENG DES, V28, P190, DOI 10.1016/0920-3796(95)90039-X; Kanezaki T., 2008, INT J HYDROGEN ENERG, V33, P2064; Perrig T. P., 1986, ACTA METALL, V34, P1771; Tsuchiyama T, 2010, SCRIPTA MATER, V62, P731, DOI 10.1016/j.scriptamat.2010.01.042	7	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6462			SCRIPTA MATER	Scr. Mater.	NOV	2014	90-91						14	16		10.1016/j.scriptamat.2014.07.005		3	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Science & Technology - Other Topics; Materials Science; Metallurgy & Metallurgical Engineering	AQ6AN	WOS:000342889800004		
J	Bhattacharjee, T; Nakata, T; Sasaki, TT; Kamado, S; Hono, K				Bhattacharjee, T.; Nakata, T.; Sasaki, T. T.; Kamado, S.; Hono, K.			Effect of microalloyed Zr on the extruded microstructure of Mg-6.2Zn-based alloys	SCRIPTA MATERIALIA			English	Article						Mg-Zn alloy; ZK60; Precipitation; Transmission electron microscopy	GRAIN-REFINEMENT; MAGNESIUM	The addition of a small amount of Zr to a Mg-6.2Zn (Z6) binary alloy causes a substantial increase in the tensile yield strength of the extruded form of this alloy. This is attributed to the formation of thermally stable fine Mg(Zn,Zr) precipitates, which refine the extruded microstructure. A fine dispersion of beta'(1) and beta'(2) precipitates within the refined grains after T6 aging at 160 degrees C results in a high tensile yield strength of 275 MPa, and an ultimate tensile strength of 318 MPa with an elongation to failure of 17.1%. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Bhattacharjee, T.; Hono, K.] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058577, Japan; [Bhattacharjee, T.; Sasaki, T. T.; Hono, K.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Nakata, T.; Kamado, S.] Nagaoka Univ Technol, Nagaoka, Niigata 9402188, Japan	Hono, K (reprint author), Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.	kazuhiro.hono@nims.go.jp	Hono, Kazuhiro/B-9202-2008; Sasaki, Taisuke/H-2866-2011	Hono, Kazuhiro/0000-0001-7367-0193; 	MEXT; JST, ALCA	One of the authors (T.B.) acknowledges the National Institute for Materials Science (NIMS) for the provision of a NIMS Junior Research Assistantship. This work was supported by MEXT, Grant-in-Aid for Scientific Research on Innovative Areas on "Bulk Nanostructured Metals" and JST, ALCA.	Bhattacharjee T, 2014, MAT SCI ENG A-STRUCT, V609, P154, DOI 10.1016/j.msea.2014.04.058; Bhattacharjee T, 2012, SCRIPTA MATER, V67, P967, DOI 10.1016/j.scriptamat.2012.08.031; Stanford N, 2008, MAT SCI ENG A-STRUCT, V496, P399, DOI 10.1016/j.msea.2008.05.045; Oh-ishi K, 2009, ACTA MATER, V57, P5593, DOI 10.1016/j.actamat.2009.07.057; StJohn DH, 2005, METALL MATER TRANS A, V36A, P1669, DOI 10.1007/s11661-005-0030-6; Homma T, 2010, MAT SCI ENG A-STRUCT, V527, P2356, DOI 10.1016/j.msea.2009.12.024; DOAN JP, 1947, T AM I MIN MET ENG, V171, P286; Emley E. F., 1966, PRINCIPLES MAGNESIUM; GALLOT J, 1965, CR HEBD ACAD SCI, V261, P728; Lee YC, 2000, METALL MATER TRANS A, V31, P2895, DOI 10.1007/BF02830349; Qian M., 2003, Magnesium Technology 2003 Symposium; Tamura Y., 1997, Journal of Japan Institute of Light Metals, V47, DOI 10.2464/jilm.47.679; Underwood E., 1970, QUANTITATIVE STEREOL; Williams D.B., 2009, TRANSMISSION ELECT M	14	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6462			SCRIPTA MATER	Scr. Mater.	NOV	2014	90-91						37	40		10.1016/j.scriptamat.2014.07.011		4	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Science & Technology - Other Topics; Materials Science; Metallurgy & Metallurgical Engineering	AQ6AN	WOS:000342889800010		
J	Kawano, S				Kawano, Shuichi			Selection of tuning parameters in bridge regression models via Bayesian information criterion	STATISTICAL PAPERS			English	Article						Bridge penalty; Model selection; Penalized maximum likelihood method; Sparse regression	NONCONCAVE PENALIZED LIKELIHOOD; VARIABLE SELECTION; LASSO; ESTIMATORS; PENALTIES	We consider bridge regression models, which can produce a sparse or non-sparse model by controlling a tuning parameter in the penalty term. A crucial part of a model building strategy is the selection of the values for adjusted parameters, such as regularization and tuning parameters. Indeed, this can be viewed as a problem in selecting and evaluating the model. We propose a Bayesian selection criterion for evaluating bridge regression models. This criterion enables us to objectively select the values of the adjusted parameters. We investigate the effectiveness of our proposed modeling strategy with some numerical examples.	Osaka Prefecture Univ, Grad Sch Engn, Dept Math Sci, Sakai, Osaka 5998531, Japan	Kawano, S (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Dept Math Sci, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	skawano@ms.osakafu-u.ac.jp			Ministry of Education, Science, Sports and Culture [24700280]	The author would like to thank the anonymous reviewers for their constructive and helpful comments. This work was supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Young Scientists (B), #24700280, 2012-2015.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Lv JC, 2009, ANN STAT, V37, P3498, DOI 10.1214/09-AOS683; Fu WJJ, 1998, J COMPUT GRAPH STAT, V7, P397, DOI 10.2307/1390712; Antoniadis A, 2014, STAT PAP, V55, P727, DOI 10.1007/s00362-013-0522-1; Knight K, 2000, ANN STAT, V28, P1356; Yuan M, 2006, J ROY STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Hurvich CM, 1998, J ROY STAT SOC B, V60, P271, DOI 10.1111/1467-9868.00125; Huang J, 2008, ANN STAT, V36, P587, DOI 10.1214/009053607000000875; Huang J, 2009, BIOMETRIKA, V96, P339, DOI 10.1093/biomet/asp020; Zhang CH, 2010, ANN STAT, V38, P894, DOI 10.1214/09-AOS729; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.1093/biomet/76.2.297; Zou H, 2008, ANN STAT, V36, P1509, DOI 10.1214/009053607000000802; Liu YF, 2007, COMPUT STAT DATA AN, V51, P6380, DOI 10.1016/j.csda.2007.02.006; Zou H, 2005, J ROY STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Ishiguro M, 1997, ANN I STAT MATH, V49, P411, DOI 10.1023/A:1003158526504; Fan JQ, 2008, J ROY STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Antoniadis A, 2011, ANN I STAT MATH, V63, P585, DOI 10.1007/s10463-009-0242-4; CRAVEN P, 1979, NUMER MATH, V31, P377; Armagan A, 2009, P 12 INT C ART INT S, V5, P17; Buhlmann P, 2011, SPRINGER SER STAT, P1, DOI 10.1007/978-3-642-20192-9; Frank JE, 1993, TECHNOMETRICS, V35, P109; Hastie T. J., 1990, GEN ADDITIVE MODELS; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI DOI 10.1080/00401706.1970.10488634; Konishi S, 2004, BIOMETRIKA, V91, P27, DOI 10.1093/biomet/91.1.27; MCDONALD GC, 1973, TECHNOMETRICS, V15, P463, DOI 10.2307/1266852; Neykov NM, 2014, STAT PAP, V55, P187, DOI 10.1007/s00362-013-0516-z; Park C, 2011, J STAT PLAN INFER, V141, P3506, DOI 10.1016/j.jspi.2011.05.004; Polson NG, 2011, ARXIV11092279; Shimamura T, 2007, GENOME INFORM SER, V19, P142; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; TIERNEY L, 1986, J AM STAT ASSOC, V81, P82, DOI 10.2307/2287970	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0932-5026	1613-9798		STAT PAP	Stat. Pap.	NOV	2014	55	4					1207	1223		10.1007/s00362-013-0561-7		17	Statistics & Probability	Mathematics	AQ8BK	WOS:000343046200017		
J	Ren, YS; Ma, WH; Wei, KX; Yu, WZ; Dai, YN; Morita, K				Ren, Yongsheng; Ma, Wenhui; Wei, Kuixian; Yu, Wenzhou; Dai, Yongnian; Morita, Kazuki			Degassing of aluminum alloys via the electromagnetic directional solidification	VACUUM			English	Article						Degassing; Aluminum alloy; Electromagnetic directional solidification; Microstructure; Defects	ROTATING IMPELLER DEGASSER; COMPUTER-SIMULATION; HYDROGEN; VACUUM; MELT	A new route for degassing of molten aluminum alloys has been developed via the electromagnetic directional solidification. We evaluated the degassing feasibility and mechanism for the formation and evolution of the porosity. As expected, it enabled the migration of porosity to the upper end instead of the distribution in the whole sample. Furthermore, we investigated the effects of various pull-down rates, i.e., solidification rates on the degassing efficiency, porosity area fraction, and microstructure of alloys, etc. Clearly, the experimental results show that with the reducing of pull-down rates, the degassing efficiency increases and the porosity area fraction decreases, respectively. The lowest porosity area fraction is down to 0.08% under the 5 mu m/s pull-down rate. Simultaneously, there are almost no porosity and other defects in the lower part of the final product. In conclusion, it offers an alternative method for degassing and possesses potential applications in aeronautic and space industry. (C) 2014 Elsevier Ltd. All rights reserved.	[Ren, Yongsheng; Ma, Wenhui; Wei, Kuixian; Yu, Wenzhou; Dai, Yongnian] Kunming Univ Sci & Technol, Natl Engn Lab Vacuum Met, Fac Met & Energy Engn, Kunming 650093, Peoples R China; [Ren, Yongsheng; Ma, Wenhui; Wei, Kuixian; Yu, Wenzhou; Dai, Yongnian] State Key Lab Complex Nonferrous Met Resources Cl, Kunming 650093, Peoples R China; [Morita, Kazuki] Univ Tokyo, Grad Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan	Ma, WH (reprint author), Kunming Univ Sci & Technol, State Key Lab Complex Nonferrous Met Resources Cl, Fac Met & Energy Engn, Natl Engn Lab Vacuum Met, Kunming 650093, Peoples R China.	mwhsilicon@163.com; kxwei2008@hotmail.com	Morita, Kazuki/N-6397-2015		National Natural Science Foundation of China [51066003, U1137601]; National Key Technology RD Program [2011BAE03B01]; Program for Innovative Research Team in University of Ministry of Education of China [IRT1250]	The authors are gratefully acknowledged the financial supports from the National Natural Science Foundation of China (No. 51066003 and U1137601), the National Key Technology R&D Program (No. 2011BAE03B01), and the Program for Innovative Research Team in University of Ministry of Education of China (No. IRT1250).	SAMUEL AM, 1992, J MATER SCI, V27, P6533, DOI 10.1007/BF01165936; [Anonymous], CASTINGS; Eskin GI, 1997, ADV PERFORM MATER, V4, P223, DOI 10.1023/A:1008603815525; ASMI, 1988, METALS HDB, V15; Booth CW, 1984, BR FOUNDRVM      FEB, P69; Botor J, 1980, ALUMINIUM, V8, P519; Choudhury A., 1989, ALUMINIUM, V65, P462; Davis J.R., 1993, ASM SPECIALTY HDB AL; Eskin G. I., 1995, ULTRASON SONOCHEM, V2, P137, DOI DOI 10.1016/1350-4177(95)00020-7; Eskin GI, 1998, METALLURGIST+, V42, P284, DOI 10.1007/BF02511801; Gruzleski J E, 1990, TREATMENT LIQUID ALU; Han Q, 2002, METALL MATER TRANS A, V33, P2067, DOI 10.1007/s11661-002-0038-0; POIRIER DR, 1987, METALL TRANS A, V18, P1979, DOI 10.1007/BF02647028; Richly O., 1981, ALUMINIUM, V57, P546; Wang LP, 2009, RARE METALS, V28, P309, DOI 10.1007/s12598-009-0060-0; Warke VS, 2005, J MATER PROCESS TECH, V168, P119, DOI 10.1016/j.jmatprotec.2004.10.016; Warke VS, 2005, J MATER PROCESS TECH, V168, P112, DOI 10.1016/j.jmatprotec.2004.10.017; Wu RZ, 2005, MAT SCI ENG A-STRUCT, V408, P19, DOI 10.1016/j.msea.2005.05.055; Wu RZ, 2007, MAT SCI ENG A-STRUCT, V456, P386, DOI 10.1016/j.msea.2006.11.094; Xu HB, 2007, MATER LETT, V61, P1246, DOI 10.1016/j.matlet.2006.07.012; Zhao L, 2012, MATER LETT, V66, P328, DOI 10.1016/j.matlet.2011.09.012; Zhu XW, 2001, MATER LETT, V51, P363, DOI 10.1016/S0167-577X(01)00322-6; Zuo YB, 2013, INT J CAST METAL RES, V26, P16, DOI 10.1179/1743133612Y.0000000019	23	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	NOV	2014	109				SI		82	85		10.1016/j.vacuum.2014.06.026		4	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AQ3TI	WOS:000342716000013		
J	Latief, FH; Kakehi, K				Latief, F. H.; Kakehi, K.			Influence of post ageing on creep behaviour of aluminized Ni-based single crystal superalloy prepared by low-activity high-temperature	VACUUM			English	Article						Ni-based superalloys; Ageing; Creep; Coatings; Microstructure	NICKEL; MICROSTRUCTURES; DEFORMATION; EVOLUTION; PHASE	The influence of post ageing treatment on creep behaviour of aluminide coating prepared by low-activity high-temperature on a Ni-based single crystal superalloy was investigated. The results showed that the aluminide coating reduced the creep behaviour of Ni-based single crystal superalloy. The decrease in creep behaviour may be due to the change in microstructures after aluminizing treatment. However, the post ageing treatment at low temperature has successfully improved the creep behaviour of aluminized Ni-based single crystal superalloy. The increase in creep behaviour of aluminized Ni-based single crystal superalloy after post ageing treatment was due to the formation of fine spherical carbides which are distributed in the substrate of Ni-based single crystal superalloy. These fine spherical carbides are able to hinder the dislocation movement and suppress the amount of topologically close-packed phase. (C) 2014 Elsevier Ltd. All rights reserved.	[Latief, F. H.; Kakehi, K.] Tokyo Metropolitan Univ, Dept Mech Engn, Hachioji, Tokyo 1920397, Japan	Latief, FH (reprint author), Tokyo Metropolitan Univ, Dept Mech Engn, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.	fahamsyah78@gmail.com			Light Metal Educational Foundation, Inc.	The authors would like to gratefully acknowledge to the Light Metal Educational Foundation, Inc. and Dr. Murakami of NIMS (National Institute for Materials Science), Tsukuba, for the support.	Simonetti M, 1998, MAT SCI ENG A-STRUCT, V254, P1, DOI 10.1016/S0921-5093(98)00766-7; Xiang ZD, 2001, J MATER SCI, V36, P5673, DOI 10.1023/A:1012534220165; Zhou H, 2004, MAT SCI ENG A-STRUCT, V381, P20, DOI 10.1016/j.msea.2004.04.051; Choux C, 2008, INTERMETALLICS, V16, P1, DOI 10.1016/j.intermet.2007.07.014; Chen QZ, 2002, ACTA MATER, V50, P1095, DOI 10.1016/S1359-6454(01)00410-4; Das DK, 1998, METALL MATER TRANS A, V29, P2173, DOI 10.1007/s11661-998-0042-0; Jackson MP, 1999, MAT SCI ENG A-STRUCT, V259, P85, DOI 10.1016/S0921-5093(98)00867-3; Liu LR, 2003, MATER LETT, V57, P4540, DOI [10.1016/S0167-577X(03)00359-8, 10.1016/S0167-577X(03)00359-7]; Nikitin VI, 1975, MAT SCI, V10, P5; Rae CMF, 2005, MAT SCI ENG A-STRUCT, V396, P231, DOI 10.1016/j.msea.2005.01.005; Wei H, 2009, J ALLOY COMPD, V481, P326, DOI 10.1016/j.jallcom.2009.02.130	11	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	NOV	2014	109				SI		157	161		10.1016/j.vacuum.2014.07.003		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AQ3TI	WOS:000342716000026		
J	Thungsuk, N; Nuchuay, P; Hirotani, D; Okamura, Y; Nakabayashi, K; Kinoshita, H; Yuji, T; Mungkung, N; Kasayapanand, N				Thungsuk, Nuttee; Nuchuay, Peerapong; Hirotani, Daisuke; Okamura, Yoshimi; Nakabayashi, Kenichi; Kinoshita, Hiroyuki; Yuji, Toshifumi; Mungkung, Narong; Kasayapanand, Nat			Development of low-pressure high-frequency plasma chemical vapor deposition method on surface modification of silicon wafer	VACUUM			English	Article						Argon plus oxygen mixture gas; Flexible solar cell; Plasma CVD; Surface treatment; Low pressure	SOLAR-CELLS; OXYGEN-PLASMA; LOW-TEMPERATURE; SUBSTRATE; LAYER; FILMS; COATINGS	Even though silicon based solar cell currently has more efficient, the dye sensitized solar cell is considerably cheaper for manufacturing because of its low cost materials and simplicity process of fabrication. In this paper, the development of plasma formed equipments for thin film material on flexible solar cell using low-pressure high-frequency plasma chemical vapor deposition method on the surface of Si wafer with the mixture of Ar gas and O-2 gas is presented. The results indicate that using this method can be possible for surface modification. (C) 2014 Elsevier Ltd. All rights reserved.	[Thungsuk, Nuttee; Nuchuay, Peerapong; Kasayapanand, Nat] King Mongkuts Univ Technol Thonburi, Sch Energy Environm & Mat, Div Energy Technol, Bangkok 10140, Thailand; [Hirotani, Daisuke; Okamura, Yoshimi; Nakabayashi, Kenichi; Yuji, Toshifumi] Miyazaki Univ, Fac Educ & Culture, Miyazaki 8892192, Japan; [Kinoshita, Hiroyuki] Miyazaki Univ, Dept Mech Design Syst Engn, Miyazaki 8892192, Japan; [Mungkung, Narong] King Mongkuts Univ Technol Thonburi, Dept Elect Technol Educ, Bangkok 10140, Thailand	Thungsuk, N (reprint author), King Mongkuts Univ Technol Thonburi, Sch Energy Environm & Mat, Div Energy Technol, 126 Pracha Uthit Rd, Bangkok 10140, Thailand.	tonsai8996@yahoo.com					Moriwaki K, 2013, SOL ENERG MAT SOL C, V112, P106, DOI 10.1016/j.solmat.2013.01.016; Feng XJ, 2013, THIN SOLID FILMS, V535, P202, DOI 10.1016/j.tsf.2012.11.103; Lizin S, 2012, SOL ENERG MAT SOL C, V103, P1, DOI 10.1016/j.solmat.2012.04.001; Dupont SR, 2012, SOL ENERG MAT SOL C, V97, P171, DOI 10.1016/j.solmat.2011.10.012; Kim SH, 2005, SURF COAT TECH, V200, P2072, DOI 10.1016/j.surfcoat.2005.05.021; Espinosa N, 2012, SOL ENERG MAT SOL C, V97, P3, DOI 10.1016/j.solmat.2011.09.048; Wang FH, 2011, CURR APPL PHYS, V11, pS12, DOI 10.1016/j.cap.2010.11.109; Kim JT, 2011, SOL ENERG MAT SOL C, V95, P336, DOI 10.1016/j.solmat.2010.04.045; Breyer C, 2013, ENERG POLICY, V62, P1570, DOI 10.1016/j.enpol.2013.07.003; Ganthner M, 2014, SOL ENERG MAT SOL C, V123, P97; Golda M, 2013, MAT SCI ENG C-MATER, V33, P4221, DOI 10.1016/j.msec.2013.06.014; Gordon I, 2006, THIN SOLID FILMS, V511, P608, DOI 10.1016/j.tsf.2005.12.124; Hua F, 2012, ELECTROCHIM ACTA, V69, P97; Lay E, 2011, SURF COAT TECH, V205, P4267, DOI 10.1016/j.surfcoat.2011.03.037; Lei PH, 2012, SURF COAT TECH, V206, P3258, DOI 10.1016/j.surfcoat.2012.01.023; Murakami TN, 2004, J PHOTOCH PHOTOBIO A, V164, P187, DOI 10.1016/j.jphotochem.2003.11.021; Pazheri FR, 2014, RENEW SUST ENERG REV, V31, P835, DOI 10.1016/j.rser.2013.12.020; Rath JK, 2010, SOL ENERG MAT SOL C, V94, P1534, DOI 10.1016/j.solmat.2010.01.013; Setsuhara Y, 2009, THIN SOLID FILMS, V518, P1006, DOI 10.1016/j.tsf.2009.07.161; Soderstrom K, 2011, SOL ENERG MAT SOL C, V95, P3585, DOI 10.1016/j.solmat.2011.09.016; Wang ZY, 2010, SOL ENERG MAT SOL C, V94, P1591, DOI 10.1016/j.solmat.2010.04.077; Yuji T, 2005, THIN SOLID FILMS, V475, P348, DOI 10.1016/j.tsf.2004.07.037; Yuji T, 2011, IEEE T PLASMA SCI, V39, P1427, DOI 10.1109/TPS.2011.2140383; Zheng S., 2009, VACUUM, V83, P238	24	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	NOV	2014	109				SI		166	169		10.1016/j.vacuum.2014.06.029		4	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AQ3TI	WOS:000342716000028		
J	Panomsuwan, G; Takai, O; Saito, N				Panomsuwan, Gasidit; Takai, Osamu; Saito, Nagahiro			Effect of growth temperature on structural and morphological evolution of epitaxial SrTiO3 thin films grown on LaAlO3 (001) substrates by ion beam sputter deposition	VACUUM			English	Article						SrTiO3; Epitaxial film; Crystal structure; Growth mode; Ion beam sputter deposition	PULSED-LASER DEPOSITION; SUPERLATTICES; LAYER; MODE; HOMOEPITAXY; ORIENTATION; OXIDES	A series of epitaxial SrTiO3 (STO) thin films were grown on (001)-oriented LaAlO3 (LAO) substrates by ion beam sputter deposition (IBSD) at various growth temperatures in the range of 350-800 degrees C. Our results have shown that the growth temperature plays an essential role in influencing the structural and morphological evolution of the STO thin films. X-ray structural analysis demonstrates that the STO thin films are grown under in-plane compressive strain due to the effect of lattice mismatch. The out-of-plane lattice constant is found to decrease with increasing growth temperature. Atomic force microscopy observation reveals that the growth mode of STO thin films transforms from a three-dimensional island mode to a two-dimensional layer-by-layer mode at a sufficiently high growth temperature of 750 degrees C. We believe that high-quality epitaxial STO thin films with atomically flat surface prepared by IBSD in this study would be beneficial for the fabrication of perovskite STO-based superlattices. (C) 2014 Elsevier Ltd. All rights reserved.	[Panomsuwan, Gasidit; Saito, Nagahiro] Nagoya Univ, Grad Sch Engn, Dept Mat Phys & Energy Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Takai, Osamu] Kanto Gakuin Univ, Mat & Surface Engn Res Inst, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Saito, Nagahiro] Nagoya Univ, Green Mobil Collaborat Res Ctr, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Panomsuwan, G (reprint author), Nagoya Univ, Grad Sch Engn, Dept Mat Phys & Energy Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	gasidit@rd.numse.nagoya-u.ac.jp	Saito, Nagahiro/I-6113-2014	Saito, Nagahiro/0000-0001-8757-3933	Center of Excellence (COE) for Education and Research of Micro-Nano Mechatronics of Nagoya University	This work was partially supported by the Center of Excellence (COE) for Education and Research of Micro-Nano Mechatronics of Nagoya University. The authors gratefully thank to Assoc. Prof. Sung-Pyo Cho for the TEM observation and discussion.	Lippmaa M, 2000, APPL PHYS LETT, V76, P2439, DOI 10.1063/1.126369; Lee HN, 2005, NATURE, V433, P395, DOI 10.1038/nature03261; Son J, 2010, NAT MATER, V9, P482, DOI [10.1038/nmat2750, 10.1038/NMAT2750]; Habermeier HU, 2007, MATER TODAY, V10, P34, DOI 10.1016/S1369-7021(07)70243-2; Nakagawara O, 2002, VACUUM, V66, P397, DOI 10.1016/S0042-207X(02)00161-6; Panomsuwan G, 2013, PHYS STATUS SOLIDI A, V210, P311, DOI 10.1002/pssa.201228077; Ohnishi T, 1999, APPL PHYS LETT, V74, P2531, DOI 10.1063/1.123888; Perez-Casero R, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.165317; Ohta H, 2007, NAT MATER, V6, P129, DOI 10.1038/nmat1821; Bowen D K, 1998, HIGH RESOLUTION XRAY; Choi WS, 2012, ADV MATER, V24, P6423, DOI 10.1002/adma.201202691; Cuomo J J, 1989, HDB ION BEAM PROCESS; Fush D, 2000, J APPL PHYS, V88, P1844; Khodan AN, 2007, THIN SOLID FILMS, V515, P6422, DOI 10.1016/j.tsf.2006.11.099; Kim JS, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.201407; Li YR, 2004, J APPL PHYS, V96, P1640, DOI 10.1063/1.1763987; Ohtomo A, 2007, J APPL PHYS, V102, DOI 10.1063/1.2798385; Panomsuwan G, 2013, SOLID STATE COMMUN, V158, P65, DOI 10.1016/j.ssc.2012.12.026; Panomsuwan G, 2013, VACUUM, V89, P35, DOI 10.1016/j.vacuum.2012.08.011; Song JH, 2003, SOLID STATE COMMUN, V125, P563, DOI 10.1016/S0038-1098(03)00005-X; Wang X, 2000, THIN SOLID FILMS, V360, P181, DOI 10.1016/S0040-6090(99)01099-8; Wordenweber R, 2007, J APPL PHYS, V102, DOI 10.1063/1.2773680; Wu ZP, 2010, VACUUM, V85, P639, DOI 10.1016/j.vacuum.2010.09.008; Zhang QL, 2006, VACUUM, V81, P539, DOI 10.1016/j.vacuum.2006.07.015	24	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	NOV	2014	109				SI		175	179		10.1016/j.vacuum.2014.07.007		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AQ3TI	WOS:000342716000030		
J	Takeyasu, K; Matsumoto, M; Fukutani, K				Takeyasu, Kotaro; Matsumoto, Masuaki; Fukutani, Katsuyuki			Temperature dependence of hydrogen depth distribution in the near-surface region of stainless steel	VACUUM			English	Article						Stainless steel; Surface; Hydrogen; Water	WATER; UHV	The depth profile of hydrogen at a type 304 stainless steel surface was investigated with H-1(N-15,alpha gamma)C-12 nuclear reaction analysis at various temperatures. Hydrogen was predominantly distributed in the region shallower than 10 nm (surface hydrogen) with an area density of similar to 1 x 10(16) cm(-2). Hydrogen was found to also exist in a deeper region (>30 nm) with a constant volume density of similar to 4 x 10(20) cm(-3) (bulk hydrogen). While both bulk and surface components gradually decreased as the temperature rose, part of the intensities remained even at 975 K. From the temperature dependence of the amount of the surface hydrogen, the distribution of the activation energy for desorption is discussed. (C) 2014 Elsevier Ltd. All rights reserved.	[Takeyasu, Kotaro; Fukutani, Katsuyuki] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Matsumoto, Masuaki] Tokyo Gakugei Univ, Dept Phys, Koganei, Tokyo 1848501, Japan	Takeyasu, K (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	takeyasu@iis.u-tokyo.ac.jp; fukutani@iis.u-tokyo.ac.jp					Akaishi K, 2002, J VAC SCI TECHNOL A, V20, P848, DOI 10.1116/1.1471354; Ishikawa Y, 2003, VACUUM, V69, P501, DOI 10.1016/S0042-207X(02)00562-6; CHRISTMANN K, 1988, SURF SCI REP, V9, P1, DOI 10.1016/0167-5729(88)90009-X; Henderson MA, 2000, SURF SCI, V449, P135, DOI 10.1016/S0039-6028(99)01246-7; ORIANI RA, 1970, ACTA METALL MATER, V18, P147, DOI 10.1016/0001-6160(70)90078-7; Costa D, 2009, SURF SCI, V603, P2484, DOI 10.1016/j.susc.2009.05.037; BAETZOLD RC, 1976, J CATAL, V45, P94, DOI 10.1016/0021-9517(76)90059-2; Fukai Y., 1993, METAL HYDROGEN SYSTE; Fukutani K, 1999, PHYS REV B, V59, P13020, DOI 10.1103/PhysRevB.59.13020; Fukutani K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.116101; Henrich V, 1994, SURFACE SCI METAL OX; HORIKOSHI G, 1987, J VAC SCI TECHNOL A, V5, P2501, DOI 10.1116/1.574407; KANAZAWA K, 1989, J VAC SCI TECHNOL A, V7, P3361, DOI 10.1116/1.576151; KUBIAK GD, 1985, J CHEM PHYS, V83, P2538, DOI 10.1063/1.449300; RUCKMAN MW, 1995, J VAC SCI TECHNOL A, V13, P1994, DOI 10.1116/1.579642; Takeyasu K, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.114602; Takeyasu K, 2013, J VAC SOC JPN, V56, P457; Westerberg L, 1996, VACUUM, V47, P687, DOI 10.1016/0042-207X(96)00047-4; Yoshimura T, 2002, J VAC SCI TECHNOL A, V20, P1450, DOI 10.1116/1.1487874; Ziegler JF, 1980, HDB STOPPING CROSS S	20	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	NOV	2014	109				SI		230	233		10.1016/j.vacuum.2014.06.008		4	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AQ3TI	WOS:000342716000041		
J	Tzoganis, V; Jeff, A; Welsch, CP				Tzoganis, Vasilis; Jeff, Adam; Welsch, Carsten P.			Gas dynamics considerations in a non-invasive profile monitor for charged particle beams	VACUUM			English	Article						Non-invasive beam profile measurements; Beam diagnostics; Gas jet curtain		A non-invasive, gas jet-based, beam profile monitor has been developed in the QUASAR Group at the Cockcroft Institute, UK. This allows on-line measurement of the 2-dimensional transverse profile of particle beams with negligible disturbance to either primary beam or accelerator vacuum. The monitor is suitable for use with beams across a wide range of energies and intensities. In this setup a nozzle-skimmer system shapes a thin supersonic gas jet into a curtain. However, the small dimensions of the gas inlet nozzle and subsequent skimmers were shown to be the cause of many operational problems. In this paper, the dynamics of gas jet formation transport and shaping is discussed before an image-processing based alignment technique is introduced. Furthermore, experimental results obtained with a 5 keV electron beam are discussed and the effects of gas stagnation pressure on the acquired beam are presented. (C) 2014 Elsevier Ltd. All rights reserved.	[Tzoganis, Vasilis; Jeff, Adam; Welsch, Carsten P.] Cockcroft Inst, Warrington WA4 4AD, Cheshire, England; [Tzoganis, Vasilis; Jeff, Adam; Welsch, Carsten P.] Univ Liverpool, Dept Phys, Liverpool L69 7ZE, Merseyside, England; [Jeff, Adam] CERN, CH-1211 Geneva, Switzerland; [Tzoganis, Vasilis] RIKEN, Nishina Ctr, Wako, Saitama 3510198, Japan	Tzoganis, V (reprint author), Cockcroft Inst, Warrington WA4 4AD, Cheshire, England.	vasileios.tzoganis@cockcroft.ac.uk		Tzoganis, Vasilis/0000-0003-0756-7600			Ashkenaz H, 1964, RAREFIED GAS DYMAMIC, P1965; Harasimowicz J, 2009, PAC, P4048; Hashimoto Y, 2004, NUCL INSTRUM METH A, V527, P289, DOI 10.1016/j.nima.2004.05.034; Hashimoto Y, 2013, IBIC, P848; Hashimoto Y, 2000, DEV BEAM PROFILE MON, P1729; Putignano M, 2012, NUCL INSTRUM METH A, V667, P44, DOI 10.1016/j.nima.2011.11.054; Putignano M, 2012, BIW, P198; Putignano M, 2009, HYPERFINE INTERACT, V194, P189, DOI 10.1007/s10751-009-0049-y; Putignano M, 2010, IPAC, P1149; Putignano M, 2010, BIW 2010, P243; Sharipov F, 2014, VACUUM, V109, P246, DOI 10.1016/j.vacuum.2014.03.027; Tzoganis V, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4879285; Tzoganis V, 2013, IBIC OXF UK, P803; Ulrich J, 2003, REP PROG PHYS, V66, P1463; Welsch CP, 2011, HYPERFINE INTERACT, V213, P205	15	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	NOV	2014	109				SI		417	424		10.1016/j.vacuum.2014.07.009		8	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AQ3TI	WOS:000342716000066		
J	Ikiz, Y; Jung, H; Orhan, D				Ikiz, Yuksel; Jung, Hyojin; Orhan, Dogan			Evaluation of Washfastness and Crockfastness Values: Pigment Printed Fabrics	AATCC JOURNAL OF RESEARCH			English	Article						Acrylate; Butadiene; Color; Cotton; Fastness; Pigments; Printing		Washfastness and crockfastness values were evaluated to study the effects of binder and process parameters on pigment printing. Acrylate-and butadiene-based binders, and three different colorants, were used for pigment printing on 100% cotton fabrics. Sixty-six pigment printed fabrics were evaluated for washfastness and crockfastness by standard test methods. Fastness values were evaluated based on binder, softener, fixator, process, fastness developer, pH, and curing temperature/time. Results indicated that wet crockfastness values were dependent on the processing parameters. In addition, using butadiene-based binder and adding fixator into the printing paste had significant effect on improved fastness values.	[Ikiz, Yuksel] Pamukkale Univ, Denizli, Turkey; [Jung, Hyojin] Kyoto Inst Technol, Kyoto, Japan; [Orhan, Dogan] DEBA, Gipuzkoa, Spain	Ikiz, Y (reprint author), Pamukkale Univ, Muhendislik Fak, Tekstil Bolumu, Denizli, Turkey.	yikiz@pau.edu.tr					Yaman N, 2012, J ENG FIBER FABR, V7, P40; Neral B, 2006, DYES PIGMENTS, V68, P143, DOI 10.1016/j.dyepig.2005.01.022; El-Shishtawy M, 2002, COLOR TECHNOL, V118, P115; Haggag K., 2012, INT J TEXTILE SCI, V1, P49; Iqbal M., 2012, J ANAL SCI METHODS I, V2, P87; Kanik M., 1995, TEKST KONFEKSIYON, V5, P447; Kulkarni S. V., 1986, TEXTILE DYEING OPERA; Provost J., 1990, PRACTICAL MANUAL TEX	8	0	0	AMER ASSOC TEXTILE CHEMISTS COLORISTS	RES TRIANGLE PK	PO BOX 12215, RES TRIANGLE PK, NC 27709 USA	2330-5517			AATCC J RES	AATCC J. Res.	NOV-DEC	2014	1	6					1	7				7	Materials Science, Textiles	Materials Science	CU6BJ	WOS:000363616200001		
J	Rennie, JJ; Lawrimore, JH; Gleason, BE; Thorne, PW; Morice, CP; Menne, MJ; Williams, CN; de Almeida, WG; Christy, JR; Flannery, M; Ishihara, M; Kamiguchi, K; Klein-Tank, AMG; Mhanda, A; Lister, DH; Razuvaev, V; Renom, M; Rusticucci, M; Tandy, J; Worley, SJ; Venema, V; Angel, W; Brunet, M; Dattore, B; Diamond, H; Lazzara, MA; Le Blancq, F; Luterbacher, J; Machel, H; Revadekar, J; Vose, RS; Yin, X				Rennie, J. J.; Lawrimore, J. H.; Gleason, B. E.; Thorne, P. W.; Morice, C. P.; Menne, M. J.; Williams, C. N.; de Almeida, W. Gambi; Christy, J. R.; Flannery, M.; Ishihara, M.; Kamiguchi, K.; Klein-Tank, A. M. G.; Mhanda, A.; Lister, D. H.; Razuvaev, V.; Renom, M.; Rusticucci, M.; Tandy, J.; Worley, S. J.; Venema, V.; Angel, W.; Brunet, M.; Dattore, B.; Diamond, H.; Lazzara, M. A.; Le Blancq, F.; Luterbacher, J.; Maechel, H.; Revadekar, J.; Vose, R. S.; Yin, X.			The international surface temperature initiative global land surface databank: monthly temperature data release description and methods	GEOSCIENCE DATA JOURNAL			English	Article						global climate; surface land temperature; statistical analysis	MINIMUM; PROJECT; MAXIMUM; MODEL	Described herein is the first version release of monthly temperature holdings of a new Global Land Surface Meteorological Databank. Organized under the auspices of the International Surface Temperature Initiative (ISTI), an international group of scientists have spent three years collating and merging data from numerous sources to create a merged holding. This release in its recommended form consists of over 30 000 individual station records, some of which extend over the past 300 years. This article describes the sources, the chosen merge methodology, and the resulting databank characteristics. Several variants of the databank have also been released that reflect the structural uncertainty in merging datasets. Variants differ in, for example, the order in which sources are considered and the degree of congruence required in station geolocation for consideration as a merged or unique record. Also described is a version control protocol that will be applied in the event of updates. Future updates are envisaged with the addition of new data sources, and with changes in processing, where public feedback is always welcomed. Major updates, when necessary, will always be accompanied by a new journal paper. This databank release forms the foundation for the construction of new global land surface air temperature analyses by the global research community and their assessment by the ISTI's benchmarking and assessment working group.	[Rennie, J. J.; Thorne, P. W.] N Carolina State Univ, Cooperat Inst Climate & Satellites NC, Asheville, NC 28804 USA; [Rennie, J. J.; Lawrimore, J. H.; Gleason, B. E.; Thorne, P. W.; Menne, M. J.; Williams, C. N.; Angel, W.; Diamond, H.; Vose, R. S.] NOAA, Natl Climat Data Ctr, Asheville, NC USA; [Thorne, P. W.] Nansen Environm & Remote Sensing Ctr, Bergen, Norway; [Morice, C. P.; Tandy, J.] Met Off Hadley Ctr, Exeter, Devon, England; [de Almeida, W. Gambi] Inst Nacl Pesquisas Espaciais, Ctr Previsao Tempo & Estudos Climat, Cachoeira Paulista, SP, Brazil; [Christy, J. R.] Univ Alabama, Huntsville, AL 35899 USA; [Flannery, M.] Bur Meteorol, Melbourne, Vic, Australia; [Ishihara, M.; Kamiguchi, K.] Japan Meteorol Agcy, Tokyo, Japan; [Klein-Tank, A. M. G.] Royal Netherlands Meteorol Inst KNMI, De Bilt, Netherlands; [Mhanda, A.] African Ctr Meteorol Applicat Dev, Niamey, Niger; [Lister, D. H.; Brunet, M.] Univ E Anglia, Climat Res Unit, Norwich NR4 7TJ, Norfolk, England; [Razuvaev, V.] Russian Res Inst Hydrometeorol Informat, Obninsk, Russia; [Renom, M.] Univ Republica, Montevideo, Uruguay; [Rusticucci, M.] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Worley, S. J.; Dattore, B.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Venema, V.] Univ Bonn, Meteorol Inst, Bonn, Germany; [Brunet, M.] Univ Rovira & Virgili, Ctr Climate Change, E-43007 Tarragona, Spain; [Lazzara, M. A.] Univ Wisconsin, Space Sci & Engn Ctr, Antarctic Meteorol Res Ctr, Madison, WI USA; [Le Blancq, F.] States Jersey Meteorol Dept, Jersey, NC USA; [Luterbacher, J.] Univ Giessen, Dept Geog, D-35390 Giessen, Germany; [Maechel, H.] Deutsch Wetterdiest DWD, Offenbach, Germany; [Revadekar, J.] Indian Inst Trop Meteorol, Ctr Climate Change Res, Pune, Maharashtra, India; [Yin, X.] ERT Inc, Asheville, NC USA	Rennie, JJ (reprint author), N Carolina State Univ, Cooperat Inst Climate & Satellites NC, Asheville, NC 28804 USA.	jared.rennie@noaa.gov	Thorne, Peter/F-2225-2014; Rennie, Jared/E-2984-2015	Thorne, Peter/0000-0003-0485-9798; Rennie, Jared/0000-0002-3316-9668	NOAA through the Cooperative Institute for Climate and Satellites - North Carolina [NA09NES4400006]; National Science Foundation, Office of Polar Programs [ANT-0944018, ANT-1141908]; Joint DECC/Defra Met Office Hadley Centre Climate Programme [GA01101]	This study was supported by NOAA through the Cooperative Institute for Climate and Satellites - North Carolina under Cooperative Agreement NA09NES4400006. We thank the many contributors of data, which made establishment of the databank possible. This includes many National Meteorological Agencies, who have provided data either directly towards the databank effort, or have provided data for input into products such as GHCN-M and GHCN-D. Special thanks go out to CICS-NC interns Jennifer Meyer and Andrew Rogers, who provided essential analysis towards the databank. We also thank members of the public who provided feedback during the beta release of the databank, including Nick Stokes (http://moyhu.blogspot.com/). We would like to thank NCDC's graphics team for providing Figures 2 and 5. Thanks to Richard Chandler, Scott Stevens, Blair Trewin, Jesse Bell, Scott Applequist and anonymous reviewers for providing comments on the paper. A portion of the Antarctic observations (Turner et al., 2004; Lazzara et al., 2012) is partially based on work support by the National Science Foundation, Office of Polar Programs under Grant ANT-0944018 and ANT-1141908. The work of Colin Morice is supported by the Joint DECC/Defra Met Office Hadley Centre Climate Programme (GA01101).	Turner J, 2004, J CLIMATE, V17, P2890, DOI 10.1175/1520-0442(2004)017<2890:TSRPTA>2.0.CO;2; Hansen J, 1999, J GEOPHYS RES-ATMOS, V104, P30997, DOI 10.1029/1999JD900835; Allan R, 2011, B AM METEOROL SOC, V92, P1421, DOI 10.1175/2011BAMS3218.1; WILLMOTT CJ, 1985, J GEOPHYS RES-OCEANS, V90, P8995, DOI 10.1029/JC090iC05p08995; Peterson TC, 1997, B AM METEOROL SOC, V78, P2837, DOI 10.1175/1520-0477(1997)078<2837:AOOTGH>2.0.CO;2; Compo GP, 2011, Q J ROY METEOR SOC, V137, P1, DOI 10.1002/qj.776; Legates DR, 1999, WATER RESOUR RES, V35, P233, DOI 10.1029/1998WR900018; Skansi MD, 2013, GLOBAL PLANET CHANGE, V100, P295, DOI 10.1016/j.gloplacha.2012.11.004; Camuffo D, 2012, CLIMATIC CHANGE, V111, P335, DOI 10.1007/s10584-011-0142-5; Menne MJ, 2009, B AM METEOROL SOC, V90, P993, DOI 10.1175/2008BAMS2613.1; Blunden J, 2013, B AM METEOROL SOC, V94, pS1, DOI 10.1175/2013BAMSStateoftheClimate.1; Jones PD, 2003, J CLIMATE, V16, P206, DOI 10.1175/1520-0442(2003)016<0206:HALSSA>2.0.CO;2; Williams CN, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016761; Smith A, 2011, B AM METEOROL SOC, V92, P704, DOI 10.1175/2011BAMS3015.1; Lazzara MA, 2012, B AM METEOROL SOC, V93, P1519, DOI 10.1175/BAMS-D-11-00015.1; [Anonymous], 2011, J GEOPHYS RES-ATMOS; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Trewin B, 2010, WIRES CLIM CHANGE, V1, P490, DOI 10.1002/wcc.46; Jones PD, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017139; Menne MJ, 2012, J ATMOS OCEAN TECH, V29, P897, DOI 10.1175/JTECH-D-11-00103.1; Caesar J, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006280; KARL TR, 1986, J CLIM APPL METEOROL, V25, P145, DOI 10.1175/1520-0450(1986)025<0145:AMTETT>2.0.CO;2; International Surface Temperature Initiative (ISTI), 2014, GLOB LAND SURF MET D, DOI [10.7289/V5PK0D3G, DOI 10.7289/V5PK0D3G]; JACCARD P., 1901, B SOC VAUD SCI NAT, V37, P547; Melillo JM, 2014, CLIMATE CHANGE IMPAC; Ropelewski CF, 1984, CLIMATE ANOMALY MONI; Stocker TF, 2013, CONTRIBUTION WORKING, P187; Thorne P. W., 2011, B AM METEOROL SOC, V92, pES40, DOI [10.1175/2011BAMMS3124.1, DOI 10.1175/2011BAMS3124.1, 10.1175/2011BAMS3124.1]; Vose RS, 1992, ORNLCDIAC53; Willmott C.J., 1981, PHYS GEOG, V2, P184, DOI DOI 10.1080/02723646.1981.10642213; WMO, 2011, GUID CLIM PRAT	31	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2049-6060			GEOSCI DATA J	Geosci. Data J.	NOV	2014	1	2					75	102		10.1002/gdj3.8		28	Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences	Geology; Meteorology & Atmospheric Sciences	CV4ES	WOS:000364219800001		
J	Sugi, T; Masatani, T; Murakoshi, F; Kawazu, SI; Kato, K				Sugi, Tatsuki; Masatani, Tatsunori; Murakoshi, Fumi; Kawazu, Shin-Ichiro; Kato, Kentaro			Microplate assay for screening Toxoplasma gondii bradyzoite differentiation with DUAL luciferase assay	ANALYTICAL BIOCHEMISTRY			English	Article						Bradyzoite; DUAL luciferase assay; High-throughput screening; Reporter parasite; Toxoplasma gondii	IN-VIVO; PROTEIN-KINASE; IDENTIFICATION; INHIBITOR; 1NM-PP1; INFECTION; VITRO	Toxoplasma gondii can differentiate into tachyzoites or bradyzoites. To accelerate the investigation of bradyzoite differentiation mechanisms, we constructed a reporter parasite, PLK/DLUC_1C9, for a high-throughput assay. PLK/DLUC_1C9 expressed firefly luciferase under the bradyzoite-specific BAG1 promoter. Firefly luciferase activity was detected with a minimum of 102 parasites induced by pH 8.1. To normalize bradyzoite differentiation, PLK/DLUC1_C9 expressed Renilla luciferase under the parasite's a-tubulin promoter. Renilla luciferase activity was detected with at least 102 parasites. By using PLK/DLUC_1C9 with this 96-well format screening system, we found that the protein kinase inhibitor analogs, bumped kinase inhibitors 1NM-PP1, 3MB-PP1, and 3BrB-PP1, had bradyzoite-inducing effects. (C) 2014 Elsevier Inc. All rights reserved.	[Sugi, Tatsuki; Masatani, Tatsunori; Murakoshi, Fumi; Kawazu, Shin-Ichiro; Kato, Kentaro] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan; [Masatani, Tatsunori] Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Ctr, Kagoshima 8900065, Japan; [Murakoshi, Fumi; Kato, Kentaro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Bunkyo Ku, Tokyo 1138657, Japan	Kato, K (reprint author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan.	kkato@obihiro.ac.jp			Japan Society for the Promotion of Science (JSPS) [24780295, 26850183]; Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan [3308]; Program for the Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry; Program to Disseminate Tenure Tracking System from the Japan Science and Technology Agency (JST)	PLK/hxgprt<SUP>-</SUP> was obtained through the AIDS Reagent Program, Division of AIDS, National Institute of Allergies and Infectious Diseases (NIAID), National Institutes of Health (NIH), from David Roos. SalmonE monoclonal antibody was a kind gift from Louis M. Weiss. We thank T. Tomita for technical advice regarding cyst wall staining. T.S. and F.M. were supported by a Japan Society for the Promotion of Science (JSPS) Research Fellowship for Young Scientists. K.K. was supported by Grants-in-Aid for Young Scientists, Exploratory Research, Scientific Research on Innovative Areas (3308) from the Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan, the Program for the Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN), the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry, and the Program to Disseminate Tenure Tracking System from the Japan Science and Technology Agency (JST). T.M. was supported by JSPS KAKENHI grants (24780295 and 26850183).	Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; Buchholz KR, 2011, EUKARYOT CELL, V10, P1637, DOI 10.1128/EC.05182-11; Sugi T, 2010, EUKARYOT CELL, V9, P667, DOI 10.1128/EC.00351-09; Behnke MS, 2008, MOL MICROBIOL, V68, P1502, DOI 10.1111/j.1365-2958.2008.06249.x; Lourido S, 2013, J MED CHEM, V56, P3068, DOI 10.1021/jm4001314; Di Cristina M, 2008, INFECT IMMUN, V76, P3491, DOI 10.1128/IAI.00254-08; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Carlier Y, 2012, ACTA TROP, V121, P55, DOI 10.1016/j.actatropica.2011.10.018; Brumlik MJ, 2004, INT J PARASITOL, V34, P1245, DOI 10.1016/j.ijpara.2004.07.007; da Silva MDF, 2008, MOL BIOSYST, V4, P824, DOI 10.1039/b800520f; Doggett JS, 2014, ANTIMICROB AGENTS CH, V58, P3547, DOI 10.1128/AAC.01823-13; Narasimhan J, 2008, J BIOL CHEM, V283, P16591, DOI 10.1074/jbc.M800681200; Ojo KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092929; Ojo KK, 2014, J INFECT DIS, V209, P275, DOI 10.1093/infdis/jit522; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Sugi T, 2011, J VET MED SCI, V73, P1377, DOI 10.1292/jvms.11-0085; Sugi T, 2013, INT J PARASITOL-DRUG, V3, P93, DOI 10.1016/j.ijpddr.2013.04.001; Tomita T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003823; Unno A, 2009, Parasitology, V136, P579, DOI 10.1017/S0031182009005836; Wulf MWH, 2005, J CLIN MICROBIOL, V43, P3544, DOI 10.1128/JCM.43.7.3544-3547.2005; Zhang HS, 2013, EXP PARASITOL, V134, P275, DOI 10.1016/j.exppara.2013.03.015	21	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-2697	1096-0309		ANAL BIOCHEM	Anal. Biochem.	NOV 1	2014	464						9	11		10.1016/j.ab.2014.06.018		3	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	AQ1MI	WOS:000342545100002		
J	Niwa, K; Oribe, A; Okumura, H; Shimono, M; Nagai, K; Hirota, T; Yasue, H; Kawase, M				Niwa, Kousuke; Oribe, Akinobu; Okumura, Hidemasa; Shimono, Masahiro; Nagai, Kenkichi; Hirota, Toshikazu; Yasue, Hiroshi; Kawase, Mitsuo			Tag/hybridization-based sensitive detection of polymerase chain reaction products	ANALYTICAL BIOCHEMISTRY			English	Article						Single-stranded DNA tag; Non-nucleic acid spacer; DNA microarray; Hybridization; Fluorescence label	ENZYMATIC AMPLIFICATION; DNA INVITRO; ASSAY; ELECTROPHORESIS; POLYMORPHISM; DIAGNOSIS	The polymerase chain reaction (PCR) is an important technology to amplify a single copy or a few copies of DNA segment in genomic DNAs, visualizing the segment as DNA fragment. Thus, PCR is frequently used in various examinations such as detection of bacteria and fungi in the food industry. Here, we report a simple and sensitive method for detection of PCR products using single-strand tag sequence and hybridization of the tag sequence to the complementary tag sequence immobilized on solid material (STH). The detection sensitivity was found to be at least 50 times higher than electrophoresis/ethidium bromide (EtBr) visualization for approximately a 500-bp fragment and higher than the ordinary hybridization, that is, hybridization of denatured PCR product to probe sequence immobilized on solid material. (C) 2014 Elsevier Inc. All rights reserved.	[Niwa, Kousuke; Oribe, Akinobu; Okumura, Hidemasa; Shimono, Masahiro; Nagai, Kenkichi; Hirota, Toshikazu; Kawase, Mitsuo] NGK Insulators, Corp R&D, Future Technol Management Ctr, Nagoya, Aichi 4678530, Japan; [Yasue, Hiroshi] Tsukuba Gene Technol Labs, Ibaraki 3000873, Japan; [Kawase, Mitsuo] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 9808579, Japan	Niwa, K (reprint author), NGK Insulators, Corp R&D, Future Technol Management Ctr, Nagoya, Aichi 4678530, Japan.	kniwa@ngk.co.jp					Nishida N, 2007, ANAL BIOCHEM, V364, P78, DOI 10.1016/j.ab.2007.02.005; MCCANN J, 1975, P NATL ACAD SCI USA, V72, P5135, DOI 10.1073/pnas.72.12.5135; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; Saez R, 2004, MEAT SCI, V66, P659, DOI 10.1016/S0309-1740(03)00186-4; SHARP PA, 1973, BIOCHEMISTRY-US, V12, P3055, DOI 10.1021/bi00740a018; THIERRY D, 1990, J CLIN MICROBIOL, V28, P2668; GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725; Singer VL, 1999, MUTAT RES-GEN TOX EN, V439, P37, DOI 10.1016/S1383-5718(98)00172-7; GOTTLIEB M, 1987, ANAL BIOCHEM, V165, P33, DOI 10.1016/0003-2697(87)90197-7; Huang Q, 2005, CLIN CHEM LAB MED, V43, P841, DOI 10.1515/CCLM.2005.141; INOKO H, 1986, HUM IMMUNOL, V16, P304, DOI 10.1016/0198-8859(86)90058-3; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263; NEWTON CR, 1993, NUCLEIC ACIDS RES, V21, P1155, DOI 10.1093/nar/21.5.1155; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; TAKEWAKI S, 1993, J CLIN MICROBIOL, V31, P446	16	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-2697	1096-0309		ANAL BIOCHEM	Anal. Biochem.	NOV 1	2014	464						12	16		10.1016/j.ab.2014.07.010		5	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	AQ1MI	WOS:000342545100003		
J	El-Maghrabey, MH; Kishikawa, N; Ohyama, K; Kuroda, N				El-Maghrabey, Mahmoud H.; Kishikawa, Naoya; Ohyama, Kaname; Kuroda, Naotaka			Analytical method for lipoperoxidation relevant reactive aldehydes in human sera by high-performance liquid chromatography-fluorescence detection	ANALYTICAL BIOCHEMISTRY			English	Article						Lipoperoxidation; Aldehydes; HPLC-fluorescence detection; 2,2 '-Furil; Diabetes; Rheumatoid arthritis	OXIDATIVE STRESS; RHEUMATOID-ARTHRITIS; LIPID-PEROXIDATION; MASS-SPECTROMETRY; PLASMA; ACROLEIN; MALONDIALDEHYDE; DERIVATIZATION; DISEASE; METHYLGLYOXAL	A validated, simple and sensitive HPLC method was developed for the simultaneous determination of lipoperoxidation relevant reactive aldehydes: glyoxal (GO), acrolein (ACR), malondialdehyde (MDA), and 4-hydroxy-2-nonenal (HNE) in human serum. The studied aldehydes were reacted with 2,2'-furil to form fluorescent difurylimidazole derivatives that were separated on a C-18 column using gradient elution and fluorescence detection at excitation and emission wavelengths of 250 and 355 nm, respectively. The method showed good linearity over the concentration ranges of 0.100-5.00, 0.200-10.0, 0.200-40.0, and 0.400-10.0 nmol/mL for GO, ACR, HNE, and MDA, respectively, with detection limits ranging from 0.030 to 0.11 nmol/mL. The percentage RSD of intraday and interday precision did not exceed 5.0 and 6.2%, respectively, and the accuracy (%found) ranged from 95.5 to 103%. The proposed method was applied for monitoring the four aldehydes in sera of healthy, diabetic, and rheumatic human subjects with simple pretreatment steps and without interference from endogenous components. By virtue of its high sensitivity and accuracy, our method enabled detection of differences between analytes concentrations in sera of human subjects under different clinical conditions. (C) 2014 Elsevier Inc. All rights reserved.	[El-Maghrabey, Mahmoud H.; Kishikawa, Naoya; Ohyama, Kaname; Kuroda, Naotaka] Nagasaki Univ, Grad Sch Biomed Sci, Course Pharmaceut Sci, Nagasaki 8528521, Japan; [El-Maghrabey, Mahmoud H.] Mansoura Univ, Fac Pharm, Dept Analyt Chem, Mansoura 35516, Egypt	Kuroda, N (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Course Pharmaceut Sci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	n-kuro@nagasaki-u.ac.jp					Ali MFB, 2013, J CHROMATOGR A, V1300, P199, DOI 10.1016/j.chroma.2013.03.033; Touyz RM, 2004, HYPERTENSION, V44, P248, DOI 10.1161/01.HYP.0000138070.47616.9d; Gambhir JK, 1997, CLIN BIOCHEM, V30, P351, DOI 10.1016/S0009-9120(96)00007-0; Shibamoto T, 2006, J PHARMACEUT BIOMED, V41, P12, DOI 10.1016/j.jpba.2006.01.047; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Stevens JF, 2008, MOL NUTR FOOD RES, V52, P7, DOI 10.1002/mnfr.200700412; Ozkan Y, 2007, CLIN RHEUMATOL, V26, P64, DOI 10.1007/s10067-006-0244-z; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Eggink M, 2008, ANAL CHEM, V80, P9042, DOI 10.1021/ac801429w; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Sakata K, 2003, BIOCHEM BIOPH RES CO, V305, P143, DOI 10.1016/S0006-291X(03)00716-2; Delgado M, 2013, RSC ADV, V3, P23057, DOI 10.1039/c3ra44669g; Santaniello E, 2007, REDOX REP, V12, P55, DOI 10.1179/135100007X162293; Andreoli R, 2003, RAPID COMMUN MASS SP, V17, P637, DOI 10.1002/rcm.960; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; Giera M, 2012, CHROMATOGRAPHIA, V75, P433, DOI 10.1007/s10337-012-2237-1; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P29, DOI 10.1161/01.ATV.0000150649.39934.13; Ellis EM, 2007, PHARMACOL THERAPEUT, V115, P13, DOI 10.1016/j.pharmthera.2007.03.015; Han Y, 2007, MOL CELL BIOCHEM, V305, P123, DOI 10.1007/s11010-007-9535-1; Niedowicz DM, 2005, CELL BIOCHEM BIOPHYS, V43, P289, DOI 10.1385/CBB:43:2:289; Bohnenstengel F, 1997, J CHROMATOGR B, V692, P163, DOI 10.1016/S0378-4347(96)00457-4; Cooley JC, 2011, ELECTROPHORESIS, V32, P2994, DOI 10.1002/elps.201100143; Espinosa-Mansilla A, 2007, ANAL BIOCHEM, V371, P82, DOI 10.1016/j.ab.2007.07.028; [Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) US Department of Health and Human Services], GUID IND BIOAN METH; FURUMITSU Y, 1993, J RHEUMATOL, V20, P1661; HICKS M, 1988, BIOCHEM BIOPH RES CO, V151, P649, DOI 10.1016/S0006-291X(88)80330-9; Kobayashi K, 2008, J TOXICOL SCI, V33, P97, DOI 10.2131/jts.33.97; Li D, 2006, TOXICOLOGY, V226, P172, DOI 10.1016/j.tox.2006.06.013; Miyake T, 1996, FOOD CHEM TOXICOL, V34, P1009, DOI 10.1016/S0278-6915(96)00063-4; Ojeda A.G., 2013, ANAL BIOCHEM, V449, P52; Paci A, 2000, J CHROMATOGR B, V739, P239, DOI 10.1016/S0378-4347(99)00485-5; Sim AS, 2003, J CHROMATOGR B, V785, P337, DOI 10.1016/S1570-0232(02)00956-X; STROHMAIER H, 1995, J LIPID MEDIAT CELL, V11, P51, DOI 10.1016/0929-7855(94)00027-A; Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4; Wang S. J., 2011, EUR J CHEM, V2, P173, DOI 10.5155/eurjchem.2.2.173-177.283; WHITE JS, 1984, CHEM-BIOL INTERACT, V52, P233, DOI 10.1016/0009-2797(84)90076-0; Wu MY, 2008, J CHROMATOGR A, V1204, P81, DOI 10.1016/j.chroma.2008.07.040; Zardari LA, 2009, CHROMATOGRAPHIA, V70, P891, DOI 10.1365/s10337-009-1202-0; Zhang DM, 2010, ANAL BIOANAL CHEM, V398, P3193, DOI 10.1007/s00216-010-4225-3; Zhang GB, 2013, ANAL BIOCHEM, V443, P16, DOI 10.1016/j.ab.2013.08.011	40	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-2697	1096-0309		ANAL BIOCHEM	Anal. Biochem.	NOV 1	2014	464						36	42		10.1016/j.ab.2014.07.002		7	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	AQ1MI	WOS:000342545100007		
J	Takamitsu, E; Fukunaga, K; Iio, Y; Moriya, K; Utsumi, T				Takamitsu, Emi; Fukunaga, Kazuki; Iio, Yusuke; Moriya, Koko; Utsumi, Toshihiko			Cell-free identification of novel N-myristoylated proteins from complementary DNA resources using bioorthogonal myristic acid analogues	ANALYTICAL BIOCHEMISTRY			English	Article						N-myristoylation; Cell-free protein synthesis system; Click chemistry; Metabolic labeling	SYNTHESIS SYSTEM; TERMINAL ALKYNES; FATTY-ACYLATION; RAT-LIVER; MYRISTOYLTRANSFERASE; MITOCHONDRIA; TRANSLATION; ENZYMOLOGY; APOPTOSIS; CLEAVAGE	To establish a non-radioactive, cell-free detection system for protein N-myristoylation, metabolic labeling in a cell-free protein synthesis system using bioorthogonal myristic acid analogues was performed. After Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) with a biotin tag, the tagged proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and blotted on a polyvinylidene fluoride (PVDF) membrane, and then protein N-myristoylation was detected by enhanced chemiluminescence (ECL) using horseradish peroxidase (HRP)-conjugated streptavidin. The results showed that metabolic labeling in an insect cell-free protein synthesis system using an azide analogue of myristic acid followed by CuAAC with alkynyl biotin was the most effective strategy for cell-free detection of protein N-myristoylation. To determine whether the newly developed detection method can be applied for the detection of novel N-myristoylated proteins from complementary DNA (cDNA) resources, four candidate cDNA clones were selected from a human cDNA resource and their susceptibility to protein N-myristoylation was evaluated using the newly developed strategy. As a result, the products of three cDNA clones were found to be novel N-myristoylated protein, and myristoylation-dependent specific intracellular localization was observed for two novel N-myristoylated proteins. Thus, the metabolic labeling in an insect cell-free protein synthesis system using bioorthogonal azide analogue of myristic acid was an effective strategy to identify novel N-myristoylated proteins from cDNA resources. (C) 2014 Elsevier Inc. All rights reserved.	[Takamitsu, Emi; Fukunaga, Kazuki; Iio, Yusuke; Moriya, Koko; Utsumi, Toshihiko] Yamaguchi Univ, Grad Sch Med, Yamaguchi 7538515, Japan; [Utsumi, Toshihiko] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 7538515, Japan	Utsumi, T (reprint author), Yamaguchi Univ, Grad Sch Med, Yamaguchi 7538515, Japan.	utsumi@yamaguchi-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23580136, 26450125]	This work was supported in part by Grants-in-Aid for Scientific Research (23580136 and 26450125) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T.U.).	Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Moriya K, 2012, BIOSCI BIOTECH BIOCH, V76, P1201, DOI 10.1271/bbb.120069; Utsumi T, 2001, J BIOL CHEM, V276, P10505, DOI 10.1074/jbc.M006134200; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Utsumi T, 2003, FEBS LETT, V539, P37, DOI 10.1016/S0014-5793(03)00180-7; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Maurer-Stroh S, 2002, J MOL BIOL, V317, P523, DOI 10.1006/jmbi.2001.5425; Heal WP, 2008, ORG BIOMOL CHEM, V6, P2308, DOI 10.1039/b803258k; Bologna G, 2004, PROTEOMICS, V4, P1626, DOI 10.1002/pmic.200300783; DEICHAITE I, 1988, MOL CELL BIOL, V8, P4295; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; JACKSON RJ, 1983, METHOD ENZYMOL, V96, P50; Vilas GL, 2006, P NATL ACAD SCI USA, V103, P6542, DOI 10.1073/pna5.0600824103; Sakurai N, 2006, J BIOL CHEM, V281, P14288, DOI 10.1074/jbc.M510338200; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/nmeth.1293, 10.1038/NMETH.1293]; TOWLER DA, 1988, J BIOL CHEM, V263, P1784; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Martin DDO, 2008, FASEB J, V22, P797, DOI 10.1096/fj.07-9198com; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69; Maurer-Stroh S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r21; Cheng TM, 2011, FREE RADICAL RES, V45, P303, DOI 10.3109/10715762.2010.532492; Griffin R J, 1994, Prog Med Chem, V31, P121, DOI 10.1016/S0079-6468(08)70020-1; Kitamura S, 2002, DRUG METAB DISPOS, V30, P414, DOI 10.1124/dmd.30.4.414; Moriya K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078235; ROCQUE WJ, 1993, J BIOL CHEM, V268, P9964; Sakurai N, 2007, ANAL BIOCHEM, V362, P236, DOI 10.1016/j.ab.2006.12.030; SPIEGEL AM, 1991, TRENDS BIOCHEM SCI, V16, P338, DOI 10.1016/0968-0004(91)90139-M; Suzuki T, 2006, J BIOSCI BIOENG, V102, P69, DOI 10.1263/jbb.102.69; Suzuki T, 2010, PROTEOMICS, V10, P1780, DOI 10.1002/pmic.200900783	36	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-2697	1096-0309		ANAL BIOCHEM	Anal. Biochem.	NOV 1	2014	464						83	93		10.1016/j.ab.2014.07.006		11	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	AQ1MI	WOS:000342545100014		
J	Kanamori, T; Fujisawa, H				Kanamori, Takafumi; Fujisawa, Hironori			Affine invariant divergences associated with proper composite scoring rules and their applications	BERNOULLI			English	Article						affine invariance; Bregman score; composite scoring rule; divergence; Holder score	ROBUST; PARAMETER; GEOMETRY	In statistical analysis, measuring a score of predictive performance is an important task. In many scientific fields, appropriate scoring rules were tailored to tackle the problems at hand. A proper scoring rule is a popular tool to obtain statistically consistent forecasts. Furthermore, a mathematical characterization of the proper scoring rule was studied. As a result, it was revealed that the proper scoring rule corresponds to a Bregman divergence, which is an extension of the squared distance over the set of probability distributions. In the present paper, we introduce composite scoring rules as an extension of the typical scoring rules in order to obtain a wider class of probabilistic forecasting. Then, we propose a class of composite scoring rules, named Holder scores, that induce equivariant estimators. The equivariant estimators have a favorable property, implying that the estimator is transformed in a consistent way, when the data is transformed. In particular, we deal with the affine transformation of the data. By using the equivariant estimators under the affine transformation, one can obtain estimators that do no essentially depend on the choice of the system of units in the measurement. Conversely, we prove that the Holder score is characterized by the invariance property under the affine transformations. Furthermore, we investigate statistical properties of the estimators using Holder scores for the statistical problems including estimation of regression functions and robust parameter estimation, and illustrate the usefulness of the newly introduced scoring rules for statistical forecasting.	[Kanamori, Takafumi] Nagoya Univ, Dept Comp Sci & Math Informat, Nagoya, Aichi 4648601, Japan; [Fujisawa, Hironori] Inst Stat Math, Tokyo 1908562, Japan	Kanamori, T (reprint author), Nagoya Univ, Dept Comp Sci & Math Informat, Nagoya, Aichi 4648601, Japan.	kanamori@is.nagoya-u.ac.jp; fujisawa@ism.ac.jp			JSPS KAKENHI [24500340]	The authors are grateful to the anonymous reviewers for their helpful comments. TK was partially supported by JSPS KAKENHI Grant Number 24500340.	Abernethy J. D., 2012, J MACH LEARN RES WOR, V23, P271; Banerjee A, 2005, J MACH LEARN RES, V6, P1705; Jones MC, 2001, BIOMETRIKA, V88, P865, DOI 10.1093/biomet/88.3.865; Murata N, 2004, NEURAL COMPUT, V16, P1437, DOI 10.1162/089976604323057452; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437; Cichocki A, 2010, ENTROPY-SWITZ, V12, P1532, DOI 10.3390/e12061532; Basu A, 1998, BIOMETRIKA, V85, P549, DOI 10.1093/biomet/85.3.549; Fujisawa H, 2008, J MULTIVARIATE ANAL, V99, P2053, DOI 10.1016/j.jmva.2008.02.004; Tsuda K, 2005, J MACH LEARN RES, V6, P995; Berger J.O., 1985, STAT DECISION THEORY; Bregman L. M., 1967, VYCISL MAT MAT FIZ, V7, P620; Bremnes B. J., 2004, MON WEATHER REV, V132, P338; Brier G. W., 1950, MONTHLY WEATHER REVI, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; Collins M., 2000, P 13 ANN C COMP LEAR, P158; COVER T. M., 2006, ELEMENTS INFORM THEO, V2nd; Dawid A. P., 1998, COHERENT MEASURES DI; Dawid A.P., 2012, ANN STAT, V40, P593; Dawid AP, 2007, ANN I STAT MATH, V59, P77, DOI 10.1007/s10463-006-0099-8; Duffie D., 1997, J DERIV, V4, P7, DOI 10.3905/jod.1997.407971; Eguchi S, 2011, ENTROPY-SWITZ, V13, P1746, DOI 10.3390/e13101746; Ehm W, 2012, ANN STAT, V40, P609, DOI 10.1214/12-AOS973; Fabian M., 2001, CMS BOOKS MATH, V8; Good I. J., 1971, FDN STAT INFERENCE, P337; Grunwald P.D., 2004, ANN STAT, V32, P1367; Hampel F.R., 1986, WILEY SERIES PROBABI; HENDRICK.AD, 1971, ANN MATH STAT, V42, P1916, DOI 10.1214/aoms/1177693057; Maronna R. A., 2006, WILEY SERIES PROBABI; Park C., 2011, MONOGRAPHS STAT APPL, V120; Parry M, 2012, ANN STAT, V40, P561, DOI 10.1214/12-AOS971; VAN DER VAART A. W., 1998, CAMBRIDGE SERIES STA, V3; Zhu Q. J., 2005, CMS BOOKS MATH, V20	33	1	1	INT STATISTICAL INST	VOORBURG	428 PRINSES BEATRIXLAAN, 2270 AZ VOORBURG, NETHERLANDS	1350-7265	1573-9759		BERNOULLI	Bernoulli	NOV	2014	20	4					2278	2304		10.3150/13-BEJ557		27	Statistics & Probability	Mathematics	AQ1LG	WOS:000342542300021		
J	Okamura, H; Yang, D; Yoshida, K; Teramachi, J; Haneji, T				Okamura, Hirohiko; Yang, Di; Yoshida, Kaya; Teramachi, Jumpei; Haneji, Tatsuji			Reduction of PP2A C alpha stimulates adipogenesis by regulating the Wnt/GSK-3 beta/beta-catenin pathway and PPAR gamma expression	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						Protein phosphatase 2A; Adipogenesis; Wnt/GSK-3 beta/beta-catenin; PPAR gamma	PROTEIN PHOSPHATASE 2A; BETA-CATENIN; ADIPOCYTE DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; SIGNALING COMPONENTS; TRANSCRIPTION FACTOR; ADIPOSE-TISSUES; BONE MASS; INSULIN; WNT10B	Serine/threonine protein phosphatase 2A (PP2A) regulates several physiological processes such as the cell cycle, cell growth, apoptosis, and signal transduction. In this study, we examined the expression and role of PP2A C alpha in adipocyte differentiation. PP2A C alpha expression and PP2A activity decreased during adipocyte differentiation in C3H10T1/2 and 3T3-L1 cells and the expression of adipocyte marker genes such as PPAR gamma and adiponectin increased. To further clarify the role of PP2A C alpha in adipocyte differentiation, we constructed PP2A knockdown cells by infecting C3H10T1/2 cells with a lentivirus expressing a shRNA specific for the PP2A C alpha (shPP2A cells). Silencing of PP2A C alpha in C3H10T1/2 cells dramatically stimulated adipocyte differentiation and lipid accumulation, which were accompanied by expression of adipocyte marker genes. Silencing of PP2A C alpha suppressed Wnt10b expression and reduced the levels of the inactivated form of GSK-3 beta (phospho-GSK-3 beta), leading to the reduction of beta-catenin levels in the nucleus and its transcriptional activity. Treatment with LiCl, a GSK-3 beta inhibitor, and inhibition of PPAR gamma expression suppressed the accelerated adipogenesis of shPP2A cells. Our data indicate that PP2A C alpha plays an important role in the regulation of adipocyte differentiation by regulating the Wnt/GSK-3 beta/beta-catenin pathway and PPAR gamma expression. (C) 2014 Published by Elsevier B.V.	[Okamura, Hirohiko; Yang, Di; Teramachi, Jumpei; Haneji, Tatsuji] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Histol & Oral Histol, Tokushima 7708504, Japan; [Yoshida, Kaya] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Tokushima 7708504, Japan	Okamura, H (reprint author), 3-18-15 Kuramoto, Tokushima 7708504, Japan.	okamura@tokushima-u.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [23592703]; Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care; Takeda Science Foundation	We would like to thank Ms. E. Sasaki for her skillful technical assistance. We also thank the Support Center for Advanced Medical Sciences, Institute of Health Biosciences, the University of Tokushima Graduate School, for technical support. This study was supported by grants from the Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan (23592703, HO), the Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care, and Takeda Science Foundation.	Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Modica S, 2013, BBA-MOL CELL BIOL L, V1831, P915, DOI 10.1016/j.bbalip.2013.01.010; Gotz J, 2000, MECH DEVELOP, V93, P83, DOI 10.1016/S0925-4773(00)00267-7; Okamura H, 2011, BONE, V49, P368, DOI 10.1016/j.bone.2011.06.004; Gotz J, 2003, METHOD ENZYMOL, V366, P390; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Vural B, 2008, CARDIOVASC PATHOL, V17, P392, DOI 10.1016/j.carpath.2008.02.006; Lyon CJ, 2003, ENDOCRINOLOGY, V144, P2195, DOI 10.1210/en.2003-0285; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Shin J, 2009, J ANIM SCI, V87, P3923, DOI 10.2527/jas.2009-2124; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Naito M, 2012, HISTOCHEM CELL BIOL, V138, P833, DOI 10.1007/s00418-012-1007-3; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Li HX, 2008, MOL CELL ENDOCRINOL, V291, P116, DOI 10.1016/j.mce.2008.05.005; Okamura H, 2013, J CELL PHYSIOL, V228, P1031, DOI 10.1002/jcp.24250; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Bauche IB, 2007, ENDOCRINOLOGY, V148, P1539, DOI 10.1210/en.2006-0838; Begum N, 1999, BIOCHEM J, V344, P895, DOI 10.1042/0264-6021:3440895; Cho YM, 2013, FEBS LETT, V587, P1644, DOI 10.1016/j.febslet.2013.04.005; Hojlund K, 2002, EUR J CLIN INVEST, V32, P918, DOI 10.1046/j.1365-2362.2002.01098.x; Okamura H, 2013, FEBS LETT, V587, P48, DOI 10.1016/j.febslet.2012.10.041; Ragolia L, 1998, MOL CELL BIOCHEM, V182, P49, DOI 10.1023/A:1006827227162; Rahman S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051746; Shi YG, 2009, SCI CHINA SER C, V52, P135, DOI 10.1007/s11427-009-0018-3	40	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	NOV	2014	1843	11					2376	2384		10.1016/j.bbamcr.2014.06.008		9	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	AQ1FR	WOS:000342527800002		
J	Lampiasi, N; Umezawa, K; Montalto, G; Cervello, M				Lampiasi, Nadia; Umezawa, Kazuo; Montalto, Giuseppe; Cervello, Melchiorre			Poly (ADP-ribose) polymerase inhibition synergizes with the NF-kappa B inhibitor DHMEQ to kill hepatocellular carcinoma cells	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						DHMEQ; Olaparib; NF-kappa B; Hepatocellular carcinoma cell; Rad51; AKT	LIVER-CANCER CELLS; POLY(ADP-RIBOSE) POLYMERASE; BREAST-CANCER; HOMOLOGOUS RECOMBINATION; DEPENDENT MECHANISM; INDUCED AUTOPHAGY; PARP INHIBITORS; DNA-DAMAGE; APOPTOSIS; DEHYDROXYMETHYLEPOXYQUINOMICIN	Poly (ADP-ribose) polymerase (PARP) enzymes play a key role in the cellular machinery responsible for DNA repair. Dehydroxymethylepoxyquinomicin (DHMEQ), a new inhibitor of NF-kappa B, induces oxidative stress and DNA damage. The effects of DHMEQ in combination with Olaparib (PARP inhibitor) were studied on hepatocellular carcinoma (HCC) cells. The DHMEQ-Olaparib combination synergistically inhibited cell viability, cell proliferation and colony formation of Hep3B, but had additive effects on Huh7 cells. The synergistic effects of the combination correlated with increased apoptosis, caspase 3/7 activity and PARP cleavage. There was an induction of an endoplasmic reticulum (ER) stress response with significant up-regulation of CHOP and TRB3 genes and splicing of XBP1 mRNA in Hep3B cells but not in Huh7 cells. Silencing of the TRB3 mRNA in Hep3B cells reversed the reduction in viability caused by DHMEQ-Olaparib treatment, while depletion of unspliced XBP1 mRNA in DHMEQ-Olaparib-treated Huh7 cells reduced viability. ROS production was increased after DHMEQ-Olaparib treatment of Hep3B, which caused DNA damage by an accumulation of gamma H2AX, increased AKT phosphorylation and reduced cell viability. The combination reduced Rad51 nuclear foci in Hep3B cells (not Huh7 cells), and silencing of Rad51 enhanced sensitivity of Huh7 cells to the DHMEQ-Olaparib combination. Knockdown of AKT in Hep3B cells restored the number of Rad51 nuclear foci after DHMEQ-Olaparib treatment. In summary, the DHMEQ-Olaparib combination induced ROS production, which killed HCC cells via DNA damage that could not be repaired by Rad51. PARPs and NF-kappa B are frequently deregulated in HCC. The DHMEQ-Olaparib combination exerted synergistic antitumour effects on HCC cells through ROS production via DNA damage that could not be repaired by Rad51. This suggested that the DHMEQ-Olaparib combination could be used to treat tumours that were resistant to Olaparib treatment. (C) 2014 Elsevier B.V. All rights reserved.	[Lampiasi, Nadia; Cervello, Melchiorre] CNR, Inst Biomed & Mol Immunol Alberto Monroy, I-90146 Palermo, Italy; [Umezawa, Kazuo] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, Yokohama, Kanagawa, Japan; [Montalto, Giuseppe] Univ Palermo, Biomed Dept Internal Med & Specialties, I-90127 Palermo, Italy	Lampiasi, N (reprint author), CNR, Inst Biomed & Mol Immunol Alberto Monroy, Via Ugo La Malfa 153, I-90146 Palermo, Italy.	lampiasi@ibim.cnr.it		MONTALTO, Giuseppe/0000-0002-8731-8577	Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)" FIRB-MERIT [RBNE08YYBM]; CNR from the Italian Ministry of Economy; Finance for the Project FaReBio di Qualita	This work was supported in part by grants from the Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)" FIRB-MERIT [RBNE08YYBM] to M.C. and G.M.; M.C. has also been supported in part by a grant to the CNR from the Italian Ministry of Economy and Finance for the Project FaReBio di Qualita.	Min A, 2013, MOL CANCER THER, V12, P865, DOI 10.1158/1535-7163.MCT-12-0950; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Guo XL, 2012, CANCER LETT, V320, P171, DOI 10.1016/j.canlet.2012.03.002; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Lampiasi N, 2012, CANCER LETT, V322, P35, DOI 10.1016/j.canlet.2012.02.008; Lampiasi N, 2009, MOL PHARMACOL, V76, P290, DOI 10.1124/mol.109.055418; Bundred N, 2013, INVEST NEW DRUG, V31, P949, DOI 10.1007/s10637-012-9922-7; Sunayama J, 2004, CELL DEATH DIFFER, V11, P771, DOI 10.1038/sj.cdd.4401418; Shimizu S, 2004, ONCOL REP, V12, P821; Noel G, 2006, MOL CANCER THER, V5, P564, DOI 10.1158/1535-7163.MCT-05-0418; Gong K, 2012, J BIOL CHEM, V287, P35576, DOI 10.1074/jbc.M112.370585; Drew Y, 2009, DRUG RESIST UPDATE, V12, P153, DOI 10.1016/j.drup.2009.10.001; Plo I, 2008, CANCER RES, V68, P9404, DOI 10.1158/0008-5472.CAN-08-0861; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Rodriguez-Vargas JM, 2012, CELL RES, V22, P1181, DOI 10.1038/cr.2012.70; Lou ZY, 2013, J INT MED RES, V41, P1505, DOI 10.1177/0300060513490618; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Wyrsch P, 2012, MOL CELL BIOL, V32, P3541, DOI 10.1128/MCB.00437-12; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Chuang HC, 2012, BREAST CANCER RES TR, V134, P649, DOI 10.1007/s10549-012-2106-5; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Zhao Y, 2013, CELL RES, V23, P491, DOI 10.1038/cr.2013.2; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Zhang JX, 2012, HEPATOLOGY, V55, P1840, DOI 10.1002/hep.25566; Liu P, 2002, J HEPATOL, V37, P63, DOI 10.1016/S0168-8278(02)00064-8; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; Das Gupta S, 2013, LIFE SCI, V93, P271, DOI 10.1016/j.lfs.2013.06.022; Hu M., 2013, ONCOL REP, V31, P649; Kummar S, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-25; Minami D., 2012, MOL CANCER RES, V11, P140; Mukherjee A., 2012, MOL CARCINOG, V52, P611; Nishimura D, 2006, INT J ONCOL, V29, P713; Salh-Gohari N., 2005, MOL CELL BIOL, V25, P7158; Starenki DV, 2004, CLIN CANCER RES, V10, P6821, DOI 10.1158/1078-0432.CCR-04-0463; Suzuki Y, 2004, TETRAHEDRON, V60, P7061, DOI 10.1016/j.tet.2004.01.103; Yashida H., 2006, J CELL BIOL, V172, P565	39	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	NOV	2014	1843	11					2662	2673		10.1016/j.bbamcr.2014.07.010		12	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	AQ1FR	WOS:000342527800028		
J	Akita, H; Imaizumi, Y; Suzuki, H; Doi, K; Ohshima, T				Akita, Hironaga; Imaizumi, Yoshifumi; Suzuki, Hirokazu; Doi, Katsumi; Ohshima, Toshihisa			Spectrophotometric assay of D-isoleucine using an artificially created D-amino acid dehydrogenase	BIOTECHNOLOGY LETTERS			English	Article						D-Amino acid; D-Amino acid dehydrogenase; Endpoint assay; D-Isoleucine; Spectrophotometric assay; Water-soluble Tetrazolium-3	D-SERINE	d-isoleucine (d-Ile) can be assayed using chiral chromatography but the availability of that method is limited by the necessity for special expertise and expensive equipment. We therefore developed a simple and specific colorimetric assay system for d-Ile determination using an artificially created NADP(+)-dependent d-amino acid dehydrogenase (DAADH). The system consists of two reaction steps: the first is the quantitative conversion of d-Ile to (3R)-2-oxo-3-methyl valerate by DAADH in which NADP(+) is converted to NADPH, while the second is chemical conversion of NADPH to reduced water-soluble Tetrazolium-3 via a redox mediator. d-Ile was determined from 1 to 50 A mu M, and the assay was unaffected by the presence of any of three other isomers (100 A mu M), alcohol and organic acids.	[Akita, Hironaga; Imaizumi, Yoshifumi] Kyushu Univ, Fac Agr, Higashi Ku, Fukuoka 8128581, Japan; [Akita, Hironaga] Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr, Hiroshima 7390046, Japan; [Suzuki, Hirokazu] Tottori Univ, Fac Engn, Dept Chem & Biotechnol, Tottori 6808552, Japan; [Doi, Katsumi] Kyushu Univ, Fac Agr, Microbial Genet Div, Inst Genet Resources,Higashi Ku, Fukuoka 8128581, Japan; [Ohshima, Toshihisa] Osaka Inst Technol, Fac Engn, Dept Biomed Engn, Asahi Ku, Osaka 5358585, Japan	Ohshima, T (reprint author), Osaka Inst Technol, Fac Engn, Dept Biomed Engn, Asahi Ku, 5-16-1 Omiya, Osaka 5358585, Japan.	h-akita@aist.go.jp; imaizumiy@agr.kyushu-u.ac.jp; hirokazusuzuki@bio.tottori-u.ac.jp; doi@agr.kyushu-u.ac.jp; ohshima@bme.oit.ac.jp			KAKENHI [25 4653]; Promotion of Basic Research Activities for Innovate Bioscience from the Bio-oriented Technology Research Advancement Institution (BRAIN); NPO Geo Biotechnology Development Organization	We thank Professor Tadao Oikawa for his kind advice. This work was supported by Grants of KAKENHI (25 4653) to H. Akita, Promotion of Basic Research Activities for Innovate Bioscience from the Bio-oriented Technology Research Advancement Institution (BRAIN) and NPO Geo Biotechnology Development Organization to T. Ohshima.	Akita H, 2013, APPL MICROBIOL BIOT, V98, P1135; Akita H, 2012, BIOTECHNOL LETT, V34, P1693, DOI 10.1007/s10529-012-0952-1; Rosenberg D, 2013, J NEUROSCI, V33, P3533, DOI 10.1523/JNEUROSCI.3836-12.2013; Gogami Y, 2011, J CHROMATOGR B, V879, P3259, DOI 10.1016/j.jchromb.2011.04.006; Akita H, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-43; Min JZ, 2011, J CHROMATOGR B, V879, P3220, DOI 10.1016/j.jchromb.2011.02.016; Friedman M, 2010, CHEM BIODIVERS, V7, P1491, DOI 10.1002/cbdv.200900225; Wu XX, 2004, BIOSENS BIOELECTRON, V20, P879, DOI [10.1016/j.bios.2004.04.002, 10.1016/j.jios.2004.04.002]; Hamase K, 2007, J CHROMATOGR A, V1143, P105, DOI 10.1016/j.chroma.2006.12.078; Kawagishi H, 2004, BIOSCI BIOTECH BIOCH, V68, P2405, DOI 10.1271/bbb.68.2405; Molla G, 2012, METHODS MOL BIOL, V794, P273, DOI 10.1007/978-1-61779-331-8_18; Suzuki C, 2011, J CHROMATOGR B, V879, P3326, DOI 10.1016/j.jchromb.2011.07.028; Tani Y, 2009, ANAL SCI, V25, P913; Zhou ND, 2008, ANAL LETT, V41, P1408, DOI 10.1080/00032710802119376	14	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0141-5492	1573-6776		BIOTECHNOL LETT	Biotechnol. Lett.	NOV	2014	36	11					2245	2248		10.1007/s10529-014-1597-z		4	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	AP9QF	WOS:000342413700013		
J	Kashiwagi, N; Miyake, M; Hirose, S; Sota, M; Ogino, C; Kondo, A				Kashiwagi, Norimasa; Miyake, Michiru; Hirose, Shuichi; Sota, Masahiro; Ogino, Chiaki; Kondo, Akihiko			Cloning and starch degradation profile of maltotriose-producing amylases from Streptomyces species	BIOTECHNOLOGY LETTERS			English	Article						Amylase; Maltotriose; Starch hydrolysis; Streptomyces avermitilis; Streptomyces griseus; Streptomyces lividans	ALPHA-AMYLASE; NUCLEOTIDE-SEQUENCE; GENOME SEQUENCE; EXPRESSION; GENE; PURIFICATION; AVERMITILIS	The end products from starch hydrolysis by amylases have important applications in various industries. Here, two amylases derived from two Streptomyces species that hydrolyze soluble starch from potato produced maltotriose as the primary maltooligosaccharide product. The genes, annotated as putative glycoside hydrolases, were cloned and expressed in Streptomyces lividans. These amylases displayed hydrolysis activity from pH 3 to 9.5 and were not affected by Ca2+. Optimal production of maltotriose was between 20 and 30 A degrees C at pH 6.5. At the optimal temperature, both amylases produced maltotriose-rich end products rather than either maltose or maltotetraose.	[Kashiwagi, Norimasa; Miyake, Michiru] Kobe Univ, Org Adv Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan; [Hirose, Shuichi; Sota, Masahiro] Nagase & Co Ltd, R&D Ctr, Kobe, Hyogo 6512241, Japan; [Ogino, Chiaki; Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Kondo, A (reprint author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodaicho, Kobe, Hyogo 6578501, Japan.	akondo@kobe-u.ac.jp	Kondo, Akihiko/A-2130-2015		Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction, Kobe), Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was partially supported by Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction, Kobe), Ministry of Education, Culture, Sports, Science and Technology, Japan.	Ogino C, 2004, APPL MICROBIOL BIOT, V64, P823, DOI 10.1007/s00253-003-1552-8; Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; Gupta R, 2003, PROCESS BIOCHEM, V38, P1599, DOI 10.1016/S0032-9592(03)00053-0; Kaneko T, 2005, BIOSCI BIOTECH BIOCH, V69, P1073, DOI 10.1271/bbb.69.1073; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Yang CH, 2007, J IND MICROBIOL BIOT, V34, P325, DOI 10.1007/s10295-006-0200-6; Doukyu N, 2008, BIOSCI BIOTECH BIOCH, V72, P2444, DOI 10.1271/bbb.80207; Hwang SY, 2013, BIOSCI BIOTECH BIOCH, V77, P2449, DOI 10.1271/bbb.130556; Kieser T., 2000, PRACTICAL STREPTOMYC; KOBAYASHI T, 1994, J BACTERIOL, V176, P5131; Satoh E, 1997, APPL ENVIRON MICROB, V63, P4941; VIGAL T, 1991, MOL GEN GENET, V225, P278, DOI 10.1007/BF00269860; WAKO K, 1979, J JPN SOC STARCH SCI, V26, P175	13	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0141-5492	1573-6776		BIOTECHNOL LETT	Biotechnol. Lett.	NOV	2014	36	11					2311	2317		10.1007/s10529-014-1611-5		7	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	AP9QF	WOS:000342413700022		
J	Gotoh, K; Izuka, M; Arai, J; Okada, Y; Sugiyama, T; Takeda, K; Ishida, H				Gotoh, Kazuma; Izuka, Misato; Arai, Juichi; Okada, Yumika; Sugiyama, Teruyasu; Takeda, Kazuyuki; Ishida, Hiroyuki			In situ Li-7 nuclear magnetic resonance study of the relaxation effect in practical lithium ion batteries	CARBON			English	Article							HARD-CARBON; ELECTROCHEMICAL INTERCALATION; NMR; INSERTION; GRAPHITE; ELECTRODES; CATHODE; ANODE; CYCLE	Lithium ion cells comprising actual components of positive electrodes (LiCoO2, LiNixCoyAlz, and LiMn2O4) and negative electrodes (graphite and hard carbon) were assembled for in situ Li-7 nuclear magnetic resonance (NMR) experiments. The Li-7 NMR measurements of the cells revealed a "relaxation effect" after overcharging: a decrease of the signal assigned to Li metal deposited on the negative electrode surface by overcharging. The reduction of the Li metal signal was inversely proportional to the increase of the signal of lithium stored in carbon. Therefore, the effect was ascribed to absorption of deposited lithium into the carbon of negative electrodes. The effect, which occurred rapidly in a few hours, reached an equilibrium state at 8-15 h. The slight shift of deposited metal suggests that dendritic Li easily re-dissolved, although larger Li particles remained. A hard carbon electrode has a greater effect of Li metal relaxation than graphite electrodes do, which is explainable by the bufferable structure of the carbon. Results are expected to be important for the discussion of the state of lithium, and for safer battery design. (C) 2014 Elsevier Ltd. All rights reserved.	[Gotoh, Kazuma; Izuka, Misato; Ishida, Hiroyuki] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Arai, Juichi; Okada, Yumika; Sugiyama, Teruyasu] Yamaha Motor Co Ltd, Iwata, Shizuoka 4388501, Japan; [Takeda, Kazuyuki] Kyoto Univ, Grad Sch Sci, Div Chem, Kyoto 6068502, Japan	Gotoh, K (reprint author), Okayama Univ, Grad Sch Nat Sci & Technol, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	kgotoh@cc.okayama-u.ac.jp	Gotoh, Kazuma/B-2576-2011; ISHIDA, Hiroyuki/B-2069-2011	Gotoh, Kazuma/0000-0002-8197-5701; 			Key B, 2009, J AM CHEM SOC, V131, P9239, DOI 10.1021/ja8086278; Gotoh K, 2008, J PHYS CHEM SOLIDS, V69, P147, DOI 10.1016/j.jpcs.2007.08.010; Shimoda K, 2013, ELECTROCHIM ACTA, V108, P343, DOI 10.1016/j.electacta.2013.06.120; Trease NM, 2012, SOLID STATE NUCL MAG, V42, P62, DOI 10.1016/j.ssnmr.2012.01.004; Chandrashekar S, 2012, NAT MATER, V11, P311, DOI [10.1038/nmat3246, 10.1038/NMAT3246]; OHZUKU T, 1990, J ELECTROCHEM SOC, V137, P769, DOI 10.1149/1.2086552; Letellier M, 2007, CARBON, V45, P1025, DOI 10.1016/j.carbon.2006.12.018; Blanc F, 2013, ACCOUNTS CHEM RES, V46, P1952, DOI 10.1021/ar400022u; Zhou LN, 2013, J MAGN RESON, V234, P44, DOI 10.1016/j.jmr.2013.05.011; Letellier M, 2003, J CHEM PHYS, V118, P6038, DOI 10.1063/1.1556092; Letellier M, 2006, J PHYS CHEM SOLIDS, V67, P1228, DOI 10.1016/j.jpcs.2006.01.088; Grey CP, 2004, CHEM REV, V104, P4493, DOI 10.1021/cr020734p; Takeda K, 2008, J MAGN RESON, V192, P218, DOI 10.1016/j.jmr.2008.02.019; Chevalier F, 2013, CARBON, V61, P140, DOI 10.1016/j.carbon.2013.04.078; CONARD J, 2000, TANSO, V191, P62; Fujimoto H, 2011, J POWER SOURCES, V196, P1365, DOI 10.1016/j.jpowsour.2010.09.026; Gotoh K, 2006, J POWER SOURCES, V162, P1322, DOI 10.1016/j.jpowsour.2006.09.001; Kuwata N, 2011, MAT INTEGR, V24, P172; Letellier M, 2004, J PHYS CHEM SOLIDS, V65, P245, DOI 10.1016/j.jpcs.2003.10.022; Mustarelli P, 1997, PHYS REV B, V55, P12018, DOI 10.1103/PhysRevB.55.12018; Ogata K., 2014, NAT COMMUN, V5; Trease Nicole M., 2011, Electrochemical Society Interface, V20; Yoshio M., 2009, LITHIUM ION BATTERIE	23	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0008-6223	1873-3891		CARBON	Carbon	NOV	2014	79						380	387		10.1016/j.carbon.2014.07.080		8	Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	AQ2YY	WOS:000342657100039		
J	Xiu, SL; Zheng, MM; Zhao, P; Zhang, Y; Liu, HY; Li, SJ; Chen, G; Kawazoe, Y				Xiu, S. L.; Zheng, M. M.; Zhao, P.; Zhang, Y.; Liu, H. Y.; Li, S. J.; Chen, G.; Kawazoe, Y.			An effective method of tuning conducting properties: First-principles studies on electronic structures of graphene nanomeshes	CARBON			English	Article							ANTIDOT LATTICES; BILAYER GRAPHENE; BANDGAP; LITHOGRAPHY	Based on detailed first-principles investigations of the hexagonal antidot patterned graphene nanomeshes, we have studied the mechanisms of the conducting property modification of graphene. The band-folding analysis shows that the (3n,3m) (n and m are integers) superlattice would have fourfold degeneracy at Gamma point. An effective method by removing this fourfold degeneracy, such as regularly arranging antidots to make the (3n,3m) nanomesh, is proposed to open a sizable bandgap no matter whether the sublattice equivalence keeps or not. In the nanomeshes patterned with the magnetic antidots, the antiferromagnetic coupling adds a quantum parameter to break the sublattice equivalence, resulting in the bandgap opening at the twofold degenerate K (K') point. Our studies also show that the gap width could be tuned by controlling the antidot density. These results could facilitate the fascinating applications of graphene in the next-generation nanoelectronics. (C) 2014 Elsevier Ltd. All rights reserved.	[Xiu, S. L.; Zheng, M. M.; Zhao, P.; Zhang, Y.; Liu, H. Y.; Li, S. J.; Chen, G.] Univ Jinan, Dept Phys, Jinan 250022, Shandong, Peoples R China; [Zheng, M. M.] Qufu Normal Univ, Dept Phys, Qufu 273165, Shandong, Peoples R China; [Kawazoe, Y.] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 9808577, Japan; [Kawazoe, Y.] Russian Acad Sci, Siberian Branch, Kutateladze Inst Thermophys, Novosibirsk 630090, Russia	Chen, G (reprint author), Univ Jinan, Dept Phys, Jinan 250022, Shandong, Peoples R China.	phdgchen@hotmail.com			Taishan Scholar Professorship [TSHW20101004]; Shandong Provincial Natural Science Foundation [ZR2012AL10]; Science Foundation for Middle-Aged Young Scientist of Shandong Province [BS2012DX002]; Shandong Province High School Scientific Research Plan Project [J11LA12]; National Natural Science Foundation of China (NSFC) [11074100, 11104114, 21303072, 11374128]	The authors gratefully acknowledge the SR16000 supercomputing resources from the Center for Computational Materials Science of the Institute for Materials Research, Tohoku University, and the computing resources from the University of Jinan. The authors acknowledge the financial supports from the Taishan Scholar Professorship (TSHW20101004), the Shandong Provincial Natural Science Foundation (ZR2012AL10), the Science Foundation for Middle-Aged Young Scientist of Shandong Province (BS2012DX002), the Shandong Province High School Scientific Research Plan Project (J11LA12), and the National Natural Science Foundation of China (NSFC) (Grant Nos. 11074100, 11104114, 21303072, and 11374128).	Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Sun ML, 2014, APPL SURF SCI, V307, P158, DOI 10.1016/j.apsusc.2014.04.005; Schulte K, 2013, APPL SURF SCI, V267, P74, DOI 10.1016/j.apsusc.2012.07.122; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Kim M, 2010, NANO LETT, V10, P1125, DOI 10.1021/nl9032318; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; Nguyen VH, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/6/065201; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; Denis PA, 2010, CHEM PHYS LETT, V492, P251, DOI 10.1016/j.cplett.2010.04.038; Bai JW, 2010, NAT NANOTECHNOL, V5, P190, DOI [10.1038/nnano.2010.8, 10.1038/NNANO.2010.8]; Takahashi T, 2014, CARBON, V73, P141, DOI 10.1016/j.carbon.2014.02.049; Zhou J, 2009, NANO LETT, V9, P3867, DOI 10.1021/nl9020733; Lu YH, 2009, J PHYS CHEM B, V113, P2, DOI 10.1021/jp806905e; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Liang XG, 2010, NANO LETT, V10, P2454, DOI 10.1021/nl100750v; Ouyang FP, 2014, PHYSICA E, V56, P222, DOI 10.1016/j.physe.2013.09.006; Tang GP, 2014, CARBON, V76, P348, DOI 10.1016/j.carbon.2014.04.086; Wang TH, 2014, CARBON, V77, P431, DOI 10.1016/j.carbon.2014.05.048; Cottam M. G., 1989, INTRO SURFACE SUPERL; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Liu LZ, 2014, VACUUM, V105, P21, DOI 10.1016/j.vacuum.2014.01.015; Lopata K, 2010, CHEM PHYS LETT, V498, P334, DOI 10.1016/j.cplett.2010.08.086; Ouyang FP, 2010, J PHYS CHEM C, V114, P15578, DOI 10.1021/jp1028454; Sheu SY, 2014, CARBON, V71, P76, DOI 10.1016/j.carbon.2014.01.015; Tsu R., 2005, SUPERLATTICE NANOELE; Yang CK, 2010, CARBON, V48, P3901, DOI 10.1016/j.carbon.2010.06.056; Zhou J, 2010, CARBON, V48, P1405, DOI 10.1016/j.carbon.2009.12.031	29	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0008-6223	1873-3891		CARBON	Carbon	NOV	2014	79						646	653		10.1016/j.carbon.2014.08.050		8	Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	AQ2YY	WOS:000342657100068		
J	Rozada, R; Solis-Fernandez, P; Paredes, JI; Martinez-Alonso, A; Ago, H; Tascon, JMD				Rozada, R.; Solis-Fernandez, P.; Paredes, J. I.; Martinez-Alonso, A.; Ago, H.; Tascon, J. M. D.			Controlled generation of atomic vacancies in chemical vapor deposited graphene by microwave oxygen plasma	CARBON			English	Article							NANOSCALE; DEFECTS	The introduction of atomic-scale defects in a controllable manner and the understanding of their effect on the characteristics of graphene are essential to develop many applications based on this two-dimensional material. Here, we investigate the use of microwave-induced oxygen plasma towards the generation of small-sized atomic vacancies (holes) in graphene grown by chemical vapor deposition. Scanning tunneling microscopy revealed that tunable vacancy densities in the 10(3)-10(5) mu m(-3) range could be attained with proper plasma parameters. Transport measurements and Raman spectroscopy revealed p-type doping and a decrease in charge carrier mobility for the vacancy-decorated samples. This plasma-modified graphene could find use in, e.g., gas or liquid separation, or molecular sensing. (C) 2014 Elsevier Ltd. All rights reserved.	[Rozada, R.; Paredes, J. I.; Martinez-Alonso, A.; Tascon, J. M. D.] INCAR CSIC, Inst Nacl Carbon, Oviedo 33080, Spain; [Solis-Fernandez, P.; Ago, H.] Kyushu Univ, Inst Mat Chem & Engn, Fukuoka 8168580, Japan	Rozada, R (reprint author), INCAR CSIC, Inst Nacl Carbon, Apartado 73, Oviedo 33080, Spain.	rozada@incar.csic.es	Ago, Hiroki/A-3405-2011; 	Ago, Hiroki/0000-0002-4597-9510; Solis Fernandez, Pablo/0000-0003-1001-5874	Spanish MINECO; European Regional Development Fund [MAT2011-26399]; PRESTO, Japan Science and Technology; JSPS; Spanish MECD	Financial support from the Spanish MINECO and the European Regional Development Fund (project MAT2011-26399) is gratefully acknowledged. Part of this work was supported by PRESTO, Japan Science and Technology. P.S.-F- acknowledges the receipt of a postdoctoral fellowship from JSPS. R.R. is grateful for the receipt of a pre-doctoral contract (FPU) from the Spanish MECD.	Banhart F, 2011, ACS NANO, V5, P26, DOI 10.1021/nn102598m; Rozada R, 2013, NANO RES, V6, P216, DOI 10.1007/s12274-013-0298-6; Yamada Y, 2014, J AM CHEM SOC, V136, P2232, DOI 10.1021/ja4117268; Casiraghi C, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2818692; Ferrari AC, 2013, NAT NANOTECHNOL, V8, P235, DOI 10.1038/nnano.2013.46; Xie GB, 2014, SMALL, V10, P2280, DOI 10.1002/smll.201303671; Novoselov KS, 2012, NATURE, V490, P192, DOI 10.1038/nature11458; Schwierz F, 2010, NAT NANOTECHNOL, V5, P487, DOI [10.1038/nnano.2010.89, 10.1038/NNANO.2010.89]; Kim JH, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826642; Orofeo CM, 2012, CARBON, V50, P2189, DOI 10.1016/j.carbon.2012.01.030; Chen JH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.236805; Mao HY, 2014, CARBON, V76, P212, DOI 10.1016/j.carbon.2014.04.070; Nourbakhsh A, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/43/435203; Paredes JI, 2002, LANGMUIR, V18, P4314, DOI 10.1021/la0115280; Paredes JI, 2009, J PHYS CHEM C, V113, P10249, DOI 10.1021/jp901578c; Robertson AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2141; Yang DP, 2014, J PHYS CHEM C, V118, P725, DOI 10.1021/jp409898d	17	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0008-6223	1873-3891		CARBON	Carbon	NOV	2014	79						664	669		10.1016/j.carbon.2014.08.015		6	Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	AQ2YY	WOS:000342657100070		
J	Kotake, M; Sato, K; Mogi, C; Tobo, M; Aoki, H; Ishizuka, T; Sunaga, N; Imai, H; Kaira, K; Hisada, T; Yamada, M; Okajima, F				Kotake, Mie; Sato, Koichi; Mogi, Chihiro; Tobo, Masayuki; Aoki, Haruka; Ishizuka, Tamotsu; Sunaga, Noriaki; Imai, Hisao; Kaira, Kyoichi; Hisada, Takeshi; Yamada, Masanobu; Okajima, Fumikazu			Acidic pH increases cGMP accumulation through the OGR1/phospholipase C/Ca2+/neuronal NOS pathway in N1E-115 neuronal cells	CELLULAR SIGNALLING			English	Article						Acidification; nNOS; cGMP; OGR1; N1E-115 neuronal cell	NITRIC-OXIDE SYNTHASE; PROTEIN-COUPLED RECEPTORS; EXTRACELLULAR ACIDIFICATION; LYSOPHOSPHATIDIC ACID; SIGNALING PATHWAYS; INTRACELLULAR PH; NERVOUS-SYSTEM; PC12 CELLS; KINASE-G; PHOSPHORYLATION	Neuronal NO synthase (nNOS)-mediated cGMP accumulation has been shown to affect a variety of neuronal cell activities, regardless of whether they are detrimental or beneficial, depending on the amount of their levels, under the physiological and pathological situations. In the present study, we examined the role of protonsensing G protein-coupled receptors (GPCRs), which have been identified as new pH sensors, in the acidic pH-induced nNOS/cGMP activity in N1E-115 neuronal cells. In this cell line, ovarian cancer G protein-coupled receptor 1 (OGR1) and G protein-coupled receptor 4 (GPR4) mRNAs are expressed. An extracellular acidic pH increased cGMP accumulation, which was inhibited by nNOS-specific inhibitors. Acidic pH also activated phospholipase C/Ca2+ pathways and Akt-induced phosphorylation of nNOS at S1412, both of which have been shown to be critical regulatory mechanisms for nNOS activation. The acidic pH-induced activation of the phospholipase C/Ca2+ pathway, but not Alct/nNOS phosphorylation, was inhibited by small interfering RNA specific to OGR1 and YM-254890, an inhibitor of G(q/11) proteins, in association with the inhibition of cGMP accumulation. Moreover cGMP accumulation was inhibited by 2-aminoethoxydiphenyl borate, an inhibitor of inositol 1,4,5-trisphosphate channel; however, it was not by wortmannin, a phosphatidylinositol 3-kinase inhibitor, which inhibited Akt/nNOS phosphorylation. In conclusion, acidic pH stimulates cGMP accumulation preferentially through the OGR1/G(q/11) proteins/phospholipase C/Ca2+/nNOS in N1E-115 neuronal cells. Akt-mediated phosphorylation of nNOS, however, does not appreciably contribute to the acidification-induced accumulation of cGMP. (C) 2014 Elsevier Inc. All rights reserved.	[Kotake, Mie; Sato, Koichi; Mogi, Chihiro; Tobo, Masayuki; Aoki, Haruka; Okajima, Fumikazu] Gunma Univ, Inst Mol & Cellular Regulat, Lab Signal Transduct, Maebashi, Gumma 3718512, Japan; [Kotake, Mie; Aoki, Haruka; Sunaga, Noriaki; Imai, Hisao; Kaira, Kyoichi; Hisada, Takeshi; Yamada, Masanobu] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gumma 3718511, Japan; [Ishizuka, Tamotsu] Univ Fukui, Fac Med Sci, Dept Internal Med 3, Fukui 9101193, Japan	Sato, K (reprint author), Gunma Univ, Inst Mol & Cellular Regulat, Lab Signal Transduct, Maebashi, Gumma 3718512, Japan.	kosato@gunma-u.ac.jp; okajima@gunma-u.ac.jp			Japan Society for the Promotion of Science [25670617, 24500435]	We appreciate Ms. Mutsumi Takano for technical assistance. This work was funded by grants from Grant-in-Aid for Challenging Exploratory Research (25670617 to F.O.) and for Scientific Research (C) (24500435 to K.S.) from the Japan Society for the Promotion of Science.	Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Hurt KJ, 2012, P NATL ACAD SCI USA, V109, P16624, DOI 10.1073/pnas.1213790109; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Zhou L, 2009, NITRIC OXIDE-BIOL CH, V20, P223, DOI 10.1016/j.niox.2009.03.001; Cunha TM, 2010, P NATL ACAD SCI USA, V107, P4442, DOI 10.1073/pnas.0914733107; Wang YZ, 2011, MOL NEUROBIOL, V44, P350, DOI 10.1007/s12035-011-8204-2; Obara M, 2008, NEUROCHEM INT, V52, P905, DOI 10.1016/j.neuint.2007.10.015; Seuwen K, 2006, J RECEPT SIG TRANSD, V26, P599, DOI 10.1080/10799890600932220; Mandal S, 2013, J NEUROSCI, V 33, P16897, DOI 10.1523/JNEUROSCI.1871-13.2013; Sato K, 2014, NEUROCHEM INT, V68, P38, DOI 10.1016/j.neuint.2014.02.005; SMITH ML, 1986, J CEREBR BLOOD F MET, V6, P574; Kimura T, 2001, J BIOL CHEM, V276, P31780, DOI 10.1074/jbc.M104353200; Takenouchi T, 2005, BBA-GEN SUBJECTS, V1726, P177, DOI 10.1016/j.bbagen.2005.08.001; Yuasa K, 2012, BIOCHEM BIOPH RES CO, V421, P239, DOI 10.1016/j.bbrc.2012.03.143; Fiscus RR, 2002, NEUROSIGNALS, V11, P175, DOI 10.1159/000065431; Johlfs MG, 2010, NEUROCHEM INT, V56, P546, DOI 10.1016/j.neuint.2009.12.017; Tomura H, 2005, CELL SIGNAL, V17, P1466, DOI 10.1016/j.cellsig.2005.06.002; Ferreira JM, 2011, J NEUROSCI, V31, P1991, DOI 10.1523/JNEUROSCI.1850-09.2011; REHNCRONA S, 1985, ANN EMERG MED, V14, P770, DOI 10.1016/S0196-0644(85)80055-X; Doucet MV, 2012, PHARMACOL THERAPEUT, V133, P218, DOI 10.1016/j.pharmthera.2011.11.005; Rameau GA, 2007, J NEUROSCI, V27, P3445, DOI 10.1523/JNEUROSCI.4799-06.2007; Aoki H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079985; Cooke RM, 2013, J NEUROSCI, V33, P5626, DOI 10.1523/JNEUROSCI.3659-12.2013; Esplugues JV, 2002, BRIT J PHARMACOL, V135, P1079, DOI 10.1038/sj.bjp.0704569; Fan YY, 2014, J CEREBR BLOOD F MET, V34, P275, DOI 10.1038/jcbfm.2013.193; Ho Karen W, 2012, Am J Neurodegener Dis, V1, P1; Holzer Peter, 2009, Handb Exp Pharmacol, P283, DOI 10.1007/978-3-540-79090-7_9; Jin Y, 2014, J NEUROCHEM, V129, P683, DOI 10.1111/jnc.12661; Lam TI, 2013, P NATL ACAD SCI USA, V110, pE4362, DOI 10.1073/pnas.1313029110; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Okajima F, 2013, CELL SIGNAL, V25, P2263, DOI 10.1016/j.cellsig.2013.07.022; Pittaluga A, 2005, BRIT J PHARMACOL, V144, P293, DOI 10.1038/sj.bjp.0705960; Sato K, 2011, J NEUROCHEM, V117, P164, DOI 10.1111/j.1471-4159.2011.07188.x; Sato K, 2005, J NEUROCHEM, V92, P904, DOI 10.1111/j.1471-4159.2004.02933.x; SIEMKOWICZ E, 1981, STROKE, V12, P236; Song T, 2012, INT J MOL MED, V30, P15, DOI 10.3892/ijmm.2012.971	37	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0898-6568	1873-3913		CELL SIGNAL	Cell. Signal.	NOV	2014	26	11					2326	2332		10.1016/j.cellsig.2014.07.010		7	Cell Biology	Cell Biology	AQ3TW	WOS:000342717400004		
J	Hamamura, K; Chen, A; Nishimura, A; Tanjung, N; Sudo, A; Yokota, H				Hamamura, Kazunori; Chen, Andy; Nishimura, Akinobu; Tanjung, Nancy; Sudo, Akihiro; Yokota, Hiroki			Predicting and validating the pathway of Wnt3a-driven suppression of osteoclastogenesis	CELLULAR SIGNALLING			English	Article						Wnt3a; Osteoclasts; RANKL; NFATc1; c-Fos	BONE-DISEASE; DIFFERENTIATION; WNT; TRANSCRIPTION; ACTIVATION; OSTEOBLAST; PROTEINS; OSTEOPROTEGERIN; PROMOTER; CELLS	Wnt signaling plays a major role in bone homeostasis and mechanotransduction, but its role and regulatory mechanism in osteoclast development are not fully understood. Through genome-wide in silico analysis, we examined Wnt3a-driven regulation of osteoclast development. Mouse bone marrow-derived cells were incubated with RANKL in the presence and absence of Wnt3a. Using microarray mRNA expression data, we conducted principal component analysis and predicted transcription factor binding sites (TFBSs) that were potentially involved in the responses to RANKL and Wnt3a. The principal component analysis predicted potential Wnt3a responsive regulators that would reverse osteoclast development, and a TFBS prediction algorithm indicated that the AP1 binding site would be linked to Wnt3a-driven suppression. Since c-Fos was upregulated by RANKL and downregulated by Wnt3a in a dose-dependent manner, we examined its role using RNA interference. The partial silencing of c-Fos suppressed RANKL-driven osteoclastogenesis by downregulating NFATc1, a master transcription factor of osteoclast development. Although the involvement of c-Myc was predicted and partially silencing c-Myc slightly reduced the level of TRAP, c-Myc silencing did not alter the expression of NFATc1. Collectively, the presented systems-biology approach demonstrates that Wnt3a attenuates RAM-driven osteoclastogenesis by blocking c-Fos expression and suggests that mechanotransduction of bone alters the development of not only osteoblasts but also osteoclasts through Wnt signaling. (C) 2014 Elsevier Inc. All rights reserved.	[Hamamura, Kazunori; Nishimura, Akinobu; Tanjung, Nancy; Yokota, Hiroki] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Chen, Andy] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Nishimura, Akinobu; Sudo, Akihiro] Mie Univ, Sch Med, Dept Orthopaed Surg, Tsu, Mie 514, Japan; [Yokota, Hiroki] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA	Hamamura, K (reprint author), Indiana Univ Purdue Univ, Dept Biomed Engn, SL155,723 West Michigan St, Indianapolis, IN 46202 USA.	hamamurk@iupui.edu			NIH [R01AR052144]; CTSA [UL1-TR000157]	The authors appreciate M. Hamamura and J.W. Shim for their technical assistance and Y. Liu for the curated list of transcription factor positional weight matrices. Research reported in this publication was supported by NIH R01AR052144 and CTSA UL1-TR000157. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. All authors state that they have no conflicts of interest.	Kanamori M, 2004, BIOCHEM BIOPH RES CO, V322, P787, DOI 10.1016/j.bbrc.2004.07.179; Miao CG, 2013, CELL SIGNAL, V25, P2069, DOI 10.1016/j.cellsig.2013.04.002; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Nakashima A, 2005, J BIOL CHEM, V280, P37660, DOI 10.1074/jbc.M504612200; Santos A, 2009, J ORTHOP RES, V27, P1280, DOI 10.1002/jor.20888; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Hamamura K, 2008, CELL BIOL INT, V32, P1238, DOI 10.1016/j.cellbi.2008.07.007; Indo Y, 2013, J BONE MINER RES, V28, P2392, DOI 10.1002/jbmr.1976; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Monroe DG, 2012, GENE, V492, P1, DOI 10.1016/j.gene.2011.10.044; Winkler DG, 2005, J BIOL CHEM, V280, P2498, DOI 10.1074/jbc.M400524200; Battaglino R, 2002, J BONE MINER RES, V17, P763, DOI 10.1359/jbmr.2002.17.5.763; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Albers J, 2013, J CELL BIOL, V200, P537, DOI 10.1083/jcb.201207142; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Wagner EF, 2003, ANN RHEUM DIS, V62, P83; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Robling AG, 2009, CRIT REV EUKAR GENE, V19, P319; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Wan YH, 2010, TRENDS ENDOCRIN MET, V21, P722, DOI 10.1016/j.tem.2010.08.006; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Stevens JR, 2010, J BONE MINER RES, V25, P2138, DOI 10.1002/jbmr.118; Wagner EF, 2002, ANN RHEUM DIS, V61, P40; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Chen Andy B., 2007, Genomics Proteomics & Bioinformatics, V5, P158, DOI 10.1016/S1672-0229(08)60003-0; Daumer KM, 2002, J BONE MINER RES, V17, P1701, DOI 10.1359/jbmr.2002.17.9.1701; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Liu XM, 2010, AM J PHYSIOL-LUNG C, V299, pL694, DOI 10.1152/ajplung.00140.2010; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Qiang YW, 2008, BLOOD, V112, P374, DOI 10.1182/blood-2007-10-120253; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Takayanagi H, 2005, J CELL BIOCHEM, V94, P232, DOI 10.1002/jcb.20316; Tamura M, 2013, MOL MED REP, V8, P1807, DOI 10.3892/mmr.2013.1713	34	3	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0898-6568	1873-3913		CELL SIGNAL	Cell. Signal.	NOV	2014	26	11					2358	2369		10.1016/j.cellsig.2014.07.018		12	Cell Biology	Cell Biology	AQ3TW	WOS:000342717400008		
J	Kaname, T; Ki, CS; Niikawa, N; Baillie, GS; Day, JP; Yamamura, K; Ohta, T; Nishimura, G; Mastuura, N; Kim, OH; Sohn, YB; Kim, HW; Cho, SY; Ko, AR; Lee, JY; Kim, HW; Ryu, SH; Rhee, H; Yang, KS; Joo, K; Lee, J; Kim, CH; Cho, KH; Kim, D; Yanagi, K; Naritomi, K; Yoshiura, K; Kondoh, T; Nii, E; Tonoki, H; Houslay, MD; Jin, DK				Kaname, Tadashi; Ki, Chang-Seok; Niikawa, Norio; Baillie, George S.; Day, Jonathan P.; Yamamura, Ken-ichi; Ohta, Tohru; Nishimura, Gen; Mastuura, Nobuo; Kim, Ok-Hwa; Sohn, Young Bae; Kim, Hyun Woo; Cho, Sung Yoon; Ko, Ah-Ra; Lee, Jin Young; Kim, Hyun Wook; Ryu, Sung Ho; Rhee, Hwanseok; Yang, Kap-Seok; Joo, Keehyoung; Lee, Jooyoung; Kim, Chi Hwa; Cho, Kwang-Hyun; Kim, Dongsan; Yanagi, Kumiko; Naritomi, Kenji; Yoshiura, Ko-ichiro; Kondoh, Tatsuro; Nii, Eiji; Tonoki, Hidefumi; Houslay, Miles D.; Jin, Dong-Kyu			Heterozygous mutations in cyclic AMP phosphodiesterase-4D (PDE4D) and protein kinase A (PKA) provide new insights into the molecular pathology of acrodysostosis	CELLULAR SIGNALLING			English	Article						Acrodysostosis; PDE4D; cAMP; Knok out rat	CAMP-SPECIFIC PHOSPHODIESTERASE; OBSTRUCTIVE PULMONARY-DISEASE; SIGNALING SCAFFOLD PROTEINS; GS-ALPHA BIOACTIVITY; N-TERMINAL REGION; BETA-ARRESTIN; MEMBRANE ASSOCIATION; FEEDBACK-REGULATION; CARDIAC MYOCYTES; PLASMA-MEMBRANE	Acrodysostosis without hormone resistance is a rare skeletal disorder characterized by brachydactyly, nasal hypoplasia, mental retardation and occasionally developmental delay. Recently, loss-of-function mutations in the gene encoding cAMP-hydrolyzing phosphodiesterase-4D (PDE4D) have been reported to cause this rare condition but the pathomechanism has not been fully elucidated. To understand the pathogenetic mechanism of PDE4D mutations, we conducted 3D modeling studies to predict changes in the binding efficacy of CAMP to the catalytic pocket in PDE4D mutants. Our results indicated diminished enzyme activity in the two mutants we analyzed (Gly673Asp and Ile678Thr; based on PDE4D4 residue numbering). Ectopic expression of PDE4D mutants in HEK293 cells demonstrated this reduction in activity, which was identified by increased CAMP levels. However, the cells from an acrodysostosis patient showed low cAMP accumulation, which resulted in a decrease in the phosphorylated CAMP Response Element-Binding Protein (pCREB)/CREB ratio. The reason for this discrepancy was due to a compensatory increase in expression levels of PDE4A and PDE4B isoforms, which accounted for the paradoxical decrease in cAMP levels in the patient cells expressing mutant isoforms with a lowered PDE4D activity. Skeletal radiographs of 10-week-old knockout (KO) rats showed that the distal part of the forelimb was shorter than in wild-type (WT) rats and that all the metacarpals and phalanges were also shorter in KO, as the name acrodysostosis implies. Like the G-protein a-stimulatory subunit and PRKAR1A, PDE4D critically regulates the cAMP signal transduction pathway and influences bone formation in a way that activity-compromising PDE4D mutations can result in skeletal dysplasia. We propose that specific inhibitory PDE4D mutations can lead to the molecular pathology of acrodysostosis without hormone resistance but that the pathological phenotype may well be dependent on an over-compensatory induction of other PDE4 isoforms that can be expected to be targeted to different signaling complexes and exert distinct effects on compartmentalized CAMP signaling. (C) 2014 Published by Elsevier Inc.	[Kaname, Tadashi; Yanagi, Kumiko; Naritomi, Kenji] Univ Ryukyus, Grad Sch Med, Dept Med Genet, Nishihara, Okinawa 90301, Japan; [Ki, Chang-Seok] Sungkyunkwan Univ, Sch Med, Dept Lab Med & Genet, Seoul 135710, South Korea; [Niikawa, Norio] Hlth Sci Univ Hokkaido, Tobetsu, Hokkaido, Japan; [Baillie, George S.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland; [Day, Jonathan P.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Yamamura, Ken-ichi] Kumamoto Univ, Inst Resource Dev & Anal, Div Dev Genet, Kumamoto, Japan; [Ohta, Tohru] Hlth Sci Univ Hokkaido, Res Inst Personalized Hlth Sci, Tobetsu, Hokkaido, Japan; [Nishimura, Gen] Tokyo Metropolitan Childrens Med Ctr, Dept Pediat Imaging, Tokyo, Japan; [Mastuura, Nobuo] Seitoku Univ, Chiba, Japan; [Kim, Ok-Hwa] Gachon Univ, Gil Med Ctr, Dept Radiol, Inchon, South Korea; [Sohn, Young Bae] Ajou Univ, Sch Med, Ajou Univ Hosp, Dept Med Genet, Suwon 441749, South Korea; [Kim, Hyun Woo] Yonsei Univ, Coll Med, Dept Orthoped Surg, Seoul, South Korea; [Cho, Sung Yoon; Jin, Dong-Kyu] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul 135710, South Korea; [Ko, Ah-Ra; Lee, Jin Young] Samsung Biomed Res Inst, Clin Res Ctr, Seoul, South Korea; [Kim, Hyun Wook; Ryu, Sung Ho] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea; [Ryu, Sung Ho] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Ryu, Sung Ho] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Rhee, Hwanseok; Yang, Kap-Seok] Macrogen Inc, Seoul, South Korea; [Joo, Keehyoung; Lee, Jooyoung] Korea Inst Adv Study, Ctr In Silico Prot Sci, Seoul, South Korea; [Joo, Keehyoung; Lee, Jooyoung] Korea Inst Adv Study, Ctr Adv Computat, Seoul, South Korea; [Lee, Jooyoung] Korea Inst Adv Study, Sch Computat Sci, Seoul, South Korea; [Kim, Chi Hwa] Mogam Biotechnol Res Inst, Yongin, South Korea; [Cho, Kwang-Hyun; Kim, Dongsan] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon, South Korea; [Yoshiura, Ko-ichiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki 852, Japan; [Kondoh, Tatsuro] Misakaenosono Mutsumi Dev Med & Welf Ctr, Div Dev Disabil, Isahaya, Japan; [Nii, Eiji] Mie Prefectural Kusanomi Rehabil Ctr, Dept Orthopaed Surg, Tsu, Mie, Japan; [Tonoki, Hidefumi] Tenshi Hosp, Dept Pediat, Clin Genet Sect, Sapporo, Hokkaido, Japan; [Houslay, Miles D.] Kings Coll London, Inst Pharmaceut Sci, London, England	Jin, DK (reprint author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, 50 Irwon Dong, Seoul 135710, South Korea.	jindk@skku.edu	Cho, Kwang-Hyun/C-1684-2011; ki, cs/O-5931-2014; 	Houslay, Miles/0000-0002-3826-8091	Ministry for Health, Welfare and Family Affairs, Republic of Korea [A080588]; Samsung Biomedical Research Institute [SBRI C-A9-240-3]; Korea Science and Engineering Foundation (KOSEF) - Korean government (MEST) [2008-006198]; Center for Clinical Research [PHO 1100931 Green Cross]; Ministry of Health, Labour and Welfare, Japan [H23-Jitsuyoka(Nanbyo)-Ippan-007]	This study was supported by grants from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A080588), the Samsung Biomedical Research Institute grant (SBRI C-A9-240-3), the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korean government (MEST) (no. 2008-006198), Center for Clinical Research (PHO 1100931 Green Cross), and a grant from the Ministry of Health, Labour and Welfare, Japan (H23-Jitsuyoka(Nanbyo)-Ippan-007). We thank KIAS Center for Advanced Computation for providing the Linux cluster system for computational modeling.	Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Breckler M, 2011, CELL SIGNAL, V23, P1257, DOI 10.1016/j.cellsig.2011.03.007; McCahill A, 2005, CELL SIGNAL, V17, P1158, DOI 10.1016/j.cellsig.2005.04.003; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; Linglart A, 2011, NEW ENGL J MED, V364, P2218, DOI 10.1056/NEJMoa1012717; Terrin A, 2012, J CELL BIOL, V198, P607, DOI 10.1083/jcb.201201059; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Baillie GS, 2009, FEBS J, V276, P1790, DOI 10.1111/j.1742-4658.2009.06926.x; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Joo K, 2007, PROTEINS, V69, P83, DOI 10.1002/prot.21628; MacKenzie SJ, 2002, BRIT J PHARMACOL, V136, P421, DOI 10.1038/sj.bjp.0704743; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Beghe B, 2013, AM J RESP CRIT CARE, V188, P271, DOI 10.1164/rccm.201301-0021PP; Hatzelmann A, 2010, PULM PHARMACOL THER, V23, P235, DOI 10.1016/j.pupt.2010.03.011; Willoughby D, 2007, J BIOL CHEM, V282, P34235, DOI 10.1074/jbc.M706765200; Joo K, 2009, PROTEINS, V75, P1010, DOI 10.1002/prot.22312; Hoffmann R, 1998, BIOCHEM J, V333, P139; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; McCormick K, 2014, CURR OPIN GENET DEV, V27, P20, DOI 10.1016/j.gde.2014.02.001; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Rabe KF, 2011, BRIT J PHARMACOL, V163, P53, DOI 10.1111/j.1476-5381.2011.01218.x; Edwards HV, 2012, SEMIN CELL DEV BIOL, V23, P181, DOI 10.1016/j.semcdb.2011.09.005; Houslay MD, 1997, TRENDS BIOCHEM SCI, V22, P217, DOI 10.1016/S0968-0004(97)01050-5; Sheppard CL, 2014, CELL SIGNAL, V26, P1958, DOI 10.1016/j.cellsig.2014.04.023; Kirschner LS, 2000, NAT GENET, V26, P89; MacKenzie KF, 2011, BIOCHEM J, V435, P755, DOI 10.1042/BJ20101184; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Sette C, 1996, J BIOL CHEM, V271, P16526; Michot C, 2012, AM J HUM GENET, V90, P740, DOI 10.1016/j.ajhg.2012.03.003; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Page CP, 2012, CURR OPIN PHARMACOL, V12, P275, DOI 10.1016/j.coph.2012.02.016; Keravis T, 2010, CURR PHARM DESIGN, V16, P1114; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Wakabayashi S, 2002, J BONE MINER RES, V17, P249, DOI 10.1359/jbmr.2002.17.2.249; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Beard MB, 2000, J BIOL CHEM, V275, P10349, DOI 10.1074/jbc.275.14.10349; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Lee H, 2012, AM J HUM GENET, V90, P746, DOI 10.1016/j.ajhg.2012.03.004; Baillie GS, 2002, J BIOL CHEM, V277, P28298, DOI 10.1074/jbc.M108353200; BOLGER G, 1993, MOL CELL BIOL, V13, P6558; Bolger GB, 1997, BIOCHEM J, V328, P539; BUTLER MG, 1988, AM J MED GENET, V30, P971, DOI 10.1002/ajmg.1320300416; Collins DM, 2008, CELL SIGNAL, V20, P2356, DOI 10.1016/j.cellsig.2008.09.017; Graham JM, 2001, PEDIATR RADIOL, V31, P2, DOI 10.1007/s002470000355; Henderson DJP, 2014, BRIT J CANCER, V110, P1278, DOI 10.1038/bjc.2014.22; Houslay MD, 2001, PROG NUCLEIC ACID RE, V69, P249, DOI 10.1016/S0079-6603(01)69049-4; Huston E, 2006, J CELL SCI, V119, P3799, DOI 10.1242/jcs.03106; Jin SLC, 1999, P NATL ACAD SCI USA, V96, P11998, DOI 10.1073/pnas.96.21.11998; Joo K, 2008, BIOPHYS J, V95, P4813, DOI 10.1529/biophysj.108.129684; Ko J.M., 2010, J GENET MED, V7, P145; Le Jeune IR, 2002, J BIOL CHEM, V277, P35980, DOI 10.1074/jbc.M204832200; Lu BS, 2007, MAMM GENOME, V18, P338, DOI 10.1007/s00335-007-9025-5; Lynch MJ, 2007, BIOCHEM SOC T, V35, P938, DOI 10.1042/BST0350938; McCahill A, 2008, CELL SIGNAL, V20, P2071, DOI 10.1016/j.cellsig.2008.07.017; Mika D, 2014, J CELL SCI, V127, P1033, DOI 10.1242/jcs.140251; Nii E, 2007, AM J MED GENET B, V144B, P824, DOI 10.1002/ajmg.b.30492; NIIKAWA N, 1978, HUM GENET, V42, P227, DOI 10.1007/BF00283643; Oki N, 2000, J BIOL CHEM, V275, P10831, DOI 10.1074/jbc.275.15.10831; Owens RJ, 1997, CELL SIGNAL, V9, P575, DOI 10.1016/S0898-6568(97)00072-7; Page C P, 2011, Handb Exp Pharmacol, P391, DOI 10.1007/978-3-642-17969-3_17; Rena G, 2001, MOL PHARMACOL, V59, P996; Schafer PH, 2013, J AM ACAD DERMATOL, V68, P1041, DOI 10.1016/j.jaad.2012.10.064; SHAKUR Y, 1993, BIOCHEM J, V292, P677; Shifman S, 2008, MOL PSYCHIATR, V13, P302, DOI 10.1038/sj.mp.4002048; Smith KJ, 2007, CELL SIGNAL, V19, P2612, DOI 10.1016/j.cellsig.2007.08.015; Sullivan M, 1999, CELL SIGNAL, V11, P735, DOI 10.1016/S0898-6568(99)00037-6; Tress M, 2007, PROTEINS, V69, P137, DOI 10.1002/prot.21675; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vicini E, 1997, MOL ENDOCRINOL, V11, P839, DOI 10.1210/me.11.7.839; Wallace DA, 2005, MOL PHARMACOL, V67, P1920, DOI 10.1124/mol.104.009423; Wilson LC, 1997, J MED GENET, V34, P133, DOI 10.1136/jmg.34.2.133; Wittmann Miriam, 2013, Dermatol Ther (Heidelb), V3, P1, DOI 10.1007/s13555-013-0023-0	73	6	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0898-6568	1873-3913		CELL SIGNAL	Cell. Signal.	NOV	2014	26	11					2446	2459		10.1016/j.cellsig.2014.07.025		14	Cell Biology	Cell Biology	AQ3TW	WOS:000342717400017		
J	Takenaka, N; Yasuda, N; Nihata, Y; Hosooka, T; Noguchi, T; Aiba, A; Satoh, T				Takenaka, Nobuyuki; Yasuda, Naoto; Nihata, Yuma; Hosooka, Tetsuya; Noguchi, Tetsuya; Aiba, Atsu; Satoh, Takaya			Role of the guanine nucleotide exchange factor in Akt2-mediated plasma membrane translocation of GLUT4 in insulin-stimulated skeletal muscle	CELLULAR SIGNALLING			English	Article						Akt2; FLJ00068; Glucose uptake; GLUT4; Small GTPase; Guanine nucleotide exchange factor; Insulin; Rac1; Skeletal muscle	SMALL GTPASE RAC1; GLUCOSE-UPTAKE; MICE LACKING; RHO-GTPASES; CELLS; PROTEIN; RESISTANCE; ACTIN; ADIPOCYTES; ACTIVATION	The small GTPase Rac1 plays a key role in insulin-promoted glucose uptake mediated by the GLUT4 glucose transporter in skeletal muscle. Our recent studies have demonstrated that the serine/threonine protein kinase Akt2 is critically involved in insulin-dependent Rac1 activation. The purpose of this study is to clarify the role of the guanine nucleotide exchange factor FLJ00068 in Akt2-mediated Rac1 activation and GLUT4 translocation in mouse skeletal muscle and cultured myocytes. Constitutively activated FLJ00068 induced GLUT4 translocation in a Rac1-dependent and Akt2-independent manner in L6 myocytes. On the other hand, knockdown of FLJ00068 significantly reduced constitutively activated Akt2-triggered GLUT4 translocation. Furthermore, Rac1 activation and GLUT4 translocation induced by constitutively activated phosphoinositide 3-kinase were inhibited by knockdown of FLJ00068. In mouse gastrocnemius muscle, constitutively activated FLJ00068 actually induced GLUT4 translocation to the sarcolemma. GLUT4 translocation by constitutively activated FLJ00068 was totally abolished in rod knockout mouse gastrocnemius muscle. Additionally, we were successful in detecting the activation of Rac1 following the expression of constitutively activated FLJ00068 in gastrocnemius muscle by immunofluorescence microscopy using an activation-specific probe. Collectively, these results strongly support the notion that FLJ00068 regulates Rac1 downstream of Akt2, leading to the stimulation of glucose uptake in skeletal muscle. (C) 2014 Elsevier Inc. All rights reserved.	[Takenaka, Nobuyuki; Yasuda, Naoto; Nihata, Yuma; Satoh, Takaya] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Cell Biol Lab,Naka Ku, Sakai, Osaka 5998531, Japan; [Hosooka, Tetsuya; Noguchi, Tetsuya] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet & Endocrinol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Aiba, Atsu] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Lab Anim Resources,Bunkyo Ku, Tokyo 1130033, Japan	Satoh, T (reprint author), Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Cell Biol Lab,Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	tkysato@b.s.osakafu-u.ac.jp	Satoh, Takaya/K-2628-2014		Ministry of Education, Culture, Sports, Science and Technology of Japan [26440103]; Naito Foundation	We thank Wataru Ogawa (Kobe University Graduate School of Medicine) for a recombinant adenovirus for Myr-p110 alpha. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (26440103) and the Naito Foundation.	Jebailey L, 2004, MOL ENDOCRINOL, V18, P359, DOI 10.1210/me.2003-0294; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; NIWA H, 1991, GENE, V108, P193; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; KLIP A, 1990, DIABETES CARE, V13, P228, DOI 10.2337/diacare.13.3.228; Balamatsias D, 2011, J BIOL CHEM, V286, P43229, DOI 10.1074/jbc.M111.306621; Nozaki S, 2013, CELL SIGNAL, V25, P1361, DOI 10.1016/j.cellsig.2013.02.023; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Chiu TT, 2011, CELL SIGNAL, V23, P1546, DOI 10.1016/j.cellsig.2011.05.022; MARCUSOHN J, 1995, CURR BIOL, V5, P1296, DOI 10.1016/S0960-9822(95)00256-9; JeBailey L, 2007, DIABETES, V56, P394, DOI 10.2337/db06-0823; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Nozaki S, 2012, CELL SIGNAL, V24, P2111, DOI 10.1016/j.cellsig.2012.07.013; Kassai H, 2008, EUR J NEUROSCI, V28, P257, DOI 10.1111/j.1460-9568.2008.06343.x; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sun Y, 2010, P NATL ACAD SCI USA, V107, P19909, DOI 10.1073/pnas.1009523107; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Xie XY, 2011, CELL METAB, V14, P378, DOI 10.1016/j.cmet.2011.06.015; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Li J, 2012, DEV CELL, V22, P1286, DOI 10.1016/j.devcel.2012.03.004; Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867; Khayat ZA, 2000, J CELL SCI, V113, P279; Ueda S, 2010, FASEB J, V24, P2254, DOI 10.1096/fj.09-137380; Sylow L, 2013, DIABETES, V62, P1865, DOI 10.2337/db12-1148; Chiu TT, 2013, J BIOL CHEM, V288, P17520, DOI 10.1074/jbc.M113.467647; Gupta M, 2013, J BIOL CHEM, V288, P14522, DOI 10.1074/jbc.M112.430371; LEE AD, 1995, FEBS LETT, V361, P51, DOI 10.1016/0014-5793(95)00147-2; Satoh T., 2014, SMALL GTPASES; Sylow L, 2014, CELL SIGNAL, V26, P323, DOI 10.1016/j.cellsig.2013.11.007; Sylow L, 2013, DIABETES, V62, P1139, DOI 10.2337/db12-0491; Takenaka N, 2014, FEBS J, V281, P1493, DOI 10.1111/febs.12719; Ueda S, 2008, BIOL CELL, V100, P645, DOI 10.1042/BC20070160	36	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0898-6568	1873-3913		CELL SIGNAL	Cell. Signal.	NOV	2014	26	11					2460	2469		10.1016/j.cellsig.2014.07.002		10	Cell Biology	Cell Biology	AQ3TW	WOS:000342717400018		
J	Mori, Y; Koshi, A; Liao, J; Asoh, H; Ono, S				Mori, Yoichi; Koshi, Akihiko; Liao, Jinsun; Asoh, Hidetaka; Ono, Sachiko			Characteristics and corrosion resistance of plasma electrolytic oxidation coatings on AZ31B Mg alloy formed in phosphate - Silicate mixture electrolytes	CORROSION SCIENCE			English	Article						Alloy; Magnesium; Polarization; SEM; Anodic films; Oxide coatings	AM50 MAGNESIUM ALLOY; MICRO-ARC OXIDATION; PEO COATINGS; BEHAVIOR; AZ91D; ANODIZATION; FILMS; MICROSTRUCTURE; PERFORMANCE; PROTECTION	AZ31B magnesium alloy was treated by plasma electrolytic oxidation (PEO) in phosphate-silicate mixture electrolytes. The concentration ratio of phosphate to silicate was varied from 100:0 to 0:100 in order to investigate the influence of the electrolyte composition on the morphology, compositions and corrosion resistance of PEO coatings by using SEM, EDS, XRD, XPS analyses, immersion test, salt spray test and potentiodynamic polarization. When a mixture electrolyte with an optimum concentration ratio of phosphate to silicate (i.e. P:Si = 20:80) is used, the corrosion resistance of PEO coatings is the highest. (C) 2014 Elsevier Ltd. All rights reserved.	[Mori, Yoichi; Koshi, Akihiko; Liao, Jinsun] Kurimoto Ltd, Technol Dev Div, Suminoe Ku, Osaka 5590021, Japan; [Asoh, Hidetaka; Ono, Sachiko] Kogakuin Univ, Dept Appl Chem, Hachioji, Tokyo 1920015, Japan	Mori, Y (reprint author), Kurimoto Ltd, Technol Dev Div, Suminoe Ku, Shibatani 2-8-45, Osaka 5590021, Japan.	y_mori@kurimoto.co.jp					Duan HP, 2007, ELECTROCHIM ACTA, V52, P3785, DOI 10.1016/j.electacta.2006.10.066; Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0; Srinivasan PB, 2010, APPL SURF SCI, V256, P3928, DOI 10.1016/j.apsusc.2010.01.052; Hussein RO, 2011, SURF COAT TECH, V206, P1990, DOI 10.1016/j.surfcoat.2011.08.060; Arrabal R, 2009, SURF COAT TECH, V203, P2207, DOI 10.1016/j.surfcoat.2009.02.011; Arrabal R, 2008, CORROS SCI, V50, P1744, DOI 10.1016/j.corsci.2008.03.002; Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7; Hsiao HY, 2005, SURF COAT TECH, V199, P127, DOI 10.1016/j.surfcoat.2004.12.010; Birss V, 2004, J ELECTROCHEM SOC, V151, pB1, DOI 10.1149/1.1629095; Yagi S, 2013, CORROS SCI, V73, P188, DOI 10.1016/j.corsci.2013.03.035; Chai LY, 2008, CORROS SCI, V50, P3274, DOI 10.1016/j.corsci.2008.08.038; Li XJ, 2011, APPL SURF SCI, V257, P9135, DOI 10.1016/j.apsusc.2011.05.115; Liao JS, 2012, CORROS SCI, V61, P208, DOI 10.1016/j.corsci.2012.04.039; Luo HH, 2009, CURR APPL PHYS, V9, P1341, DOI 10.1016/j.cap.2009.02.017; Liang J, 2010, CORROS SCI, V52, P540, DOI 10.1016/j.corsci.2009.10.011; Liang J, 2007, APPL SURF SCI, V253, P4490, DOI 10.1016/j.apsusc.2006.09.064; Yagi S, 2012, CORROS SCI, V57, P74, DOI 10.1016/j.corsci.2011.12.032; Khaselev O, 1999, J ELECTROCHEM SOC, V146, P1757, DOI 10.1149/1.1391838; Ma Y, 2004, THIN SOLID FILMS, V469, P472, DOI 10.1016/j.tsf.2004.06.168; Liao JS, 2013, CORROS SCI, V71, P53, DOI 10.1016/j.corsci.2013.02.003; Liang J, 2009, ELECTROCHIM ACTA, V54, P3842, DOI 10.1016/j.electacta.2009.02.004; Seyfoori A, 2012, APPL SURF SCI, V261, P92, DOI 10.1016/j.apsusc.2012.07.105; Sreekanth D, 2012, CERAM INT, V38, P4607, DOI 10.1016/j.ceramint.2012.02.040; Blawert C, 2005, SURF COAT TECH, V200, P68, DOI 10.1016/j.surfcoat.2005.02.035; Bonilla FA, 2002, J ELECTROCHEM SOC, V149, pB4, DOI 10.1149/1.1424896; Durdu S, 2011, J ALLOY COMPD, V509, P8601, DOI 10.1016/j.jallcom.2011.06.059; FLEISCH H, 1968, CALC TISS RES, V2, P49, DOI 10.1007/BF02279193; Ghasemi A, 2008, SURF COAT TECH, V202, P3513, DOI 10.1016/j.surfcoat.2007.12.033; Khaselev O, 1998, J ELECTROCHEM SOC, V145, P190, DOI 10.1149/1.1838234; Krishna LR, 2010, METALL MATER TRANS A, V41A, P3499, DOI 10.1007/s11661-010-0412-2; Kuhn Anselm, 2003, MET FINISH, V101, P44, DOI 10.1016/S0026-0576(03)90261-3; Ma Y, 2006, THIN SOLID FILMS, V494, P296, DOI 10.1016/j.tsf.2005.08.156; Moulder J. F., 1995, HDB XRAY PHOTOELECTR; Murakami K, 2008, MATER TRANS, V49, P1057, DOI 10.2320/matertrans.MC200718; Sachiko Ono, 2011, J SURF FIN SOC JPN, V62, P198; Srinivasan PB, 2009, APPL SURF SCI, V255, P4212, DOI 10.1016/j.apsusc.2008.11.008; Stojadinovic S, 2012, ELECTROCHIM ACTA, V59, P354, DOI 10.1016/j.electacta.2011.10.084; Wang Y, 2005, MATER CORROS, V56, P88, DOI 10.1002/maco.200403822; Zhang RF, 2010, CURR APPL PHYS, V10, P255, DOI 10.1016/j.cap.2009.06.008	39	9	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	NOV	2014	88						254	262		10.1016/j.corsci.2014.07.038		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AQ1GP	WOS:000342530200027		
J	Kinose, Y; Azuchi, F; Uehara, Y; Kanomata, T; Kobayashi, A; Yamaguchi, M; Izuta, T				Kinose, Yoshiyuki; Azuchi, Fumika; Uehara, Yui; Kanomata, Tomoaki; Kobayashi, Ayumi; Yamaguchi, Masahiro; Izuta, Takeshi			Modeling of stomatal conductance to estimate stomatal ozone uptake by Fagus crenata, Quercus serrata, Quercus mongolica var. crispula and Betula platyphylla	ENVIRONMENTAL POLLUTION			English	Article						Stomatal conductance; Ozone uptake; Deciduous broad-leaved tree species; Spring; Leaf maturation	FLUX-RESPONSE RELATIONSHIPS; TROPOSPHERIC OZONE; RISK-ASSESSMENT; CLIMATE-CHANGE; AIR-POLLUTION; DO3SE MODEL; EXPOSURE; FORESTS; TREES; JAPAN	To construct stomatal conductance models and estimate stomatal O-3 uptake for Fagus crenata, Quercus serrata, Quercus mongolica var. crispula and Betula platyphylla, stomatal conductance (g(s))was measured in seedlings of the four tree species. Better estimates of gs were made by incorporating the acute effects of O-3 on gs into the models and the models could explain 34-52% of the variability in gs. Although the O-3 concentration was relatively high in spring from April to May, COU of E crenata, Q. serrata and Q mongolica var. crispula were relatively low and the ratios of COU in spring to total COU in one year were 16.8% in all tree species because of low g(s) limited mainly by leaf pre-maturation and/or low temperature. The COU of B. platyphylla were relatively high mainly because of rapid leaf maturation and lower optimal temperature for stomatal opening. (C) 2014 Elsevier Ltd. All rights reserved.	[Kinose, Yoshiyuki; Azuchi, Fumika] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Fuchu, Tokyo 1838509, Japan; [Uehara, Yui; Kanomata, Tomoaki; Kobayashi, Ayumi] Tokyo Univ Agr & Technol, Grad Sch Agr, Fuchu, Tokyo 1838509, Japan; [Yamaguchi, Masahiro] Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Nagasaki 8528521, Japan; [Izuta, Takeshi] Tokyo Univ Agr & Technol, Inst Agr, Fuchu, Tokyo 1838509, Japan	Izuta, T (reprint author), Tokyo Univ Agr & Technol, Inst Agr, Fuchu, Tokyo 1838509, Japan.	izuta@cc.tuat.ac.jp	Izuta, Takeshi/C-9404-2013		Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [5B-1105]	This research was supported by the Environment Research and Technology Development Fund (5B-1105) of the Ministry of the Environment, Japan.	Alonso R, 2007, THESCIENTIFICWORLDJO, V7, P119, DOI 10.1100/tsw.2007.27; Emberson LD, 2000, ENVIRON POLLUT, V109, P403, DOI 10.1016/S0269-7491(00)00043-9; Danielsson H, 2003, ATMOS ENVIRON, V37, P475, DOI 10.1016/S1352-2310(02)00924-X; Bytnerowicz A, 2007, ENVIRON POLLUT, V147, P438, DOI 10.1016/j.envpol.2006.08.028; Reich PB, 1987, TREE PHYSIOL, V3, P63; Gerosa G, 2005, ATMOS ENVIRON, V39, P3255, DOI 10.1016/j.atmosenv.2005.01.056; Wittig VE, 2007, PLANT CELL ENVIRON, V30, P1150, DOI 10.1111/j.1365-3040.2007.01717.x; Pleijel H, 2002, EUR J AGRON, V17, P303, DOI 10.1016/S1161-0301(02)00068-0; Kume A, 2009, ECOL RES, V24, P821, DOI 10.1007/s11284-008-0557-2; Wittig VE, 2009, GLOBAL CHANGE BIOL, V15, P396, DOI 10.1111/j.1365-2486.2008.01774.x; Pleijel H, 2007, ATMOS ENVIRON, V41, P3022, DOI 10.1016/j.atmosenv.2006.12.002; Tanimoto H, 2009, ATMOS ENVIRON, V43, P1358, DOI 10.1016/j.atmosenv.2008.12.006; Emberson LD, 2000, ENVIRON POLLUT, V109, P393, DOI 10.1016/S0269-7491(00)00042-7; Alonso R, 2008, ENVIRON POLLUT, V155, P473, DOI 10.1016/j.envpol.2008.01.032; Hoshika Y, 2012, ATMOS ENVIRON, V55, P271, DOI 10.1016/j.atmosenv.2012.02.083; Hoshika Y, 2011, ANN FOREST SCI, V68, P607, DOI 10.1007/s13595-011-0051-9; Massman WJ, 1998, ATMOS ENVIRON, V32, P1111, DOI 10.1016/S1352-2310(97)00391-9; Karlsson P, 2007, ENVIRON POLLUT, V146, P608, DOI 10.1016/j.envpol.2006.06.012; Musselman RC, 2006, ATMOS ENVIRON, V40, P1869, DOI 10.1016/j.atmosenv.2005.10.064; Nagashima T, 2010, ATMOS CHEM PHYS, V10, P11305, DOI 10.5194/acp-10-11305-2010; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419; Sitch S, 2007, NATURE, V448, P791, DOI 10.1038/nature06059; Vahisalu T, 2010, PLANT J, V62, P442, DOI 10.1111/j.1365-313X.2010.04159.x; Azuchi F, 2014, ENVIRON POLLUT, V184, P481, DOI 10.1016/j.envpol.2013.09.025; Bytnerowicz A, 2004, ENVIRON POLLUT, V130, P5, DOI 10.1016/j.envpol.2003.10.032; Dizengremel P, 2009, PLANT BIOLOGY, V11, P35, DOI 10.1111/j.1438-8677.2009.00261.x; Emberson L., 2000, 62000 EMEP MSCW; Gerosa G, 2009, ENVIRON POLLUT, V157, P1727, DOI 10.1016/j.envpol.2008.06.028; Gerosa G, 2008, ENVIRON POLLUT, V152, P274, DOI 10.1016/j.envpol.2007.06.045; Grulke NE, 2007, ENVIRON POLLUT, V146, P640, DOI 10.1016/j.envpol.2006.04.014; Hoshika Y, 2012, WATER AIR SOIL POLL, V223, P3893, DOI 10.1007/s11270-012-1158-9; JARVIS PG, 1976, PHILOS T ROY SOC B, V273, P593, DOI 10.1098/rstb.1976.0035; Kikuzawa K, 1988, PLANT SPEC BIOL, V3, P67, DOI 10.1111/j.1442-1984.1988.tb00172.x; KIKUZAWA K, 1995, CAN J BOT, V73, P158; Kitao M, 2014, ENVIRON POLLUT, V184, P457, DOI 10.1016/j.envpol.2013.09.023; Kohno Y., 2007, RESULTS SCI RES TANZ, P383; Kohno Y, 2005, Plant Responses to Air Pollution and Global Change, P243, DOI 10.1007/4-431-31014-2_27; Krause G.H.M., 1986, WATER AIR SOIL POLL, V31, P47; Maruta E., 1999, ENV SCI, V12, P241; McAinsh MR, 2002, NEW PHYTOL, V153, P441, DOI 10.1046/j.0028-646X.2001.00336.x; McLaughlin S.B., 1985, JAPCA-INT J AIR POLL, V35, P516; Millan MM, 1997, J GEOPHYS RES-ATMOS, V102, P8811, DOI 10.1029/96JD03610; Mills G., 2010, MAPP MAN 2004 CONV L; Miyazawa Y, 2004, TREE PHYSIOL, V24, P631; Nakashizuka T, 1995, VEGETATIO, V121, P23, DOI 10.1007/BF00044669; Pell E.J., 1996, P 1995 M NO GLOB CHA, P13; Takeda M., 2007, J JPN SOC ATMOS ENV, V42, P107; Watanabe M, 2012, EUR J FOREST RES, V131, P475, DOI 10.1007/s10342-011-0521-5; WEBB RA, 1972, J HORTIC SCI BIOTECH, V47, P309; Yamaguchi M, 2014, ENVIRON POLLUT, V184, P472, DOI 10.1016/j.envpol.2013.09.024; Yamaji K, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008663	51	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0269-7491	1873-6424		ENVIRON POLLUT	Environ. Pollut.	NOV	2014	194						235	245		10.1016/j.envpol.2014.07.030		11	Environmental Sciences	Environmental Sciences & Ecology	AQ1GV	WOS:000342530800029		
J	Tuyen, LH; Tue, NM; Takahashi, S; Suzuki, G; Viet, PH; Subramanian, A; Bulbule, KA; Parthasarathy, P; Ramanathan, A; Tanabe, S				Le Huu Tuyen; Nguyen Minh Tue; Takahashi, Shin; Suzuki, Go; Pham Hung Viet; Subramanian, Annamalai; Bulbule, Kesav A.; Parthasarathy, Peethambaram; Ramanathan, Alagappan; Tanabe, Shinsuke			Methylated and unsubstituted polycyclic aromatic hydrocarbons in street dust from Vietnam and India: Occurrence, distribution and in vitro toxicity evaluation	ENVIRONMENTAL POLLUTION			English	Article						MePAHs; AhR; CALUX; Street dust; Vietnam; India	JUNCTIONAL INTERCELLULAR COMMUNICATION; LIVER EPITHELIAL-CELLS; HEALTH-RISK ASSESSMENT; ROAD DUST; DIAGNOSTIC RATIOS; SOURCE APPORTIONMENT; SIZE DISTRIBUTION; RELATIVE POTENCY; CRUDE EXTRACT; PAHS	Methylated polycyclic aromatic hydrocarbons (MePAHs), unsubstituted PAHs and AhR-mediated activities were determined in street dust collected from Vietnam and India using a combined approach of chemical analysis and in vitro reporter gene assay. MePAHs and PAHs diagnostic ratios indicated that the main sources of MePAHs in Vietnam were pyrogenic emissions, whereas in India there were mixed sources of pyrogenic and petrogenic emissions. AhR-mediated activities determined by using DR-CALUX assay were observed in urban street dust at mean 40,29 and 20 ng CALUX-TEQ/g dw for Hanoi, Bangalore and New Delhi, respectively. MePAHs and PAHs contributed only 5% or less to AhR-mediated activity in street dust, indicating the occurrence of unknown AhR agonists. The principal contributors to Theoretical-TEQs among target compounds were methyl benz[a]anthracene, benzo[b]- and benzo[k] fluoranthene. The present study indicates importance of MePAHs in evaluation of toxic risk related to AhR-mediated activity in urban polluted areas. (C) 2014 Elsevier Ltd. All rights reserved.	[Le Huu Tuyen; Nguyen Minh Tue; Subramanian, Annamalai; Tanabe, Shinsuke] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime 7908577, Japan; [Le Huu Tuyen; Nguyen Minh Tue; Pham Hung Viet] Hanoi Univ Sci, Res Ctr Environm Technol & Sustainable Dev CETASD, Hanoi, Vietnam; [Suzuki, Go] Natl Inst Environm Studies, Ctr Mat Cycles & Waste Management Res, Tsukuba, Ibaraki, Japan; [Takahashi, Shin] Ehime Univ, Fac Agr, Matsuyama, Ehime 790, Japan; [Bulbule, Kesav A.] Kles Nijalingappa Coll, Bangalore, Karnataka, India; [Parthasarathy, Peethambaram] E Parisara Pvt Ltd, Bangalore, Karnataka, India; [Ramanathan, Alagappan] Jawaharlal Nehru Univ, New Delhi 110067, India	Takahashi, S (reprint author), Ehime Univ, Fac Agr, 3-5-7 Tarumi, Matsuyama, Ehime 790, Japan.	shint@agr.ehime-u.ac.jp	Tanabe, Shinsuke/G-6950-2013		Japan Society for the Promotion of Science (JSPS) [A: 25257403, P 13072]; Environment Research and Technology Development Fund from the Ministry of the Environment, Japan [K123001, 3K133010]	This study was partly supported by Grants-in-Aid for Scientific Research (A: 25257403) from Japan Society for the Promotion of Science (JSPS) and the Environment Research and Technology Development Fund (K123001 and 3K133010) from the Ministry of the Environment, Japan. The award of a JSPS postdoctoral fellowship to N. M. Tue (P 13072) is also acknowledged.	Zhao HT, 2009, J ENVIRON SCI-CHINA, V21, P162, DOI 10.1016/S1001-0742(08)62245-7; Saha M, 2009, MAR POLLUT BULL, V58, P189, DOI 10.1016/j.marpolbul.2008.04.049; Wang ZD, 1999, ENVIRON SCI TECHNOL, V33, P3100, DOI 10.1021/es990031y; Garrison PM, 1996, FUND APPL TOXICOL, V30, P194, DOI 10.1006/faat.1996.0056; Barron MG, 2004, MAR ENVIRON RES, V58, P95, DOI 10.1016/j.marenvres.2004.03.001; Tobiszewski M, 2012, ENVIRON POLLUT, V162, P110, DOI 10.1016/j.envpol.2011.10.025; AARTS JMMJG, 1995, EUR J PHARM-ENVIRON, V293, P463, DOI 10.1016/S0014-2999(95)80105-7; Behnisch PA, 2001, ENVIRON INT, V27, P413, DOI 10.1016/S0160-4120(01)00028-9; Chen SC, 2006, SCI TOTAL ENVIRON, V366, P112, DOI 10.1016/j.scitotenv.2005.08.047; Oanh NTK, 2006, ATMOS ENVIRON, V40, P3367, DOI 10.1016/j.atmosenv.2006.01.050; Ha SY, 2012, ARCH ENVIRON CON TOX, V63, P189, DOI 10.1007/s00244-012-9765-4; Boonyatumanond R, 2006, MAR POLLUT BULL, V52, P942, DOI 10.1016/j.marpolbul.2005.12.015; Kume K, 2007, J HAZARD MATER, V144, P513, DOI 10.1016/j.jhazmat.2006.10.079; Saeedi M, 2012, J HAZARD MATER, V227, P9, DOI 10.1016/j.jhazmat.2012.04.047; Fang GC, 2004, SCI TOTAL ENVIRON, V327, P135, DOI 10.1016/j.scitotenv.2003.10.016; Khairy MA, 2012, ENVIRON SCI TECHNOL, V46, P3990, DOI 10.1021/es300012u; Brack W, 2003, ENVIRON SCI TECHNOL, V37, P3062, DOI 10.1021/es020248j; Li XH, 2006, J ENVIRON SCI-CHINA, V18, P944, DOI 10.1016/S1001-0742(06)60019-3; Peng C, 2011, ENVIRON POLLUT, V159, P802, DOI 10.1016/j.envpol.2010.11.003; Tue NM, 2010, ENVIRON SCI TECHNOL, V44, P9195, DOI 10.1021/es102505j; Machala M, 2001, MUTAT RES-GEN TOX EN, V497, P49, DOI 10.1016/S1383-5718(01)00240-6; BAEK SO, 1991, WATER AIR SOIL POLL, V60, P279, DOI 10.1007/BF00282628; Agarwal T, 2009, J HAZARD MATER, V171, P894, DOI 10.1016/j.jhazmat.2009.06.081; Dvorska A, 2011, ATMOS ENVIRON, V45, P420, DOI 10.1016/j.atmosenv.2010.09.063; Wang W, 2011, SCI TOTAL ENVIRON, V409, P4519, DOI 10.1016/j.scitotenv.2011.07.030; Vondracek J, 2007, ENVIRON TOXICOL CHEM, V26, P2308, DOI 10.1897/07-161R.1; Ravindra K, 2008, ATMOS ENVIRON, V42, P2895, DOI 10.1016/j.atmosenv.2007.12.010; Yunker MB, 2002, ORG GEOCHEM, V33, P489, DOI 10.1016/S0146-6380(02)00002-5; Rhodes S, 2005, ECOTOX ENVIRON SAFE, V60, P247, DOI 10.1016/j.ecoenv.2004.08.002; Katsoyiannis A, 2011, ENVIRON SCI TECHNOL, V45, P8897, DOI 10.1021/es202277u; Khairy MA, 2013, CHEMOSPHERE, V91, P895, DOI 10.1016/j.chemosphere.2013.02.018; Andrysik Z, 2011, MUTAT RES-FUND MOL M, V714, P53, DOI 10.1016/j.mrfmmm.2011.06.011; DENISON MS, 1995, J BIOL CHEM, V270, P18175; Lee BK, 2010, J HAZARD MATER, V175, P540, DOI 10.1016/j.jhazmat.2009.10.039; Larsson M, 2014, ENVIRON TOXICOL CHEM, V33, P943, DOI 10.1002/etc.2517; Di Filippo P, 2010, ATMOS ENVIRON, V44, P2742, DOI 10.1016/j.atmosenv.2010.04.035; Hahn ME, 2006, J EXP ZOOL PART A, V305A, P693, DOI 10.1002/jez.323; Choate LaDonna M, 2006, Integr Environ Assess Manag, V2, P375, DOI 10.1897/1551-3793(2006)2[375:DASAAP]2.0.CO;2; Dimitriou-Christidis P, 2003, CHEMOSPHERE, V52, P869, DOI 10.1016/S0045-6535(03)00288-1; EPA U.S, 1991, RISK ASS GUID SUP B, VI; Goyal P, 2010, TRANSPORT RES D-TR E, V15, P298, DOI 10.1016/j.trd.2010.03.002; Goyal P, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-216; Hien PD, 2014, ATMOS ENVIRON, V88, P66, DOI 10.1016/j.atmosenv.2014.01.036; Larsen J.C., 1998, AIR POLLUTION HLTH; Lee BK, 2011, J MATER CYCLES WASTE, V13, P34, DOI 10.1007/s10163-010-0287-8; Lefevre B, 2009, ENERG POLICY, V37, P940, DOI 10.1016/j.enpol.2008.10.036; Lehndorff E, 2009, ENVIRON POLLUT, V157, P1323, DOI 10.1016/j.envpol.2008.11.037; Machala M, 2008, TOXICOLOGY, V247, P93, DOI 10.1016/j.tox.2008.02.008; Marvanova S, 2008, CHEM RES TOXICOL, V21, P503, DOI 10.1021/tx700305x; Oanh NIK, 2012, ATMOS ENVIRON, V59, P438; SAUER T, 1991, NAT RES DAM ASS P 19, P363; Suzuki G, 2006, TOXICOL LETT, V161, P174, DOI 10.1016/j.toxlet.2005.09.004; Suzuki G, 2013, ENVIRON SCI TECHNOL, V47, P2898, DOI 10.1021/es304691a; Suzuki G, 2004, ENVIRON INT, V30, P1055, DOI 10.1016/j.envint.2004.05.005; Tran NL, 2012, PROCD SOC BEHV, V43, P265, DOI 10.1016/j.sbspro.2012.04.099; Trilecova L, 2011, CHEM RES TOXICOL, V24, P866, DOI 10.1021/tx200049x; Tuyen LH, 2014, SCI TOTAL ENVIRON, V491, P246, DOI 10.1016/j.scitotenv.2014.01.086; Upham BL, 1996, FUND APPL TOXICOL, V34, P260, DOI 10.1006/faat.1996.0195; U.S. EPA, 2005, GUID CARC RISK ASS; Weis LM, 1998, ENVIRON HEALTH PERSP, V106, P17, DOI 10.1289/ehp.9810617	60	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0269-7491	1873-6424		ENVIRON POLLUT	Environ. Pollut.	NOV	2014	194						272	280		10.1016/j.envpol.2014.07.029		9	Environmental Sciences	Environmental Sciences & Ecology	AQ1GV	WOS:000342530800033		
J	Kato, E; Ibara, S; Kumazawa, K; Maruyama, Y; Tokuhisa, T; Matsui, T; Shimono, R; Maede, Y; Minakami, H				Kato, E.; Ibara, S.; Kumazawa, K.; Maruyama, Y.; Tokuhisa, T.; Matsui, T.; Shimono, R.; Maede, Y.; Minakami, H.			Effects of supplemental oxygen on urinary 8-hydroxy-2 '-deoxyguanosine levels in extremely low birth weight infants	FREE RADICAL RESEARCH			English	Article						biomarker; oxidative stress; oxygen supplementation; preterm infants; reactive oxygen species	OXIDATIVE STRESS; BRONCHOPULMONARY DYSPLASIA; NECROTIZING ENTEROCOLITIS; LIPID-PEROXIDATION; PRETERM INFANTS; BREAST-MILK; VITAMIN-E; BIOMARKERS; TERM; EXCRETION	As the effects of supplementary oxygen on urinary excretion of 8-hydroxy-2'-deoxyguanosine (8-OHdG) are poorly understood, urinary 8-OHdG levels (ng/mg creatinine) were determined longitudinally on the postnatal day (PND) 1, 3, and 30 in 16 neonates with birth weight < 1000 g. No supplementary oxygen was required in 9 neonates during the first 24 h of life. Urinary 8-OHdG level on PND 1 was inversely correlated with birth weight in these 9 neonates (P = 0.0323) and was higher in four with birth weight < 750 g than five with birth weight > 750 g (41.0 +/- 6.9 vs. 5.6 +/- 2.7, respectively, P = 0.0200). Median urinary 8-OHdG on PND 1 of these 9 neonates was significantly lower than that of 7 neonates with oxygen (9.3 vs. 60.2, respectively), although there were no significant differences in clinical background, such as birth weight, between the two groups. Five of the 9 did not require supplemental oxygen at all during the first 30 days of life. Median urinary 8-OHdG levels were consistently significantly lower in the 5 neonates than in 11 neonates with oxygen transiently or persistently (9.3 vs. 54.6, 19.1 vs. 61.4, and 28.3 vs. 145 on PND 1, 3, and 30, respectively), although there were no differences in clinical background, such as birth weight, between the two groups. Urinary 8-OHdG on PND 30 was significantly positively correlated with supplemental oxygen dose on PND 30 (P < 0.0001), but not with birth weight in the 16 neonates. These results suggest that higher supplemental oxygen tension caused higher urinary 8-OHdG in this population.	[Kato, E.; Ibara, S.; Kumazawa, K.; Maruyama, Y.; Tokuhisa, T.; Matsui, T.; Shimono, R.; Maede, Y.] Kagoshima City Hosp, Div Neonatol, Perinatal Med Ctr, Kagoshima, Japan; [Minakami, H.] Hokkaido Univ, Grad Sch Med, Dept Obstet, Sapporo, Hokkaido, Japan	Kato, E (reprint author), Funabashi Cent Hosp, Dept Neonatol, 1-13-10 Kaijin, Funabashi, Chiba 2738556, Japan.	e.kato.funa@funasyusanki.ecnet.jp					Bogdanov MB, 1999, FREE RADICAL BIO MED, V27, P647, DOI 10.1016/S0891-5849(99)00113-6; Georgeson GD, 2002, EUR J OBSTET GYN R B, V103, P136, DOI 10.1016/S0301-2115(02)00050-7; Shoji H, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.018390; Joung KE, 2011, FREE RADICAL RES, V45, P1024, DOI 10.3109/10715762.2011.588229; LINDEMAN JHN, 1989, PEDIATR RES, V26, P20, DOI 10.1203/00006450-198907000-00008; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; PITKANEN OM, 1990, J PEDIATR-US, V116, P760, DOI 10.1016/S0022-3476(05)82668-X; Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P698, DOI 10.1016/j.freeradbiomed.2004.09.017; Baydas G, 2002, ARCH MED RES, V33, P276, DOI 10.1016/S0188-4409(02)00356-9; Il'yasova D, 2012, CLIN CHIM ACTA, V413, P1446, DOI 10.1016/j.cca.2012.06.012; Drury JA, 1998, FREE RADICAL RES, V28, P423, DOI 10.3109/10715769809070811; Dziaman T, 2007, FREE RADICAL RES, V41, P997, DOI 10.1080/10715760701468757; FUJIMURA M, 1977, ARCH DIS CHILD, V52, P105; Kawada S, 2008, J STRENGTH COND RES, V22, P66, DOI 10.1519/JSC.0b013e31815eefa2; Matsubasa T, 2002, FREE RADICAL RES, V36, P189, DOI 10.1080/10715760290006510; MULLER DPR, 1992, EYE, V6, P221; OKUR H, 1995, J PEDIATR SURG, V30, P1416, DOI 10.1016/0022-3468(95)90395-X; Phylactos AC, 1995, ACTA PAEDIATR, V84, P1421, DOI 10.1111/j.1651-2227.1995.tb13580.x; Rogers S, 2000, ARCH PEDIAT ADOL MED, V154, P544; Saugstad OD, 1997, ACTA PAEDIATR, V86, P1277, DOI 10.1111/j.1651-2227.1997.tb14897.x; Shoji H, 2003, PEDIATR RES, V53, P850, DOI 10.1203/01.PDR.0000058924.30819.17; SULLIVAN JL, 1988, ARCH DIS CHILD, V63, P748; Tsukahara H, 2005, PEDIATR INT, V47, P528, DOI 10.1111/j.1442-200x.2005.02123.x; Tsukahara H, 2004, LIFE SCI, V75, P933, DOI 10.1016/j.lfs.2004.01.025	25	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1071-5762	1029-2470		FREE RADICAL RES	Free Radic. Res.	NOV	2014	48	11					1285	1290		10.3109/10715762.2014.951841		6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AQ4LC	WOS:000342767500002		
J	Hara, S; Kobayashi, M; Kuriiwa, F; Mukai, T; Mizukami, H				Hara, S.; Kobayashi, M.; Kuriiwa, F.; Mukai, T.; Mizukami, H.			Different mechanisms of hydroxyl radical production susceptible to purine P2 receptor antagonists between carbon monoxide poisoning and exogenous ATP in rat striatum	FREE RADICAL RESEARCH			English	Article						carbon monoxide poisoning; hydroxyl radical; ATP; P2 receptor antagonists; rat striatum	IN-VIVO; PHARMACOLOGICAL PROFILES; P2Y(11)-LIKE RECEPTORS; GLUTAMATE RELEASE; P2X(6) RECEPTORS; P2Y(4) RECEPTORS; SENSORY NEURONS; NITRIC-OXIDE; BRAIN; ACTIVATION	Previous studies have suggested that carbon monoxide (CO) poisoning stimulates cAMP production via purine P2Y11-like receptors in the rat striatum, activating cAMP signaling pathways, resulting in hydroxyl radical ((OH)-O-center dot) production. Extracellular ATP was thought likely to trigger the cascade, but the present study has failed to demonstrate a clear increase in the extracellular ATP due to CO poisoning. The CO-induced (OH)-O-center dot production was attenuated by the P2Y11 receptor antagonist NF157, in parallel with its abilities to suppress the CO-induced cAMP production. The (OH)-O-center dot production was more strongly suppressed by a non-selective P2 receptor antagonist, PPADS, which had no effect on cAMP production. More selective antagonists toward the respective P2 receptors susceptible to PPADS, including NF279, had little or no effect on the CO-induced (OH)-O-center dot production. The intrastriatal administration of exogenous ATP dose-dependently stimulated (OH)-O-center dot production, which was dose-dependently antagonized by PPADS and NF279 but not by NF157. Exogenous GTP and CTP dose-dependently stimulated (OH)-O-center dot production, though less potently. The GTP-induced (OH)-O-center dot production was susceptible to both of NF279 and PPADS, but the CTP-induced (OH)-O-center dot production was resistant to PPADS. The mechanism of (OH)-O-center dot production may differ between CO poisoning and exogenous ATP, while multiple P2 receptors could participate in (OH)-O-center dot production. The CO-induced (OH)-O-center dot production was susceptible to the inhibition of NADPH oxidase, but not xanthine oxidase. Also, the NADPH oxidase inhibition suppressed (OH)-O-center dot production induced by forskolin, a stimulator of intracellular cAMP formation. It is likely that (OH)-O-center dot is produced by NADPH oxidase activation via cAMP signaling pathways during CO poisoning.	[Hara, S.; Kobayashi, M.; Kuriiwa, F.; Mizukami, H.] Tokyo Med Univ, Dept Forens Med, Tokyo 1608402, Japan; [Mukai, T.] St Marianna Univ, Sch Med, Dept Legal Med, Kawasaki, Kanagawa, Japan	Hara, S (reprint author), Tokyo Med Univ, Dept Forens Med, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	s-hara@tokyo-med.ac.jp			Ministry of Education, Science, Sports and Culture, Japan [21590747, 24590866]	S. Hara reports a Grant-in-Aid for Scientific Research (C) (21590747 and 24590866) from the Ministry of Education, Science, Sports and Culture, Japan, during the conduct of the study. M. Kobayashi, F. Kuriiwa, T. Mukai and H. Mizukami report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Donnelly-Roberts DL, 2009, BRIT J PHARMACOL, V157, P1203, DOI 10.1111/j.1476-5381.2009.00233.x; Tofighi R, 2006, BRAIN RES, V1098, P1, DOI 10.1016/j.brainres.2006.04.095; O'Donnell P, 2000, CLIN RADIOL, V55, P273, DOI 10.1053/crad.1999.0369; Franke H, 2006, PFLUG ARCH EUR J PHY, V452, P622, DOI 10.1007/s00424-006-0071-8; Rodrigues RJ, 2005, J NEUROSCI, V25, P6286, DOI 10.1523/JNEUROSCI.0628-05.2005; Jaquet V, 2009, ANTIOXID REDOX SIGN, V11, P2535, DOI 10.1089/ARS.2009.2585; Rigutto S, 2009, J BIOL CHEM, V284, P6725, DOI 10.1074/jbc.M806893200; Xing JH, 2008, BRAIN RES, V1208, P46, DOI 10.1016/j.brainres.2008.02.083; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1250; Soto F, 1996, P NATL ACAD SCI USA, V93, P3684, DOI 10.1073/pnas.93.8.3684; Obata T, 2006, J NEURAL TRANSM, V113, P1131, DOI 10.1007/s00702-005-0415-0; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Hampson NB, 2008, AM J EMERG MED, V26, P665, DOI 10.1016/j.ajem.2007.10.005; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Shen MH, 2013, CNS NEUROSCI THER, V19, P361, DOI 10.1111/cns.12094; Kostandy BB, 2012, NEUROL SCI, V33, P223, DOI 10.1007/s10072-011-0828-5; Gale SD, 1999, BRAIN INJURY, V13, P229, DOI 10.1080/026990599121601; Hibell AD, 2001, J PHARMACOL EXP THER, V296, P947; Jiang LH, 2000, MOL PHARMACOL, V58, P82; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Balogh J, 2005, J MOL CELL CARDIOL, V39, P223, DOI 10.1016/j.yjmcc.2005.03.007; Baqi Y, 2011, J MED CHEM, V54, P817, DOI 10.1021/jm1012193; O'Shea SD, 2008, SENSORS-BASEL, V8, P7428, DOI 10.3390/s8117428; Diatchuk V, 1997, J BIOL CHEM, V272, P13292, DOI 10.1074/jbc.272.20.13292; von Kugelgen I, 2000, N-S ARCH PHARMACOL, V362, P310, DOI 10.1007/s002100000310; Lin YP, 2005, NEUROSCI LETT, V377, P97, DOI 10.1016/j.neulet.2004.11.075; Michel AD, 2008, BRIT J PHARMACOL, V153, P737, DOI 10.1038/sj.bjp.0707625; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Parvathenani LK, 2003, J BIOL CHEM, V278, P13309, DOI 10.1074/jbc.M209478200; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Amadio S, 2005, NEUROCHEM INT, V47, P334, DOI 10.1016/j.neuint.2005.05.008; Sun QA, 2011, CRIT CARE MED, V39, P765, DOI 10.1097/CCM.0b013e318206bf44; Ullmann H, 2005, J MED CHEM, V48, P7040, DOI 10.1021/jm050301p; Choi IS, 1999, EUR NEUROL, V42, P141, DOI 10.1159/000008088; Bennett GC, 2003, BRIT J PHARMACOL, V139, P279, DOI 10.1038/sj.bjp.0705242; BO XN, 1995, FEBS LETT, V375, P129, DOI 10.1016/0014-5793(95)01203-Q; Bo XN, 2003, MOL PHARMACOL, V63, P1407, DOI 10.1124/mol.63.6.1407; Brown SG, 2000, DRUG DEVELOP RES, V49, P253; Buell G, 1996, EMBO J, V15, P55; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; Church WH, 1999, EXP BRAIN RES, V127, P147, DOI 10.1007/s002210050784; Collo G, 1996, J NEUROSCI, V16, P2495; Damer S, 1998, EUR J PHARMACOL, V350, pR5, DOI 10.1016/S0014-2999(98)00316-1; Damiano S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034405; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; Ernst A, 1998, NEW ENGL J MED, V339, P1603, DOI 10.1056/NEJM199811263392206; Ginsberg MD., 1980, EXPT CLIN NEUROTOXIC, P374; Hara S, 2011, ARCH TOXICOL, V85, P1091, DOI 10.1007/s00204-010-0637-2; Hara S, 2011, TOXICOLOGY, V288, P49, DOI 10.1016/j.tox.2011.07.001; Hara S, 2012, FREE RADICAL BIO MED, V52, P1086, DOI 10.1016/j.freeradbiomed.2012.01.002; Hara S, 2004, BRAIN RES, V1016, P281, DOI 10.1016/j.brainres.2004.05.047; INGELMANSUNDBERG M, 1991, BIOCHEM J, V276, P753; Jones CA, 2004, MOL PHARMACOL, V65, P979, DOI 10.1124/mol.65.4.979; Juranyi Z, 1999, BRAIN RES, V823, P183, DOI 10.1016/S0006-8993(99)01169-5; Kil HY, 1996, J CEREBR BLOOD F MET, V16, P100; King BF, 1997, BRIT J PHARMACOL, V121, P1445, DOI 10.1038/sj.bjp.0701286; Lancelot E, 1998, BRAIN RES, V809, P294, DOI 10.1016/S0006-8993(98)00942-1; LAURENZA A, 1987, MOL PHARMACOL, V32, P133; Liu M, 2001, J PHARMACOL EXP THER, V296, P1043; Miyoshi H, 2012, REPROD SCI, V19, P1285, DOI 10.1177/1933719112450333; Paxinos G, 1998, RAT BRAIN STEREOTAXI; Perez-Andres E, 2002, J LIPID RES, V43, P1244, DOI 10.1194/jlr.M100372-JLR200; PHILLIS JW, 1993, NEUROSCI LETT, V151, P94, DOI 10.1016/0304-3940(93)90054-O; Rettinger J, 2000, NEUROPHARMACOLOGY, V39, P2044, DOI 10.1016/S0028-3908(00)00022-8; Ryu JK, 2002, NEUROREPORT, V13, P1611, DOI 10.1097/00001756-200209160-00008; Talasila A, 2009, BRIT J PHARMACOL, V158, P339, DOI 10.1111/j.1476-5381.2009.00172.x; Teismann P, 2000, BRAIN RES PROTOC, V5, P204, DOI 10.1016/S1385-299X(00)00014-3; Themann C, 2001, J NEUROSCI METH, V108, P57, DOI 10.1016/S0165-0270(01)00370-3; Varma DR, 2009, HANDBOOK OF TOXICOLOGY OF CHEMICAL WARFARE AGENTS, P271, DOI 10.1016/B978-0-12-374484-5.00020-1; Wildman SS, 2003, BRIT J PHARMACOL, V140, P1177, DOI 10.1038/sj.bjp.0705544; Wildman SS, 2002, MOL PHARMACOL, V62, P957, DOI 10.1124/mol.62.4.957; Xia XG, 2001, J NEUROCHEM, V79, P63, DOI 10.1046/j.1471-4159.2001.00525.x	74	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1071-5762	1029-2470		FREE RADICAL RES	Free Radic. Res.	NOV	2014	48	11					1322	1333		10.3109/10715762.2014.951842		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AQ4LC	WOS:000342767500006		
J	Matsunaga, T; Yamaji, Y; Tomokuni, T; Morita, H; Morikawa, Y; Suzuki, A; Yonezawa, A; Endo, S; Ikari, A; Iguchi, K; El-Kabbani, O; Tajima, K; Hara, A				Matsunaga, T.; Yamaji, Y.; Tomokuni, T.; Morita, H.; Morikawa, Y.; Suzuki, A.; Yonezawa, A.; Endo, S.; Ikari, A.; Iguchi, K.; El-Kabbani, O.; Tajima, K.; Hara, A.			Nitric oxide confers cisplatin resistance in human lung cancer cells through upregulation of aldo-keto reductase 1B10 and proteasome	FREE RADICAL RESEARCH			English	Article						cisplatin resistance; nitric oxide; aldo-keto reductase 1B10; lung cancer; peroxynitrite	NF-KAPPA-B; HUMAN SERUM-ALBUMIN; ENDOTHELIAL-CELLS; SELECTIVITY POCKET; S-NITROSYLATION; GENE-REGULATION; COLON-CANCER; ACTIVE-SITE; MITOMYCIN-C; EXPRESSION	In this study, we show that exposure of human lung cancer A549 cells to cisplatin (cis-diamminedichloroplatinum, CDDP) promotes production of nitric oxide (NO) through generation of reactive oxygen species (ROS) and resulting upregulation of inducible NO synthase (iNOS). The incubation of the cells with a NO donor, diethylenetriamine NONOate, not only reduced the CDDP-induced cell death and apoptotic alterations (induction of CCAAT-enhancer-binding protein homologous protein and caspase-3 activation), but also elevated proteolytic activity of 26S proteasome, suggesting that the activation of proteasome function contributes to the reduction of CDDP sensitivity by NO. Monitoring expression levels of six aldo-keto reductases (AKRs) (1A1, 1B1, 1B10, 1C1, 1C2, and 1C3) during the treatment with the NO donor and subsequent CDDP sensitivity test using the specific inhibitors also proposed that upregulation of AKR1B10 by NO is a key process for acquiring the CDDP resistance in A549 cells. Treatment with CDDP and NO increased amounts of nitrotyrosine protein adducts, indicative of peroxynitrite formation, and promoted the induction of AKR1B10, inferring a relationship between peroxynitrite formation and the enzyme upregulation in the cells. The treatment with CDDP or a ROS-related lipid aldehyde, 4-hydroxy-2-nonenal, facilitated the iNOS upregulation, which was restored by increasing the AKR1B10 expression. In contrast, the facilitation of NO production by CDDP treatment was hardly observed in AKR1B10-overexpressing A549 cells and established CDDP-resistant cancer cells (A549, LoVo, and PC3). Collectively, these results suggest the NO functions as a key regulator controlling AKR1B10 expression and 26S proteasome function leading to gain of the CDDP resistance.	[Matsunaga, T.; Yamaji, Y.; Tomokuni, T.; Morita, H.; Morikawa, Y.; Suzuki, A.; Yonezawa, A.; Endo, S.; Ikari, A.] Gifu Pharmaceut Univ, Biochem Lab, Gifu 5011196, Japan; [Iguchi, K.] Gifu Pharmaceut Univ, Lab Clin Pharm, Gifu 5011196, Japan; [El-Kabbani, O.] Monash Univ, Monash Inst Pharmaceut Sci, Clayton, Vic 3800, Australia; [Tajima, K.] Hokuriku Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 92011, Japan; [Hara, A.] Gifu Univ, Fac Engn, Gifu 50111, Japan	Matsunaga, T (reprint author), Gifu Pharmaceut Univ, Biochem Lab, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	matsunagat@gifu-pu.ac.jp			Japan Society for the Promotion of Science [25460068]	This work was supported in part by a grant-in-aids for scientific research (C) (25460068) from the Japan Society for the Promotion of Science.	HUGHES MN, 1968, J CHEM SOC A, P450, DOI 10.1039/j19680000450; Rao CV, 2004, MUTAT RES-FUND MOL M, V555, P107, DOI 10.1016/j.mrfmmm.2004.05.022; Das J, 2011, BIOCHEM PHARMACOL, V81, P891, DOI 10.1016/j.bcp.2011.01.008; YOKOMIZO A, 1995, CANCER RES, V55, P4293; Wong JC, 2012, J CELL BIOCHEM, V113, P3587, DOI 10.1002/jcb.24237; Aranda E, 2012, CURR MOL MED, V12, P50; NATHAN C, 1992, FASEB J, V6, P3051; Endo S, 2009, ARCH BIOCHEM BIOPHYS, V487, P1, DOI 10.1016/j.abb.2009.05.009; Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m; Matsunaga T, 2014, TOXICOL APPL PHARM, V278, P180, DOI 10.1016/j.taap.2014.04.024; Crosas B, 2003, BIOCHEM J, V373, P973, DOI 10.1042/BJ20021818; Matsunaga T, 2013, CHEM-BIOL INTERACT, V202, P234, DOI 10.1016/j.cbi.2012.09.024; Baruah H, 2004, CURR TOP MED CHEM, V4, P1537, DOI 10.2174/1568026043387313; KASAHARA K, 1991, CANCER RES, V51, P3237; Heringlake S, 2010, J HEPATOL, V52, P220, DOI 10.1016/j.jhep.2009.11.005; Speranza L, 2007, INT J BIOL MARKER, V22, P226; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Owatari S, 2007, CANCER RES, V67, P4860, DOI 10.1158/0008-5472.CAN-06-3096; MARLETTA MA, 1994, CELL, V78, P927, DOI 10.1016/0092-8674(94)90268-2; Endo S, 2010, ARCH BIOCHEM BIOPHYS, V503, P230, DOI 10.1016/j.abb.2010.08.010; Maimaitiyiming H, 2013, AM J PHYSIOL-RENAL, V305, pF881, DOI 10.1152/ajprenal.00192.2013; Yan RL, 2007, INT J CANCER, V121, P2301, DOI 10.1002/ijc.22933; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Takemura M, 2011, J NAT PROD, V74, P1201, DOI 10.1021/np200118q; Cao DL, 1998, J BIOL CHEM, V273, P11429, DOI 10.1074/jbc.273.19.11429; Liu H, 2005, J AM SOC NEPHROL, V16, P1985, DOI 10.1681/ASN.20004090768; Liu CY, 1998, BRIT J CANCER, V78, P534, DOI 10.1038/bjc.1998.528; Anestal K, 2003, J BIOL CHEM, V278, P15966, DOI 10.1074/jbc.M210733200; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Martin HJ, 2009, CHEM-BIOL INTERACT, V178, P145, DOI 10.1016/j.cbi.2008.10.021; Lin YD, 2011, LUNG CANCER, V71, P291, DOI 10.1016/j.lungcan.2010.06.004; Chanvorachote P, 2006, CANCER RES, V66, P6353, DOI 10.1158/0008-5472.CAN-05-4533; Song J, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/846126; Alvarez B, 1999, J BIOL CHEM, V274, P842, DOI 10.1074/jbc.274.2.842; Fukumoto S, 2005, CLIN CANCER RES, V11, P1776, DOI 10.1158/1078-0432.CCR-04-1238; Soda M, 2012, EUR J MED CHEM, V48, P321, DOI 10.1016/j.ejmech.2011.12.034; Babbar N, 2006, CANCER RES, V66, P11125, DOI 10.1158/0008-5472.CAN-06-3174; BUNGO M, 1990, CANCER RES, V50, P2549; BUNN PA, 1989, SEMIN ONCOL, V16, P10; Chung YM, 2001, ANTICANCER RES, V21, P1129; Coling DE, 2007, HEARING RES, V226, P140, DOI 10.1016/j.heares.2006.12.017; Dawson TM, 1996, ANNU REV MED, V47, P219; El-Kabbani O, 2009, J MED CHEM, V52, P3259, DOI 10.1021/jm9001633; Endo S, 2011, CHEM-BIOL INTERACT, V191, P261, DOI 10.1016/j.cbi.2010.12.017; ESTERBAU.H, 1967, MONATSH CHEM, V98, P1994, DOI 10.1007/BF01167162; FORSTERMANN U, 1995, BIOCHEM PHARMACOL, V50, P1321, DOI 10.1016/0006-2952(95)00181-6; Hirst D, 2010, CURR PHARM DESIGN, V16, P411; Iino T, 2003, ARCH BIOCHEM BIOPHYS, V416, P180, DOI 10.1016/S0003-9861(03)00295-9; Kaur H, 1998, J NEUROCHEM, V70, P2220; Kotamraju S, 2006, FREE RADICAL BIO MED, V40, P1034, DOI 10.1016/j.freeradbiomed.2005.10.052; Lala P K, 2001, Lancet Oncol, V2, P149, DOI 10.1016/S1470-2045(00)00256-4; Li Q, 2006, J BIOL CHEM, V281, P1495, DOI 10.1074/jbc.M51153200; Matsunaga T, 2004, J BIOL CHEM, V279, P28614, DOI 10.1074/jbc.M400977200; Matsunaga T, 2012, BIOL PHARM BULL, V35, P1598; Matsunaga T, 2011, ANTI-CANCER DRUG, V22, P402, DOI 10.1097/CAD.0b013e3283448df0; Matsunaga T, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00005; MEIJER C, 1990, BRIT J CANCER, V62, P72, DOI 10.1038/bjc.1990.232; Mohan S, 1997, AM J PHYSIOL-CELL PH, V273, pC572; Sanson M, 2009, CIRC RES, V104, P328, DOI 10.1161/CIRCRESAHA.108.183749; Shen Y, 2011, CHEM-BIOL INTERACT, V191, P192, DOI 10.1016/j.cbi.2011.02.004; Shiraishi H, 1999, ADV EXP MED BIOL, V463, P539; Srivastava AN, 2010, ASIAN PAC J CANCER P, V11, P465; Usui S, 1997, BIOSCI BIOTECH BIOCH, V61, P1924; Wongvaranon P, 2013, ANTICANCER RES, V33, P5433; XIE QW, 1994, J BIOL CHEM, V269, P4705	67	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1071-5762	1029-2470		FREE RADICAL RES	Free Radic. Res.	NOV	2014	48	11					1371	1385		10.3109/10715762.2014.957694		15	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AQ4LC	WOS:000342767500011		
J	Takano, S; Ishikawa, E; Matsuda, M; Yamamoto, T; Matsumura, A				Takano, Shingo; Ishikawa, Eiichi; Matsuda, Masahide; Yamamoto, Tetsuya; Matsumura, Akira			Interferon-beta inhibits glioma angiogenesis through downregulation of vascular endothelial growth factor and upregulation of interferon inducible protein 10	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						angiogenesis; glioma; interferon-beta; interferon inducible protein 10; vascular endothelial growth factor	GENE-EXPRESSION; IFN-BETA; MALIGNANT GLIOMAS; ALPHA-INTERFERON; VEGF SECRETION; CELL LINES; PHASE-II; TEMOZOLOMIDE; THERAPY; GLIOBLASTOMA	Interferon-beta (IFN-beta) has been used clinically for malignant glioma growth inhibition. Recently IFN-beta is re-evaluated for its sensitization mechanism to the chemotherapeutic agent temozolomide, because angiogenesis is essential for malignant glioma growth. In this study, we investigated new mechanisms of inhibition of glioma angiogenesis by IFN-beta. Three malignant glioma cell lines, U87, TK2 and Becker, were used for in vitro study. The effect of IFN-beta for these cell lines were evaluated by means of proliferation (MTT assay), conditioned medium induced HUVEC migration, VEGF and interferon inducible protein 10 (IP10, angiogenesis inhibitor) expression by RT-PCR and western blot analysis. SCID mouse U87 subcutaneous model and U87 implant cranial window model were used for in vivo study. The effect of IFN-beta with the models was evaluated by means of tumor growth, tumor tissue expression for VEGF and IP10, tumor tissue CD31 positive vessel densities, apoptosis and tumor microcirculation (blood velocity, interaction between leukocytes and endothelial cells). In vitro, IFN-beta upregulated IP10 expression and downregulated VEGF expression time-(4-48 h) and dose-(10-5,000 U/ml) dependently. At the same dose, glioma cell-induced HUVEC migration was inhibited, but cell proliferation was not affected. IFN-beta local and systemic injection at 10(5)U and at 5x10(5)U/day, for 15 days inhibited U87 subcutaneous growth significantly. In the tumor tissues, VEGF expression and vessel densities were downregulated, but IP10 expression and apoptosis index upregulated. In addition, IFN-beta local injection increased collagen fiber deposition in the tumor tissues. IFN-beta 5x10(5) U/day, s.c. injection for 7 days reversed the decreased leukocyte adhesion to endothelial cells, but did not affect blood velocity and vessel images. One of the important roles of IFN-beta for malignant glioma growth inhibition was anti-angiogenesis by directly inhibiting angiogenesis through downregulation of VEGF and upregulation of IP-10 and indirectly changing the tumor microcirculation and regulating the interstitial pressure.	[Takano, Shingo; Ishikawa, Eiichi; Matsuda, Masahide; Yamamoto, Tetsuya; Matsumura, Akira] Univ Tsukuba, Fac Med, Dept Neurosurg, Tsukuba, Ibaraki 3058575, Japan	Takano, S (reprint author), Univ Tsukuba, Fac Med, Dept Neurosurg, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	shingo4@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Brain Foundation; Japanese Foundation for Multidisciplinary Treatment of Cancer	We gratefully acknowledge Norio Ohshima, Department of Biomedical Engineering, University of Tsukuba, Koji Tsuboi, Proton Medical Research Center, University of Tsukuba, and Youji Mitsui, Biophysiology, Tokushima Bunri University for the excellent discussion, Toray Industries, Inc. and Daiichi Pharmaceutical Co. for supply of human interferon-beta, and Yoshiko Tsukada, Makiko Miyagawa, and Momoyo Ito for the excellent technical assistance. This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S.T.), Japan Brain Foundation (S.T.) and Japanese Foundation for Multidisciplinary Treatment of Cancer (S.T.).	TAKANO S, 1994, CANCER RES, V54, P2654; REAL FX, 1986, J CLIN ONCOL, V4, P544; Cindrova-Davies T, 2011, CARDIOVASC RES, V89, P671, DOI 10.1093/cvr/cvq346; Colman H, 2006, INT J RADIAT ONCOL, V66, P818, DOI 10.1016/j.ijrobp.2006.05.021; Takano S, 1996, CANCER RES, V56, P2185; Natsume A, 2005, CANCER RES, V65, P7573, DOI 10.1158/0008-5472.CAN-05-0036; SINGH RK, 1995, P NATL ACAD SCI USA, V92, P4562, DOI 10.1073/pnas.92.10.4562; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Norden AD, 2008, LANCET NEUROL, V7, P1152, DOI 10.1016/S1474-4422(08)70260-6; Dinney CPN, 1998, CANCER RES, V58, P808; Zheng H, 2011, BLOOD, V118, P4003, DOI 10.1182/blood-2011-06-359745; Bjorndahl M, 2004, CIRC RES, V94, P1443, DOI 10.1161/01.RES.0000129194.61747.bf; Emblem KE, 2013, NAT MED, V19, P1178, DOI 10.1038/nm.3289; BREM S, 1972, J NATL CANCER I, V48, P347; Wakabayashi T, 2011, J NEURO-ONCOL, V104, P573, DOI 10.1007/s11060-011-0529-1; Fatterpekar GM, 2012, AM J ROENTGENOL, V198, P19, DOI 10.2214/AJR.11.7417; Liu ML, 2011, ONCOL LETT, V2, P583, DOI 10.3892/ol.2011.300; Yoshino A, 2011, INT J ONCOL, V39, P529, DOI 10.3892/ijo.2011.1068; YUAN F, 1994, CANCER RES, V54, P4564; Motomura K, 2011, CANCER-AM CANCER SOC, V117, P1721, DOI 10.1002/cncr.25637; Keane MP, 1998, P ASSOC AM PHYSICIAN, V110, P288; Nagane M, 2012, JPN J CLIN ONCOL, V42, P887, DOI 10.1093/jjco/hys121; Arenberg DA, 1996, J EXP MED, V184, P981, DOI 10.1084/jem.184.3.981; Xiao HB, 2012, GENE THER, V19, P1030, DOI 10.1038/gt.2011.171; Bedogni B, 2004, CANCER RES, V64, P2552, DOI 10.1158/0008-5472.CAN-03-3327; BOETHIUS J, 1983, ACTA NEUROCHIR, V68, P239, DOI 10.1007/BF01401182; BOORSMA DM, 1994, ARCH DERMATOL RES, V286, P471, DOI 10.1007/BF00371574; Boucher E, 2000, P AM ASSOC CANC RES, V41; EZEKOWITZ RAB, 1992, NEW ENGL J MED, V326, P1456, DOI 10.1056/NEJM199205283262203; Fine HA, 1997, CLIN CANCER RES, V3, P381; FOLTZ RM, 1995, NEUROSURGERY, V36, P976; Goel S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006486; GOHJI K, 1994, INT J CANCER, V58, P380, DOI 10.1002/ijc.2910580313; Hong YK, 2000, CLIN CANCER RES, V6, P3354; Kallmann BA, 2000, BRAIN, V123, P687, DOI 10.1093/brain/123.4.687; Kirn DH, 1996, J NATL CANCER I, V88, P764, DOI 10.1093/jnci/88.11.764-b; Lou JN, 1999, LAB INVEST, V79, P1015; OLIVEIRA IC, 1992, P NATL ACAD SCI USA, V89, P9049, DOI 10.1073/pnas.89.19.9049; ORCHARD PJ, 1989, LANCET, V2, P565; Raig ET, 2008, J INTERF CYTOK RES, V28, P553, DOI 10.1089/jir.2008.0118; Rozera C, 1999, AM J PATHOL, V154, P1211, DOI 10.1016/S0002-9440(10)65373-4; Sato E, 2007, ONCOLOGY-BASEL, V73, P246, DOI 10.1159/000127422; STOUT AJ, 1993, INT J EXP PATHOL, V74, P79; Suzuki Toshishige, 1996, Frontiers of Medical and Biological Engineering, V7, P253; Takano S, 2000, J CANCER RES CLIN, V126, P145, DOI 10.1007/s004320050024; Von Marschall A, 2003, JNCI-J NATL CANCER I, V95, P421; Yoshino A, 2009, INT J ONCOL, V35, P139, DOI 10.3892/ijo_00000322	47	2	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	NOV	2014	45	5					1837	1846		10.3892/ijo.2014.2620		10	Oncology	Oncology	AQ3SN	WOS:000342713900007		
J	Yoshikawa, T; Takahara, M; Tomiyama, M; Nieda, M; Maekawa, R; Nakatsura, T				Yoshikawa, Toshiaki; Takahara, Masashi; Tomiyama, Mai; Nieda, Mie; Maekawa, Ryuji; Nakatsura, Tetsuya			Large-scale expansion of gamma delta T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapy	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						adoptive cell transfer; cytotoxic T lymphocyte; gamma delta T cell; glypican-3; hepatocellular carcinoma	HEPATOCELLULAR-CARCINOMA; CANCER-IMMUNOTHERAPY; GLYPICAN-3 EXPRESSION; TUMOR-CELLS; POOR-PROGNOSIS; ANTIGEN; VACCINE; IDENTIFICATION; LYMPHOCYTES; SURVIVAL	Specific cellular immunotherapy for cancer requires efficient generation and expansion of cytotoxic T lymphocytes (CTLs) that recognize tumor-associated antigens. However, it is difficult to isolate and expand functionally active T-cells ex vivo. In this study, we investigated the efficacy of a new method to induce expansion of antigen-specific CTLs for adoptive immunotherapy. We used tumor-associated antigen glypican-3 (GPC3)-derived peptide and cytomegalovirus (CMV)-derived peptide as antigens. Treatment of human peripheral blood mononuclear cells (PBMCs) with zoledronate is a method that enables large-scale gamma delta T-cell expansion. To induce expansion of gamma delta T cells and antigen-specific CTLs, the PBMCs of healthy volunteers or patients vaccinated with GPC3 peptide were cultured with both peptide and zoledronate for 14 days. The expansion of gamma delta T cells and peptide-specific CTLs from a few PBMCs using zoledronate yields cell numbers sufficient for adoptive transfer. The rate of increase of GPC3-specific CTLs was approximately 24- to 170,000-fold. These CD8(+) cells, including CTLs, showed GPC3-specific cytotoxicity against SK-Hep-1/hGPC3 and 12 pulsed with GPC3 peptide, but not against SK-Hep-l/vec and T2 pulsed with human immunodeficiency virus peptide. On the other hand, CD8(-) cells, including gamma delta T cells, showed cytotoxicity against SK-Hep-1/hGPC3 and SK-Hep-l/vec, but did not show GPC3 specificity. Furthermore, adoptive cell transfer of CD8(+) cells, CD8(-) cells, and total cells after expansion significantly inhibited tumor growth in an NOD/SCID mouse model. This study indicates that simultaneous expansion of gamma delta T cells and peptide-specific CTLs using zoledronate is useful for adoptive immunotherapy.	[Yoshikawa, Toshiaki; Nakatsura, Tetsuya] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Canc Immunotherapy, Kashiwa, Chiba 2778577, Japan; [Takahara, Masashi; Tomiyama, Mai; Nieda, Mie; Maekawa, Ryuji] Medinet Med Inst, Setagaya Ku, Tokyo 1580096, Japan	Nakatsura, T (reprint author), Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Canc Immunotherapy, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	tnakatsu@east.ncc.go.jp			Japan Science and Technology Agency; Ministry of Health, Labor and Welfare, Japan	This study was supported in part by the Adaptable and Seamless Technology Transfer Program from the Japan Science and Technology Agency, as well as Health and Labor Science Research Grants for Clinical Research and Third Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor and Welfare, Japan.	Altvater B, 2012, CANCER IMMUNOL IMMUN, V61, P385, DOI 10.1007/s00262-011-1111-6; Aviel-Ronen S, 2008, MODERN PATHOL, V21, P817, DOI 10.1038/modpathol.2008.37; Chargui J, 2010, J IMMUNOTHER, V33, P591, DOI 10.1097/CJI.0b013e3181dda207; Moser B, 2011, CELL MOL LIFE SCI, V68, P2443, DOI 10.1007/s00018-011-0706-6; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Aarntzen EHJG, 2008, CANCER IMMUNOL IMMUN, V57, P1559, DOI 10.1007/s00262-008-0553-y; Nakatsura T, 2004, CLIN CANCER RES, V10, P8630, DOI 10.1158/1078-0432.CCR-04-1177; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; Mookerjee-Basu J, 2010, J IMMUNOL, V184, P6920, DOI 10.4049/jimmunol.0904024; Shirakawa H, 2009, CANCER SCI, V100, P1403, DOI 10.1111/j.1349-7006.2009.01206.x; Nakatsura T, 2004, CLIN CANCER RES, V10, P6612, DOI 10.1158/1078-0432.CCR-04-0348; Perez SA, 2010, CANCER-AM CANCER SOC, V116, P2071, DOI 10.1002/cncr.24988; D'Asaro M, 2010, J IMMUNOL, V184, P3260, DOI 10.4049/jimmunol.0903454; Rosenberg SA, 2011, NAT REV CLIN ONCOL, V8, P577, DOI 10.1038/nrclinonc.2011.116; Nakatsura T, 2003, BIOCHEM BIOPH RES CO, V306, P16, DOI 10.1016/S0006-291X(03)00908-2; Wilhelm M, 2003, BLOOD, V102, P200, DOI 10.1182/blood-2002-12-3665; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sadelain M, 2013, CANCER DISCOV, V3, P388, DOI 10.1158/2159-8290.CD-12-0548; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; Yoshikawa T, 2011, CANCER SCI, V102, P918, DOI 10.1111/j.1349-7006.2011.01896.x; Gomes AQ, 2010, HAEMATOL-HEMATOL J, V95, P1397, DOI [10.3324/haematol.2009.020602, 10.3324/haemato1.2009.020602]; Sawada Y, 2012, CLIN CANCER RES, V18, P3686, DOI 10.1158/1078-0432.CCR-11-3044; Todaro M, 2009, J IMMUNOL, V182, P7287, DOI 10.4049/jimmunol.0804288; Komori H, 2006, CLIN CANCER RES, V12, P2689, DOI 10.1158/1078-0432.CCR-05-2267; Sant M, 2001, EUR J CANCER, V37, P1659, DOI 10.1016/S0959-8049(01)00206-4; Verdecchia A, 2007, LANCET ONCOL, V8, P784, DOI 10.1016/S1470-2045(07)70246-2; Gomes AQ, 2010, CANCER RES, V70, P10024, DOI 10.1158/0008-5472.CAN-10-3236; Nobuoka D, 2013, CANCER IMMUNOL IMMUN, V62, P639, DOI 10.1007/s00262-012-1366-6; Sakamoto M, 2011, J IMMUNOTHER, V34, P202, DOI 10.1097/CJI.0b013e318207ecfb; Capietto AH, 2011, J IMMUNOL, V187, P1031, DOI 10.4049/jimmunol.1100681; Champagne E, 2011, ARCH IMMUNOL THER EX, V59, P117, DOI 10.1007/s00005-011-0118-1; Correia DV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005657; Gertner-Dardenne J, 2009, BLOOD, V113, P4875, DOI 10.1182/blood-2008-08-172296; Landmeier S, 2009, J IMMUNOTHER, V32, P310, DOI 10.1097/CJI.0b013e31819b7c30; Maeda D, 2009, MODERN PATHOL, V22, P824, DOI 10.1038/modpathol.2009.40; Motomura Y, 2008, INT J ONCOL, V32, P985; Nakajima J, 2010, EUR J CARDIO-THORAC, V37, P1191, DOI 10.1016/j.ejcts.2009.11.051; Nedellec S, 2010, SEMIN IMMUNOL, V22, P199, DOI 10.1016/j.smim.2010.04.004; Nobuoka D, 2013, HUM VACC IMMUNOTHER, V9, P1234, DOI 10.4161/hv.23990; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Saikali Z, 2000, INT J CANCER, V89, P418; Sawada Y, 2012, ONCOIMMUNOLOGY, V1, P1448, DOI 10.4161/onci.21351; Takahara M, 2008, J LEUKOCYTE BIOL, V83, P742, DOI 10.1189/jlb.0307185; Toretsky JA, 2001, J PEDIAT HEMATOL ONC, V23, P496, DOI 10.1097/00043426-200111000-00006; Weber J, 2011, CLIN CANCER RES, V17, P1664, DOI 10.1158/1078-0432.CCR-10-2272	45	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	NOV	2014	45	5					1847	1856		10.3892/ijo.2014.2634		10	Oncology	Oncology	AQ3SN	WOS:000342713900008		
J	Watanabe, Y; Yoshimura, K; Yoshikawa, K; Tsunedomi, R; Shindo, Y; Matsukuma, S; Maeda, N; Kanekiyo, S; Suzuki, N; Kuramasu, A; Sonoda, K; Tamada, K; Kobayashi, S; Saya, H; Hazama, S; Oka, M				Watanabe, Yusaku; Yoshimura, Kiyoshi; Yoshikawa, Koichi; Tsunedomi, Ryoichi; Shindo, Yoshitaro; Matsukuma, Sou; Maeda, Noriko; Kanekiyo, Shinsuke; Suzuki, Nobuaki; Kuramasu, Atsuo; Sonoda, Kouhei; Tamada, Koji; Kobayashi, Sei; Saya, Hideyuki; Hazama, Shoichi; Oka, Masaaki			A stem cell medium containing neural stimulating factor induces a pancreatic cancer stem-like cell-enriched population	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						cancer stem cells; cell culture method; pancreatic cancer	EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; CARCINOMA; IDENTIFICATION; EXPRESSION; APOPTOSIS; GROWTH; TUMORS; LINES	Cancer stem cells (CSCs) have been studied for their self-renewal capacity and pluripotency, as well as their resistance to anticancer therapy and their ability to metastasize to distant organs. CSCs are difficult to study because their population is quite low in tumor specimens. To overcome this problem, we established a culture method to induce a pancreatic cancer stem-like cell (P-CSLC)-enriched population from human pancreatic cancer cell lines. Human pancreatic cancer cell lines established at our department were cultured in CSC-inducing media containing epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), leukemia inhibitory factor (LIF), neural cell survivor factor-1 (NSF-1), and N-acetylcysteine. Sphere cells were obtained and then transferred to a laminin-coated dish and cultured for approximately two months. The surface markers, gene expression, aldehyde dehydrogenase (ALDH) activity, cell cycle, and tumorigenicity of these induced cells were examined for their stem cell-like characteristics. The population of these induced cells expanded within a few months. The ratio of CD24high, CD44high, epithelial specific antigen (ESA) high, and CD44variant (CD44v) high cells in the induced cells was greatly enriched. The induced cells stayed in the GO/G1 phase and demonstrated mesenchymal and sternness properties. The induced cells had high tumorigenic potential. Thus, we established a culture method to induce a P-CSLC-enriched population from human pancreatic cancer cell lines. The CSLC population was enriched approximately 100-fold with this method. Our culture method may contribute to the precise analysis of CSCs and thus support the establishment of CSC-targeting therapy.	[Watanabe, Yusaku; Yoshimura, Kiyoshi; Tsunedomi, Ryoichi; Shindo, Yoshitaro; Matsukuma, Sou; Maeda, Noriko; Kanekiyo, Shinsuke; Suzuki, Nobuaki; Hazama, Shoichi; Oka, Masaaki] Yamaguchi Univ, Sch Med, Dept Digest Surg & Surg Oncol, Ube, Yamaguchi 7558505, Japan; [Yoshikawa, Koichi] Yamaguchi Univ, Sch Med, Dept Neurosurg, Ube, Yamaguchi 7558505, Japan; [Kuramasu, Atsuo] Yamaguchi Univ, Sch Med, Dept Mol Pharmacol, Ube, Yamaguchi 7558505, Japan; [Sonoda, Kouhei] Yamaguchi Univ, Sch Med, Dept Ophthalmol, Ube, Yamaguchi 7558505, Japan; [Tamada, Koji] Yamaguchi Univ, Sch Med, Dept Immunol & Cell Signaling Anal, Ube, Yamaguchi 7558505, Japan; [Kobayashi, Sei] Yamaguchi Univ, Sch Med, Dept Mol Physiol & Med Bioregulat, Ube, Yamaguchi 7558505, Japan; [Saya, Hideyuki] Keio Univ, Grad Sch Med, Inst Adv Med Res, Div Gene Regulat,Shinjuku Ku, Tokyo 1608582, Japan	Oka, M (reprint author), Yamaguchi Univ, Sch Med, Dept Digest Surg & Surg Oncol, Minami Kogushi 1-1-1, Ube, Yamaguchi 7558505, Japan.	2geka-1@yamaguchi-u.ac.jp	Saya, Hideyuki/J-4325-2013		Japan Society for the Promotion of Science KAKENHI [24390317]; Yamaguchi University	We thank Hirokazu Sadahiro and Moeko Inoue for technical support. This study was supported by Japan Society for the Promotion of Science KAKENHI grants 24390317 (to M.O.) and Yamaguchi University research grant Project of Priming Water (Strategic Research Promotion Project) (to K.Y.).	Abdullah Lissa Nurrul, 2013, Clin Transl Med, V2, P3, DOI 10.1186/2001-1326-2-3; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Tsunedomi R, 2008, CLIN CANCER RES, V14, P1025, DOI 10.1158/1078-0432.CCR-07-1116; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Takeishi S, 2013, CANCER CELL, V23, P347, DOI 10.1016/j.ccr.2013.01.026; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Zhong Y, 2010, CANCER LETT, V299, P150, DOI 10.1016/j.canlet.2010.08.013; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Costello RT, 2000, CANCER RES, V60, P4403; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; TIMPL R, 1979, J BIOL CHEM, V254, P9933; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Nagano O, 2013, ONCOGENE, V32, P5191, DOI 10.1038/onc.2012.638; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hueng DY, 2011, J NEURO-ONCOL, V104, P45, DOI 10.1007/s11060-010-0469-1; Guzman ML, 2002, P NATL ACAD SCI USA, V99, P16220, DOI 10.1073/pnas.252462599; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Mor G, 2011, CANCER BIOL THER, V11, P708, DOI 10.4161/cbt.11.8.14967; Morel Anne-Pierre, 2008, PLoS One, V3, pe2888, DOI 10.1371/journal.pone.0002888; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; TANABE KK, 1993, LANCET, V341, P725, DOI 10.1016/0140-6736(93)90490-8; Tsunedomi R, 2013, INT J ONCOL, V42, P1159, DOI 10.3892/ijo.2013.1811; Yamamoto K, 2002, B YAMAGUCHI MED SCH, V49, P33; Ziober AF, 2006, HEAD NECK-J SCI SPEC, V28, P740, DOI 10.1002/hed.20382	35	2	3	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	NOV	2014	45	5					1857	1866		10.3892/ijo.2014.2603		10	Oncology	Oncology	AQ3SN	WOS:000342713900009		
J	Nirasawa, S; Kobayashi, D; Kondoh, T; Kuribayashi, K; Tanaka, M; Yanagihara, N; Watanabe, N				Nirasawa, Shinya; Kobayashi, Daisuke; Kondoh, Takashi; Kuribayashi, Kageaki; Tanaka, Maki; Yanagihara, Nozomi; Watanabe, Naoki			Significance of serine threonine tyrosine kinase 1 as a drug resistance factor and therapeutic predictor in acute leukemia	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						serine threonine tyrosine kinase 1; mRNA expression; chemo-resistance; prediction; acute leukemia	ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; MESSENGER-RNA; DIAGNOSTIC RELEVANCE; NUDE-MICE; ONCOGENE; NOK; EXPRESSION; CELLS; TUMORIGENESIS	Alterations in the mRNA expression or the mutation of previously reported tyrosine kinases have been detected only in a limited number of patients with acute leukemia. In this study, we examined whether the widely expressed serine threonine tyrosine kinase 1 (STYK1)/novel oncogene with kinase domain (NOK) acts as a drug resistance factor in acute leukemia. The transfection of leukemic HL-60 cells with an STYK1 expression vector resulted in the resistance to doxorubicin and etoposide and decreased drug-induced caspase-3/7 activity and sub-GI population. To investigate the mechanism of STYK1-induced drug resistance, microarray analysis was performed using HL-60 cells transfected with control or STYK1 expression vectors. Three tyrosine kinases (EphA4, FLT4 and STK31), two NF-kappa B inducers (MAPK4 and TNF-RSF11A), and two genes essential for stem cell replication (SALL4 and NOV) were identified as novel STYK1-induced genes. In addition to the data using cell line, a comparison of the leukemic patients who did and did not respond to therapy revealed that STYK1 expression before therapy was significantly higher in the non-responder group compared with the group that responded completely. These results suggest that STYK1 is a novel drug resistance factor and could be a predictor of the therapeutic response in acute leukemia.	[Nirasawa, Shinya; Kobayashi, Daisuke; Kondoh, Takashi; Kuribayashi, Kageaki; Tanaka, Maki; Yanagihara, Nozomi; Watanabe, Naoki] Sapporo Med Univ, Sch Med, Dept Clin Lab Med, Sapporo, Hokkaido 0608543, Japan	Watanabe, N (reprint author), Sapporo Med Univ, Sch Med, Dept Clin Lab Med, Chuo Ku, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.	watanabn@sapmed.ac.jp			Japan Society for the Promotion of Science	Grants from 'Japan Society for the Promotion of Science' supported this study.	Amachika T, 2007, LUNG CANCER, V56, P337, DOI 10.1016/j.lungcan.2007.01.002; Tazzari PL, 2007, LEUKEMIA, V21, P427, DOI 10.1038/sj.leu.2404523; Liu L, 2004, CANCER RES, V64, P3491, DOI 10.1158/0008-5472.CAN-03-2106; Ma YP, 2006, BLOOD, V108, P2726, DOI 10.1182/blood-2006-02-001594; Gupta R, 2007, SCIENCE, V316, P590, DOI 10.1126/science.1136031; Wang YY, 2005, P NATL ACAD SCI USA, V102, P1104, DOI 10.1073/pnas.0408831102; Yanada M, 2006, J CLIN ONCOL, V24, P460, DOI 10.1200/JCO.2005.03.2177; Nakao M, 1996, LEUKEMIA, V10, P1911; George P, 2004, CANCER RES, V64, P3645, DOI 10.1158/0008-5472.CAN-04-0006; Chiarini F, 2008, LEUKEMIA, V22, P1106, DOI 10.1038/leu.2008.79; Bard JD, 2009, FASEB J, V23, P1405, DOI 10.1096/fj.08-117721; Chen Y, 2005, CANCER RES, V65, P10838, DOI 10.1158/0008-5472.CAN-05-1091; Gambacorti-Passerini CB, 2003, LANCET ONCOL, V4, P75, DOI 10.1016/S1470-2045(03)00979-3; Harbott J, 1997, BLOOD, V90, P4933; Jeong HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018372; Kondoh T, 2009, EXP HEMATOL, V37, P824, DOI 10.1016/j.exphem.2009.04.010; Moriai R, 2006, ANTICANCER RES, V26, P4969; Paietta E, 2004, BLOOD, V104, P558, DOI 10.1182/blood-2004-01-0168	18	3	3	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	NOV	2014	45	5					1867	1874		10.3892/ijo.2014.2633		8	Oncology	Oncology	AQ3SN	WOS:000342713900010		
J	Hayashido, Y; Kitano, H; Sakaue, T; Fujii, T; Suematsu, M; Sakurai, S; Okamoto, T				Hayashido, Yasutaka; Kitano, Hisataka; Sakaue, Taishi; Fujii, Takahiko; Suematsu, Mirei; Sakurai, Shigeru; Okamoto, Tetsuji			Overexpression of integrin alpha v facilitates proliferation and invasion of oral squamous cell carcinoma cells via MEK/ERK signaling pathway that is activated by interaction of integrin alpha v beta 8 with type I collagen	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						integrin alpha v; integrin beta 8; squamous cell carcinoma; proliferation; invasion; MEK/ERK signaling pathway	CANCER-CELLS; STROMAL INTERACTIONS; OVARIAN-CARCINOMA; MELANOMA-CELLS; LINKED KINASE; EXPRESSION; METASTASIS; MIGRATION; ADHESION; PROGRESSION	To examine the role of integrin alpha v subunit in the progression of squamous cell carcinoma (SCC), oral SCC cells were stably transfected with integrin av cDNA. Integrin alpha v transfectants exhibited the enhancement of proliferation on type I collagen, and seemed to have a high ability to invade type I collagen gel. Overexpression of integrin alpha v led to rapid phosphorylation of focal adhesion kinase (FAK), mitogen-activated protein kinase kinase 1/2 (MEK1/2) and extracellular signal-regulated kinase 1/2 (ERK1/2) in SCC cells on type I collagen. The downregulation of integrin beta 8 in integrin alpha v transfectants by its specific antisense oligonucleotide led to a decrease in type I collagen-stimulated activation of FAK and the MEK/ERK signaling pathway, and also suppressed the proliferation on type I collagen and the invasiveness into type I collagen gel. Moreover, the expression of integrin (38 was induced following transfection with integrin av cDNA. These results indicated that the overexpression of integrin av induces integrin alpha v beta 8 heterodimer formation and the binding of integrin alpha v beta 8 to type I collagen might enhance the proliferation and invasion of SCC cells via the activation of the MEK/ERK signaling pathway.	[Hayashido, Yasutaka; Sakaue, Taishi; Fujii, Takahiko; Suematsu, Mirei; Sakurai, Shigeru; Okamoto, Tetsuji] Hiroshima Univ, Grad Sch Biomed Sci, Div Frontier Med Sci, Dept Mol Oral Med & Maxillofacial Surg,Minami Ku, Hiroshima 7348553, Japan; [Kitano, Hisataka] Nihon Univ, Itabashi Hosp, Dept Oral Surg, Itabashi Ku, Tokyo 1738610, Japan	Hayashido, Y (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Div Frontier Med Sci, Dept Mol Oral Med & Maxillofacial Surg,Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	hayashiy@hiroshima-u.ac.jp					Khatib AM, 2001, INT J CANCER, V91, P300, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1055>3.3.CO;2-E; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Fabricius EM, 2011, EXP THER MED, V2, P9, DOI 10.3892/etm.2010.171; Cabodi S, 2010, ADV EXP MED BIOL, V674, P43; Schwartz MA, 2001, J CELL SCI, V114, P2553; Wong NC, 1998, CLIN EXP METASTAS, V16, P50; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Gleason B, 2005, J HISTOCHEM CYTOCHEM, V53, P799, DOI 10.1369/jhc.4B6522.2005; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Nemeth JA, 2007, CANCER INVEST, V25, P632, DOI 10.1080/07357900701522638; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Dutta A, 2014, CANCER RES, V74, P1598, DOI 10.1158/0008-5472.CAN-13-1796; Hood JD, 2003, J CELL BIOL, V162, P933, DOI 10.1083/job.200304105; Huang CY, 2009, J CELL PHYSIOL, V221, P204, DOI 10.1002/jcp.21846; Cary LA, 1999, HISTOL HISTOPATHOL, V14, P1001; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Vogetseder A, 2013, INT J CANCER, V133, P2362, DOI 10.1002/ijc.28267; BARTOLAZZI A, 1995, INT J CANCER, V64, P248, DOI 10.1002/ijc.2910640407; Bianchi-Smiraglia A, 2013, ONCOGENE, V32, P3049, DOI 10.1038/onc.2012.320; BOSMAN FT, 1993, INT J DEV BIOL, V37, P203; Boudjadi Salah, 2013, Biomark Res, V1, P16, DOI 10.1186/2050-7771-1-16; Chrenek MA, 2001, BREAST CANCER RES, V3, P224, DOI 10.1186/bcr300; Chung J, 2004, MOL CELLS, V17, P203; Cruet-Hennequart S, 2003, ONCOGENE, V22, P1688, DOI 10.1038/sj.onc.1206347; Davidson B, 2003, GYNECOL ONCOL, V90, P248, DOI 10.1016/S0090-8258(03)00321-4; Dedhar S, 2000, CURR OPIN CELL BIOL, V12, P250, DOI 10.1016/S0955-0674(99)00083-6; Enns A, 2005, EUR J CANCER, V41, P1065, DOI 10.1016/j.ejca.2004.12.031; Goldberg I, 2001, CLIN CANCER RES, V7, P4073; Hayashido Y, 1996, CANCER LETT, V108, P81, DOI 10.1016/S0304-3835(96)04396-0; Hayashido Y, 2003, INT J ONCOL, V22, P657; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Jin Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048575; Kawashima A, 2003, PATHOL RES PRACT, V199, P57, DOI 10.1078/0344-0338-00355; Kobayashi-Sakamoto M, 2008, MICROVASC RES, V76, P139, DOI 10.1016/j.mvr.2008.06.004; Labat-Robert J, 2002, SEMIN CANCER BIOL, V12, P187, DOI 10.1016/S1044-579X(02)00022-6; Metlapally R, 2006, MOL VIS, V12, P725; Natali PG, 1997, CANCER RES, V57, P1554; Samanna V, 2006, EXP CELL RES, V312, P2214, DOI 10.1016/j.yexcr.2006.03.022; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; VALEA FA, 1995, AM J OBSTET GYNECOL, V173, P808, DOI 10.1016/0002-9378(95)90345-3; Wang SY, 2009, CELL ONCOL, V31, P273, DOI 10.3233/CLO-2009-0469; Webb DL, 1996, J CELL BIOCHEM, V61, P127, DOI 10.1002/(SICI)1097-4644(19960401)61:1<127::AID-JCB14>3.0.CO;2-L; Xuan SH, 2013, CANCER BIOMARK, V13, P323, DOI 10.3233/CBM-130361; Yamanaka T, 2000, IN VITRO CELL DEV-AN, V36, P548; Ziober BL, 1996, SEMIN CANCER BIOL, V7, P119, DOI 10.1006/scbi.1996.0017	45	2	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	NOV	2014	45	5					1875	1882		10.3892/ijo.2014.2642		8	Oncology	Oncology	AQ3SN	WOS:000342713900011		
J	Akita, M; Suzuki-Karasaki, M; Fujiwara, K; Nakagawa, C; Soma, M; Yoshida, Y; Ochiai, T; Tokuhashi, Y; Suzuki-Karasaki, Y				Akita, Mamoru; Suzuki-Karasaki, Miki; Fujiwara, Kyoko; Nakagawa, Chinatsu; Soma, Masayoshi; Yoshida, Yukihiro; Ochiai, Toyoko; Tokuhashi, Yasuaki; Suzuki-Karasaki, Yoshihiro			Mitochondrial division inhibitor-1 induces mitochondrial hyperfusion and sensitizes human cancer cells to TRAIL-induced apoptosis	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						tumor-selective killing; tumor necrosis factor-related apoptosis-inducing ligand; mitochondrial division inhibitor-1; mitochondrial fission; ROS	HUMAN-MELANOMA CELLS; PLASMA-MEMBRANE DEPOLARIZATION; ADENINE-NUCLEOTIDE TRANSLOCASE; CYTOCHROME-C; FISSION; DEATH; APO2L/TRAIL; THERAPY; RELEASE; AGGREGATION	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising candidate for cancer treatment, but some cancer cell types are resistant to TRAIL cytotoxicity. Therefore, overcoming this resistance is necessary for effective TRAIL therapy. Mitochondrial morphology is important for the maintenance of cell function and survival, and is regulated by the delicate balance between fission and fusion. However, the role of mitochondrial morphology dynamics in TRAIL-induced apoptosis is unknown. Here we show that mitochondrial division inhibitor-1 (mdivi-1), an inhibitor of dynamin-related protein1 (Drp1), modulates mitochondrial morphology and TRAIL-induced apoptosis in human cancer cells. mdivi-1 treatment (>= 12.5 mu M) caused dose- and time-dependent cell death in malignant melanoma, lung cancer and osteosarcoma cells, while sparing normal cells. mdivi-1 also sensitized cancer cells to TRAIL-induced apoptosis. This potentiation of apoptosis occurred through a caspase-depependent mechanism including the mitochondrial and endoplasmic reticulum (ER) stress pathways. Mdivi-1 potentiated mitochondrial oxidative stress, a major cause of mitochondrial and ER stresses, as evidenced by increases in mitochondrial reactive oxygen species levels, mitochondrial mass, and cardiolipin oxidation. Live cell fluorescence imaging using MitoTracker Red CMXRos revealed that Mdivi-1 caused substantial mitochondrial hyperfusion. Moreover, silencing of Drp1 expression also caused mitochondrial hyperfusion and sensitized cancer cells to TRAIL-induced apoptosis. Our results suggest that cancer cells are more vulnerable than normal cells to a perturbation in mitochondrial morphology dynamics and that this higher susceptibility can be exploited to selectively kill cancer cells and sensitize to TRAIL.	[Akita, Mamoru; Fujiwara, Kyoko; Soma, Masayoshi; Suzuki-Karasaki, Yoshihiro] Nihon Univ, Res Inst Med Sci, Innovat Therapy Res Grp, Tokyo 1738610, Japan; [Akita, Mamoru; Yoshida, Yukihiro; Tokuhashi, Yasuaki] Nihon Univ, Sch Med, Dept Orthoped Surg, Tokyo 1738610, Japan; [Suzuki-Karasaki, Miki; Nakagawa, Chinatsu; Ochiai, Toyoko] Nihon Univ, Surugadai Hosp, Dept Dermatol, Tokyo 1018309, Japan; [Suzuki-Karasaki, Yoshihiro] Nihon Univ, Sch Med, Dept Biomed Sci, Div Physiol, Tokyo 1738610, Japan	Suzuki-Karasaki, Y (reprint author), Nihon Univ, Dept Biomed Sci, Div Physiol, Sch Med,Itabashi Ku, 30-1 Oyaguchikamimachi, Tokyo 1738610, Japan.	suzuki.yoshihiro@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [KAKENHI 23591631]; Nihon University	The authors thank Dr M. Murai and Dr T. Inoue for technical assistance. This study was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (KAKENHI 23591631; to Y.S.-K.) and Grants-in-Aid from Nihon University (to Y.S.-K.).	Alirol E, 2006, MOL BIOL CELL, V17, P4593, DOI 10.1091/mbc.E06-05-0377; Suzuki-Karasaki M, 2014, INT J ONCOL, V44, P616, DOI 10.3892/ijo.2013.2215; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI [10.1016/j.devcel.2007.11.019, 10.1016/j.devce1.2007.11.019]; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Halestrap AP, 2003, CURR MED CHEM, V10, P1507, DOI 10.2174/0929867033457278; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Hail N, 2005, APOPTOSIS, V10, P687, DOI 10.1007/s10495-005-0792-8; Skulachev VP, 1996, FEBS LETT, V397, P7, DOI 10.1016/0014-5793(96)00989-1; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Dimberg LY, 2013, ONCOGENE, V32, P1341, DOI 10.1038/onc.2012.164; Sheridan C, 2008, MOL CELL, V31, P570, DOI 10.1016/j.molcel.2008.08.002; Landes T, 2011, BBA-MOL CELL RES, V1813, P540, DOI 10.1016/j.bbamcr.2011.01.021; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Suzuki Y, 2012, INT J ONCOL, V41, P465, DOI 10.3892/ijo.2012.1483; PETIT JM, 1992, EUR J BIOCHEM, V209, P267, DOI 10.1111/j.1432-1033.1992.tb17285.x; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Elgass K, 2013, BBA-MOL CELL RES, V1833, P150, DOI 10.1016/j.bbamcr.2012.05.002; Wang S, 2008, ONCOGENE, V27, P6207, DOI 10.1038/onc.2008.298; Orrenius S, 2007, DRUG METAB REV, V39, P443, DOI 10.1080/03602530701468516; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Almasan A, 2003, CYTOKINE GROWTH F R, V14, P337, DOI 10.1016/S1359-6101(03)00029-7; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107; Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Bortner CD, 2001, J BIOL CHEM, V276, P4304, DOI 10.1074/jbc.M005171200; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; Jiang CC, 2007, CANCER RES, V67, P5880, DOI 10.1158/0008-5472.CAN-07-0213; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Murai M, 2012, INT J ONCOL, V41, P2029, DOI 10.3892/ijo.2012.1656; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Nolte F, 2004, FEBS LETT, V578, P85, DOI 10.1016/j.febslet.2004.10.075; Dyer MJS, 2007, J CLIN ONCOL, V25, P4505, DOI 10.1200/JCO.2007.13.1011; Haga N, 2005, CANCER SCI, V96, P825, DOI 10.1111/j.1349-7006.2005.00114.x; Haga N, 2003, ONCOGENE, V22, P5579, DOI 10.1038/sj.onc.1206576; Inoue T, 2013, FREE RADICAL BIO MED, V61, P273, DOI 10.1016/j.freeradbiomed.2013.04.020; Kischkel FC, 2000, IMMUNITY, V12, P612; Lackner LL, 2010, CHEM BIOL, V17, P578, DOI 10.1016/j.chembiol.2010.05.016; Ralph SJ, 2010, MOL ASPECTS MED, V31, P29, DOI 10.1016/j.mam.2009.12.006; Suzuki-Karasaki Y, FRONT ONCOL IN PRESS; Tochigi M, 2013, INT J ONCOL, V42, P863, DOI 10.3892/ijo.2013.1769; Yin W, 2009, BIOCHEM PHARMACOL, V78, P191, DOI 10.1016/j.bcp.2009.03.025; Zhivotovsky B, 2009, CELL DEATH DIFFER, V16, P1419, DOI 10.1038/cdd.2009.118	48	3	3	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	NOV	2014	45	5					1901	1912		10.3892/ijo.2014.2608		12	Oncology	Oncology	AQ3SN	WOS:000342713900014		
J	Tanaka, N; Yoshida, H; Suzuki, Y; Harigaya, K				Tanaka, Noriyuki; Yoshida, Hiroshi; Suzuki, Yoshio; Harigaya, Kenichi			Relative expression of hMena(11a) and hMena(INV) splice isoforms is a useful biomarker in development and progression of human breast carcinoma	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						hMena; ena/VASP; splicing isoform; breast; invasive ductal carcinoma	EPITHELIAL-MESENCHYMAL TRANSITION; CANCER CELL-LINES; ENA/VASP PROTEINS; INVASION; MECHANISMS; MIGRATION; MOTILITY; MARKER; ENAH	Alternative splicing provides additional genomic complexity by producing multiple mRNAs and protein variants from any given gene. Splice variants have been identified in a large variety of cancer genes, suggesting that widespread aberrant and alternative splicing may be a consequence or even a cause of cancer. Human ortholog of mammalian enabled (hMena), a family of enabled/vasodilator-stimulated phosphoproteins (Ena/VASP), is an actin regulatory protein involved in the regulation of cell motility. hMena has been shown to have several splice variants, including the hMena(INV) isoform, expressed in invasive cancer cells, and the epithelial-specific isoform, hMena(11a). We assessed the relative mRNA expression of hMena splice variants in 50 cases of invasive ductal breast carcinoma of no special type (IDC-NST) and 45 cases of ductal breast carcinoma in situ (DCIS) with special reference to non-neoplastic breast epithelial tissues. The samples were dissected from their respective regions by laser microdissection. Our results confirmed previous reports that hMena(INV) expression is augmented during tumor progression, while hMena(11a) is downregulated. Furthermore, simultaneous expression of hMena(11a) and hMena(INV) was found only in malignant lesions, while their expression was hardly detected in normal breast tissue and benign proliferative breast lesions. These results indicate that the higher relative expression of hMena(11a) compared with hMena(INV) may predict malignant transformation in breast epithelial cells, and, furthermore, a reversal of expression of hMena(11a) and hMena(INV) may dictate the state of cancer progression. Here, we demonstrate that determination of hMenalla and hMena' expression could be a useful biomarker for predicting malignant behavior in breast epithelial lesions, and show that their relative expression is linked to adverse prognostic factors. Although the biological activity of the majority of alternatively spliced isoforms and their contribution to cancer biology has yet to be determined, their elucidation will have a large impact on therapeutic strategies for cancer.	[Tanaka, Noriyuki; Yoshida, Hiroshi; Harigaya, Kenichi] Chiba Univ, Grad Sch Med, Dept Mol & Tumor Pathol, Chuo Ku, Chiba 2608670, Japan; [Tanaka, Noriyuki; Yoshida, Hiroshi; Suzuki, Yoshio] Asahi Gen Hosp, Dept Pathol, Chiba 2892515, Japan; [Harigaya, Kenichi] Chiba Rosai Hosp, Lab Med, Ichihara, Chiba 2900003, Japan	Harigaya, K (reprint author), Chiba Rosai Hosp, Lab Med, 2-16 Tatsumidaihigashi, Ichihara, Chiba 2900003, Japan.	harigaya@faculty.chiba-u.jp			Japan Society for the Promotion of Science [15390122, 22390074]	A portion of these data were presented at the 101st and 102nd annual meeting of the Japanese Society of Pathology in Tokyo and Sapporo. We are grateful to Asahi General Hospital for surgical specimens, and T. Shida, T. Umemiya, K. Azuma and K. Takaoka for technical help. This study was supported by Grants-in-Aid for Scientific Research 15390122 and 22390074 from the Japan Society for the Promotion of Science (to K. Harigaya).	Agarwal S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3318; Roussos ET, 2011, J CELL SCI, V124, P2120, DOI 10.1242/jcs.086231; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; SAVAGNER P, 1994, MOL BIOL CELL, V5, P851; Warzecha CC, 2012, SEMIN CANCER BIOL, V22, P417, DOI 10.1016/j.semcancer.2012.04.003; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Matsuda A, 2014, JPN J CLIN ONCOL, V44, P388, DOI 10.1093/jjco/hyu003; Roussos ET, 2011, CLIN EXP METASTAS, V28, P515, DOI 10.1007/s10585-011-9388-6; Gertler F, 2011, TRENDS CELL BIOL, V21, P81, DOI 10.1016/j.tcb.2010.10.001; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Di Modugno F, 2007, CANCER RES, V67, P2657, DOI 10.1158/0008-5472.CAN-06-1997; Wapnir IL, 2011, J NATL CANCER I, V103, P478, DOI 10.1093/jnci/djr027; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Rybinski B, 2014, PHYSIOL GENOMICS, V46, P223, DOI 10.1152/physiolgenomics.00158.2013; DeSantis C, 2013, CA-CANCER J CLIN, V64, P52, DOI DOI 10.3322/CAAC.21203; Ellis I, 2012, WHO CLASSIFICATION T, P19; Goswami S, 2009, CLIN EXP METASTAS, V26, P153, DOI 10.1007/s10585-008-9225-8; Itakura M, 2013, BRIT J CANCER, V109, P1100, DOI 10.1038/bjc.2013.440; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Pino MS, 2008, CLIN CANCER RES, V14, P4943, DOI 10.1158/1078-0432.CCR-08-0436; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Urbanelli L, 2006, BBA-GENE STRUCT EXPR, V1759, P99, DOI 10.1016/j.bbaexp.2006.01.001	24	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	NOV	2014	45	5					1921	1928		10.3892/ijo.2014.2591		8	Oncology	Oncology	AQ3SN	WOS:000342713900016		
J	Kanda, M; Sugimoto, H; Nomoto, S; Oya, H; Shimizu, D; Takami, H; Hashimoto, R; Sonohara, F; Okamura, Y; Yamada, S; Fuji, T; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y				Kanda, Mitsuro; Sugimoto, Hiroyuki; Nomoto, Shuji; Oya, Hisaharu; Shimizu, Dai; Takami, Hideki; Hashimoto, Ryoji; Sonohara, Fuminori; Okamura, Yukiyasu; Yamada, Suguru; Fuji, Tsutomu; Nakayama, Goro; Koike, Masahiko; Fujiwara, Michitaka; Kodera, Yasuhiro			Clinical utility of PDSS2 expression to stratify patients at risk for recurrence of hepatocellular carcinoma	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						prenyl diphosphate synthase subunit 2; expression; hepatocellular carcinoma; methylation; recurrence	TUMOR-SUPPRESSOR GENE; PROMOTER HYPERMETHYLATION; UNITED-STATES; CANCER; CARCINOGENESIS; IDENTIFICATION; DENND2D; TUSC1	Identification of novel genetic and epigenetic alterations is required for optimal stratification of patients with hepatocellular carcinoma (HCC) at risk for recurrence and adverse prognosis. Coenzyme Q10 (COQ10), which mediates apoptosis, is synthesized by prenyl diphosphate synthase subunit 2 (PDSS2). In the present study we evaluated the clinical significance and regulatory mechanisms of PDSS2 expression in HCC. PDSS2 expression levels and those of genes encoding potentially interacting proteins as well as the methylation status of the PDSS2 promoter region were analyzed in HCC cell lines. PDSS2 mRNA levels in 151 pairs of resected specimens were determined to evaluate the association of PDSS2 expression and clinicopathological factors. The expression and distribution of PDSS2 were determined using immunohistochemistry. PDSS2 mRNA expression was decreased in six of nine HCC cell lines and significantly correlated with those of hepatocyte nuclear factor 4 alpha. PDSS2 transcription in HCC cells with decreased PDSS2 expression accompanying hypermethylation was reactivated after treating these cells with a methylation inhibitor. Mean expression levels of PDSS2 mRNA relative to that of uninvolved liver diminished gradually in the order of chronic hepatitis to cirrhosis, and each was significantly higher than those of HCCs. PDSS2 and PDSS2 mRNA levels were consistent. Decreased PDSS2 mRNA levels were detected in HCC tissues of 56 patients, correlated with shorter disease-specific survival, and was identified as an independent prognostic factor. PDSS2 is a putative tumor suppressor, and promoter hypermethylation is a key regulatory mechanism in HCC. Decreased levels of PDSS2 mRNA expression may represent a novel biomarker of HCC.	[Kanda, Mitsuro; Sugimoto, Hiroyuki; Nomoto, Shuji; Oya, Hisaharu; Shimizu, Dai; Takami, Hideki; Hashimoto, Ryoji; Sonohara, Fuminori; Okamura, Yukiyasu; Yamada, Suguru; Fuji, Tsutomu; Nakayama, Goro; Koike, Masahiko; Fujiwara, Michitaka; Kodera, Yasuhiro] Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Nagoya, Aichi 4668550, Japan	Kanda, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	m-kanda@med.nagoya-u.ac.jp					Kanda M, 2011, MOL CARCINOGEN, V50, P571, DOI 10.1002/mc.20735; Minguez B, 2011, DIS MARKERS, V31, P181, DOI 10.3233/DMA-2011-0841; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Miki D, 2012, CANCER SCI, V103, P846, DOI 10.1111/j.1349-7006.2012.02242.x; Shiraha H, 2013, INT J ONCOL, V42, P1133, DOI 10.3892/ijo.2013.1829; Kanda M, 2009, INT J ONCOL, V35, P477, DOI 10.3892/ijo_00000359; Saandi T, 2013, ONCOGENE, V32, P3782, DOI 10.1038/onc.2012.401; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Herath NI, 2006, J GASTROEN HEPATOL, V21, P15, DOI 10.1111/j.1440-1746.2005.04043.x; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Kanda M, 2014, INT J ONCOL, V44, P44, DOI 10.3892/ijo.2013.2165; Walesky C, 2013, HEPATOLOGY, V57, P2480, DOI 10.1002/hep.26251; Quinzii CM, 2007, NEUROCHEM RES, V32, P723, DOI 10.1007/s11064-006-9190-z; Saiki R, 2005, FEBS J, V272, P5606, DOI 10.1111/j.1742-4658.2005.04956.x; Kanda M, 2008, J SURG ONCOL, V98, P190, DOI 10.1002/jso.21095; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; Kanda M, 2014, J SURG ONCOL, V110, P136, DOI 10.1002/jso.23614; Hibino S, 2014, ONCOL REP, V31, P693, DOI 10.3892/or.2013.2901; Chen P, 2013, CANCER EPIDEMIOL, V37, P166, DOI 10.1016/j.canep.2012.12.004; DiMauro S, 2007, J CLIN INVEST, V117, P587, DOI 10.1172/JCI31423; Ehehalt F, 2011, ANN SURG, V254, P302, DOI 10.1097/SLA.0b013e31821994a8; Fung JMW, 2009, CLIN CANCER RES, V15, P797, DOI 10.1158/1078-0432.CCR-08-1472; Kanda M, 2014, GASTRIC CANC; Li SP, 2001, J HEPATOL, V34, P840, DOI 10.1016/S0168-8278(01)00047-2; Nagai H, 1997, ONCOGENE, V14, P2927, DOI 10.1038/sj.onc.1201136; Oya H, 2015, DIS ESOPHAGUS, V28, P188, DOI 10.1111/dote.12156; Shimizu D, 2014, ONCOL REP, V31, P1305, DOI 10.3892/or.2013.2939; Sobin L, 2009, INT UNION CANC TNM C; Takai Daiya, 2003, In Silico Biology, V3, P235; Takami H, 2013, J SURG ONCOL, V108, P557, DOI 10.1002/jso.23440	33	2	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	NOV	2014	45	5					2005	2012		10.3892/ijo.2014.2637		8	Oncology	Oncology	AQ3SN	WOS:000342713900025		
J	Indo, K; Hoshikawa, H; Kamitori, K; Yamaguchi, F; Mori, T; Tokuda, M; Mori, N				Indo, Kanako; Hoshikawa, Hiroshi; Kamitori, Kazuyo; Yamaguchi, Fuminori; Mori, Terusige; Tokuda, Masaaki; Mori, Nozomu			Effects of D-allose in combination with docetaxel in human head and neck cancer cells	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						D-allose; docetaxel; head and neck cancer; anticancer effects	REGULATED PROTEIN-1 VDUP1; CARCINOMA-CELLS; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; THIOREDOXIN EXPRESSION; ANTIOXIDANT ENZYMES; IONIZING-RADIATION; UP-REGULATION; ACTIVE-DRUG; PHASE-II	In this study we investigated the combined effects of docetaxel and D-allose in HSC3 human oral carcinoma cells. The dose enhancement ratios at the 25% survival level were 1.3 and 1.71 for combined treatment with 10 or 25 mM D-allose, respectively. Apoptosis was significantly increased by addition of D-allose. Additionally, a synchronous increase in the G(2)/M-phase population was observed after docetaxel plus D-allose treatment. In vivo experiments revealed that docetaxel plus D-allose was more effective than either agent alone. Thus, D-allose enhanced the anticancer effects of docetaxel, and combined treatment may be useful to achieve clinical efficacy with reduced toxicity.	[Indo, Kanako; Hoshikawa, Hiroshi; Mori, Terusige; Mori, Nozomu] Kagawa Univ, Fac Med, Dept Otolaryngol, Miki, Kagawa 7610793, Japan; [Kamitori, Kazuyo; Yamaguchi, Fuminori; Tokuda, Masaaki] Kagawa Univ, Fac Med, Dept Cell Physiol, Miki, Kagawa 7610793, Japan	Indo, K (reprint author), Kagawa Univ, Fac Med, Dept Otolaryngol, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	kanakana@med.kagawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [20592019]	This study was supported in part by a Grant-in-Aid for General Scientific Research (Grant 20592019) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Adachi I, 1996, BRIT J CANCER, V73, P210, DOI 10.1038/bjc.1996.37; Grogan TM, 2000, HUM PATHOL, V31, P475, DOI 10.1053/hp.2000.6546; Raffel J, 2003, J LAB CLIN MED, V142, P46, DOI 10.1016/S0022-2143(03)00068-4; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.biochem.54.1.237; Nakamura H, 2000, CANCER DETECT PREV, V24, P53; Pradier O, 2001, INT J CANCER, V91, P840, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1142>3.0.CO;2-U; Chung JW, 2006, J DERMATOL, V33, P662, DOI 10.1111/j.1346-8138.2006.00156.x; Sun J, 1998, FREE RADICAL BIO MED, V24, P586, DOI 10.1016/S0891-5849(97)00291-8; CATIMEL G, 1994, ANN ONCOL, V5, P533; Lee HC, 2004, INT J MOL MED, V13, P883; Kakolyris S, 2001, CLIN CANCER RES, V7, P3087; Mitani T, 2009, HEAD NECK-J SCI SPEC, V31, P1049, DOI 10.1002/hed.21070; Iwao-Koizumi K, 2005, J CLIN ONCOL, V23, P422, DOI 10.1200/JCO.2005.09.078; Dreyfuss AI, 1996, J CLIN ONCOL, V14, P1672; Tishler RB, 2006, INT J RADIAT ONCOL, V65, P1036, DOI 10.1016/j.ijrobp.2006.02.010; Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299; Miyazaki K, 1998, BIOTHERAPY, V11, P277, DOI 10.1023/A:1008032703468; Han SH, 2003, ONCOGENE, V22, P4035, DOI 10.1038/sj.onc.1206610; Yamaguchi F, 2008, INT J ONCOL, V32, P377; Lorch JH, 2011, LANCET ONCOL, V12, P153, DOI [10.1016/S1470-2045(10)70279-5, 10.1016/S1420-2045(10)20279-5]; Naha N, 2008, APOPTOSIS, V13, P1121, DOI 10.1007/s10495-008-0232-7; Haldar S, 1997, CANCER RES, V57, P229; Kim SJ, 2005, CLIN CANCER RES, V11, P8425, DOI 10.1158/1078-0432.CCR-05-0449; Mason KA, 1999, CLIN CANCER RES, V5, P4191; Baur M, 2002, CANCER, V94, P2953, DOI 10.1002/cncr.10574; de Vos S, 2003, LAB INVEST, V83, P271, DOI 10.1097/01.LAB.0000053913.85892.E9; Furuse S, 2010, ONCOL REP, V23, P1339, DOI 10.3892/or_00000769; Hirooka K, 2006, INVEST OPHTH VIS SCI, V47, P1653, DOI 10.1167/iovs.05-1018; HIROSE K, 1993, FASEB J, V7, P361; Hoshikawa H, 2011, CANCER LETT, V306, P60, DOI 10.1016/j.canlet.2011.02.032; Hoshikawa H, 2010, ANN OTO RHINOL LARYN, V119, P567; Ikarashi M, 2002, ANTICANCER RES, V22, P4045; Katori H, 2007, CANCER CHEMOTH PHARM, V60, P399, DOI 10.1007/s00280-006-0370-y; KHAN IA, 1991, BIOCHIM BIOPHYS ACTA, V1076, P289, DOI 10.1016/0167-4838(91)90280-D; Mirkovic N, 1997, ONCOGENE, V15, P1461, DOI 10.1038/sj.onc.1201310; Mizote M, 2011, JPN J OPHTHALMOL, V55, P294, DOI 10.1007/s10384-011-0012-8; Mizumachi T, 2008, ONCOGENE, V27, P831, DOI 10.1038/sj.onc.1210681; Ohta S, 2005, INT J CANCER, V114, P139, DOI 10.1002/ijc.20670	39	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	NOV	2014	45	5					2044	2050		10.3892/ijo.2014.2590		7	Oncology	Oncology	AQ3SN	WOS:000342713900029		
J	Ohtani, T; Yamada, Y; Furuhashi, A; Ohmura, Y; Nakamura, S; Kato, H; Yoshikawa, K; Kazaoka, Y				Ohtani, Tomoko; Yamada, Yoichi; Furuhashi, Akifumi; Ohmura, Yukinobu; Nakamura, Sayaka; Kato, Hidefumi; Yoshikawa, Kazuhiro; Kazaoka, Yoshiaki			Activated cytotoxic T-lymphocyte immunotherapy is effective for advanced oral and maxillofacial cancers	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						oral cancer; quality of life; adoptive immunotherapy; cytotoxic T-lymphocytes; treatment outcome	TUMOR-INFILTRATING LYMPHOCYTES; ADOPTIVE IMMUNOTHERAPY; RECOMBINANT INTERLEUKIN-2; METASTATIC MELANOMA; KILLER CELLS; CARCINOMA; THERAPY	Conventional cancer treatments are surgery, radiotherapy, and chemotherapy, but treatment efficiency is insufficient and cancer recurrence is common. Immunotherapy has been added as an important cancer treatment component, but no reports on its efficacy in oral and maxillofacial cancers exist. We evaluated the clinical efficacy of adoptive immunotherapy using ex vivo-activated cytotoxic T lymphocytes (CTL) in the treatment of 7 patients with advanced oral and maxillofacial cancers with stage IV disease at diagnosis. The mean follow-up period was 26.2 months. Phenotype of the lymphocyte assay revealed that the percentage of CD4(+) T cells decreased and that of CD8(+) T cells increased among infused lymphocytes compared to that in unstimulated peripheral blood mononuclear cells (PBMCs), and infused lymphocytes produced a significantly higher level of IFN-gamma' than PBMCs or tumor cells alone. In a representative patient who refused surgery tumor regression was confirmed after CTL infusion. Computed tomography clearly indicated a significant reduction in tumor size followed by the complete disappearance of the tumor. Histological examination showed that the cancers in patients receiving CTL therapy were heavily infiltrated with lymphocytes. The other 2 patients who received CTL therapy as adjuvant therapy showed neither recurrent disease nor new disease lesions. The 1-year survival rates showing response and those with progressive disease were 100 and 25%, respectively. Moreover, no significant adverse reactions were reported during the study period. CTL therapy remains in the early stages of treatment options, but it has potential as a valuable treatment and improvement of quality of life for patients with otherwise incurable cancers.	[Ohtani, Tomoko; Yamada, Yoichi; Furuhashi, Akifumi; Ohmura, Yukinobu; Nakamura, Sayaka; Kazaoka, Yoshiaki] Aichi Med Univ, Sch Med, Dept Oral & Maxillofacial Surg, Nagakute, Aichi 4801195, Japan; [Kato, Hidefumi] Aichi Med Univ, Sch Med, Dept Transfus Med, Nagakute, Aichi 4801195, Japan; [Yoshikawa, Kazuhiro] Aichi Med Univ, Sch Med, Cell Therapy Ctr Biochem, Nagakute, Aichi 4801195, Japan; [Yoshikawa, Kazuhiro] Aichi Med Univ, Adv Med Res Ctr, Div Adv Med, Nagakute, Aichi 4801195, Japan	Yamada, Y (reprint author), Aichi Med Univ, Sch Med, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	yyamada@aichi-med-u.ac.jp					Agra IMG, 2010, HEAD NECK-J SCI SPEC, V32, P997, DOI 10.1002/hed.21298; BAXEVANIS CN, 1994, CANCER, V74, P1275, DOI 10.1002/1097-0142(19940815)74:4<1275::AID-CNCR2820740416>3.0.CO;2-Q; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Ratto GB, 1996, CANCER, V78, P244, DOI 10.1002/(SICI)1097-0142(19960715)78:2<244::AID-CNCR9>3.0.CO;2-L; DeVita VT, 2012, NEW ENGL J MED, V366, P2207, DOI 10.1056/NEJMra1204479; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099; Soda H, 1999, J SURG ONCOL, V72, P211, DOI 10.1002/(SICI)1096-9098(199912)72:4<211::AID-JSO6>3.0.CO;2-A; ROSENBERG SA, 1986, SCIENCE, V233, P1318, DOI 10.1126/science.3489291; Straathof KCM, 2005, BLOOD, V105, P1898, DOI 10.1182/blood-2004-07-2975; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P3515, DOI 10.1073/pnas.91.9.3515; Colevas AD, 2006, J CLIN ONCOL, V24, P2644, DOI 10.1200/JCO.2005.05.3348; Khammari A, 2007, CANCER IMMUNOL IMMUN, V56, P1853, DOI 10.1007/s00262-007-0340-1; da Silva SD, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00149; Desombere I, 2004, J IMMUNOL METHODS, V286, P167, DOI 10.1016/j.jim.2004.01.001; ETTINGHAUSEN SE, 1988, J NATL CANCER I, V80, P177, DOI 10.1093/jnci/80.3.177; KNUTH A, 1992, CANCER SURV, V13, P39; Marijt E, 2007, HAEMATOL-HEMATOL J, V92, P72, DOI 10.3324/haematol.10433; ROSENBERG SA, 1985, NEW ENGL J MED, V313, P1485, DOI 10.1056/NEJM198512053132327; Saitoh S, 1997, JPN J CANCER RES, V88, P289; Toh U, 2000, CLIN CANCER RES, V6, P4663; World Health Organization, 2004, WORLD HLTH REP 2004	22	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	NOV	2014	45	5					2051	2057		10.3892/ijo.2014.2599		7	Oncology	Oncology	AQ3SN	WOS:000342713900030		
J	Lou, CH; Takahashi, K; Irimura, T; Saiki, I; Hayakawa, Y				Lou, Chenghua; Takahashi, Kei; Irimura, Tatsuro; Saiki, Ikuo; Hayakawa, Yoshihiro			Identification of Hirsutine as an anti-metastatic phytochemical by targeting NF-kappa B activation	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						metastasis; NF-kappa B; migration; invasion; matrix metalloproteinase	CELL-CYCLE ARREST; CANCER CELLS; NATURAL-PRODUCTS; MULTIPLE-MYELOMA; DRUG DISCOVERY; TUMOR-GROWTH; IKK-ALPHA; MAGNOLOL; PATHWAYS; APOPTOSIS	Nuclear factor-kappa B (NF-kappa B) activation has been implicated not only in carcinogenesis but also in cancer cell invasion and metastatic process; therefore, targeting the NF-kappa B pathway is an attractive strategy for controlling metastasis. Amongst 56 chemically defined compounds derived from natural products, we have identified a new phytochemical compound Hirsutine, which strongly suppresses NF-kappa B activity in murine 4T1 breast cancer cells. In accordance with the NF-kappa B inhibition, Hirsutine reduced the metastatic potential of 4T1 cells, as seen in the inhibition of the migration and invasion capacity of 4T1 cells. Hirsutine further inhibited the constitutive expression of MMP-2 and MMP-9 in 4T1 cells, and reduced the in vivo lung metastatic potential of 4T1 cells in the experimental model. Given that the migration of human breast cancer cells was also inhibited, our present study implies that Hirsutine is an attractive phytochemical compound for reducing metastasis potential of cancer cells by regulating tumor-promoting NF-kappa B activity.	[Lou, Chenghua; Saiki, Ikuo; Hayakawa, Yoshihiro] Toyama Univ, Inst Nat Med, Dept Biosci, Div Pathogen Biochem, Toyama 9300194, Japan; [Takahashi, Kei; Irimura, Tatsuro; Hayakawa, Yoshihiro] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Canc Biol & Mol Immunol, Tokyo 1130033, Japan; [Irimura, Tatsuro] St Lukes Int Univ, Inst Med Innovat, Tokyo 1040044, Japan	Hayakawa, Y (reprint author), Toyama Univ, Inst Nat Med, Dept Biosci, Div Pathogen Biochem, Sugitani 2630, Toyama 9300194, Japan.	haya@inm.u-toyama.ac.jp			Yokoyama Foundation; Institute of Natural Medicine, University of Toyama; Campus Asian Program of the University of Toyama	We are grateful to Satoru J. Yokoyama and Hiroaki Sakurai for discussions and colleagues in Saiki Laboratory for generous support. This study was partly supported by Yokoyama Foundation and a Grant-in-aid for the 2012 and 2013 Cooperative Research Project I from the Institute of Natural Medicine, University of Toyama. Chenghua Lou is a graduate student supported by the Campus Asian Program of the University of Toyama.	HORIE S, 1992, LIFE SCI, V50, P491, DOI 10.1016/0024-3205(92)90388-6; Tse AKW, 2007, MOL IMMUNOL, V44, P2647, DOI 10.1016/j.molimm.2006.12.004; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Scartozzi M, 2007, J CLIN ONCOL, V25, P3930, DOI 10.1200/JCO.2007.11.5022; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Lee J, 2005, PLANTA MED, V71, P338, DOI 10.1055/s-2005-864100; Chen MC, 2013, BIOCHEM PHARMACOL, V85, P1278, DOI 10.1016/j.bcp.2013.02.009; Yang JM, 2007, CANCER RES, V67, P3127, DOI 10.1158/0008-5472.CAN-06-3547; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Huang CY, 2009, BIOCHEM PHARMACOL, V77, P794, DOI 10.1016/j.bcp.2008.11.014; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Kumar A, 2010, BIOCHEM BIOPH RES CO, V394, P360, DOI 10.1016/j.bbrc.2010.03.014; Chhunchha B, 2013, AM J PHYSIOL-CELL PH, V304, pC636, DOI 10.1152/ajpcell.00345.2012; Zhang WZ, 2013, CANCER CELL, V23, P647, DOI 10.1016/j.ccr.2013.03.012; Wu LX, 2011, EUR J PHARMACOL, V650, P290, DOI 10.1016/j.ejphar.2010.09.057; Lee SJ, 2008, BIOCHEM PHARMACOL, V75, P2289, DOI 10.1016/j.bcp.2008.03.022; Panwalkar A, 2004, CANCER, V100, P1578, DOI 10.1002/cncr.20182; Rasul A, 2012, INT J ONCOL, V40, P1153, DOI 10.3892/ijo.2011.1277; Cragg GM, 1997, J NAT PROD, V60, P52, DOI 10.1021/np9604893; Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953; Singh NP, 2011, MOL NUTR FOOD RES, V55, P1207, DOI 10.1002/mnfr.201000576; Youn J, 2009, NUTR CANCER, V61, P847, DOI 10.1080/01635580903285072; Mann J, 2002, NAT REV CANCER, V2, P143, DOI 10.1038/nrc723; Tsai JR, 2014, ARCH PHARM RES, V37, P548, DOI 10.1007/s12272-013-0232-1; Bours V, 2000, TOXICOLOGY, V153, P27, DOI 10.1016/S0300-483X(00)00302-4; Chen YY, 2013, ENV TOXICOL; Crowell JA, 2005, EUR J CANCER, V41, P1889, DOI 10.1016/j.ejca.2005.04.016; Hsu YF, 2007, MOL CARCINOGEN, V46, P275, DOI 10.1002/mc.20274; Huang SH, 2007, J CELL BIOCHEM, V101, P1011, DOI 10.1002/jcb.21100; Ikeda K, 2003, PHYTOTHER RES, V17, P933, DOI 10.1002/ptr.1264; Leclercq IA, 2004, J HEPATOL, V41, P926, DOI 10.1016/j.jhep.2004.08.010; Lin SY, 2001, MOL CARCINOGEN, V32, P73, DOI 10.1002/mc.1066; Lin TH, 2013, INT J MOL SCI, V14, P9790, DOI 10.3390/ijms14059790; Nottingham LK, 2014, ONCOGENE, V33, P1135, DOI 10.1038/onc.2013.49; Sha WC, 1998, J EXP MED, V187, P143, DOI 10.1084/jem.187.2.143; Xiao GT, 2011, AM J CANCER RES, V1, P192; Yang SE, 2003, BRIT J PHARMACOL, V138, P193, DOI 10.1038/sj.bjp.0705024; Yang XC, 2013, EUR REV MED PHARMACO, V17, P1669; Yeh CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031055	42	3	3	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	NOV	2014	45	5					2085	2091		10.3892/ijo.2014.2624		7	Oncology	Oncology	AQ3SN	WOS:000342713900034		
J	Zapata, U; Dechow, PC; Watanabe, I; Elsalanty, ME; Opperman, LA				Zapata, Uriel; Dechow, Paul C.; Watanabe, Ikuya; Elsalanty, Mohammed E.; Opperman, Lynne A.			Biomechanics of the Canine Mandible During Bone Transport Distraction Osteogenesis	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							GRADUAL DISTRACTION; ELASTIC PROPERTIES; VALIDATION; DEVICES; OSTEODISTRACTION; RECONSTRUCTION; REGENERATION; VERIFICATION; IMPLANTS; SCIENCE	This study compared biomechanical patterns between finite element models (FEMs) and a fresh dog mandible tested under molar and incisal physiological loads in order to clarify the effect of the bone transport distraction osteogenesis (BTDO) surgical process. Three FEMs of dog mandibles were built in order to evaluate the effects of BTDO. The first model evaluated the mandibular response under two physiological loads resembling bite processes. In the second model, a 5.0 cm bone defect was bridged with a bone transport reconstruction plate (BTRP). In the third model, new regenerated bony tissue was incorporated within the defect to mimic the surgical process without the presence of the device. Complementarily, a mandible of a male American foxhound dog was mechanically tested in the laboratory both in the presence and absence of a BTRP, and mechanical responses were measured by attaching rosettes to the bone surface of the mandible to validate the FEM predictions. The relationship between real and predicted values indicates that the stress patterns calculated using FEM are a valid predictor of the biomechanics of the BTDO procedures. The present study provides an interesting correlation between the stiffness of the device and the biomechanical response of the mandible affected for bone transport.	[Zapata, Uriel] EAFIT Univ, Dept Mech Engn, Medellin 050022, Colombia; [Dechow, Paul C.; Opperman, Lynne A.] Texas A&M Univ, Baylor Coll Dent, Dallas, TX 75246 USA; [Watanabe, Ikuya] Nagasaki Univ, Grad Sch Biomed Sci, Dept Dent & Biomed Mat Sci, Nagasaki 8528523, Japan; [Elsalanty, Mohammed E.] Georgia Regents Univ, Coll Dent Med, Dept Oral Biol & Maxillofacial Surg, Augusta, GA 30912 USA	Zapata, U (reprint author), EAFIT Univ, Dept Mech Engn, Medellin 050022, Colombia.	uzapata@eafit.edu.co; pdechow@bcd.tamhsc.edu; ikuyaw@nagasaki-u.ac.jp; melsalanty@gru.edu; lopperman@bcd.tamhsc.edu	Zapata M, Uriel/G-5411-2011	Zapata M, Uriel/0000-0002-9309-7571	NIH/NIDCR [R42 DE015437-03, R43 DE017259-05]; COLCIENCIAS-Colombia; Matsumae International Foundation (MIF)-Japan	This work was supported by NIH/NIDCR grants R42 DE015437-03, R43 DE017259-05, a fellowship from COLCIENCIAS-Colombia, and a fellowship from The Matsumae International Foundation (MIF)-Japan.	Abbott LC, 1927, J BONE JOINT SURG, V9, P128; Viceconti M, 2005, CLIN BIOMECH, V20, P451, DOI 10.1016/j.clinbiomech.2005.01.010; SCAPINO R, 1981, J MORPHOL, V167, P339, DOI 10.1002/jmor.1051670308; Marinescu R, 2005, ANAT REC PART A, V283A, P300, DOI 10.1002/ar.a.20166; MCCARTHY JG, 1992, PLAST RECONSTR SURG, V89, P1; SNYDER CC, 1973, PLAST RECONSTR SURG, V51, P506, DOI 10.1097/00006534-197305000-00003; KEYAK JH, 1993, J BIOMED ENG, V15, P505, DOI 10.1016/0141-5425(93)90066-8; Wang JJ, 2012, INT J ORAL MAX SURG, V41, P587, DOI 10.1016/j.ijom.2011.12.015; Henninger HB, 2010, P I MECH ENG H, V224, P801, DOI 10.1243/09544119JEIM649; CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954; Swennen G, 2001, INT J ORAL MAX SURG, V30, P89, DOI 10.1054/ijom.2000.0033; Jurvelin JS, 2000, J BIOMECH, V33, P669, DOI 10.1016/S0021-9290(00)00007-5; Babuska I, 2004, COMPUT METHOD APPL M, V193, P4057, DOI 10.1016/j.cma.2004.03.002; Boyer R., 2007, MAT PROPERIES HDB TI; Campos Tomie N, 2006, Braz Dent J, V17, P279, DOI 10.1590/S0103-64402006000400003; Castaño M C, 2002, Int J Comput Dent, V5, P87; Chopra Shamit, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P197, DOI 10.1097/MOO.0b013e3282495925; Codivilla A., 1905, J BONE JOINT SURG AM, V22, P353; Cope JB, 1999, J ORAL MAXIL SURG, V57, P952, DOI 10.1016/S0278-2391(99)90017-4; Cope JB, 2002, J PERIODONTOL, V73, P271, DOI 10.1902/jop.2002.73.3.271; Cope JB, 2000, ANGLE ORTHOD, V70, P99; COSTANTINO PD, 1990, ARCH OTOLARYNGOL, V116, P535; Djasim UM, 2007, INT J ORAL MAX SURG, V36, P877, DOI 10.1016/j.ijom.2007.05.012; GILMORE RS, 1970, ARCH ORAL BIOL, V15, P787, DOI 10.1016/0003-9969(70)90042-7; Hibbeller R. C., 2010, MECH MAT; ILIZAROV GA, 1989, CLIN ORTHOP RELAT R, P249; ILIZAROV GA, 1989, CLIN ORTHOP RELAT R, P263; Jorgensen CS, 2002, J ORTHOPAED RES, V20, P151, DOI 10.1016/S0736-0266(01)00061-4; KARP NS, 1990, ANN PLAS SURG, V24, P231, DOI 10.1097/00000637-199003000-00007; Kim SM, 2010, J PLAST RECONSTR AES, V63, pE644, DOI 10.1016/j.bjps.2009.11.047; Kofod T, 2005, J CRANIOFAC SURG, V16, P586, DOI 10.1097/01.SCS.0000157305.60505.B5; Kontogiorgos E, 2011, CALCIFIED TISSUE INT, V89, P43, DOI 10.1007/s00223-011-9492-2; Kontogiorgos E, 2013, INT J ORAL MAX IMPL, V28, P677, DOI 10.11607/jomi.2977; Lindner D L, 1995, J Vet Dent, V12, P49; MICHIELI S, 1977, J ORAL SURG, V35, P187; Nosaka Y, 2000, INT J ORAL MAX IMPL, V15, P185; Panagiotopoulou O, 2010, J BIOMECH, V43, P1603, DOI 10.1016/j.jbiomech.2009.12.027; Pressel Thomas, 2005, Biomed Eng Online, V4, P17, DOI 10.1186/1475-925X-4-17; Rubio-Bueno P, 2002, J CRANIOFAC SURG, V13, P224, DOI 10.1097/00001665-200203000-00008; THROCKMORTON GS, 1994, ARCH ORAL BIOL, V39, P853, DOI 10.1016/0003-9969(94)90017-5; Trucano T, 2004, COMPUT SCI ENG, V6, P8, DOI 10.1109/MCSE.2004.38; Zapata U, 2011, CALCIFIED TISSUE INT, V89, P379, DOI 10.1007/s00223-011-9529-6; Zapata U, 2010, TISSUE ENG PART B-RE, V16, P273, DOI 10.1089/ten.TEB.2009.0502; Zapata U, 2011, J TISSUE ENG REGEN M, V5, P551, DOI 10.1002/term.347	44	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	NOV	2014	136	11							111011	10.1115/1.4028409		8	Biophysics; Engineering, Biomedical	Biophysics; Engineering	AQ4GE	WOS:000342750600012		
J	Nam, K; Seo, JH; Kimura, T; Yui, N; Kishida, A				Nam, Kwangwoo; Seo, Ji-Hun; Kimura, Tsuyoshi; Yui, Nobuhiko; Kishida, Akio			Relationships between molecular mobility, fibrillogenesis of collagen molecules, and the inflammatory response: An experimental study in vitro and in vivo	JOURNAL OF COLLOID AND INTERFACE SCIENCE			English	Article						Molecular mobility; Polyrotaxane; Collagen; Fibrillogenesis; Inflammatory response	QUARTZ-CRYSTAL MICROBALANCE; PROTEIN ADSORPTION; ADSORBED COLLAGEN; NANOSCALE ORGANIZATION; POLYMERIC IMPLANTS; SURFACE-PROPERTIES; BLOCK-COPOLYMERS; BIOMATERIALS; DENATURATION; CHEMISTRY	This study was designed to investigate the in vitro adsorption and fibrillogenesis of collagen on a surface with dynamic properties and to investigate how this surface affected the inflammatory response in vivo. Investigation of collagen-surface interactions is directly related to the control of wound healing where collagen adsorption, fibrillization, deposition, and maturation occur. ABA-type block copolymers, composed of polyrotaxane (which possesses a-cyclodextrin threaded along poly(ethylene glycol)) and hydrophobic terminal segments, were used to prepare mobile surfaces with representative dynamic properties. Analyses using a quartz crystal microbalance with dissipation monitoring (QCM-D) indicated that increasing the mobility of the polymer on the surface led to the formation of a soft collagen layer. The collagens in this layer had rearranged, leading to the formation of thicker collagen fibrils by lateral aggregation. When a surface with a high molecular mobility was subcutaneously implanted into rats, collagen rearrangement occurred leading to suppression of macrophage recruitment at the interface and the formation of a fibrotic capsule around the implant. These results suggest that surface mobility on an implant is an important parameter for normal wound healing. (C) 2014 Elsevier Inc. All rights reserved.	[Kishida, Akio] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan; Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020076, Japan	Kishida, A (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.	kishida.mbme@tmd.ac.jp			Japan Society for the Promotion of Sciences	This work was partly supported by Grant-in-Aid from the Japan Society for the Promotion of Sciences.	Andersson M, 2007, J MATER SCI-MATER M, V18, P283, DOI 10.1007/s10856-006-0690-9; Andersson M, 2008, J BIOMED MATER RES A, V84A, P652, DOI 10.1002/jbm.a.31389; Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o; Seo JH, 2012, SOFT MATTER, V8, P5477, DOI 10.1039/c2sm25318f; Pamula E, 2004, J COLLOID INTERF SCI, V271, P80, DOI 10.1016/j.jcis.2003.11.012; Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5; Dufrene YF, 1999, LANGMUIR, V15, P2871, DOI 10.1021/la981066z; Seo JH, 2013, BIOMATERIALS, V34, P3206, DOI 10.1016/j.biomaterials.2013.01.080; Seo JH, 2013, BIOMATERIALS, V34, P55, DOI 10.1016/j.biomaterials.2012.09.063; Hashimoto Y, 2010, BIOMATERIALS, V31, P3941, DOI 10.1016/j.biomaterials.2010.01.122; Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u; Mitsukami Y, 2001, MACROMOLECULES, V34, P2248, DOI 10.1021/ma0018087; Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649; Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o; Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Berglin M, 2004, BIOMATERIALS, V25, P4581, DOI 10.1016/j.biomaterials.2003.11.050; Feller A.A., 2007, J COLLOID INTERF SCI, V315, P475; Gurdak E, 2005, LANGMUIR, V21, P10684, DOI 10.1021/la051227g; Gurdak E, 2006, J COLLOID INTERF SCI, V302, P475, DOI 10.1016/j.jcis.2006.06.064; Ikeda T, 2001, LANGMUIR, V17, P234, DOI 10.1021/la001205o; Inoue Y, 2012, COLLOID SURFACE B, V89, P223, DOI 10.1016/j.colsurfb.2011.09.020; Nam K, 2012, SOFT MATTER, V8, P472, DOI 10.1039/c1sm06543b; Nam K, 2011, J BIOMAT SCI-POLYM E, V22, P1963, DOI 10.1163/092050610X529182; Nezu T, 2010, INT J BIOL MACROMOL, V46, P396, DOI 10.1016/j.ijbiomac.2010.02.005; Parkinson J, 1994, J MOL BIOL, V247, P823; Rolfe B., 2011, REGENERATIVE MED TIS; Strodtbeck F., 2001, NEWBORN INFANT NURS, V1, P43, DOI 10.1053/nbin.2001.23176; Xu SH, 2007, COLLOID POLYM SCI, V285, P899, DOI 10.1007/s.00396-006-1636-y; Yip C, 2002, ANN NY ACAD SCI, V961, P109; Yui N., 2010, ADV SCI TECHNOL, V76, P10	31	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0021-9797	1095-7103		J COLLOID INTERF SCI	J. Colloid Interface Sci.	NOV 1	2014	433						16	25		10.1016/j.jcis.2014.06.017		10	Chemistry, Physical	Chemistry	AQ1IR	WOS:000342535600003		
J	Mokhtari, O; Nishikawa, H				Mokhtari, Omid; Nishikawa, Hiroshi			Effects of In and Ni Addition on Microstructure of Sn-58Bi Solder Joint	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Pb-free solder; Sn-Bi solder; Bi coarsening and microstructure refinement	LEAD-FREE SOLDER; SN-BI; INTERFACIAL REACTIONS; CU; ALLOY; TEMPERATURE; GROWTH; STABILITY; DIFFUSION; SUBSTRATE	In this study, the effect of adding 0.5 wt.% and 1 wt.% In and Ni to Sn-58Bi solder on intermetallic compound (IMC) layers at the interface and the microstructure of the solder alloys were investigated during reflow and thermal aging by scanning electron microscopy and electron probe micro-analysis. The results showed that the addition of minor elements was not effective in suppressing the IMC growth during the reflow; however, the addition of 0.5 wt.% In and Ni was effective in suppressing the IMC layer growth during thermal aging. The thickening kinetics of the total IMC layer was analyzed by plotting the mean thickness versus the aging time on log-log coordinates, and the results showed the transition point from grain boundary diffusion control to a volume diffusion control mechanism. The results also showed that the minor addition of In can significantly suppress the coarsening of the Bi phase.	[Mokhtari, Omid; Nishikawa, Hiroshi] Osaka Univ, Joining & Welding Res Inst, Ibaraki, Osaka 5670047, Japan	Mokhtari, O (reprint author), Osaka Univ, Joining & Welding Res Inst, 11-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.	mokhtari@jwri.osaka-u.ac.jp					Tsai JY, 2003, J ELECTRON MATER, V32, P1203, DOI 10.1007/s11664-003-0012-7; Dong WX, 2008, J ELECTRON MATER, V37, P982, DOI 10.1007/s11664-008-0458-8; RAEDER CH, 1994, J ELECTRON MATER, V23, P611, DOI 10.1007/BF02653346; Kim KS, 2003, MICROELECTRON RELIAB, V43, P259, DOI 10.1016/S0026-2714(02)00239-1; Zhang QK, 2010, J MATER RES, V25, P303, DOI 10.1557/JMR.2010.0035; [Anonymous], 2003, 60068258 IEC; VIANCO PT, 1995, J ELECTRON MATER, V24, P1493, DOI 10.1007/BF02655468; Chen WT, 2002, J MATER RES, V17, P263, DOI 10.1557/JMR.2002.0036; Kim HK, 1996, PHYS REV B, V53, P16027, DOI 10.1103/PhysRevB.53.16027; KANG SK, 1994, J ELECTRON MATER, V23, P701, DOI 10.1007/BF02651362; Anderson IE, 2001, J ELECTRON MATER, V30, P1050, DOI 10.1007/s11664-001-0129-5; Schaefer M, 1998, J ELECTRON MATER, V27, P1167, DOI 10.1007/s11664-998-0066-7; Miao HW, 2001, MATER CHEM PHYS, V71, P255, DOI 10.1016/S0254-0584(01)00298-X; Kotadia HR, 2014, MICROELECTRON RELIAB, V54, P1253, DOI 10.1016/j.microrel.2014.02.025; Kotadia HR, 2010, J ELECTRON MATER, V39, P2720, DOI 10.1007/s11664-010-1382-2; Chen W, 2011, J MIN METALL B, V47, P11, DOI 10.2298/JMMB1101011C; MCCORMACK M, 1993, JOM-J MIN MET MAT S, V45, P36; Li JF, 2006, ACTA MATER, V54, P2907, DOI 10.1016/j.actamat.2006.02.030; FELTON LE, 1993, JOM-J MIN MET MAT S, V45, P28; Gao F, 2006, MAT SCI ENG A-STRUCT, V420, P39, DOI 10.1016/j.msea.2006.01.032; Huang YC, 2011, J ELECTRON MATER, V40, P62, DOI 10.1007/s11664-010-1386-y; Jung HR, 2006, J ELECTRON MATER, V35, P1067, DOI 10.1007/BF02692568; Kotadia HR, 2012, J ALLOY COMPD, V511, P176, DOI 10.1016/j.jallcom.2011.09.024; Li B, 2005, J ELECTRON MATER, V34, P217, DOI 10.1007/s11664-005-0207-1; Liu PL, 2001, J MATER RES, V16, P1651, DOI 10.1557/JMR.2001.0229; Nishikawa H, 2006, J ELECTRON MATER, V35, P1127, DOI 10.1007/BF02692576; Sharif A, 2005, J ALLOY COMPD, V390, P67, DOI 10.1016/j.jallcom.2004.08.023	27	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	NOV	2014	43	11					4158	4170		10.1007/s11664-014-3359-z		13	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	AQ0TE	WOS:000342494800035		
J	Zhao, X; Saka, M; Muraoka, M; Yamashita, M; Hokazono, H				Zhao, Xu; Saka, Masumi; Muraoka, Mikio; Yamashita, Mitsuo; Hokazono, Hiroaki			Electromigration Behaviors and Effects of Addition Elements on the Formation of a Bi-rich Layer in Sn58Bi-Based Solders	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Electromigration; Sn58Bi solder; Bi-rich layer; microelements	EUTECTIC SNBI SOLDER; INTERFACIAL REACTIONS; JOINTS; METALLIZATION; KINETICS; FAILURE; GROWTH; LINES	This study investigates the electromigration (EM) behaviors and effects of the addition elements on the formation of a Bi-rich layer in Sn58Bi-based solders including Sn58Bi (SB), Sn58Bi0.5Ag (SBA) and Sn58Bi0.5Ag0.1Cu0.07Ni0.01Ge (SBACNG) solders. The EM tests were conducted at a relatively high temperature of 373 K and at a current density of 30 kA/cm(2). Although the dominant diffusing atom was Bi, hillocks were formed from Sn more easily than from Bi. The electrical resistance increased in the solder during the current stressing, and the dominant factor was attributed to the formation of a Bi-rich layer. SBACNG solder showed the highest resistance to the formation of a Bi-rich layer, followed by SBA, and then SB solder. The possible addition elements enhancing the resistance of SBACNG solder are Ag, Ni and Ge. The effects of the addition elements are summarized as follows: (1) Ag distributes in the Sn phase as Ag3Sn intermetallic compounds (IMCs) that enhance the mechanical strength of Sn; (2) Ni distribution in Bi as Ni-Bi IMCs stabilizes Bi and suppresses its migration; and (3) Ge may distribute in Bi, stabilizing Bi, or Ge exists at the phase boundaries as a precipitate that inhibits Bi migration.	[Zhao, Xu; Muraoka, Mikio] Akita Univ, Dept Mech Engn, Akita 0108502, Japan; [Saka, Masumi] Tohoku Univ, Dept Nanomech, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Yamashita, Mitsuo] Fuji Elect Co Ltd, Shinagawa Ku, Tokyo 1410032, Japan; [Hokazono, Hiroaki] Fuji Elect Co Ltd, Hino, Tokyo 1918502, Japan	Zhao, X (reprint author), Akita Univ, Dept Mech Engn, Tegatagakuen Machi 1-1, Akita 0108502, Japan.	zhao@gipc.akita-u.ac.jp					Abe H, 2006, INT J FRACTURE, V138, P219, DOI 10.1007/s10704-006-0059-6; BLACK JR, 1969, P IEEE, V57, P1587, DOI 10.1109/PROC.1969.7340; MEI Z, 1992, J ELECTRON MATER, V21, P599, DOI 10.1007/BF02655427; Gan H, 2005, J APPL PHYS, V97, DOI 10.1063/1.1861151; Chen CM, 2007, J ELECTRON MATER, V36, P168, DOI 10.1007/s11664-006-0025-0; GLAZER J, 1994, J ELECTRON MATER, V23, P693, DOI 10.1007/BF02651361; Zhao X, 2012, MICROSYST TECHNOL, V18, P2077, DOI 10.1007/s00542-012-1577-y; Lin YH, 2005, ACTA MATER, V53, P2029, DOI 10.1016/j.actamat.2005.01.014; Gan H, 2002, JOM-J MIN MET MAT S, V54, P34, DOI 10.1007/BF02701847; ATTARDO MJ, 1970, J APPL PHYS, V41, P2381, DOI 10.1063/1.1659233; Chen CM, 2001, J APPL PHYS, V90, P1208, DOI 10.1063/1.1380219; Chen CM, 2008, J ALLOY COMPD, V461, P235, DOI 10.1016/j.jallcom.2007.07.059; Chen CM, 2007, J ELECTRON MATER, V36, P760, DOI 10.1007/s11664-007-0150-4; Chen CM, 2000, J ELECTRON MATER, V29, P1222, DOI 10.1007/s11664-000-0016-5; Chen LT, 2006, J MATER RES, V21, P962, DOI 10.1557/JMR.2006.0113; Dybkov VI, 1996, J ALLOY COMPD, V234, P295, DOI 10.1016/0925-8388(95)02096-9; He HW, 2009, J MATER SCI, V44, P2089, DOI 10.1007/s10853-009-3276-3; KAWANOUE T, 1993, J APPL PHYS, V74, P4423, DOI 10.1063/1.354413; Lee MS, 1999, J ELECTRON MATER, V28, P57, DOI 10.1007/s11664-999-0195-7; ROSENBER.R, 1968, APPL PHYS LETT, V12, P201, DOI 10.1063/1.1651951; Yand Q.L., 2005, J ELECT MAT, V34, P1363; Yeh C.C., 2002, APPL PHYS LETT, V80, P580; Zhao X., 2013, J SOLID MECH MAT ENG, V7, P118	23	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	NOV	2014	43	11					4179	4185		10.1007/s11664-014-3400-2		7	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	AQ0TE	WOS:000342494800037		
J	Okamoto, D; Nakayama, H; Ikeda, T; Ikeya, S; Nagashima, S; Takahashi, M; Sugai, Y; Okamoto, H				Okamoto, Daisuke; Nakayama, Haruo; Ikeda, Tomoyuki; Ikeya, Shinichi; Nagashima, Shigeo; Takahashi, Masaharu; Sugai, Yoshiki; Okamoto, Hiroaki			Molecular Analysis of the Interspousal Transmission of Hepatitis B Virus in Two Japanese Patients Who Acquired Fulminant Hepatitis B After 50 and 49 Years of Marriage	JOURNAL OF MEDICAL VIROLOGY			English	Article						hepatitis viruses; entire genome; phylogenetic analysis; precore mutant	DISEASES STUDY-GROUP; ACUTE LIVER-FAILURE; E-ANTIGEN; SURFACE-ANTIGEN; PRECORE REGION; CORE PROMOTER; PHYLOGENETIC RELATEDNESS; LARGE OUTBREAK; RISK-FACTORS; GENOTYPE-C	A 71-year-old (C1I) and 69-year-old (C2I) Japanese female contracted fulminant hepatitis B after 50 and 49 years of marriage, respectively. Both index cases exhibited high levels of anti-HBc IgM antibodies (24.2 and 31.5 S/CO, respectively), suggestive of acute hepatitis B virus (HBV) infection, although they had no discernible risk factors for HBV infection, except for chronically HBV-infected spouses with detectable HBV DNA (3.3 log copies/ml [C1S: 72-year-old] and 7.2 log copies/ml [C2S: 71-year-old]). The HBV genotype/subgenotype was identical in each couple (B/B1 or C/C2). The HBV isolates from the index cases and spouses shared a nucleotide sequence identity of 99.5% and 99.7%, respectively, over the entire genome, and these four isolates had the highest nucleotide sequence identity of only 97% to HBV isolates deposited in DNA databases. Phylogenetic trees confirmed a close relationship of the HBV isolates between C1I and C1S and between C2I and C2S, supported by a high bootstrap value of 100% within each couple, indicating the transfer of HBV infection between spouses. These four isolates shared a precore mutation of G1896A known to be associated with fulminant hepatitis B. Although the history of sexual contact within a reasonable incubation period was obscure for one stable, monogamous couple (C1I and C1S), the other couple had a monogamous sexual relationship within six months prior to disease onset. This study indicates that two elderly Japanese patients with fulminant hepatitis B acquired HBV infection via interspousal (most likely sexual) transmission during long-lasting marriages. J. Med. Virol. 86:1851-1860, 2014. (c) 2014 Wiley Periodicals, Inc.	[Okamoto, Daisuke; Nakayama, Haruo; Ikeda, Tomoyuki; Ikeya, Shinichi; Sugai, Yoshiki] Iwaki Kyoritsu Gen Hosp, Dept Internal Med, Iwaki, Fukushima, Japan; [Nagashima, Shigeo; Takahashi, Masaharu; Okamoto, Hiroaki] Jichi Med Univ, Sch Med, Dept Infect & Immun, Div Virol, Shimotsuke, Tochigi 3290498, Japan	Okamoto, H (reprint author), Jichi Med Univ, Sch Med, Dept Infect & Immun, Div Virol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	hokamoto@jichi.ac.jp	Okamoto, Hiroaki/H-4371-2011	Okamoto, Hiroaki/0000-0003-0827-0964	Ministry of Health, Labour, and Welfare of Japan [H24-Hepatitis-General-007]	Grant sponsor: Ministry of Health, Labour, and Welfare of Japan; Grant number: H24-Hepatitis-General-007.	Aikawa T, 2013, KANZO, V54, P373; Koyama T, 2003, HEPATOL RES, V26, P287, DOI 10.1016/S1386-6346(03)00168-2; Yotsuyanagi H, 2013, CLIN INFECT DIS, V57, P935, DOI 10.1093/cid/cit348; SEEFF LB, 1978, ANN INTERN MED, V88, P285; LIANG TJ, 1991, NEW ENGL J MED, V324, P1705, DOI 10.1056/NEJM199106133242405; NORDER H, 1994, VIROLOGY, V198, P489, DOI 10.1006/viro.1994.1060; Mochida S, 2011, HEPATOL RES, V41, P805, DOI 10.1111/j.1872-034X.2011.00860.x; OKAMOTO H, 1994, J VIROL, V68, P8102; Tanaka J, 2011, INTERVIROLOGY, V54, P185, DOI 10.1159/000324525; LOK ASF, 1991, GASTROENTEROLOGY, V100, P182; Rodella A, 2006, J CLIN VIROL, V37, P206, DOI 10.1016/j.jcv.2006.06.011; KOSAKA Y, 1991, GASTROENTEROLOGY, V100, P1087; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; Shouval D, 2013, SEMIN LIVER DIS, V33, P167, DOI 10.1055/s-0033-1345722; Takahashi M, 2005, J CLIN MICROBIOL, V43, P49, DOI 10.1128/JCM.43.1.49-56.2005; CARMAN WF, 1989, LANCET, V2, P588; Tamada Y, 2012, GUT, V61, P765, DOI 10.1136/gutjnl-2011-300832; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; OKAMOTO H, 1990, J VIROL, V64, P1298; OMATA M, 1991, NEW ENGL J MED, V324, P1699, DOI 10.1056/NEJM199106133242404; SATO S, 1995, ANN INTERN MED, V122, P241; Imamura T, 2003, GUT, V52, P1630, DOI 10.1136/gut.52.11.1630; Harpaz R, 1996, NEW ENGL J MED, V334, P549, DOI 10.1056/NEJM199602293340901; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059; MICHALAK TI, 1994, J CLIN INVEST, V94, P907, DOI 10.1172/JCI116950C1; Inoue J, 2012, J CLIN VIROL, V55, P147, DOI 10.1016/j.jcv.2012.06.011; Yoshikawa A, 2009, TRANSFUSION MED, V19, P172, DOI 10.1111/j.1365-3148.2009.00930.x; Tanaka Y, 2005, HEPATOL RES, V33, P216, DOI 10.1016/j.hepres.2005.08.006; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; OKAMOTO H, 1987, JPN J EXP MED, V57, P231; Candan F, 2002, OCCUP MED-OXFORD, V52, P31, DOI 10.1093/occmed/52.1.31; Stuyver L, 2000, J GEN VIROL, V81, P67; Usuda S, 1999, J VIROL METHODS, V80, P97, DOI 10.1016/S0166-0934(99)00039-7; Nakayama H, 2005, J MED VIROL, V75, P258, DOI 10.1002/jmv.20265; Kobayashi M, 2002, J GASTROENTEROL, V37, P35, DOI 10.1007/s535-002-8130-z; Mochida S, 2008, HEPATOL RES, V38, P970, DOI 10.1111/j.1872-034X.2008.00368.x; BERNIER RH, 1982, AM J EPIDEMIOL, V116, P199; FAGAN EA, 1986, LANCET, V2, P538; Inoue J, 2005, J MED VIROL, V76, P333, DOI 10.1002/jmv.20363; Ito K, 2014, HEPATOLOGY, V59, P89, DOI 10.1002/hep.26635; KENT GP, 1988, AM J EPIDEMIOL, V127, P591; Kou K, 2010, J JPN SOC GASTROENTE, V107, pA367; Kusakabe A, 2009, HEPATOL RES, V39, P648, DOI 10.1111/j.1872-034X.2009.00519.x; LIMENTANI AE, 1979, LANCET, V2, P86; Mason WS, 2012, VIRUS TAXONOMY, P445; Mulyanto, 2010, ARCH VIROL, V155, P705, DOI 10.1007/s00705-010-0628-x; Nakao R, 2006, KANZO, V47, P279, DOI 10.2957/kanzo.47.279; OHBAYASHI A, 1977, LANCET, V1, P433; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Seth P, 2002, BONE MARROW TRANSPL, V30, P189, DOI 10.1038/sj.bmt.1703614; SHAW FE, 1986, JAMA-J AM MED ASSOC, V255, P3260, DOI 10.1001/jama.255.23.3260; SHIMIZU M, 1983, GASTROENTEROLOGY, V84, P604; Shimizu T, 2003, EUR J PEDIATR, V162, P804, DOI 10.1007/s00431-003-1303-y; SZMUNESS W, 1975, ANN INTERN MED, V83, P489; Takeda Y, 2006, INFECTION, V34, P201, DOI 10.1007/s15010-006-5099-3; Tanaka Motohiko, 2004, Nihon Rinsho, V62 Suppl 8, P195; TOUKAN AU, 1990, AM J EPIDEMIOL, V132, P220; Tran Thien Tuan Huy, 2008, J Virol, V82, P5657, DOI 10.1128/JVI.02556-07; van Duynhoven YTHP, 1997, GENITOURIN MED, V73, P488; Webster GJM, 2000, LANCET, V356, P379, DOI 10.1016/S0140-6736(00)02529-0; YOTSUMOTO S, 1992, HEPATOLOGY, V16, P31, DOI 10.1002/hep.1840160107; Zachou Kalliopi, 2013, World J Hepatol, V5, P387, DOI 10.4254/wjh.v5.i7.387	67	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0146-6615	1096-9071		J MED VIROL	J. Med. Virol.	NOV	2014	86	11					1851	1860		10.1002/jmv.24040		10	Virology	Virology	AQ3HD	WOS:000342681200005		
J	Oda, K; Uto, H; Kumagai, K; Ido, A; Kusumoto, K; Shimoda, K; Hayashi, K; Stuver, SO; Tanaka, Y; Nishida, N; Tokunaga, K; Tsubouchi, H				Oda, Kohei; Uto, Hirofumi; Kumagai, Kotaro; Ido, Akio; Kusumoto, Kazunori; Shimoda, Kazuya; Hayashi, Katsuhiro; Stuver, Sherri O.; Tanaka, Yasuhito; Nishida, Nao; Tokunaga, Katsushi; Tsubouchi, Hirohito			Impact of a Single Nucleotide Polymorphism Upstream of the IL28B Gene in Patients Positive for Anti-HCV Antibody in an HCV Hyperendemic Area in Japan	JOURNAL OF MEDICAL VIROLOGY			English	Article						interleukin 28B; hepatitis C virus; SNP; natural course	CHRONIC HEPATITIS-C; GENOME-WIDE ASSOCIATION; TRANSIENT ELASTOGRAPHY; SPONTANEOUS CLEARANCE; VIRUS-INFECTION; LIVER FIBROSIS; NONINVASIVE ASSESSMENT; NATURAL-HISTORY; INTERLEUKIN 28B; EXPRESSION	The influence of genetic variation at the interleukin-28B (IL28B) locus on the natural course of hepatitis C virus (HCV) infection has not been fully investigated. The goal of this study was to examine whether an IL28B polymorphism (rs8099917) is associated with natural clearance of HCV and with disease parameters of HCV infection in an HCV hyperendemic area of Japan. The patients were 502 anti-HCV antibody-positive residents who participated in liver disease screening program from 2002 to 2004. Patients who underwent interferon-based therapy or had hepatocellular carcinoma were excluded. Of these patients, 149 were negative for HCV RNA (prior infection) and 353 were positive for HCV RNA or HCV core antigen (HCV carriers). In multivariate analysis, the IL28B TT genotype was a predictor for prior HCV infection. In addition, nine of the patients with prior HCV infection were positive for anti-HCV antibody with positive for HCV core antigen or HCV RNA before 2001, and these nine patients all had the IL28B TT genotype. Furthermore, the IL28B TT genotype was associated independently with higher HCV core antigen levels in HCV carriers. In contrast, the IL28B genotype did not affect the biochemical markers, such as alanine aminotransferase, hepatic fibrosis markers, and -fetoprotein, and the degree of hepatic fibrosis assessed by transient elastography in HCV carriers. We concluded that IL28B polymorphism (TT genotype) is associated with spontaneous clearance of HCV and conversely with high viral loads in HCV carriers. In contrast, the IL28B genotype does not affect disease progression such as hepatic fibrosis. J. Med. Virol. 86:1877-1885, 2014. (c) 2014 Wiley Periodicals, Inc.	[Oda, Kohei; Uto, Hirofumi; Kumagai, Kotaro; Ido, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, Kagoshima 8908544, Japan; [Ido, Akio; Tsubouchi, Hirohito] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept HGF Tissue Repair & Regenerat Med, Kagoshima 8908544, Japan; [Kusumoto, Kazunori; Shimoda, Kazuya] Miyazaki Univ, Fac Med, Div Gastroenterol & Hematol, Miyazaki, Japan; [Hayashi, Katsuhiro] Miyazaki Univ, Ctr Med Educ, Fac Med, Miyazaki, Japan; [Stuver, Sherri O.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol & Liver Unit, Nagoya, Aichi, Japan; [Nishida, Nao; Tokunaga, Katsushi] Univ Tokyo, Dept Human Genet, Grad Sch Med, Tokyo, Japan	Uto, H (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	hirouto@m2.kufm.kagoshima-u.ac.jp			United States National Institutes of Health [CA87982]	Grant sponsor: United States National Institutes of Health; Grant number: CA87982.	Ahmad W, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-44; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Labarga P, 2011, AIDS, V25, P761, DOI 10.1097/QAD.0b013e32834488e7; Uto H, 2009, HEPATOLOGY, V50, P393, DOI 10.1002/hep.23002; Maasoumy B, 2012, BEST PRACT RES CL GA, V26, P401, DOI 10.1016/j.bpg.2012.09.009; Siren J, 2005, J IMMUNOL, V174, P1932; Friedrich-Rust M, 2009, RADIOLOGY, V252, P595, DOI 10.1148/radiol.2523081928; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Chayama K, 2013, J GASTROENTEROL, V48, P1, DOI 10.1007/s00535-012-0714-9; Beinhardt S, 2012, GASTROENTEROLOGY, V142, P78, DOI 10.1053/j.gastro.2011.09.039; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Liu L, 2012, HEPATOLOGY, V55, P1684, DOI 10.1002/hep.25575; Thio CL, 2010, GASTROENTEROLOGY, V138, P1240, DOI 10.1053/j.gastro.2010.02.033; Uto H, 2006, HEPATOL RES, V34, P28, DOI 10.1016/j.hepres.2005.10.004; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Kobayashi M, 2012, J GASTROENTEROL, V47, P596, DOI 10.1007/s00535-012-0531-1; Ito K, 2011, J CLIN MICROBIOL, V49, P1853, DOI 10.1128/JCM.02139-10; Abe H, 2010, J HEPATOL, V53, P439, DOI 10.1016/j.jhep.2010.03.022; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Stattermayer AF, 2014, ALIMENT PHARM THER, V39, P104, DOI 10.1111/apt.12547; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Marabita F, 2011, HEPATOLOGY, V54, P1127, DOI 10.1002/hep.24503; Abe H, 2011, J MED VIROL, V83, P1597, DOI 10.1002/jmv.22158; Joshita S, 2012, HUM IMMUNOL, V73, P298, DOI 10.1016/j.humimm.2011.12.021; Montes-Cano MA, 2010, HEPATOLOGY, V52, P33, DOI 10.1002/hep.23624; Fabris C, 2011, J HEPATOL, V54, P716, DOI 10.1016/j.jhep.2010.07.019; Berzigotti A, 2010, J HEPATOL, V52, P846, DOI 10.1016/j.jhep.2009.12.031; Chayama K, 2012, HEPATOL RES, V42, P841, DOI 10.1111/j.1872-034X.2012.01002.x; Cross TJS, 2010, HEPATOL RES, V40, P237, DOI 10.1111/j.1872-034X.2010.00626.x; Fabris C, 2012, J MED VIROL, V84, P747, DOI 10.1002/jmv.23259; Friedrich-Rust M, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-103; Kobayashi Y, 2011, J GASTROENTEROL, V46, P529, DOI 10.1007/s00535-010-0338-x; Marcellin P, 2011, GASTROENTEROLOGY, V140, P459, DOI 10.1053/j.gastro.2010.10.046; van den Berg CHBS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027555; Zeuzem S, 2013, NEW ENGL J MED, V369, P630, DOI 10.1056/NEJMoa1213557	42	2	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0146-6615	1096-9071		J MED VIROL	J. Med. Virol.	NOV	2014	86	11					1877	1885		10.1002/jmv.24037		9	Virology	Virology	AQ3HD	WOS:000342681200008		
J	Mimuro, J; Mizukami, H; Shima, M; Matsushita, T; Taki, M; Muto, S; Higasa, S; Sakai, M; Ohmori, T; Madoiwa, S; Ozawa, K; Sakata, Y				Mimuro, Jun; Mizukami, Hiroaki; Shima, Midori; Matsushita, Tadashi; Taki, Masashi; Muto, Shinji; Higasa, Satoshi; Sakai, Michio; Ohmori, Tsukasa; Madoiwa, Seiji; Ozawa, Keiya; Sakata, Yoichi			The Prevalence of Neutralizing Antibodies Against Adeno-Associated Virus Capsids Is Reduced in Young Japanese Individuals	JOURNAL OF MEDICAL VIROLOGY			English	Article						AAV vector; gene therapy; epidemiology	NONHUMAN PRIMATE LIVER; MEDIATED GENE-TRANSFER; T-CELL RESPONSES; FACTOR-IX; HEMOPHILIA-B; AAV VECTOR; SKELETAL-MUSCLE; IN-VIVO; THERAPY; EXPRESSION	Pre-existing antibodies against adeno-associated virus (AAV), caused by natural AAV infections, interfere with recombinant AAV vector-mediated gene transfer. We studied the prevalence of neutralizing antibodies against AAV serotypes 1, 2, 5, 8, and 9 in healthy subjects (n=85) and hemophilia patients (n=59) in a Japanese population. For healthy subjects, the prevalence of neutralizing antibodies against AAV serotypes 1, 2, 5, 8, and 9 was 36.5%, 35.3%, 37.6%, 32.9%, and 36.5%, respectively, while that in hemophilia patients was 39.7%, 28.8%, 35.6%, 32.9%, and 27.4%, respectively. There was no difference in the prevalence of neutralizing antibody against each AAV serotype between the healthy subjects and the hemophilia patients. The prevalence of neutralizing antibodies against all AAV serotypes increased with age in both healthy subjects and hemophilia patients. High titers of neutralizing antibodies against AAV2 (1:224) and AAV8 (1:224) were more evident in older individuals (42 years old). Approximately 50% of all screened individuals were seronegative for neutralizing antibodies against each AAV tested, while approximately 25% of individuals were seropositive for each AAV serotype tested. The prevalence of seronegativity for all AAV serotypes was 67.0% (healthy subjects, 68.6%; hemophilia patients, 65.0%) and 18.6% (healthy subjects, 20.5%; hemophilia patients, 15.7%) in young (<42 years old) and older subjects (42 years old), respectively. The findings from this study suggested that young subjects are more likely to be eligible for gene therapy based on AAV vectors delivered via an intravascular route because of the low prevalence of antibodies to AAV capsids. J. Med. Virol. 86:1990-1997, 2014. (c) 2013 Wiley Periodicals, Inc.	[Mimuro, Jun; Ohmori, Tsukasa; Madoiwa, Seiji; Sakata, Yoichi] Jichi Med Univ, Div Cell & Mol Med, Ctr Mol Med, Shimotsuke 3290498, Japan; [Mizukami, Hiroaki; Ozawa, Keiya] Jichi Med Univ, Div Genet Therapeut, Ctr Mol Med, Shimotsuke 3290498, Japan; [Shima, Midori] Nara Med Univ, Dept Pediat, Kashihara, Nara 634, Japan; [Matsushita, Tadashi] Nagoya Univ Hosp, Dept Blood Transfus, Nagoya, Aichi, Japan; [Taki, Masashi] St Marianna Univ, Sch Med, Dept Pediat, Yokohama City Seibu Hosp, Yokohama, Kanagawa, Japan; [Muto, Shinji] St Marianna Univ, Dept Pediat, Sch Med, Kawasaki, Kanagawa, Japan; [Higasa, Satoshi] Hyogo Coll Med, Dept Internal Med, Div Hematol, Nishinomiya, Hyogo 6638501, Japan; [Sakai, Michio] Univ Occupat & Environm Hlth, Sch Med, Dept Pediat, Kitakyushu, Fukuoka 807, Japan	Mimuro, J (reprint author), Jichi Med Univ, Div Cell & Mol Med, Ctr Mol Med, 3311-1 Yakushiji, Shimotsuke 3290498, Japan.	cell.mol.bio.j@gmail.com	Mizukami, Hiroaki/D-7674-2013	Mizukami, Hiroaki/0000-0001-8954-874X	Japanese Ministry of Education, Culture, Sports, Science and Technology; Health, Labour and Science Research Grants for Research on HIV/AIDS; Research on Intractable Diseases from the Japanese Ministry of Health, Labour and Welfare;  [20591155];  [21591249];  [21790920]	Grant sponsor: Grants-in-Aid for Scientific Research; Grant numbers: 20591155; 21591249; 21790920.; Grant sponsor: Support Program for Strategic Research Infrastructure from the Japanese Ministry of Education, Culture, Sports, Science and Technology; Grant sponsor: Health, Labour and Science Research Grants for Research on HIV/AIDS; Grant sponsor: Research on Intractable Diseases from the Japanese Ministry of Health, Labour and Welfare	Mingozzi F, 2011, CURR GENE THER, V11, P321; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Erles K, 1999, J MED VIROL, V59, P406, DOI 10.1002/(SICI)1096-9071(199911)59:3<406::AID-JMV22>3.0.CO;2-N; Rapti K, 2012, MOL THER, V20, P73, DOI 10.1038/mt.2011.177; Gao GP, 2009, HUM GENE THER, V20, P930, DOI 10.1089/hum.2009.060; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Campagna M, 2012, HEPAT MON, V12, P382, DOI 10.5812/hepatmon.5940; Mingozzi F, 2009, BLOOD, V114, P2077, DOI 10.1182/blood-2008-07-167510; Foster H, 2012, HUM GENE THER, V23, P676, DOI 10.1089/hum.2012.099; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Chuah MK, 2012, HUM GENE THER, V23, P557, DOI 10.1089/hum.2012.088; Nathwani AC, 2011, MOL THER, V19, P876, DOI 10.1038/mt.2010.274; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Nathwani AC, 2006, BLOOD, V107, P2653, DOI 10.1182/blood-2005-10-4035; Grieger JC, 2012, METHOD ENZYMOL, V507, P229, DOI 10.1016/B978-0-12-386509-0.00012-0; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Manno CS, 2003, BLOOD, V101, P2963, DOI 10.1182/blood-2002-10-3296; Li C, 2012, GENE THER, V19, P288, DOI 10.1038/gt.2011.90; Jiang HY, 2006, BLOOD, V108, P3321, DOI 10.1182/blood-2006-04-017913; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Bartel M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00204; Chandler RJ, 2011, MOL THER, V19, P826, DOI 10.1038/mt.2011.73; High K., 2007, HEMATOL-AM SOC HEMAT, V2007, P466, DOI 10.1182/asheducation-2007.1.466; Hufnagel RB, 2012, GRAEF ARCH CLIN EXP, V250, P1117, DOI 10.1007/s00417-012-2028-2; Li CW, 2009, J VIROL, V83, P6817, DOI 10.1128/JVI.00278-09; Mimuro J, 2013, MOL THER, V21, P318, DOI 10.1038/mt.2012.258; Mizukami H, 2006, HUM GENE THER, V17, P921, DOI 10.1089/hum.2006.17.921; Mohammadi ES, 2004, NUCLEIC ACIDS RES, V32, P2652, DOI 10.1093/nar/gkh593; Muramatsu S, 2010, MOL THER, V18, P1731, DOI 10.1038/mt.2010.135	32	3	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0146-6615	1096-9071		J MED VIROL	J. Med. Virol.	NOV	2014	86	11					1990	1997		10.1002/jmv.23818		8	Virology	Virology	AQ3HD	WOS:000342681200021		
J	Dahy, AA; Koga, N				Dahy, AbdelRahman A.; Koga, Nobuaki			A computational study on the formation of pyridin-2(1H)-one and pyridine-2(1H)-thione from the reaction of cobaltacyclopentadiene with isocyanate and isothiocyanate	JOURNAL OF ORGANOMETALLIC CHEMISTRY			English	Article						Isocyanate; Isothiocyanate; Cobaltacyclopentadiene; DFT calculations; Minimum-energy crossing points; Two-state reaction mechanism	CATALYZED 2+2+2 CYCLOADDITION; MOLECULAR-ORBITAL METHODS; GAUSSIAN-TYPE BASIS; REACTION-MECHANISM; SUBSTITUTED PYRIDINES; ALKENYL ISOCYANATES; ORGANIC-MOLECULES; CARBON-DISULFIDE; COBALT COMPLEX; BASIS SETS	The reaction mechanisms for the reactions of cobaltacyclopentadiene with isocyanate and isothiocyanate exclusively in singlet or triplet states, or involving transition between states, were studied by means of hybrid density functional theory (B3LYP) calculations. The results clearly showed that a two-state mechanism involving both singlet and triplet states is more favorable than the corresponding single-state mechanism for all the reactions. We also found that the reactions of isocyanate and isothiocyanate to give pyridin-2(1H)-one and pyridine-2(1H)-thione complexes, respectively, are more favorable than those that give 2H-pyran-2-imine and 2H-thiopyran-2-imine complexes. This is mainly due to the greater stabilities of pyridin-2(1H)-one and pyridine-2(1H)-thione compared with 2H-pyran-2-imine and 2H-thiopyran-2-imine. A change in spin state plays a crucial role in the two-state mechanism; first, the C=N bond of the isocyanate or isothiocyanate inserts into the Co-C-alpha bond of cobaltacyclopentadiene in the singlet state to give azacobaltacycloheptadienone or azacobaltacycloheptadienethione intermediates, and subsequent reductive elimination in the triplet state gives the pyridin-2(1H)-one or pyridine-2(1H)-thione complex, respectively. (C) 2014 Elsevier B. V. All rights reserved.	[Dahy, AbdelRahman A.] Assiut Univ, Dept Chem, Fac Sci, Assiut 71516, Egypt; [Dahy, AbdelRahman A.; Koga, Nobuaki] Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan	Koga, N (reprint author), Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan.	koga@is.nagoya-u.ac.jp					GONZALEZ C, 1989, J CHEM PHYS, V90, P2154, DOI 10.1063/1.456010; Alkorta I, 2002, J ORG CHEM, V67, P1515, DOI 10.1021/jo016069m; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x; Harvey JN, 1999, PHYS CHEM CHEM PHYS, V1, P5555, DOI 10.1039/a907723e; Portmann S, 2000, CHIMIA, V54, P766; HUTCHINSON CR, 1981, TETRAHEDRON, V37, P1047, DOI 10.1016/S0040-4020(01)92034-4; Kondo T, 2006, TETRAHEDRON LETT, V47, P7107, DOI 10.1016/j.tetlet.2006.07.105; THORN DL, 1979, NOUV J CHIM, V3, P39; Tanaka K, 2005, ORG LETT, V7, P4737, DOI 10.1021/ol052041b; Tsuchida N, 2005, J PHYS CHEM A, V109, P1974, DOI 10.1021/jp040451w; WACHTERS AJ, 1970, J CHEM PHYS, V52, P1033, DOI 10.1063/1.1673095; Takahashi T, 2002, J AM CHEM SOC, V124, P5059, DOI 10.1021/ja017507+; MCLEAN AD, 1980, J CHEM PHYS, V72, P5639, DOI 10.1063/1.438980; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; Agenet N, 2007, J AM CHEM SOC, V129, P8860, DOI 10.1021/ja072208r; Henry GD, 2004, TETRAHEDRON, V60, P6043, DOI 10.1016/j.tet.2004.04.043; Lautens M, 1996, CHEM REV, V96, P49, DOI 10.1021/cr950016l; Varela JA, 2003, CHEM REV, V103, P3787, DOI 10.1021/cr030677f; Chopade PR, 2006, ADV SYNTH CATAL, V348, P2307, DOI 10.1002/adsc.200600325; Dahy AA, 2005, B CHEM SOC JPN, V78, P781, DOI 10.1246/bcsj.78.781; Reiher M, 2001, THEOR CHEM ACC, V107, P48, DOI 10.1007/s00214-001-0300-3; EARL RA, 1984, J ORG CHEM, V49, P4786, DOI 10.1021/jo00199a009; Tanaka K, 2006, ORG LETT, V8, P907, DOI 10.1021/ol053044r; Yu RT, 2006, J AM CHEM SOC, V128, P2782, DOI 10.1021/ja057803c; Tanaka K, 2012, HETEROCYCLES, V85, P1017, DOI 10.3987/REV-12-729; MUKERJEE AK, 1991, CHEM REV, V91, P1, DOI 10.1021/cr00001a001; Yamamoto Y, 2001, ORG LETT, V3, P2117, DOI 10.1021/ol016082t; Dahy AA, 2005, B CHEM SOC JPN, V78, P792, DOI 10.1246/bcsj.78.792; Nakamura I, 2004, CHEM REV, V104, P2127, DOI 10.1021/cr020095i; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; REPPE W, 1948, LIEBIGS ANN CHEM, V560, P1; Boaga L. V. R., 2008, J AM CHEM SOC, V127, P3473; BONNEMANN H, 1980, ERDOL KOHLE ERDGAS P, V33, P328; BONNEMANN H, 1978, ANGEW CHEM INT EDIT, V17, P505, DOI 10.1002/anie.197805051; Dahy AA, 2009, ORGANOMETALLICS, V28, P3636, DOI 10.1021/om900025m; Dahy AA, 2010, J ORGANOMET CHEM, V695, P2240, DOI 10.1016/j.jorganchem.2010.06.015; DITCHFIE.R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902; DIVERSI P, 1987, J MOL CATAL, V40, P267, DOI 10.1016/0304-5102(87)80091-3; Duong HA, 2004, J AM CHEM SOC, V126, P11438, DOI 10.1021/ja046477i; Duong HA, 2006, TETRAHEDRON, V62, P7552, DOI 10.1016/j.tet.2006.03.119; EARL RA, 1983, J AM CHEM SOC, V105, P6991, DOI 10.1021/ja00361a057; Flukiger P., 2000, MOLEKEL 4 3; FLYNN ST, 1985, J MOL CATAL, V32, P101, DOI 10.1016/0304-5102(85)85036-7; Frisch M. J., 2004, GAUSSIAN 03 REVISION; FRISCH MJ, 1998, GAUSSIAN 98 REVISION; Fujiwara M., 2003, MODERN RHODIUM CATAL, P129; GONZALEZ C, 1990, J PHYS CHEM-US, V94, P5523, DOI 10.1021/j100377a021; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; HOBERG H, 1982, SYNTHESIS-STUTTGART, P324; HOBERG H, 1982, J ORGANOMET CHEM, V234, pC35, DOI 10.1016/S0022-328X(00)85864-7; HOBERG H, 1983, J ORGANOMET CHEM, V252, P359, DOI 10.1016/S0022-328X(00)99836-X; HONG P, 1977, SYNTHESIS-STUTTGART, P50; Hong P., 1977, TETRAHEDRON LETT, V15, P1333; KOGA N, 1985, CHEM PHYS LETT, V119, P371, DOI 10.1016/0009-2614(85)80436-X; Kotha S, 2005, EUR J ORG CHEM, P4741, DOI 10.1002/ejoc.200500411; Ladjarafi A., 2004, J MOL STRUC-THEOCHEM, V209, P129; Lednicer D., 1977, ORGANIC CHEM DRUG SY, V1-5; Lv LL, 2013, ORGANOMETALLICS, V32, P3837, DOI 10.1021/om400301y; Onodera G, 2012, J ORG CHEM, V77, P908, DOI 10.1021/jo202083z; Pelletier S. W., 1970, CHEM ALKALOIDS; Poli R, 2009, COMMENT INORG CHEM, V30, P177, DOI 10.1080/02603590903423942; Raghavachari K., 1980, J CHEM PHYS, V72, P650, DOI DOI 10.1063/1.438955; Reppe W., 1948, LIEBIGS ANN CHEM, V560, P104; Yu RT, 2006, J AM CHEM SOC, V128, P12370, DOI 10.1021/ja064868m; Schmid R, 2003, J ORG CHEM, V68, P8339, DOI 10.1021/jo034985p; SCHULTZ AG, 1973, CHEM REV, V73, P385, DOI 10.1021/cr60284a004; Selimov F. A., 2001, ARKIVOC, V9, P85; Tanaka K, 2007, SYNLETT, P1977, DOI 10.1055/s-2007-984541; VOLLHARDT KPC, 1984, ANGEW CHEM INT EDIT, V23, P539, DOI 10.1002/anie.198405393; WAKATSUK.Y, 1973, J CHEM SOC CHEM COMM, P280; Yale H. L., 1975, CHEM HETEROCYCLIC 4, P189; YAMADA K, 1980, J MOL SPECTROSC, V79, P323, DOI 10.1016/0022-2852(80)90217-9; Yamamoto Y, 2002, J AM CHEM SOC, V124, P28, DOI 10.1021/ja016510q; Yamamoto Y, 2005, J AM CHEM SOC, V127, P605, DOI 10.1021/ja045694g; Yamazaki H., 1987, YUKI GOSEI KAGAKU KY, V45, P244	76	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-328X	1872-8561		J ORGANOMET CHEM	J. Organomet. Chem.	NOV 1	2014	770						101	115		10.1016/j.jorganchem.2014.08.008		15	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	AQ1UX	WOS:000342569500014		
J	Cai, ZG; Su, HH; Nakayama, Y; Shiono, T; Akita, M				Cai, Zhengguo; Su, Haihui; Nakayama, Yuushou; Shiono, Takeshi; Akita, Munetaka			Synthesis of C-1 symmetrical ansa-cyclopentadienylamidotitanium complexes and their application for living polymerization of propylene	JOURNAL OF ORGANOMETALLIC CHEMISTRY			English	Article						Cyclopentadienylamido ligand; Ti complex; Single-site catalyst; Propylene; Living polymerization	ZIEGLER-NATTA POLYMERIZATION; ALPHA-OLEFIN POLYMERIZATION; IMINE CHELATE LIGANDS; ISOTACTIC POLYPROPYLENE; PROPENE POLYMERIZATION; ZIRCONOCENE COMPLEXES; METALLOCENE CATALYSTS; STEREOSPECIFIC POLYMERIZATION; ELASTOMERIC POLY(PROPYLENE); MECHANISTIC ASPECTS	Optically active C-1 symmetrical [(R)-NCHMe(Naphthyl)SiMe(2)Flu]TiMe2 (1) and [(R)-NCHMe(Naphthyl)SiMe2(C5Me4)]TiMe2 (2) were synthesized and characterized by elemental analysis, H-1 NMR and single crystal X-ray analysis. These complexes were applied for propylene polymerization using dried modified methyaluminoxane (dMMAO) as a cocatalyst at 0 degrees C in toluene, heptane and chlorobenzene, respectively. All the systems showed steady polymerization rate and gave high molecular weight polypropylene with narrow molecular weight distribution, and the toluene system showed higher activity than the heptane system. The postpolymerization testified that each catalytic system conducted the propylene polymerization in a living manner. The 2-chlorobenzene system showed fastest propagation rate of 437 mol min(-1). The polymers produced with the 1-heptane and -toluene systems or 2-heptane system were statistically atactic, while the polymers produced with the 2-toluene system were isotactic-rich PP with isotactic triad (mm) of 0.61. (C) 2014 Elsevier B. V. All rights reserved.	[Cai, Zhengguo; Su, Haihui] Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai 201620, Peoples R China; [Nakayama, Yuushou; Shiono, Takeshi] Hiroshima Univ, Grad Sch Engn, Higashihiroshima 7398527, Japan; [Akita, Munetaka] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan	Cai, ZG (reprint author), Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, 2999 North Renmin Rd, Shanghai 201620, Peoples R China.	caizg@dhu.edu.cn; tshiono@hiroshima-u.ac.jp	Akita, Munetaka/C-5614-2011; SHIONO, Takeshi/D-7024-2011	Akita, Munetaka/0000-0001-7007-9621; SHIONO, Takeshi/0000-0002-1118-9991	National Natural Science Foundation of China [21174026]; Program for New Century Excellent Talents in University; Shanghai Municipal Education Commission; Shanghai Education Development Foundation; Fundamental Research Funds for the Central Universities	This work was supported by National Natural Science Foundation of China (21174026), Program for New Century Excellent Talents in University, the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, "Shu Guang" project supported by Shanghai Municipal Education Commission and Shanghai Education Development Foundation and the Fundamental Research Funds for the Central Universities. We thank Tosoh-Finechem Co. for donating MMAO.	McKnight AL, 1998, CHEM REV, V98, P2587, DOI 10.1021/cr940442r; Hustad PD, 2002, J AM CHEM SOC, V124, P3614, DOI 10.1021/ja0122593; Harney MB, 2006, ANGEW CHEM INT EDIT, V45, P2400, DOI 10.1002/anie.200600027; Resconi L, 2000, CHEM REV, V100, P1253, DOI 10.1021/cr9804691; Dietrich U, 1999, J AM CHEM SOC, V121, P4348, DOI 10.1021/ja9833220; MALLIN DT, 1990, J AM CHEM SOC, V112, P2030, DOI 10.1021/ja00161a075; Busico V, 2003, MACROMOLECULES, V36, P3806, DOI 10.1021/ma0342527; Hasan T, 2001, MACROMOLECULES, V34, P3142, DOI 10.1021/ma0017438; Mitani M, 2003, J AM CHEM SOC, V125, P4293, DOI 10.1021/ja029560j; SHAPIRO PJ, 1990, ORGANOMETALLICS, V9, P867, DOI 10.1021/om00117a055; EWEN JA, 1991, MAKROMOL CHEM-M SYMP, V48-9, P253, DOI 10.1002/masy.19910480121; GAUTHIER WJ, 1995, MACROMOLECULES, V28, P3771, DOI 10.1021/ma00115a004; Domski GJ, 2008, CHEM COMMUN, P6137, DOI 10.1039/b811384j; BRINTZINGER HH, 1995, ANGEW CHEM INT EDIT, V34, P1143, DOI 10.1002/anie.199511431; Irwin LJ, 2005, J AM CHEM SOC, V127, P9972, DOI 10.1021/ja052256g; Bochmann M., 1996, J CHEM SOC DA, V255; Bravakis AM, 1998, MACROMOLECULES, V31, P1000, DOI 10.1021/ma971325b; Busico V, 2004, MACROMOLECULES, V37, P8201, DOI 10.1021/ma048144b; Cai ZG, 2005, MACROMOLECULES, V38, P8135, DOI 10.1021/ma050898i; FIERRO R, 1994, J POLYM SCI POL CHEM, V32, P2817, DOI 10.1002/pola.1994.080321503; GIARDELLO MA, 1993, J AM CHEM SOC, V115, P3326, DOI 10.1021/ja00061a040; Gibson VC, 2003, CHEM REV, V103, P283, DOI 10.1021/cr980461r; Hagihara H, 1998, MACROMOLECULES, V31, P3184, DOI 10.1021/ma971697k; Hagihara H, 1997, MACROMOLECULES, V30, P4783, DOI 10.1021/ma970352z; Ioku A, 2002, MACROMOL CHEM PHYSIC, V203, P748, DOI 10.1002/1521-3935(20020301)203:4<748::AID-MACP748>3.0.CO;2-G; Kleinschmidt R, 2000, J MOL CATAL A-CHEM, V157, P83, DOI 10.1016/S1381-1169(00)00036-4; Kukral J, 2000, ORGANOMETALLICS, V19, P3767, DOI 10.1021/om000224q; Lee MH, 1998, J ORGANOMET CHEM, V561, P37, DOI 10.1016/S0022-328X(98)00548-8; LLINAS GH, 1992, MACROMOLECULES, V25, P1242, DOI 10.1021/ma00030a007; LLINAS GH, 1993, ORGANOMETALLICS, V12, P1283, DOI 10.1021/om00028a051; Mason AF, 2004, J AM CHEM SOC, V126, P16326, DOI 10.1021/ja044268s; MIYAKE S, 1995, MACROMOLECULES, V28, P3074, DOI 10.1021/ma00113a009; Nishii K, 2006, J ORGANOMET CHEM, V691, P193, DOI 10.1016/j.jorganchem.2005.08.027; Nishii K, 2004, MACROMOL CHEM PHYSIC, V205, P363, DOI 10.1002/macp.200300137; OKUDA J, 1995, ORGANOMETALLICS, V14, P789, DOI 10.1021/om00002a028; Razavi A, 1996, J ORGANOMET CHEM, V520, P115, DOI 10.1016/0022-328X(96)06306-1; Razavi A, 2001, J ORGANOMET CHEM, V621, P267, DOI 10.1016/S0022-328X(00)00863-9; RAZAVI A, 1995, MACROMOL SYMP, V89, P345, DOI 10.1002/masy.19950890133; Resconi L, 2002, J ORGANOMET CHEM, V664, P5, DOI 10.1016/S0022-328X(02)01853-3; RIEGER B, 1994, ORGANOMETALLICS, V13, P647, DOI 10.1021/om00014a041; Saito J, 2001, CHEM LETT, P576, DOI 10.1246/cl.2001.576; Shiomura T, 1996, MACROMOL RAPID COMM, V17, P9, DOI 10.1002/marc.1996.030170102; Thomas EJ, 2000, ORGANOMETALLICS, V19, P4077, DOI 10.1021/om000256d; Thomas EJ, 2000, MACROMOLECULES, V33, P1546, DOI 10.1021/ma991463w; ZAMBELLI A, 1991, MAKROMOL CHEM-M SYMP, V48-9, P297, DOI 10.1002/masy.19910480122	45	0	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-328X	1872-8561		J ORGANOMET CHEM	J. Organomet. Chem.	NOV 1	2014	770						136	141		10.1016/j.jorganchem.2014.08.019		6	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	AQ1UX	WOS:000342569500018		
J	Kanazawa, T; Furumatsu, T; Matsumoto-Ogawa, E; Maehara, A; Ozaki, T				Kanazawa, Tomoko; Furumatsu, Takayuki; Matsumoto-Ogawa, Emi; Maehara, Ami; Ozaki, Toshifumi			Role of Rho Small GTPases in Meniscus Cells	JOURNAL OF ORTHOPAEDIC RESEARCH			English	Article						CREB; Mechanical stretch; Meniscus; Rac1; ROCK; SOX9	HUMAN ARTICULAR CHONDROCYTES; MEDIATED TRANSCRIPTION; DYNAMIC COMPRESSION; GENE-EXPRESSION; SOX9 PROMOTER; CREB; DIFFERENTIATION; CHONDROGENESIS; CHROMATIN; PATHWAY	We previously reported that mechanical stretch regulates Sry-type HMG box (SOX) 9-dependent 1(II) collagen (COL2A1) expression in inner meniscus cells. This study examined the role of the small Rho guanosine 5' triphosphatase Rac1 and Rho-associated kinase (ROCK) in the regulation of stretch-induced SOX9 gene expression in cultured human inner meniscus cells. COL2A1 and SOX9 gene expression was assessed by real-time PCR after application of uni-axial cyclic tensile strain (CTS) in the presence or absence of ROCK and Rac1 inhibitors. The subcellular localization of SOX9 and the Rac1 effector cyclic AMP response element-binding protein (CREB), the phosphorylation state of SOX9, Rac1 activation, and the binding of CREB to the SOX9 promoter were assessed. CTS increased the expression of COL2A1 and SOX9, which was suppressed by inhibition of Rac1. ROCK inhibition enhanced COL2A1 and SOX9 gene expression in the absence of CTS. CTS stimulated the nuclear translocation and phosphorylation of SOX9, and increased Rac1 activation. CTS also increased the binding of CREB to the SOX9 promoter. The results suggest that mechanical stretch-dependent upregulation of SOX9 by CREB in inner meniscus cells depends on the antagonistic activities of ROCK and Rac1. (c) 2014 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 32:1479-1486, 2014.	[Kanazawa, Tomoko; Furumatsu, Takayuki; Matsumoto-Ogawa, Emi; Maehara, Ami; Ozaki, Toshifumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthopaed Surg, Kita Ku, Okayama 7008558, Japan	Furumatsu, T (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthopaed Surg, Kita Ku, 2-5-1 Shikatacho, Okayama 7008558, Japan.	matino@md.okayama-u.ac.jp	FURUMATSU, Takayuki/B-2233-2011		Japan Society for the Promotion of Science [24791546]	Grant sponsor: Dr. Aki Yoshida and Dr. Zhichao Lu for their technical assistance. This work was supported by Japan Society for the Promotion of Science (no. 24791546 to T.F.).	Alenghat FJ, 2009, J CELL BIOCHEM, V106, P529, DOI 10.1002/jcb.22001; Kumar D, 2009, MOL CELL BIOL, V29, P4262, DOI 10.1128/MCB.01779-08; Ling SZ, 2011, CANCER RES, V71, P3812, DOI 10.1158/0008-5472.CAN-10-3072; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Furumatsu T, 2013, J BIOMECH, V46, P1508, DOI 10.1016/j.jbiomech.2013.03.028; Ikeda T, 2005, J BONE MINER METAB, V23, P337, DOI 10.1007/s00774-005-0610-y; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Adams JP, 2000, ACTA NEUROBIOL EXP, V60, P377; Woods A, 2006, J BIOL CHEM, V281, P13134, DOI 10.1074/jbc.M509433200; Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037; Zhao L, 2009, J BONE MINER RES, V24, P826, DOI [10.1359/jbmr.081236, 10.1359/JBMR.081236]; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; MCDEVITT CA, 1990, CLIN ORTHOP RELAT R, P8; Tsuda M, 2003, J BIOL CHEM, V278, P27224, DOI 10.1074/jbc.M303471200; Haudenschild DR, 2008, BIORHEOLOGY, V45, P219, DOI 10.3233/BIR-2008-0499; Piera-Velazquez S, 2007, EXP CELL RES, V313, P1069, DOI 10.1016/j.yexcr.2007.01.001; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293; Kanai Y, 1999, HUM MOL GENET, V8, P691, DOI 10.1093/hmg/8.4.691; Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173; Juhasz T, 2014, CELL SIGNAL, V26, P468, DOI 10.1016/j.cellsig.2013.12.001; Furumatsu T, 2005, J BIOL CHEM, V280, P35203, DOI 10.1074/jbc.M502409200; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Furumatsu T, 2010, ACTA MED OKAYAMA, V64, P351; Togo T, 2004, J BIOL CHEM, V279, P44996, DOI 10.1074/jbc.M406327200; Furumatsu T, 2009, INT J BIOCHEM CELL B, V41, P1198, DOI 10.1016/j.biocel.2008.10.032; Haudenschild DR, 2010, ARTHRITIS RHEUM-US, V62, P191, DOI 10.1002/art.25051; Haditsch U, 2013, J NEUROSCI, V33, P12229, DOI 10.1523/JNEUROSCI.2939-12.2013; CHEUNG HS, 1987, CONNECT TISSUE RES, V16, P343, DOI 10.3109/03008208709005619; Date H, 2010, J ORTHOP RES, V28, P225, DOI 10.1002/jor.20981; FITHIAN DC, 1990, CLIN ORTHOP RELAT R, P19; Fujii M, 2013, J ORTHOP RES, V31, P538, DOI 10.1002/jor.22257; Furumatsu T, 2010, INT J BIOCHEM CELL B, V42, P148, DOI 10.1016/j.biocel.2009.10.003; Furumatsu T, 2014, CONNECT TISSUE RES, V55, P89, DOI 10.3109/03008207.2013.852544; Furumatsu T, 2010, BIOCHEM BIOPH RES CO, V391, P1142, DOI 10.1016/j.bbrc.2009.12.044; Furumatsu T, 2011, CONNECT TISSUE RES, V52, P459, DOI 10.3109/03008207.2011.562061; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; Haudenschild DR, 2008, ARTHRITIS RHEUM-US, V58, P2735, DOI 10.1002/art.23797; Husse Britta, 2010, Heart Int, V5, pe3, DOI 10.4081/hi.2010.e3; Kanazawa T, 2012, J ORTHOP RES, V30, P468, DOI 10.1002/jor.21528; Matsumoto E, 2012, BIOCHEM BIOPH RES CO, V420, P124, DOI 10.1016/j.bbrc.2012.02.127; Tetsunaga T, 2009, J BIOMECH, V42, P2097, DOI 10.1016/j.jbiomech.2009.06.016; Upton ML, 2006, CONNECT TISSUE RES, V47, P207, DOI 10.1080/03008200600846663	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-0266	1554-527X		J ORTHOP RES	J. Orthop. Res.	NOV	2014	32	11					1479	1486		10.1002/jor.22703		8	Orthopedics	Orthopedics	AQ2QQ	WOS:000342633300012		
J	Wagner, D; Kamer, L; Rommens, PM; Sawaguchi, T; Richards, RG; Noser, H				Wagner, Daniel; Kamer, Lukas; Rommens, Pol M.; Sawaguchi, Takeshi; Richards, Robert Geoff; Noser, Hansrudi			3D Statistical Modeling Techniques to Investigate the Anatomy of the Sacrum, Its Bone Mass Distribution, and the Trans-Sacral Corridors	JOURNAL OF ORTHOPAEDIC RESEARCH			English	Article						sacrum; statistical model; fracture; anatomy; corridor	CONTRAST-ENHANCED MDCT; COMPUTED-TOMOGRAPHY; MINERAL DENSITY; FRACTURES; SCREWS; FIXATION; CT; STABILIZATION; OSTEOPOROSIS; PLACEMENT	The complex anatomy of the sacrum makes surgical fracture fixation challenging. We developed statistical models to investigate sacral anatomy with special regard to trans-sacral implant fixation. We used computed tomographies of 20 intact adult pelves to establish 3D statistical models: a surface model of the sacrum and the trans-sacral corridor S1, including principal component analysis (PCA), and an averaged gray value model of the sacrum given in Hounsfield Units. PCA demonstrated large variability in sacral anatomy markedly affecting the diameters of the trans-sacral corridors. The configuration of the sacral alae and the vertical position of the auricular surfaces were important determinants of the trans-sacral corridor dimension on level S1. The statistical model of trans-sacral corridor S1 including the adjacent parts of the iliac bones showed main variation in length; however, the diameter was the main criterion for the surgically available corridor. The averaged gray value model revealed a distinct pattern of bone mass distribution with lower density particularly in the sacral alae. These advanced 3D statistical models provide a thorough anatomical understanding demonstrating the impact of sacral anatomy on positioning trans-sacral implants. (c) 2014 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 32:1543-1548, 2014.	[Wagner, Daniel; Kamer, Lukas; Richards, Robert Geoff; Noser, Hansrudi] AO Res Inst Davos, CH-7270 Davos, Switzerland; [Wagner, Daniel; Rommens, Pol M.] Univ Med Ctr Mainz, Dept Trauma Surg, Ctr Orthopaed & Traumatol, D-55131 Mainz, Germany; [Sawaguchi, Takeshi] Toyama Municipal Hosp, Dept Orthoped & Joint Reconstruct Surg, Toyama, Japan	Wagner, D (reprint author), AO Res Inst Davos, Clavadelerstr 8, CH-7270 Davos, Switzerland.	wagner.daniel@gmx.ch	Richards, Robert/I-8235-2015	Richards, Robert/0000-0002-7778-2480	TK System of the AO Foundation, Davos Switzerland; DePuy Synthes, Solothurn, Switzerland	Grant sponsor: TK System of the AO Foundation, Davos Switzerland.; Grant sponsor: DePuy Synthes, Solothurn, Switzerland.	ABITBOL MM, 1987, AM J PHYS ANTHROPOL, V74, P65, DOI 10.1002/ajpa.1330740107; Pickhardt PJ, 2013, ANN INTERN MED, V158, P588, DOI 10.7326/0003-4819-158-8-201304160-00003; Gardner MJ, 2010, J ORTHOP TRAUMA, V24, P622, DOI 10.1097/BOT.0b013e3181cf0404; Genant HK, 2008, RHEUMATOLOGY, V47, P9, DOI 10.1093/rheumatology/ken180; Heimann T, 2009, MED IMAGE ANAL, V13, P543, DOI 10.1016/j.media.2009.05.004; Gardner MJ, 2011, J ORTHOP TRAUMA, V25, P378, DOI 10.1097/BOT.0b013e3181e47fad; Routt MLC, 1996, J ORTHOP TRAUMA, V10, P171; Rommens PM, 2013, INJURY, V44, P1733, DOI 10.1016/j.injury.2013.06.023; Graves ML, 2011, J TRAUMA, V71, P204, DOI 10.1097/TA.0b013e31821e842a; Rommens PM, 2012, EUR J TRAUMA EMERG S, V38, P499, DOI 10.1007/s00068-012-0224-8; Routt ML, 1996, CLIN ORTHOP RELAT R, P121; Zheng YG, 2000, SPINE, V25, P353, DOI 10.1097/00007632-200002010-00016; van de Giessen M, 2010, J BIOMECH, V43, P1463, DOI 10.1016/j.jbiomech.2010.02.006; KRAEMER W, 1994, INJURY, V25, P5, DOI 10.1016/0020-1383(94)90176-7; Mendel T, 2013, INJURY, V44, P1773, DOI 10.1016/j.injury.2013.08.006; Mendel T, 2011, INJURY, V42, P1164, DOI 10.1016/j.injury.2010.03.016; Linstrom NJ, 2009, SPINE, V34, P309, DOI 10.1097/BRS.0b013e318191ea01; Kamer L, 2013, J CRANIOFAC SURG, V24, P264, DOI 10.1097/SCS.0b013e318270f9e7; Mehling I, 2012, INJURY, V43, P446, DOI 10.1016/j.injury.2011.08.005; Schreiber JJ, 2011, J BONE JOINT SURG AM, V93A, P1057, DOI 10.2106/JBJS.J.00160; Bauer JS, 2007, AM J ROENTGENOL, V188, P1294, DOI 10.2214/AJR.06.1006; Baum T, 2012, CALCIFIED TISSUE INT, V90, P481, DOI 10.1007/s00223-012-9596-3; Daruwalla ZJ, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-21; Day C S, 2000, Am J Orthop (Belle Mead NJ), V29, P16; Hasenboehler Erik A, 2011, Patient Saf Surg, V5, P8, DOI 10.1186/1754-9493-5-8; Kamer L, 2010, INT J ORAL MAX SURG, V39, P666, DOI 10.1016/j.ijom.2010.03.005; MAZESS RB, 1983, CALCIFIED TISSUE INT, V35, P148, DOI 10.1007/BF02405022; Mendel T, 2008, UNFALLCHIRURG, V111, P19, DOI 10.1007/s00113-007-1386-4; Mendel T, 2013, INJURY, V44, P957, DOI 10.1016/j.injury.2012.11.013; Noser H, 2010, J DIGIT IMAGING, V23, P422, DOI 10.1007/s10278-009-9187-7; Peretz AM, 1998, SPINE, V23, P971, DOI 10.1097/00007632-199805010-00001; Sarkalkan N, 2014, BONE, V60, P129, DOI 10.1016/j.bone.2013.12.006; Vanderschot P, 2001, INJURY, V32, P587, DOI 10.1016/S0020-1383(01)00039-0; Whitmarsh T, 2012, BONE, V51, P896, DOI 10.1016/j.bone.2012.08.114; Zollikofer CPE, 2005, VIRTUAL RECONSTRUCTI, p[Hoboken, 303]	35	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-0266	1554-527X		J ORTHOP RES	J. Orthop. Res.	NOV	2014	32	11					1543	1548		10.1002/jor.22667		6	Orthopedics	Orthopedics	AQ2QQ	WOS:000342633300020		
J	Takase, H; Shibita, A; Shibata, M				Takase, Hayato; Shibita, Ayaka; Shibata, Mitsuhiro			Semi-Interpenetrating Polymer Networks Composed of Diisocyanate-Bridged 4-Arm Star-Shaped L-Lactide Oligomers and Poly(epsilon-caprolactone)	JOURNAL OF POLYMER SCIENCE PART B-POLYMER PHYSICS			English	Article						biodegradable; polyesters; interpenetrating networks (IPN); star polymers; toughness	IN-VITRO DEGRADATION; EPSILON-CAPROLACTONE; POLY(LACTIC ACID); MECHANICAL-PROPERTIES; THERMAL-PROPERTIES; MEMORY PROPERTIES; BLENDS; BEHAVIOR; MORPHOLOGY; POLYURETHANE	Semi-interpenetrating polymer networks (semi-IPNs) were prepared by reactions of 2,4-tolylene diisocyanate (TDI) and hydroxy-terminated 4-arm star-shaped l-lactide oligomers (H4LAO(n)'s) with the degrees of polymerization of lactate unit per one arm, n=3, 5, and 10 in the presence of poly(epsilon-caprolactone) (PCL). Morphologies, thermal, and mechanical properties of the TDI-bridged H4LAO(n) (TH4LAO(n))/PCL semi-IPNs were evaluated by comparing with those of poly(l-lactide) (PLA)/PCL blends. Compatibility between the two components of the TH4LAO(n)/PCL semi-IPN with a PCL content not more than 50 wt % was much better than those of the PLA/PCL blends with the same PCL content. All the TH4LAO(n) networks were substantially amorphous and their tan peak or glass transition temperatures increased with decreasing n value. Most of the semi-IPNs did not show clear glass transition temperature related to both the components. Tensile toughness and elongation at break for all the TH4LAO(n)/PCL semi-IPNs were much higher than those for the PLA/PCL blends with the same PCL content. (c) 2014 Wiley Periodicals, Inc. J. Polym. Sci., Part B: Polym. Phys. 2014, 52, 1420-1428	[Takase, Hayato; Shibita, Ayaka; Shibata, Mitsuhiro] Chiba Inst Technol, Fac Engn, Dept Life & Environm Sci, Narashino, Chiba 2750016, Japan	Shibata, M (reprint author), Chiba Inst Technol, Fac Engn, Dept Life & Environm Sci, 2-17-1 Tsudanuma, Narashino, Chiba 2750016, Japan.	mitsuhiro.shibata@p.chiabkoudai.jp					Amsden B, 2004, BIOMACROMOLECULES, V5, P1399, DOI 10.1021/bm034538j; Vilay V, 2009, J APPL POLYM SCI, V114, P1784, DOI 10.1002/app.30683; Vilay V, 2010, MAT SCI ENG A-STRUCT, V527, P6930, DOI 10.1016/j.msea.2010.07.079; Ikeda T, 2013, POLYMER, V54, P3206, DOI 10.1016/j.polymer.2013.04.052; Defize T, 2012, MACROMOL CHEM PHYS, V213, P187, DOI 10.1002/macp.201100408; Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002; Cohn D, 2005, BIOMATERIALS, V26, P2297, DOI 10.1016/j.biomaterials.2004.07.052; Liu QY, 2012, PROG POLYM SCI, V37, P715, DOI 10.1016/j.progpolymsci.2011.11.001; Chattopadhyay DK, 2009, PROG POLYM SCI, V34, P1068, DOI 10.1016/j.progpolymsci.2009.06.002; Rasal RM, 2010, PROG POLYM SCI, V35, P338, DOI 10.1016/j.progpolymsci.2009.12.003; Wang L, 1998, POLYM DEGRAD STABIL, V59, P161, DOI 10.1016/S0141-3910(97)00196-1; Liu HZ, 2011, J POLYM SCI POL PHYS, V49, P1051, DOI 10.1002/polb.22283; Lopez-Rodriguez N, 2006, POLYM ENG SCI, V46, P1299, DOI 10.1002/pen.20609; Korhonen H, 2001, POLYMER, V42, P7541, DOI 10.1016/S0032-3861(01)00150-1; Choi NS, 2002, J APPL POLYM SCI, V86, P1892, DOI 10.1002/app.11134; Wu DF, 2008, EUR POLYM J, V44, P2171, DOI 10.1016/j.eurpolymj.2008.04.023; Simoes CL, 2009, J APPL POLYM SCI, V112, P345, DOI 10.1002/app.29425; Lee SH, 2001, J POLYM SCI POL CHEM, V39, P973, DOI 10.1002/1099-0518(20010401)39:7<973::AID-POLA1073>3.0.CO;2-8; GRASSIE N, 1978, J POLYM SCI POL CHEM, V16, P1563, DOI 10.1002/pol.1978.170160710; Kim ES, 2004, J POLYM SCI POL PHYS, V42, P939, DOI 10.1002/polb.10685; Dell'Erba R, 2001, POLYMER, V42, P7831, DOI 10.1016/S0032-3861(01)00269-5; Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017; KIM SH, 1992, MAKROMOL CHEM, V193, P1623; Kang YM, 2010, BIOMATERIALS, V31, P2453, DOI 10.1016/j.biomaterials.2009.11.115; Huang MH, 2004, POLYMER, V45, P8675, DOI 10.1016/j.polymer.2004.10.054; Cameron DJA, 2011, CHEM SOC REV, V40, P1761, DOI 10.1039/c0cs00091d; Melchels FPW, 2009, BIOMATERIALS, V30, P3801, DOI 10.1016/j.biomaterials.2009.03.055; Chavalitpanya K., 2013, ENERGY PROCEDIA, V4, P52; CRESCENZ.V, 1972, EUR POLYM J, V8, P449, DOI 10.1016/0014-3057(72)90109-7; George KA, 2012, POLYM DEGRAD STABIL, V97, P964, DOI 10.1016/j.polymdegradstab.2012.03.017; Hakala RA, 2011, BIOMACROMOLECULES, V12, P2806, DOI 10.1021/bm200554c; Hao JY, 2003, BIOMATERIALS, V24, P1531, DOI 10.1016/S0142-9612(02)00516-1; Helminen O., 2002, J APPL POLYM SCI, V86, P3616; Lemmouchi Y, 2008, J POLYM SCI POL CHEM, V46, P5363, DOI 10.1002/pola.22835; Nijenhuis J., 1996, POLYMER, V37, P2783; Patricio T, 2013, PROC CIRP, V5, P110, DOI 10.1016/j.procir.2013.01.022; Patricio T, 2013, PROCEDIA ENGINEER, V59, P292, DOI 10.1016/j.proeng.2013.05.124; Serra RSI, 2009, J POLYM SCI POL PHYS, V47, P183, DOI 10.1002/polb.21629; Sisson L. A., 2013, POLYMER, V54, P4333; Tba F., 2011, ENG FRACT MECH, V78, P3123; Turunen MPK, 2006, J APPL POLYM SCI, V101, P3677, DOI 10.1002/app.22832; Younes HM, 2004, BIOMATERIALS, V25, P5261, DOI 10.1016/j.biomaterials.2003.12.024; Yuan YM, 1998, POLYM BULL, V40, P485, DOI 10.1007/s002890050280; Zhang SF, 2007, J POLYM SCI POL CHEM, V45, P768, DOI 10.1002/pola.21832	44	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-6266	1099-0488		J POLYM SCI POL PHYS	J. Polym. Sci. Pt. B-Polym. Phys.	NOV 1	2014	52	21					1420	1428		10.1002/polb.23581		9	Polymer Science	Polymer Science	AQ4CI	WOS:000342739400006		
J	Phongsisay, V; Iizasa, E; Hara, H; Yamasaki, S				Phongsisay, Vongsavanh; Iizasa, Ei'ichi; Hara, Hiromitsu; Yamasaki, Sho			LMIR5 extracellular domain activates myeloid cells through Toll-like receptor 4	MOLECULAR IMMUNOLOGY			English	Article						LMIR5; CD300b; TLR4; Inflammation	T-CELLS; SEPSIS; LETHAL; TLR4; MOUSE; SHOCK; INFLAMMATION; MEDIATORS; PROTEINS; HISTONES	LMIR5/CD300b is an activating immunoglobulin-like receptor whose extracellular domain (LMIR5-Fc) is constitutively released from immune cells. The release of LMIR5-Fc is augmented upon stimulation with TLR agonists. LMIR5-Fc is reported to possess inflammatory activity and amplify LPS-induced lethal inflammation; however, its action mechanism has not been clarified. This study was aimed to identify receptors for LMIR5-Fc. Using NF-kappa B reporter cells in human monocytes THP1, LMIR5-Fc was solely found to trigger NF-kappa B activation among various signaling receptors examined. In addition, an injection of LMIR5-Fc into the mouse peritoneal resulted in a rapid production of inflammatory mediators and an amplification of LPS activity. Moreover, LMIR5-Fc-induced cytokine production was markedly reduced in TLR4-deficient mouse macrophages. Using TLR4 reporter cells, the LMIR5-Fc sample that contained a trace amount of endotoxin under the sensitivity of reporter cells triggered a potent NF-kappa B activation. Furthermore, the inflammatory activity of LMIR5-Fc was completely lost by heating but unchanged by polymyxin B pretreatment. Using TLR4 fusion protein, TLR4 was found to interact specifically with LMIR5-overexpressing cells. Therefore, LMIR5-Fc is new inflammatory mediator and endogenous ligand of TLR4. This study provides an insight into the positive feedback mechanism of inflammation through TLR4-LMIR5-Fc axis. (C) 2014 Elsevier Ltd. All rights reserved.	[Phongsisay, Vongsavanh; Yamasaki, Sho] Kyushu Univ, Med Inst Bioregulat, Div Mol Immunol, Higashi Ku, Fukuoka 8128582, Japan; [Iizasa, Ei'ichi; Hara, Hiromitsu] Saga Univ, Dept Biomol Sci, Div Mol & Cellular Immunosci, Saga 840, Japan	Phongsisay, V (reprint author), Homsavanh Sch, Hatsaifong, Vientiane, Laos.	vongsavanh@bioreg.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [11F01107]; Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government [24390256]; JSPS fellowship under the program of JSPS Postdoctoral Fellowship [FY2011-2013]	This work was supported by grant-in-aid for scientific research from Japan Society for the Promotion of Science (JSPS, 11F01107 to S.Y.) and the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government (24390256 to H.H.). V.P. is the recipient of a JSPS fellowship under the FY2011-2013 program of JSPS Postdoctoral Fellowship for Foreign Researcher.	Quintana FJ, 2005, J IMMUNOL, V175, P2777; Lartigue A, 2009, J IMMUNOL, V183, P6207, DOI 10.4049/jimmunol.0803219; Loser K, 2010, NAT MED, V16, P713, DOI 10.1038/nm.2150; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Ding Q, 2011, J CLIN INVEST, V121, P3645, DOI 10.1172/JCI46274; Qiang XL, 2013, NAT MED, V19, P1489, DOI 10.1038/nm.3368; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; van Sorge NM, 2009, CELL MICROBIOL, V11, P1768, DOI 10.1111/j.1462-5822.2009.01370.x; Park SY, 1998, J CLIN INVEST, V102, P1229, DOI 10.1172/JCI3256; Xu J, 2011, J IMMUNOL, V187, P2626, DOI 10.4049/jimmunol.1003930; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Kandadi MR, 2012, BRIT J PHARMACOL, V167, P612, DOI 10.1111/j.1476-5381.2012.02040.x; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Kerfoot SM, 2004, J IMMUNOL, V173, P7070; Higgins SC, 2006, J IMMUNOL, V177, P7980; Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014; Brigotti M, 2013, J IMMUNOL, V191, P4748, DOI 10.4049/jimmunol.1300122; Arribillaga L, 2013, BIOMED RES INT, DOI 10.1155/2013/864720; Gasiorowski RE, 2013, IMMUNOL LETT, V149, P93, DOI 10.1016/j.imlet.2012.10.005; Hutchens MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000153; Hwang IY, 2009, J EXP MED, V206, P2641, DOI 10.1084/jem.20091982; Martinez-Barriocanal A, 2010, J BIOL CHEM, V285, P41781, DOI 10.1074/jbc.M110.140889; Martinez-Barriocanal A, 2006, J IMMUNOL, V177, P2819; Yamanishi Y, 2012, J IMMUNOL, V189, P1773, DOI 10.4049/jimmunol.1201139; Yamanishi Y, 2010, J EXP MED, V207, P1501, DOI 10.1084/jem.20090581; Yamanishi Y, 2008, BLOOD, V111, P688, DOI 10.1182/blood-2007-04-085787	29	5	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0161-5890			MOL IMMUNOL	Mol. Immunol.	NOV	2014	62	1					169	177		10.1016/j.molimm.2014.06.012		9	Biochemistry & Molecular Biology; Immunology	Biochemistry & Molecular Biology; Immunology	AQ1NI	WOS:000342547700021		
J	Miura, E; Hasegawa, T; Konno, M; Suzuki, M; Sugeno, N; Fujikake, N; Geisler, S; Tabuchi, M; Oshima, R; Kikuchi, A; Baba, T; Wada, K; Nagai, Y; Takeda, A; Aoki, M				Miura, Emiko; Hasegawa, Takafumi; Konno, Masatoshi; Suzuki, Mari; Sugeno, Naoto; Fujikake, Nobuhiro; Geisler, Sven; Tabuchi, Mitsuaki; Oshima, Ryuji; Kikuchi, Akio; Baba, Toru; Wada, Keiji; Nagai, Yoshitaka; Takeda, Atsushi; Aoki, Masashi			VPS35 dysfunction impairs lysosomal degradation of alpha-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease	NEUROBIOLOGY OF DISEASE			English	Article						Parkinson's disease; VPS35; alpha-Synuclein; Retromer; Cathepsin D; Lysosome; Vesicular transport	MANNOSE 6-PHOSPHATE RECEPTOR; CHAPERONE-MEDIATED AUTOPHAGY; CATHEPSIN-D; ALZHEIMERS-DISEASE; IN-VIVO; RETROMER COMPLEX; LIFE-SPAN; NEURODEGENERATION; TOXICITY; CELLS	Mutations in vacuolar protein sorting 35 (VPS35) have been linked to familial Parkinson's disease (PD). VPS35, a component of the retromer, mediates the retrograde transport of cargo from the endosome to the trans-Golgi network. Here we showed that retromer depletion increases the lysosomal turnover of the mannose 6-phosphate receptor, thereby affecting the trafficking of cathepsin D (CTSD), a lysosome protease involved in a-synuclein (alpha SYN) degradation. VPS35 knockdown perturbed the maturation step of CTSD in parallel with the accumulation of alpha SYN in the lysosomes. Furthermore, we found that the knockdown of Drosophila VPS35 not only induced the accumulation of the detergent-insoluble alpha SYN species in the brain but also exacerbated both locomotor impairments and mild compound eye disorganization and interommatidial bristle loss in flies expressing human alpha SYN. These findings indicate that the retromer may play a crucial role in alpha SYN degradation by modulating the maturation of CTSD and might thereby contribute to the pathogenesis of the disease. (C) 2014 Elsevier Inc. All rights reserved.	[Miura, Emiko; Hasegawa, Takafumi; Konno, Masatoshi; Sugeno, Naoto; Oshima, Ryuji; Kikuchi, Akio; Baba, Toru; Takeda, Atsushi; Aoki, Masashi] Tohoku Univ, Grad Sch Med, Dept Neurosci & Sensory Organs, Div Neurol, Sendai, Miyagi 9808574, Japan; [Konno, Masatoshi; Suzuki, Mari; Fujikake, Nobuhiro; Wada, Keiji; Nagai, Yoshitaka] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Kodaira, Tokyo 1878502, Japan; [Geisler, Sven] Univ Tubingen, German Ctr Neurodegenerat Dis DZNE, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis,Lab Funct Neurogenet, D-72076 Tubingen, Germany; [Tabuchi, Mitsuaki] Kagawa Univ, Fac Agr, Lab Appl Mol Cell Biol, Kagawa 7610795, Japan; [Takeda, Atsushi] Natl Hosp Org, Nishitaga Hosp, Dept Neurol, Sendai, Miyagi 9828555, Japan	Hasegawa, T (reprint author), Tohoku Univ, Grad Sch Med, Dept Neurosci & Sensory Organs, Div Neurol,Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9808574, Japan.	thasegawa@med.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [26461263, 24390219, 24659423]; Research Committee for Ataxic Diseases; Ministry of Health, Labor, and Welfare, Japan [24111502]; Intramural Research Grant for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry (NCNP), Japan [24-5]	The authors thank Dr. Matthew J. Farrer (Centre of Applied Neurogenetics, University of British Columbia, Canada) for providing the human wt and mutant (D620N and P316S) VPS35 constructs. This work was supported in part by a Grant-in-Aid for Scientific Research (C) [grant number 26461263], a Grant-in-Aid for Scientific Research (B) [grant number 24390219], and a Grant-in-Aid for Exploratory Research [grant number 24659423] from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); a grant from the Research Committee for Ataxic Diseases, a Grant-in-Aid for Scientific Research on Innovative Areas (Brain Environment) [grant number 24111502] from the Ministry of Health, Labor, and Welfare, Japan; and the Intramural Research Grant [grant number 24-5] for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry (NCNP), Japan.	Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Sevlever D, 2008, BIOCHEMISTRY-US, V47, P9678, DOI 10.1021/bi800699v; Wales P, 2013, J PARKINSON DIS, V3, P415, DOI 10.3233/JPD-130216; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Follett J, 2014, TRAFFIC, V15, P230, DOI 10.1111/tra.12136; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Korolchuk VI, 2007, J CELL SCI, V120, P4367, DOI 10.1242/jcs.012336; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Hasegawa T, 2006, FEBS LETT, V580, P2147, DOI 10.1016/j.febslet.2006.03.018; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Tofaris GK, 2012, MOVEMENT DISORD, V27, P1364, DOI 10.1002/mds.25136; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Muhammad A, 2008, P NATL ACAD SCI USA, V105, P7327, DOI 10.1073/pnas.0802545105; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; CAPONY F, 1989, CANCER RES, V49, P3904; Tsika E, 2014, HUM MOL GENET, V23, P4621, DOI 10.1093/hmg/ddu178; Hasegawa T, 2004, BRAIN RES, V1013, P51, DOI 10.1016/j.brainres.2004.04.018; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Laurent-Matha V, 2006, J BIOCHEM, V139, P363, DOI 10.1093/jb.mvj037; Chu YP, 2009, NEUROBIOL DIS, V35, P385, DOI 10.1016/j.nbd.2009.05.023; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Wen L, 2011, J CELL BIOL, V195, P765, DOI 10.1083/jcb.201105109; Vilarino-Guell C, 2014, HUM MOL GENET, V23, P1794, DOI 10.1093/hmg/ddt570; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Hasegawa T, 2010, NEUROCHEM INT, V57, P857, DOI 10.1016/j.neuint.2010.09.002; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Koike M, 2000, J NEUROSCI, V20, P6898; Seaman MNJ, 1997, J CELL BIOL, V137, P79, DOI 10.1083/jcb.137.1.79; Dehay B, 2013, MOVEMENT DISORD, V28, P725, DOI 10.1002/mds.25462; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Sugeno N, 2008, J BIOL CHEM, V283, P23179, DOI 10.1074/jbc.M802223200; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Cullen V, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-5; Davies SE, 2014, NEUROBIOL DIS, V64, P79, DOI 10.1016/j.nbd.2013.12.011; Edvardson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036458; Hasegawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029460; Hilgers V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000396; Konno M, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-38; Lee BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023939; Linhart R, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-23; LUDWIG T, 1994, EMBO J, V13, P3430; Poewe Werner, 2009, Parkinsonism Relat Disord, V15 Suppl 4, pS28, DOI 10.1016/S1353-8020(09)70831-4; Schneider L, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-14; Springer W, 2011, AUTOPHAGY, V7, P266, DOI 10.4161/auto.7.3.14348; Sugeno N, 2014, J BIOL CHEM, V289, P18137, DOI 10.1074/jbc.M113.529461; Tsakiri EN, 2013, FREE RADICAL BIO MED, V65, P1155, DOI 10.1016/j.freeradbiomed.2013.08.186; Yamaguchi M, 1999, ONCOGENE, V18, P6767, DOI 10.1038/sj.onc.1203113; Zavodszky E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4828; Zhao X, 2007, TRAFFIC, V8, P1829, DOI 10.1111/j.1600-0854.2007.00658.x	57	11	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	NOV	2014	71						1	13		10.1016/j.nbd.2014.07.014		13	Neurosciences	Neurosciences & Neurology	AQ1OE	WOS:000342549900001		
J	Koga, S; Kojima, A; Ishikawa, C; Kuwabara, S; Arai, K; Yoshiyama, Y				Koga, Shunsuke; Kojima, Ayako; Ishikawa, Chieko; Kuwabara, Satoshi; Arai, Kimihito; Yoshiyama, Yasumasa			Effects of diet-induced obesity and voluntary exercise in a tauopathy mouse model: Implications of persistent hyperleptinemia and enhanced astrocytic leptin receptor expression	NEUROBIOLOGY OF DISEASE			English	Article						Obesity; Leptin; Tau; Astrocyte; Neuroinflammation	ALZHEIMERS-DISEASE; MESSENGER-RNA; TAU PATHOLOGY; INSULIN-RESISTANCE; IMPROVES INSULIN; TRANSGENIC MICE; NEURONAL CELLS; INFLAMMATION; DEMENTIA; BRAIN	The number of patients with Alzheimer's disease (AD) is increasing worldwide, and available drugs have shown limited efficacy. Hence, preventive interventions and treatments for presymptomatic AD are currently considered very important. Obesity rates have also been increasing dramatically and it is an independent risk factor of AD. Therefore, for the prevention of AD, it is important to elucidate the pathomechanism between obesity and AD. We generated high calorie diet (HCD)-induced obese tauopathy model mice (PS19), which showed hyperleptinemia but limited insulin resistance. HCD enhanced tau pathology and glial activation. Conversely, voluntary exercise with a running wheel normalized the serum leptin concentration without reducing body weight, and restored the pathological changes induced by HCD. Thus, we speculated that persistent hyperleptinemia played an important role in accelerating pathological changes in PS19 mice. Leptin primarily regulates food intake and body weight via leptin receptor b (LepRb). Interestingly, the nuclear staining for p-STAT3, which was activated by LepRb, was decreased in hippocampal neurons in HCD PS19 mice, indicating leptin resistance. Meanwhile, astroglial activation and the astrocytic expression of a short LepR isoform, LepRa, were enhanced in the hippocampus of HCD PS19 mice. Real-time PCR analysis demonstrated that leptin increased mRNA levels for pro-inflammatory cytokines including IL-1 beta and TNF-alpha in primary cultured astrocytes from wild type and LepRb-deficient mice. These observations suggest that persistent hyperleptinemia caused by obesity induces astrocytic activation, astrocytic leptin hypersensitivity with enhanced LepRa expression, and enhanced inflammation, consequently accelerating tau pathology in PS19 mice. (C) 2014 The Authors. Published by Elsevier Inc.	[Kojima, Ayako; Ishikawa, Chieko; Yoshiyama, Yasumasa] Chiba East Natl Hosp, Clin Res Ctr, Lab Neurodegenerat Disorder Res, Chiba, Japan; [Ishikawa, Chieko; Arai, Kimihito; Yoshiyama, Yasumasa] Chiba East Natl Hosp, Dept Neurol, Chiba, Japan; [Koga, Shunsuke; Kuwabara, Satoshi; Arai, Kimihito; Yoshiyama, Yasumasa] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan	Yoshiyama, Y (reprint author), 679 Nitona,Chuo Ku, Chiba 260, Japan.	neuroyy@cehpnet.com			Takeda Science Foundation	This work was supported by funding from Grant-in-Aid for Scientific Research (C), and Takeda Science Foundation to Y.Y. The authors declare that the research was carried out in the absence of any commercial or financial relationships that might be construed as a potential conflict of interest.	Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Kola B, 2006, TRENDS ENDOCRIN MET, V17, P205, DOI 10.1016/j.tem.2006.05.006; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Tezapsidis N, 2009, J ALZHEIMERS DIS, V16, P731, DOI 10.3233/JAD-2009-1021; Jayaram B, 2013, J APPL PHYSIOL, V114, P734, DOI 10.1152/japplphysiol.01499.2012; Lafrance V, 2010, BRAIN BEHAV IMMUN, V24, P358, DOI 10.1016/j.bbi.2009.11.003; Folch J, 2012, J MOL ENDOCRINOL, V49, pR149, DOI 10.1530/JME-12-0151; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Gan LX, 2012, ENDOCRINOLOGY, V153, P5821, DOI 10.1210/en.2012-1510; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Aleffi S, 2005, HEPATOLOGY, V42, P1339, DOI 10.1002/hep.20965; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Fukutani Y, 2000, PSYCHIAT CLIN NEUROS, V54, P523, DOI 10.1046/j.1440-1819.2000.00747.x; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Bradley RL, 2008, AM J PHYSIOL-ENDOC M, V295, pE586, DOI 10.1152/ajpendo.00309.2007; Leung JCK, 2012, NEPHROL DIAL TRANSPL, V27, P3119, DOI 10.1093/ndt/gfr774; Leboucher A, 2013, DIABETES, V62, P1681, DOI 10.2337/db12-0866; Gustafson DR, 2009, NEUROLOGY, V73, P1559, DOI 10.1212/WNL.0b013e3181c0d4b6; Chen F, 2012, CANCER RES, V72, P379, DOI 10.1158/0008-5472.CAN-11-1982; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; [Anonymous], 2011, CURR ALZHEIMER RES; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; RANSOHOFF RM, 1993, FASEB J, V7, P592; Carhuatanta KAK, 2011, ENDOCRINOLOGY, V152, P2655, DOI 10.1210/en.2010-1340; Yoshiyama Y, 2012, NEUROBIOL DIS, V45, P329, DOI 10.1016/j.nbd.2011.08.017; Yoshiyama Y, 2010, J ALZHEIMERS DIS, V22, P295, DOI 10.3233/JAD-2010-100681; Signore AP, 2008, J NEUROCHEM, V106, P1977, DOI 10.1111/j.1471-4159.2008.05457.x; Yoshiyama Y, 2013, J NEUROL NEUROSUR PS, V84, P784, DOI 10.1136/jnnp-2012-303144; Shen JH, 2005, LIFE SCI, V77, P1502, DOI 10.1016/j.lfs.2005.04.004; Balducci S, 2010, NUTR METAB CARDIOVAS, V20, P608, DOI 10.1016/j.numecd.2009.04.015; Greco SJ, 2008, BIOCHEM BIOPH RES CO, V376, P536, DOI 10.1016/j.bbrc.2008.09.026; van Greevenbroek MMJ, 2013, NETH J MED, V71, P174; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Flores MBS, 2006, DIABETES, V55, P2554, DOI 10.2337/db05-1622; Garcia-Caceres C, 2011, ENDOCRINOLOGY, V152, P1809, DOI 10.1210/en.2010-1252; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P103, DOI 10.2174/156720507780362047; Greco SJ, 2009, NEUROSCI LETT, V455, P191, DOI 10.1016/j.neulet.2009.03.066; Wang MY, 1996, FEBS LETT, V392, P87, DOI 10.1016/0014-5793(96)00790-9; Hsuchou H, 2009, BRAIN, V132, P889, DOI 10.1093/brain/awp029; Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Fernandez-Riejos P, 2010, MEDIAT INFLAMM, V2010, DOI [10.1155/2010/568343, DOI 10.1155/2010/568343]; Funahashi H, 2003, INT REV CYTOL, V224, P1, DOI 10.1016/S0074-7696(05)24001-9; Greco SJ, 2010, J ALZHEIMERS DIS, V19, P1155, DOI 10.3233/JAD-2010-1308; Haskell-Luevano C, 2009, FASEB J, V23, P642, DOI 10.1096/fj.08-109686; Hekerman P, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-41; Hosoi T, 2000, BIOCHEM BIOPH RES CO, V273, P312, DOI 10.1006/bbrc.2000.2937; Knight EM, 2014, NEUROBIOL AGING, V35, P1821, DOI 10.1016/j.neurobiolaging.2014.02.010; Li NC, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5465; McArdle Maeve A, 2013, Front Endocrinol (Lausanne), V4, P52, DOI 10.3389/fendo.2013.00052; Ropelle ER, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003856; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Wong CK, 2007, EUR J IMMUNOL, V37, P2337, DOI 10.1002/eji.200636866	60	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	NOV	2014	71						180	192		10.1016/j.nbd.2014.08.015		13	Neurosciences	Neurosciences & Neurology	AQ1OE	WOS:000342549900018		
J	Pappolla, M; Sambamurti, K; Vidal, R; Pacheco-Quinto, J; Poeggeler, B; Matsubara, E				Pappolla, Miguel; Sambamurti, Kumar; Vidal, Ruben; Pacheco-Quinto, Javier; Poeggeler, Burkhard; Matsubara, Etsuro			Evidence for lymphatic A beta clearance in Alzheimer's transgenic mice	NEUROBIOLOGY OF DISEASE			English	Article						Lymph node; Amyloid beta protein; Alzheimer's disease; Protein clearance	CEREBRAL AMYLOID ANGIOPATHY; DEEP CERVICAL LYMPH; CEREBROSPINAL-FLUID; INTERSTITIAL FLUID; DOWNS-SYNDROME; DISEASE; PROTEIN; BRAIN; DRAINAGE; PLASMA	Evidence has shown that lymphatic drainage contributes to removal of debris from the brain but its role in the accumulation of amyloid beta peptides (A beta) has not been demonstrated. We examined the levels of various forms of A beta in the brain, plasma and lymph nodes in a transgenic model of Alzheimer's disease (AD) at different ages. Herein, we report on the novel finding that A beta is present in the cervical and axillary lymph nodes of AD transgenic mice and that A beta levels in lymph nodes increase over time, mirroring the increase of A beta levels observed in the brain. A beta levels in lymph nodes were significantly higher than in plasma. At age 15.5 months, there was a significant increase of monomeric soluble A beta 40 (p = 0.003) and A beta 42 (p = 0.05) in the lymph nodes over the baseline values measured at 6 months of age. In contrast, plasma levels of A beta 40 showed no significant changes (p = 0.68) and plasma levels A beta 42 significantly dropped (p = 0.02) at the same age. A beta concentration was low to undetectable in splenic lymphoid tissue and several other control tissues including heart, lung, liver, kidneys and intestine of the same animals, strongly suggesting that A beta peptides in lymph nodes are derived from the brain. (C) 2014 Elsevier Inc. All rights reserved.	[Pappolla, Miguel] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA; [Sambamurti, Kumar] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Vidal, Ruben] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Pacheco-Quinto, Javier] Mid Atlantic Neonatol Associates & Atlantic Hlth, Biomed Res Inst New Jersey, Morristown, NJ 07960 USA; [Poeggeler, Burkhard] Univ Gottingen, Fac Biol & Psychol, D-37073 Gottingen, Germany; [Matsubara, Etsuro] Hirosaki Univ, Grad Sch Med, Inst Brain Sci, Dept Neurol, Aomori, Japan	Pappolla, M (reprint author), Univ Texas Med Branch, Dept Neurol, 301 Univ Blvd, Galveston, TX 77555 USA.	pappolla@aol.com			NIH [AG046200, AG016783]; Alzheimer's Association for IIRG [10-173180]; Zenith award	The authors thank the NIH for grants AG046200; AG016783, the Alzheimer's Association for IIRG 10-173180 and Zenith award to MAP.	MORI H, 1992, J BIOL CHEM, V267, P17082; Weller RO, 1998, AM J PATHOL, V153, P725, DOI 10.1016/S0002-9440(10)65616-7; Boulton M, 1996, NEUROPATH APPL NEURO, V22, P325, DOI 10.1111/j.1365-2990.1996.tb01111.x; Sambamurti K, 2011, J NEUROCHEM, V117, P359, DOI 10.1111/j.1471-4159.2011.07213.x; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Hawkes CA, 2011, ACTA NEUROPATHOL, V121, P431, DOI 10.1007/s00401-011-0801-7; Nedergaard M, 2013, SCIENCE, V340, P1529, DOI 10.1126/science.1240514; Vidal R, 2009, BRAIN PATHOL, V19, P58, DOI 10.1111/j.1750-3639.2008.00164.x; CSERR HF, 1992, BRAIN PATHOL, V2, P269, DOI 10.1111/j.1750-3639.1992.tb00703.x; Kawarabayashi T, 2001, J NEUROSCI, V21, P372; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Carare RO, 2013, NEUROPATH APPL NEURO, V39, P593, DOI 10.1111/nan.12042; Cella M, 1997, J EXP MED, V185, P1743, DOI 10.1084/jem.185.10.1743; Huang YF, 2012, ARCH NEUROL-CHICAGO, V69, P1591, DOI 10.1001/archneurol.2012.18107; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Toledo JB, 2011, ACTA NEUROPATHOL, V122, P401, DOI 10.1007/s00401-011-0861-8; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Matsubara E, 1999, ANN NEUROL, V45, P537, DOI 10.1002/1531-8249(199904)45:4<537::AID-ANA20>3.0.CO;2-2; ASAMIODAKA A, 1995, BIOCHEMISTRY-US, V34, P10272, DOI 10.1021/bi00032a022; BRADBURY MWB, 1981, AM J PHYSIOL, V240, pF329; Brinker T, 1997, ACTA NEUROPATHOL, V94, P493; Hatterer E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003321; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Ji Yong, 2001, Journal of Alzheimer's Disease, V3, P23; Koh Lena, 2005, Cerebrospinal Fluid Res, V2, P6, DOI 10.1186/1743-8454-2-6; Neve RL, 1998, TRENDS NEUROSCI, V21, P15, DOI 10.1016/S0166-2236(97)01168-5; Sagare A.P., 2012, COLD SPRING HARB PER, V2; Takamura A, 2011, J NEUROSCI RES, V89, P815, DOI 10.1002/jnr.22615; Takamura A, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-20; Vega JL, 2004, NEUROPATH APPL NEURO, V30, P416, DOI 10.1111/j.1365-2990.2004.00575.x	33	4	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	NOV	2014	71						215	219		10.1016/j.nbd.2014.07.012		5	Neurosciences	Neurosciences & Neurology	AQ1OE	WOS:000342549900021		
J	Kurata, T; Hatanaka, N; Morimoto, N; Deguchi, S; Deguchi, K; Ikeda, Y; Abe, K				Kurata, Tomoko; Hatanaka, Noriko; Morimoto, Nobutoshi; Deguchi, Shoko; Deguchi, Kentaro; Ikeda, Yoshio; Abe, Koji			Pulsion severity showed a good correlation with cognitive function in Parkinson's disease	NEUROLOGICAL RESEARCH			English	Article						Parkinson's disease; Cognitive impairment; Posturography; Postural instability; Pulsion	MINI-MENTAL-STATE; FRONTAL ASSESSMENT BATTERY; POSTURAL SWAY; COMPUTERIZED POSTUROGRAPHY; DUAL-TASKING; IMPAIRMENT; DEMENTIA; BALANCE; GAIT; STIMULATION	Objectives: To examine the correlation between cognitive impairment and postural instability in Parkinson's disease (PD) patients by using posturography. Methods: We investigated 88 PD patients comparing clinical scorings of cognitive functions and pulsion severity, and quantitative measurement of postural instability by posturography with the length of the center of gravity (LNG) and envelope area (ENV). Results: The number of patients with severe pulsion increased in PD with disease progression assessed by Hoehn and Yahr (H & Y) scale regardless of age, and a significant correlation was observed between the pulsion severity and both LNG (R = 0.4242) and ENV (R = 0.4335). Both LNG and ENV showed a good correlation with all cognitive assessments such as mini-mental state examination (MMSE), Montreal cognitive assessment (MoCA), and frontal assessment battery (FAB), suggesting that cognitive impairment became worse with the longer LNG and the larger ENV. Among the cognitive assessments, MoCA showed the highest correlation (R = 0.56-0.62) with both LNG and ENV, reflecting that MoCA is the most sensitive and reliable screening for dementia in PD. Discussion: The present study showed that posturography is useful to quantify the pulsion severity in PD patients, that pulsion severity and cognitive function showed a good correlation especially assessed by MoCA, and that posturography thus provides a more detailed quantitative correlation of postural instability to cognitive impairment.	[Kurata, Tomoko; Hatanaka, Noriko; Morimoto, Nobutoshi; Deguchi, Shoko; Deguchi, Kentaro; Ikeda, Yoshio; Abe, Koji] Okayama Univ, Grad Sch Med & Dent, Dept Neurol, Okayama 7008558, Japan	Abe, K (reprint author), Okayama Univ, Grad Sch Med & Dent, Dept Neurol, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	toko11@cc.okayama-u.ac.jp			Ministry of Education, Science, Culture and Sports of Japan; Research Committee of CNS Degenerative Diseases; Ministry of Health, Labour and Welfare of Japan;  [21390267]	This work was partly supported by Grant-in-Aid for Scientific Research (B) 21390267 and the Ministry of Education, Science, Culture and Sports of Japan, grants-in-aid from the Research Committee of CNS Degenerative Diseases (I. Nakano), and grants (Y. Itoyama, T. Imai, G. Sobue) from the Ministry of Health, Labour and Welfare of Japan.	Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Dalrymple-Alford JC, 2010, NEUROLOGY, V75, P1717, DOI 10.1212/WNL.0b013e3181fc29c9; Frenklach A, 2009, MOVEMENT DISORD, V24, P377, DOI 10.1002/mds.22358; Fujita T, 2005, J BONE MINER METAB, V23, P152, DOI 10.1007/s00774-004-0554-7; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Rocchi L, 2006, NEUROSCI LETT, V394, P140, DOI 10.1016/j.neulet.2005.10.020; Caviness JN, 2007, MOVEMENT DISORD, V22, P1272, DOI 10.1002/mds.21453; Nazem S, 2009, J AM GERIATR SOC, V57, P304, DOI 10.1111/j.1532-5415.2008.02096.x; Bloem BR, 1996, MOVEMENT DISORD, V11, P509, DOI 10.1002/mds.870110506; Zadikoff C, 2008, MOVEMENT DISORD, V23, P297, DOI 10.1002/mds.21837; Buter TC, 2008, NEUROLOGY, V70, P1017, DOI 10.1212/01.wnl.0000306632.43729.24; Tombaugh TN, 2005, ARCH CLIN NEUROPSYCH, V20, P485, DOI 10.1016/j.acn.2004.11.004; Sollinger AB, 2010, PARKINSONISM RELAT D, V16, P177, DOI 10.1016/j.parkreldis.2009.11.002; Lima C, 2008, J NEUROL, V255, P1756, DOI 10.1007/s00415-008-0024-6; Dubois B, 2000, NEUROLOGY, V55, P1621; Frisina PG, 2009, PARKINSONISM RELAT D, V15, P144, DOI 10.1016/j.parkreldis.2008.04.038; Burn DJ, 2003, MOVEMENT DISORD, V18, P884, DOI 10.1002/mds.10455; Bloem BR, 1998, J NEUROL, V245, P669, DOI 10.1007/s004150050265; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ebersbach G, 1999, BRAIN, V122, P1349, DOI 10.1093/brain/122.7.1349; Ismail Z, 2010, INT J GERIATR PSYCH, V25, P111, DOI 10.1002/gps.2306; Jacobs JV, 2006, J NEUROL NEUROSUR PS, V77, P322, DOI 10.1136/jnnp.2005.068742; Adkin AL, 2003, MOVEMENT DISORD, V18, P496, DOI 10.1002/mds.10396; HORAK FB, 1992, J NEUROL SCI, V111, P46, DOI 10.1016/0022-510X(92)90111-W; Aarsland D, 2000, J AM GERIATR SOC, V48, P938; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; Williams-Gray CH, 2007, BRAIN, V130, P1787, DOI 10.1093/brain/awm111; RINNE JO, 1989, ANN NEUROL, V26, P47, DOI 10.1002/ana.410260107; BRONSTEIN AM, 1990, BRAIN, V113, P767, DOI 10.1093/brain/113.3.767; Chastan N, 2008, MOVEMENT DISORD, V23, P366, DOI 10.1002/mds.21840; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujita T, 2007, J BONE MINER METAB, V25, P68, DOI 10.1007/s00774-006-0729-5; Levy G, 2000, NEUROLOGY, V55, P539; Rocchi L, 2004, GAIT POSTURE, V19, P172, DOI 10.1016/S0966-6362(03)00059-6; WATERSTON JA, 1993, J NEUROL NEUROSUR PS, V56, P1276, DOI 10.1136/jnnp.56.12.1276	35	1	1	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	NOV	2014	36	11					962	967		10.1179/1743132814Y.0000000384		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AQ0WU	WOS:000342504200005		
J	Toda, Y; Katsura, K; Saito, M; Inaba, T; Sakurazawa, M; Katayama, Y				Toda, Yusuke; Katsura, Ken-ichiro; Saito, Moeko; Inaba, Toshiki; Sakurazawa, Makoto; Katayama, Yasuo			The effect of cilostazol and aspirin pre-treatment against subsequent transient focal cerebral ischemia in rat	NEUROLOGICAL RESEARCH			English	Article						Rat; Cerebral infarction; Combination therapy; Cilostazol; Aspirin; Neuroprotection	BRAIN-DAMAGE; COMBINATION THERAPY; COX-2 INHIBITORS; ACUTE STROKE; NEUROPROTECTION; HYPOPERFUSION; CLOPIDOGREL; PROTECTS; TRIAL	Objectives: Among several anti-platelet drugs to prevent recurrent stroke, cilostazol has shown various effects besides its anti-platelet activity. We examined whether 7 days of oral administration of cilostazol protects against subsequent cerebral ischemia, and whether or not the effect of combination therapy with aspirin is more protective. Methods: We used Sprague-Dawley (SD) rats and assigned them to four groups: vehicle, aspirin, cilostazol, and aspirin plus cilostazol combination therapy. After oral administration of anti-platelets for 7 days, we performed transient middle cerebral artery occlusion (MCAO) for 90 minutes, and examined infarct volume, neurological symptoms, and regional cerebral blood flow (rCBF). Immunostaining of Bax, Bcl-2, TUNEL, 4-HNE, 8-OHdG, and COX-2 was performed 24 hours after ischemia. Results: The cilostazol group and the combination therapy group showed significant decreases of infarct volume and significant improvements of rCBF during ischemia, compared with the vehicle or aspirin group. Significant decreases of Bax, TUNEL, 8-OHdG, and 4-HNE expression in the combination therapy group, compared with those in the vehicle or aspirin group, were shown in the boundary zone. COX-2 expression was unexpectedly increased in the combination therapy group. Discussion: Aspirin co-administration did not inhibit this effect. The addition of the oral administration of cilostazol either alone or with aspirin administration may be beneficial for subsequent cerebral ischemic damage in terms of reducing infarct volume, improving rCBF during ischemia, inhibiting the apoptotic pathway, and reducing oxidative stress.	[Toda, Yusuke; Katsura, Ken-ichiro; Saito, Moeko; Inaba, Toshiki; Sakurazawa, Makoto; Katayama, Yasuo] Nippon Med Sch, Grad Sch Med, Dept Neurol Sci, Tokyo 1138603, Japan	Katsura, K (reprint author), Nippon Med Sch, Grad Sch Med, Dept Neurol Sci, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	k-katsur@nms.ac.jp			The Ministry of Education of Japan	The Ministry of Education of Japan via Grant-in-Aid for Scientific Research.	Akram A, 2013, NEUROPHARMACOLOGY, V65, P165, DOI 10.1016/j.neuropharm.2012.09.010; Lee JH, 2007, BRAIN RES, V1185, P246, DOI 10.1016/j.brainres.2007.09.016; Katsura K, 2012, J NIPPON MED SCH, V79, P104; Goto S, 2005, ATHEROSCLEROSIS SUPP, V6, P3, DOI 10.1016/j.atherosclerosissup.2005.09.002; Elam MB, 1998, ARTERIOSCL THROM VAS, V18, P1942; Lee JH, 2006, BRAIN RES, V1082, P182, DOI 10.1016/j.brainres.2006.01.088; Yonemori F, 1998, J CEREBR BLOOD F MET, V18, P1099, DOI 10.1097/00004647-199810000-00006; Sakurai H, 2013, GERIATR GERONTOL INT, V13, P90, DOI 10.1111/j.1447-0594.2012.00866.x; Watanabe T, 2006, STROKE, V37, P1539, DOI 10.1161/01.STR.0000221783.08037.a9; Diener HC, 2004, LANCET, V364, P331; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Choi SH, 2009, TRENDS PHARMACOL SCI, V30, P174, DOI 10.1016/j.tips.2009.01.002; Nito C, 2011, NEUROL RES, V33, P881, DOI 10.1179/1743132811Y.0000000019; Chen ZM, 2000, STROKE, V31, P1240; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290; Jiang T, 2012, BRIT J PHARMACOL, V167, P1520, DOI 10.1111/j.1476-5381.2012.02105.x; Shinohara Y, 2010, LANCET NEUROL, V9, P959, DOI 10.1016/S1474-4422(10)70198-8; Ay I, 2001, MOL BRAIN RES, V87, P71, DOI 10.1016/S0169-328X(00)00285-0; Becker RW, 2005, ANN VASC SURG, V19, P393, DOI 10.1007/s10016-005-0012-6; GROTTA JC, 1985, NEUROLOGY, V35, P632; Katsura KI, 2008, J NEUROCHEM, V106, P258, DOI 10.1111/j.0022-3042.2008.05360.x; Lee JH, 2005, NEUROL RES, V27, P483, DOI 10.1179/016164105X17134; Nagayama T, 2000, J NEUROCHEM, V75, P1716, DOI 10.1046/j.1471-4159.2000.0751716.x; Nakamura T, 2012, J NEUROL SCI, V313, P22, DOI 10.1016/j.jns.2011.09.038; Omote Y, 2012, STROKE, V43, P1639, DOI 10.1161/STROKEAHA.111.643098; Pinsky DJ, 2002, J CLIN INVEST, V109, P1031, DOI 10.1172/JCI200210649; Suda S, 2011, LIFE SCI, V89, P50, DOI 10.1016/j.lfs.2011.05.001; Vane JR, 1998, INFLAMM RES, V47, pS77; WILLIAMS DS, 1993, MAGNET RESON MED, V30, P361, DOI 10.1002/mrm.1910300314; Yoshino H, 1997, BRAIN RES, V767, P81, DOI 10.1016/S0006-8993(97)00616-1; Zheng Z, 2007, BRAIN RES, V1186, P275, DOI 10.1016/j.brainres.2007.10.029	31	1	1	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	NOV	2014	36	11					1011	1019		10.1179/1743132814Y.0000000389		9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AQ0WU	WOS:000342504200011		
J	Nariyama, N				Nariyama, Nobuteru			Multi-concentric-ring open-air ionization chamber for high-intensity X-ray beams	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article						Ionization chamber; Ring electrode; Synchrotron radiation; High intensity	SYNCHROTRON-RADIATION	An ionization chamber with four concentric ring electrodes was used to measure doses of white, 10, 15 and 20 keV synchrotron X-ray beams. The ring-shaped electrodes, which had diameters less than 11.8 mm, collected charges independently only around the beam, excluding strong in-beam charges when the beams passed through a small hole in the electrode centers. As a result, under low saturation voltages, the measured dose rates were confirmed to correlate with the beam intensity when conversion factors calculated with a Monte Carlo code were employed. The influence of the assumed beam sizes and incident positions on the current was almost negligible, with the exception of the incident position dependence at 10 keV. (C) 2014 Elsevier B.V. All rights reserved,	Japan Synchrotron Radiat Res Inst, Light Source & Opt Div, Sayo, Hyogo 6795198, Japan	Nariyama, N (reprint author), Japan Synchrotron Radiat Res Inst, Light Source & Opt Div, Kouto 1-1-1, Sayo, Hyogo 6795198, Japan.						Ishikawa T, 2012, NAT PHOTONICS, V6, P540, DOI 10.1038/nphoton.2012.141; Boag J.W., 1966, RADIATION DOSIMETRY, V2, P1; Nariyama N, 2004, REV SCI INSTRUM, V75, P2860, DOI 10.1063/1.1784566; Nariyama N, 2009, APPL RADIAT ISOTOPES, V67, P155, DOI 10.1016/j.apradiso.2008.08.002; Sempau J, 1997, NUCL INSTRUM METH B, V132, P377, DOI 10.1016/S0168-583X(97)00414-X	5	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	NOV 1	2014	763						13	17		10.1016/j.nima.2014.06.031		5	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	AP3ON	WOS:000341986200003		
J	Sako, H; Sugimura, H; Ahn, JK; Han, Y; Hasegawa, S; Hwang, SH; Ichikawa, Y; Imai, K; Kiuchi, R; Ozawa, K; Sato, S; Shirotori, K				Sako, H.; Sugimura, H.; Ahn, J. K.; Han, Y.; Hasegawa, S.; Hwang, S. H.; Ichikawa, Y.; Imai, K.; Kiuchi, R.; Ozawa, K.; Sato, S.; Shirotori, K.			Development of a prototype GEM TPC with a gating grid for an H-dibaryon search experiment at J-PARC	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article						Time projection chamber; Gas electron multiplier; Gating grid	TIME PROJECTION CHAMBER; GAS ELECTRON MULTIPLIER; DETECTORS; AMPLIFICATION; PERFORMANCE; RESOLUTION; MIXTURES; ILC	We have developed a prototype TPC (Time Projection Chamber) based on GEMs (Gas Electron Multipliers) with a gating grid for an H-dibaryon search experiment at J-PARC. To investigate its performance, we conducted laboratory tests and a beam Lest with two kinds of gases, Ar-CH4 (90:10) and Ar-CF4 (95:5), where the former is mainly used for the tests. The hit detection efficiency per pad row was measured to be 98% at the beam rate up to 5 x 10(5) cps cm(2) (counts per second), and 90% at the rate of 3 x 10(6) cps/cm(2). Based on the measured horizontal resolution of 0.19-0.46 mm at the drift length of 5-20 cm, the horizontal position resolution of better than 0.3 mm is estimated in 1 T magnetic field for the final experiment. The ion backflow fraction was measured to be 5% and reduced up to 3% by tuning the GEM voltage configuration, at the gain of 1.6 x 10(4). The horizontal position distortion due to ion backflow in the gate operation was suppressed within 0.2 min at the beam rates up to 5 x 10(5) cps/cm(2), corresponding to the ion backflow up to 2.7 x 10(8) s(-1) cm(-1). On the other hand, the distortion with the gate open was measured to be 1.3 mm, corresponding to the backflow of 1.3 x 10(9) s(-1) cm(-1). The distortion in the final experiment is estimated to be 0.3 +/- 0.2 mm, within the requirement of 1 mm. The GEMs have been operated continuously for a comparable period of the final experiment, with average energy deposit rates per unit GEM area of 30 times as high as that expected for the experiment. rt. (C) 2014 Elsevier B.V. All rights reserved.	[Sako, H.; Sugimura, H.; Hasegawa, S.; Hwang, S. H.; Ichikawa, Y.; Imai, K.; Kiuchi, R.; Ozawa, K.; Sato, S.] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki, Japan; [Sugimura, H.; Ichikawa, Y.] Kyoto Univ, Dept Phys, Kyoto 606, Japan; [Ahn, J. K.] Korea Univ, Dept Phys, Seoul 136701, South Korea; [Kiuchi, R.] Seoul Natl Univ, Dept Phys, Seoul, South Korea; [Ozawa, K.] High Energy Accelerator Res Org, Tsukuba, Ibaraki, Japan; [Shirotori, K.] Nucl Phys Res Ctr, Osaka, Japan; [Han, Y.] Univ New Mexico, Albuquerque, NM 87131 USA	Sako, H (reprint author), Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki, Japan.	hiroyuki.sako@j-parc.jp			MEXT [24105002]; JSPS [24244038]; National Research Foundation of Koreaal Research Foundation of Korea [2012R1A2A1A01011926]	This work was supported by the Grant-in-Aid for Scientific Research on Innovative Areas Grant Number 24105002 from MEXT, the Grant-in-Aid for Scientific Research (A) Grant Number 24244038 from JSPS, and the National Research Foundation of Koreaal Research Foundation of Korea (2012R1A2A1A01011926).	Ahn J. K., J PARC PROPOSAL P42, pP42; Ahn JK, 1998, PHYS LETT B, V444, P267, DOI 10.1016/S0370-2693(98)01416-6; Anderson M, 2003, NUCL INSTRUM METH A, V499, P659, DOI 10.1016/S0168-9002(02)01964-2; Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Allison J, 2006, IEEE T NUCL SCI, V53, P270, DOI 10.1109/TNS.2006.869826; JAFFE RL, 1977, PHYS REV LETT, V38, P617, DOI 10.1103/PhysRevLett.38.617; Takahashi H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.212502; Inoue T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.162002; Beane SR, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.162001; JAFFE RL, 1977, PHYS REV LETT, V38, P195, DOI 10.1103/PhysRevLett.38.195; Kobayashi M, 2006, NUCL INSTRUM METH A, V562, P136, DOI 10.1016/j.nima.2006.03.001; Bachmann S, 2001, NUCL INSTRUM METH A, V470, P548, DOI 10.1016/S0168-9002(01)00802-6; Bachmann S, 2002, NUCL INSTRUM METH A, V479, P294, DOI 10.1016/S0168-9002(01)00931-7; Bachmann S, 1999, NUCL INSTRUM METH A, V438, P376, DOI 10.1016/S0168-9002(99)00820-7; Beane SR, 2011, MOD PHYS LETT A, V26, P2587, DOI 10.1142/S0217732311036978; Beringer J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.010001; Carnegie RK, 2005, NUCL INSTRUM METH A, V538, P372, DOI [10.1016/j.nima.2004.08.132, 10.1016/J.NIMA.2004.08.132]; CHRISTOPHOROU LG, 1979, NUCL INSTRUM METHODS, V163, P141, DOI 10.1016/0029-554X(79)90042-9; Etkin A., 1992, NUCL INSTRUMENTS M A, V323, P224; ETKIN A, 1989, IEEE T NUCL SCI, V36, P58, DOI 10.1109/23.34401; Fabbietti L, 2011, NUCL INSTRUM METH A, V628, P204, DOI 10.1016/j.nima.2010.06.317; Fenker H, 2008, NUCL INSTRUM METH A, V592, P273, DOI 10.1016/j.nima.2008.04.047; Inuzuka M, 2004, NUCL INSTRUM METH A, V525, P529, DOI 10.1016/j.nima.2004.01.073; Kaminski J, 2004, NUCL INSTRUM METH A, V535, P201, DOI 10.1016/j.nima.2004.07.128; Killenberg M, 2007, NUCL INSTRUM METH A, V573, P183, DOI 10.1016/j.nima.2006.10.396; Kobayashi M, 2007, NUCL INSTRUM METH A, V581, P265, DOI 10.1016/j.nima.2007.07.102; Kobayashi M, 2011, NUCL INSTRUM METH A, V641, P37, DOI 10.1016/j.nima.2011.02.042; Ledermann B, 2007, NUCL INSTRUM METH A, V581, P232, DOI 10.1016/j.nima.2007.07.084; Oda SX, 2006, NUCL INSTRUM METH A, V566, P312, DOI 10.1016/j.nima.2006.07.003; Lener MP, 2010, NUCL INSTRUM METH A, V617, P183, DOI 10.1016/j.nima.2009.06.074; Sako H, 2014, J INSTRUM, V9, DOI 10.1088/1748-0221/9/04/C04009; Sauli F, 2006, NUCL INSTRUM METH A, V560, P269, DOI 10.1016/j.nima.2005.12.239; Sauli F, 1997, NUCL INSTRUM METH A, V386, P531, DOI 10.1016/S0168-9002(96)01172-2; Shanahan PE, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.092004; WONG L, 1988, NUCL INSTRUM METH A, V273, P476, DOI 10.1016/0168-9002(88)90039-3; Yoon CJ, 2007, PHYS REV C, V75, DOI [10.1103/PhysRevC.75.022201, 10.1103/PhysRevC.022201]	36	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	NOV 1	2014	763						65	81		10.1016/j.nima.2014.06.007		17	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	AP3ON	WOS:000341986200010		
J	Kang, KH; Hara, K; Higuchi, T; Hyun, HJ; Jeon, HB; Joo, CW; Kah, DH; Kim, HJ; Mibe, T; Onuki, Y; Park, H; Rao, KK; Sato, N; Shimizu, N; Tanida, K; Tsuboyama, T; Uozumi, S				Kang, K. H.; Hara, K.; Higuchi, T.; Hyun, H. J.; Jeon, H. B.; Joo, C. W.; Kah, D. H.; Kim, H. J.; Mibe, T.; Onuki, Y.; Park, H.; Rao, K. K.; Sato, N.; Shimizu, N.; Tanida, K.; Tsuboyama, T.; Uozumi, S.			Study of gluing and wire bonding for the Belle II Silicon Vertex Detector	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article						Gluing; Wire bonding; Belle II; Silicon Vertex Detector; Silicon sensor; Pitch adapter	TRACKER; DESIGN; CHIP	This paper describes an investigation into gluing and wire bonding for assembling the Silicon Vertex Detector (SVD) for the Belle II experiment at KEK in Japan. Optimizing the gluing of the silicon microstrip sensors, the support frame, and the readout Ilex cables is important for achieving the required mechanical precision. The wire bonding between the sensors and the readout electronic chips also needs special care to maximize the physics capability of the SVD. The silicon sensors and signal fan out Ilex circuits (pitch adapters) are glued and connected using wire bonding. We determine that gluing quality is important for achieving good bonding efficiency. The standard deviation in the glue thickness for the best result is measured to be 3.11 mu m. Optimal machine parameters for wire bonding are determined to be 70 mW power, 20 gf force, and 20 ms for the pitch adapter and GO mW power, 20 gf force, and 20 ms for the silicon strip sensors; these parameters provide a pull force of (10.92 +/- 0.72) gf. With these settings, 75% of the pitch adapters and 25% of the strip sensors experience the neck-broken type of break. (C) 2014 Elsevier B.V. All rights reserved.	[Kang, K. H.; Hyun, H. J.; Jeon, H. B.; Kim, H. J.; Park, H.; Uozumi, S.] Kyungpook Natl Univ, Dept Phys, Taegu 702701, South Korea; [Higuchi, T.] Univ Tokyo, Kavli IPMU WPI, Kashiwa, Chiba 2778583, Japan; [Joo, C. W.; Tanida, K.] Seoul Natl Univ, Dept Phys, Seoul 151742, South Korea; [Kah, D. H.] Agcy Def Dev, CBRN Directorate, Taejon 305600, South Korea; [Hara, K.; Mibe, T.; Sato, N.; Tsuboyama, T.] KEK, High Energy Accelerator Res Org, Tsukuba, Ibaraki 3050801, Japan; [Onuki, Y.; Shimizu, N.] Univ Tokyo, Fac Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Rao, K. K.] Tata Inst Fundamental Res, Expt High Energy Phys Grp, Bombay 400005, Maharashtra, India	Park, H (reprint author), Kyungpook Natl Univ, Dept Phys, Taegu 702701, South Korea.	sunshine@knu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0021196]	This research was supported by the Basic Science Research Program (2011-0021196) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology.	Agram JL, 2004, NUCL INSTRUM METH A, V517, P77, DOI 10.1016/j.nima.2003.08.175; Dolezal Z., 2010, 20101 KEK; Friedl M, 2013, NUCL INSTRUM METH A, V732, P83, DOI 10.1016/j.nima.2013.05.171; Hashimoto S., 2004, 20044 KEK; Higuchi Takeo, 2013, QUALITY MANAGEMENT T; Ionica M, 2003, NUCL INSTRUM METH A, V513, P222, DOI 10.1016/j.nima.2003.08.036; Irmler C, 2013, NUCL INSTRUM METH A, V732, P109, DOI 10.1016/j.nima.2013.05.169; Konig S, 2007, NUCL INSTRUM METH A, V582, P776, DOI 10.1016/j.nima.2007.07.090; Marinas C, 2011, NUCL INSTRUM METH A, V650, P59, DOI 10.1016/j.nima.2010.12.116; Schneider-Ramelow M., 2003, WORKSH BOND DIE ATT; French MJ, 2001, NUCL INSTRUM METH A, V466, P359, DOI 10.1016/S0168-9002(01)00589-7	11	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	NOV 1	2014	763						255	259		10.1016/j.nima.2014.06.053		5	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	AP3ON	WOS:000341986200035		
J	Francis, K; Repond, J; Schlereth, J; Smith, J; Xia, L; Baldolemar, E; Li, J; Park, ST; Sosebee, M; White, AP; Yu, J; Eigen, G; Mikami, Y; Watson, NK; Thomson, MA; Ward, DR; Benchekroun, D; Hoummada, A; Khoulaki, Y; Apostolakis, J; Dotti, A; Folger, G; Ivantchenko, V; Ribon, A; Uzhinskiy, V; Carloganu, C; Gay, P; Manen, S; Royer, L; Tytgat, M; Zaganidis, N; Blazey, GC; Dyshkant, A; Lima, JGR; Zutshi, V; Hostachy, JY; Morin, L; Cornett, U; David, D; Ebrahimi, A; Falley, G; Gadow, K; Gottlicher, P; Gunter, C; Hartbrich, O; Hermberg, B; Karstensen, S; Krivan, F; Kruger, K; Lutz, B; Morozov, S; Morgunov, V; Neubuser, C; Reinecke, M; Sefkow, F; Smirnov, P; Terwort, M; Garutti, E; Laurien, S; Lu, S; Marchesini, I; Matysek, M; Ramilli, M; Briggl, K; Eckert, P; Harion, T; Schultz-Coulon, HC; Shen, W; Stamen, R; Bilki, B; Norbeck, E; Northacker, D; Onel, Y; Wilson, GW; Kawagoe, K; Sudo, Y; Yoshioka, T; Dauncey, PD; Wing, M; Salvatore, F; Gil, EC; Mannai, S; Baulieu, G; Calabria, P; Caponetto, L; Combaret, C; Della Negra, R; Grenier, G; Han, R; Ianigro, JC; Kieffer, R; Laktineh, I; Lumb, N; Mathez, H; Mirabito, L; Petrukhin, A; Steen, A; Tromeur, W; Vander Donckt, M; Zoccarato, Y; Alamillo, EC; Fouz, MC; Puerta-Pelayo, J; Corriveau, F; Bobchenko, B; Chadeeva, M; Danilov, M; Epifantsev, A; Markin, O; Mizuk, R; Novikov, E; Popov, V; Rusinov, V; Tarkovsky, E; Besson, D; Buzhan, P; Ilyin, A; Kantserov, V; Kaplin, V; Karakash, A; Popova, E; Tikhomirov, V; Kiesling, C; Seidel, K; Simon, F; Soldner, C; Weuste, L; Amjad, MS; Bonis, J; Callier, S; di Lorenzo, SC; Cornebise, P; Doublet, P; Dulucq, F; Fleury, J; Frisson, T; van der Kolk, N; Li, H; Martin-Chassard, G; Richard, F; de la Taille, C; Poschl, R; Raux, L; Rouene, J; Seguin-Moreau, N; Anduze, M; Balagura, V; Boudry, V; Brient, JC; Cornat, R; Frotin, M; Gastaldi, F; Guliyev, E; Haddad, Y; Magniette, F; Musat, G; Ruan, M; Tran, TH; Videau, H; Bulanek, B; Zacek, J; Cvach, J; Gallus, P; Havranek, M; Janata, M; Kvasnicka, J; Lednicky, D; Marcisovsky, M; Polak, I; Popule, J; Tomasek, L; Tomasek, M; Ruzicka, P; Sicho, P; Smolik, J; Vrba, V; Zalesak, J; Belhorma, B; Ghazlane, H; Kotera, K; Ono, H; Takeshita, T; Uozumi, S; Jeans, D; Chang, S; Khan, A; Kim, DH; Kong, DJ; Oh, YD; Gotze, M; Sauer, J; Weber, S; Zeitnitz, C				Francis, K.; Repond, J.; Schlereth, J.; Smith, J.; Xia, L.; Baldolemar, E.; Li, J.; Park, S. T.; Sosebee, M.; White, A. P.; Yu, J.; Eigen, G.; Mikami, Y.; Watson, N. K.; Thomson, M. A.; Ward, D. R.; Benchekroun, D.; Hoummada, A.; Khoulaki, Y.; Apostolakis, J.; Dotti, A.; Folger, G.; Ivantchenko, V.; Ribon, A.; Uzhinskiy, V.; Carloganu, C.; Gay, P.; Manen, S.; Royer, L.; Tytgat, M.; Zaganidis, N.; Blazey, G. C.; Dyshkant, A.; Lima, J. G. R.; Zutshi, V.; Hostachy, J. -Y.; Morin, L.; Cornett, U.; David, D.; Ebrahimi, A.; Falley, G.; Gadow, K.; Goettlicher, P.; Guenter, C.; Hartbrich, O.; Hermberg, B.; Karstensen, S.; Krivan, F.; Krueger, K.; Lutz, B.; Morozov, S.; Morgunov, V.; Neubueser, C.; Reinecke, M.; Sefkow, F.; Smirnov, P.; Terwort, M.; Garutti, E.; Laurien, S.; Lu, S.; Marchesini, I.; Matysek, M.; Ramilli, M.; Briggl, K.; Eckert, P.; Harion, T.; Schultz-Coulon, H. -Ch.; Shen, W.; Stamen, R.; Bilki, B.; Norbeck, E.; Northacker, D.; Onel, Y.; Wilson, G. W.; Kawagoe, K.; Sudo, Y.; Yoshioka, T.; Dauncey, P. D.; Wing, M.; Salvatore, F.; Gil, E. Cortina; Mannai, S.; Baulieu, G.; Calabria, P.; Caponetto, L.; Combaret, C.; Della Negra, R.; Grenier, G.; Han, R.; Ianigro, J. -C.; Kieffer, R.; Laktineh, I.; Lumb, N.; Mathez, H.; Mirabito, L.; Petrukhin, A.; Steen, A.; Tromeur, W.; Vander Donckt, M.; Zoccarato, Y.; Calvo Alamillo, E.; Fouz, M. -C.; Puerta-Pelayo, J.; Corriveau, F.; Bobchenko, B.; Chadeeva, M.; Danilov, M.; Epifantsev, A.; Markin, O.; Mizuk, R.; Novikov, E.; Popov, V.; Rusinov, V.; Tarkovsky, E.; Besson, D.; Buzhan, P.; Ilyin, A.; Kantserov, V.; Kaplin, V.; Karakash, A.; Popova, E.; Tikhomirov, V.; Kiesling, C.; Seidel, K.; Simon, F.; Soldner, C.; Weuste, L.; Amjad, M. S.; Bonis, J.; Callier, S.; di Lorenzo, S. Conforti; Cornebise, P.; Doublet, Ph.; Dulucq, F.; Fleury, J.; Frisson, T.; van der Kolk, N.; Li, H.; Martin-Chassard, G.; Richard, F.; de la Taille, Ch.; Poeschl, R.; Raux, L.; Rouene, J.; Seguin-Moreau, N.; Anduze, M.; Balagura, V.; Boudry, V.; Brient, J. -C.; Cornat, R.; Frotin, M.; Gastaldi, F.; Guliyev, E.; Haddad, Y.; Magniette, F.; Musat, G.; Ruan, M.; Tran, T. H.; Videau, H.; Bulanek, B.; Zacek, J.; Cvach, J.; Gallus, P.; Havranek, M.; Janata, M.; Kvasnicka, J.; Lednicky, D.; Marcisovsky, M.; Polak, I.; Popule, J.; Tomasek, L.; Tomasek, M.; Ruzicka, P.; Sicho, P.; Smolik, J.; Vrba, V.; Zalesak, J.; Belhorma, B.; Ghazlane, H.; Kotera, K.; Ono, H.; Takeshita, T.; Uozumi, S.; Jeans, D.; Chang, S.; Khan, A.; Kim, D. H.; Kong, D. J.; Oh, Y. D.; Goetze, M.; Sauer, J.; Weber, S.; Zeitnitz, C.			Performance of the first prototype of the CALICE scintillator strip electromagnetic calorimeter	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article						Particle Flow; Electromagnetic calorimeter; Scintillator; MPPC		A first prototype of a scintillator strip-based electromagnetic calorimeter was built, consisting of 26 layers of tungsten absorber plates interleaved with planes of 45 x 10 x 3 mm plastic scintillator strips. Data were collected using a positron test beam at DESY with momenta between 1 and 6 GeV/c. The prototype's performance is presented in terms of the linearity and resolution of the energy measurement. These results represent an important milestone in the development of highly granular calorimeters using scintillator strip technology. A number of possible design improvements were identified, which should be implemented in a future detector of this type. This technology is being developed for a future linear collider experiment, aiming at the precise measurement of jet energies using particle flow techniques. (C) 2014 Elsevier B.V. All rights reserved.	[Francis, K.; Repond, J.; Schlereth, J.; Smith, J.; Xia, L.; Bilki, B.] Argonne Natl Lab, Argonne, IL 60439 USA; [Baldolemar, E.; Li, J.; Park, S. T.; Sosebee, M.; White, A. P.; Yu, J.] Univ Texas Arlington, Dept Phys, Arlington, TX 76019 USA; [Eigen, G.] Univ Bergen, Inst Phys, N-5007 Bergen, Norway; [Mikami, Y.; Watson, N. K.] Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; [Thomson, M. A.; Ward, D. R.] Univ Cambridge, Cavendish Lab, Cambridge CB3 OHE, England; [Benchekroun, D.; Hoummada, A.; Khoulaki, Y.] Univ Hassan II Ain Chock, Fac Sci, Casablanca, Morocco; [Apostolakis, J.; Dotti, A.; Folger, G.; Ivantchenko, V.; Ribon, A.; Uzhinskiy, V.] CERN, CH-1211 Geneva 23, Switzerland; [Carloganu, C.; Gay, P.; Manen, S.; Royer, L.] Univ Clermont Ferrand, Clermont Univ, CNRS, Phys Corpusculaire Lab,IN2P3, F-63000 Clermont Ferrand, France; [Tytgat, M.; Zaganidis, N.] Univ Ghent, Dept Phys & Astron, B-9000 Ghent, Belgium; [Blazey, G. C.; Dyshkant, A.; Lima, J. G. R.; Zutshi, V.] No Illinois Univ, NICADD, Dept Phys, De Kalb, IL 60115 USA; [Hostachy, J. -Y.; Morin, L.] Univ Grenoble 1, CNRS, Inst Polytech Grenoble, Lab Phys Subatom & Cosmol,IN2P3, F-38026 Grenoble, France; [Cornett, U.; David, D.; Ebrahimi, A.; Falley, G.; Gadow, K.; Goettlicher, P.; Guenter, C.; Hartbrich, O.; Hermberg, B.; Karstensen, S.; Krivan, F.; Krueger, K.; Lutz, B.; Morozov, S.; Morgunov, V.; Neubueser, C.; Reinecke, M.; Sefkow, F.; Smirnov, P.; Terwort, M.; Marchesini, I.] DESY, D-22603 Hamburg, Germany; [Garutti, E.; Laurien, S.; Lu, S.; Marchesini, I.; Matysek, M.; Ramilli, M.] Univ Hamburg, Inst Expt Phys, Dept Phys, D-22761 Hamburg, Germany; [Briggl, K.; Eckert, P.; Harion, T.; Schultz-Coulon, H. -Ch.; Shen, W.; Stamen, R.] Heidelberg Univ, Fac Phys & Astron, D-69120 Heidelberg, Germany; [Bilki, B.; Norbeck, E.; Northacker, D.; Onel, Y.] Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; [Wilson, G. W.] Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; [Kawagoe, K.; Sudo, Y.; Yoshioka, T.] Kyushu Univ, Dept Phys, Fukuoka 8128581, Japan; [Dauncey, P. D.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, Blackett Lab, London SW7 2AZ, England; [Wing, M.] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Salvatore, F.] Royal Holloway Univ London, Dept Phys, Egham TW20 0EX, Surrey, England; [Gil, E. Cortina; Mannai, S.] Catholic Univ Louvain, Ctr Cosmol Particle Phys & Cosmol CP3, B-1320 Louvain la Neuve, Belgium; Univ Lyon 1, CNRS, IPNL, IN2P3, F-69622 Villeurbanne, France; [Calvo Alamillo, E.; Fouz, M. -C.; Puerta-Pelayo, J.] CIEMAT, E-28040 Madrid, Spain; [Corriveau, F.] Inst Particle Phys Canada, Montreal, PQ H3A 2T8, Canada; [Corriveau, F.] Dept Phys, Montreal, PQ H3A 2T8, Canada; [Bobchenko, B.; Chadeeva, M.; Danilov, M.; Epifantsev, A.; Markin, O.; Mizuk, R.; Novikov, E.; Popov, V.; Rusinov, V.; Tarkovsky, E.] Inst Theoret & Expt Phys, RU-117218 Moscow, Russia; [Danilov, M.; Mizuk, R.; Besson, D.; Buzhan, P.; Ilyin, A.; Kantserov, V.; Kaplin, V.; Karakash, A.; Popova, E.; Tikhomirov, V.] Moscow Phys Engn Inst, MEPhI, Dept Phys, Moscow 115409, Russia; [Kiesling, C.; Seidel, K.; Simon, F.; Soldner, C.; Weuste, L.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; [Amjad, M. S.; Bonis, J.; Callier, S.; di Lorenzo, S. Conforti; Cornebise, P.; Doublet, Ph.; Dulucq, F.; Fleury, J.; Frisson, T.; van der Kolk, N.; Li, H.; Martin-Chassard, G.; Richard, F.; de la Taille, Ch.; Poeschl, R.; Raux, L.; Rouene, J.; Seguin-Moreau, N.] Univ Paris 11, Ctr Sci Orsay, Lab Accelerateur Lineaire, CNRS IN2P3, F-91898 Orsay, France; [Anduze, M.; Balagura, V.; Boudry, V.; Brient, J. -C.; Cornat, R.; Frotin, M.; Gastaldi, F.; Guliyev, E.; Haddad, Y.; Magniette, F.; Musat, G.; Ruan, M.; Tran, T. H.; Videau, H.] Ecole Polytech, CNRS, LLR, IN2P3, F-91128 Palaiseau, France; [Bulanek, B.; Zacek, J.] Charles Univ Prague, Inst Nucl & Particle Phys, CZ-18000 Prague 8, Czech Republic; [Cvach, J.; Gallus, P.; Havranek, M.; Janata, M.; Kvasnicka, J.; Lednicky, D.; Marcisovsky, M.; Polak, I.; Popule, J.; Tomasek, L.; Tomasek, M.; Ruzicka, P.; Sicho, P.; Smolik, J.; Vrba, V.; Zalesak, J.] Acad Sci Czech Republic, Inst Phys, CZ-18221 Prague 8, Czech Republic; [Belhorma, B.; Ghazlane, H.] Ctr Natl Energie Sci & Tech Nucl, Rabat, Morocco; [Kotera, K.; Ono, H.; Takeshita, T.; Uozumi, S.] Shinshu Univ, Dept Phys, Nagano 3908621, Japan; [Jeans, D.] Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Chang, S.; Khan, A.; Kim, D. H.; Kong, D. J.; Oh, Y. D.] Kyungpook Natl Univ, Dept Phys, Taegu 702701, South Korea; [Goetze, M.; Sauer, J.; Weber, S.; Zeitnitz, C.] Berg Univ Wuppertal, Fachbereich C Phys, D-42097 Wuppertal, Germany	Uozumi, S (reprint author), KNU, Taegu, South Korea.	satoru@knu.ac.kr; jeans@icepp.s.u-tokyo.ac.jp		Watson, Nigel/0000-0002-8142-4678	Bundesministerium fur Bildung und Forschung, Germany; DEG cluster of excellence 'Origin and Structure of the Universe' of Germany; Helmholtz-Nachwuchsgruppen grant [VH-NG-206]; BMBF [05HS6VH1]; JSPS KAKENHI [17340071, 18GS0202]; Russian Ministry of Education and Science [8174, 8411, 1366.2012.2, 14.A12.31.0006]; MICINN, Spain; CPAN, Spain; CRI(MST) of MOST/KOSEF in Korea; World Class University (WCU) project through the National Research Foundation (NRF) of Korea - Ministry of Education, Science Technology [R32-2008-000-20001-0]; US Department of Energy and the US National Science Foundation; Ministry of Education, Youth and Sports of the Czech Republic [AV0 Z3407391, AV0 Z10100502, LC527, LA09042]; Grant Agency of the Czech Republic [202/05/0653]; National Sciences and Engineering Research Council of Canada; Science and Technology Facilities Council, UK	We gratefully acknowledge the DESY management for its support and hospitality, and the DESY accelerator staff for the reliable and efficient beam operation. We would like to thank the HEP group of the University of Tsukuba for the loan of drift chambers. This work was supported by the Bundesministerium fur Bildung und Forschung, Germany; by the DEG cluster of excellence 'Origin and Structure of the Universe' of Germany; by the Helmholtz-Nachwuchsgruppen grant VH-NG-206; by the BMBF, grant no, 05HS6VH1; by JSPS KAKENHI Grant-in-Aid for Scientific Research numbers 17340071 and 18GS0202; by the Russian Ministry of Education and Science contracts 8174, 8411, 1366.2012.2, and 14.A12.31.0006; by MICINN and CPAN, Spain; by CRI(MST) of MOST/KOSEF in Korea; by the World Class University (WCU) project through the National Research Foundation (NRF) of Korea funded by the Ministry of Education, Science & Technology (Grant no. R32-2008-000-20001-0); by the US Department of Energy and the US National Science Foundation; by the Ministry of Education, Youth and Sports of the Czech Republic under the projects AV0 Z3407391, AV0 Z10100502, LC527 and LA09042 and by the Grant Agency of the Czech Republic under the project 202/05/0653; by the National Sciences and Engineering Research Council of Canada; and by the Science and Technology Facilities Council, UK.	Abe T., ARXIV10063396; Adloff C, 2010, J INSTRUM, V5, DOI 10.1088/1748-0221/5/05/P05004; Aicheler M., 2012, CERN2012007; Thomson MA, 2009, NUCL INSTRUM METH A, V611, P25, DOI 10.1016/j.nima.2009.09.009; Behnke T., 2013, ILCREPORT2013040; Behnke T., 2013, ILCREPORT2013040; Blin S., 2006, LCDET2006007; Brient J.-C., 2001, ECONF C010630, pE3047; Gomi S, 2007, NUCL INSTRUM METH A, V581, P427, DOI 10.1016/j.nima.2007.08.020; Kotera K., P CHEF2013 CONFERENC, P325; Linssen L, 2012, CERN2012003; Lutz B., 2006, THESIS HAMBURG U; MOKKA, 2013, DET GEANT4 SIM INT L; Repond J, 2008, J INSTRUM, V3, DOI 10.1088/1748-0221/3/08/P08001	14	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	NOV 1	2014	763						278	289		10.1010/j.nima.2014.06.039		12	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	AP3ON	WOS:000341986200039		
J	Suzuki, T; Miyata, H; Katsumata, M; Nakano, S; Matsuda, K; Tamura, M				Suzuki, T.; Miyata, H.; Katsumata, M.; Nakano, S.; Matsuda, K.; Tamura, M.			Organic semiconductors as real-time radiation detectors	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article						Radiation detector; Organic semiconductor; Polyaniline	SOLAR-CELLS; TRANSISTORS	In this study, the possibility of using pi-conjugated organic semiconducting polymers as real-time radiation detectors was explored. Polyaniline (PAni) was used to fabricate radiation sensors because of its relative long-term stability in air. Each fabricated sensor was then subjected to irradiation by alpha- and beta-particles, and the real-time response was measured. The multichannel analyzer (MCA) data of the response signal for each irradiation was acquired and the detection efficiency, relative to the electrode bias voltage of the detector, was extracted. (C) 2014 Elsevier B.V. All rights reserved.	[Suzuki, T.; Nakano, S.; Matsuda, K.] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan; [Miyata, H.; Katsumata, M.] Niigata Univ, Dept Phys, Niigata 9502181, Japan; [Tamura, M.] Carlit Holdings Co Ltd, Tokyo 1040031, Japan	Suzuki, T (reprint author), Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan.	tsuzuki@hep.sc.niigata-u.ac.jp; miyata@hep.sc.niigata-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [20654022]	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant number 20654022.	Agostinelli T, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3028640; Majewski LA, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2208938; Beckerle P, 2000, NUCL INSTRUM METH A, V449, P302, DOI 10.1016/S0168-9002(00)00255-2; Natali D, 2003, NUCL INSTRUM METH A, V512, P419, DOI 10.1016/S0168-9002(03)01921-1; Murphy AR, 2007, CHEM REV, V107, P1066, DOI 10.1021/cr0501386; Keivanidis PE, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3120547; D'Andrade BW, 2004, ADV MATER, V16, P1585, DOI 10.1002/adma.200400684; Dennler G, 2009, ADV MATER, V21, P1323, DOI 10.1002/adma.200801283; Gather MC, 2007, ADV FUNCT MATER, V17, P191, DOI 10.1002/adfm.200600651; Gunes S, 2007, CHEM REV, V107, P1324, DOI 10.1021/cr050149z; ATLAS Collab, 2011, EUR PHYS J C, V71, P1593; Binda M, 2010, NUCL INSTRUM METH A, V624, P443, DOI 10.1016/j.nima.2010.04.026; Boroumand FA, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2748337; Feng H, 2006, NUCL INSTRUM METH A, V564, P347, DOI 10.1016/j.nima.2006.05.013; Keivanidis PE, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2834364; Miyata H., 2012, U.S. Patent, Patent No. 8212141; Ng TN, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2937018; Sugimoto Y, 1997, NUCL INSTRUM METH A, V385, P463, DOI 10.1016/S0168-9002(96)01213-2; Taketani A, 2006, NUCL PHYS A, V774, P911, DOI 10.1016/j.nuclphysa.2006.06.164; Taylor G, 2003, NUCL INSTRUM METH A, V501, P22, DOI 10.1016/S0168-9002(02)02006-5; The Belle Collaboration, 2002, NUCL INSTR MATH A, V479, P117; Wauters F, 2009, NUCL INSTRUM METH A, V604, P563, DOI 10.1016/j.nima.2009.03.012	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	NOV 1	2014	763						304	307		10.1016/j.nima.2014.05.120		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	AP3ON	WOS:000341986200041		
J	Tsunesada, Y; Katsuya, R; Mitsumori, Y; Nakayama, K; Kakimoto, F; Tokuno, H; Tajima, N; Miranda, P; Salinas, J; Tavera, W				Tsunesada, Yoshiki; Katsuya, Ryoichi; Mitsumori, Yu; Nakayama, Keisuke; Kakimoto, Fumio; Tokuno, Hisao; Tajima, Norio; Miranda, Pedro; Salinas, Juan; Tavera, Wilfredo			New air Cherenkov light detectors to study mass composition of cosmic rays with energies above knee region	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article						Cosmic rays; Mass composition; Extensive air showers; Cherenkov light detectors; High altitude	CHEMICAL-COMPOSITION; RADIATION PULSES; SHOWERS; DISTRIBUTIONS; SPECTRUM; SIMULATION; PROTONS; ARRAY	We have installed a hybrid detection system for air showers generated by cosmic rays with energies greater than 3 x 10(15) eV at Mount Chacaltaya (5200 m above the sea level), in order to study the mass composition of cosmic rays above the knee region. This detection system comprises an aft shower at with 49 scintillation counters in an area of 500 m x 650 in, and seven new Cherenkov light detectors installed in a radial direction from the center of the an shower array with a separation of 50 m, It is known that the longitudinal development of a particle cascade in the atmosphere strongly depends on the type of the primary nucleus, and an aft shower initiated by a heavier nucleus develops faster than that by a lighter primary of the same energy, because of the differences in the interaction cross-section and the energy per nucleon. This can be measured by detecting the Cherenkov radiation emitted from charged particles in air showers at higher altitudes. In this paper we describe the design and performance of our new non-imaging Cherenkov light detectors at Mount Chacaltaya that are operated in conjunction with the air shower array. The arrival directions and energies of air showers are determined by the shower array, and information about the primary masses is obtained from the Cherenkov light data including the time profiles and lateral distributions. The detector consists of photomultiplier tube (PMT), high-speed ADCs, other control modules, and data storage device. The Cherenkov light signals from an air shower are typically 10100 ns long, and the waveforms are digitized with a sampling frequency of 1 GHz and recorded in situ without long-distance analog signal transfers. All the Cherenkov light detectors record their time-series data by receiving a triggering signal transmitted from the trigger module of the air shower array, which is fired by a coincidence of shower signals in four neighboring scintillation counters. The optical characteristics of the detectors and the control and the data acquisition systems are discussed. (C) 2014 Elsevier B.V. All rights reserved.	[Tsunesada, Yoshiki; Katsuya, Ryoichi; Mitsumori, Yu; Nakayama, Keisuke; Kakimoto, Fumio; Tokuno, Hisao] Tokyo Inst Technol, Grad Sch Sci & Engn, Meguro, Tokyo 1528550, Japan; [Tajima, Norio] RIKEN, Wako, Saitama 3510198, Japan; [Miranda, Pedro; Salinas, Juan; Tavera, Wilfredo] Univ Mayor San Andres, Inst Invest Fis, La Paz, Bolivia	Tsunesada, Y (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Meguro, Tokyo 1528550, Japan.	tsunesada@cr.phys.titech.ac.jp; katsuya@cr.phys.titech.ac.jp			(KAKENHI) Ministry of Education, Culture, Sports, Science and Technology of Japan [23403002]	The authors would like to thank the staff of the Instituto de Investigaciones Fisicas, Universidad Mayor de San Andres, La Paz, Bolivia, for their support to our experiment at Mount Chacaltaya, We also acknowledge long-standing assistance from the Institute for Cosmic Ray Research, University of Tokyo. This work is supported a Grant-in-Aid for Scientific Research (KAKENHI) (23403002) by the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abu-Zayyad T, 2013, ASTROPART PHYS, V48, P16, DOI 10.1016/j.astropartphys.2013.06.007; Tokuno H, 2008, ASTROPART PHYS, V29, P453, DOI 10.1016/j.astropartphys.2008.05.001; Abbasi RU, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.161101; Bergmann T, 2007, ASTROPART PHYS, V26, P420, DOI 10.1016/j.astrophys.2006.08.005; Apel WD, 2009, ASTROPART PHYS, V31, P86, DOI 10.1016/j.astropartphys.2008.11.008; Amenomori M, 2006, PHYS LETT B, V632, P58, DOI 10.1016/j.physletb.2005.10.048; Muraki Y, 2008, ASTROPART PHYS, V29, P229, DOI 10.1016/j.astropartphys.2007.12.007; Abraham J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.091101; Apel WD, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.171104; Forler J.W., 2001, ASTROPART PHYS, V15, P49; Furuhata A., 2005, P 29 INT COSM RAY C, V6, P329; Heck D., 1998, 6019 FZKA; HILLAS AM, 1982, J PHYS G NUCL PARTIC, V8, P1461, DOI 10.1088/0305-4616/8/10/016; HILLAS AM, 1982, J PHYS G NUCL PARTIC, V8, P1475, DOI 10.1088/0305-4616/8/10/017; Kakimoto F, 1996, NUCL INSTRUM METH A, V373, P282, DOI 10.1016/0168-9002(95)01508-6; Kampert K.H., 2002, ARXIVASTROPH02123478; KOBAYASHI M, 1994, NUCL INSTRUM METH A, V337, P355, DOI 10.1016/0168-9002(94)91103-7; Nerling F, 2006, ASTROPART PHYS, V24, P421, DOI 10.1016/j.astropartphys.2005.09.002; Ogio S, 2004, ASTROPHYS J, V612, P268, DOI 10.1086/422510; Ogio S., NUCL INSTRUMEN UNPUB; PATTERSON JR, 1983, J PHYS G NUCL PARTIC, V9, P1433, DOI 10.1088/0305-4616/9/11/015; Pierog T, 2006, NUCL PHYS B-PROC SUP, V151, P159, DOI 10.1016/j.nuclphysbps.2005.07.029; Rozsa C., 1999, IEEE NUCL SCI S; Sako T, 2006, ASTROPHYS J, V651, pL69, DOI 10.1086/509145; Sakurai H., 2011, P 32 ICRC, V0364; Shirasaki Y, 2001, ASTROPART PHYS, V15, P357, DOI 10.1016/S0927-6505(00)00166-3; Vasiliev RV, 2009, INSTRUM EXP TECH+, V52, P166, DOI 10.1134/S0020441209020043	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	NOV 1	2014	763						320	328		10.1016/j.nima.2014.06.054		9	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	AP3ON	WOS:000341986200044		
J	Kamiya, J; Ogiwara, N; Hotchi, H; Hayashi, N; Kinsho, M				Kamiya, J.; Ogiwara, N.; Hotchi, H.; Hayashi, N.; Kinsho, M.			Beam loss reduction by magnetic shielding using beam pipes and bellows of soft magnetic materials	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article						Vacuum; Magnetic shielding; Permalloy; Ferritic stainless steel; Magnetic annealing; Vacuum firing	VACUUM	One of the main sources of beam loss in high power accelerators is unwanted stray magnetic fields from magnets near the beam line, which can distort the beam orbit. The most effective way to shield such magnetic fields is to perfectly surround the beam region without any gaps with a soft magnetic high permeability material. This leads to the manufacture of vacuum chambers (beam pipes and bellows) with soft magnetic materials. A Ni-Fe alloy (permalloy) was selected for the material of the pipe parts and outer bellows parts, while a ferritic stainless steel was selected for the flanges. An austenitic stainless steel, which is non-magnetic material, was used for the inner bellows for vacuum tightness. To achieve good magnetic shielding and vacuum performances, a heat treatment under high vacuum was applied during the manufacturing process of the vacuum chambers. Using this heat treatment, the ratio of the integrated magnetic flux density along the beam orbit between the inside and outside of the beam pipe and bellows became small enough to suppress beam orbit distortion. The outgassing rate of the materials with this heat treatment was reduced by one order magnitude compared to that without heat treatment. By installing the beam pipes and bellows of soft magnetic materials as part of the Japan Proton Accelerator Research Complex 3 GeV rapid cycling synchrotron beam line, the closed orbit distortion (COD) was reduced by more than 80%. In addition, a 95.5% beam survival ratio was achieved by this COD improvement. (C) 2014 Elsevier B.V. All rights reserved.	[Kamiya, J.; Ogiwara, N.; Hotchi, H.; Hayashi, N.; Kinsho, M.] Japan Atom Energy Agcy, Naka, Ibaraki 3191195, Japan	Kamiya, J (reprint author), Japan Atom Energy Agcy, 2-4 Shirakata Shirane, Naka, Ibaraki 3191195, Japan.	kamiya.junichiro@jaea.go.jp					CALDER R, 1967, BRIT J APPL PHYS, V18, P1459, DOI 10.1088/0508-3443/18/10/313; Redhead PA, 2002, J VAC SCI TECHNOL A, V20, P1667, DOI 10.1116/1.1496783; Hotchi H., COMMUNICATIONS; Hotchi H., 2011, P IPAC2011 SAN SEB S, P6; Jousten K, 1998, VACUUM, V49, P359, DOI 10.1016/S0042-207X(98)00002-5; Kamiya J, 2013, VACUUM, V98, P12, DOI 10.1016/j.vacuum.2012.10.007; Ogiwara N, 2008, J PHYS CONF SER, V100, DOI 10.1088/1742-6596/100/9/092024; Ogiwara N., 2011, P IPAC 2011 SAN SEB, P971; Redhead P.A., 1962, Vacuum, V12, DOI 10.1016/0042-207X(62)90978-8; Yamazaki Y., 2002, 200213 KEK; Yoshimoto M., 2011, P 2011 INT PART ACC, P2412	11	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	NOV 1	2014	763						329	339		10.1016/j.nima.2014.06.062		11	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	AP3ON	WOS:000341986200045		
J	Nakamura, T; Ohzu, A; Toh, K; Sakasai, K; Suzuki, H; Honda, K; Birumachi, A; Ebine, M; Yamagishi, H; Takase, M; Haruyama, M; Kureta, M; Soyama, K; Nakamura, H; Seya, M				Nakamura, T.; Ohzu, A.; Toh, K.; Sakasai, K.; Suzuki, H.; Honda, K.; Birumachi, A.; Ebine, M.; Yamagishi, H.; Takase, M.; Haruyama, M.; Kureta, M.; Soyama, K.; Nakamura, H.; Seya, M.			Neutron-sensitive ZnS/(B2O3)-B-10 ceramic scintillator detector as an alternative to a He-3-gas-based detector for a plutonium canister assay system	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article						Neutron detector; ZnS/(B2O3)-B-10 ceramic scintillator; Alternative to He-3-gas-based detector; Nuclear safeguard; Alternative plutonium canister assay system		A neutron-sensitive ZnS/(B2O3)-B-10 ceramic scintillator detector was developed as an alternative to a He-3-gas-based detector for use in a plutonium canister assay system. The detector has a modular structure, with a flat ZnS/(B2O3)-B-10 ceramic scintillator strip that is installed diagonally inside a light-reflecting aluminium case with a square cross-section, and where the scintillation light is detected using two photomultiplier tubes attached at both ends of the case. The prototype detectors, which have a neutron-sensitive area of 30 mm x 250 mm, exhibited a sensitivity of 21.7-23.4 +/- 0.1 cps/nv (mean +/- SD) for thermal neutrons, a(137)Cs gamma-ray sensitivity of 1.1-1.9 +/- 0.2 x 10(-7) and a count variation of less than 6% over the detector length. A trial experiment revealed a temperature coefficient of less than -0.24 +/- 0.05%/degrees C over the temperature range of 20-50 degrees C. The detector design and the experimental results are presented. (C) 2014 Elsevier B.V. All rights reserved.	[Nakamura, T.; Toh, K.; Sakasai, K.; Suzuki, H.; Honda, K.; Yamagishi, H.; Soyama, K.] Japan Atom Energy Agcy, J PARC, Naka, Ibaraki 3191195, Japan; [Ohzu, A.; Takase, M.; Haruyama, M.; Kureta, M.] Japan Atom Energy Agcy, Nucl Sci & Engn Directorate, Naka, Ibaraki 3191195, Japan; [Birumachi, A.; Ebine, M.] Japan Atom Energy Agcy, Inst Sci Nucl, Naka, Ibaraki 3191195, Japan; [Nakamura, H.] Japan Atom Energy Agcy, Tokai Reproc Dev Ctr, Naka, Ibaraki 3191195, Japan; [Seya, M.] Japan Atom Energy Agcy, Integrated Support Ctr Nucl Nonproliferat & Nucl, Naka, Ibaraki 3191195, Japan	Nakamura, T (reprint author), Japan Atom Energy Agcy, J PARC, 2-4 Shirakatashirane, Naka, Ibaraki 3191195, Japan.	nakamura.tatsuya@jaca.go.jp			Ministry of Education, Culture, Sports, Science and Technology-Japan, Japan	T.N. is indebted to Dr. Katagiri for his valuable comments, fruitful discussions and dedicated support. The authors greatly appreciate the dedicated experimental support at JAEA/FRS provided by Dr. Yoshitomi and Dr. Kowatari. The work is supported by the Ministry of Education, Culture, Sports, Science and Technology-Japan, Japan (Kakusekyurity kyoukatou suishin jigyou hojokin).	Nakamura T, 2012, NUCL INSTRUM METH A, V686, P64, DOI 10.1016/j.nima.2012.05.038; Hosoya T, 2009, NUCL INSTRUM METH A, V600, P217, DOI 10.1016/j.nima.2008.11.123; Kojima T, 2004, NUCL INSTRUM METH A, V529, P325, DOI 10.1016/j.nima.2004.05.005; Browne M. C., 2001, P 23 ANN M S SAF NUC; Doyle JE, 2008, NUCL SAFEGUARDS SECU; Evans L.G., 2012, J NUCL MAT MANAG, V3, P88; Katagiri M., NUCL INSTRUM A UNPUB; KOUZES R. T., 2010, PNNL19600; Lacy J.L., 2012, P 53 ANN M I NUCL MA; Menlove H.L., 1985, LA10615M LOS AL NAT; Nakamura H., 2012, P INMM 53 ANN M ORL; Nakamura T, 2009, NUCL INSTRUM METH A, V600, P164, DOI 10.1016/j.nima.2008.11.117; Nakamura T., 2013, P 54 INT WORKSH NUCL; Ohzu A., 2013, P 2013 IEEE NUCL SCI	14	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	NOV 1	2014	763						340	346		10.1016/j.nima.2014.05.049		7	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	AP3ON	WOS:000341986200046		
J	Kiuchi, R; Asano, H; Hasegawa, S; Honda, R; Ichikawa, Y; Imai, K; Joo, CW; Nakazawa, K; Sako, H; Sato, S; Shirotori, K; Sugimura, H; Tanida, K; Watabe, T				Kiuchi, R.; Asano, H.; Hasegawa, S.; Honda, R.; Ichikawa, Y.; Imai, K.; Joo, C. W.; Nakazawa, K.; Sako, H.; Sato, S.; Shirotori, K.; Sugimura, H.; Tanida, K.; Watabe, T.			Development of a silicon micro-strip detector for tracking high intensity secondary beams	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article						Silicon detector; Micro-strip; Tracker; Beam test; DAQ	FRONT-END CHIP; APV25; PERFORMANCE; TELESCOPE; SENSORS; SCT	A single-sided silicon micro-strip detector (SSD) has been developed as a tracking detector for hadron experiments at J-PARC where secondary meson beams with intensities of up to 10(8) Hz are available. The performance of the detector has been investigated and verified in a series of Lest beam experiments in the years 2009-2011. The hole mobility was deduced from the analysis of cluster events. The beam rate dependence was measured in terms of timing resolution, signal-to-noise ratio, and hit efficiency. This paper describes the detector with its read-out system, details of the test experiments, and discusses the performance achieved. (C) 2014 Elsevier B.V. All rights reserved.	[Kiuchi, R.; Hasegawa, S.; Ichikawa, Y.; Imai, K.; Sako, H.; Sato, S.; Sugimura, H.; Tanida, K.] Japan Atom Energy Agcy, Adv Sci Res Ctr, Naka, Ibaraki 3191195, Japan; [Asano, H.; Ichikawa, Y.; Sugimura, H.] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; [Honda, R.] Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan; [Joo, C. W.; Tanida, K.] Seoul Natl Univ, Dept Phys & Astron, Seoul 151747, South Korea; [Nakazawa, K.] Gifu Univ, Dept Phys, Gifu 5011193, Japan; [Shirotori, K.] Osaka Univ, Nucl Phys Res Ctr, Ibaraki, Osaka 5670047, Japan; [Watabe, T.] Nagoya Univ, Dept Phys, Nagoya, Aichi 4648602, Japan	Tanida, K (reprint author), Seoul Natl Univ, Dept Phys & Astron, Seoul 151747, South Korea.	tanida@phya.snu.ac.kr			Belle SVD group; MEXT [20028001, 24105002]; JSPS [23224006, 21684011]; National Research Foundation in Korea [2010-0004752]; NRF grant (Center for Korean J-PARC Users - MEST [2013K1A3A7A060565]	We acknowledge the Belle SVD group for their great support with the fabrication of the SSD, and we are also grateful to M. Friedl for advice concerning the DAQ system. We would like to thank the technical staff at RCNP, especially A. Tamii for the operation of the accelerators and the beamline facilities. We also deeply appreciate the staff of LNS in particular T. Ishikawa for help with the experimental setup and also the accelerator operation. Special thanks go to the E10 collaborators for their assistance to the operation of the SSD during the experiment.; This work was supported by the Grants-in-Aid for Scientific Research (KAKENHI) for Scientific Research on Priority Areas No. 20028001, for Scientific Research on Innovative Areas, No. 24105002 from MEXT, for Scientific Research (S) No. 23224006, for Young Scientists (A) No. 21684011 from JSPS, and for Basic Research (Young Researcher) No, 2010-0004752 from National Research Foundation in Korea. It was also supported by the NRF grant (Center for Korean J-PARC Users, Grant no. 2013K1A3A7A060565) funded by MEST	Angerer H, 2003, NUCL INSTRUM METH A, V512, P229, DOI 10.1016/S0168-9002(03)01898-9; Atwood WB, 2009, ASTROPHYS J, V697, P1071, DOI 10.1088/0004-637X/697/2/1071; Turala M, 2005, NUCL INSTRUM METH A, V541, P1, DOI 10.1016/j.nima.2005.01.032; Sugimura H, 2014, PHYS LETT B, V729, P39, DOI 10.1016/j.physletb.2013.12.062; Barbiellini G, 2002, NUCL INSTRUM METH A, V490, P146, DOI 10.1016/S0168-9002(02)01062-8; DORKEL JM, 1981, SOLID STATE ELECTRON, V24, P821, DOI 10.1016/0038-1101(81)90097-6; JACOBONI C, 1977, SOLID STATE ELECTRON, V20, P77, DOI 10.1016/0038-1101(77)90054-5; Banicz K, 2005, NUCL INSTRUM METH A, V539, P137, DOI 10.1016/j.nima.2004.10.019; Beringer J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.010001; Campabadal F, 2005, NUCL INSTRUM METH A, V538, P384, DOI [10.1016/j.nima.2004.08.133, 10.1016/J.NIMA.2004.08.133]; Friedl M, 2007, NUCL INSTRUM METH A, V572, P385, DOI 10.1016/j.nima.2006.10.203; Friedl M, 2002, NUCL INSTRUM METH A, V488, P175, DOI 10.1016/S0168-9002(02)00511-9; Gorelov I, 2002, NUCL INSTRUM METH A, V481, P204, DOI 10.1016/S0168-9002(01)01413-9; Miyoshi T, 2003, NUCL INSTRUM METH A, V496, P362, DOI 10.1016/S0168-9002(02)01662-5; Takahashi T, 2012, PROG THEOR EXP PHYS, V2012; French MJ, 2001, NUCL INSTRUM METH A, V466, P359, DOI 10.1016/S0168-9002(01)00589-7; Unno Y, 2000, NUCL INSTRUM METH A, V453, P109, DOI 10.1016/S0168-9002(00)00615-X; Zeghbroeck B.V., PRINCIPLES SEMICONDU	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	NOV 1	2014	763						399	403		10.1016/j.nima.2014.06.060		5	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	AP3ON	WOS:000341986200054		
J	Aryshey, A; Araki, S; Fukuda, M; Karataev, P; Konkov, A; Naumenko, G; Potylitsyn, A; Sakaue, K; Sukhikh, L; Terunuma, N; Verigin, D; Urakawa, J				Aryshey, A.; Araki, S.; Fukuda, M.; Karataev, P.; Konkov, A.; Naumenko, G.; Potylitsyn, A.; Sakaue, K.; Sukhikh, L.; Terunuma, N.; Verigin, D.; Urakawa, J.			Observation of the stimulated coherent diffraction radiation in an open resonator at LUCX facility	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article						Coherent diffraction radiation; Stimulated radiation; Microwave resonator	TRANSITION RADIATION; ELECTRON BUNCH; PREBUNCHED FEL; BEAM; ACCELERATOR; SCATTERING; REGION; LASER; GUN	We present an initial test of a new type of a pre-bunched beam pumped free electron maser based on Stimulated Coherent Diffraction Radiation (SCDR) generated in an open resonator. A fast Schottky Barrier Diode (time response < 1 ns) has enabled us to investigate the properties of the radiation stored in the cavity as well as the intrinsic properties of the cavity itself. We observed a turn-by-turn SCDR generated by a multibunch beam. When the cavity length was exactly a half of the bunch spacing a clear resonance was observed. Moreover, turn-by-turn measurements revealed the cavity quality factor of 72.88, which was rather high for an open resonator in the wavelength range of 3-5 mm. An exponential growth of the photon intensity as a function of the number of bunches was also demonstrated. (C) 2014 Elsevier B.V. All rights reserved	[Aryshey, A.; Araki, S.; Fukuda, M.; Terunuma, N.; Urakawa, J.] KEK, High Energy Accelerator Res Org, Tsukuba, Ibaraki 3050801, Japan; [Konkov, A.; Naumenko, G.; Potylitsyn, A.; Sukhikh, L.; Verigin, D.] Tomsk Polytech Univ, Inst Phys & Technol, Tomsk 634050, Russia; [Karataev, P.] Univ London, John Adams Inst Royal Holloway, Egham TW20 0EX, Surrey, England; [Sakaue, K.] Waseda Univ, Shinju Ku, Tokyo 1698555, Japan	Aryshey, A (reprint author), KEK, High Energy Accelerator Res Org, 1-1 Oho, Tsukuba, Ibaraki 3050801, Japan.	alar@post.kek.jp	Sukhikh, Leonid/I-5274-2013; Karataev, Pavel/O-5440-2015	Sukhikh, Leonid/0000-0002-9406-6021; Karataev, Pavel/0000-0002-1961-3793	Quantum Beam Technology Program of the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT); SASAKAWA foundation [3875]; JSPS KAKENHI [23226020]; program "Advancement of the scientific potential of high education" by Russian Ministry of Education and Science [2.1799.2011]	The work was supported by the Quantum Beam Technology Program of the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and SASAKAWA foundation (Grant no, 3875), JSPS KAKENHI Grant no. 23226020, and program "Advancement of the scientific potential of high education" by Russian Ministry of Education and Science No, 2.1799.2011	Aryshev A, 2010, J PHYS CONF SER, V236, DOI 10.1088/1742-6596/236/1/012009; Aryshev A, 2007, NUCL INSTRUM METH A, V580, P1544, DOI 10.1016/j.nima.2007.07.028; Aryshev A., 2010, P 1 INT PART ACC C K; Dattoli G., 1993, LECT FREE ELECT LASE; Deshpande A, 2009, NUCL INSTRUM METH A, V600, P361, DOI 10.1016/j.nima.2008.11.142; Frohlich L., 2005, THESIS DESY; Fukuda M, 2011, NUCL INSTRUM METH A, V637, pS67, DOI 10.1016/j.nima.2010.02.024; Ginzburg V.L., 1990, TRANSITION RAD TRANS; Gover A., 2006 P FREE EL LAS C, V1; Hirano K, 2006, NUCL INSTRUM METH A, V560, P233, DOI 10.1016/j.nima.2006.01.106; Karataev P, 2005, NUCL INSTRUM METH B, V227, P198, DOI 10.1016/j.nimb.2004.03.014; Karataev P, 2008, PHYS REV SPEC TOP-AC, V11, DOI 10.1103/PhysRevSTAB.11.032804; Karataev PV, 2005, PHYS LETT A, V345, P428, DOI 10.1016/j.physleta.2005.07.027; Lihn HC, 1996, PHYS REV LETT, V76, P4163, DOI 10.1103/PhysRevLett.76.4163; Liu SG, 2008, NUCL INSTRUM METH A, V584, P1, DOI 10.1016/j.nima.2007.09.053; NODVICK JS, 1954, PHYS REV, V96, P180, DOI 10.1103/PhysRev.96.180; Potylitsyn AP, 2000, NUCL INSTRUM METH A, V455, P213, DOI 10.1016/S0168-9002(00)00734-8; Potylitsyn A.P., 2010, DIFFRACTION RAD RELA; Potylitsyn AP, 1999, PHYS REV E, V60, P2272, DOI 10.1103/PhysRevE.60.2272; Sakaue K, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3272789; Sasaki S, 2002, NUCL INSTRUM METH A, V483, P209; Shibata Y, 1997, PHYS REV LETT, V78, P2740, DOI 10.1103/PhysRevLett.78.2740; Shibata Y, 2002, NUCL INSTRUM METH A, V483, P440, DOI 10.1016/S0168-9002(02)00358-3	23	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	NOV 1	2014	763						424	432		10.1016/j.nima.2014.06.056		9	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	AP3ON	WOS:000341986200058		
J	Yoshida, E; Tashima, H; Yamaya, T				Yoshida, Eiji; Tashima, Hideaki; Yamaya, Taiga			Sensitivity booster for DOI-PET scanner by utilizing Compton scattering events between detector blocks	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article						PET; Sensitivity; Compton scatter; Simulation	INTER-CRYSTAL SCATTER; PERFORMANCE EVALUATION; XTAL CUBE; RESOLUTION; SCINTILLATOR; GATE	In a conventional PET scanner, coincidence events are measured with a limited energy window for detection of photoelectric events in order to reject Compton scatter events that occur in a patient, but Compton scatter events caused in detector crystals are also rejected. Scatter events within the patient causes scatter coincidences, but inter crystal scattering (ICS) events have useful information for determining an activity distribution. Some researchers have reported the feasibility of PET scanners based on a Compton camera for tracing ICS into the detector. However, these scanners require expensive semiconductor detectors for high-energy resolution. In the Anger-type block detector, single photons interacting with multiple detectors can be obtained for each interacting position and complete information can be gotten just as for photoelectric events in the single detector. ICS events in the single detector have been used to get coincidence, but single photons interacting with multiple detectors have not been used to get coincidence. In this work, we evaluated effect of sensitivity improvement using Compton kinetics in several types of DOI-PET scanners. The proposed method promises to improve the sensitivity using coincidence events of single photons interacting with multiple detectors, which are identified as the first interaction (R). El estimation accuracy can be improved to determine FI validity from the correlation between Compton scatter angles calculated on the coincidence line-of-response. We simulated an animal PET scanner consisting of 42 detectors. Each detector block consists of three types of scintillator crystals (LSO, GSO and GAGG). After the simulation, coincidence events are added as information for several depth-of-interaction (DOI) resolutions. From the simulation results, we concluded the proposed method promises to improve the sensitivity considerably when effective atomic number of a scintillator is low. Also, we showed that FI estimate accuracy is improved, as DOI resolution is high. (C) 2014 Elsevier B.V. All rights reserved.	[Yoshida, Eiji; Tashima, Hideaki; Yamaya, Taiga] Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, Chiba 2638555, Japan	Yoshida, E (reprint author), Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	rush@nirs.go.jp			Japan Society for the Promotion of Science [24601019]	This work was supported by a Grant-in-Aid for Scientific Research (No. 24601019) from the Japan Society for the Promotion of Science.	Rafecas M, 2003, PHYS MED BIOL, V48, P821, DOI 10.1088/0031-9155/48/7/302; Shao YP, 1996, IEEE T NUCL SCI, V43, P1938; Jan S, 2004, PHYS MED BIOL, V49, P4543, DOI 10.1088/0031-9155/49/19/007; Jan S, 2011, PHYS MED BIOL, V56, P881, DOI 10.1088/0031-9155/56/4/001; Champley KM, 2009, PHYS MED BIOL, V54, P6369, DOI 10.1088/0031-9155/54/20/022; Chinn G., 2008, IEEE NSS MIC 2008, V2008, P5249; Iwanowska J, 2013, NUCL INSTRUM METH A, V712, P34, DOI 10.1016/j.nima.2013.01.064; Kamada K, 2012, IEEE T NUCL SCI, V59, P2112, DOI 10.1109/TNS.2012.2197024; Park SJ, 2007, PHYS MED BIOL, V52, P2807, DOI 10.1088/0031-9155/52/10/012; Park SJ, 2007, IEEE T NUCL SCI, V54, P1543, DOI 10.1109/TNS.2007.902358; Pratx G., 2007, IEEE NSS MIC 2007, V2007, P2660; Tsuda T, 2006, IEEE T NUCL SCI, V53, P35, DOI 10.1109/TNS.2005.862961; Wagadarikar AA, 2014, IEEE T NUCL SCI, V61, P121, DOI 10.1109/TNS.2013.2282119; Yamaya T, 2011, PHYS MED BIOL, V56, P6793, DOI 10.1088/0031-9155/56/21/003; Yoshida E, 2013, IEEE T NUCL SCI, V60, P3172, DOI 10.1109/TNS.2013.2280631; Yoshida E., 2005, IEEE NSS MIC 2005, V2005, P1800	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	NOV 1	2014	763						502	509		10.1016/j.nima.2014.07.002		8	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	AP3ON	WOS:000341986200064		
J	Murayama, I; Nakamura, S				Murayama, Ikuko; Nakamura, Shogo			Time profile of the scintillation from liquid and gaseous xenon	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article						Scintillation; Liquid xenon; Photon counting; Decay constant	ARGON; KRYPTON; LUMINESCENCE; DEPENDENCE; LIFETIMES	The decay time profile of vacuum ultraviolet scintillation induced by electronic recoils has been studied for liquid and gaseous xenon. The scintillation light from xenon excited by a gamma source was measured by using two vacuum ultraviolet sensitive photomultipliers, one for detecting scintillation and the other for counting photons of weak monochromatic light. The analysis results based on the timecorrelated single photon counting method show that the time profile in the 176 rim scintillation decay curve for liquid xenon is consistent with a single exponential component and the decay time constant is 31.5 + 1.3 ns. This constant does not change significantly for pressure ranges between 90 kPa and 130 kPa. There is no emission wavelength dependence of the decay constant. The result corresponds to an average on electronic recoil energies up to 1.3 MeV. (C) 2014 Elsevier B.V. All rights reserved.	[Murayama, Ikuko; Nakamura, Shogo] Yokohama Natl Univ, Fac Engn, Dept Phys, Yokohama, Kanagawa 2408501, Japan	Murayama, I (reprint author), Yokohama Natl Univ, Fac Engn, Dept Phys, Yokohama, Kanagawa 2408501, Japan.	murayama-ikuko-gr@ynu.jp	NAKAMURA, Shogo/M-5177-2014	NAKAMURA, Shogo/0000-0003-2921-7046	JSPS KAKENHI [22540307]	We would like to thank H.Tawara, S. Mihara, K. Saito, K. Kasami and S.Sasaki for their technical support and useful comments during this study. We would also like to thanks to M.Fujita, S.Oyama and K.Fujii for their assistance in data taking. This work was partially supported by JSPS KAKENHI Grant no. 22540307.	HITACHI A, 1983, PHYS REV B, V27, P5279, DOI 10.1103/PhysRevB.27.5279; JORTNER J, 1965, J CHEM PHYS, V42, P4250, DOI 10.1063/1.1695927; KUBOTA S, 1979, PHYS REV B, V20, P3486, DOI 10.1103/PhysRevB.20.3486; Akimov D, 2002, PHYS LETT B, V524, P245, DOI 10.1016/S0370-2693(01)01411-3; SUZUKI M, 1982, NUCL INSTRUM METHODS, V192, P565, DOI 10.1016/0029-554X(82)90874-6; KETO JW, 1979, J CHEM PHYS, V71, P2676, DOI 10.1063/1.438625; Becker W., 2005, ADV TIME CORRELATED; BONIFIELD TD, 1980, J CHEM PHYS, V72, P2914, DOI 10.1063/1.439490; Dawson J.V., 2005, DETECTORS ASS EQUIPM, V545, P690; Fujii K., 2011, P 25 WORKSH RAD DET, P84; KETO JW, 1974, PHYS REV LETT, V33, P1365, DOI 10.1103/PhysRevLett.33.1365; KUBOTA S, 1978, J PHYS C SOLID STATE, V11, P2645, DOI 10.1088/0022-3719/11/12/024; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE; LEICHNER PK, 1976, PHYS REV A, V13, P1787, DOI 10.1103/PhysRevA.13.1787; Lemmon E. W., 2014, NIST CHEM WEBBOOK; Mock J, 2014, J INSTRUM, V9, DOI 10.1088/1748-0221/9/04/T04002; Nakamura S., 2007, P WORKSH ION SCI COU, P27; Saito K., 2007, P 68 AUT M JAP SOC A	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	NOV 1	2014	763						533	537		10.1016/j.nima.2014.07.003		5	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	AP3ON	WOS:000341986200068		
J	Ogawa, T; Sato, T; Hashimoto, S; Niita, K				Ogawa, T.; Sato, T.; Hashimoto, S.; Niita, K.			Development of a reaction ejectile sampling algorithm to recover kinematic correlations from inclusive cross-section data in Monte-Carlo particle transport simulations	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article						Particle transport simulation; Evaluated cross-section data; Inclusive cross-sections; Correlations; Conservation laws		A new phenomenological approach is developed to reproduce the stochastic distributions of secondary particle energy and angle with conservation of momentum and energy in reactions ejecting more than one ejectiles using inclusive cross-section data. The summation of energy and momentum in each reaction is generally not conserved in Monte-Carlo particle transport simulation based on the inclusive cross-sections because the particle correlations are lost in the inclusive cross-section data However, the energy and angular distributions are successfully reproduced by randomly generating numerous sets of secondary particle configurations which are compliant with the conservation laws, and sampling one set considering their likelihood. This developed approach was applied to simulation of (n,xn) reactions (x >= 2) of various targets and to other reactions such as (n,np) and (n,2n alpha). The calculated secondary particle energy and angular distributions were compared with those of the original inclusive cross-section data to validate the algorithm. The calculated distributions reproduce the trend of original cross-section data considerably well especially in case of heavy targets. The developed algorithm is beneficial to improve the accuracy of event-by-event analysis in particle transport simulation. (C) 2014 Elsevier B.V. All rights reserved,	[Ogawa, T.; Sato, T.; Hashimoto, S.] Japan Atom Energy Agcy, Nucl Sci & Engn Ctr, Environm & Radiat Sci Unit, Res Grp Radiat Protect, Tokai, Ibaraki 3191195, Japan; [Niita, K.] Res Org Informat Sci & Technol, Tokai, Ibaraki 3191188, Japan	Ogawa, T (reprint author), Japan Atom Energy Agcy, Nucl Sci & Engn Ctr, Environm & Radiat Sci Unit, Res Grp Radiat Protect, Shirakata Shirane, Tokai, Ibaraki 3191195, Japan.	ogawa.tatsuhiko@jaea.go.jp					Mokhov NV, 2007, AIP CONF PROC, V896, P50, DOI 10.1063/1.2720456; Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Chadwick MB, 1999, NUCL SCI ENG, V131, P293; Watanabe Y, 2011, J KOREAN PHYS SOC, V59, P1040, DOI 10.3938/jkps.59.1040; Shibata K, 2011, J NUCL SCI TECHNOL, V48, P1, DOI 10.3327/jnst.48.1; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; GILBERT A, 1965, CAN J PHYS, V43, P1446; Ferrari A., 2005, CERN200510; Furihata S, 2000, NUCL INSTRUM METH B, V171, P251, DOI 10.1016/S0168-583X(00)00332-3; Goorley T., 1322934 LAUR; KALBACH C, 1981, PHYS REV C, V23, P112, DOI 10.1103/PhysRevC.23.112; Niita K, 2008, INTERNATIONAL CONFERENCE ON NUCLEAR DATA FOR SCIENCE AND TECHNOLOGY, VOL 2, PROCEEDINGS, P1167, DOI 10.1051/ndata:07398	12	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	NOV 1	2014	763						575	590		10.1016/j.nima.2014.06.088		16	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	AP3ON	WOS:000341986200074		
J	Takeuchi, S; Motobayashi, T; Togano, Y; Matsushita, M; Aoi, N; Demichi, K; Hasegawa, H; Murakami, H				Takeuchi, S.; Motobayashi, T.; Togano, Y.; Matsushita, M.; Aoi, N.; Demichi, K.; Hasegawa, H.; Murakami, H.			DALI2: A NaI(Tl) detector array for measurements of gamma rays from fast nuclei	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article						Scintillation detector; In beam gamma-ray spectroscopy; Radioactive beam experiment	EXCITED-STATES; COULOMB-EXCITATION; VALENCE NEUTRONS; TRACKING ARRAY; COLLECTIVITY; SPECTROSCOPY; SPECTROMETER; DEFORMATION; COLLISIONS; BEAMS	A NaI(Tl) detector array called DALI2 (Detector Array for Low Intensity radiation 2) has been constructed for in beam gamma-ray spectroscopy experiments with fast radioactive isotope (RI) beams. It consists typically of 186 NaI(Tl) scintillators covering polar angles from similar to 15 degrees to similar to 160 degrees with an average angular resolution of 6 degrees in full width at half maximum. Its high granularity (good angular resolution) enables Doppler-shift corrections that result in, for example, 10% energy resolution and 20% full energy photopeak efficiency for 1-MeV gamma rays emitted from fast-moving nuclei (velocities of v/c similar or equal to 0.6). DALI2 has been employed successfully in numerous experiments using fast RI beams with velocities of v/c=0.3-0.6 provided by the RIKEN RI Beam Factory. (C) 2014 Elsevier B.V. All rights reserved.	[Takeuchi, S.; Motobayashi, T.; Murakami, H.] RIKEN, Nishina Ctr, Wako, Saitama 3510198, Japan; [Togano, Y.] Tokyo Inst Technol, Dept Phys, Tokyo 1528551, Japan; [Matsushita, M.] Univ Tokyo, CNS, Wako, Saitama 3510198, Japan; [Aoi, N.] Osaka Univ, RCNP, Ibaraki, Osaka 5670047, Japan; [Demichi, K.; Hasegawa, H.] Rikkyo Univ, Dept Phys, Tokyo 1718501, Japan	Takeuchi, S (reprint author), RIKEN, Nishina Ctr, Wako, Saitama 3510198, Japan.	takesato@riken.jp			Research Center for Measurement in Advanced Science (RCMAS) of Rikkyo University, "High-Tech Research Center" Project for Private Universities from MEXT (Ministry of Education, Culture, Sports, Science and Technology); RIKEN Nishina Center for Accelerator-Based Science	The construction of DALI2 was supported financially by Research Center for Measurement in Advanced Science (RCMAS) of Rikkyo University, "High-Tech Research Center" Project for Private Universities, matching fund subsidy from MEXT (Ministry of Education, Culture, Sports, Science and Technology), and RIKEN Nishina Center for Accelerator-Based Science, We thank the RCMAS staff members and collaborators of experiments that were performed with DALI and DALI2. We are grateful to Dr. D. Steppenbeck for proofreading the paper,	Akkoyun S, 2012, NUCL INSTRUM METH A, V668, P26, DOI 10.1016/j.nima.2011.11.081; ANHOLT R, 1986, PHYS REV A, V33, P2270, DOI 10.1103/PhysRevA.33.2270; Iwasaki H, 2005, PHYS LETT B, V620, P118, DOI 10.1016/j.physletb.2005.06.032; Doornenbal P, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.032501; ANHOLT R, 1984, PHYS REV LETT, V53, P234, DOI 10.1103/PhysRevLett.53.234; Li KA, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/10/102301; [Anonymous], 2012, PROGR THEORETICAL EX, V2012; MOTOBAYASHI T, 1995, PHYS LETT B, V346, P9, DOI 10.1016/0370-2693(95)00012-A; Iwasaki H, 2001, PHYS LETT B, V522, P227, DOI 10.1016/S0370-2693(01)01244-8; Suzuki H, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.024326; Takeuchi S, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.054319; Lee IY, 2003, REP PROG PHYS, V66, P1095, DOI 10.1088/0034-4885/66/7/201; Yoneda K, 2001, PHYS LETT B, V499, P233, DOI 10.1016/S0370-2693(01)00025-9; Gibelin J, 2007, PHYS REV C, V75, DOI 10.1103/PhysRevC.75.057306; Takeuchi S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.182501; LEE IY, 1990, NUCL PHYS A, V520, pC641, DOI 10.1016/0375-9474(90)91181-P; Iwasa N, 2008, PHYS REV C, V78, DOI 10.1103/PhysRevC.78.024306; Kondo Y, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.014602; Aoi N, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.012502; Weisshaar D, 2010, NUCL INSTRUM METH A, V624, P615, DOI 10.1016/j.nima.2010.09.148; Togano Y, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.222501; Elekes Z, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.044314; Yanagisawa Y, 2003, PHYS LETT B, V566, P84, DOI 10.1016/S0370-2693(03)00802-5; Mueller WF, 2001, NUCL INSTRUM METH A, V466, P492, DOI 10.1016/S0168-9002(01)00257-1; Ong HJ, 2008, PHYS REV C, V78, DOI 10.1103/PhysRevC.78.014308; Elekes Z, 2005, PHYS LETT B, V614, P174, DOI 10.1016/j.physletb.2005.04.007; Steppenbeck D, 2013, NATURE, V502, P207, DOI 10.1038/nature12522; Suzuki D, 2008, PHYS LETT B, V666, P222, DOI 10.1016/j.physletb.2008.07.055; Baba H, 2010, NUCL INSTRUM METH A, V616, P65, DOI 10.1016/j.nima.2010.02.120; BECK FA, 1992, PROG PART NUCL PHYS, V28, P443, DOI 10.1016/0146-6410(92)90047-6; Dombradi Z, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.182501; Dombradi Z, 2005, PHYS LETT B, V621, P81, DOI 10.1016/j.physletb.2005.06.031; Doornenbal P, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.212502; Doornenbal P, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.041305; Doornenbal P., 2009, RIKEN ACCEL PROG REP, V42, P182; Elekes Z, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.011302; Elekes Z, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.027305; Elekes Z, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.017306; Elekes Z, 2004, PHYS LETT B, V586, P34, DOI 10.1016/j.physletb.2004.02.022; Elekes Z, 2004, PHYS LETT B, V599, P17, DOI 10.1016/j.physletb.2004.08.028; Farnea E, 2010, NUCL INSTRUM METH A, V621, P331, DOI 10.1016/j.nima.2010.04.043; GEANT3, 1993, CERN PROGR LIB LONG; Holzmann R., 1993, GSI ANN REPORT, V1992, P48; Imai N, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.062501; Iwasa N, 2003, PHYS REV C, V67, DOI 10.1103/PhysRevC.67.064315; Iwasaki H, 2008, PHYS REV C, V78, DOI 10.1103/PhysRevC.78.021304; Iwasaki H., 2000, PHYS LETT B, V481; Iwasaki H., 2000, PHYS LETT B, V491; Kanungo R, 2005, PHYS LETT B, V608, P206, DOI 10.1016/j.physletb.2005.01.022; Knoll G. F., 1979, RAD DETECTION MEASUR; Kondo Y, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.044611; Lee IY, 2004, NUCL PHYS A, V746, p255C, DOI 10.1016/j.nuclphysa.2004.09.038; Leo W R, 1994, TECHNIQUES NUCL PART; METAG V, 1983, NUCL PHYS A, V409, pC331; Michimasa S, 2006, PHYS LETT B, V638, P146, DOI 10.1016/j.physletb.2006.05.035; Mizoi Y., 2005, RIKEN ACCEL PROG REP, V38, P297; Nakamura T, 1997, PHYS LETT B, V394, P11, DOI 10.1016/S0370-2693(96)01690-5; Nishio T., 1996, RIKEN ACCEL PROG REP, V29, P184; Ong HJ, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.024610; Raynal J., UNPUB; Ryuto H., 2008, NUCL INSTRUMENTS M A, V590, P204; Shimoura S, 2004, NUCL INSTRUM METH A, V525, P188, DOI 10.1016/j.nima.2004.03.044; Shimoura S, 2003, PHYS LETT B, V560, P31, DOI 10.1016/S0370-2693(03)00341-1; Simpson J., 2000, HEAVY ION PHYS, V11, P159; TAKEUCHI S, 2003, RIKEN ACCEL PROG REP, V36, P148; Uesaka T, 2008, NUCL INSTRUM METH B, V266, P4218, DOI 10.1016/j.nimb.2008.05.095; Warr N, 2013, EUR PHYS J A, V49, DOI 10.1140/epja/i2013-13040-9; WISSHAK K, 1990, NUCL INSTRUM METH A, V292, P595, DOI 10.1016/0168-9002(90)90179-A; Yamada K, 2004, PHYS LETT B, V579, P265, DOI 10.1016/j.physletb.2003.11.024; Yoneda K., 2012, RIKEN ACCELERATOR PR, V45, pi	70	9	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	NOV 1	2014	763						596	603		10.1016/j.nima.2014.06.087		8	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	AP3ON	WOS:000341986200076		
J	Kitayama, S; Natsume, S				Kitayama, Satoshi; Natsume, Shinji			Multi-objective optimization of volume shrinkage and clamping force for plastic injection molding via sequential approximate optimization	SIMULATION MODELLING PRACTICE AND THEORY			English	Article						Plastic injection molding; Multi-objective optimization; Sequential approximate optimization; Radial basis function network	RESPONSE-SURFACE METHODOLOGY; THIN SHELL FEATURE; WARPAGE OPTIMIZATION; NEURAL-NETWORK; MOLDED PART; GENETIC ALGORITHM; MODEL	Process parameters in plastic injection molding (PIM), such as the packing pressure, the mold temperature, the melt temperature, and so on, are generally determined by a trial-and error method through the experiments. Computer-aided engineering (CAE) in the PIM is an alternative approach to determine the optimal process parameters. In cap-type plastic product, large volume shrinkage makes the clamping difficult. Furthermore, small clamping force leads to high productivity as well as cost reduction. Both volume shrinkage and clamping force should then be minimized simultaneously, and a multi-objective design optimization is formulated. Inappropriate process parameters easily lead to short shot that the melt plastic is not fully filled into cavity. In this paper, short shot is handled as the design constraint. Numerical simulation of the PIM is so expensive that the response surface approach is valid. In particular, a sequential approximate optimization (SAO) that the response surface is repeatedly constructed and optimized with some new sampling points is recognized as one of the most powerful tools available. In this paper, the radial basis function (RBF) network is adopted for the SAO, and the pareto-frontier is identified with a small number of simulation runs. Numerical result shows that the pareto-frontier is well identified with a small number of simulation runs. (C) 2014 Elsevier B.V. All rights reserved.	[Kitayama, Satoshi] Kanazawa Univ, Kanazawa, Ishikawa 9201192, Japan; [Natsume, Shinji] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan	Kitayama, S (reprint author), Kanazawa Univ, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	kitayama-s@se.kanazawa-u.ac.jp; n.shinji@stu.kanazawa-u.ac.jp					Gao YH, 2009, J MATER PROCESS TECH, V209, P1302, DOI 10.1016/j.jmatprotec.2008.03.048; Kitayama S, 2011, APPL SOFT COMPUT, V11, P4726, DOI 10.1016/j.asoc.2011.07.011; Chiang KT, 2007, INT J ADV MANUF TECH, V35, P468, DOI 10.1007/s00170-006-0739-4; Sadeghi BHM, 2000, J MATER PROCESS TECH, V103, P411, DOI 10.1016/S0924-0136(00)00498-2; Erzurumlu T, 2006, MATER DESIGN, V27, P853, DOI 10.1016/j.matdes.2005.03.017; Shi HZ, 2010, INT J ADV MANUF TECH, V48, P955, DOI 10.1007/s00170-009-2346-7; Kitayama S, 2011, OPTIM ENG, V12, P535, DOI 10.1007/s11081-010-9118-y; Kurtaran H, 2005, J MATER PROCESS TECH, V169, P314, DOI 10.1016/j.jmatprotec.2005.03.013; Chang RY, 2001, INT J NUMER METH FL, V37, P125, DOI 10.1002/fld.166; Chen WC, 2009, INT J ADV MANUF TECH, V44, P501, DOI 10.1007/s00170-008-1843-4; Cheng J, 2013, INT J ADV MANUF TECH, V66, P907, DOI 10.1007/s00170-012-4376-9; Deng YM, 2010, MATER DESIGN, V31, P2118, DOI 10.1016/j.matdes.2009.10.026; Gao YH, 2008, INT J ADV MANUF TECH, V37, P953, DOI 10.1007/s00170-007-1044-6; Huang MC, 2001, J MATER PROCESS TECH, V110, P1, DOI 10.1016/S0924-0136(00)00649-X; Kurtaran H, 2006, INT J ADV MANUF TECH, V27, P468, DOI 10.1007/s00170-004-2321-2; Li C, 2010, INT J ADV MANUF TECH, V48, P505, DOI 10.1007/s00170-009-2302-6; Miettinen KM, 1998, NONLINEAR MULTIOBJEC; Myers R. H., 1995, RESPONSE SURFACE MET; Oktem H, 2012, INT J ADV MANUF TECH, V61, P519, DOI 10.1007/s00170-011-3750-3; Orr M.J.L., INTRO RADIAL BASIS F; Shi F, 2003, INT J ADV MANUF TECH, V21, P656, DOI 10.1007/s00170-002-1374-3; Shi HZ, 2013, INT J ADV MANUF TECH, V65, P343, DOI 10.1007/s00170-012-4173-5; Yarlagadda PKDV, 2001, J MATER PROCESS TECH, V118, P110; Yin F, 2011, MATER DESIGN, V32, P3457, DOI 10.1016/j.matdes.2011.01.058	24	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1569-190X	1878-1462		SIMUL MODEL PRACT TH	Simul. Model. Pract. Theory	NOV	2014	48						35	44		10.1016/j.simpat.2014.07.004		10	Computer Science, Interdisciplinary Applications; Computer Science, Software Engineering	Computer Science	AQ1MM	WOS:000342545500003		
J	Brus, G; Miyawaki, K; Iwai, H; Saito, M; Yoshida, H				Brus, Grzegorz; Miyawaki, Kosuke; Iwai, Hiroshi; Saito, Motohiro; Yoshida, Hideo			Tortuosity of an SOFC anode estimated from saturation currents and a mass transport model in comparison with a real micro-structure	SOLID STATE IONICS			English	Article						FIB-SEM; Solid oxide fuel cells; Tortuosity; Saturation current; Button cell testing; Microstructure	OXIDE FUEL-CELLS; CURRENT FLOW-RATES; SURFACE-DIFFUSION; SUPPORTED SOFC; GAS; POLARIZATION; PERFORMANCE; ELECTRODES; CHEMISTRY	This work provides discussion on the subject of deriving tortuosity from a saturation current and a mass transport model. In the conducted research an anode-supported solid oxide fuel cell (SOFC) with Nickel/Yttria-Stabilized Zirconia (Ni/YSZ) anode, Yttria-Stabilized Zirconia (YSZ) electrolyte, and Lanthanum Strontium Cobalt Ferrite oxide (LSCF) cathode was tested. Current densities under concentration polarization were measured for different hydrogen partial pressure on the anodic side. Mass transport through a porous anode was analyzed for the H-2-N-2-H2O ternary system. Cell performances were measured at 700 [degrees C] and 800 [degrees C]with air as an oxidant. Obtained saturation current densities were used for the tortuosity calculations. The presented calculation methodology was based on the Stefan-Maxwell equation and Kundsen diffusion. After the power generation experiment, a three dimensional structure was reconstructed using a combination of scanning electron microscope and focus ion beam milling (FIB-SEM). Finally, tortuosity values derived from the transport limitation and structure analysis were juxtaposed. (C) 2014 Elsevier B.V. All rights reserved.	[Brus, Grzegorz; Miyawaki, Kosuke; Iwai, Hiroshi; Saito, Motohiro; Yoshida, Hideo] Kyoto Univ, Dept Aeronaut & Astronaut, Kyoto 6158530, Japan; [Brus, Grzegorz] AGH Univ Sci & Technol, Fac Energy & Fuels, Krakow, Poland	Brus, G (reprint author), Kyoto Univ, Dept Aeronaut & Astronaut, Thermal Engn Lab, Nishikyo Ku, Kyoto 6158530, Japan.	grzegorz.brus.26e@st.kyoto-u.ac.jp			JSPS Postdoctoral Fellowship; PAN-JSPS Joint Research Project; New Energy and Industrial Technology Development Organization (NEDO)	The first author was supported by JSPS Postdoctoral Fellowship for Foreign Researchers. Additionally, the present work was partially supported by the PAN-JSPS Joint Research Project "Thermal Interaction between Stack and Reformer in Small Scale SOFC' and partially by the New Energy and Industrial Technology Development Organization (NEDO).	Virkar AV, 2000, SOLID STATE IONICS, V131, P189, DOI 10.1016/S0167-2738(00)00633-0; Kishimoto M, 2011, J POWER SOURCES, V196, P4555, DOI 10.1016/j.jpowsour.2010.12.100; Williford RE, 2003, J ELECTROCHEM SOC, V150, pA1067, DOI 10.1149/1.1586300; Duda A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036319; Yakabe H, 2000, J POWER SOURCES, V86, P423, DOI 10.1016/S0378-7753(99)00444-9; Xie YY, 2012, SOLID STATE IONICS, V224, P64, DOI 10.1016/j.ssi.2012.07.015; Kishimoto M, 2009, ECS TRANSACTIONS, V25, P1887, DOI 10.1149/1.3205731; Iwai H, 2010, J POWER SOURCES, V195, P955, DOI 10.1016/j.jpowsour.2009.09.005; Cassidy M, 1996, J POWER SOURCES, V61, P189, DOI 10.1016/S0378-7753(96)02359-2; Mukhopadhyay M, 2013, SOLID STATE IONICS, V233, P20, DOI 10.1016/j.ssi.2012.12.005; Matyka M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026306; Kim JW, 1999, J ELECTROCHEM SOC, V146, P69, DOI 10.1149/1.1391566; Zhu HY, 2005, J ELECTROCHEM SOC, V152, pA2427, DOI 10.1149/1.2116607; Cronin JS, 2013, J POWER SOURCES, V233, P174, DOI 10.1016/j.jpowsour.2013.01.060; Bao C., 2009, AICHE J, V56, P1363; Carman P.C., 1956, FLOW GASES POROUS ME; DENG HM, 1995, SOLID STATE IONICS, V80, P213, DOI 10.1016/0167-2738(95)00116-N; Hussain MM, 2007, INT J THERM SCI, V46, P48, DOI 10.1016/j.ijthermalsci.2006.04.004; Jiang Y, 2003, J ELECTROCHEM SOC, V150, pA942, DOI 10.1149/1.1579480; Kishimoto M., 2013, 3 DIMENSIONAL MICROS; Kulikovsky AA, 2009, ELECTROCHIM ACTA, V54, P6686, DOI 10.1016/j.electacta.2009.06.054; Milewski J, 2011, GREEN ENERGY TECHNOL, P1, DOI 10.1007/978-0-85729-262-9; Poling BE, 2001, PROPERTIES GASES LIQ; Schmidt H.V., 2008, ECS T, V6, P11; Schmidt VH, 2008, J POWER SOURCES, V180, P253, DOI 10.1016/j.jpowsour.2008.01.073; Shi JX, 2011, J FUEL CELL SCI TECH, V8, DOI 10.1115/1.4004642; Shi JX, 2011, J ELECTROCHEM SOC, V158, pB143, DOI 10.1149/1.3517476; Shi YX, 2007, J POWER SOURCES, V164, P639, DOI 10.1016/j.jpowsour.2006.10.091; Tsai CL, 2011, J POWER SOURCES, V196, P692, DOI 10.1016/j.jpowsour.2010.08.005; Williford RE, 2003, SURF SCI, V547, P421, DOI 10.1016/j.susc.2003.10.026; Zhu HY, 2006, J ELECTROCHEM SOC, V153, pA1765, DOI 10.1149/1.2220065	31	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2738	1872-7689		SOLID STATE IONICS	Solid State Ion.	NOV 1	2014	265						13	21		10.1016/j.ssi.2014.07.002		9	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	AQ1NK	WOS:000342547900003		
J	Watanabe, K				Watanabe, Kazumi			Reflection of an impulsive torsional wave by a moving boundary	WAVE MOTION			English	Article						Moving boundary; Torsional wave; Reflection; Closed form solution	SCATTERING; EDGE	Reflection of an impulsive torsional wave by a uniformly moving surface/boundary is discussed. Applying the Cagniard-de Hoop technique, the solution for the reflected wave is obtained in the closed form and a new wave that runs along the moving boundary has been found. Its wave front singularity is stronger than those of the incident and the regular reflected waves. This new wave has the cylindrical surface, but the shape of the disturbed region is a torus with a triangular-like cross section. (C) 2014 Elsevier B.V. All rights reserved.		Watanabe, K (reprint author), Sakuragaoka 1-4, Shimonoseki, Yamaguchi 7500083, Japan.	kazy@yz.yamagata-u.ac.jp					Watanabe K, 2005, INT J ENG SCI, V43, P1283, DOI 10.1016/j.ijengsci.2005.05.005; Brunel C., 1998, ULTARSONICS, V36, P391; CENSOR D, 1973, J FRANKLIN I, V295, P103, DOI 10.1016/0016-0032(73)90222-6; CENSOR D, 1969, RADIO SCI, V4, P1079, DOI 10.1029/RS004i011p01079; CENSOR D, 1972, J SOUND VIB, V25, P101, DOI 10.1016/0022-460X(72)90599-8; De Hoop A.T., 1960, Applied Scientific Research, Section B (Electrophysics, Acoustics, Optics, Mathematical Methods), V8; Gakenheimer D. C., 1971, Transactions of the ASME. Series E, Journal of Applied Mechanics, V38; HUANG YX, 1994, J APPL PHYS, V76, P2575, DOI 10.1063/1.357552; Kimura H., 2005, T JSME C, V71, P1871; Lee S.-Y., 2002, Transactions of the ASME. Journal of Applied Mechanics, V69, DOI 10.1115/1.1427337; Moriguchi S., 1987, MATH FORMULAS, VIII; Norwood F.R., 1969, T ASME E, V36, P516; Sneddon I, 1951, FOURIER TRANSFORMS; Watanabe K, 2010, Q J MECH APPL MATH, V63, P335, DOI 10.1093/qjmam/hbq006; Watanabe K, 2012, ACTA MECH, V223, P1823, DOI 10.1007/s00707-012-0631-2; Watanabe K, 2010, INT J ENG SCI, V48, P1995, DOI 10.1016/j.ijengsci.2010.05.002; Watanabe K., 2014, ZAMM Z ANGE IN PRESS; Watanabe K., 2014, INTEGRAL TRANSFORM T; Watson G.N., 1966, TREATISE THEORY BESS, P20; Wunenburger R, 2004, J ACOUST SOC AM, V115, P507, DOI 10.1121/1.1635414; Zutter D., 1981, IEEE T ANTENN PROPAG, VAP-30, P898	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-2125	1878-433X		WAVE MOTION	Wave Motion	NOV	2014	51	7					1209	1224		10.1016/j.wavemoti.2014.07.004		16	Acoustics; Mechanics; Physics, Multidisciplinary	Acoustics; Mechanics; Physics	AQ1MJ	WOS:000342545200014		
J	Imataki, O; Arai, T; Yamaoka, G; Matsuoka, A; Uemura, M				Imataki, Osamu; Arai, Takeshi; Yamaoka, Genji; Matsuoka, Akihito; Uemura, Makiko			NKT cell-infiltrating aseptic meningitis on the central nervous system in Philadelphia chromosome-positive acute lymphoblastic leukemia treated with dasatinib	ANNALS OF HEMATOLOGY			English	Letter							THERAPY		[Imataki, Osamu; Matsuoka, Akihito; Uemura, Makiko] Kagawa Univ, Div Hematol, Dept Internal Med, Fac Med, Miki, Kagawa 7610793, Japan; [Arai, Takeshi; Yamaoka, Genji] Kagawa Univ Hosp, Dept Lab Med, Takamatsu, Kagawa, Japan	Imataki, O (reprint author), Kagawa Univ, Div Hematol, Dept Internal Med, Fac Med, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	oima@med.kagawa-u.ac.jp					[Anonymous], CANC RES; Kreutzman A, 2010, BLOOD, V116, P772, DOI 10.1182/blood-2009-12-256800; O'Hare T, 2005, CANCER RES, V65, P4500, DOI 10.1158/0008-5472.CAN-05-0259; Porkka K, 2008, BLOOD, V112, P1005, DOI 10.1182/blood-2008-02-140665; Mustjoki S, 2009, LEUKEMIA, V23, P1398, DOI 10.1038/leu.2009.46	5	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-5555	1432-0584		ANN HEMATOL	Ann. Hematol.	NOV	2014	93	11					1935	1936		10.1007/s00277-014-2074-4		2	Hematology	Hematology	AQ0SA	WOS:000342491800018		
J	Yoshida, T; Mihara, K; Arihiro, K; Mino, T; Asaoku, H; Ichinohe, T				Yoshida, Tetsumi; Mihara, Keichiro; Arihiro, Koji; Mino, Tatsuji; Asaoku, Hideki; Ichinohe, Tatsuo			Concurrent administration of darbepoetin alfa, cyclosporine A, and prednisolone is useful for T cell large granular lymphocyte leukemia associated with myelodysplastic syndrome complicated by Coombs-negative hemolytic anemia	ANNALS OF HEMATOLOGY			English	Letter									[Yoshida, Tetsumi; Mihara, Keichiro; Mino, Tatsuji; Ichinohe, Tatsuo] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Hematol & Oncol, Minami Ku, Hiroshima 7348553, Japan; [Arihiro, Koji] Hiroshima Univ, Dept Pathol, Hiroshima 7348553, Japan; [Asaoku, Hideki] Hiroshima Red Cross Hosp, Dept Clin Lab, Hiroshima, Japan; [Asaoku, Hideki] Atom Bomb Survivors Hosp, Hiroshima, Japan	Mihara, K (reprint author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Hematol & Oncol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	kmmihara@hiroshima-u.ac.jp					Saunthararajah Y, 2001, BRIT J HAEMATOL, V112, P195, DOI 10.1046/j.1365-2141.2001.02561.x; Huh YO, 2009, AM J CLIN PATHOL, V131, P347, DOI 10.1309/AJCP6YHI1JEXAWAP; Rose MG, 2004, ONCOLOGIST, V9, P247, DOI 10.1634/theoncologist.9-3-247; DHODAPKAR MV, 1994, BLOOD, V84, P1620; PLATANIAS L, 1987, EUR J HAEMATOL, V38, P89	5	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-5555	1432-0584		ANN HEMATOL	Ann. Hematol.	NOV	2014	93	11					1937	1939		10.1007/s00277-014-2075-3		3	Hematology	Hematology	AQ0SA	WOS:000342491800019		
J	Li, X; Oka, Y				Li, Xin; Oka, Yoshiaki			Numerical simulation of the SURC-2 and SURC-4 MCCI experiments by MPS method	ANNALS OF NUCLEAR ENERGY			English	Article						MCCI; MPS method; Basaltic concrete ablation	PARTICLE SEMIIMPLICIT METHOD; BEHAVIOR; STRATIFICATION; TUBE	The molten corium-concrete interaction (MCCI) phenomenon was analyzed based on the Moving Particle Semi-implicit (MPS) method. The developed code was applied to one-dimensional SURC-2 and SURC-4 experiments, in which a mixture composed of UO2-ZrO2-Zr and Steel-Zr was used as the melt materials. The phase transition of the melt and the concrete was modeled based on a phase transition model for mixture. The effect of Zr oxidation on the concrete ablation was taken into consideration by introducing the reaction heat of Zr/SiO2 obtained from the condensed phase chemical equations into the melt pool. The calculated concrete ablation rate was compared with the experimental measurements and the simulation results of the CORCON code. The simulation results by MPS agreed well with the experimental measurements. The experimental and MPS results both indicated that for both experiments Zr oxidation could significantly increase the ablation rate. On the other hand, crust formation and remelting was observed to occur on the interface between the melt and the concrete in the MPS simulation. During the period before crust remelted, the concrete ablation rate calculated by MPS decreased significantly. It was indicated by the MPS results that the crust formation could play an important part in MCCI since it could slow down the concrete ablation rate by preventing the melt from interacting with the concrete. Although the experiments did not clarify this observation, the proof for this phenomenon could be deduced from the decreased concrete ablation rate during the same period of interaction presented by the experimental results. (C) 2014 Elsevier Ltd. All rights reserved.	[Li, Xin; Oka, Yoshiaki] Waseda Univ, Fac Sci & Engn, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan	Li, X (reprint author), Waseda Univ, Fac Sci & Engn, Grad Sch Adv Sci & Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	lixin@fuji.waseda.jp			China Scholarship Council	The MPS code of the present study was developed based on the original code, MPS-SW-Main-Ver2.0 that was kindly provided by S. Koshizuka and K. Shibata (Koshizuka and Shibata, 2006). The financial help from China Scholarship Council through offering scholarship to the first author is gratefully acknowledged.	Chen RH, 2010, NUCL ENG DES, V240, P3830, DOI 10.1016/j.nucengdes.2010.08.008; Koshizuka S, 1998, INT J NUMER METH FL, V26, P751, DOI 10.1002/(SICI)1097-0363(19980415)26:7<751::AID-FLD671>3.0.CO;2-C; Li X, 2013, NUCL ENG DES, V256, P227, DOI 10.1016/j.nucengdes.2012.12.018; Tian WX, 2010, ANN NUCL ENERGY, V37, P5, DOI 10.1016/j.anucene.2009.10.011; Chen RH, 2011, CHEM ENG SCI, V66, P5055, DOI 10.1016/j.ces.2011.06.058; Kawahara T, 2012, J NUCL SCI TECHNOL, V49, P1156, DOI 10.1080/00223131.2012.740944; Koshizuka S, 1996, NUCL SCI ENG, V123, P421; Blose R.E., 1987, NUREGCR4727; Chen RH, 2014, ANN NUCL ENERGY, V71, P322, DOI 10.1016/j.anucene.2014.04.008; Chen RH, 2014, NUCL ENG DES, V273, P440, DOI 10.1016/j.nucengdes.2014.03.049; Copus E.R., 1989, NUREGCR4994 SAND NAT; Copus E.R., 1992, NUREGCR5564 SAND NAT; Cranga M., 2010, MCCI OXIDE METAL POO; Cranga M, 2010, PROG NUCL ENERG, V52, P76, DOI 10.1016/j.pnucene.2009.09.016; Cranga M., 2007, MCCI OECD SEM CAD ST; Farmer M.T., 2001, P 9 INT C NUCL ENG A; Foit J.J., 1995, WECHSL MOD3 CODE COM; Foit JJ, 1997, NUCL ENG DES, V170, P73, DOI 10.1016/S0029-5493(97)00013-7; Koshizuka S, 2006, MPS SW MAIN VER2 0; Li G, 2013, NUCL ENG DES, V265, P210, DOI 10.1016/j.nucengdes.2013.09.006; Li G, 2014, NUCL ENG DES, V272, P109, DOI 10.1016/j.nucengdes.2014.02.023; Matsuura T., 2013, P 3 INT C PART BAS M; Nie M., 2002, P 10 INT C NUCL ENG; Shibata K, 2012, OCEAN ENG, V42, P13, DOI 10.1016/j.oceaneng.2012.01.016; Spencer B.R., 1992, P 2 OECD NEA CSNI SP; Strizhov V., 1996, NUREGIA0129 OFF NUCL; Thompson D.H., 1992, 2 OECD NEA CSNI SPEC	27	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4549			ANN NUCL ENERGY	Ann. Nucl. Energy	NOV	2014	73						46	52		10.1016/j.anucene.2014.06.011		7	Nuclear Science & Technology	Nuclear Science & Technology	AP7HM	WOS:000342248400006		
J	Shimazu, Y				Shimazu, Yoichiro			A simple procedure to estimate reactivity with good noise filtering characteristics	ANNALS OF NUCLEAR ENERGY			English	Article						Reactivity estimation; Inverse Point Kinetic equation; Noise filtering; Subcriticality; Reactivity monitoring	CRITICALITY APPROACH; METER	A new and simple on-line reactivity estimation method is proposed. The estimator has robust noise filtering characteristics without the use of complex filters. The noise filtering capability is equivalent to or better than that of a conventional estimator based on Inverse Point Kinetics (IPK). The new estimator can also eliminate the burden of selecting optimum filter time constants, such as would be required for the IPK-based estimator, or noise covariance matrices, which are needed if the extended Kalman filter (EKF) technique is used. In this paper, the new estimation method is introduced and its performance assessed without and with measurement noise. (C)2014 Elsevier Ltd. All rights reserved.	Univ Fukui, Res Inst Nucl Engn, Tsuruga, Fukui 9140055, Japan	Shimazu, Y (reprint author), Univ Fukui, Res Inst Nucl Engn, 1-2-4 Kanawa, Tsuruga, Fukui 9140055, Japan.	shimazu@u-fukui.ac.jp					Bhatt TU, 2013, ANN NUCL ENERGY, V60, P98, DOI 10.1016/j.anucene.2013.04.028; Chao YA, 2000, NUCL TECHNOL, V132, P403; Glasstone S, 1970, NUCL REACTOR THEORY; Naing W, 2005, J NUCL SCI TECHNOL, V42, P145, DOI 10.3327/jnst.42.145; Shimazu Y, 2006, J NUCL SCI TECHNOL, V43, P1414, DOI 10.3327/jnst.43.1414; Shimazu Y, 2005, J NUCL SCI TECHNOL, V42, P515, DOI 10.3327/jnst.42.515; SHIMAZU Y, 1987, NUCL TECHNOL, V77, P247; Shimazu Y, 2003, J NUCL SCI TECHNOL, V40, P970, DOI 10.3327/jnst.40.970; Shimazu Y, 2014, ANN NUCL ENERGY, V66, P161, DOI 10.1016/j.anucene.2013.12.004	9	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4549			ANN NUCL ENERGY	Ann. Nucl. Energy	NOV	2014	73						392	397		10.1016/j.anucene.2014.07.005		6	Nuclear Science & Technology	Nuclear Science & Technology	AP7HM	WOS:000342248400039		
J	Borodin, A; Corwin, I; Sasamoto, T				Borodin, Alexei; Corwin, Ivan; Sasamoto, Tomohiro			FROM DUALITY TO DETERMINANTS FOR q-TASEP AND ASEP	ANNALS OF PROBABILITY			English	Article						Interacting particle systems; Kardar-Parisi-Zhang universality class; Markov duality; asymmetric simple exclusion process	ASYMMETRIC EXCLUSION PROCESSES; DIRECTED POLYMERS; FREE-ENERGY; INITIAL CONDITION; FLUCTUATIONS; DIFFUSION; FORMULAS; EQUATION; DRIVEN	We prove duality relations for two interacting particle systems: the q-deformed totally asymmetric simple exclusion process (q-TASEP) and the asymmetric simple exclusion process (ASEP). Expectations of the duality functionals correspond to certain joint moments of particle locations or integrated currents, respectively. Duality implies that they solve systems of ODEs. These systems are integrable and for particular step and half-stationary initial data we use a nested contour integral ansatz to provide explicit formulas for the systems' solutions, and hence also the moments. We form Laplace transform-like generating functions of these moments and via residue calculus we compute two different types of Fredholm determinant formulas for such generating functions. For ASEP, the first type of formula is new and readily lends itself to asymptotic analysis (as necessary to reprove GUE Tracy-Widom distribution fluctuations for ASEP), while the second type of formula is recognizable as closely related to Tracy and Widom's ASEP formula [Comm. Math. Phys. 279 (2008) 815-844, J. Stat. Phys. 132 (2008) 291-300, Comm. Math. Phys. 290 (2009) 129-154, J. Stat. Phys. 140 (2010) 619-634]. For q-TASEP, both formulas coincide with those computed via Borodin and Corwin's Macdonald processes [Probab. Theory Related Fields (2014) 158 225-400]. Both q-TASEP and ASEP have limit transitions to the free energy of the continuum directed polymer, the logarithm of the solution of the stochastic heat equation or the Hopf-Cole solution to the Kardar-Parisi-Zhang equation. Thus, q-TASEP and ASEP are integrable discretizations of these continuum objects; the systems of ODEs associated to their dualities are deformed discrete quantum delta Bose gases; and the procedure through which we pass from expectations of their duality functionals to characterizing generating functions is a rigorous version of the replica trick in physics.	[Borodin, Alexei; Corwin, Ivan] MIT, Dept Math, Cambridge, MA 02139 USA; [Borodin, Alexei] Inst Informat Transmiss Problems, Moscow 127994, Russia; [Corwin, Ivan] Columbia Univ, Dept Math, New York, NY 10027 USA; [Corwin, Ivan] Clay Math Inst, Providence, RI 02903 USA; [Sasamoto, Tomohiro] Chiba Univ, Dept Math, Inage Ku, Chiba 2638522, Japan	Borodin, A (reprint author), MIT, Dept Math, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	borodin@math.mit.edu; ivan.corwin@gmail.com; sasamoto@math.s.chiba-u.ac.jp			NSF [DMS-10-56390]; NSF PIRE [OISE-07-30136, DMS-12-08998]; Schramm Memorial Fellowship; Clay Mathematics Institute; KAKENHI [22740054]	Supported in part by NSF Grant DMS-10-56390.; Supported in part by NSF PIRE Grant OISE-07-30136 and DMS-12-08998 as well as by Microsoft Research through the Schramm Memorial Fellowship, and by the Clay Mathematics Institute.; Supported by KAKENHI (22740054).	ANDREWS G. E., 1999, SPECIAL FUNCTIONS; Sasamoto T, 2010, J STAT PHYS, V140, P209, DOI 10.1007/s10955-010-9990-z; Bornemann F, 2010, MATH COMPUT, V79, P871, DOI 10.1090/S0025-5718-09-02280-7; Borodin A, 2014, COMMUN PUR APPL MATH, V67, P1129, DOI 10.1002/cpa.21520; Tracy CA, 2009, COMMUN MATH PHYS, V290, P129, DOI 10.1007/s00220-009-0761-0; Amir G, 2011, COMMUN PUR APPL MATH, V64, P466, DOI 10.1002/cpa.20347; SANDOW S, 1994, EUROPHYS LETT, V26, P7, DOI 10.1209/0295-5075/26/1/002; Tracy CA, 2008, J STAT PHYS, V132, P291, DOI 10.1007/s10955-008-9562-7; SPITZER F, 1970, ADV MATH, V5, P246, DOI 10.1016/0001-8708(70)90034-4; O'Connell N, 2012, ANN PROBAB, V40, P437, DOI 10.1214/10-AOP632; Johansson K, 2000, COMMUN MATH PHYS, V209, P437, DOI 10.1007/s002200050027; Imamura T, 2011, J STAT PHYS, V142, P919, DOI 10.1007/s10955-011-0149-3; Imamura T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.190603; Bertini L, 1997, COMMUN MATH PHYS, V183, P571, DOI 10.1007/s002200050044; Sasamoto T, 1998, J PHYS A-MATH GEN, V31, P6057, DOI 10.1088/0305-4470/31/28/019; O'Connell N, 2001, STOCH PROC APPL, V96, P285, DOI 10.1016/S0304-4149(01)00119-3; Schutz GM, 1997, J STAT PHYS, V86, P1265, DOI 10.1007/BF02183623; Balazs M, 2012, ANN I H POINCARE-PR, V48, P151, DOI 10.1214/11-AIHP415; BANGEREZAKO G., 2007, PREPRINT; Bogoliubov NM, 1998, NUCL PHYS B, V516, P501, DOI 10.1016/S0550-3213(98)00038-8; Borodin A, 2015, INT MATH RES NOTICES, P499, DOI 10.1093/imrn/rnt206; BORODIN A., 2014, PROBAB SURV, V11, P1, DOI DOI 10.1214/13-PS225; Borodin A, 2014, PROBAB THEORY REL, V158, P225, DOI 10.1007/s00440-013-0482-3; Calabrese P, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/20002; Coddington E. A., 1955, THEORY ORDINARY DIFF; Corwin I., 2012, RANDOM MATRICES THEO, V1, P1; Dotsenko V, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/20003; GARTNER J, 1988, STOCH PROC APPL, V27, P233; Hahn W., 1949, MATH NACHR, V2, P340, DOI 10.1002/mana.19490020604; Hobson T, 2005, ELECTRON COMMUN PROB, V10, P136; Kac V., 2002, QUANTUM CALCULUS; LAX PD, 2002, FUNCTIONAL ANAL, P92228; LIGGETT T. M., 2005, INTERACTING PARTICLE; MACDONALD I. G., 1995, SYMMETRIC FUNCTIONS; MacDonald J., 1968, BIOPOLYMERS, V6, P1; Moreno Flores G., UNPUB; Povolotsky AM, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061109; Spohn H., 1991, LARGE SCALE DYNAMICS; Spohn H, 2012, IAMP NEWS B; Tracy CA, 2008, COMMUN MATH PHYS, V279, P815, DOI 10.1007/s00220-008-0443-3; Tracy CA, 2010, J STAT PHYS, V140, P619, DOI 10.1007/s10955-010-0013-x	41	12	12	INST MATHEMATICAL STATISTICS	CLEVELAND	3163 SOMERSET DR, CLEVELAND, OH 44122 USA	0091-1798			ANN PROBAB	Ann. Probab.	NOV	2014	42	6					2314	2382		10.1214/13-AOP868		69	Statistics & Probability	Mathematics	AP9KS	WOS:000342399300003		
J	Watanabe, H; Li, DL; Nakagawa, Y; Tomishige, K; Kaya, K; Watanabe, MM				Watanabe, Hideo; Li, Dalin; Nakagawa, Yoshinao; Tomishige, Keiichi; Kaya, Kunimitsu; Watanabe, Makoto M.			Characterization of oil-extracted residue biomass of Botryococcus braunii as a biofuel feedstock and its pyrolytic behavior	APPLIED ENERGY			English	Article						Botryococcus braunii; Algal biomass; Oil-extracted residue; Biofuel; Thermogravimetric analysis; Pyrolysis	HYDROCARBON PRODUCTION; THERMOCHEMICAL LIQUEFACTION; ENERGY-PRODUCTION; STRAIN BOT-22; MICROALGAE; GASIFICATION; CATALYSTS; SYSTEM; PRODUCTS; GROWTH	Botryococcus braunii (B. braunii), a green colonial microalga, is one of the most potentially significant renewable energy sources, because of its high productivity of hydrocarbon oils. In order to maximize energy utilization from this alga, it should be important to recover energy from not only the extracted oil but also the biomass residue after oil-extraction. In this work, oil-extracted residue biomass of an identified strain of B. braunii (BOT-22) with different original hydrocarbon content (HC%: from 28 to 51 wt%) has been characterized as a biofuel feedstock in terms of the elemental composition as well as the pyrolytic behavior by thermogravimetric (TG) analysis and steam pyrolysis test. This paper has revealed that the B. braunii with higher HC%, even biomass residue after oil-extraction, is superior in quality of a biofuel feedstock because of higher content of C, H and volatile matter and lower content of N, O, S, P, ash and fixed carbon as compared to that with lower HC% and other algal biomass. Steam pyrolysis of the oil-extracted residue biomass of the B. braunii at 873-973 K can produce highly carbonized char (similar to 10%-C), gases of C1-C4 (similar to 30%-C) and H-2, and tar (similar to 60%-C) including mainly heavy component such as polycyclic aromatic hydrocarbons. From the analysis of the pyrolyzed products and its higher heating values from 29 to 36 MJ/kg, the residue biomass of B. braunii can be classified as a hydrogen-rich solid fuel comparable to fossil fuel such as a coal rather than other algal and terrestrial biomass. In summary, not only hydrocarbon oils produced from the B. braunii but also its oil-extracted residue biomass should be a superior feedstock for biofuel production. (C) 2014 Elsevier Ltd. All rights reserved.	[Watanabe, Hideo] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan; [Li, Dalin; Nakagawa, Yoshinao; Tomishige, Keiichi] Tohoku Univ, Sch Engn, Dept Appl Chem, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Kaya, Kunimitsu; Watanabe, Makoto M.] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Watanabe, H (reprint author), Univ Tsukuba, Project Res Bldg 4F Rm 401,1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	h.watanabe@ims.tsukuba.ac.jp			Special Fund for the Next Generation Energy Development Project, MEXT, Japan	This study was supported by the Special Fund for the Next Generation Energy Development Project, MEXT, Japan. The authors are grateful to the Chemical Analysis Center, University of Tsukuba, for conducting CHN elemental analysis. Elemental analysis was carried out with EDX-820HS in Shimadzu Corporation.	Tomishige K, 2004, CATAL TODAY, V89, P389, DOI 10.1016/j.cattod.2004.01.002; DERENNE S, 1994, GEOCHIM COSMOCHIM AC, V58, P3703, DOI 10.1016/0016-7037(94)90160-0; Chen CX, 2011, APPL ENERG, V88, P3189, DOI 10.1016/j.apenergy.2011.03.003; Sydney EB, 2011, APPL ENERG, V88, P3291, DOI 10.1016/j.apenergy.2010.11.024; Li DL, 2011, APPL CATAL B-ENVIRON, V102, P528, DOI 10.1016/j.apcatb.2010.12.035; Coll R, 2001, FUEL PROCESS TECHNOL, V74, P19, DOI 10.1016/S0378-3820(01)00214-4; Minkova V, 2001, FUEL PROCESS TECHNOL, V70, P53, DOI 10.1016/S0378-3820(00)00153-3; Bird MI, 2011, BIORESOURCE TECHNOL, V102, P1886, DOI 10.1016/j.biortech.2010.07.106; Singh A, 2011, APPL ENERG, V88, P3548, DOI 10.1016/j.apenergy.2010.12.012; Powell N, 2008, ENVIRON SCI TECHNOL, V42, P5958, DOI 10.1021/es703118s; Hirano A, 1998, CATAL TODAY, V45, P399, DOI 10.1016/S0920-5861(98)00275-2; Heilmann SM, 2011, APPL ENERG, V88, P3286, DOI 10.1016/j.apenergy.2010.12.041; Yonezawa N, 2012, BIORESOURCE TECHNOL, V109, P304, DOI 10.1016/j.biortech.2011.07.090; Yan J, 2009, APPL ENERG, V86, pS1, DOI 10.1016/j.apenergy.2009.07.004; Kanda H, 2013, FUEL, V105, P535, DOI 10.1016/j.fuel.2012.08.032; Liu YQ, 2012, IND ENG CHEM RES, V51, P10320, DOI 10.1021/ie202799e; Maddi B, 2011, BIORESOURCE TECHNOL, V102, P11018, DOI 10.1016/j.biortech.2011.09.055; Rizzo AM, 2013, APPL ENERG, V102, P24, DOI 10.1016/j.apenergy.2012.08.039; Minowa T, 1999, FUEL, V78, P1213, DOI 10.1016/S0016-2361(99)00047-2; Liu CZ, 2013, APPL ENERG, V102, P971, DOI 10.1016/j.apenergy.2012.08.016; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; MINOWA T, 1995, FUEL, V74, P1735, DOI 10.1016/0016-2361(95)80001-X; Banerjee A, 2002, CRIT REV BIOTECHNOL, V22, P245, DOI 10.1080/07388550290789513; DOTE Y, 1994, FUEL, V73, P1855, DOI 10.1016/0016-2361(94)90211-9; Biller P, 2011, BIORESOURCE TECHNOL, V102, P4841, DOI 10.1016/j.biortech.2010.12.113; Ross AB, 2010, FUEL, V89, P2234, DOI 10.1016/j.fuel.2010.01.025; Ioki M, 2012, BIORESOURCE TECHNOL, V109, P292, DOI 10.1016/j.biortech.2011.08.104; Frigon JC, 2013, APPL ENERG, V108, P100, DOI 10.1016/j.apenergy.2013.02.051; Phukan MM, 2011, APPL ENERG, V88, P3307, DOI 10.1016/j.apenergy.2010.11.026; HILLEN LW, 1982, BIOTECHNOL BIOENG, V24, P193, DOI 10.1002/bit.260240116; Metzger P, 2005, APPL MICROBIOL BIOT, V66, P486, DOI 10.1007/s00253-004-1779-z; Rawat I, 2011, APPL ENERG, V88, P3411, DOI 10.1016/j.apenergy.2010.11.025; Chisti Y, 2011, APPL ENERG, V88, P3277, DOI 10.1016/j.apenergy.2011.04.038; KADOURI A, 1988, PHYTOCHEMISTRY, V27, P551, DOI 10.1016/0031-9422(88)83140-6; Valdez PJ, 2012, BIOMASS BIOENERG, V46, P317, DOI 10.1016/j.biombioe.2012.08.009; Asadullah M, 2004, APPL CATAL A-GEN, V267, P95, DOI 10.1016/j.apcata.2004.02.028; Demirbas A, 2009, ENERG SOURCE PART A, V31, P746, DOI 10.1080/15567030701752594; Demirbas A, 2010, ENERG SOURCE PART A, V32, P172, DOI 10.1080/15567030802464388; Demirbas FM, 2011, APPL ENERG, V88, P3473; Fisher CH, COMPOSITION COAL TAR; Haynes W.M., 2013, CRC HDB CHEM PHYS, P5; Hodaifa G, 2013, APPL ENERG, V104, P345, DOI 10.1016/j.apenergy.2012.11.005; INOUE S, 1994, BIOMASS BIOENERG, V6, P269, DOI 10.1016/0961-9534(94)90066-3; Ioki M, 2012, BIORESOURCE TECHNOL, V109, P271, DOI 10.1016/j.biortech.2011.11.078; Ishimatsu A, 2012, PROCEDIA ENVIRON SCI, V15, P56, DOI 10.1016/j.proenv.2012.05.010; Jane U, 2012, APPL ENERG, V98, P368; Kimura T, 2006, APPL CATAL B-ENVIRON, V68, P160, DOI 10.1016/j.apcatb.2006.08.007; Kita K, 2010, APPL ENERG, V87, P2420, DOI 10.1016/j.apenergy.2009.11.036; Kitazato H, 1989, J JAPAN PETROLEUM I, V32, P28; Lewin R. A., 1962, PHYSL BIOCH ALGAE, P211; McKendry P, 2002, BIORESOURCE TECHNOL, V83, P37, DOI 10.1016/S0960-8524(01)00118-3; MIYACHI S, 1961, PLANT CELL PHYSIOL, V2, P405; Miyazawa T, 2005, J JPN PETROL INST, V48, P161; Moheimani RN, 2014, J APPL PHYCOL, V26, P1453; Nagano S, 2012, PROCEDIA ENVIRON SCI, V15, P73, DOI 10.1016/j.proenv.2012.05.012; Rawat I, 2013, APPL ENERG, V88, P444; Sakamoto K, 2012, BIORESOURCE TECHNOL, V110, P474, DOI 10.1016/j.biortech.2012.01.091; Schiff J. A., 1962, PHYSL BIOCH ALGAE, P239; Shiho M, 2012, PROCEDIA ENVIRON SCI, V15, P90, DOI 10.1016/j.proenv.2012.05.014; Shimamura R, 2012, PROCEDIA ENVIRON SCI, V15, P80, DOI 10.1016/j.proenv.2012.05.013; Soares B, 2008, BIORESOURCE TECHNOL, V110, P730; Tanoi T, 2011, J APPL PHYCOL, V23, P25, DOI 10.1007/s10811-010-9528-4; Thangalazhy-Gopakumar S, 2012, BIORESOURCE TECHNOL, V118, P150, DOI 10.1016/j.biortech.2012.05.080; Tomishige K, 2005, APPL CATAL B-ENVIRON, V60, P299, DOI 10.1016/j.apcatb.2005.04.003; Tomishige K, 2005, CATAL COMMUN, V6, P37, DOI 10.1016/j.catcom.2004.10.007; Van Krevelen D.W., 1993, COAL	66	6	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0306-2619	1872-9118		APPL ENERG	Appl. Energy	NOV 1	2014	132						475	484		10.1016/j.apenergy.2014.07.037		10	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	AP7HC	WOS:000342247400045		
J	Kikuchi, Y; Kimura, S; Okamoto, Y; Koyama, M				Kikuchi, Yasunori; Kimura, Seiichiro; Okamoto, Yoshitaka; Koyama, Michihisa			A scenario analysis of future energy systems based on an energy flow model represented as functionals of technology options	APPLIED ENERGY			English	Article						Feasible technology; Technology roadmapping; Greenhouse gas emission; Electricity daily load curve; New generation vehicles; Centralized or distributed power generation	EMISSIONS; SECURITY; SECTOR; JAPAN	The design of energy systems has become an issue all over the world. A single optimal system cannot be suggested because the availability of infrastructure and resources and the acceptability of the system should be discussed locally, involving all related stakeholders in the energy system. In particular, researchers and engineers of technologies related to energy systems should be able to perform the forecasting and roadmapping of future energy systems and indicate quantitative results of scenario analyses. We report an energy flow model developed for analysing scenarios of future Japanese energy systems implementing a variety of feasible technology options. The model was modularized and represented as functionals of appropriate technology options, which enables the aggregation and disaggregation of energy systems by defining functionals for single technologies, packages integrating multi-technologies, and mini-systems such as regions implementing industrial symbiosis. Based on the model, the combinations of technologies on both energy supply and demand sides can be addressed considering not only the societal scenarios such as resource prices, economic growth and population change but also the technical scenarios including the development and penetration of energy-related technologies such as distributed solid oxide fuel cells in residential sectors and new-generation vehicles, and the replacement and shift of current technologies such as heat pumps for air conditioning and centralized power generation. The developed model consists of two main modules; namely, a power generation dispatching module for the Japanese electricity grid and a demand-side energy flow module based on a sectorial energy balance table. Both modules are divided and implemented as submodules represented as functionals of supply- and demand-side technology options. Using the developed model, three case studies were performed. Required data were collected through workshops involving researchers and engineers in the energy technology field in Japan. The functionals of technologies were defined on the basis of the availability of data and understanding of the current and future energy systems. Through case studies, it was demonstrated that the potential of energy technologies can be analysed by the developed model considering the mutual relationships of technologies. The contribution of technologies to, e.g., the reduction in greenhouse gas emissions should be carefully examined by quantitative analyses of interdependencies of the technology options. (c) 2014 Elsevier Ltd. All rights reserved.	[Kikuchi, Yasunori] Univ Tokyo, Ito Int Res Ctr, Presidential Endowed Chair Platinum Soc, Bunkyo Ku, Tokyo 1130033, Japan; [Kikuchi, Yasunori; Kimura, Seiichiro; Koyama, Michihisa] Kyushu Univ, Int Inst Carbon Neutral Energy Res, Nishi Ku, Fukuoka 8190395, Japan; [Okamoto, Yoshitaka; Koyama, Michihisa] Kyushu Univ, Dept Hydrogen Energy Syst, Nishi Ku, Fukuoka 8190395, Japan; [Koyama, Michihisa] Kyushu Univ, Inamori Frontier Res Ctr, Nishi Ku, Fukuoka 8190395, Japan	Kikuchi, Y (reprint author), Univ Tokyo, Ito Int Res Ctr, Presidential Endowed Chair Platinum Soc, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kikuchi@platinum.u-tokyo.ac.jp					Agency for Natural Resources and Energy (ANRE), 2012, TABL FY2010 COMPR EN; Agency for Natural Resources and Energy (ANRE) METI, 2014, EST PEAK EL DEM STRU; Tonini D, 2012, APPL ENERG, V99, P234, DOI 10.1016/j.apenergy.2012.03.006; Wetterlund E, 2010, APPL ENERG, V87, P2914, DOI 10.1016/j.apenergy.2009.11.032; Gracceva F, 2014, APPL ENERG, V123, P335, DOI 10.1016/j.apenergy.2013.12.018; Klatt KU, 2009, COMPUT CHEM ENG, V33, P536, DOI 10.1016/j.compchemeng.2008.09.002; Kannan R, 2009, APPL ENERG, V86, P416, DOI 10.1016/j.apenergy.2008.08.005; Bouffard F, 2008, ENERG POLICY, V36, P4504, DOI 10.1016/j.enpol.2008.09.060; McDowall W, 2006, ENERG POLICY, V34, P1236, DOI 10.1016/j.enpol.2005.12.006; Lee DH, 2013, APPL ENERG, V103, P306, DOI 10.1016/j.apenergy.2012.09.046; Kajikawa Y, 2008, TECHNOL FORECAST SOC, V75, P771, DOI 10.1016/j.techfore.2007.05.005; Yamagata Y, 2013, APPL ENERG, V112, P1466, DOI 10.1016/j.apenergy.2013.01.061; Takeshita T, 2009, APPL ENERG, V86, pS222, DOI 10.1016/j.apenergy.2009.04.023; Ichinohe M, 2006, APPL ENERG, V83, P1047, DOI 10.1016/j.apenergy.2005.08.002; Heyne S, 2013, APPL ENERG, V101, P203, DOI 10.1016/j.apenergy.2012.03.034; Kiriyama E, 2014, APPL ENERG, V123, P415, DOI 10.1016/j.apenergy.2014.01.026; Chen IC, 2012, INT J LIFE CYCLE ASS, V17, P270, DOI 10.1007/s11367-011-0359-6; Chen IC, 2012, INT J LIFE CYCLE ASS, V17, P119, DOI 10.1007/s11367-011-0356-9; Chertow M, 2011, J IND ECOL, V16, P13; Chua KJ, 2012, APPL ENERG, V87, P3611; Chubu Electric Power Company (Chubu-EPCO), 2013, REC POW DEM; Chugoku Electric Power Company (Chugoku-EPCO), 2013, REC POW DEM; COMMEND (Community for Energy Environment and Development), 2012, INTR LEAP; Cost Verification Committee (CVC), 2011, REP COST VER COMM; CRDS (Center for Research and Development Strategy Japan Science and Technology Agency), 2011, CRDSFY2011WR112011 J; Fukushima Y, 2011, J CHEM ENG JPN, V44, P365, DOI 10.1252/jcej.11we094; Fukushima Y, 2004, J POWER SOURCES, V131, P327, DOI 10.1016/j.jpowsour.2003.11.093; Gebremedhin A, 2012, APPL ENERG, V95, P300, DOI 10.1016/j.apenergy.2012.02.067; Greenhouse Gas Inventory Office of Japan, 2013, GHGS EM DAT JAP; Hokkaido Electric Power Company (HEPCO), 2013, REC POW DEM; Hokuriku Electric Power Company (Hokuriku-EPCO), 2013, REC POW DEM; Ichimoto K, 2010, HITACHI REV, V92, P762; IEA, 2012, 2012 KEY WORLD EN ST; Ikeboh Y, 2012, JOURNAL OF THE INSTI, V132, P539; IPSS (National Institute of Population and Social Security Research Japan), 2012, POP PROJ JAP; Japan Automobile Dealers Association, 2013, STAT VEH SAL; Japan Center for Climate Change Actions, 2007, FACT SHEET HOM EL AP; JARI (Japan Automatic Research Institute), 2014, RES HYDR STAT; JARI (Japan Automatic Research Institute), 2011, REP AN OV EFF GHG EM; Kajikawa Y, 2013, STRATEGIC PLANNING D, P231; Kannan R, 2011, APPL ENERG, V88, P2261, DOI 10.1016/j.apenergy.2010.12.066; Kansai Electric Power Company (KEPCO), 2013, REC POW DEM; Kato Y, 2012, JISSO KANO NA GIJUTU; Kato Y., 2010, ENERGY 20 FUTURES BU; Kikuchi Y, 2014, INT J LIFE CYCLE ASS, V19, P307, DOI 10.1007/s11367-013-0625-x; Kimura S, 2013, THESIS KYUSHU U, P92; Koo J, 2011, APPL ENERG, V8, P2254; Koyama M, 2004, INT J ENERG RES, V28, P13, DOI 10.1002/er.948; Koyama M, 2014, J CHEM ENG JPN; Kyushu Electric Power Company (Kyushu-EPCO), 2013, REC POW DEM; Loulou R., 2004, DOCUMENTATION MARKAL; McLellan B, 2012, ENERGY, V3, P153; Ministry of Economy Trade and Industry (METI) Japan, 2010, STRAT TECHN ROADM 20; Ministry of Finance Japan (MOFJ), 2013, TRAD STAT JAP; Marquardt W, 2010, RWTHEDITION, P1, DOI 10.1007/978-3-642-04655-1; Nishimura K, 2001, APPL ENERG, V69, P307, DOI 10.1016/S0306-2619(01)00010-1; Shikoku Electric Power Company (Shikoku-EPCO), 2013, REC POW DEM; The Federation of Electric Power Companies of Japan (FEPC), 2014, EL DEM REC; Thermal and Nuclear Power Engineering Society, 2008, HDB THERM NUCL POW P; Tohoku Electric Power Company (Tohoku-EPCO), 2013, REC POW DEM; Tokyo Electric Power Company (TEPCO), 2013, REC POW DEM; Ueno T, 2012, R11017 CRIEPI	62	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0306-2619	1872-9118		APPL ENERG	Appl. Energy	NOV 1	2014	132						586	601		10.1016/j.apenergy.2014.07.005		16	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	AP7HC	WOS:000342247400056		
J	Furuki, T; Sakurai, M				Furuki, Takao; Sakurai, Minoru			Group 3 LEA protein model peptides protect liposomes during desiccation	BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES			English	Article						Group 3 LEA protein model peptide; Intrinsically disordered; Liposome; Desiccation; Molecular shield	INTRINSICALLY DISORDERED PROTEINS; TRANSFORM INFRARED-SPECTROSCOPY; EMBRYOGENESIS ABUNDANT PROTEIN; NATIVELY UNFOLDED PROTEINS; DEHYDRATION TOLERANCE; UNSTRUCTURED PROTEINS; MOLECULAR RESPONSES; STRESS TOLERANCE; PLANT-RESPONSES; WATER-DEFICIT	We investigated whether a model peptide for group 3 LEA (G3LEA) proteins we developed in previous studies can protect liposomes from desiccation damage. Four different peptides were compared: 1) PvLEA-22, which consists of two tandem repeats of the 11-mer motif characteristic of LEA proteins from the African sleeping chironomid; 2) a peptide with amino acid composition identical to that of PvLEA-22, but with its sequence scrambled; 3) poly-L-glutamic acid; and 4) poly-L-lysine. Peptides 1) and 2) protected liposomes composed of 1-palmitoyl 2-oleoyl-sn-glycero-3-phosphatidylcholine (POPC) against fusion caused by desiccation, as revealed by particle size distribution measurements with dynamic light scattering. Indeed, liposomes maintain their pre-stress size distribution when these peptides are added at a peptide/POPC molar ratio of more than 0.5. Interestingly, peptide 1) achieved the comparable or higher retention of a fluorescent probe inside liposomes than did several native LEA proteins published previously. In contrast, the other peptides exhibited less protective effects. These results demonstrate that the synthetic peptide derived from the G3LEA protein sequence can suppress desiccation-induced liposome fusion. Fourier transform infrared (FT-IR) spectroscopic measurements were performed for the dried mixture of each peptide and liposome. Based on results for the gel-to-liquid crystalline phase transition temperature of the liposome and the secondary structure of the peptide backbone, we discuss possible underlying mechanisms for the protection effect of the synthetic peptide on dried liposomes. (C) 2014 Elsevier B.V. All rights reserved.	[Furuki, Takao; Sakurai, Minoru] Tokyo Inst Technol, Ctr Biol Resources & Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Sakurai, M (reprint author), Tokyo Inst Technol, Ctr Biol Resources & Informat, Midori Ku, 4259-B-62,Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	msakurai@bio.titech.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24370065]	This work was supported by Grants-in-Aid for Scientific Research on Priority Areas (no. 24370065) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Seki M, 2003, CURR OPIN BIOTECH, V14, P194, DOI 10.1016/S0958-1669(03)00030-2; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Wise MJ, 2004, TRENDS PLANT SCI, V9, P13, DOI 10.1016/j.tplants.2003.10.012; Eliezer D, 2009, CURR OPIN STRUC BIOL, V19, P23, DOI 10.1016/j.sbi.2008.12.004; Hatanaka R, 2013, INSECT BIOCHEM MOLEC, V43, P1055, DOI 10.1016/j.ibmb.2013.08.004; Chakrabortee S, 2007, P NATL ACAD SCI USA, V104, P18073, DOI 10.1073/pnas.0706964104; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Goyal K, 2005, FEBS LETT, V579, P4093, DOI 10.1016/j.febslet.2005.06.036; Chakrabortee S, 2012, MOL BIOSYST, V8, P210, DOI 10.1039/c1mb05263b; Goyal K, 2003, J BIOL CHEM, V278, P12977, DOI 10.1074/jbc.M212007200; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Browne JA, 2004, EUKARYOT CELL, V3, P966, DOI 10.1128/EC.3.4.966-975.2004; Chen JH, 2012, ARCH BIOCHEM BIOPHYS, V524, P123, DOI 10.1016/j.abb.2012.04.024; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; Tolleter D, 2010, BBA-BIOMEMBRANES, V1798, P1926, DOI 10.1016/j.bbamem.2010.06.029; Hand SC, 2007, J EXP ZOOL PART A, V307A, P62, DOI 10.1002/jez.a.343; Wolkers WF, 1998, BBA-GEN SUBJECTS, V1425, P127, DOI 10.1016/S0304-4165(98)00059-2; Tunnacliffe A, 2005, HYDROBIOLOGIA, V546, P315, DOI 10.1007/s10750-005-4239-6; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a; Hincha DK, 2004, BIOCHEM J, V383, P277, DOI 10.1042/BJ20040746; Pelton JT, 2000, ANAL BIOCHEM, V277, P167, DOI 10.1006/abio.1999.4320; BRAY EA, 1993, PLANT PHYSIOL, V103, P1035; Wolkers WF, 2001, BBA-PROTEIN STRUCT M, V1544, P196, DOI 10.1016/S0167-4838(00)00220-X; Shimizu T, 2010, BIOCHEMISTRY-US, V49, P1093, DOI 10.1021/bi901745f; Kikawada T, 2006, BIOCHEM BIOPH RES CO, V348, P56, DOI 10.1016/j.bbrc.2006.07.003; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Goormaghtigh E, 1994, Subcell Biochem, V23, P405; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Hincha DK, 2012, BIOCHEM SOC T, V40, P1000, DOI 10.1042/BST20120109; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Bardwell JCA, 2012, TRENDS BIOCHEM SCI, V37, P517, DOI 10.1016/j.tibs.2012.08.006; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Shih MD, 2012, PLANT SCI, V196, P152, DOI 10.1016/j.plantsci.2012.07.012; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Oldenhof H, 2005, BIOTECHNOL PROGR, V21, P885, DOI 10.1021/bp049559j; Bahrndorff S, 2009, J INSECT PHYSIOL, V55, P210, DOI 10.1016/j.jinsphys.2008.11.010; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Gal TZ, 2004, FEBS LETT, V577, P21, DOI 10.1016/j.febslet.2004.09.049; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; GRZELCZAK ZF, 1982, CAN J BIOCHEM CELL B, V60, P389; Cacela C, 2006, BBA-BIOMEMBRANES, V1758, P680, DOI 10.1016/j.bbamem.2006.04.005; Cuming AC, 1999, SEED PROTEINS, P753; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; Forster F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-469; Furuki T, 2012, BBA-PROTEINS PROTEOM, V1824, P891, DOI 10.1016/j.bbapap.2012.04.013; Furuki T, 2011, BIOCHEMISTRY-US, V50, P7093, DOI 10.1021/bi200719s; Gal TZ, 2003, J PARASITOL, V89, P761, DOI 10.1645/GE-3105; Hand C.S., 2011, ANNU REV PHYSIOL, V73, P115; Hong-Bo Shao, 2005, Colloids Surf B Biointerfaces, V45, P131, DOI 10.1016/j.colsurfb.2005.07.017; NISHIWAKI T, 1990, CHEM LETT, P1841, DOI 10.1246/cl.1990.1841; Oktem H.A., 2006, FLORICULTURE ORNAMEN, V3, P194; Popava A.V., 2011, BIOCHIM BIOPHYS ACTA, V1808, P1879; Pouchkina-Stantcheva NN, 2007, SCIENCE, V318, P268, DOI 10.1126/science.1144363; Shih MD, 2008, ADV BOT RES, V48, P211, DOI 10.1016/S0065-2296(08)00404-7; Shokraie E., 2010, PLOS ONE, V5, P1; Watanabe T., 2012, CRYOBIOL CRYOTECH, V58, P165	64	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2736	0006-3002		BBA-BIOMEMBRANES	Biochim. Biophys. Acta-Biomembr.	NOV	2014	1838	11					2757	2766		10.1016/j.bbamem.2014.07.009		10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AQ0MM	WOS:000342477400002		
J	Ito, S; Ikuta, K; Kato, D; Shibusa, K; Niizeki, N; Tanaka, H; Addo, L; Toki, Y; Hatayama, M; Inamura, J; Shindo, M; Sasaki, K; Iizuka, N; Fujiya, M; Torimoto, Y; Kohgo, Y				Ito, Satoshi; Ikuta, Katsuya; Kato, Daisuke; Shibusa, Kotoe; Niizeki, Noriyasu; Tanaka, Hiroki; Addo, Lynda; Toki, Yasumichi; Hatayama, Mayumi; Inamura, Junki; Shindo, Motohiro; Sasaki, Katsunori; Iizuka, Naomi; Fujiya, Mikihiro; Torimoto, Yoshihiro; Kohgo, Yutaka			Non-transferrin-bound iron assay system utilizing a conventional automated analyzer	CLINICA CHIMICA ACTA			English	Article						Iron overload; Iron toxicity; Non-transferrin-bound iron; Quantification; Automated analyzer; Nitroso-PSAP	PERFORMANCE LIQUID-CHROMATOGRAPHY; LABILE PLASMA IRON; BETA-THALASSEMIA; CHELATION-THERAPY; OXIDATIVE STRESS; SERUM; HEMOCHROMATOSIS; QUANTIFICATION; OVERLOAD; METABOLISM	Background: Iron is an essential metal in the body, but its excessive accumulation causes damage in various organs through free radical production. Iron homeostasis is therefore tightly regulated. However, when iron balance collapses, such as in prolonged transfusion, transferrin (Tf) is fully saturated and non-Tf-bound iron (NTBI) appears in the serum. Monitoring serum NTBI levels is therefore crucial in the assessment of the clinical status of patients with iron overload, since NTBI is associated with cellular and organ damage. Several methods for NTBI determination have been reported, but these are extremely complicated and very few laboratories can quantify NTBI at present. Methods: We established a novel assay system utilizing automated analyzers that are widely used in clinical laboratories for diagnostic testing. In this assay, NTBI is chelated by nitrilotriacetic acid (NTA), after which the iron is reduced and transferred to nitroso-PSAP, a chromogen. Results: The assay shows excellent linearity, reproducibility, and compatibility with HPLC, one of the most reliable conventional methods for NTBI quantification. Conclusions: Our novel method for NTBI measurement is high-throughput and may be a useful and powerful tool in the study of the physiological and clinical importance of NTBI. (C) 2014 Elsevier B.V. All rights reserved.	[Ito, Satoshi; Ikuta, Katsuya; Shibusa, Kotoe; Addo, Lynda; Toki, Yasumichi; Hatayama, Mayumi; Inamura, Junki; Shindo, Motohiro; Fujiya, Mikihiro; Kohgo, Yutaka] Asahikawa Med Univ, Div Gastroenterol & Hematol Oncol, Dept Med, Asahikawa, Hokkaido 0788510, Japan; [Kato, Daisuke; Iizuka, Naomi] Shino Test Corp, Dept Res & Dev, Sagamihara, Kanagawa, Japan; [Niizeki, Noriyasu] Asahikawa Med Univ, Dept Lab Med, Asahikawa, Hokkaido 0788510, Japan; [Niizeki, Noriyasu] Asahikawa Med Univ, Ctr Blood, Asahikawa, Hokkaido 0788510, Japan; [Tanaka, Hiroki; Sasaki, Katsunori] Asahikawa Med Univ, Dept Gastrointestinal Immunol & Regenerat Med, Asahikawa, Hokkaido 0788510, Japan; [Torimoto, Yoshihiro] Asahikawa Med Univ Hosp, Ctr Oncol, Asahikawa, Hokkaido, Japan	Ikuta, K (reprint author), Asahikawa Med Univ, Div Gastroenterol & Hematol Oncol, Dept Med, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	ikuta@asahikawa-med.ac.jp					Garrick MD, 2009, BBA-GEN SUBJECTS, V1790, P309, DOI 10.1016/j.bbagen.2009.03.018; SINGH S, 1990, ANAL BIOCHEM, V186, P320, DOI 10.1016/0003-2697(90)90088-Q; Esposito BP, 2003, BLOOD, V102, P2670, DOI 10.1182/blood-2003-03-0807; HERSHKO C, 1978, BRIT J HAEMATOL, V40, P255, DOI 10.1111/j.1365-2141.1978.tb03662.x; Walter PB, 2006, BRIT J HAEMATOL, V135, P254, DOI 10.1111/j.1365-2141.2006.06277.x; von Bonsdorff L, 2002, CLIN CHEM, V48, P307; Kohgo Y, 2008, INT J HEMATOL, V88, P7, DOI 10.1007/s12185-008-0120-5; Hunt JR, 2004, AM J CLIN NUTR, V80, P924; Hider RC, 2002, EUR J CLIN INVEST, V32, P50, DOI 10.1046/j.1365-2362.2002.0320s1050.x; Livrea MA, 1996, BLOOD, V88, P3608; Cabantchik ZI, 2005, BEST PRACT RES CL HA, V18, P277, DOI 10.1016/j.beha.2004.10.003; Lee DH, 2006, DIABETES CARE, V29, P1090, DOI 10.2337/DC05-2471; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Kolb AM, 2009, ANAL BIOCHEM, V385, P13, DOI 10.1016/j.ab.2008.11.003; Breuer W, 2000, TRANSFUS SCI, V23, P185, DOI 10.1016/S0955-3886(00)00087-4; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; GUTTERIDGE JMC, 1981, BIOCHEM J, V199, P263; Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; Breuer W, 2001, BLOOD, V97, P792, DOI 10.1182/blood.V97.3.792; Breuer W, 2000, BLOOD, V95, P2975; Breuer W, 2001, ANAL BIOCHEM, V299, P194, DOI 10.1006/abio.2001.5378; Brissot P, 2012, BBA-GEN SUBJECTS, V1820, P403, DOI 10.1016/j.bbagen.2011.07.014; Durken M, 1997, FREE RADICAL BIO MED, V22, P1159, DOI 10.1016/S0891-5849(96)00497-2; FARGION S, 1981, SCAND J HAEMATOL, V26, P161; Gosriwatana I, 1999, ANAL BIOCHEM, V273, P212, DOI 10.1006/abio.1999.4216; Goto T, 2013, INT J HEMATOL, V97, P125, DOI 10.1007/s12185-012-1252-1; GROOTVELD M, 1989, J BIOL CHEM, V264, P4417; Gutterridge KM, 1994, THORAX, V49, P707; Hershko C, 2010, ANN NY ACAD SCI, V1202, P1, DOI 10.1111/j.1749-6632.2010.05544.x; Hershko C, 2007, FOOD NUTR BULL, V28, pS500; Hilton RJ, 2012, J INORG BIOCHEM, V110, P1, DOI 10.1016/j.jinorgbio.2012.02.017; Le Lan C, 2005, BLOOD, V105, P4527, DOI 10.1182/blood2004-09-3468; Loreal O, 2000, J HEPATOL, V32, P727, DOI 10.1016/S0168-8278(00)80240-8; Meo A, 2006, HEMOGLOBIN, V30, P131, DOI 10.1080/03630260500455615; Mumby S, 1998, BBA-GEN SUBJECTS, V1380, P102, DOI 10.1016/S0304-4165(97)00124-4; Sasaki K, 2011, MOL MED REP, V4, P913, DOI 10.3892/mmr.2011.518; Xu XL, 2008, J FLUORESC, V18, P193, DOI 10.1007/s10895-007-0263-4	37	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	NOV 1	2014	437						129	135		10.1016/j.cca.2014.07.013		7	Medical Laboratory Technology	Medical Laboratory Technology	AP7GX	WOS:000342246900023		
J	Nishimukai, M; Maeba, R; Ikuta, A; Asakawa, N; Kamiya, K; Yamada, S; Yokota, T; Sakakibara, M; Tsutsui, H; Sakurai, T; Takahashi, Y; Hui, SP; Chiba, H; Okazaki, T; Hara, H				Nishimukai, Megumi; Maeba, Ryouta; Ikuta, Akiko; Asakawa, Naoya; Kamiya, Kiwamu; Yamada, Shiro; Yokota, Takashi; Sakakibara, Mamoru; Tsutsui, Hiroyuki; Sakurai, Toshihiro; Takahashi, Yuji; Hui, Shu-Ping; Chiba, Hitoshi; Okazaki, Tomoki; Hara, Hiroshi			Serum choline plasmalogens-those with oleic acid in sn-2-are biomarkers for coronary artery disease	CLINICA CHIMICA ACTA			English	Article						Plasmalogen; Choline plasmalogen; Ether glycerophospholipid; Coronary artery disease; LC/MS/MS; Significant coronary stenosis	ETHANOLAMINE PLASMALOGENS; ADIPONECTIN LEVELS; CARDIOVASCULAR-DISEASE; LIQUID-CHROMATOGRAPHY; DENSITY-LIPOPROTEIN; VINYL ETHER; HYDROLYSIS; OXIDATION; TARGET; MEN	Background: Identifying risk factors is crucial for preventing cardiovascular events, but there are no widely accepted predictive biomarkers. In our previous study of Japanese asymptomatic cohorts, we performed global analysis of serum ether glycerophospholipids (Egp) molecular profiles, and found that choline plasmalogens (PlsCho; 1-O-alk-1'-enyl-2-acyl-sn-glycero-3-phosphocholine), particularly those containing oleic acid (18:1) in the sn-2 position, were strongly associated with a wide range of risk factors for metabolic syndrome/atherosclerosis. Methods: We determined serum concentrations of Egp molecular species of coronary artery disease patients (n = 50; 31 males and 19 females) by LC/MS/MS, and plasmalogen (Pls; 1-O-alk-1'-enyl-2-acyl-sn-glycerophospholipids) contents in lipoprotein fractions by HPLC using radioactive iodine. Results: We found that the serum concentrations of ether choline glycerophospholipids (EgpCho), particularly PlsCho, were not only significantly lower in males with significant coronary stenosis but also associated with atherosclerosis-related parameters, and their association was stronger than either high-density lipoprotein cholesterol or adiponectin. In addition, serum PlsCho containing 18:1 or linoleic acid (18:2) in sn-2 showed the highest correlations with a wide range of atherogenic parameters among PlsCho molecular species. Conclusion: These results verify our previous findings that serum PlsCho, particularly those containing 18:1 in sn-2, may serve as reliable biomarkers for atherosclerosis. (C) 2014 Elsevier B.V. All rights reserved.	[Nishimukai, Megumi; Hara, Hiroshi] Hokkaido Univ, Res Fac Agr, Div Appl Biosci, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Ikuta, Akiko; Sakurai, Toshihiro; Takahashi, Yuji; Hui, Shu-Ping; Chiba, Hitoshi] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido 0600812, Japan; [Asakawa, Naoya; Kamiya, Kiwamu; Yamada, Shiro; Yokota, Takashi; Sakakibara, Mamoru; Tsutsui, Hiroyuki] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Nishimukai, Megumi] Iwate Univ, Dept Anim Sci, Fac Agr, Morioka, Iwate 0208550, Japan	Maeba, R (reprint author), Teikyo Univ, Sch Med, Dept Biochem, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	maeba@med.teikyo-u.ac.jp			Knowledge Cluster Initiative (2nd stage, Sapporo Biocluster Bio-S) of the Ministry of Education, Science, Sports and Culture of Japan	This study was supported by the Knowledge Cluster Initiative (2nd stage, Sapporo Biocluster Bio-S) of the Ministry of Education, Science, Sports and Culture of Japan.	Demopoulos CA, 2003, EUR J LIPID SCI TECH, V105, P705, DOI 10.1002/ejlt.200300845; Zoeller RA, 1999, BIOCHEM J, V338, P769, DOI 10.1042/0264-6021:3380769; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Wallner S, 2011, CHEM PHYS LIPIDS, V164, P573, DOI 10.1016/j.chemphyslip.2011.06.008; Hahnel D, 1999, ARTERIOSCL THROM VAS, V19, P2431; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Thukkani AK, 2003, CIRCULATION, V108, P3128, DOI 10.1161/01.CIR.0000104564.01539.6A; Mitchell TW, 2007, EXP GERONTOL, V42, P1053, DOI 10.1016/j.exger.2007.09.004; Nishimukai M, 2011, EUR J NUTR, V50, P427, DOI 10.1007/s00394-010-0149-0; Beckett CS, 2007, THROMB RES, V120, P259, DOI 10.1016/j.thromres.2006.09.005; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Maeba R, 2012, ANN CLIN BIOCHEM, V49, P86, DOI 10.1258/acb.2011.011069; Messner MC, 2006, CHEM PHYS LIPIDS, V144, P34, DOI 10.1016/j.chemphyslip.2006.06.003; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Maeba R, 2004, ANAL BIOCHEM, V331, P169, DOI 10.1016/j.ab.2004.05.030; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Hui SP, 2011, ANAL BIOANAL CHEM, V400, P1923, DOI 10.1007/s00216-011-4921-7; Norris C, 2009, LIPIDS, V44, P1047, DOI 10.1007/s11745-009-3357-8; Gerszten RE, 2008, NATURE, V451, P949, DOI 10.1038/nature06802; Albert CJ, 2001, J BIOL CHEM, V276, P23733, DOI 10.1074/jbc.M101447200; Maeba R, 2003, J LIPID RES, V44, P164, DOI 10.1194/jlr.M200340-JLR200; Nishimukai M, 2014, J LIPID RES, V55, P956, DOI 10.1194/jlr.P045591; CHEN X, 1995, BIOCHEMISTRY-US, V34, P7356, DOI 10.1021/bi00022a008; Ford DA, 1996, FEBS LETT, V394, P99, DOI 10.1016/0014-5793(96)00930-1; Heilbronn LK, 2013, OBESITY, V21, pE649, DOI 10.1002/oby.20508; Kishida K, 2014, BEST PRACT RES CL EN, V28, P119, DOI 10.1016/j.beem.2013.08.006; Marsche G, 2004, ARTERIOSCL THROM VAS, V24, P2302, DOI 10.1161/01.ATV.0000148703.43429.25; McHowat J, 1998, AM J PHYSIOL-CELL PH, V274, pC1727; Meyer MC, 2007, AM J PHYSIOL-CELL PH, V292, pC251, DOI 10.1152/ajpcell.00120.2006; Patel JV, 2008, J INTERN MED, V264, P593, DOI 10.1111/j.1365-2796.2008.02007.x; Pepe MS, 2000, BIOSTATISTICS, V1, P123, DOI DOI 10.1093/BI0STATISTICS/1.2.123; Pietilainen KH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000623; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; SCHUEP W, 1994, METHOD ENZYMOL, V234, P294; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; Thukkani AK, 2003, J BIOL CHEM, V278, P36365, DOI 10.1074/jbc.M305449200; Thukkani AK, 2002, J BIOL CHEM, V277, P3842, DOI 10.1074/jbc.M109489200; Van de Voorde Johan, 2013, Metabolism, V62, P1513, DOI 10.1016/j.metabol.2013.06.004; von Eynatten M, 2006, J AM COLL CARDIOL, V47, P2124, DOI 10.1016/j.jacc.2006.02.033; Wang WY, 2014, ARTERIOSCL THROM VAS, V34, P526, DOI 10.1161/ATVBAHA.113.302544; Wilson PWF, 2004, CIRCULATION, V110, pE568, DOI 10.1161/01.CIR.0000149077.87074.DE	43	5	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	NOV 1	2014	437						147	154		10.1016/j.cca.2014.07.024		8	Medical Laboratory Technology	Medical Laboratory Technology	AP7GX	WOS:000342246900026		
J	Kotani, K; Abe, T; Sato, J; Yamada, T				Kotani, Kazuhiko; Abe, Toshiaki; Sato, Junji; Yamada, Toshiyuki			Consideration of the factors that can influence a new point-of-care testing system for measuring white blood cell and C-reactive protein levels in blood	CLINICA CHIMICA ACTA			English	Letter									[Kotani, Kazuhiko; Yamada, Toshiyuki] Jichi Med Univ, Dept Clin Lab Med, Shimotsuke, Tochigi 3290498, Japan; [Abe, Toshiaki; Sato, Junji] Eiken Chem Co Ltd, Shimotsuga, Tochigi 3290114, Japan	Kotani, K (reprint author), Jichi Med Univ, Dept Clin Lab Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	kazukotani@jichi.ac.jp					Kotani K, 2014, CLIN CHIM ACTA, V433, P145, DOI 10.1016/j.cca.2014.03.004; Syal K, 2014, CLIN CHIM ACTA, V437, P218, DOI 10.1016/j.cca.2014.05.023	2	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	NOV 1	2014	437						219	219		10.1016/j.cca.2014.05.025		1	Medical Laboratory Technology	Medical Laboratory Technology	AP7GX	WOS:000342246900038		
J	Kawada, T				Kawada, Tomoyuki			Estimated glomerular filtration rate by two equations and their relationship with metabolic syndrome	CLINICA CHIMICA ACTA			English	Letter							RISK		Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					Otsuka T, 2014, AM J HYPERTENS, V27, P596, DOI 10.1093/ajh/hpt164; Madero M, 2011, CURR OPIN NEPHROL HY, V20, P622, DOI 10.1097/MNH.0b013e32834ba210; Earley A, 2012, ANN INTERN MED, V156, P785, DOI [10.7326/0003-4819-156-6-201203200-00391, 10.7326/0003-4819-156-11-201203200-00391]; Okada R, 2012, NEPHROL DIAL TRANSPL, V27, P1821, DOI 10.1093/ndt/gfr651; Cirillo M, 2008, ARCH INTERN MED, V168, P617, DOI 10.1001/archinte.168.6.617; Hong N, 2014, CLIN CHIM ACTA, V429, P157, DOI 10.1016/j.cca.2013.12.008; Ohsawa M, 2013, INT J CARDIOL, V170, P167, DOI 10.1016/j.ijcard.2013.10.076	7	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	NOV 1	2014	437						220	221		10.1016/j.cca.2014.04.017		2	Medical Laboratory Technology	Medical Laboratory Technology	AP7GX	WOS:000342246900039		
J	Islam, MS; Ushida, K; Tanaka, S; Makino, T; Hashimoto, A				Islam, Md. Sherajul; Ushida, Kenji; Tanaka, Satoru; Makino, Takayuki; Hashimoto, Akihiro			Effect of boron and nitrogen doping with native point defects on the vibrational properties of graphene	COMPUTATIONAL MATERIALS SCIENCE			English	Article						B- and N-doped graphene; Vibrational properties; Phonon localization	CHEMICAL-VAPOR-DEPOSITION; DOPED GRAPHENE; EPITAXIAL GRAPHENE; CARBON; LOCALIZATION; GRAPHITE; SYSTEMS; ELECTRONICS; SCATTERING; BANDGAP	Boron and nitrogen doping in graphene has important implications in graphene-based devices. We investigate systematically the vibrational properties of B- and N-doped graphene with vacancies using forced vibrational method. We have calculated the phonon density of states (PDOSs), typical mode patterns and phonon localization length for different concentration of B, N and vacancies. We find that the interference between native point defects and B or N dopant break down the phonon degeneracy at the Gamma point of the LO and TO modes, distort and shift down the PDOSs significantly. We observe a broadening and softening of the Raman active E-2g phonon mode with an increase of B and N atoms. The PDOS peaks for the mixture of vacancies and B or N atoms show the remarkable increase in the low-frequency region induced by their defect formations. Our computer experiments demonstrate that the disordered graphene show the spatially localized vibrations due to the resonant vibrations of the impurity atoms relative to the main C atoms. The calculated typical mode patterns for in-plane K point optical phonon modes indicate that the phonon is localized strongly within a region of several nanometers in the random disordered graphene structures. In particular, a typical localization length is on the order of approximate to 9.5 nm for B- and N-doping, approximate to 9 nm for mixture of B-doping and vacancy, and approximate to 8.5 nm for mixture of N-doping and vacancy concentrations of 20%. This study provides a useful basis for the understanding of a wide variety of physical properties such as thermal conductivity, specific heat capacity, and electron-phonon interaction, as well as in the experiments of infrared, Raman, and neutron-diffraction spectra of doped-graphene. (C) 2014 Elsevier B.V. All rights reserved.	[Islam, Md. Sherajul; Ushida, Kenji; Makino, Takayuki; Hashimoto, Akihiro] Univ Fukui, Grad Sch Elect & Elect Engn, Fukui 9108507, Japan; [Tanaka, Satoru] Kyushu Univ, Dept Appl Quantum Phys & Nucl Engn, Fukuoka 8190395, Japan	Islam, MS (reprint author), Univ Fukui, Grad Sch Elect & Elect Engn, 3-9-1 Bunkyo, Fukui 9108507, Japan.	sheraj_ruet@yahoo.com			Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work was supported by a Grant-in-Aid of Basic Research (A) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Imamura G, 2011, J PHYS CHEM C, V115, P10000, DOI 10.1021/jp202128f; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; Panchokarla LS, 2009, ADV MATER, V21, P4726, DOI 10.1002/adma.200901285; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Lin YC, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3368697; Dubay O, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.035401; Wirtz L, 2004, SOLID STATE COMMUN, V131, P141, DOI 10.1016/j.ssc.2004.04.042; Casiraghi C, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2818692; Wang XR, 2009, SCIENCE, V324, P768, DOI 10.1126/science.1170335; Zhang CH, 2011, ADV MATER, V23, P1020, DOI 10.1002/adma.201004110; Khantha M, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.125422; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Hwang JO, 2012, ACS NANO, V6, P159, DOI 10.1021/nn203176u; Gruneis A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.085423; Hashimoto A, 2004, NATURE, V430, P870, DOI 10.1038/nature02817; Schedin F, 2007, NAT MATER, V6, P652, DOI 10.1038/nmat1967; Avouris P, 2007, NAT NANOTECHNOL, V2, P605, DOI 10.1038/nnano.2007.300; LEE PA, 1985, REV MOD PHYS, V57, P287, DOI 10.1103/RevModPhys.57.287; Ci L, 2010, NAT MATER, V9, P430, DOI 10.1038/nmat2711; Deng DH, 2011, CHEM MATER, V23, P1188, DOI 10.1021/cm102666r; Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052; Michel KH, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.085424; Das A, 2008, NAT NANOTECHNOL, V3, P210, DOI 10.1038/nnano.2008.67; Zhou SY, 2007, NAT MATER, V6, P770, DOI 10.1038/nmat2003; Yan JA, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.125401; Bai JW, 2010, NAT NANOTECHNOL, V5, P190, DOI [10.1038/nnano.2010.8, 10.1038/NNANO.2010.8]; KOHN W, 1959, PHYS REV LETT, V2, P393, DOI 10.1103/PhysRevLett.2.393; Gupta SK, 2013, AIP ADV, V3, DOI 10.1063/1.4794949; Rotenberg E, 2008, NAT MATER, V7, P258, DOI 10.1038/nmat2154a; JISHI RA, 1993, CHEM PHYS LETT, V209, P77, DOI 10.1016/0009-2614(93)87205-H; Pisana S, 2007, NAT MATER, V6, P198, DOI 10.1038/nmat1846; Subrahmanyam KS, 2010, CHEM PHYS LETT, V497, P70, DOI 10.1016/j.cplett.2010.07.091; Savic I, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.165502; KRAMER B, 1993, REP PROG PHYS, V56, P1469, DOI 10.1088/0034-4885/56/12/001; Mounet N, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.205214; Yang QH, 2005, NANO LETT, V5, P2465, DOI 10.1021/nl051779j; Piscanec S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.185503; Hou ZF, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.165401; Li XL, 2009, J AM CHEM SOC, V131, P15939, DOI 10.1021/ja907098f; Wei DC, 2009, NANO LETT, V9, P1752, DOI 10.1021/nl803279t; Chen ZH, 2007, PHYSICA E, V40, P228, DOI 10.1016/j.physe.2007.06.020; Pereira VM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.036801; Guo BD, 2010, NANO LETT, V10, P4975, DOI 10.1021/nl103079j; MOTT NF, 1961, ADV PHYS, V10, P107, DOI 10.1080/00018736100101271; BORLAND RE, 1963, PROC R SOC LON SER-A, V274, P529, DOI 10.1098/rspa.1963.0148; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Castro Neto AH, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.045404; dos Santos MC, 1998, PHYS REV B, V58, P13918, DOI 10.1103/PhysRevB.58.13918; Han MY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206805; Hou ZF, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.165439; Landry ES, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165304; Maradudin A. A., 1966, SOLID STATE PHYS, V18 and 19, P273; Maradudin A.A., 1963, THEORY LATTICE DYNAM; Mariani E, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.195403; Martins TB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.196803; Morozov SV, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.016602; NISHIGUCHI N, 1993, PHYS REV B, V48, P2515, DOI 10.1103/PhysRevB.48.2515; Ochoa H, 2012, PHYSICA E, V44, P963, DOI 10.1016/j.physe.2011.03.017; Piscanec S, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.035427; Rodriguez-Nieva JF, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.245406; Saha SK, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.155414; Sheng P., 2006, INTRO WAVE SCATTERIN; WEGNER F, 1980, Z PHYS B CON MAT, V36, P209, DOI 10.1007/BF01325284; WILLIAMS ML, 1985, PHYS REV B, V31, P4508, DOI 10.1103/PhysRevB.31.4508	64	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0256	1879-0801		COMP MATER SCI	Comput. Mater. Sci.	NOV	2014	94				SI		35	43		10.1016/j.commatsci.2014.01.040		9	Materials Science, Multidisciplinary	Materials Science	AP8WL	WOS:000342360000006		
J	Islam, MS; Ushida, K; Tanaka, S; Makino, T; Hashimoto, A				Islam, Md. Sherajul; Ushida, Kenji; Tanaka, Satoru; Makino, Takayuki; Hashimoto, Akihiro			Analysis of vibrational properties of C-doped hexagonal boron nitride (h-BN)	COMPUTATIONAL MATERIALS SCIENCE			English	Article						Vibrational properties; h-BN; BCN network; Phonon localization	ATOMIC LAYERS; GRAPHENE; NANOTUBES; NANOSHEETS; CARBON; LOCALIZATION; RESISTANCE; SCATTERING; CRYSTALS; NITROGEN	We present a systematic theoretical investigation of the vibrational properties of C-doped single layer hexagonal boron nitride (h-BN). Our studies have been carried out by the forced vibrational method, which is based on the idea of mechanical resonance and efficient for very complex and large system. We have estimated the phonon density of states (PDOSs) of h-BCN network with random and regular distribution of C atoms. It is found that the PDOS greatly depends on the C distribution and coverage. For randomly distributed C atoms, we observe that the longitudinal and the transverse optical (LO) and (TO) phonon branches for in-plane motion are nondegenerate at the C-point of the Brillouin zone. We determine a critical value of C concentration for the onset of this C-induced vibrational transition. We have found that C concentrations of about 10% and higher, the E-2g peak of h-BN has been reduced into a shoulder or it has completely disappeared. For h-BCN network with regular domains of C, the PDOSs changes more abruptly. With the increase of C concentration, the high frequency optical phonons peaks above the 1400 cm(-1) increase linearly while the h-BN peaks below the 1400 cm(-1) are broadened and distorted. The disorder causes the phonon modes to be localized in the real space. Phonon localization in the hybrid BCN network is studied and the extent of localization is quantified by the typical mode pattern and the localization length. Spatial analyses of the eigenvectors using typical mode patterns show that C-point of the LO and TO phonon modes is strongly localized and show random behavior within a region of several nanometers in the BCN structure. In particular at 1400 cm(-1), a typical localization length is on the order of approximate to 4 nm for randomly distributed C atoms and approximate to 8.5 nm for the regular domains of C of 20% concentration, while at 1590 cm(-1), these values are approximate to 2 nm and approximate to 4 nm for randomly distributed C atoms and regular domains of C, respectively. These results are expected to stimulate further studies aimed at better understanding of the phenomena allied with vibrational properties such as thermal conductivity, specific heat capacity, and electron-phonon interaction of h-BN and BCN networks. (C) 2014 Elsevier B.V. All rights reserved.	[Islam, Md. Sherajul; Ushida, Kenji; Makino, Takayuki; Hashimoto, Akihiro] Univ Fukui, Grad Sch Elect & Elect Engn, Fukui 9108507, Japan; [Tanaka, Satoru] Kyushu Univ, Dept Appl Quantum Phys & Nucl Engn, Fukuoka 8190395, Japan	Islam, MS (reprint author), Univ Fukui, Grad Sch Elect & Elect Engn, 3-9-1 Bunkyo, Fukui 9108507, Japan.	sheraj_ruet@yahoo.com			Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work was supported by a Grant-in-Aid of Basic Research (A) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Wei XL, 2010, ADV MATER, V22, P4895, DOI 10.1002/adma.201001829; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Reich S, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.205201; Yu WJ, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.014108; Mohr M, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.035439; Gorbachev RV, 2012, NAT PHYS, V8, P896, DOI [10.1038/nphys2441, 10.1038/NPHYS2441]; Sanchez-Portal D, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.235415; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Wirtz L, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.045425; Ponomarenko LA, 2008, SCIENCE, V320, P356, DOI 10.1126/science.1154663; Song L, 2012, ADV MATER, V24, P4878, DOI 10.1002/adma.201201792; Golberg D, 2010, ACS NANO, V4, P2979, DOI 10.1021/nn1006495; Kawaguchi M, 1996, CHEM MATER, V8, P1197, DOI 10.1021/cm950471y; Zhang T, 2012, NANO TODAY, V7, P180, DOI 10.1016/j.nantod.2012.04.006; Xiao Y, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.205415; Watanabe K, 2004, NAT MATER, V3, P404, DOI 10.1038/nmat1134; Ci L, 2010, NAT MATER, V9, P430, DOI 10.1038/nmat2711; Serrano J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.095503; Zhi CY, 2009, ADV MATER, V21, P2889, DOI 10.1002/adma.200900323; Rokuta E, 1997, PHYS REV LETT, V79, P4609, DOI 10.1103/PhysRevLett.79.4609; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Michel KH, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.085424; Topsakal M, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.115442; Wei XL, 2011, ACS NANO, V5, P2916, DOI 10.1021/nn103548r; GEICK R, 1966, PHYS REV, V146, P543, DOI 10.1103/PhysRev.146.543; Malard LM, 2009, PHYS REP, V473, P51, DOI 10.1016/j.physrep.2009.02.003; Chen Y, 2004, APPL PHYS LETT, V84, P2430, DOI 10.1063/1.1667278; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; SWARTZ ET, 1989, REV MOD PHYS, V61, P605, DOI 10.1103/RevModPhys.61.605; Yu J, 2010, ACS NANO, V4, P414, DOI 10.1021/nn901204c; JISHI RA, 1993, CHEM PHYS LETT, V209, P77, DOI 10.1016/0009-2614(93)87205-H; Chen M, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.045459; Savic I, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.165502; Novoselov KS, 2007, SCIENCE, V315, P1379, DOI 10.1126/science.1137201; KRAMER B, 1993, REP PROG PHYS, V56, P1469, DOI 10.1088/0034-4885/56/12/001; Yang Z, 2011, NANO, V6, P205, DOI 10.1142/S1793292011002536; Golberg D, 2007, ADV MATER, V19, P2413, DOI 10.1002/adma.200700179; Kern G, 1999, PHYS REV B, V59, P8551, DOI 10.1103/PhysRevB.59.8551; Park H, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4730392; NEMANICH RJ, 1981, PHYS REV B, V23, P6348, DOI 10.1103/PhysRevB.23.6348; Gao H, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/27/275605; Islam MS, 2013, DIAM RELAT MATER, V40, P115, DOI 10.1016/j.diamond.2013.10.013; Jorio A., 2011, RAMAN SPECTROSCOPY G; Landry ES, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165304; LIU J, 1995, PHYS REV B, V51, P8591, DOI 10.1103/PhysRevB.51.8591; Lv R, 2012, SCI REP-UK, V2, DOI 10.1038/srep00586; Maradudin A.A., 1963, THEORY LATTICE DYNAM; Mariani E, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.195403; Ochoa H, 2012, PHYSICA E, V44, P963, DOI 10.1016/j.physe.2011.03.017; Rodriguez-Nieva JF, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.245406; Saito R., 2003, PHYS PROPERTIES CARB; SANJURJO JA, 1983, PHYS REV B, V28, P4579, DOI 10.1103/PhysRevB.28.4579; Sheng P., 2006, INTRO WAVE SCATTERIN; WEGNER F, 1980, Z PHYS B CON MAT, V36, P209, DOI 10.1007/BF01325284; WILLIAMS ML, 1985, PHYS REV B, V31, P4508, DOI 10.1103/PhysRevB.31.4508	55	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0256	1879-0801		COMP MATER SCI	Comput. Mater. Sci.	NOV	2014	94				SI		225	233		10.1016/j.commatsci.2014.04.047		9	Materials Science, Multidisciplinary	Materials Science	AP8WL	WOS:000342360000027		
J	Pop, N; Vladareanu, L; Popescu, IN; Ghita, C; Gal, A; Cang, S; Yu, HN; Bratu, V; Deng, MC				Pop, Nicolae; Vladareanu, Luige; Popescu, Ileana Nicoleta; Ghita, Constantin; Gal, Alexandru; Cang, Shuang; Yu, Hongnian; Bratu, Vasile; Deng, Mingcong			A numerical dynamic behaviour model for 3D contact problems with friction	COMPUTATIONAL MATERIALS SCIENCE			English	Article						Contact problem with friction; Friction Coulomb law; Stick-slip motion; Contact surface materials	DEPENDENT FRICTION; LAWS; ELASTICITY; EXISTENCE	This paper proposes a novel algorithm for the condition detection in which the slip state transitions in a stick-slip motion, or the solution breaks down and also to study the state transition of nodes belonging to the contact area: stick, slip or open contact state. We designed a Matlab Simulink program to simulate the occurrence conditions for the slip-stick transition analysing three types of contact surface materials, with respectively 0.5, 0.75 and 0.9 friction coefficients, using finite element contact. The proposed method is able to detect the stick-slip motion and implicit the numerical instability of the model. By applying this method to control walking robots on uncertain, unknown and unstructured surfaces, the occurrence conditions for the slip-stick transition depending on the friction coefficient of contact material were determined. The presented simulations demonstrates through a numeric modelling of the dynamic behaviour of 3D contact problems with friction we can detect the slip/stick phenomenon for a walking robot motion on a uneven terrain, so it can improve the real time control in order to predict and avoid robot overthrow. (C) 2014 Elsevier B.V. All rights reserved.	[Pop, Nicolae] Tech Univ Cluj Napoca, North Univ Ctr Baia Mare, Baia Mare, Romania; [Pop, Nicolae; Vladareanu, Luige; Gal, Alexandru] Acad Romana, Inst Solid Mech, Bucharest, Romania; [Popescu, Ileana Nicoleta; Bratu, Vasile] VALAHIA Univ Targoviste, Fac Mat Engn & Mech, Targoviste 130082, Romania; [Ghita, Constantin] VALAHIA Univ Targoviste, Fac Sci & Arts, Targoviste 130082, Romania; [Cang, Shuang] Bournemouth Univ, Sch Tourism, Poole BH12 5BB, Dorset, England; [Yu, Hongnian] Bournemouth Univ, Fac Sci & Technol, Poole BH12 5BB, Dorset, England; [Deng, Mingcong] Tokyo Univ Agr & Technol, Grad Sch Engn, Koganei, Tokyo 1848588, Japan	Vladareanu, L (reprint author), Acad Romana, Inst Solid Mech, Ctin Mille 15, Bucharest, Romania.	luigiv2007@yahoo.com.sg; pinicoleta24@yahoo.com	Deng, Mingcong/G-1093-2013		Romanian Academy; FP7 IRSES RABOT Project [318902/2012-2016]	This work was supported in part by the Romanian Academy and the FP7 IRSES RABOT Project No. 318902/2012-2016.	Sima G, 2011, MATER SCI FORUM, V672, P241, DOI 10.4028/www.scientific.net/MSF.672.241; Gingu O, 2011, P I MECH ENG E-J PRO, V225, P62, DOI 10.1243/09544089JPME307; RABINOWICZ E, 1951, J APPL PHYS, V22, P1373, DOI 10.1063/1.1699869; Potra FA, 2006, INT J NUMER METH ENG, V66, P1079, DOI 10.1002/nme.1582; Berman AD, 1996, LANGMUIR, V12, P4559, DOI 10.1021/la950896z; Popescu IN, 2013, APPL SURF SCI, V285, P72, DOI 10.1016/j.apsusc.2013.08.007; Boscoianu M., 2008, P INT C MATH METH CO, P228; COCU M, 1984, INT J ENG SCI, V22, P567, DOI 10.1016/0020-7225(84)90058-2; Cook RD, 2001, CONCEPTS APPL FINITE; Corneschi C., 2002, J APPL ANAL, V8, P63, DOI 10.1515/JAA.2002.63; David M. F., 2009, Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Agriculture, V66, P51; Deng M, 2006, IEEE T AUTOMAT CONTR, V51, P645, DOI 10.1109/TAC.2006.872758; Duvaut G, 1976, INEQUALITIES MECH PH; Ionescu IR, 2003, NONLINEAR ANAL-THEOR, V53, P375, DOI 10.1016/S0362-546X(02)00302-4; Ionescu IR, 1996, INT J ENG SCI, V34, P471, DOI 10.1016/0020-7225(95)00109-3; Khoei AR, 2009, COMP MATER SCI, V46, P203, DOI 10.1016/j.commatsci.2009.02.026; Kikuchi N., 1988, CONTACT PROBLEMS ELA; Konyukhov A., 2013, COMPUTATIONAL CONTAC; Kuttler KL, 1997, NONLINEAR ANAL-THEOR, V28, P559, DOI 10.1016/0362-546X(95)00170-Z; Liu H, 2011, PATTERN ANAL MACHINE, P1; MARTINS JAC, 1987, NONLINEAR ANAL-THEOR, V11, P407, DOI 10.1016/0362-546X(87)90055-1; ODEN JT, 1983, J APPL MECH-T ASME, V50, P67; Pang Jong-Shi, 1996, MATH PROG, V73, P99; Pop N, 2011, COMP MATER SCI, V50, P1283, DOI 10.1016/j.commatsci.2010.03.018; Pop N., 2009, ADV STUDIES PURE MAT, V53, P225; Popescu I.N., 2011, B VALAHIA U MAT MECH, V6, P83; Popescu I.N., 2011, P EUR PM2011 BARC SP, V3, P439; Ren W, 2012, UKACC INT C CONTR CA, P650; Roosen Stephen, 2012, THESIS U MELBOURNE, P25; Sadowski T., 2011, COMP MATER SCI, V52, P231; Sandru OI, 2013, U POLITEH BUCH SER A, V75, P3; Smarandache F., 2011, 2011 IEEE International Conference on Granular Computing, DOI 10.1109/GRC.2011.6122666; Smarandache F., 2012, 6 C SOFTW KNOWL INF, P12; Vladareanu L., 2012, J BIOMECH, V45, pS279; Vladareanu L, 2010, ADV ELECTR COMPUT EN, V10, P145, DOI 10.4316/AECE.2010.02026; Vladareanu L., 2010, P AM C APPL MATH AM, P510; Vladareanu L, 2013, INT C ADV MECH SYST, P517; Vladareanu Luige, 2010, Recent Advances in Applied Mathematics. Proceedings of the American Conference on Applied Mathematics (AMERICAN-MATH 2010); Yang Liu, 2011, APPL MECH, V56, P247; Yu Hongnian, 2008, 9 WSEAS INT C MATH C, V20, P152	40	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0256	1879-0801		COMP MATER SCI	Comput. Mater. Sci.	NOV	2014	94				SI		285	291		10.1016/j.commatsci.2014.05.072		7	Materials Science, Multidisciplinary	Materials Science	AP8WL	WOS:000342360000034		
J	Fukuda, S; Karino, K				Fukuda, Shoko; Karino, Kenji			Male red coloration, female mate preference, and sperm longevity in the cyprinid fish Puntius titteya	ENVIRONMENTAL BIOLOGY OF FISHES			English	Article						Female mate choice; Sexual selection; Sexual ornament; Sperm longevity; Coloration	SECONDARY SEX TRAITS; OXIDATIVE STRESS; ARCTIC CHARR; IMMUNOCOMPETENCE HANDICAP; FERTILIZATION SUCCESS; SPAWNING COLORATION; PRIMARY DETERMINANT; SPECIES PISCES; GERM-LINE; SRI-LANKA	In recent decades, the link between the exaggeration of male sexual ornaments and ejaculate quality has received much attention. When males with conspicuous sexual ornaments have high-quality ejaculate, females are believed to obtain benefits, such as high fertilization success and offspring with good genes, by choosing mates on the basis of male ornamentation. In this study, we examined the relationships among male body coloration, female mate preference, and sperm longevity in the sexually dichromatic fish Puntius titteya. Males of this species assume a bright red coloration over the entire body, and neither sex invests in the parental care of eggs. In the female preference test, females preferred males with redder body coloration over their counterpart males with duller coloration. In addition, the sperm longevity test indicated that redder males had sperm with greater longevity. These results suggest that the red coloration of males in this species may signal sperm longevity and that females can mate with males with higher quality sperm by choosing redder males.	[Fukuda, Shoko; Karino, Kenji] Tokyo Gakugei Univ, Dept Biol, Koganei, Tokyo 1848501, Japan	Karino, K (reprint author), Tokyo Gakugei Univ, Dept Biol, Nukui Kita 4-1-1, Koganei, Tokyo 1848501, Japan.	kkarino@u-gakugei.ac.jp					Andersson M., 1994, SEXUAL SELECTION; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1; Gage MJG, 2003, CURR BIOL, V13, P754, DOI 10.1016/S0960-9822(03)00282-3; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; DESILVA SS, 1985, ENVIRON BIOL FISH, V12, P201; Gomendio M, 2007, REPRODUCTION, V134, P19, DOI 10.1530/REP-07-0143; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Pike TW, 2010, BIOL LETTERS, V6, P191, DOI 10.1098/rsbl.2009.0815; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Rowe M, 2010, ANIM BEHAV, V79, P1239, DOI 10.1016/j.anbehav.2010.02.020; Pitcher TE, 2007, J FISH BIOL, V70, P165, DOI 10.1111/j.1095-8649.2006.01292.x; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Costantini D, 2010, FUNCT ECOL, V24, P950, DOI 10.1111/j.1365-2435.2010.01746.x; Janhunen M, 2009, BIOL J LINN SOC, V98, P794; Kekalainen J, 2010, ETHOLOGY, V116, P895, DOI 10.1111/j.1439-0310.2010.01802.x; Gomendio M, 2008, INT J DEV BIOL, V52, P439, DOI 10.1387/ijdb.082595mg; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; Helfenstein F, 2010, ECOL LETT, V13, P213, DOI 10.1111/j.1461-0248.2009.01419.x; Liljedal S, 2008, BEHAV ECOL SOCIOBIOL, V62, P1805, DOI 10.1007/s00265-008-0609-1; Locatello L, 2006, J EVOLUTION BIOL, V19, P1595, DOI 10.1111/j.1420-9101.2006.01117.x; WARNER RR, 1995, P ROY SOC B-BIOL SCI, V262, P135, DOI 10.1098/rspb.1995.0187; Beausoleil JMJ, 2012, ANIM BEHAV, V83, P969, DOI 10.1016/j.anbehav.2012.01.017; Blount JD, 2001, ECOL LETT, V4, P393, DOI 10.1046/j.1461-0248.2001.00255.x; Folstad I, 1997, BEHAV ECOL, V8, P109, DOI 10.1093/beheco/8.1.109; Hillgarth N, 1997, BEHAV ECOL, V8, P108, DOI 10.1093/beheco/8.1.108; Karino K, 2004, BEHAVIOUR, V141, P585, DOI 10.1163/1568539041166672; Kortet R, 2004, BIOL J LINN SOC, V81, P111, DOI 10.1111/j.1095-8312.2004.00275.x; KORTMULDER K, 1982, NETH J ZOOL, V32, P144; Liljedal S, 1999, P ROY SOC B-BIOL SCI, V266, P1893, DOI 10.1098/rspb.1999.0863; Linhart O, 2005, REPRODUCTION, V130, P705, DOI 10.1530/rep.1.00541; Losdat S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022221; Masvaer M, 2004, P ROY SOC B-BIOL SCI, V271, pS40, DOI 10.1098/rsbl.2003.0090; Nusslein-Volhard C, 2002, ZEBRAFISH; Peters A, 2004, J EVOLUTION BIOL, V17, P1111, DOI 10.1111/j.1420-9101.2004.00743.x; SCHUT J, 1984, NETH J ZOOL, V34, P159; Simmons LW, 2010, BEHAV ECOL, V21, P1330, DOI 10.1093/beheco/arq154; TUREK PJ, 1994, UROL CLIN N AM, V21, P447; Velando A, 2008, BIOESSAYS, V30, P1212, DOI 10.1002/bies.20838; Yasui Y, 1997, AM NAT, V149, P573, DOI 10.1086/286006	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0378-1909	1573-5133		ENVIRON BIOL FISH	Environ. Biol. Fishes	NOV	2014	97	11					1197	1205		10.1007/s10641-013-0207-6		9	Ecology; Marine & Freshwater Biology	Environmental Sciences & Ecology; Marine & Freshwater Biology	AP9UB	WOS:000342424600001		
J	Fuji, T; Kasai, A; Ueno, M; Yamashita, Y				Fuji, Taiki; Kasai, Akihide; Ueno, Masahiro; Yamashita, Yoh			Growth and migration patterns of juvenile temperate seabass Lateolabrax japonicus in the Yura River estuary, Japan-combination of stable isotope ratio and otolith microstructure analyses	ENVIRONMENTAL BIOLOGY OF FISHES			English	Article						Carbon stable isotope ratio; Feeding condition; Density dependent; Growth back-calculation; Otolith microstructure analysis; Partial migration	CHIKUGO RIVER; WHITE PERCH; ARIAKE BAY; EARLY-LIFE; FISHES; MORTALITY; LARVAE	It is important to know the characteristics of migration pattern and vital rates of juveniles to understand the early life history and its effect on the population dynamics of fishes. The relationship between growth and migration pattern of juvenile temperate seabass Lateolabrax japonicus in the Yura River estuary was examined by combination of stable carbon isotope ratio (delta C-13) and otolith microstructure. Gut fullness indices were also examined to know the feeding condition of juveniles. delta C-13 values of seabass juveniles in the lower estuary and surf zone (LES) were enriched, while those in freshwater zone (FW) were depleted, consistent with delta C-13 differences in prey items. The back-calculated growth rates of juveniles in FW were significantly lower than those of juveniles that resided in the LES from 50 days to 90 days old, implying that juveniles with poor growth ascended the river while those with better growth remained in the LES. However, the growth rates of the juveniles, which resided in FW for more than 1 month, caught up with and even overtook those of juveniles in LES within 1 month after ascended the river. The higher water temperature and better feeding conditions would contribute to better growth rates of juveniles in FW than those in LES.	[Fuji, Taiki; Kasai, Akihide] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan; [Ueno, Masahiro; Yamashita, Yoh] Kyoto Univ, Field Sci Educ & Res Ctr, Nagahama, Maizuru 6250086, Japan	Fuji, T (reprint author), Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan.	taiki@kais.kyoto-u.ac.jp			Coastal Ecosystem Complex Project of the Ocean Resource Use Promotion Technology Development Program, MEXT of Japan	Stable isotope ratios were analyzed at the Center for Ecological Research, Kyoto University. This study was partly supported by the Coastal Ecosystem Complex Project of the Ocean Resource Use Promotion Technology Development Program, MEXT of Japan. Japanese ethical rules regarding experimental fishing were followed during this study.	MATSUMIYA Y, 1982, B JPN SOC SCI FISH, V48, P129; Chapman BB, 2012, J FISH BIOL, V81, P456, DOI 10.1111/j.1095-8649.2012.03342.x; Kraus RT, 2004, MAR ECOL PROG SER, V279, P247, DOI 10.3354/meps279247; JONSSON B, 1993, REV FISH BIOL FISHER, V3, P348, DOI 10.1007/BF00043384; Kasai A, 2010, ESTUAR COAST SHELF S, V86, P408, DOI 10.1016/j.ecss.2009.06.001; Suzuki KW, 2005, CAN J FISH AQUAT SCI, V62, P671, DOI 10.1139/F04-231; Olsson IC, 2006, ECOL LETT, V9, P645, DOI 10.1111/j.1461-0248.2006.00909.x; HOUDE ED, 1989, J FISH BIOL, V35, P29; van der Veer HW, 2000, ICES J MAR SCI, V57, P202, DOI 10.1006/jmsc.1999.0523; Fuji T, 2011, J FISH BIOL, V78, P2010, DOI 10.1111/j.1095-8649.2011.02990.x; Kerr LA, 2009, FISHERIES, V34, P114, DOI 10.1577/1548-8446-34.3.114; Suzuki KW, 2008, MAR ECOL PROG SER, V358, P245, DOI 10.3354/meps07300; Sirois P, 1998, CAN J FISH AQUAT SCI, V55, P2662, DOI 10.1139/cjfas-55-12-2662; Juanes F, 2007, J FISH BIOL, V70, P661, DOI 10.1111/j.1095-8649.2007.01394.x; LI HW, 1977, J FISH BIOL, V11, P329, DOI 10.1111/j.1095-8649.1977.tb04126.x; Campana SE, 2001, J FISH BIOL, V59, P197, DOI 10.1006/jfbi.2001.1668; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Herzka SZ, 2005, ESTUAR COAST SHELF S, V64, P58, DOI 10.1016/j.ecss.2005.02.006; Bujold V, 2004, CAN J FISH AQUAT SCI, V61, P273, DOI 10.1139/F03-162; CAMPANA SE, 1990, CAN J FISH AQUAT SCI, V47, P2219, DOI 10.1139/f90-246; Franco A, 2010, J SEA RES, V64, P457, DOI 10.1016/j.seares.2010.01.006; Fuji T, 2010, FISHERIES SCI, V76, P643, DOI 10.1007/s12562-010-0258-y; Fujii T, 1996, SURVIVAL STRATEGIES IN EARLY LIFE STAGES OF MARINE RESOURCES, P141; Hibino M, 2007, ICHTHYOL RES, V54, P367, DOI 10.1007/s10228-007-0411-5; Hirata M, 1967, REPORT KUMAMOTO PREF, V41, P349; Hobson AK, 1999, OECOLOGIA, V120, P314; Ichthyological Society of Japan, 2003, GUID US FISH RES; Islam MS, 2005, J EXP MAR BIOL ECOL, V323, P172, DOI 10.1016/j.jembe.2005.04.007; Islam M. S., 2009, Journal of Applied Ichthyology, V25, P423, DOI 10.1111/j.1439-0426.2009.01251.x; Islam MS, 2010, FISH OCEANOGR, V19, P230, DOI 10.1111/j.1365-2419.2010.00539.x; Ohta T, 2004, THESIS KYOTO U KYOTO; Shoji J, 2007, MAR ECOL PROG SER, V334, P255, DOI 10.3354/meps334255; Tanaka M, 1982, SAIBAIGIKEN, V11, P49; Tanaka Y, 2006, NIPPON SUISAN GAKK, V72, P50, DOI 10.2331/suisan.72.50	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0378-1909	1573-5133		ENVIRON BIOL FISH	Environ. Biol. Fishes	NOV	2014	97	11					1221	1232		10.1007/s10641-013-0209-4		12	Ecology; Marine & Freshwater Biology	Environmental Sciences & Ecology; Marine & Freshwater Biology	AP9UB	WOS:000342424600003		
J	Otsuki, H; Yano, S				Otsuki, Hatsune; Yano, Shuichi			Potential lethal and non-lethal effects of predators on dispersal of spider mites	EXPERIMENTAL AND APPLIED ACAROLOGY			English	Article						Dispersal; Anti-predator behavior; Conservation biological control; Density-mediated effects; Trait-mediated effects; Tetranychus kanzawai	TYPHLODROMUS-PYRI SCHEUTEN; TETRANYCHUS-URTICAE ACARI; CORN-PEANUT AGROECOSYSTEM; WOMERSLEYI SCHICHA ACARI; SOJAENSIS EHARA ACARINA; BIOLOGICAL-CONTROL; AMBLYSEIUS-ANDERSONI; PREY INTERACTIONS; PHYTOSEIID MITES; HIDING BEHAVIOR	Predators can affect prey dispersal lethally by direct consumption or non-lethally by making prey hesitate to disperse. These lethal and non-lethal effects are detectable only in systems where prey can disperse between multiple patches. However, most studies have drawn their conclusions concerning the ability of predatory mites to suppress spider mites based on observations of their interactions on a single patch or on heavily infested host plants where spider mites could hardly disperse toward intact patches. In these systems, specialist predatory mites that penetrate protective webs produced by spider mites quickly suppress the spider mites, whereas generalist predators that cannot penetrate the webs were ineffective. By using a connected patch system, we revealed that a generalist ant, Pristomyrmex punctatus Mayr (Hymenoptera: Formicidae), effectively prevented dispersal of spider mites, Tetranychus kanzawai Kishida (Acari: Tetranychidae), by directly consuming dispersing individuals. We also revealed that a generalist predatory mite, Euseius sojaensis Ehara (Acari: Phytoseiidae), prevented between-patch dispersal of T. kanzawai by making them hesitate to disperse. In contrast, a specialist phytoseiid predatory mite, Neoseiulus womersleyi Schicha, allowed spider mites to escape an initial patch, increasing the number of colonized patches within the system. Our results suggest that ants and generalist predatory mites can effectively suppress Tetranychus species under some conditions, and should receive more attention as agents for conservation biological control in agroecosystems.	[Otsuki, Hatsune; Yano, Shuichi] Kyoto Univ, Grad Sch Agr, Lab Ecol Informat, Sakyo Ku, Kyoto 6068502, Japan	Otsuki, H (reprint author), Kyoto Univ, Grad Sch Agr, Lab Ecol Informat, Sakyo Ku, Kyoto 6068502, Japan.	ootsuki.hatsune.44e@st.kyoto-u.ac.jp			Japan Society for the Promotion of Science [21580066]	We thank members of the Laboratory of Ecological Information for valuable suggestions and encouragement. This work was supported by the Japan Society for the Promotion of Science [Basis Research C; Grant Number 21580066 to S. Y.].	Amano H, 1996, PRINCIPLES PLANT ACA, P159; Bonnet X, 1999, BIOL CONSERV, V89, P39, DOI 10.1016/S0006-3207(98)00140-2; MCMURTRY JA, 1992, EXP APPL ACAROL, V14, P371, DOI 10.1007/BF01200574; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Grostal P, 1999, BEHAV ECOL, V10, P422, DOI 10.1093/beheco/10.4.422; Duso C, 2003, BIOL CONTROL, V27, P229, DOI 10.1016/S1049-9644(03)00016-1; SABELIS MW, 1990, OECOLOGIA, V82, P289, DOI 10.1007/BF00317473; McMurtry JA, 1997, ANNU REV ENTOMOL, V42, P291, DOI 10.1146/annurev.ento.42.1.291; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Blackwood JS, 2001, ENVIRON ENTOMOL, V30, P1103, DOI 10.1603/0046-225X-30.6.1103; SABELIS MW, 1992, EXP APPL ACAROL, V16, P203, DOI 10.1007/BF01193804; Janssen A, 1998, EXP APPL ACAROL, V22, P497, DOI 10.1023/A:1006089924336; DUSO C, 1989, J APPL ENTOMOL, V107, P474; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; SIH A, 1994, J FISH BIOL, V45, P111, DOI 10.1006/jfbi.1994.1217; Martin J, 1999, BEHAV ECOL, V10, P487, DOI 10.1093/beheco/10.5.487; SMITLEY DR, 1985, ANN ENTOMOL SOC AM, V78, P609; Koivula K, 1995, ARDEA, V83, P397; [Anonymous], ANIM BEHAV; MARGOLIES DC, 1985, ENTOMOL EXP APPL, V37, P55; Nelson EH, 2004, ECOLOGY, V85, P1853, DOI 10.1890/03-3109; Schausberger P, 2001, BIOL CONTROL, V20, P269, DOI 10.1006/bcon.2000.0908; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Cooper WE, 1999, BEHAV ECOL SOCIOBIOL, V47, P54, DOI 10.1007/s002650050649; CROFT BA, 1992, ENVIRON ENTOMOL, V21, P202; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; BERNSTEIN C, 1984, OECOLOGIA, V61, P134, DOI 10.1007/BF00379099; Bowler DE, 2013, J ZOOL, V289, P52, DOI 10.1111/j.1469-7998.2012.00961.x; BRANDENBURG RL, 1982, ENTOMOL EXP APPL, V32, P269; BURNETT T, 1979, RES POPUL ECOL, V20, P227, DOI 10.1007/BF02512628; CHANT D. A., 1961, CANADIAN ENT, V93, P437; DAS G. M., 1959, BULL ENT RES, V50, P265; Dill LM, 1997, BEHAV ECOL, V8, P186, DOI 10.1093/beheco/8.2.186; Duso C, 1988, INFLUENCE ENV FACTOR; FERNANDO MHJP, 1980, RES POPUL ECOL, V22, P301; Furuichi H, 2005, APPL ENTOMOL ZOOL, V40, P675, DOI 10.1303/aez.2005.675; Hamamura T, 1986, B NATL RES I TEA, V21, P121; Helle W, 1985, SPIDER MITES THEIR A, V1; Hiddink JG, 2002, MAR BIOL, V140, P1149, DOI 10.1007/s00227-002-0794-9; ITOW T, 1984, INSECT SOC, V31, P87, DOI 10.1007/BF02223694; JAMES DG, 1990, AUST J ZOOL, V37, P645; Janssen A, 1997, EXP APPL ACAROL, V21, P415, DOI 10.1023/A:1018479828913; Jeppson LR, 1975, MITES INJURIOUS EC P, P370; Johnson WT, 1988, INSECTS FEED TREES S, P468; Kennedy G.G., 1985, P233; KENNETT CE, 1979, ENTOMOPHAGA, V24, P83, DOI 10.1007/BF02377513; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; McMURTRY J. A., 1965, ANN ENTOMOL SOC AMER, V58, P49; McMurtry J.A., 1985, P327; McMurtry J.A., 1982, RECENT ADV KNOWLEDGE, V3284, P23; MIZUTANI A, 1980, Kontyu, V48, P327; Oku K, 2004, J ETHOL, V22, P109, DOI 10.1007/s10164-003-0102-2; OSAKABE M, 1988, APPL ENTOMOL ZOOL, V23, P45; OSAKABE M, 1986, APPL ENTOMOL ZOOL, V21, P322; Osborne LS, 1995, FLA ENTOMOL, V78, P565, DOI 10.2307/3496041; Otsuki H, 2014, ENTOMOL EXP APPL, V151, P27, DOI 10.1111/eea.12164; Ozawa M, 2009, ECOL RES, V24, P257, DOI 10.1007/s11284-008-0501-5; SAITO Y, 1983, ACAROLOGIA, V24, P377; SAS Institute, 2010, US JMP 9; Shinmen T, 2010, EXP APPL ACAROL, V52, P111, DOI 10.1007/s10493-010-9356-x; Shirotsuka K, 2012, EXP APPL ACAROL, V56, P355, DOI 10.1007/s10493-012-9514-4; TAKAFUJI A, 1976, Researches on Population Ecology (Tokyo), V17, P255, DOI 10.1007/BF02530777; WOLF NG, 1987, OECOLOGIA, V73, P127, DOI 10.1007/BF00376988; Yano S, 2012, BEHAV ECOL SOCIOBIOL, V66, P845, DOI 10.1007/s00265-012-1332-5; Yano S, 2009, ECOL RES, V24, P1173, DOI 10.1007/s11284-009-0598-1; YOUNG OP, 1988, J ARACHNOL, V16, P121	67	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0168-8162	1572-9702		EXP APPL ACAROL	Exp. Appl. Acarol.	NOV	2014	64	3					265	275		10.1007/s10493-014-9824-9		11	Entomology	Entomology	AQ0RS	WOS:000342491000001		
J	Abou El-Atta, DA; Ghazy, NA; Osman, MA				Abou El-Atta, Doaa Abd El-Maksoud; Ghazy, Noureldin Abuelfadl; Osman, Mohamed Ali			Effects of temperature on the life-history traits of Sancassania (Caloglyphus) berlesei (Acari: Astigmatina: Acaridae) feeding on root-knot nematodes, Meloidogyne spp. (Nematoda: Meloidogynidae)	EXPERIMENTAL AND APPLIED ACAROLOGY			English	Article						Biology; Biocontrol; Life table; Nematophagy; Predator	MITES; TYROPHAGUS; FUNGI	Sancassania (Caloglyphus) berlesei (Michael) is a cosmopolitan and free-living mite that inhabits soil as well as laboratory colonies of insects and fungi and may have a role as a biocontrol agent of nematodes. In this study, we investigated the effects of temperature on the development, reproduction, and food consumption of S. berlesei fed egg masses of root-knot nematodes, Meloidogyne spp., an important group of agricultural pests. Mites were reared at 20, 25 or 30 A degrees C in the dark. The mites could feed on the nematode egg masses, and their developmental time decreased at higher temperatures. Time from the egg to adult was similar in females and males reared at the same temperature. Adult females lived longer than males at 25 A degrees C, but not at 20 or 30 A degrees C. Generally, females showed a higher rate of food consumption than males. Females laid the largest number of eggs at 20 and 25 A degrees C (199.7 and 189.8 eggs/female, respectively), but the intrinsic rate of natural increase was highest at 30 A degrees C (r (m) = 0.29). In comparing our data with previous reports, we noted that S. berlesei that fed on egg masses of root-knot nematodes showed a longer developmental time and a lower reproductive rate than Sancassania mites that fed on other diets. Nonetheless, the relatively high value of r (m) (e.g., at 25 and 30 A degrees C) suggests that this mite may have certain advantages as a biocontrol agent of root-knot nematodes.	[Abou El-Atta, Doaa Abd El-Maksoud] Plant Protect Res Inst, Agr Res Ctr, Giza 12619, Egypt; [Ghazy, Noureldin Abuelfadl; Osman, Mohamed Ali] Mansoura Univ, Agr Zool Dept, Fac Agr, Mansoura 35516, Egypt; [Ghazy, Noureldin Abuelfadl] Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan	Osman, MA (reprint author), Mansoura Univ, Agr Zool Dept, Fac Agr, Mansoura 35516, Egypt.	mesoma20@mans.edu.eg		Ghazy, Noureldin/0000-0001-5911-086X			WALTER DE, 1986, OECOLOGIA, V70, P357, DOI 10.1007/BF00379497; Chmielewski W, 2009, J APIC SCI, V53, P75; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; MEYER JS, 1986, ECOLOGY, V67, P1156, DOI 10.2307/1938671; BILGRAMI AL, 1994, FUND APPL NEMATOL, V17, P293; Cakmak I, 2010, PEDOBIOLOGIA, V53, P235, DOI 10.1016/j.pedobi.2009.11.002; Cakmak I, 2011, EXP APPL ACAROL, V53, P41, DOI 10.1007/s10493-010-9386-4; Chmielewski W, 2003, FAGOPYRUM, V18, P85; CROSS EA, 1990, J KANSAS ENTOMOL SOC, V63, P603; DANESHVAR H, 1977, J INVERTEBR PATHOL, V30, P175, DOI 10.1016/0022-2011(77)90216-6; Ekmen ZI, 2010, BIOL CONTROL, V54, P166, DOI 10.1016/j.biocontrol.2010.05.004; El-Sherif A. G., 2009, Plant Pathology Journal (Faisalabad), V8, P159; Eraky S. A., 2008, Acarines, V2, P45; Gerson U., 2008, MITES ACARI PEST CON; Hughes A. M., 1976, TECHNICAL B MINISTRY; Karagoz M, 2007, EXP APPL ACAROL, V43, P85, DOI 10.1007/s10493-007-9105-y; Krantz G.W., 1978, MANUAL ACAROLOGY; LINFORD M. B., 1938, Phytopathology, V28, P14; Lotka A., 1924, ELEMENTS PHYS BIOL; Moens Maurice, 2009, P1, DOI 10.1079/9781845934927.0001; MURAOKA M, 1976, Applied Entomology and Zoology, V11, P1; RODRIGUEZ J G, 1973, Journal of the Kansas Entomological Society, V46, P176; SELL P, 1988, NEMATOLOGICA, V34, P246; TIMMS S, 1981, Acarologia (Paris), V22, P385; Walia Kum Kum, 1995, Nematologia Mediterranea, V23, P255; WALTER DE, 1993, J NEMATOL, V25, P789; WALTER DE, 1988, PEDOBIOLOGIA, V31, P247	27	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0168-8162	1572-9702		EXP APPL ACAROL	Exp. Appl. Acarol.	NOV	2014	64	3					299	307		10.1007/s10493-014-9826-7		9	Entomology	Entomology	AQ0RS	WOS:000342491000004		
J	Moghadam, HS; Ghorbani, G; Khedr, MZ; Fazlnia, N; Chiaradia, M; Eyuboglu, Y; Santosh, M; Francisco, CG; Martinez, ML; Gourgaud, A; Arai, S				Moghadam, H. Shafaii; Ghorbani, G.; Khedr, M. Zaki; Fazlnia, N.; Chiaradia, M.; Eyuboglu, Y.; Santosh, M.; Galindo Francisco, C.; Lopez Martinez, M.; Gourgaud, A.; Arai, S.			Late Miocene K-rich volcanism in the Eslamieh Peninsula (Saray), NW Iran: Implications for geodynamic evolution of the Turkish-Iranian High Plateau	GONDWANA RESEARCH			English	Article						High-K lavas; Geochemistry; Sr-Nd-Pb isotopes; Post-collisional magmatism; Iran	MASSIF EASTERN PONTIDES; NE TURKEY; ULTRAPOTASSIC ROCKS; TRACE-ELEMENT; GARNET PERIDOTITES; OROGENIC BELT; ARC MAGMAS; SUBDUCTED LITHOSPHERE; MEDITERRANEAN REGION; CHEMICAL-COMPOSITION	Post-collisional volcanism in northwestern Iran is represented by the Saray high-K rocks including leucite-bearing under-saturated and leucite-free silica saturated rocks. We report Ar-Ar age data which constrain the age as ca. 11 Ma (late Miocene). Most of clinopyroxene phenocrysts from the volcanic rocks have complex oscillatory zoning, with high Ti and Al cores, low Ti and high Al mantled clinopyroxenes, grading into low Ti and Al outer rims. All the rocks are highly enriched in incompatible trace elements and have identical Sr-Nd-Pb isotopes. Enrichment in incompatible elements and other geochemical features for the Saray lavas suggest a metasomatized subcontinental lithospheric mantle (SCLM) as the magma source. The negative Nb-Ta-Ti anomalies for the Saray lavas compare with the features of subduction-related magmatism with negligible contamination with ancient crustal components. The highly radiogenic Sr-87/Sr-86 and Pb-207/Pb-204 isotopic values of the Saray lavas imply the involvement of slab terrigenous sediments and/or a continental lithosphere. Isotopically, the volcanic rocks define a binary trend, representing 5-8% mixing between the primary mantle and sediment melts. Our melting models suggest residual garnet in the source and are incompatible with partial melting of amphibole and/or phlogopite bearing lherzolites, although the complex geochemical features might indicate the result of mixing between melts produced by different sources or a homogenous melt passing through a compositionally-zoned mantle during multiple stages of partial melting and melt migration. The geochronological, geochemical and isotopic data for the Saray rocks suggest that these Late Miocene magmas were derived from a small degree of partial melting of subduction-metasomatized (subcontinental) lithospheric mantle source in a post-collisional setting. (C) 2013 International Association for Gondwana Research. Published by Elsevier B.V. All rights reserved.	[Moghadam, H. Shafaii; Ghorbani, G.] Damghan Univ, Sch Earth Sci, Damghan 3671641167, Iran; [Khedr, M. Zaki; Arai, S.] Kanazawa Univ, Dept Earth Sci, Kanazawa, Ishikawa 9201192, Japan; [Khedr, M. Zaki] Kafrelsheikh Univ, Fac Sci, Dept Geol, Kafr Al Sheikh, Egypt; [Fazlnia, N.] Urumieh Univ, Dept Geol, Urumieh, Iran; [Chiaradia, M.] Univ Geneva, Dept Mineral, Geneva, Switzerland; [Eyuboglu, Y.] Karadeniz Tech Univ, Dept Geol Engn, TR-1080 Trabzon, Turkey; [Santosh, M.] China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; [Galindo Francisco, C.] Univ Complutense Madrid, IGEO UCM CSIC, Dept Petrol & Geoquim, E-28040 Madrid, Spain; [Lopez Martinez, M.] Ctr Invest Cientif & Educac Super Ensenada, Dept Geol, Ensenada 22860, Baja California, Mexico; [Gourgaud, A.] Univ Clermont Ferrand, CNRS, OPGC, UMR Magmas & Volcans 6524, F-63038 Clermont Ferrand, France	Moghadam, HS (reprint author), Damghan Univ, Sch Earth Sci, Damghan 3671641167, Iran.	hadishafaii@du.ac.ir	Santosh, M/B-2563-2012		Damghan University (Iran)	We thank Prof. Zeming Zhang for his efficient editorial handling and two anonymous referees for their helpful comments which enhanced the scientific value of this paper. Partial support from Damghan University (Iran) is acknowledged. The first author (HSM) thanks Y. Ersoy for providing him the latest version of FC-AFC-FCA and mixing modeler software. Special thanks go to M.A. Gracia for the assistance during mass spectrometry and A.S. Rosas Montoya and V.M. Perez Arroyo for the sample preparation during the Ar-Ar dating. Sh. Shahabi is thanked for the assistance during the field work. We thank also S. Moghadasi and A. Torabi for their help during the thin section and microphotograph preparations. This study also contributes to the 1000 Talent Award from the Chinese Government to M. Santosh.	Alici Sen P., 2004, J VOLCANOLOGY GEOTHE, V85, P423; Allen B.M., 2002, GEOLOGY, V30, P775; Altunkaynak S, 2012, GONDWANA RES, V21, P961, DOI 10.1016/j.gr.2011.10.010; Altunkaynak S, 2008, LITHOS, V102, P316, DOI 10.1016/j.lithos.2007.06.003; Yilmaz Y, 1998, J VOLCANOL GEOTH RES, V85, P173, DOI 10.1016/S0377-0273(98)00055-9; Sapienza GT, 2009, CONTRIB MINERAL PETR, V158, P401, DOI 10.1007/s00410-009-0389-2; Eyuboglu Y, 2011, LITHOS, V121, P151, DOI 10.1016/j.lithos.2010.10.012; Hassanzadeh J, 2008, TECTONOPHYSICS, V451, P71, DOI 10.1016/j.tecto.2007.11.062; Eyuboglu Y, 2010, GONDWANA RES, V18, P230, DOI 10.1016/j.gr.2010.01.008; Prelevic D, 2008, GEOCHIM COSMOCHIM AC, V72, P2125, DOI 10.1016/j.gca.2008.01.029; DEWEY JF, 1973, GEOL SOC AM BULL, V84, P3137, DOI 10.1130/0016-7606(1973)84<3137:PTATEO>2.0.CO;2; Eyuboglu Y, 2006, GEOL CARPATH, V57, P337; Lu YJ, 2012, GONDWANA RES, V22, P737, DOI 10.1016/j.gr.2011.11.016; MULLER B, 1992, J GEOPHYS RES-SOL EA, V97, P11783, DOI 10.1029/91JB01096; Zhao ZD, 2009, LITHOS, V113, P190, DOI 10.1016/j.lithos.2009.02.004; Yilmaz Y, 2001, J GEODYN, V31, P243, DOI 10.1016/S0264-3707(01)00002-3; MCCULLOCH MT, 1991, EARTH PLANET SC LETT, V102, P358, DOI 10.1016/0012-821X(91)90029-H; Carpentier M, 2009, EARTH PLANET SC LETT, V287, P86, DOI 10.1016/j.epsl.2009.07.043; [Anonymous], 2013, GEOSCI FRONT, DOI DOI 10.1016/j.gsf.2012.10.001; BUDDINGTON AF, 1964, J PETROL, V5, P310; Rampone E, 2001, J PETROL, V42, P207, DOI 10.1093/petrology/42.1.207; Conceicao RV, 2004, LITHOS, V72, P209, DOI 10.1016/j.lithos.2003.09.003; ADAMIA SA, 1977, TECTONOPHYSICS, V40, P183, DOI 10.1016/0040-1951(77)90065-8; Frezzotti ML, 2009, CHEM GEOL, V262, P108, DOI 10.1016/j.chemgeo.2009.02.015; FOLEY S, 1992, LITHOS, V28, P435, DOI 10.1016/0024-4937(92)90018-T; Eyuboglu Y, 2012, LITHOS, V146, P218, DOI 10.1016/j.lithos.2012.04.034; GULEC N, 1991, GEOL MAG, V128, P417; LEBAS MJ, 1986, J PETROL, V27, P745; Omrani J, 2008, LITHOS, V106, P380, DOI 10.1016/j.lithos.2008.09.008; Eyuboglu Y, 2007, INT GEOL REV, V49, P1103, DOI 10.2747/0020-6814.49.12.1103; DERCOURT J, 1986, TECTONOPHYSICS, V123, P241, DOI 10.1016/0040-1951(86)90199-X; Eyuboglu Y, 2011, GONDWANA RES, V19, P413, DOI 10.1016/j.gr.2010.07.006; PEARCE JA, 1990, J VOLCANOL GEOTH RES, V44, P189, DOI 10.1016/0377-0273(90)90018-B; [Anonymous], 1992, AAPG MEMOIR; CONTICELLI S, 1990, LITHOS, V24, P305; MORIMOTO N, 1988, MINERAL MAG, V52, P535, DOI 10.1180/minmag.1988.052.367.15; FOLEY SF, 1987, EARTH-SCI REV, V24, P81, DOI 10.1016/0012-8252(87)90001-8; Pang KN, 2013, TERRA NOVA, V25, P405, DOI 10.1111/ter.12050; Perini G, 2004, J PETROL, V45, P139, DOI 10.1093/petrology/egg084; TSUCHIYAMA A, 1985, CONTRIB MINERAL PETR, V89, P1, DOI 10.1007/BF01177585; Plank T, 1998, CHEM GEOL, V145, P325, DOI 10.1016/S0009-2541(97)00150-2; Moghadam HS, 2011, GEOL MAG, V148, P762, DOI 10.1017/S0016756811000410; SENGOR AMC, 1981, TECTONOPHYSICS, V75, P181, DOI 10.1016/0040-1951(81)90275-4; DEPAOLO DJ, 1981, EARTH PLANET SC LETT, V53, P189, DOI 10.1016/0012-821X(81)90153-9; Agard P, 2005, INT J EARTH SCI, V94, P401, DOI 10.1007/s00531-005-0481-4; Hawkesworth CJ, 1997, SCIENCE, V276, P551, DOI 10.1126/science.276.5312.551; Prelevic D, 2005, J PETROL, V46, P1443, DOI 10.1093/petrology/egi022; Gregoire M, 2002, CONTRIB MINERAL PETR, V142, P603, DOI 10.1007/s00410-001-0315-8; Zhang RY, 2008, CHEM GEOL, V255, P250, DOI 10.1016/j.chemgeo.2008.06.049; HART SR, 1984, NATURE, V309, P753, DOI 10.1038/309753a0; Hofmann AW, 1996, J GEOPHYS RES-SOL EA, V101, P11831, DOI 10.1029/95JB03701; HARTMANN G, 1993, GEOCHIM COSMOCHIM AC, V57, P1761, DOI 10.1016/0016-7037(93)90112-A; CONTICELLI S, 1992, LITHOS, V28, P221, DOI 10.1016/0024-4937(92)90008-M; PEARCE JA, 1973, EARTH PLANET SC LETT, V19, P290, DOI 10.1016/0012-821X(73)90129-5; Conticelli S, 2009, LITHOS, V107, P68, DOI 10.1016/j.lithos.2008.07.016; Dilek Y, 2009, GEOL SOC SPEC PUBL, V311, P213, DOI 10.1144/SP311.8; Chiu HY, 2013, LITHOS, V162, P70, DOI 10.1016/j.lithos.2013.01.006; DEFANT MJ, 1990, NATURE, V347, P662, DOI 10.1038/347662a0; Kheirkhah M, 2009, J VOLCANOL GEOTH RES, V182, P1, DOI 10.1016/j.jvolgeores.2009.01.026; Walter MJ, 1998, J PETROL, V39, P29, DOI 10.1093/petrology/39.1.29; Okay AI, 1997, AAPG MEMOIR, V68, P291; HART SR, 1992, SCIENCE, V256, P517, DOI 10.1126/science.256.5056.517; CONTICELLI S, 1992, EUR J MINERAL, V4, P1359; Aldanmaz E, 2000, J VOLCANOL GEOTH RES, V102, P67, DOI 10.1016/S0377-0273(00)00182-7; Ersoy EY, 2010, J VOLCANOL GEOTH RES, V198, P112, DOI 10.1016/j.jvolgeores.2010.08.014; Eyuboglu Y, 2010, INT GEOL REV, V52, P142, DOI 10.1080/00206810902757164; PEARCE JA, 1995, ANNU REV EARTH PL SC, V23, P251, DOI 10.1146/annurev.ea.23.050195.001343; Pe-Piper G, 2009, GEOL SOC AM BULL, V121, P39, DOI 10.1130/B26317.1; Aldanmaz E, 2006, LITHOS, V86, P50, DOI 10.1016/j.lithos.2005.04.003; Castillo PR, 1999, CONTRIB MINERAL PETR, V134, P33, DOI 10.1007/s004100050467; Bektas O, 1999, GEOL J, V34, P95, DOI 10.1002/(SICI)1099-1034(199901/06)34:1/2<95::AID-GJ816>3.0.CO;2-J; ZINDLER A, 1986, ANNU REV EARTH PL SC, V14, P493, DOI 10.1146/annurev.earth.14.1.493; HEMPTON MR, 1987, TECTONICS, V6, P687, DOI 10.1029/TC006i006p00687; Dilek Y, 2010, INT GEOL REV, V52, P536, DOI 10.1080/00206810903360422; NELSON ST, 1992, AM MINERAL, V77, P1242; [Anonymous], 1993, GEOL SOC SPEC PUBL; Allen MB, 2013, J PETROL, V54, P887, DOI 10.1093/petrology/egs090; Jahangiri A, 2007, J ASIAN EARTH SCI, V30, P433, DOI 10.1016/j.jseaes.2006.11.008; Dokuz A, 2011, GONDWANA RES, V19, P926, DOI 10.1016/j.gr.2010.09.006; Handley HK, 2011, EARTH PLANET SC LETT, V304, P212, DOI 10.1016/j.epsl.2011.01.034; Prelevic D, 2007, EARTH PLANET SC LETT, V256, P120, DOI 10.1016/j.epsl.2007.01.018; PECCERILLO A, 1976, CONTRIB MINERAL PETR, V58, P63, DOI 10.1007/BF00384745; FARLEY KA, 1992, EARTH PLANET SC LETT, V111, P183, DOI 10.1016/0012-821X(92)90178-X; DEFANT MJ, 1993, GEOLOGY, V21, P547, DOI 10.1130/0091-7613(1993)021<0547:MSHPEO>2.3.CO;2; Bell K., 2004, T AGU, V85, P541; Bell K, 2013, J S AM EARTH SCI, V41, P22, DOI 10.1016/j.jsames.2012.10.005; BERBERIAN M, 1981, CAN J EARTH SCI, V18, P210, DOI 10.1139/e81-019; Bianchini G, 2010, MINER PETROL, V98, P111, DOI 10.1007/s00710-009-0056-3; CELLAI D, 1994, CONTRIB MINERAL PETR, V116, P301, DOI 10.1007/BF00306499; Chorowicz J., 1998, 3 INT TURK GEOL S AN, P258; Conticelli S, 1997, J VOLCANOL GEOTH RES, V75, P107, DOI 10.1016/S0377-0273(96)00062-5; Conticelli S., 2012, CHEM GEOLOGY; Conticelli S, 2011, MINER PETROL, V103, P123, DOI 10.1007/s00710-011-0161-y; Didon J., 1976, THESIS U GRENOBLE FR; DOSTAL J, 1978, CHEM GEOL, V22, P31, DOI 10.1016/0009-2541(78)90019-0; Elitok O, 2010, INT GEOL REV, V52, P454, DOI 10.1080/00206810902951411; Ersoy EY, 2010, COMPUT GEOSCI, V36, P383; Ersoy E.Y., 2012, J VOLCANOLOGY GEOTHE, V241-242, P21; Ersoy E.Y., 2008, CHEM GEOL, V255, P265; Ersoy E.Y., 2012, CONTRIB MINERAL PETR, V163, P379; Eyuboglu Y, 2011, J GEOL, V119, P394, DOI 10.1086/660158; Eyuboglu Y., 2011, GEOSCIENCE FRONTIERS, V2, P49, DOI 10.1016/j.gsf.2010.12.004; Yener Eyuboglu, 2013, [Geoscience Frontiers, 地学前缘], V4, P349; Eyuboglu Y, 2011, J GEODYN, V52, P2, DOI 10.1016/j.jog.2010.11.006; Eyuboglu Y, 2013, GONDWANA RES, V24, P742, DOI 10.1016/j.gr.2012.11.014; Gasparon M, 1998, MINER PETROL, V64, P89, DOI 10.1007/BF01226565; HAWKESWORTH CJ, 1991, PHILOS T ROY SOC A, V335, P393, DOI 10.1098/rsta.1991.0054; Kelemen P.B., 2004, OMAN OPHIOLITE MIDOC; Keskin M, 1998, J VOLCANOL GEOTH RES, V85, P355, DOI 10.1016/S0377-0273(98)00063-8; Keskin M, 2003, GEOPHYS RES LETT, V30, P1, DOI 10.1029/2003GL018019; Khedr MZ, 2010, LITHOS, V119, P439, DOI 10.1016/j.lithos.2010.07.021; Maden N., 2013, GEOSCIENCE FRONTIERS; MITCHELL R. H., 1991, PETROLOGY LAMPROITES; MITCHELL RH, 1994, LITHOS, V32, P243, DOI 10.1016/0024-4937(94)90042-6; Moghadam HS, 2012, ISL ARC, V21, P202, DOI 10.1111/j.1440-1738.2012.00815.x; MOINEVAZIRI H, 1991, CR ACAD SCI II, V313, P1603; Pearce J.A, 1982, ANDESITES, P525; Prelevic D, 2012, J PETROL, V53, P1019, DOI 10.1093/petrology/egs008; Prelevic D, 2004, J PETROL, V45, P759, DOI 10.1093/petrology/egg109; Rock N.M.S., 1987, GEOL SOC LOND SPEC P, V30, P191, DOI 10.1144/GSL.SP.1987.030.01.09; Schreyer W., 1987, MAGMATIC PROCESSES P, P155; Sengor A. M. C., 1996, TECTONIC EVOLUTION A; Shafaii Moghadam H., 2013, GONDWANA RES; Shahabi Sh., 2013, THESIS DAMGHAN U; Sorensen H., 1999, GEOLINES, V9, P114; Temel A, 1998, J VOLCANOL GEOTH RES, V85, P327, DOI 10.1016/S0377-0273(98)00062-6; Tommasini S, 2011, EARTH PLANET SC LETT, V301, P469, DOI 10.1016/j.epsl.2010.11.023; Turner S, 1996, J GEOPHYS RES-SOL EA, V101, P11503, DOI 10.1029/96JB00430; Workman R.K., 2004, GEOCHEMISTRY GEOPHYS; Yilmaz Y., 1997, AAPG MEMOIR, V68	130	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1342-937X	1878-0571		GONDWANA RES	Gondwana Res.	NOV	2014	26	3-4					1028	1050		10.1016/j.gr.2013.09.015		23	Geosciences, Multidisciplinary	Geology	AQ1EH	WOS:000342524200013		
J	Okada, K				Okada, Kanzo			Electromagnetic fluctuations from a nonlocal continuum point of view	INTERNATIONAL JOURNAL OF ENGINEERING SCIENCE			English	Article						Nonlocal electromagnetic continua; Electromagnetic fluctuations; Fluctuation-dissipation theorem; Photon Green's function; Casimir forces		In the present paper it is shown that the theory of electromagnetic fluctuations in arbitrary media developed by Landau and Lifshitz using the methods of quantum field theory in statistical physics can also be derived by the nonlocal theory of electromagnetic solids without resorting to what is known as random fields or stochastic inductions introduced by the former approach. The electrodynamics of memory-dependent nonlocal continua is shown to lead in a natural way to the partial differential equation, associated with the Maxwell-Ampere's law, for the retarded photon Green's function, in terms of which Casimir forces can be calculated for neutral bodies. In the process of derivation, the inverse of nonlocal electric conduction moduli is found to be matched suitably with the generalized susceptibilities of the fluctuation-dissipation theorem of statistical physics. (C) 2014 Elsevier Ltd. All rights reserved.	Kyushu Univ, Inst Math Ind, Nishi Ku, Fukuoka 8190395, Japan	Okada, K (reprint author), Kyushu Univ, Inst Math Ind, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	okada@imi.kyushu-u.ac.jp					Rodriguez AW, 2011, NAT PHOTONICS, V5, P211, DOI [10.1038/nphoton.2011.39, 10.1038/NPHOTON.2011.39]; Eringen A. C., 1980, MECH CONTINUA; Eringen AC, 2002, NONLOCAL CONTINUUM F; Johnson S. G., 2011, LECT NOTE PHYS, V834, P175; Landau L. D., 1960, ELECTRODYNAMICS CONT; Lifshitz E M, 1980, STAT PHYS 2; Rytov S.M., 1953, THEORY ELECT FLUCTUA	7	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7225	1879-2197		INT J ENG SCI	Int. J. Eng. Sci.	NOV	2014	84						127	132		10.1016/j.ijengsci.2014.06.016		6	Engineering, Multidisciplinary	Engineering	AP7JA	WOS:000342252400010		
J	Kikugawa, G; Ohara, T; Kawaguchi, T; Kinefuchi, I; Matsumoto, Y				Kikugawa, Gota; Ohara, Taku; Kawaguchi, Tohru; Kinefuchi, Ikuya; Matsumoto, Yoichiro			A molecular dynamics study on heat conduction characteristics inside the alkanethiolate SAM and alkane liquid	INTERNATIONAL JOURNAL OF HEAT AND MASS TRANSFER			English	Article						Molecular dynamics simulation; Heat conduction; Self-assembled monolayer; Solid-liquid interface	SELF-ASSEMBLED MONOLAYERS; THERMAL CONDUCTANCE; SIMULATION; GOLD; SURFACES; METAL; DNA; AU(111); MODEL; FILMS	In the present study, we performed molecular dynamics (MD) simulations of the self-assembled monolayer (SAM) and alkane solvent interface. In particular, 1-dodecanethiol (C12H25S-) SAM chemisorbed on a gold substrate contacting with n-dodecane (C12H26) solvent was examined to compare the heat transfer mechanisms inside both the SAM and solvent phases from a microscopic viewpoint. The nonequilibrium MD (NEMD) simulation, in which a constant heat flux across the SAM interface was imposed, was performed. Here, we introduced the novel approach to clarify the molecular-scale mechanism on heat conduction in both SAM and alkane solvent. This approach enables us to decompose the macroscopic heat flux into the microscopic "building blocks", i.e., the contribution of energy transfer associated with molecular motion and those of energy exchange by intermolecular (nonbonded) and intramolecular (covalent bond) interactions. Interestingly, we have obviously demonstrated that inside the SAM layer, almost all of the energy is transferred by the intramolecular interaction along the alkyl chain. On the other hand, inside the alkane liquid, the intramolecular and intermolecular interactions have similar contributions to the total heat flux in spite of the same molecular structure and alkyl chain length as the SAM molecules. This striking difference in heat conduction mechanism originates from the ordering structure of alkyl chains in the SAM layer. (C) 2014 Elsevier Ltd. All rights reserved.	[Kikugawa, Gota; Ohara, Taku] Tohoku Univ, Inst Fluid Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Kawaguchi, Tohru] DENSO CORP, Nisshin, Aichi 4700111, Japan; [Kinefuchi, Ikuya; Matsumoto, Yoichiro] Univ Tokyo, Dept Mech Engn, Bunkyo Ku, Tokyo 1138656, Japan	Kikugawa, G (reprint author), Tohoku Univ, Inst Fluid Sci, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	kikugawa@microheat.ifs.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [23760172]	This research has been supported by Grant-in-Aid for Young Scientists (B) (No. 23760172) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) to GK. Numerical simulations were performed on the SGI Altix 3700x2 and Altix UV1000 at the Advanced Fluid Information Research Center, Institute of Fluid Science, Tohoku University.	Gohler B, 2011, SCIENCE, V331, P894, DOI 10.1126/science.1199339; Sasikumar K, 2011, J APPL PHYS, V109, DOI 10.1063/1.3592296; Zhang Y, 2010, PHYS CHEM CHEM PHYS, V12, P4435, DOI 10.1039/b923858c; LAIBINIS PE, 1992, J AM CHEM SOC, V114, P9022, DOI 10.1021/ja00049a038; Nakano T, 2013, J HEAT TRANS-T ASME, V135, DOI 10.1115/1.4023572; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; MAR W, 1994, LANGMUIR, V10, P188, DOI 10.1021/la00013a028; Zhang T, 2012, J APPL PHYS, V112, DOI 10.1063/1.4759293; Liu J, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.104307; Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357; Nath SK, 1998, J CHEM PHYS, V108, P9905, DOI 10.1063/1.476429; LINCOLN RC, 1967, PHYS REV, V157, P463, DOI 10.1103/PhysRev.157.463; Schreiber F, 2000, PROG SURF SCI, V65, P151, DOI 10.1016/S0079-6816(00)00024-1; Shen S, 2010, NAT NANOTECHNOL, V5, P251, DOI 10.1038/nnano.2010.27; SELLERS H, 1993, J AM CHEM SOC, V115, P9389, DOI 10.1021/ja00074a004; Jund P, 1999, PHYS REV B, V59, P13707, DOI 10.1103/PhysRevB.59.13707; Wang RY, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2358856; Smits ECP, 2008, NATURE, V455, P956, DOI 10.1038/nature07320; Henry A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.235502; Wang ZH, 2007, SCIENCE, V317, P787, DOI 10.1126/science.1145220; Henry A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.144305; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Liu J, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.174122; Singh RA, 2008, WEAR, V265, P42, DOI 10.1016/j.wear.2007.08.016; Torii D, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2821963; Jadzinsky PD, 2007, SCIENCE, V318, P430, DOI 10.1126/science.1148624; Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789; Zhang LZ, 2002, J CHEM PHYS, V117, P7342, DOI 10.1063/1.1507777; DUBOIS LH, 1992, ANNU REV PHYS CHEM, V43, P437, DOI 10.1146/annurev.pc.43.100192.002253; LAIBINIS PE, 1991, J AM CHEM SOC, V113, P7152, DOI 10.1021/ja00019a011; Zhuang YX, 2007, J MICROELECTROMECH S, V16, P1451, DOI 10.1109/JMEMS.2007.904342; O'Brien PJ, 2013, NAT MATER, V12, P118, DOI [10.1038/nmat3465, 10.1038/NMAT3465]; BALASUBRAMANIAN S, 1995, J CHEM PHYS, V103, P3184, DOI 10.1063/1.470251; BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801; Kaur S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4082; Kikugawa G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3077315; Kikugawa G., 2014, ASME J HEAT TRANSFER, V136; Manikandan P, 2011, J PHYS CHEM C, V115, P9622, DOI 10.1021/jp200672e; Mao YD, 2007, NAT NANOTECHNOL, V2, P366, DOI 10.1038/nnano.2007.148; Nagaraju DH, 2008, LANGMUIR, V24, P13855, DOI 10.1021/la803156a; Nakamura F, 2003, NANO LETT, V3, P1083, DOI 10.1021/nl0342794; Nakano T., 2011, J CHEM PHYS, V133; Ohara T, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3613648; Pal S, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3678848; RAPPE AK, 1992, J AM CHEM SOC, V114, P10024, DOI 10.1021/ja00051a040; Shevade AV, 2001, LANGMUIR, V17, P7566, DOI 10.1021/la0108151; Vargaftik N. B., 1994, HDB THERMAL CONDUCTI; Zhang QX, 2002, J CHEM PHYS, V117, P808, DOI 10.1063/1.1483297	48	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0017-9310	1879-2189		INT J HEAT MASS TRAN	Int. J. Heat Mass Transf.	NOV	2014	78						630	635		10.1016/j.ijheatmasstransfer.2014.07.040		6	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	AP7HO	WOS:000342248600068		
J	Liu, HZ; Nagano, K				Liu, Hongzhi; Nagano, Katsunori			Numerical simulation of an open sorption thermal energy storage system using composite sorbents built into a honeycomb structure	INTERNATIONAL JOURNAL OF HEAT AND MASS TRANSFER			English	Article						Composite mesoporous material; Open sorption thermal energy storage; Heat and mass transfer; Linear driving force model (LDF)	DESICCANT WHEELS; MASS-TRANSFER; AIR DEHUMIDIFICATION; ENTHALPY RECOVERY; CALCIUM-CHLORIDE; WATER SORPTION; COOLING SYSTEM; HEAT-STORAGE; PERFORMANCE	A new composite mesoporous honeycomb material was developed to be a thermal energy storage medium that can contact the functional fluid directly. In our previous study, this honeycombed composite material acted as a promising sorption thermal energy storage medium in an open system, exhibiting a lower regeneration temperature as 80 degrees C, high volumetric heat storage density, and high stability. In the present study, a one-dimensional transient model was used to predict both the heat storage process (desorption process) and heat release process (sorption process) occurring in the open sorption thermal energy storage unit. Our model was validated using the experimental results obtained in our previous experiments, and a close agreement was observed for the sorption process. Some discrepancy was observed in the desorption process, but it has been explained. The sorption and desorption processes were simulated repeatedly for 20 cycles, whose result was also compared with the experimental result. The operating parameters of the open thermal energy storage system were evaluated to determine its operation performance. Finally, our open thermal energy storage system was assumed to be incorporated into a paint-drying system, within which the heat storage unit is regenerated for 10 h by the exhaust heat produced by a blower in the daytime and releases its stored heat during the nighttime for 14 h. The simulation result shows that almost 51.3% of the blower's waste heat can be reutilized if the proposed thermal energy storage system is incorporated. (C) 2014 Elsevier Ltd. All rights reserved.	[Liu, Hongzhi; Nagano, Katsunori] Hokkaido Univ, Environm Syst Res Lab, Sapporo, Hokkaido 0608628, Japan	Liu, HZ (reprint author), Hokkaido Univ, Environm Syst Res Lab, N13-W8, Sapporo, Hokkaido 0608628, Japan.				Ministry of Education, Culture, Sports, Science and Technology in Japan	The authors would like to thank Dr. Togawa and Dr. Nabeshima, researchers from Hokkaido University, and Mr. Sugiyama, a master's student, for their help with both experiments and simulations. Financial support from the Ministry of Education, Culture, Sports, Science and Technology in Japan is greatly appreciated.	Ge TS, 2010, APPL THERM ENG, V30, P1005, DOI 10.1016/j.applthermaleng.2010.01.012; SLADEK KJ, 1974, IND ENG CHEM FUND, V13, P100, DOI 10.1021/i160050a002; Fedorov AG, 1999, INT J HEAT MASS TRAN, V42, P803, DOI 10.1016/S0017-9310(98)00228-2; Yamaguchi S, 2013, INT J HEAT MASS TRAN, V60, P51, DOI 10.1016/j.ijheatmasstransfer.2012.12.036; Majumdar P, 1998, SOL ENERGY, V62, P1, DOI 10.1016/S0038-092X(97)00080-7; Zhang LZ, 2002, APPL THERM ENG, V22, P1347, DOI 10.1016/S1359-4311(02)00050-9; Zhu DS, 2006, INT J THERM SCI, V45, P804, DOI 10.1016/j.ijthermalsci.2005.10.009; SAKODA A, 1984, J CHEM ENG JPN, V17, P52, DOI 10.1252/jcej.17.52; Wu HJ, 2007, SOL ENERGY, V81, P864, DOI 10.1016/j.solener.2006.11.013; Zhang XJ, 2003, APPL THERM ENG, V23, P989, DOI 10.1016/S1359-4311(03)00047-4; Niu JL, 2002, INT COMMUN HEAT MASS, V29, P255, DOI 10.1016/S0735-1933(02)00316-0; Aristov YI, 1996, REACT KINET CATAL L, V59, P325, DOI 10.1007/BF02068130; Gao ZM, 2005, HEAT MASS TRANSFER, V41, P1033, DOI 10.1007/s00231-005-0663-4; Balasubramanian G, 2010, INT J HEAT MASS TRAN, V53, P5700, DOI 10.1016/j.ijheatmasstransfer.2010.08.012; Cengel Y., 2003, HEAT TRANSFER PRACTI, P759; CHAROENSUPAYA D, 1988, ENERGY, V13, P739, DOI 10.1016/0360-5442(88)90106-5; Dincer I, 2002, INT J ENERG RES, V26, P567, DOI 10.1002/er.805; Karger J., 2012, DIFFUSION NANOPOROUS, V2, P85; Liu HZ, 2013, INT J HEAT MASS TRAN, V65, P471, DOI 10.1016/j.ijheatmasstransfer.2013.06.021; Ostrovskii NM, 2007, THEOR FOUND CHEM ENG, V41, P200, DOI 10.1134/S0040579507020145; Ostrovskii NM, 2007, THEOR FOUND CHEM ENG, V41, P83, DOI 10.1134/S0040579507010095; Suzuki M., 1990, ADSORPTION ENG; Tsujiguchi T., 2012, P JAP SOC REFR AIR C, P107; ZHENG W, 1993, NUMER HEAT TR A-APPL, V23, P211, DOI 10.1080/10407789308913669; Wu HJ, 2009, INT J HEAT MASS TRAN, V52, P5262, DOI 10.1016/j.ijheatmasstransfer.2009.05.016; Xing H.H., 2000, THESIS MIT; Zhai C, 2008, PERFORMANCE MODELING; ZHENG W, 1995, J SOL ENERG-T ASME, V117, P40, DOI 10.1115/1.2847724	28	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0017-9310	1879-2189		INT J HEAT MASS TRAN	Int. J. Heat Mass Transf.	NOV	2014	78						648	661		10.1016/j.ijheatmasstransfer.2014.07.034		14	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	AP7HO	WOS:000342248600070		
J	Yang, YH; Hong, CP; Morini, GL; Asako, Y				Yang, Yahui; Hong, Chungpyo; Morini, Gian Luca; Asako, Yutaka			Experimental and numerical investigation of forced convection of subsonic gas flows in microtubes	INTERNATIONAL JOURNAL OF HEAT AND MASS TRANSFER			English	Article						Micro convection; Nusselt number; Flow compressibility; Kinetic energy; Mach number	HEAT-TRANSFER CHARACTERISTICS; GASEOUS FLOWS; MICROCHANNELS; TEMPERATURE; LAMINAR; CHANNELS; WALL	The aim of this paper is to investigate the impact of gas compressibility on forced convection through commercial stainless steel microtubes with an inner diameter of 750 mu m, 510 mu m and 170 mu m by combining experimental data with numerical simulations. The analysis covers both transitional and turbulent flow regimes (3000 < Re < 12,000). The results have evidenced that compressibility effects can significantly enhance convective heat transfer when the gas flow is heated by the walls (H boundary condition). This enhancement turns out to be more remarkable for microtubes with smaller inner diameter (lower than 200 mu m). In order to explore in-depth the heat transfer mechanism along the microtube in presence of non negligible compressibility effects, the experimental data have been integrated with the numerical results obtained by modeling the fluid flow through the microtube with the adoption of the Arbitrary-Lagrangian-Eulerian (ALE) method and the Lam-Bremhorst Low-Reynolds number turbulence model in order to evaluate eddy viscosity coefficient and turbulence energy within the gas flow. The results presented in this work put in evidence that the integration of the experimental data with the numerical results is strongly beneficial in order to obtain a deep investigation of the physics of micro convection for compressible flows. The experimental values of the Nusselt numbers obtained for three different microtubes have been compared with both classical correlations validated for conventional pipes and specific correlations proposed for microtubes. This comparison highlights that the conventional correlations still holds for gas flow convection through microtubes when the compressibility effect is not significant. On the contrary, when compressibility is no longer negligible, the conventional correlations tend to underestimate the value of the Nusselt number. It is also demonstrated that the specific correlations proposed for the prediction of the Nusselt number in microtubes fail in presence of strong compressibility effects. (c) 2014 Elsevier Ltd. All rights reserved.	[Yang, Yahui; Morini, Gian Luca] Univ Bologna, DIN, Alma Mater Studiorum, I-40136 Bologna, Italy; [Hong, Chungpyo] Kagoshima Univ, Dept Mech Engn, Kagoshima 890, Japan; [Asako, Yutaka] Tokyo Univ Sci, Dept Mech Engn, Tokyo 162, Japan	Morini, GL (reprint author), Univ Bologna, DIN, Sch Engn & Architecture, Alma Mater Studiorum, Viale Risorgimento 2, I-40136 Bologna, Italy.	gianluca.morini3@unibo.it			European Community [215504]; Italian PRIN	This research has received funding from the European Community's Seventh Framework Programme 2007-2012 under Grant agreement No. 215504 and Italian PRIN 2009.	GNIELINSKI V, 1995, FORSCH INGENIEURWES, V61, P240, DOI 10.1007/BF02607964; Lijo V, 2012, INT J HEAT MASS TRAN, V55, P701, DOI 10.1016/j.ijheatmasstransfer.2011.10.040; Sieder EN, 1936, IND ENG CHEM, V28, P1429, DOI 10.1021/ie50324a027; Colin S, 2012, J HEAT TRANS-T ASME, V134, DOI 10.1115/1.4005063; Morini GL, 2006, HEAT TRANSFER ENG, V27, P64, DOI 10.1080/01457630500523865; WU P, 1984, CRYOGENICS, V24, P415, DOI 10.1016/0011-2275(84)90015-8; Morini GL, 2004, INT J THERM SCI, V43, P631, DOI 10.1016/j.ijthermalsci.2004.01.003; Hetsroni G, 2005, INT J HEAT MASS TRAN, V48, P5580, DOI 10.1016/j.ijheatmasstransfer.2005.05.041; Chen C.W., 2011, P 9 ASME INT C NAN M; Yang CY, 2012, EXP THERM FLUID SCI, V37, P12, DOI 10.1016/j.expthermflusci.2011.09.003; Choi S.B., 1991, ASME DSC, V32, P123; Croce G, 2009, INT J THERM SCI, V48, P252, DOI 10.1016/j.ijthermalsci.2008.07.009; Dittus F. W., 1930, U CALIF BERKELEY PUB, V2, P443; Hara K., 2007, J ENV ENG, V2, P525, DOI 10.1299/jee.2.525; Hausen H, 1959, ALLG WARMETECH, V9-415, P75; Hong C, 2014, HEAT TRANSFER ENG, V35, P142, DOI 10.1080/01457632.2013.812482; Hong C, 2007, NUMER HEAT TR A-APPL, V52, P219, DOI 10.1080/10407780601149847; Hong C, 2007, INT J THERM SCI, V46, P1153, DOI 10.1016/j.ijthermalsci.2006.10.015; Hong C, 2012, J PHYS CONF SER, V362, DOI 10.1088/1742-6596/362/1/012022; Kandlikar SG, 2013, J HEAT TRANS-T ASME, V135, DOI 10.1115/1.4024354; Lin T.Y., 2014, ASME J HEAT TRANSFER, V135; Lin TY, 2012, J HEAT TRANS-T ASME, V134, DOI 10.1115/1.4004936; Lin TY, 2012, J HEAT TRANS-T ASME, V134, DOI 10.1115/1.4006844; Morini G.L., 2013, ASME J HEAT TRANSFER, V135; Morini GL, 2010, EXP HEAT TRANSFER, V23, P73, DOI 10.1080/08916150903402757; Yang Y., 2011, P 4 INT C HEAT TRANS; Yang YH, 2014, HEAT TRANSFER ENG, V35, P159, DOI 10.1080/01457632.2013.812489; Yu D., 1995, P ASME JSME THERM EN	28	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0017-9310	1879-2189		INT J HEAT MASS TRAN	Int. J. Heat Mass Transf.	NOV	2014	78						732	740		10.1016/j.ijheatmasstransfer.2014.07.017		9	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	AP7HO	WOS:000342248600077		
J	Messmer, B; Lemee, T; Ikebukuro, K; Ueno, I; Narayanan, R				Messmer, B.; Lemee, T.; Ikebukuro, K.; Ueno, I.; Narayanan, R.			Confined thermo-capillary flows in a double free-surface film with small Marangoni Numbers	INTERNATIONAL JOURNAL OF HEAT AND MASS TRANSFER			English	Article						Thermocapillary; Flow structures; Scaling; curved-surface heat transfer	THERMOCAPILLARY CONVECTION; SQUARE CAVITY	Experiments on double free-surface films with thermo-capillary forcing show two basic flow structures at low imposed Marangoni Numbers. Physical reasoning and simple scaling arguments are advanced to show that differences arise on account of the lower velocity gradient in the direction of the imposed temperature gradient. It is reasoned that these results originate from inevitable surface deformations. A restricted numerical model is presented that captures the main features of the flow and lends credence to our reasoning. (C) 2014 Elsevier Ltd. All rights reserved.	[Messmer, B.] Univ Florida, Gainesville, FL 32611 USA; Univ Paris 11, Orsay, France; Tokyo Univ Sci, Noda, Chiba 278, Japan	Messmer, B (reprint author), Univ Florida, Gainesville, FL 32611 USA.	bmessmer123@gmail.com			JSPS; NSF PIRE [0968313]; NASA [NNX11AC16G]; NSF [1402151]	We thank JSPS, NSF PIRE 0968313, NASA NNX11AC16G and NSF 1402151 for their generosity in providing students with support for research.	Schatz MF, 2001, ANNU REV FLUID MECH, V33, P93, DOI 10.1146/annurev.fluid.33.1.93; CARPENTER BM, 1989, J FLUID MECH, V207, P121, DOI 10.1017/S0022112089002521; Xu JY, 1998, J FLUID MECH, V364, P187, DOI 10.1017/S0022112098001232; PELTIER LJ, 1993, J FLUID MECH, V257, P339, DOI 10.1017/S0022112093003106; CARPENTER BM, 1990, PHYS FLUIDS A-FLUID, V2, P137, DOI 10.1063/1.857763; CHANDRASEKHAR S., 1961, HYDRODYNAMIC HYDROMA; EYER A, 1985, J CRYST GROWTH, V71, P173, DOI 10.1016/0022-0248(85)90059-4; Guo W., 2013, APPL CHEBYSHEV SPECT; Kuhlmann HC, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036303; Kuhlmann H.C., 1999, SPRINGER TRACTS MOD, V152; Labrosse G., 2011, METHODES SPECTRALES; LUIKOV A. V., 1968, ANAL HEAT DIFFUSION; Pettit D., 2003, SATURDAY MORNING SCI; Schwabe D., 1988, SUPERHARD MAT CONVEC, P75; Ueno I, 2010, ACTA ASTRONAUT, V66, P1017, DOI 10.1016/j.actaastro.2009.09.027; Watanabe T., 2011, P INT S TURBUL SHEAR, V2, P1; Yamamoto T., 2013, PHYS FLUIDS, V25; ZEBIB A, 1985, PHYS FLUIDS, V28, P3467, DOI 10.1063/1.865300	18	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0017-9310	1879-2189		INT J HEAT MASS TRAN	Int. J. Heat Mass Transf.	NOV	2014	78						1060	1067		10.1016/j.ijheatmasstransfer.2014.06.053		8	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	AP7HO	WOS:000342248600109		
J	Song, D; Erkan, N; Jo, B; Okamoto, K				Song, Daehun; Erkan, Nejdet; Jo, Byeongnam; Okamoto, Koji			Dimensional analysis of thermal stratification in a suppression pool	INTERNATIONAL JOURNAL OF MULTIPHASE FLOW			English	Article						Thermal stratification; Suppression pool; Direct contact condensation; Richardson number	DIRECT-CONTACT CONDENSATION; JET-PLUME CONDENSATION; STEAM-AIR MIXTURES; SUBCOOLED WATER; DISCHARGE	Due to complexity of direct contact condensation (DCC), it is difficult to predict the thermal hydraulic phenomenon in a suppression pool (SP) of LWRs. Especially, the momentum, induced at condensation interfaces, depends on several interrelated parameters such as the steam mass flux, subcooling, and the diameter of the injection nozzle. Complicated interaction of those parameters creates difficulties in developing a comprehensive analytical model, which applicable to various conditions. To investigate the criteria of thermal stratification created by DCC, experiments were performed using a downsized suppression pool. Time resolved temperatures were acquired by vertically aligned thermocouples. Additionally, steam bubbles were visualized by a high speed camera in order to examine bubble shapes according to the mass flux and subcooling. Both steam bubble frequency and amplitude were analyzed for different DCC regimes. Finally, Richardson number was chosen as a suitable parameter for the dimensional analysis of experimental results. Corresponding velocity at far field in synthetic jet theory was employed to calculate Richardson number. The criteria for the occurrence of the thermal stratification were clearly determined according to the Richardson number. (C) 2014 Elsevier Ltd. All rights reserved.	[Song, Daehun; Erkan, Nejdet; Jo, Byeongnam; Okamoto, Koji] Univ Tokyo, Nucl Profess Sch, Tokai, Ibaraki 3191188, Japan; [Song, Daehun] Univ Tokyo, Dept Human & Engineered Environm Studies, Kashiwa, Chiba 2778563, Japan	Song, D (reprint author), Univ Tokyo, Dept Human & Engineered Environm Studies, 5-1-5 Kashiwano Ha, Kashiwa, Chiba 2778563, Japan.	dhsong@vis.t.u-tokyo.ac.jp					Norman TL, 2010, NUCL ENG DES, V240, P524, DOI 10.1016/j.nucengdes.2009.09.019; de With AP, 2007, INT J HEAT MASS TRAN, V50, P1762, DOI 10.1016/j.ijheatmasstransfer.2006.10.017; LIANG KS, 1994, NUCL ENG DES, V147, P425, DOI 10.1016/0029-5493(94)90225-9; Gamble RE, 2001, NUCL ENG DES, V204, P321, DOI 10.1016/S0029-5493(00)00363-0; AYA I, 1987, NUCL ENG DES, V99, P31, DOI 10.1016/0029-5493(87)90105-1; Choo YJ, 2010, NUCL ENG DES, V240, P2215, DOI 10.1016/j.nucengdes.2009.11.028; BANKOFF SG, 1980, INT J MULTIPHAS FLOW, V6, P51, DOI 10.1016/0301-9322(80)90039-7; CHAN CK, 1982, INT J MULTIPHAS FLOW, V8, P11, DOI 10.1016/0301-9322(82)90003-9; Cheng L., 2006, 14 INT C NUCL ENG MI; de With A, 2009, INT J HEAT FLUID FL, V30, P971, DOI 10.1016/j.ijheatfluidflow.2009.06.001; Incropera F.P., 2007, FUNDAMENTALS HEAT MA; Kang HS, 2008, NUCL ENG DES, V238, P492, DOI 10.1016/j.nucengdes.2007.02.044; Kline S. J., 1953, MECH ENG, V75, P3; Laine J., 2006, THERMAL STRATIFICATI; Li H., 2012, EFFECTIVE MOMENTUM H; Li H., 2011, DEV VALIDATION EFFEC; Li H., 2010, CFD4NRS 3 WORKSH BET; Mallinson S.G., 1999, AIAA 30 FLUID DYN C, P99; Norman TL, 2010, NUCL ENG DES, V240, P533, DOI 10.1016/j.nucengdes.2009.09.020; Purhonen H., 2005, NUCL EN NEW EUR 2005; Tanskanen V., 2008, XCFD4NRS OECD C GREN; Zhao H., 2012, NUTHOS 9 KAOHS TAIW	22	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0301-9322	1879-3533		INT J MULTIPHAS FLOW	Int. J. Multiph. Flow	NOV	2014	66						92	100		10.1016/j.ijmultiphaseflow.2014.07.003		9	Mechanics	Mechanics	AQ1NO	WOS:000342548300008		
J	Saito, R; Hirano, T; Maki, S; Niwa, H				Saito, Ryota; Hirano, Takashi; Maki, Shojiro; Niwa, Haruki			Synthesis and chemiluminescent properties of 6,8-diaryl-2-methylimidazo[1,2-alpha]pyrazin-3(7H)-ones: Systematic investigation of substituent effect at para-position of phenyl group at 8-position	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY			English	Article						Imidazo[1,2-alpha]pyrazin-3(7H)-one; Chemiluminescence; Substituent effect	ELECTRON-EXCHANGE LUMINESCENCE; DIFFERENTIAL-OVERLAP TECHNIQUE; CYPRIDINA LUCIFERIN ANALOGS; TRANSITION-METAL-COMPLEXES; SINGLET-EXCITED-STATE; INTERMEDIATE NEGLECT; LIGHT-EMITTER; BIMODAL CHEMILUMINESCENCE; AEQUORIN BIOLUMINESCENCE; DIPHENOYL PEROXIDE	6,8-Diphenylimidazopyrazinone derivatives having a substituent R (R=CF3, H, and OMe) at pare position of the 8-phenyl group were synthesized and their chemiluminescent properties were investigated. The chemiluminescence maxima (CLmax) of these compounds were observed to be in the range of 513-553 nm with a bathochromic shift that increased with the electron-withdrawing character of R, contrary to the previously observed substituent effect at the 6-postion. The chemiluminescence efficiencies (phi(CL)) of these imidazopyrazinones were improved by the introduction of a p-substituted phenyl group at the 8-position. The quantitative investigation of the three quantum efficiencies (phi(R), phi(S), and phi(FL)) whose product gives us phi(CL) revealed that the phi(CL) gains made were largely because of the increase in the values of the fluorescence quantum yields of the corresponding light emitters (phi(FL)). The yields of the singlet-excited emitters (phi(S)) during the chemiluminescent reaction were found to be very small (0.015-0.019), suggesting that one cannot construct an efficient imidazopyrazinone-chemiluminescence system that is comparable to the aequorin bioluminescence system only by using the electronic effects of substituents. (C) 2014 Elsevier B.V. All rights reserved.	[Saito, Ryota] Toho Univ, Dept Chem, Chiba 2748510, Japan; [Saito, Ryota] Toho Univ, Res Ctr Mat Integrated Properties, Chiba 2748510, Japan; [Hirano, Takashi; Maki, Shojiro; Niwa, Haruki] Univ Electrocommun, Grad Sch Informat & Engn, Dept Engn Sci, Tokyo 1828585, Japan	Saito, R (reprint author), Toho Univ, Dept Chem, 2-2-1 Miyama, Chiba 2748510, Japan.	saito@chem.sci.toho-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25410179, 22550031]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities	The authors gratefully acknowledge support for this research by a Grant-in-Aid for Scientific Research C (No 25410179 for R.S. and No. 22550031 for T.H.) from the Japan Society for the Promotion of Science (JSPS). Financial support to R.S. from MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2012-2016) is also gratefully appreciated. We would like to thank Mr. Grant White for his kind assistance in correcting this manuscript.	Adamson RD, 1998, CHEM PHYS LETT, V284, P6, DOI 10.1016/S0009-2614(97)01282-7; AKUTSU K, 1995, J CHEM SOC PERK T 2, P1699, DOI 10.1039/p29950001699; RIDLEY J, 1973, THEOR CHIM ACTA, V32, P111, DOI 10.1007/BF00528484; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Ishii Y, 2014, PHOTOCH PHOTOBIO SCI, V13, P182, DOI 10.1039/c3pp50197c; MATAGA N, 1955, B CHEM SOC JPN, V28, P690, DOI 10.1246/bcsj.28.690; Stewart JJP, 2013, J MOL MODEL, V19, P1, DOI 10.1007/s00894-012-1667-x; Mori K, 2006, TETRAHEDRON, V62, P6272, DOI 10.1016/j.tet.2006.04.044; BACON AD, 1979, THEOR CHIM ACTA, V53, P21, DOI 10.1007/BF00547605; Nakamura H, 2000, TETRAHEDRON LETT, V41, P2185, DOI 10.1016/S0040-4039(00)00131-3; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; ZAKLIKA KA, 1979, PHOTOCHEM PHOTOBIOL, V30, P35, DOI 10.1111/j.1751-1097.1979.tb07111.x; Ohmiya Y, 1996, CHEM BIOL, V3, P337, DOI 10.1016/S1074-5521(96)90116-7; MATAGA N, 1956, B CHEM SOC JPN, V29, P465, DOI 10.1246/bcsj.29.465; Nakamura H, 1998, TETRAHEDRON LETT, V39, P301, DOI 10.1016/S0040-4039(97)10547-0; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; ZERNER MC, 1980, J AM CHEM SOC, V102, P589, DOI 10.1021/ja00522a025; Hertwig RH, 1997, CHEM PHYS LETT, V268, P345, DOI 10.1016/S0009-2614(97)00207-8; BERTHELOT J, 1989, CAN J CHEM, V67, P2061, DOI 10.1139/v89-320; CATALANI LH, 1989, J AM CHEM SOC, V111, P2633, DOI 10.1021/ja00189a043; Cavalier JF, 2001, SYNTHESIS-STUTTGART, P768; Elliott P., 2009, REV COMPUTATIONAL CH; Gordon MS, 2005, THEORY AND APPLICATIONS OF COMPUTATIONAL CHEMISTRY: THE FIRST FORTY YEARS, P1167, DOI 10.1016/B978-044451719-7/50084-6; GOTO T, 1968, ANGEW CHEM INT EDIT, V7, P407, DOI 10.1002/anie.196804071; Hirano T, 2008, PHOTOCH PHOTOBIO SCI, V7, P197, DOI 10.1039/b713374j; Hirano T., 1994, CHEM COMMUN, P165; Isobe H, 2005, J AM CHEM SOC, V127, P8667, DOI 10.1021/ja043295; Jensen F., 2007, INTRO COMPUTATIONAL; Klamt A, 1993, J CHEM SOC P2, V2, P799, DOI DOI 10.1039/P29930000799; KOO JY, 1978, J AM CHEM SOC, V100, P4496, DOI 10.1021/ja00482a030; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE; Lasinski ME, 2012, J COMPUT CHEM, V33, P723, DOI 10.1002/jcc.22890; LEE J, 1972, PHOTOCHEM PHOTOBIOL, V15, P227, DOI 10.1111/j.1751-1097.1972.tb06241.x; Lee J, 1965, Photochem Photobiol, V4, P1015, DOI 10.1111/j.1751-1097.1965.tb09293.x; Leffler J. E., 1963, RATES EQUILIBRIA ORG; LIPPERT E, 1957, Z ELEKTROCHEM, V61, P962; LIPPERT E, 1955, Z NATURFORSCH PT A, V10, P541; Matsumoto M, 1997, TETRAHEDRON LETT, V38, P5825, DOI 10.1016/S0040-4039(97)01332-4; MCCAPRA F, 1967, CHEM COMMUN, P1011, DOI 10.1039/c19670001011; MCCAPRA F, 1977, J CHEM SOC CHEM COMM, P946, DOI 10.1039/c39770000946; NAKAMURA H, 1995, SYNLETT, P1227; Saito R., 2005, P 13 INT S BIOL CHEM, P335; Saito R, 1998, CHEM LETT, P95; Saito R, 1997, J CHEM SOC PERK T 2, P1711, DOI 10.1039/a701156c; Saito R, 2011, B CHEM SOC JPN, V84, P90, DOI 10.1246/bcsj.20100185; Saito R, 2004, HETEROCYCLES, V63, P759; SATO N, 1982, J HETEROCYCLIC CHEM, V19, P673; SCHUSTER GB, 1979, PHOTOCHEM PHOTOBIOL, V30, P17, DOI 10.1111/j.1751-1097.1979.tb07109.x; SCHUSTER GB, 1979, ACCOUNTS CHEM RES, V12, P366, DOI 10.1021/ar50142a003; Senda N., 2013, WINMOSTAR VERSION 4; SHIMOMUR.O, 1973, TETRAHEDRON LETT, P2963; SHIMOMUR.O, 1970, NATURE, V227, P1356, DOI 10.1038/2271356a0; Stewart J. J. P., 2012, STEWART COMPUTATIONA; Takano Y, 1999, B CHEM SOC JPN, V72, P213, DOI 10.1246/bcsj.72.213; TERANISHI K, 1989, B CHEM SOC JPN, V62, P2009, DOI 10.1246/bcsj.62.2009; TERANISHI K, 1989, CHEM LETT, P1423, DOI 10.1246/cl.1989.1423; Turro N.J., 1991, MODERN MOL PHOTOCHEM; Usami K, 1996, TETRAHEDRON, V52, P12061, DOI 10.1016/0040-4020(96)00699-0; ZAKLIKA KA, 1978, J AM CHEM SOC, V100, P4916, DOI 10.1021/ja00483a060	60	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1010-6030			J PHOTOCH PHOTOBIO A	J. Photochem. Photobiol. A-Chem.	NOV 1	2014	293						12	25		10.1016/j.jphotochem.2014.07.016		14	Chemistry, Physical	Chemistry	AQ0MV	WOS:000342478300002		
J	Tanaka, M; Nagao, M; Matsushita, Y; Fujioka, M; Denholme, SJ; Yamaguchi, T; Takeya, H; Takano, Y				Tanaka, Masashi; Nagao, Masanori; Matsushita, Yoshitaka; Fujioka, Masaya; Denholme, Saleem J.; Yamaguchi, Takahide; Takeya, Hiroyuki; Takano, Yoshihiko			First single crystal growth and structural analysis of superconducting layered bismuth oxyselenide, La(O,F)BiSe2	JOURNAL OF SOLID STATE CHEMISTRY			English	Article						Single crystals growth; Single crystal X-ray structural analysis; BiSe2-based superconductor	CE; ND	Single crystals of La(O,F)BiSe2 were successfully grown for the first time by a CsCl flux method. Single crystal X-ray structural analysis clearly showed that La(0,F)BiSe2 crystallizes with space group P4/nmm (lattice parameters a=4.1408(2) angstrom, c=14.1096(6) angstrom). The structure is composed of alternating BiSe2 and La(0,F) layers. The bond distances and angles are similar to those of La(O,F)BiS2. The bond valence sum calculation indicates the refined structure is slightly cation rich, suggesting the charge neutrality should be kept by modification of valence state of the cations. Magnetic susceptibility and resistivity measurements showed the compound is a superconductor with a transition temperature of 3.6 K, which is higher than that of as-grown La(O,F)BiS2. (C) 2014 Elsevier Inc. All rights reserved.	[Tanaka, Masashi; Matsushita, Yoshitaka; Fujioka, Masaya; Denholme, Saleem J.; Yamaguchi, Takahide; Takeya, Hiroyuki; Takano, Yoshihiko] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Nagao, Masanori] Univ Yamanashi, Kofu, Yamanashi 4008511, Japan	Tanaka, M (reprint author), Natl Inst Mat Sci, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	Tanaka.Masashi@nims.go.jp			Japan Science and Technology Agency through Strategic International Collaborative Research Program (SICORP-EU-Japan); Advanced Low Carbon Technology R&D Program (ALCA) of the Japan Science and Technology Agency	This work was partially supported by Japan Science and Technology Agency through Strategic International Collaborative Research Program (SICORP-EU-Japan) and Advanced Low Carbon Technology R&D Program (ALCA) of the Japan Science and Technology Agency.	Sugimoto T, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.201117; Yazici D, 2013, PHILOS MAG, V93, P673, DOI 10.1080/14786435.2012.724185; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Mizuguchi Y, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.220510; Miura A, 2014, J SOLID STATE CHEM, V212, P213, DOI 10.1016/j.jssc.2014.01.035; Mizuguchi Y, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.114725; Deguchi K, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/5/054303; Yazici D, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.174512; [Anonymous], 2005, CRYSTALCLEAR; Nagao M, 2014, SOLID STATE COMMUN, V178, P33, DOI 10.1016/j.ssc.2013.10.019; Nagao M, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.113701; Krzton-Maziopa A, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/21/215702; Jha R, 2013, J SUPERCOND NOV MAGN, V26, P499, DOI 10.1007/s10948-012-2097-9; Demura S., 2012, J PHYS SOC JPN, V82; Farrugia LJ, 2012, J APPL CRYSTALLOGR, V45, P849, DOI 10.1107/S0021889812029111; Lin X, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.020504; Liu J. Z., ARXIV13100377; Mizuguchi Y, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.053704; Nagira S, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.033703; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Wang X.-C., ARXIV14047562; Xing J, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.214518	22	12	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4596	1095-726X		J SOLID STATE CHEM	J. Solid State Chem.	NOV	2014	219						168	172		10.1016/j.jssc.2014.07.026		5	Chemistry, Inorganic & Nuclear; Chemistry, Physical	Chemistry	AP8NQ	WOS:000342336100023		
J	Onoda, M; Inagaki, M; Saito, H				Onoda, Masashige; Inagaki, Makoto; Saito, Hiroaki			Crystal structures and electronic properties for the over-lithiated and Li-Ag substituted phases of Li9V3(P2O7)(3)(PO4)(2) insertion electrode system	JOURNAL OF SOLID STATE CHEMISTRY			English	Article						Li ion battery; Crystal structure; Electrochemistry; Electrical resistivity; Magnetic susceptibility		For the Li6V3(P2O7)(3)(PO4)(2) insertion electrode system with a multiple-electron reaction, the over-lithiated phase LixV3(P2O7)(3)(PO4)(2) with 9 < x <= 10 and the Li Ag substituted phase Li9-yAgyV3 (P2O7)(3)(PO4)(2) with 0 < y <= 1 are synthesized, and their crystal structures and electronic properties are explored through measurements of X-ray diffraction with a four-circle diffractometer, electrochemistry, electrical resistivity, and magnetization. Both the structures are isomorphous to that of Li6V3(P2O7)(3)(PO4)(2) which has (VP2(2)O(7))(3)(P1O(4))(2) layers in the ab-plane built up of VO6 octahedra sharing corners with P1O(4) tetrahedra and P2(2)O(7) groups. In LixV3(P2O7)(3)(PO4)(2), the over-inserted Li4 ion surrounded by three oxygens in a planar triangular arrangement resides with a significantly large thermal parameter in the tunnels formed by the stacking of the layers and in between the octahedral Li1 sites, leading to a linear chain of Li ions with the distance 3.40 angstrom parallel to the direction of diffusion pathways. In Li9-yAgyV3(P2O7)(3)(PO4)(2), where the Li1 site is substituted by Ag, the reduction of the electron hopping and the electrostatic potential for V ions are revealed in comparison with those of unsubstituted parent, which may account for the increase of mean voltage in the Li ion battery. (C) 2014 Elsevier Inc. All rights reserved.	[Onoda, Masashige; Inagaki, Makoto; Saito, Hiroaki] Univ Tsukuba, Fac Pure & Appl Sci, Div Phys, Tsukuba, Ibaraki 3058571, Japan	Onoda, M (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Div Phys, Tsukuba, Ibaraki 3058571, Japan.	onoda.masashige.ft@u.tsukuba.ac.jp			JSPS KAKENHI [24550207]	We are grateful to Y. Yanagi for his help with the electrical resistivity measurements. This work was partly supported by JSPS KAKENHI Grant number 24550207.	Abragam A, 1970, ELECT PARAMAGNETIC R; HAMILTON WC, 1965, ACTA CRYSTALLOGR, V18, P502, DOI 10.1107/S0365110X65001081; Kuang Q, 2011, ELECTROCHIM ACTA, V56, P2201, DOI 10.1016/j.electacta.2010.11.051; Goodenough JB, 2010, CHEM MATER, V22, P587, DOI 10.1021/cm901452z; BROWN ID, 1985, ACTA CRYSTALLOGR B, V41, P244, DOI 10.1107/S0108768185002063; Yin SC, 2003, J AM CHEM SOC, V125, P10402, DOI 10.1021/ja034565h; Creagh D.C., 1992, INT TABLES CRYSTAL C, VC; Cromer D. T., 1974, INT TABLES XRAY CRYS, V4; Konig E., 1984, MAGNETIC PROPERTIES, V12; Onoda M, 2005, J PHYS-CONDENS MAT, V17, P4057, DOI 10.1088/0953-8984/17/26/006; Onoda M, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.074801; Onoda M, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/8/085402; Onoda M, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.094801; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930	15	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4596	1095-726X		J SOLID STATE CHEM	J. Solid State Chem.	NOV	2014	219						220	227		10.1016/j.jssc.2014.07.040		8	Chemistry, Inorganic & Nuclear; Chemistry, Physical	Chemistry	AP8NQ	WOS:000342336100030		
J	Yubuta, K; Mori, T; Leithe-Jasper, A; Borrmann, H; Grin, Y; Okada, S; Shishido, T				Yubuta, Kunio; Mori, Takao; Leithe-Jasper, Andreas; Borrmann, Horst; Grin, Yuri; Okada, Shigeru; Shishido, Toetsu			Intergrowth structure of alpha-phase in beta-type TmAlB4 compound studied by high-angle annular detector dark-field scanning transmission electron microscopy	JOURNAL OF SOLID STATE CHEMISTRY			English	Article						Rare earth aluminoboride; Intergrowth; Nanostructure; Building defect; High-angle annular detector dark-field scanning transmission electron microscopy (HAADF-STEM)	CRYSTAL-STRUCTURE; SINGLE-CRYSTALS; SUPERCONDUCTIVITY; LOCALIZABILITY; DIFFRACTION; LU2ALB6; BORIDES; GROWTH; LU; YB	Nanostructure of a ThMoB4-type (beta-type) TmAlB4 compound, in which YCrB(4)type (alpha-type) domains are locally intergrown, is studied by high-angle annular detector dark-field scanning transmission electron microscopy (HAADF-STEM). Z-contrast images by HAADF-STEM directly represent the arrangements of Tm atoms located at centers of heptagonal atomic columns of B atoms as bright dots, and give us detailed information of intergrowth of type domains in the matrix of the beta-type phase, which coherently occurs. Structural and bonding analyses for beta-TmAlB4 point out the closeness in atomic interactions and energy of the alpha- and beta-type structures which support the easy formation of such nanostructure intergrowths. From combination between HAADF-STEM and electronic structure calculation, a detailed local crystal structure with intrinsic building defects is effectively revealed. (C) 2014 Elsevier Inc. All rights reserved.	[Yubuta, Kunio; Shishido, Toetsu] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Mori, Takao] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan; [Leithe-Jasper, Andreas; Borrmann, Horst; Grin, Yuri] Max Planck Inst Chem Phys Fester Stoffe, D-01187 Dresden, Germany; [Okada, Shigeru] Kokushikan Univ, Dept Sci & Engn, Tokyo 1548515, Japan	Yubuta, K (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.	yubuta@imr.tohoku.ac.jp	Leithe-Jasper, Andreas/O-9303-2014; Yubuta, Kunio/B-8124-2011	Yubuta, Kunio/0000-0002-3401-6874	Japan Society for the Promotion of Science (JSPS) [24360284]; AOARD	A part of this work was supported by Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS): Grant Program of Scientific Research (B) (Grant no. 24360284). T.M. was partially supported by a grant from AOARD	Alekseeva A., 2014, J CHEM UHYS IN PRESS; ANDERSEN OK, 1975, PHYS REV B, V12, P3060, DOI 10.1103/PhysRevB.12.3060; Wagner FR, 2013, Z ANORG ALLG CHEM, V639, P2025, DOI 10.1002/zaac.201200523; JESSON DE, 1995, P R SOC-MATH PHYS SC, V449, P273, DOI 10.1098/rspa.1995.0044; ROGL P, 1974, MONATSH CHEM, V105, P1082, DOI 10.1007/BF00910277; Kohout M, 2004, INT J QUANTUM CHEM, V97, P651, DOI 10.1002/qua.10768; Okada S, 2006, J ALLOY COMPD, V408, P547, DOI 10.1016/j.jallcom.2005.01.078; Kohout M, 2006, INT J QUANTUM CHEM, V106, P1499, DOI 10.1002/qua.20925; Okada S, 1996, JPN J APPL PHYS 1, V35, P4718, DOI 10.1143/JJAP.35.4718; Holland TJB, 1997, MINERAL MAG, V61, P65, DOI 10.1180/minmag.1997.061.404.07; OKADA S, 1994, JPN J APPL PHYS 1, V33, P2663, DOI 10.1143/JJAP.33.2663; Kohout M, 2007, FARADAY DISCUSS, V135, P43, DOI 10.1039/b605951c; Zhang H, 2011, INORG CHEM, V50, P1250, DOI 10.1021/ic1016559; Abe E, 2002, ACTA MATER, V50, P3845, DOI 10.1016/S1359-6454(02)00191-X; Mori T, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.064404; Yan Y, 1998, PHYS REV LETT, V81, P5145, DOI 10.1103/PhysRevLett.81.5145; Buban JP, 2006, SCIENCE, V311, P212, DOI 10.1126/science.1119839; Hoffmann RD, 2001, Z KRISTALLOGR, V216, P127, DOI 10.1524/zkri.216.3.127.20327; Mori T, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.104418; Nakatsuji S, 2008, NAT PHYS, V4, P603, DOI 10.1038/nphys1002; Bader R. F. W., 1994, ATOMS MOL QUANTUM TH; Emsley J., 1994, ELEMENTE; Gignoux D., 1997, HANDB MAG M, V10, P239, DOI 10.1016/S1567-2719(97)10006-3; Jepsen O., 1999, PROGRAM TB LMTO ASA; Kaiser U, 2002, NAT MATER, V1, P102, DOI 10.1038/nmat729; Kohout M., 2010, DGRID VERSION 4 6; Konno TJ, 2001, SCRIPTA MATER, V44, P2303, DOI 10.1016/S1359-6462(01)00909-5; Kuga K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.137004; KUZMA YB, 1970, SOV PHYS CRYSTALLOGR, V15, P312; Macaluso RT, 2007, CHEM MATER, V19, P1918, DOI 10.1021/cm062244+; Mori T., 2012, RARE EARTH ELEMENTS, P263; Mori T, 2010, J APPL PHYS, V107, DOI 10.1063/1.3365067; Mori T, 2005, J APPL PHYS, V97, DOI 10.1063/1.1850365; Mori T, 2012, J APPL PHYS, V111, DOI 10.1063/1.3674285; Mori T, 2008, HBK PHYS CHEM RARE, V38, P105, DOI 10.1016/S0168-1273(07)38003-3; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; Nishijima M, 2008, MATER TRANS, V49, P227, DOI 10.2320/matertrans.MEP2007257; VONBARTH U, 1972, J PHYS PART C SOLID, V5, P1629, DOI 10.1088/0022-3719/5/13/012; Yubuta K, 2009, MATER RES BULL, V44, P1743, DOI 10.1016/j.materresbull.2009.03.013; Yubuta K, 2013, PHILOS MAG, V93, P1054, DOI 10.1080/14786435.2012.741727	40	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4596	1095-726X		J SOLID STATE CHEM	J. Solid State Chem.	NOV	2014	219						274	279		10.1016/j.jssc.2014.07.038		6	Chemistry, Inorganic & Nuclear; Chemistry, Physical	Chemistry	AP8NQ	WOS:000342336100037		
J	Abe, K; Horiuchi, T; Nishibayashi, Y; Kobayashi, K; Aburai, N				Abe, Katsuya; Horiuchi, Tomoya; Nishibayashi, Yuki; Kobayashi, Kotaro; Aburai, Nobuhiro			Development of a novel enzyme-CdS nanoparticle hybrid system for the oxidation of NADH to NAD(+)	MATERIALS LETTERS			English	Article						CdS nanoparticles; Enzyme-semiconductor hybrid; NADH oxidation; Catalyst; Water-in-oil microemulsion	GOLD NANOPARTICLES; GLUCOSE-OXIDASE; BIOSENSORS; FILMS	Inorganic semiconductor CdS nanoparticles (NPs) incorporating NADH dehydrogenase (diaphorase: DA) were successfully synthesized using a water-in-oil microemulsion method. The X-ray diffraction pattern of the enzyme-CdS NPs was assigned to a cubic structure CdS phase. The catalytic effect of enzyme-CdS NPs hybrid systems on the oxidation of dihydronicotinamide adenine dinucleotide (NADH) to dihydronicotinamide adenine dinucleotide (NAD(+)) was investigated. Enzyme-CdS NPs incorporating DA and ferrocene-modified polyethylenimine (Fc-PEI) (1:0.2, w/w) exhibited a significantly increased rate of NADH oxidation under illumination compared with pure CdS NPs. The redox mediator Fc-PEI acted to transfer electrons between the valence band of the CdS NPs and the flavin-bound enzyme during the oxidation reaction. Switchable oxidation of NADH in a colloidal solution of the enzyme-CdS NPs was induced with respect to the dark/light cycle. The catalytic properties of the present CdS NPs activated with an enzyme towards NADH oxidation might have future importance in biochemistry and medical applications. (C) 2014 Elsevier B.V. All rights reserved.	[Abe, Katsuya; Horiuchi, Tomoya; Nishibayashi, Yuki; Kobayashi, Kotaro; Aburai, Nobuhiro] Kogakuin Univ, Dept Appl Chem, Fac Engn, Hachioji, Tokyo 1920015, Japan	Abe, K (reprint author), Kogakuin Univ, Dept Appl Chem, Fac Engn, 2665-1 Nakano Machi, Hachioji, Tokyo 1920015, Japan.	bt10335@ns.kogakuin.ac.jp			Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT) [S1411005]	The authors are grateful to Dr. Chihiro Mochizuki (Research Institute of Science and Technology, Kogakuin University) for XRD measurement. This study was supported in part by a grant of Strategic Research Foundation Grant-aided Project for Private Universities from Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT), 2014-2018 (S1411005).	Abe K, 2005, ELECTROANAL, V17, P226; Chaudhary YS, 2012, CHEM COMMUN, V48, P58, DOI 10.1039/c1cc16107e; Jiang JZ, 2013, CHEM COMMUN, V49, P1912, DOI 10.1039/c2cc38202d; Hodak J, 1997, LANGMUIR, V13, P2708, DOI 10.1021/la962014h; Onda M, 1999, J BIOSCI BIOENG, V87, P69, DOI 10.1016/S1389-1723(99)80010-3; Li YY, 2010, GOLD BULL, V43, P29; Kameyama T, 2009, PHYS CHEM CHEM PHYS, V11, P5369, DOI 10.1039/b902023c; Morelli E, 2013, BIOPHYS CHEM, V182, P4, DOI 10.1016/j.bpc.2013.06.007; Qian Z, 2010, BIOSENS BIOELECTRON, V25, P2045, DOI 10.1016/j.bios.2010.01.036; LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026; Willner I, 2007, FEBS J, V274, P302, DOI 10.1111/j.1742-4658.2006.05602.x; Huang XH, 2005, J PHOTOCH PHOTOBIO B, V81, P76, DOI 10.1016/j.photobiol.2005.05.010; Shim JH, 2013, MATER LETT, V91, P330, DOI 10.1016/j.matlet.2012.10.005; Vastarella W, 2005, TALANTA, V66, P627, DOI 10.1016/j.talanta.2004.12.007	14	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-577X	1873-4979		MATER LETT	Mater. Lett.	NOV 1	2014	134						20	23		10.1016/j.matlet.2014.07.051		4	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AP7GE	WOS:000342245000006		
J	Hasumi, M; Taniguchi, I				Hasumi, Maki; Taniguchi, Izumi			Synthesis and characterization of Li2MnP2O7/C composite by a combination of spray pyrolsis and wet ball milling followed by annealing	MATERIALS LETTERS			English	Article						Li2MnP2O7; Lithium-ion batteries; Microstructure; Cathode materials; Powder technology	LITHIUM-ION BATTERIES; HIGH-RATE PERFORMANCE; PYROPHOSPHATE CATHODES; HEAT-TREATMENT; PYROLYSIS; LIFEPO4; POWDERS; LIMNPO4	A Li2MnP2O7/C composite was synthesized by a combination of spray pyrolysis and wet ball milling followed by annealing. The peaks of the Li2MnP2O7/C composite obtained by X-ray diffraction analysis were indexed to the monoclinic structure with the space group P2(1)/c. Field-emission scanning electron microscopy and transmission electron microscopy together with energy-dispersive spectroscopy verified that the Li2MnP2O7/C composite consisted of agglomerates of Li2MnSiO4 primary particles, and that a thin carbon layer was partially formed on the surface of these agglomerates. The Li2MnP2O7/C composite cathode delivered a first discharge capacity of 72 mA h g(-1) at 0.1 C and 60 degrees C, while the theoretical capacity is 110 mA h g(-1) for the Mn3+/Mn2+ redox reaction. The cathode also showed good cycling performance over 15 cycles. (C) 2014 Elsevier B.V. All rights reserved.	[Hasumi, Maki; Taniguchi, Izumi] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Chem Engn, Meguro Ku, Tokyo 1528552, Japan	Taniguchi, I (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Chem Engn, Meguro Ku, 12-1,Ookayama 2, Tokyo 1528552, Japan.	taniguchi.i.aa@m.titech.ac.jp	Taniguchi, Izumi/C-1332-2015	Taniguchi, Izumi/0000-0002-2833-6994	Ministry of Education, Culture, Sports, Science and Technology of Japan [24360405]	This research was partially supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant no. 24360405). The authors are also grateful to Mr. A. Hori and Mr. J. Koki, staff members of the Center for Advanced Materials Analysis (Tokyo Institute of Technology, Japan), for the FE-SEM and TEM observations of the samples.	Furuta N, 2012, CHEM MATER, V24, P1055, DOI 10.1021/cm2032465; Barpanda P, 2012, ADV ENERGY MATER, V2, P841, DOI 10.1002/aenm.201100772; Konarova M, 2008, MATER RES BULL, V43, P3305, DOI 10.1016/j.materresbull.2008.02.014; Adam L, 2008, J SOLID STATE CHEM, V181, P3110, DOI 10.1016/j.jssc.2008.07.039; Bakenov Z, 2010, ELECTROCHEM COMMUN, V12, P75, DOI 10.1016/j.elecom.2009.10.039; Tamaru M, 2012, J MATER CHEM, V22, P24526, DOI 10.1039/c2jm35260e; Kim H, 2011, CHEM MATER, V23, P3930, DOI 10.1021/cm201305z; Wu L, 2013, MATER LETT, V110, P38, DOI 10.1016/j.matlet.2013.07.112; Gutierrez A, 2013, CHEM MATER, V25, P4010, DOI 10.1021/cm401949n; Doan TNL, 2011, J POWER SOURCES, V196, P5679, DOI 10.1016/j.jpowsour.2011.02.039; Taniguchi I, 2002, SOLID STATE IONICS, V146, P239, DOI 10.1016/S0167-2738(01)01016-5; Wang JJ, 2012, ENERG ENVIRON SCI, V5, P5163, DOI 10.1039/c1ee01263k; Akimoto S, 2013, J POWER SOURCES, V242, P627, DOI 10.1016/j.jpowsour.2013.05.104; Aravindan V, 2013, J MATER CHEM A, V1, P3518, DOI 10.1039/c2ta01393b; Padhi AK, 1997, J ELECTROCHEM SOC, V144, P1188, DOI 10.1149/1.1837571; Doan TNL, 2010, ADV POWDER TECHNOL, V21, P187, DOI 10.1016/j.apt.2009.10.016; Konarova M, 2010, J POWER SOURCES, V195, P3661, DOI 10.1016/j.jpowsour.2009.11.147; Du J, 2013, ELECTROCHIM ACTA, V103, P219, DOI 10.1016/j.electacta.2013.04.036; Li LF, 2013, MATER LETT, V108, P156, DOI 10.1016/j.matlet.2013.06.076; Bin Shao, 2013, Powder Technology, V235, DOI 10.1016/j.powtec.2012.09.040; Bin Shao, 2012, Journal of Power Sources, V199, DOI 10.1016/j.jpowsour.2011.10.050; Nishimura S, 2014, DALTON T, V43, P1502, DOI 10.1039/c3dt52347k	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-577X	1873-4979		MATER LETT	Mater. Lett.	NOV 1	2014	134						202	205		10.1016/j.matlet.2014.07.037		4	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AP7GE	WOS:000342245000053		
J	Zhao, WW; Tanaka, A; Tanaka, A; Unno, M; Yamamoto, S; Noguchi, H				Zhao, Wenwen; Tanaka, Ayaka; Tanaka, Akinobu; Unno, Masashi; Yamamoto, Shinji; Noguchi, Hideyuki			Synthesis of LiNi1/3Mn2/3O2 related cathode material from P2-Na2/3Ni1/3Mn2/3O2 for lithium ion battery	MATERIALS LETTERS			English	Article						Lithium ion battery; Reduction-ion exchange; O3 structure; Improved performance	LI-ION; LI(2/3)+X(NI1/3MN2/3)O-2; BRONZES; OXIDE; MN; NI; O2	LixNi1/3Mn2/3O2 (x > 2/3) with O3 structure has been synthesized from P2 type Na2/3Ni1/3Mn2/3O2 via reduction-ion exchange method. Raman scattering and Fourier transform infrared spectroscopy (FTIR) results demonstrate that cation environment in the as-prepared LixNi1/3Mn2/3O2 is similar to that of O3-LixNi1/3Mn2/3O2 prepared from P3-Na2/3Ni1/3Mn2/3O2. It was found that the galvanostatic charge-discharge and cyclic voltammetry (CV) curves of the LixNi1/3Mn2/3O2 compound are different from that of the Li2/3Ni1/3Mn2/3O2 compound. The LixNi1/3Mn2/3O2 cathode exhibits stable cycling performance and delivers a discharge capacity of 230 mAhg(-1) at the end of 30th cycle in the voltage window between 2.5 and 4.7 V (50 degrees C). Furthermore, LixNi1/3Mn2/3O2 cathode delivers a discharge capacity of 190 mAhg(-1) at 500 mAg(-1) (similar to 2.5 C rate). (C) 2014 Published by Elsevier B.V.	[Zhao, Wenwen; Tanaka, Ayaka; Tanaka, Akinobu; Unno, Masashi; Noguchi, Hideyuki] Saga Univ, Grad Sch Sci & Engn, Dept Adv Technol Fus, Saga 8408520, Japan; [Yamamoto, Shinji] Nissan Motor Co Ltd, Nissan Res Ctr, Yokosuka, Kanagawa 2378523, Japan	Noguchi, H (reprint author), Saga Univ, Grad Sch Sci & Engn, Dept Adv Technol Fus, Honjo 1, Saga 8408520, Japan.	noguchih@cc.saga-u.ac.jp					Mohanty D, 2013, J POWER SOURCES, V229, P239, DOI 10.1016/j.jpowsour.2012.11.144; Zhao WW, 2014, J POWER SOURCES, V261, P324, DOI 10.1016/j.jpowsour.2014.03.069; Paulsen JM, 1999, SOLID STATE IONICS, V126, P3, DOI 10.1016/S0167-2738(99)00147-2; Paulsen JM, 2000, CHEM MATER, V12, P2257, DOI 10.1021/cm990810d; Paulsen JM, 1999, J ELECTROCHEM SOC, V146, P3560, DOI 10.1149/1.1392514; Komaba S, 2009, ELECTROCHIM ACTA, V54, P2353, DOI 10.1016/j.electacta.2008.10.070; Paulsen JM, 2000, J ELECTROCHEM SOC, V147, P86; Shaju KM, 2003, J ELECTROCHEM SOC, V150, pA1, DOI 10.1149/1.1521754; Shaju KM, 2002, ELECTROCHEM COMMUN, V4, P633, DOI 10.1016/S1388-2481(02)00392-2	9	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-577X	1873-4979		MATER LETT	Mater. Lett.	NOV 1	2014	134						206	209		10.1016/j.matlet.2014.07.042		4	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AP7GE	WOS:000342245000054		
J	Liu, ZQ; Miyamoto, G; Yang, ZG; Zhang, C; Furuhara, T				Liu, Zhen-Qing; Miyamoto, Goro; Yang, Zhi-Gang; Zhang, Chi; Furuhara, Tadashi			Effects of Pre-tempering on Intercritical Annealing in Fe-2Mn-0.3C Alloy	METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND MATERIALS SCIENCE			English	Article							REVERSE TRANSFORMATION; AUSTENITE; STEEL; NUCLEATION; MARTENSITE; CEMENTITE	As-quenched martensite was pre-tempered at 623 K and 923 K (350 A degrees C and 650 A degrees C), and then it reverted to austenite by intercritical annealing at 998 K (725 A degrees C) in a Fe-2Mn-0.3C alloy. Pre-tempering at 623 K (350 A degrees C) accelerates austenite formation, while pre-tempering at 923 K (650 A degrees C) significantly retards it. It is proposed that austenite nucleation is accelerated by increasing the number density and particle size of cementite during tempering, whereas austenite growth is retarded by Mn enrichment in cementite during tempering at high temperature, leading to opposite effects of pre-tempering on reversion kinetics.	[Liu, Zhen-Qing; Yang, Zhi-Gang; Zhang, Chi] Tsinghua Univ, Sch Mat Sci & Engn, Key Lab Adv Mat MOE, Beijing 100084, Peoples R China; [Liu, Zhen-Qing] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Miyamoto, Goro; Furuhara, Tadashi] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Liu, ZQ (reprint author), Tsinghua Univ, Sch Mat Sci & Engn, Key Lab Adv Mat MOE, Beijing 100084, Peoples R China.	zhqliu@yeah.net	Furuhara, Tadashi/B-2149-2010; Miyamoto, Goro/G-2802-2010		China Scholarship Council; JST, CREST; Ministry of Education, Culture, Sports, Science and Technology [23360316]; National Natural Science Foundation of China [51171087]	Financial support provided by China Scholarship Council through Joint-Supervising Ph.D. Program is gratefully acknowledged. A part of this research was supported by JST, CREST. T. F. greatly acknowledged the financial support provided by the Ministry of Education, Culture, Sports, Science and Technology through a Grant-in-Aid for Scientific Research (B) No. 23360316 (2011-2013). Z.-G. Y. and Z.-Q. L. greatly acknowledged the financial support provided by the National Natural Science Foundation of China (Grant No. 51171087).	MATSUDA S, 1974, T IRON STEEL I JPN, V14, P363; HILLERT M, 1971, J IRON STEEL I, V209, P49; Wei R, 2013, ACTA MATER, V61, P697, DOI 10.1016/j.actamat.2012.10.019; Luo HW, 2011, ACTA MATER, V59, P4002, DOI 10.1016/j.actamat.2011.03.025; KIMMINS ST, 1983, MET SCI, V17, P519; Lee TK, 2000, ISIJ INT, V40, P1260, DOI 10.2355/isijinternational.40.1260; Liu ZQ, 2013, METALL MATER TRANS A, V44A, P4872, DOI 10.1007/s11661-013-1973-7; Miyamoto G, 2010, ACTA MATER, V58, P4492, DOI 10.1016/j.actamat.2010.04.045; Nakada N, 2011, ISIJ INT, V51, P299, DOI 10.2355/isijinternational.51.299	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5623	1543-1940		METALL MATER TRANS A	Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.	NOV	2014	45A	12					5290	5294		10.1007/s11661-014-2519-3		5	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AQ0AI	WOS:000342443200003		
J	Tian, YZ; Bai, Y; Chen, MC; Shibata, A; Terada, D; Tsuji, N				Tian, Y. Z.; Bai, Y.; Chen, M. C.; Shibata, A.; Terada, D.; Tsuji, N.			Enhanced Strength and Ductility in an Ultrafine-Grained Fe-22Mn-0.6C Austenitic Steel Having Fully Recrystallized Structure	METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND MATERIALS SCIENCE			English	Article							SEVERE PLASTIC-DEFORMATION; STACKING-FAULT ENERGY; HIGH-PRESSURE TORSION; TWIP STEEL; MECHANICAL-PROPERTIES; EVOLUTION; MICROSTRUCTURE; BEHAVIOR; ALLOYS; ARB	Fe-22 wt pct Mn-0.6 wt pct C twinning-induced plasticity (TWIP) steel having fully recrystallized ultrafine-grained structure was obtained through a simple thermomechanical process repeating cold rolling and annealing. The minimum average grain size of 550 nm was successfully obtained. The ultrafine-grained steel exhibited good mechanical properties superior to those previously reported in Fe-Mn-Al-Si TWIP steels, and the origin was discussed based on the difference of stacking fault energies.	[Tian, Y. Z.; Bai, Y.; Chen, M. C.; Shibata, A.; Tsuji, N.] Kyoto Univ, Dept Mat Sci & Engn, Sakyo Ku, Kyoto 6068501, Japan; [Shibata, A.; Terada, D.; Tsuji, N.] Kyoto Univ, ESISM, Kyoto 6068501, Japan; [Terada, D.] Kyoto Univ, Dept Mat Sci & Engn, Kyoto 6068501, Japan; [Terada, D.] Chiba Inst Technol, Dept Mech Sci, Narashino, Chiba 2750016, Japan	Tian, YZ (reprint author), Kyoto Univ, Dept Mat Sci & Engn, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	yztianyztian@gmail.com	Tian, Yan-Zhong/E-8731-2011; Tsuji, Nobuhiro/F-7951-2010; Shibata, Akinobu/C-7884-2012	Tsuji, Nobuhiro/0000-0002-2132-1327; 	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [2201, 24246114, 25600039]; Elements Strategy Initiative for Structural Materials (ESISM) through the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Y.Z.T. gratefully acknowledges the support of the Japan Society for the Promotion of Science (JSPS) for awarding a postdoctoral fellowship. This work was financially supported by the Grant-in-Aids for Scientific Research on Innovative Area "Bulk Nanostructured Metals" (Area No. 2201), for Scientific Research (A) (No. 24246114) and for Challenging Exploratory Research (No. 25600039), and the Elements Strategy Initiative for Structural Materials (ESISM), all through the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Dini G, 2010, MATER DESIGN, V31, P3395, DOI 10.1016/j.matdes.2010.01.049; Tsuji N, 2002, SCRIPTA MATER, V47, P893, DOI 10.1016/S1359-6462(02)00282-8; An XH, 2012, SCRIPTA MATER, V66, P227, DOI 10.1016/j.scriptamat.2011.10.043; Chun YS, 2012, SCRIPTA MATER, V66, P960, DOI 10.1016/j.scriptamat.2012.02.038; Bracke L, 2009, ACTA MATER, V57, P1512, DOI 10.1016/j.actamat.2008.11.036; Bouaziz O, 2011, CURR OPIN SOLID ST M, V15, P141, DOI 10.1016/j.cossms.2011.04.002; Zhao YH, 2008, ADV MATER, V20, P3028, DOI 10.1002/adma.200800214; Santos DB, 2011, MAT SCI ENG A-STRUCT, V528, P3545, DOI 10.1016/j.msea.2011.01.052; Tsuji N, 2004, MATER TRANS, V45, P2272, DOI 10.2320/matertrans.45.2272; Dumay A, 2008, MAT SCI ENG A-STRUCT, V483-84, P184, DOI 10.1016/j.msea.2006.12.170; Ueji R, 2008, SCRIPTA MATER, V59, P963, DOI 10.1016/j.scriptamat.2008.06.050; de las Cuevas F, 2010, ADV MATER RES-SWITZ, V89-91, P153, DOI 10.4028/www.scientific.net/AMR.89-91.153; Saeed-Akbari A, 2012, SCRIPTA MATER, V66, P1024, DOI 10.1016/j.scriptamat.2011.12.041; Idrissi H, 2010, SCRIPTA MATER, V63, P961, DOI 10.1016/j.scriptamat.2010.07.016; Zhao YH, 2005, MAT SCI ENG A-STRUCT, V410, P188, DOI 10.1016/j.msea.2005.08.074; Albou A, 2013, SCRIPTA MATER, V68, P400, DOI 10.1016/j.scriptamat.2012.10.052; Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9; Tian YZ, 2014, J MATER SCI, V49, P6629, DOI 10.1007/s10853-014-8299-8; Saha R, 2013, SCRIPTA MATER, V68, P813, DOI 10.1016/j.scriptamat.2013.01.038; Timokhina IB, 2014, MAT SCI ENG A-STRUCT, V593, P163, DOI 10.1016/j.msea.2013.11.013; Park KT, 2010, MAT SCI ENG A-STRUCT, V527, P3651, DOI 10.1016/j.msea.2010.02.058; Jeong K, 2013, ACTA MATER, V61, P3399, DOI 10.1016/j.actamat.2013.02.031; Gutierrez-Urrutia I, 2011, ACTA MATER, V59, P6449, DOI 10.1016/j.actamat.2011.07.009; Hamada A.S., 2011, MAT SCI ENG A-STRUCT, V527, P5715; Li YS, 2008, SCRIPTA MATER, V59, P475, DOI 10.1016/j.scriptamat.2008.04.043; Yan FK, 2012, ACTA MATER, V60, P1059, DOI 10.1016/j.actamat.2011.11.009	26	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5623	1543-1940		METALL MATER TRANS A	Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.	NOV	2014	45A	12					5300	5304		10.1007/s11661-014-2552-2		5	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AQ0AI	WOS:000342443200005		
J	Tsuji, S				Tsuji, Shinji			A Numerical Model Describing Multiphase Binary Diffusion in Liquid Metal/Solid Metal Couples	METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND MATERIALS SCIENCE			English	Article							LAYER GROWTH; COMPUTER-SIMULATION; SEMIINFINITE MEDIA; SOLID COPPER; DEGREES-C; ZN; FE; SYSTEMS; PHASES; TIN	A numerical model for multiphase binary diffusion in liquid metal/solid metal infinite couples is developed by introducing a bisection method which determines a location of the Matano interface. The model makes use of phase diagram sources and kinetic data without any adjustable parameters. The model gives displacements of the interphase interfaces including the liquid/solid interface relative to the x = 0 plane, a change in the mass of a solid metal and a distance-composition profile at diffusion time given. The calculated rates of phase layer growth agreed reasonably well with the measured rates by other researchers in liquid Sn saturated with Cu/solid Cu couples and liquid Zn/solid Fe couples in the diffusion-controlled stage.	[Tsuji, Shinji] Teikyo Univ, Dept Mech & Precis Syst, Utsunomiya, Tochigi 3208551, Japan	Tsuji, S (reprint author), Ibaraki Lab Diffus Alloys, 3-22-16 Yamatedai, Osaka 5670009, Japan.	sm-tsuji@coast.ocn.ne.jp					Nakano J, 2007, CALPHAD, V31, P125, DOI 10.1016/j.calphad.2006.09.003; Bouche K, 1998, MAT SCI ENG A-STRUCT, V249, P167, DOI 10.1016/S0921-5093(98)00573-5; HICKL AJ, 1975, METALL TRANS, VA  6, P431, DOI 10.1007/BF02658400; Jordan CE, 1997, J MATER SCI, V32, P5593, DOI 10.1023/A:1018680625668; Coulet A, 1997, J APPL PHYS, V82, P6001, DOI 10.1063/1.366465; DYBKOV VI, 1990, J MATER SCI, V25, P3615, DOI 10.1007/BF00575397; ENGSTROM A, 1994, METALL MATER TRANS A, V25, P1127, DOI 10.1007/BF02652288; FIDOS H, 1970, Z METALLKD, V61, P225; Hayashi A, 1997, SCRIPTA MATER, V37, P393, DOI 10.1016/S1359-6462(97)00129-2; Horstmann D., 1953, STAHL EISEN, V73, P659; HOSHINO K, 1980, T JPN I MET, V21, P674; Jost W., 1960, DIFFUSION SOLIDS LIQ, P71; Kainuma R, 2007, ISIJ INT, V47, P740, DOI 10.2355/isijinternational.47.740; Kainuma R., 2005, TETSU TO HAGANE, V91, P45; Loy A.K., 1988, METALL T A, V19A, P273; LUBYOVA Z, 1975, Z METALLKD, V66, P179; Massalski T.B., 1990, BINARY ALLOY PHASE D, P1128; Metin E, 2005, METALL MATER TRANS A, V36A, P1407, DOI 10.1007/s11661-005-0233-x; Okamoto H., 2010, DESK HDB PHASE DIAGR, P321; Onishi M., 1972, Journal of the Japan Institute of Metals, V36; Suzuki H., 1972, Journal of the Japan Institute of Metals, V36; TSUJI S, 1977, J JPN I MET, V41, P678; Tsuji S, 2005, MATER TRANS, V46, P1248, DOI 10.2320/matertrans.46.1248; TSUJI S, 1994, METALL MATER TRANS A, V25, P741, DOI 10.1007/BF02665451; TSUJI S, 1994, METALL MATER TRANS A, V25, P753, DOI 10.1007/BF02665452; WAKAMATSU Y, 1977, J JPN I MET, V41, P664	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5623	1543-1940		METALL MATER TRANS A	Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.	NOV	2014	45A	12					5371	5378		10.1007/s11661-014-2510-z		8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AQ0AI	WOS:000342443200015		
J	Nagira, T; Morita, S; Yokota, H; Yasuda, H; Gourlay, CM; Yoshiya, M; Sugiyama, A; Uesugi, K; Takeuchi, A; Suzuki, Y				Nagira, Tomoya; Morita, Shugo; Yokota, Hiroyoshi; Yasuda, Hideyuki; Gourlay, Christopher M.; Yoshiya, Masato; Sugiyama, Akira; Uesugi, Kentaro; Takeuchi, Akihisa; Suzuki, Yoshio			In Situ Observation of Deformation in Semi-solid Fe-C Alloys at High Shear Rate	METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND MATERIALS SCIENCE			English	Article							DENDRITIC SOLIDIFICATION; EQUIAXED MICROSTRUCTURE; CARBON-STEELS; AL-CU; BEHAVIOR; STATE; MECHANISMS; GROWTH	Synchrotron X-ray radiography at 125 frames per second was used to study deformation mechanisms in semi-solid Fe-C alloys at high solid fraction and shear strain rates of 10(-1)/s. An image correlation approach was also used to quantify the shear strain fields and study shear-induced dilation and the origin of shear cracking. It was shown that, at high solid fraction (90 to 93 pct solid), rearrangement including rotation and translation of solid particles became restricted and shear strain localized into narrow liquid-filled channels/fissures. Shear cracking was shown to originate from inadequate liquid flow into the expanding spaces between solid particles caused by shear-induced dilation. At lower solid fraction (similar to 85 pct solid), solid particles rearranged with a significantly higher component of rotation leading to more shear-induced dilation and a wider shear band.	[Nagira, Tomoya; Yokota, Hiroyoshi; Yoshiya, Masato] Osaka Univ, Dept Adapt Machine Syst, Suita, Osaka 5650871, Japan; [Morita, Shugo; Yasuda, Hideyuki] Kyoto Univ, Dept Mat Sci & Engn, Sakyo Ku, Kyoto 6068501, Japan; [Gourlay, Christopher M.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England; [Sugiyama, Akira] Osaka Sangyo Univ, Dept Engn, Osaka 5748530, Japan; [Uesugi, Kentaro; Takeuchi, Akihisa; Suzuki, Yoshio] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan	Nagira, T (reprint author), Osaka Univ, Dept Adapt Machine Syst, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	nagira@ams.eng.osaka-u.ac.jp	Yoshiya, Masato/A-6155-2011	Yoshiya, Masato/0000-0003-2029-2525	JSPS KAKENHI [24560910, 24246124, 24226018]; Royal Society Daiwa Anglo-Japanese Foundation International Exchanges Award; "ISIJ Innovative Program for Advanced Technology", ISIJ Research Promotion Grant	Synchrotron experiments were performed at the 20B2 of SPring-8 under Proposal No. 2009A(B)0014, 2010A1420, 2011A1209. 2011B1096, 2012A1110, 2012B1173, 2013B1242 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI). The in situ observation technique was developed with the support of "ISIJ Innovative Program for Advanced Technology", ISIJ Research Promotion Grant. Analysis was carried out under JSPS KAKENHI Grant number 24560910, 24246124, 24226018. This collaboration is also supported by a Royal Society Daiwa Anglo-Japanese Foundation International Exchanges Award.	Mangelinck-Noel N, 2005, J PHYS D APPL PHYS, V38, pA28, DOI 10.1088/0022-3727/38/10A/006; Mathiesen RH, 1999, PHYS REV LETT, V83, P5062, DOI 10.1103/PhysRevLett.83.5062; Yasuda H, 2011, ISIJ INT, V51, P402, DOI 10.2355/isijinternational.51.402; Li B, 2006, J PHYS D APPL PHYS, V39, P4450, DOI 10.1088/0022-3727/39/20/023; Yasuda H, 2004, J CRYST GROWTH, V262, P645, DOI 10.1016/j.jcrysgro.2003.09.052; Nagira T, 2011, SCRIPTA MATER, V64, P1129, DOI 10.1016/j.scriptamat.2011.03.009; Yasuda H, 2009, INT J CAST METAL RES, V22, P15, DOI 10.1179/136404609X368118; Fonseca J, 2013, ACTA MATER, V61, P4169, DOI 10.1016/j.actamat.2013.03.043; Terzi S, 2009, SCRIPTA MATER, V61, P449, DOI 10.1016/j.scriptamat.2009.04.041; Gourlay CM, 2011, ACTA MATER, V59, P4933, DOI 10.1016/j.actamat.2011.04.038; Tzimas E, 2000, MAT SCI ENG A-STRUCT, V289, P228, DOI 10.1016/S0921-5093(00)00908-4; Gourlay CM, 2007, NATURE, V445, P70, DOI 10.1038/nature05426; FLEMINGS MC, 1991, METALL TRANS A, V22, P957, DOI 10.1007/BF02661090; DAHLE AK, 1999, ACTA MAT, V47, P31; Dantzig J A, 2009, SOLIDIFICATION, P567; Goto S, 2001, NUCL INSTRUM METH A, V467, P682, DOI 10.1016/S0168-9002(01)00445-4; Gourlay C.M., 2011, IOP C SER MAT SCI EN, V27; Gourlay CM, 2008, ACTA MATER, V56, P3403, DOI 10.1016/j.actamat.2008.03.020; Kang I, 1997, J JFS, V69, P119; Metz S A, 1969, AFS T, V77, P329; Nagira T, 2013, ISIJ INT, V53, P1195, DOI 10.2355/isijinternational.53.1195; Puttgen W, 2007, ADV ENG MATER, V9, P231, DOI 10.1002/adem.200700006; Sumitomo T, 2000, MAT SCI ENG A-STRUCT, V289, P18, DOI 10.1016/S0921-5093(00)00936-9; Tzimas E, 1999, ACTA MATER, V47, P517, DOI 10.1016/S1359-6454(98)00356-5; VANVLACK LH, 1951, T AM I MIN MET ENG, V191, P251; Yasuda H., 2008, INT J CAST METAL RES, V22, P125; Yasuda H., 2011, IOP C SER MAT SCI EN, V27	27	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5623	1543-1940		METALL MATER TRANS A	Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.	NOV	2014	45A	12					5613	5623		10.1007/s11661-014-2489-5		11	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AQ0AI	WOS:000342443200034		
J	Okayasu, M; Takeuchi, S; Ohfuji, H				Okayasu, Mitsuhiro; Takeuchi, Shuhei; Ohfuji, Hiroaki			Mechanical Strength and Failure Characteristics of Cast Mg-9 pctAl-1 pctZn Alloys Produced by a Heated-Mold Continuous Casting Process: Tensile Properties	METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND MATERIALS SCIENCE			English	Article							AZ91 MAGNESIUM ALLOY; ELEVATED-TEMPERATURE; SUPERPLASTICITY; MICROSTRUCTURE; BEHAVIOR; FATIGUE	The mechanical properties and failure characteristics of a cast Mg alloy (AZ91: Mg-Al-8.9-Zn-0.6-Mn-0.2) produced by a heated-mold continuous casting process (HMC) are investigated. In a modification of the original HMC process, the cooling of the liquid alloy by direct water spray is carried out in an atmosphere of high-purity argon gas. The HMC-AZ91 alloy exhibits excellent mechanical properties (high strength and high ductility) that are about twice as high as those for the same alloy produced by conventional gravity casting. The increased material strength and ductility of the HMC sample are attributed to nanoscale and microscale microstructural characteristics. The fine grains and tiny spherical eutectic structures (e.g., Mg17Al12 and Al6Mn) distributed randomly in the matrix of the HMC alloy result in resistance to dislocation movement, leading to high tensile strength. Basal slip on (0001) planes in the relatively organized crystal orientation of the HMC alloy, as well as grain boundary sliding through tiny spherical eutectic structures, results in high ductility. Details of the failure mechanism under static loading in the HMC alloy are also discussed using failure models.	[Okayasu, Mitsuhiro; Takeuchi, Shuhei] Ehime Univ, Dept Mat Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Ohfuji, Hiroaki] Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan	Okayasu, M (reprint author), Ehime Univ, Dept Mat Sci & Engn, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	mitsuhiro.okayasu@utoronto.ca			Japanese Government (Ministry of Education, Science, Sports and Culture); Ehime University	This work was supported by a grant (Grant-in-Aid for Scientific Research (C), 2014) from the Japanese Government (Ministry of Education, Science, Sports and Culture) and Ehime University.	Sugiyama K, 2008, WEAR, V265, P713, DOI [10.1016/j.wear.2008.01.020, 10.1016/j.wear.2009.01.020]; Zhang JH, 2009, J ALLOY COMPD, V471, P322, DOI 10.1016/j.jallcom.2008.03.089; Caceres CH, 2002, MAT SCI ENG A-STRUCT, V325, P344, DOI 10.1016/S0921-5093(01)01467-8; Kulekci MK, 2008, INT J ADV MANUF TECH, V39, P851, DOI 10.1007/s00170-007-1279-2; Hu H, 1998, J MATER SCI, V33, P1579, DOI 10.1023/A:1017567821209; Potzies C, 2004, ADV ENG MATER, V6, P281, DOI 10.1002/adem.200400021; Kim WJ, 2001, ACTA MATER, V49, P3337, DOI 10.1016/S1359-6454(01)00008-8; Xu SW, 2009, MAT SCI ENG A-STRUCT, V523, P47, DOI 10.1016/j.msea.2009.05.032; Okayasu M, 2012, MAT SCI ENG A-STRUCT, V543, P185, DOI 10.1016/j.msea.2012.02.073; Wang QD, 2001, METALL MATER TRANS A, V32, P787, DOI 10.1007/s11661-001-1013-x; Hirai K, 2005, MAT SCI ENG A-STRUCT, V403, P276, DOI 10.1016/j.msea.2005.05.028; Kawamura Y, 2001, MATER TRANS, V42, P1172, DOI 10.2320/matertrans.42.1172; Avedesian M.M., 1999, ASM SPECIALTY HDB MA, P67; Callister Jr W.D., 2007, MATER SCI ENG, P378; Cerri E, 2007, J MATER PROCESS TECH, V189, P97, DOI 10.1016/j.jmatprotec.2007.01.010; Du XH, 2007, MATER LETT, V61, P2333, DOI 10.1016/j.matlet.2006.09.007; Goh C.S., 2010, MATER DESIGN, V31, P550; Harada H, 2014, METALL MATER TRANS B, V45, P427, DOI 10.1007/s11663-013-9913-x; Hertzberg R.W., 1996, DEFORMATION FRACTURE, P89; Hnilica F, 2005, KOVOVE MATER, V43, P300; Kleiner S, 2002, J LIGHT MET, V2, P277, DOI 10.1016/S1471-5317(03)00012-9; Lohmuller A., 2003, P 6 INT C MAGN ALL T, P738; LUO A, 1994, J MATER SCI, V29, P5259, DOI 10.1007/BF01171534; Munitz A, 2000, WELD J, V79, p202S; Ohno A., 1987, SOLIDIFICATION, Vfirst, P113; Okayasu M, 2011, MATER SCI TECH-LOND, V27, P76, DOI 10.1179/174328409X425245; Okayasu M, 2013, INT J CAST METAL RES, V26, P160, DOI 10.1179/1743133612Y.0000000049; Okayasu M, 2013, INT J CAST METAL RES, V26, P319, DOI 10.1179/1743133613Y.0000000065; Tzamtzis S, 2010, MAT SCI ENG A-STRUCT, V527, P2929, DOI 10.1016/j.msea.2010.01.013; Wei YH, 2003, MAT SCI ENG A-STRUCT, V360, P107, DOI 10.1016/S0921-5093(03)00407-6; Wu X, 2002, SCRIPTA MATER, V46, P269, DOI 10.1016/S1359-6462(01)01234-9; Zhan Y., 2010, T NONFERR METAL SOC, V20, P318; Zhang Z.M., 2008, ACTA METALL SIN, V21, P275, DOI 10.1016/S1006-7191(08)60049-6	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5623	1543-1940		METALL MATER TRANS A	Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.	NOV	2014	45A	12					5767	5776		10.1007/s11661-014-2497-5		10	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AQ0AI	WOS:000342443200047		
J	Wenner, S; Nishimura, K; Matsuda, K; Matsuzaki, T; Tomono, D; Pratt, FL; Marioara, CD; Holmestad, R				Wenner, Sigurd; Nishimura, Katsuhiko; Matsuda, Kenji; Matsuzaki, Teiichiro; Tomono, Dai; Pratt, Francis L.; Marioara, Calin D.; Holmestad, Randi			Clustering and Vacancy Behavior in High- and Low-Solute Al-Mg-Si Alloys	METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND MATERIALS SCIENCE			English	Article							PRECIPITATION SEQUENCE; CRYSTAL-STRUCTURE; ATOM-PROBE; NANOCLUSTERS; PHASES	The precipitate microstructure and vacancy distribution in Al-Mg-Si alloys with different amounts of solute and different heat treatments were investigated by transmission electron microscopy and muon spin relaxation measurements. A high amount of vacancies is normally present in Al-Mg-Si alloys as these bind to atomic clusters. We observe these vacancies to leave the material not before over-aging at very high temperatures such as 623 K (350 A degrees C), meaning that vacancies do not bind to incoherent over-aged precipitates. For samples only stored at room temperature after solution heat treatment, a reduction of muon trapping was found at a temperature of 140 K (-133 A degrees C) when reducing the amount of solute in the alloy. This might be connected to a lower number density of Cluster (1), which contrary to Cluster (2) do not nucleate precipitates upon further aging of the material.	[Wenner, Sigurd; Holmestad, Randi] NTNU, Dept Phys, N-7491 Trondheim, Norway; [Nishimura, Katsuhiko; Matsuda, Kenji] Toyama Univ, Dept Mat Sci & Engn, Gofu Ku, Toyama 9308555, Japan; [Matsuzaki, Teiichiro; Tomono, Dai] RIKEN, Nishina Ctr Accelerator Based Sci, Adv Meson Sci Lab, Wako, Saitama 3510198, Japan; [Pratt, Francis L.] Rutherford Appleton Lab, ISIS Facil, Chilton OX11 0QX, England; [Marioara, Calin D.] SINTEF, N-7491 Trondheim, Norway	Wenner, S (reprint author), NTNU, Dept Phys, Hogskoleringen 5, N-7491 Trondheim, Norway.	sigurd.wenner@ntnu.no			Research Council of Norway; Norsk Hydro [193619]	This work was financially supported by The Research Council of Norway and Norsk Hydro via project no. 193619, The Norwegian-Japanese Al-Mg-Si Alloy Precipitation Project.	Matsuda K, 2000, J MATER SCI, V35, P179, DOI 10.1023/A:1004769305736; Vissers R, 2007, ACTA MATER, V55, P3815, DOI 10.1016/j.actamat.2007.02.032; Marioara CD, 2006, J MATER SCI, V41, P471, DOI 10.1007/s10853-005-2470-1; Wenner S, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.104201; Dupasquier A, 2004, ACTA MATER, V52, P4707, DOI 10.1016/j.atamat.2004.07.004; Zandbergen HW, 1997, SCIENCE, V277, P1221, DOI 10.1126/science.277.5330.1221; Ravi C, 2004, ACTA MATER, V52, P4213, DOI 10.1016/j.actamat.2004.05.037; Marioara CD, 2005, METALL MATER TRANS A, V36A, P691, DOI 10.1007/s11661-005-0185-1; Chang CST, 2009, ULTRAMICROSCOPY, V109, P585, DOI 10.1016/j.ultramic.2008.12.002; Wenner S, 2013, ACTA MATER, V61, P6082, DOI 10.1016/j.actamat.2013.06.050; Martinsen FA, 2012, ACTA MATER, V60, P6091, DOI 10.1016/j.actamat.2012.07.047; Kim S, 2013, MATER TRANS, V54, P297, DOI 10.2320/matertrans.MBW201208; Edwards GA, 1998, ACTA MATER, V46, P3893, DOI 10.1016/S1359-6454(98)00059-7; Banhart J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.014101; De Geuser F, 2006, PHIL MAG LETT, V86, P227, DOI 10.1080/09500830600643270; DOYAMA M, 1984, HYPERFINE INTERACT, V17, P225, DOI 10.1007/BF02065906; Matsuzaki T, 2001, NUCL INSTRUM METH A, V465, P365, DOI 10.1016/S0168-9002(01)00694-5; Serizawa A, 2008, METALL MATER TRANS A, V39A, P243, DOI 10.1007/s11661-007-9438-5; Wenner S, 2012, INT J MATER RES, V103, P948, DOI 10.3139/146.110795; Yaouanc A., 2011, MUON SPIN ROTATION R, P115; Zurob HS, 2009, SCRIPTA MATER, V61, P141, DOI 10.1016/j.scriptamat.2009.03.025	21	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5623	1543-1940		METALL MATER TRANS A	Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.	NOV	2014	45A	12					5777	5781		10.1007/s11661-014-2527-3		5	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AQ0AI	WOS:000342443200048		
J	Guan, JZ; Guan, WP; Maeda, T; Makino, N				Guan, Jing-Zhi; Guan, Wei Ping; Maeda, Toyoki; Makino, Naoki			Changes in telomere length distribution in low-dose X-ray-irradiated human umbilical vein endothelial cells	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						Telomere length distribution; Telomerase; Vascular endothelial cell; X-ray; Ionizing irradiation	DOUBLE-STRAND BREAKS; IONIZING-RADIATION; REPLICATIVE SENESCENCE; DNA; INDUCTION; IMMORTALITY; INSTABILITY; FUSIONS; PROTEIN; STRESS	Ionizing radiation (IR) is known to be a cause of telomere dysfunction in tumor cells; however, very few studies have investigated X-ray-related changes in telomere length and the telomerase activity in normal human cells, such as umbilical vein endothelial cells (HUVECs). The loss of a few hundred base pairs from a shortened telomere has been shown to be important with respect to cellular senescence, although it may not be detected according to traditional mean telomere length [assessed as the terminal restriction fragment (TRF)] analyses. In the present study, a continuous time window from irradiation was selected to examine changes in the telomere length, including the mean TRF length, percentage of the telomere length, telomerase activity, apoptotic rate, and survival rate in HUVECs from the first day to the fourth day after the administration of a 0.5-Gy dose of irradiation. The mean TRF length in the irradiated HUVECs showed shorter telomere length in first 3 days, but they were not statistically significant. On the other hand, according to the percentage analysis of the telomere length, a decreasing tendency was noted in the longer telomere lengths (9.4-4.4 kb), with a significant increase in the shortest telomeres (4.4-2.3 kb) among the irradiated cells versus the controls from the first day to the third after irradiation; no significant differences were noted on the fourth day. These results suggest that the shortest telomeres are sensitive to the late stage of radiation damage. The proliferation of irradiated cells was suppressed after IR in contrast to the non-irradiated cells. The apoptotic rate was elevated initially both in IR- and non-IR-cells, but that of IR-cells was maintained at an elevated level thereafter in contrast to that of non-IR-cells decreasing promptly. Therefore, a 0.5-Gy dose of IR induces persistent apoptosis leading to an apparent growth arrest of the normal HUVECs.	[Guan, Jing-Zhi] Chinese Peoples Liberat Army, Hosp 309, Beijing 100091, Peoples R China; [Guan, Wei Ping] Chinese Peoples Liberat Army Gen Hosp, Nanlou Neurol Dept, Beijing 100853, Peoples R China; [Maeda, Toyoki; Makino, Naoki] Kyushu Univ, Div Cardiovasc Resp & Geriatr Med, Beppu Hosp, Beppu, Oita 8740838, Japan	Maeda, T (reprint author), Kyushu Univ, Div Cardiovasc Resp & Geriatr Med, Beppu Hosp, Beppu, Oita 8740838, Japan.	maedat@beppu.kyushu-u.ac.jp			National Natural Science Fund (NSFC) [81170329/H2501]; Ministry of Education, Science, and Culture of Japan [23590885]; Health and Labour Sciences Research Grants Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus	This work was supported, in part, by the National Natural Science Fund (NSFC) (81170329/H2501), the Ministry of Education, Science, and Culture of Japan (#23590885), the 2012 Health and Labour Sciences Research Grants Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus.	Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; Neuhof D, 2001, RADIAT RES, V155, P693, DOI 10.1667/0033-7587(2001)155[0693:IOTABI]2.0.CO;2; Wong KK, 2000, NAT GENET, V26, P85; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Ojima M, 2004, J RADIAT RES, V45, P105, DOI 10.1269/jrr.45.105; Suzuki K, 2001, RADIAT RES, V155, P248, DOI 10.1667/0033-7587(2001)155[0248:RISLGA]2.0.CO;2; Chiu CP, 1997, P SOC EXP BIOL MED, V214, P99; Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Joo OH, 1998, MUTAT RES-FUND MOL M, V401, P121; DELANGE T, 1990, MOL CELL BIOL, V10, P518; Rubio MA, 2002, J BIOL CHEM, V277, P28609, DOI 10.1074/jbc.M203747200; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Leteurtre F, 1997, LEUKEMIA, V11, P1681, DOI 10.1038/sj.leu.2400784; Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047; Von Zglinicki T, 2003, EXP GERONTOL, V38, P1259, DOI 10.1016/j.exger.2003.09.015; Ogretmen B, 2001, J BIOL CHEM, V276, P24901, DOI 10.1074/jbc.M100314200; Jones KR, 2005, INT J RADIAT BIOL, V81, P445, DOI 10.1080/09553000500168549; McIlrath J, 2001, CANCER RES, V61, P912; Rubio MA, 2004, EXP CELL RES, V298, P17, DOI 10.1016/j.yexcr.2004.04.004; Goytisolo FA, 2001, MOL CELL BIOL, V21, P3642, DOI 10.1128/MCB.21.11.3642-3651.2001; Hande P, 1999, GENOMICS, V56, P221, DOI 10.1006/geno.1998.5668; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Lanza V, 2005, J RADIAT RES, V46, P265, DOI 10.1269/jrr.46.265; Little JB, 2006, HEALTH PHYS, V91, P416, DOI 10.1097/01.HP.0000232847.23192.3e; Nagata T, 2008, NUCLEIC ACIDS RES, V36, P6816, DOI 10.1093/nar/gkn767; Przybyszewski Waldemar M, 2006, Postepy Hig Med Dosw (Online), V60, P397; Sugano M, 2007, ATHEROSCLEROSIS, V191, P33, DOI 10.1016/j.atherosclerosis.2006.04.021; Undarmaa B, 2004, BIOCHEM BIOPH RES CO, V315, P51, DOI 10.1016/j.bbrc.2004.01.014	32	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	NOV	2014	396	1-2					129	135		10.1007/s11010-014-2149-5		7	Cell Biology	Cell Biology	AP9YL	WOS:000342437900014		
J	Sugiyama, J				Sugiyama, Junta			Dr. Shin-Ichi Hatanaka (1931-2014) Obituary	MYCOSCIENCE			English	Biographical-Item									TechnoSuruga Lab, Chiba Branch Off, Funabashi, Chiba 2740822, Japan	Sugiyama, J (reprint author), TechnoSuruga Lab, Chiba Branch Off, 3-1532-13 Hasama Cho, Funabashi, Chiba 2740822, Japan.	jsugiyam@tecsrg.co.jp					[Anonymous], PUBLICATION LIST	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1340-3540	1618-2545		MYCOSCIENCE	Mycoscience	NOV	2014	55	6					423	424		10.1016/j.myc.2014.07.001		2	Mycology	Mycology	AP4VF	WOS:000342076300001		
J	Okane, I; Koide, Y; Nakamura, H; Yamaoka, Y				Okane, Izumi; Koide, Yuriko; Nakamura, Hitoshi; Yamaoka, Yuichi			Life cycle of Melampsora coleosporioides, a leaf rust of Salix babylonica in Japan	MYCOSCIENCE			English	Article						Corydalis; Host alternation; Perennial infection; Pucciniales; Willow	TREE RUSTS	Melampsora coleosporioides produces uredinia and telia on the leaves of Salix babylonica. Since the life cycle of this fungus is largely unknown, inoculation experiments were conducted to find alternate host plants. Results showed that M. coleosporioides can use Corydalis incisa as a spermogonial and aecial host. The morphological characteristics of the spermogonial and aecial states of the fungus are first described. Furthermore, field observations and histological studies demonstrated that the fungus was able to overwinter in twigs of S. babylonica and produced urediniospores in early spring. Thus, the leaf rust occurs on S. babylonica every year and alternation with the spermogonial and aecial host is not necessary. (C) 2014 The Mycological Society of Japan. Published by Elsevier B. V. All rights reserved.	[Okane, Izumi; Koide, Yuriko; Yamaoka, Yuichi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Nakamura, Hitoshi] NARO Inst Fruit Tree Sci, Tsukuba, Ibaraki 3058605, Japan	Okane, I (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	okane.izumi.fw@u.tsukuba.ac.jp			Ibaraki Nature Museum	We thank Botanical Gardens, Tohoku University, for providing willow rust and willows for inoculation. We are grateful to the Ibaraki Nature Museum for supporting field studies. Part of this study was presented at the annual meeting of Kanto branch of the Mycological Society of Japan in 2010, 24 Apr 2010, Funabashi, Chiba.	HIRATSUKA Y, 1963, MYCOLOGIA, V55, P487, DOI 10.2307/3756340; Yamaoka Yuichi, 2010, Nippon Kingakukai Kaiho, V51, P35; Pota S, 2013, MYCOSCIENCE, V54, P19, DOI 10.1016/j.myc.2012.07.004; Cummins GB, 2003, ILLUSTRATED GENERA R; Dietel P, 1902, BOT JB, V32, P47; Gaumann E, 1959, BEITRAGE KRYPTOGAMEN, V12, P1; Hersperger C, 1929, MITTHEILUNGEN NATURF, P27; Hiratsuka N, 1982, TAXONOMIC REVISION M, V20, P1; Hiratsuka N, 1992, RUST FLORA JAPAN; Hylander N, 1953, OPERA BOT, V1, P1; Jorstad I, 1951, SKR NORSKE VIDENSK A, V2, P1; KANEKO S, 1981, T MYCOL SOC JPN, V22, P219; Katumoto K., 2010, LIST FUNGI RECORDED; Kondo Shigeru, 1997, Mycoscience, V38, P163, DOI 10.1007/BF02460852; Matsumoto T, 1919, ANN MISSOURI BOT GAR, V6, P309, DOI 10.2307/2990133; MATSUMOTO TAKASHI, 1926, BOT MAG [TOKYO], V40, P43; Nakamura H, 1998, ANN PHYTOPATHOLOGICA, V64, P329; Pei MH, 2005, RUST DISEASES OF WILLOW AND POPLAR, P11, DOI 10.1079/9780851999999.0011; SAVILE DBO, 1953, MYCOLOGIA, V45, P75; Savile DBO, 1982, ARCT ALP MYC 1 INT S, P357; Shinyama Yukie, 2012, Nippon Kingakukai Kaiho, V53, P15; Wilson M, 1966, BRIT RUST FUNGI; ZILLER WG, 1970, CAN J BOTANY, V48, P1471; Ziller WG, 1974, TREE RUST W CANADA	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1340-3540	1618-2545		MYCOSCIENCE	Mycoscience	NOV	2014	55	6					431	438		10.1016/j.myc.2014.01.005		8	Mycology	Mycology	AP4VF	WOS:000342076300003		
J	Bito, T; Teng, F; Ohishi, N; Takenaka, S; Miyamoto, E; Sakuno, E; Terashima, K; Yabuta, Y; Watanabe, F				Bito, Tomohiro; Teng, Fei; Ohishi, Noriharu; Takenaka, Shigeo; Miyamoto, Emi; Sakuno, Emi; Terashima, Kazuhisa; Yabuta, Yukinori; Watanabe, Fumio			Characterization of vitamin B-12 compounds in the fruiting bodies of shiitake mushroom (Lentinula edodes) and bed logs after fruiting of the mushroom	MYCOSCIENCE			English	Article						Chloramine-T; Cobalamin; Pseudovitamin B-12; Vegetarians; Vitamin B-12[c-lactone]	VEGETARIANS; DEFICIENCY	This study determined the vitamin B-12 content in commercially available dried fruiting bodies of shiitake mushroom, Lentinula edodes. The vitamin B-12 contents in dried donko-type fruiting bodies with closed caps (5.61 +/- 3.90 mu g/100 g dry weight), did not significantly differ from those of dried koushin-type fruiting bodies with open caps (4.23 +/- 2.42 mg/100 g dry weight). The bed logs after fruiting of the mushroom also contained the vitamin B-12 levels similar to that in the dried shiitake fruiting bodies. To determine whether the dried shiitake fruiting bodies and their bed logs contained vitamin B-12 or other corrinoid compounds that are inactive in humans, we purified corrinoid compounds using an immunoaffinity column and identified vitamin B-12 using vitamin B-12-dependent Escherichia coli 215 bioautograms and liquid chromatography-electrospray ionization tandem mass spectrometry (LC/ESI-MS/MS) chromatograms. Dried shiitake fruiting bodies rarely contained an unnatural corrinoid vitamin B-12[c-lactone] that is inactive in humans. Given that shiitake mushroom lacks the ability to synthesize vitamin B12 de novo, the vitamin B-12 found in dried shiitake fruiting bodies must have been derived from the bed logs. (C) 2014 The Mycological Society of Japan. Published by Elsevier B. V. All rights reserved.	[Bito, Tomohiro; Teng, Fei; Yabuta, Yukinori; Watanabe, Fumio] Tottori Univ, Div Appl Bioresources Chem, United Grad Sch Agr Sci, Tottori 6808553, Japan; [Ohishi, Noriharu; Yabuta, Yukinori; Watanabe, Fumio] Tottori Univ, Sch Agr Biol & Environm Sci, Tottori 6808553, Japan; [Takenaka, Shigeo] Osaka Prefecture Univ, Dept Vet Sci, Grad Sch Life & Environm Sci, Osaka 5988531, Japan; [Miyamoto, Emi] Nagasaki Int Univ, Dept Hlth & Nutr, Sasebo, Japan; [Sakuno, Emi; Terashima, Kazuhisa] Japan Kinoko Res Ctr Fdn, Tottori Mycol Inst, Tottori 6891125, Japan	Watanabe, F (reprint author), Tottori Univ, Sch Agr Biol & Environm Sci, Tottori 6808553, Japan.	watanabe@muses.tottori-u.ac.jp					Scalabrino G, 2009, PROG NEUROBIOL, V88, P203, DOI 10.1016/j.pneurobio.2009.04.004; BONNETT R, 1963, CHEM REV, V63, P573, DOI 10.1021/cr60226a002; Watanabe F, 2013, J AGR FOOD CHEM, V61, P6769, DOI 10.1021/jf401545z; Shibata K, 2013, J NUTR SCI VITAMINOL, V59, pS67; Watanabe F, 2007, EXP BIOL MED, V232, P1266, DOI 10.3181/0703-MR-67; Institute of Medicine, 1998, DIET REF INT THIAM R; MILLET P, 1989, AM J CLIN NUTR, V50, P718; Pathare PM, 1996, BIOCONJUGATE CHEM, V7, P217, DOI 10.1021/bc9600022; Resources Council Science and Technology Agency, 1995, STAND TABL FOOD COMP; Scheider Z, 1987, COMPREHENSIVE B12; STEVERINK ATG, 1979, J AGR FOOD CHEM, V27, P932, DOI 10.1021/jf60225a027; Tanioka Y, 2008, J LIQ CHROMATOGR R T, V31, P1977, DOI 10.1080/10826070802197453; Watanabe F, 2012, J NUTR SCI VITAMINOL, V58, P438, DOI 10.3177/jnsv.58.438	13	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1340-3540	1618-2545		MYCOSCIENCE	Mycoscience	NOV	2014	55	6					462	468		10.1016/j.myc.2014.01.008		7	Mycology	Mycology	AP4VF	WOS:000342076300007		
J	Tamano, H; Fukura, K; Suzuki, M; Sakamoto, K; Yokogoshi, H; Takeda, A				Tamano, Haruna; Fukura, Kotaro; Suzuki, Miki; Sakamoto, Kazuhiro; Yokogoshi, Hidehiko; Takeda, Atsushi			Advantageous effect of theanine intake on cognition	NUTRITIONAL NEUROSCIENCE			English	Article						Theanine; Green tea; Recognition memory; Hippocampus	LONG-TERM POTENTIATION; RECOGNITION MEMORY; NEUROTROPHIC FACTOR; DENTATE GYRUS; GREEN TEA; PERIRHINAL CORTEX; IN-VIVO; BRAIN; BDNF; HIPPOCAMPUS	Theanine, gamma-glutamylethylamide, is one of the major amino acid components in green tea. On the basis of the preventive effect of theanine intake after weaning on stress-induced impairment of recognition memory, the advantageous effect of theanine intake on recognition memory was examined in young rats, which were fed water containing 0.3% theanine for 3 weeks after weaning. The rats were subjected to object recognition test. Object recognition memory was maintained in theanine-administered rats 48 hours after the training, but not in the control rats. When in vivo dentate gyrus long-term potentiation (LTP) was induced, it was more greatly induced in theanine-administered rats than in the control rats. The levels of brain-derived neurotropic factor and nerve growth factor in the hippocampus were significantly higher in theanine-administered rats than in the control rats. The present study indicates the advantageous effect of theanine intake after weaning on recognition memory. It is likely that theanine intake is of advantage to the development of hippocampal function after weaning.	[Tamano, Haruna; Suzuki, Miki; Takeda, Atsushi] Univ Shizuoka, Grad Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan; [Fukura, Kotaro; Sakamoto, Kazuhiro; Yokogoshi, Hidehiko] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Suruga Ku, Shizuoka 4228526, Japan	Takeda, A (reprint author), Univ Shizuoka, Grad Sch Pharmaceut Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	takedaa@u-shizuoka-ken.ac.jp		Sakamoto, Kazuhiro/0000-0002-5166-9068			Bolling BW, 2009, CURR OPIN CLIN NUTR, V12, P42, DOI 10.1097/MCO.0b013e32831b9c48; Wibrand K, 2006, EUR J NEUROSCI, V23, P1501, DOI 10.1111/j.1460-9568.2006.04687.x; Hennigan A, 2009, BEHAV BRAIN RES, V197, P371, DOI 10.1016/j.bbr.2008.09.037; Malleret G, 2010, J NEUROSCI, V30, P3813, DOI 10.1523/JNEUROSCI.1330-09.2010; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Matsuda N, 2009, J NEUROSCI, V29, P14185, DOI 10.1523/JNEUROSCI.1863-09.2009; Tamano H, 2013, BRAIN RES BULL, V95, P1, DOI 10.1016/j.brainresbull.2013.02.005; Einother SJL, 2010, APPETITE, V54, P406, DOI 10.1016/j.appet.2010.01.003; Takeda A, 2010, NEUROSCIENCE, V171, P443, DOI 10.1016/j.neuroscience.2010.09.017; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Haskell CF, 2008, BIOL PSYCHOL, V77, P113, DOI 10.1016/j.biopsycho.2007.09.008; de Mejia EG, 2009, BRAIN BEHAV IMMUN, V23, P721, DOI 10.1016/j.bbi.2009.02.013; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534; Alonso M, 2005, LEARN MEMORY, V12, P504, DOI 10.1101/lm.27305; de Lima MN, 2006, NEUROSCI LETT, V405, P142, DOI 10.1016/j.neulet.2006.06.044; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Egashira N, 2004, NEUROSCI LETT, V363, P58, DOI 10.1016/j.neulet.2004.03.046; Aicardi G, 2004, P NATL ACAD SCI USA, V101, P15788, DOI 10.1073/pnas.040696101; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Izquierdo I, 2006, TRENDS NEUROSCI, V29, P496, DOI 10.1016/j.tins.2006.07.005; Terashima T, 1999, BIOSCI BIOTECH BIOCH, V63, P615, DOI 10.1271/bbb.63.615; Yokogoshi H, 1998, NEUROCHEM RES, V23, P667, DOI 10.1023/A:1022490806093; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Cho HS, 2008, NEUROTOXICOLOGY, V29, P656, DOI 10.1016/j.neuro.2008.03.004; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Chen J, 2007, NEUROBIOL LEARN MEM, V88, P409, DOI 10.1016/j.nlm.2007.07.009; Kakuda T, 2002, BIOSCI BIOTECH BIOCH, V66, P2683; Callaghan CK, 2012, HIPPOCAMPUS, V22, P2127, DOI 10.1002/hipo.22033; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Callaghan CK, 2013, NEUROBIOL LEARN MEM; Di X, 2010, NEUROSCIENCE, V168, P778, DOI 10.1016/j.neuroscience.2010.04.019; GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F; Kakuda T, 2011, PHARMACOL RES, V64, P162, DOI 10.1016/j.phrs.2011.03.010; Kandel E.R., 2001, BRAIN RES, V294, P1030, DOI DOI 10.1126/SCIENCE.1067020; Kelly SP, 2008, J NUTR, V138, P1572; Panja D, 2013, NEUROPHARMACOLOGY; Scheid L, 2012, J NUTR, V142, P2091, DOI 10.3945/jn.112.166371; Takeda A, 2012, CELL MOL NEUROBIOL, V32, P41, DOI 10.1007/s10571-011-9732-z; Takeda A, 2011, CELL MOL NEUROBIOL, V31, P1079, DOI 10.1007/s10571-011-9707-0	41	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1028-415X	1476-8305		NUTR NEUROSCI	Nutr. Neurosci.	NOV	2014	17	6					279	283		10.1179/1476830513Y.0000000094		5	Neurosciences; Nutrition & Dietetics	Neurosciences & Neurology; Nutrition & Dietetics	AQ0XY	WOS:000342507200005		
J	Kawaguchi, E; Ishikura, K; Hamada, R; Nagaoka, Y; Morikawa, Y; Sakai, T; Hamasaki, Y; Hataya, H; Noda, E; Miura, M; Ando, T; Honda, M				Kawaguchi, Emi; Ishikura, Kenji; Hamada, Riku; Nagaoka, Yoshinobu; Morikawa, Yoshihiko; Sakai, Tomoyuki; Hamasaki, Yuko; Hataya, Hiroshi; Noda, Eiichiro; Miura, Masaru; Ando, Takashi; Honda, Masataka			Early and frequent development of ocular hypertension in children with nephrotic syndrome	PEDIATRIC NEPHROLOGY			English	Article						Intraocular pressure; Children; Prednisolone; Nephrotic syndrome; iCare tonometer; Goldmann applanation tonometry; Side effect	GOLDMANN APPLANATION TONOMETER; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE	Prednisolone, the first-line treatment for children with nephrotic syndrome, causes severe side effects. One of these side effects is ocular hypertension, which can result in severe and permanent visual disturbance. However, the exact prevalence, severity and timing of development of ocular hypertension have yet to be fully explored in this pediatric patient group. In this retrospective cohort study, children with nephrotic syndrome treated with prednisolone for their first episode were analyzed. Intraocular pressure was screened with an iCareA (R) tonometer and confirmed with Goldmann applanation tonometry before the initiation of prednisolone treatment and at 1 and 4 weeks thereafter. A total of 26 children with nephrotic syndrome were included in this study, of whom eight (30.8 %) required treatment with eye drops for ocular hypertension. The median time interval between the diagnosis of ocular hypertension and start of treatment was 9 (range 5-31) days. At relapse of nephrotic syndrome, all children who had undergone treatment for ocular hypertension in their first episode again required treatment for ocular hypertension. Routine ophthalmologic examination should be conducted from the early phase after the start of prednisolone treatment. In addition, children with episodes of ocular hypertension may be at greater risk of its reappearance with relapse of the nephrotic syndrome.	[Kawaguchi, Emi] Tokyo Metropolitan Childrens Med Ctr, Div Gen Pediat, Tokyo 1838561, Japan; [Kawaguchi, Emi; Ishikura, Kenji; Hamada, Riku; Hataya, Hiroshi; Honda, Masataka] Tokyo Metropolitan Childrens Med Ctr, Dept Nephrol, Tokyo 1838561, Japan; [Kawaguchi, Emi; Morikawa, Yoshihiko; Miura, Masaru] Tokyo Metropolitan Childrens Med Ctr, Clin Res Support Ctr, Tokyo 1838561, Japan; [Nagaoka, Yoshinobu] Hokkaido Med Ctr, Natl Hosp Org, Dept Pediat, Sapporo, Hokkaido, Japan; [Sakai, Tomoyuki] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga 52021, Japan; [Hamasaki, Yuko] Toho Univ, Fac Med, Dept Pediat Nephrol, Tokyo, Japan; [Noda, Eiichiro] Tokyo Metropolitan Childrens Med Ctr, Div Ophthalmol, Tokyo 1838561, Japan; [Ando, Takashi] Japan Clin Res Support Unit, Tokyo, Japan	Ishikura, K (reprint author), Tokyo Metropolitan Childrens Med Ctr, Dept Nephrol, 2-8-29 Musashidai Fuchu, Tokyo 1838561, Japan.	kenzo@ii.e-mansion.com			Novartis Pharma; Asahi Kasei Pharma; Astellas Pharma; Baxter; JMS; Meiji Seika Pharma Co. LTD.	Kenji Ishikura has received lecture fees from Novartis Pharma and Asahi Kasei Pharma. Yuko Hamasaki has received research grants from Novartis Pharma, and lecture fee from Novartis Pharma and Astellas Pharma. Hiroshi Hataya has received lecture fees and travel expenses from Asahi Kasei Pharma, Astellas Pharma, Baxter, JMS, and Meiji Seika Pharma Co. LTD. Masataka Honda has received lecture fees from Novartis Pharma and Asahi Kasei Pharma.	Fingert JH, 2010, MOL VIS, V16, P596; LEWIS JM, 1988, AM J OPHTHALMOL, V106, P607, DOI 10.1016/0002-9394(88)90595-8; Pakrou N, 2008, J GLAUCOMA, V17, P43, DOI 10.1097/IJG.0b013e318133fb32; Iliev ME, 2006, BRIT J OPHTHALMOL, V90, P833, DOI 10.1136/bjo.2005.089870; Tarshish P, 1997, J AM SOC NEPHROL, V8, P769; Gipson DS, 2009, PEDIATRICS, V124, P747, DOI 10.1542/peds.2008-1559; Yamashita T, 2010, J GLAUCOMA, V19, P188, DOI 10.1097/IJG.0b013e3181af321d; Razeghinejad MR, 2012, OPHTHALMIC RES, V47, P66, DOI 10.1159/000328630; [Anonymous], 2012, NIHON GANKA GAKKAI Z, V116, P3; [Anonymous], 1982, J PEDIAT, V101, P514; Jones R, 2006, CURR OPIN OPHTHALMOL, V17, P163; [Anonymous], 1981, J PEDIAT, V98, P561; [Anonymous], 1984, PEDIATRICS, V73, P497; Kontiola AI, 2000, ACTA OPHTHALMOL SCAN, V78, P142, DOI 10.1034/j.1600-0420.2000.078002142.x; Barnett H L, 1979, Nihon Jinzo Gakkai Shi, V21, P1141; BERNSTEIN HN, 1962, ARCH OPHTHALMOL-CHIC, V68, P742; Brito Pedro Nuno, 2012, Clin Ophthalmol, V6, P1675, DOI 10.2147/OPTH.S36261; Fitzgerald LA, 2012, BMJ CASE REP, DOI [10.1136/bcr-2012-006955, DOI 10.1136/BCR-2012-006955]; FRANCOIS J, 1984, OPHTHALMOLOGICA, V188, P76; Kanei M, 1993, JPN REV CLIN OPHTHAL, V87, P312; Kim KN, 2013, ACTA OPHTHALMOL, V91, pE392, DOI 10.1111/aos.12109; Krzyzanowska-Berkowska Patrycjia, 2010, Klin Oczna, V112, P217; LEWIS MA, 1989, LANCET, V1, P255; Lombel RM, 2013, PEDIATR NEPHROL, V28, P415, DOI 10.1007/s00467-012-2310-x; López-Caballero C, 2007, Arch Soc Esp Oftalmol, V82, P273; Mohan R, 1989, Indian J Ophthalmol, V37, P13; Sandhu SS, 2005, J GLAUCOMA, V14, P215, DOI 10.1097/00061198-200506000-00009; Sapir-Pichhadze R, 2003, HAREFUAH, V142, P157; Seth Anju, 2004, Indian Pediatr, V41, P349	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0931-041X	1432-198X		PEDIATR NEPHROL	Pediatr. Nephrol.	NOV	2014	29	11					2165	2171		10.1007/s00467-014-2848-x		7	Pediatrics; Urology & Nephrology	Pediatrics; Urology & Nephrology	AQ0FG	WOS:000342457700015		
J	Nagata, M; Hanaki, Y; Ikeda, A; Sekine, Y				Nagata, Masato; Hanaki, Yasunari; Ikeda, Atsushi; Sekine, Yasushi			Effect of Ozone Addition to Lean NOx Trap Method Using Plasma-Catalyst System	PLASMA CHEMISTRY AND PLASMA PROCESSING			English	Article						Dielectric barrier discharge; Ozone injection; Lean NOx trap; Plasma-catalyst; Automobile exhaust gas cleaning	NITRIC-OXIDE; DIRECT DECOMPOSITION; NONTHERMAL PLASMA; ATMOSPHERIC-PRESSURE; REDUCTION CATALYST; STORAGE-REDUCTION; NITROGEN-OXIDES; REMOVAL; OXIDATION; DISCHARGE	Although diesel vehicles have high energy efficiency, the removal of emitted NOx at low temperature persists as an important issue. This report presents an examination of low-temperature NOx removal using ozone injection and a plasma-lean NOx trap (LNT) catalyst system. Ozone is readily producible by a dielectric barrier discharge reactor using oxygen in air, and its injection to emitted NO enables oxidation to NO2 even at low temperatures. Results show that synergetic effects of ozone injection and plasma-LNT catalyst system enable low-temperature NOx removal.	[Nagata, Masato; Hanaki, Yasunari] Nissan Motor Co Ltd, Yokosuka, Kanagawa, Japan; [Ikeda, Atsushi; Sekine, Yasushi] Waseda Univ, Shinjuku Ku, Tokyo, Japan	Sekine, Y (reprint author), Waseda Univ, Shinjuku Ku, 3-4-1 Okubo, Tokyo, Japan.	ysekine@waseda.jp					Brandenberger S, 2010, APPL CATAL B-ENVIRON, V95, P348, DOI 10.1016/j.apcatb.2010.01.013; Iwamoto S, 2007, APPL CATAL B-ENVIRON, V70, P146, DOI 10.1016/j.apcatb.2006.01.016; Teraoka Y, 1998, J CHEM SOC FARADAY T, V94, P1887, DOI 10.1039/a800872h; Szailer T, 2006, J CATAL, V239, P51, DOI 10.1016/j.jcat.2006.01.014; Miessner H, 2002, CATAL TODAY, V75, P325, DOI 10.1016/S0920-5861(02)00085-8; Klingstedt F, 2006, ACCOUNTS CHEM RES, V39, P273, DOI 10.1021/ar050185k; Malik MA, 2014, PLASMA CHEM PLASMA P, V34, P93, DOI 10.1007/s11090-013-9497-x; Nagao I, 2002, VACUUM, V65, P481, DOI 10.1016/S0042-207X(01)00460-2; GENTILE AC, 1995, J APPL PHYS, V78, P2074, DOI 10.1063/1.360185; Li JH, 2009, APPL CATAL B-ENVIRON, V90, P360, DOI 10.1016/j.apcatb.2009.03.017; Mok YS, 2004, J CHEM ENG JPN, V37, P1337, DOI 10.1252/jcej.37.1337; Gervasini A, 1996, CATAL TODAY, V29, P449, DOI 10.1016/0920-5861(95)00319-3; Malik MA, 2011, J HAZARD MATER, V197, P220, DOI 10.1016/j.jhazmat.2011.09.079; Matsumoto SI, 2004, CATAL TODAY, V90, P183, DOI 10.1016/j.cattod.2004.04.048; Takahashi N, 1996, CATAL TODAY, V27, P63, DOI 10.1016/0920-5861(95)00173-5; Shimizu K, 2000, APPL CATAL B-ENVIRON, V25, P239, DOI 10.1016/S0926-3373(99)00135-6; Forzatti P, 2009, ANGEW CHEM INT EDIT, V48, P8366, DOI 10.1002/anie.200903857; Jin M, 2013, CATAL TODAY, V204, P108, DOI 10.1016/j.cattod.2012.09.026; Iwamoto M, 1991, CATAL TODAY, V10, P57, DOI 10.1016/0920-5861(91)80074-J; Imanaka N, 2012, APPL CATAL A-GEN, V431, P1, DOI 10.1016/j.apcata.2012.02.047; Baik JH, 2004, TOP CATAL, V30-1, P37, DOI 10.1023/B:TOCA.0000029725.88068.97; Lietti L, 2001, J CATAL, V204, P175, DOI 10.1006/jcat.2001.3370; Broer S, 2000, APPL CATAL B-ENVIRON, V28, P101, DOI 10.1016/S0926-3373(00)00166-1; Sedlmair C, 2003, J CATAL, V214, P308, DOI 10.1016/S0021-9517(02)00085-4; Liu ZM, 2006, CATAL REV, V48, P43, DOI 10.1080/01614940500439891; Yokomichi Y, 2000, APPL CATAL B-ENVIRON, V28, P1, DOI 10.1016/S0926-3373(00)00155-7; Barman S, 2006, ENVIRON SCI TECHNOL, V40, P1035, DOI 10.1021/es0515102; Bokova M, 2004, APPL CATAL B-ENVIRON, V54, P9, DOI 10.1016/j.apcatb.2004.05.019; Busca G, 1998, APPL CATAL B-ENVIRON, V18, P1, DOI 10.1016/S0926-3373(98)00040-X; Epling WS, 2004, CATALYSIS REV SCI EN, V46, P1; Goto K, 2009, TOP CATAL, V52, P1776, DOI 10.1007/s11244-009-9337-7; Iwakuni H, 2000, APPL CATAL B-ENVIRON, V74, P300; IWAMOTO M, 2000, STUD SURF SCI CATAL, V130, P23; James D, 2003, APPL CATAL B-ENVIRON, V45, P147, DOI 10.1016/S0926-3373(03)00123-1; Jobson E, 2004, TOP CATAL, V28, P191, DOI 10.1023/B:TOCA.0000024350.93474.d1; Kogel M, 2001, CATAL COMMUN, V2, P273, DOI 10.1016/S1566-7367(01)00046-2; Luo J, 1998, J PHYS CHEM A, V102, P7954, DOI 10.1021/jp982013t; MIYADERA T, 1993, APPL CATAL B-ENVIRON, V2, P199, DOI 10.1016/0926-3373(93)80048-I; MIZUNO A, 1995, IEEE T IND APPL, V31, P957, DOI 10.1109/28.464504; Mok YS, 2004, KOREAN J CHEM ENG, V21, P976, DOI 10.1007/BF02705580; Naydenov A, 1993, DOKL BULG AKAD NAUK, V46, P49; NAYDENOV A, 1995, J MOL CATAL A-CHEM, V98, P9, DOI 10.1016/1381-1169(94)00060-3; Sekine Y, 2013, NEW FUTURE DEV CATAL, P439; Shimizu K, 1999, IEEE T IND APPL, V35, P1311, DOI 10.1109/28.806044; Takahara Y, 2013, CATAL TODAY, V211, P44, DOI 10.1016/j.cattod.2013.03.032; Wang XQ, 2005, APPL CATAL B-ENVIRON, V56, P261, DOI 10.1016/j.apcatb.2004.09.014; Xie SB, 1999, J CATAL, V188, P24, DOI 10.1006/jcat.1999.2648; Yin SE, 2009, PLASMA CHEM PLASMA P, V29, P421, DOI 10.1007/s11090-009-9190-2	48	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4324	1572-8986		PLASMA CHEM PLASMA P	Plasma Chem. Plasma Process.	NOV	2014	34	6					1303	1315		10.1007/s11090-014-9568-7		13	Engineering, Chemical; Physics, Applied; Physics, Fluids & Plasmas	Engineering; Physics	AP9YY	WOS:000342439400005		
J	Shibata, T; Nishiyama, H				Shibata, Tomohiro; Nishiyama, Hideya			Acetic Acid Decomposition in a Coaxial Dielectric Barrier Discharge Tube with Mist Flow	PLASMA CHEMISTRY AND PLASMA PROCESSING			English	Article						Water treatment; Non-thermal plasma; Mist flow; Organic compounds	AQUEOUS-SOLUTION; WATER-PURIFICATION; HYDROXYL RADICALS; HYDROGEN-PEROXIDE; CORONA DISCHARGE; RATE CONSTANTS; SPRAY	Non-thermal plasmas can be used for water treatment system because they allow free radical generation without heating. Advanced oxidation processes using non-thermal plasmas have been developed to decompose persistent organic pollutants. In this study, a water treatment method that involves spraying a solution into a coaxial dielectric barrier discharge (DBD) tube using an air, argon or oxygen carrier gas was investigated. The alumina DBD tube had an inner high-voltage electrode and an outer ground electrode. Acetic acid was used as the decomposition target because acetic acid is a known persistent organic material. An acetic acid solution, diluted 10,000 times in purified water, was atomized by an ultrasonic atomizer unit and introduced into the DBD tube. The residence time of the droplets sprayed into the discharge area was almost 7 ms. Acetic acid was effectively decomposed and the decomposition ratio reached almost 80 % when Ar was employed as the carrier gas. This is due to the very fine droplets in the sprayed mist having a large specific surface area and OH radicals being able to react directly in solution. Furthermore, the results suggest that the chemical processes involved in acetic acid decomposition can be controlled by varying the carrier gas composition.	[Shibata, Tomohiro] Tohoku Univ, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Nishiyama, Hideya] Tohoku Univ, Inst Fluid Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan	Shibata, T (reprint author), Tohoku Univ, Grad Sch Engn, Aoba Ku, 6-6 Aoba, Sendai, Miyagi 9808577, Japan.	shibata@paris.ifs.tohoku.ac.jp			JSPS [24656117];  [249008]	This work was partly supported by a Grant-in-Aid for Challenging Exploratory Research (24656117) from the JSPS and a Grant-in-Aid for JSPS Fellows (249008). The authors are thankful to Associate Professor Hidemasa Takana for his valuable discussion, Mr. Tomoki Nakajima and Mr. Hiroki Sanada for their technical supports with IFS, Tohoku University.	Burlica R, 2010, IND ENG CHEM RES, V49, P6342, DOI 10.1021/ie100038g; JOSHI AA, 1995, J HAZARD MATER, V41, P3, DOI 10.1016/0304-3894(94)00099-3; Matsui Y, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/3/034015; Malik MA, 2001, PLASMA SOURCES SCI T, V10, P82, DOI 10.1088/0963-0252/10/1/311; KATO K, 1995, J MATER SCI, V30, P837, DOI 10.1007/BF00356349; Malik MA, 2010, PLASMA CHEM PLASMA P, V30, P21, DOI 10.1007/s11090-009-9202-2; WARDMAN P, 1989, J PHYS CHEM REF DATA, V18, P1637; Tachibana K, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/3/034005; Tan Y, 2012, ATMOS CHEM PHYS, V12, P801, DOI 10.5194/acp-12-801-2012; Chocholousova J, 2003, J PHYS CHEM A, V107, P3086, DOI [10.1021/jp027637k, 10.1021/jp027367k]; Buxton GV, 2001, PHYS CHEM CHEM PHYS, V3, P2618, DOI 10.1039/b101932p; EXNER M, 1994, J ATMOS CHEM, V18, P359, DOI 10.1007/BF00712451; LANG RJ, 1962, J ACOUST SOC AM, V34, P6, DOI 10.1121/1.1909020; Leitner NKV, 1997, WATER RES, V31, P1383; Nishiyama H, 2011, IEEE T PLASMA SCI, V39, P2660, DOI 10.1109/TPS.2011.2160367; Sano N, 2004, SEP PURIF TECHNOL, V37, P169, DOI 10.1016/S1383-5866(03)00166-7; Shin KY, 2011, IEEE T PLASMA SCI, V39, P883; Suzuki T, 2011, IEEE T DIELECT EL IN, V18, P1281, DOI 10.1109/TDEI.2011.5976128; Takeuchi N, 2011, IEEE T PLASMA SCI, V39, P3358, DOI 10.1109/TPS.2011.2171374; Yamatake A, 2006, IEEE T PLASMA SCI, V34, P1375, DOI 10.1109/TPS.2006.877249	20	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4324	1572-8986		PLASMA CHEM PLASMA P	Plasma Chem. Plasma Process.	NOV	2014	34	6					1331	1343		10.1007/s11090-014-9575-8		13	Engineering, Chemical; Physics, Applied; Physics, Fluids & Plasmas	Engineering; Physics	AP9YY	WOS:000342439400007		
J	Abdelaziz, AA; Seto, T; Abdel-Salam, M; Otani, Y				Abdelaziz, Ayman A.; Seto, Takafumi; Abdel-Salam, M.; Otani, Yoshio			Influence of N-2/O-2 Mixtures on Decomposition of Naphthalene in Surface Dielectric Barrier Discharge Based Reactor	PLASMA CHEMISTRY AND PLASMA PROCESSING			English	Article						Surface discharge; Decomposition efficiency; Naphthalene; Oxygen content	POLYCYCLIC AROMATIC-HYDROCARBONS; VOLATILE ORGANIC-COMPOUNDS; PULSED CORONA DISCHARGES; NONTHERMAL PLASMA; ELECTRON COLLISIONS; CROSS-SECTIONS; GAS-PHASE; REMOVAL; DESTRUCTION; ACENAPHTHENE	The decomposition of naphthalene in surface dielectric barrier discharge (SDBD) based reactor is investigated in different carrier gases (air, nitrogen, and oxygen) in order to understand the reaction mechanism of the decomposition process. The decomposition efficiency of naphthalene is determined at different oxygen content (from 0 to 10 vol%) and different input power. The highest decomposition efficiency is obtained in nitrogen at low input power, due to the role played by the nitrogen excited species in the decomposition process. In addition, the decomposition efficiency is decreased with increasing the oxygen content at a low input power. At a relatively high input power, the decomposition efficiency reached its maximum value in pure oxygen. Moreover, the decomposition efficiency decreases with the increase of the oxygen content reaching minimum value at a small content of oxygen (similar to 3 vol% O-2) and relatively high input power, and then increases at higher oxygen content. The results show that the decomposition of naphthalene in the present reactor could be treated as a first order reaction with respect to the concentration of naphthalene.	[Abdelaziz, Ayman A.] Assiut Univ, Dept Phys, Fac Sci, Assiut 71516, Egypt; [Seto, Takafumi; Otani, Yoshio] Kanazawa Univ, Grad Sch Nat Sci & Technol, Dept Chem & Mat Engn, Kanazawa, Ishikawa 9201192, Japan; [Abdel-Salam, M.] Assiut Univ, Dept Elect Engn, Assiut 71516, Egypt	Abdelaziz, AA (reprint author), Assiut Univ, Dept Phys, Fac Sci, Assiut 71516, Egypt.	a.abdelaziz@science.au.edu.eg	Seto, Takafumi/D-2874-2012; OTANI, Yoshio/L-3581-2015	OTANI, Yoshio/0000-0002-5751-6898			Abdelaziz AA, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/11/115201; Chen HL, 2009, ENVIRON SCI TECHNOL, V43, P2216, DOI 10.1021/es802679b; Marchand N, 2004, ATMOS CHEM PHYS, V4, P1167; Bunce NJ, 1997, ENVIRON SCI TECHNOL, V31, P2252, DOI 10.1021/es960813g; Enloe CL, 2008, J APPL PHYS, V103, DOI 10.1063/1.2896590; Byeon JH, 2010, J HAZARD MATER, V175, P417, DOI 10.1016/j.jhazmat.2009.10.022; Lee HM, 2003, PLASMA CHEM PLASMA P, V23, P541, DOI 10.1023/A:1023239122885; Wang L, 2007, ENVIRON SCI TECHNOL, V41, P2803, DOI 10.1021/es0628102; Agnihotri S, 2004, J ENVIRON ENG-ASCE, V130, P349, DOI 10.1061/(ASCE)0733-9372(2004)130:3(349); Zhu T, 2008, INT J ENVIRON SCI TE, V5, P375, DOI 10.1007/BF03326032; KEITH LH, 1979, ENVIRON SCI TECHNOL, V13, P416, DOI 10.1021/es60152a601; Beegle LW, 2001, SPECTROCHIM ACTA A, V57, P737, DOI 10.1016/S1386-1425(00)00440-6; Chen J, 2009, CHEMOSPHERE, V75, P261, DOI 10.1016/j.chemosphere.2008.12.010; Kim HH, 2004, PLASMA PROCESS POLYM, V1, P91, DOI 10.1002/ppap.200400028; Ravindra K, 2008, ATMOS ENVIRON, V42, P2895, DOI 10.1016/j.atmosenv.2007.12.010; Guo YF, 2007, CATAL TODAY, V126, P328, DOI 10.1016/j.cattod.2007.06.025; Redolfi M, 2009, PLASMA CHEM PLASMA P, V29, P173, DOI 10.1007/s11090-009-9169-z; Itikawa Y, 2006, J PHYS CHEM REF DATA, V35, P31, DOI [10.1063/1.1937426, 10.1063/1.937426]; ATKINSON R, 1988, INT J CHEM KINET, V20, P513, DOI 10.1002/kin.550200703; Bityurin VA, 2009, IEEE T PLASMA SCI, V37, P911, DOI 10.1109/TPS.2009.2019756; Blin-Simiand N, 2008, PLASMA CHEM PLASMA P, V28, P429, DOI 10.1007/s11090-008-9135-1; Blin-Simiand N, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/12/122003; Chang CL, 2005, PLASMA CHEM PLASMA P, V25, P641, DOI 10.1007/s11090-005-6818-8; Dann T, 1989, POLYCYCLIC AROMATIC; Falkenstein Z, 1999, J APPL PHYS, V85, P525, DOI 10.1063/1.369484; Harvey R. G., 1997, POLYCYCLIC AROMATIC; Herron JT, 2001, PLASMA CHEM PLASMA P, V21, P581, DOI 10.1023/A:1012003218939; Huang L, 2001, ENVIRON SCI TECHNOL, V35, P1276, DOI 10.1021/es0011414; Itikawa Y, 2009, J PHYS CHEM REF DATA, V38, P1, DOI 10.1063/1.3025886; Kogelschatz U., 1997, LE J PHYS 4, V07; Liang WJ, 2011, J ELECTROSTAT, V69, P206, DOI 10.1016/j.elstat.2011.03.011; Lu B, 2007, J MATER ENG PERFORM, V17, P428; Lu B, 2009, INT C ENV SCI INF AP, P623; Mok YS, 2009, IEEE T PLASMA SCI, V37, P449, DOI 10.1109/TPS.2008.2011800; Mok YS, 2008, J PHYS CHEM A, V112, P6586, DOI 10.1021/jp8020084; Nair SA, 2003, FUEL PROCESS TECHNOL, V84, P161, DOI 10.1016/S0378-3820(03)00053-5; Ni MJ, 2011, J ZHEJIANG UNIV-SC A, V12, P71, DOI 10.1631/jzus.A1010009; Oda T, 2001, IEEE T IND APPL, V37, P965, DOI 10.1109/TIA.2001.936385; Ostapczuk A, 2008, PLASMA CHEM PLASMA P, V28, P483, DOI 10.1007/s11090-008-9144-0; Petrov A. A., 1987, PETROLEUM HYDROCARBO; SZEPESY L, 1981, J CHROMATOGR, V206, P611, DOI 10.1016/S0021-9673(00)88934-7; Yu L, 2010, J PHYS CHEM A, V114, P360, DOI 10.1021/jp905082s	42	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4324	1572-8986		PLASMA CHEM PLASMA P	Plasma Chem. Plasma Process.	NOV	2014	34	6					1371	1385		10.1007/s11090-014-9578-5		15	Engineering, Chemical; Physics, Applied; Physics, Fluids & Plasmas	Engineering; Physics	AP9YY	WOS:000342439400009		
J	Nawata, N				Nawata, Norio			A NOTE ON TRACE SCALING ACTIONS AND FUNDAMENTAL GROUPS OF C*-ALGEBRAS	PROCEEDINGS OF THE AMERICAN MATHEMATICAL SOCIETY			English	Article						Fundamental group; trace scaling action; dimension group; Effros-Handelman-Shen theorem	STABLE UHF-ALGEBRAS; II1 FACTORS; AUTOMORPHISMS; EQUIVALENCE	Using the Effros-Handelman-Shen theorem and Elliott's classification theorem of AF algebras, we show that there exists a unital simple AF algebra A with unique trace such that A circle times K admits no trace scaling action of the fundamental group of A.	[Nawata, Norio] Chiba Univ, Grad Sch Sci, Dept Math & Informat, Inage Ku, Chiba 2638522, Japan	Nawata, N (reprint author), Osaka Kyoiku Univ, Dept Arts & Sci, 4-698-1 Asahigaoka, Osaka 5828582, Japan.	nawata@cc.osaka-kyoiku.ac.jp					Murray FJ, 1943, ANN MATH, V44, P716, DOI 10.2307/1969107; VOICULESCU D, 1990, PROG MATH, V92, P45; BROWN LG, 1977, PAC J MATH, V71, P349; ELLIOTT GA, 1976, J ALGEBRA, V38, P29, DOI 10.1016/0021-8693(76)90242-8; EFFROS EG, 1980, AM J MATH, V102, P385, DOI 10.2307/2374244; Popa S, 2006, INVENT MATH, V165, P369, DOI 10.1007/s00222-006-0501-4; Popa S, 2010, J AM MATH SOC, V23, P383; Bratteli O, 2000, Q J MATH, V51, P131, DOI 10.1093/qjmath/51.2.131; Connes A., 1977, TOHOKU MATH J, V29, P473, DOI 10.2748/tmj/1178240493; Connes A., 1980, J OPERAT THEOR, V4, P151; Elliott GA, 1998, MATH SCAND, V83, P74; Evans David E., 1997, HOKKAIDO MATH J, V26, P211; Jacobson Jr Michael J., 2009, CMS BOOKS MATH; Kodaka K, 1997, J LOND MATH SOC, V56, P179, DOI 10.1112/S0024610797005243; Kodaka K, 1999, GLASGOW MATH J, V41, P345, DOI 10.1017/S0017089599000336; Kodaka Kazunori, 1997, J OPERAT THEOR, V37, P357; Nawata N, 2011, J FUNCT ANAL, V260, P428, DOI 10.1016/j.jfa.2010.09.014; Nawata N, 2010, ADV MATH, V225, P307, DOI 10.1016/j.aim.2010.02.019; Nawata N, 2012, CAN J MATH, V64, P573, DOI 10.4153/CJM-2011-052-0; Popa Sorin, 2010, CLAY MATH P, V11, P519; RADULESCU F, 1992, CR ACAD SCI I-MATH, V314, P1027; Radulescu Florin, 1992, J AM MATH SOC, V5, P517, DOI 10.2307/2152703; Rocca Giulio Della, 2001, CONT MATH, V282, P47, DOI 10.1090/conm/282/04678; TAKESAKI M, 1973, ACTA MATH-DJURSHOLM, V131, P249, DOI 10.1007/BF02392041	24	0	0	AMER MATHEMATICAL SOC	PROVIDENCE	201 CHARLES ST, PROVIDENCE, RI 02940-2213 USA	0002-9939	1088-6826		P AM MATH SOC	Proc. Amer. Math. Soc.	NOV	2014	142	11					3903	3908	PII S0002-9939(2014)12346-X			6	Mathematics, Applied; Mathematics	Mathematics	AP8AJ	WOS:000342299800023		
J	Mineta, K; Higashino, K; Sakai, T; Fukui, Y; Sairyo, K				Mineta, Kazuaki; Higashino, Kosaku; Sakai, Toshinori; Fukui, Yoshihiro; Sairyo, Koichi			Recurrence of type I Modic inflammatory changes in the lumbar spine: effectiveness of intradiscal therapy	SKELETAL RADIOLOGY			English	Article						Modic; Intradiscal injection; Low back pain; Lumbar spine	DEGENERATIVE DISK DISEASE; PLATE SIGNAL CHANGES; LOW-BACK-PAIN; END-PLATES; MRI; ASSOCIATION	Here we report a case of recurrence of Modic type I inflammatory changes in the lumbar spine. A 49-year-old man was referred to our department with a history of chronic low back pain of at least 20 years. At the first consultation, he complained of low back pain only and had no other symptoms such as leg pain, numbness, or weakness. Although his pain was typically mild, he experienced one or two episodes of severe and incapacitating low back pain a year. After two intradiscal steroid injections, his pain disappeared immediately and completely. After 6 months of conservative treatment, Modic type I change switched to Modic type II change. However, 12 months after the first treatment, he once again experienced severe low back pain. Follow-up magnetic resonance imaging (MRI) indicated recurrence of Modic type I change that was stronger than the first occurrence. Two intradiscal injections relieved the pain. Six months after the second episode, follow-up MRI showed another switch of Modic type I change to Modic type II change. Switches of Modic change have been controversial, with mixed findings on pain, natural history, and degenerative changes. The present case reinforces the notion that Modic type I change corresponds to reversible local inflammation.	[Mineta, Kazuaki; Higashino, Kosaku; Sakai, Toshinori; Sairyo, Koichi] Univ Tokushima, Dept Orthoped, Tokushima 7708503, Japan; [Higashino, Kosaku; Fukui, Yoshihiro] Univ Tokushima, Dept Anat, Tokushima 7708503, Japan	Sairyo, K (reprint author), Univ Tokushima, Dept Orthoped, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	sairyokun@hotmail.com					Mitra D, 2004, EUR RADIOL, V14, P1574, DOI 10.1007/s00330-004-2314-4; MODIC MT, 1988, RADIOLOGY, V168, P177; Kuisma M, 2006, SPINE, V31, P1714, DOI 10.1097/01.brs.0000224167.18483.14; Ohtori S, 2006, SPINE, V31, P1026, DOI 10.1097/01.brs.0000215027.87102.7c; Fayad F, 2007, EUR SPINE J, V16, P925, DOI 10.1007/s00586-006-0301-y; MODIC MT, 1988, RADIOLOGY, V166, P193; Zhang YH, 2008, EUR SPINE J, V17, P1289, DOI 10.1007/s00586-008-0758-y; Kuisma M, 2007, SPINE, V32, P1116, DOI 10.1097/01.brs.0000261561.12944.ff; Cao P, 2011, SPINE J, V11, P100, DOI 10.1016/j.spinee.2010.07.001; Carragee Eugene J, 2005, Spine J, V5, P24, DOI 10.1016/j.spinee.2004.05.250; Esposito P, 2006, NEUROCHIRURGIE, V52, P315, DOI 10.1016/S0028-3770(06)71225-5; Higashino Kosaku, 2012, J Bone Joint Surg Am, V94, pe74, DOI 10.2106/JBJS.K.00343; Mefford J, 2011, SKELETAL RADIOL, V40, P467, DOI 10.1007/s00256-010-1066-2; Sandhu HS, 2000, J SPINAL DISORD, V13, P438, DOI 10.1097/00002517-200010000-00012; SIMMONS JW, 1992, SPINE, V17, pS172, DOI 10.1097/00007632-199206001-00019	15	1	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2348	1432-2161		SKELETAL RADIOL	Skeletal Radiol.	NOV	2014	43	11					1645	1649		10.1007/s00256-014-1947-x		5	Orthopedics; Radiology, Nuclear Medicine & Medical Imaging	Orthopedics; Radiology, Nuclear Medicine & Medical Imaging	AQ0JU	WOS:000342470100020		
J	Saengsai, A; Otsuka, Y; Mutoh, Y				Saengsai, Anchalee; Otsuka, Yuichi; Mutoh, Yoshiharu			Fretting fatigue behavior of SUS304 stainless steel under pressurized hot water	TRIBOLOGY INTERNATIONAL			English	Article						Fretting fatigue; Sensitized SUS304; Pressurized hot water; Stress ratio	CRACK-GROWTH BEHAVIOR; CORROSION-FATIGUE; REACTOR CONDITIONS; TEMPERATURE WATER; ENVIRONMENT; DAMAGE; CYCLE	Fretting fatigue behavior of the sensitized SUS304 stainless steel under a pressurized hot water at 7.3 MPa and 288 degrees C was investigated. The tests were carried out under a contact pressure of 100 MPa and a frequency of 20 Hz. From the experimental result, combined effect of pressurized hot water and localized high tangential stress due to fretting resulted in nucleation of intergranular crack along the outer edge of contact region at lower stress amplitudes, while a fretting fatigue crack was nucleated at the highest tangential force point independently from these intergranular cracks at higher stress amplitudes. No intergranular crack nucleation was observed for fretting fatigue at the same temperature in air. The higher stress ratio reduced the fatigue strength, where the crack tip was exposed more in corrosive environment due to the high mean stress compared to the lower stress ratio. (C) 2014 Elsevier Ltd. All rights reserved.	[Saengsai, Anchalee] Nagaoka Univ Technol, Grad Sch Engn, Nagaoka, Niigata 94021, Japan; [Otsuka, Yuichi; Mutoh, Yoshiharu] Nagaoka Univ Technol, Dept Syst Safety, Nagaoka, Niigata 94021, Japan	Mutoh, Y (reprint author), Nagaoka Univ Technol, Dept Syst Safety, 1603-1 Kamitomioka, Nagaoka, Niigata 94021, Japan.	anchalee_o_o@hotmail.com; otsuka@vos.nagaokaut.ac.jp; mutoh@mech.nagaokaut.ac.jp					Hattori T, 2006, TRIBOL INT, V39, P1100, DOI 10.1016/j.triboint.2006.02.049; Attia MH, 2006, TRIBOL INT, V39, P1294, DOI 10.1016/j.triboint.2006.02.052; Seifert HP, 2012, CORROS SCI, V55, P61, DOI 10.1016/j.corsci.2011.10.005; Uematsu Y, 2008, INT J FATIGUE, V30, P642, DOI 10.1016/j.ijfatigue.2007.05.004; Ritter S, 2008, J NUCL MATER, V375, P72, DOI 10.1016/j.jnucmat.2007.10.010; Lo KH, 2009, MAT SCI ENG R, V65, P39, DOI 10.1016/j.mser.2009.03.001; Arioka K, 2005, STUDY CARBIDE PRECIP; Chan PC, 2002, PRACTICAL FAILURE AN, V2, P85; Chiang MF, 2011, J NUCL MATER, V411, P83, DOI 10.1016/j.jnucmat.2011.01.035; Filatov VM, 2004, INT J PRES VES PIP, V81, P719, DOI 10.1016/j.ijpvp.2004.02.018; Hofmann PJ, 1986, ASME PRESS VESS PIP; Hojo K, 2012, J PRESS VESS-T ASME, V134, DOI 10.1115/1.4005855; IIDA K, 1992, NUCL ENG DES, V138, P297, DOI 10.1016/0029-5493(92)90068-7; Itatani M, 2001, J PRESS VESS-T ASME, V123, P166, DOI 10.1115/1.1358841; Ko SJ, 2012, MAT SCI ENG A-STRUCT, V534, P7, DOI 10.1016/j.msea.2011.10.106; Lancha AM, 2000, ENG FAIL ANAL, V7, P333, DOI 10.1016/S1350-6307(99)00030-8; Lindley TC, 1997, INT J FATIGUE, V19, P539; Mendez J, 1999, MAT SCI ENG A-STRUCT, V263, P187, DOI 10.1016/S0921-5093(98)01164-2; MUTOH Y, 1995, JSME INT J A-MECH M, V38, P405; Nagata K, 1992, T JSME, V58, P1561; Seifert HP, 2012, CORROS SCI, V59, P20, DOI 10.1016/j.corsci.2012.02.008; Solomon H. D., 2005, P 12 INT C ENV DEGR, P1101; Suresh S, 1998, FATIGUE MAT; TAKEUCHI M, 1994, FATIGUE FRACT ENG M, V17, P949, DOI 10.1111/j.1460-2695.1994.tb00824.x; Wade KC, 1995, STEAM GENERATOR DEGR, pix; Waterhouse AB, 1992, INT MATER REV, V37, P77; Wire GL, 2004, J PRESS VESS-T ASME, V126, P318, DOI 10.1115/1.1767859; WRIGHT GP, 1971, INT J ENG SCI, V9, P555, DOI 10.1016/0020-7225(71)90038-3	28	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0301-679X	1879-2464		TRIBOL INT	Tribol. Int.	NOV	2014	79						52	58		10.1016/j.triboint.2014.05.023		7	Engineering, Mechanical	Engineering	AP7PG	WOS:000342268600007		
J	Bair, S; Yamaguchi, T; Brouwer, L; Schwarze, H; Vergne, P; Poll, G				Bair, Scott; Yamaguchi, Tsuyoshi; Brouwer, Ludwig; Schwarze, Hubert; Vergne, Philippe; Poll, Gerhard			Oscillatory and steady shear viscosity: The Cox-Merz rule, superposition, and application to EHL friction	TRIBOLOGY INTERNATIONAL			English	Article						Elastohydrodynamic lubrication; Shear thinning; Time-temperature-pressure superposition; Cox-Merz rule	ELASTOHYDRODYNAMIC LUBRICATION; HIGH-PRESSURE; QUANTITATIVE ELASTOHYDRODYNAMICS; FILM THICKNESS; TRACTION; LIQUIDS; RHEOLOGY; FLOW; PREDICTION; OILS	The new quantitative approach to elastohydrodynamic lubrication requires a description of the steady shear dependent viscosity for calculations of film thickness and friction. This property can be obtained from measurements in pressurized thin-film Couette viscometers. However, frequency dependent viscosity can be obtained from a torsionally vibrating quartz crystal viscometer at high pressure or a relatively simple ambient pressure measurement with a shear impedance spectrometer. Here it is Shown for squalane and for a cyclic hydrocarbon and for a diester that both the steady shear dependent viscosity and the frequency dependent viscosity obey time-temperature-pressure superposition with the simplest shifting rule over the range of conditions investigated. Flow curves shift along a constant steady stress path or a constant complex modulus path. The Cox-Merz rule has been confirmed only for squalane and then only near the transition. The EHL friction for squalane at low pressure may be predicted with fair accuracy from the frequency dependent viscosity measured at ambient pressure. It appears that the Cox-Merz rule only applies to low-molecular-weight liquids when the molecule is composed of a long chain. (C) 2014 Elsevier Ltd. All rights reserved.	[Bair, Scott] Georgia Inst Technol, Ctr High Pressure Rheol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Yamaguchi, Tsuyoshi] Nagoya Univ, Grad Sch Engn, Dept Mol Design & Engn, Nagoya, Aichi 4648603, Japan; [Brouwer, Ludwig; Schwarze, Hubert] Tech Univ Clausthal, Inst Tribol & Energiewandlungsmaschinen, D-38678 Clausthal Zellerfeld, Germany; [Vergne, Philippe] Univ Lyon, INSA Lyon, CNRS, LaMCoS UMR5259, F-69621 Villeurbanne, France; [Poll, Gerhard] Leibniz Univ Hannover, Inst Maschinenkonstrukt & Tribol, D-30060 Hannover, Germany	Bair, S (reprint author), Georgia Inst Technol, Ctr High Pressure Rheol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.	scott.bair@me.gatech.edu; tyama@nuce.nagoya-u.ac.jp; brouwer@itr.tu-clausthal.de; schwarze@itr.tu-clausthal.de; philippe.vergne@insa-lyon.fr; poll@imkt.uni-hannover.de	Yamaguchi, Tsuyoshi/I-6771-2014; VERGNE, Philippe/D-5163-2013	VERGNE, Philippe/0000-0001-8058-6256	Center for Compact and Efficient Fluid Power, a National Science Foundation Engineering Research Center [EEC-0540834]	Bair was supported by the Center for Compact and Efficient Fluid Power, a National Science Foundation Engineering Research Center funded under cooperative agreement number EEC-0540834. Yamaguchi is grateful to Professor Tatsuro Matsuoka (Nagoya University) for discussion.	ADERIN M, 1992, LUBR ENG, V48, P633; Harris KR, 2009, J CHEM ENG DATA, V54, P2729, DOI 10.1021/je900284z; COX WP, 1958, J POLYM SCI, V28, P619, DOI 10.1002/pol.1958.1202811812; Bair S, 2002, P I MECH ENG J-J ENG, V216, P139, DOI 10.1243/1350650021543960; Bridgman PW, 1925, P NATL ACAD SCI USA, V11, P603, DOI 10.1073/pnas.11.10.603; Bair S, 2004, TRIBOL INT, V37, P783, DOI 10.1016/j.triboint.2004.05.002; COLLINGS AF, 1971, T FARADAY SOC, V67, P340, DOI 10.1039/tf9716700340; Habchi W, 2013, TRIBOL INT, V58, P107, DOI 10.1016/j.triboint.2012.10.005; Bjorling M, 2013, TRIBOL INT, V66, P19, DOI 10.1016/j.triboint.2013.04.008; Bair S, 2005, TRIBOL LETT, V18, P145, DOI 10.1007/s11249-004-1770-y; Moore JD, 2000, J CHEM PHYS, V113, P8833, DOI 10.1063/1.1318768; Bair S, 2007, P I MECH ENG J-J ENG, V221, P801, DOI 10.1243/13506501JET278; Bair S, 1998, J FLUID ENG-T ASME, V120, P621, DOI 10.1115/1.2820709; Bair S, 2006, TRIBOL T, V49, P218, DOI 10.1080/05698190600614817; Bair S, 2001, TRIBOLOGY SERIES, V39, P733; Bair S, 2005, P I MECH ENG J-J ENG, V219, P69, DOI 10.1243/135065005X9709; Bair S, 2006, TRIBOL LETT, V22, P197, DOI 10.1007/s11249-006-9083-y; Bair SS, 2007, HIGH PRESSURE RHEOLO, V54, P227; Bird RB, 1987, DYNAMICS POLYM LIQUI, P150; Bode B, 1988, TRIBOL SCHMIER, V35, P256; Bridgman PW, 1926, P AM ACAD ARTS SCI, P57; DYSON A, 1965, PHILOS TR R SOC S-A, V258, P529, DOI 10.1098/rsta.1965.0050; DYSON A, 1970, PHILOS TR R SOC S-A, V266, P1, DOI 10.1098/rsta.1970.0001; Gleissle W., 1980, RHEOLOGY, V2, P457; Hafer RF, 2003, MEAS SCI TECHNOL, V14, P663, DOI 10.1088/0957-0233/14/5/318; Hellwege KH, 1967, RHEOL ACTA, V6, P165, DOI 10.1007/BF01969169; HIRST W, 1979, P ROY SOC LOND A MAT, V365, P537, DOI 10.1098/rspa.1979.0033; Hutton JF, 1973, INTERDISCIPLINARY AP, P187; HUTTON JF, 1984, J TRIBOL-T ASME, V106, P536; Kottke PA, 2005, AICHE J, V51, P2150, DOI 10.1002/aic.10480; Liu Y, 2007, TRIBOL LETT, V28, P171, DOI 10.1007/s11249-007-9262-5; Mizuno H, 2012, EUR PHYS J E, V35, P1; Mylona SK, 2014, J PHYS CHEM REF DATA, V43, DOI [10.1063/1.4901166, 10.1063/1.4863984]; Olver AV, 1998, P I MECH ENG J-J ENG, V212, P321, DOI 10.1243/1350650981542137; PHILIPPOFF W, 1960, T SOC RHEOL, V4, P169; Spikes HA, 2006, LUBR SCI, V18, P265, DOI DOI 10.1002/LS.23; Wilson A., 1965, P I MECH ENG, V180, P97; Winters HH, 1977, ADV HEAT TRANSFER, V13, P205, DOI 10.1016/S0065-2717(08)70224-7; Yamaguchi T, 2009, J PHYS CHEM B, V113, P11988, DOI 10.1021/jp903871f; Yamaguchi T, 2013, J PHYS CHEM B, V117, P3232, DOI 10.1021/jp4010983	40	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0301-679X	1879-2464		TRIBOL INT	Tribol. Int.	NOV	2014	79						126	131		10.1016/j.triboint.2014.06.001		6	Engineering, Mechanical	Engineering	AP7PG	WOS:000342268600014		
J	Nitta, I; Tsukiyama, Y; Tsukada, T; Terao, H				Nitta, Isami; Tsukiyama, Yosuke; Tsukada, Tsuyoshi; Terao, Hirotoshi			Measurement of real contact area on thermal print head using a laser microscope with a wide field of view	TRIBOLOGY INTERNATIONAL			English	Article						Laser Microscope; Dye sublimation printer; Real contact area; Thermal print head		In a dye-sublimation printer, a thermal print head presses and heats a dye-based ribbon to diffuse ink dyes to the desired positions into the receiving layer of paper. The print quality will deteriorate if the contact condition between the thermal print head and the paper is insufficient. Thus, it is necessary to analyze the contact condition for finer printing. Direct observation of the contact area with an optical microscope is effective to clarify the contact conditions of the thermal print head. However, conventional optical microscopes take too much time to observe the whole apparent contact area, because their fields of view are not sufficiently wide. Previously, we developed a laser microscope with a wide field of view and applied this laser microscope to observe the whole apparent contact area of rubber elements. In this study, we examined the contact conditions between the thermal print head and the paper. In general, when we observe the contact area of two solid surfaces, one is restricted to a transparent material such as a glass plate. Instead of the thermal print head, a glass head of the same shape as an existing thermal print head was pressed on the paper and observed through the glass head. This allowed us to clearly determine the contact situations of the interface and measure the contact widths and distributions of real contact area. In this method, it was confirmed that the contact width and the real contact area changed in accordance with the type of paper used, steps of the printing process, and density of color printing. (C) 2014 Elsevier Ltd. All rights reserved.	[Nitta, Isami; Tsukiyama, Yosuke; Tsukada, Tsuyoshi; Terao, Hirotoshi] Niigata Univ, Dept Mech Engn, Nishi Ku, Niigata 9502181, Japan	Nitta, I (reprint author), Niigata Univ, Dept Mech Engn, Nishi Ku, 8050 Ikarashi 2 Nocho, Niigata 9502181, Japan.	nitta@eng.niigata-u.ac.jp					Chen YM, 2001, SENSOR ACTUAT A-PHYS, V88, P93, DOI 10.1016/S0924-4247(00)00497-0; Foster GS, 2009, P INT S TECHN DIG FU, P68; Ikegami M, 2006, P ASIATRIB, V1, P25; Johnson KL, 1985, CONTACT MECH, P101; Joyce RD, 1967, P FALL JOINT COMP C, P261, DOI 10.1145/1465611.1465645; Nagata T, 1995, T JSME, V61(B), P289; Nitta I, 2007, P CONT MECH 2007 COM, P321; Puterbaugh WH, 1967, P SPRING JOINT COMP, P121, DOI 10.1145/1465482.1465500; Shibata S, 2009, FUJIFILM RES DEV, V54, P1; Shih PJ, 2008, NIP24/DIGITAL FABRICATION 2008: 24TH INTERNATIONAL CONFERENCE ON DIGITAL PRINTING TECHNOLOGIES, TECHNICAL PROGRAM AND PROCEEDINGS, P819; Terao H, 2010, P INT C DIG PRINT TE, P697; Uyhan R, 2008, APPL MATH MODEL, V32, P405, DOI 10.1016/j.apm.2006.12.013; WONG CJ, 1984, COMPUT STRUCT, V19, P315, DOI 10.1016/0045-7949(84)90041-5	13	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0301-679X	1879-2464		TRIBOL INT	Tribol. Int.	NOV	2014	79						162	173		10.1016/j.triboint.2014.06.005		12	Engineering, Mechanical	Engineering	AP7PG	WOS:000342268600018		
J	Murata, K; Esaki, M; Ogura, T; Arai, S; Yamamoto, Y; Tanaka, N				Murata, Kazuyoshi; Esaki, Masatoshi; Ogura, Teru; Arai, Shigeo; Yamamoto, Yuta; Tanaka, Nobuo			Whole-cell imaging of the budding yeast Saccharomyces cerevisiae by high-voltage scanning transmission electron tomography	ULTRAMICROSCOPY			English	Article						Electron tomography; Scanning transmission electron microscopy; High-voltage electron microscopy; Yeast; Organelle; Thick specimen	3-DIMENSIONAL RECONSTRUCTION; BIOLOGICAL SPECIMENS; STEM TOMOGRAPHY; THICK SECTIONS; MICROSCOPY; CLASSIFICATION; MOLECULES; ALIGNMENT; TISSUE	Electron tomography using a high voltage electron microscope (HVEM) provides three-dimensional information about cellular components in sections thicker than 1 pm, although in bright held mode image degradation caused by multiple inelastic scattering of transmitted electrons limit the attainable resolution. Scanning transmission electron microscopy (STEM) is believed to give enhanced contrast and resolution compared to conventional transmission electron microscopy (CTEM). Samples up to 1 mu m in thickness have been analyzed with an intermediate voltage electron microscope because inelastic scattering is nor a critical limitation, and probe broadening can be minimized. Here, we employed STEM at 1 MeV high voltage to extend the useful specimen thickness for electron tomography, which we demonstrate by a seamless Lomographic reconstruction of a whole, budding Saccharomyces cerevisiae yeast cell, which is similar to 3 mu m in thickness. High voltage STEM tomography, especially in the bright field mode, demonstrated sufficiently enhanced contrast and intensity, compared to CTEM tomography, to permit segmentation of major organelles in the whole cell. STEM imaging also reduced specimen shrinkage during tilt series acquisition. The fidelity of structural preservation was limited by cytoplasmic extraction, and the spatial resolution was limited by the relatively large convergence angle of the scanning probe. However, the new technique has potential to solve longstanding problems of image blurring in biological specimens beyond 1 pill in thickness, and may facilitate new research in cellular structural biology. (C) 2014 Elsevier B.V. All rights reserved.	[Murata, Kazuyoshi] Natl Inst Physiol Sci, Okazaki, Aichi 4448585, Japan; [Esaki, Masatoshi; Ogura, Teru] Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; [Arai, Shigeo; Yamamoto, Yuta; Tanaka, Nobuo] Nagoya Univ, Ecotopia Sci Inst, Nagakute, Aichi 4648603, Japan	Murata, K (reprint author), Natl Inst Physiol Sci, Okazaki, Aichi 4448585, Japan.	kazum@nips.ac.jp			program of the Joint Usage/Research Center for Development Medicine, IMEG, Kumamoto University; Nanotechnology Platform, MEXT, at Nagoya University	This study was supported in part by the program of the Joint Usage/Research Center for Development Medicine, IMEG, Kumamoto University. We thank Drs. Masashi Yamaguchi, and Misuzu Baba for their help and advice regarding the preparation of yeast samples. The initial observations on the thick specimen were performed with the H-1250M, 1 MeV HVEM at the National Institute for Physiological Sciences in Okazaki, Japan. The use of JEM 1000K RS was supported by the Nanotechnology Platform, MEXT, at Nagoya University. We thank Mr. Shigemasa Ohta, and Mr. Sadamasa Takakuwa for their technical assistance in operating the microscopes.	Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Nagayama K, 2008, PHILOS T R SOC B, V363, P2153, DOI 10.1098/rstb.2008.2268; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kuybeda O, 2013, J STRUCT BIOL, V181, P116, DOI 10.1016/j.jsb.2012.10.010; Hohmann-Marriott MF, 2009, NAT METHODS, V6, P729, DOI [10.1038/nmeth.1367, 10.1038/NMETH.1367]; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; CROWTHER RA, 1970, PROC R SOC LON SER-A, V317, P319, DOI 10.1098/rspa.1970.0119; Wright R, 2000, MICROSC RES TECHNIQ, V51, P496, DOI 10.1002/1097-0029(20001215)51:6<496::AID-JEMT2>3.0.CO;2-9; SAXTON WO, 1984, ULTRAMICROSCOPY, V13, P57, DOI 10.1016/0304-3991(84)90057-3; Baumeister W, 1999, TRENDS CELL BIOL, V9, P81, DOI 10.1016/S0962-8924(98)01423-8; Biskupek J, 2010, ULTRAMICROSCOPY, V110, P1231, DOI 10.1016/j.ultramic.2010.05.008; Murata K, 2010, STRUCTURE, V18, P903, DOI 10.1016/j.str.2010.06.006; Esaki M, 2012, J STRUCT BIOL, V179, P112, DOI 10.1016/j.jsb.2012.04.017; Wei DG, 2012, BIOTECHNIQUES, V53, P41, DOI 10.2144/000113850; Hohn K, 2011, HISTOCHEM CELL BIOL, V135, P1, DOI 10.1007/s00418-010-0765-z; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; Motoki S, 2010, J ELECTRON MICROSC, V59, pS45, DOI 10.1093/jmicro/dfq030; Bouwer JC, 2004, J STRUCT BIOL, V148, P297, DOI 10.1016/j.jsb.2004.08.005; O'Toole ET, 2002, METHOD ENZYMOL, V351, P81; Aoyama K, 2008, ULTRAMICROSCOPY, V109, P70, DOI 10.1016/j.ultramic.2008.08.005; BEORCHIA A, 1993, J MICROSC-OXFORD, V170, P247; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Esaki M, 2010, BIOCHEM CELL BIOL, V88, P109, DOI [10.1139/o09-116, 10.1139/O09-116]; FAVARD P, 1973, J MICROSC-OXFORD, V97, P59; FRANK J, 1995, CURR OPIN STRUC BIOL, V5, P194, DOI 10.1016/0959-440X(95)80075-1; Frank J., 2006, ELECT TOMOGRAPHY; HAMA K, 1970, Journal of Electron Microscopy, V19, P170; Hoog JL, 2007, METHOD CELL BIOL, V79, P145, DOI 10.1016/S0091-679X(06)79006-9; Kortje KH, 1996, J MICROSC-OXFORD, V183, P89; LUTHER PK, 1988, ULTRAMICROSCOPY, V24, P7, DOI 10.1016/0304-3991(88)90322-1; Midgley PA, 2001, CHEM COMMUN, P907, DOI 10.1039/b101819c; ROUT MP, 1993, J CELL BIOL, V123, P771, DOI 10.1083/jcb.123.4.771; Takaoka A, 2008, ULTRAMICROSCOPY, V108, P230, DOI 10.1016/j.ultramic.2007.06.008; Tanaka N, 2013, MICROSCOPY-JPN, V62, P205, DOI 10.1093/jmicro/dfs095; Uchida M, 2011, YEAST, V28, P227, DOI 10.1002/yea.1834; Walther Paul, 2013, Methods Mol Biol, V931, P525, DOI 10.1007/978-1-62703-056-4_28; Xu M, 2012, J STRUCT BIOL, V178, P152, DOI 10.1016/j.jsb.2012.02.014; Yakushevska AE, 2007, J STRUCT BIOL, V159, P381, DOI 10.1016/j.jsb.2007.04.006	40	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3991	1879-2723		ULTRAMICROSCOPY	Ultramicroscopy	NOV	2014	146						39	45		10.1016/j.ultramic.2014.05.008		7	Microscopy	Microscopy	AP8XO	WOS:000342362900006		
J	Sannomiya, T; Junesch, J; Hosokawa, F; Nagayama, K; Arai, Y; Kayama, Y				Sannomiya, Takumi; Junesch, Juliane; Hosokawa, Fumio; Nagayama, Kuniaki; Arai, Yoshihiro; Kayama, Yoko			Multi-pore carbon phase plate for phase-contrast transmission electron microscopy	ULTRAMICROSCOPY			English	Article						Transmission electron microscopy; Phase plate; Colloidal lithography; Stencil; Carbon	COLLOIDAL LITHOGRAPHY; TEM; ENHANCEMENT	A new fabrication method of carbon based phase plates for phase-contrast transmission electron microscopy is presented. This method utilizes colloidal masks to produce pores as well as disks on thin carbon membranes for phase modulation. Since no serial process is involved, carbon phase plate membranes containing hundreds of pores can be mass-produced on a large scale, which allows "disposal" of contaminated or degraded phase modulating objects after use. Due to the spherical shape of the mask colloid particles, the produced pores are perfectly circular. The pore size and distribution can be easily tuned by the mask colloid size and deposition condition. By using the stencil method, disk type phase plates can also be fabricated on a pore type phase plate. Both pore and disk type phase plates were tested by measuring amorphous samples and confirmed to convert the sinus phase contrast transfer function to the cosine shape. (C) 2014 Elsevier B.V. All rights reserved,	[Sannomiya, Takumi] Tokyo Inst Technol, Tokyo, Kanagawa, Japan; [Junesch, Juliane] ETH, Zurich, Switzerland; [Hosokawa, Fumio] JEOL Ltd, Tokyo, Japan; [Nagayama, Kuniaki] Natl Inst Physiol Sci, Okazaki, Aichi, Japan; [Nagayama, Kuniaki] Sokendai, Hayama, Kanagawa, Japan; [Arai, Yoshihiro; Kayama, Yoko] Terabase Inc, Okazaki, Aichi, Japan	Sannomiya, T (reprint author), Takumi Sannomiya Tokyo Inst Technol, Dept Innovat & Engn Mat, Midori Ku, J2-49,Bld J2,Room 1502,4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	sannomiya.t.aa@m.titech.ac.jp	Sannomiya, Takumi/D-4835-2009; Junesch, Juliane/I-2748-2015	Sannomiya, Takumi/0000-0001-7079-2937; Junesch, Juliane/0000-0002-7243-4030	Tokyo Institute of Technology; JSPS Kakenhi [26870184]	This work is financially supported by Tokyo Institute of Technology and JSPS Kakenhi Grant #26870184. We thank Dr, Thomas Harper of Summit Chemical Specialty Products for providing ACH powders.	Danev R, 2009, ULTRAMICROSCOPY, V109, P312, DOI 10.1016/j.ultramic.2008.12.006; Glaeser RM, 2013, ULTRAMICROSCOPY, V135, P6, DOI 10.1016/j.ultramic.2013.05.023; Junesch J, 2014, ACS APPL MATER INTER, V6, P6322, DOI 10.1021/am405443y; Malac M, 2012, ULTRAMICROSCOPY, V118, P77, DOI 10.1016/j.ultramic.2012.02.004; Vazquez-Mena O, 2011, ACS NANO, V5, P844, DOI 10.1021/nn1019253; Hanarp P, 2003, COLLOID SURFACE A, V214, P23, DOI 10.1016/S0927-7757(02)00367-9; Danev R, 2011, ULTRAMICROSCOPY, V111, P1305, DOI 10.1016/j.ultramic.2011.04.004; Danev R, 2001, ULTRAMICROSCOPY, V88, P243, DOI 10.1016/S0304-3991(01)00088-2; Danev R, 2010, METHOD ENZYMOL, V481, P343, DOI 10.1016/S0076-6879(10)81014-6; Glaeser RM, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4830355; HOSOKAWA F, 1991, ULTRAMICROSCOPY, V36, P367, DOI 10.1016/0304-3991(91)90128-S; Hosokawa F, 2005, J ELECTRON MICROSC, V54, P317, DOI 10.1093/jmicro/dfi049; Iijima H., 2012, MICROSC MICROANAL, V18, P492; Marko M, 2011, J STRUCT BIOL, V174, P400, DOI 10.1016/j.jsb.2011.01.005; Nagayama K, 2005, ADV IMAG ELECT PHYS, V138, P69, DOI 10.1016/S1076-5670(05)38002-5; Stevens-Kalceff MA, 2007, MICROSC RES TECHNIQ, V70, P195, DOI 10.1002/jemt.20399; YASAKA A, 1991, J VAC SCI TECHNOL B, V9, P2642, DOI 10.1116/1.585663	17	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3991	1879-2723		ULTRAMICROSCOPY	Ultramicroscopy	NOV	2014	146						91	96		10.1016/j.ultramic.2014.07.008		6	Microscopy	Microscopy	AP8XO	WOS:000342362900013		
J	Shirai, M; Tanigaki, T; Aizawa, S; Park, HS; Matsuda, T; Shindo, D				Shirai, Manabu; Tanigaki, Toshiaki; Aizawa, Shinji; Park, Hyun Soon; Matsuda, Tsuyoshi; Shindo, Daisuke			In situ electron holographic study of Ionic liquid	ULTRAMICROSCOPY			English	Article						Electron holography; Ionic liquid; Electron irradiation; Electrostatic potential; Charge	MICROSCOPE; CELLS	Investigation of the effect of electron irradiation on ionic liquid (IL) droplets using electron holography revealed that electron irradiation changed the electrostatic potential around the IL. The potential for low electron flux irradiation (0.5 x 10(17) e/m(2) s) was almost constant as a function of time (up to 180 min). For higher electron flux irradiation (2 x 10(17) e/m(2) s), the potential increased exponentially for a certain time, reflecting the charging effect and then leveled off. The IL was found to be changed from liquid to solid state after a significant increase in the electrostatic potential due to electron irradiation. (C) 2014 Elsevier B.V. All rights reserved.	[Shirai, Manabu; Tanigaki, Toshiaki] Hitachi Ltd, Cent Res Lab, Hatoyama, Saitama 3500395, Japan; [Tanigaki, Toshiaki; Aizawa, Shinji; Park, Hyun Soon; Shindo, Daisuke] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Matsuda, Tsuyoshi] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Shindo, Daisuke] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan	Shirai, M (reprint author), Hitachi High Technol Corp, Takatsu Ku, Sakado 3-2-1, Kawasaki, Kanagawa 2130012, Japan.	shirai-manabu@naka.hitachi-hitec.com	Shindo, Daisuke/I-3865-2012		Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading innovative R&D on Science and Technology (FIRST program)"	The authors are grateful to Dr. E. Nakazawa and Dr. T. Sato of Hitachi High-Technologies Co. for providing the ionic liquid samples and giving their comments. The authors also thank Dr. Y. A. Ono for critical reading of the manuscript and for comments and suggestions. This research was supported by the grant from the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading innovative R&D on Science and Technology (FIRST program)", initiated by the Council for Science and Technology Policy (CSTP).	Harada K, 2004, APPL PHYS LETT, V84, P3229, DOI 10.1063/1.1715155; Tariq M, 2012, CHEM SOC REV, V41, P829, DOI 10.1039/c1cs15146k; Arimoto S, 2008, ELECTROCHIM ACTA, V53, P6228, DOI 10.1016/j.electacta.2008.01.001; Ishigaki Y, 2011, MICROSC RES TECHNIQ, V74, P415, DOI 10.1002/jemt.20924; Bazant MZ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.046102; Nakano M, 2012, NATURE, V487, P459, DOI 10.1038/nature11296; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; Kuwabata S, 2006, CHEM LETT, V35, P600, DOI 10.1246/cl.2006.600; Yoshida K, 2007, J ELECTRON MICROSC, V56, P177, DOI 10.1093/jmicro/dfm021; Seki S, 2006, J PHYS CHEM B, V110, P10228, DOI 10.1021/jp0620872; JEONG JS, 2011, J APPL PHYS, V109, P13125; Tonomura A, 1999, ELECT HOLOGRAPHY; TORIMOTO T, 2006, APPL PHYS LETT, V89, P13125; WILKES JS, 1992, J CHEM SOC CHEM COMM, P965, DOI 10.1039/c39920000965; Yamanaka N, 2005, CHEM COMMUN, P740, DOI 10.1039/b417610c	15	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3991	1879-2723		ULTRAMICROSCOPY	Ultramicroscopy	NOV	2014	146						125	129		10.1016/j.ultramic.2014.08.003		5	Microscopy	Microscopy	AP8XO	WOS:000342362900017		
J	Kitagawa, J; Fujiki, T; Yamada, K; Hoshino, Y; Yonenobu, H; Yasuda, Y				Kitagawa, Junko; Fujiki, Toshiyoshi; Yamada, Kazuyoshi; Hoshino, Yasuharu; Yonenobu, Hitoshi; Yasuda, Yoshinori			Human impact on the Kiso-hinoki cypress woodland in Japan: a history of exploitation and regeneration	VEGETATION HISTORY AND ARCHAEOBOTANY			English	Article						Kiso-hinoki cypress; Lake Tadachi; Pollen; Phytolith; Shikinen-sengu (rebuilding the shrine); Conservation	RADIOCARBON CALIBRATION; VEGETATION HISTORY; NORTHEAST JAPAN; PREFECTURE; PROGRAM	The Kiso-hinoki (Kiso-Japanese cypress, Chamaecyparis obtusa) woodland underwent severe deforestation in the early 17th century, then regenerated through conservation during the Edo period. Now, a suitable management strategy is sought in order to maintain its ecological function in the forest. To understand the vegetation changes and human impact, sediment cores were recovered from Lake Tadachi in the Kiso-hinoki cypress woodland in the central uphill region of Honshu island. In addition, stratigraphic pollen analysis on two cores (Nos. 6 and 10) and phytolith analysis on three strata of one core (No. 6) was conducted. The age-depth models were constructed based on C-14 dating, greyscale analysis on the sediments, and the increasing level of Cryptomeria pollen (about a.d. 1960) from the pollen profiles. In all periods, the dominant pollen taxa were Cupressaceae and Quercus subgen. Lepidobalanus type. Our analysis indicates that after the commencement of Shikinen-sengu, which is the rebuilding of the Ise Grand Shrine every 20 years, Cupressaceae pollen decreased and the woodland was gradually replaced by Quercus subgen. Lepidobalanus. The percentages of Cupressaceae pollen decreased dramatically and the expansion of secondary woodlands was accompanied by an increase of Quercus subgen. Lepidobalanus in the early 17th century cal. a.d. However, depletion of the woodland was determined from a decrease in concentration of Quercus pollen. The conservation activity during the Edo period and after the Meiji Restoration brought about woodland recovery. However, based on our pollen and phytolith analysis, significant changes to the woodland habitats can be detected. These were probably due to human impacts, most notably in the years after World War II. Four major turning points as the result of human influence were identified: the 10th century, the late 16th century, the Meiji restoration (a.d. 1863), and the end of World War II. The original cypress woodland mixed with deciduous broad-leaved elements has been greatly reduced, preventing future cypress woodland regeneration after World War II.	[Kitagawa, Junko] Natl Inst Humanities, Int Res Ctr Japanese Studies, Nishikyo Ku, Kyoto 6101192, Japan; [Fujiki, Toshiyoshi] Fukuoka Univ, AIG Collaborat Res Inst Int Study Eruput Hist & I, Jonan Ku, Fukuoka 8140180, Japan; [Yamada, Kazuyoshi] Waseda Univ, Sch Human Sci, Tokorozawa, Saitama 3591192, Japan; [Hoshino, Yasuharu] Nara Natl Res Inst Cultural Properties, Nara 6308577, Japan; [Yonenobu, Hitoshi] Naruto Univ Educ, Naruto 7728502, Japan; [Yasuda, Yoshinori] Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, Sendai, Miyagi 9808579, Japan	Kitagawa, J (reprint author), Natl Inst Humanities, Int Res Ctr Japanese Studies, Nishikyo Ku, 3-2 Oeyama Cho, Kyoto 6101192, Japan.	junkokit@me.com			MEXT-Japan; JSPS KAKENHI [22500992, 21101002, 23240116]	This study was partly supported by MEXT-Japan and JSPS KAKENHI (grant nos. 22500992, 21101002 and 23240116). We cordially thank Mr. Nobuyuki Kitazawa at the Nagiso branch of the Kiso District Forest Office for his help in the forest.	Ala T, 2009, J JPN SOC REV TECHNO, V34, P524; Yamada K, 2010, QUATERN INT, V220, P122, DOI 10.1016/j.quaint.2009.09.006; Ramsey CB, 2001, RADIOCARBON, V43, P355; Froyd CA, 2008, QUATERNARY SCI REV, V27, P1723, DOI 10.1016/j.quascirev.2008.06.006; Ramsey CB, 1995, RADIOCARBON, V37, P425; Chikusa K, 2010, EIEN NO SECHI ISE JI; Crawford GW, 1992, ORIGINS AGR INT PERS; Forestry and Forest Product Research Institute, 2012, HIN FOR; Fukuyado K, 1980, CHIRI GEOLOGY, V25, P54; Goto T, 1994, GRAND DICT HORTICULT, V2, P1; Hatanaka K, 1998, VEGETATION HIST JAPA, P159; Hayashi R, 2012, JPN J PALYNOL, V58, P5; Hibino K, 1998, VEGETATION HIST JAPA, P62; Inada Akira, 2004, Quaternary Research (Tokyo), V43, P1; Inada Akira, 2008, Quaternary Research (Tokyo), V47, P313; Iwamoto S., 1998, Journal of the Japanese Forestry Society, V80, P311; Iwatsuki K, 1995, FLORA JAPAN PTERYDOP, V1; KITAGAWA H, 1995, GEOPHYS RES LETT, V22, P2155, DOI 10.1029/95GL02066; Kitagawa Y, 2009, JPN J PALYNOL, V55, P15; Kitagawa Yoichiro, 2009, Quaternary Research (Tokyo), V48, P351; Kito H, 2000, JINKO KARA YOMU NIHO; Miyake Nao, 2000, Quaternary Research (Tokyo), V39, P139; Mizumoto K, 2003, KUSAYAMA NO KATARU K; Morita M, 1998, VEGETATION HIST JAPA, P92; Nagano Regional Forestry Office, 1980, KIS HIN SEIIN KAIM C; Nagumo H, 1988, B TOKYO U FORESTS, V78, P259; Nakamura T, 2010, SHIGAKUZASSHI, V119, P1; NAKASHIZUKA T, 1982, Japanese Journal of Ecology, V32, P57; Ogashishi-hensaniinkai, 1995, OG; Oka M, 1998, SHIGAKU KENKYU, V220, P40; Okada T, 1997, QUATERNARY RES DAIYO, V36, P207; Ouchi U, 1987, RINGYO KEIZAI KENKYU, V111, P3; Sakaguchi Y, 1983, B DEP GEOGRAPHY U TO, V15, P1; Shibata S, 1988, J JPN I LANDSCAPE AR, V51, P138; SUGITA S, 1993, QUATERNARY RES, V39, P239, DOI 10.1006/qres.1993.1027; Suzuki M, 1994, GRAND DICT HORTICULT, V2, P1; Takahara H, 1998, VEGETATION HIST JAPA, P114; Takahara H, 2007, LOW TEMP SCI, V65, P97; Takeoka M, 1990, B KYOTO PREFECTURAL, V34, P55; Takeoka M, 1991, B KYOTO PREFECTURAL, V35, P29; Taylor RE, 1996, QUATERNARY SCI REV, V15, P655, DOI 10.1016/0277-3791(96)00024-8; Togashi H, 2004, B NAGANO NAT CONSERV, V7, P1; Totman C, 1989, GREEN ARCHIPELAGO; Totman C, 1985, ORIGINS JAPANS MODER; Totman C, 2007, JAPAN'S IMPERIAL FOREST, GORYORIN, 1889-1946, P1; Tsukada M, 1974, NAGANO NO REKISHI; TSUKADA M, 1966, BOT MAG TOKYO, V79, P179; Uchiyama T, 1998, VEGETATION HIST JAPA, P71; Yamada M, 1997, GRAND DICT HORTICULT, V14, P279; Yanai T, 2010, J FAC HUMANTIT U KIT, V18, P35; Yoshida Akihiro, 2009, Quaternary Research (Tokyo), V48, P417; Yoshida Akihiro, 2008, Quaternary Research (Tokyo), V47, P71	52	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-6314	1617-6278		VEG HIST ARCHAEOBOT	Veg. Hist. Archaeobot.	NOV	2014	23	6					649	664		10.1007/s00334-013-0423-1		16	Plant Sciences; Paleontology	Plant Sciences; Paleontology	AQ0PY	WOS:000342486400001		
J	Takeda, O; Toyama, T; Watanabe, K; Sato, T; Sasaguri, K; Akimoto, S; Sato, S; Kawata, T; Hamada, N				Takeda, Orie; Toyama, Toshizo; Watanabe, Kiyoko; Sato, Takenori; Sasaguri, Kenichi; Akimoto, Susumu; Sato, Sadao; Kawata, Toshitsugu; Hamada, Nobushiro			Ameliorating effects of juzentaihoto on restraint stress and P-gingivalis-induced alveolar bone loss	ARCHIVES OF ORAL BIOLOGY			English	Article						Juzentaihoto; Porphyromonas gingivalis; Alveolar bone loss; Stress	NECROTIZING ULCERATIVE GINGIVITIS; NF-KAPPA-B; PORPHYROMONAS-GINGIVALIS; PERIODONTAL-DISEASES; MEDICINE JUZENTAIHOTO; PSYCHOSOCIAL FACTORS; CELLS; ACTIVATION; EXPRESSION; MOLECULES	Objective: Juzentaihoto (JTX) is a traditional Japanese medicine that consists of 10 herbs. The purpose of this study was to evaluate the efficacy of multi-herbal medicine JTX as a preventive and therapeutic drug for periodontal bone resorption and for reducing restraint stress. Materials and methods: Porphyromonas gingivalis ATCC 33277 was used for testing the antibacterial activity of JTX and a rat experimental periodontitis model. To evaluate the effect of JTX against P. gingivalis infection, we determined the differences in alveolar bone loss among experimental groups. The concentrations of adrenocorticotropic hormones were measured as stress markers, and atrophy of the thymus and spleen was assessed. Results: JTX had antibacterial activity against P. gingivalis ATCC 33277. JTX treatment of mouse bone marrow cells at a concentration of 0.1 mu g/ml significantly inhibited osteoclast formation. Administration of JTX to rats with P. gingivalis infection and restraint stress significantly reduced alveolar bone loss compared with the case with just the combination of P. gingivalis infection and restraint stress. In the restrained groups, stress markers were elevated, and the thymus and spleen were atrophied. The groups with administration of JTX showed not only inhibition of the decrease of weight but also normalization of corticosterone and cortisol values. Conclusion: JTX effectively inhibited restraint stress and osteoclastogenesis. It appears that the effects of JTX inhibit the destruction of periodontal tissue by suppressing stress. Our study demonstrated that JTX affects the correlation between restraint stress and periodontitis. (C) 2014 Elsevier Ltd. All rights reserved.	[Takeda, Orie; Sasaguri, Kenichi; Akimoto, Susumu; Sato, Sadao; Kawata, Toshitsugu] Kanagawa Dent Univ, Dept Orthodont Sci, Yokosuka, Kanagawa 2388580, Japan; [Toyama, Toshizo; Watanabe, Kiyoko; Sato, Takenori; Hamada, Nobushiro] Kanagawa Dent Univ, Dept Microbiol, Yokosuka, Kanagawa 2388580, Japan	Hamada, N (reprint author), Kanagawa Dent Univ, Dept Microbiol, 82 Inaoka Cho, Yokosuka, Kanagawa 2388580, Japan.	hamada@kdu.ac.jp					ADACHI Y, 1995, P NATL ACAD SCI USA, V92, P1200, DOI 10.1073/pnas.92.4.1200; MARCENES WS, 1992, SOC SCI MED, V35, P1511; He L, 2012, BONE, V50, P1207, DOI 10.1016/j.bone.2012.03.022; Genco CA, 1998, TRENDS MICROBIOL, V6, P444, DOI 10.1016/S0966-842X(98)01363-8; Kato M, 2007, WORLD J GASTROENTERO, V13, P2289; Matsui S, 2004, INT IMMUNOPHARMACOL, V4, P1633, DOI 10.1016/j.intimp.2004.07.023; Fujiki K, 2008, INT J MOL SCI, V9, P1142, DOI 10.3390/ijms9071142; Warren KR, 2014, PERIODONTOL 2000, V64, P127, DOI 10.1111/prd.12036; Gafner S, 2011, J NAT PROD, V74, P2514, DOI 10.1021/np2004775; Lee SJ, 2003, ARCH PHARM RES, V26, P832, DOI 10.1007/BF02980029; Keum YS, 2003, MUTAT RES-FUND MOL M, V523, P75, DOI 10.1016/S0027-5107(02)00323-8; Breivik T, 2000, EUR J ORAL SCI, V108, P115, DOI 10.1034/j.1600-0722.2000.00774.x; BAKER PJ, 1994, ARCH ORAL BIOL, V39, P1035, DOI 10.1016/0003-9969(94)90055-8; Genco RJ, 1996, J PERIODONTOL, V67, P1041, DOI 10.1902/jop.1996.67.10s.1041; Moss ME, 1996, J PERIODONTOL, V67, P1060; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244; DASILVA AMM, 1995, J CLIN PERIODONTOL, V22, P516; Yamada N, 2002, BONE, V30, P901, DOI 10.1016/S8756-3282(02)00722-6; Hoang T, 2003, J PERIODONTAL RES, V38, P311; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Stoeken JE, 2007, J PERIODONTOL, V78, P1218, DOI 10.1902/jop.2007.060269; Tan BKH, 2004, CURR MED CHEM, V11, P1423; Lee YJ, 1997, MOL CELL ENDOCRINOL, V133, P135, DOI 10.1016/S0303-7207(97)00160-3; LOESCHE WJ, 1981, J CLIN PERIODONTOL, V8, P29, DOI 10.1111/j.1600-051X.1981.tb02022.x; Kil JS, 2008, PHYTOTHER RES, V22, P472, DOI 10.1002/ptr.2342; Baltina LA, 2003, CURR MED CHEM, V10, P155; Breivik T, 2000, BEHAV GENET, V30, P123, DOI 10.1023/A:1001903221046; Brevik T, 1996, EUR J ORAL SCI, V104, P327; CHRISTERSSON LA, 1989, J DENT RES, V68, P1633; Cohen-Cole SA, INT J PSYCHIAT MED; Dhuley J. N., 1999, Indian Journal of Experimental Biology, V37, P238; Didry N, 1994, Pharm Acta Helv, V69, P25, DOI 10.1016/0031-6865(94)90027-2; FREEMAN R, 1993, COMMUNITY DENT ORAL, V21, P176, DOI 10.1111/j.1600-0528.1993.tb00748.x; Genco R J, 1998, Ann Periodontol, V3, P288, DOI 10.1902/annals.1998.3.1.288; Hamada N, 2007, J PERIODONTOL, V78, P933, DOI 10.1902/jop.2007.060245; HIAI S, 1979, PLANTA MED, V37, P15; HORNING GM, 1995, J PERIODONTOL, V66, P990; JOHNSON BD, 1986, J PERIODONTOL, V57, P141; Liu Jing, 2011, Chinese Herbal Medicines, V3, P90; Morgan TD, 2001, J APPL MICROBIOL, V90, P53, DOI 10.1046/j.1365-2672.2001.01217.x; Murayama Y, 2000, PERIODONTOL, V1994, P116; Schoor R S, 1986, Int J Psychosom, V33, P35; Shin EM, 2008, INT IMMUNOPHARMACOL, V8, P1524, DOI 10.1016/j.intimp.2008.06.008; Shon YH, 2003, PHYTOTHER RES, V17, P1016, DOI 10.1002/ptr.1276; SOCRANSKY SS, 1991, J CLIN PERIODONTOL, V18, P766, DOI 10.1111/j.1600-051X.1991.tb00070.x; Watanabe S, 2001, TOHOKU J EXP MED, V194, P55, DOI 10.1620/tjem.194.55; Yan XW, 2002, MICROBIOL IMMUNOL, V46, P475	48	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	NOV	2014	59	11					1130	1138		10.1016/j.archoralbio.2014.06.010		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AP7FY	WOS:000342244400002		
J	Kuma, Y; Usumi-Fujita, R; Hosomichi, J; Oishi, S; Maeda, H; Nagai, H; Shimizu, Y; Kaneko, S; Shitano, C; Suzuki, JI; Yoshida, KI; Ono, T				Kuma, Yoichiro; Usumi-Fujita, Risa; Hosomichi, Jun; Oishi, Shuji; Maeda, Hideyuki; Nagai, Hisashi; Shimizu, Yasuhiro; Kaneko, Sawa; Shitano, Chisa; Suzuki, Jun-ichi; Yoshida, Ken-ichi; Ono, Takashi			Impairment of nasal airway under intermittent hypoxia during growth period in rats	ARCHIVES OF ORAL BIOLOGY			English	Article						Paediatric obstructive sleep apnoea; Intermittent hypoxia; Nasomaxillary complex; Micro-CT	OBSTRUCTIVE SLEEP-APNEA; MESENCHYMAL STEM-CELLS; OSTEOBLAST-LIKE CELLS; CARDIOVASCULAR-DISEASE; PARATHYROID-HORMONE; VITAMIN-D; CHILDREN; INDUCTION; SYMPTOMS; PREVALENCE	Objective: To clarify the influences of intermittent hypoxia (IH) on the growth and development of the midfacial area, including the nasal cavity, in growing rats. Design: Seven-week-old male Sprague-Dawley rats were divided into two groups: the experimental group (n = 5), which was exposed to IH for 8 h during light periods at a rate of 20 cycles/h (nadir, 4% O-2 to peak, 21% O-2 with 0% CO2), and the control group (n = 5), which was exposed to room air. After 3 weeks, the maxillofacial structures in both groups were evaluated with respect to the height, width, length, surface area, cross-sectional area, and volume of the nasal cavity using soft X-ray and micro-CT. Results: The experimental group showed a significantly smaller cross-sectional area and volume than did the control group. The surface area exhibited no significant differences between the two groups, although it tended to be smaller in the experimental group than in the control group. The nasal volume divided by the length of the tibia (for comparison with whole-body growth) was significantly smaller in the experimental group than in the control group. Conclusions: These data suggest that IH exposure suppresses growth and development of the nasal cavity and may result in nasal breathing disturbance. (C) 2014 Elsevier Ltd. All rights reserved.	[Kuma, Yoichiro; Usumi-Fujita, Risa; Hosomichi, Jun; Oishi, Shuji; Shimizu, Yasuhiro; Kaneko, Sawa; Shitano, Chisa; Ono, Takashi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Orofacial Dev & Funct, Div Oral Hlth Sci,Bunkyo Ku, Tokyo 1138549, Japan; [Maeda, Hideyuki; Nagai, Hisashi; Yoshida, Ken-ichi] Univ Tokyo, Grad Sch Med, Dept Forens Med, Bunkyo Ku, Tokyo 1130033, Japan; [Suzuki, Jun-ichi] Univ Tokyo, Dept Adv Clin Sci & Therapeut, Bunkyo Ku, Tokyo 1130033, Japan	Hosomichi, J (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Orofacial Dev & Funct, Div Oral Hlth Sci,Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	hosomichi.orts@tmd.ac.jp			KAKENHI	Grant-in-Aid for Scientific Research (KAKENHI).	Abdul-Razzak KK, 2014, J PEDIATR ADOL GYNEC, V27, P78, DOI 10.1016/j.jpag.2013.07.005; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; American Thoracic Society, 1996, AM J CRIT CARE MED, V153, P866; Teramura T, 2013, CELL TRANSPLANT, V22, P309, DOI 10.3727/096368912X653291; Zerega B, 1999, J BONE MINER RES, V14, P1281, DOI 10.1359/jbmr.1999.14.8.1281; Nieminen P, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.4.e55; Huynh NT, 2011, AM J ORTHOD DENTOFAC, V140, P762, DOI 10.1016/j.ajodo.2011.03.023; Abbassy MA, 2008, ARCH ORAL BIOL, V53, P819, DOI 10.1016/j.archoralbio.2008.02.008; Cheung CC, 2001, NEUROENDOCRINOLOGY, V74, P12, DOI 10.1159/000054666; Castronovo V, 2003, J PEDIATR-US, V142, P377, DOI 10.1067/mpd.2003.118; Peng YJ, 2003, P NATL ACAD SCI USA, V100, P10073, DOI 10.1073/pnas.1734109100; Marcus CL, 2012, PEDIATRICS, V130, P576, DOI 10.1542/peds.2012-1671; Yuan GX, 2011, J CELL PHYSIOL, V226, P2925, DOI 10.1002/jcp.22640; ALI NJ, 1993, ARCH DIS CHILD, V68, P360; Tosun F, 2009, J CRANIOFAC SURG, V20, P446, DOI 10.1097/SCS.0b013e31819b97ef; Guner I, 2013, BIOL TRACE ELEM RES, V154, P262, DOI 10.1007/s12011-013-9722-8; Sforza E, 2013, SLEEP, V36, P1509, DOI 10.5665/sleep.3046; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P1504; Barcelo A, 2005, AM J RESP CRIT CARE, V171, P183, DOI 10.1164/rccm.200405-579OC; Strauss SG, 1999, ANESTH ANALG, V89, P328, DOI 10.1097/00000539-199908000-00015; Maeda H, 2013, BBA-MOL BASIS DIS, V1832, P1159, DOI 10.1016/j.bbadis.2013.02.014; Marquez S, 2008, ANAT REC, V291, P1420, DOI 10.1002/ar.20785; Farahani R, 2008, PEDIATR PULM, V43, P20, DOI 10.1002/ppul.20729; Marquez S, 2008, ANAT REC, V291, P1535, DOI 10.1002/ar.20775; Vrabec JT, 2002, ACTA OTO-LARYNGOL, V122, P831, DOI 10.1080/0036554021000028085; Padzys GS, 2012, EUR J ORAL SCI, V120, P21, DOI 10.1111/j.1600-0722.2011.00896.x; Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164; Garvey JF, 2009, EUR RESPIR J, V33, P1195, DOI 10.1183/09031936.00111208; McNicholas WT, 2007, EUR RESPIR J, V29, P156, DOI 10.1183/09031936.00027406; Azagra-Calero E, 2012, MED ORAL PATOL ORAL, V17, P925; Balbani Aracy P S, 2005, Braz J Otorhinolaryngol, V71, P74; ENGSTROM C, 1982, J ANAT, V134, P299; Erden ES, 2014, ENDOCRINE, V45, P311, DOI 10.1007/s12020-013-0022-z; Holland TH, 1902, J R ANTHROPOL INST G, V32, P96, DOI 10.2307/2842906; Ishii M, 2010, ADV EXP MED BIOL, V662, P121, DOI 10.1007/978-1-4419-1241-1_17; Karsila S, 2000, EUR J ORAL SCI, V108, P426, DOI 10.1034/j.1600-0722.2000.108005426.x; Kuwahira II, 2000, PATHOPHYSIOLOGY, V7, P165, DOI 10.1016/S0928-4680(00)00047-X; Nakata S, 2008, AM J RHINOL, V22, P59, DOI 10.2500/ajr.2008.22.3120; NODA M, 1989, J CELL BIOL, V108, P713, DOI 10.1083/jcb.108.2.713; Owen GO, 1996, CLIN OTOLARYNGOL, V21, P130, DOI 10.1111/j.1365-2273.1996.tb01316.x; Ronen O, 2007, PEDIATRICS, V120, pE1028, DOI 10.1542/peds.2006-3433; Schwartz JE, 1998, BIOL NEONATE, V73, P313, DOI 10.1159/000013990; Sogut A, 2009, INT J PEDIATR OTORHI, V73, P1769, DOI 10.1016/j.ijporl.2009.09.026; Spence J. M., 1940, ANGLE ORTHOD, V10, P127; Urschitz MS, 2004, PEDIATRICS, V114, P1041, DOI 10.1542/peds.2003-1145-L; Xu NY, 2004, NEUROENDOCRINOL LETT, V25, P361	46	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	NOV	2014	59	11					1139	1145		10.1016/j.archoralbio.2014.06.005		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AP7FY	WOS:000342244400003		
J	Cai, Y; Kobayashi, R; Hashizume-Takizawa, T; Kurita-Ochiai, T				Cai, Yu; Kobayashi, Ryoki; Hashizume-Takizawa, Tomomi; Kurita-Ochiai, Tomoko			Porphyromonas gingivalis infection enhances Th17 responses for development of atherosclerosis	ARCHIVES OF ORAL BIOLOGY			English	Article						Atherosclerosis; Porphyromonas gingivalis; Regulatory T cells; T-helper 1 cells; T-helper 17 cells	REGULATORY T-CELLS; DEFICIENT MICE; TGF-BETA; INFLAMMATION; DISEASE; MECHANISMS; CYTOKINES; PATHWAYS; T(H)17; DIFFERENTIATION	Objectives: Porphyromonas gingivalis has been shown to associate with the development of atherosclerosis. Recent studies indicate that IL-17-producing T helper 17 (Th17) cells have been correlated with the emergence of atherosclerosis. Therefore, we investigated whether the Th17 cell response and expression of Th17-related molecules, in contrast with Th1- and Treg cells, are enhanced by P. gingivalis-challenge in Apolipoprotein E knockout (ApoE KO) mice. Design: Five mice were intravenously injected with P. gingivalis three times a week for 3 weeks and killed at 15 weeks of age. The proximal aorta lesion area, flow cytometry analysis and IL-17, IL-10, IFN-gamma, and IL-1 beta levels in splenic cultures, and expression of Th17-related molecules in spleen and hearts were examined. Results: P. gingivalis-challenge showed notable accumulation of atherosclerotic plaques by Oil Red O-staining in ApoE KO mice. Intracellular cytokine staining revealed that significantly elevated CD4(+) interleukin (IL)-17A(+) T cells and slightly increased CD4(+)Foxp3(+) T cells was recognized in spleen cells of P. gingivalis-challenged mice compared with those from non-infected mice. P. gingivalis-challenge significantly increased IL-17 and IL-1 beta production and ROR gamma t expression in splenic cells. Furthermore, the expression of Th17-related genes such as IL-6, TGF-beta, ROR gamma t and STAT3 were elevated in splenic cells as well as heart tissue of P. gingivalis-challenged mice. Conclusion: These results suggest that P. gingivalis infection may enhance pro-inflammatory Th17 cell responses in lesion areas and spleen, thereby accelerating atherosclerosis. (C) 2014 Elsevier Ltd. All rights reserved.	[Cai, Yu; Kobayashi, Ryoki; Hashizume-Takizawa, Tomomi; Kurita-Ochiai, Tomoko] Nihon Univ Sch Dent Matsudo, Dept Microbiol & Immunol, Matsudo, Chiba 2718587, Japan; [Cai, Yu] Peking Univ Sch & Hosp Stomatol, Dept Periodontol, Beijing 100081, Peoples R China	Kurita-Ochiai, T (reprint author), Nihon Univ Sch Dent Matsudo, Dept Microbiol & Immunol, Sakaecho Nishi 2-870-1, Matsudo, Chiba 2718587, Japan.	ochiai.tomoko@nihon-u.ac.jp			Japan Society for the Promotion of Science [22390398]; Japan [MEXT for Private Universities of the Ministry of Education, Culture, Sports, Science and Technology, Japan [S1001024]	This study was supported by grants-in-aid for Scientific Research (22390398) from the Japan Society for the Promotion of Science, and for the "Strategic Research Base Development" Program (Japan [MEXT], 2010-2014 [S1001024]) for Private Universities of the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Ranjbaran H, 2007, J IMMUNOL, V178, P592; Maskrey BH, 2011, ARTERIOSCL THROM VAS, V31, P1001, DOI 10.1161/ATVBAHA.110.213850; Usui F, 2012, BIOCHEM BIOPH RES CO, V420, P72, DOI 10.1016/j.bbrc.2012.02.117; Chen SA, 2010, J INNATE IMMUN, V2, P325, DOI 10.1159/000314626; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Hayashi C, 2010, MOL ORAL MICROBIOL, V25, P305, DOI 10.1111/j.2041-1014.2010.00582.x; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Zhang T, 2010, FEMS IMMUNOL MED MIC, V59, P143, DOI 10.1111/j.1574-695X.2010.00674.x; Singh K, 2013, J IMMUNOL, V190, P2544, DOI 10.4049/jimmunol.1202399; Moutsopoulos NM, 2012, J AUTOIMMUN, V39, P294, DOI 10.1016/j.jaut.2012.03.003; Okui T, 2012, J DENT RES, V91, P574, DOI 10.1177/0022034512446341; Afzali B, 2010, CLIN EXP IMMUNOL, V159, P120, DOI 10.1111/j.1365-2249.2009.04038.x; Liu ZD, 2012, ATHEROSCLEROSIS, V221, P232, DOI 10.1016/j.atherosclerosis.2011.12.026; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409; Adibrad M, 2012, J PERIODONTAL RES, V47, P525, DOI 10.1111/j.1600-0765.2011.01464.x; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Gao Q, 2010, J IMMUNOL, V185, P5820, DOI 10.4049/jimmunol.1000116; de Boer OJ, 2010, J PATHOL, V220, P499, DOI 10.1002/path.2667; Jager A, 2010, SCAND J IMMUNOL, V72, P173, DOI 10.1111/j.1365-3083.2010.02432.x; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; George J, 2008, NAT CLIN PRACT CARD, V5, P531, DOI 10.1038/ncpcardio1279; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cheng X, 2008, J MOL CELL CARDIOL, V45, P168, DOI 10.1016/j.yjmcc.2008.04.003; Xie JJ, 2010, CYTOKINE, V49, P185, DOI 10.1016/j.cyto.2009.09.007; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Roth GA, 2009, THROMB RES, V123, P780, DOI 10.1016/j.thromres.2008.07.008; Coffman RL, 2006, NAT IMMUNOL, V7, P539, DOI 10.1038/ni0606-539; Hajishengallis G., 2011, J ORAL BIOSCI, V53, P233; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Irmler IM, 2007, J IMMUNOL, V179, P6228; Xinghua Z, 2000, CIRCULATION, V102, P2919; Yang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086599	39	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	NOV	2014	59	11					1183	1191		10.1016/j.archoralbio.2014.07.012		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AP7FY	WOS:000342244400008		
J	Nakajima, A; Ito, Y; Tanaka, E; Sano, R; Karasawa, Y; Maeno, M; Iwata, K; Shimizu, N; Shuler, CF				Nakajima, Akira; Ito, Yoshihiro; Tanaka, Eiji; Sano, Remi; Karasawa, Yoko; Maeno, Masao; Iwata, Koichi; Shimizu, Noriyoshi; Shuler, Charles F.			Functional role of TGF-beta receptors during palatal fusion in vitro	ARCHIVES OF ORAL BIOLOGY			English	Article						Palatal development; TGF-beta receptor; TGF-beta signalling; SMAD2 phosphorylation; MMP-13 expression; siRNA	GROWTH-FACTOR-BETA; MEDIAL EDGE EPITHELIUM; CLEFT-PALATE; III RECEPTOR; MATRIX METALLOPROTEINASES; MESENCHYMAL TRANSITION; TISSUE INHIBITORS; CELL-MEMBRANE; MUTANT MICE; DEFECTS	Objective: Reported expression patterns for TGF-beta receptors (T beta R-I, -II, and -III) during palatogenesis suggest that they play essential roles in the mechanisms leading to palatal fusion. The purpose of this study was to compare the functions of the three T beta Rs during palatal fusion. Methods: Using organ culture of mouse palatal shelves, expression levels of T beta R-I, -II, and -III were suppressed by transfecting the siRNAs siT beta R-I, -II, and -III, respectively. Phosphorylation of SMAD2 was examined as an indicator of downstream signalling via each T beta R. Linkage between TGF-beta signalling and critical events in palatal fusion led to the use of MMP-13 expression as an outcome measure for the function of the TGF-beta receptors. Results: The siRNA treatment decreased the expression level of each receptor by more than 85%. When treated with either siT beta R-I or -II, palatal shelves at E13 + 72 h were not fused, with complete clefting in the anterior and posterior regions. The middle palatal region following treatment with either siT beta R-I or -II had fusion from one-half or one-third of the palatal region. Treatment with siT beta R-III resulted in a persistent midline seam of medial edge epithelium (MEE) in the anterior region with islands of persistent MEE in the middle and posterior regions of the midline. Treatment with all three siT beta Rs altered the pattern of SMAD2 phosphorylation. Palatal shelf cultures treated with siT beta R-I or -II, but not -III, showed altered MMP-13 expression levels. Conclusion: The ability to identify and recover MEE and palatal mesenchymal cells during palatal fusion will aid in the evaluation of the different mechanistic events regulated by each T beta R during palatogenesis. (C) 2014 Elsevier Ltd. All rights reserved.	[Nakajima, Akira; Shimizu, Noriyoshi] Nihon Univ Sch Dent, Dept Orthodont, Chiyoda Ku, Tokyo 1018310, Japan; [Nakajima, Akira; Maeno, Masao; Iwata, Koichi; Shimizu, Noriyoshi] Nihon Univ Sch Dent, Dent Res Ctr, Chiyoda Ku, Tokyo 1018310, Japan; [Ito, Yoshihiro] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Tanaka, Eiji] Tokushima Univ Grad Sch, Inst Hlth Biosci, Dept Orthodont & Dentofacial Orthoped, Tokushima 7708504, Japan; [Sano, Remi; Karasawa, Yoko] Nihon Univ Grad Sch Dent, Nihon Univ, Chiyoda Ku, Tokyo 1018310, Japan; [Shuler, Charles F.] Univ British Columbia, Dept Oral Biol & Med Sci, Fac Dent, Vancouver, BC V6T 1Z3, Canada	Nakajima, A (reprint author), Nihon Univ Sch Dent, Dept Orthodont, 1-8-13 Chiyoda Ku, Tokyo, Japan.	nakajima.akira@nihon-u.ac.jp	Tanaka, Eiji/E-7105-2015		NIDCR [PO1DE-12941, RO1DE-16296]; MEXT [23593046, 26463100]; Dental Research Center, Nihon University School of Dentistry to Graduate School of Dentistry	This work was supported by NIDCR grants (PO1DE-12941 and RO1DE-16296), MEXT Grant for Multidisciplinary Research Projects, MEXT Grant-in-Aid for Scientific Research (C) (23593046 and 26463100), and Grant from Dental Research Center, Nihon University School of Dentistry to Graduate School of Dentistry (A and B, 2014).	Ahmed S, 2007, DEV BIOL, V309, P193, DOI 10.1016/j.ydbio.2007.06.018; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; Esparza-Lopez J, 2001, J BIOL CHEM, V276, P14588, DOI 10.1074/jbc.M008866200; Stenvers KL, 2003, MOL CELL BIOL, V23, P4371, DOI 10.1128/MCB.23.12.4371-4385.2003; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Yu WL, 2008, DEV DYNAM, V237, P2716, DOI 10.1002/dvdy.21627; Gordon KJ, 2008, CARCINOGENESIS, V29, P252, DOI 10.1093/carcin/bgm249; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Davies JA, 2004, HUM MOL GENET, V13, P235, DOI 10.1093/hmg/ddh015; GRIFFITH CM, 1992, DEVELOPMENT, V116, P1087; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Iwata J, 2011, ORAL DIS, V17, P733, DOI 10.1111/j.1601-0825.2011.01806.x; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Verstappen J, 2006, J DENT RES, V85, P1074; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Iwata J, 2012, J CLIN INVEST, V122, P873, DOI 10.1172/JCI61498; Martinez-Alvarez C, 2000, DEV BIOL, V220, P343, DOI 10.1006/dbio.2000.9644; Cui XM, 2005, DEV BIOL, V278, P193, DOI 10.1016/j.ydbio.2004.10.023; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Gatza CE, 2010, CELL SIGNAL, V22, P1163, DOI 10.1016/j.cellsig.2010.01.016; Blavier L, 2001, MOL BIOL CELL, V12, P1457; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Brown CB, 1996, DEV BIOL, V174, P248, DOI 10.1006/dbio.1996.0070; Cui XM, 1998, INT J DEV BIOL, V42, P817; Cui XM, 2000, INT J DEV BIOL, V44, P397; Cui XM, 2003, DEV DYNAM, V227, P387, DOI 10.1002/dvdy.10326; Demarchi ACCD, 2010, CELL TISSUE RES, V340, P61, DOI 10.1007/s00441-010-0931-6; Dudas M, 2006, DEV BIOL, V296, P298, DOI 10.1016/j.ydbio.2006.05.030; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kaartinen V, 1997, DEV DYNAM, V209, P224; Li WY, 2008, MECH DEVELOP, V125, P874, DOI 10.1016/j.mod.2008.06.003; Morris-Wiman J, 2000, ANAT EMBRYOL, V202, P129, DOI 10.1007/s004290000098; Nakajima A, 2010, J MOL HISTOL, V41, P343, DOI 10.1007/s10735-010-9296-0; Nakajima A, 2007, DEV DYNAM, V236, P791, DOI 10.1002/dvdy.21090; Rotzer D, 2001, EMBO J, V20, P480, DOI 10.1093/emboj/20.3.480; Shiomi N, 2006, DEV DYNAM, V235, P1785, DOI 10.1002/dvdy.20819; SHULER C F, 1991, International Journal of Developmental Biology, V35, P463; Wong F. K., 2004, Hong Kong Medical Journal, V10, P331; Xu X, 2006, DEV BIOL, V297, P238, DOI 10.1016/j.ydbio.2006.05.014; Xu X, 2008, DEV CELL, V15, P322, DOI 10.1016/j.devcel.2008.06.004; Yu WL, 2009, EXP BIOL MED, V234, P483, DOI 10.3181/0812-MR-365; Yumoto K, 2013, J BIOL CHEM, V288, P13467, DOI 10.1074/jbc.M112.431775	46	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	NOV	2014	59	11					1192	1204		10.1016/j.archoralbio.2014.07.007		13	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AP7FY	WOS:000342244400009		
J	Iwakami, W; Yatagai, Y; Hatakeyama, N; Hattori, Y				Iwakami, Wakana; Yatagai, Yuzuru; Hatakeyama, Nozomu; Hattori, Yuji			A New Approach for Error Reduction in the Volume Penalization Method	COMMUNICATIONS IN COMPUTATIONAL PHYSICS			English	Article						Volume penalization method; immersed boundary method; compact scheme; error reduction	NAVIER-STOKES EQUATIONS; TRANSIENT FLOW BEHAVIOR; NUMERICAL-SIMULATION; SPECTRAL METHOD; TUBE BUNDLES; OBSTACLES	A new approach for reducing error of the volume penalization method is proposed. The mask function is modified by shifting the interface between solid and fluid by root nu eta toward the fluid region, where nu and eta are the viscosity and the permeability, respectively. The shift length root nu eta is derived from the analytical solution of the one-dimensional diffusion equation with a penalization term. The effect of the error reduction is verified numerically for the one-dimensional diffusion equation, Burgers' equation, and the two-dimensional Navier-Stokes equations. The results show that the numerical error is reduced except in the vicinity of the interface showing overall second-order accuracy, while it converges to a non-zero constant value as the number of grid points increases for the original mask function. However, the new approach is effective when the grid resolution is sufficiently high so that the boundary layer, whose width is proportional to root nu eta, is resolved. Hence, the approach should be used when an appropriate combination of nu and eta is chosen with a given numerical grid.	[Iwakami, Wakana] Kyoto Univ, Yukawa Inst Theoret Phys, Sakyo Ku, Kyoto 6068502, Japan; [Iwakami, Wakana] Waseda Univ, Adv Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Yatagai, Yuzuru] Tohoku Univ, Grad Sch Informat Sci, Dept Appl Informat Sci, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Hatakeyama, Nozomu] Tohoku Univ, NICHe, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Hattori, Yuji] Tohoku Univ, Inst Fluid Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan	Iwakami, W (reprint author), Kyoto Univ, Yukawa Inst Theoret Phys, Sakyo Ku, Kyoto 6068502, Japan.	wakana@heap.phys.waseda.ac.jp; yuzun@dragon.ifs.tohoku.ac.jp; hatakeyama@aki.niche.tohoku.ac.jp; hattori@fmail.ifs.tohoku.ac.jp			Maekawa Houonkai	Numerical calculations were performed on the Altix UV1000 at the Institute of Fluid Science, Tohoku University. This study was partially supported by the academic research grant by Maekawa Houonkai in 2011.	Kevlahan NKR, 2001, EUR J MECH B-FLUID, V20, P333, DOI 10.1016/S0997-7546(00)01121-3; Schneider K, 2005, COMPUT FLUIDS, V34, P1223, DOI 10.1016/j.compfluid.2004.09.006; Mittal R, 2005, ANNU REV FLUID MECH, V37, P239, DOI 10.1146/annurev.fluid.37.061903.175743; Schneider K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.244502; Angot P, 1999, NUMER MATH, V81, P497, DOI 10.1007/s002110050401; Kolomenskiy D, 2009, J COMPUT PHYS, V228, P5687, DOI 10.1016/j.jcp.2009.04.026; LELE SK, 1992, J COMPUT PHYS, V103, P16, DOI 10.1016/0021-9991(92)90324-R; COLE JD, 1951, Q APPL MATH, V9, P225; Kadoch B, 2012, J COMPUT PHYS, V231, P4365, DOI 10.1016/j.jcp.2012.01.036; Keetels GH, 2007, J COMPUT PHYS, V227, P919, DOI 10.1016/j.jcp.2007.07.036; BRINKMAN HC, 1947, APPL SCI RES, V1, P27; Burgers J.M., 1939, VERH NEDERL AKAD WET, V17, P1; Carbou G, 2003, ADV DIFFERENTIAL EQU, V8, P1453; HOPF E, 1950, COMMUN PUR APPL MATH, V3, P201, DOI 10.1002/cpa.3160030302; Kevlahan NKR, 2005, J FLUID STRUCT, V20, P611, DOI 10.1016/j.jfluidstructs.2005.02.010; Schneider K, 2005, J FLUID STRUCT, V20, P555, DOI 10.1016/j.jfluidstructs.2005.02.006; Schneider K, 2008, PHYSICA D, V237, P2228, DOI 10.1016/j.physd.2008.02.012; Tritton D J, 1988, PHYS FLUID DYNAMICS	18	1	1	GLOBAL SCIENCE PRESS	WANCHAI	ROOM 3208, CENTRAL PLAZA, 18 HARBOUR RD, WANCHAI, HONG KONG 00000, PEOPLES R CHINA	1815-2406	1991-7120		COMMUN COMPUT PHYS	Commun. Comput. Phys.	NOV	2014	16	5					1181	1200		10.4208/cicp.220513.070514a		20	Physics, Mathematical	Physics	AP4XZ	WOS:000342085000002		
J	Toshimoto, K; Wakayama, N; Kusama, M; Maeda, K; Sugiyama, Y; Akiyama, Y				Toshimoto, Kouta; Wakayama, Naomi; Kusama, Makiko; Maeda, Kazuya; Sugiyama, Yuichi; Akiyama, Yutaka			In Silico Prediction of Major Drug Clearance Pathways by Support Vector Machines with Feature-Selected Descriptors	DRUG METABOLISM AND DISPOSITION			English	Article							CLASSIFICATION-SYSTEM; METABOLISM; PARAMETERS; DISCOVERY; MOLECULE; CYPS	We have previously established an in silico classification method ("CPathPred") to predict the major clearance pathways of drugs based on an empirical decision with only four physicochemical descriptors-charge, molecular weight, octanol-water distribution coefficient, and protein unbound fraction in plasma-using a rectangular method. In this study, we attempted to improve the prediction performance of the method by introducing a support vector machine (SVM) and increasing the number of descriptors. The data set consisted of 141 approved drugs whose major clearance pathways were classified into metabolism by CYP3A4, CYP2C9, or CYP2D6; organic anion transporting polypeptide-mediated hepatic uptake; or renal excretion. With the same four default descriptors as used in CPathPred, the SVM-based predictor (named "default descriptor SVM") resulted in higher prediction performance compared with a rectangular-based predictor judged by 10-fold cross-validation. Two SVM-based predictors were also established by adding some descriptors as follows: 1) 881 descriptors predicted in silico from the chemical structures of drugs in addition to 4 default descriptors ("885 descriptor SVM"); and 2) selected descriptors extracted by a feature selection based on a greedy algorithm with default descriptors ("feature selection SVM"). The prediction accuracies of the rectangular-based predictor, default descriptor SVM, 885 descriptor SVM, and feature selection SVM were 0.49, 0.60, 0.72, and 0.91, respectively, and the overall precision values for these four methods were 0.72, 0.77, 0.86, and 0.98, respectively. In conclusion, we successfully constructed SVM-based predictors with limited numbers of descriptors to classify the major clearance pathways of drugs in humans with high prediction performance.	[Toshimoto, Kouta; Akiyama, Yutaka] Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Dept Comp Sci, Tokyo 1528552, Japan; [Wakayama, Naomi] Eisai & Co Ltd, Eisai Product Creat Syst, Biopharmaceut Assessment Core Funct Unit, Drug Metab & Pharmacokinet Japan, Ibaraki, Japan; [Kusama, Makiko] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Pharmaceut Regulatory Sci, Tokyo, Japan; [Maeda, Kazuya] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Mol Pharmacokinet, Tokyo, Japan; [Sugiyama, Yuichi] RIKEN, RIKEN Res Cluster Innovat, RIKEN Innovat Ctr, Sugiyama Lab, Yokohama, Kanagawa, Japan	Akiyama, Y (reprint author), Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Dept Comp Sci, Meguro Ku, 2-12-1-W8-76, Tokyo 1528552, Japan.	akiyama@cs.titech.ac.jp			Okawa Foundation;  [24689009]	This research was partly supported by the Okawa Foundation (to K.T. and Y.A.) and by the Grant-in-aid for Young Scientists (A) [Grant 24689009] (to K.M.).	Yu LX, 2002, PHARMACEUT RES, V19, P921, DOI 10.1023/A:1016473601633; Venkatakrishnan K, 2000, DRUG METAB DISPOS, V28, P1493; Varma MVS, 2009, J MED CHEM, V52, P4844, DOI 10.1021/jm900403j; Obach RS, 2008, DRUG METAB DISPOS, V36, P1385, DOI 10.1124/dmd.108.020479; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Emoto C, 2010, CURR DRUG METAB, V11, P678, DOI 10.2174/138920010794233503; Wu CY, 2005, PHARM RES, V22, P11, DOI 10.1007/s11095-004-9004-4; Cheng FX, 2012, J CHEM INF MODEL, V52, P3099, DOI 10.1021/ci300367a; Kusama M, 2010, DRUG METAB DISPOS, V38, P1362, DOI 10.1124/dmd.110.032789; van de Waterbeemd H, 2003, NAT REV DRUG DISCOV, V2, P192, DOI 10.1038/nrd1032; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Lewis DFV, 2010, EXPERT OPIN DRUG MET, V6, P661, DOI 10.1517/17425251003674380; Benet LZ, 2011, AAPS J, V13, P519, DOI 10.1208/s12248-011-9290-9; Yoshida K, 2013, ANNU REV PHARMACOL, V53, P581, DOI 10.1146/annurev-pharmtox-011112-140309; Liu Y, 2006, LECT NOTES ARTIF INT, V3918, P107; TOMEK I, 1976, IEEE T SYST MAN CYB, V6, P769; Batista G.E.A.P.A., 2004, ACM SIGKDD EXPLORATI, V6, P20, DOI DOI 10.1145/1007730.1007735; Benet L. Z, 1996, GOODMAN GILMANS PHAR, P1707; Caruana R, 1994, GREEDY ATTRIBUTE SEL; European Medicines Agency, 2010, GUID INV DRUG INT; FDA, 2012, GUID IND DRUG INT ST; Mishra Nitish K., 2010, BMC Pharmacology, V10, P8, DOI 10.1186/1471-2210-10-8; Sakiyama Y, 2008, J MOL GRAPH MODEL, V26, P907, DOI 10.1016/j.jmgm.2007.06.005; Sugiyama M., 2005, STAT DECISIONS, V23, P249, DOI 10.1524/stnd.2005.23.4.249; Thummel KE, 2001, GOODMAN GILMANS PHAR, P1917; Thummel KE, 2006, GOODMAN GILMANS PHAR, P1787; Vapnik V., 2000, NATURE STAT LEARNING; Yamashita F, 2008, J CHEM INF MODEL, V48, P364, DOI 10.1021/ci700262y	29	1	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0090-9556	1521-009X		DRUG METAB DISPOS	Drug Metab. Dispos.	NOV	2014	42	11					1811	1819		10.1124/dmd.114.057893		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AP4OU	WOS:000342058100006		
J	Batkhishig, B; Noriyoshi, T; Bignall, G				Batkhishig, Bayaraa; Noriyoshi, Tsuchiya; Bignall, Greg			Magmatic-Hydrothermal Activity in the Shuteen Area, South Mongolia	ECONOMIC GEOLOGY			English	Article							SYNTHETIC FLUID INCLUSIONS; STABLE-ISOTOPE GEOCHEMISTRY; PORPHYRY COPPER-DEPOSIT; KELIAN GOLD MINE; SYSTEM H2O-NACL; GEOTHERMAL SYSTEMS; ORE-DEPOSITS; QUARTZ; CATHODOLUMINESCENCE; MINERALIZATION	The Shuteen area is located in the Gurvansaikhan island arc terrane of South Mongolia. It contains a large domain of intensely developed silicic and advanced argillic alteration that has strongly affected the adakitic volcanoplutonic Shuteen Complex. The local occurrence of low-grade copper mineralization within porphyritic intrusive rocks is indicative of porphyry-style mineralization. Hydrothermal quartz veins host gold mineralization locally. The results of scanning electron microscope-cathodoluminescence imaging and fluid inclusion microthermomeny indicate that the veins and altered rocks at Shuteen were produced by multiple hydrothermal events. The occurrence of CO2 inclusions in quartz from granitoids and the delta S-34 values obtained for sulfide and sulfate within the hydrothermal breccias provide evidence of the involvement of magmatically derived fluids in the early stages of the Shuteen magmatic-hydrothermal system, inferred to be sourced from a porphyry-style intrusive center. Late-stage fluids produced abundant barren quartz veins and clay alteration assemblages. The weak mineralization and widespread alteration in the Shuteen Complex are typical of lithocaps found in high-level porphyry copper-(gold-molybdenum) and high sulfidation epithermal districts. The present-day erosion level at Shuteen is relatively shallow, implying that economic porphyry-style mineralization may exist at depth within or beneath the Shuteen lithocap.	[Batkhishig, Bayaraa] Mongolian Univ Sci & Technol, Sch Geol & Petr Engn, Ulaanbaatar 210646, Mongol Peo Rep; [Noriyoshi, Tsuchiya] Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 980, Japan	Batkhishig, B (reprint author), Mongolian Univ Sci & Technol, Sch Geol & Petr Engn, POB 46-520, Ulaanbaatar 210646, Mongol Peo Rep.	bkhishig@must.edu.mn			Global COE Fellowship	This paper was supported by a Global COE Fellowship and was prepared while BB was at Tohoku University, Japan, in 2009. The authors wish to thank Prof. Kakegawa Takeshi (Graduate School of Science, Tohoku University) and Dr. Ryoichi Yamada (Graduate School of Environmental Studies, Tohoku University) for their useful comments and valuable suggestions. We thank Dr. Fumiko Nara (Faculty of Science, Tohoku University) for sulfur isotope analyses and Dr. Delgertsogt Baljinnyam for providing useful data and figures. Our special thanks are extended to the journal editor, Dr. Larry Meinert, and reviewers, especially Dr. David R. Cooke, for their tireless efforts and editorial comments on the subsequent drafts, which greatly improved this manuscript.	Rusk BG, 2006, AM MINERAL, V91, P1300, DOI 10.2138/am.2006.1984; BODNAR RJ, 1985, GEOCHIM COSMOCHIM AC, V49, P1861, DOI 10.1016/0016-7037(85)90081-X; OHMOTO H, 1982, GEOCHIM COSMOCHIM AC, V46, P1727, DOI 10.1016/0016-7037(82)90113-2; Bignall G, 2004, GEOTHERMICS, V33, P615, DOI 10.1016/j.geothermics.2004.03.001; ARRIBAS A, 1995, ECON GEOL BULL SOC, V90, P795; RYE RO, 1992, ECON GEOL BULL SOC, V87, P225; SOURIRAJAN S, 1962, AM J SCI, V260, P115; Sillitoe RH, 2010, ECON GEOL, V105, P3; HEDENQUIST JW, 1994, GEOLOGY, V22, P585, DOI 10.1130/0091-7613(1994)022<0585:FOVAOF>2.3.CO;2; Wilson AJ, 2007, ECON GEOL, V102, P3, DOI 10.2113/gsecongeo.102.1.3; Hart CJR, 2002, MINER DEPOSITA, V37, P326, DOI 10.1007/s00126-001-0239-2; Wolfe RC, 2011, ECON GEOL, V106, P1279; OHMOTO H, 1986, REV MINERAL, V16, P491; Badarch G, 2002, J ASIAN EARTH SCI, V21, P87, DOI 10.1016/S1367-9120(02)00017-2; Rusk B, 2002, GEOLOGY, V30, P727, DOI 10.1130/0091-7613(2002)030<0727:SEMCAO>2.0.CO;2; Herzig PM, 1998, MINER DEPOSITA, V33, P226, DOI 10.1007/s001260050143; Mao JW, 2003, ECON GEOL BULL SOC, V98, P517, DOI 10.2113/98.3.517; Chang ZS, 2011, ECON GEOL, V106, P1365; Davies AGS, 2008, ECON GEOL, V103, P689, DOI 10.2113/gsecongeo.103.4.689; Wilkinson JJ, 1999, ECON GEOL BULL SOC, V94, P289; Batkhishig B, 2010, J ASIAN EARTH SCI, V37, P399, DOI 10.1016/j.jseaes.2009.10.004; Batkhishig B., 2005, THESIS TOHOKU U JAPA; Batkhishig B, 2005, RESOUR GEOL, V55, P1, DOI 10.1111/j.1751-3928.2005.tb00223.x; Berzina A. P., 1983, SOVIET GEOLOGY GEOPH, V24, P53; Berzina A. P., 1994, RUSSIAN GEOLOGY GEOP, V35, P204; Berzina A. P., 1999, MINERAL DEPOSITS PRO, V1, P317; Blight JHS, 2010, LITHOS, V116, P35, DOI 10.1016/j.lithos.2010.01.001; STERNER SM, 1988, GEOCHIM COSMOCHIM AC, V52, P989, DOI 10.1016/0016-7037(88)90254-2; Bodnar RJ, 1995, MINERALOGICAL ASS CA, V23, P139; Bodnar R.J., 1994, FLUID INCLUSIONS MIN, P117; BODNAR RJ, 1994, GEOCHIM COSMOCHIM AC, V58, P1053, DOI 10.1016/0016-7037(94)90571-1; BURROWS DR, 1987, ECON GEOL, V82, P1931; BURROWS DR, 1986, NATURE, V321, P851, DOI 10.1038/321851a0; CAMERON EM, 1987, ECON GEOL, V82, P1177; Corlett G. J., 1997, PETROGRAPHIC D UNPUB; Davies AGS, 2008, ECON GEOL, V103, P717, DOI 10.2113/gsecongeo.103.4.717; Delgertsogt B., 2008, THESIS U SCI TECHNOL; Gerel O., 1998, B GEOLOGICAL SURVEY, V49, P239; Hattori K.H., 2004, SOC RES GEOL JAP ANN, pS; HEDENQUIST JW, 1985, ECON GEOL, V80, P1379; HIGGINS NC, 1982, CAN J EARTH SCI, V19, P2247, DOI 10.1139/e82-198; HO SE, 1992, J VOLCANOL GEOTH RES, V50, P173, DOI 10.1016/0377-0273(92)90044-E; Hovan M., 1984, RESULT GEOLOGICAL PR; Hovan M., 1982, 35 GEOINF CTR; Iizumi S., 2000, GEOL SOC JAP ANN M 1, P319; Japan International Cooperation Agency and Metal Mining Agency of Japan (JICA MMAJ), 1995, REP MIN EXPL ALT TAL; Kavalieris I., 2013, SOC EC GEOLOGISTS SP, V16, P187; Koval P. V., 1988, INT GEOL REV, V30, P990; Lamb MA, 1998, ECON GEOL BULL SOC, V93, P524; MCKIBBEN MA, 1990, ECON GEOL BULL SOC, V85, P1917; Muller A, 2002, CONTRIB MINERAL PETR, V143, P510, DOI 10.1007/s00410-002-0361-x; Ohmoto H., 1979, GEOCHEMISTRY HYDROTH, P509; Penniston-Dorland SC, 2001, AM MINERAL, V86, P652; Perello J, 2001, ECON GEOL BULL SOC, V96, P1407, DOI 10.2113/96.6.1407; Ruzhentsev S. V., 1992, Geotectonics, V26; RYE RO, 1993, ECON GEOL BULL SOC, V88, P733; Seedorff E., 2005, EC GEOLOGY 100 ANNIV, V29, P251; Sekine K, 2004, GEOTHERMICS, V33, P775, DOI 10.1016/j.geothermics.2004.05.003; Sillitoe R.H., 1995, AUSTR I MIN MET PAC, P527; SO CS, 1995, ANTARCT SCI, V7, P63; Sotnikov V.I., 1985, COPPER BEARING FORMA; Sotnikov V.I., 1980, GEOLOGY MINERAL DEPO, V3, P34; Watanabe Y., 2000, ECON GEOL, V95, P537; Watanabe Y, 1999, RESOUR GEOL, V49, P123, DOI 10.1111/j.1751-3928.1999.tb00038.x	64	1	1	SOC ECONOMIC GEOLOGISTS, INC	LITTLETON	7811 SCHAFFER PARKWAY, LITTLETON, CO 80127 USA	0361-0128	1554-0774		ECON GEOL	Econ. Geol.	NOV	2014	109	7					1929	1942				14	Geochemistry & Geophysics	Geochemistry & Geophysics	AP5KK	WOS:000342117900006		
J	Nozaki, T; Kato, Y; Suzuki, K				Nozaki, Tatsuo; Kato, Yasuhiro; Suzuki, Katsuhiko			Re-Os Geochronology of the Hitachi Volcanogenic Massive Sulfide Deposit: The Oldest Ore Deposit in Japan	ECONOMIC GEOLOGY			English	Article							CENTRAL SHIKOKU; BROOKS RANGE; GOLD DEPOSIT; OSMIUM; ISOTOPE; GEOCHEMISTRY; RHENIUM; MINERALIZATION; SPECTROMETRY; SYSTEMATICS	The Hitachi volcanogenic massive sulfide (VMS) deposit in the Hitachi belt is one of the largest Cu-Zn sulfide deposits in Japan. However, its primary formation age has not been precisely determined because regional and contact metamorphism have disturbed some radiometric isotope systems, e.g., K-Ar ages on wall rocks. Further metamorphism has greatly reduced the fossil record, which has limited the use of biostratigraphy. To establish the ore deposit age, we applied Re-Os isotope dating to samples from two representative sulfide deposits of the greater Hitachi VMS deposit: the Fudotaki and Fujimi deposits. Re-Os isotope data from the Fudotaki deposit yields a model 3 age of 533 +/- 13 Ma, with an initial Os-187/Os-188 ratio of 0.35 +/- 0.20. In contrast, Re-Os isotope data from the Fujimi sulfide ore did not exhibit a linear correlation, suggesting that the Re-Os isotope system there has been disturbed by regional metamorphism of higher grade than the Fudotaki deposit as well as contact metamorphism during intrusion of Cretaceous granitic rocks. Although the Fudotaki sulfide ores have been metamorphosed to lower epidote-amphibolite facies, the well-defined Re-Os isochron allowed us to interpret the timing of primary sulfide deposition on the paleoseafloor. Some orebodies of the greater Hitachi VMS deposit have been estimated to be Early Carboniferous based on the scarce fossil records and considered to be distributed in the Daioin Formation, but our results revealed that the Fudotaki deposit were formed during the Cambrian and occurs in the Upper Akazawa Formation, which strongly supports the idea that the Cambrian beds are widely distributed in the Hitachi belt and that a significant unconformity exists between the Cambrian and Early Carboniferous above the Fudotaki deposit. The Cambrian Re-Os date classifies the Hitachi VMS deposit as the oldest dated ore deposit in Japan, and in turn provides an insight to understand the geologic framework and genesis of the proto-Japanese islands and the East Asian region.	[Nozaki, Tatsuo; Kato, Yasuhiro; Suzuki, Katsuhiko] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Inst Res Earth Evolut IFREE, Yokosuka, Kanagawa 2370061, Japan; [Nozaki, Tatsuo; Kato, Yasuhiro; Suzuki, Katsuhiko] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Submarine Resources Res Project, Yokosuka, Kanagawa 2370061, Japan; [Nozaki, Tatsuo; Kato, Yasuhiro] Univ Tokyo, Sch Engn, Dept Syst Innovat, Bunkyo Ku, Tokyo 1138656, Japan; [Kato, Yasuhiro] Univ Tokyo, Sch Engn, Frontier Res Ctr Energy & Resources, Bunkyo Ku, Tokyo 1138656, Japan	Nozaki, T (reprint author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Inst Res Earth Evolut IFREE, 2-15 Natsushima cho, Yokosuka, Kanagawa 2370061, Japan.	nozaki@jamstec.go.p			Japan Society for the Promotion of Science [21840069, 24740360, 21109006, 22226015, 20109006, 20340158]	The sulfide ore samples we used were kindly provided by K. Kase of Okayama University. We thank Y. Takaya, R. Senda, H. Yamamoto and Y. Otsuki for assistance with sample preparation and Re-Os isotope analyses. We also thank K. Shimada and J. Ishibashi of the Microregion Analytical Laboratory, Kyushu University, for technical assistance with electron microprobe analyses. Constructive review comments by L. Meinert (editor), M. Tagiri and D. Selby much improved our manuscript. This study was supported by the Japan Society for the Promotion of Science through Grants-in-Aid Nos. 21840069 and 24740360 to T.N., 21109006 and 22226015 to Y.K., and 20109006 and 20340158 to K.S.	Morelli RM, 2004, ECON GEOL, V99, P1569, DOI 10.2113/99.7.1569; Kato Y, 2005, RESOUR GEOL, V55, P291, DOI 10.1111/j.1751-3928.2005.tb00251.x; Birck JL, 1997, GEOSTANDARD NEWSLETT, V21, P19, DOI 10.1111/j.1751-908X.1997.tb00528.x; Selby D, 2009, ECON GEOL, V104, P437; Sakashima T, 2003, J ASIAN EARTH SCI, V21, P1019, DOI 10.1016/S1367-9120(02)00108-6; Stein H, 2003, GEOCHIM COSMOCHIM AC, V67, P3673, DOI 10.1016/S0016-7037(00)00269-2; SHIREY SB, 1995, ANAL CHEM, V67, P2136, DOI 10.1021/ac00109a036; CRAIG JR, 1993, MINERAL MAG, V57, P3, DOI 10.1180/minmag.1993.057.386.02; MORGAN JW, 1991, TALANTA, V38, P259, DOI 10.1016/0039-9140(91)80045-2; WALKER RJ, 1994, GEOCHIM COSMOCHIM AC, V58, P4179, DOI 10.1016/0016-7037(94)90272-0; Wakita K, 2013, J ASIAN EARTH SCI, V72, P75, DOI 10.1016/j.jseaes.2012.04.014; Cohen AS, 1996, ANAL CHIM ACTA, V332, P269, DOI 10.1016/0003-2670(96)00226-7; Isozaki Y, 2010, GONDWANA RES, V18, P82, DOI 10.1016/j.gr.2010.02.015; Ohmoto H, 1996, ORE GEOL REV, V10, P135, DOI 10.1016/0169-1368(95)00021-6; Ravizza G, 1996, EARTH PLANET SC LETT, V138, P105, DOI 10.1016/0012-821X(95)00216-Y; NIER AO, 1950, PHYS REV, V77, P789, DOI 10.1103/PhysRev.77.789; Stein HJ, 2000, ECON GEOL BULL SOC, V95, P1657, DOI 10.2113/95.8.1657; Brugmann G. E., 1998, P ODP SCI RESULTS, V158, P91; Fujimoto H., 1924, J GEOGR, V36, P559; Hiroi Y., 1996, J MINERALOGY PETROLO, V91, P220, DOI 10.2465/ganko.91.220; Isozald Y., 2010, J GEOGR, V119, P999; Kanamitsu G., 2011, J GEOGR, V120, P889; Kase K., 2003, RESOURCE ENV GEOLOGY, P87; Kase K., 1985, MINING GEOL JAPAN, V35, P17; Kase K., 1978, MINING GEOL, V28, P13; Kato Y, 2011, GONDWANA RES, V20, P594, DOI 10.1016/j.gr.2010.12.007; Kato Y, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC0000920; Kato Y, 2009, EARTH PLANET SC LETT, V278, P40, DOI 10.1016/j.epsl.2008.11.021; Kawano Y., 1965, J JAPANESE ASS MINER, V54, P162; Kitami M., 1969, MINING GEOL, V19, P170; Kobayashi E., 1992, J MINERALOGY PETROLO, V87, P135; Kullerud G., 1959, ECON GEOL, V54, P533; Kuroda Y., 1959, SCI REPT TOKYO KYO C, V7, P1; Kurosaki K., 2010, GEOL SOC JAP 117 ANN, P288; Kurosalci K., 2009, SOC RES GEOL 59 ANN, P87; LUDWIG KR, 1980, EARTH PLANET SC LETT, V46, P212, DOI 10.1016/0012-821X(80)90007-2; Ludwig K.R., 2003, ISOPLOT EX VERSION 3; Mariko T., 1994, RESOUR GEOL, V44, P353; MINATO MASAO, 1955, JOUR FAC SCI HOKKAIDO UNIV SER IV, V9, P1; Morelli RM, 2010, MINER DEPOSITA, V45, P461, DOI 10.1007/s00126-010-0284-9; Mosier D. L., 1983, 198389 US GEOL SURV; Mosier D. L., 2009, 20091034 US GEOL SUR; Nakamura T., 1990, PRECRETACEOUS TERRAN, P381; Nier AO, 1937, PHYS REV, V52, P0885, DOI 10.1103/PhysRev.52.885; Nozaki T, 2010, GEOCHIM COSMOCHIM AC, V74, P4322, DOI 10.1016/j.gca.2010.04.055; Nozaki T, 2006, RESOUR GEOL, V56, P423, DOI 10.1111/j.1751-3928.2006.tb00295.x; Nozaki T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01889; Peucker-Ehrenbrink B., 2001, GEOCHEMISTRY GEOPHYS, P2; ROYBARMAN M, 1994, GEOCHIM COSMOCHIM AC, V58, P5043, DOI 10.1016/0016-7037(94)90230-5; Sato K., 1996, ISL ARC, V5, P216, DOI 10.1111/j.1440-1738.1996.tb00028.x; Schmitz MD, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001492; Scotese C. R., 2001, ATLAS EARTH HIST, V1; Sekine R, 2002, RESOUR GEOL, V52, P395, DOI 10.1111/j.1751-3928.2002.tb00149.x; SHIBATA K, 1974, ECON GEOL, V69, P1207; SHIMAZAKI H, 1990, MINER DEPOSITA, V25, P221; Sugiyama S., 1972, CHIKYU KAGAKU, V26, P173; Suzuki K, 2004, INT J MASS SPECTROM, V235, P97, DOI 10.1016/j.ijms.2004.04.006; Suzuki K, 1996, GEOCHIM COSMOCHIM AC, V60, P3151, DOI 10.1016/0016-7037(96)00164-0; Suzuki K, 2006, GEOCHEM J, V40, P297, DOI 10.2343/geochemj.40.297; Tagiri M., 1971, J MINERALOGY PETROLO, V65, P77; Tagiri M., 2010, J GEOGR, V119, P245; TAGIRI M, 2011, BULL IBARAKI NAT MUS, V14, P1; Tagiri M, 2011, ISL ARC, V20, P259, DOI 10.1111/j.1440-1738.2011.00764.x; Tagiri M., 1973, MINER PETROL, V12, P1; Terakado Y, 2001, GEOCHEM J, V35, P169; Terakado Y., 2001, J GEOL SOC JAPAN, V107, P354; Ueda Y., 1969, J MINERAL PETROL EC, V61, P92; VOKES FM, 1993, MINERAL MAG, V57, P19, DOI 10.1180/minmag.1993.057.386.03; Watanabe M., 1920, J GEOLOGICAL SOC JAP, V27, P441	69	0	0	SOC ECONOMIC GEOLOGISTS, INC	LITTLETON	7811 SCHAFFER PARKWAY, LITTLETON, CO 80127 USA	0361-0128	1554-0774		ECON GEOL	Econ. Geol.	NOV	2014	109	7					2023	2034				12	Geochemistry & Geophysics	Geochemistry & Geophysics	AP5KK	WOS:000342117900010		
J	Shimizu, T				Shimizu, Toru			REINTERPRETATION OF QUARTZ TEXTURES IN TERMS OF HYDROTHERMAL FLUID EVOLUTION AT THE KORYU Au-Ag DEPOSIT, JAPAN	ECONOMIC GEOLOGY			English	Article							GEOTHERMAL SYSTEM; MINERAL TEXTURES; SLEEPER DEPOSIT; NEW-ZEALAND; QUEENSLAND; GOLD; INCLUSION; NEVADA; SILICA; ORES	Spatial and temporal variations in quartz textures and the types of quartz-hosted fluid inclusions in the no. 3 vein of the Pleistocene Koryu epithermal Au-Ag deposit were studied. Bonanza-grade ore zones contain multiple generations of quartz with six distinct textures-crustiforrn, comb, microcrystalline, colloform, cockade, and platy. Early-formed parts of the vein are mainly composed of comb quartz that is overgrown by later quartz with a variety of textures, including comb, microcrystalline, and colloform; the latter two are the most common textures of later parts of the vein. Comb, microcrystalline, and colloform textures can be traced along each mineral band at the scale of the ore deposit, suggesting the existence of uniform silica-supersaturated conditions during the deposition of the band. Interpretation of petrographic features of fluid inclusions in quartz at the same mine level reveals three types of fluid conditions intense boiling (flashing), gentle boiling, and nonboiling conditions. The presence of comb quartz texture corresponds to fluid inclusion evidence for gentle boiling or nonboiling conditions. The presence of microcrystalline and colloform quartz textures indicates intense boiling, as suggested in previous studies, although the secondary fluid inclusions in earlier-formed quartz only correspond to fluid inclusion evidence for intense boiling. A fluid inclusion microthermometric study using fluid inclusion assemblages in comb quartz trapped under both gentle boiling and nonboiling conditions shows hydrothermal temperature fluctuates mostly between 243 and 268 degrees C. The relationship between boiling conditions and quartz textures suggests that the intensity of boiling of silica-supersaturated hydrothermal fluid fluctuates at a given depth overtime. The close association between precious metal content and microcrystalline and colloform quartz supports the idea that the metals precipitated due to intense boiling. Intense boiling at the base of the boiling zone likely was the main mechanism for bonanza precious metal precipitation, whereas physical transportation of the metals by gently boiling fluids was only a minor mechanism for local precipitation of precious metals at Koryu. On the basis of the observations of this study and previous paleodepth data, quartz textures are overprinted; a deep assemblage of the early comb quartz, formed at >500-m depth below the paleowater table, was overprinted by a late microcrystalline and colloform quartz assemblage formed at <500-m depth. Such textural variations may be attributed to a decrease in the depth of the water table caused by nearby volcanic eruptions.	Geol Survey Japan, AIST, Inst Geol & Geoinformat, Tsukuba, Ibaraki 3058567, Japan	Shimizu, T (reprint author), Geol Survey Japan, AIST, Inst Geol & Geoinformat, 1-1-1 Higashi, Tsukuba, Ibaraki 3058567, Japan.	t.shimizu@aist.go.jp					Adams SF, 1920, ECON GEOL, V15, P623; Craig JR, 2001, CAN MINERAL, V39, P937, DOI 10.2113/gscanmin.39.4.937; SAUNDERS JA, 1990, GEOLOGY, V18, P757, DOI 10.1130/0091-7613(1990)018<0757:CTOGAS>2.3.CO;2; ROEDDER E, 1980, ANNU REV EARTH PL SC, V8, P263, DOI 10.1146/annurev.ea.08.050180.001403; Saunders JA, 2011, GREAT BASIN EVOLUTION AND METALLOGENY, VOLS I AND II, P825; SIMMONS SF, 1994, AM J SCI, V294, P361; SAUNDERS JA, 1994, ECON GEOL BULL SOC, V89, P628; Simmons SF, 2000, ECON GEOL BULL SOC, V95, P971, DOI 10.2113/95.5.971; Moncada D, 2012, J GEOCHEM EXPLOR, V114, P20, DOI 10.1016/j.gexplo.2011.12.001; Christie AB, 2007, ECON GEOL, V102, P785, DOI 10.2113/gsecongeo.102.5.785; Chauvet A, 2006, MINER DEPOSITA, V41, P387, DOI 10.1007/s00126-006-0068-4; Dong G, 1995, ECON GEOL BULL SOC, V90, P1841; Shimizu T, 1998, ECON GEOL BULL SOC, V93, P303; BARTON PB, 1991, MINERAL MAG, V55, P303, DOI 10.1180/minmag.1991.055.380.02; BARTON PB, 1993, GEOCHIM COSMOCHIM AC, V57, P2715, DOI 10.1016/0016-7037(93)90385-A; Bobis RE, 1995, ECON GEOL BULL SOC, V90, P1776; Bobis R.E., 1994, JOURNAL OF THE GEOLO, V49, P15; Bodnar R. J., 1985, REV EC GEOLOGY, V2, P73; Bodnar R.J., 2003, SHORT COURSE SERIES, V32, P1; Brown K.L., 1989, EC GEOL MONOGR, V6, P320; BROWN KL, 1986, ECON GEOL, V81, P979; Buchanan LJ., 1981, ARIZ GEOL SOC DIG, V14, P237; Dong GY, 1996, MINER DEPOSITA, V31, P210, DOI 10.1007/BF00204028; Dowling K., 1989, EC GEOLOGY MONOGRAPH, V6, P342; Fournier R.O., 1985, REV EC GEOLOGY, V2, P45; Goldstein R.H., 1994, SOCIETY OF SEDIMENTA, V31; Grigor'ev D.P., 1965, ONTOGENY OF MINERALS; HEDENQUIST JW, 1985, ECON GEOL, V80, P1379; Hedenquist J.W., 2000, REV EC GEOLOGY, V13, P245; Henley R.W., 1984, REV EC GEOL, V1, P267; International Commission on Stratigraphy, 2012, INTERNATIONAL CHRONO; Lindgren W., 1933, MINERAL DEPOSITS; Morgan P.G., 1925, ECON GEOL, V20, P203; Neuendorf K.K.E., 2005, GLOSSARY GEOLOGY; Nodatamagawa Mining Development Inc., 1995, KORYU MINE INFORMATI; Roedder E., 1984, REV MINERAL, V12, P644; Rogers AF, 1917, J GEOL, V25, P515; Sato A., 2004, RESOUR GEOL, V45, pP; Saunders JA, 2012, MINERAL-BASEL, V2, P228, DOI 10.3390/min2030228; Shimizu T., 2011, BULLETIN OF THE GEOL, V62, P235; Shimizu T., 1993, RESOUCE GEOL, V15, P435; Simmons S.F., 2005, ECON GEOL, V100, P485; Strujkov S.F., 1996, INT GEOL REV, V38, P625; Watanabe Y., 1990, MINING GEOL, V40, P289	44	0	0	SOC ECONOMIC GEOLOGISTS, INC	LITTLETON	7811 SCHAFFER PARKWAY, LITTLETON, CO 80127 USA	0361-0128	1554-0774		ECON GEOL	Econ. Geol.	NOV	2014	109	7					2051	2065				15	Geochemistry & Geophysics	Geochemistry & Geophysics	AP5KK	WOS:000342117900012		
J	Hanada, I; Terui, K; Ikeda, F; Toki, T; Kanezaki, R; Sato, T; Kamio, T; Kudo, K; Sasaki, S; Takahashi, Y; Hayashi, Y; Inukai, T; Kojima, S; Koike, K; Kosaka, Y; Kobayashi, M; Imaizumi, M; Mitsui, T; Hori, H; Hara, J; Horibe, K; Nagai, J; Goto, H; Ito, E				Hanada, Isamu; Terui, Kiminori; Ikeda, Fumika; Toki, Tsutomu; Kanezaki, Rika; Sato, Tomohiko; Kamio, Takuya; Kudo, Ko; Sasaki, Shinya; Takahashi, Yoshihiro; Hayashi, Yasuhide; Inukai, Takeshi; Kojima, Seiji; Koike, Kenichi; Kosaka, Yoshiyuki; Kobayashi, Masao; Imaizumi, Masue; Mitsui, Tetsuo; Hori, Hiroki; Hara, Junichi; Horibe, Keizo; Nagai, Jun-ichi; Goto, Hiroaki; Ito, Etsuro			Gene Alterations Involving the CRLF2-JAK Pathway and Recurrent Gene Deletions in Down Syndrome-Associated Acute Lymphoblastic Leukemia in Japan	GENES CHROMOSOMES & CANCER			English	Article							DOWN-SYNDROME; BTG1 DELETIONS; B-PROGENITOR; MUTATIONS; JAK2; CHILDHOOD; CHILDREN; IKZF1; REARRANGEMENT; ABERRATIONS	In Western countries, gene alterations involving the CRLF2-JAK signaling pathway are identified in approximately 50-60% of patients with Down syndrome-associated acute lymphoblastic leukemia (DS-ALL), and this pathway is considered a potential therapeutic target. The frequency of BTG1 deletions in DS-ALL is controversial. IKZF1 deletions, found in 20-30% of DS-ALL patients, are associated with a poor outcome and EBF1 deletions are very rare (approximate to 2%). We analyzed 38 patients to determine the frequencies and clinical implications of CRLF2-JAK pathway genetic alterations and recurrent gene deletions in Japanese DS-ALL patients. We confirmed a high incidence of P2RY8-CRLF2 (29%) and JAK2 mutations (16%), though the frequency of P2RY8-CRLF2 was slightly lower than that in Western countries (approximate to 50%). BTG1 deletions were common in our cohort (25%). IKZF1 deletions were detected in 25% of patients and associated with shorter overall survival (OS). EBF1 deletions were found at an unexpectedly high frequency (16%), and at a significantly higher level in P2RY8-CRLF2-positive patients than in P2RY8-CRLF2-negative patients (44% vs. 4%, P=0.015). Deletions of CDKN2A/B and PAX5 were common in P2RY8-CRLF2-negative patients (48 and 39%, respectively) but not in P2RY8-CRLF2-positive patients (11% each). Associations between these genetic alterations and clinical characteristics were not observed except for inferior OS in patients with IKZF1 deletions. These results suggest that differences exist between the genetic profiles of DS-ALL patients in Japan and in Western countries, and that P2RY8-CRLF2 and EBF1 deletions may cooperate in leukemogenesis in a subset of Japanese DS-ALL patients. (c) 2014 Wiley Periodicals, Inc.	[Hanada, Isamu; Terui, Kiminori; Ikeda, Fumika; Toki, Tsutomu; Kanezaki, Rika; Sato, Tomohiko; Kamio, Takuya; Kudo, Ko; Sasaki, Shinya; Ito, Etsuro] Hirosaki Univ, Grad Sch Med, Dept Pediat, Hirosaki, Aomori 0368562, Japan; [Takahashi, Yoshihiro] Aomori Prefectural Cent Hosp, Dept Pediat, Aomori, Japan; [Hayashi, Yasuhide] Gunma Childrens Med Ctr, Dept Hematol & Oncol, Gunma, Japan; [Inukai, Takeshi] Univ Yamanashi, Dept Pediat, Sch Med, Kofu, Yamanashi, Japan; [Kojima, Seiji] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan; [Koike, Kenichi] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 390, Japan; [Kosaka, Yoshiyuki] Hyogo Prefectural Kobe Childrens Hosp, Dept Hematol & Oncol, Kobe, Hyogo, Japan; [Kobayashi, Masao] Hiroshima Univ, Grad Sch Biomed Sci, Dept Pediat, Hiroshima, Japan; [Imaizumi, Masue] Miyagi Childrens Hosp, Dept Hematol & Oncol, Sendai, Miyagi, Japan; [Mitsui, Tetsuo] Yamagata Univ, Sch Med, Dept Pediat, Yamagata 99023, Japan; [Hori, Hiroki] Mie Univ, Dept Pediat & Dev Sci, Grad Sch Med, Tsu, Mie 514, Japan; [Hara, Junichi] Osaka City Gen Hosp, Dept Pediat Hematol Oncol, Osaka, Japan; [Horibe, Keizo] Natl Hosp Org, Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan; [Nagai, Jun-ichi] Kanagawa Childrens Med Ctr, Div Lab Med, Clin Res Inst, Yokohama, Kanagawa, Japan; [Goto, Hiroaki] Kanagawa Childrens Med Ctr, Div Hematooncol & Regenerat Med, Yokohama, Kanagawa, Japan	Ito, E (reprint author), Hirosaki Univ, Grad Sch Med, Dept Pediat, 5 Zaifucho, Hirosaki, Aomori 0368562, Japan.	eturou@cc.hirosaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan	Supported by: Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan; Grant for Clinical Cancer Research from the Ministry of Health, Labour and Welfare of Japan.	Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Forestier E, 2008, BLOOD, V111, P1575, DOI 10.1182/blood-2007-09-114231; Harvey RC, 2010, BLOOD, V115, P5312, DOI 10.1182/blood-2009-09-245944; Gaikwad A, 2009, BRIT J HAEMATOL, V144, P930, DOI 10.1111/j.1365-2141.2008.07552.x; Buitenkamp TD, 2014, BLOOD, V123, P70, DOI 10.1182/blood-2013-06-509463; Buitenkamp TD, 2012, LEUKEMIA, V26, P2204, DOI 10.1038/leu.2012.84; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Bercovich D, 2008, LANCET, V372, P1484, DOI 10.1016/S0140-6736(08)61341-0; Yoda A, 2010, P NATL ACAD SCI USA, V107, P252, DOI 10.1073/pnas.0911726107; Kearney L, 2009, BLOOD, V113, P646, DOI 10.1182/blood-2008-08-170928; Shochat C, 2011, J EXP MED, V208, P901, DOI 10.1084/jem.20110580; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Hertzberg L, 2010, BLOOD, V115, P1006, DOI 10.1182/blood-2009-08-235408; Roberts KG, 2012, CANCER CELL, V22, P153, DOI 10.1016/j.ccr.2012.06.005; Sato T, 2008, BRIT J HAEMATOL, V141, P681, DOI 10.1111/j.1365-2141.2008.07081.x; Maloney KW, 2010, BLOOD, V116, P1045, DOI 10.1182/blood-2009-07-235291; Blink M, 2011, LEUKEMIA, V25, P1365, DOI 10.1038/leu.2011.86; Schwab CJ, 2010, GENE CHROMOSOME CANC, V49, P1104, DOI 10.1002/gcc.20818; Patrick K, 2014, BRIT J HAEMATOL, V165, P552, DOI 10.1111/bjh.12739; Asai D, 2013, CANCER MED-US, V2, P412, DOI 10.1002/cam4.87; Ensor HM, 2011, BLOOD, V117, P2129, DOI 10.1182/blood-2010-07-297135; Yamashita Y, 2013, PEDIATR BLOOD CANCER, V60, P1587, DOI 10.1002/pbc.24571; Buitenkamp TD, 2013, LEUKEMIA, V27, P251, DOI 10.1038/leu.2012.199; Loudin MG, 2011, LEUKEMIA, V25, P1555, DOI 10.1038/leu.2011.128; Lundin C, 2012, GENE CHROMOSOME CANC, V51, P196, DOI 10.1002/gcc.20944; Morak M, 2012, BLOOD, V120, P5134, DOI 10.1182/blood-2012-07-443218; Nieti D, 2012, NAT REV CANCER, V12, P721	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-2257	1098-2264		GENE CHROMOSOME CANC	Gene Chromosomes Cancer	NOV	2014	53	11					902	910		10.1002/gcc.22201		9	Oncology; Genetics & Heredity	Oncology; Genetics & Heredity	AP5ZZ	WOS:000342158500003		
J	Xu, SL; Shimada, K; Mizutani, M; Kuriyagawa, T				Xu, Shaolin; Shimada, Keita; Mizutani, Masayoshi; Kuriyagawa, Tsunemoto			Fabrication of hybrid micro/nano-textured surfaces using rotary ultrasonic machining with one-point diamond tool	INTERNATIONAL JOURNAL OF MACHINE TOOLS & MANUFACTURE			English	Article						Rotary ultrasonic texturing; Micro/nano; Hybrid surface textures; One-point diamond tool; Sinusoidal cutting locus		A novel rotary ultrasonic texturing (RUT) technique is proposed to fabricate hybrid periodic micro/nano-textures on flat surfaces. Different from conventional rotary ultrasonic machining, a tailored one-point diamond tool was manufactured and employed for RUT on surfaces of electroless nickel-phosphorus (Ni-P) plating. A one-dimensional longitudinal-vibration mode is used. The combined effect of ultrasonic vibration, rotation and feed motion leads to high-frequency periodic change of cutting edge's motion, which is the basic principle for the RUT process. Therefore, to accurately predict and control the texturing process, the cutting locus is firstly mathematically calculated. Hybrid periodic micro/nanotextures comprising linear grooves at the micrometer scale and sinusoidal grooves at the micrometer or nanometer scale were successfully fabricated on machined surfaces, which are in compliance with the results of the mathematical calculations. Different types of surface textures were generated by changing machining conditions. The surface generation mechanism of RUT is illustrated and discussed by analyzing the surface textural features, the cutting locus and the tool tip's geometry, including various tool faces, cutting edges, and the cutting corner. The requirements for RUT technique are concluded. (C) 2014 Elsevier Ltd. All rights reserved.	[Xu, Shaolin; Shimada, Keita; Mizutani, Masayoshi; Kuriyagawa, Tsunemoto] Tohoku Univ, Grad Sch Engn, Dept Mech Syst & Design, Aoba Ku, Sendai, Miyagi 9808579, Japan	Xu, SL (reprint author), Tohoku Univ, Grad Sch Engn, Dept Mech Syst & Design, Aoba Ku, Aoba 6-6-01, Sendai, Miyagi 9808579, Japan.	shaolin@pm.mech.tohoku.ac.jp			Just Co., Ltd. in Japan under Tohoku Bureau of the Ministry of Economy, Trade and Industry (METI, Japan); Japan Society for the Promotion of Science (JSPS) [26.4115]	The authors gratefully acknowledge the support of Just Co., Ltd. in Japan with respect to the manufacture of diamond tools, under a research grant from Tohoku Bureau of the Ministry of Economy, Trade and Industry (METI, Japan). The first author would like to thank the financial support of Japan Society for the Promotion of Science (JSPS) as a JSPS Research Fellow (Grant no. 26.4115).	Abbas M. N., 2007, INT J MACH TOOL MANU, V47, P1214; Bruzzone AAG, 2008, CIRP ANN-MANUF TECHN, V57, P750, DOI 10.1016/j.cirp.2008.09.003; Denkena B, 2010, CIRP ANN-MANUF TECHN, V59, P67, DOI 10.1016/j.cirp.2010.03.066; Dubey AK, 2008, INT J MACH TOOL MANU, V48, P609, DOI 10.1016/j.ijmachtools.2007.10.017; Guo P, 2013, INT J MACH TOOL MANU, V64, P85, DOI 10.1016/j.ijmachtools.2012.08.003; Brehl DE, 2008, PRECIS ENG, V32, P153, DOI 10.1016/j.precisioneng.2007.08.003; Suzuki N, 2011, PRECIS ENG, V35, P44, DOI 10.1016/j.precisioneng.2010.09.006; Brinksmeier E, 2012, CIRP J MANUF SCI TEC, V5, P1; Chiffrel L., 2003, CIRP ANN-MANUF TECHN, V52, P561; Evans C. J., 1999, CIRP ANN-MANUF TECHN, V48, P541, DOI DOI 10.1016/S0007-8506(07)63233-8; Yan JW, 2009, J MATER PROCESS TECH, V209, P4802, DOI 10.1016/j.jmatprotec.2008.12.008	11	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0890-6955	1879-2170		INT J MACH TOOL MANU	Int. J. Mach. Tools Manuf.	NOV	2014	86						12	17		10.1016/j.ijmachtools.2014.06.005		6	Engineering, Manufacturing; Engineering, Mechanical	Engineering	AP7JT	WOS:000342254300002		
J	Ibaraki, S; Ota, Y				Ibaraki, Soichi; Ota, Yusuke			A machining test to calibrate rotary axis error motions of five-axis machine tools and its application to thermal deformation test	INTERNATIONAL JOURNAL OF MACHINE TOOLS & MANUFACTURE			English	Article						Five-axis machine tool; Machining test; Error motion; Location error; Error calibration; Thermal deformation	GEOMETRIC ERRORS; IDENTIFICATION; CENTERS; AXES	This paper proposes a machining test to parameterize error motions, or position-dependent-geometric errors, of rotary axes in a five-axis machine tool. At the given set of angular positions of rotary axes, a square-shaped step is machined by a straight end mill. By measuring geometric errors of the finished test piece, the position and the orientation of rotary axis average lines (location errors), as well as position-dependent geometric errors of rotary axes, can be numerically identified based on the machine's kinematic model. Furthermore, by consequently performing the proposed machining test, one can quantitatively observe how error motions of rotary axes change due to thermal deformation induced mainly by spindle rotation. Experimental demonstration is presented. (C) 2014 Elsevier Ltd. All rights reserved.	[Ibaraki, Soichi; Ota, Yusuke] Kyoto Univ, Dept Micro Engn, Nishigyo Ku, Kyoto 6158530, Japan	Ibaraki, S (reprint author), Kyoto Univ, Dept Micro Engn, Nishigyo Ku, Kyoto 6158530, Japan.	ibaraki@prec.kyoto-u.ac.jp					Abbaszadeh-Mir Y, 2002, INT J PROD RES, V40, P4781, DOI 10.1080/00207540210164459; Bringmann B, 2008, CIRP ANN-MANUF TECHN, V57, P529, DOI 10.1016/j.cirp.2008.03.114; [Anonymous], 9791969 NAS, P34; Ibaraki S, 2010, PRECIS ENG, V34, P387, DOI 10.1016/j.precisioneng.2009.09.007; Bringmann B, 2006, CIRP ANN-MANUF TECHN, V55, P531, DOI 10.1016/S0007-8506(07)60475-2; Tsutsumi M, 2003, INT J MACH TOOL MANU, V43, P771, DOI 10.1016/S0890-6955(03)00053-1; [Anonymous], 263032012 ISO; Zhu SW, 2012, INT J MACH TOOL MANU, V52, P24, DOI 10.1016/j.ijmachtools.2011.08.011; Ibaraki S, 2011, INT J MACH TOOL MANU, V51, P190, DOI 10.1016/j.ijmachtools.2010.11.011; Erkan T, 2011, PRECIS ENG, V35, P116, DOI 10.1016/j.precisioneng.2010.08.003; [Anonymous], 23072006 ISO; Weikert S, 2004, CIRP ANN-MANUF TECHN, V53, P429, DOI 10.1016/S0007-8506(07)60732-X; [Anonymous], 2007, 23032007 ISO; [Anonymous], 10791722014 ISODIS; Hong CF, 2011, PRECIS ENG, V35, P1, DOI 10.1016/j.precisioneng.2010.09.004; [Anonymous], 2014, 1079162014 ISOFDIS; [Anonymous], 23012012 ISO; [Anonymous], 1079112012 ISODIS; Ibaraki S, 2013, INT J MACH TOOL MANU, V68, P21, DOI 10.1016/j.ijmachtools.2013.01.001; Bringmann B, 2009, PRECIS ENG, V33, P524, DOI 10.1016/j.precisioneng.2009.02.002; Bossoni S., 2009, THESIS ETH ZURICH; Gebhardt M, 2013, P 13 EUSP INT C; Gebhardt M, 2012, P 12 EUSP INT C; Hocken R, 1977, ANN CIRP, V26, P403; Hong C., 2012, INT J AUTOMATION TEC, V6-2, P196; Ibaraki S., 2012, INT J AUTOM TECHNOL, V6; Ibaraki S., INT J AUTOM TECHNOL, V8; Inasaki I., 1997, SHAPER GENERATION TH; Kakino Y., 1994, Journal of the Japan Society of Precision Engineering, V60; Matsushita T., 2010, P 2010 SPR JSPE SEM, V1, P1105; Morimoto Y., 2012, INT J AUTOMATION TEC, V6, P675; Ohta K, 2012, KEY ENG MATER, V523-524, P475, DOI 10.4028/www.scientific.net/KEM.523-524.475; Reshetov D. N., 1988, ACCURACY MACHINE TOO; Schwenke H., 2008, CIRP ANN-MANUF TECHN, V57, P560; Takeshima H., 2009, P INT C LEAD EDG MAN, P123	35	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0890-6955	1879-2170		INT J MACH TOOL MANU	Int. J. Mach. Tools Manuf.	NOV	2014	86						81	88		10.1016/j.ijmachtools.2014.07.005		8	Engineering, Manufacturing; Engineering, Mechanical	Engineering	AP7JT	WOS:000342254300008		
J	Jha, S; Pal, A				Jha, Somnath; Pal, Aprameyo			Algebraic functional equation for Hida family	INTERNATIONAL JOURNAL OF NUMBER THEORY			English	Article						Selmer group; congruences of modular forms; Iwasawa theory; Hida family; p-adic Galois representation	MODULAR-FORMS; GALOIS REPRESENTATIONS; ELLIPTIC-CURVES; IWASAWA THEORY; SELMER GROUPS; DEFORMATIONS; VALUES	We prove a functional equation for the characteristic ideal of the "big" Selmer group X(T-F/F-cyc) associated to an ordinary Hida family of elliptic modular forms over the cyclotomic Z(p) extension of a general number field F, under the assumption that there is at least one arithmetic specialization whose Selmer group is torsion over its Iwasawa algebra. For a general number field, the two-variable cyclotomic Iwasawa main conjecture for ordinary Hida family is not proved and this can be thought of as an evidence to the validity of the Iwasawa main conjecture. The central idea of the proof is to prove a variant of the result of Perrin-Riou [Groupes de Selmer et accouplements; cas particulier des courbes elliptiques, Doc. Math. 2003 (2003) 725-760, Extra Volume: Kazuya Kato's fiftieth birthday] by constructing a generalized pairing on the individual Selmer groups corresponding to the arithmetic points and make use of the appropriate specialization techniques of Ochiai [Euler system for Galois deformations, Ann. Inst. Fourier (Grenoble) 55(1) (2005) 113-146].	[Jha, Somnath] Osaka Univ, Grad Sch Sci, Dept Math, Toyonaka, Osaka 5600043, Japan; [Pal, Aprameyo] Heidelberg Univ, Math Inst, D-69120 Heidelberg, Germany	Jha, S (reprint author), Osaka Univ, Grad Sch Sci, Dept Math, Machikaneyama 1-1, Toyonaka, Osaka 5600043, Japan.	jha@cr.math.sci.osaka-u.ac.jp; pal@mathi.uni-heidelberg.de			Mathematics Centre Heidelberg; JSPS; ERC	The first author is supported by the Mathematics Centre Heidelberg postdoctoral fellowship and JSPS postdoctoral fellowship. The second author is supported by ERC Iwasawa grant. We would like to thank T. Ochiai for answering many questions, discussions and comments. We thank R. Sujatha and O. Venjakob for discussions and encouragement. Thanks are also due to A. Sharma and F. Nuccio for discussions. We thank the referee for his/her valuable comments.	MAZUR B, 1972, INVENT MATH, V18, P183, DOI 10.1007/BF01389815; Hachimori Y, 1999, J ALGEBRAIC GEOM, V8, P581; Skinner C, 2014, INVENT MATH, V195, P1, DOI 10.1007/s00222-013-0448-1; GREENBERG R, 1993, INVENT MATH, V111, P407, DOI 10.1007/BF01231294; MAZUR B, 1986, COMPOS MATH, V59, P231; Coates J., 2000, TATA I FUNDAMENTAL R, P88; Greenberg R, 1999, LECT NOTES MATH, V1716, P51; Greenberg R., 1989, ADV STUDIES PURE MAT, V17, P97; HIDA H, 1986, INVENT MATH, V85, P545, DOI 10.1007/BF01390329; Jha S, 2012, ASIAN J MATH, V16, P353; Kato K, 2004, ASTERISQUE, P117; NEUKIRCH J., 2000, COHOMOLOGY NUMBER FI; Ochiai T, 2003, AM J MATH, V125, P849, DOI 10.1353/ajm.2003.0027; Ochiai T, 2001, J NUMBER THEORY, V88, P59, DOI 10.1006/jnth.2000.2611; Ochiai T, 2006, COMPOS MATH, V142, P1157, DOI 10.1112/S0010437X06002223; Ochiai T, 2005, ANN I FOURIER, V55, P113; OGG AP, 1969, MATH ANN, V179, P101, DOI 10.1007/BF01350121; Perrin-Riou B., 2003, DOC MATH, V2003, P725; Sujatha R, 2006, PURE APPL MATH Q, V2, P519	19	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	1793-0421	1793-7310		INT J NUMBER THEORY	Int. J. Number Theory	NOV	2014	10	7					1649	1674		10.1142/S1793042114500493		26	Mathematics	Mathematics	AP2WI	WOS:000341936300003		
J	Komatsu, T; Szalay, L				Komatsu, Takao; Szalay, Laszlo			Balancing with binomial coefficients	INTERNATIONAL JOURNAL OF NUMBER THEORY			English	Article						Diophantine equations; binomial coefficients; balancing problems	EQUATION; NUMBERS	In this paper, we study a balancing problem of ordinary binomial coefficients. The diophantine equation ((0)(k)) + ((1)(k)) + ... +((k) (x - 1) ) = ((l) (x+ 1)) + ... +((l) (y - 1)) in positive integers x and y >= x + 2 will be investigated, where k and l are given positive integers. In case of k < l the basic tool is the Runge method. If k >= l, then the main results state effective and non- effective finiteness theorems on the subject matter. Further, computational results are also reported including the complete solutions when 1 <= k, l <= 3, and a computer search otherwise.	[Komatsu, Takao] Hirosaki Univ, Grad Sch Sci & Technol, Hirosaki, Aomori 0368561, Japan; [Szalay, Laszlo] Univ West Hungary, Inst Math, H-9400 Sopron, Hungary	Komatsu, T (reprint author), Hirosaki Univ, Grad Sch Sci & Technol, Hirosaki, Aomori 0368561, Japan.	komatsu@cc.hirosaki-u.ac.jp; laszalay@emk.nyme.hu			Japan Society for the Promotion of Science [22540005]; Campus Hungary	The first author was supported in part by the Grant-in-Aid for Scientific research (C) (No. 22540005), the Japan Society for the Promotion of Science. This paper was written when the second author visited Hirosaki University. He would like to express his gratitude for the kind hospitality there and for the financial support by the Grant-in-Aid for Scientific research (C) (No. 22540005), the Japan Society for the Promotion of Science, represented by the first author. The journey to Japan was also supported by Campus Hungary.	BAKER A, 1969, PROC CAMB PHILOS S-M, V65, P439; Behera A, 1999, FIBONACCI QUART, V37, P98; Belbachir H., BALANCING DIRECTION; ERDOS P, 1975, ILLINOIS J MATH, V19, P292; FINKELST.R, 1965, AM MATH MON, V72, P1082, DOI 10.2307/2315953; Kulkarni M, 2003, INDAGAT MATH NEW SER, V14, P35, DOI 10.1016/S0019-3577(03)90069-3; Liptai K, 2009, INDAGAT MATH NEW SER, V20, P87; PINTER A, 1993, PUBL MATH-DEBRECEN, V42, P329; Pinter A, 2009, J NUMBER THEORY, V129, P1664, DOI 10.1016/j.jnt.2008.10.013; Rademacher H., 1973, ANAL NUMBER THEORY; Rakaczki Cs., 2004, PERIOD MATH HUNG, V49, P119, DOI 10.1007/s10998-004-0527-6	11	1	1	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	1793-0421	1793-7310		INT J NUMBER THEORY	Int. J. Number Theory	NOV	2014	10	7					1729	1742		10.1142/S1793042114500523		14	Mathematics	Mathematics	AP2WI	WOS:000341936300006		
J	Matsumoto, Y; Miwa, S; Zhang, Y; Hiroshima, Y; Yano, S; Uehara, F; Yamamoto, M; Toneri, M; Bouvet, M; Matsubara, H; Hoffman, RM; Zhao, M				Matsumoto, Yasunori; Miwa, Shinji; Zhang, Yong; Hiroshima, Yukihiko; Yano, Shuya; Uehara, Fuminari; Yamamoto, Mako; Toneri, Makoto; Bouvet, Michael; Matsubara, Hisahiro; Hoffman, Robert M.; Zhao, Ming			Efficacy of Tumor-Targeting Salmonella Typhimurium A1-R on Nude Mouse Models of Metastatic and Disseminated Human Ovarian Cancer	JOURNAL OF CELLULAR BIOCHEMISTRY			English	Article						GFP; Salmonella typhimurium; BACTERIA; TUMOR-TARGETING; OVARIAN CANCER; NUDE MICE; IMAGING	HUMAN PANCREATIC-CANCER; INTRAPERITONEAL CHEMOTHERAPY; LIVE MICE; CARCINOMA; THERAPY	We report here the efficacy of tumor-targeting Salmonella typhimurium A1-R (A1-R) on mouse models of disseminated and metastatic ovarian cancer. The proliferation-inhibitory efficacy of A1-R on human ovarian cancer cell lines (SKOV-3-GFP, OVCAR-3-RFP) was initially demonstrated in vitro. Orthotopic and dissemination mouse models of ovarian cancer were made with the human ovarian cancer cell line SKOV-3-GFP. After tumor implantation, the mice were treated with A1-R (5x10(7)colony-forming units [CFU], i.v.), and there were no severe adverse events observed. In the orthotopic model, tumor volume after treatment was 276 +/- 60.8mm(3), compared to 930 +/- 342mm(3) in the untreated control group (P=0.022). There was also a significant difference in survival between treated mice and untreated mice in a peritoneal dissemination model (P=0.005). The results of this report demonstrate that A1-R is effective for highly aggressive human ovarian cancer in metastatic and dissemination mouse models and suggest its clinical potential for this highly treatment-resistant disease. J. Cell. Biochem. 115: 1996-2003, 2014. (c) 2014 Wiley Periodicals, Inc.	[Matsumoto, Yasunori; Miwa, Shinji; Zhang, Yong; Hiroshima, Yukihiko; Yano, Shuya; Uehara, Fuminari; Yamamoto, Mako; Toneri, Makoto; Hoffman, Robert M.; Zhao, Ming] AntiCancer Inc, San Diego, CA 92111 USA; [Matsumoto, Yasunori; Miwa, Shinji; Hiroshima, Yukihiko; Yano, Shuya; Uehara, Fuminari; Yamamoto, Mako; Toneri, Makoto; Bouvet, Michael; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Matsumoto, Yasunori; Matsubara, Hisahiro] Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chiba, Japan	Zhao, M (reprint author), AntiCancer Inc, 7917 Ostrow St, San Diego, CA 92111 USA.	all@anticancer.com			NCI [CA126023]	Grant sponsor: NCI; Grant number: CA126023.	Tome Y, 2013, ANTICANCER RES, V33, P97; Pawelek JM, 2003, LANCET ONCOL, V4, P548, DOI 10.1016/S1470-2045(03)01194-X; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Zhao M, 2005, P NATL ACAD SCI USA, V102, P755, DOI 10.1073/pnas.0408422102; Takakura M, 2010, CANCER GENE THER, V17, P11, DOI 10.1038/cgt.2009.44; Cascales-Campos PA, 2014, ANN SURG ONCOL, V21, P2383, DOI 10.1245/s10434-014-3599-4; Zhao M, 2007, P NATL ACAD SCI USA, V104, P10170, DOI 10.1073/pnas.0703867104; Momiyama M, 2012, CELL CYCLE, V11, P628, DOI 10.4161/cc.11.3.19116; Bakrin N, 2013, EJSO-EUR J SURG ONC, V39, P1435, DOI 10.1016/j.ejso.2013.09.030; Liu F, 2010, CELL CYCLE, V9, P4518, DOI 10.4161/cc.9.22.13744; Kimura H, 2010, CELL PROLIFERAT, V43, P41, DOI 10.1111/j.1365-2184.2009.00652.x; Nagakura C, 2009, ANTICANCER RES, V29, P1873; Hiroshima Y, 2014, J CELL BIOCHEM, V115, P1254, DOI 10.1002/jcb.24769; Hayashi K, 2009, CELL CYCLE, V8, P870, DOI 10.4161/cc.8.6.7891; Hiroshima Y, 2013, CELL CYCLE, V12, P2774, DOI 10.4161/cc.25872; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Yam C, 2010, J SURG RES, V164, P248, DOI 10.1016/j.jss.2009.02.023; Kiguchi K, 1998, CLIN EXP METASTAS, V16, P751, DOI 10.1023/A:1006537013317; Zhao M, 2006, CANCER RES, V66, P7647, DOI 10.1158/0008-5472.CAN-06-0716; HAMILTON TC, 1983, CANCER RES, V43, P5379; Uchugonova A, 2012, ANTICANCER RES, V32, P4331; Toso JF, 2002, J CLIN ONCOL, V20, P142, DOI 10.1200/JCO.20.1.142; BUICK RN, 1985, CANCER RES, V45, P3668; Cannistra Stephen A, 2003, J Clin Oncol, V21, p129s, DOI 10.1200/JCO.2003.04.003; Cascales Campos P, 2014, Eur J Surg Oncol, V40, P970, DOI 10.1016/j.ejso.2013.08.013; FU XY, 1993, ANTICANCER RES, V13, P283; Goshima F, 2013, INT J CANCER, V134, P2865; Howlader N., SEER CANCER STATISTI; Leschner S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006692; O'Malley DM, 2011, GYNECOL ONCOL, V121, P269, DOI 10.1016/j.ygyno.2011.01.009; Yang SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025131	31	11	11	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-2312	1097-4644		J CELL BIOCHEM	J. Cell. Biochem.	NOV	2014	115	11					1996	2003		10.1002/jcb.24871		8	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	AP4TC	WOS:000342070700016		
J	Fang, GS; Tsukamoto, K; Maebayashi, M; Ohba, M; Ogawa, H				Fang, G. S.; Tsukamoto, K.; Maebayashi, M.; Ohba, M.; Ogawa, H.			Excess enthalpy for the (benzene plus cyclohexane) mixture over a wide range of temperature and pressure	JOURNAL OF CHEMICAL THERMODYNAMICS			English	Article						Excess enthalpies; Flow mixing calorimeter; High temperature - high pressure; Benzene; Cyclohexane	NEAR-CRITICAL REGION; MOLAR ENTHALPIES; 15 MPA; 513 K; VOLUMES; (ETHANOL; ETHANOL; V-M(E); H-M(E); CALORIMETER	A twin flow type of mixing calorimeter was constructed for measuring excess enthalpies of fluid mixtures over wide temperature and pressure ranges. The precision of the calorimeter was tested with (water + ethanol) mixture. The excess molar enthalpies H-m(E) for the (water + ethanol) mixture at temperatures T = (423.2 and 523.2) K and pressure p = 5.00 MPa and at T = 523.2 K and p = 15.00 MPa are in good agreement with the literature values. The H-m(E) values for the (benzene + cyclohexane) mixture were measured using this calorimeter over the temperature range from T = 298.2 K to T = 573.2 K and the pressure range from p = 5.00 MPa to p = 25.00 MPa. All H-m(E) values are positive and all mole fraction dependencies of H-m(E) are almost symmetrically parabolic. The maximum values of the mole fraction dependence of H-m(E) decrease with increasing temperature and are independent of the pressure, except for the conditions at T = (498.2 and 523.2) K and p = 5.00 MPa whose states are near the critical point of benzene. The maximum values of H-m(E) of these states were greater than the values expected from the curve representing the temperature dependence of other maximum values of the mole fraction dependence of H-m(E). (C) 2014 Elsevier Ltd. All rights reserved.	[Fang, G. S.; Tsukamoto, K.; Maebayashi, M.; Ohba, M.] Meijo Univ, Fac Agr, Tenpaku Ku, Nagoya, Aichi 4688502, Japan; [Ogawa, H.] Tokyo Denki Univ, Sch Sci & Engn, Hatoyama, Saitama 3500394, Japan	Fang, GS (reprint author), Meijo Univ, Fac Agr, Tenpaku Ku, Shiogamaguchi 1-501, Nagoya, Aichi 4688502, Japan.	n0861502@ccalumni.meijo-u.ac.jp			Ministry of Education, Science and Culture, Japan	This study was partly supported by the fund for Agriomics Project from the Ministry of Education, Science and Culture, Japan.	Blanco A, 2012, J CHEM ENG DATA, V57, P1009, DOI 10.1021/je201152j; Brown PR, 1996, J CHEM THERMODYN, V28, P905, DOI 10.1006/jcht.1996.0080; COLLING CN, 1993, J CHEM SOC FARADAY T, V89, P77, DOI 10.1039/ft9938900077; Coxam JY, 2004, FLUID PHASE EQUILIBR, V226, P141, DOI 10.1016/j.fluid.2004.06.051; David R.L., 1995, HDB ORGANIC SOLVENTS, p[22, 105]; Dettmann C, 2006, J CHEM THERMODYN, V38, P56, DOI 10.1016/j.jct.2005.03.012; ELLIOTT K, 1976, J CHEM THERMODYN, V8, P881, DOI 10.1016/0021-9614(76)90166-X; Fang G.S., UNPUB; FUJIHARA I, 1983, J CHEM THERMODYN, V15, P1, DOI 10.1016/0021-9614(83)90097-6; Gibson R.E., 1941, Journal of the American Chemical Society, V63, DOI 10.1021/ja01849a002; Gibson R.E., 1939, Journal of the American Chemical Society, V61, DOI 10.1021/ja01878a076; GRUSZKIEWICZ MS, 1995, J CHEM THERMODYN, V27, P507, DOI 10.1006/jcht.1995.0052; Ikeda T., 2010, J CHEM PHYS, V132, P1; Lohmann J, 2001, J CHEM ENG DATA, V46, P208, DOI 10.1021/je000297g; MATHONAT C, 1994, J SOLUTION CHEM, V23, P1161, DOI 10.1007/BF00974028; Moravkova L, 2003, FLUID PHASE EQUILIBR, V209, P81, DOI 10.1016/S0378-3812(03)00079-7; Ogawa H., 2005, DAI 5 HAN JIKKEN KAG, V6, P227; OTT JB, 1987, J CHEM THERMODYN, V19, P337, DOI 10.1016/0021-9614(87)90115-7; Ott JB, 1997, J CHEM THERMODYN, V29, P149, DOI 10.1006/jcht.1996.0144; OTT JB, 1986, J CHEM THERMODYN, V18, P1, DOI 10.1016/0021-9614(86)90036-4; OTT JB, 1986, J CHEM THERMODYN, V18, P867, DOI 10.1016/0021-9614(86)90121-7; Poling B.E., 2001, PROPERTIES GASES LIQ, P5; Reid R.C., 1987, PROPERTIES GASES LIQ, P212; SAVINI CG, 1966, J CHEM ENG DATA, V11, P40, DOI 10.1021/je60028a009; SIMONSON JM, 1987, J CHEM THERMODYN, V19, P479, DOI 10.1016/0021-9614(87)90145-5; Tsukamoto K., UNPUB; Tsukamoto K, 2013, J THERM ANAL CALORIM, V113, P1551, DOI 10.1007/s10973-013-3073-8; Watson G, 2006, J CHEM ENG DATA, V51, P112, DOI 10.1021/jei050261u; Wormald CJ, 1996, J CHEM THERMODYN, V28, P627, DOI 10.1006/jcht.1996.0059; Wormald CJ, 2002, J CHEM THERMODYN, V34, P303, DOI 10.1006/jcht.2001.0921; WORMALD CJ, 1988, J CHEM SOC FARAD T 1, V84, P1437, DOI 10.1039/f19888401437; Wormald CJ, 2001, FLUID PHASE EQUILIBR, V187, P391, DOI 10.1016/S0378-3812(01)00550-7; Wormald CJ, 1997, J CHEM SOC FARADAY T, V93, P1921, DOI 10.1039/a608259i; Wormald CJ, 1997, J CHEM THERMODYN, V29, P75, DOI 10.1006/jcht.1996.0141; WORMALD CJ, 1985, J CHEM THERMODYN, V17, P903, DOI 10.1016/0021-9614(85)90001-1; Wormald CJ, 1997, THERMOCHIM ACTA, V300, P169, DOI 10.1016/S0040-6031(96)03129-2; Wormald CJ, 1996, J CHEM THERMODYN, V28, P603, DOI 10.1006/jcht.1996.0057; WORMALD CJ, 1988, J CHEM THERMODYN, V20, P323, DOI 10.1016/0021-9614(88)90129-2; Wormald CJ, 1996, J CHEM THERMODYN, V28, P615, DOI 10.1006/jcht.1996.0058; Zhou JG, 2010, J CHEM ENG DATA, V55, P5569, DOI 10.1021/je100353j	40	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0021-9614	1096-3626		J CHEM THERMODYN	J. Chem. Thermodyn.	NOV	2014	78						204	214		10.1016/j.jct.2014.05.020		11	Thermodynamics; Chemistry, Physical	Thermodynamics; Chemistry	AP4PP	WOS:000342060500026		
J	Minamida, M; Tonokura, K				Minamida, Maya; Tonokura, Kenichi			Air broadening coefficients for the nu(3) band of hydroperoxyl radicals	JOURNAL OF QUANTITATIVE SPECTROSCOPY & RADIATIVE TRANSFER			English	Article						Hydroperoxyl radical; Mid-infrared absorption; Pressure broadening coefficient; Rotational quantum number	HO2; FORMALDEHYDE; LASER; CO2; N2	Using mid-infrared laser absorption spectroscopy, we investigated the room-temperature pressure broadening coefficients for hydroperoxyl radicals (HO2) in nitrogen and oxygen over the 1060.0-1065.5 cm(-1) range of the 113 band. The HO2 radicals were produced by flash photolysis of a chlorine/1,4-cyclohexadiene/oxygen mixture. The 20 measured absorption profiles were analyzed with Voigt functions. Air broadening coefficients were estimated from the nitrogen- and oxygen-broadening results and compared with previous results. We discuss the dependence of air broadening on rotational states. (C) 2014 Elsevier Ltd. All rights reserved.	[Minamida, Maya; Tonokura, Kenichi] Univ Tokyo, Grad Sch Frontier Sci, Dept Environm Syst, Kashiwa, Chiba 2778563, Japan	Tonokura, K (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Environm Syst, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778563, Japan.	tonokura@k.u-tokyo.ac.jp					Graham C, 1998, MOL PHYS, V93, P49, DOI 10.1080/002689798169429; CHANCE K, 1994, J MOL SPECTROSC, V163, P67, DOI 10.1006/jmsp.1994.1007; Barry HR, 2003, PHYS CHEM CHEM PHYS, V5, P3106, DOI 10.1039/b304139p; Stone D, 2012, CHEM SOC REV, V41, P6348, DOI 10.1039/c2cs35140d; Rothman LS, 2013, J QUANT SPECTROSC RA, V130, P4, DOI 10.1016/j.jqsrt.2013.07.002; Ibrahim N, 2007, J MOL SPECTROSC, V242, P64, DOI 10.1016/j.jms.2007.02.007; BOUANICH JP, 1992, J QUANT SPECTROSC RA, V47, P243, DOI 10.1016/0022-4073(92)90142-Q; Bell CL, 2012, J PHYS CHEM A, V116, P5090, DOI 10.1021/jp301038r; CHARO A, 1982, J MOL SPECTROSC, V94, P426, DOI 10.1016/0022-2852(82)90018-2; HOLLOWAY AM, 2010, ATM CHEM, P1; Jacquemart D, 2010, J QUANT SPECTROSC RA, V111, P1209, DOI 10.1016/j.jqsrt.2010.02.004; LUBIC KG, 1984, J CHEM PHYS, V81, P4826, DOI 10.1063/1.447508; Miyano S, 2011, J MOL SPECTROSC, V265, P47, DOI 10.1016/j.jms.2010.10.010; Mizoguchi A, 2012, J QUANT SPECTROSC RA, V113, P279, DOI 10.1016/j.jqsrt.2011.11.009; NELSON DD, 1994, J MOL SPECTROSC, V166, P273, DOI 10.1006/jmsp.1994.1193; Sakamoto Y, 2012, J PHYS CHEM A, V116, P215, DOI 10.1021/jp207477n; WINNEWISSER G, 1979, J MOL SPECTROSC, V74, P327, DOI 10.1016/0022-2852(79)90062-6; Yamada M., 2004, THESIS IBARAKI U	18	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4073	1879-1352		J QUANT SPECTROSC RA	J. Quant. Spectrosc. Radiat. Transf.	NOV	2014	148						65	69		10.1016/j.jqsrt.2014.06.020		5	Optics; Spectroscopy	Optics; Spectroscopy	AP7JR	WOS:000342254100010		
J	Iizuka, H; Fan, SH				Iizuka, Hideo; Fan, Shanhui			Consideration of enhancement of thermal rectification using metamaterial models	JOURNAL OF QUANTITATIVE SPECTROSCOPY & RADIATIVE TRANSFER			English	Article						Heat transfer; Near-field; Metamaterials; Radiative; Thermal rectification	RADIATIVE HEAT-TRANSFER; ENERGY-TRANSFER; NANOSCALE; SILICON; NANOSTRUCTURES	We present a systematic study to highlight some of the fundamental physics that governs metamaterial based electromagnetic thermal rectifiers. In such thermal rectifiers, the rectification arises from the alignment or misalignment of surface resonances in the forward or reverse scenarios, whereas the bulk states of metamaterials do not contribute to rectification. Therefore, we show that one can understand the behavior of such rectifiers by examining the relative excitation strength of the surface and bulk resonances. We verify such an understanding by accounting for the dependence of the contrast ratio on various parameters that define the dielectric response of the metamaterials. (C) 2014 Elsevier Ltd. All rights reserved.	[Iizuka, Hideo] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan; [Fan, Shanhui] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA	Iizuka, H (reprint author), Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan.	hiizuka@mosk.tytlabs.co.jp; shanhui@stanford.edu	Fan, Shanhui/B-4659-2012				Abdallah PB, 2013, APPL PHYS LETT, V103; Otey C, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.245431; Kruger M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.210404; Petersen SJ, 2013, PHOTONIC NANOSTRUCT, V11, P167, DOI 10.1016/j.photonics.2013.03.002; Shen S, 2009, NANO LETT, V9, P2909, DOI 10.1021/nl901208v; Jones AC, 2012, NANO LETT, V12, P1475, DOI 10.1021/nl204201g; Worbes L, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.134302; Raman A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.183901; Guha B, 2012, NANO LETT, V12, P4546, DOI 10.1021/nl301708e; Pendry JB, 1996, PHYS REV LETT, V76, P4773, DOI 10.1103/PhysRevLett.76.4773; POLDER D, 1971, PHYS REV B, V4, P3303, DOI 10.1103/PhysRevB.4.3303; Otey CR, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.154301; Ottens RS, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.014301; Messina R, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.244302; Francoeur M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075436; Biehs SA, 2011, OPT EXPRESS, V19, pA1088, DOI 10.1364/OE.19.0A1088; Basu S, 2009, INT J ENERG RES, V33, P1203, DOI 10.1002/er.1607; Huang JG, 2013, INT J HEAT MASS TRAN, V67, P575, DOI 10.1016/j.ijheatmasstransfer.2013.08.057; Challener WA, 2009, NAT PHOTONICS, V3, P220, DOI 10.1038/NPHOTON.2009.26; Wang L, 2006, NANO LETT, V6, P361, DOI 10.1021/nl052371p; Kittel A, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3025140; Pendry JB, 1999, J PHYS-CONDENS MAT, V11, P6621, DOI 10.1088/0953-8984/11/35/301; Biehs SA, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.104301; Francoeur M, 2011, OPT EXPRESS, V19, P18774, DOI 10.1364/OE.19.018774; Rousseau E, 2009, NAT PHOTONICS, V3, P514, DOI 10.1038/NPHOTON.2009.144; Fu CJ, 2006, INT J HEAT MASS TRAN, V49, P1703, DOI 10.1016/j.ijheatmasstransfer.2005.09.037; Francoeur M, 2011, IEEE T ENERGY CONVER, V26, P686, DOI 10.1109/TEC.2011.2118212; Basu S., 2011, APPL PHYS LETT, V98; Basu S., 2011, APPL PHYS LETT, V99; Biehs SA, 2013, J OPT SOC AM B, V30, P700, DOI 10.1364/JOSAB.30.000700; Biehs SA, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.245414; Calhill DG, 2014, APPL PHYS REV, V1; Cui L. J., 2013, APPL PHYS LETT, V102; Haus H A, 1984, WAVES FIELDS OPTOELE; Hu L., 2008, APPL PHYS LETT, V92; Iizuka H, 2012, J APPL PHYS, V112; Joulain K., 2010, PHYS REV B, V81; Khurgin JB, 2011, APPL PHYS LETT, V99; Kralik T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.224302; Otey CR, 2014, J QUANT SPECTROSC RA, V132, P3, DOI 10.1016/j.jqsrt.2013.04.017; Rodriguez AW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.114302; Solymar L., 2009, WAVES METAMATERIALS; Wang F, 2006, PHYS REV LETT, V97; Wang LP, 2013, NANOSC MICROSC THERM, V17, P337, DOI 10.1080/15567265.2013.776154; Wilde Y. D., 2006, NATURE, V444, P740; Yang Y, 2013, APPL PHYS LETT, V103; Zhu LX, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.184301	47	5	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4073	1879-1352		J QUANT SPECTROSC RA	J. Quant. Spectrosc. Radiat. Transf.	NOV	2014	148						156	164		10.1016/j.jqsrt.2014.07.007		9	Optics; Spectroscopy	Optics; Spectroscopy	AP7JR	WOS:000342254100018		
J	Akimoto, T; Miyaguchi, T				Akimoto, Takuma; Miyaguchi, Tomoshige			Phase Diagram in Stored-Energy-Driven Levy Flight	JOURNAL OF STATISTICAL PHYSICS			English	Article						Anomalous diffusion; Distributional ergodicity; Stochastic model	RANDOM-WALKS; INTRACELLULAR-TRANSPORT; ANOMALOUS DIFFUSION; ENHANCED DIFFUSION; CHAOTIC SYSTEMS; TIME	Phase diagram based on the mean square displacement (MSD) and the distribution of diffusion coefficients of the time-averaged MSD for the stored-energy-driven L,vy flight (SEDLF) is presented. In the SEDLF, a random walker cannot move while storing energy, and it jumps by the stored energy. The SEDLF shows a whole spectrum of anomalous diffusions including subdiffusion and superdiffusion, depending on the coupling parameter between storing time (trapping time) and stored energy. This stochastic process can be investigated analytically with the aid of renewal theory. Here, we consider two different renewal processes, i.e., ordinary renewal process and equilibrium renewal process, when the mean trapping time does not diverge. We analytically show the phase diagram according to the coupling parameter and the power exponent in the trapping-time distribution. In particular, we find that distributional behavior of time-averaged MSD intrinsically appears in superdiffusive as well as normal diffusive regime even when the mean trapping time does not diverge.	[Akimoto, Takuma] Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan; [Miyaguchi, Tomoshige] Naruto Univ Educ, Dept Math Educ, Tokushima 7728502, Japan	Akimoto, T (reprint author), Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan.	akimoto@z8.keio.jp; tmiyaguchi@naruto-u.ac.jp	Akimoto, Takuma/A-7610-2012		 [26800204]	This work was partially supported by Grant-in-Aid for Young Scientists (B) (Grant no. 26800204).	Aaronson J., 1997, INTRO INFINITE ERGOD; Akimoto T, 2007, J KOREAN PHYS SOC, V50, P254; Akimoto T., ARXIV13104055; Akimoto T., 2011, CHAOS, V20; Akimoto T, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.030102; Miyaguchi T, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.031926; Froemberg D, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40436-1; BOUCHAUD JP, 1990, PHYS REP, V195, P127, DOI 10.1016/0370-1573(90)90099-N; ZUMOFEN G, 1993, PHYSICA D, V69, P436, DOI 10.1016/0167-2789(93)90105-A; Golding I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.098102; Barkai E, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.104101; Miyaguchi T, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.062101; Tabei SMA, 2013, P NATL ACAD SCI USA, V110, P4911, DOI 10.1073/pnas.1221962110; Miyaguchi T, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.032130; Weigel AV, 2011, P NATL ACAD SCI USA, V108, P6438, DOI 10.1073/pnas.1016325108; Magdziarz M, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051138; Lubelski A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.250602; Meerschaert MM, 2006, PHYSICA A, V370, P114, DOI 10.1016/j.physa.2006.04.034; Akimoto T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.164101; SHLESINGER MF, 1987, PHYS REV LETT, V58, P1100, DOI 10.1103/PhysRevLett.58.1100; Akimoto T, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062134; Caspi A, 2000, PHYS REV LETT, V85, P5655, DOI 10.1103/PhysRevLett.85.5655; Corral A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.178501; Magdziarz M, 2012, J STAT PHYS, V147, P74, DOI 10.1007/s10955-012-0465-2; Brokmann X, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.120601; Stefani FD, 2009, PHYS TODAY, V62, P34, DOI 10.1063/1.3086100; Meroz Y, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.090601; Akimoto T, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.178103; KLAFTER J, 1987, PHYS REV A, V35, P3081, DOI 10.1103/PhysRevA.35.3081; He Y, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.058101; Liu J, 2013, PHYSICA A, V392, P612, DOI 10.1016/j.physa.2012.10.019; Tejedor V, 2010, BIOPHYS J, V98, P1364, DOI 10.1016/j.bpj.2009.12.4282; Barkai E, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021036; Weber SC, 2012, P NATL ACAD SCI USA, V109, P7338, DOI 10.1073/pnas.1119505109; Cox D. R., 1962, RENEWAL THEORY; Froemberg D, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.030104; Godec A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.020603; Graneli A, 2006, P NATL ACAD SCI USA, V103, P1221, DOI 10.1073/pnas.0508366103; Jeon JH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.048103; Kepten E, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.041919; Lippiello E, 2013, EPL-EUROPHYS LETT, V102, DOI 10.1209/0295-5075/102/59002; Magdziarz M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.180602; Schulz JHP, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.020602; SHLESINGER MF, 1982, J STAT PHYS, V27, P499, DOI 10.1007/BF01011089; Uneyama T., 2012, J CHEM PHYS, V137, P114	45	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-4715	1572-9613		J STAT PHYS	J. Stat. Phys.	NOV	2014	157	3					515	530		10.1007/s10955-014-1084-x		16	Physics, Mathematical	Physics	AP6YJ	WOS:000342224200007		
J	Xiao, F; Noro, T; Tokuda, T				Xiao, Feng; Noro, Tomoya; Tokuda, Takehiro			FINDING NEWS-TOPIC ORIENTED INFLUENTIAL TWITTER USERS BASED ON TOPIC RELATED HASHTAG COMMUNITY DETECTION	JOURNAL OF WEB ENGINEERING			English	Article						Social Network Analysis; Twitter; hashtag; PageRank; characteristic co-occurrence word		Recently, more and more users would like to collect and provide information about news topics in Twitter, which is one of the most popular microblogging services. Virtual communities defined by hashtags in Twitter are created for exchanging information about the news topic. Finding influential Twitter users in these communities related to a news topic would help us understand why some opinions are popular, and get valuable and reliable information for the news topic. In this paper, we propose a new approach to detect news-topic-related user communities defined by hashtags based on characteristic co-occurrence word detection. We also propose RetweetRank and MentionRank to find two types of influential Twitter users from these news-topic-related communities based on user's retweet and mention activities. Experimental results show that our characteristic co-occurrence word detection methods could detect words which are highly relevant to the news topic. RetweetRank could find influential Twitter users whose tweets about the news topic are valuable and more likely to interest others. MentionRank could find influential Twitter users who have high authority on the news topic. Our methods also outperform other related methods in evaluations.	[Xiao, Feng; Noro, Tomoya; Tokuda, Takehiro] Tokyo Inst Technol, Dept Comp Sci, Meguro Ku, Tokyo 1528552, Japan	Xiao, F (reprint author), Tokyo Inst Technol, Dept Comp Sci, Meguro Ku, Tokyo 1528552, Japan.	xiao@tt.cs.titech.ac.jp; noro@tt.cs.titech.ac.jp; tokuda@tt.cs.titech.ac.jp	Noro, Tomoya/B-9307-2015	Noro, Tomoya/0000-0002-5645-8497			Anger I., 2011, P 11 INT C KNOWL MAN, P31; Jarvelin K, 2002, ACM T INFORM SYST, V20, P422, DOI 10.1145/582415.582418; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Ye SZ, 2010, LECT NOTES COMPUT SC, V6430, P216; [Anonymous], 2010, P 7 C INT LANG RES E; SALTON G, 1975, COMMUN ACM, V18, P613, DOI 10.1145/361219.361220; Bigonha C., 2010, P BRAZ S MULT WEB BE, P107; Cano A. E., 2011, SEMANTIC WEB J, P1; Cha M., 2010, P 4 INT AAAI C WEBL; EFRON M, 2010, P 33 INT ACM SIGIR C, P787, DOI DOI 10.1145/1835449.1835616; Finkel Jenny Rose, 2005, P 43 ANN M ASS COMP, P363, DOI 10.3115/1219840.1219885; Hajian B., 2011, IEEE 3 INT C SOC COM, P497; Huang J., 2010, P 21 ACM C HYP HYP, P173, DOI DOI 10.1145/1810617.181064; Jones K. S., 1972, Journal of Documentation, V28, DOI 10.1108/eb026526; Kwak H., 2010, P 19 INT C WORLD WID, V112, P591, DOI DOI 10.1145/1772690.1772751; KYWE SM, 2012, P 4 INT C SOC INF, V7710, P337; Leavitt A, 2009, INFLUENTIALS NEW APP; Lehmann J., 2012, P 21 INT C WORLD WID, P251; Manning C.D., 1999, FDN STAT NATURAL LAN; Mazzia A., 2011, SUGGESTING HASHTAGS; Noro T., 2012, 22 EUR JAP C INF MOD, P31; ROMERO DM, 2011, ECML PKDD 11, V6913, P18; Schmid H., 1994, P INT C NEW METH LAN, V12, P44; Singhal A., 1996, P 19 ANN INT ACM SIG, P21, DOI DOI 10.1145/243199.243206; Tokuda T., 2011, 21 EUR JAP C INF MOD, V237, P187; Weng J., 2010, P 2010 IEEE INT C DA, P1121; Weng Jianshu, 2010, P 3 ACM INT C WEB SE, P261, DOI DOI 10.1145/1718487.1718520; Xiao F., 2012, P 12 INT C WEB ENG, P16; Yang L., 2012, P 21 INT C WORLD WID, P261, DOI DOI 10.1145/2187836.2187872; Zangerle E., 2011, P WORKSH SEM AD SOC, P67	31	0	0	RINTON PRESS, INC	PARAMUS	565 EDMUND TERRACE, PARAMUS, NJ 07652 USA	1540-9589	1544-5976		J WEB ENG	J. Web Eng.	NOV	2014	13	5-6					405	429				25	Computer Science, Software Engineering; Computer Science, Theory & Methods	Computer Science	AP5JZ	WOS:000342116800003		
J	Hatae, N; Satoh, R; Chiba, H; Osaki, T; Nishiyama, T; Ishikura, M; Abe, T; Hibino, S; Choshi, T; Okada, C; Toyota, E				Hatae, Noriyuki; Satoh, Risa; Chiba, Hitomi; Osaki, Takahiro; Nishiyama, Takashi; Ishikura, Minoru; Abe, Takumi; Hibino, Satoshi; Choshi, Tominari; Okada, Chiaki; Toyota, Eiko			N-Substituted calothrixin B derivatives inhibited the proliferation of HL-60 promyelocytic leukemia cells	MEDICINAL CHEMISTRY RESEARCH			English	Article						Calothrix cyanobacteria; Calothrixin B; Antiproliferative activity; N-OMe calothrixin B; HL-60 cells	BIOMIMETIC SYNTHESIS; CYANOBACTERIA; METABOLITES; QUINONES	Calothrixin B, whose structure consists of a pentacyclic indolo[3,2-j] phenanthridine framework, was originally isolated as a secondary metabolite from Calothrix cyanobacteria and was found to exhibit potent antiproliferative activity. In this study, treatment with 100 mu M of calothrixin B did not inhibit the proliferation of HL-60 promyelocytic leukemia cells, the result indicated that calothrixin B could possess weaker activity against leukemia cells. In a previous study of the structure-antiproliferative activity relationships of calothrixin B analogs, the tetracyclic 5H-pyrido[4,3-b] carbazole-4,11(6H)-dione structure, which does not include the benzene ring found in calothrixin B, was reported to be necessary for antiproliferative activity; however, the induction of substituents on the indole nitrogen atom of calothrixin B decreased the antiproliferative activity of the compound. To develop calothrixin B analogs with good antiproliferative activity against both HL-60 and HCT-116 cells, we synthesized various N-substituted calothrixin B analogs and assessed their activity. Compared with calothrixin B, N-OMe calothrixin B displayed almost the same or slightly stronger antiproliferative activity against HCT-116 cells, whereas the N-MOM analog demonstrated slightly weaker activity against these cells. These two analogs also inhibited proliferation of HL-60 cells, whereas calothrixin B did not exhibit antiproliferative activity toward these cells. Among calothrixin B analogs, N-OMe and N-MOM calothrixins B are cytotoxic against HCT-116 cells and not the lack of the effect on HL-60 cells.	[Hatae, Noriyuki; Satoh, Risa; Chiba, Hitomi; Osaki, Takahiro; Ishikura, Minoru; Abe, Takumi; Okada, Chiaki; Toyota, Eiko] Hokkaido Univ, Sch Pharmaceut Sci, Ishikari, Hokkaido 0610293, Japan; [Nishiyama, Takashi; Hibino, Satoshi; Choshi, Tominari] Fukuyama Univ, Grad Sch Pharm & Pharmaceut Sci, Fukuyama, Hiroshima 7290292, Japan; [Nishiyama, Takashi; Hibino, Satoshi; Choshi, Tominari] Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Fukuyama, Hiroshima 7290292, Japan	Hatae, N (reprint author), Hokkaido Univ, Sch Pharmaceut Sci, Ishikari, Hokkaido 0610293, Japan.	nhatae@hoku-iryo-u.ac.jp; toyota@hoku-iryo-u.ac.jp			Japan Society for the Promotion of Science [14572026, 22590010, 23590143]; Suzuken Memorial Foundation	This study was supported in part by a Grants-in Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 14572026 for S. H., No. 22590010 for M. I., and No. 23590143 for N. H.) and the Suzuken Memorial Foundation.	Abe T, 2012, EUR J ORG CHEM, P5018, DOI 10.1002/ejoc.201200657; Tohyama S, 2010, HETEROCYCLES, V82, P397, DOI 10.3987/COM-10-S(E)11; Bernardo PH, 2004, J MED CHEM, V47, P4958, DOI 10.1021/jm049625o; ISHIYAMA M, 1993, CHEM PHARM BULL, V41, P1118; Choshi T, 2009, HETEROCYCLES, V77, P85, DOI 10.3987/REV-08-SR(F)2; Abe T, 2011, ORG LETT, V13, P3356, DOI 10.1021/ol201107a; McErlean CSP, 2007, TETRAHEDRON, V63, P10963, DOI 10.1016/j.tet.2007.08.057; Singh RK, 2011, J ANTIBIOT, V64, P401, DOI 10.1038/ja.2011.21; Paz MM, 2001, J MED CHEM, V44, P2834, DOI 10.1021/jm010072g; Yamabuki A, 2006, TETRAHEDRON LETT, V47, P5859, DOI 10.1016/j.tetlet.2006.06.077; Kelly TR, 2000, ORG LETT, V2, P3735, DOI 10.1021/ol006649q; Bernardo PH, 2007, BIOORG MED CHEM LETT, V17, P82, DOI 10.1016/j.bmcl.2006.09.090; Singh S, 2005, CRIT REV BIOTECHNOL, V25, P73, DOI 10.1080/07388550500248498; Sperry J, 2007, TETRAHEDRON LETT, V48, P231, DOI 10.1016/j.tetlet.2006.11.053; Rickards RW, 1999, TETRAHEDRON, V55, P13513, DOI 10.1016/S0040-4020(99)00833-9; Matsumoto K, 2012, BIOORG MED CHEM LETT, V22, P4762, DOI 10.1016/j.bmcl.2012.05.064; Gademann K, 2008, CURR ORG CHEM, V12, P326, DOI 10.2174/138527208783743750; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Russo P, 2012, CURR DRUG TARGETS, V13, P1048	19	3	3	SPRINGER BIRKHAUSER	NEW YORK	233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA	1054-2523	1554-8120		MED CHEM RES	Med. Chem. Res.	NOV	2014	23	11					4956	4961		10.1007/s00044-014-1061-6		6	Chemistry, Medicinal	Pharmacology & Pharmacy	AP4HX	WOS:000342038900028		
J	Fan, XL; Xu, R; Wang, TJ				Fan, Xueling; Xu, Rong; Wang, T. J.			Interfacial delamination of double-ceramic-layer thermal bather coating system	CERAMICS INTERNATIONAL			English	Article						Films; Failure analysis; Fracture; Substrates	CRACK CLOSURE TECHNIQUE; FILM-SUBSTRATE SYSTEMS; ENERGY RELEASE RATE; BARRIER COATINGS; SURFACE CRACKING; DESIGN; TOP; PERFORMANCE; BEHAVIOR; FRACTURE	Thermal barrier coating system (TBCs) must withstand the most demanding high temperature conditions where state-of-the-art top coat material Y2O3-stabilized ZrO2 may undergo significant sintering and phase change. The concept of double-ceramic-layer (DCL) TBCs seems to be an effective way to meet the need for both thermal stability and transformation toughening. In this paper, a virtual crack closure technique based interface element method is introduced to study the mechanics associated with the interfacial delamination of DCL TBCs. The evolution of energy release rate of interfacial delamination is explored for DCL TBCs with various geometrical and material parameters. Analysis of fracture mechanisms of delamination reveals that considering the integrated thermal and mechanical functionalities of coatings an optimal thickness ratio of outer to inner ceramic layers exists, which can be preliminarily evaluated by running numerical calculations of fracture parameters and performing thermal life experiments over a wide range of thickness ratios of outer to inner coating layers. In addition, the influence of separation centered at the interface of two ceramic layers is also examined. It is demonstrated that the local separation between two ceramic layers makes delamination readily to form and propagate at the interface between the inner coating and the underlying layer. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.	[Fan, Xueling; Xu, Rong; Wang, T. J.] Xi An Jiao Tong Univ, Sch Aerosp Engn, State Key Lab Strength & Vibrat Mech Struct, Xian 710049, Peoples R China; [Fan, Xueling] Tokyo Univ Sci, Fac Sci & Technol, Dept Mech Engn, Chiba 2788510, Japan	Wang, TJ (reprint author), Xi An Jiao Tong Univ, Sch Aerosp Engn, State Key Lab Strength & Vibrat Mech Struct, Xian 710049, Peoples R China.	wangtj@mail.xjtu.edj.cn	Fan, Xueling/B-2861-2015		State 973 Program of China [2013CB035700]; NSFC [11272259, 11321062, 11002104]; Tokyo University of Science, Japan	This work is supported by the State 973 Program of China (2013CB035700), NSFC (11272259, 11321062 and 11002104) and the Research Fund of Tokyo University of Science, Japan.	Agrawal A, 2006, INT J FRACTURE, V141, P75, DOI 10.1007/s10704-006-0069-4; Padture NP, 2002, SCIENCE, V296, P280, DOI 10.1126/science.1068609; Cao XQ, 2006, J EUR CERAM SOC, V26, P247, DOI 10.1016/j.jeurceramsoc.2004.11.007; Xu R, 2013, MATER DESIGN, V47, P566, DOI 10.1016/j.matdes.2012.12.053; Clarke DR, 2012, MRS BULL, V37, P891, DOI 10.1557/mrs.2012.232; RYBICKI EF, 1977, ENG FRACT MECH, V9, P931, DOI 10.1016/0013-7944(77)90013-3; Evans AG, 2007, SURF COAT TECH, V201, P7905, DOI 10.1016/j.surfcoat.2007.03.029; RAJU IS, 1988, ENG FRACT MECH, V30, P383, DOI 10.1016/0013-7944(88)90196-8; Han M, 2014, SURF COAT TECH, V240, P320, DOI 10.1016/j.surfcoat.2013.12.047; BRANDON JR, 1991, SURF COAT TECH, V46, P75, DOI 10.1016/0257-8972(91)90151-L; SUN CT, 1987, ENG FRACT MECH, V28, P13, DOI 10.1016/0013-7944(87)90115-9; Wright PK, 1999, CURR OPIN SOLID ST M, V4, P255, DOI 10.1016/S1359-0286(99)00024-8; Fan XL, 2012, APPL SURF SCI, V258, P9816, DOI 10.1016/j.apsusc.2012.06.036; Clarke DR, 2003, ANNU REV MATER RES, V33, P383, DOI 10.1146/annurev.matsci.33.011403.113718; Vassen R, 2004, INT J APPL CERAM TEC, V1, P351; Mei HX, 2007, INT J FRACTURE, V148, P331, DOI 10.1007/s10704-008-9205-7; HUTCHINSON JW, 1992, ADV APPL MECH, V29, P63; Zhang WX, 2011, APPL SURF SCI, V258, P811, DOI 10.1016/j.apsusc.2011.08.103; Vassen R, 2000, J AM CERAM SOC, V83, P2023; Nicholls J, 2003, MRS BULL, V28, P659, DOI 10.1557/mrs2003.194; Han M, 2014, CERAM INT, V40, P2901, DOI 10.1016/j.ceramint.2013.10.021; Tolpygo VK, 2004, SURF COAT TECH, V188, P62, DOI 10.1016/j.surfcoat.2004.08.001; Xie D, 2006, FINITE ELEM ANAL DES, V42, P977, DOI 10.1016/j.finel.2006.03.007; YE T, 1992, INT J SOLIDS STRUCT, V29, P2639, DOI 10.1016/0020-7683(92)90227-K; BEUTH JL, 1992, INT J SOLIDS STRUCT, V29, P1657, DOI 10.1016/0020-7683(92)90015-L; Brown MA, 2007, INT J SOLIDS STRUCT, V44, P1755, DOI 10.1016/j.ijsolstr.2006.10.015; Chen HF, 2010, J AM CERAM SOC, V93, P1732, DOI 10.1111/j.1551-2916.2010.03610.x; Cheng ZB, 2013, ADV DIFFER EQU-NY, P1, DOI 10.1186/1687-1847-2013-202; Dai H., 2007, MAT SCI ENG A-STRUCT, V433, P1; Fan XL, 2014, SURF COAT TECH, V244, P117, DOI 10.1016/j.surfcoat.2014.01.045; Fan XL, 2012, SURF COAT TECH, V208, P7, DOI 10.1016/j.surfcoat.2012.06.074; Fan XL, 2011, APPL SURF SCI, V257, P6718, DOI 10.1016/j.apsusc.2011.02.111; Feng X, 2008, J APPL MECH-T ASME, V75, DOI 10.1115/1.2755178; Feng X, 2008, INT J SOLIDS STRUCT, V45, P3688, DOI 10.1016/j.ijsolstr.2007.09.012; Heeg B, 2011, J AM CERAM SOC, V94, pS112, DOI 10.1111/j.1551-2916.2011.04496.x; Krueger R., 2013, P 54 AIAA ASME ASCE, P2013; Lu TQ, 2011, INT J ENG SCI, V49, P967, DOI 10.1016/j.ijengsci.2011.05.009; Mabson G., 2003, MIL HDB, V17; HE MY, 1989, INT J SOLIDS STRUCT, V25, P1053, DOI 10.1016/0020-7683(89)90021-8; Wang L, 2012, APPL SURF SCI, V258, P3540, DOI 10.1016/j.apsusc.2011.11.109; Zhou K, 2011, J MECH MATER STRUCT, V6, P627, DOI 10.2140/jomms.2011.6.627	41	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0272-8842	1873-3956		CERAM INT	Ceram. Int.	NOV	2014	40	9	A				13793	13802		10.1016/j.ceramint.2014.05.095		10	Materials Science, Ceramics	Materials Science	AO6LL	WOS:000341463500004		
J	Kim, IY; Koichi, K; Ohtsuki, C				Kim, Ill Yong; Koichi, Kikuta; Ohtsuki, Chikara			Hydroxyapatite formation through dissolution-precipitation reaction: Effects of solubility of starting materials	CERAMICS INTERNATIONAL			English	Article						Apatite; Microstructure-final; Hydrothermal processing	HYDROTHERMAL SYNTHESIS; MORPHOLOGY; PHOSPHATE; CALCITE; WATER	Hydrothermal processing has been the subject of much attention for hydroxyapatite (HAp) formation because the formed HAp has various morphology. We investigated the effects of solubility of starting materials on the HAp formation and its morphology under a hydrothermal condition. Single crystals of calcite, fluorite and calcium tartrate tetrahydrate with different solubilities were used as starting materials. After hydrothermal processing for 24 h, HAp formed on the surfaces of all the starting materials. Needle-like HAp formed on the surface of calcite and plate-like HAp formed on the fluorite. In the case of the calcium tartrate tetrahydrate, aggregation of nano-sized HAp was observed on its surface. The difference in the solubility of the starting materials might affect the morphology of HAp formed on their surfaces under hydrothermal conditions. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.	[Kim, Ill Yong; Koichi, Kikuta; Ohtsuki, Chikara] Nagoya Univ, Dept Crystalline Mat Sci, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Kim, IY (reprint author), Nagoya Univ, Dept Crystalline Mat Sci, Grad Sch Engn, Chikusa Ku, B2-3 611 Furo Cho, Nagoya, Aichi 4648603, Japan.	kim.ill-yong@apchem.nagoya-u.ac.jp	Ohtsuki, Chikara/E-4973-2010		Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [2206]	This work was supported by Grant-in-Aid for Scientific Research on the Innovative Areas: "Fusion Materials: Creative Development of Materials and Exploration of their Function through Molecular Control" (No. 2206) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT).	Sivakumar M, 1996, BIOMATERIALS, V17, P1709, DOI 10.1016/0142-9612(96)87651-4; Liu JB, 2003, CERAM INT, V29, P629, DOI 10.1016/S0272-8842(02)00210-9; Sanosh KP, 2009, MATER LETT, V63, P2100, DOI 10.1016/j.matlet.2009.06.062; Ioku K, 2006, J MATER SCI, V41, P1341, DOI 10.1007/s10853-006-7338-5; Goto T, 2012, J CERAM SOC JPN, V120, P131, DOI 10.2109/jcersj2.120.131; Goto T, 2012, CERAM INT, V38, P1003, DOI 10.1016/j.ceramint.2011.08.023; Zhang HB, 2009, J PHYS CHEM SOLIDS, V70, P243, DOI 10.1016/j.jpcs.2008.10.011; Ishikawa K, 2010, J CERAM SOC JPN, V118, P341, DOI 10.2109/jcersj2.118.341; Watanabe T, 2009, J CERAM SOC JPN, V117, P759, DOI 10.2109/jcersj2.117.759; Neira IS, 2009, CRYST GROWTH DES, V9, P466, DOI 10.1021/cg800738a; SEGNIT ER, 1962, GEOCHIM COSMOCHIM AC, V26, P1301, DOI 10.1016/0016-7037(62)90057-1; YOSHIMURA M, 1994, J MATER SCI, V29, P3399, DOI 10.1007/BF00352039; Zhang CM, 2009, CRYST GROWTH DES, V9, P2725, DOI 10.1021/cg801353n; Jinawath S, 2002, J MATER SCI-MATER M, V13, P491, DOI 10.1023/A:1014774923619; BERNARDI G, 1965, NATURE, V206, P779, DOI 10.1038/206779a0; Kim I.Y., 2012, KOREAN J MAT RES, V22, P397; Park J.B., 1998, BIOCERAMICS PROPERTI; Pujiyanto E., 2014, ADV MAT RES, V898, P56; Ramirez-Rodriguez GB, 2013, CRYSTENGCOMM, V15, P2206, DOI 10.1039/c2ce26556g	19	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0272-8842	1873-3956		CERAM INT	Ceram. Int.	NOV	2014	40	9	A				14385	14390		10.1016/j.ceramint.2014.06.031		6	Materials Science, Ceramics	Materials Science	AO6LL	WOS:000341463500079		
J	Yin, DQ; Yang, Y; Peng, XH; Qin, Y; Wang, ZC				Yin, Deqiang; Yang, Yi; Peng, Xianghe; Qin, Yi; Wang, Zhongchang			Tensile and fracture process of the TiN/VN interface from first principles	CERAMICS INTERNATIONAL			English	Article						Fracture; First-principles calculations; Tensile; TiN/VN interfaces	MULTILAYER HARD COATINGS; MECHANICAL-PROPERTIES; 1ST-PRINCIPLES; ADHESION; CONSTANTS; NITRIDES; TIN/CRN; AL/TIN; ENERGY; FILMS	We have conducted a comprehensive first-principles investigation of tensile and fracture process of the TiN/VN interface by focusing on the strain stress relationships, the ideal tensile strength and bonding breaking process. The deformation analysis reveals that all bonds are extended at the initial stage until the critical point of fracture is reached. The fracture occurs between the second and third layers on the VN side in both (111) and (001) interfaces and the interaction of potential bonds of facture weakens gradually with the increment of strain during the tensile process. By using several analytical techniques, we identify a charge transfer in both the TiN and VN layers near to interface at the points of fracture during the tensile process, which plays a crucial role in affecting the fracture process. We further demonstrate that the fracture of the TiN/VN interface occurs within the VN and that adhesion energy cannot be simply used to represent tensile strength. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.	[Yin, Deqiang; Yang, Yi] Sichuan Univ, Sch Mfg Sci & Engn, Chengdu 610064, Peoples R China; [Peng, Xianghe; Wang, Zhongchang] Chongqing Univ, Coll Aerosp Engn, Dept Engn Mech, Chongqing 400044, Peoples R China; [Qin, Yi] Univ Strathclyde, Dept Design Manufacture & Engn Management, Glasgow G1 1XQ, Lanark, Scotland; [Wang, Zhongchang] Tohoku Univ, Adv Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan	Wang, ZC (reprint author), Tohoku Univ, Adv Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	zcwang@wpi-aimr.tohoku.ac.jp			National Science Foundation of China (NSFC) [11302141]; Specialized Research Fund for Doctoral Program of Higher Education [20130181120118]; NSFC [11332013]; European Commission [EU FP7 M3-2S]; JSPS [25106005]; JGC-S Foundation; Kurata Memorial Hitachi Science and Technology Foundation;  [24686069]	This study is supported in part by National Science Foundation of China (NSFC) under Grant no. 11302141 and Specialized Research Fund for Doctoral Program of Higher Education (New teachers) under Grant no. 20130181120118. X.P. appreciates the financial supports from NSFC (Grant no. 11332013). D.Y. and Y.Q. acknowledge European Commission for financial funding of research through the EU FP7 M3-2S project and the permission for using the CASTEP code as a registered academic license of CASTEP under the STFC/York/Accelrys agreement (UK). Z.W. thanks the financial supports from the Grant-in-Aid for Young Scientists (A) (Grant no. 24686069), the JSPS Grant-in-Aid for Scientific Research on Innovative Areas "Nano Informatics" (Grant no. 25106005), the JGC-S Foundation, and the Kurata Memorial Hitachi Science and Technology Foundation.	Yashar PC, 1999, VACUUM, V55, P179, DOI 10.1016/S0042-207X(99)00148-7; PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244; Abadias G, 2006, SURF COAT TECH, V200, P6538, DOI 10.1016/j.surfcoat.2005.11.053; PRICE DL, 1992, PHYS REV B, V46, P11368, DOI 10.1103/PhysRevB.46.11368; PULAY P, 1969, MOL PHYS, V17, P197, DOI 10.1080/00268976900100941; Chen KY, 2003, J PHYS D APPL PHYS, V36, P2725, DOI 10.1088/0022-3727/36/21/021; Yin DQ, 2012, PHYSICA E, V44, P1838, DOI 10.1016/j.physe.2012.05.008; Zhao LR, 2005, SURF COAT TECH, V200, P1595, DOI 10.1016/j.surfcoat.2005.08.097; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; PAYNE MC, 1992, REV MOD PHYS, V64, P1045, DOI 10.1103/RevModPhys.64.1045; Zhang HZ, 2007, COMP MATER SCI, V38, P800, DOI 10.1016/j.commatsci.2006.05.017; KIM JO, 1992, J APPL PHYS, V72, P1805, DOI 10.1063/1.351651; Liu LM, 2003, J PHYS-CONDENS MAT, V15, P8103, DOI 10.1088/0953-8984/15/47/013; Zhou Z, 2007, METALL MATER TRANS A, V38A, P2464, DOI 10.1007/s11661-007-9293-4; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Kim SH, 2004, SURF COAT TECH, V187, P47, DOI 10.1016/j.surfcoat.2004.01.011; Latella BA, 2006, SURF COAT TECH, V200, P3605, DOI 10.1016/j.surfcoat.2004.09.008; Stampfl C, 2012, APPL SURF SCI, V258, P5638, DOI 10.1016/j.apsusc.2012.02.046; Luo QS, 2011, J MATER CHEM, V21, P9746, DOI 10.1039/c1jm10707k; Caicedo JC, 2010, MATER SCI ENG B-ADV, V171, P56, DOI 10.1016/j.mseb.2010.03.069; Chen KY, 2008, SURF COAT TECH, V203, P598, DOI 10.1016/j.surfcoat.2008.05.040; Chu X, 1999, J MATER RES, V14, P2500, DOI 10.1557/JMR.1999.0335; Kohyama M., 2002, PHYS REV B, V65; Li W., 1998, PHYS REV B, V59, P3993; Liao T, 2009, J MATER RES, V24, P556, DOI 10.1557/JMR.2009.0066; Liu LM, 2005, J PHYS-CONDENS MAT, V17, P5335, DOI 10.1088/0953-8984/17/35/002; Lu GH, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.224115; Ogata S., 2004, PHYS REV B, V70; Qi Y, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.201403; Roldan MA, 2012, CERAM INT, V38, P687, DOI 10.1016/j.ceramint.2011.07.057; Roudy D., 1999, PHYS REV LETT, V82, P2713; Rzepiejewska-Malyska K, 2009, MICRON, V40, P22, DOI 10.1016/j.micron.2008.02.013; Subramanian B, 2012, J MATER SCI-MATER M, V23, P329, DOI 10.1007/s10856-011-4500-7; Yin DQ, 2010, J APPL PHYS, V108, DOI 10.1063/1.3466958; Zhang HZ, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/22/226003; Zhang RF, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2759265; Zhang RF, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3105990; Zhang SH, 2010, CURR APPL PHYS, V10, P842, DOI 10.1016/j.cap.2009.10.005; Zhang Y, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.174101	39	7	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0272-8842	1873-3956		CERAM INT	Ceram. Int.	NOV	2014	40	9	A				14453	14462		10.1016/j.ceramint.2014.07.016		10	Materials Science, Ceramics	Materials Science	AO6LL	WOS:000341463500088		
J	Kumar, G; Shah, J; Kotnala, RK; Dhiman, P; Rani, R; Singh, VP; Garg, G; Shirsath, SE; Batoo, KM; Singh, M				Kumar, Gagan; Shah, Jyoti; Kotnala, R. K.; Dhiman, Pooja; Rani, Ritu; Singh, Virender Pratap; Garg, Godawari; Shirsath, Sagar E.; Batoo, Khalid M.; Singh, M.			Self-ignited synthesis of Mg-Gd-Mn nanoferrites and impact of cation distribution on the dielectric properties	CERAMICS INTERNATIONAL			English	Article						Dielectric properties; Electrical properties; Cation distribution; Nanostructures; X-ray diffraction	SOLUTION COMBUSTION TECHNIQUE; MAGNETIC-PROPERTIES; AC CONDUCTIVITY; COBALT FERRITE; X-RAY; NANOPARTICLES; TEMPERATURE; SPINELS; IONS; SUBSTITUTION	Mg0.9Mn0.1GdxFe2-xO4 nanoferrites were processed for the first time by a solution combustion technique. X-ray diffraction studies revealed the spinel cubic structure of the synthesized ferrites. The particle size was observed to increase (13-16 nm) with an increase in Gd3+ ion content The cation distribution is inferred from the X-ray diffraction. It is observed from cation distribution that Gd3+ ions preferred octahedral (B) sites. The DC resistivity was found to be increasing with an increase in Gd3+ content The dielectric constant epsilon' and loss tangent (tan delta) was observed to decrease with the addition of Gd3+ content as well as with the increase in frequency. The variations in DC resistivity as well as dielectric constant with the increasing substitution of Gd3+ ions have been correlated to the cation distribution. The very high values of DC resistivity (similar to 10(8) Omega cm) and low values of loss tangent (0.9-0.008) are the prime achievements of this work. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.	[Kumar, Gagan; Dhiman, Pooja; Rani, Ritu; Singh, Virender Pratap; Singh, M.] Himachal Pradesh Univ, Dept Phys, Shimla 171005, Himachal Prades, India; [Shah, Jyoti; Kotnala, R. K.] Natl Phys Lab CSIR, New Delhi, India; [Garg, Godawari] Himachal Pradesh Univ, Dept Chem, Shimla 171005, Himachal Prades, India; [Shirsath, Sagar E.] Shinshu Univ, Fac Engn, Spin Device Technol Ctr, Nagano 380, Japan; [Batoo, Khalid M.] King Saud Univ, King Abdullah Inst Nanotechnol, Riyadh, Saudi Arabia	Kumar, G (reprint author), Himachal Pradesh Univ, Dept Phys, Shimla 171005, Himachal Prades, India.	bhargava_phy_hpu@yahoo.co.in					GOODENOUGH JB, 1955, PHYS REV, V98, P391, DOI 10.1103/PhysRev.98.391; Wahba AM, 2014, CERAM INT, V40, P6127, DOI 10.1016/j.ceramint.2013.11.064; Vegard L, 1921, Z PHYS, V5, P17, DOI 10.1007/BF01349680; Chand J, 2011, J ALLOY COMPD, V509, P9638, DOI 10.1016/j.jallcom.2011.07.055; Rana A, 2011, MATER LETT, V65, P3191, DOI 10.1016/j.matlet.2011.06.076; More SS, 2010, J ALLOY COMPD, V502, P477, DOI 10.1016/j.jallcom.2010.04.201; WEIL L, 1950, J PHYS-PARIS, V11, P208, DOI 10.1051/jphysrad:01950001105020800; Kumar G, 2013, CERAM INT, V39, P4813, DOI 10.1016/j.ceramint.2012.11.071; Kumar G, 2013, J MOL STRUCT, V1051, P336, DOI 10.1016/j.molstruc.2013.08.019; Jadhav SS, 2008, J OPTOELECTRON ADV M, V10, P2644; PORTA P, 1974, J SOLID STATE CHEM, V11, P135, DOI 10.1016/0022-4596(74)90108-X; Najmoddin N, 2014, CERAM INT, V40, P3619, DOI 10.1016/j.ceramint.2013.09.063; Shirsath SE, 2014, PHYS CHEM CHEM PHYS, V16, P2347, DOI 10.1039/c3cp54257b; Verwey EJW, 1936, RECL TRAV CHIM PAY-B, V55, P531; Singh N, 2012, J MAGN MAGN MATER, V324, P2506, DOI 10.1016/j.jmmm.2012.03.023; Hashim M, 2013, CERAM INT, V39, P1807, DOI 10.1016/j.ceramint.2012.08.028; Kahn ML, 2001, APPL PHYS LETT, V78, P3651, DOI 10.1063/1.1377621; BALTZER PK, 1966, PHYS REV, V151, P367, DOI 10.1103/PhysRev.151.367; Bertaut E.F., 1950, CR HEBD ACAD SCI, V230, P213; Cullity B.D., 1956, ELEMENTS XRAY DIFFRA, P474; Dar MA, 2010, J ALLOY COMPD, V493, P553, DOI 10.1016/j.jallcom.2009.12.154; FURUHASH.H, 1973, J INORG NUCL CHEM, V35, P3009, DOI 10.1016/0022-1902(73)80531-7; Hodgman Charles D., 1954, HDB CHEM PHYSICS, P3095; Kumar G, 2010, J PHYS CHEM SOLIDS, V71, P375, DOI 10.1016/j.jpcs.2010.01.003; Kumar Gagan, 2009, J PHYS D, V42; Kumar S, 2007, SOLID STATE COMMUN, V142, P706, DOI 10.1016/j.ssc.2007.04.019; Lakshman A, 2005, J PHYS D APPL PHYS, V38, P673, DOI 10.1088/0022-3727/38/5/002; Mane DR, 2011, J SOL-GEL SCI TECHN, V58, P70, DOI 10.1007/s10971-010-2357-8; Mansour SF, 2011, CERAM INT, V37, P1175, DOI 10.1016/j.ceramint.2010.11.038; Muroi M., 2001, PHYS REV B, V63; Pervaiz Erum, 2012, INT J CURR ENG TECHN, V2, P377; PURI RK, 1994, J MATER SCI, V29, P2182, DOI 10.1007/BF01154698; Rani R, 2014, APPL PHYS A-MATER, V115, P1401, DOI 10.1007/s00339-013-8051-2; Rani Ritu, 2013, AM J NANOMATER, V1, P9; Ravinder D, 2001, MATER LETT, V48, P210, DOI 10.1016/S0167-577X(00)00305-0; Sharma SK, 2006, NUCL INSTRUM METH B, V248, P37, DOI 10.1016/j.nimb.2006.03.188; Singh M, 2000, MOD PHYS LETT B, V14, P531, DOI 10.1142/S0217984900000677; Wei QM, 2001, MATER CHARACT, V47, P247, DOI 10.1016/S1044-5803(01)00177-2	38	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0272-8842	1873-3956		CERAM INT	Ceram. Int.	NOV	2014	40	9	A				14509	14516		10.1016/j.ceramint.2014.07.017		8	Materials Science, Ceramics	Materials Science	AO6LL	WOS:000341463500095		
J	Qian, K; Li, ST; Ji, SD; Li, WJ; Li, YM; Chen, RX; Jin, P				Qian, Kun; Li, Shaotang; Ji, Shidong; Li, Wenjing; Li, Yamei; Chen, Rongxiang; Jin, Ping			Fabrication Of VO2 nanorods/PVP composite fiber mats and their unique optical diffuse reflectance properties	CERAMICS INTERNATIONAL			English	Article						VO2 nanorods; Annealing; VO2 nanorods/PVP composite fibers; Diffuse reflectance	VANADIUM DIOXIDE; PHASE-TRANSITION; THIN-FILMS; STOICHIOMETRY; V2O5	Thermochromic (VO2) single phase nanorods were prepared by one-step hydrothermal process and the influence of the annealing process on their crystal structure and properties were studied. The results show that VO2 nanorods exhibit an increased lattice parameter, accompanied by improved optical properties after annealing. Functional fiber mats were fabricated by electrospinning with a suspension of VO2 nanorods dispersed in polyvinyl pyrrolidone (PVP), and their structure and optical properties were characterized by scanning electron microscopy (SEM), ultraviolet visible (UV-vis) spectrophotometry and Fourier transform infrared (FT-IR) spectroscopy. Results show that the fiber mats demonstrate a unique and tunable diffuse reflectance, the extent of which can be varied by changing the amount of VO2. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.	[Qian, Kun; Li, Shaotang; Ji, Shidong; Li, Wenjing; Li, Yamei; Chen, Rongxiang; Jin, Ping] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China; [Qian, Kun; Li, Shaotang; Li, Wenjing; Li, Yamei; Chen, Rongxiang] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China; [Jin, Ping] Natl Inst Adv Ind Sci & Technol, Moriyama Ku, Nagoya, Aichi 4638560, Japan	Jin, P (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.	p-jin@mail.sic.ac.cn			high-tech project of MOST [2012AA030305]; National Natural Science Foundation of China (NSFC) [51272273, 51172265, 51372264]; Science and Technology Commission of Shanghai Municipality (STCSM) [13PJ1409000, 13NM1402200]	This study was financially supported by the high-tech project of MOST (2012AA030305), the national sci-tech support plan the National Natural Science Foundation of China (NSFC, no.: 51272273, 51172265, 51372264), and the Science and Technology Commission of Shanghai Municipality (STCSM, no.: 13PJ1409000, 13NM1402200).	Zhang SX, 2011, NANO LETT, V11, P1443, DOI 10.1021/nl103925m; Pan AQ, 2013, ANGEW CHEM INT EDIT, V52, P2226, DOI 10.1002/anie.201209535; DENATALE JF, 1989, J APPL PHYS, V66, P5844, DOI 10.1063/1.343605; Ji SD, 2010, J CRYST GROWTH, V312, P282, DOI 10.1016/j.jcrysgro.2009.10.026; Ji SD, 2011, SOL ENERG MAT SOL C, V95, P3520, DOI 10.1016/j.solmat.2011.08.015; MORIN FJ, 1959, PHYS REV LETT, V3, P34, DOI 10.1103/PhysRevLett.3.34; Gao YF, 2012, ENERG ENVIRON SCI, V5, P6104, DOI 10.1039/c2ee02803d; Cao CX, 2008, J PHYS CHEM C, V112, P18810, DOI 10.1021/jp8073688; Zhang YF, 2013, CURR APPL PHYS, V13, P47, DOI 10.1016/j.cap.2012.06.013; Chen SH, 2004, SENSOR ACTUAT A-PHYS, V115, P28, DOI 10.1016/j.sna.2004.03.018; Guinneton F, 2004, THIN SOLID FILMS, V446, P287, DOI 10.1016/j.tsf.2003.09.062; BALBERG I, 1975, J APPL PHYS, V46, P2111, DOI 10.1063/1.321849; GRIFFITH.CH, 1974, J APPL PHYS, V45, P2201, DOI 10.1063/1.1663568; Li ST, 2014, ACS APPL MATER INTER, V6, P9, DOI 10.1021/am405006g; Li Y., 2013, SCI REP, V3, P1; Zhang YF, 2012, MATER LETT, V71, P127, DOI 10.1016/j.matlet.2011.12.061; Zhang YF, 2012, MATER RES BULL, V47, P1978, DOI 10.1016/j.materresbull.2012.04.015	17	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0272-8842	1873-3956		CERAM INT	Ceram. Int.	NOV	2014	40	9	A				14517	14521		10.1016/j.ceramint.2014.05.110		5	Materials Science, Ceramics	Materials Science	AO6LL	WOS:000341463500096		
